Citrus Sinensis ID: 006779
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 631 | 2.2.26 [Sep-21-2011] | |||||||
| Q944Q0 | 563 | Serine/threonine-protein | yes | no | 0.868 | 0.973 | 0.549 | 1e-176 | |
| Q6EU49 | 612 | Probable serine/threonine | yes | no | 0.936 | 0.965 | 0.518 | 1e-164 | |
| Q8S8Y8 | 567 | Probable serine/threonine | no | no | 0.657 | 0.731 | 0.624 | 1e-153 | |
| Q8LST2 | 557 | Probable serine/threonine | no | no | 0.656 | 0.743 | 0.628 | 1e-152 | |
| Q8RXE5 | 524 | Probable serine/threonine | no | no | 0.651 | 0.784 | 0.662 | 1e-151 | |
| Q0D598 | 704 | Probable serine/threonine | no | no | 0.690 | 0.619 | 0.555 | 1e-139 | |
| A2YMV6 | 704 | Probable serine/threonine | N/A | no | 0.690 | 0.619 | 0.555 | 1e-139 | |
| Q9CAV6 | 700 | Serine/threonine-protein | no | no | 0.667 | 0.601 | 0.533 | 1e-136 | |
| Q65X23 | 621 | Probable serine/threonine | no | no | 0.646 | 0.657 | 0.559 | 1e-135 | |
| Q8S8Y9 | 568 | Serine/threonine-protein | no | no | 0.738 | 0.820 | 0.494 | 1e-132 |
| >sp|Q944Q0|WNK8_ARATH Serine/threonine-protein kinase WNK8 OS=Arabidopsis thaliana GN=WNK8 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 619 bits (1597), Expect = e-176, Method: Compositional matrix adjust.
Identities = 353/642 (54%), Positives = 426/642 (66%), Gaps = 94/642 (14%)
Query: 1 MDCGSGFTK--SETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV 58
M GSGF S EE +F+EKDPS RY RYD++LG+GAFKTVYK FDEVDGIEVAWN V
Sbjct: 1 MASGSGFLGQISSMEEADFAEKDPSGRYIRYDDVLGRGAFKTVYKAFDEVDGIEVAWNLV 60
Query: 59 NIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY 118
+IEDVMQ P QLERLYSEVHLLK+LKHENIIK + SWVD+ N+TINMITELFTSGSLR Y
Sbjct: 61 SIEDVMQMPGQLERLYSEVHLLKALKHENIIKLFYSWVDEKNKTINMITELFTSGSLRVY 120
Query: 119 RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178
RKKH+ VD KAIKNWARQIL+GL+YLHS NPP+IHRDLKCDNIFVNGN GEVKIGDLGLA
Sbjct: 121 RKKHRKVDPKAIKNWARQILKGLNYLHSQNPPVIHRDLKCDNIFVNGNTGEVKIGDLGLA 180
Query: 179 IVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
V+QQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPYNEC+N AQIY
Sbjct: 181 TVLQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYNECRNQAQIY 240
Query: 239 KKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDP-- 296
KKVTS IKP SL KV DPQV+QFIEKC++PAS R ALEL KDPFL D KD
Sbjct: 241 KKVTSNIKPQSLGKVDDPQVRQFIEKCLLPASSRPTALELSKDPFLARDGGKDSALLASS 300
Query: 297 ------LRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTE 350
+R P L E PMD+D N K S + + W T+ELQR+ E
Sbjct: 301 STSSKYVRPPQL----------EHLPMDVDHNENK----SVSSNEDYPWSQTIELQRIAE 346
Query: 351 NNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHED 410
N EF LRGE++DD T S+ LRI D SG +HF FYL +DTA +IAEEMVE+L L+ ++
Sbjct: 347 NKEFRLRGERSDDVTASMVLRIADPSGKCRIVHFAFYLESDTATAIAEEMVEELHLTSQE 406
Query: 411 VVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFA 470
VV IA++ID+ IM+L+ T+S N P +
Sbjct: 407 VVVIADMIDDFIMQLLSD------RTSSHHNQ------------------NSPRLTHEDH 442
Query: 471 EAVSQQGVLS--ELASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVY 528
EA +QQ V S E A+G +S SDISA++ P + DG +A A
Sbjct: 443 EAANQQTVNSKDEEAAG------QSMKSDISADYYFPYSAN---------DGNAAMEAGR 487
Query: 529 DHGGHEVKADEVSLGESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDG 588
D ES+ +S++DSCS M S+I +LS++D ++ +
Sbjct: 488 D-------------AESM----------SSYLDSCSMM------STIYNLSISDNDYPED 518
Query: 589 LKLELDAINSKYQQCFQELLRQREDEMENARKRWLAGSNVSV 630
LK EL+ I S++ Q FQ+LL+ +ED +ENA+++W+ +V
Sbjct: 519 LKTELNLIESQFNQSFQDLLKLKEDAIENAKRKWITKKQKAV 560
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates the vacuolar ATPase subunit C (VATC). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6EU49|WNK4_ORYSJ Probable serine/threonine-protein kinase WNK4 OS=Oryza sativa subsp. japonica GN=WNK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 579 bits (1493), Expect = e-164, Method: Compositional matrix adjust.
Identities = 323/623 (51%), Positives = 418/623 (67%), Gaps = 32/623 (5%)
Query: 11 ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL 70
+ ++ E E DP+ RY RY+E+LG+GA KTVYK FDEV+GIEVAW+QV I++VMQSPD L
Sbjct: 9 KVDDAECVEVDPTRRYIRYNEVLGRGAMKTVYKAFDEVEGIEVAWSQVEIDEVMQSPDNL 68
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
ERLYSEVHLLKSLKHEN++KFYN WVDD +TIN+ITELFTSGSLRQYR+KH VD+KAI
Sbjct: 69 ERLYSEVHLLKSLKHENVMKFYNYWVDDQKKTINVITELFTSGSLRQYRQKHPRVDLKAI 128
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
KNWARQ+LRGL YLH+H PPIIHRDLKCDNIFVNGN+GEVKIGDLGLA VM P A+SVI
Sbjct: 129 KNWARQVLRGLDYLHTHQPPIIHRDLKCDNIFVNGNHGEVKIGDLGLATVMLTPRAKSVI 188
Query: 191 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250
GTPEFMAPELY+E Y+ELVDIYSFGMC+LEM T EYPY+EC N AQI+KKV+ G+KPA+L
Sbjct: 189 GTPEFMAPELYDENYDELVDIYSFGMCMLEMFTLEYPYSECTNAAQIFKKVSKGVKPAAL 248
Query: 251 SKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLA 310
+K+T+ Q KQFI+KC+VPAS RL A ELL+DPFL +DN LV + P+ +P+ ++++
Sbjct: 249 AKITNIQAKQFIDKCLVPASERLSAKELLQDPFLCSDNSSVLV--GTKFPSSLPKSVDVS 306
Query: 311 HSEPHPMDIDLNHKKVSADSCAKSNTGTWFLT-LELQRLTENNEFTLRGEKNDDDTVSLT 369
H MD+D N ++ +C +++ G + LE R +N E L GEK DD++VSL
Sbjct: 307 LEALH-MDVDTNESMCTS-TCKRNDLGGPHRSVLEFTRTNKNTELKLTGEKLDDNSVSLV 364
Query: 370 LRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPS- 428
LRI D GH NIHF+FYL++DTA+S+A EMVEQL+L+ DV IA+ ID LI+ LVP
Sbjct: 365 LRIADLCGHARNIHFLFYLDSDTAMSVAAEMVEQLELADCDVTFIADFIDLLIVNLVPGQ 424
Query: 429 --WNPSLGSTASQQN-GLLKGSPVSQGNSISLK---CPGEPGSNNAFAEAVSQQGVLSEL 482
N ++ ST+S+ G + SQ + L E ++ A A + S L
Sbjct: 425 QLMNDAVMSTSSESKMGESEHVITSQQHPSELTHDYVLVEGMMHSKEANASPSDYIDSLL 484
Query: 483 ASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVS- 541
+ S SDIS + D KSL + Y V ++ E A + +
Sbjct: 485 NATNLGGPNSSEGSDISVQLDGS-------SKSL------SEYGVDEYRTLECGAYKGTD 531
Query: 542 -LGESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKY 600
LG + + N +D S S+ + +S+S E+ D L EL I ++Y
Sbjct: 532 KLGCRHPLSNGSSNFAIFQMDQASHHSELVIGASVSI-----TENRDVLNGELGLIEAQY 586
Query: 601 QQCFQELLRQREDEMENARKRWL 623
+Q F+EL R RE+ +E ARK+WL
Sbjct: 587 EQWFRELTRMREEALEGARKKWL 609
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8S8Y8|WNK6_ARATH Probable serine/threonine-protein kinase WNK6 OS=Arabidopsis thaliana GN=WNK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 541 bits (1393), Expect = e-153, Method: Compositional matrix adjust.
Identities = 269/431 (62%), Positives = 329/431 (76%), Gaps = 16/431 (3%)
Query: 11 ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL 70
E + E E DP+ RY RY E++GKGAFKTVYK FDEVDGIEVAWNQV I+DV+QSP+ L
Sbjct: 12 EPPDPEVLEVDPTFRYIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVRIDDVLQSPNCL 71
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
ERLYSEV LLKSLKH NII+FYNSW+DD N+T+N+ITELFTSGSLR YRKKH+ V+MKA+
Sbjct: 72 ERLYSEVRLLKSLKHNNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKHRKVNMKAV 131
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
KNWARQIL GL YLH PPIIHRDLKCDNIF+NGN+GEVKIGDLGLA VM+Q A+SVI
Sbjct: 132 KNWARQILMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVI 191
Query: 191 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250
GTPEFMAPELY+E YNEL DIYSFGMC+LEMVT +YPY ECKN AQIYKKV+SGIKPASL
Sbjct: 192 GTPEFMAPELYDENYNELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSSGIKPASL 251
Query: 251 SKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV-PE---- 305
S+V DP+VKQFIEKC++PAS RL A ELL DPFL + + +PL LP++V P+
Sbjct: 252 SRVKDPEVKQFIEKCLLPASERLSAKELLLDPFLQLNGLT--MNNPLPLPDIVMPKEGAF 309
Query: 306 ----VMNLAHSEPHP---MDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRG 358
+M+ P + IDL+ N+G+ +E++R N F L+G
Sbjct: 310 GDRCLMSEGPPTTRPSKTLSIDLDEDSNLPIVTFSDNSGSR--CIEVRRAKRGNFFVLKG 367
Query: 359 EKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELI 418
E+ND+ +VSL LRI D++G V NIHF+FY DTA ++ EMVEQL+L+ ++V IAELI
Sbjct: 368 EENDEQSVSLILRIVDENGRVRNIHFLFYQEGDTASKVSSEMVEQLELTDQNVTFIAELI 427
Query: 419 DNLIMKLVPSW 429
D L++ ++P+W
Sbjct: 428 DILLVNMIPTW 438
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LST2|WNK7_ARATH Probable serine/threonine-protein kinase WNK7 OS=Arabidopsis thaliana GN=WNK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 540 bits (1390), Expect = e-152, Method: Compositional matrix adjust.
Identities = 271/431 (62%), Positives = 336/431 (77%), Gaps = 17/431 (3%)
Query: 11 ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL 70
E + E E DP+CRY RY E++GKGA KTV+KGFDEVDGIEVAWNQV I+D++QSPD L
Sbjct: 12 EPPDPEVLEIDPTCRYIRYKEVIGKGASKTVFKGFDEVDGIEVAWNQVRIDDLLQSPDCL 71
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
ERLYSEV LLKSLKH+NII+FYNSW+DD N+T+N+ITELFTSGSLRQYRKKH+ V+MKA+
Sbjct: 72 ERLYSEVRLLKSLKHKNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYRKKHRKVNMKAV 131
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
K WARQIL GL YLHS +PPIIHRD+KCDNIF+NGN+GEVKIGDLGLA VM+Q A+SVI
Sbjct: 132 KCWARQILTGLKYLHSQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVI 191
Query: 191 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250
GTPEFMAPELY+E YNEL DIYSFGMC+LEMVT EYPY EC+N AQIYKKV+SGIKPASL
Sbjct: 192 GTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYCECRNSAQIYKKVSSGIKPASL 251
Query: 251 SKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVC-DPLRLPNLV-PEVMN 308
SKV DP+V +FIEKC++PAS RL A ELL D FL N LV +PL LP++V P+ +
Sbjct: 252 SKVKDPEVMKFIEKCLLPASERLSAEELLLDSFL---NVNGLVMNNPLPLPDIVMPKEGS 308
Query: 309 LAH----SEPHP------MDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRG 358
SE P M ++L+ + +N+GT +E++R N F L+G
Sbjct: 309 FGERCLMSEGPPNARNRTMSMNLDEDNNLPIVISSNNSGTN--CIEVRRAKRGNFFVLKG 366
Query: 359 EKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELI 418
E+ND+++VSL LRI D++G V NIHF+F+ DTA +++ EMVEQL+L+ ++V IAELI
Sbjct: 367 EENDENSVSLILRIVDENGRVRNIHFLFFQEGDTASNVSSEMVEQLELTDKNVKFIAELI 426
Query: 419 DNLIMKLVPSW 429
D L++ L+P+W
Sbjct: 427 DVLLVNLIPNW 437
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RXE5|WNK10_ARATH Probable serine/threonine-protein kinase WNK10 OS=Arabidopsis thaliana GN=WNK10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 536 bits (1380), Expect = e-151, Method: Compositional matrix adjust.
Identities = 275/415 (66%), Positives = 316/415 (76%), Gaps = 4/415 (0%)
Query: 13 EEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER 72
EE +F +KDP+ RY RY+++LG+GAFKTVYK FDEV+GIEVAWN ++IEDV+Q P QL+R
Sbjct: 2 EEADFVQKDPTGRYIRYNDVLGRGAFKTVYKAFDEVEGIEVAWNLMSIEDVLQMPGQLDR 61
Query: 73 LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKN 132
LYSEVHLL SLKH+NIIK + SWVDD N++INMITELFTSGSL YRKKH+ VD KAI N
Sbjct: 62 LYSEVHLLNSLKHDNIIKLFYSWVDDHNKSINMITELFTSGSLTLYRKKHRKVDPKAIMN 121
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 192
WARQIL+GLHYLHS PP+IHRDLKCDNIFVNGN G+VKIGDLGLA VMQQPTARSVIGT
Sbjct: 122 WARQILKGLHYLHSQTPPVIHRDLKCDNIFVNGNTGKVKIGDLGLAAVMQQPTARSVIGT 181
Query: 193 PEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
PEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPY EC+N AQIYKKVTSGIKP SLSK
Sbjct: 182 PEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYRECRNQAQIYKKVTSGIKPQSLSK 241
Query: 253 VTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHS 312
V DPQVKQFIEKC++PA R ALELLKD L D KD P +
Sbjct: 242 VDDPQVKQFIEKCLLPAPSRPTALELLKDQLLAVDGAKDSTLTASSNTTFKPAMP--PQC 299
Query: 313 EPHPMDIDL-NHKKVSADSCAKSNTGTWFL-TLELQRLTENNEFTLRGEKNDDDTVSLTL 370
E PMD++ + VS S AKS+ L T+E+QR+ E+ EF L GE+ DD S+ L
Sbjct: 300 EYRPMDVEYKKNTSVSICSSAKSSQECALLQTMEVQRVAESTEFKLSGERRDDVAASMAL 359
Query: 371 RIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKL 425
RI SG + F F L DTA ++ EMVE+LDLS +V IAE+ID LIMKL
Sbjct: 360 RIAGSSGQARKVDFDFNLKTDTARAVTGEMVEELDLSSHEVTVIAEMIDELIMKL 414
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D598|WNK1_ORYSJ Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. japonica GN=WNK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 495 bits (1274), Expect = e-139, Method: Compositional matrix adjust.
Identities = 254/457 (55%), Positives = 314/457 (68%), Gaps = 21/457 (4%)
Query: 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
E++E DP+ RYGRY+++LGKGA KTVY+ FDE G+EVAWNQV + D +QSP+ LERLY
Sbjct: 16 EYAEVDPTGRYGRYNDVLGKGASKTVYRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLYC 75
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
E+HLLK+LKH NI+KFY SWVD + R IN ITE+FTSG+LRQYR+KH V++ A+K+W R
Sbjct: 76 EIHLLKTLKHRNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCR 135
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
QIL GL YLHSH+PPIIHRDLKCDNIFVNGN GEVKIGDLGLA ++++ A +GTPEF
Sbjct: 136 QILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAVHCVGTPEF 195
Query: 196 MAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255
MAPE+YEEEYNELVDIYSFGMC+LEMVT EYPY+EC +P QIYKKV SG KP +L KV D
Sbjct: 196 MAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVISGTKPEALYKVKD 255
Query: 256 PQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDP----------LRLPNLVPE 305
P V+QF+EKC+ AS RL A ELLKDPFL D DLV P LR P L
Sbjct: 256 PMVRQFVEKCLATASRRLSARELLKDPFLQVD---DLVFCPGDGDYSLMNYLRQPYLEHA 312
Query: 306 VMNLAH-----SEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEK 360
N++ SE D + D K++ F E + L N + T++G K
Sbjct: 313 YSNVSMMSNGLSESIDEDTPTEDRWDCEDDDIKADGIDLFNGHEDEPLG-NVDITIKGRK 371
Query: 361 NDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDN 420
++D ++ L LRI D GHV NI+F F + ADTA+S+A EMV +LD++ +V IAE+ID
Sbjct: 372 SEDGSIFLRLRIADNDGHVRNIYFPFDIEADTALSVATEMVAELDITDHEVTRIAEMIDG 431
Query: 421 LIMKLVPSWNPSLGSTASQQNGLLK--GSPVSQGNSI 455
+ LVP W P G SQ GS VS S+
Sbjct: 432 EVSALVPDWRPGPGIEESQDTTYCHNCGSNVSSCGSL 468
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YMV6|WNK1_ORYSI Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. indica GN=WNK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 494 bits (1273), Expect = e-139, Method: Compositional matrix adjust.
Identities = 254/457 (55%), Positives = 314/457 (68%), Gaps = 21/457 (4%)
Query: 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
E++E DP+ RYGRY+++LGKGA KTVY+ FDE G+EVAWNQV + D +QSP+ LERLY
Sbjct: 16 EYAEVDPTGRYGRYNDVLGKGASKTVYRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLYC 75
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
E+HLLK+LKH NI+KFY SWVD + R IN ITE+FTSG+LRQYR+KH V++ A+K+W R
Sbjct: 76 EIHLLKTLKHRNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCR 135
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
QIL GL YLHSH+PPIIHRDLKCDNIFVNGN GEVKIGDLGLA ++++ A +GTPEF
Sbjct: 136 QILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAVHCVGTPEF 195
Query: 196 MAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255
MAPE+YEEEYNELVDIYSFGMC+LEMVT EYPY+EC +P QIYKKV SG KP +L KV D
Sbjct: 196 MAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVISGTKPEALYKVKD 255
Query: 256 PQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDP----------LRLPNLVPE 305
P V+QF+EKC+ AS RL A ELLKDPFL D DLV P LR P L
Sbjct: 256 PMVRQFVEKCLATASRRLSARELLKDPFLQVD---DLVFCPGDGDYSLMNYLRQPYLEHA 312
Query: 306 VMNLAH-----SEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEK 360
N++ SE D + D K++ F E + L N + T++G K
Sbjct: 313 YSNVSMMSNGLSESIDEDTPTEDRWDCEDDDIKADGIDLFNGHEDEPLG-NVDITIKGRK 371
Query: 361 NDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDN 420
++D ++ L LRI D GHV NI+F F + ADTA+S+A EMV +LD++ +V IAE+ID
Sbjct: 372 SEDGSIFLRLRIADNDGHVRNIYFPFDIEADTALSVATEMVAELDITDHEVTRIAEMIDG 431
Query: 421 LIMKLVPSWNPSLGSTASQQNGLLK--GSPVSQGNSI 455
+ LVP W P G SQ GS VS S+
Sbjct: 432 EVSALVPDWRPGPGIEESQDTTYCHNCGSNVSSCGSL 468
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAV6|WNK1_ARATH Serine/threonine-protein kinase WNK1 OS=Arabidopsis thaliana GN=WNK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 486 bits (1251), Expect = e-136, Method: Compositional matrix adjust.
Identities = 246/461 (53%), Positives = 310/461 (67%), Gaps = 40/461 (8%)
Query: 11 ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL 70
E + EF E DP+ RYGRY+E+LGKGA KTVY+ FDE +GIEVAWNQV + D +QSP+ L
Sbjct: 8 EPDYSEFVEVDPTGRYGRYNEVLGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDL 67
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
ERLY E+HLLK+LKH+NI+KFY SWVD NR IN +TELFTSG+LRQYR +HK V+++A+
Sbjct: 68 ERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHKRVNIRAM 127
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
K+W RQILRGLHYLHSH+PP+IHRDLKCDNIFVNGN GEVKIGDLGLA ++++ A +
Sbjct: 128 KHWCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCV 187
Query: 191 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250
GTPEFMAPE+YEE YNELVDIYSFGMCILEMVT +YPY+EC +PAQIYKKV SG KP +L
Sbjct: 188 GTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMSGKKPDAL 247
Query: 251 SKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNP---------KDLVCDPLRLPN 301
KV DP+VK FIEKC+ SLR+ A ELL DPFL D+ +D V R P+
Sbjct: 248 YKVKDPEVKCFIEKCLATVSLRVSARELLDDPFLRIDDGEFDLRSVDMEDSVGPLYRQPH 307
Query: 302 LVPEVMNLAHSEP----------HPMD-IDLNHKKVSADSCAKSNTGTWFLT-------- 342
+P+ N + +P + LN + + + W
Sbjct: 308 HLPDYYNYPSNSSSLNRQYSNGNYPSNSSSLNRQYSNGYNSHHEYQNGWAYNPAETEETH 367
Query: 343 -LEL-----------QRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNA 390
+EL ++ + N + T++G++ DD + L LRI DK G V NI+F F +
Sbjct: 368 GIELFESRNNDDQEEEKKSGNVDITIKGKRRDDGGLFLRLRIADKEGRVRNIYFPFDIET 427
Query: 391 DTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNP 431
DTA+S+A EMV +LD+ V IA +ID I LVPSW P
Sbjct: 428 DTALSVATEMVAELDMDDHGVTKIANMIDGEISSLVPSWRP 468
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates APRR3. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica GN=WNK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 483 bits (1243), Expect = e-135, Method: Compositional matrix adjust.
Identities = 239/427 (55%), Positives = 306/427 (71%), Gaps = 19/427 (4%)
Query: 14 EGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERL 73
E EF+E DP+ RYGRY E+LGKGAFKTVYK FD+++G+EVAWNQ+ + D++++ D LERL
Sbjct: 15 EPEFAEVDPTARYGRYTEVLGKGAFKTVYKAFDQLEGLEVAWNQIKVGDILRNNDDLERL 74
Query: 74 YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
SEV LLK+LKH+NIIKFYNSW+D N IN ITE+FTSG+LRQYR KHK VD++A+K W
Sbjct: 75 RSEVRLLKTLKHKNIIKFYNSWLDKKNNNINFITEVFTSGTLRQYRIKHKKVDVRALKKW 134
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGT 192
+RQIL GL YLHSH+PP+IHRDLKCDNIFVNGN GEVKIGDLGLA ++ +A S+IGT
Sbjct: 135 SRQILSGLVYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLATILDNARSAHSIIGT 194
Query: 193 PEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
PEFMAPELY+EEYNELVDIY+FGMC+LE+VT EYPY EC N AQIYKKV+ G KP+SL+K
Sbjct: 195 PEFMAPELYDEEYNELVDIYAFGMCLLELVTFEYPYCECSNAAQIYKKVSDGEKPSSLAK 254
Query: 253 VTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHS 312
+ DP+V+ FIEKCI AS RL A ELL DPFL D K + PL+ + ++S
Sbjct: 255 IEDPEVRFFIEKCIAKASQRLSAQELLMDPFLRDDGEK--IFYPLQSNTKASDGAGSSNS 312
Query: 313 EPHPMDIDLNHKKVSADSCAKSNTGTW----------FLTLELQRLTENNEFTLRGEKND 362
+ + + ++ + +TG++ T++ Q T+ + D
Sbjct: 313 S-----MGYKYDRDASSMAIREHTGSFAEEHPSDRYIHSTMDPQ-AAAGRIITVESQMKD 366
Query: 363 DDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLI 422
+T+ L LRI D +GH NIHF F + ADT+IS+A EMV QLDL+ +DV +IAE+ID I
Sbjct: 367 LNTIFLKLRIADSTGHAQNIHFPFDIEADTSISVATEMVVQLDLTDQDVTAIAEMIDAEI 426
Query: 423 MKLVPSW 429
+P W
Sbjct: 427 RAHIPDW 433
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8S8Y9|WNK2_ARATH Serine/threonine-protein kinase WNK2 OS=Arabidopsis thaliana GN=WNK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 473 bits (1217), Expect = e-132, Method: Compositional matrix adjust.
Identities = 241/487 (49%), Positives = 321/487 (65%), Gaps = 21/487 (4%)
Query: 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
F E DPS RYGRYDEILGKGA KTVY+ FDE +GIEVAWNQV + + ++P++LE+ + E
Sbjct: 14 FVEIDPSGRYGRYDEILGKGASKTVYRAFDEYEGIEVAWNQVKLRNFTRNPEELEKFFRE 73
Query: 77 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ 136
+HLLK+L H+NI+KFY SWVD N +IN +TELFTSG+LRQYR +H+ V+++A+K W +Q
Sbjct: 74 IHLLKTLNHQNIMKFYTSWVDTNNLSINFVTELFTSGTLRQYRLRHRRVNIRAVKQWCKQ 133
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 196
IL+GL YLHS +PPIIHRDLKCDNIF+NGN GEVKIGDLGLA ++++ A +GTPEFM
Sbjct: 134 ILKGLLYLHSRSPPIIHRDLKCDNIFINGNQGEVKIGDLGLAAILRKSHAVRCVGTPEFM 193
Query: 197 APELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256
APE+Y+EEYNELVD+Y+FGMC+LEMVT +YPY+EC +PAQIYKKVTSG KP + V DP
Sbjct: 194 APEVYDEEYNELVDVYAFGMCVLEMVTFDYPYSECTHPAQIYKKVTSGKKPEAFYLVKDP 253
Query: 257 QVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHP 316
+V++F+EKC+ + RL ALELL+DPFL DN V P+ N E HP
Sbjct: 254 EVREFVEKCLANVTCRLTALELLQDPFLQDDNMDGFVMRPIDYYNGYDETGVFLR---HP 310
Query: 317 M-DIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDK 375
+ D L H + + + + L ++ + +++G++N DD + L LRI D
Sbjct: 311 LIDDPLYHDQFESSQICE-------IDLFANDDEDHVDISIKGKRNGDDGIFLRLRISDA 363
Query: 376 SGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGS 435
G + NI+F F DTA S+A EMV +LD++++DV IAE+ID I LVP W
Sbjct: 364 EGRIRNIYFPFETAIDTAWSVAVEMVSELDITNQDVAKIAEMIDAEIAALVPDWK---ND 420
Query: 436 TASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASGKYQYNQESSD 495
T S QN + + G GE SN E VS G S ++ +++ S
Sbjct: 421 TESSQNVNNNKNNNTAGFC------GECASNGYIQETVS-SGEKSHHNHHEFDSSEDKSC 473
Query: 496 SDISAEF 502
S + F
Sbjct: 474 SSVHGRF 480
|
Regulates flowering time by modulating the photoperiod pathway. Possesses kinase activity in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 631 | ||||||
| 224072272 | 596 | predicted protein [Populus trichocarpa] | 0.933 | 0.988 | 0.654 | 0.0 | |
| 255555709 | 585 | kinase, putative [Ricinus communis] gi|2 | 0.920 | 0.993 | 0.633 | 0.0 | |
| 359474135 | 645 | PREDICTED: serine/threonine-protein kina | 0.977 | 0.956 | 0.636 | 0.0 | |
| 224058021 | 571 | predicted protein [Populus trichocarpa] | 0.893 | 0.987 | 0.643 | 0.0 | |
| 357462359 | 614 | Serine/threonine protein kinase WNK8 [Me | 0.966 | 0.993 | 0.612 | 0.0 | |
| 449452398 | 679 | PREDICTED: serine/threonine-protein kina | 0.971 | 0.902 | 0.585 | 0.0 | |
| 351724041 | 618 | with no lysine kinase 8 [Glycine max] gi | 0.946 | 0.966 | 0.597 | 0.0 | |
| 356547519 | 618 | PREDICTED: serine/threonine-protein kina | 0.949 | 0.969 | 0.594 | 0.0 | |
| 255564615 | 693 | kinase, putative [Ricinus communis] gi|2 | 0.971 | 0.884 | 0.542 | 1e-180 | |
| 225470964 | 625 | PREDICTED: probable serine/threonine-pro | 0.954 | 0.963 | 0.565 | 1e-180 |
| >gi|224072272|ref|XP_002303683.1| predicted protein [Populus trichocarpa] gi|222841115|gb|EEE78662.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 748 bits (1930), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/625 (65%), Positives = 469/625 (75%), Gaps = 36/625 (5%)
Query: 1 MDCGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI 60
MD GS SE G F+EKDP+ RY R DE LGKGAFKTVYK FDEVDGIEVAWNQVNI
Sbjct: 1 MDFGS---LSEDGGGVFAEKDPTGRYIRNDEFLGKGAFKTVYKAFDEVDGIEVAWNQVNI 57
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK 120
EDV+QS QLERLYSEVHLLKSLKHENIIKFY+SWVDD N+TIN+ITELFTSGS+RQYRK
Sbjct: 58 EDVLQSSQQLERLYSEVHLLKSLKHENIIKFYSSWVDDKNKTINIITELFTSGSMRQYRK 117
Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
KHK VDMKAIKNWARQILRGLHYLH+H+PPIIHRDLKCDNIFVNGN GEVKIGDLGLAIV
Sbjct: 118 KHKTVDMKAIKNWARQILRGLHYLHTHSPPIIHRDLKCDNIFVNGNTGEVKIGDLGLAIV 177
Query: 181 MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240
MQQP ARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPY+ECKNPAQIYKK
Sbjct: 178 MQQPIARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYSECKNPAQIYKK 237
Query: 241 VTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 300
V+SGIKPASL KV+D QVK FIEKC+VPAS RLPA+ELLKDPFL T+N K+LV L+LP
Sbjct: 238 VSSGIKPASLGKVSDHQVKVFIEKCLVPASTRLPAIELLKDPFLATENSKELVSSSLQLP 297
Query: 301 NLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKS-NTGTWFLTLELQRLTENNEFTLRGE 359
NL+ ++L SE H MDID KK+S SC KS N F TLEL R TENNEF LRG
Sbjct: 298 NLISRQVHLLQSESHLMDIDC--KKLSVGSCTKSINESPQFSTLELSRFTENNEFRLRGA 355
Query: 360 KNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELID 419
KN+D+TVSLTLRI D G NIHF FYL++DTA+ IAEEMVEQLDL EDV IAELID
Sbjct: 356 KNNDNTVSLTLRIADPCGRARNIHFTFYLDSDTAVLIAEEMVEQLDLLTEDVAVIAELID 415
Query: 420 NLIMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVL 479
NLI KLVPSWN SP + S L+ N++ +EAV + L
Sbjct: 416 NLIAKLVPSWNT---------------SPSVRNGSSELE-------NHSTSEAVKKPDFL 453
Query: 480 SELASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADE 539
L + ++S +SDISAE+++ + D+ +KSL +YD E E
Sbjct: 454 P-LTNMTDLETKQSVNSDISAEYNMAIASDSGTNKSLGSSDCCLQSNMYD---LEFGMLE 509
Query: 540 VSLGESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSK 599
+ + N+ST+NS S+I S SGMS+N S SSI SLSLADK+ S+ LK ELD+I+S
Sbjct: 510 DGISK---HNKSTRNSNDSYIGSFSGMSRNASMSSICSLSLADKDGSE-LKQELDSIDSH 565
Query: 600 YQQCFQELLRQREDEMENARKRWLA 624
Y QC QEL++ RE+ +ENA+KR +
Sbjct: 566 YNQCLQELMKMREEAIENAKKRGIT 590
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555709|ref|XP_002518890.1| kinase, putative [Ricinus communis] gi|223541877|gb|EEF43423.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 740 bits (1911), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/627 (63%), Positives = 461/627 (73%), Gaps = 46/627 (7%)
Query: 7 FTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS 66
F + ++ EF EKDP+ RY RYDE+LGKGAFKTVYK FDE++GIEVAWNQV++EDV+QS
Sbjct: 3 FCSRDDDDSEFEEKDPTGRYVRYDEVLGKGAFKTVYKAFDEINGIEVAWNQVSVEDVLQS 62
Query: 67 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD 126
PDQLERLYSEVHLLKSLKHENI+KFYNSWVDD N+TINMITELFTSGSLR+YRKKHKNVD
Sbjct: 63 PDQLERLYSEVHLLKSLKHENIMKFYNSWVDDNNKTINMITELFTSGSLRKYRKKHKNVD 122
Query: 127 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 186
+KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN+FVNGNNGEVKIGDLGLA VMQQPTA
Sbjct: 123 IKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNVFVNGNNGEVKIGDLGLATVMQQPTA 182
Query: 187 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246
RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPY+ECKNPAQIYKKVTSGIK
Sbjct: 183 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYSECKNPAQIYKKVTSGIK 242
Query: 247 PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 306
PASL KV DP VK+FIEKCIVPAS+RLPALELLKDPFL T+NPK+LV L LP+L+ +
Sbjct: 243 PASLCKVNDPLVKRFIEKCIVPASMRLPALELLKDPFLATENPKELVFASLHLPDLMLKQ 302
Query: 307 MNLAHSEPHPMDIDLNHKKVSADSCAKS-NTGTWFLTLELQRLTENNEFTLRGEKNDDDT 365
++ SE +PMDID NHKK+S SC KS + F T E QRLT NEF LRGEKNDD+T
Sbjct: 303 VSRGQSESYPMDIDSNHKKLSVGSCTKSMDESLHFSTSEFQRLTVKNEFRLRGEKNDDNT 362
Query: 366 VSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKL 425
+SLTLRI D+ G V NIHF FYL++DT +SIAEEMVEQLDLS+EDV IAELID LI+KL
Sbjct: 363 ISLTLRIVDRCGGVKNIHFTFYLDSDTTLSIAEEMVEQLDLSNEDVAIIAELIDALILKL 422
Query: 426 VPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASG 485
VP + S GST+S NG N+A + S+ L LA
Sbjct: 423 VPHLSQS-GSTSSMPNGF------------------SELHNDATFKVASKHDFLP-LADL 462
Query: 486 KYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGES 545
K Q Q+S S++S E + V DA +K L Y+ + Y+ G +D + G+
Sbjct: 463 KGQETQDSLLSELSTELPLTVASDASTNKPLGSSDYTIDFNTYEFG-----SDFMMHGDG 517
Query: 546 IL-FNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCF 604
+ + T++SE L A E D LKLELDAI+ +Y QCF
Sbjct: 518 TFKYGKYTKHSE-------------------KHLPSAKGEVQDDLKLELDAIDMQYNQCF 558
Query: 605 QELLRQREDEMENARKRWLAGSNVSVI 631
+EL RE+ +ENA+K+W+ V I
Sbjct: 559 RELSMMREEAIENAKKKWITRKKVPAI 585
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474135|ref|XP_002273005.2| PREDICTED: serine/threonine-protein kinase WNK8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 738 bits (1905), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/636 (63%), Positives = 480/636 (75%), Gaps = 19/636 (2%)
Query: 9 KSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD 68
K ET++ +F EKDP+ RY RY+E LGKGAFKTVYK FDEVDGIEVAW QV IED++QSP
Sbjct: 5 KFETDDSDFEEKDPTGRYVRYNEFLGKGAFKTVYKAFDEVDGIEVAWGQVEIEDLLQSPQ 64
Query: 69 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
QLERLYSEVHLLKSLKH+NIIKFYNSWVDDTN+TIN+ITELFTSGSLRQYRKKHKNVD+K
Sbjct: 65 QLERLYSEVHLLKSLKHDNIIKFYNSWVDDTNKTINLITELFTSGSLRQYRKKHKNVDLK 124
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
AIKNWA+QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS
Sbjct: 125 AIKNWAKQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 184
Query: 189 VIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 248
VIGTPEFMAPELYEEEYNELVDIYSFGMCILE+VTCEYPYNECKNPAQIYKKV+SGIKPA
Sbjct: 185 VIGTPEFMAPELYEEEYNELVDIYSFGMCILELVTCEYPYNECKNPAQIYKKVSSGIKPA 244
Query: 249 SLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVC------DPLRLPNL 302
SL KV+DPQVKQFIEKC+VPASLRL A ELLKD F T+N K+ V D L+ N
Sbjct: 245 SLGKVSDPQVKQFIEKCLVPASLRLSAQELLKDAFFATENSKEPVYNHMHVDDSLQSSNF 304
Query: 303 VPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGT-WFLTLELQRLTENNEFTLRGEKN 361
+P +MNL E PMD+D N+KK+S + KS +GT F L+ +R +NN F LRGEK
Sbjct: 305 MPNLMNLPKPELQPMDMDPNYKKLSVSTHMKSISGTPHFRALQFERFNKNNLFKLRGEKI 364
Query: 362 DDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNL 421
DD+++S+TL I D G NIHF FYL++DTA+SIA EMVEQLDL +EDV IAELID +
Sbjct: 365 DDNSISMTLHIADPCGRAKNIHFAFYLDSDTALSIAGEMVEQLDLYNEDVAVIAELIDVM 424
Query: 422 IMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSE 481
I +LVP+W P+ S N + S V SL+ P + GS ++AV++ ++S
Sbjct: 425 ISELVPTWKPAFESMLCGANSSCEDSLVLHNGGTSLRHPSDSGSAKGTSDAVTEH-LISL 483
Query: 482 LASGKYQYNQESSDSDISAEFDVPVILDAHIDKSL-VPDG----------YSAHYAVYDH 530
A+G+ Q ES+ S +S + D V DA+ KSL PD ++ V DH
Sbjct: 484 SANGEEQSTVESALSGMSTKDDATVASDANDIKSLECPDDECYEASDRCCFNGDRQVLDH 543
Query: 531 GGHEVKADEVSLGESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLK 590
H+ ++GE + N T++ E S I+SCSGMS +LS SSI SLSLADK+ SD LK
Sbjct: 544 ERHKEGRYNGNIGEPVAMNGFTKDWEISCIESCSGMSNSLSLSSICSLSLADKDPSDELK 603
Query: 591 LELDAINSKYQQCFQELLRQREDEMENARKRWLAGS 626
LE+D I+++Y QCFQELLR RE+ +E A+ RW+ S
Sbjct: 604 LEVDTIDTQYHQCFQELLRMREEAIEKAKNRWITKS 639
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224058021|ref|XP_002299436.1| predicted protein [Populus trichocarpa] gi|222846694|gb|EEE84241.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1900), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/626 (64%), Positives = 461/626 (73%), Gaps = 62/626 (9%)
Query: 1 MDCGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI 60
MD GS SE GEF+EKDP+ RY RYDEILGKGAFKTVYK FDEVDGIEVAWNQV+I
Sbjct: 1 MDFGSF---SEDGCGEFAEKDPTGRYVRYDEILGKGAFKTVYKAFDEVDGIEVAWNQVDI 57
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK 120
EDV+QS QLERLYSEVHLLKSLKHENIIKFYNSWVDD N+TINMITEL TSG+LRQYRK
Sbjct: 58 EDVLQSSQQLERLYSEVHLLKSLKHENIIKFYNSWVDDKNKTINMITELLTSGNLRQYRK 117
Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
KHK VDMKAIKNWARQILRGL YLH+ +P IIHRDLKCDNI VNGNNGEVKIGDLGLAIV
Sbjct: 118 KHKTVDMKAIKNWARQILRGLQYLHTRSPRIIHRDLKCDNILVNGNNGEVKIGDLGLAIV 177
Query: 181 MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240
MQQP ARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPY+ECKNPAQIYKK
Sbjct: 178 MQQPIARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYSECKNPAQIYKK 237
Query: 241 VTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 300
VTSGIKPASL KV D QVK+FIEKC+VPAS+RL A++LLKDPFL T+N K++V +LP
Sbjct: 238 VTSGIKPASLVKVNDLQVKEFIEKCLVPASVRLSAIDLLKDPFLATENSKEVVSSLSQLP 297
Query: 301 NLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKS-NTGTWFLTLELQRLTENNEFTLRGE 359
N++ + ++L SE H MDID K +S SC KS N FLTLEL+R TENNEF LR E
Sbjct: 298 NVICKQVHLPQSESHHMDIDC--KMLSLGSCPKSINESPQFLTLELRRFTENNEFRLRAE 355
Query: 360 KNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELID 419
KNDD+TVSLTLRI D G NIHF FYLN+DTA+SIAEEMVEQLDLS EDV IAELID
Sbjct: 356 KNDDNTVSLTLRIADPCGRARNIHFTFYLNSDTAVSIAEEMVEQLDLSSEDVAVIAELID 415
Query: 420 NLIMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPG-EPGSNNAFAEAVSQQGV 478
+LI+KLVP WN S +S +NG + S + K P P +N EA+
Sbjct: 416 SLIVKLVPCWNTS----SSVRNG--SSELENHATSETGKTPDFSPLTNITDHEAL----- 464
Query: 479 LSELASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKAD 538
+S +SDISAE+++ + DA +KSL S V+
Sbjct: 465 -------------QSVNSDISAEYNMAIASDASTNKSLGSSSCSLQSNVF---------- 501
Query: 539 EVSLGESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINS 598
IDSCSGMS+N S S I SL LADK+ S+ LKLELD+I+S
Sbjct: 502 --------------------HIDSCSGMSRNASLSIICSLFLADKDGSE-LKLELDSIDS 540
Query: 599 KYQQCFQELLRQREDEMENARKRWLA 624
Y QCFQEL++ RE+ +ENA++RW++
Sbjct: 541 HYNQCFQELMKTREEAIENAKRRWIS 566
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357462359|ref|XP_003601461.1| Serine/threonine protein kinase WNK8 [Medicago truncatula] gi|355490509|gb|AES71712.1| Serine/threonine protein kinase WNK8 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 706 bits (1822), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/624 (61%), Positives = 458/624 (73%), Gaps = 14/624 (2%)
Query: 10 SETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ 69
SE ++ EKDP+ RY RYDE+LGKGAFKTVYK FDEVDGIEVAWNQ++IEDVMQSP
Sbjct: 3 SEIDDVGVVEKDPTLRYARYDEMLGKGAFKTVYKAFDEVDGIEVAWNQISIEDVMQSPQN 62
Query: 70 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA 129
LE+LYSEVHLLKSLKHENIIK Y+SWVD+ + INMITELFTSGSLRQYRKKHKNVDMKA
Sbjct: 63 LEKLYSEVHLLKSLKHENIIKMYSSWVDEKSSNINMITELFTSGSLRQYRKKHKNVDMKA 122
Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 189
IKNWARQILRGL +LHSHNPP+IHRDLKCDNIFVNGNNG+VKIGDLGLAIVMQQPTARSV
Sbjct: 123 IKNWARQILRGLCFLHSHNPPVIHRDLKCDNIFVNGNNGQVKIGDLGLAIVMQQPTARSV 182
Query: 190 IGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 249
IGTPEFMAPELYEEEYNELVD+YSFGMCILEM+TCEYPY+ECKNPAQIYKKVTSGIKPAS
Sbjct: 183 IGTPEFMAPELYEEEYNELVDVYSFGMCILEMITCEYPYSECKNPAQIYKKVTSGIKPAS 242
Query: 250 LSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNL 309
L++V DP+VKQFIEKC+VPAS+RLPA ELLKDPFL T N K++ D L LPN + +N
Sbjct: 243 LARVNDPEVKQFIEKCLVPASMRLPASELLKDPFLATGNTKEIYHDNLLLPNPPSKSLNP 302
Query: 310 AHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTL--ELQRLTENNEFTLRGEKNDDDTVS 367
EPHPM+ID N K S S + + T ++ ++ R TENNEF LRGEKN D T+S
Sbjct: 303 PTCEPHPMEIDSNVKHTSPASTVERDKETSQVSSNHDILRKTENNEFRLRGEKNADRTIS 362
Query: 368 LTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVP 427
LTLRI D +G NIHF FY+++DT ISIAEEMVE L+L EDV IAELI N+I KLVP
Sbjct: 363 LTLRIADANGGARNIHFPFYIDSDTTISIAEEMVEHLELKDEDVAVIAELIHNMIFKLVP 422
Query: 428 SWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASGKY 487
W P L +S + L + P+ N L C GSNN +++ + S+L G+
Sbjct: 423 DWKP-LCENSSGTDNLYR--PLEPQNE-QLNCHWTLGSNNFDMKSMYEDLGHSQL-DGED 477
Query: 488 QYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGESIL 547
Q QES SDISAE+ + DA K + + + H G D G+
Sbjct: 478 QDKQESVSSDISAEYGTVIATDA---KGVEQNCFILHECCKGSNGLNTNPDVRICGQE-- 532
Query: 548 FNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQEL 607
+ ++ SE S + CS S+NL S SL+ D++H D L+LE++AI +YQQ F+EL
Sbjct: 533 -DGNSNQSENSVVSCCSP-SENLDRLSKCSLTALDQDHLDELQLEIEAIEIQYQQSFREL 590
Query: 608 LRQREDEMENARKRWLAGSNVSVI 631
++ RE+ +EN +KRW + N+SV+
Sbjct: 591 MKMREEAIENVKKRWTSKKNISVM 614
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449452398|ref|XP_004143946.1| PREDICTED: serine/threonine-protein kinase WNK8-like [Cucumis sativus] gi|449529646|ref|XP_004171809.1| PREDICTED: serine/threonine-protein kinase WNK8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 687 bits (1773), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/651 (58%), Positives = 457/651 (70%), Gaps = 38/651 (5%)
Query: 1 MDCGSGFT---KSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQ 57
+ CGS SE ++ EKDPS RY RYDEILGKGAFKTVYK FDEV GIEVAW+Q
Sbjct: 47 LSCGSDLIMSGNSEADDRGIVEKDPSGRYIRYDEILGKGAFKTVYKAFDEVGGIEVAWSQ 106
Query: 58 VNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ 117
V+IEDV+QSP+QL+RLYSEVHLLKSLKHENIIKFY+ WVDD ++TINMITELFTSGSLRQ
Sbjct: 107 VDIEDVLQSPEQLQRLYSEVHLLKSLKHENIIKFYSYWVDDKHKTINMITELFTSGSLRQ 166
Query: 118 YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177
YRKKH+ VD+KA KNWARQILRGL YLH HNPPIIHRDLKCDNIFVNGN GEVKIGDLGL
Sbjct: 167 YRKKHRKVDLKAFKNWARQILRGLTYLHGHNPPIIHRDLKCDNIFVNGNTGEVKIGDLGL 226
Query: 178 AIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 237
AIVMQQPTARSVIGTPEFMAPELY+E+YNELVDIYSFGMC+LE+VTCEYPYNECKN AQI
Sbjct: 227 AIVMQQPTARSVIGTPEFMAPELYDEDYNELVDIYSFGMCMLEIVTCEYPYNECKNSAQI 286
Query: 238 YKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPL 297
+KKVTSGIKPASL KV DPQVKQFIEKC+VPAS RLPA ELLKDPFL ++PKD +
Sbjct: 287 FKKVTSGIKPASLEKVLDPQVKQFIEKCLVPASTRLPASELLKDPFLAAESPKDNSSELS 346
Query: 298 RLPNLVPEVMNLAHSEPHPMDIDLNHKKVSAD--SCAKSNTG-TWFLTLELQRLTENNEF 354
R N + +N HPM+ D N K+S S KSN G + F T ELQRLTENNE
Sbjct: 347 RSLNEHFKSVNPPLLGSHPMETDHNCTKLSGSVASSVKSNNGISHFSTQELQRLTENNEL 406
Query: 355 TLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSI 414
TL+G+ D +T+S LRI + G NIHF FYL++DT+++IA EMVEQL+LS+ED I
Sbjct: 407 TLKGDMTDHNTMSFHLRIAELYGKSRNIHFAFYLDSDTSLAIALEMVEQLELSNEDATII 466
Query: 415 AELIDNLIMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAV- 473
A+LID LI K VPSW P QQ SP +Q + + + F+E V
Sbjct: 467 AKLIDELIAKFVPSWKPCPNYCEEQQQN-TPHSPEAQEDKTFI--------SPFFSELVL 517
Query: 474 ------SQQGVLSELASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLV------PDGY 521
+ + L+ LA + Q NQ+S S S E+ + D I K PD
Sbjct: 518 SSPMVAAARNNLTGLAKVEDQENQQSIISCASVEYIYSTVSDYSIGKGSECGEFGHPDCE 577
Query: 522 SAHYAVYDHGGHEVKADEV-SLGESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSL 580
A+ + G ++ A+ V SL +I F ++ S I SCS MSK LS SS S+LS+
Sbjct: 578 KAYIS---SGTIDLDAEAVGSLSTTIDF------AKPSLISSCSEMSKELSLSSFSTLSM 628
Query: 581 ADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENARKRWLAGSNVSVI 631
+++H D LK+E+DAI+ +Y QC EL R RE+ +E+A+KRW++ + I
Sbjct: 629 EERDHQDELKMEIDAIDLQYHQCLCELSRMREEAIESAKKRWMSKKKATGI 679
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351724041|ref|NP_001236020.1| with no lysine kinase 8 [Glycine max] gi|225348645|gb|ACN87284.1| with no lysine kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 672 bits (1734), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/604 (59%), Positives = 447/604 (74%), Gaps = 7/604 (1%)
Query: 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH 78
EKDP+ RY RYDE+LGKGAFKTVYK FDEVDGIEVAWN++ +EDV+Q+P QL +LYSEVH
Sbjct: 8 EKDPTSRYARYDELLGKGAFKTVYKAFDEVDGIEVAWNRIGVEDVVQTPQQLGKLYSEVH 67
Query: 79 LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 138
LLKSLKH+N+IK YNSWVDDT TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL
Sbjct: 68 LLKSLKHDNVIKLYNSWVDDTAGTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 127
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAP 198
RGL +LHS +PPI+HRDLKCDNIFVNGN+G VKIGDLGLAIVMQQPTARSVIGTPEFMAP
Sbjct: 128 RGLCFLHSQSPPIVHRDLKCDNIFVNGNSGLVKIGDLGLAIVMQQPTARSVIGTPEFMAP 187
Query: 199 ELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258
ELYEEEYNELVDIYSFGMCILEMVTCEYPY+ECKNPAQIYKKVTSGIKPA+L+KV DP+V
Sbjct: 188 ELYEEEYNELVDIYSFGMCILEMVTCEYPYSECKNPAQIYKKVTSGIKPAALAKVNDPEV 247
Query: 259 KQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMD 318
KQFIEKC+VPAS+RL A ELLKDPFL T+N K++ D L+LPN +++NL EPHPM+
Sbjct: 248 KQFIEKCLVPASMRLSASELLKDPFLATENTKEINHDTLQLPNPHIKLVNLPKCEPHPME 307
Query: 319 IDLNHKKVS-ADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSG 377
ID ++ S S + + +L R+T+NN+ LRGEKN + T+SLTLRI D G
Sbjct: 308 IDSYSRRTSPGSSMGRIEETSQVSFFDLVRMTDNNKLMLRGEKNAESTISLTLRIPDACG 367
Query: 378 HVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTA 437
NIHF FY+++DTAISIAEEMVE L+L++EDV IAELI+++I KLVP+ P +
Sbjct: 368 GARNIHFPFYMDSDTAISIAEEMVEHLELTNEDVSVIAELINDMIAKLVPNSKPLCEKLS 427
Query: 438 SQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASGKYQYNQESSDSD 497
S+ N L + S Q N C S++ +A+ + V S G Q QES SD
Sbjct: 428 SETNLLYRPSSEVQ-NGEQFNCHWPLQSSDYDMKAMYKDLVHSRPVDGDDQEKQESVMSD 486
Query: 498 ISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGESILFNESTQNSET 557
ISA + + D+ K + PD + + + G +D G+ ++NS
Sbjct: 487 ISAACGITIASDS---KVVEPDIFI--FDEFWEGFFNSTSDIRFCGQEDGHKNQSENSVG 541
Query: 558 SFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMEN 617
S I+SC KN SSI SL+LADK+ S+GL+L+++AI++ + + F EL R++ +++
Sbjct: 542 SLINSCCCPFKNFDMSSICSLTLADKDPSEGLRLDIEAIDTYFDRRFLELEMMRQEAIKS 601
Query: 618 ARKR 621
A++R
Sbjct: 602 AKRR 605
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356547519|ref|XP_003542159.1| PREDICTED: serine/threonine-protein kinase WNK8-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 664 bits (1712), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/604 (59%), Positives = 437/604 (72%), Gaps = 5/604 (0%)
Query: 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH 78
EKD + RY RYDE+LGKGAFKTVYK FDEVDGIEVAWN +++EDV+Q+P QLE+LYSE+H
Sbjct: 8 EKDLTSRYARYDELLGKGAFKTVYKAFDEVDGIEVAWNMISVEDVVQTPQQLEKLYSEIH 67
Query: 79 LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 138
LLKSLKH+N+IK YNSWVDDT TINMITELFTSGSLRQYR KHKNVDMKAIKNWARQIL
Sbjct: 68 LLKSLKHDNVIKLYNSWVDDTTGTINMITELFTSGSLRQYRNKHKNVDMKAIKNWARQIL 127
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAP 198
RGL +LH H+PPI+HRDLKCDNIFVNGN+G VKIGDLGLAIVMQQPTARSVIGTPEFMAP
Sbjct: 128 RGLCFLHCHSPPIVHRDLKCDNIFVNGNSGLVKIGDLGLAIVMQQPTARSVIGTPEFMAP 187
Query: 199 ELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258
ELYEEEYNELVDIYSFGMCILEMVTCEYPY+EC NPAQIYKKVTSGIKPA+L+KV DP+V
Sbjct: 188 ELYEEEYNELVDIYSFGMCILEMVTCEYPYSECNNPAQIYKKVTSGIKPAALAKVNDPEV 247
Query: 259 KQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMD 318
KQFIEKC+VPAS+RL A ELLKDPFL T+N K++ D L LPN +++N EPHPM+
Sbjct: 248 KQFIEKCLVPASMRLSASELLKDPFLATENTKEINHDILELPNPHTKLVNPPTCEPHPME 307
Query: 319 IDLNHKKVS-ADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSG 377
ID ++ S S + + +L R+TENN+F LRGEKN + T+SLTLRI + G
Sbjct: 308 IDSKSRRTSPGSSMGRIEETSQVSFFDLVRMTENNKFMLRGEKNAESTISLTLRIANACG 367
Query: 378 HVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTA 437
NIHF FY+N+DTAISIAEEMVE L+L++EDV IAELI+++I KLVP+ P +
Sbjct: 368 GARNIHFPFYINSDTAISIAEEMVEHLELTNEDVSVIAELINDMIAKLVPNLKPLSEKLS 427
Query: 438 SQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASGKYQYNQESSDSD 497
S + L + S Q N C S++ + V + V S G QES SD
Sbjct: 428 SGTDQLYRPSSEVQ-NGEQFNCHWPLQSSDYDMKPVFKDLVHSWPVDGDDLEKQESVMSD 486
Query: 498 ISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGESILFNESTQNSET 557
IS E + V D+ K + PD + +D G+ ++NS
Sbjct: 487 ISVECGITVASDS---KVVEPDIFIFDEFWEGFDAFNSTSDVRFCGQEDGHKNQSENSSG 543
Query: 558 SFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMEN 617
S I+SC KN SSI SL+LADK+ S+GL+LE++AI++ ++Q F+EL R +E+
Sbjct: 544 SLINSCCCPFKNFDISSICSLTLADKDPSEGLRLEIEAIDTYFEQRFRELEMMRVAAIES 603
Query: 618 ARKR 621
++R
Sbjct: 604 LKRR 607
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255564615|ref|XP_002523302.1| kinase, putative [Ricinus communis] gi|223537390|gb|EEF39018.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 637 bits (1643), Expect = e-180, Method: Compositional matrix adjust.
Identities = 360/663 (54%), Positives = 449/663 (67%), Gaps = 50/663 (7%)
Query: 14 EGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERL 73
+G+F E DP+ RY RYDE+LGKGAFKTVYKGFDEVDGIEVAWNQV I DV++SP LE+L
Sbjct: 28 KGDFVETDPTSRYVRYDEVLGKGAFKTVYKGFDEVDGIEVAWNQVRIADVLRSPKDLEKL 87
Query: 74 YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
+SEVHLL+SLKHENI++ NSWVDD +TINMITELFTSG+LRQYRKKHKNVDMKAIKNW
Sbjct: 88 HSEVHLLRSLKHENIMELCNSWVDDKKKTINMITELFTSGNLRQYRKKHKNVDMKAIKNW 147
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
ARQIL+GL YLH HNPPIIHRDLKCDNIFVNG+NG VKIGDLGLAI+MQQPTA SVIGTP
Sbjct: 148 ARQILQGLVYLHGHNPPIIHRDLKCDNIFVNGHNGVVKIGDLGLAIIMQQPTATSVIGTP 207
Query: 194 EFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 253
EFMA ELYEEEYNEL+DIYSFGMC+LEMVT EYPY+EC+NPAQIYKKVTSGIKPASL V
Sbjct: 208 EFMATELYEEEYNELIDIYSFGMCMLEMVTFEYPYSECRNPAQIYKKVTSGIKPASLGNV 267
Query: 254 TDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSE 313
+DPQVK+FI KC+VPAS RL A ELLKDPFL N + V DPL LPN P+ + S
Sbjct: 268 SDPQVKEFILKCLVPASERLSAKELLKDPFLQPQNLVEPVRDPLLLPNQYPKSSSATKSG 327
Query: 314 PHPMDIDLNHKKVSADSCAKSNT-GTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRI 372
P MDID ++K++S+ +C SN GT F E QR +N F L+G+++DD++VSLTLRI
Sbjct: 328 PLSMDIDADYKQISSSTCTGSNNEGTRFPVPEYQREHKNKVFKLKGKESDDNSVSLTLRI 387
Query: 373 GDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPS 432
D SG V NIHF+FYL++DTA+S+A EMV+QL+L+ DV IAE ID+LIMKL P W S
Sbjct: 388 ADSSGRVWNIHFLFYLDSDTALSVASEMVDQLELADHDVAFIAEFIDHLIMKLSPGWKLS 447
Query: 433 LGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLS---------ELA 483
+ ++ S + S+ CP + ++ +Q LS L
Sbjct: 448 SNYSLNELTSFYTASAALEN---SVACPWDSVLTTVLSQPAVEQEALSGMTTTPPEGSLQ 504
Query: 484 SGKYQYN--------------------QESSDSDISAEFDVPVILDAHIDKSL--VPD-- 519
+ + YN E DS S ++ V + D + +PD
Sbjct: 505 ADDFNYNDNRDGAVFHINYHSSPSFGYMEDQDSQTSGVSEILVEDVSSKDDRISELPDYN 564
Query: 520 ---------GYSAHYAVYD-HGGHEVKADEVSLGESILFNESTQNSETSFIDSCSGMSKN 569
GY++ + D + +++ ++ +GE I NE+ + SET F SG +
Sbjct: 565 TDGNCKYLNGYTSEPELRDSYSLRKLERNDSGVGECIPMNENAKVSETPF-PKLSGAPND 623
Query: 570 --LSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENARKRWLAGSN 627
++ SS SSL L K LKLELDAI ++YQ F++L R+RE+ +E+ +KRW A
Sbjct: 624 MSMTSSSSSSLYLVGKSMDTELKLELDAIEAQYQNWFRDLSRRREEALESTKKRWTAKKK 683
Query: 628 VSV 630
+ V
Sbjct: 684 LPV 686
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225470964|ref|XP_002266888.1| PREDICTED: probable serine/threonine-protein kinase WNK4-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 637 bits (1643), Expect = e-180, Method: Compositional matrix adjust.
Identities = 358/633 (56%), Positives = 437/633 (69%), Gaps = 31/633 (4%)
Query: 13 EEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER 72
+E + EKDP+ RY R+ EILGKGAFKTVYK FDEVDGIE+AWNQV I+DV++SP+ LE+
Sbjct: 8 DEAAYVEKDPTGRYVRFKEILGKGAFKTVYKAFDEVDGIEIAWNQVKIDDVLRSPEDLEK 67
Query: 73 LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKN 132
LYSEVHLLKSLKHENIIKFYNSWVDD +T+NMITELFTSGSLRQYRKKHKNVDMKAIKN
Sbjct: 68 LYSEVHLLKSLKHENIIKFYNSWVDDKKKTVNMITELFTSGSLRQYRKKHKNVDMKAIKN 127
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 192
WARQ+LRGL YLHSHNPPIIHRDLKCDNIFVNGN+GEVKIGDLGLAIVMQQPTARSVIGT
Sbjct: 128 WARQVLRGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIVMQQPTARSVIGT 187
Query: 193 PEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
PEFMAPELYEEEYNELVDIYSFGMC+LEMVT EYPYNECKNPAQIYKKVTSGIKPASL K
Sbjct: 188 PEFMAPELYEEEYNELVDIYSFGMCMLEMVTFEYPYNECKNPAQIYKKVTSGIKPASLCK 247
Query: 253 VTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHS 312
VTD Q+K+FI KC+ PAS RLPA ELLKDPF ++NPK+ + PL+LP+ P+ + L+ S
Sbjct: 248 VTDLQIKEFIVKCLAPASERLPAKELLKDPFFQSENPKEPIRVPLQLPSRSPKSIILSKS 307
Query: 313 EPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRI 372
P MDID +H ++S+ + ++N F LE QR+ +++EF LR +K +D+++SLTLR
Sbjct: 308 GPFSMDIDPDHPQLSSSTSTENNGSPDFPVLEFQRMYKSSEFRLRAKKINDNSISLTLRT 367
Query: 373 GDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNP- 431
D G V NIHF F L+ DT S+ EMVEQL+L+ +V IA+ ID +IM+L+P W P
Sbjct: 368 VDSYGPVKNIHFPFSLDTDTVHSVVGEMVEQLELAEHEVAFIADFIDYVIMRLLPGWKPP 427
Query: 432 ---SLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNA---FAEAVSQQGV------- 478
LG S P GN + C G N+ A A Q +
Sbjct: 428 RDDPLGGARSPN-----AEPPVLGNGNNHDCTISHGDGNSSPNLANAEDQDSLASAGLVT 482
Query: 479 LSELASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKAD 538
L+ AS K D +I + H + D Y H ++++ +
Sbjct: 483 LTVDASKKNDKTVGFGDYNIGGNYKGSN--GGHASEQESRDPY--------HEDYKLQRN 532
Query: 539 EVSLGESILFNESTQNSETSFIDSCSGMSK-NLSFSSISSLSLADKEHSDGLKLELDAIN 597
S+ E N+ +++ SF D SG+S S SSLSLAD + GLK ELDAI+
Sbjct: 533 NSSIEEFTPMNKFQKSTVLSF-DDLSGLSNVRSLTCSCSSLSLADIDQDPGLKQELDAID 591
Query: 598 SKYQQCFQELLRQREDEMENARKRWLAGSNVSV 630
+YQ FQEL R R + +E +KRW+ ++V
Sbjct: 592 LQYQHWFQELSRMRVEALEATKKRWMTKKKLAV 624
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 631 | ||||||
| TAIR|locus:2165790 | 563 | WNK8 "with no lysine (K) kinas | 0.665 | 0.746 | 0.689 | 3.2e-167 | |
| TAIR|locus:2093994 | 567 | WNK6 "with no lysine (K) kinas | 0.657 | 0.731 | 0.624 | 2.1e-143 | |
| TAIR|locus:2019404 | 524 | WNK10 "with no lysine (K) kina | 0.768 | 0.925 | 0.587 | 3.7e-142 | |
| TAIR|locus:2028521 | 557 | WNK7 [Arabidopsis thaliana (ta | 0.656 | 0.743 | 0.628 | 1.5e-138 | |
| TAIR|locus:2114845 | 700 | WNK1 "with no lysine (K) kinas | 0.446 | 0.402 | 0.696 | 4e-130 | |
| TAIR|locus:504955638 | 516 | WNK3 "with no lysine (K) kinas | 0.435 | 0.532 | 0.703 | 3.5e-124 | |
| TAIR|locus:2182039 | 492 | WNK9 [Arabidopsis thaliana (ta | 0.670 | 0.859 | 0.528 | 8.5e-120 | |
| TAIR|locus:2098242 | 549 | WNK5 "with no lysine (K) kinas | 0.461 | 0.530 | 0.641 | 9.8e-116 | |
| TAIR|locus:2161278 | 571 | WNK4 "with no lysine (K) kinas | 0.431 | 0.476 | 0.633 | 5.7e-107 | |
| TAIR|locus:2176135 | 314 | AT5G55560 [Arabidopsis thalian | 0.461 | 0.926 | 0.577 | 8.3e-90 |
| TAIR|locus:2165790 WNK8 "with no lysine (K) kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1498 (532.4 bits), Expect = 3.2e-167, Sum P(3) = 3.2e-167
Identities = 295/428 (68%), Positives = 338/428 (78%)
Query: 1 MDCGSGFTK--SETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQV 58
M GSGF S EE +F+EKDPS RY RYD++LG+GAFKTVYK FDEVDGIEVAWN V
Sbjct: 1 MASGSGFLGQISSMEEADFAEKDPSGRYIRYDDVLGRGAFKTVYKAFDEVDGIEVAWNLV 60
Query: 59 NIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY 118
+IEDVMQ P QLERLYSEVHLLK+LKHENIIK + SWVD+ N+TINMITELFTSGSLR Y
Sbjct: 61 SIEDVMQMPGQLERLYSEVHLLKALKHENIIKLFYSWVDEKNKTINMITELFTSGSLRVY 120
Query: 119 RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178
RKKH+ VD KAIKNWARQIL+GL+YLHS NPP+IHRDLKCDNIFVNGN GEVKIGDLGLA
Sbjct: 121 RKKHRKVDPKAIKNWARQILKGLNYLHSQNPPVIHRDLKCDNIFVNGNTGEVKIGDLGLA 180
Query: 179 IVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
V+QQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPYNEC+N AQIY
Sbjct: 181 TVLQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYNECRNQAQIY 240
Query: 239 KKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLR 298
KKVTS IKP SL KV DPQV+QFIEKC++PAS R ALEL KDPFL D KD L
Sbjct: 241 KKVTSNIKPQSLGKVDDPQVRQFIEKCLLPASSRPTALELSKDPFLARDGGKDSAL--LA 298
Query: 299 LPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRG 358
+ + + E PMD+D N K S + + W T+ELQR+ EN EF LRG
Sbjct: 299 SSSTSSKYVRPPQLEHLPMDVDHNENK----SVSSNEDYPWSQTIELQRIAENKEFRLRG 354
Query: 359 EKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELI 418
E++DD T S+ LRI D SG +HF FYL +DTA +IAEEMVE+L L+ ++VV IA++I
Sbjct: 355 ERSDDVTASMVLRIADPSGKCRIVHFAFYLESDTATAIAEEMVEELHLTSQEVVVIADMI 414
Query: 419 DNLIMKLV 426
D+ IM+L+
Sbjct: 415 DDFIMQLL 422
|
|
| TAIR|locus:2093994 WNK6 "with no lysine (K) kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1357 (482.7 bits), Expect = 2.1e-143, Sum P(2) = 2.1e-143
Identities = 269/431 (62%), Positives = 329/431 (76%)
Query: 11 ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL 70
E + E E DP+ RY RY E++GKGAFKTVYK FDEVDGIEVAWNQV I+DV+QSP+ L
Sbjct: 12 EPPDPEVLEVDPTFRYIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVRIDDVLQSPNCL 71
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
ERLYSEV LLKSLKH NII+FYNSW+DD N+T+N+ITELFTSGSLR YRKKH+ V+MKA+
Sbjct: 72 ERLYSEVRLLKSLKHNNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKHRKVNMKAV 131
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
KNWARQIL GL YLH PPIIHRDLKCDNIF+NGN+GEVKIGDLGLA VM+Q A+SVI
Sbjct: 132 KNWARQILMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVI 191
Query: 191 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250
GTPEFMAPELY+E YNEL DIYSFGMC+LEMVT +YPY ECKN AQIYKKV+SGIKPASL
Sbjct: 192 GTPEFMAPELYDENYNELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSSGIKPASL 251
Query: 251 SKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV-PE---- 305
S+V DP+VKQFIEKC++PAS RL A ELL DPFL + + +PL LP++V P+
Sbjct: 252 SRVKDPEVKQFIEKCLLPASERLSAKELLLDPFLQLNGLT--MNNPLPLPDIVMPKEGAF 309
Query: 306 ----VMNLAHSEPHP---MDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRG 358
+M+ P + IDL+ N+G+ +E++R N F L+G
Sbjct: 310 GDRCLMSEGPPTTRPSKTLSIDLDEDSNLPIVTFSDNSGS--RCIEVRRAKRGNFFVLKG 367
Query: 359 EKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELI 418
E+ND+ +VSL LRI D++G V NIHF+FY DTA ++ EMVEQL+L+ ++V IAELI
Sbjct: 368 EENDEQSVSLILRIVDENGRVRNIHFLFYQEGDTASKVSSEMVEQLELTDQNVTFIAELI 427
Query: 419 DNLIMKLVPSW 429
D L++ ++P+W
Sbjct: 428 DILLVNMIPTW 438
|
|
| TAIR|locus:2019404 WNK10 "with no lysine (K) kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1390 (494.4 bits), Expect = 3.7e-142, P = 3.7e-142
Identities = 293/499 (58%), Positives = 346/499 (69%)
Query: 13 EEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER 72
EE +F +KDP+ RY RY+++LG+GAFKTVYK FDEV+GIEVAWN ++IEDV+Q P QL+R
Sbjct: 2 EEADFVQKDPTGRYIRYNDVLGRGAFKTVYKAFDEVEGIEVAWNLMSIEDVLQMPGQLDR 61
Query: 73 LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKN 132
LYSEVHLL SLKH+NIIK + SWVDD N++INMITELFTSGSL YRKKH+ VD KAI N
Sbjct: 62 LYSEVHLLNSLKHDNIIKLFYSWVDDHNKSINMITELFTSGSLTLYRKKHRKVDPKAIMN 121
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 192
WARQIL+GLHYLHS PP+IHRDLKCDNIFVNGN G+VKIGDLGLA VMQQPTARSVIGT
Sbjct: 122 WARQILKGLHYLHSQTPPVIHRDLKCDNIFVNGNTGKVKIGDLGLAAVMQQPTARSVIGT 181
Query: 193 PEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
PEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPY EC+N AQIYKKVTSGIKP SLSK
Sbjct: 182 PEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYRECRNQAQIYKKVTSGIKPQSLSK 241
Query: 253 VTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHS 312
V DPQVKQFIEKC++PA R ALELLKD L D KD P +
Sbjct: 242 VDDPQVKQFIEKCLLPAPSRPTALELLKDQLLAVDGAKDSTLTASSNTTFKPAMP--PQC 299
Query: 313 EPHPMDIDLN-HKKVSADSCAKSNTGTWFL-TLELQRLTENNEFTLRGEKNDDDTVSLTL 370
E PMD++ + VS S AKS+ L T+E+QR+ E+ EF L GE+ DD S+ L
Sbjct: 300 EYRPMDVEYKKNTSVSICSSAKSSQECALLQTMEVQRVAESTEFKLSGERRDDVAASMAL 359
Query: 371 RIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWN 430
RI SG + F F L DTA ++ EMVE+LDLS +V IAE+ID LIMKL N
Sbjct: 360 RIAGSSGQARKVDFDFNLKTDTARAVTGEMVEELDLSSHEVTVIAEMIDELIMKLKA--N 417
Query: 431 PSLGSTASQQNGLLKGSPVSQGNSISL----KCPGEPGSN-NAFAEAVSQQGVLSELASG 485
SL + S + + S + IS + GS EAV + +LS
Sbjct: 418 RSLPNANSVYQSKDEEAGESMKSEISADYYHRVSSNEGSRLGCCCEAV--ESLLSSFLDS 475
Query: 486 KYQYNQESSDSDISAEFDV 504
+ + S+ D+ E +V
Sbjct: 476 CSMVSNKQSE-DLKTELNV 493
|
|
| TAIR|locus:2028521 WNK7 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1356 (482.4 bits), Expect = 1.5e-138, P = 1.5e-138
Identities = 271/431 (62%), Positives = 336/431 (77%)
Query: 11 ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL 70
E + E E DP+CRY RY E++GKGA KTV+KGFDEVDGIEVAWNQV I+D++QSPD L
Sbjct: 12 EPPDPEVLEIDPTCRYIRYKEVIGKGASKTVFKGFDEVDGIEVAWNQVRIDDLLQSPDCL 71
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
ERLYSEV LLKSLKH+NII+FYNSW+DD N+T+N+ITELFTSGSLRQYRKKH+ V+MKA+
Sbjct: 72 ERLYSEVRLLKSLKHKNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYRKKHRKVNMKAV 131
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
K WARQIL GL YLHS +PPIIHRD+KCDNIF+NGN+GEVKIGDLGLA VM+Q A+SVI
Sbjct: 132 KCWARQILTGLKYLHSQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVI 191
Query: 191 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250
GTPEFMAPELY+E YNEL DIYSFGMC+LEMVT EYPY EC+N AQIYKKV+SGIKPASL
Sbjct: 192 GTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYCECRNSAQIYKKVSSGIKPASL 251
Query: 251 SKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD-PLRLPNLV-PEVMN 308
SKV DP+V +FIEKC++PAS RL A ELL D FL N LV + PL LP++V P+ +
Sbjct: 252 SKVKDPEVMKFIEKCLLPASERLSAEELLLDSFL---NVNGLVMNNPLPLPDIVMPKEGS 308
Query: 309 LAH----SEPHP------MDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRG 358
SE P M ++L+ + +N+GT +E++R N F L+G
Sbjct: 309 FGERCLMSEGPPNARNRTMSMNLDEDNNLPIVISSNNSGT--NCIEVRRAKRGNFFVLKG 366
Query: 359 EKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELI 418
E+ND+++VSL LRI D++G V NIHF+F+ DTA +++ EMVEQL+L+ ++V IAELI
Sbjct: 367 EENDENSVSLILRIVDENGRVRNIHFLFFQEGDTASNVSSEMVEQLELTDKNVKFIAELI 426
Query: 419 DNLIMKLVPSW 429
D L++ L+P+W
Sbjct: 427 DVLLVNLIPNW 437
|
|
| TAIR|locus:2114845 WNK1 "with no lysine (K) kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1071 (382.1 bits), Expect = 4.0e-130, Sum P(3) = 4.0e-130
Identities = 197/283 (69%), Positives = 234/283 (82%)
Query: 11 ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL 70
E + EF E DP+ RYGRY+E+LGKGA KTVY+ FDE +GIEVAWNQV + D +QSP+ L
Sbjct: 8 EPDYSEFVEVDPTGRYGRYNEVLGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDL 67
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
ERLY E+HLLK+LKH+NI+KFY SWVD NR IN +TELFTSG+LRQYR +HK V+++A+
Sbjct: 68 ERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHKRVNIRAM 127
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
K+W RQILRGLHYLHSH+PP+IHRDLKCDNIFVNGN GEVKIGDLGLA ++++ A +
Sbjct: 128 KHWCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCV 187
Query: 191 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250
GTPEFMAPE+YEE YNELVDIYSFGMCILEMVT +YPY+EC +PAQIYKKV SG KP +L
Sbjct: 188 GTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMSGKKPDAL 247
Query: 251 SKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL-VTDNPKDL 292
KV DP+VK FIEKC+ SLR+ A ELL DPFL + D DL
Sbjct: 248 YKVKDPEVKCFIEKCLATVSLRVSARELLDDPFLRIDDGEFDL 290
|
|
| TAIR|locus:504955638 WNK3 "with no lysine (K) kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1053 (375.7 bits), Expect = 3.5e-124, Sum P(2) = 3.5e-124
Identities = 195/277 (70%), Positives = 235/277 (84%)
Query: 9 KSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD 68
++ +EE EF E DP+ RYGRY E+LGKGAFK VY+ FD+++GIEVAWNQV ++D S +
Sbjct: 5 ENNSEE-EFVEIDPTGRYGRYKEVLGKGAFKEVYRAFDQLEGIEVAWNQVKLDDKFCSSE 63
Query: 69 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
L+RLYSEVHLLK+LKH++IIKFY SW+D + TIN+ITE+FTSG+LRQYRKKHK VD++
Sbjct: 64 DLDRLYSEVHLLKTLKHKSIIKFYTSWIDHQHMTINLITEVFTSGNLRQYRKKHKCVDLR 123
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TAR 187
A+K W+RQIL GL YLHSH+PP+IHRDLKCDNIF+NGN GEVKIGDLGLA ++ + +A
Sbjct: 124 ALKKWSRQILEGLVYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILHRARSAH 183
Query: 188 SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 247
SVIGTPEFMAPELYEE+YN LVDIY+FGMC+LE+VT EYPY+EC N AQIY+KVTSGIKP
Sbjct: 184 SVIGTPEFMAPELYEEDYNVLVDIYAFGMCLLELVTFEYPYSECTNAAQIYRKVTSGIKP 243
Query: 248 ASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 284
A+L VTDPQV+ FIEKCI S RL A ELL DPFL
Sbjct: 244 AALLNVTDPQVRAFIEKCIAKVSQRLSAKELLDDPFL 280
|
|
| TAIR|locus:2182039 WNK9 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1179 (420.1 bits), Expect = 8.5e-120, P = 8.5e-120
Identities = 239/452 (52%), Positives = 311/452 (68%)
Query: 11 ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL 70
E++ E+ E DP+ RYGRY+E+LGKG+ KTVY+GFDE GIEVAWNQV + D +QSP +L
Sbjct: 9 ESDYSEYVEVDPTGRYGRYNEVLGKGSSKTVYRGFDEYQGIEVAWNQVKLYDFLQSPQEL 68
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
ERLY E+HLLK+LKH++I+KFY SWVD NR IN +TE+FTSG+LRQYR KHK V+++A+
Sbjct: 69 ERLYCEIHLLKTLKHKSIMKFYASWVDTDNRNINFVTEMFTSGTLRQYRLKHKRVNIRAV 128
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
KNW RQILRGL+YLH+H+PP+IHRDLKCDNIF+NGN GEVKIGDLGLA +Q A +
Sbjct: 129 KNWCRQILRGLNYLHTHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAACLQHSHAAHCV 188
Query: 191 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250
GTPEFMAPE+Y+EEYN+LVDIYSFGMC+LEMVT +YPY+EC +PAQIYK+V SG KP L
Sbjct: 189 GTPEFMAPEVYKEEYNQLVDIYSFGMCVLEMVTFDYPYSECSHPAQIYKRVISGKKPDGL 248
Query: 251 SKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTD--------NPKDLVCD---PLRL 299
KV DP+V+ FIEKC+ SLRL A ELL D FL D + K L+ + PLR
Sbjct: 249 DKVKDPEVRGFIEKCLATVSLRLSACELLDDHFLCIDESDMRRVESEKGLIDEAGTPLRH 308
Query: 300 PNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNE------ 353
+P N +S + D N D +S+ LE Q + E
Sbjct: 309 SYHIPHYSNGYYSLYNQNQWDYN-----GDETVESHE---IDLLEFQNDDDEEEEDKRFG 360
Query: 354 ---FTLRGEKNDD-DTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHE 409
+++G++ D+ D + L L+ +K G V NI+F F + DTAIS+A EMVE+L++
Sbjct: 361 SVDISIKGKRRDNGDGLFLRLKTVNKEGCVRNIYFPFDIETDTAISVAREMVEELEMDDR 420
Query: 410 DVVSIAELIDNLIMKLVPSWNPSLGSTASQQN 441
DV IA +ID I LVP+W+ S +++ +
Sbjct: 421 DVTKIANMIDGEIASLVPNWSIFCSSESNRSS 452
|
|
| TAIR|locus:2098242 WNK5 "with no lysine (K) kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1003 (358.1 bits), Expect = 9.8e-116, Sum P(2) = 9.8e-116
Identities = 190/296 (64%), Positives = 234/296 (79%)
Query: 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
+ E DPS RYGR+ E+LGKGA KTVYK FD+V G+EVAWNQV + +V +SP+ L+RLYSE
Sbjct: 15 YVETDPSGRYGRFREVLGKGAMKTVYKAFDQVLGMEVAWNQVKLNEVFRSPEPLQRLYSE 74
Query: 77 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ 136
VHLLK+L HE+II++ SW+D RT N ITELFTSG+LR+YR+K++ VD++AIK+WARQ
Sbjct: 75 VHLLKNLNHESIIRYCTSWIDVNRRTFNFITELFTSGTLREYRRKYQKVDIRAIKSWARQ 134
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEF 195
IL GL YLH H+PP+IHRDLKCDNIFVNG+ G+VKIGDLGLA +++ A SVIGTPEF
Sbjct: 135 ILNGLAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQNAHSVIGTPEF 194
Query: 196 MAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255
MAPELYEE+YNELVDIYSFGMC+LEM+T EYPY+EC NPAQIYKKVTSG P S +
Sbjct: 195 MAPELYEEDYNELVDIYSFGMCVLEMLTGEYPYSECTNPAQIYKKVTSGKLPDSFHLIQH 254
Query: 256 PQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNLA 310
+ ++F+ KC+ S RLPA ELL DPFL + +DL PL RLP + + NLA
Sbjct: 255 TEAQRFVGKCLETVSRRLPAKELLADPFLAATDERDLA--PLFRLPQQLA-IQNLA 307
|
|
| TAIR|locus:2161278 WNK4 "with no lysine (K) kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 947 (338.4 bits), Expect = 5.7e-107, Sum P(2) = 5.7e-107
Identities = 173/273 (63%), Positives = 221/273 (80%)
Query: 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
E+ E DP+ RYGR+ EILG+GA KTVYK DE GIEVAW+QV +++V++S L+RLYS
Sbjct: 8 EYVETDPTGRYGRFAEILGRGAMKTVYKAIDEKLGIEVAWSQVKLKEVLRSSVDLQRLYS 67
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
EVHLL +L H++II+FY SW+D N T+N ITELFTSG+LRQY+ K+ +D++AIK+WAR
Sbjct: 68 EVHLLSTLNHKSIIRFYTSWIDVHNHTLNFITELFTSGTLRQYKNKYLRIDIRAIKSWAR 127
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPE 194
QIL GL YLH H+PP+IHRDLKCDNIFVNG+ G+VKIGDLGLA +++ +A S+IGTPE
Sbjct: 128 QILEGLVYLHEHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLARMLRDCHSAHSIIGTPE 187
Query: 195 FMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254
FMAPELYEE YNEL+D+YSFGMC LEM+T E+PY+EC +PAQIYKKV G P + +V
Sbjct: 188 FMAPELYEENYNELIDVYSFGMCFLEMITSEFPYSECNHPAQIYKKVVGGKLPGAFYRVG 247
Query: 255 DPQVKQFIEKCIVPASLRLPALELLKDPFLVTD 287
D + ++FI KC+V AS R+ A ELL+DPFL +D
Sbjct: 248 DIEAQRFIGKCLVSASKRVSAKELLQDPFLASD 280
|
|
| TAIR|locus:2176135 AT5G55560 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 896 (320.5 bits), Expect = 8.3e-90, P = 8.3e-90
Identities = 172/298 (57%), Positives = 219/298 (73%)
Query: 1 MDCGSGF-TKSETEEGE--FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQ 57
M C S +SE ++ F E DP+ RYGRY E+LG GA K VY+ FD+ +GIEVAWNQ
Sbjct: 2 MTCASSDDNESEKDKDSESFVEVDPTGRYGRYGELLGSGAVKKVYRAFDQEEGIEVAWNQ 61
Query: 58 VNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ 117
V + P ERLYSEV LLK+LK+ NII Y W D+ N T+N ITE+ TSG+LR+
Sbjct: 62 VKLRCFSDDPAMTERLYSEVRLLKNLKNSNIITLYKVWRDERNNTLNFITEICTSGNLRE 121
Query: 118 YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177
YRKKH++V M+A+K W++QIL+GL YLH+H+P IIHRDL C NIFVNGN G+VKIGDLGL
Sbjct: 122 YRKKHRHVSMRALKKWSKQILKGLDYLHTHDPCIIHRDLNCSNIFVNGNIGQVKIGDLGL 181
Query: 178 A-IVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ 236
A IV + A S++GTPEFMAPELYEE Y E+VDIYS+GMC+LE+V+ E PY+EC + A+
Sbjct: 182 AAIVGKNHLAHSILGTPEFMAPELYEENYTEMVDIYSYGMCVLELVSLEIPYSECDSVAK 241
Query: 237 IYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPF---LVTDNPKD 291
IYK+V+ G+KP +L+KV DP+ K FIEKCI R A ELL DPF ++ D+ +D
Sbjct: 242 IYKRVSKGLKPEALNKVNDPEAKAFIEKCIAQPRARPSAAELLCDPFFDGILDDDDED 299
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q6EU49 | WNK4_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.5184 | 0.9366 | 0.9656 | yes | no |
| Q944Q0 | WNK8_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5498 | 0.8684 | 0.9733 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 631 | |||
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-71 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-70 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-62 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-57 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-53 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-53 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-51 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-51 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-47 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-42 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-42 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-42 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-42 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-40 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-39 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-39 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-39 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-38 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-37 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-37 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-37 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-37 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-36 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-36 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-36 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-36 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-35 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-34 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-34 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-34 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-33 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-33 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-33 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-33 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-32 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-32 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-32 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-32 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-31 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-31 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-30 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-29 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-29 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-29 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-29 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-29 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-29 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-28 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-27 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-27 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-27 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-27 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-27 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-27 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-27 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-26 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-26 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-25 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-25 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-25 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-25 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-25 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-25 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-24 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-24 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-24 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-23 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-23 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-23 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-23 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-23 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-23 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-23 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-22 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-22 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-22 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-22 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-21 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-21 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-21 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-21 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-20 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-20 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-20 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-19 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-19 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-19 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-19 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-19 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-18 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-18 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-18 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-18 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-18 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-18 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-18 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-17 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-17 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-17 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-17 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-16 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-16 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-15 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-15 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-15 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-15 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-14 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-14 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-14 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-13 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-13 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-13 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-10 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-08 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 9e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.002 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 230 bits (588), Expect = 4e-71
Identities = 96/260 (36%), Positives = 141/260 (54%), Gaps = 11/260 (4%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E+LG+G+F +VY D+ G +A V + S ++LE L E+ +L SL+H NI++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSG--DSEEELEALEREIRILSSLQHPNIVR 63
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
+Y S D+ T+N+ E + GSL KK + I+ + RQIL GL YLHS+
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG-- 121
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYE-EEY 205
I+HRD+K NI V ++G VK+ D G A + SV GTP +MAPE+ EEY
Sbjct: 122 IVHRDIKGANILV-DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180
Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
DI+S G ++EM T + P++E NP K+ S +P + + + K F+ KC
Sbjct: 181 GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKC 240
Query: 266 IVP-ASLRLPALELLKDPFL 284
+ R A ELL+ PFL
Sbjct: 241 LRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 227 bits (580), Expect = 6e-70
Identities = 87/259 (33%), Positives = 132/259 (50%), Gaps = 14/259 (5%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E LG+G+F VY D+ G VA + + + ER+ E+ +LK LKH NI++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI---KKDRERILREIKILKKLKHPNIVR 61
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
Y+ + D+ + ++ E G L KK + + + RQIL L YLHS
Sbjct: 62 LYDVFEDEDK--LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG-- 117
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPE-LYEEEYNEL 208
I+HRDLK +NI ++ +G VK+ D GLA + + +GTPE+MAPE L + Y +
Sbjct: 118 IVHRDLKPENILLD-EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA 176
Query: 209 VDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT-DPQVKQFIEKCI 266
VDI+S G IL E++T + P+ +++KK+ P + P+ K I K +
Sbjct: 177 VDIWSLG-VILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLL 235
Query: 267 VP-ASLRLPALELLKDPFL 284
V RL A E L+ PF
Sbjct: 236 VKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 207 bits (528), Expect = 2e-62
Identities = 80/263 (30%), Positives = 128/263 (48%), Gaps = 16/263 (6%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
LG G+F TVYK + G VA + + + + E+ +L+ L H NI++
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS--EKSKKDQTARREIRILRRLSHPNIVR 62
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
+++ D + + ++ E G L Y + + K A QILRGL YLHS+
Sbjct: 63 LIDAFEDKDH--LYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG-- 118
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPE--LYEEEYN 206
IIHRDLK +NI ++ NG VKI D GLA + + + +GTP +MAPE L Y
Sbjct: 119 IIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK--KVTSGIKPASLSKVTD--PQVKQFI 262
VD++S G+ + E++T + P++ Q+ ++ K + + K I
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 263 EKCIVP-ASLRLPALELLKDPFL 284
+KC+ S R A E+L+ P+
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 190 bits (486), Expect = 6e-57
Identities = 79/256 (30%), Positives = 122/256 (47%), Gaps = 47/256 (18%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG+G F TVY D+ G +VA + ED S LE L E+ +LK L H NI+K Y
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED---SSSLLEELLREIEILKKLNHPNIVKLY 57
Query: 93 NSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
+ D+ + + ++ E GSL+ ++ + I QIL GL YLHS+ I
Sbjct: 58 GVFEDENH--LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--I 113
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE--EYNE 207
IHRDLK +NI ++ +NG+VK+ D GL+ ++ ++++GTP +MAPE+ Y+E
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 267
DI+S G+ + E+ P++K I K +
Sbjct: 174 KSDIWSLGVILYEL----------------------------------PELKDLIRKMLQ 199
Query: 268 P-ASLRLPALELLKDP 282
R A E+L+
Sbjct: 200 KDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 2e-53
Identities = 94/262 (35%), Positives = 147/262 (56%), Gaps = 17/262 (6%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ-LERLYSEVHLLKSLKHENII 89
E+LG G+F +VY+G + DG A +V++ D Q+ + +++L E+ LL L+H NI+
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
++ + ++ N + + EL GSL + KK+ + I+ + RQIL GL YLH N
Sbjct: 66 QYLGTEREEDN--LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN- 122
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAPELY--EEEYN 206
+HRD+K NI V+ NG VK+ D G+A V++ A+S G+P +MAPE+ + Y
Sbjct: 123 -TVHRDIKGANILVD-TNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180
Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLSKVTDPQVKQFIE 263
DI+S G +LEM T + P+++ + A ++K S P LS + K FI
Sbjct: 181 LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLS----DEAKDFIL 236
Query: 264 KCI-VPASLRLPALELLKDPFL 284
KC+ SLR A ELL+ PF+
Sbjct: 237 KCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 2e-53
Identities = 95/282 (33%), Positives = 146/282 (51%), Gaps = 24/282 (8%)
Query: 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
SE DP Y E +G+GA VYK D G EVA ++ + E + +E+
Sbjct: 13 SEGDPRELYKNL-EKIGEGASGEVYKATDRATGKEVAIKKMRLRK-----QNKELIINEI 66
Query: 78 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKNW 133
++K KH NI+ +Y+S++ + ++ E GSL Q + + +
Sbjct: 67 LIMKDCKHPNIVDYYDSYLVG--DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV--- 121
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 191
R++L+GL YLHS N +IHRD+K DNI ++ +G VK+ D G A + ++ SV+G
Sbjct: 122 CREVLQGLEYLHSQN--VIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVG 178
Query: 192 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGIKPAS 249
TP +MAPE+ + ++Y VDI+S G+ +EM E PY + P + ++ T GI P
Sbjct: 179 TPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR-EPPLRALFLITTKGIPPLK 237
Query: 250 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
+ P+ K F+ KC+V R A ELL+ PFL PK
Sbjct: 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPK 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 1e-51
Identities = 80/267 (29%), Positives = 139/267 (52%), Gaps = 19/267 (7%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
+Y+ I +GKG+F VY + DG ++++ + S + E +EV +LK L H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN--MSEKEREDALNEVKILKKLNH 58
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM----KAIKNWARQILRGL 141
NIIK+Y S+ + + ++ E G L Q KK K + I +W Q+ L
Sbjct: 59 PNIIKYYESFEEKGK--LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE 199
YLHS I+HRD+K NIF+ +NG VK+GD G++ V+ A++V+GTP +++PE
Sbjct: 117 KYLHSRK--ILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPE 173
Query: 200 LYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258
L + + YN DI+S G + E+ T ++P+ E +N ++ K+ G + + ++
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPF-EGENLLELALKILKG-QYPPIPSQYSSEL 231
Query: 259 KQFIEKCIVP-ASLRLPALELLKDPFL 284
+ + + R ++L+ PF+
Sbjct: 232 RNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 5e-51
Identities = 88/258 (34%), Positives = 143/258 (55%), Gaps = 15/258 (5%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E +GKG F VYK + G EVA + +E S ++ E++ +E+ +LK KH NI+K
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLE----SKEKKEKIINEIQILKKCKHPNIVK 61
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQ-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
+Y S++ I M E + GSL+ + ++ + I +++L+GL YLHS+
Sbjct: 62 YYGSYLKKDELWIVM--EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG- 118
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTPEFMAPE-LYEEEYNE 207
IIHRD+K NI + ++GEVK+ D GL+ + AR +++GTP +MAPE + + Y+
Sbjct: 119 -IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDY 176
Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQFIEKCI 266
DI+S G+ +E+ + PY+E ++K T+G + K +D K F++KC+
Sbjct: 177 KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDE-FKDFLKKCL 235
Query: 267 VPA-SLRLPALELLKDPF 283
R A +LLK PF
Sbjct: 236 QKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 8e-47
Identities = 88/258 (34%), Positives = 142/258 (55%), Gaps = 13/258 (5%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+++G+GAF VYKG + G VA Q+++E + + L+ + E+ LLK+LKH NI+K
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
+ S +T+ ++ +I E +GSLRQ KK + + Q+L+GL YLH
Sbjct: 64 YIGSI--ETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG-- 119
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYEEE-YNE 207
+IHRD+K NI +G VK+ D G+A + SV+GTP +MAPE+ E +
Sbjct: 120 VIHRDIKAANILTTK-DGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAST 178
Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 267
DI+S G ++E++T PY + A +++ V P L + P++K F+ +C
Sbjct: 179 ASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP--LPEGISPELKDFLMQCFQ 236
Query: 268 P-ASLRLPALELLKDPFL 284
+LR A +LLK P++
Sbjct: 237 KDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 1e-42
Identities = 90/264 (34%), Positives = 140/264 (53%), Gaps = 14/264 (5%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLKHE 86
R ++LG+GAF VY +D G E+A QV + D ++ ++ L E+ LLK+L+HE
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE 64
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
I+++Y DD +I M E GS++ K + + + + RQIL G+ YLHS
Sbjct: 65 RIVQYYGCLRDDETLSIFM--EYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS 122
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVIGTPEFMAPELY 201
+ I+HRD+K NI + + G VK+GD G + I +SV GTP +M+PE+
Sbjct: 123 NM--IVHRDIKGANI-LRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 202 E-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
E Y D++S G ++EM+T + P+ E + A I+K T P S V P +
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHV-SPDARN 238
Query: 261 FIEKCIVPASLRLP-ALELLKDPF 283
F+ + V + + P A ELL+ F
Sbjct: 239 FLRRTFVENAKKRPSAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 1e-42
Identities = 82/265 (30%), Positives = 146/265 (55%), Gaps = 16/265 (6%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E +GKG+F TV K + DG + W +++ + M ++ ++L SEV++L+ LKH NI++
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN-MTEKEK-QQLVSEVNILRELKHPNIVR 63
Query: 91 FYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
+Y+ +D +N+T+ ++ E G L ++ +K+ K ++ + I Q+L L+ H+
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 147 HNPP---IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-L 200
+ P ++HRDLK NIF++ NN VK+GD GLA ++ + A++ +GTP +M+PE L
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANN-NVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL 182
Query: 201 YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
Y+E DI+S G I E+ P+ +N Q+ K+ G + ++ +
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPPF-TARNQLQLASKIKEGKFR-RIPYRYSSELNE 240
Query: 261 FIEKCI-VPASLRLPALELLKDPFL 284
I+ + V R ELL+ P +
Sbjct: 241 VIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 3e-42
Identities = 90/267 (33%), Positives = 141/267 (52%), Gaps = 25/267 (9%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+G G F VY + G +A ++ I+D P ++ + E+ +L+ LKH N++K+Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQD--NDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
V I M E + G+L + + + +D I+ + Q+L GL YLHSH I+
Sbjct: 66 GVEVHREKVYIFM--EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IV 121
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR------SVIGTPEFMAPELY----E 202
HRD+K NIF+ +NG +K+GD G A+ ++ T S+ GTP +MAPE+
Sbjct: 122 HRDIKPANIFL-DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLSKVTDPQVK 259
+ + DI+S G +LEM T + P++E N QI V +G KP SL P+ K
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQL--SPEGK 238
Query: 260 QFIEKCIV--PASLRLPALELLKDPFL 284
F+++C+ P R A ELL+ PF+
Sbjct: 239 DFLDRCLESDP-KKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 7e-42
Identities = 74/259 (28%), Positives = 133/259 (51%), Gaps = 15/259 (5%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG+G+ VYK + G A +++++ + ++L E+ L+S + ++K Y
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDG---DEEFRKQLLRELKTLRSCESPYVVKCY 65
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPI 151
++ I+++ E GSL KK + + ARQIL+GL YLH+ + I
Sbjct: 66 GAF--YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--I 121
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE-LYEEEYNEL 208
IHRD+K N+ +N + GEVKI D G++ V++ + +GT +M+PE + E Y+
Sbjct: 122 IHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYA 180
Query: 209 VDIYSFGMCILEMVTCEYPY--NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266
DI+S G+ +LE ++P+ + ++ + + G P+ ++ P+ + FI C+
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACL 240
Query: 267 VP-ASLRLPALELLKDPFL 284
R A ELL+ PF+
Sbjct: 241 QKDPKKRPSAAELLQHPFI 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 9e-40
Identities = 90/264 (34%), Positives = 143/264 (54%), Gaps = 11/264 (4%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLKHE 86
R ++LG+GAF VY +D G E+A QV + + ++ ++ L E+ LLK+L HE
Sbjct: 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE 64
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
I+++Y D RT+++ E GS++ K + + + + RQIL G+ YLHS
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS 124
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVIGTPEFMAPELY 201
+ I+HRD+K NI + + G VK+GD G + I + +SV GTP +M+PE+
Sbjct: 125 NM--IVHRDIKGANILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 202 E-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
E Y DI+S G ++EM+T + P+ E + A I+K T P V+D +
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD-HCRD 240
Query: 261 FIEKCIVPASLRLPALELLKDPFL 284
F+++ V A LR A ELL+ F+
Sbjct: 241 FLKRIFVEAKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 85/283 (30%), Positives = 136/283 (48%), Gaps = 31/283 (10%)
Query: 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
+ + I GKG+F VYK D+ VA +++E+ + D++E + E+ L +
Sbjct: 2 LFTLLECI-GKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCR 57
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
I K+Y S++ + I M E GS K K +D I R++L GL YL
Sbjct: 58 SPYITKYYGSFLKGSKLWIIM--EYCGGGSCLDLLKPGK-LDETYIAFILREVLLGLEYL 114
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY- 201
H IHRD+K NI ++ G+VK+ D G++ + ++ + +GTP +MAPE+
Sbjct: 115 HEEGK--IHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIK 171
Query: 202 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASL--SKVTDP 256
+ Y+E DI+S G+ +E+ E P ++ +P +V I P SL +K + P
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPPLSD-LHPM----RVLFLIPKNNPPSLEGNKFSKP 226
Query: 257 QVKQFIEKCIV--PASLRLPALELLKDPFL----VTDNPKDLV 293
K F+ C+ P R A ELLK F+ T L+
Sbjct: 227 -FKDFVSLCLNKDPKE-RPSAKELLKHKFIKKAKKTSYLTLLI 267
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 78/244 (31%), Positives = 128/244 (52%), Gaps = 14/244 (5%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+GKG F VYK +DG VA +V I ++M + E+ LLK L H N+IK+
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-DAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 93 NSWVDDTNRTINMITELFTSGSLRQ----YRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
S+++ N +N++ EL +G L + ++K+ + + + I + Q+ L ++HS
Sbjct: 69 ASFIE--NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR 126
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-LYEEEY 205
I+HRD+K N+F+ G VK+GDLGL T A S++GTP +M+PE ++E Y
Sbjct: 127 --IMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 206 NELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
N DI+S G + EM + P Y + N + KK+ P + +++ + +
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSR 243
Query: 265 CIVP 268
CI P
Sbjct: 244 CINP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 145 bits (366), Expect = 3e-39
Identities = 89/263 (33%), Positives = 141/263 (53%), Gaps = 11/263 (4%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLKHE 86
R ++LG+GAF VY +D G E+A QV + + ++ ++ L E+ LLK+L+HE
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE 64
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
I+++Y D +T+ + E GS++ K + + + + RQIL G+ YLHS
Sbjct: 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVIGTPEFMAPELY 201
+ I+HRD+K NI + + G VK+GD G + I M RSV GTP +M+PE+
Sbjct: 125 NM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 202 E-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
E Y D++S G ++EM+T + P+ E + A I+K T P S +++ +
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE-HARD 240
Query: 261 FIEKCIVPASLRLPALELLKDPF 283
F+ V A R A ELL+ PF
Sbjct: 241 FLGCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 6e-38
Identities = 86/263 (32%), Positives = 141/263 (53%), Gaps = 11/263 (4%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLKHE 86
R ++LG+GAF VY +D G E+A QV + D ++ ++ L E+ LLK+L+H+
Sbjct: 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD 64
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
I+++Y D + +++ E GS++ K + + + + RQIL+G+ YLHS
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS 124
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVIGTPEFMAPELY 201
+ I+HRD+K NI + + G VK+GD G + I M +SV GTP +M+PE+
Sbjct: 125 NM--IVHRDIKGANILRD-SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 202 E-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
E Y D++S ++EM+T + P+ E + A I+K T KP V+D +
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD-ACRD 240
Query: 261 FIEKCIVPASLRLPALELLKDPF 283
F+++ V R A LL+ PF
Sbjct: 241 FLKQIFVEEKRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 79/260 (30%), Positives = 143/260 (55%), Gaps = 15/260 (5%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+GKG+F V+K + D A Q+++ M ++ E + E +L L II+
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK-MNRREREEAI-DEARVLAKLDSSYIIR 63
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR--QILRGLHYLHSHN 148
+Y S++D +N++ E +G L + K + + + W QIL GL +LHS
Sbjct: 64 YYESFLDK--GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEEE-Y 205
I+HRD+K N+F++ + VKIGDLG+A ++ T A +++GTP +++PEL E++ Y
Sbjct: 122 --ILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPY 178
Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
NE D+++ G+ + E T ++P+ + N + K+ G+ P +S++ Q+ Q I++C
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPF-DANNQGALILKIIRGVFP-PVSQMYSQQLAQLIDQC 236
Query: 266 IVPASLRLP-ALELLKDPFL 284
+ + P +LL++P L
Sbjct: 237 LTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 86/265 (32%), Positives = 137/265 (51%), Gaps = 26/265 (9%)
Query: 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
E LG+G++ +VYK + G VA V +E+ +Q + E+ +LK I+
Sbjct: 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE------IIKEISILKQCDSPYIV 61
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHN 148
K+Y S+ +T+ I M E +GS+ K +K + + I Q L+GL YLHS+
Sbjct: 62 KYYGSYFKNTDLWIVM--EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEE-Y 205
IHRD+K NI +N G+ K+ D G++ + A+ +VIGTP +MAPE+ +E Y
Sbjct: 120 --KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---PASLSKVTD--PQVKQ 260
N DI+S G+ +EM + PY++ I+ I P +LS P+
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-----IPNKPPPTLSDPEKWSPEFND 231
Query: 261 FIEKCIV-PASLRLPALELLKDPFL 284
F++KC+V R A++LL+ PF+
Sbjct: 232 FVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 139 bits (354), Expect = 2e-37
Identities = 63/229 (27%), Positives = 99/229 (43%), Gaps = 22/229 (9%)
Query: 28 RYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
+ LG+GAF VYKG E +VA + S ++ E E ++K L
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA---SEEEREEFLEEASIMKKL 58
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLH 142
H NI++ + ++TE G L + +KH + +K + A QI +G+
Sbjct: 59 SHPNIVRLLGVCTQG--EPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF-----MA 197
YL S N +HRDL N V N VKI D GL+ + MA
Sbjct: 117 YLESKN--FVHRDLAARNCLV-TENLVVKISDFGLSRDI-YEDDYYRKRGGGKLPIKWMA 172
Query: 198 PELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244
PE ++ ++ D++SFG+ + E+ T E PY N ++ + + G
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLELLEDG 220
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 70/246 (28%), Positives = 109/246 (44%), Gaps = 20/246 (8%)
Query: 30 DEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
+ LG+GAF VYKG +EVA V S Q+E E +++ L H
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVA---VKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYL 144
N++K ++ + ++ E G L Y RK + + + ++A QI RG+ YL
Sbjct: 61 PNVVKLLGVCTEEEP--LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE---FMAPE-L 200
S N IHRDL N V G N VKI D GL+ + G +MAPE L
Sbjct: 119 ESKN--FIHRDLAARNCLV-GENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESL 175
Query: 201 YEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259
E ++ D++SFG+ + E+ T E PY N ++ + + +G + +
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLEYLKNGYRLPQPPNCPPE-LY 233
Query: 260 QFIEKC 265
+ +C
Sbjct: 234 DLMLQC 239
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 5e-37
Identities = 72/247 (29%), Positives = 113/247 (45%), Gaps = 21/247 (8%)
Query: 30 DEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
+ LG+GAF VYKG + +EVA V S Q+E E +++ L H
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVA---VKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--NWARQILRGLHY 143
NI+K ++ + ++ E G L Y +K++ ++ ++A QI RG+ Y
Sbjct: 61 PNIVKLLGVCTEEEP--LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE---FMAPE- 199
L S N IHRDL N V G N VKI D GL+ + V G +MAPE
Sbjct: 119 LESKN--FIHRDLAARNCLV-GENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPES 175
Query: 200 LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258
L E ++ D++SFG+ + E+ T E PY N A++ + + G + +
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN-AEVLEYLKKGYRLPKPPNCPPE-L 233
Query: 259 KQFIEKC 265
+ + +C
Sbjct: 234 YKLMLQC 240
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-36
Identities = 84/260 (32%), Positives = 131/260 (50%), Gaps = 19/260 (7%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS--EVHLLKSLKHENIIK 90
LGKG++ +VYK D A +V++ S Q ER + E+ +L S+ H NII
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDL----GSMSQKEREDAVNEIRILASVNHPNIIS 63
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKN-VDMKAIKNWARQILRGLHYLHS 146
+ +++D I M E G L + RKK + + + I Q+LRGL LH
Sbjct: 64 YKEAFLDGNKLCIVM--EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-Y 205
I+HRDLK NI + N VKIGDLG++ V+++ A++ IGTP +MAPE+++ Y
Sbjct: 122 QK--ILHRDLKSANILLV-ANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPY 178
Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
+ DI+S G + EM T P+ E ++ + KV G P + + ++ FI
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYPP-IPPIYSQDLQNFIRSM 236
Query: 266 IVP-ASLRLPALELLKDPFL 284
+ LR ++L P +
Sbjct: 237 LQVKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 7e-36
Identities = 88/268 (32%), Positives = 142/268 (52%), Gaps = 22/268 (8%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ-----LERLYSEVHLLKSLKHE 86
++G G+F +VY G + G +A QV + V S L+ L E+ LLK L+HE
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
NI+++ S +D + +N+ E GS+ + + ++N+ RQIL+GL+YLH+
Sbjct: 67 NIVQYLGSSLDADH--LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-------IVMQQPTAR-SVIGTPEFMAP 198
IIHRD+K NI V+ N G +KI D G++ + + AR S+ G+ +MAP
Sbjct: 125 RG--IIHRDIKGANILVD-NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 199 ELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
E+ ++ Y DI+S G ++EM+T ++P+ +C I+ K+ P S ++ +
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF-KIGENASPEIPSNISS-E 239
Query: 258 VKQFIEKCIVP-ASLRLPALELLKDPFL 284
F+EK + R A ELLK PFL
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 9e-36
Identities = 78/264 (29%), Positives = 126/264 (47%), Gaps = 16/264 (6%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNI--EDVMQSPDQLERLYSEVHLLKSLKHENI 88
+ LG GAF + Y+ D G +A QV + + +E L E+ L+ L H +I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
I+ + +D++ N+ E GS+ K+ I N+ Q+LRGL YLH +
Sbjct: 66 IRMLGATCEDSH--FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ 123
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS------VIGTPEFMAPE-LY 201
IIHRD+K N+ ++ ++I D G A + + ++GT FMAPE L
Sbjct: 124 --IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 202 EEEYNELVDIYSFGMCILEMVTCEYPYN--ECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259
E+Y D++S G I+EM T + P+N + N + K+ S S+ + P ++
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLR 241
Query: 260 QFIEKCI-VPASLRLPALELLKDP 282
+C+ + R P+ ELLK P
Sbjct: 242 DVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 9e-36
Identities = 88/270 (32%), Positives = 132/270 (48%), Gaps = 25/270 (9%)
Query: 26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP-DQLERLYSEVHLLKSLK 84
Y R E++G+GA+ VY+G G VA +N++ +P D + + EV LL L+
Sbjct: 3 YQRL-ELIGRGAYGAVYRGKHVPTGRVVALKIINLD----TPDDDVSDIQREVALLSQLR 57
Query: 85 H---ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
NI K+Y S++ I M E GS+R K + K I R++L L
Sbjct: 58 QSQPPNITKYYGSYLKGPRLWIIM--EYAEGGSVRTLMKAGP-IAEKYISVIIREVLVAL 114
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE 199
Y+H +IHRD+K NI V N G VK+ D G+A ++ Q +++ + +GTP +MAPE
Sbjct: 115 KYIHKV--GVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPE 171
Query: 200 LYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS-KVTDP 256
+ E Y+ DI+S G+ I EM T PY A + KP L
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPPY--SDVDAFRAMMLIPKSKPPRLEDNGYSK 229
Query: 257 QVKQFIEKCI--VPASLRLPALELLKDPFL 284
+++F+ C+ P RL A ELLK ++
Sbjct: 230 LLREFVAACLDEEPKE-RLSAEELLKSKWI 258
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 91/269 (33%), Positives = 131/269 (48%), Gaps = 31/269 (11%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
+LGKG + VY D + +A ++ D + L+ E+ L LKH NI+++
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV----QPLHEEIALHSYLKHRNIVQY 70
Query: 92 YNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMK--AIKNWARQILRGLHYLHSHN 148
S D N + E GSL R K + I + +QIL GL YLH +
Sbjct: 71 LGS--DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLG----LAIVMQQPTARSVIGTPEFMAPELYEE- 203
I+HRD+K DN+ VN +G VKI D G LA + P + GT ++MAPE+ ++
Sbjct: 129 --IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEVIDKG 184
Query: 204 --EYNELVDIYSFGMCILEMVTCEYPYNECKNP-AQIYK----KVTSGIKPASLSKVTDP 256
Y DI+S G I+EM T + P+ E P A ++K K+ I P SLS
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI-PESLSA---- 239
Query: 257 QVKQFIEKCIVPASLRLP-ALELLKDPFL 284
+ K FI +C P + A +LL+DPFL
Sbjct: 240 EAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 94/295 (31%), Positives = 134/295 (45%), Gaps = 58/295 (19%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS----EVHLLKSLKHE 86
E LG+G + VYK D+ G VA ++ +++ + E + S E+ LLK LKH
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDN------EEEGIPSTALREISLLKELKHP 58
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLH 145
NI+K + V T R + ++ E + L++Y K+ + IK+ Q+LRGL Y H
Sbjct: 59 NIVKLLD--VIHTERKLYLVFE-YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA----IVMQQPTARSVIGTPEFMAPELY 201
SH I+HRDLK NI +N +G +K+ D GLA I ++ T V T + APE+
Sbjct: 116 SHR--ILHRDLKPQNILIN-RDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPEIL 170
Query: 202 --EEEYNELVDIYSFGMCILEMVT--------CE------------YPYNE-----CKNP 234
+ Y+ VDI+S G EM+T E P E K P
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230
Query: 235 AQIYKKVTSGIKPASLSKVT---DPQVKQFIEK--CIVPASLRLPALELLKDPFL 284
YK P L KV DP+ + K PA R+ A E LK P+
Sbjct: 231 D--YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAK-RISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 79/271 (29%), Positives = 129/271 (47%), Gaps = 29/271 (10%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E++G GA VY + +VA ++++E + ++ L EV + H N++K
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLE---KCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 91 FYNSWVDDTNRTINMITELFTSGSLR---QYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
+Y S+V + M + GSL + +D I +++L+GL YLHS+
Sbjct: 64 YYTSFVVGDELWLVM--PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS------VIGTPEFMAPELY 201
IHRD+K NI + G +G VKI D G++ + R+ +GTP +MAPE+
Sbjct: 122 G--QIHRDIKAGNILL-GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 202 EEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV- 258
E+ Y+ DI+SFG+ +E+ T PY++ P ++ P SL D +
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYP-PMKVLMLTLQN-DPPSLETGADYKKY 236
Query: 259 ----KQFIEKCIV--PASLRLPALELLKDPF 283
++ I C+ P+ R A ELLK F
Sbjct: 237 SKSFRKMISLCLQKDPSK-RPTAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 7e-34
Identities = 75/267 (28%), Positives = 126/267 (47%), Gaps = 45/267 (16%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ----LERLYSEVHLLKSLKHE 86
+I+G+G+F TV ++ E A ++ +++ +E+ EV L + H
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEK---EV-LTRLNGHP 62
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
IIK Y ++ D+ N + + E +G L QY +K+ ++D K + +A +IL L YLHS
Sbjct: 63 GIIKLYYTFQDEEN--LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----------------------QQP 184
IIHRDLK +NI ++ + +KI D G A V+ +
Sbjct: 121 KG--IIHRDLKPENILLD-KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177
Query: 185 TARSVIGTPEFMAPELYEEEY-NELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVT 242
S +GT E+++PEL E+ + D+++ G CI+ +M+T + P+ N ++K
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALG-CIIYQMLTGKPPFR-GSNEYLTFQK-- 233
Query: 243 SGIKPASLS--KVTDPQVKQFIEKCIV 267
I S P K IEK +V
Sbjct: 234 --ILKLEYSFPPNFPPDAKDLIEKLLV 258
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 64/253 (25%), Positives = 112/253 (44%), Gaps = 28/253 (11%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ---SPDQLERLYSEVHLLKSLKHEN 87
+ LG+GAF VYKG ++ G + +V ++ ++ S ++ + E ++K L H N
Sbjct: 1 KKLGEGAFGEVYKG--KLKGKDGKTTEVAVK-TLKEDASEEERKDFLKEARVMKKLGHPN 57
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKN---------WARQIL 138
+++ V + ++ E G L Y +K + V K+ +A QI
Sbjct: 58 VVRLLG--VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPE--- 194
+G+ YL S +HRDL N V G + VKI D GL+ + R G
Sbjct: 116 KGMEYLASKK--FVHRDLAARNCLV-GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
Query: 195 FMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 252
+MAPE L + + D++SFG+ + E+ T PY N ++ + + G +
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-EEVLEYLRKGYRLPKPEY 231
Query: 253 VTDPQVKQFIEKC 265
D ++ + + C
Sbjct: 232 CPD-ELYELMLSC 243
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 80/269 (29%), Positives = 127/269 (47%), Gaps = 23/269 (8%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
Y+ I +G G + VYK D G VA + +E D E + E+ +LK +H
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRH 59
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQ-YRKKHKNVDMKAIKNWARQILRGLHYL 144
NI+ ++ S++ I M E GSL+ Y+ + I R+ L+GL YL
Sbjct: 60 PNIVAYFGSYLRRDKLWIVM--EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL 117
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYE 202
H IHRD+K NI + +G+VK+ D G++ + A+ S IGTP +MAPE+
Sbjct: 118 HETG--KIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 203 EE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGIKPASLSKVT--D 255
E Y+ DI++ G+ +E+ + P + +P + ++ S P L
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMFDL-HPMRALFLISKSNFPPPKLKDKEKWS 233
Query: 256 PQVKQFIEKCIVPASLRLP-ALELLKDPF 283
P FI+KC+ + P A +LL+ PF
Sbjct: 234 PVFHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 86/287 (29%), Positives = 149/287 (51%), Gaps = 25/287 (8%)
Query: 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
DP + +I G+G+ V D+ G +VA ++++ + + E L++EV
Sbjct: 13 DPGDPRSYLDNFVKI-GEGSTGIVCIATDKSTGRQVAVKKMDL----RKQQRRELLFNEV 67
Query: 78 HLLKSLKHENIIKFYNSW-VDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ 136
+++ +H NI++ Y+S+ V D + ++ E G+L H ++ + I
Sbjct: 68 VIMRDYQHPNIVEMYSSYLVGDE---LWVVMEFLEGGALTDI-VTHTRMNEEQIATVCLA 123
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPE 194
+L+ L +LH+ +IHRD+K D+I + ++G VK+ D G + + P +S++GTP
Sbjct: 124 VLKALSFLHAQG--VIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY 180
Query: 195 FMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIKPAS--L 250
+MAPE+ Y VDI+S G+ ++EMV E PY NE P Q K++ + P L
Sbjct: 181 WMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE--PPLQAMKRIRDNLPPKLKNL 238
Query: 251 SKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCD 295
KV+ P+++ F+++ +V PA R A ELL PFL P +
Sbjct: 239 HKVS-PRLRSFLDRMLVRDPAQ-RATAAELLNHPFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 5e-33
Identities = 84/372 (22%), Positives = 136/372 (36%), Gaps = 38/372 (10%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE- 86
R LG+G+F VY D VA + + ++ER E+ +L SL H
Sbjct: 3 RILRKLGEGSFGEVYLARDR---KLVALKVLAK-KLESKSKEVERFLREIQILASLNHPP 58
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHY 143
NI+K Y+ + D+ + + M E GSL KK + QIL L Y
Sbjct: 59 NIVKLYDFFQDEGSLYLVM--EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--------QQPTARSVIGTPEF 195
LHS IIHRD+K +NI ++ + VK+ D GLA ++ + +GTP +
Sbjct: 117 LHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 196 MAPELY----EEEYNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSGIKPA 248
MAPE+ + DI+S G+ + E++T P+ +Q K + P+
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 249 SLSKV-------TDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 300
S + ++K + RL + L L L L
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL---AHLKLKESDLSDL 291
Query: 301 NLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEK 360
+ L S P ++ ++ A S + + EL ++
Sbjct: 292 LKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSL 351
Query: 361 NDDDTVSLTLRI 372
S +
Sbjct: 352 LLSTASSKRSSL 363
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 9e-33
Identities = 62/238 (26%), Positives = 118/238 (49%), Gaps = 12/238 (5%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LGKG+F V + G A + + +++ ++E +E ++L + H I+K +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR-KEVEHTLTERNILSRINHPFIVKLH 59
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
++ + + ++ E G L + K + + +A +I+ L YLHS II
Sbjct: 60 YAFQTEEK--LYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--II 115
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEYNELV 209
+RDLK +NI ++ +G +K+ D GLA + + + GTPE++APE L + Y + V
Sbjct: 116 YRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAV 174
Query: 210 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 267
D +S G+ + EM+T + P+ ++ +IY+K+ P + P+ + I +
Sbjct: 175 DWWSLGVLLYEMLTGKPPF-YAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQ 229
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 92/275 (33%), Positives = 146/275 (53%), Gaps = 19/275 (6%)
Query: 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
DP +Y R+++I G+GA TVY D G EVA Q+N++ Q P + E + +E+ ++
Sbjct: 16 DPKKKYTRFEKI-GQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKK-ELIINEILVM 70
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
+ KH NI+ + +S++ + ++ E GSL + +D I R+ L+
Sbjct: 71 RENKHPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 127
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAP 198
L +LHS+ +IHRD+K DNI + G +G VK+ D G I +Q +++GTP +MAP
Sbjct: 128 LEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
Query: 199 ELY-EEEYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGIKPASLSKVTD 255
E+ + Y VDI+S G+ +EMV E PY NE NP + +Y T+G +
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE--NPLRALYLIATNGTPELQNPEKLS 242
Query: 256 PQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 289
+ F+ +C+ + R A ELL+ PFL P
Sbjct: 243 AIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 1e-32
Identities = 82/262 (31%), Positives = 141/262 (53%), Gaps = 14/262 (5%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
R ++ +G+G F VY+ +DG+ VA +V I D+M + + + + E+ LLK L H N
Sbjct: 5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCI-KEIDLLKQLNHPN 63
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHY 143
+IK+Y S+++D +N++ EL +G L + ++K+ + + K + + Q+ L +
Sbjct: 64 VIKYYASFIEDNE--LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-L 200
+HS ++HRD+K N+F+ G VK+GDLGL T A S++GTP +M+PE +
Sbjct: 122 MHSRR--VMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 201 YEEEYNELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259
+E YN DI+S G + EM + P Y + N + KK+ P S +++
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238
Query: 260 QFIEKCIVPASLRLPALELLKD 281
Q + CI P + P + + D
Sbjct: 239 QLVNMCINPDPEKRPDITYVYD 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 79/256 (30%), Positives = 138/256 (53%), Gaps = 13/256 (5%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
++G+GAF V+ + D V Q+ +E + + D+ +E +LK L H NII++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK--DERLAAQNECQVLKLLSHPNIIEY 64
Query: 92 YNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNP 149
Y ++++D I M E G+L +Y +K N +D I ++ QIL LH++H+
Sbjct: 65 YENFLEDKALMIVM--EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL- 121
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAPELYE-EEYNE 207
I+HRDLK NI ++ + VKIGD G++ I+ + A +V+GTP +++PEL E + YN+
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI- 266
DI++ G + E+ + + + PA + K+ SG A +S P ++Q I +
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAANLPA-LVLKIMSG-TFAPISDRYSPDLRQLILSMLN 238
Query: 267 VPASLRLPALELLKDP 282
+ S R +++ P
Sbjct: 239 LDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 6e-32
Identities = 85/267 (31%), Positives = 131/267 (49%), Gaps = 20/267 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIE--DVMQSPDQLERLYSEVHLLKSLKHENI 88
E+LGKGA+ TVY G G +A QV ++ +V+ + + E+L EV LLKSLKH NI
Sbjct: 6 EVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
+++ + +DD TI++ E GS+ + + + +QIL G+ YLH++
Sbjct: 65 VQYLGTCLDDN--TISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--------VMQQPTARSVIGTPEFMAPEL 200
++HRD+K +N+ + NG +K+ D G A +S+ GTP +MAPE+
Sbjct: 123 --VVHRDIKGNNVMLM-PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 201 YEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQI-YKKVTSGIKPASLSKVTDPQV 258
E Y DI+S G + EM T + P A + Y G+ P L
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP-RLPDSFSAAA 238
Query: 259 KQFIEKCIVPASLRLP-ALELLKDPFL 284
F+ C+ P AL+LL+ FL
Sbjct: 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 7e-31
Identities = 92/275 (33%), Positives = 146/275 (53%), Gaps = 19/275 (6%)
Query: 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
DP +Y RY++I G+GA TV+ D G EVA Q+N +Q + E + +E+ ++
Sbjct: 16 DPKKKYTRYEKI-GQGASGTVFTAIDVATGQEVAIKQIN----LQKQPKKELIINEILVM 70
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
K LK+ NI+ F +S++ + ++ E GSL + +D I R+ L+
Sbjct: 71 KELKNPNIVNFLDSFL--VGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQA 127
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAP 198
L +LH++ +IHRD+K DN+ + G +G VK+ D G I +Q +++GTP +MAP
Sbjct: 128 LEFLHANQ--VIHRDIKSDNVLL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
Query: 199 ELYEEE-YNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGIKPASLSKVTD 255
E+ + Y VDI+S G+ +EMV E PY NE NP + +Y T+G +
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE--NPLRALYLIATNGTPELQNPEKLS 242
Query: 256 PQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 289
P + F+ +C+ + R A ELL+ PFL P
Sbjct: 243 PIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 86/279 (30%), Positives = 138/279 (49%), Gaps = 27/279 (9%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG GAF VYK + G+ A + IE ++LE E+ +L KH NI+ Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIES----EEELEDFMVEIDILSECKHPNIVGLY 68
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
++ + ++ E G+L + + + I+ RQ+L L++LHSH +
Sbjct: 69 EAYFYENKLW--ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--V 124
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEE----- 204
IHRDLK NI + +G+VK+ D G++ + + + IGTP +MAPE+ E
Sbjct: 125 IHRDLKAGNILLT-LDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDN 183
Query: 205 -YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTDPQVKQF 261
Y+ DI+S G+ ++E+ E P++E NP ++ K+ P SK + F
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLDQPSKWSS-SFNDF 241
Query: 262 IEKCIVP-ASLRLPALELLKDPFL--VTDNP--KDLVCD 295
++ C+V R A ELLK PF+ +DN KDL+ +
Sbjct: 242 LKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKDLLAE 280
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 70/214 (32%), Positives = 103/214 (48%), Gaps = 30/214 (14%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY+ + +G GA+ V D+ G +VA I +V +R+ E+ LL+ L+H
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK--KISNVFDDLIDAKRILREIKLLRHLRH 58
Query: 86 ENIIKFYNSWVDDTN---RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
ENII + + + ++TEL + L + K + + I+ + QILRGL
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLK 117
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM------ 196
YLHS N +IHRDLK NI VN N ++KI D GLA + F+
Sbjct: 118 YLHSAN--VIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDED-----EKGFLTEYVVT 169
Query: 197 ----APE--LYEEEYNELVDIYSFGMCIL-EMVT 223
APE L Y + +DI+S G CI E++T
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVG-CIFAELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 76/261 (29%), Positives = 133/261 (50%), Gaps = 19/261 (7%)
Query: 32 ILGKGAF--KTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
+LGKGAF T+Y+ + D V W +VN+ + S + +E+ +L L+H NII
Sbjct: 7 VLGKGAFGEATLYRRTE--DDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNII 62
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQ--YRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
+YN ++DD I M E G+L R+K + + + + + QI+ + Y+H
Sbjct: 63 AYYNHFMDDNTLLIEM--EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-EE 204
I+HRD+K NIF+ G +K+GD G++ ++ A +V+GTP +M+PEL + +
Sbjct: 121 G--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK 177
Query: 205 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
YN DI++ G + E++T + + + NP + K+ G +S + ++ +
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTF-DATNPLNLVVKIVQGNYTPVVSVYSS-ELISLVHS 235
Query: 265 CI-VPASLRLPALELLKDPFL 284
+ R A E+L P L
Sbjct: 236 LLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 63/235 (26%), Positives = 107/235 (45%), Gaps = 9/235 (3%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG G F V + A V + + Q E ++SE +L+ H I+K Y
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVK-KRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
++ D + I M+ E G L + D + + ++ YLH+ II
Sbjct: 60 RTFKD--KKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--II 115
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEEE-YNELVD 210
+RDLK +N+ ++ +NG VK+ D G A ++ + GTPE++APE+ + Y+ VD
Sbjct: 116 YRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVD 174
Query: 211 IYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
+S G+ + E++T P+ E +P +IY + G D K I++
Sbjct: 175 YWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQ 229
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-29
Identities = 95/279 (34%), Positives = 149/279 (53%), Gaps = 27/279 (9%)
Query: 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
DP +Y R+++I G+GA TVY D G EVA Q+N++ Q P + E + +E+ ++
Sbjct: 16 DPKKKYTRFEKI-GQGASGTVYTAIDIATGQEVAIKQMNLQ---QQPKK-ELIINEILVM 70
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
+ K+ NI+ + +S++ + ++ E GSL + +D I R+ L+
Sbjct: 71 RENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 127
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAP 198
L +LHS+ +IHRD+K DNI + G +G VK+ D G I +Q +++GTP +MAP
Sbjct: 128 LDFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
Query: 199 ELY-EEEYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGI----KPASLS 251
E+ + Y VDI+S G+ +EMV E PY NE NP + +Y T+G P LS
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE--NPLRALYLIATNGTPELQNPERLS 242
Query: 252 KVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 289
V + F+ +C+ + R A ELL+ PFL P
Sbjct: 243 AV----FRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 68/201 (33%), Positives = 104/201 (51%), Gaps = 17/201 (8%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER-LYSEVHLLKSLK 84
RY++ LG+G + VYK D+ G VA ++ + + ++ D + E+ LL+ LK
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA-IKNWARQILRGLHY 143
H NII + + +N IN++ E F L + K V A IK++ LRGL Y
Sbjct: 61 HPNIIGLLDVFGHKSN--INLVFE-FMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPEL 200
LHS+ I+HRDLK +N+ + ++G +K+ D GLA P + V+ T + APEL
Sbjct: 118 LHSNW--ILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPEL 173
Query: 201 Y--EEEYNELVDIYSFGMCIL 219
Y VD++S G CI
Sbjct: 174 LFGARHYGVGVDMWSVG-CIF 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 73/250 (29%), Positives = 133/250 (53%), Gaps = 14/250 (5%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+G+G F VY+ +D VA +V I ++M + + + E+ LLK L H N+IK+
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR-QDCVKEIDLLKQLNHPNVIKYL 68
Query: 93 NSWVDDTNRTINMITELFTSGSLRQ----YRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
+S+++D +N++ EL +G L Q ++K+ + + + + + Q+ + ++HS
Sbjct: 69 DSFIEDNE--LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-LYEEEY 205
++HRD+K N+F+ G VK+GDLGL T A S++GTP +M+PE ++E Y
Sbjct: 127 --VMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 206 NELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
N DI+S G + EM + P Y + N + +K+ P ++ ++++ +
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSM 243
Query: 265 CIVPASLRLP 274
CI P + P
Sbjct: 244 CIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 67/260 (25%), Positives = 124/260 (47%), Gaps = 14/260 (5%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG G V K G +A + +E + +++ E+ +L I+ FY
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLE---INEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
++ ++ + I++ E GSL + K+ + + + A +L+GL YLH I
Sbjct: 66 GAFYNNGD--ISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH-EKHKI 122
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVD 210
IHRD+K NI VN + G++K+ D G++ + A++ +GT +MAPE + +Y+ D
Sbjct: 123 IHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSD 181
Query: 211 IYSFGMCILEMVTCEYPYNEC----KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266
I+S G+ ++E+ T +PY ++ + + + P S P + F+ C+
Sbjct: 182 IWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCL 241
Query: 267 VPASLRLPAL-ELLKDPFLV 285
+ P+ ELL+ PF+
Sbjct: 242 IKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIED-VMQSPDQLERLYSEVHLLKSLKHENII 89
+G+G + VYK ++ G VA ++ +E+ P R E+ LL+ L+H NI+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR---EIKLLQKLRHPNIV 61
Query: 90 KFYNSWVDDTNRTINMITELFT---SGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
+ +I M+ E +G L K IK + +Q+L GL YLHS
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK---FTESQIKCYMKQLLEGLQYLHS 118
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS----VIGTPEFMAPELY- 201
+ I+HRD+K NI +N N+G +K+ D GLA + + VI T + PEL
Sbjct: 119 NG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLL 174
Query: 202 -EEEYNELVDIYSFGMCIL-EMVT 223
Y VD++S G CIL E+
Sbjct: 175 GATRYGPEVDMWSVG-CILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 87/301 (28%), Positives = 145/301 (48%), Gaps = 20/301 (6%)
Query: 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
FS+ DP + EI G G+F VY D VA +++ QS ++ + + E
Sbjct: 8 FSKDDPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQDIIKE 65
Query: 77 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFT-SGSLRQYRKKHKNVDMKAIKNWAR 135
V L+ L+H N I++ ++ + + M L + S L ++K + V++ AI
Sbjct: 66 VRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAI---CH 122
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
L+GL YLHSH IHRD+K NI + G VK+ D G A ++ A S +GTP +
Sbjct: 123 GALQGLAYLHSHE--RIHRDIKAGNILLT-EPGTVKLADFGSASLVS--PANSFVGTPYW 177
Query: 196 MAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 251
MAPE+ E +Y+ VD++S G+ +E+ + P + +Y + +LS
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSPTLS 235
Query: 252 KVTDPQ-VKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMN 308
+ F++ C+ R + ELLK F++ + P ++ D + R + V E+ N
Sbjct: 236 SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLIQRTKDAVRELDN 295
Query: 309 L 309
L
Sbjct: 296 L 296
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 92/279 (32%), Positives = 148/279 (53%), Gaps = 27/279 (9%)
Query: 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
DP +Y R+++I G+GA TVY D G EVA Q+N++ Q P + E + +E+ ++
Sbjct: 17 DPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKK-ELIINEILVM 71
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
+ K+ NI+ + +S++ + ++ E GSL + +D I R+ L+
Sbjct: 72 RENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 128
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAP 198
L +LHS+ +IHRD+K DNI + G +G VK+ D G I +Q +++GTP +MAP
Sbjct: 129 LEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 199 ELY-EEEYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGI----KPASLS 251
E+ + Y VDI+S G+ +EM+ E PY NE NP + +Y T+G P LS
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--NPLRALYLIATNGTPELQNPEKLS 243
Query: 252 KVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 289
+ + F+ +C+ + R A ELL+ FL P
Sbjct: 244 AI----FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 77/271 (28%), Positives = 127/271 (46%), Gaps = 24/271 (8%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNI------EDVMQSPDQLERLYSEVHLLKSLK 84
E++GKG + VY + G +A QV + + D ++ L SE+ LK L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
H NI+++ + T +++ E GS+ + + + + ++ + Q+L GL YL
Sbjct: 67 HLNIVQYLG--FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL----AIVMQQPTARSVIGTPEFMAPE- 199
HS I+HRDLK DN+ V+ +G KI D G+ + S+ G+ +MAPE
Sbjct: 125 HSKG--ILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 200 --LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK----KVTSGIKPASLSKV 253
Y + Y+ VDI+S G +LEM P+++ + A ++K + I P +
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241
Query: 254 TDPQVKQFIEKCIVPASLRLP-ALELLKDPF 283
+ P F+ C P A ELL+ PF
Sbjct: 242 S-PVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 78/236 (33%), Positives = 128/236 (54%), Gaps = 18/236 (7%)
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
E L++EV +++ +HEN+++ YNS++ + ++ E G+L H ++ + I
Sbjct: 62 ELLFNEVVIMRDYQHENVVEMYNSYL--VGDELWVVMEFLEGGALTDI-VTHTRMNEEQI 118
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARS 188
+L+ L LH+ +IHRD+K D+I + ++G VK+ D G + + P +S
Sbjct: 119 AAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKS 175
Query: 189 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIK 246
++GTP +MAPEL Y VDI+S G+ ++EMV E PY NE P + K + +
Sbjct: 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLP 233
Query: 247 P--ASLSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLR 298
P +L KV+ P +K F+++ +V PA R A ELLK PFL P + +R
Sbjct: 234 PKLKNLHKVS-PSLKGFLDRLLVRDPAQ-RATAAELLKHPFLAKAGPPSCIVPLMR 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 69/238 (28%), Positives = 121/238 (50%), Gaps = 15/238 (6%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+G G F V+ D + A + I +V+ Q + +++E +LK + H II+ +
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQEQHVHNEKRVLKEVSHPFIIRLF 67
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
+ D + M+ E G L Y + +A +I+ L YLHS I+
Sbjct: 68 WTEHDQRF--LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IV 123
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 211
+RDLK +NI ++ G +K+ D G A ++ T ++ GTPE++APE+ + + +N+ VD
Sbjct: 124 YRDLKPENILLD-KEGHIKLTDFGFAKKLRDRTW-TLCGTPEYLAPEVIQSKGHNKAVDW 181
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASLSKVTDPQVKQFIEKCIV 267
++ G+ I EM+ P+ + NP IY+K+ +G ++ P L D K I+K +V
Sbjct: 182 WALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKLEFPRHL----DLYAKDLIKKLLV 234
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 87/274 (31%), Positives = 141/274 (51%), Gaps = 16/274 (5%)
Query: 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
DP + + ++I GKG+F V+KG D VA + I D+ ++ D++E + E+ +L
Sbjct: 1 DPEELFTKLEKI-GKGSFGEVFKGIDNRTQKVVA---IKIIDLEEAEDEIEDIQQEITVL 56
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
+ K+Y S++ DT I I E GS + +D I R+IL+G
Sbjct: 57 SQCDSPYVTKYYGSYLKDTKLWI--IMEYLGGGSALDLLEPGP-LDETQIATILREILKG 113
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAP 198
L YLHS IHRD+K N+ ++ +GEVK+ D G+A + Q + +GTP +MAP
Sbjct: 114 LDYLHSEKK--IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
Query: 199 ELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
E+ ++ Y+ DI+S G+ +E+ E P++E +P ++ + P + P
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL-HPMKVLFLIPKNNPPTLEGNYSKP- 228
Query: 258 VKQFIEKCI-VPASLRLPALELLKDPFLVTDNPK 290
+K+F+E C+ S R A ELLK F+V K
Sbjct: 229 LKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 80/291 (27%), Positives = 138/291 (47%), Gaps = 43/291 (14%)
Query: 20 KDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
DP+ G ++ E++G+G + VYK + G VA + I D++ D+ E + E
Sbjct: 2 PDPT---GIFELVEVIGEGTYGKVYKARHKKTGQLVA---IKIMDII--EDEEEEIKEEY 53
Query: 78 HLLKSL-KHENIIKFYNSWV--DDTNR--TINMITELFTSGSLRQYRKKHKNVDMKAIKN 132
++L+ H NI FY +++ + + ++ EL GS+ K + + +
Sbjct: 54 NILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEE 113
Query: 133 W----ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR- 187
W R+ LRGL YLH + +IHRD+K NI + N EVK+ D G++ + R
Sbjct: 114 WIAYILRETLRGLAYLHENK--VIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRR 170
Query: 188 -SVIGTPEFMAPEL------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPA----- 235
+ IGTP +MAPE+ + Y+ D++S G+ +E+ + P C
Sbjct: 171 NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL--CDMHPMRALF 228
Query: 236 QIYKKVTSGIK-PASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFL 284
+I + +K P + SK + FI +C++ + P ELL+ PF+
Sbjct: 229 KIPRNPPPTLKSPENWSK----KFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 66/267 (24%), Positives = 124/267 (46%), Gaps = 22/267 (8%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+ KGA+ V+ + G A + + M +Q++++ +E +L + ++K Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIK-KADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
S+ N + ++ E G L + ++D + + +I+ L YLHS+ II
Sbjct: 60 YSFQGKKN--LYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--II 115
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGL--------AIVMQQPTARS--VIGTPEFMAPE-LY 201
HRDLK DNI ++ +NG +K+ D GL I + ++GTP+++APE +
Sbjct: 116 HRDLKPDNILID-SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 202 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261
+ +++ VD +S G + E + P++ + P +I++ + +G +
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSDEAIDL 233
Query: 262 IEKCIVPASL-RLPAL---ELLKDPFL 284
I K +VP RL A E+ PF
Sbjct: 234 ISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 74/209 (35%), Positives = 108/209 (51%), Gaps = 26/209 (12%)
Query: 29 YDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNI---EDVMQSPDQLERLYSEVHLLKSL 83
Y+E+ +G+GA+ TVYK D G VA +V + E+ + P R E+ LLK L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI--PLSTLR---EIALLKQL 55
Query: 84 K---HENIIKFYN---SWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWAR 135
+ H NI++ + D + ++ E L Y K + + IK+ R
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFE-HVDQDLATYLSKCPKPGLPPETIKDLMR 114
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTPE 194
Q+LRG+ +LHSH I+HRDLK NI V ++G+VKI D GLA + A SV+ T
Sbjct: 115 QLLRGVDFLHSHR--IVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLW 171
Query: 195 FMAPE-LYEEEYNELVDIYSFGMCIL-EM 221
+ APE L + Y VD++S G CI E+
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVG-CIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 73/270 (27%), Positives = 133/270 (49%), Gaps = 21/270 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
LG+GA +V K + G+ A + +PD +++ E+ + KS K I+K
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTIT---TDPNPDLQKQILRELEINKSCKSPYIVK 63
Query: 91 FYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
+Y +++D+++ +I + E GSL ++ +K+ + K + A +L+GL YLHS
Sbjct: 64 YYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS 123
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEY 205
IIHRD+K NI + G+VK+ D G++ + A + GT +MAPE + + Y
Sbjct: 124 RK--IIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPY 180
Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD-PQV------ 258
+ D++S G+ +LE+ +P+ P ++ S I ++ D P
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSE 240
Query: 259 --KQFIEKCIVPASLRLPA-LELLKDPFLV 285
K FI++C+ R P ++L+ P++
Sbjct: 241 EFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 79/265 (29%), Positives = 134/265 (50%), Gaps = 25/265 (9%)
Query: 33 LGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
LGKG+F TVY K + ++V ++ + ++ +P++ + E LL L H I
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVL-KEIPVGEL--NPNETVQANQEAQLLSKLDHPAI 64
Query: 89 IKFYNSWVDDTNRTINMITELFTSG-----SLRQYRKKHKNVDMKAIKNWARQILRGLHY 143
+KF+ S+++ I ITE + G L + + K + + W Q+L G+HY
Sbjct: 65 VKFHASFLERDAFCI--ITE-YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-L 200
+H I+HRDLK NIF+ N +KIGD G++ ++ A + GTP +M+PE L
Sbjct: 122 MHQRR--ILHRDLKAKNIFLKNN--LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL 177
Query: 201 YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
+ Y+ DI+S G + EM + + E +N + ++ G P SL + Q+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCCLAHAF-EGQNFLSVVLRIVEGPTP-SLPETYSRQLNS 235
Query: 261 FIEKCIVP-ASLRLPALELLKDPFL 284
++ + SLR A E+L++PF+
Sbjct: 236 IMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 1e-25
Identities = 78/273 (28%), Positives = 141/273 (51%), Gaps = 20/273 (7%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+G+G+ V ++ G +VA +++ ++ + E L++EV +++ HEN++ Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD----LRKQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
NS++ + ++ E G+L H ++ + I +LR L YLH+ +I
Sbjct: 86 NSYL--VGDELWVVMEFLEGGALTDI-VTHTRMNEEQIATVCLSVLRALSYLHNQG--VI 140
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYEE-EYNELV 209
HRD+K D+I + ++G +K+ D G + + P +S++GTP +MAPE+ Y V
Sbjct: 141 HRDIKSDSILLT-SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 210 DIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCI 266
DI+S G+ ++EM+ E PY NE P Q +++ + P KV+ ++ F++ +
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNE--PPLQAMRRIRDNLPPRVKDSHKVSS-VLRGFLDLML 256
Query: 267 V-PASLRLPALELLKDPFLVTDNPKDLVCDPLR 298
V S R A ELL+ PFL P + +R
Sbjct: 257 VREPSQRATAQELLQHPFLKLAGPPSCIVPLMR 289
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 74/265 (27%), Positives = 129/265 (48%), Gaps = 16/265 (6%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY+ + +G+G+F +Y + D ++++ + + + EV LL +KH
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK--KEVILLAKMKH 58
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKAIKNWARQILRGLHY 143
NI+ F+ S+ ++ I M E G L + + + V I +W QI GL
Sbjct: 59 PNIVTFFASFQENGRLFIVM--EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK- 115
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY 201
H H+ I+HRD+K NIF++ N K+GD G+A + A + +GTP +++PE+
Sbjct: 116 -HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC 174
Query: 202 EEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
+ YN DI+S G + E+ T ++P+ E N Q+ K+ G A +S ++
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPF-EGNNLHQLVLKICQG-YFAPISPNFSRDLRS 232
Query: 261 FIEKCIVPASLRLPAL-ELLKDPFL 284
I + + P++ +LK PFL
Sbjct: 233 LISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 74/256 (28%), Positives = 131/256 (51%), Gaps = 34/256 (13%)
Query: 31 EILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
+ LG G+F V +KG + A ++ +++ Q+E + +E +L+S++H
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKY----YALKILSKAKIVKL-KQVEHVLNEKRILQSIRHP 61
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
++ Y S+ DD+N + ++ E G L + +K + +A Q++ L YLHS
Sbjct: 62 FLVNLYGSFQDDSN--LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS 119
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-Y 205
+ I++RDLK +N+ + ++G +KI D G A ++ T ++ GTPE++APE+ + Y
Sbjct: 120 LD--IVYRDLKPENLLL-DSDGYIKITDFGFAKRVKGRT-YTLCGTPEYLAPEIILSKGY 175
Query: 206 NELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGIKPASLSKVT-----DPQV 258
+ VD ++ G+ I EM+ YP +++ NP QIY+K+ G KV P
Sbjct: 176 GKAVDWWALGILIYEML-AGYPPFFDD--NPIQIYEKILEG-------KVRFPSFFSPDA 225
Query: 259 KQFIEK-CIVPASLRL 273
K I V + RL
Sbjct: 226 KDLIRNLLQVDLTKRL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 82/269 (30%), Positives = 134/269 (49%), Gaps = 16/269 (5%)
Query: 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
DP + + + I GKG+F VYKG D VA + I D+ ++ D++E + E+ +L
Sbjct: 1 DPEELFTKLERI-GKGSFGEVYKGIDNRTKEVVA---IKIIDLEEAEDEIEDIQQEITVL 56
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
I ++Y S++ T I I E GS K ++ I R+IL+G
Sbjct: 57 SQCDSPYITRYYGSYLKGTKLWI--IMEYLGGGSALDLLKPGP-LEETYIATILREILKG 113
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAP 198
L YLHS IHRD+K N+ ++ G+VK+ D G+A + Q + +GTP +MAP
Sbjct: 114 LDYLHSERK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
Query: 199 ELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
E+ ++ Y+ DI+S G+ +E+ E P ++ +P ++ + P + + P
Sbjct: 171 EVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNSPPTLEGQYSKP- 228
Query: 258 VKQFIEKCI-VPASLRLPALELLKDPFLV 285
K+F+E C+ R A ELLK F+
Sbjct: 229 FKEFVEACLNKDPRFRPTAKELLKHKFIT 257
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 4e-25
Identities = 72/262 (27%), Positives = 133/262 (50%), Gaps = 14/262 (5%)
Query: 29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
+ ++GKG++ V DG + ++N+ + S + + E LL LKH NI
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA--SRRERKAAEQEAQLLSQLKHPNI 61
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHS 146
+ + SW + + + ++ G L K+ K + + W QI L YLH
Sbjct: 62 VAYRESW-EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTARSVIGTPEFMAPELYEEE 204
+ I+HRDLK N+F+ N +K+GDLG+A V+ Q A ++IGTP +M+PEL+ +
Sbjct: 121 KH--ILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNK 177
Query: 205 -YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263
YN D+++ G C+ EM T ++ +N + +Y+ + + P + K P++ + I
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP--MPKDYSPELGELIA 235
Query: 264 KCIVPASLRLPALE-LLKDPFL 284
+ + P+++ +L+ P++
Sbjct: 236 TMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 8e-25
Identities = 83/274 (30%), Positives = 135/274 (49%), Gaps = 16/274 (5%)
Query: 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
DP + + + I GKG+F V+KG D VA + I D+ ++ D++E + E+ +L
Sbjct: 1 DPEELFTKLERI-GKGSFGEVFKGIDNRTQQVVA---IKIIDLEEAEDEIEDIQQEITVL 56
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
+ K+Y S++ T I I E GS + D I ++IL+G
Sbjct: 57 SQCDSPYVTKYYGSYLKGTKLWI--IMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKG 113
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAP 198
L YLHS IHRD+K N+ ++ G+VK+ D G+A + Q + +GTP +MAP
Sbjct: 114 LDYLHSEKK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
Query: 199 ELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
E+ ++ Y+ DI+S G+ +E+ E P N +P ++ + P + +
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGE-PPNSDMHPMRVLFLIPKNNPPTLTGEFSK-P 228
Query: 258 VKQFIEKCI-VPASLRLPALELLKDPFLVTDNPK 290
K+FI+ C+ S R A ELLK F+V + K
Sbjct: 229 FKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 78/272 (28%), Positives = 139/272 (51%), Gaps = 23/272 (8%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG GAF VYK ++ G+ A ++ +S ++LE E+ +L S H NI+K
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVID----TKSEEELEDYMVEIDILASCDHPNIVKLL 68
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
+++ + N I + E G++ + + + I+ +Q L L+YLH + I
Sbjct: 69 DAFYYENNLWI--LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--I 124
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY------EE 203
IHRDLK NI +G++K+ D G++ + R S IGTP +MAPE+ +
Sbjct: 125 IHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 204 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT--DPQVKQF 261
Y+ D++S G+ ++EM E P++E NP ++ K+ +P +L++ + + K F
Sbjct: 184 PYDYKADVWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKS-EPPTLAQPSRWSSEFKDF 241
Query: 262 IEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 292
++KC+ R +LL+ PF+ ++ K +
Sbjct: 242 LKKCLEKNVDARWTTTQLLQHPFVTVNSNKPI 273
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 8/200 (4%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
++GKGAF V A +N + + + + +E +L+ L H ++
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-EKGSVRNVLNERRILQELNHPFLVNL 65
Query: 92 YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
+ S+ D+ N + ++ +L G LR + + + +K W +I+ L YLHS I
Sbjct: 66 WYSFQDEEN--MYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--I 121
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAPELY-EEEYNELV 209
IHRD+K DNI ++ G V I D +A V S GTP +MAPE+ + Y+ V
Sbjct: 122 IHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAV 180
Query: 210 DIYSFGMCILEMVTCEYPYN 229
D +S G+ E + + PY
Sbjct: 181 DWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 68/212 (32%), Positives = 110/212 (51%), Gaps = 19/212 (8%)
Query: 24 CRYGRYDEILGKGAFKTVYKG-FDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHL 79
R+ ++ + LG+G F V +D + G +VA +N Q ER E+ +
Sbjct: 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFER---EIEI 59
Query: 80 LKSLKHENIIKFYNSWVDDTN-RTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQI 137
L++L HENI+K Y + R++ +I E SGSLR Y ++H+ +++K + ++ QI
Sbjct: 60 LRTLDHENIVK-YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQI 118
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTP 193
+G+ YL S IHRDL NI V + VKI D GLA V+ + + +P
Sbjct: 119 CKGMDYLGSQR--YIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESP 175
Query: 194 EF-MAPE-LYEEEYNELVDIYSFGMCILEMVT 223
F APE L +++ D++SFG+ + E+ T
Sbjct: 176 IFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 7e-24
Identities = 83/279 (29%), Positives = 142/279 (50%), Gaps = 18/279 (6%)
Query: 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
DP Y +I G+G+ V ++ G +VA V + D ++ + E L++EV ++
Sbjct: 18 DPRSLLENYIKI-GEGSTGIVCIAREKHSGRQVA---VKMMD-LRKQQRRELLFNEVVIM 72
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
+ +H+N+++ Y S++ + ++ E G+L + + ++ + I +L+
Sbjct: 73 RDYQHQNVVEMYKSYL--VGEELWVLMEFLQGGALTDIVSQTR-LNEEQIATVCESVLQA 129
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAP 198
L YLHS +IHRD+K D+I + +G VK+ D G I P +S++GTP +MAP
Sbjct: 130 LCYLHSQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 186
Query: 199 ELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDP 256
E+ Y VDI+S G+ ++EMV E PY +P Q K++ P + P
Sbjct: 187 EVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNAHKISP 245
Query: 257 QVKQFIEKCIVPASL-RLPALELLKDPFLV-TDNPKDLV 293
++ F+E+ + R A ELL PFL+ T P+ LV
Sbjct: 246 VLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLV 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 13/196 (6%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+G+G + VYK D++ G VA ++ + +S + E+ LLK L H NIIK
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRF--ESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
+ V + ++ E + + + + + + IK++ Q+L+GL + HSH I+
Sbjct: 65 D--VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--IL 120
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTARSVIGTPEFMAPELY--EEEYNEL 208
HRDLK +N+ +N G +K+ D GLA + T + APEL ++ Y+
Sbjct: 121 HRDLKPENLLINT-EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179
Query: 209 VDIYSFGMCIL-EMVT 223
VDI+S G CI E+++
Sbjct: 180 VDIWSVG-CIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 65/201 (32%), Positives = 110/201 (54%), Gaps = 18/201 (8%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E LG+G + TVYKG + G VA +++++ +P R E+ L+K LKHENI++
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR---EISLMKELKHENIVR 62
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN---VDMKAIKNWARQILRGLHYLHSH 147
++ V T + ++ E + L++Y H +D +K++ Q+L+G+ + H +
Sbjct: 63 LHD--VIHTENKLMLVFE-YMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEE 203
++HRDLK N+ +N GE+K+ D GLA P T + + T + AP+ L
Sbjct: 120 R--VLHRDLKPQNLLINK-RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176
Query: 204 EYNELVDIYSFGMCIL-EMVT 223
Y+ +DI+S G CI+ EM+T
Sbjct: 177 TYSTSIDIWSVG-CIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 76/211 (36%), Positives = 107/211 (50%), Gaps = 30/211 (14%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM---QSPDQLERLYSEVHLLKS 82
RY + +G GA+ V FD G +VA I+ + QS +R Y E+ LLK
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVA-----IKKLSRPFQSAIHAKRTYRELRLLKH 70
Query: 83 LKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 138
+ HEN+I + + ++ + + ++T L + L K K D I+ QIL
Sbjct: 71 MDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQKLSDDH-IQFLVYQIL 128
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG---TPEF 195
RGL Y+HS IIHRDLK NI VN + E+KI D GLA + T + G T +
Sbjct: 129 RGLKYIHSAG--IIHRDLKPSNIAVNEDC-ELKILDFGLA----RHTDDEMTGYVATRWY 181
Query: 196 MAPE--LYEEEYNELVDIYSFGMCIL-EMVT 223
APE L YN+ VDI+S G CI+ E++T
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVG-CIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 29/211 (13%)
Query: 29 YDEI--LGKGAFKTVYKGFDEVDGIEVAWNQV-----NIEDVMQSPDQLERLYSEVHLLK 81
Y I LG G F +VY ++ G VA ++ + E+ M EV L+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR--------EVKSLR 52
Query: 82 SLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM--KAIKNWARQIL 138
L H NI+K + + N + + E + G+L Q K K I++ QIL
Sbjct: 53 KLNEHPNIVKLKEVFRE--NDELYFVFE-YMEGNLYQLMKDRKGKPFSESVIRSIIYQIL 109
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGTPEFMA 197
+GL ++H H HRDLK +N+ V+G VKI D GLA + +P + T + A
Sbjct: 110 QGLAHIHKHG--FFHRDLKPENLLVSG-PEVVKIADFGLAREIRSRPPYTDYVSTRWYRA 166
Query: 198 PE--LYEEEYNELVDIYSFGMCIL-EMVTCE 225
PE L Y+ VDI++ G CI+ E+ T
Sbjct: 167 PEILLRSTSYSSPVDIWALG-CIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 81/269 (30%), Positives = 133/269 (49%), Gaps = 20/269 (7%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
+Y EILG G TVYK + + +A V + + + + +++ SE+ +L
Sbjct: 4 QYQEILGHGNGGTVYKAYHLLTRRILA---VKVIPLDITVELQKQIMSELEILYKCDSPY 60
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
II FY ++ + NR I++ TE GSL YRK ++V + A +++GL YL S
Sbjct: 61 IIGFYGAFFVE-NR-ISICTEFMDGGSLDVYRKIPEHV----LGRIAVAVVKGLTYLWSL 114
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYN 206
I+HRD+K N+ VN G+VK+ D G++ + A++ +GT +MAPE + E+Y
Sbjct: 115 K--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYG 171
Query: 207 ELVDIYSFGMCILEMVTCEYPY-----NECK-NPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
D++S G+ +E+ +PY N+ P Q+ + + P +
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH 231
Query: 261 FIEKCIVPASLRLPALELLKD-PFLVTDN 288
FI +C+ PA E L D PF+V N
Sbjct: 232 FITQCMRKQPKERPAPENLMDHPFIVQYN 260
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 82/270 (30%), Positives = 133/270 (49%), Gaps = 25/270 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NII 89
E++G G + VYKG G A + + DV + D+ E + E+++LK H NI
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAA---IKVMDVTE--DEEEEIKLEINMLKKYSHHRNIA 76
Query: 90 KFYNSWVDDT----NRTINMITELFTSGSLRQYRKKHKNVDMKA--IKNWARQILRGLHY 143
+Y +++ + + + ++ E +GS+ K K +K I R+ILRGL +
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH 136
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY 201
LH+H +IHRD+K N+ + N EVK+ D G++ + + R + IGTP +MAPE+
Sbjct: 137 LHAHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 193
Query: 202 ------EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255
+ Y+ DI+S G+ +EM P + +P + + P SK
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPPPKLKSKKWS 252
Query: 256 PQVKQFIEKCIVPASLRLPALE-LLKDPFL 284
+ FIE C+V L P+ E LLK PF+
Sbjct: 253 KKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 71/202 (35%), Positives = 108/202 (53%), Gaps = 19/202 (9%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ---SPDQLERLYSEVHLLKS 82
RY ++ +G GAF V D++ G VA I+ +M+ +P +R Y E+ LLK
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVA-----IKKIMKPFSTPVLAKRTYRELKLLKH 65
Query: 83 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
L+HENII + ++ I +TEL + R + ++ + I+ + QILRGL
Sbjct: 66 LRHENIISLSDIFISPLE-DIYFVTELLGTDLHRLL--TSRPLEKQFIQYFLYQILRGLK 122
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE--L 200
Y+HS ++HRDLK NI +N N ++KI D GLA + Q P + T + APE L
Sbjct: 123 YVHSAG--VVHRDLKPSNILIN-ENCDLKICDFGLARI-QDPQMTGYVSTRYYRAPEIML 178
Query: 201 YEEEYNELVDIYSFGMCILEMV 222
++Y+ VDI+S G EM+
Sbjct: 179 TWQKYDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 2e-23
Identities = 79/270 (29%), Positives = 131/270 (48%), Gaps = 25/270 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENII 89
E++G G + VYKG G A + + DV + D+ E + E+++LK H NI
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAA---IKVMDV--TGDEEEEIKQEINMLKKYSHHRNIA 66
Query: 90 KFYNSWVDDT----NRTINMITELFTSGSLRQYRKKHKNVDMKA--IKNWARQILRGLHY 143
+Y +++ + + ++ E +GS+ K K +K I R+ILRGL +
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY 201
LH H +IHRD+K N+ + N EVK+ D G++ + + R + IGTP +MAPE+
Sbjct: 127 LHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183
Query: 202 ------EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255
+ Y+ D++S G+ +EM P + +P + + P SK
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPAPRLKSKKWS 242
Query: 256 PQVKQFIEKCIVPASLRLPALE-LLKDPFL 284
+ + FIE C+V + P E L+K PF+
Sbjct: 243 KKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 5e-23
Identities = 54/163 (33%), Positives = 92/163 (56%), Gaps = 10/163 (6%)
Query: 68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VD 126
+ + L E+ +L++L HENI+K+ +D I +I E SGSL++Y ++KN ++
Sbjct: 48 NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKIN 107
Query: 127 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 184
+K +A QI +G+ YL S +HRDL N+ V + +VKIGD GL ++
Sbjct: 108 LKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKE 164
Query: 185 --TARSVIGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEMVT 223
T + + +P F APE L + ++ D++SFG+ + E++T
Sbjct: 165 YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 89/302 (29%), Positives = 150/302 (49%), Gaps = 18/302 (5%)
Query: 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
F + DP + EI G G+F VY D + VA +++ QS ++ + + E
Sbjct: 8 FFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKE 65
Query: 77 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWAR 135
V L+ L+H N I++ ++ + + M L ++ L + KK + V++ A+ + A
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGA- 124
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
L+GL YLHSHN +IHRD+K NI ++ G VK+GD G A +M A +GTP +
Sbjct: 125 --LQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMA--PANXFVGTPYW 177
Query: 196 MAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 251
MAPE+ E +Y+ VD++S G+ +E+ + P + +Y + PA S
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQS 236
Query: 252 KVTDPQVKQFIEKCIVPASLRLPALE-LLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNL 309
+ F++ C+ P E LLK F++ + P ++ D + R + V E+ NL
Sbjct: 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNL 296
Query: 310 AH 311
+
Sbjct: 297 QY 298
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 67/210 (31%), Positives = 106/210 (50%), Gaps = 18/210 (8%)
Query: 25 RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
R+ ++ + LGKG F +V Y + G VA ++ + + L E+ +L
Sbjct: 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ----HSTAEHLRDFEREIEIL 59
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILR 139
KSL+H+NI+K+ R + ++ E GSLR Y +KH+ +D + + +A QI +
Sbjct: 60 KSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICK 119
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE----- 194
G+ YL S +HRDL NI V N VKIGD GL V+ Q + P
Sbjct: 120 GMEYLGSKR--YVHRDLATRNILVESEN-RVKIGDFGLTKVLPQDKEYYKVREPGESPIF 176
Query: 195 FMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
+ APE L E +++ D++SFG+ + E+ T
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 3e-22
Identities = 89/303 (29%), Positives = 152/303 (50%), Gaps = 20/303 (6%)
Query: 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
F ++DP + EI G G+F VY D VA +++ QS ++ + + E
Sbjct: 18 FFKEDPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQDIIKE 75
Query: 77 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWAR 135
V L+ +KH N I++ ++ + + M L ++ L + KK + V++ AI + A
Sbjct: 76 VKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGA- 134
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
L+GL YLHSHN +IHRD+K NI + G+VK+ D G A + A S +GTP +
Sbjct: 135 --LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASIAS--PANSFVGTPYW 187
Query: 196 MAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 251
MAPE+ E +Y+ VD++S G+ +E+ + P + +Y + P S
Sbjct: 188 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPTLQS 246
Query: 252 KVTDPQVKQFIEKCI--VPASLRLPALELLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMN 308
+ F++ C+ +P R + ELLK F++ + P+ ++ D + R + V E+ N
Sbjct: 247 NEWSDYFRNFVDSCLQKIPQD-RPTSEELLKHMFVLRERPETVLIDLIQRTKDAVRELDN 305
Query: 309 LAH 311
L +
Sbjct: 306 LQY 308
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-22
Identities = 88/302 (29%), Positives = 146/302 (48%), Gaps = 18/302 (5%)
Query: 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
F + DP + EI G G+F VY + VA +++ Q+ ++ + + E
Sbjct: 14 FYKDDPEEIFVGLHEI-GHGSFGAVYFATNSHTNEVVAVKKMSYSG-KQTNEKWQDIIKE 71
Query: 77 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWAR 135
V L+ LKH N I++ ++ + + M L ++ L + KK + V++ AI + A
Sbjct: 72 VKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGA- 130
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
L+GL YLHSHN +IHRD+K NI + G+VK+ D G A A S +GTP +
Sbjct: 131 --LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASKSS--PANSFVGTPYW 183
Query: 196 MAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 251
MAPE+ E +Y+ VD++S G+ +E+ + P + +Y + P S
Sbjct: 184 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPTLQS 242
Query: 252 KVTDPQVKQFIEKCIVPASLRLPA-LELLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNL 309
+ F++ C+ PA ELL+ F+ D P ++ D + R + V E+ NL
Sbjct: 243 NEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQRTKDAVRELDNL 302
Query: 310 AH 311
+
Sbjct: 303 QY 304
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 67/214 (31%), Positives = 106/214 (49%), Gaps = 31/214 (14%)
Query: 34 GKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERL----YSEVHLLKSLKHEN 87
G+G + VYK + DG E A I+ +Q + E+ LL+ LKHEN
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYA-----IKKFKGDKEQYTGISQSACREIALLRELKHEN 63
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQ-----YRKKHKNVDMKAIKNWARQILRGLH 142
++ +++ ++++ ++ + + L Q + K ++ +K+ QIL G+H
Sbjct: 64 VVSLVEVFLEHADKSVYLLFD-YAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQP-----TARSVIGTPE 194
YLHS+ ++HRDLK NI V G G VKIGDLGLA + P V+ T
Sbjct: 123 YLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180
Query: 195 FMAPELY--EEEYNELVDIYSFGMCIL-EMVTCE 225
+ APEL Y + +DI++ G CI E++T E
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIG-CIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 9e-22
Identities = 78/264 (29%), Positives = 131/264 (49%), Gaps = 23/264 (8%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG GAF VYK ++ G A + +S ++LE E+ +L + H I+K
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIE----TKSEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
++ D I MI E G++ + + + I+ RQ+L L YLHS I
Sbjct: 76 GAFYWDGKLWI-MI-EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--I 131
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE------LYEE 203
IHRDLK N+ + +G++K+ D G++ + R S IGTP +MAPE + +
Sbjct: 132 IHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 204 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT--DPQVKQF 261
Y+ DI+S G+ ++EM E P++E NP ++ K+ +P +LS+ + + + F
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKS-EPPTLSQPSKWSMEFRDF 248
Query: 262 IEKCIVP-ASLRLPALELLKDPFL 284
++ + R A +LL+ PF+
Sbjct: 249 LKTALDKHPETRPSAAQLLEHPFV 272
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 72/253 (28%), Positives = 127/253 (50%), Gaps = 21/253 (8%)
Query: 31 EILGKGAFKTVYKGFDEVDGIE-VAWNQVNIEDVMQSPDQLER------LYSEVHLLK-S 82
E LG GAF VYK + +G +A ++N+ + D+ ER + SEV ++K
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 83 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY----RKKHKNVDMKAIKNWARQIL 138
L+H NI+++Y ++++ N + ++ +L L ++ ++K + + I N Q++
Sbjct: 66 LRHPNIVRYYKTFLE--NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFM 196
L YLH I+HRDL +NI + G + +V I D GLA +QP ++ SV+GT +
Sbjct: 124 LALRYLHKEKR-IVHRDLTPNNIML-GEDDKVTITDFGLA-KQKQPESKLTSVVGTILYS 180
Query: 197 APELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255
PE+ + E Y E D+++FG + +M T + P+ N + K+ + +
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPEGMYS 239
Query: 256 PQVKQFIEKCIVP 268
V I C+ P
Sbjct: 240 EDVTDVITSCLTP 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 70/228 (30%), Positives = 116/228 (50%), Gaps = 14/228 (6%)
Query: 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
+Y + +I G+G+F + DG + ++NI + SP + E EV +L ++K
Sbjct: 1 KYVKVKKI-GEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMK 57
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKAIKNWARQILRGLH 142
H NI+++ S+ ++ N I M + G L + + V I +W QI L
Sbjct: 58 HPNIVQYQESFEENGNLYIVM--DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPEL 200
H H+ I+HRD+K NIF+ +G +K+GD G+A V+ AR+ IGTP +++PE+
Sbjct: 116 --HVHDRKILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI 172
Query: 201 YEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 247
E YN DI++ G + EM T ++ + E N + K+ G P
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAF-EAGNMKNLVLKIIRGSYP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 55/206 (26%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLK 84
RY + +G+GA V+K D G VA +V + + P+Q R E+ L++ +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR---EIKALQACQ 57
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
H ++K + + + ++ E S R + + + +K++ R +L+G+ Y+
Sbjct: 58 HPYVVKLLDVFPHGSG--FVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV---IGTPEFMAPELY 201
H++ I+HRDLK N+ + +G +KI D GLA + + R + T + APEL
Sbjct: 116 HANG--IMHRDLKPANLLI-SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172
Query: 202 --EEEYNELVDIYSFGMCIL-EMVTC 224
+Y+ VD+++ G CI E++
Sbjct: 173 YGARKYDPGVDLWAVG-CIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 32 ILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
+LG GAF TVYKG +G I VA + E SP + + E +++ S+ H +
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE---TSPKANKEILDEAYVMASVDHPH 70
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHS 146
+++ + + + +IT+L G L Y + HK N+ + + NW QI +G+ YL
Sbjct: 71 VVRLLGICL---SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE 127
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT----P-EFMAPE-L 200
++HRDL N+ V VKI D GLA + + P ++MA E +
Sbjct: 128 KR--LVHRDLAARNVLVKTPQ-HVKITDFGLA-KLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 201 YEEEYNELVDIYSFGMCILEMVT 223
Y D++S+G+ + E++T
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-21
Identities = 63/205 (30%), Positives = 117/205 (57%), Gaps = 23/205 (11%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLK 84
+Y+++ +G+G + TV+K + VA +V ++D + P R E+ LLK LK
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELK 57
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHY 143
H+NI++ Y+ V +++ + ++ E + L++Y + ++D + +K++ Q+L+GL +
Sbjct: 58 HKNIVRLYD--VLHSDKKLTLVFE-YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA----IVMQQPTARSVIGTPEFMAPE 199
HSHN ++HRDLK N+ +N NGE+K+ D GLA I ++ +A V T + P+
Sbjct: 115 CHSHN--VLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPD 169
Query: 200 --LYEEEYNELVDIYSFGMCIL-EM 221
+ Y+ +D++S G CI E+
Sbjct: 170 VLFGAKLYSTSIDMWSAG-CIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 7e-21
Identities = 77/286 (26%), Positives = 131/286 (45%), Gaps = 38/286 (13%)
Query: 30 DEI-----LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
DEI LGKG + +VYK G+ +A ++ +E + ++ E+ +L
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE---LDESKFNQIIMELDILHKAV 57
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNVDMKAIKNWARQILRGL 141
I+ FY ++ + + M E +GSL + + + ++ +++GL
Sbjct: 58 SPYIVDFYGAFFIEG--AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGL 115
Query: 142 HYL-HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL 200
+L HN IIHRD+K N+ VNGN G+VK+ D G++ + A++ IG +MAPE
Sbjct: 116 KFLKEEHN--IIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVASLAKTNIGCQSYMAPER 172
Query: 201 YEEE-------YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------P 247
+ Y D++S G+ ILEM YPY P + Y + + + P
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY-----PPETYANIFAQLSAIVDGDP 227
Query: 248 ASLSKVTDPQVKQFIEKCI--VPASLRLPALELLKDPFLVTDNPKD 291
+L + F+ KC+ +P + R +LL+ P+LV D
Sbjct: 228 PTLPSGYSDDAQDFVAKCLNKIP-NRRPTYAQLLEHPWLVKYKNAD 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ LG+G++ TVYKG ++ G VA ++ +E +P R E LLK LKH NI+
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR---EASLLKDLKHANIVT 67
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNP 149
++ + T +T+ ++ E + L+QY + M ++ + Q+LRGL Y H
Sbjct: 68 LHD--IIHTKKTLTLVFE-YLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR- 123
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEEEY 205
++HRDLK N+ ++ GE+K+ D GLA P T + + T + P+ L EY
Sbjct: 124 -VLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 206 NELVDIYSFGMCILEMVT 223
+ +D++ G EM T
Sbjct: 182 STSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 4e-20
Identities = 67/238 (28%), Positives = 104/238 (43%), Gaps = 52/238 (21%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ------SPDQLERLYS----EVHLL 80
+ LG G+F V +G W+ V+ D+L + E ++
Sbjct: 1 KKLGDGSFGVVRRG---------EWSTSG-GKVIPVAVKCLKSDKLSDIMDDFLKEAAIM 50
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQIL 138
SL HEN+I+ Y + + M+TEL GSL +K + + ++A QI
Sbjct: 51 HSLDHENLIRLYGVVLTH---PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA 107
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---------IVMQQ----PT 185
G+ YL S IHRDL NI + ++ +VKIGD GL VM++ P
Sbjct: 108 NGMRYLESKR--FIHRDLAARNILLASDD-KVKIGDFGLMRALPQNEDHYVMEEHLKVPF 164
Query: 186 ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKV 241
A + APE L ++ D++ FG+ + EM T E P+ + +QI KK+
Sbjct: 165 A--------WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 4e-20
Identities = 66/196 (33%), Positives = 102/196 (52%), Gaps = 14/196 (7%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG+G + TV+KG ++ VA ++ +E +P R EV LLK+LKH NI+ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR---EVSLLKNLKHANIVTLH 69
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNPPI 151
+ + T R + ++ E S L+QY N+ M +K + Q+LRGL Y H I
Sbjct: 70 D--IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--I 124
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE--LYEEEYNE 207
+HRDLK N+ +N GE+K+ D GLA PT + + T + P+ L EY+
Sbjct: 125 LHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 208 LVDIYSFGMCILEMVT 223
+D++ G + EM T
Sbjct: 184 PIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 9e-20
Identities = 75/267 (28%), Positives = 131/267 (49%), Gaps = 20/267 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL-LKSLKHENII 89
E LG+GA+ V K G +A + I + S +Q +RL ++ + ++S+ +
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKR--IRATVNSQEQ-KRLLMDLDISMRSVDCPYTV 63
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK----AIKNWARQILRGLHYLH 145
FY + + + I M E+ + SL ++ KK + + + A I++ L YLH
Sbjct: 64 TFYGALFREGDVWICM--EVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELYEEE 204
S +IHRD+K N+ +N NG+VK+ D G++ + A+++ G +MAPE E
Sbjct: 121 S-KLSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPE 178
Query: 205 -----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259
Y+ D++S G+ ++E+ T +PY+ K P Q K+V P ++ P+ +
Sbjct: 179 LNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQ 238
Query: 260 QFIEKCIVPASLRLPAL-ELLKDPFLV 285
F+ KC+ P ELL+ PF
Sbjct: 239 DFVNKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 1e-19
Identities = 72/261 (27%), Positives = 122/261 (46%), Gaps = 20/261 (7%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+G G + VYK + G A + +E + + E+ ++K KH NI+ ++
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLE----PGEDFAVVQQEIIMMKDCKHSNIVAYF 72
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
S++ I M E GSL+ + I +R+ L+GL+YLHS +
Sbjct: 73 GSYLRRDKLWICM--EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK--M 128
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEE----YN 206
HRD+K NI + +NG VK+ D G++ + A+ S IGTP +MAPE+ E YN
Sbjct: 129 HRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS---KVTDPQVKQFIE 263
+L DI++ G+ +E+ + P + ++ S +P L K ++ F++
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN-SFHHFVK 246
Query: 264 KCIVPASLRLPALE-LLKDPF 283
+ + P E LL+ PF
Sbjct: 247 MALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 63/196 (32%), Positives = 103/196 (52%), Gaps = 14/196 (7%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG+G + TVYKG ++ VA ++ +E +P R EV LLK LKH NI+ +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVTLH 70
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPI 151
+ + T +++ ++ E + L+QY N ++M +K + Q+LRGL+Y H +
Sbjct: 71 D--IIHTEKSLTLVFE-YLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--V 125
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE--LYEEEYNE 207
+HRDLK N+ +N GE+K+ D GLA PT + + T + P+ L +Y+
Sbjct: 126 LHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184
Query: 208 LVDIYSFGMCILEMVT 223
+D++ G EM T
Sbjct: 185 QIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
E +G+G + VYK +++ G VA ++ ++ + P R E+ LLK L H NI+
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 62
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRK--KHKNVDMKAIKNWARQILRGLHYLHSH 147
K + V T + ++ E F L+++ + + IK++ Q+L+GL + HSH
Sbjct: 63 KLLD--VIHTENKLYLVFE-FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEE 203
++HRDLK N+ +N G +K+ D GLA P T + T + APE L +
Sbjct: 120 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 176
Query: 204 EYNELVDIYSFGMCILEMVT 223
Y+ VDI+S G EMVT
Sbjct: 177 YYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 71/255 (27%), Positives = 115/255 (45%), Gaps = 17/255 (6%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+G G + VYK + G A + +E D + E+ ++K KH NI+ ++
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLE----PGDDFSLIQQEIFMVKECKHCNIVAYF 72
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
S++ I M E GSL+ + I R+ L+GL YLHS +
Sbjct: 73 GSYLSREKLWICM--EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK--M 128
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEE----YN 206
HRD+K NI + +NG+VK+ D G+A + A+ S IGTP +MAPE+ E YN
Sbjct: 129 HRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT--DPQVKQFIEK 264
+L DI++ G+ +E+ + P + ++ S +P L T F++
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKI 247
Query: 265 CIVPASLRLPALELL 279
+ + P E L
Sbjct: 248 SLTKNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 18/208 (8%)
Query: 32 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKHE 86
+LGKG+F V KG +E I+ V +ED D +E E +L + +H
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED-----DDVECTMVERRVLALAWEHP 56
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
+ + ++ T + + E G L + + D + +A +I+ GL +LH
Sbjct: 57 FLTHLFCTF--QTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK 114
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE-E 203
II+RDLK DN+ ++ +G +KI D G+ + + A + GTP+++APE+ + +
Sbjct: 115 KG--IIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ 171
Query: 204 EYNELVDIYSFGMCILEMVTCEYPYNEC 231
+YNE VD +SFG+ + EM+ + P++
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 65/203 (32%), Positives = 104/203 (51%), Gaps = 22/203 (10%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
E +G+G + VYK D++ G VA ++ +E + P R E+ LLK L H NI+
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR---EISLLKELNHPNIV 61
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLHSH 147
+ + + + ++ E F L++Y +D IK++ Q+L+G+ Y HSH
Sbjct: 62 RLLDVVHSENK--LYLVFE-FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA----IVMQQPTARSVIGTPEFMAPE--LY 201
++HRDLK N+ ++ G +K+ D GLA + ++ T V T + APE L
Sbjct: 119 R--VLHRDLKPQNLLID-REGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLG 173
Query: 202 EEEYNELVDIYSFGMCIL-EMVT 223
+Y+ VDI+S G CI EMV
Sbjct: 174 SRQYSTPVDIWSIG-CIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 68/275 (24%), Positives = 123/275 (44%), Gaps = 24/275 (8%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG G +V K G +A V+I Q+ R E+ ++ + I+ FY
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILR---ELQIMHECRSPYIVSFY 69
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPI 151
+++++ N I M E GSL + KK + ++ + A ++ GL YL++ H I
Sbjct: 70 GAFLNENN--ICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--I 125
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVD 210
+HRD+K NI VN G++K+ D G++ + A + +GT +M+PE + +Y D
Sbjct: 126 MHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSD 184
Query: 211 IYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI----------KPASLSKVTDPQV-K 259
++S G+ I+E+ ++P+ N + GI P L P+ +
Sbjct: 185 VWSLGISIIELALGKFPFAF-SNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLR 243
Query: 260 QFIEKCIV--PASLRLPALELLKDPFLVTDNPKDL 292
F++ C++ P P PF+ ++
Sbjct: 244 DFVDACLLKDPTERPTPQQLCAMPPFIQALRASNV 278
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 5e-19
Identities = 64/255 (25%), Positives = 125/255 (49%), Gaps = 18/255 (7%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG G F V++G + + + VA + +D+++ + EV LK L+H+++I +
Sbjct: 14 LGSGYFGEVWEGLWK-NRVRVAIKILKSDDLLK----QQDFQKEVQALKRLRHKHLISLF 68
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRK--KHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
V + +ITEL GSL + + + + + + ++ + A Q+ G+ YL N
Sbjct: 69 A--VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN-- 124
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE-LYEEEYNE 207
IHRDL NI V G + K+ D GLA ++++ + ++ APE ++
Sbjct: 125 SIHRDLAARNILV-GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFST 183
Query: 208 LVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266
D++SFG+ + EM T + PY N ++Y ++T+G + +K ++ + + +C
Sbjct: 184 KSDVWSFGILLYEMFTYGQVPY-PGMNNHEVYDQITAGYRMPCPAKCP-QEIYKIMLECW 241
Query: 267 VPASLRLPALELLKD 281
P+ + L++
Sbjct: 242 AAEPEDRPSFKALRE 256
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 6e-19
Identities = 67/211 (31%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 25 RYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
RY + +LG+G F V Y ++ G VA + E E+++L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINIL 60
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
K+L HENI+K+ + + + +I E GSLR Y KH +++ + +A+QI G
Sbjct: 61 KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEG 119
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA------RSVIGTPE 194
+ YLHS + IHRDL N+ ++ N+ VKIGD GLA + P R +P
Sbjct: 120 MAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAV--PEGHEYYRVREDGDSPV 174
Query: 195 F-MAPE-LYEEEYNELVDIYSFGMCILEMVT 223
F A E L E +++ D++SFG+ + E++T
Sbjct: 175 FWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 6e-19
Identities = 78/269 (28%), Positives = 129/269 (47%), Gaps = 32/269 (11%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQV--NIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
+G GA TVYK G A + N ED ++ Q+ R E+ +L+ + H N++
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR--QICR---EIEILRDVNHPNVV 135
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
K ++ + D N I ++ E GSL + + + + ARQIL G+ YLH +
Sbjct: 136 KCHDMF--DHNGEIQVLLEFMDGGSLEGTHIADE----QFLADVARQILSGIAYLHRRH- 188
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ---PTARSVIGTPEFMAPELYEEEYN 206
I+HRD+K N+ +N VKI D G++ ++ Q P SV GT +M+PE + N
Sbjct: 189 -IVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLN 245
Query: 207 ELV------DIYSFGMCILEMVTCEYPYNECKNP--AQIYKKVTSGIKPASLSKVTDPQV 258
DI+S G+ ILE +P+ + A + + P + + + +
Sbjct: 246 HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS-REF 304
Query: 259 KQFIEKCIV--PASLRLPALELLKDPFLV 285
+ FI C+ PA R A++LL+ PF++
Sbjct: 305 RHFISCCLQREPAK-RWSAMQLLQHPFIL 332
|
Length = 353 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-19
Identities = 59/177 (33%), Positives = 86/177 (48%), Gaps = 10/177 (5%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNW 133
E LL +KH NI+ F S+ D + I M E G L Q K + I W
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVM--EYCDGGDLMQKIKLQRGKLFPEDTILQW 105
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV--IG 191
Q+ G+ H H ++HRD+K NIF+ NG+VK+GD G A ++ P A + +G
Sbjct: 106 FVQMCLGVQ--HIHEKRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVG 162
Query: 192 TPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 247
TP ++ PE++E YN DI+S G + E+ T ++P+ I K KP
Sbjct: 163 TPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 7e-19
Identities = 71/263 (26%), Positives = 115/263 (43%), Gaps = 36/263 (13%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQ---VNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
LG G F V++G WN V ++ + + +E ++K L+H +I
Sbjct: 14 LGAGQFGEVWEGL---------WNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLI 64
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLHSH 147
+ Y V I ++TEL GSL +Y + + + + + A Q+ G+ YL +
Sbjct: 65 QLYA--VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ 122
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPELYEEE 204
N IHRDL N+ V G N K+ D GLA V+++ AR P ++ APE
Sbjct: 123 N--YIHRDLAARNVLV-GENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPE--AAL 177
Query: 205 YNELV---DIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK---PASLSKVTDPQ 257
YN D++SFG+ + E+VT PY N A++ ++V G + P +
Sbjct: 178 YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-AEVLQQVDQGYRMPCPPG----CPKE 232
Query: 258 VKQFIEKCIVPASLRLPALELLK 280
+ + C P E L+
Sbjct: 233 LYDIMLDCWKEDPDDRPTFETLQ 255
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 8e-19
Identities = 85/290 (29%), Positives = 143/290 (49%), Gaps = 33/290 (11%)
Query: 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY + E++GKG++ V D G +VA ++N DV + R+ E+ LL+ L+
Sbjct: 1 RY-KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN--DVFEHVSDATRILREIKLLRLLR 57
Query: 85 HENIIKFYNSWVDDTNRT---INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
H +I++ + + + R I ++ EL S L Q K + ++ + + + Q+LR L
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-----IGTPEFM 196
Y+H+ N + HRDLK NI N + ++KI D GLA V T ++ + T +
Sbjct: 117 KYIHTAN--VFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 197 APEL---YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASL 250
APEL + +Y +DI+S G CI V P KN +T + P ++
Sbjct: 174 APELCGSFFSKYTPAIDIWSIG-CIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232
Query: 251 SKVTDPQVKQFI----EKCIVPASLRLP-----ALELLKDPFLVTDNPKD 291
S+V + + ++++ +K VP S + P AL LL+ L+ +PKD
Sbjct: 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLER--LLAFDPKD 280
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-18
Identities = 75/249 (30%), Positives = 121/249 (48%), Gaps = 24/249 (9%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY + +G GA+ +V FD G+ VA +++ QS +R Y E+ LLK +KH
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKH 75
Query: 86 ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
EN+I + + + + ++T L L K K D ++ QILRGL
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGL 133
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG---TPEFMAP 198
Y+HS + IIHRDLK N+ VN + E+KI D GLA + T + G T + AP
Sbjct: 134 KYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLA----RHTDDEMTGYVATRWYRAP 186
Query: 199 ELYEE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVT 254
E+ YN+ VDI+S G + E++T +P + + ++ ++ L K++
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246
Query: 255 DPQVKQFIE 263
+ +I+
Sbjct: 247 SESARNYIQ 255
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 64/198 (32%), Positives = 103/198 (52%), Gaps = 14/198 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E LG+G + TV+KG ++ VA ++ +E +P R EV LLK LKH NI+
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVT 68
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNP 149
++ + T++++ ++ E + L+QY N+ M +K + QILRGL Y H
Sbjct: 69 LHD--IVHTDKSLTLVFE-YLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK- 124
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE--LYEEEY 205
++HRDLK N+ +N GE+K+ D GLA PT + + T + P+ L EY
Sbjct: 125 -VLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182
Query: 206 NELVDIYSFGMCILEMVT 223
+ +D++ G EM +
Sbjct: 183 STQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 30/215 (13%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--DQL--ERLYSEVHLLK 81
RY +G+GA+ V + G++VA ++ SP Q +R E+ +L+
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-------SPFEHQTFCQRTLREIKILR 58
Query: 82 SLKHENIIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 138
KHENII + + + N ++ EL + + + +H + D I+ + QIL
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDH--IQYFLYQIL 116
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTP 193
RGL Y+HS N ++HRDLK N+ +N N ++KI D GLA + + + T
Sbjct: 117 RGLKYIHSAN--VLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 194 EFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTCE 225
+ APE L + Y + +DI+S G CIL EM++
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVG-CILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-18
Identities = 65/197 (32%), Positives = 106/197 (53%), Gaps = 14/197 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E LG+G++ TVYKG +V+G VA + +++ +P R E LLK LKH NI+
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR---EASLLKGLKHANIVL 67
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNP 149
++ + T T+ ++ E + L QY KH + + +K + Q+LRGL Y+H
Sbjct: 68 LHD--IIHTKETLTLVFE-YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY- 123
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEEEY 205
I+HRDLK N+ ++ + GE+K+ D GLA P T + + T + P+ L EY
Sbjct: 124 -ILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 206 NELVDIYSFGMCILEMV 222
+ +D++ G +EM+
Sbjct: 182 STCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 54/199 (27%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
++G+GA+ V K ++ G VA + + D + EV +L+ L+HENI+
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESE--DDEDVKKTALREVKVLRQLRHENIVN 64
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
++ + ++ E L + A++++ Q+L+ + Y HSHN
Sbjct: 65 LKEAFRRK--GRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN-- 120
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPELY--EEEY 205
IIHRD+K +NI V+ +G +K+ D G A ++ A + T + APEL + Y
Sbjct: 121 IIHRDIKPENILVS-ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179
Query: 206 NELVDIYSFGMCIL-EMVT 223
+ VD+++ G CI+ E++
Sbjct: 180 GKPVDVWAIG-CIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 65/212 (30%), Positives = 104/212 (49%), Gaps = 25/212 (11%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK- 84
+Y+ + LGKGA+ V+K D VA + I D ++ +R + E+ L+ L
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKK--IFDAFRNATDAQRTFREIMFLQELGD 65
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLH 142
H NI+K N + ++ I ++ E + L + + ++V + I Q+L+ L
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANILEDVHKRYI---MYQLLKALK 121
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-------IVMQQPTARSVIGTPEF 195
Y+HS N +IHRDLK NI +N ++ VK+ D GLA + P + T +
Sbjct: 122 YIHSGN--VIHRDLKPSNILLN-SDCRVKLADFGLARSLSELEENPENPVLTDYVATRWY 178
Query: 196 MAPE--LYEEEYNELVDIYSFGMCIL-EMVTC 224
APE L Y + VD++S G CIL EM+
Sbjct: 179 RAPEILLGSTRYTKGVDMWSVG-CILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 30/210 (14%)
Query: 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQV-NIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
E +G GA+ V D G +VA ++ + DV +R E+ +L+ KH+NI
Sbjct: 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLA---KRTLRELKILRHFKHDNI 66
Query: 89 IKFYNSWVDDTNRT-------INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
I + D R + ++ +L S L + + + I+ + Q+LRGL
Sbjct: 67 IA-----IRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGL 120
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSV-----IGTPEF 195
Y+HS N +IHRDLK N+ VN + E++IGD G+A + PT + T +
Sbjct: 121 KYIHSAN--VIHRDLKPSNLLVNE-DCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWY 177
Query: 196 MAPELY--EEEYNELVDIYSFGMCIL-EMV 222
APEL EY +D++S G CI EM+
Sbjct: 178 RAPELLLSLPEYTTAIDMWSVG-CIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 50/141 (35%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
I+ FY ++ D +I M E GSL Q KK + + + +LRGL YL
Sbjct: 61 IVGFYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE- 117
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYN 206
I+HRD+K NI VN + GE+K+ D G++ + A S +GT +M+PE L Y
Sbjct: 118 KHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYT 176
Query: 207 ELVDIYSFGMCILEMVTCEYP 227
DI+S G+ ++EM YP
Sbjct: 177 VQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 51/197 (25%), Positives = 90/197 (45%), Gaps = 15/197 (7%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKF 91
+G+G F V K G A + +S +Q+ L E+ L+ L H NI++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMK--KHFKSLEQVNNL-REIQALRRLSPHPNILRL 63
Query: 92 YNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPP 150
D + ++ EL +L + K K + K +K++ Q+L+ L ++H +
Sbjct: 64 IEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG-- 120
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE--LYEEEYN 206
I HRD+K +NI + + +K+ D G I + P I T + APE L + Y
Sbjct: 121 IFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYT-EYISTRWYRAPECLLTDGYYG 177
Query: 207 ELVDIYSFGMCILEMVT 223
+DI++ G E+++
Sbjct: 178 PKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 8e-18
Identities = 58/262 (22%), Positives = 110/262 (41%), Gaps = 17/262 (6%)
Query: 35 KGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NIIKFYN 93
KGAF +VY G A + D M + +Q+ + +E ++ + K Y
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSD-MIAKNQVTNVKAERAIMMIQGESPYVAKLY- 63
Query: 94 SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIH 153
+ + + ++ E G K + K + +++ G+ LH IIH
Sbjct: 64 -YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIH 120
Query: 154 RDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIY 212
RD+K +N+ ++ G +K+ D GL+ + + +GTP+++APE +++ D +
Sbjct: 121 RDIKPENLLID-QTGHLKLTDFGLSRNGLEN--KKFVGTPDYLAPETILGVGDDKMSDWW 177
Query: 213 SFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIVP-A 269
S G I E + YP + P ++ + S P + + P+ I + +
Sbjct: 178 SLGCVIFEFLF-GYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP 236
Query: 270 SLRLPA---LELLKDPFLVTDN 288
+ RL A E+ PF + N
Sbjct: 237 AKRLGANGYQEIKSHPFFKSIN 258
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 9e-18
Identities = 66/227 (29%), Positives = 99/227 (43%), Gaps = 42/227 (18%)
Query: 27 GRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQV---NIEDVMQSPDQLERLYSEVHLLK 81
Y+ + LG+G F VYK G VA ++ N +D P R E+ +LK
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF--PITALR---EIKILK 62
Query: 82 SLKHENIIKFYNSWVDDTNRTINMITELFT---------SGSLRQYRKKHKNVDMKAIKN 132
LKH N++ + V+ +++ ++ SG L K + IK
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTESQIKC 119
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARS 188
+ Q+L G++YLH ++ I+HRD+K NI ++ N G +KI D GLA P
Sbjct: 120 YMLQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 189 VIGTPEFM---------APELY--EEEYNELVDIYSFGMCIL-EMVT 223
GT ++ PEL E Y VDI+ G C+ EM T
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIG-CVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 76/340 (22%), Positives = 142/340 (41%), Gaps = 58/340 (17%)
Query: 27 GRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY ++ LG G+ V+ D VA ++ V+ P ++ E+ +++ L
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKI----VLTDPQSVKHALREIKIIRRLD 60
Query: 85 HENIIKFYNSWVD---DTNRTINMITELFTSGSLRQYRK-------KHKNVDMKAIKNWA 134
H+NI+K Y D + +TEL + +++Y + + + + + +
Sbjct: 61 HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFM 120
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----V 189
Q+LRGL Y+HS N ++HRDLK N+F+N + +KIGD GLA ++ +
Sbjct: 121 YQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178
Query: 190 IGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTC---------------------- 224
+ T + +P L Y + +D+++ G CI EM+T
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAG-CIFAEMLTGKPLFAGAHELEQMQLILESVPV 237
Query: 225 --EYPYNECKNPAQIYKKVTSGIKPASLSKV---TDPQVKQFIEKCIVPASL-RLPALEL 278
E NE N + + G L + +P+ F+E+ + + RL A E
Sbjct: 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEA 297
Query: 279 LKDPFL-VTDNPKD--LVCDPLRLPNLVPEVMNLAHSEPH 315
L P++ P D + P + + + +++ +
Sbjct: 298 LMHPYMSCYSCPFDEPVSLHPFHIEDELDDILLMTEIHSI 337
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 41/99 (41%), Positives = 63/99 (63%), Gaps = 6/99 (6%)
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVI 190
+ QI+ GL +LH II+RDLK +N+ ++ N+G V+I DLGLA+ ++ Q +
Sbjct: 102 YTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYA 158
Query: 191 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPY 228
GTP FMAPEL + EEY+ VD ++ G+ + EM+ P+
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 67/201 (33%), Positives = 102/201 (50%), Gaps = 23/201 (11%)
Query: 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
D +G GAF V+ D DG VA + + +V Q+ +R++ E+ +L KH+N++
Sbjct: 5 DRPIGYGAFGVVWSVTDPRDGKRVALKK--MPNVFQNLVSCKRVFRELKMLCFFKHDNVL 62
Query: 90 KFYNSWVD-------DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
S +D D I ++TEL S L + + + +K + QILRGL
Sbjct: 63 ----SALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLK 117
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV---IGTPEFMAPE 199
YLHS I+HRD+K N+ VN +N +KI D GLA V + ++ + + T + APE
Sbjct: 118 YLHSAG--ILHRDIKPGNLLVN-SNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174
Query: 200 LY--EEEYNELVDIYSFGMCI 218
+ Y VDI+S G CI
Sbjct: 175 ILMGSRHYTSAVDIWSVG-CI 194
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 40/216 (18%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIK 90
+G+G + VYK D+ G VA +V +++ + P R E+ +L+ L H NI+
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR---EIKILRQLNHRNIVN 70
Query: 91 FYNSWVDDTN--------RTINMITE--------LFTSGSLRQYRKKHKNVDMKAIKNWA 134
D + ++ E L SG L + + H IK++
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESG-LVHFSEDH-------IKSFM 122
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVI 190
+Q+L GL+Y H N +HRD+KC NI +N N G++K+ D GLA + +P VI
Sbjct: 123 KQLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 191 GTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT 223
T + PEL EE Y +D++S G CIL E+ T
Sbjct: 180 -TLWYRPPELLLGEERYGPAIDVWSCG-CILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 78/276 (28%), Positives = 130/276 (47%), Gaps = 35/276 (12%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENII 89
E +GKG + VYK ++ DG A V I D + D E + +E ++L+SL H N++
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAA---VKILDPISDVD--EEIEAEYNILQSLPNHPNVV 82
Query: 90 KFYNSWVDDTNRT---INMITELFTSGSLRQYRK----KHKNVDMKAIKNWARQILRGLH 142
KFY + + ++ EL GS+ + K + +D I L GL
Sbjct: 83 KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ 142
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPEL 200
+LH N IIHRD+K +NI + G VK+ D G++ + R + +GTP +MAPE+
Sbjct: 143 HLH--NNRIIHRDVKGNNILLTTEGG-VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 199
Query: 201 ------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254
Y+ Y+ D++S G+ +E+ + P + +P + K+ P L
Sbjct: 200 IACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD-MHPVKTLFKIPRNPPPTLL---- 254
Query: 255 DPQ-----VKQFIEKCIVPASLRLPAL-ELLKDPFL 284
P+ FI +C++ P++ LL+ PF+
Sbjct: 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 35/228 (15%)
Query: 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS--- 75
S RY + LG+G + V K +D + G VA +V I ++ + +L
Sbjct: 3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62
Query: 76 -------EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
E+ ++ +KHENI+ + +V+ IN++ ++ + L++ + +
Sbjct: 63 IHFTTLRELKIMNEIKHENIMGLVDVYVEGD--FINLVMDIM-ASDLKKVVDRKIRLTES 119
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---------- 178
+K QIL GL+ LH +HRDL NIF+N + G KI D GLA
Sbjct: 120 QVKCILLQILNGLNVLHKWY--FMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSD 176
Query: 179 -IVMQQPTARSVIGTPE-----FMAPELY--EEEYNELVDIYSFGMCI 218
+ + R T + + APEL E+Y+ VD++S G CI
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG-CI 223
|
Length = 335 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 32 ILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK---SLK 84
+LG+G F V YK E+ I+ + D++ + D++E L E + + S +
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKA----LKKGDII-ARDEVESLMCEKRIFETANSER 60
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHY 143
H ++ + + T + + E G L H +V +A ++ GL Y
Sbjct: 61 HPFLVNLFACF--QTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVLGLQY 116
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--VIGTPEFMAPE-L 200
LH + I++RDLK DN+ ++ G VKI D GL R+ GTPEF+APE L
Sbjct: 117 LHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVL 173
Query: 201 YEEEYNELVDIYSFGMCILEMVTCEYPY 228
E Y VD + G+ I EM+ E P+
Sbjct: 174 TETSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 23/204 (11%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
E +G+G + VYK D V +A ++ +E + P R E+ LLK ++H NI+
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR---EISLLKEMQHGNIV 64
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV------DMKAIKNWARQILRGLHY 143
+ + V + + + ++ E L KKH + + + IK + QILRG+ Y
Sbjct: 65 RLQD--VVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE-- 199
HSH ++HRDLK N+ ++ +K+ D GLA P T + T + APE
Sbjct: 118 CHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEIL 175
Query: 200 LYEEEYNELVDIYSFGMCILEMVT 223
L Y+ VDI+S G EMV
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 30 DEILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
+G+G F VY+G E + I VA SP E+ E ++++ H
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHP 67
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLH 145
+I+K ++ + ++ EL G LR Y + +K +D+ ++ ++ Q+ L YL
Sbjct: 68 HIVKLIGVITEN---PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTP-EFMAPE-LY 201
S +HRD+ N+ V+ + VK+GD GL+ ++ + S P ++MAPE +
Sbjct: 125 SKR--FVHRDIAARNVLVSSPDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181
Query: 202 EEEYNELVDIYSFGMCILEM 221
+ D++ FG+C+ E+
Sbjct: 182 FRRFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 14/197 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E LG+G++ TVYKG ++G VA ++++ P R E LLK LKH NI+
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR---EASLLKGLKHANIVL 67
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNP 149
++ + T T+ + E + L QY +H + ++ + Q+LRGL Y+H +
Sbjct: 68 LHD--IIHTKETLTFVFE-YMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH- 123
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEEEY 205
I+HRDLK N+ ++ GE+K+ D GLA P T S + T + P+ L +Y
Sbjct: 124 -ILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDY 181
Query: 206 NELVDIYSFGMCILEMV 222
+ +DI+ G +EM+
Sbjct: 182 SSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 5e-17
Identities = 67/204 (32%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 28 RYDEIL--GKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY ++ G GA+ TV D G +VA + + QS +R Y E+ LLK +KH
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKK--LYRPFQSELFAKRAYRELRLLKHMKH 73
Query: 86 ENIIKFYNSWVDDTNRTINMITELFT----SGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
EN+I + + D + ++ + + G+ KH+ + I+ Q+L+GL
Sbjct: 74 ENVIGLLDVFTPDLS--LDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGL 131
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-- 199
Y+H+ IIHRDLK N+ VN + E+KI D GLA V+ T + APE
Sbjct: 132 KYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQTDSEMTGYVV-TRWYRAPEVI 187
Query: 200 LYEEEYNELVDIYSFGMCILEMVT 223
L Y + VDI+S G + EM+T
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 6e-17
Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 32 ILGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKHE 86
+LGKG+F V KG DE+ ++V V ++D D +E +E +L + KH
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQD-----DDVECTMTEKRVLALAGKHP 56
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
+ + ++ + T + + E G L + ++ D + +A +I+ GL +LH
Sbjct: 57 FLTQLHSCF--QTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE 114
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYEE 203
II+RDLK DN+ ++ G +KI D G+ ++ T + GTP+++APE L +
Sbjct: 115 RG--IIYRDLKLDNVLLDS-EGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQ 171
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY 228
Y VD ++ G+ + EM+ + P+
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 7e-17
Identities = 67/203 (33%), Positives = 106/203 (52%), Gaps = 21/203 (10%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENII 89
E +G+G + VYKG ++ G VA ++ +E + P R E+ LLK L+H NI+
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR---EISLLKELQHPNIV 62
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQYR---KKHKNVDMKAIKNWARQILRGLHYLHS 146
+ + + +R + +I E F S L++Y K + +D + +K++ QIL+G+ + HS
Sbjct: 63 CLQDVLMQE-SR-LYLIFE-FLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPE--L 200
++HRDLK N+ ++ N G +K+ D GLA P T V T + APE L
Sbjct: 120 RR--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVLL 174
Query: 201 YEEEYNELVDIYSFGMCILEMVT 223
Y+ VDI+S G EM T
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 68/244 (27%), Positives = 118/244 (48%), Gaps = 21/244 (8%)
Query: 31 EILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKH 85
++LGKG+F V KG DEV I+V V ++D D ++ +E +L + KH
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQD-----DDVDCTMTEKRILALAAKH 55
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
+ + + T + + E G L ++ + D + +A ++ L +LH
Sbjct: 56 PFLTALHCCF--QTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYE 202
H +I+RDLK DNI ++ G K+ D G+ ++ T + GTP+++APE L E
Sbjct: 114 RHG--VIYRDLKLDNILLDA-EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE 170
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSKVTDPQVKQ 260
EY VD ++ G+ + EM+ + P+ E N +++ + + P LSK +K
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPF-EADNEDDLFESILHDDVLYPVWLSKEAVSILKA 229
Query: 261 FIEK 264
F+ K
Sbjct: 230 FMTK 233
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 55/205 (26%), Positives = 103/205 (50%), Gaps = 19/205 (9%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD--QLERL-YSEVHLLKS 82
+Y+++ +G+G++ V+K + G VA I+ ++S D ++++ E+ +LK
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVA-----IKKFVESEDDPVIKKIALREIRMLKQ 56
Query: 83 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
LKH N++ V R ++++ E L + K + V IK Q L+ ++
Sbjct: 57 LKHPNLVNLIE--VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVN 114
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPEL 200
+ H HN IHRD+K +NI + G++K+ D G A ++ P + T + APEL
Sbjct: 115 FCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPEL 171
Query: 201 Y--EEEYNELVDIYSFGMCILEMVT 223
+ +Y VD+++ G E++T
Sbjct: 172 LVGDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 77/328 (23%), Positives = 138/328 (42%), Gaps = 49/328 (14%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+G+GA+ V + +VA + I + + +R E+ LL+ L HEN+I
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKK--IANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70
Query: 93 NSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
+ N ++ EL + L Q + + + + + Q+LRGL Y+HS N
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN- 128
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM----------APE 199
++HRDLK N+ +N N ++KI D GL AR+ +FM APE
Sbjct: 129 -VLHRDLKPSNLLLNANC-DLKICDFGL--------ARTTSEKGDFMTEYVVTRWYRAPE 178
Query: 200 LY--EEEYNELVDIYSFGMCIL-EMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVT 254
L EY +D++S G CI E++ + +P + + ++ ++ L +
Sbjct: 179 LLLNCSEYTTAIDVWSVG-CIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237
Query: 255 DPQVKQFIEKCIVPASLRLP-----------ALELLKDPFLVTDNPKDL-VCDPLRLPNL 302
+ + +++I +P + R A++LL + LV D K + V + L P L
Sbjct: 238 NEKARRYIRS--LPYTPRQSFARLFPHANPLAIDLL-EKMLVFDPSKRITVEEALAHPYL 294
Query: 303 VP-EVMNLAHSEPHPMDIDLNHKKVSAD 329
+ P D ++ +
Sbjct: 295 ASLHDPSDEPVCQTPFSFDFEEDALTEE 322
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 62/204 (30%), Positives = 92/204 (45%), Gaps = 34/204 (16%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS--EVHLLKSLKHENII 89
+G+G + VY+ D G VA +V ++ D + + S E+ LL +L+H NI+
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMD---NERDGIP-ISSLREITLLLNLRHPNIV 69
Query: 90 KFYNSWVDDTNRTINMITELFTS--GSLRQYRKKHKNVDMKA------IKNWARQILRGL 141
+ V +I ++ E SL +M +K Q+LRGL
Sbjct: 70 ELKEVVVGKHLDSIFLVMEYCEQDLASLLD--------NMPTPFSESQVKCLMLQLLRGL 121
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMA 197
YLH + IIHRDLK N+ + G +KI D GLA P T + V T + A
Sbjct: 122 QYLHENF--IIHRDLKVSNLLLTD-KGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRA 176
Query: 198 PELY--EEEYNELVDIYSFGMCIL 219
PEL Y +D+++ G CIL
Sbjct: 177 PELLLGCTTYTTAIDMWAVG-CIL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 39/207 (18%)
Query: 36 GAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIKFYNS 94
G + VY+ D+ G VA ++ +E + P R E+++L L+H NI+
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR---EINILLKLQHPNIVTVKEV 72
Query: 95 WVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA-------------IKNWARQILRGL 141
V I M+ E +H D+K+ +K Q+L G+
Sbjct: 73 VVGSNLDKIYMVMEYV----------EH---DLKSLMETMKQPFLQSEVKCLMLQLLSGV 119
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE 199
+LH + I+HRDLK N+ +N N G +KI D GLA P ++ T + APE
Sbjct: 120 AHLHDNW--ILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPE 176
Query: 200 LY--EEEYNELVDIYSFGMCIL-EMVT 223
L +EY+ +D++S G CI E++T
Sbjct: 177 LLLGAKEYSTAIDMWSVG-CIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 71/276 (25%), Positives = 130/276 (47%), Gaps = 35/276 (12%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENII 89
E +GKG + V+K ++ +G + A V I D + D E + +E ++LK+L H N++
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAA---VKILDPIHDID--EEIEAEYNILKALSDHPNVV 78
Query: 90 KFYNSWVDDTNRT---INMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLH 142
KFY + + + ++ EL GS+ + + K+ + ++ I + L GL
Sbjct: 79 KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ 138
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPEL 200
+LH IHRD+K +NI + G VK+ D G++ + R + +GTP +MAPE+
Sbjct: 139 HLH--VNKTIHRDVKGNNILLTTEGG-VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195
Query: 201 ------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254
+ Y+ D++S G+ +E+ + P + +P + K+ P +
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL-HPMRALFKIPRNPPP----TLH 250
Query: 255 DPQV-----KQFIEKCIVPA-SLRLPALELLKDPFL 284
P++ FI KC+ R +LL+ F+
Sbjct: 251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 18/206 (8%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLKHEN-I 88
E +G+G + VYK D+ G VA + +E D P R E+ LL+ L I
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR---EISLLQMLSESIYI 63
Query: 89 IKFYN-SWVDDTNRTINM-ITELFTSGSLRQY-----RKKHKNVDMKAIKNWARQILRGL 141
++ + V++ N ++ + + L+++ R + + K IK++ Q+L+G+
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV--IGTPEFMAPE 199
+ H H ++HRDLK N+ V+ G +KI DLGL P I T + APE
Sbjct: 124 AHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPE 181
Query: 200 --LYEEEYNELVDIYSFGMCILEMVT 223
L Y+ VDI+S G EM
Sbjct: 182 VLLGSTHYSTPVDIWSVGCIFAEMSR 207
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 66/256 (25%), Positives = 116/256 (45%), Gaps = 25/256 (9%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG G F V+ G I+VA + E M D +E E ++ L H N+++ Y
Sbjct: 12 LGSGQFGVVHLGKWR-GKIDVAIKMIR-EGAMSEDDFIE----EAKVMMKLSHPNLVQLY 65
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNPPI 151
V R I ++TE +G L Y ++ K + + + + + YL S+
Sbjct: 66 G--VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--F 121
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP-EFMAPELYE-EEYNE 207
IHRDL N V G + VK+ D GLA ++ Q T+ P ++ PE+++ ++
Sbjct: 122 IHRDLAARNCLV-GEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 208 LVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIE 263
D++SFG+ + E+ + + PY N +++ + V++G +P K+ +V +
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYERFSN-SEVVESVSAGYRLYRP----KLAPTEVYTIMY 235
Query: 264 KCIVPASLRLPALELL 279
C PA + L
Sbjct: 236 SCWHEKPEDRPAFKKL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.9 bits (204), Expect = 2e-16
Identities = 58/202 (28%), Positives = 108/202 (53%), Gaps = 29/202 (14%)
Query: 72 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-RQYRKKHK---NVDM 127
+L EV++++ LKH+NI+++ + +++ N+ + ++ E +G L R +K +K ++
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117
Query: 128 KAIKNWARQILRGLHYLHS-----HNPPIIHRDLKCDNIFV--------------NGNNG 168
AI + RQ+L L Y H+ + ++HRDLK NIF+ N NG
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 169 E--VKIGDLGLAI-VMQQPTARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMV 222
KIGD GL+ + + A S +GTP + +PEL E Y++ D+++ G I E+
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 223 TCEYPYNECKNPAQIYKKVTSG 244
+ + P+++ N +Q+ ++ G
Sbjct: 238 SGKTPFHKANNFSQLISELKRG 259
|
Length = 1021 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 28/208 (13%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
LG G F V+ G WN +V ++ + E E ++K L+H+ ++
Sbjct: 14 LGAGQFGEVWMGT---------WNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLV 64
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSH 147
+ Y V I ++TE + GSL + K K + + + + A QI G+ YL S
Sbjct: 65 QLYA--VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPE--LYE 202
N IHRDL NI V G N KI D GLA +++ TAR P ++ APE Y
Sbjct: 123 N--YIHRDLAARNILV-GENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY- 178
Query: 203 EEYNELVDIYSFGMCILEMVT---CEYP 227
+ D++SFG+ + E+VT YP
Sbjct: 179 GRFTIKSDVWSFGILLTEIVTYGRVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 75/208 (36%), Positives = 105/208 (50%), Gaps = 22/208 (10%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLK 84
+Y+ + +G GA+ TVYK D G VA V ++ P R EV LLK L+
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR---EVALLKRLE 57
Query: 85 ---HENIIKFYNSWVDDTNRTIN--MITELF--TSGSLRQYRKK--HKNVDMKAIKNWAR 135
H NI++ + V T+RT +T +F LR Y K + + IK+ R
Sbjct: 58 AFDHPNIVRLMD--VCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMR 115
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPE 194
Q LRGL +LH++ I+HRDLK +NI V + G+VK+ D GLA I Q V+ T
Sbjct: 116 QFLRGLDFLHANC--IVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTLW 172
Query: 195 FMAPE-LYEEEYNELVDIYSFGMCILEM 221
+ APE L + Y VD++S G EM
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER---LYSEVHLLKSLKHEN 87
++G+G++ V K + G VA I+ ++S D E+ +LK L+HEN
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVA-----IKKFLESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
++ V + + ++ E L K +D ++ + QILRG+ + HSH
Sbjct: 62 LVNLIE--VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH 119
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY--EE 203
N IIHRD+K +NI V+ +G VK+ D G A + P + T + APEL +
Sbjct: 120 N--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT 176
Query: 204 EYNELVDIYSFGMCILEMVTCE 225
+Y VDI++ G + EM+T E
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 23/266 (8%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+G+GAF TV K + G +A ++ + +L + +V +++S I+KFY
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRL-LMDLDV-VMRSSDCPYIVKFY 69
Query: 93 NSWVDDTNRTINMITELFTSGSL-----RQYRKKHKNVDMKAIKNWARQILRGLHYL-HS 146
+ + + I M EL SL Y + + + A ++ L+YL
Sbjct: 70 GALFREGDCWICM--ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE 126
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELYEEE- 204
IIHRD+K NI ++ NG +K+ D G++ + A++ G +MAPE +
Sbjct: 127 LK--IIHRDVKPSNILLDR-NGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA 183
Query: 205 ---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSKVTDPQV 258
Y+ D++S G+ + E+ T ++PY + + +V G I S + P
Sbjct: 184 RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSF 243
Query: 259 KQFIEKCIVP-ASLRLPALELLKDPF 283
FI C++ S R ELL+ PF
Sbjct: 244 VNFINLCLIKDESKRPKYKELLEHPF 269
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 5e-16
Identities = 56/222 (25%), Positives = 101/222 (45%), Gaps = 20/222 (9%)
Query: 33 LGKGAFKTVYKG-FDEVDG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
LG G F +V KG + G +EVA + E + + R E ++ L H I+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLR---EASVMAQLDHPCIV 59
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
+ + + ++ EL G L +Y KK + + + +K A Q+ G+ YL S +
Sbjct: 60 RLIGVCKGEP---LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH- 115
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTP-EFMAPE-LYEE 203
+HRDL N+ + N + KI D G++ + A + P ++ APE +
Sbjct: 116 -FVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173
Query: 204 EYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+++ D++S+G+ + E + PY E K ++ + SG
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-EVIAMLESG 214
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 6e-16
Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG G V K + G+ +A +++E P ++ E+ +L I+ FY
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
++ D +I M E GSL Q K+ K + + + + +LRGL YL + I+
Sbjct: 70 GAFYSDGEISICM--EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ-IM 126
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
HRD+K NI VN + GE+K+ D G++ + A S +GT +M+PE L Y+ DI
Sbjct: 127 HRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 185
Query: 212 YSFGMCILEMVTCEYP 227
+S G+ ++E+ YP
Sbjct: 186 WSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 7e-16
Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 31 EILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
++LG GAF TVYKG E I VA + I + P E ++ S+ H
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVA---IKILNETTGPKANVEFMDEALIMASMDHP 69
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLH 145
++++ + + TI ++T+L G L Y +HK N+ + + NW QI +G+ YL
Sbjct: 70 HLVRLLGVCL---SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTARSVIGTPEFMAPE-L 200
++HRDL N+ V N VKI D GLA +++ + A ++MA E +
Sbjct: 127 ERR--LVHRDLAARNVLVKSPN-HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 201 YEEEYNELVDIYSFGMCILEMVT 223
+ ++ D++S+G+ I E++T
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-16
Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG G V+K + G+ +A +++E P ++ E+ +L I+ FY
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
++ D +I M E GSL Q KK + + + + +++GL YL + I+
Sbjct: 70 GAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 126
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
HRD+K NI VN + GE+K+ D G++ + A S +GT +M+PE L Y+ DI
Sbjct: 127 HRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 185
Query: 212 YSFGMCILEMVTCEYP 227
+S G+ ++EM YP
Sbjct: 186 WSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 7e-16
Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 33/219 (15%)
Query: 33 LGKGAFKTVYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
LG+G+F VY+G VA VN M+ +++E +E ++K +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR--ERIE-FLNEASVMKEFNCHH 70
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA----------IKNWARQI 137
+++ V T+ ++ EL G L+ Y + + A +I
Sbjct: 71 VVRLLGV-VSTGQPTL-VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQ---QPTARSVIGT 192
G+ YL + +HRDL N V + VKIGD G+ I + + ++
Sbjct: 129 ADGMAYLAAKK--FVHRDLAARNCMVAE-DLTVKIGDFGMTRDIYETDYYRKGGKGLL-- 183
Query: 193 P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPY 228
P +MAPE L + + D++SFG+ + EM T E PY
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 13/198 (6%)
Query: 33 LGKGAFKTVYKGFDEVDGIE-VAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIK 90
+G+GA+ V+K D +G VA +V ++ + P R + + L++ +H N+++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 91 FYN-SWVDDTNRTINMITELF--TSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLH 145
++ V T+R + T +F L Y K V + IK+ Q+LRGL +LH
Sbjct: 69 LFDVCTVSRTDRETKL-TLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAPE-LYEE 203
SH ++HRDLK NI V ++G++K+ D GLA I Q SV+ T + APE L +
Sbjct: 128 SHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 184
Query: 204 EYNELVDIYSFGMCILEM 221
Y VD++S G EM
Sbjct: 185 SYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 52/154 (33%), Positives = 83/154 (53%), Gaps = 9/154 (5%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
E LL+++ H ++I+ ++ V + M+ ++S K+ + + + +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLV--SGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEK 164
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPE 194
QIL GL YLH+ IIHRD+K +NIF+N + +V IGDLG A + P + GT E
Sbjct: 165 QILEGLRYLHAQR--IIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAFLGLAGTVE 221
Query: 195 FMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
APE L ++YN DI+S G+ + EM+ YP
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEMLA--YP 253
|
Length = 357 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-15
Identities = 65/240 (27%), Positives = 113/240 (47%), Gaps = 43/240 (17%)
Query: 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
E + K+ + +Y +LG GA TV DG A V++E + S R +
Sbjct: 24 EATAKEQAKKY-WISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQA 80
Query: 76 EVHLLKSLKHENIIKFYNSWV--DDTN----RTINMITELFTSGSLRQYRKKHKNVDMKA 129
EV L + +I+K + + D N I ++ + +G LRQ
Sbjct: 81 EVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQ-----------E 129
Query: 130 IKNWAR---------------QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174
IK+ A+ Q+L +H++HS + +IHRD+K NI + +NG VK+GD
Sbjct: 130 IKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILL-CSNGLVKLGD 186
Query: 175 LGL----AIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYN 229
G A + R+ GTP ++APE++ + Y++ D++S G+ + E++T + P++
Sbjct: 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 71/239 (29%), Positives = 116/239 (48%), Gaps = 16/239 (6%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+G GA+ +V +D +VA +++ QS R Y E+ LLK +KHEN+I
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLS--RPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 93 NSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
+ + T+ + ++T L L K K D + ++ Q+LRGL Y+HS
Sbjct: 81 DVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSD-EHVQFLIYQLLRGLKYIHSAG 138
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE--LYEEEYN 206
IIHRDLK N+ VN + E++I D GLA + T + APE L YN
Sbjct: 139 --IIHRDLKPSNVAVN-EDCELRILDFGLARQADDEMT-GYVATRWYRAPEIMLNWMHYN 194
Query: 207 ELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263
+ VDI+S G + E++ + +P N+ + + +V P L K++ +++I+
Sbjct: 195 QTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQ 253
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 57/204 (27%), Positives = 106/204 (51%), Gaps = 19/204 (9%)
Query: 30 DEILGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKH 85
++LG GAF TVYKG E + +++ V I+++ + SP + + E +++ S+ +
Sbjct: 12 IKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYL 144
++ + + T+ +IT+L G L Y ++HK N+ + + NW QI +G++YL
Sbjct: 69 PHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 125
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE- 199
++HRDL N+ V VKI D GLA ++ ++ A ++MA E
Sbjct: 126 EERR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182
Query: 200 LYEEEYNELVDIYSFGMCILEMVT 223
+ Y D++S+G+ + E++T
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 45/164 (27%), Positives = 83/164 (50%), Gaps = 12/164 (7%)
Query: 137 ILRGLHYL-HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-VIGTPE 194
I++ LHYL H +IHRD+K NI ++ +G VK+ D G++ + A++ G
Sbjct: 123 IVKALHYLKEKHG--VIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179
Query: 195 FMAPELYE-----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA- 248
+MAPE + +Y+ D++S G+ ++E+ T ++PY CK ++ K+ P+
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL 239
Query: 249 SLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLVTDNPKD 291
++ P F++ C+ + P ELL+ PF+ +
Sbjct: 240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 66/249 (26%), Positives = 120/249 (48%), Gaps = 24/249 (9%)
Query: 1 MDCGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTV----YKGFDEVDGIEVAWN 56
M FTK +T + S+ + E LG G+F V +KG E I+
Sbjct: 1 MKAAYMFTKPDTSSWKLSDFE-------MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKK 53
Query: 57 QVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR 116
+ ++ M+ Q++ + E +L L H I+ S+ D+ + + E G L
Sbjct: 54 REILK--MK---QVQHVAQEKSILMELSHPFIVNMMCSFQDE--NRVYFLLEFVVGGELF 106
Query: 117 QYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176
+ +K K + +++ YLHS + II+RDLK +N+ ++ N G VK+ D G
Sbjct: 107 THLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFG 163
Query: 177 LAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPA 235
A + T ++ GTPE++APE+ + + + + VD ++ G+ + E + P+ + P
Sbjct: 164 FAKKVPDRTF-TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPF 221
Query: 236 QIYKKVTSG 244
+IY+K+ +G
Sbjct: 222 RIYEKILAG 230
|
Length = 329 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 67/291 (23%), Positives = 119/291 (40%), Gaps = 50/291 (17%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
++G+GAF V+ D+ G A + D+++ Q+ + +E +L I+K
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRN-QIAHVRAERDILADADSPWIVKL 66
Query: 92 YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
Y S+ D+ + + ++ E G L + + + + +++ L +H
Sbjct: 67 YYSFQDEEH--LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--F 122
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----------------------------Q 182
IHRD+K DNI + +G +K+ D GL M +
Sbjct: 123 IHRDIKPDNILI-DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181
Query: 183 QPT--ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQI 237
Q A S +GTP+++APE L Y D +S G+ + EM+ +P Y++ +
Sbjct: 182 QRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY-GFPPFYSD--TLQET 238
Query: 238 YKKVTSGIKPASLSKVTDPQV----KQFIEKCIVPASLRL-PALELLKDPF 283
Y K+ + + SL DP V I + + RL E+ PF
Sbjct: 239 YNKIINWKE--SLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPF 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 38/103 (36%), Positives = 61/103 (59%), Gaps = 7/103 (6%)
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTARSVI 190
+A QI+ GL +LH I++RDLK +N+ ++ ++G V+I DLGLA+ + +
Sbjct: 100 YAAQIICGLEHLHQRR--IVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRA- 155
Query: 191 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECK 232
GTP +MAPE L E Y+ VD ++ G + EM+ P+ + K
Sbjct: 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 4e-15
Identities = 94/334 (28%), Positives = 146/334 (43%), Gaps = 51/334 (15%)
Query: 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY ++ G GA+ +V D+ G +VA +++ QS +R Y E+ LLK ++
Sbjct: 16 RYTSLKQV-GSGAYGSVCSAIDKRTGEKVAIKKLS--RPFQSEIFAKRAYRELTLLKHMQ 72
Query: 85 HENIIKFYNSWV-----DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILR 139
HEN+I + + D+ ++ + T L++ + D ++ Q+L
Sbjct: 73 HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSED--KVQYLVYQMLC 128
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE 199
GL Y+HS IIHRDLK N+ VN + E+KI D GLA V+ T + APE
Sbjct: 129 GLKYIHSAG--IIHRDLKPGNLAVN-EDCELKILDFGLARHADAEMTGYVV-TRWYRAPE 184
Query: 200 --LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK--KVTSGIKPASLSKVTD 255
L YN+ VDI+S G + EM+T + + Q+ + KVT P + K+ D
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244
Query: 256 PQVKQFIEKCIVPA------SLRLP-----ALELLKDPFLVTDNPKDLVC---------D 295
K +I+ +P S P A++LL + L D K L D
Sbjct: 245 KAAKSYIKS--LPKYPRKDFSTLFPKASPQAVDLL-EKMLELDVDKRLTATEALEHPYFD 301
Query: 296 PLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSAD 329
R + E P D L ++K+S D
Sbjct: 302 SFRDADEET--------EQQPYDDSLENEKLSVD 327
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 64/262 (24%), Positives = 127/262 (48%), Gaps = 14/262 (5%)
Query: 9 KSETEEGEFSEKDPSCRYGRYDEI--LGKGAF-KTVYKGFDEVDGIEVAWNQVNIEDVMQ 65
K +++ + ++ +Y ++ I LG G+F + + + D VA + +++
Sbjct: 12 KKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK 71
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 125
Q++ ++SE +L + H + Y S+ D++ + ++ E G + +++K
Sbjct: 72 Q-KQVDHVFSERKILNYINHPFCVNLYGSFKDES--YLYLVLEFVIGGEFFTFLRRNKRF 128
Query: 126 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185
+A QI+ YL S N I++RDLK +N+ ++ +G +K+ D G A V+ T
Sbjct: 129 PNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLD-KDGFIKMTDFGFAKVVDTRT 185
Query: 186 ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
++ GTPE++APE L + + D ++ G+ I E++ P+ P IY+K+ G
Sbjct: 186 -YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF-YANEPLLIYQKILEG 243
Query: 245 IKPASLSKVTDPQVKQFIEKCI 266
I K D K ++K +
Sbjct: 244 I--IYFPKFLDNNCKHLMKKLL 263
|
Length = 340 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 5e-15
Identities = 66/239 (27%), Positives = 113/239 (47%), Gaps = 35/239 (14%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
LG G F V+ G WN +V ++ + E E ++K L+H+ ++
Sbjct: 14 LGNGQFGEVWMG---------TWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLV 64
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRK--KHKNVDMKAIKNWARQILRGLHYLHSH 147
+ Y + I ++TE + GSL + K + + + + + + A Q+ G+ Y+
Sbjct: 65 QLYAVV---SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE--LYE 202
N IHRDL+ NI V G+ KI D GLA +++ + TAR P ++ APE LY
Sbjct: 122 N--YIHRDLRSANILV-GDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY- 177
Query: 203 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK-------PASLSKV 253
+ D++SFG+ + E+VT PY N ++ ++V G + P SL ++
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVERGYRMPCPQDCPISLHEL 235
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 22/220 (10%)
Query: 53 VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112
VA ++N++ S + L+ L E+ + L+H NI+ + S++ D+ + +++ L
Sbjct: 28 VAVKKINLDS--CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE--LYVVSPLMAY 83
Query: 113 GSLRQYRKKHKNVDMK--AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 170
GS K H + AI + +L L Y+HS IHR +K +I ++G +G+V
Sbjct: 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSG-DGKV 140
Query: 171 KIGDLGLAIVM--QQPTARSVIGTPEF-------MAPELYEEE---YNELVDIYSFGMCI 218
+ L ++ M R V P+ ++PE+ ++ YNE DIYS G+
Sbjct: 141 VLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITA 200
Query: 219 LEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258
E+ P+ + Q+ + G P L K T P
Sbjct: 201 CELANGHVPFKDMP-ATQMLLEKVRGTVPCLLDKSTYPLY 239
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 18/207 (8%)
Query: 31 EILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKH 85
++LGKG+F V+ KG ++ I+ +DV+ D +E E +L + +H
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKAL-----KKDVVLMDDDVECTMVEKRVLSLAWEH 55
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
+ Y ++ T + + E G L + + D+ +A +I+ GL +LH
Sbjct: 56 PFLTHLYCTF--QTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH 113
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYE 202
S I++RDLK DNI ++ +G +KI D G+ ++ + GTP+++APE L
Sbjct: 114 SKG--IVYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYN 229
++YN VD +SFG+ + EM+ + P++
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 9e-15
Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG G F V+ G+ +V I+ + Q E +E +L+K L+H +++ Y
Sbjct: 14 LGAGQFGEVWMGYYNGH------TKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLY 67
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--NWARQILRGLHYLHSHNPP 150
T I +ITE +GSL + K + + + K + A QI G+ ++ N
Sbjct: 68 AVV---TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN-- 122
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP-EFMAPE-LYEEEYN 206
IHRDL+ NI V+ KI D GLA I + TAR P ++ APE + +
Sbjct: 123 YIHRDLRAANILVS-ETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 181
Query: 207 ELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 237
D++SFG+ + E+VT PY NP I
Sbjct: 182 IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 50/201 (24%), Positives = 101/201 (50%), Gaps = 9/201 (4%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
++LGKG F V ++ G A + E V+ + D++ +E +L++ +H +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKE-VIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
+ T+ + + E G L + + + + + + +I+ L YLHS +
Sbjct: 60 L--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD-- 115
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYEE-EYNE 207
+++RD+K +N+ ++ +G +KI D GL + T ++ GTPE++APE+ E+ +Y
Sbjct: 116 VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 208 LVDIYSFGMCILEMVTCEYPY 228
VD + G+ + EM+ P+
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 33 LGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+G+G + VYK D D E A Q+ + S + E+ LL+ LKH N+I
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR------EIALLRELKHPNVIA 62
Query: 91 FYNSWVDDTNRTINMITE--------LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
++ ++R + ++ + + + KK + +K+ QIL G+H
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-----RSVIGTPE 194
YLH++ ++HRDLK NI V G G VKI D+G A + P V+ T
Sbjct: 123 YLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 195 FMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECK 232
+ APEL Y + +DI++ G E++T E P C+
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 58/214 (27%), Positives = 110/214 (51%), Gaps = 9/214 (4%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+++GKG+F V ++DG A + + V+ +Q + LLK++KH ++
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
+ S+ T + + + G L + ++ ++ + +A +I L YLHS N
Sbjct: 61 LHYSF--QTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN-- 116
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYEEEYNE 207
I++RDLK +NI ++ + G V + D GL + Q T + GTPE++APE + ++ Y+
Sbjct: 117 IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
VD + G + EM+ P+ C++ A++Y +
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPF-YCRDVAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 26/206 (12%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLK 84
R + LG+G F V+ G WN +V I+ + E E ++K L+
Sbjct: 9 RLEVKLGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 59
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLH 142
HE +++ Y ++ I ++TE + GSL + K K + + + + A QI G+
Sbjct: 60 HEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 116
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE 199
Y+ N +HRDL+ NI V G N K+ D GLA +++ + TAR P ++ APE
Sbjct: 117 YVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 200 --LYEEEYNELVDIYSFGMCILEMVT 223
LY + D++SFG+ + E+ T
Sbjct: 174 AALY-GRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 53/201 (26%), Positives = 101/201 (50%), Gaps = 9/201 (4%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
++LGKG F V ++ G A ++ ++V+ + D++ +E +LK+ +H +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAM-KILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
S+ T + + E G L + + + + + +I+ L YLHS
Sbjct: 60 LKYSF--QTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK-- 115
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYEE-EYNE 207
I++RDLK +N+ ++ +G +KI D GL + T ++ GTPE++APE+ E+ +Y
Sbjct: 116 IVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 208 LVDIYSFGMCILEMVTCEYPY 228
VD + G+ + EM+ P+
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-14
Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 22/175 (12%)
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFT---SGSLRQ 117
E V+ Q +E H+L+++ H +II+ ++ T N T L L
Sbjct: 118 EHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTF------TYNKFTCLILPRYKTDLYC 171
Query: 118 YRKKHKNV---DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174
Y +N+ D+ AI+ R +LR + YLH IIHRD+K +NIF+N + G+V +GD
Sbjct: 172 YLAAKRNIAICDILAIE---RSVLRAIQYLH--ENRIIHRDIKAENIFIN-HPGDVCLGD 225
Query: 175 LGLA---IVMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCE 225
G A + + GT APEL + Y VDI+S G+ + EM TC
Sbjct: 226 FGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 79/311 (25%), Positives = 126/311 (40%), Gaps = 75/311 (24%)
Query: 13 EEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLE 71
++ EF D +Y + +I G+G F V+K + VA +V +E+ + P
Sbjct: 1 DQYEFPFCDEVSKYEKLAKI-GQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITAL 59
Query: 72 RLYSEVHLLKSLKHENIIKFY---NSWVDDTNR---TINMITELFT---SGSLRQYRKKH 122
R E+ +L+ LKHEN++ + NR + ++ E +G L
Sbjct: 60 R---EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN----- 111
Query: 123 KNVDMK--AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
KNV IK + +L GL+Y+H + I+HRD+K NI + +G +K+ D GLA
Sbjct: 112 KNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILIT-KDGILKLADFGLARA 168
Query: 181 MQQP--------TARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT------ 223
T R V T + PEL E +Y +D++ G CI+ EM T
Sbjct: 169 FSLSKNSKPNRYTNRVV--TLWYRPPELLLGERDYGPPIDMWGAG-CIMAEMWTRSPIMQ 225
Query: 224 --------------C------------EYP-YNECKNPAQIYKKVTSGIKPASLSKVTDP 256
C + + + + P +KV +KP V DP
Sbjct: 226 GNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKP----YVKDP 281
Query: 257 QVKQFIEKCIV 267
I+K +V
Sbjct: 282 HALDLIDKLLV 292
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 69/244 (28%), Positives = 119/244 (48%), Gaps = 23/244 (9%)
Query: 32 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
+LGKG+F V KG DE+ I++ V I+D D +E E +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQD-----DDVECTMVEKRVLALPGKPP 61
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLR-QYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
+ +S +R + + E G L ++ K + A+ +A +I GL +LHS
Sbjct: 62 FLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVGKFKEPHAV-FYAAEIAIGLFFLHS 119
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE--LYE 202
II+RDLK DN+ ++ G +KI D G+ + T R+ GTP+++APE Y
Sbjct: 120 KG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY- 175
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT--SGIKPASLSKVTDPQVKQ 260
+ Y + VD ++FG+ + EM+ + P+ + ++ ++++ + + P SLSK K
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG 234
Query: 261 FIEK 264
+ K
Sbjct: 235 LLTK 238
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 26/206 (12%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWN---QVNIEDVMQSPDQLERLYSEVHLLKSLK 84
R D LG+G F V+ G WN +V I+ + E E ++K L+
Sbjct: 9 RLDVKLGQGCFGEVWMG---------TWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLR 59
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLH 142
H+ ++ Y ++ I ++TE GSL + K+ K + + + + A QI G+
Sbjct: 60 HDKLVPLYAVVSEEP---IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMA 116
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE 199
Y+ N IHRDL+ NI V G+N KI D GLA +++ + TAR P ++ APE
Sbjct: 117 YIERMN--YIHRDLRAANILV-GDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 200 --LYEEEYNELVDIYSFGMCILEMVT 223
LY + D++SFG+ + E+VT
Sbjct: 174 AALY-GRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 31 EILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
++LGKG+F V KG E ++ +DV+ D +E E +L +L E
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKAL-----KKDVVLIDDDVECTMVEKRVL-ALAWE 54
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
N + T + + E G L + + D+ +A +I+ GL +LHS
Sbjct: 55 NPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS 114
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE-E 203
II+RDLK DN+ ++ +G +KI D G+ V A + GTP+++APE+ +
Sbjct: 115 KG--IIYRDLKLDNVMLDR-DGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGL 171
Query: 204 EYNELVDIYSFGMCILEMVTCEYPYN 229
+Y VD +SFG+ + EM+ + P++
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-14
Identities = 58/216 (26%), Positives = 108/216 (50%), Gaps = 9/216 (4%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+++GKG+F V + DG A + + +++ +Q + LLK+LKH ++
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
+ S+ T + + + G L + ++ + + +A ++ + YLHS N
Sbjct: 61 LHYSF--QTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN-- 116
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE-LYEEEYNE 207
II+RDLK +NI ++ + G V + D GL +P T + GTPE++APE L +E Y+
Sbjct: 117 IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 243
VD + G + EM+ P+ ++ +Q+Y +
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-14
Identities = 57/236 (24%), Positives = 114/236 (48%), Gaps = 11/236 (4%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+++GKG+F V + + A + + +++ ++ + LLK++KH ++
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
+ S+ T + + + G L + ++ + + +A +I L YLHS N
Sbjct: 61 LHFSF--QTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN-- 116
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE-LYEEEYNE 207
I++RDLK +NI ++ + G + + D GL + T + GTPE++APE L+++ Y+
Sbjct: 117 IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175
Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263
VD + G + EM+ P+ +N A++Y + + KP L + +E
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILN--KPLQLKPNITNSARHLLE 228
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 29/220 (13%)
Query: 33 LGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+G+G + VYK D D + A Q+ + S + E+ LL+ LKH N+I
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR------EIALLRELKHPNVIS 62
Query: 91 FYNSWVDDTNRTINMITE--------LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
++ +R + ++ + + + KK + +K+ QIL G+H
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-----RSVIGTPE 194
YLH++ ++HRDLK NI V G G VKI D+G A + P V+ T
Sbjct: 123 YLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 195 FMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECK 232
+ APEL Y + +DI++ G E++T E P C+
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 38/226 (16%)
Query: 30 DEILGKGAFKTVYKGFD-EVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHE 86
+ LG+G F V K + G + V ++ + + S +L L SE +LLK + H
Sbjct: 5 GKTLGEGEFGKVVKATAFRLKGR-AGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHP 63
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD-------------------- 126
++IK Y + D + +I E GSLR + ++ + V
Sbjct: 64 HVIKLYGACSQD--GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 127 ----MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182
M + ++A QI RG+ YL ++HRDL N+ V ++KI D GL+ +
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLV-AEGRKMKISDFGLSRDVY 178
Query: 183 QPTA---RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
+ + RS P ++MA E L++ Y D++SFG+ + E+VT
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 59/205 (28%), Positives = 108/205 (52%), Gaps = 23/205 (11%)
Query: 31 EILGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV--HLLK--SLK 84
++LG G F TV+KG E D I++ I+D +S Q + E+ H+L SL
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD--RSGRQT---FQEITDHMLAMGSLD 67
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHY 143
H I++ ++ ++T+L GSL + ++H+ ++D + + NW QI +G++Y
Sbjct: 68 HAYIVRLLGIC---PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYY 124
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTP-EFMAPE 199
L H ++HR+L NI + ++ V+I D G+A ++ + S TP ++MA E
Sbjct: 125 LEEHR--MVHRNLAARNILLK-SDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 200 -LYEEEYNELVDIYSFGMCILEMVT 223
+ Y D++S+G+ + EM++
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 62/206 (30%), Positives = 88/206 (42%), Gaps = 18/206 (8%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E +GKG F VYKG + EVA PD + E +LK H NI+K
Sbjct: 1 EKIGKGNFGDVYKGVLK-GNTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVK 56
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
V + I ++ EL GSL + RKK + +K + + G+ YL S N
Sbjct: 57 LIGVCVQ--KQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN- 113
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE----FMAPE-LYEEE 204
IHRDL N V G N +KI D G++ + G + + APE L
Sbjct: 114 -CIHRDLAARNCLV-GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171
Query: 205 YNELVDIYSFGMCILEMVT---CEYP 227
Y D++S+G+ + E + YP
Sbjct: 172 YTSESDVWSYGILLWETFSLGDTPYP 197
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 35/221 (15%)
Query: 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER----LYSEVHLLKSL-K 84
+ LG+GAF V K E G++ + M D E+ L SE+ ++K + K
Sbjct: 17 GKPLGEGAFGQVVKA--EAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 74
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM----------------K 128
H+NII V + ++ E G+LR + + + K
Sbjct: 75 HKNIINLLG--VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQ 183
+ ++A Q+ RG+ +L S IHRDL N+ V ++ +KI D GLA I +
Sbjct: 133 DLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDH-VMKIADFGLARDIHHIDYYR 189
Query: 184 PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
T + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 190 KTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY + +G GA V +D V G VA + + Q+ +R Y E+ L+K + H
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKK--LSRPFQNVTHAKRAYRELVLMKLVNH 74
Query: 86 ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
+NII N + + + + ++ EL + +L Q ++D + + Q+L G+
Sbjct: 75 KNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQV--IQMDLDHERMSYLLYQMLCGI 131
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-----FM 196
+LHS IIHRDLK NI V ++ +KI D GLA + S + TP +
Sbjct: 132 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 184
Query: 197 APE-LYEEEYNELVDIYSFGMCIL-EMV 222
APE + Y E VDI+S G CI+ EM+
Sbjct: 185 APEVILGMGYKENVDIWSVG-CIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 67/254 (26%), Positives = 121/254 (47%), Gaps = 16/254 (6%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKHENII 89
+LGKG+F V + G + +V +DV+ D +E +E +L + H +
Sbjct: 1 RVLGKGSFGKVMLARLKESG-RLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
+ Y + T + + E G L + +K + D + +A +I L +LH
Sbjct: 60 QLYCCF--QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG- 116
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYEEEYN 206
II+RDLK DN+ ++ + G K+ D G+ + T + GTP+++APE L E Y
Sbjct: 117 -IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174
Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSKVTDPQVKQFIEK 264
VD ++ G+ + EM+ P+ E +N +++ + + + P LS+ +K F+ K
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTK 233
Query: 265 CIVPASLRLPALEL 278
++RL +L L
Sbjct: 234 ---NPTMRLGSLTL 244
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-13
Identities = 70/235 (29%), Positives = 106/235 (45%), Gaps = 38/235 (16%)
Query: 27 GRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RYD I +GKG VY +D V VA ++ ED+ ++P +R E + L
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIR-EDLSENPLLKKRFLREAKIAADLI 60
Query: 85 HENIIKFYN--SWVDDTNRTINMITELFTSGS-LRQYRKK-------HKNVDMKAIKNWA 134
H I+ Y+ S D T+ I E +T S L+ +K + + A +
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYI-EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----------P 184
+I + Y+HS ++HRDLK DNI + G GEV I D G AI +
Sbjct: 120 HKICATIEYVHSKG--VLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 185 TARS----------VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY 228
++GTP++MAPE L +E DIY+ G+ + +M+T +PY
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 30/214 (14%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE--RLYSEVHLLKSLKHENIIK 90
LGKG GF EV + QV M + +L+ RL + +L + I++
Sbjct: 1 LGKG-------GFGEVCAV-----QVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILE 48
Query: 91 FYNS-------WVDDTNRTINMITELFTSGSLRQ--YRKKHKNVDMKAIKNWARQILRGL 141
NS + ++ + ++ L G L+ Y + ++M+ + +++ QI G+
Sbjct: 49 KVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGI 108
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPE 199
LH H+ I++RD+K +N+ ++ + G ++ DLGLA+ ++ + + GT +MAPE
Sbjct: 109 --LHLHSMDIVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRA-GTNGYMAPE 164
Query: 200 -LYEEEYNELVDIYSFGMCILEMVTCEYPYNECK 232
L EE Y+ VD ++ G I EMV P+ + K
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 25/233 (10%)
Query: 32 ILGKGAFKTVYKG-FDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSLKHENI 88
LG GAF VY+G ++ G +V ++ + + E+ E HL+ + H NI
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-------VDMKAIKNWARQILRGL 141
+K + N +I EL G L Y + + + +K + + + +G
Sbjct: 62 VKLLGVCLL--NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGE----VKIGDLGLAIVMQQPTARSVIGTP---- 193
YL + IHRDL N V+ + VKIGD GLA + + G
Sbjct: 120 VYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 194 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+MAPE L + ++ D++SFG+ + E++T + PY N ++ + VT+G
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-QEVLQHVTAG 229
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 78/294 (26%), Positives = 138/294 (46%), Gaps = 20/294 (6%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
++GKG+F V + DG A + + +++ +Q + LLK++KH ++
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 92 YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
+ S+ T + + + G L + ++ ++ + +A +I L YLHS N I
Sbjct: 62 HYSF--QTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--I 117
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYEEEYNEL 208
I+RDLK +NI ++ + G V + D GL + T + GTPE++APE L ++ Y+
Sbjct: 118 IYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT 176
Query: 209 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP 268
VD + G + EM+ P+ ++ A++Y + + KP L + +E +
Sbjct: 177 VDWWCLGAVLYEMLYGLPPF-YSRDTAEMYDNILN--KPLRLKPNISVSARHLLEGLLQK 233
Query: 269 -ASLRLPA----LELLKDPFLVTDNPKDLVCDPLRLPNLVPEV---MNLAHSEP 314
+ RL A LE+ F + N DLV + P P V M+L H +P
Sbjct: 234 DRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPP-FNPNVSGPMDLKHFDP 286
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 47/182 (25%), Positives = 88/182 (48%), Gaps = 12/182 (6%)
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKA 129
+ E ++ L HE +++ Y V R I ++TE ++G L Y ++H K
Sbjct: 44 DEFIEEAKVMMKLSHEKLVQLYG--VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQ 101
Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 189
+ + + G+ YL S IHRDL N V+ + G VK+ D GL+ + S
Sbjct: 102 LLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDEYTSS 158
Query: 190 IGTP---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+G+ + PE L +++ D+++FG+ + E+ + + PY N ++ +KV+ G
Sbjct: 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-SETVEKVSQG 217
Query: 245 IK 246
++
Sbjct: 218 LR 219
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 6e-13
Identities = 47/197 (23%), Positives = 83/197 (42%), Gaps = 23/197 (11%)
Query: 77 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ 136
VH L + N IK Y S T + +I + G L KK + +K RQ
Sbjct: 61 VHQLMK-DNPNFIKLYYSV--TTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQ 117
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 196
++ L+ LH HN IIH D+K +N+ + + + D GL ++ P+ GT ++
Sbjct: 118 LVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD--GTLDYF 173
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPY----NECKNPAQ----IYKKVTSGIKP 247
+PE + Y+ D ++ G+ E++T ++P+ +E + KK+
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLP----- 228
Query: 248 ASLSKVTDPQVKQFIEK 264
K F++
Sbjct: 229 --FIKNVSKNANDFVQS 243
|
Length = 267 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 54/204 (26%), Positives = 102/204 (50%), Gaps = 9/204 (4%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
++LGKG F V ++ G A + E V+ + D++ +E +L++ +H +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKE-VIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
S+ T+ + + E G L + + + + + +I+ L YLHS
Sbjct: 60 LKYSF--QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN- 116
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYEE-EYNE 207
+++RDLK +N+ ++ +G +KI D GL + T ++ GTPE++APE+ E+ +Y
Sbjct: 117 VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175
Query: 208 LVDIYSFGMCILEMVTCEYP-YNE 230
VD + G+ + EM+ P YN+
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPFYNQ 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 78/277 (28%), Positives = 123/277 (44%), Gaps = 27/277 (9%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY ++ +G GA V FD V GI VA +++ Q+ +R Y E+ LLK + H
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS--RPFQNQTHAKRAYRELVLLKCVNH 79
Query: 86 ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
+NII N + + + + ++ EL + + H +D + + Q+L G+
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI---HMELDHERMSYLLYQMLCGI 136
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV-----MQQPTARSVIGTPEFM 196
+LHS IIHRDLK NI V ++ +KI D GLA M P + T +
Sbjct: 137 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTACTNFMMTP----YVVTRYYR 189
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVT 254
APE + Y E VDI+S G + E+V + + Q K + G A
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249
Query: 255 DPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKD 291
P V+ ++E P + EL D +++ +D
Sbjct: 250 QPTVRNYVEN--RPQYPGISFEELFPDWIFPSESERD 284
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 73/245 (29%), Positives = 111/245 (45%), Gaps = 25/245 (10%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE-RLYSEVHLLKSLKHENII 89
E+LGKG F V+KG + D VA ED+ P +L+ + SE +LK H NI+
Sbjct: 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCK-EDL---PQELKIKFLSEARILKQYDHPNIV 55
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
K V + I ++ EL G + RKK + K + +A G+ YL S N
Sbjct: 56 KLIG--VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN 113
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE----FMAPE-LYEE 203
IHRDL N V G N +KI D G++ + S G + + APE L
Sbjct: 114 --CIHRDLAARNCLV-GENNVLKISDFGMS-RQEDDGIYSSSGLKQIPIKWTAPEALNYG 169
Query: 204 EYNELVDIYSFGMCILEMVT---CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
Y+ D++S+G+ + E + C YP Q ++V G + + K D V +
Sbjct: 170 RYSSESDVWSYGILLWETFSLGVCPYP---GMTNQQAREQVEKGYRMSCPQKCPD-DVYK 225
Query: 261 FIEKC 265
+++C
Sbjct: 226 VMQRC 230
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 32 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
+LGKG+F V KG DE+ I++ V I+D D +E E +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD-----DDVECTMVEKRVLALQDKPP 61
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
+ +S +R + + E G L + ++ +A +I GL +LH
Sbjct: 62 FLTQLHSCFQTVDR-LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE-EE 204
II+RDLK DN+ ++ + G +KI D G+ ++ T R+ GTP+++APE+ +
Sbjct: 121 G--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP 177
Query: 205 YNELVDIYSFGMCILEMVTCEYPYN 229
Y + VD +++G+ + EM+ + P++
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 9e-13
Identities = 88/340 (25%), Positives = 146/340 (42%), Gaps = 61/340 (17%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII-- 89
I+G G+F VY+ +D E +V I+ V+Q P R E+ ++K+L H NII
Sbjct: 73 IIGNGSFGVVYEAIC-IDTSE----KVAIKKVLQDPQYKNR---ELLIMKNLNHINIIFL 124
Query: 90 --KFYNSWV--DDTNRTINMITELF---TSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
+Y ++ N +N++ E ++ Y + + + + +K ++ Q+ R L
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGTPEFMAPELY 201
Y+HS I HRDLK N+ ++ N +K+ D G A ++ + S I + + APEL
Sbjct: 185 YIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELM 242
Query: 202 --EEEYNELVDIYSFGMCILEMVTCEYPYNECKN--------------PAQIYKKVTS-- 243
Y +D++S G I EM+ YP ++ P + K +
Sbjct: 243 LGATNYTTHIDLWSLGCIIAEMIL-GYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPN 301
Query: 244 -------GIKPASLSKV----TDPQVKQFIEKCIVPASL-RLPALELLKDPFLVTDNPKD 291
+KP L KV T FI + + L RL +E L DPF D
Sbjct: 302 YADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF------D 355
Query: 292 LVCDP-LRLPNLV---PEVMNLAHSEPHPMDIDLNHKKVS 327
+ DP ++LP + P++ N +E M K +
Sbjct: 356 DLRDPCIKLPKYIDKLPDLFNFCDAEIKEMSDACRRKIIP 395
|
Length = 440 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 9e-13
Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 22/223 (9%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG G + VY+G + + VA + ED M+ +E E ++K +KH N+++
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 68
Query: 93 NSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
V +ITE T G+L Y + V+ + A QI + YL N
Sbjct: 69 G--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPE-LYEEEYN 206
IHRDL N V G N VK+ D GL+ +M T + G ++ APE L +++
Sbjct: 125 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 183
Query: 207 ELVDIYSFGMCILEMVT---CEYPYNECKNPAQIYKKVTSGIK 246
D+++FG+ + E+ T YP + +Q+Y+ + G +
Sbjct: 184 IKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKGYR 223
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 56/181 (30%), Positives = 92/181 (50%), Gaps = 19/181 (10%)
Query: 75 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAI 130
SE+H L + H I+K ++ + D + +I E + G L +Q K+H +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDK--LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEV 171
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----A 186
QI+ L +HS ++HRDLK NIF+ G +K+GD G + A
Sbjct: 172 GLLFYQIVLALDEVHSRK--MMHRDLKSANIFLM-PTGIIKLGDFGFSKQYSDSVSLDVA 228
Query: 187 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ--IYKKVTS 243
S GTP ++APEL+E + Y++ D++S G+ + E++T P+ K P+Q I ++V
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF---KGPSQREIMQQVLY 285
Query: 244 G 244
G
Sbjct: 286 G 286
|
Length = 478 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 63/230 (27%), Positives = 112/230 (48%), Gaps = 19/230 (8%)
Query: 32 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
+LGKG+F V KG DE+ I++ V I+D D +E E +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD-----DDVECTMVEKRVLALSGKPP 61
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
+ +S +R + + E G L ++ +A +I GL +LHS
Sbjct: 62 FLTQLHSCFQTMDR-LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE-EE 204
II+RDLK DN+ ++ + G +KI D G+ + T ++ GTP+++APE+ +
Sbjct: 121 G--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQP 177
Query: 205 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSK 252
Y + VD ++FG+ + EM+ + P+ E ++ ++++ + P S+SK
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSMSK 226
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 28/218 (12%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE--RLYSEVHLLKSLKH 85
R+ +LGKG F EV QV M + +LE R+ +L
Sbjct: 3 RHYRVLGKGGFG------------EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE 50
Query: 86 ENIIKFYNS-------WVDDTNRTINMITELFTSGSLR--QYRKKHKNVDMKAIKNWARQ 136
+ I++ NS + +T + ++ L G L+ Y + D + +A +
Sbjct: 51 KQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE 110
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGTPEF 195
I GL LH I++RDLK +NI ++ + G ++I DLGLA+ + + T R +GT +
Sbjct: 111 ITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGY 167
Query: 196 MAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK 232
MAPE+ + E Y D + G I EM+ + P+ + K
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 37/210 (17%)
Query: 33 LGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
+G+G + V+ K E+ VA ++ + ++ +++ + +E +L + K E +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEI----VALKRMK-KSLLFKLNEVRHVLTERDILTTTKSEWL 63
Query: 89 IKFYNSWVDDTNRTINM--------ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
+K ++ DD + M T L G L + + +M +
Sbjct: 64 VKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVD-------A 116
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAP 198
LH L IHRDLK +N F+ +G +K+ D GL+ IV A SV+G+P++MAP
Sbjct: 117 LHELG-----YIHRDLKPEN-FLIDASGHIKLTDFGLSKGIVTY---ANSVVGSPDYMAP 167
Query: 199 E-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
E L + Y+ VD +S G C+L C +P
Sbjct: 168 EVLRGKGYDFTVDYWSLG-CMLYEFLCGFP 196
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 17/197 (8%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG G F V+ G+ +V ++ + ++ E +L+K+L+H+ +++ Y
Sbjct: 14 LGAGQFGEVWMGYYNNS------TKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLY 67
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPP 150
V I +ITE GSL + K + V + + +++ QI G+ Y+ N
Sbjct: 68 A--VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN-- 123
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPELYE-EEYN 206
IHRDL+ N+ V+ + KI D GLA V++ + TAR P ++ APE +
Sbjct: 124 YIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 207 ELVDIYSFGMCILEMVT 223
D++SFG+ + E+VT
Sbjct: 183 IKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 51/201 (25%), Positives = 103/201 (51%), Gaps = 9/201 (4%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
++LGKG F V ++ G A ++ ++V+ + D++ +E +L++ +H +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAM-KILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
S+ T+ + + E G L + + + + + +I+ L YLHS +
Sbjct: 60 LKYSF--QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD-- 115
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYEE-EYNE 207
+++RDLK +N+ ++ +G +KI D GL + T ++ GTPE++APE+ E+ +Y
Sbjct: 116 VVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 208 LVDIYSFGMCILEMVTCEYPY 228
VD + G+ + EM+ P+
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 40/210 (19%)
Query: 33 LGKGAFKTV--YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENII 89
LG+GA+ V + + + VA + I +V +R E+ LL+ + H+NI
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKK--ITNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI------------KNWARQI 137
Y D EL+ L + D+ I +++ QI
Sbjct: 66 CLY----DMDIVFPGNFNELYLYEELMEA-------DLHQIIRSGQPLTDAHFQSFIYQI 114
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA------IVMQQPTARSVIG 191
L GL Y+HS N ++HRDLK N+ VN + E+KI D GLA +
Sbjct: 115 LCGLKYIHSAN--VLHRDLKPGNLLVNA-DCELKICDFGLARGFSENPGENAGFMTEYVA 171
Query: 192 TPEFMAPE--LYEEEYNELVDIYSFGMCIL 219
T + APE L + Y + +D++S G CIL
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVG-CIL 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 39/129 (30%), Positives = 69/129 (53%), Gaps = 5/129 (3%)
Query: 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 165
I +L G L + +H K ++ +A +I+ GL H HN +++RDLK NI ++
Sbjct: 75 ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE--HMHNRFVVYRDLKPANILLD- 131
Query: 166 NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT 223
+G V+I DLGLA + + +GT +MAPE+ ++ Y+ D +S G + +++
Sbjct: 132 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR 191
Query: 224 CEYPYNECK 232
P+ + K
Sbjct: 192 GHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 19/202 (9%)
Query: 32 ILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
+LG GAF TVYKG DG I VA + + SP + + E +++ +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVA---IKVLRENTSPKANKEILDEAYVMAGVGSPY 70
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHS 146
+ + + T+ ++T+L G L Y +++K+ + + + NW QI +G+ YL
Sbjct: 71 VCRLLGICL---TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE 127
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTARSVIG--TP-EFMAPE-LY 201
++HRDL N+ V N VKI D GLA ++ T G P ++MA E +
Sbjct: 128 VR--LVHRDLAARNVLVKSPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 202 EEEYNELVDIYSFGMCILEMVT 223
+ D++S+G+ + E++T
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 65/277 (23%), Positives = 130/277 (46%), Gaps = 38/277 (13%)
Query: 32 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHE 86
++G+G++ V K + + ++V ++ +D + ++ + +E H+ ++ H
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD-----EDIDWVQTEKHVFEQASNHP 56
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
++ ++ + T + + E G L + ++ + + + + ++ +I L+YLH
Sbjct: 57 FLVGLHSCF--QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 114
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-E 203
II+RDLK DN+ ++ + G +K+ D G+ +P T + GTP ++APE+ E
Sbjct: 115 RG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 171
Query: 204 EYNELVDIYSFGMCILEMVTCEYPYN---ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
+Y VD ++ G+ + EM+ P++ NP Q D +
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---------------NTEDYLFQV 216
Query: 261 FIEKCI-VPASLRLPALELLKDPFLVTDNPKDLVCDP 296
+EK I +P SL + A +LK FL D + L C P
Sbjct: 217 ILEKQIRIPRSLSVKAASVLKS-FLNKDPKERLGCHP 252
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 9e-12
Identities = 61/230 (26%), Positives = 108/230 (46%), Gaps = 18/230 (7%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSL-KHENI 88
LG GAF V + A +V ++ + + ER L SE+ ++ L HENI
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLHS 146
+ + I +ITE G L + RK+ + ++ + +++ Q+ +G+ +L S
Sbjct: 102 VNLLGACT--IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEV-KIGDLGLAIVMQQPTARSVIGTP----EFMAPE-L 200
N IHRDL N+ + +G++ KI D GLA + + V G ++MAPE +
Sbjct: 160 KN--CIHRDLAARNVLL--THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215
Query: 201 YEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPAS 249
+ Y D++S+G+ + E+ + PY ++ YK + G + A
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 58/231 (25%), Positives = 107/231 (46%), Gaps = 17/231 (7%)
Query: 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
+++G G F V++G ++ G + + + Q + SE ++ H NII
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--NWARQILRGLHYLHSH 147
+ V + +ITE +G+L +Y + H + + + R I G+ YL
Sbjct: 70 RLEG--VVTKFKPAMIITEYMENGALDKYLRDHDG-EFSSYQLVGMLRGIAAGMKYLSDM 126
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFMAPE-LY 201
N +HRDL NI VN +N E K+ D GL+ V++ + + + APE +
Sbjct: 127 N--YVHRDLAARNILVN-SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183
Query: 202 EEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIK-PASL 250
++ D++SFG+ + E+++ E PY + N ++ K + G + PA +
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAINDGFRLPAPM 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 68/235 (28%), Positives = 103/235 (43%), Gaps = 37/235 (15%)
Query: 20 KDPSCRYGRYDEILGK----GAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLE 71
+DP + R LGK G F V G D+ E V + + L
Sbjct: 6 EDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLS 65
Query: 72 RLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
L SE+ ++K + KH+NII + D + +I E + G+LR+Y + + M+
Sbjct: 66 DLVSEMEMMKMIGKHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYS 123
Query: 131 KNWAR----------------QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174
+ AR Q+ RG+ YL S IHRDL N+ V NN +KI D
Sbjct: 124 YDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIAD 180
Query: 175 LGLA-----IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
GLA I + T + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 181 FGLARDVNNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 66/241 (27%), Positives = 98/241 (40%), Gaps = 36/241 (14%)
Query: 31 EILGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
LG+GAF V+ G E D VA V S D + E LL + +H
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVA---VKTLKETASNDARKDFEREAELLTNFQH 67
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKN------------- 132
ENI+KFY + M+ E G L ++ + H
Sbjct: 68 ENIVKFYGVCTEGD--PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 133 -WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 191
A QI G+ YL S + +HRDL N V G + VKIGD G++ + V G
Sbjct: 126 QIAVQIASGMVYLASQH--FVHRDLATRNCLV-GYDLVVKIGDFGMSRDVYTTDYYRVGG 182
Query: 192 TP----EFMAPE--LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+M PE +Y + E D++SFG+ + E+ T + P+ N ++ + +T G
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSN-EEVIECITQG 240
Query: 245 I 245
Sbjct: 241 R 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 76 EVHLLKSLKHENIIKFYNSWVD--DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
E+ L+ + NI+K Y +D D +++I E T G LR+ K K++ K +
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDM 127
Query: 134 ARQILRGLHYLH-SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 192
A +GL+ L+ N P +++L + V N ++KI GL ++ P ++V
Sbjct: 128 AIDCCKGLYNLYKYTNKP--YKNLTSVSFLVT-ENYKLKIICHGLEKILSSPPFKNV--- 181
Query: 193 PEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246
FM Y+ EY DIYS G+ + E+ T + P+ +IY + +
Sbjct: 182 -NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL-TTKEIYDLIINKNN 239
Query: 247 PASLSKVTDPQVKQFIEKCIVPASLRLPAL 276
L ++K +E C S++ P +
Sbjct: 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNI 269
|
Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 71/268 (26%), Positives = 119/268 (44%), Gaps = 39/268 (14%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE--RLYSEVHLLKSLKH 85
R +LGKG F EV QV M + +LE R+ +L
Sbjct: 3 RQYRVLGKGGFG------------EVCACQVRATGKMYACKKLEKKRIKKRKGESMALNE 50
Query: 86 ENIIKFYNS-------WVDDTNRTINMITELFTSGSLR--QYRKKHKNVDMKAIKNWARQ 136
+ I++ NS + +T + ++ L G L+ Y + +A +
Sbjct: 51 KQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE 110
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGTPEF 195
I GL LH I++RDLK +NI ++ ++G ++I DLGLA+ V + T + +GT +
Sbjct: 111 ICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGY 167
Query: 196 MAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254
MAPE+ + E Y D ++ G + EM+ + P+ + K KK IK + ++
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK------KK----IKREEVERLV 217
Query: 255 DPQVKQFIEKCIVPASLRLPALELLKDP 282
+++ EK P + L + L KDP
Sbjct: 218 KEVQEEYSEK-FSPDARSLCKMLLCKDP 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 38/129 (29%), Positives = 68/129 (52%), Gaps = 5/129 (3%)
Query: 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 165
I +L G L + +H ++ +A +I+ GL H HN +++RDLK NI ++
Sbjct: 75 ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLE--HMHNRFVVYRDLKPANILLD- 131
Query: 166 NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT 223
+G V+I DLGLA + + +GT +MAPE+ ++ Y+ D +S G + +++
Sbjct: 132 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 191
Query: 224 CEYPYNECK 232
P+ + K
Sbjct: 192 GHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 2e-11
Identities = 51/180 (28%), Positives = 93/180 (51%), Gaps = 17/180 (9%)
Query: 73 LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT-----ELFTSGSLRQYRKKHKNVDM 127
L +E+ L L HENI+K + N MIT +L++ + K + + +
Sbjct: 210 LENEILALGRLNHENILKIEEILRSEANTY--MITQKYDFDLYSFMYDEAFDWKDRPL-L 266
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TA 186
K + +Q+L + Y+H +IHRD+K +NIF+N +G++ +GD G A+ ++ A
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNC-DGKIVLGDFGTAMPFEKEREA 323
Query: 187 RSV--IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEY-PYNE-CKNPAQIYKKV 241
+GT +PE L + Y E+ DI+S G+ +L+M++ ++ P + P + K+
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383
|
Length = 501 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 33 LGKGAFKTVYK----GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 87
LG+G F V G D+ V V + + L L SE+ ++K + KH+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIK 131
II + D + +I E + G+LR+Y + + + K +
Sbjct: 86 IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTA 186
+ A Q+ RG+ YL S IHRDL N+ V +N +KI D GLA I + T
Sbjct: 144 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTT 200
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
+ ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 201 NGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 64/273 (23%), Positives = 126/273 (46%), Gaps = 32/273 (11%)
Query: 32 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
++G+G++ V K D++ ++V ++ +D + ++ + +E H+ +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDD-----EDIDWVQTEKHVFEQASSNP 56
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
+ +S T+R ++ E G L + ++ + + + + +A +I L++LH
Sbjct: 57 FLVGLHSCFQTTSRLF-LVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EE 204
II+RDLK DN+ ++ +G +K+ D G+ P T + GTP ++APE+ EE
Sbjct: 116 G--IIYRDLKLDNVLLDA-DGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 205 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
Y VD ++ G+ + EM+ P++ + + D + +EK
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM--------------NTEDYLFQVILEK 218
Query: 265 CI-VPASLRLPALELLKDPFLVTDNPKDLVCDP 296
I +P L + A +LK FL D + L C P
Sbjct: 219 PIRIPRFLSVKASHVLKG-FLNKDPKERLGCQP 250
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 20/196 (10%)
Query: 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 164
+ E + G L + ++ + + + + ++ +I L++LH II+RDLK DN+ ++
Sbjct: 73 FVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLD 130
Query: 165 GNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 221
G +K+ D G+ +P T + GTP ++APE L E+Y VD ++ G+ + EM
Sbjct: 131 A-EGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 189
Query: 222 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLK 280
+ P++ G+ D + +EK I +P SL + A +LK
Sbjct: 190 MAGRSPFD------------IVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237
Query: 281 DPFLVTDNPKDLVCDP 296
FL D + L C P
Sbjct: 238 G-FLNKDPKERLGCHP 252
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 65/236 (27%), Positives = 104/236 (44%), Gaps = 41/236 (17%)
Query: 21 DPSCRYGRYDEILGK----GAFKTVYKGFDEVDGIEVAWNQ------VNIEDVMQSPDQL 70
DP + R +LGK G F V + E GI+ + V + + L
Sbjct: 4 DPKWEFPRDRLVLGKPLGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDL 61
Query: 71 ERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY----------- 118
L SE+ L+K + KH+NII + + +I E G+LR++
Sbjct: 62 ADLISEMELMKLIGKHKNIINLLGVCTQEG--PLYVIVEYAAKGNLREFLRARRPPGPDY 119
Query: 119 -----RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173
+ + + K + + A Q+ RG+ YL S IHRDL N+ V +N +KI
Sbjct: 120 TFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDN-VMKIA 176
Query: 174 DLGLA-----IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
D GLA I + T+ + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 177 DFGLARGVHDIDYYKKTSNGRLPV-KWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 40/150 (26%), Positives = 78/150 (52%), Gaps = 8/150 (5%)
Query: 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158
T+ + ++T+ + G L + +K K + +++ L +LH ++ I++RDLK
Sbjct: 67 TDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKP 124
Query: 159 DNIFVNGNNGEVKIGDLGL--AIVMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSF 214
+NI ++ G + + D GL A + T + GT E++APE+ +E Y + VD +S
Sbjct: 125 ENILLDA-TGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSL 183
Query: 215 GMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
G+ + EM P+ ++ Q+Y+ + G
Sbjct: 184 GVLVFEMCCGWSPF-YAEDTQQMYRNIAFG 212
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 13/175 (7%)
Query: 70 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDM 127
+E +E +++K+L+H+ ++K ++ V T I +ITE GSL + K + +
Sbjct: 45 VEAFLAEANVMKTLQHDKLVKL-HAVV--TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL 101
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPT 185
+ +++ QI G+ ++ N IHRDL+ NI V+ + KI D GLA V++ + T
Sbjct: 102 PKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYT 158
Query: 186 ARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 237
AR P ++ APE + + D++SFG+ ++E+VT PY NP I
Sbjct: 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 7e-11
Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 17/223 (7%)
Query: 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
D SC + +E++G G F V +G ++ G + + + Q SE ++
Sbjct: 2 DVSCV--KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 59
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILR 139
H NII V +R + +ITE +G+L + R+ + + R I
Sbjct: 60 GQFDHPNIIHLEG--VVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAA 117
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----PTARSVIGTP-- 193
G+ YL N +HRDL NI VN +N K+ D GL+ ++ PT S +G
Sbjct: 118 GMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIP 174
Query: 194 -EFMAPE-LYEEEYNELVDIYSFGMCILE-MVTCEYPYNECKN 233
+ APE + ++ D++S+G+ + E M E PY + N
Sbjct: 175 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 59/259 (22%), Positives = 116/259 (44%), Gaps = 27/259 (10%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ +GKG F V G + G +VA + + Q+ +E ++ L+H N+++
Sbjct: 12 QTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQA------FLAEASVMTQLRHSNLVQ 63
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNV-DMKAIKNWARQILRGLHYLHSHN 148
V++ + ++TE GSL Y R + ++V + ++ + + YL ++N
Sbjct: 64 LLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN 122
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEY 205
+HRDL N+ V+ +N K+ D GL Q T + + ++ APE L E+++
Sbjct: 123 --FVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREKKF 176
Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD---PQVKQFI 262
+ D++SFG+ + E+ Y + P K V ++ D P V +
Sbjct: 177 STKSDVWSFGILLWEI----YSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVM 232
Query: 263 EKCIVPASLRLPALELLKD 281
++C + P+ L++
Sbjct: 233 KQCWHLDAATRPSFLQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 28/214 (13%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE--RLYSEVHLLKSLKH 85
R +LGKG F EV QV M + +LE R+ +L
Sbjct: 3 RQYRVLGKGGFG------------EVCACQVRATGKMYACKRLEKKRIKKRKGESMALNE 50
Query: 86 ENIIKFYNS-------WVDDTNRTINMITELFTSGSLR--QYRKKHKNVDMKAIKNWARQ 136
+ I++ NS + +T + ++ + G L+ Y + + + +A +
Sbjct: 51 KQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE 110
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGTPEF 195
IL GL LH N ++RDLK +NI ++ + G ++I DLGLA+ + + + R +GT +
Sbjct: 111 ILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVGTVGY 167
Query: 196 MAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY 228
MAPE L + Y D + G I EM+ + P+
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 20/166 (12%)
Query: 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 167
ELFT R++ + ++ + +I+ L +LH II+RD+K +NI ++
Sbjct: 91 ELFTHLYQREHFTES------EVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDS-E 141
Query: 168 GEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY---EEEYNELVDIYSFGMCILEM 221
G V + D GL+ A S GT E+MAPE+ +++ VD +S G+ E+
Sbjct: 142 GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201
Query: 222 VTCEYPY---NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
+T P+ E + ++I +++ P K + + FI+K
Sbjct: 202 LTGASPFTVDGEQNSQSEISRRILKSKPP--FPKTMSAEARDFIQK 245
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 38/132 (28%), Positives = 72/132 (54%), Gaps = 7/132 (5%)
Query: 113 GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172
G L + ++ D+ + + ++L L LH N +I+RDLK +NI ++ G + +
Sbjct: 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIAL 134
Query: 173 GDLGLAIVMQQPTARS--VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYN 229
D GL + + ++ GTPE++APEL Y + VD ++ G+ + EM+T P+
Sbjct: 135 CDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY 194
Query: 230 ECKNPAQIYKKV 241
+ +N ++Y+K+
Sbjct: 195 D-ENVNEMYRKI 205
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTARSV 189
ARQ+L + Y+H IIHRD+K +N+ VNG ++ +GD G A + P +
Sbjct: 266 ARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHYGI 322
Query: 190 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 220
GT + APE L + Y VDI+S G+ I E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 51/207 (24%), Positives = 88/207 (42%), Gaps = 22/207 (10%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+G G F V+ G+ +V I+ + + E E ++ L H +++ Y
Sbjct: 12 IGSGQFGLVWLGYWLEK------RKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLY 65
Query: 93 NSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
V I ++ E G L Y R + + + + G+ YL S N +
Sbjct: 66 G--VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--V 121
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFMAPELYE-EEYNE 207
IHRDL N V G N VK+ D G+ + S GT ++ +PE++ +Y+
Sbjct: 122 IHRDLAARNCLV-GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNP 234
D++SFG+ + E+ ++E K P
Sbjct: 181 KSDVWSFGVLMWEV------FSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 56/218 (25%), Positives = 107/218 (49%), Gaps = 18/218 (8%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG G F V+ G I+VA +N E M D +E E ++ L H +++ Y
Sbjct: 12 LGSGQFGVVHLG-KWRAQIKVAIKAIN-EGAMSEEDFIE----EAKVMMKLSHPKLVQLY 65
Query: 93 NSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
V + + ++TE +G L Y R++ + + + + + G+ YL ++
Sbjct: 66 G--VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--F 121
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP-EFMAPELYE-EEYNE 207
IHRDL N V+ + G VK+ D G+ ++ + T+ S P ++ PE++ +Y+
Sbjct: 122 IHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 208 LVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244
D++SFG+ + E+ T + P+ E K+ ++ + ++ G
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMPF-EKKSNYEVVEMISRG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 67/291 (23%), Positives = 133/291 (45%), Gaps = 30/291 (10%)
Query: 31 EILGKGAFKTVY-----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
++LG GA+ V+ G D G A + ++Q E +E +L+ ++
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDS--GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 63
Query: 86 EN-IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
++ + ++ DT +++I + G L + + + + ++ ++ +I+ L +L
Sbjct: 64 SPFLVTLHYAFQTDTK--LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGTPEFMAPELY 201
H II+RD+K +NI ++ +NG V + D GL+ + A S GT E+MAP++
Sbjct: 122 HKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 202 ---EEEYNELVDIYSFGMCILEMVTCEYPYN---ECKNPAQIYKKVTSGIKPASLSKVTD 255
+ +++ VD +S G+ + E++T P+ E + A+I +++ P +
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMS 236
Query: 256 PQVKQFIEKCIVP-ASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLP 300
K I++ ++ RL A E+ K PF N DL + P
Sbjct: 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVPAP 287
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 50/196 (25%), Positives = 92/196 (46%), Gaps = 20/196 (10%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+GKG F V G + G +VA ++D + +E ++ +L+H N+++
Sbjct: 12 ATIGKGEFGDVMLG--DYRGQKVAVK--CLKDDSTAAQAF---LAEASVMTTLRHPNLVQ 64
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKA-IKNWARQILRGLHYLHSHN 148
+ + ++TE GSL Y R + + V A +A + G+ YL N
Sbjct: 65 LLGVVLQGNP--LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEY 205
+HRDL N+ V+ + K+ D GLA Q + + + ++ APE L E+++
Sbjct: 123 --FVHRDLAARNVLVS-EDLVAKVSDFGLAKEASQGQDSGKLPV---KWTAPEALREKKF 176
Query: 206 NELVDIYSFGMCILEM 221
+ D++SFG+ + E+
Sbjct: 177 STKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 64/237 (27%), Positives = 107/237 (45%), Gaps = 36/237 (15%)
Query: 33 LGKGAFKTV-----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLER-LYSEVHLLKSLKHE 86
LG+GAF V Y E D I VA ++ + + D + + E LL +L+HE
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVA-----VKTLKDASDNARKDFHREAELLTNLQHE 67
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-------------KNVDMKAIKNW 133
+I+KFY V+ + M+ E G L ++ + H + + +
Sbjct: 68 HIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
A+QI G+ YL S + +HRDL N V G N VKIGD G++ + V G
Sbjct: 126 AQQIAAGMVYLASQH--FVHRDLATRNCLV-GENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 194 ----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+M PE + ++ D++S G+ + E+ T + P+ + N ++ + +T G
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-NEVIECITQG 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 29/177 (16%)
Query: 70 LERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM- 127
L L SE+ ++K + KH+NII + D + ++ E + G+LR+Y + + M
Sbjct: 61 LSDLVSEMEMMKMIGKHKNIINLLGACTQDG--PLYVLVEYASKGNLREYLRARRPPGMD 118
Query: 128 ---------------KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172
K + + A Q+ RG+ YL S IHRDL N+ V +N +KI
Sbjct: 119 YSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDN-VMKI 175
Query: 173 GDLGLA-----IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
D GLA I + T + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 176 ADFGLARDVHNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE--RLYSEVHLLKSLKH 85
R+ +LGKG F EV QV M + +LE R+ +L
Sbjct: 3 RHYRVLGKGGFG------------EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE 50
Query: 86 ENIIKFYNS-------WVDDTNRTINMITELFTSGSLR--QYRKKHKNVDMKAIKNWARQ 136
+ I++ NS + +T + ++ + G L+ Y + D + +A +
Sbjct: 51 KRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE 110
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGTPEF 195
+ GL L I++RDLK +NI ++ + G ++I DLGLA+ + + T R +GT +
Sbjct: 111 LCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGY 167
Query: 196 MAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECK 232
MAPE + E+Y D + G I EM+ + P+ + K
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 43/221 (19%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-------QSPDQLER--LYSEVHLLKSL 83
LG+GAF V+ + +N +D M + P R E LL +L
Sbjct: 13 LGEGAFGKVF--------LAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 64
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDM 127
+HE+I+KFY D + M+ E G L ++ + H + +
Sbjct: 65 QHEHIVKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187
+ + A QI G+ YL S + +HRDL N V G N VKIGD G++ +
Sbjct: 123 SQMLHIASQIASGMVYLASQH--FVHRDLATRNCLV-GANLLVKIGDFGMSRDVYSTDYY 179
Query: 188 SVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
V G +M PE + ++ D++SFG+ + E+ T
Sbjct: 180 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 36/223 (16%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV--MQSPDQLERLYSEVHLLKSLKH 85
R+ E LG+ AF +YKG + G++ A V I+ + + +P Q E L+ L H
Sbjct: 8 RFMEELGECAFGKIYKGHLYLPGMDHA-QLVAIKTLKDINNPQQWGEFQQEASLMAELHH 66
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNV--------------DMK 128
NI+ + + + M+ E G L ++ R H +V D
Sbjct: 67 PNIVCLLGVVTQE--QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ------ 182
+ A QI G+ YL SH +H+DL NI + G VKI DLGL+ +
Sbjct: 125 DFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILI-GEQLHVKISDLGLSREIYSADYYR 181
Query: 183 -QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
QP + I +M PE + +++ DI+SFG+ + E+ +
Sbjct: 182 VQPKSLLPI---RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 64/234 (27%), Positives = 107/234 (45%), Gaps = 21/234 (8%)
Query: 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEV 77
DPS ++++G G F V +G ++ G I+VA ++ +L+ L +E
Sbjct: 2 DPSYV--TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKT--LKAGSSDKQRLDFL-TEA 56
Query: 78 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQ 136
++ H NII+ V +R + +ITE +GSL ++ R+ + + R
Sbjct: 57 SIMGQFDHPNIIRLEG--VVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRG 114
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGT 192
I G+ YL N +HRDL NI VN +N K+ D GL+ ++ T +
Sbjct: 115 IASGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRRLEDSEATYTTKGGKIP 171
Query: 193 PEFMAPE-LYEEEYNELVDIYSFGMCILE-MVTCEYPYNECKNPAQIYKKVTSG 244
+ APE + ++ D++SFG+ + E M E PY + N + K V G
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDG 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 73/263 (27%), Positives = 118/263 (44%), Gaps = 27/263 (10%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY + +G GA V +D V VA +++ Q+ +R Y E+ L+K + H
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 75
Query: 86 ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
+NII N + + + + ++ EL + + + + +D + + Q+L G+
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 132
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-----EFM 196
+LHS IIHRDLK NI V ++ +KI D GLA + S + TP +
Sbjct: 133 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 185
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPASLSKV 253
APE + Y E VDI+S G + EMV + + ++ + KV G K
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 254 TDPQVKQFIEKCIVPASLRLPAL 276
P V+ ++E A L P L
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKL 267
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 57/249 (22%), Positives = 110/249 (44%), Gaps = 45/249 (18%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+++G+GAF V + G A + D+++ +Q+ + +E +L ++K
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEK-EQVGHIRAERDILVEADSLWVVK 65
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
+ S+ D N + +I E G + K + + + + + + + +H
Sbjct: 66 MFYSFQDKLN--LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG-- 121
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--------------PT----------- 185
IHRD+K DN+ ++ + G VK+ D GL +++ P+
Sbjct: 122 FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 186 ------------ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECK 232
A S +GTP+++APE++ + YN+L D +S G+ + EM+ YP +
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI-GYPPFCSE 239
Query: 233 NPAQIYKKV 241
P + YKKV
Sbjct: 240 TPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 32/87 (36%), Positives = 51/87 (58%), Gaps = 4/87 (4%)
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYE 202
H H+ II+RDLK +NI ++ G +K+ D GL+ + + A S GT E+MAPE+
Sbjct: 113 HLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 203 EE-YNELVDIYSFGMCILEMVTCEYPY 228
+ + D +SFG+ + EM+T P+
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY + +G GA V +D + VA +++ Q+ +R Y E+ L+K + H
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNH 82
Query: 86 ENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
+NII N + + + + ++ EL + + + + +D + + Q+L G+
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 139
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-----FM 196
+LHS IIHRDLK NI V ++ +KI D GLA + S + TP +
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 192
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMV 222
APE + Y E VDI+S G + EM+
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 57/249 (22%), Positives = 110/249 (44%), Gaps = 45/249 (18%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+++G+GAF V + G A + D+++ +Q+ + +E +L ++K
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEK-EQVAHIRAERDILVEADGAWVVK 65
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
+ S+ D R + +I E G + K + +A + + + + + +H
Sbjct: 66 MFYSFQD--KRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG-- 121
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--------------PT----------- 185
IHRD+K DN+ ++ G VK+ D GL +++ P+
Sbjct: 122 FIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 186 ------------ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECK 232
A S +GTP+++APE++ + YN+L D +S G+ + EM+ YP +
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI-GYPPFCSE 239
Query: 233 NPAQIYKKV 241
P + Y+KV
Sbjct: 240 TPQETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 60/239 (25%), Positives = 105/239 (43%), Gaps = 42/239 (17%)
Query: 33 LGKGAFKTVYKG-FDEVDGIEVAWNQVNIEDVMQSP---DQLERLYSEVHLLKSLKHENI 88
LG GAF VY+G + DG V QV ++ + +S D+ + L E ++ H+NI
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVEL-QVAVKTLPESCSEQDESDFL-MEALIMSKFNHQNI 71
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-------VDMKAIKNWARQILRGL 141
++ + R I + EL G L+ + ++++ + MK + AR + +G
Sbjct: 72 VRLIGVSFERLPRFI--LLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 142 HYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIGTP------ 193
YL ++ IHRD+ N + G KI D G+ AR +
Sbjct: 130 KYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGM--------ARDIYRASYYRKGG 179
Query: 194 ------EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEY-PYNECKNPAQIYKKVTSG 244
++M PE + + + D++SFG+ + E+ + Y PY N ++ + VT G
Sbjct: 180 RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEVMEFVTGG 237
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 75 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWA 134
E+ +LK++ H II +++ T+ M+ + L Y + + ++
Sbjct: 135 REIDILKTISHRAIINLIHAY--RWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQ 191
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVI 190
R++L L YLH IIHRD+K +NIF++ +GD G A + P
Sbjct: 192 RRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTPQCYGWS 248
Query: 191 GTPEFMAPELYE-EEYNELVDIYSFGMCILEM 221
GT E +PEL + Y DI+S G+ + EM
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 62/218 (28%), Positives = 90/218 (41%), Gaps = 30/218 (13%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKH 85
R+ E LG+GAF VYKG ++ V I+ + + P + E L+ L+H
Sbjct: 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH 67
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNV-------------DMKA 129
NI+ V + M+ E G L ++ H +V D
Sbjct: 68 PNIVCLLG--VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 189
+ A QI G+ YL SH+ +HRDL N V G VKI D GL+ + V
Sbjct: 126 FLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLV-GEGLTVKISDFGLSRDIYSADYYRV 182
Query: 190 IGTP----EFMAPE--LYEEEYNELVDIYSFGMCILEM 221
+M PE LY + E DI+SFG+ + E+
Sbjct: 183 QSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 49/218 (22%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ--LERLYSEVHLLKSLKHENII 89
LG+G F V+ + E V ++ + ++ D+ E+ + + L H+N++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQY---------RKKHKNVDMKAIKNWARQILRG 140
+ + MI E G L+Q+ + K + K QI G
Sbjct: 72 RLLGLCREAEPHY--MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQP--TARSVIGTPEFMA 197
+ +L + +HRDL N V+ EVK+ L L+ V R+ + ++A
Sbjct: 130 MDHLSNAR--FVHRDLAARNCLVSSQR-EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLA 186
Query: 198 PE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKN 233
PE + E++++ D++SFG+ + E+ T E P+ +
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 26/208 (12%)
Query: 31 EILGKGAFKTVYKG-FDEVDGIEV--AWNQVN-IEDVMQSPDQLERLYSEVHLLKSLKHE 86
++GKG F VY G + DG ++ A +N I D+ +++E+ E ++K H
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL----EEVEQFLKEGIIMKDFSHP 56
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLH 145
N++ + + ++ G LR + R + N +K + + Q+ +G+ YL
Sbjct: 57 NVLSLLGICLPSEGSPL-VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA 115
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---------IVMQQPTARSVIGTPEFM 196
S +HRDL N ++ + VK+ D GLA V A+ + ++M
Sbjct: 116 SKK--FVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV---KWM 169
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVT 223
A E L +++ D++SFG+ + E++T
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 9e-09
Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 52/232 (22%)
Query: 31 EILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
++LGKG V+ KG ++ ++V + M ++++R+ +E +L +L H
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVL-----DKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSG----SLRQYRKKHKNVDMKAIKNWARQILRGLH 142
+ Y T + ++ + + G L Q R+ K + + + +A ++L L
Sbjct: 62 FLPTLY--ASFQTETYLCLVMD-YCPGGELFRLLQ-RQPGKCLSEEVARFYAAEVLLALE 117
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA------------------------ 178
YLH I++RDLK +NI ++ +G + + D L+
Sbjct: 118 YLH--LLGIVYRDLKPENILLHE-SGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 179 -----IVMQQPTAR--SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMV 222
++P+ R S +GT E++APE+ + + VD ++ G+ + EM+
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 38/218 (17%)
Query: 33 LGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQ-LERLYSEVHLLKSLKHE 86
LG+GAF V+ E D + VA +++ +S Q +R E LL L+H+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKA--LKEASESARQDFQR---EAELLTVLQHQ 67
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---------------KNVDMKAIK 131
+I++FY + R + M+ E G L ++ + H + + +
Sbjct: 68 HIVRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 191
A QI G+ YL S + +HRDL N V G VKIGD G++ + V G
Sbjct: 126 AIASQIASGMVYLASLH--FVHRDLATRNCLV-GQGLVVKIGDFGMSRDIYSTDYYRVGG 182
Query: 192 TP----EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 223
+M PE LY + E DI+SFG+ + E+ T
Sbjct: 183 RTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 49/192 (25%), Positives = 74/192 (38%), Gaps = 16/192 (8%)
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK 120
D + Q R E L L H NI+ +S + E +LR+
Sbjct: 13 TDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLF-AVFEYVPGRTLREVLA 71
Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGL- 177
+ Q+L L +HN I+HRDLK NI V+ K+ D G+
Sbjct: 72 ADGALPAGETGRLMLQVLDALA--CAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIG 129
Query: 178 --------AIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY 228
A V V+GTP + APE L E D+Y++G+ LE +T +
Sbjct: 130 TLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ-RV 188
Query: 229 NECKNPAQIYKK 240
+ + A+I +
Sbjct: 189 VQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 60/231 (25%), Positives = 93/231 (40%), Gaps = 36/231 (15%)
Query: 31 EILGKGAFKTVY-------KGFDEVDGIEVAWNQVNIEDVMQSP------DQLERLYSEV 77
E LG+G F V+ + F E E + ++ + E EV
Sbjct: 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70
Query: 78 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-----------KNVD 126
+L L NI + D + MI E +G L Q+ +KH K++
Sbjct: 71 KILSRLSDPNIARLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 127 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 186
+ A QI G+ YL S N +HRDL N V G N +KI D G++ +
Sbjct: 129 FSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLV-GKNYTIKIADFGMSRNLYSSDY 185
Query: 187 RSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-C-EYPYNE 230
V G +MA E + ++ D+++FG+ + E++T C E PY
Sbjct: 186 YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 52/219 (23%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
EI+G+G F V +G E G +VA + + Q+ E ++ L H+N+++
Sbjct: 12 EIIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTAQA------FLEETAVMTKLHHKNLVR 63
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHN 148
+ + + ++ EL + G+L + + V + + ++ + G+ YL S
Sbjct: 64 LLGVIL---HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK 120
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNE 207
++HRDL NI V+ +G K+ D GLA V S + ++ APE L ++++
Sbjct: 121 --LVHRDLAARNILVS-EDGVAKVSDFGLARVGSMGVDNSKLPV-KWTAPEALKHKKFSS 176
Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246
D++S+G+ + E+ + Y P K+V ++
Sbjct: 177 KSDVWSYGVLLWEV----FSYGRAPYPKMSLKEVKECVE 211
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 63/234 (26%), Positives = 102/234 (43%), Gaps = 39/234 (16%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLER---------LY 74
R E LG+G F V+ E +G+ + + + V+ + L
Sbjct: 8 RLKEKLGEGQFGEVH--LCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFL 65
Query: 75 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK---------NV 125
E+ ++ LK+ NII+ V D + MITE +G L Q+ + + N+
Sbjct: 66 KEIKIMSRLKNPNIIRLLGVCVSDD--PLCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 126 DMKAIKN---WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182
+I N A QI G+ YL S N +HRDL N V GN+ +KI D G++ +
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLV-GNHYTIKIADFGMSRNLY 180
Query: 183 QPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-C-EYPYN 229
+ G +MA E + ++ D+++FG+ + EM T C E PY+
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 45/196 (22%), Positives = 96/196 (48%), Gaps = 26/196 (13%)
Query: 68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 127
+Q+++++ E +L ++ ++ + S+ +T R + M+ E G K + +
Sbjct: 43 NQIQQVFVERDILTFAENPFVVSMFCSF--ETKRHLCMVMEYVEGGDCATLLKNIGALPV 100
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV------- 180
+ + + + L YLH++ I+HRDLK DN+ + + G +K+ D GL+ +
Sbjct: 101 DMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTT 157
Query: 181 ----------MQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE-MVTCEYPY 228
++ + V GTPE++APE + + Y + VD ++ G+ + E +V C +
Sbjct: 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 217
Query: 229 NECKNPAQIYKKVTSG 244
+ P +++ +V S
Sbjct: 218 GD--TPEELFGQVISD 231
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 41/146 (28%), Positives = 77/146 (52%), Gaps = 21/146 (14%)
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARS--VIGTPEFMA 197
+H LH +HRD+K DNI ++ NG +++ D G + +M+ T +S +GTP++++
Sbjct: 118 VHQLH-----YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171
Query: 198 PELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK----P 247
PE+ + +Y D +S G+C+ EM+ E P+ ++ + Y K+ + + P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHKERFQFP 230
Query: 248 ASLSKVTDPQVKQFIEKCIVPASLRL 273
A ++ V++ K I + I RL
Sbjct: 231 AQVTDVSE-DAKDLIRRLICSREHRL 255
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 35/135 (25%), Positives = 72/135 (53%), Gaps = 8/135 (5%)
Query: 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158
T +++I + + G + + + N ++ ++ +I+ L +LH I++RD+K
Sbjct: 76 TEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKL 133
Query: 159 DNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYS 213
+NI ++ + G V + D GL+ + ++ S GT E+MAPE+ + + + VD +S
Sbjct: 134 ENILLD-SEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWS 192
Query: 214 FGMCILEMVTCEYPY 228
G+ I E++T P+
Sbjct: 193 LGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 40/144 (27%), Positives = 78/144 (54%), Gaps = 17/144 (11%)
Query: 144 LHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARS--VIGTPEFMAPE 199
+HS H +HRD+K DN+ ++ NG +++ D G + M Q T +S +GTP++++PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLD-MNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 200 LYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK----PAS 249
+ + +Y D +S G+C+ EM+ E P+ ++ + Y K+ + + P+
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHEERFQFPSH 232
Query: 250 LSKVTDPQVKQFIEKCIVPASLRL 273
++ V++ + K I++ I RL
Sbjct: 233 ITDVSE-EAKDLIQRLICSRERRL 255
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 15/221 (6%)
Query: 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
D SC + ++++G G F V G ++ G + + Q SE ++
Sbjct: 2 DASCI--KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIM 59
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILR 139
H NII V ++ + ++TE +GSL + +KH + + R I
Sbjct: 60 GQFDHPNIIHLEG--VVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIAS 117
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPE 194
G+ YL +HRDL NI VN +N K+ D GL+ V++ T R
Sbjct: 118 GMKYLSDMG--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 174
Query: 195 FMAPE-LYEEEYNELVDIYSFGMCILE-MVTCEYPYNECKN 233
+ APE + ++ D++S+G+ + E M E PY E N
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 58/220 (26%), Positives = 105/220 (47%), Gaps = 29/220 (13%)
Query: 31 EILGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHE 86
++L +G F ++ G DE G E +V ++ V S Q+ L E LL L H+
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKE---EEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQ 68
Query: 87 NIIKFYNSWVDDTNRTINMITELFTS-GSLRQYRKKHKNVDM---KAIK-----NWARQI 137
NI+ + ++D + + + G+L+ + ++ + + +A+ + A QI
Sbjct: 69 NILPILHVCIEDGEPP--FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE--- 194
G+ YLH +IH+D+ N ++ +VKI D L+ + P +G E
Sbjct: 127 ACGMSYLHKRG--VIHKDIAARNCVID-EELQVKITDNALSRDLF-PMDYHCLGDNENRP 182
Query: 195 --FMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNE 230
+MA E L +EY+ D++SFG+ + E++T + PY E
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 36/149 (24%), Positives = 77/149 (51%), Gaps = 14/149 (9%)
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
+++ + ++ DD + + M+ E G L + +V K K + +++ L +HS
Sbjct: 105 VVQLFCAFQDD--KYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM 161
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEEE 204
+IHRD+K DN+ ++ +G +K+ D G + M + + +GTP++++PE+ + +
Sbjct: 162 G--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 205 -----YNELVDIYSFGMCILEMVTCEYPY 228
Y D +S G+ + EM+ + P+
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 47/219 (21%), Positives = 90/219 (41%), Gaps = 47/219 (21%)
Query: 64 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 123
M +Q+ + +E +L + ++K Y S+ D+ + +I E G + K
Sbjct: 39 MLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENY--LYLIMEYLPGGDMMTLLMKKD 96
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL------ 177
+ + + + + + +H IHRD+K DN+ ++ G +K+ D GL
Sbjct: 97 TFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKK 153
Query: 178 ------------------AIVMQQPT----------------ARSVIGTPEFMAPELYEE 203
+ +P A S +GTP+++APE++ +
Sbjct: 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ 213
Query: 204 E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
YN+ D +S G+ + EM+ YP NP + Y+K+
Sbjct: 214 TGYNKECDWWSLGVIMYEMLV-GYPPFCSDNPQETYRKI 251
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 8e-08
Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 23/173 (13%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-----------N 124
E+ ++ LK NII+ + + MITE +G L Q+ +H+
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184
+ + A QI G+ YL S N +HRDL N V G N +KI D G++ +
Sbjct: 127 ISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLV-GKNYTIKIADFGMSRNLYSG 183
Query: 185 -----TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVT-C-EYPYNE 230
R+V+ + ++ D+++FG+ + E++T C E PY++
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 42/135 (31%), Positives = 67/135 (49%), Gaps = 15/135 (11%)
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL---AIVMQQPTARSVIGT 192
+I L +LH II+RDLK +NI ++ G VK+ D GL +I T + GT
Sbjct: 108 EISLALEHLHQQG--IIYRDLKPENILLDA-QGHVKLTDFGLCKESIHEGTVT-HTFCGT 163
Query: 193 PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPAS 249
E+MAPE L + + VD +S G + +M+T P+ +N + K+ G P
Sbjct: 164 IEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT-AENRKKTIDKILKGKLNLPPY 222
Query: 250 LSKVTDPQVKQFIEK 264
L+ P+ + ++K
Sbjct: 223 LT----PEARDLLKK 233
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 23/214 (10%)
Query: 33 LGKG--AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+G+G +VY G V ++E+ + + L+ L +EV L +H NI+
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMT 63
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA--IKNWARQILRGLHYLHSHN 148
+ V T + +I+ GS K + M I N LRGL+YLH +
Sbjct: 64 SWT--VFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG 121
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLG--LAIVMQQPTARSVIGTPEF-------MAPE 199
IHR++K +I ++G+ G V + L ++V A+ V P+F ++PE
Sbjct: 122 --YIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178
Query: 200 LYEEE---YNELVDIYSFGMCILEMVTCEYPYNE 230
L ++ YN DIYS G+ E+ T P+ +
Sbjct: 179 LLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 16/223 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E +G+G F V+ G D VA + + + PD + E +LK H NI++
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVK--SCRETL-PPDLKAKFLQEARILKQYSHPNIVR 57
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
V + I ++ EL G + R + + +K + G+ YL S +
Sbjct: 58 LIG--VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH- 114
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE----FMAPE-LYEEE 204
IHRDL N V N +KI D G++ + S G + + APE L
Sbjct: 115 -CIHRDLAARNCLVTEKNV-LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 205 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIK 246
Y+ D++SFG+ + E + PY N Q + + G++
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSN-QQTREAIEQGVR 214
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 64/273 (23%), Positives = 94/273 (34%), Gaps = 79/273 (28%)
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM------------------------- 181
H IHRD+K DNI ++ +G +K+ D GL
Sbjct: 118 HKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 182 --------------------QQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILE 220
Q+ A S++GTP ++APE+ Y +L D +S G+ + E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236
Query: 221 MVTCEYPYNECKNPAQIYKKV-----TSGIKP-ASLSKVTDPQVKQFIEKCIVPASLRL- 273
M+ + P+ PA+ KV T I A LS + I + A RL
Sbjct: 237 MLVGQPPFLA-DTPAETQLKVINWETTLHIPSQAKLS----REASDLILRLCCGAEDRLG 291
Query: 274 --PALELLKDPFLVTDNPKDLVCDPLRLP-NLVPEVMNLAHSEPHPMDIDLNHKKVSADS 330
A E+ PF D R +P++ HP D N V +
Sbjct: 292 KNGADEIKAHPFFKG---IDFASLIRRQKAPYIPKIT-------HPTDTS-NFDPVDPEK 340
Query: 331 CAKSNTG---TWFLTLELQR-LTENN--EFTLR 357
++G R TE+ EFT R
Sbjct: 341 LRSDDSGESSPDRNVKPNNRKRTEHAFYEFTFR 373
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 36/149 (24%), Positives = 76/149 (51%), Gaps = 14/149 (9%)
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
+++ + ++ DD R + M+ E G L + +V K + + +++ L +HS
Sbjct: 105 VVQLFYAFQDD--RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM 161
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEEE 204
IHRD+K DN+ ++ +G +K+ D G + M + + +GTP++++PE+ + +
Sbjct: 162 G--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 205 -----YNELVDIYSFGMCILEMVTCEYPY 228
Y D +S G+ + EM+ + P+
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 53/182 (29%), Positives = 81/182 (44%), Gaps = 33/182 (18%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD--------- 126
EV +L LK NII+ VD+ + MITE +G L Q+ H D
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 127 ----------MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176
++ + A QI G+ YL S N +HRDL N V G N +KI D G
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLV-GENLTIKIADFG 183
Query: 177 LAIVM-----QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE--MVTCEYPY 228
++ + + R+V+ +MA E + ++ D+++FG+ + E M+ E PY
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPI-RWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242
Query: 229 NE 230
E
Sbjct: 243 GE 244
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 61/232 (26%), Positives = 105/232 (45%), Gaps = 28/232 (12%)
Query: 33 LGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERL--YSEVHLLKSLKHENI 88
LG+G+F VY+G D + G A +V ++ V +S ER+ +E ++K ++
Sbjct: 14 LGQGSFGMVYEGNARDIIKG--EAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLRQY----RKKHKN------VDMKAIKNWARQIL 138
++ V + ++ EL G L+ Y R + +N ++ + A +I
Sbjct: 72 VRLLG--VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP----E 194
G+ YL++ +HRDL N V + VKIGD G+ + + G
Sbjct: 130 DGMAYLNAKK--FVHRDLAARNCMVAHDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 195 FMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244
+MAPE L + + D++SFG+ + E+ + E PY N Q+ K V G
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFVMDG 237
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 30/108 (27%), Positives = 56/108 (51%), Gaps = 15/108 (13%)
Query: 133 WAR----QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ---QPT 185
WAR +++ L +HS IHRD+K DN+ ++ +G +K+ D G + M
Sbjct: 143 WARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDANGMVR 199
Query: 186 ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPY 228
+ +GTP++++PE+ + Y D +S G+ + EM+ + P+
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 45/192 (23%), Positives = 98/192 (51%), Gaps = 12/192 (6%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
++G+GA+ V K + VA + +D ++ + E E+ +L++LK ENI++
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKK--FKDSEENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 92 YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
++ + ++ E L + V + ++++ Q+++ +H+ H ++ I
Sbjct: 66 KEAF--RRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--I 121
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS---VIGTPEFMAPE-LYEEEYNE 207
+HRD+K +N+ ++ N+ +K+ D G A + + + + + T + +PE L Y +
Sbjct: 122 VHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 208 LVDIYSFGMCIL 219
VD++S G CIL
Sbjct: 181 AVDMWSVG-CIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 39/155 (25%), Positives = 68/155 (43%), Gaps = 19/155 (12%)
Query: 144 LHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM---QQPTARSVIGTPEFMAPE 199
+HS H +HRD+K +N+ ++ G +K+ D G A + + ++ +GTP+++APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173
Query: 200 LYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
+ Y D +S G+ EM+ P++E A+ Y + + L
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMN--FQRFLKF 230
Query: 253 VTDPQV----KQFIEKCIVPASLRLPALELLKDPF 283
DP+V I+ + RL L PF
Sbjct: 231 PEDPKVSSDFLDLIQSLLCGQKERLGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 43/136 (31%), Positives = 69/136 (50%), Gaps = 10/136 (7%)
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGT-- 192
Q+ G+ +L S N +HRDL N+ + VKI D GLA +M+ S T
Sbjct: 247 QVANGMEFLASKN--CVHRDLAARNVLI-CEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 193 P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPAS 249
P ++MAPE ++ Y L D++SFG+ + E+ T PY E Q Y + G + A
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAK 363
Query: 250 LSKVTDPQVKQFIEKC 265
+ +D ++ + ++KC
Sbjct: 364 PAHASD-EIYEIMQKC 378
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 26/201 (12%)
Query: 33 LGKGAFKTVYKGFDEVDGIE--VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
LG G F TV KG ++ E VA + ++ P + L E ++++ L + I++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVR 60
Query: 91 FY-----NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
SW+ ++ EL G L ++ +K+K+V K I Q+ G+ YL
Sbjct: 61 MIGICEAESWM--------LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTP-EFMAPE- 199
N +HRDL N+ + + KI D GL+ + A++ P ++ APE
Sbjct: 113 ETN--FVHRDLAARNVLLVTQH-YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169
Query: 200 LYEEEYNELVDIYSFGMCILE 220
+ +++ D++SFG+ + E
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 31/230 (13%)
Query: 33 LGKGAFKTVYKGFDEVD-GIEVAWNQVNIEDVMQS--PDQLERLYSEVHLLKSLKHENII 89
+G G F V G E G+ A +V ++++ S PD+ EV + L H N++
Sbjct: 3 IGNGWFGKVLLG--EAHRGMSKA--RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVL 58
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKA----IKNWARQILRGLHYL 144
+ ++ ++ E G L+ Y R V A ++ A ++ GL +L
Sbjct: 59 QCLGQCIESI--PYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPEL 200
H + IH DL N + + VKIGD GLA+ T ++APEL
Sbjct: 117 HQAD--FIHSDLALRNCQLTAD-LSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173
Query: 201 YEEEYNELV--------DIYSFGMCILEMVT-CEYPYNECKNPAQIYKKV 241
E +L+ +I+S G+ + E+ T + PY + + Q+ K+V
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-EQVLKQV 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 21/146 (14%)
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARS--VIGTPEFMA 197
+H L +HRD+K DN+ ++ NG +++ D G + ++ T +S +GTP++++
Sbjct: 118 VHQLG-----YVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYIS 171
Query: 198 PELYEE------EYNELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKPASL 250
PE+ + Y D +S G+C+ EM+ E P Y E + + Y K+ + +
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKEHFQF 229
Query: 251 -SKVTD--PQVKQFIEKCIVPASLRL 273
VTD + K I + I RL
Sbjct: 230 PPDVTDVSEEAKDLIRRLICSPETRL 255
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 63/260 (24%), Positives = 116/260 (44%), Gaps = 32/260 (12%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHE 86
++++++G+G F V + + DG+++ +++ D + E+ +L L H
Sbjct: 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRD-FAGELEVLCKLGHHP 63
Query: 87 NIIKFYNSWVDDTNRTINMIT-ELFTSGSLRQYRKKHKNVDM---------KAIKNWARQ 136
NII + NR I E G+L + +K + ++ A ++Q
Sbjct: 64 NIINLLGAC---ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 137 ILR-------GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 189
+L+ G+ YL IHRDL N+ V G N KI D GL+ + +++
Sbjct: 121 LLQFASDVATGMQYLSEKQ--FIHRDLAARNVLV-GENLASKIADFGLSRGEEVYVKKTM 177
Query: 190 IGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNEC-KNPAQIYKKVTSGI 245
P +MA E L Y D++SFG+ + E+V+ PY C A++Y+K+ G
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY--CGMTCAELYEKLPQGY 235
Query: 246 KPASLSKVTDPQVKQFIEKC 265
+ + D +V + + +C
Sbjct: 236 R-MEKPRNCDDEVYELMRQC 254
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 7e-06
Identities = 68/277 (24%), Positives = 118/277 (42%), Gaps = 42/277 (15%)
Query: 32 ILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
+LGKG F +V + ++ +VA + D+ S D +E E +K H N+
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLK-ADIFSSSD-IEEFLREAACMKEFDHPNV 63
Query: 89 IKFYNSWVDDTNRT-----INMITELFTS-GSLRQYRKKHK------NVDMKAIKNWARQ 136
IK V +R I M+ F G L + + + ++ + +
Sbjct: 64 IKLIG--VSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMID 121
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM------QQPTARSVI 190
I G+ YL S N IHRDL N +N N V + D GL+ + +Q A +
Sbjct: 122 IASGMEYLSSKN--FIHRDLAARNCMLN-ENMTVCVADFGLSKKIYSGDYYRQGCASKL- 177
Query: 191 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK-- 246
+++A E L + Y D+++FG+ + E++T + PY +N ++IY + G +
Sbjct: 178 -PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIYNYLIKGNRLK 235
Query: 247 --PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKD 281
P L V + + +C P P+ + L+D
Sbjct: 236 QPPDCLEDVYE-----LMCQCWSPEPKCRPSFQHLRD 267
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 24/101 (23%)
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
Q+ RG+ +L S IHRDL NI ++ NN VKI D GL AR + P++
Sbjct: 181 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 229
Query: 196 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVT 223
MAPE ++++ Y D++SFG+ + E+ +
Sbjct: 230 VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 29/209 (13%)
Query: 33 LGKGAFKTVYKGFDEVD-GIEVAWNQVNIEDVMQSPDQLERLY--SEVHLLKSLKHENII 89
+G G F V G EV+ G A QV ++++ S E++ E +SL+H N++
Sbjct: 3 IGNGWFGKVILG--EVNSGYTPA--QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-----DMKAIKNWARQILRGLHYL 144
+ + T + M E G L+ Y + + D ++ A +I GL +L
Sbjct: 59 QCLGQCTEVTPYLLVM--EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL 116
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPEL 200
H +N IH DL N + + VKIGD GL+ + T + ++APEL
Sbjct: 117 HKNN--FIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPEL 173
Query: 201 YEEEYNELV--------DIYSFGMCILEM 221
+E + L+ +++S G+ I E+
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 66/262 (25%), Positives = 114/262 (43%), Gaps = 36/262 (13%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHE 86
++ +++G+G F V K + DG+ + +++ S D E+ +L L H
Sbjct: 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHP 68
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK---AIKN----------- 132
NII + + + + E G+L + +K + ++ AI N
Sbjct: 69 NIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 133 --WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
+A + RG+ YL IHRDL NI V G N KI D GL+ + +++
Sbjct: 127 LHFAADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADFGLSRGQEVYVKKTMG 183
Query: 191 GTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNEC-KNPAQIYKKVTSGI- 245
P +MA E L Y D++S+G+ + E+V+ PY C A++Y+K+ G
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLPQGYR 241
Query: 246 --KPASLSKVTDPQVKQFIEKC 265
KP + D +V + +C
Sbjct: 242 LEKPLN----CDDEVYDLMRQC 259
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 193
Q+ RG+ +L S N +HRDL N+ + VKI D GLA + + G+
Sbjct: 245 QVARGMEFLASKN--CVHRDLAARNVLL-AQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 194 --EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPAS 249
++MAPE +++ Y L D++S+G+ + E+ + PY + Y K+ SG + A
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAK 361
Query: 250 LSKVTDPQVKQFIEKCIVPASLRLPALELLKD 281
T +V + KC + P+ L D
Sbjct: 362 PDHATQ-EVYDIMVKCWNSEPEKRPSFLHLSD 392
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 39/173 (22%), Positives = 62/173 (35%), Gaps = 22/173 (12%)
Query: 133 WA--RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
WA Q L L LH L + + +G V + +S
Sbjct: 20 WAVCLQCLGALRELHRQAKS--GNILLTWDGLLK-LDGSV----------AFKTPEQS-R 65
Query: 191 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 249
P FMAPE+ + Y E DIYS G+ + E + E PYNE + + I + + +G +
Sbjct: 66 PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG--MPA 123
Query: 250 LSKVTDPQVKQFIEKCIVPASLRLPALELLK---DPFLVTDNPKDLVCDPLRL 299
++ +RL A L + + + L + L L
Sbjct: 124 DDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAETLEL 176
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 24/101 (23%)
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
Q+ RG+ +L S IHRDL NI ++ NN VKI D GL AR + P++
Sbjct: 182 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 230
Query: 196 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVT 223
MAPE ++++ Y D++SFG+ + E+ +
Sbjct: 231 VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 40/144 (27%), Positives = 67/144 (46%), Gaps = 26/144 (18%)
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
Q+ +G+ +L S IHRDL NI ++ NN VKI D GL AR + P++
Sbjct: 187 QVAKGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 235
Query: 196 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKV 241
MAPE +++ Y D++SFG+ + E+ + PY K + +++
Sbjct: 236 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 295
Query: 242 TSGIKPASLSKVTDPQVKQFIEKC 265
G + + T P++ Q + C
Sbjct: 296 KEGTRMRA-PDYTTPEMYQTMLDC 318
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 30/220 (13%)
Query: 28 RYDEILGKGAFKTVYKG--FDEVDGIEVAWNQV-NIEDVMQSPDQLERLYSEVHLLKSLK 84
R+ E LG+ F VYKG F G + + ++D + P + E E + L+
Sbjct: 8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLR-EEFKHEAMMRSRLQ 66
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNV----DMKAIKNW---- 133
H NI+ + + ++MI + L ++ R H +V D K +K+
Sbjct: 67 HPNIVCLLGVVTKE--QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124
Query: 134 -----ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
QI G+ +L SH+ ++H+DL N+ V + VKI DLGL +
Sbjct: 125 DFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF-DKLNVKISDLGLFREVYAADYYK 181
Query: 189 VIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
++G +M+PE + +++ DI+S+G+ + E+ +
Sbjct: 182 LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 25/56 (44%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 126 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181
D+ IK RQ+L GL LH I+HRD+K +N+ V +G+VKI D G A+ M
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVT-VDGQVKIIDFGAAVDM 359
|
Length = 507 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 7e-05
Identities = 54/238 (22%), Positives = 102/238 (42%), Gaps = 35/238 (14%)
Query: 31 EILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
+ILG+G F +V +G D+ ++VA + ++ S ++E SE +K H N
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS--EIEEFLSEAACMKDFDHPN 62
Query: 88 IIKFYNSWVDDTNRTIN------MITELFTSGSLRQY------RKKHKNVDMKAIKNWAR 135
++K V ++ +I G L + + + ++ + +
Sbjct: 63 VMKLIG--VCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-------QQPTARS 188
I G+ YL + N IHRDL N + + V + D GL+ + Q A+
Sbjct: 121 DIALGMEYLSNRN--FIHRDLAARNCMLR-EDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244
+ +++A E L + Y D+++FG+ + E+ T + PY +N +IY + G
Sbjct: 178 PV---KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-HEIYDYLRHG 231
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 85/388 (21%), Positives = 146/388 (37%), Gaps = 81/388 (20%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG GAF V A + +DV+ +Q+ + +E +L +E ++K Y
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNR-NQVAHVKAERDILAEADNEWVVKLY 67
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
S+ D N + + + G + + + + + ++ + +H I
Sbjct: 68 YSFQDKDN--LYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FI 123
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-------------------QPT-------- 185
HRD+K DNI ++ +G +K+ D GL + +P+
Sbjct: 124 HRDIKPDNILID-LDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 186 ----------------------ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 222
A S++GTP ++APE L + Y +L D +S G+ + EM+
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 223 TCEYPYNECKNPAQIYKKVT---SGIKPASLSKVTDPQVKQFIEKCIVPASLRL---PAL 276
+ P+ P + KV + + K++ P+ I K A RL A
Sbjct: 243 VGQPPF-LAPTPTETQLKVINWENTLHIPPQVKLS-PEAVDLITKLCCSAEERLGRNGAD 300
Query: 277 ELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADS----CA 332
++ PF + D D P P V ++ HPMD N V +S +
Sbjct: 301 DIKAHPFF---SEVDFSSDIRTQP--APYVPKIS----HPMDTS-NFDPVEEESPWNDAS 350
Query: 333 KSNTGTW-FLTLELQRLTENN--EFTLR 357
+T TW L + E+ EFT R
Sbjct: 351 GDSTRTWDTLCSPNGKHPEHAFYEFTFR 378
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 9e-05
Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 31 EILGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERLYSE-----VHLLKSL 83
E LG+G F ++KG + D E+ +V +++ D+ R YSE ++ L
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEV----LLKVLDKSHRNYSESFFEAASMMSQL 56
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK-NWARQILRGLH 142
H++++ Y V M+ E GSL Y KK+KN+ + K A+Q+ LH
Sbjct: 57 SHKHLVLNYGVCVCGDESI--MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALH 114
Query: 143 YLHSHNPPIIHRDLKCDNIFV-------NGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
+L + H ++ N+ + GN +K+ D G++I + P + P +
Sbjct: 115 FLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV-LPKEILLERIP-W 170
Query: 196 MAPELYEEEYNELV--DIYSFGMCILEM 221
+ PE E N + D +SFG + E+
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 61/256 (23%), Positives = 109/256 (42%), Gaps = 30/256 (11%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NII 89
+++G+G F V K + DG+ + +++ D + E+ +L L H NII
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNII 59
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM---------KAIKNWARQILR- 139
+ + + + E G+L + +K + ++ A ++Q+L
Sbjct: 60 NLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 140 ------GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
G+ YL IHRDL NI V G N KI D GL+ + +++ P
Sbjct: 118 AADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADFGLSRGQEVYVKKTMGRLP 174
Query: 194 -EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNEC-KNPAQIYKKVTSGIKPAS 249
+MA E L Y D++S+G+ + E+V+ PY C A++Y+K+ G +
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLPQGYR-LE 231
Query: 250 LSKVTDPQVKQFIEKC 265
D +V + +C
Sbjct: 232 KPLNCDDEVYDLMRQC 247
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 52/261 (19%), Positives = 105/261 (40%), Gaps = 57/261 (21%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+++GKGAF V + + D ++ + ++ M DQL + +E +L ++
Sbjct: 7 KVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVS 65
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
Y S+ D + + +I E G L K+ + + + + + +H
Sbjct: 66 LYYSFQD--AQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG-- 121
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI-------------VMQQPTAR---------- 187
IHRD+K DNI ++ G +K+ D GL+ ++Q + +
Sbjct: 122 FIHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180
Query: 188 --------------------------SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILE 220
S +GTP+++APE++ ++ Y + D +S G + E
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
Query: 221 MVTCEYPYNECKNPAQIYKKV 241
+ +P +N + Y+K+
Sbjct: 241 CL-IGWPPFCSENSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 37/123 (30%), Positives = 52/123 (42%), Gaps = 32/123 (26%)
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----- 182
K I+ RQIL L LHS I+HRD+K NI + +G KI DLG A ++
Sbjct: 255 KIIQTIMRQILFALDGLHSTG--IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY 312
Query: 183 QPTARSVIGTPEFMAPE-----------------------LYEEEYNELVDIYSFGMCIL 219
P + + P + APE L++ + DIYS G+ L
Sbjct: 313 IP--KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 370
Query: 220 EMV 222
+M
Sbjct: 371 QMA 373
|
Length = 566 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 54/239 (22%), Positives = 105/239 (43%), Gaps = 34/239 (14%)
Query: 43 KGFDEV----------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+GF+++ G V ++N+E + + + L E+H+ K H NI+ +
Sbjct: 8 RGFEDLMTVNLARYKPTGEYVTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYR 65
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK--AIKNWARQILRGLHYLHSHNPP 150
+++ D + ++T GS + H M AI + +L+ L Y+H
Sbjct: 66 ATFIADNE--LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG-- 121
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDL--GLAIVMQQPTARSVIGTPEF-------MAPELY 201
+HR +K +I ++ +G+V + L L+++ R V P++ ++PE+
Sbjct: 122 YVHRSVKASHILISV-DGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVL 180
Query: 202 EEE---YNELVDIYSFGMCILEMVTCEYPYNECKNPA-QIYKKVTSGIKPASLSKVTDP 256
++ Y+ DIYS G+ E+ P+ + PA Q+ + +G P L T P
Sbjct: 181 QQNLQGYDAKSDIYSVGITACELANGHVPFKDM--PATQMLLEKLNGTVPCLLDTTTIP 237
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 51/246 (20%), Positives = 93/246 (37%), Gaps = 56/246 (22%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG GAF V A + +DV+ +Q+ + +E +L +E +++ Y
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLR-NQVAHVKAERDILAEADNEWVVRLY 67
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
S+ D N + + + G + + + + ++ + +H I
Sbjct: 68 YSFQDKDN--LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FI 123
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGL----------------------------------- 177
HRD+K DNI ++ +G +K+ D GL
Sbjct: 124 HRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 178 --------------AIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 222
A Q+ A S++GTP ++APE L Y +L D +S G+ + EM+
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 223 TCEYPY 228
+ P+
Sbjct: 243 VGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 21/40 (52%), Positives = 27/40 (67%), Gaps = 3/40 (7%)
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
L YLH H IIHRDLK DN+ ++ N G +K+ D GL+ V
Sbjct: 117 LDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 57/233 (24%), Positives = 101/233 (43%), Gaps = 30/233 (12%)
Query: 33 LGKGAFKTVYKG-FDEVDGI-EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
LG+G F +V +G ++ D I +VA + I +S ++E SE +K H N+++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRS--EMEDFLSEAVCMKEFDHPNVMR 64
Query: 91 FYNSWVDDTNR----TINMITELFTSGSLRQYRKKHKNVDM------KAIKNWARQILRG 140
+ + +I G L + + D + + + I G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-------QQPTARSVIGTP 193
+ YL S + IHRDL N +N N V + D GL+ + Q A+ +
Sbjct: 125 MEYLSSKS--FIHRDLAARNCMLN-ENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV--- 178
Query: 194 EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244
+++A E L + Y D++SFG+ + E+ T + PY +N ++IY + G
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-SEIYDYLRQG 230
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 37/168 (22%), Positives = 72/168 (42%), Gaps = 22/168 (13%)
Query: 83 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQIL 138
L+H NI++ V+ ++ E G L+ Y + +N + ++ A +I
Sbjct: 52 LQHPNILQCLGQCVEAI--PYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIA 109
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPE 194
G+ ++H HN +H DL N F+ + VK+GD G+ + T
Sbjct: 110 AGVTHMHKHN--FLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIETEDDKCVPLR 166
Query: 195 FMAPELYEEEYNELV--------DIYSFGMCILEMVTC-EYPYNECKN 233
++APEL E + L+ ++++ G+ + E+ PY+ +
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD 214
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 631 | |||
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.73 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.48 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.39 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.34 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.2 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.19 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.19 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.19 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.98 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.95 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.93 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.9 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.67 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.65 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.56 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.55 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.42 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.41 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.41 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.3 | |
| PF12202 | 38 | OSR1_C: Oxidative-stress-responsive kinase 1 C ter | 98.25 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.16 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.07 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.01 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.94 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.84 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.79 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.78 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.54 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.53 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.5 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.49 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.24 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.21 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.21 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.15 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.14 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.05 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.9 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.84 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.77 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.45 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.17 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.07 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.95 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 95.85 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.84 | |
| PLN02236 | 344 | choline kinase | 95.59 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.56 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.52 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.52 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.51 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.95 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.95 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.45 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.83 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.58 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.38 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 92.67 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 90.56 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 90.5 | |
| PTZ00384 | 383 | choline kinase; Provisional | 89.78 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 89.23 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 87.2 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 85.39 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-91 Score=752.86 Aligned_cols=424 Identities=61% Similarity=0.990 Sum_probs=368.1
Q ss_pred ccCCcCCcccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc
Q 006779 9 KSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88 (631)
Q Consensus 9 ~~~~~~~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnI 88 (631)
..++++..+++++|+|||.|+.++||+|+|.+||+|+|..+|.+|||..+++.+..+++...++|+.|+++|+.|+||||
T Consensus 24 ~~e~~~~~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NI 103 (632)
T KOG0584|consen 24 ESEPDESEFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNI 103 (632)
T ss_pred hhccccccccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCce
Confidence 34567899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCC
Q 006779 89 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 168 (631)
Q Consensus 89 Vkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g 168 (631)
|+||++|++..++++++|||+|++|+|+.|++++++++.+.++.|++||++||.|||++.||||||||||+||||+|+.|
T Consensus 104 irfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G 183 (632)
T KOG0584|consen 104 IRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLG 183 (632)
T ss_pred eeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cEEEccccccchhcCCCCccccCCCCCCCccccccccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC
Q 006779 169 EVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 248 (631)
Q Consensus 169 ~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~ 248 (631)
.|||||+|+|+..+.....+++|||.|||||++...|++.+||||||||++||+|+++||.+|.++++||++|++|++|.
T Consensus 184 ~VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~ 263 (632)
T KOG0584|consen 184 EVKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPA 263 (632)
T ss_pred ceeecchhHHHHhhccccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhcCCCCCCCCHHHHhcCCCCCCCCCcc-------cccCCC--CCCCCchhhhccCCCCCCCCCc
Q 006779 249 SLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKD-------LVCDPL--RLPNLVPEVMNLAHSEPHPMDI 319 (631)
Q Consensus 249 ~l~~~~~~~l~~lI~~cL~~p~~Rpsa~elL~hpff~~~~~~~-------~~~~~~--~~p~~~~~~~~~~~~~~~~~~~ 319 (631)
.+.++.+|++++||++||...+.|+|+.|||.||||..+.... .....+ .+....+.....+......++.
T Consensus 264 sl~kV~dPevr~fIekCl~~~~~R~sa~eLL~d~Ff~~d~g~~~~~~e~d~~~~~~~~~~~~~~~~~~~~~~~n~i~~~~ 343 (632)
T KOG0584|consen 264 ALSKVKDPEVREFIEKCLATKSERLSAKELLKDPFFDEDGGIVELAPEDDMSDPALSLSLRDEDGKKNKRPKANAIQFDY 343 (632)
T ss_pred HhhccCCHHHHHHHHHHhcCchhccCHHHHhhChhhccccccccccchhhcccccccccccccchhhcCCccccccccee
Confidence 9999999999999999999999999999999999999875421 000000 0111111111101111111222
Q ss_pred ccccccccccccc---ccCCCCcchhhHhhhhcccceeEeecccCCCC-ceEEEEEecCCCCCceeeeeecccCCCCHHH
Q 006779 320 DLNHKKVSADSCA---KSNTGTWFLTLELQRLTENNEFTLRGEKNDDD-TVSLTLRIGDKSGHVSNIHFVFYLNADTAIS 395 (631)
Q Consensus 320 d~~~~~~~~~~~~---~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~-~i~l~Lri~d~~~~~~~i~f~f~~~~Dta~~ 395 (631)
+... +.+...+- ....-....+.+..|...++.+.++++++++. .++|.|||+|.+|+.|||+|+|++..|||.+
T Consensus 344 ~~~~-D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~~~~~~~~l~l~i~~~~g~~r~i~fpf~~~~dta~~ 422 (632)
T KOG0584|consen 344 NLNT-DESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRNDRQTEISLELRIADEDGLVRNIHFPFDLEGDTAPS 422 (632)
T ss_pred ecCC-CchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhhcccccceeEeeccCCCCCcccccCCCcCCCcchhH
Confidence 2111 01111000 01111222345667788889999999999877 9999999999999999999999999999999
Q ss_pred HHHHHHHccCCCCcCHHHHHHHHHHHHHHhCCCCCCCC
Q 006779 396 IAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSL 433 (631)
Q Consensus 396 va~EmV~~~~i~~~d~~~ia~~i~~~i~~~~~~~~~~~ 433 (631)
||.|||+++.++++++..||+||+..|.+|+|.|+...
T Consensus 423 Va~eMv~el~~~dq~v~~ia~mid~~i~~L~p~~~~~~ 460 (632)
T KOG0584|consen 423 VAHEMVEELEITDQPVVNIAEMIDGEISALVPNWKAST 460 (632)
T ss_pred HHHHHHhhcCCcccchhhHHHHHhchhhhcCCccCCCC
Confidence 99999999999999999999999999999999998864
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-52 Score=426.89 Aligned_cols=252 Identities=29% Similarity=0.499 Sum_probs=230.2
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEec
Q 006779 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 30 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey 109 (631)
...||+|+.|+||++.|+.|++.+|+|.|... ..+....++.+|+++++.++|||||++|+.|+.... .+.|+|||
T Consensus 84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~---~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~mEY 159 (364)
T KOG0581|consen 84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLN---IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISICMEY 159 (364)
T ss_pred hhhcccCCCcEEEEEEEcCCCeEEEEEeeccc---CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEeehhh
Confidence 46799999999999999999999999999543 246677889999999999999999999999988765 79999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCCcc
Q 006779 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~ 188 (631)
|++|||++++++.+++++..+..++.+|++||.|||. ++ ||||||||+|||++ ..|.|||||||.+..+-+..+.+
T Consensus 160 MDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvN-skGeVKicDFGVS~~lvnS~a~t 236 (364)
T KOG0581|consen 160 MDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVN-SKGEVKICDFGVSGILVNSIANT 236 (364)
T ss_pred cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeec-cCCCEEeccccccHHhhhhhccc
Confidence 9999999999999999999999999999999999996 77 99999999999998 79999999999999888888899
Q ss_pred ccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCC----CCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006779 189 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNE----CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263 (631)
Q Consensus 189 ~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~----~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~ 263 (631)
++||..|||||.+.+ .|+.++||||||+.++||++|++||.. ..+..+++..|..+..|......+++++++||.
T Consensus 237 fvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~ 316 (364)
T KOG0581|consen 237 FVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVS 316 (364)
T ss_pred ccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHH
Confidence 999999999998876 599999999999999999999999976 346788888898887665555569999999999
Q ss_pred HhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 264 KCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 264 ~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
.||+ +|.+|+++.|||.|||++...
T Consensus 317 ~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 317 CCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 9998 899999999999999998644
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-51 Score=426.61 Aligned_cols=261 Identities=26% Similarity=0.380 Sum_probs=227.0
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCH---HHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP---DQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~---~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
...||-+.+.||+|+||.|-+|..+.||+.||||+++........ .....+.+|+++|++|+|||||+++++|..+.
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 455668899999999999999999999999999999876543322 12344679999999999999999999986654
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCC---CcEEEcccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLG 176 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~---g~vKL~DFG 176 (631)
..||||||++||+|.+++-.++.+.+..-+.+++|++.||.|||++| |+||||||+|||++ .+ ..+||.|||
T Consensus 250 --s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~-~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 --SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLS-NDAEDCLLKITDFG 324 (475)
T ss_pred --ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEec-cCCcceEEEecccc
Confidence 67999999999999999999999999999999999999999999999 99999999999997 44 689999999
Q ss_pred ccchhcC-CCCccccCCCCCCCccccccc----cCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC--C
Q 006779 177 LAIVMQQ-PTARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--S 249 (631)
Q Consensus 177 la~~~~~-~~~~~~~GTp~Y~APEvl~~~----ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~--~ 249 (631)
+|+.... ....+.||||.|.|||++..+ |..++||||+||++|-+++|.+||++...+..+.+.|.+|..+. .
T Consensus 325 lAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~ 404 (475)
T KOG0615|consen 325 LAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL 404 (475)
T ss_pred hhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence 9988754 356789999999999988643 45699999999999999999999998777666888898886532 3
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 250 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 250 l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
.+...+.++++||..||+ +|.+|||+.|+|+||||+...
T Consensus 405 ~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 405 QWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 445567899999999997 999999999999999998643
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-50 Score=435.30 Aligned_cols=258 Identities=33% Similarity=0.549 Sum_probs=231.1
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
+||..+.|..++.||+|||+.||.+.+..+|+.||+|.|..... ..+...+++.+||++.++|+|||||++|++|.|.+
T Consensus 13 ~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l-~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~ 91 (592)
T KOG0575|consen 13 EDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLL-KKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN 91 (592)
T ss_pred ecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHh-cCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC
Confidence 34444666889999999999999999999999999999986554 45677899999999999999999999999997664
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
++|||.|+|..++|..++++.+.++|..++.+++||+.||.|||+++ |||||||..|+|++ .+.+|||||||+|+
T Consensus 92 --nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~-~~~~VKIgDFGLAt 166 (592)
T KOG0575|consen 92 --NVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLN-ENMNVKIGDFGLAT 166 (592)
T ss_pred --ceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeec-CcCcEEecccceee
Confidence 69999999999999999999999999999999999999999999999 99999999999998 78899999999998
Q ss_pred hhcCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006779 180 VMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 180 ~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~ 256 (631)
.+..+ ...+.||||.|+|||++.. +++.-+||||+||+||-||+|++||.. .+..+.+.+|..... .++...++
T Consensus 167 ~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik~~~Y--~~P~~ls~ 243 (592)
T KOG0575|consen 167 QLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIKLNEY--SMPSHLSA 243 (592)
T ss_pred eecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHHhcCc--ccccccCH
Confidence 87754 3567899999999998764 599999999999999999999999976 677888988887533 24457789
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 257 QVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
++++||.++|. +|.+|||++++|.|+||..
T Consensus 244 ~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 244 EAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 99999999998 8999999999999999943
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-50 Score=420.85 Aligned_cols=265 Identities=27% Similarity=0.440 Sum_probs=227.5
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
-.+...-|.+.+.||.|..++||+|++..+++.||||+++++++. ...+.+.+|++.|+.++||||+++|.+|+.+.
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~---~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN---NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh---hhHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 344455568899999999999999999999999999999998763 34788999999999999999999999998764
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
.+|+||.||.+||+.++++.. ..+++..|..+++++++||.|||.+| .||||||+.||||+ .+|.|||+|||.
T Consensus 98 --~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~-~dG~VkLadFgv 172 (516)
T KOG0582|consen 98 --ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILID-SDGTVKLADFGV 172 (516)
T ss_pred --eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEc-CCCcEEEcCcee
Confidence 699999999999999999864 45999999999999999999999999 99999999999997 899999999999
Q ss_pred cchhcCC-----CC-ccccCCCCCCCcccccc---ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--
Q 006779 178 AIVMQQP-----TA-RSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-- 246 (631)
Q Consensus 178 a~~~~~~-----~~-~~~~GTp~Y~APEvl~~---~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~-- 246 (631)
+..+... .. .+.+|||+|||||++.. +|+.|+|||||||++.||++|..||........+..++...++
T Consensus 173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~ 252 (516)
T KOG0582|consen 173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTL 252 (516)
T ss_pred eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCc
Confidence 8554322 12 56789999999998643 5999999999999999999999999997666666666655432
Q ss_pred -----CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCccc
Q 006779 247 -----PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 247 -----p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~~~~ 292 (631)
+..-.+..+..++.||..||+ ||.+||||++||+|+||+....++.
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~ 304 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEY 304 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhh
Confidence 111223456789999999998 8999999999999999998776654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=400.09 Aligned_cols=266 Identities=25% Similarity=0.437 Sum_probs=235.9
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEE
Q 006779 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV 106 (631)
..+.++||+|+||.||+++.+.||+.+|+|.++...... ....+....|..+|..++||.||+++..|.+.. .+|+|
T Consensus 27 F~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~-~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~--kLylV 103 (357)
T KOG0598|consen 27 FEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVE-KKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE--KLYLV 103 (357)
T ss_pred eeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhh-hhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC--eEEEE
Confidence 367799999999999999999999999999998776544 356788999999999999999999999997654 69999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc--CC
Q 006779 107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QP 184 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~~ 184 (631)
+||+.||.|...+++.+.+++..++.|+.+|+.||.|||++| ||||||||+|||++ .+|+++|+|||+++..- ..
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd-~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLD-EQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeec-CCCcEEEeccccchhcccCCC
Confidence 999999999999999999999999999999999999999999 99999999999998 89999999999997543 23
Q ss_pred CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006779 185 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263 (631)
Q Consensus 185 ~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~ 263 (631)
...++|||+.|||||++. .+|+.++|+||||+++|||++|..||.. .+...++++|..+.. ...+...+.++++||+
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-~~~~~~~~~I~~~k~-~~~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-EDVKKMYDKILKGKL-PLPPGYLSEEARDLLK 258 (357)
T ss_pred ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-ccHHHHHHHHhcCcC-CCCCccCCHHHHHHHH
Confidence 566789999999999765 5699999999999999999999999987 677888888888752 2345567899999999
Q ss_pred HhcC-CCCCCC----CHHHHhcCCCCCCCCCcccccCCCCCC
Q 006779 264 KCIV-PASLRL----PALELLKDPFLVTDNPKDLVCDPLRLP 300 (631)
Q Consensus 264 ~cL~-~p~~Rp----sa~elL~hpff~~~~~~~~~~~~~~~p 300 (631)
++|. +|.+|. .+.++-.||||...+|+.+....+..|
T Consensus 259 ~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~Pp 300 (357)
T KOG0598|consen 259 KLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPP 300 (357)
T ss_pred HHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCC
Confidence 9998 899996 688999999999999998766555443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=396.02 Aligned_cols=259 Identities=27% Similarity=0.517 Sum_probs=225.4
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
--+.| -+.+.||+|+||+||+|+++.+|..||||.|..... .+...+.+..|+.+|+.++|||||.++++..+. +
T Consensus 8 ~~~~y-~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~--~ 82 (429)
T KOG0595|consen 8 VVGDY-ELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPNIVRLLDCIEDD--D 82 (429)
T ss_pred ccccc-eehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC--C
Confidence 34566 556679999999999999999999999999987654 567788899999999999999999999987654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC--C---CcEEEcccc
Q 006779 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--N---GEVKIGDLG 176 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~--~---g~vKL~DFG 176 (631)
++|+|||||.||+|.+|+.+++.+++..++.++.||+.||++||+++ ||||||||+|||++.. + -.+||+|||
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 89999999999999999999999999999999999999999999999 9999999999999742 1 358999999
Q ss_pred ccchhcCC-CCccccCCCCCCCcccc-ccccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCC
Q 006779 177 LAIVMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKV 253 (631)
Q Consensus 177 la~~~~~~-~~~~~~GTp~Y~APEvl-~~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~-p~~l~~~ 253 (631)
+|+.+... ...+.+|+|.|||||++ ..+|+.|+|+||+|+++|+|++|+.||.. .++.++...+.++.. .+.++..
T Consensus 161 fAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a-~t~~eL~~~~~k~~~~~~~~~~~ 239 (429)
T KOG0595|consen 161 FARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA-ETPKELLLYIKKGNEIVPVLPAE 239 (429)
T ss_pred hhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc-cCHHHHHHHHhccccccCchhhh
Confidence 99988754 46778999999999988 56799999999999999999999999987 567777777777643 3344555
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 254 ~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
.++..++++...|. ++..|.+..+-+.|+|+....
T Consensus 240 ~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 240 LSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred ccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 66677788888887 899999999999999997654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=389.39 Aligned_cols=245 Identities=31% Similarity=0.493 Sum_probs=219.1
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEE
Q 006779 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV 106 (631)
+++.+.||+|.||+||++.+..+|..||+|.++.... +....+.+..|+.+|++|+|||||++|+.-+.+++..+++|
T Consensus 21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m--d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM--DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc--cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4778999999999999999999999999999986543 45677889999999999999999999994445566679999
Q ss_pred EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCC--EEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 107 TELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPP--IIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~----~~~l~~~~i~~i~~QIl~aL~yLHs~~~~--IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
||||.+|+|.+.++. ++.++++.+++++.|++.||..||+.-+. |+||||||.|||++ .+|.+||+|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~-~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT-ANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc-CCCceeeccchhHhH
Confidence 999999999998874 45799999999999999999999995555 99999999999998 899999999999998
Q ss_pred hcCC--CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006779 181 MQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 181 ~~~~--~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~ 257 (631)
+... .+.+.+|||.||+||++. .+|+.++||||+||++|||+..+.||.+ .+-.++-++|.++..|+-....++..
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g-~n~~~L~~KI~qgd~~~~p~~~YS~~ 256 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG-DNLLSLCKKIEQGDYPPLPDEHYSTD 256 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc-ccHHHHHHHHHcCCCCCCcHHHhhhH
Confidence 8765 467899999999999775 5699999999999999999999999988 58899999999997666555778999
Q ss_pred HHHHHHHhcC-CCCCCCCH
Q 006779 258 VKQFIEKCIV-PASLRLPA 275 (631)
Q Consensus 258 l~~lI~~cL~-~p~~Rpsa 275 (631)
++.+|..|++ +|..||+.
T Consensus 257 l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 257 LRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHHHccCCcccCCCc
Confidence 9999999997 89999986
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=381.30 Aligned_cols=267 Identities=27% Similarity=0.466 Sum_probs=239.3
Q ss_pred eeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEe
Q 006779 29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE 108 (631)
Q Consensus 29 ~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~E 108 (631)
+...||.|+||+|.+++++.+|..+|+|.+++.++.+ ..+.+...+|..+|+.+.||+++++++.|.|. ..+|||||
T Consensus 48 ~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVk-lKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~--~~lymvme 124 (355)
T KOG0616|consen 48 RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVK-LKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN--SNLYMVME 124 (355)
T ss_pred heeeeccCccceEEEEEEccCCceeehhhcCHHHHHH-HHHHHHHhhHHHHHhhccCceeEEEEEeeccC--CeEEEEEe
Confidence 3478999999999999999999999999998776543 56778899999999999999999999998765 47999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCCcc
Q 006779 109 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188 (631)
Q Consensus 109 y~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~ 188 (631)
|..||.|..++++.+++++..++.++.||+.||+|||+++ |++|||||+|||++ .+|.+||.|||+|+..... +.+
T Consensus 125 yv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD-~~G~iKitDFGFAK~v~~r-T~T 200 (355)
T KOG0616|consen 125 YVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLD-QNGHIKITDFGFAKRVSGR-TWT 200 (355)
T ss_pred ccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeec-cCCcEEEEeccceEEecCc-EEE
Confidence 9999999999999999999999999999999999999999 99999999999998 8999999999999877665 677
Q ss_pred ccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC
Q 006779 189 VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 267 (631)
Q Consensus 189 ~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~ 267 (631)
.||||.|+|||++. .+|+.++|.|+|||++|||+.|..||.. .++.++|.+|..+.. .++...++.+++||.++|+
T Consensus 201 lCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~-~~~~~iY~KI~~~~v--~fP~~fs~~~kdLl~~LL~ 277 (355)
T KOG0616|consen 201 LCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD-DNPIQIYEKILEGKV--KFPSYFSSDAKDLLKKLLQ 277 (355)
T ss_pred ecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC-CChHHHHHHHHhCcc--cCCcccCHHHHHHHHHHHh
Confidence 89999999999775 5699999999999999999999999987 678999999998743 3566778999999999997
Q ss_pred -CCCCC-----CCHHHHhcCCCCCCCCCcccccCCCCCCCCchh
Q 006779 268 -PASLR-----LPALELLKDPFLVTDNPKDLVCDPLRLPNLVPE 305 (631)
Q Consensus 268 -~p~~R-----psa~elL~hpff~~~~~~~~~~~~~~~p~~~~~ 305 (631)
|-++| ....++..||||....|..+....+..|..+|.
T Consensus 278 vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~ 321 (355)
T KOG0616|consen 278 VDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPN 321 (355)
T ss_pred hhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCCcc
Confidence 87777 357899999999999999887777777765533
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=402.58 Aligned_cols=260 Identities=27% Similarity=0.540 Sum_probs=225.4
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCH-HHHHHHHHHHHHHHhCC-CCCceeeeeeEEc
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP-DQLERLYSEVHLLKSLK-HENIIKFYNSWVD 97 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~-~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d 97 (631)
....|+| ++++.||+|+||+|++|.+..+|+.||+|++......... ...+.+.+|+.+++.++ ||||+++++++..
T Consensus 13 ~~~~g~y-~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 13 QLSIGKY-ELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred ccccCce-eeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 4556777 8899999999999999999999999999977665322122 34566779999999999 9999999999866
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
.. .+|+|||||.||+|.+++.+.+++.+..++.+++||+.|++|||++| |+||||||+|||++++.+.+||+|||+
T Consensus 92 ~~--~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 92 PT--KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred CC--eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 54 49999999999999999999999999999999999999999999999 999999999999984339999999999
Q ss_pred cchh--cCCCCccccCCCCCCCcccccc-c-cC-ccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006779 178 AIVM--QQPTARSVIGTPEFMAPELYEE-E-YN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 178 a~~~--~~~~~~~~~GTp~Y~APEvl~~-~-ys-~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~ 252 (631)
+... ......+.+|||.|+|||++.+ . |+ .++||||+|++||.|++|.+||.+ .+...++.++..+... ++.
T Consensus 168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~~~~~--~p~ 244 (370)
T KOG0583|consen 168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRKGEFK--IPS 244 (370)
T ss_pred ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhcCCcc--CCC
Confidence 9887 3446788999999999999876 4 64 899999999999999999999988 6666777777776432 334
Q ss_pred CC-cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 253 VT-DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 253 ~~-~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.. +++++.||.+||+ +|.+|+++.+++.||||+..
T Consensus 245 ~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 245 YLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred CcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 44 8999999999998 89999999999999999974
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-47 Score=393.96 Aligned_cols=255 Identities=33% Similarity=0.555 Sum_probs=217.2
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
..++.||+|+||+||++.+..+|+..|+|.+.... ... .+.+.+|+.+|++|+|||||++++.........+++.|
T Consensus 20 ~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 20 SKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred hhhccccCccceEEEEEEecCCCcceeeeeeeccc---chh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 56799999999999999999999999999998663 222 67799999999999999999999963322224788999
Q ss_pred eccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC---
Q 006779 108 ELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--- 183 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~-~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~--- 183 (631)
||+.+|+|.+++++.+ .+++..++.+.+||+.||.|||++| ||||||||+|||++..+|.+||+|||++.....
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 9999999999999987 7999999999999999999999999 999999999999983378999999999976652
Q ss_pred --CCCccccCCCCCCCccccccccC--ccccchhhhHHHHHHhhcCCCCCC-CCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006779 184 --PTARSVIGTPEFMAPELYEEEYN--ELVDIYSFGMCILEMVTCEYPYNE-CKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 184 --~~~~~~~GTp~Y~APEvl~~~ys--~~sDIwSLGiilyELltG~~Pf~~-~~~~~~i~~~i~~~~~p~~l~~~~~~~l 258 (631)
.......|||.|||||++...+. .++|||||||++.||+||..||.+ ......++........| .++...++++
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P-~ip~~ls~~a 252 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP-EIPDSLSDEA 252 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC-CCCcccCHHH
Confidence 22446789999999998875433 499999999999999999999987 33344455555555334 6777789999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 259 KQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 259 ~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
++||.+|++ +|.+||||.+||.|||++....
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 999999998 8999999999999999987543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=408.70 Aligned_cols=261 Identities=32% Similarity=0.582 Sum_probs=229.4
Q ss_pred cccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEc
Q 006779 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d 97 (631)
...||..+|..+ +.||+|+.|.||.|....++..||||++.+... ...+-+..|+.+|+.++|+|||.|++.|..
T Consensus 267 ~~~dP~~~y~~~-~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q----~~keLilnEi~Vm~~~~H~NiVnfl~Sylv 341 (550)
T KOG0578|consen 267 SQGDPRSKYTDF-KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ----PKKELLLNEILVMRDLHHPNIVNFLDSYLV 341 (550)
T ss_pred cCCChhhhhcch-hhhccccccceeeeeeccCCceEEEEEEEeccC----CchhhhHHHHHHHHhccchHHHHHHHHhcc
Confidence 448999999554 779999999999999999999999999987653 334668999999999999999999998876
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
. ..+|+||||++||+|.+.+.... +++.+|+.++++++.||+|||.++ |||||||.+|||+. .+|.+||+|||+
T Consensus 342 ~--deLWVVMEym~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~-~~g~vKltDFGF 415 (550)
T KOG0578|consen 342 G--DELWVVMEYMEGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLT-MDGSVKLTDFGF 415 (550)
T ss_pred c--ceeEEEEeecCCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEec-cCCcEEEeeeee
Confidence 6 46999999999999999988766 999999999999999999999999 99999999999997 899999999999
Q ss_pred cchhcC--CCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006779 178 AIVMQQ--PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 178 a~~~~~--~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 254 (631)
+..+.. ....+.+|||.|||||+... .|++++||||||++++||+-|+.||-.......+|..-..|......+...
T Consensus 416 caqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~kl 495 (550)
T KOG0578|consen 416 CAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKL 495 (550)
T ss_pred eeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCcccc
Confidence 976644 35678899999999998865 699999999999999999999999987444455666666666666667778
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
++.+++|+.+||+ |+.+|++|.|||.||||+...+
T Consensus 496 S~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p 531 (550)
T KOG0578|consen 496 SPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKP 531 (550)
T ss_pred CHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCC
Confidence 9999999999998 9999999999999999965443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=400.62 Aligned_cols=259 Identities=27% Similarity=0.471 Sum_probs=228.0
Q ss_pred eeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCeEE
Q 006779 26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 26 y~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~l~ 104 (631)
-+.++++||.|+|++|++|.++.++.++|||++..+-..+ .....-+.+|-..|.+| .||.|+++|..|.|+. .+|
T Consensus 74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iik-e~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~--sLY 150 (604)
T KOG0592|consen 74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIK-EKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE--SLY 150 (604)
T ss_pred hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHh-hcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc--ceE
Confidence 3578999999999999999999999999999987554332 34455678899999999 8999999999998765 599
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
+|+||+++|+|.+++++.+.|++...+.++.||+.||+|||++| ||||||||+|||++ .+|++||.|||.|..+...
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd-~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLD-KDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEc-CCCcEEEeeccccccCChh
Confidence 99999999999999999999999999999999999999999999 99999999999998 8999999999999765321
Q ss_pred -------------C--CccccCCCCCCCccccccc-cCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC
Q 006779 185 -------------T--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 248 (631)
Q Consensus 185 -------------~--~~~~~GTp~Y~APEvl~~~-ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~ 248 (631)
. ..+++||..|.+||++..+ .+..+|||+||||+|.|+.|.+||.+ .|+-.++++|..- .-
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra-~NeyliFqkI~~l--~y 304 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA-ANEYLIFQKIQAL--DY 304 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc-ccHHHHHHHHHHh--cc
Confidence 1 1458999999999998765 68899999999999999999999987 6777777777653 23
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCcccc
Q 006779 249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 249 ~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~~~~~ 293 (631)
.++...++.+++||+++|+ +|..|+|+.+|-.||||...+|..+.
T Consensus 305 ~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw 350 (604)
T KOG0592|consen 305 EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLW 350 (604)
T ss_pred cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhh
Confidence 4556677999999999998 99999999999999999999998854
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=403.49 Aligned_cols=259 Identities=24% Similarity=0.465 Sum_probs=231.7
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
.+-.|=| ++++.||.|+.|.|.+|++..||+.+|||+|.... ..+......+.+|+-+|+.+.||||+++|++|.+
T Consensus 8 ~~tiGpw-kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~-~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~-- 83 (786)
T KOG0588|consen 8 KNTIGPW-KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS-ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN-- 83 (786)
T ss_pred cccccce-eccccccCCCCceehhhhcccccceeEEEeecccc-ccccccccchhhhhHHHHHhcCCCeeeeeeeecc--
Confidence 4556667 99999999999999999999999999999998663 2344556778999999999999999999999965
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
+..+|+|.||+.||.|.+|+-+.+++++..+.++++||+.|+.|||..+ |+||||||+|+|++ ..+.|||+|||.|.
T Consensus 84 ~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd-~~~nIKIADFGMAs 160 (786)
T KOG0588|consen 84 KQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLD-VKNNIKIADFGMAS 160 (786)
T ss_pred CceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhh-cccCEeeeccceee
Confidence 4579999999999999999999999999999999999999999999999 99999999999998 56679999999996
Q ss_pred hh-cCCCCccccCCCCCCCccccccc-c-CccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006779 180 VM-QQPTARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 180 ~~-~~~~~~~~~GTp~Y~APEvl~~~-y-s~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~ 256 (631)
+- ......+.||+|+|.|||++.+. | +.++||||+|||||.||||+.||++ .|...++.+|.+|... ++...++
T Consensus 161 Le~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f~--MPs~Is~ 237 (786)
T KOG0588|consen 161 LEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVFE--MPSNISS 237 (786)
T ss_pred cccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCccc--CCCcCCH
Confidence 54 44457788999999999988764 6 5899999999999999999999986 7999999999998653 4567889
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 257 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
++++||.+||. ||++|.|..|+++|||+....
T Consensus 238 eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 238 EAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 99999999997 999999999999999998754
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=390.66 Aligned_cols=260 Identities=23% Similarity=0.404 Sum_probs=227.1
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
.+..+||+||||.||+|+-+.||..+|+|+++.... ....+++.+..|-.+|...++|+||++|.+|.+. .++|+||
T Consensus 144 e~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M-~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~--~~LYLiM 220 (550)
T KOG0605|consen 144 ELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEM-LKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK--EYLYLIM 220 (550)
T ss_pred hhheeeccccceeEEEEEEccCCcEEeeecccHHHH-HhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC--CeeEEEE
Confidence 445789999999999999999999999999987764 3467788999999999999999999999999776 4799999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC----
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ---- 183 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~---- 183 (631)
||++||++..++.+.+.|++..++.++.+++.|++-||++| +|||||||+|+||+ ..|++||.|||++.-+..
T Consensus 221 EylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD-~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLID-AKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeec-CCCCEeeccccccchhhhhhhh
Confidence 99999999999999999999999999999999999999999 99999999999998 899999999999842100
Q ss_pred ------------------C--C-------------------------CccccCCCCCCCcccccc-ccCccccchhhhHH
Q 006779 184 ------------------P--T-------------------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMC 217 (631)
Q Consensus 184 ------------------~--~-------------------------~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGii 217 (631)
. . +.+.+|||.|||||++.+ +|+..+|+||||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 0 0 114679999999998765 59999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCcHHHHHHHHHhcCCCCCCCC---HHHHhcCCCCCCCCCccc
Q 006779 218 ILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 218 lyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~--~~~~~~l~~lI~~cL~~p~~Rps---a~elL~hpff~~~~~~~~ 292 (631)
+||||.|.+||.. .++.+.+.+|........++ ...++++++||.+||.+|.+|.. +.||-.||||+..+|..+
T Consensus 378 myEmLvGyPPF~s-~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v~W~~l 456 (550)
T KOG0605|consen 378 MYEMLVGYPPFCS-ETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGVDWDHL 456 (550)
T ss_pred HHHHHhCCCCCCC-CCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccCCcchh
Confidence 9999999999987 78888888888764322222 23468999999999999999985 889999999999999887
Q ss_pred cc
Q 006779 293 VC 294 (631)
Q Consensus 293 ~~ 294 (631)
..
T Consensus 457 ~~ 458 (550)
T KOG0605|consen 457 RE 458 (550)
T ss_pred hc
Confidence 54
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-46 Score=372.08 Aligned_cols=255 Identities=26% Similarity=0.469 Sum_probs=212.5
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.+|.++ .++|+|+||+||+++++.||+.||||++.-. ..++.......+|+++|++|+|||+|.+.++|- ....+
T Consensus 2 ekYE~L-gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es--edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr--rkrkl 76 (396)
T KOG0593|consen 2 EKYEKL-GKVGEGSYGVVMKCRNKDTGQIVAIKKFVES--EDDPVVKKIALREIRMLKQLKHENLVNLIEVFR--RKRKL 76 (396)
T ss_pred cHHhhh-hccccCcceEEEEeccCCcccEEEEEeeccC--CccHHHHHHHHHHHHHHHhcccchHHHHHHHHH--hccee
Confidence 356554 4599999999999999999999999998643 234566677899999999999999999999884 44579
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
++|+|||+..-|..+-.....++.+.++.+++|++.|+.|||+++ +|||||||+|||++ .+|.+||||||+|+.+..
T Consensus 77 hLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit-~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILIT-QNGVVKLCDFGFARTLSA 153 (396)
T ss_pred EEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEe-cCCcEEeccchhhHhhcC
Confidence 999999987555544444457999999999999999999999999 99999999999998 899999999999988774
Q ss_pred CC--CccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc----------------
Q 006779 184 PT--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---------------- 243 (631)
Q Consensus 184 ~~--~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~---------------- 243 (631)
+. -+.++.|.+|+|||++-+ +|+..+|||++||++.||++|+..|.+..+.+|++.....
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 43 345788999999997754 6999999999999999999999999998888888866542
Q ss_pred ---CCC---C---CCCCC---CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 244 ---GIK---P---ASLSK---VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 244 ---~~~---p---~~l~~---~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
|.. | ..+.. ..+.-+.+|+++||. ||.+|++.+++|.||||..
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 111 1 11111 124578999999998 9999999999999999943
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=393.08 Aligned_cols=261 Identities=31% Similarity=0.556 Sum_probs=230.0
Q ss_pred ccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEE
Q 006779 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (631)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 96 (631)
....+|...|.++ +.||+|+||.||+|.+..+++.||+|++.+.. ..+.++.+.+|+.+|.+++++||.++|+.|+
T Consensus 6 ~~~~~~~~~~~~~-~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~---~~deIediqqei~~Ls~~~~~~it~yygsyl 81 (467)
T KOG0201|consen 6 VLKIDPELLYTKL-ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE---AEDEIEDIQQEISVLSQCDSPNITEYYGSYL 81 (467)
T ss_pred hhcCCcccccccc-hhccccccceeeeeeeccccceEEEEEechhh---cchhhHHHHHHHHHHHhcCcchHHhhhhhee
Confidence 4456778888554 99999999999999999999999999998775 4667888999999999999999999999998
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccc
Q 006779 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 176 (631)
... .++++||||.||++.+.++....+++..+..++++++.||.|||+++ .+|||||+.|||+. ..|.+|++|||
T Consensus 82 ~g~--~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s-~~g~vkl~Dfg 156 (467)
T KOG0201|consen 82 KGT--KLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLS-ESGDVKLADFG 156 (467)
T ss_pred ecc--cHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEe-ccCcEEEEecc
Confidence 765 58899999999999999999888899999999999999999999999 99999999999998 67999999999
Q ss_pred ccchhcCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006779 177 LAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 177 la~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~ 253 (631)
++..+... ...+++|||.|||||++.+ +|+.++||||||+++|||++|+.||.++..+..++ .|. ...|+.+...
T Consensus 157 Va~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-lIp-k~~PP~L~~~ 234 (467)
T KOG0201|consen 157 VAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-LIP-KSAPPRLDGD 234 (467)
T ss_pred eeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-ecc-CCCCCccccc
Confidence 99776654 3468899999999998876 69999999999999999999999999865432222 222 2346667778
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 254 ~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
+++.+++||+.||. +|..||+|.+||+|+|++...
T Consensus 235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 89999999999998 899999999999999998844
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=383.08 Aligned_cols=250 Identities=27% Similarity=0.373 Sum_probs=212.4
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEecc
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~ 110 (631)
++||+|+||.||+|++..||+.||+|+|.+... .+.......+||.+|++|+||||+++.+..++.....+|||+|||
T Consensus 123 ~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~--~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYM 200 (560)
T KOG0600|consen 123 EKIGEGTYGQVYKARDLETGKIVALKKVRFDNE--KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYM 200 (560)
T ss_pred HHhcCcchhheeEeeecccCcEEEEEEeecccC--CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecc
Confidence 789999999999999999999999999987653 244556688999999999999999999998877667899999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC---C
Q 006779 111 TSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---A 186 (631)
Q Consensus 111 ~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~---~ 186 (631)
+. +|.-++.. .-.|++.+|+.+++||+.||+|||++| |+|||||+.||||| ++|.+||+|||+|+.+.... .
T Consensus 201 dh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLid-n~G~LKiaDFGLAr~y~~~~~~~~ 276 (560)
T KOG0600|consen 201 DH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILID-NNGVLKIADFGLARFYTPSGSAPY 276 (560)
T ss_pred cc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEc-CCCCEEeccccceeeccCCCCccc
Confidence 75 78777766 457999999999999999999999999 99999999999998 89999999999999775443 4
Q ss_pred ccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCCC-C-----CC-------
Q 006779 187 RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKP-A-----SL------- 250 (631)
Q Consensus 187 ~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~-~~~p-~-----~l------- 250 (631)
+..+.|.+|+|||++.+ .|+.++|+||.||||.||++|+..|.+....+|+-++..- |.+. . .+
T Consensus 277 T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~k 356 (560)
T KOG0600|consen 277 TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFK 356 (560)
T ss_pred ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccC
Confidence 45677999999998765 4999999999999999999999999987666666554432 1000 0 00
Q ss_pred ------------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 251 ------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 251 ------------~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
.+..++...+|+..+|. +|.+|.||.++|.++||..
T Consensus 357 p~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 357 PQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred CCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 12346788999999998 9999999999999999944
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=385.79 Aligned_cols=260 Identities=28% Similarity=0.377 Sum_probs=218.2
Q ss_pred CCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCceeeeeeEEcCC
Q 006779 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDT 99 (631)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~ 99 (631)
.-..|| .+.+.||.|+||.||+|..+.+|+.||||+++.+- .+-++ -.-.||++.|++|+ |||||++++++.+..
T Consensus 7 ~~m~RY-~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf--~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 7 IFMDRY-TVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF--YSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred hHHHHH-HHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh--ccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence 345688 56688999999999999999999999999987542 22222 23468999999998 999999999998776
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
+ .+|+|||||+ .+|.++++.. +.|++..++.|++||+.||+|+|.+| +.||||||+|||+. .+..|||+|||+|
T Consensus 83 ~-~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~-~~~~iKiaDFGLA 157 (538)
T KOG0661|consen 83 R-ILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILIS-GNDVIKIADFGLA 157 (538)
T ss_pred c-eEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEec-ccceeEecccccc
Confidence 5 8999999996 5899998754 57999999999999999999999999 99999999999997 4679999999999
Q ss_pred chhcCC-CCccccCCCCCCCccccc--cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC-----------
Q 006779 179 IVMQQP-TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG----------- 244 (631)
Q Consensus 179 ~~~~~~-~~~~~~GTp~Y~APEvl~--~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~----------- 244 (631)
+..... .-+.++.|.+|+|||++. +.|+.++|+|++|||++|+.+.+..|.+....+|+++...--
T Consensus 158 Rev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 158 REVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred cccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 877654 456688999999999764 359999999999999999999999999988888888764310
Q ss_pred -------------CCCC---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 245 -------------IKPA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 245 -------------~~p~---~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
..+. .+....++++.++|.+||. ||.+||||.++|+||||+....
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 0011 1122367899999999999 9999999999999999987543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=369.91 Aligned_cols=256 Identities=28% Similarity=0.436 Sum_probs=220.2
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
+| ++.+.||+|+||.||+|.++.+|+.||+|.+...... .....+.+.+|+.+|+.++||||+++++++.+. ..++
T Consensus 2 ~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 77 (291)
T cd05612 2 DL-ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ--RFLY 77 (291)
T ss_pred Cc-eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC--CeEE
Confidence 45 6779999999999999999999999999999754321 234456788999999999999999999987654 5799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
+||||+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~-~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLD-KEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEEecCcchhccCC
Confidence 99999999999999999889999999999999999999999999 99999999999997 7899999999999765432
Q ss_pred CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006779 185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263 (631)
Q Consensus 185 ~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~ 263 (631)
.....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...++..+..+.. .++...++.+++||+
T Consensus 155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~ 230 (291)
T cd05612 155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKL--EFPRHLDLYAKDLIK 230 (291)
T ss_pred -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCc--CCCccCCHHHHHHHH
Confidence 334579999999998764 488999999999999999999999987 566677777766532 344556889999999
Q ss_pred HhcC-CCCCCCC-----HHHHhcCCCCCCCCCcc
Q 006779 264 KCIV-PASLRLP-----ALELLKDPFLVTDNPKD 291 (631)
Q Consensus 264 ~cL~-~p~~Rps-----a~elL~hpff~~~~~~~ 291 (631)
+||+ +|.+|++ +.+++.||||...++..
T Consensus 231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~ 264 (291)
T cd05612 231 KLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDD 264 (291)
T ss_pred HHcCCCHHHccCCccCCHHHHhcCccccCCCHHH
Confidence 9998 8999995 99999999998766554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=374.80 Aligned_cols=256 Identities=24% Similarity=0.428 Sum_probs=222.0
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||+|+||.||+|.++.+|+.||+|.+...... .....+.+.+|+.+|+.++||||++++++|.+. ..+++||
T Consensus 21 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~ 97 (329)
T PTZ00263 21 EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE--NRVYFLL 97 (329)
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC--CEEEEEE
Confidence 7789999999999999999999999999999754321 234457789999999999999999999988765 4799999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCCc
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~ 187 (631)
||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...... ..
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~-~~ 173 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPDR-TF 173 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEC-CCCCEEEeeccCceEcCCC-cc
Confidence 99999999999999889999999999999999999999999 99999999999998 7899999999999765433 23
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 006779 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 188 ~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL 266 (631)
...||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .++..++..+..+.. .++...+..+++||.+||
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~L 250 (329)
T PTZ00263 174 TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAGRL--KFPNWFDGRARDLVKGLL 250 (329)
T ss_pred eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCc--CCCCCCCHHHHHHHHHHh
Confidence 4679999999998765 488999999999999999999999976 566777777776543 345567889999999999
Q ss_pred C-CCCCCCC-----HHHHhcCCCCCCCCCcccc
Q 006779 267 V-PASLRLP-----ALELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 267 ~-~p~~Rps-----a~elL~hpff~~~~~~~~~ 293 (631)
. +|.+|++ +.+++.||||...++..+.
T Consensus 251 ~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~ 283 (329)
T PTZ00263 251 QTDHTKRLGTLKGGVADVKNHPYFHGANWDKLY 283 (329)
T ss_pred hcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHH
Confidence 8 8999997 7999999999987766543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=373.22 Aligned_cols=256 Identities=23% Similarity=0.437 Sum_probs=218.5
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEecc
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~ 110 (631)
++||+|+||.||+|.++.+|+.||+|++..... ........+.+|+.+|+.++||||+++++++... ..+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI-IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH--DRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC--CEEEEEEeCC
Confidence 469999999999999999999999999875432 2344556788999999999999999999988654 4799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC--CCCcc
Q 006779 111 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARS 188 (631)
Q Consensus 111 ~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~--~~~~~ 188 (631)
.+|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++..... .....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEeeCCCCcccccCCCcccc
Confidence 99999999999889999999999999999999999999 99999999999998 788999999999864322 23345
Q ss_pred ccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC
Q 006779 189 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 267 (631)
Q Consensus 189 ~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~ 267 (631)
.+||+.|+|||++.+ .|+.++|||||||++|||++|..||.. .+...+...+..+. ..++...++.+++||.+||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEE--IRFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHcc
Confidence 679999999998764 589999999999999999999999976 45556666665442 23455678999999999998
Q ss_pred -CCCCCC-----CHHHHhcCCCCCCCCCcccccC
Q 006779 268 -PASLRL-----PALELLKDPFLVTDNPKDLVCD 295 (631)
Q Consensus 268 -~p~~Rp-----sa~elL~hpff~~~~~~~~~~~ 295 (631)
+|.+|| ++.++++||||...++..+...
T Consensus 232 ~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~ 265 (323)
T cd05571 232 KDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQK 265 (323)
T ss_pred CCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhC
Confidence 899999 8999999999998877665433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=377.10 Aligned_cols=243 Identities=36% Similarity=0.597 Sum_probs=207.8
Q ss_pred eeEecccCceEEEEEEEccCCeE-EEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEe
Q 006779 30 DEILGKGAFKTVYKGFDEVDGIE-VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE 108 (631)
Q Consensus 30 ~e~LG~G~fg~Vy~a~d~~tg~~-VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~E 108 (631)
.+.||+|+||+||+|... |.. ||+|++..... .....+.|.+|+.+|.+|+|||||+|++++..... .+.+|||
T Consensus 46 ~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~--~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~iVtE 120 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDF--DDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLCIVTE 120 (362)
T ss_pred hhhcccCCceeEEEEEeC--CceeEEEEEecchhc--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEEEEE
Confidence 466999999999999765 555 99999976543 22337789999999999999999999999866542 6889999
Q ss_pred ccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCC-cEEEccccccchhcCC-
Q 006779 109 LFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIVMQQP- 184 (631)
Q Consensus 109 y~~gGsL~~~l~~--~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g-~vKL~DFGla~~~~~~- 184 (631)
|+.+|+|.+++.+ .+.++...+..|+.||+.|++|||++++ ||||||||+|||++ .++ ++||+|||+++.....
T Consensus 121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~-~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVD-LKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEc-CCCCEEEECCCccceeecccc
Confidence 9999999999987 5789999999999999999999999986 99999999999998 676 9999999999776553
Q ss_pred -CCccccCCCCCCCccccccc---cCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006779 185 -TARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 185 -~~~~~~GTp~Y~APEvl~~~---ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~ 260 (631)
......||+.|||||++.+. |+.++|||||||++|||+||+.||.+... .++...+..+...+.++...++.+..
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp~~p~~~~~~l~~ 277 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRPPIPKECPPHLSS 277 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCCCCCccCCHHHHH
Confidence 33447899999999999854 99999999999999999999999998665 66655555444444566668899999
Q ss_pred HHHHhcC-CCCCCCCHHHHhc
Q 006779 261 FIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 261 lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+|++||. +|..||+..+++.
T Consensus 278 l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 278 LMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHhCCCCCCcCCCHHHHHH
Confidence 9999998 8999999998765
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=352.12 Aligned_cols=254 Identities=27% Similarity=0.424 Sum_probs=211.6
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.||.+ .++||+|+||.||+|.|.+||+.||||+|+..+... .......+||++|+.++|+||+.+.++|-.. ..+
T Consensus 2 ~rY~~-~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd--Gi~~talREIK~Lqel~h~nIi~LiD~F~~~--~~l 76 (318)
T KOG0659|consen 2 DRYEK-LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD--GINRTALREIKLLQELKHPNIIELIDVFPHK--SNL 76 (318)
T ss_pred chhhh-hhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc--CccHHHHHHHHHHHHccCcchhhhhhhccCC--Cce
Confidence 47754 478999999999999999999999999999875432 2235688999999999999999999999655 458
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 104 NMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
.+|+||++ .+|...++. ...++...++.|+.|+++||+|||++. |+||||||.|+|++ .+|.+||+|||+|+.+.
T Consensus 77 ~lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis-~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 77 SLVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLIS-SDGQLKIADFGLARFFG 152 (318)
T ss_pred EEEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEc-CCCcEEeecccchhccC
Confidence 88999996 489888875 457999999999999999999999999 99999999999997 89999999999999877
Q ss_pred CCCC--ccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC--CCCCC-------
Q 006779 183 QPTA--RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPAS------- 249 (631)
Q Consensus 183 ~~~~--~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~--~~p~~------- 249 (631)
.+.. ...+-|.+|+|||++-+ .|+..+|+||.|||+.||+.|..-|.+..+.+|+...+..- ..+..
T Consensus 153 ~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 153 SPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred CCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 5532 23377999999997754 59999999999999999999988888877777765554421 11111
Q ss_pred ----------------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 250 ----------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 250 ----------------l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
+....+..+.+|+.++|. +|.+|+++.|+|+|+||..
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 112235677999999998 9999999999999999986
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=385.21 Aligned_cols=250 Identities=29% Similarity=0.506 Sum_probs=220.9
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
+| -+-+.||+|.||+||+|+.+.|.+.||+|.+.... ....++..+.+|+++++.|+|||||.++++|.. ...+|
T Consensus 3 ~y-hv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g--r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt--~~~~~ 77 (808)
T KOG0597|consen 3 QY-HVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG--RNEKELKNLRQEVRILRSLKHPNIVEMLESFET--SAHLW 77 (808)
T ss_pred ch-hHHHHhcCCccceeeecccccceeEEEEEEehhcC--CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc--cceEE
Confidence 45 44588999999999999999999999999987543 466788889999999999999999999998854 45799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
+|+|||.| +|+.++...+.++++.++.++.|++.||.|||+++ |+|||+||+|||+. .+|.+|+||||+|+.+...
T Consensus 78 vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~-~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 78 VVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLE-KGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred EEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeec-CCCceeechhhhhhhcccC
Confidence 99999976 99999999999999999999999999999999999 99999999999997 7999999999999877654
Q ss_pred --CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006779 185 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 185 --~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~l 261 (631)
...+.-|||.|||||++++ .|+..+|.||+||++|||.+|++||.. ....++.+.|... |..++...+..++.|
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~~d--~v~~p~~~S~~f~nf 230 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSILKD--PVKPPSTASSSFVNF 230 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHhcC--CCCCcccccHHHHHH
Confidence 3456789999999998875 499999999999999999999999976 4556667777654 333455778899999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 262 IEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 262 I~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
++.+|. ||.+|.+..+||.|||.+.
T Consensus 231 l~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 231 LQGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred HHHHhhcChhhcccHHHHhcChHHhh
Confidence 999997 8999999999999999975
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=374.94 Aligned_cols=261 Identities=23% Similarity=0.382 Sum_probs=217.3
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||+|+||+||+|.++.+|..||+|++..... ........+.+|+.+++.++||||+++++.+.+. ..+|+||
T Consensus 4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~--~~~~lv~ 80 (363)
T cd05628 4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM-LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK--LNLYLIM 80 (363)
T ss_pred eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH-HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC--CeEEEEE
Confidence 667899999999999999999999999999975432 2234556788999999999999999999988654 4799999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC---
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--- 184 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--- 184 (631)
||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~-~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC-CCCCEEEeeccCcccccccccc
Confidence 99999999999999889999999999999999999999999 99999999999998 7899999999998643211
Q ss_pred ----------------------------------CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCC
Q 006779 185 ----------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYN 229 (631)
Q Consensus 185 ----------------------------------~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~ 229 (631)
.....+||+.|+|||++.+ .|+.++|||||||++|||++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 0124579999999998754 58999999999999999999999997
Q ss_pred CCCCHHHHHHHHHcCCCCCCCC--CCCcHHHHHHHHHhcCC---CCCCCCHHHHhcCCCCCCCCCcccccC
Q 006779 230 ECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIVP---ASLRLPALELLKDPFLVTDNPKDLVCD 295 (631)
Q Consensus 230 ~~~~~~~i~~~i~~~~~p~~l~--~~~~~~l~~lI~~cL~~---p~~Rpsa~elL~hpff~~~~~~~~~~~ 295 (631)
. .++...+..+........++ ...++++++||.+++.+ +..||++.|+++||||...++..+...
T Consensus 238 ~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~~ 307 (363)
T cd05628 238 S-ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEHIRER 307 (363)
T ss_pred C-CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHHHHHhC
Confidence 6 45667777776543222222 23578999999997764 345789999999999999887765433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=370.40 Aligned_cols=264 Identities=24% Similarity=0.429 Sum_probs=223.3
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCC-eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDG-IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg-~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
...| .+.+.||+|+||.||+|.+..++ ..||+|.+...... .....+.+.+|+.+++.++||||+++++++.+. .
T Consensus 29 ~~~y-~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~ 104 (340)
T PTZ00426 29 YEDF-NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-KQKQVDHVFSERKILNYINHPFCVNLYGSFKDE--S 104 (340)
T ss_pred hhhc-EEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC--C
Confidence 3445 67799999999999999987665 78999998754322 234556788999999999999999999998654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
.+++||||+.+|+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLD-KDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEecCCCCeec
Confidence 79999999999999999999889999999999999999999999999 99999999999997 7899999999999765
Q ss_pred cCCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006779 182 QQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 182 ~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~ 260 (631)
... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .++..+++.+..+.. .++...++.+++
T Consensus 182 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~ 257 (340)
T PTZ00426 182 DTR-TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA-NEPLLIYQKILEGII--YFPKFLDNNCKH 257 (340)
T ss_pred CCC-cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHH
Confidence 432 345679999999998765 488999999999999999999999986 566677777776543 245567889999
Q ss_pred HHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCcccccCCC
Q 006779 261 FIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPL 297 (631)
Q Consensus 261 lI~~cL~-~p~~Rp-----sa~elL~hpff~~~~~~~~~~~~~ 297 (631)
+|++||. +|.+|+ ++.++++||||...++..+....+
T Consensus 258 li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~ 300 (340)
T PTZ00426 258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNV 300 (340)
T ss_pred HHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCC
Confidence 9999998 899995 899999999999877665444333
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=368.57 Aligned_cols=258 Identities=21% Similarity=0.362 Sum_probs=217.9
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
+| ++.+.||+|+||.||+|.+..+|+.||+|++..... ........+.+|+.+|+.++||||+++++++.+. ..++
T Consensus 2 ~y-~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~--~~~~ 77 (333)
T cd05600 2 DF-QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL-FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD--EYLY 77 (333)
T ss_pred Cc-EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC--CEEE
Confidence 45 778999999999999999999999999999975432 2234556788999999999999999999988654 4799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLID-ASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEEEeCcCCccccc-
Confidence 99999999999999998889999999999999999999999999 99999999999997 789999999999975543
Q ss_pred CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC------CCCcHH
Q 006779 185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS------KVTDPQ 257 (631)
Q Consensus 185 ~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~------~~~~~~ 257 (631)
......||+.|+|||++.+ .++.++|||||||++|||++|..||.. .+..+.+..+.........+ ...+++
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~ 232 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFNLSDE 232 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC-CCHHHHHHHHHhccccccCCCCCccccccCHH
Confidence 3445679999999998754 589999999999999999999999976 45666665555432211111 234789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCcc
Q 006779 258 VKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 291 (631)
Q Consensus 258 l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~~~ 291 (631)
+++||.+||. +|.+||++.++++||||....+..
T Consensus 233 ~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~ 267 (333)
T cd05600 233 AWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNE 267 (333)
T ss_pred HHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHHH
Confidence 9999999998 688999999999999998765543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=371.90 Aligned_cols=257 Identities=23% Similarity=0.439 Sum_probs=216.1
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||+|+||+||+|.+..+|..||+|++...... .......+.+|+.+|+.++||||++++++|.+. ..+++||
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~lv~ 80 (364)
T cd05599 4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPWVVKLYYSFQDE--NYLYLIM 80 (364)
T ss_pred eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CeEEEEE
Confidence 6779999999999999999999999999999754322 234556788999999999999999999988754 4799999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC---
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--- 184 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--- 184 (631)
||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEeecccceeccccccc
Confidence 99999999999998888999999999999999999999999 99999999999997 7899999999998643211
Q ss_pred -------------------------------------CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCC
Q 006779 185 -------------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEY 226 (631)
Q Consensus 185 -------------------------------------~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~ 226 (631)
...+.+||+.|+|||++.. .|+.++|||||||++|+|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0113469999999998754 58999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCC--CCCcHHHHHHHHHhcCCCCCCCC---HHHHhcCCCCCCCCCcc
Q 006779 227 PYNECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPKD 291 (631)
Q Consensus 227 Pf~~~~~~~~i~~~i~~~~~p~~l~--~~~~~~l~~lI~~cL~~p~~Rps---a~elL~hpff~~~~~~~ 291 (631)
||.. .++.+.+..+........++ ...++.+++||.+||.+|.+|++ +.++|.||||...++..
T Consensus 238 Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~~~ 306 (364)
T cd05599 238 PFCS-DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDWEH 306 (364)
T ss_pred CCCC-CCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 9986 45555666665443322222 23578999999999999999998 99999999998876544
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=364.24 Aligned_cols=251 Identities=24% Similarity=0.409 Sum_probs=214.5
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEeccCC
Q 006779 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112 (631)
Q Consensus 33 LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~~g 112 (631)
||+|+||.||+|.+..+|+.||+|.+..... ........+.+|+.+|+.++||||+++++++.+. ..+++||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP--EKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC--CeEEEEEcCCCC
Confidence 7999999999999999999999999875432 2344567788999999999999999999988654 578999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC--CCCcccc
Q 006779 113 GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVI 190 (631)
Q Consensus 113 GsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~--~~~~~~~ 190 (631)
|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... ......+
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEEC-CCCcEEEEECcccccCccCCCcccccc
Confidence 999999998888999999999999999999999999 99999999999997 789999999999865322 2234567
Q ss_pred CCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-C
Q 006779 191 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-P 268 (631)
Q Consensus 191 GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~ 268 (631)
||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+..+++..+..+ +..++...++.+++||.+||. +
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~d 231 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQE--PLRFPDGFDRDAKDLLIGLLSRD 231 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC-CCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHcCCC
Confidence 9999999998765 589999999999999999999999976 4556666666554 334556678999999999998 8
Q ss_pred CCCCC---CHHHHhcCCCCCCCCCccc
Q 006779 269 ASLRL---PALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 269 p~~Rp---sa~elL~hpff~~~~~~~~ 292 (631)
|.+|| ++.++|.||||...++..+
T Consensus 232 p~~R~~~~~~~e~l~hp~~~~~~~~~~ 258 (312)
T cd05585 232 PTRRLGYNGAQEIKNHPFFSQLSWKKL 258 (312)
T ss_pred HHHcCCCCCHHHHHcCCCcCCCCHHHH
Confidence 99997 5899999999988655443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=369.51 Aligned_cols=259 Identities=23% Similarity=0.415 Sum_probs=218.7
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
+| ++.+.||+|+||+||+|.+..+|+.||+|++...... .......+.+|+.+|+.++||||++++++|.+. ..++
T Consensus 2 ~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~ 77 (350)
T cd05573 2 DF-EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-KRNQIAHVRAERDILADADSPWIVKLYYSFQDE--EHLY 77 (350)
T ss_pred Cc-eEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhcCCCCccchhhheecC--CeEE
Confidence 56 6789999999999999999999999999999755432 224556788999999999999999999988654 4799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILID-ADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEeecCCCCccCccc
Confidence 99999999999999998888999999999999999999999998 99999999999997 7899999999998755432
Q ss_pred C-------------------------------CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCC
Q 006779 185 T-------------------------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK 232 (631)
Q Consensus 185 ~-------------------------------~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~ 232 (631)
. .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~- 233 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD- 233 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC-
Confidence 2 234579999999998765 5899999999999999999999999874
Q ss_pred CHHHHHHHHHcCCCCCCCC--CCCcHHHHHHHHHhcCCCCCCCC-HHHHhcCCCCCCCCCcc
Q 006779 233 NPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFLVTDNPKD 291 (631)
Q Consensus 233 ~~~~i~~~i~~~~~p~~l~--~~~~~~l~~lI~~cL~~p~~Rps-a~elL~hpff~~~~~~~ 291 (631)
+....+..+........++ ...++.+++||.+||.+|.+|++ +.++|.||||....+..
T Consensus 234 ~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~~~~~ 295 (350)
T cd05573 234 TLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDWEN 295 (350)
T ss_pred CHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCCCHHH
Confidence 4555555565522222222 22589999999999999999999 99999999998765543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=362.98 Aligned_cols=256 Identities=30% Similarity=0.449 Sum_probs=214.5
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEc---CCC
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD---DTN 100 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d---~~~ 100 (631)
.+| ...+.||+|+||.|..|.++.+|+.||||++.. .....-...+..+|+++|+.++|+||+.+++++.. ..-
T Consensus 22 ~~y-~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~--~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 22 RYY-VLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN--PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred cee-cccccccCcceeeEEEEEEcCCCCEeehhhhhh--hhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 344 335889999999999999999999999999862 23456677899999999999999999999998865 223
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
.-+|+|+|+| +.+|.+.++.+..++...+..+++||+.||+|+|+.+ |+||||||.|+|++ .+..+||+|||+|+.
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n-~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLN-ADCDLKICDFGLARY 174 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeec-cCCCEEeccccceee
Confidence 4799999999 5699999999888999999999999999999999999 99999999999998 788999999999987
Q ss_pred hc----CCCCccccCCCCCCCccccc--cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHH-------------
Q 006779 181 MQ----QPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV------------- 241 (631)
Q Consensus 181 ~~----~~~~~~~~GTp~Y~APEvl~--~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i------------- 241 (631)
.. ....+.++-|.+|.|||++. ..|+.++||||+|||+.||++|+.-|.+.....|+...+
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 74 33446678899999999764 469999999999999999999999998755444432221
Q ss_pred -H---------c-CCCC-C---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 242 -T---------S-GIKP-A---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 242 -~---------~-~~~p-~---~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
. + ...| . .+....++.+.+|+++||+ ||.+|+|++|+|.||||..
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence 1 0 1111 1 1223568999999999999 9999999999999999975
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=384.78 Aligned_cols=265 Identities=24% Similarity=0.435 Sum_probs=231.7
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCceeeeeeEEcCCCCeEEE
Q 006779 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~l~l 105 (631)
.++..+||+|.||+|++|..+.+++.+|||.++...... .++++..+.|.+++.... ||.++.+|..|... .++|+
T Consensus 370 F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~-~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~--~~l~f 446 (694)
T KOG0694|consen 370 FRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQ-RDEVESLMCEKRIFELANRHPFLVNLFSCFQTK--EHLFF 446 (694)
T ss_pred eEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceec-cccHHHHHHHHHHHHHhccCCeEeecccccccC--CeEEE
Confidence 366789999999999999999999999999999877665 567888999999998885 99999999999654 57999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh--cC
Q 006779 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQ 183 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~--~~ 183 (631)
||||+.||++.. +.+.+.|++..++.++..|+.||.|||++| |||||||.+|||+| ..|.+||+|||+++.. ..
T Consensus 447 vmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD-~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 447 VMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLD-TEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEc-ccCcEEecccccccccCCCC
Confidence 999999999443 344577999999999999999999999999 99999999999998 8999999999999753 34
Q ss_pred CCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006779 184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262 (631)
Q Consensus 184 ~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI 262 (631)
..+.+++|||.|||||++.+ .|+.++|+|+|||+||||++|+.||.+ .+.++++..|... ...++...+.++..++
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-ddEee~FdsI~~d--~~~yP~~ls~ea~~il 599 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG-DDEEEVFDSIVND--EVRYPRFLSKEAIAIM 599 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcC--CCCCCCcccHHHHHHH
Confidence 45678999999999998865 599999999999999999999999987 6788888888764 3345667789999999
Q ss_pred HHhcC-CCCCCCC-----HHHHhcCCCCCCCCCcccccCCCCCCC
Q 006779 263 EKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLPN 301 (631)
Q Consensus 263 ~~cL~-~p~~Rps-----a~elL~hpff~~~~~~~~~~~~~~~p~ 301 (631)
+++|. +|.+|+. +.++..||||+..+|..+....+..|.
T Consensus 600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf 644 (694)
T KOG0694|consen 600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPF 644 (694)
T ss_pred HHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCC
Confidence 99998 8999997 478999999999999988766665543
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=372.29 Aligned_cols=259 Identities=23% Similarity=0.391 Sum_probs=214.1
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
+| ++.+.||+|+||.||+|.++.+|+.||+|.+...... .......+.+|+.+|+.++||||++++++|.+. ..+|
T Consensus 2 ~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~ 77 (377)
T cd05629 2 DF-HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA--QYLY 77 (377)
T ss_pred Cc-eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CeeE
Confidence 35 6779999999999999999999999999998754321 234567788999999999999999999998654 4799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
+||||+.+|+|.+++.+.+.+++..++.|+.|++.||+|||+++ |+||||||+|||++ .+|.+||+|||+++.+...
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~-~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEEeecccccccccc
Confidence 99999999999999998889999999999999999999999999 99999999999997 7899999999998532110
Q ss_pred -------------------------------------------------CCccccCCCCCCCcccccc-ccCccccchhh
Q 006779 185 -------------------------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSF 214 (631)
Q Consensus 185 -------------------------------------------------~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSL 214 (631)
.....+||+.|+|||++.+ .|+.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 0013579999999998754 58999999999
Q ss_pred hHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC--CCcHHHHHHHHHhcCCCCC---CCCHHHHhcCCCCCCCCC
Q 006779 215 GMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK--VTDPQVKQFIEKCIVPASL---RLPALELLKDPFLVTDNP 289 (631)
Q Consensus 215 GiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~--~~~~~l~~lI~~cL~~p~~---Rpsa~elL~hpff~~~~~ 289 (631)
||++|||+||..||.. .+....+..+........++. ..++++++||.+||.+|.+ |+++.++|.||||...++
T Consensus 235 Gvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 235 GAIMFECLIGWPPFCS-ENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred chhhhhhhcCCCCCCC-CCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 9999999999999976 455555666654332222222 3578999999999986555 569999999999987655
Q ss_pred cc
Q 006779 290 KD 291 (631)
Q Consensus 290 ~~ 291 (631)
..
T Consensus 314 ~~ 315 (377)
T cd05629 314 DT 315 (377)
T ss_pred HH
Confidence 43
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=376.90 Aligned_cols=256 Identities=30% Similarity=0.548 Sum_probs=226.8
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.+| -+.++||+|+||.+++++++.++..++||+|..... +....+...+|+.++++++|||||.+++.|+..+ ..+
T Consensus 4 ~~Y-e~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~--t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~-~~l 79 (426)
T KOG0589|consen 4 DNY-EVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKL--TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG-QLL 79 (426)
T ss_pred chh-hhhhhcCccccchhhhhhhccCCceEEEEEEecccc--CchhhHHHHHHHHHHHhccCCCeeeeccchhcCC-ceE
Confidence 455 456899999999999999999999999999998764 3445557899999999999999999999998654 359
Q ss_pred EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 104 NMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
+|||+||+||+|.+.+++. ..++++.+..|+.||+.|+.|||+++ |+|||||+.|||++ .++.|||+|||+|+.+
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Niflt-k~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLT-KDKKVKLGDFGLAKIL 156 (426)
T ss_pred EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhcc-ccCceeecchhhhhhc
Confidence 9999999999999998865 46999999999999999999999888 99999999999998 7778899999999988
Q ss_pred cCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006779 182 QQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 182 ~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l 258 (631)
... .+.+++|||.||.||++.+ +|+.++||||||||+|||++-+.+|.+ .+...+..+|..+. -..++..++.++
T Consensus 157 ~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-~~m~~Li~ki~~~~-~~Plp~~ys~el 234 (426)
T KOG0589|consen 157 NPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-SNMSELILKINRGL-YSPLPSMYSSEL 234 (426)
T ss_pred CCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-cchHHHHHHHhhcc-CCCCCccccHHH
Confidence 776 5778999999999999976 599999999999999999999999987 66777777777665 334677788999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 259 KQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 259 ~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
+.+|+.||. +|..||++.+||.+|.++...
T Consensus 235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 235 RSLVKSMLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred HHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence 999999998 899999999999999887543
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=363.94 Aligned_cols=254 Identities=23% Similarity=0.444 Sum_probs=215.6
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEecc
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~ 110 (631)
++||+|+||.||+|.+..+|..||+|.+..... ........+.+|+.+++.++||||++++++|... ..+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CEEEEEEeCC
Confidence 469999999999999999999999999875432 2344566788999999999999999999988654 4799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC--CCCcc
Q 006779 111 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARS 188 (631)
Q Consensus 111 ~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~--~~~~~ 188 (631)
.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... .....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEc-CCCCEEecccHHhccccCCCCcccc
Confidence 99999999998888999999999999999999999998 99999999999998 789999999999864322 22345
Q ss_pred ccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC
Q 006779 189 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 267 (631)
Q Consensus 189 ~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~ 267 (631)
..||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...+...+.... ..++...++.+++||.+||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE--IRFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHcc
Confidence 679999999998754 589999999999999999999999976 44555555554432 23455678999999999998
Q ss_pred -CCCCCC-----CHHHHhcCCCCCCCCCcccc
Q 006779 268 -PASLRL-----PALELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 268 -~p~~Rp-----sa~elL~hpff~~~~~~~~~ 293 (631)
+|.+|+ ++.+++.||||....+....
T Consensus 232 ~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~ 263 (323)
T cd05595 232 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV 263 (323)
T ss_pred CCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 899998 89999999999987766543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=370.82 Aligned_cols=259 Identities=23% Similarity=0.356 Sum_probs=214.2
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
+| .+.++||+|+||+||+|.+..+++.||+|.+..... ........+.+|+.+|+.++||||+++++.|.+. ..++
T Consensus 2 ~f-~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~--~~~~ 77 (382)
T cd05625 2 MF-VKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK--DNLY 77 (382)
T ss_pred Cc-EEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC--CEEE
Confidence 55 567889999999999999999999999999875432 2234567789999999999999999999998764 4799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC-
Q 006779 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ- 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~- 183 (631)
+|||||.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..+..
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~-~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 78 FVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEeECCCCcccccc
Confidence 99999999999999988888999999999999999999999999 99999999999997 789999999999742210
Q ss_pred ------------------------------------------------CCCccccCCCCCCCccccc-cccCccccchhh
Q 006779 184 ------------------------------------------------PTARSVIGTPEFMAPELYE-EEYNELVDIYSF 214 (631)
Q Consensus 184 ------------------------------------------------~~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSL 214 (631)
....+.+||+.|+|||++. ..|+.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0012357999999999775 459999999999
Q ss_pred hHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCCcHHHHHHHHHhcCCCCCCCC---HHHHhcCCCCCCCCC
Q 006779 215 GMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNP 289 (631)
Q Consensus 215 GiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l--~~~~~~~l~~lI~~cL~~p~~Rps---a~elL~hpff~~~~~ 289 (631)
||++|||++|+.||... ++.+....+........+ ....+++++++|.+++.+|.+|++ +.+++.||||+...+
T Consensus 235 Gvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 235 GVILYEMLVGQPPFLAQ-TPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred hHHHHHHHhCCCCCCCC-CHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence 99999999999999874 444444444433222222 234578999999998889999987 999999999988655
Q ss_pred cc
Q 006779 290 KD 291 (631)
Q Consensus 290 ~~ 291 (631)
..
T Consensus 314 ~~ 315 (382)
T cd05625 314 SS 315 (382)
T ss_pred HH
Confidence 43
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=369.87 Aligned_cols=262 Identities=24% Similarity=0.419 Sum_probs=218.3
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||+|+||.||+|.++.+|..||+|++..... ........+.+|+.++..++||||+++++.|.+. ..+++||
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~~lv~ 80 (360)
T cd05627 4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM-LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK--RNLYLIM 80 (360)
T ss_pred eEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEEEE
Confidence 667899999999999999999999999999975432 2234567788999999999999999999988654 4799999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC---
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--- 184 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--- 184 (631)
||+.+|+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~-~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLD-AKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEeeccCCccccccccc
Confidence 99999999999998889999999999999999999999999 99999999999997 7899999999998643211
Q ss_pred ----------------------------------CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCC
Q 006779 185 ----------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYN 229 (631)
Q Consensus 185 ----------------------------------~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~ 229 (631)
.....+||+.|+|||++.+ .|+.++|||||||++|||+||+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 0124579999999998754 58999999999999999999999997
Q ss_pred CCCCHHHHHHHHHcCCCCCCCC--CCCcHHHHHHHHHhcCCCCCCC---CHHHHhcCCCCCCCCCcccccCC
Q 006779 230 ECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIVPASLRL---PALELLKDPFLVTDNPKDLVCDP 296 (631)
Q Consensus 230 ~~~~~~~i~~~i~~~~~p~~l~--~~~~~~l~~lI~~cL~~p~~Rp---sa~elL~hpff~~~~~~~~~~~~ 296 (631)
. .++...+..+........++ ...++.+++||.+++.+|.+|+ ++.+++.||||...++..+...+
T Consensus 238 ~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~~ 308 (360)
T cd05627 238 S-ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWGHIRERP 308 (360)
T ss_pred C-CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHHHHhcCC
Confidence 6 45666666665432222222 2357899999999888888888 48999999999998877654433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=364.09 Aligned_cols=254 Identities=24% Similarity=0.442 Sum_probs=216.0
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEecc
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~ 110 (631)
++||+|+||.||+|.+..+|..||+|++..... ........+.+|+.+|+.++||||+++++++.+. ..+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI-IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK--DRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CEEEEEEeCC
Confidence 469999999999999999999999999975432 2344567788999999999999999999988654 4799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC--CCCcc
Q 006779 111 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARS 188 (631)
Q Consensus 111 ~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~--~~~~~ 188 (631)
.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... .....
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEEC-CCCcEEEecCcCCccCCCccccccc
Confidence 99999999998888999999999999999999999999 99999999999998 789999999999865322 22345
Q ss_pred ccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC
Q 006779 189 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 267 (631)
Q Consensus 189 ~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~ 267 (631)
.+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...+...+.... ..++...++.+++||.+||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~ 231 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMED--IKFPRTLSADAKSLLSGLLI 231 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC-CCHHHHHHHhccCC--ccCCCCCCHHHHHHHHHHcC
Confidence 679999999998754 589999999999999999999999976 45555555554432 23455678999999999998
Q ss_pred -CCCCCC-----CHHHHhcCCCCCCCCCcccc
Q 006779 268 -PASLRL-----PALELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 268 -~p~~Rp-----sa~elL~hpff~~~~~~~~~ 293 (631)
+|.+|+ ++.++++||||...++..+.
T Consensus 232 ~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~ 263 (328)
T cd05593 232 KDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVY 263 (328)
T ss_pred CCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence 899997 89999999999887665543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=355.35 Aligned_cols=260 Identities=22% Similarity=0.359 Sum_probs=214.5
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
+..+.||+|+||.||+|.+..+|..||+|.+...... .......+.+|+.+|+.++|+||++++++|.+. ..+++||
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~--~~~~lv~ 79 (285)
T cd05631 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKRILEKVNSRFVVSLAYAYETK--DALCLVL 79 (285)
T ss_pred eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh-hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC--CeEEEEE
Confidence 6678999999999999999999999999998755432 223345678999999999999999999988654 4789999
Q ss_pred eccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC-
Q 006779 108 ELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 184 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~- 184 (631)
||+.+|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~-~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeCCCcEEcCCCC
Confidence 999999999887643 46899999999999999999999998 99999999999997 7889999999999765332
Q ss_pred CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCH---HHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006779 185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP---AQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 185 ~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~---~~i~~~i~~~~~p~~l~~~~~~~l~~ 260 (631)
......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||...... ..+...+... +..++...++.+.+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~ 234 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED--QEEYSEKFSEDAKS 234 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc--cccCCccCCHHHHH
Confidence 2345679999999998764 5899999999999999999999999764332 2233333222 23345557889999
Q ss_pred HHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCcccccC
Q 006779 261 FIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCD 295 (631)
Q Consensus 261 lI~~cL~-~p~~Rps-----a~elL~hpff~~~~~~~~~~~ 295 (631)
||.+||. +|.+||+ +.++++||||...+++.+...
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~ 275 (285)
T cd05631 235 ICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEAN 275 (285)
T ss_pred HHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhC
Confidence 9999998 8999997 899999999999887765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=360.94 Aligned_cols=258 Identities=26% Similarity=0.445 Sum_probs=214.5
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
..+| ++.+.||+|+||.||+|.+..+|..||+|.+.... .....+++.+|+++|++++||||+++++++.+. ..
T Consensus 4 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 77 (331)
T cd06649 4 DDDF-ERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GE 77 (331)
T ss_pred cccc-eEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CE
Confidence 4566 66788999999999999999999999999987542 345567799999999999999999999988765 46
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
+++||||+.+|+|.+++.+...+++..+..++.|++.||.|||+.+ +|+||||||+|||++ .++.+||+|||++....
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLI 155 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEc-CCCcEEEccCccccccc
Confidence 8999999999999999998888999999999999999999999853 399999999999998 78999999999997665
Q ss_pred CCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHH--------------------
Q 006779 183 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV-------------------- 241 (631)
Q Consensus 183 ~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i-------------------- 241 (631)
........||+.|+|||++.+ .++.++|||||||++|+|+||+.||... +..++...+
T Consensus 156 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 156 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP-DAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred ccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhcccccccccCCccccCcccc
Confidence 555556789999999998764 5899999999999999999999999653 222222221
Q ss_pred --------------------------HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 242 --------------------------TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 242 --------------------------~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
.....+.......++++++||.+||. +|.+|||+.++|+||||+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~ 309 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV 309 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence 11111111122457889999999998 8999999999999999986443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=369.16 Aligned_cols=257 Identities=23% Similarity=0.345 Sum_probs=212.7
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||+|+||.||+|.+..+|..||+|.+...... .......+.+|+.+|+.++||||+++++.|.+. ..+++||
T Consensus 4 ~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~lv~ 80 (376)
T cd05598 4 VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-MRNQAAHVKAERDILAEADNEWVVKLYYSFQDK--DNLYFVM 80 (376)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CEEEEEE
Confidence 7789999999999999999999999999998654321 123456688999999999999999999988654 4799999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC---
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--- 184 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--- 184 (631)
||+.+|+|.+++.+.+.+++..++.|+.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEEC-CCCCEEEEeCCCCccccccccc
Confidence 99999999999999888999999999999999999999999 99999999999997 7899999999997422100
Q ss_pred ------------------------------------------CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHH
Q 006779 185 ------------------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEM 221 (631)
Q Consensus 185 ------------------------------------------~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyEL 221 (631)
.....+||+.|+|||++.+ .++.++|||||||++|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0123579999999998764 589999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCCcHHHHHHHHHhcCCCCCCC---CHHHHhcCCCCCCCCCcc
Q 006779 222 VTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIVPASLRL---PALELLKDPFLVTDNPKD 291 (631)
Q Consensus 222 ltG~~Pf~~~~~~~~i~~~i~~~~~p~~--l~~~~~~~l~~lI~~cL~~p~~Rp---sa~elL~hpff~~~~~~~ 291 (631)
++|+.||... ++......+........ .....++.+++||.+|+.+|.+|+ ++.++++||||.......
T Consensus 238 l~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~~~~ 311 (376)
T cd05598 238 LVGQPPFLAD-TPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDFAS 311 (376)
T ss_pred hhCCCCCCCC-CHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCCHHH
Confidence 9999999874 44444444443322111 223467899999999888999999 999999999998765544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=362.44 Aligned_cols=258 Identities=26% Similarity=0.431 Sum_probs=213.6
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHH-HHHhCCCCCceeeeeeEEcCCCCeEEEEEec
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~-iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey 109 (631)
++||+|+||+||+|.++.+|+.||+|++....... ......+..|.. +++.++||||+++++.|.+. ..+++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~--~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA--DKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC--CEEEEEEcC
Confidence 46999999999999999999999999997543322 223344555544 56889999999999988654 478999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc--CCCCc
Q 006779 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~~~~~ 187 (631)
+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeccCCCcccccCCCccc
Confidence 999999999998889999999999999999999999999 99999999999997 78999999999986432 22334
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 006779 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 188 ~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL 266 (631)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+..+. ..+....++.+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l 231 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDTAEMYDNILNKP--LRLKPNISVSARHLLEGLL 231 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHh
Confidence 5679999999998764 589999999999999999999999976 56667777766543 2344456889999999999
Q ss_pred C-CCCCCCCH----HHHhcCCCCCCCCCcccccCCC
Q 006779 267 V-PASLRLPA----LELLKDPFLVTDNPKDLVCDPL 297 (631)
Q Consensus 267 ~-~p~~Rpsa----~elL~hpff~~~~~~~~~~~~~ 297 (631)
+ +|.+||++ .+++.||||....+..+....+
T Consensus 232 ~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~~~ 267 (323)
T cd05575 232 QKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKI 267 (323)
T ss_pred hcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhccC
Confidence 8 89999987 6999999999877665544333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=368.94 Aligned_cols=257 Identities=23% Similarity=0.360 Sum_probs=211.2
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
.+.+.||+|+||+||+|.+..+|..||+|++...... .......+.+|+.+|+.++||||+++++++.+. ..+++||
T Consensus 4 ~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~~~lv~ 80 (381)
T cd05626 4 VKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-NRNQVAHVKAERDILAEADNEWVVKLYYSFQDK--DNLYFVM 80 (381)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC--CEEEEEE
Confidence 5678899999999999999999999999999765432 234567799999999999999999999998754 4799999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC---
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--- 184 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--- 184 (631)
||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~-~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILID-LDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEEC-CCCCEEEeeCcCCccccccccc
Confidence 99999999999999889999999999999999999999998 99999999999997 7899999999987432100
Q ss_pred ----------------------------------------------CCccccCCCCCCCcccccc-ccCccccchhhhHH
Q 006779 185 ----------------------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMC 217 (631)
Q Consensus 185 ----------------------------------------------~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGii 217 (631)
...+.+||+.|+|||++.+ .|+.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 0124579999999998754 58999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCCcHHHHHHHHHhcC---CCCCCCCHHHHhcCCCCCCCCCcc
Q 006779 218 ILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTDPQVKQFIEKCIV---PASLRLPALELLKDPFLVTDNPKD 291 (631)
Q Consensus 218 lyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l--~~~~~~~l~~lI~~cL~---~p~~Rpsa~elL~hpff~~~~~~~ 291 (631)
+|||+||..||.... +......+........+ ....++++++||.+++. ++..|+++.+++.||||....+..
T Consensus 238 l~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~~ 315 (381)
T cd05626 238 LFEMLVGQPPFLAPT-PTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSS 315 (381)
T ss_pred HHHHHhCCCCCcCCC-HHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChhH
Confidence 999999999998743 44433344332211112 22467899999999654 455699999999999998876544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=351.34 Aligned_cols=252 Identities=27% Similarity=0.482 Sum_probs=220.6
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
.+.+.||+|.|+.||++.+..||+.+|+|+|+...... ...+.+.+|+.+-+.|+||||+++++.+. ...+.|+|+
T Consensus 14 ~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~--~~~e~l~rEarIC~~LqHP~IvrL~~ti~--~~~~~ylvF 89 (355)
T KOG0033|consen 14 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--RDFQKLEREARICRKLQHPNIVRLHDSIQ--EESFHYLVF 89 (355)
T ss_pred hHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc--ccHHHHHHHHHHHHhcCCCcEeehhhhhc--ccceeEEEE
Confidence 55689999999999999999999999999998776533 36788999999999999999999999763 446899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC--CCcEEEccccccchhcCC-
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQP- 184 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~--~g~vKL~DFGla~~~~~~- 184 (631)
|+++|++|..-+-+...+++..+..+++||+.||.|||.++ |||||+||.|+++-+. ..-+||+|||+|..++..
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~ 167 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE 167 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeCCcc
Confidence 99999999876666677899999999999999999999999 9999999999999532 336999999999877633
Q ss_pred CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHHHHHH
Q 006779 185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQF 261 (631)
Q Consensus 185 ~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p~~l~~~~~~~l~~l 261 (631)
.....+|||.|||||++.. .|+..+|||+.|++||-|+.|.+||.+ .+...+|+.|..+.. |.......++++++|
T Consensus 168 ~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~-~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~L 246 (355)
T KOG0033|consen 168 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSL 246 (355)
T ss_pred ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhccccCCCCcccCcCCHHHHHH
Confidence 3556789999999998865 699999999999999999999999987 567889999988753 443455678999999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 262 IEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 262 I~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
|++||. +|.+|.|+.|+|+|||++.
T Consensus 247 vrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 247 IRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred HHHHhccChhhhccHHHHhCCchhcc
Confidence 999997 9999999999999999975
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=360.65 Aligned_cols=256 Identities=28% Similarity=0.437 Sum_probs=206.2
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC---C
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---R 101 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~---~ 101 (631)
|| ++.+.||+|+||.||+|.+..+|..||+|++.... .......++.+|+.+|+.++||||+++++++..... .
T Consensus 1 ry-~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 77 (338)
T cd07859 1 RY-KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 77 (338)
T ss_pred Ce-EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh--ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence 56 77899999999999999999999999999986432 123344568899999999999999999998865432 3
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
.+|+||||+. ++|.+++.+...+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 78 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 78 DIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLARVA 153 (338)
T ss_pred eEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEccCcccccc
Confidence 5899999995 799999998888999999999999999999999999 99999999999997 7899999999999654
Q ss_pred cCC-----CCccccCCCCCCCcccccc---ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHH--------------HH
Q 006779 182 QQP-----TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI--------------YK 239 (631)
Q Consensus 182 ~~~-----~~~~~~GTp~Y~APEvl~~---~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i--------------~~ 239 (631)
... .....+||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+.....++ ..
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 321 1234579999999998753 5889999999999999999999999764322211 11
Q ss_pred HHHc-----------CCCCCCC---CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 240 KVTS-----------GIKPASL---SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 240 ~i~~-----------~~~p~~l---~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.+.. ...+..+ ....++.+.+||.+||. +|.+||++.|+|.||||...
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 1100 0011111 12346789999999998 89999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=361.38 Aligned_cols=253 Identities=23% Similarity=0.416 Sum_probs=214.8
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCeEEEEEec
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~l~lV~Ey 109 (631)
++||+|+||+||+|.++.+|..||+|.+...... .....+.+..|..++..+ +||||+++++++.+. ..+++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP--DRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhccCCCchhceeeEEEcC--CEEEEEEcC
Confidence 4699999999999999999999999998754321 234456678888888876 799999999988654 479999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc--CCCCc
Q 006779 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~~~~~ 187 (631)
+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~-~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 78 VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeeCCCCeecCcCCCccc
Confidence 999999999998889999999999999999999999999 99999999999997 78999999999986432 22334
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 006779 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 188 ~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL 266 (631)
...||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...++..+..+.. .++...++++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~L 231 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEV--VYPTWLSQDAVDILKAFM 231 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHc
Confidence 5679999999998764 588999999999999999999999976 566677777765432 234557889999999999
Q ss_pred C-CCCCCCCH------HHHhcCCCCCCCCCccc
Q 006779 267 V-PASLRLPA------LELLKDPFLVTDNPKDL 292 (631)
Q Consensus 267 ~-~p~~Rpsa------~elL~hpff~~~~~~~~ 292 (631)
. +|.+|+++ .++++||||....+..+
T Consensus 232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~ 264 (320)
T cd05590 232 TKNPTMRLGSLTLGGEEAILRHPFFKELDWEKL 264 (320)
T ss_pred ccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence 8 89999998 89999999988766544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=361.61 Aligned_cols=253 Identities=23% Similarity=0.433 Sum_probs=214.5
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEecc
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~ 110 (631)
++||+|+||.||+|.+..+|..||+|.+..... ........+.+|+++++.++||||+++++++... ..+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~--~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC--CEEEEEEeCC
Confidence 469999999999999999999999999975432 2344556788999999999999999999988654 4799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccCCCCCeeecCCCCcEEEccccccchhc--CCCCc
Q 006779 111 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 187 (631)
Q Consensus 111 ~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~~~~~ 187 (631)
.+|+|..++.+.+.+++..++.++.||+.||.|||+ ++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEEC-CCCCEEEecCCCCeecCCCCcccc
Confidence 999999999888889999999999999999999997 67 99999999999998 78999999999986432 22334
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 006779 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 188 ~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL 266 (631)
...||+.|+|||++.+ .++.++|||||||++|+|+||..||.. .+...+...+.... ..++...++.+++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~L 231 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEE--IRFPRTLSPEAKSLLSGLL 231 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHh
Confidence 5679999999998754 589999999999999999999999976 45556666655432 2345567899999999999
Q ss_pred C-CCCCCC-----CHHHHhcCCCCCCCCCccc
Q 006779 267 V-PASLRL-----PALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 267 ~-~p~~Rp-----sa~elL~hpff~~~~~~~~ 292 (631)
+ +|.+|+ ++.++|+||||....+...
T Consensus 232 ~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~ 263 (325)
T cd05594 232 KKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDV 263 (325)
T ss_pred hcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 8 899997 8999999999988665543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=350.63 Aligned_cols=250 Identities=25% Similarity=0.336 Sum_probs=212.8
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEecc
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~ 110 (631)
..|++|+||.||+|+|+.|++.||+|+++...-. ...--.-.+||.+|.+++|||||.+-.+.+..+-..+|||||||
T Consensus 82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek--~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~ 159 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK--EGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYV 159 (419)
T ss_pred hhcccCcceeEEEeccCCcceeEEeeeccccccc--CCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHH
Confidence 5699999999999999999999999999876521 11223467999999999999999999999988888999999999
Q ss_pred CCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC--Cc
Q 006779 111 TSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--AR 187 (631)
Q Consensus 111 ~gGsL~~~l~~~~-~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~--~~ 187 (631)
+. +|+.++..-+ +|...+++.++.|++.||+|||.++ |+|||||++|+|++ +.|.+||+|||+|+.+..+. .+
T Consensus 160 Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~-~~G~lKiaDFGLAR~ygsp~k~~T 235 (419)
T KOG0663|consen 160 EH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLS-HKGILKIADFGLAREYGSPLKPYT 235 (419)
T ss_pred Hh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeec-cCCcEEecccchhhhhcCCcccCc
Confidence 75 8999988765 8999999999999999999999998 99999999999998 89999999999999988763 34
Q ss_pred cccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC------------------
Q 006779 188 SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP------------------ 247 (631)
Q Consensus 188 ~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p------------------ 247 (631)
..+.|.+|+|||++-+ .|++++|+||+|||+.||++++..|.+....+|+.+.+.---.|
T Consensus 236 ~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~ 315 (419)
T KOG0663|consen 236 PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMT 315 (419)
T ss_pred ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccc
Confidence 5677999999997754 59999999999999999999999999877777776655421000
Q ss_pred ------CCC----CCC-CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 248 ------ASL----SKV-TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 248 ------~~l----~~~-~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
..+ ... .+....+|+..+|. +|.+|.||.|.|+|.||..
T Consensus 316 f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 316 FSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred cCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 000 011 34677899999998 9999999999999999976
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=351.23 Aligned_cols=252 Identities=19% Similarity=0.344 Sum_probs=205.9
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
|| ++.+.||+|+||+||+|.++.++..||+|++..... .....+.+.+|+.+++.++||||+++++++... ..++
T Consensus 2 ~y-~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 76 (287)
T cd07848 2 KF-EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEEVKETTLRELKMLRTLKQENIVELKEAFRRR--GKLY 76 (287)
T ss_pred Cc-eEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc--cccchhhHHHHHHHHHhCCCccccchhhhEecC--CEEE
Confidence 56 778999999999999999999999999999875432 234456788999999999999999999988654 4799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
+||||+.++++..+......+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++......
T Consensus 77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 77 LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccCccccccc
Confidence 99999999888777666677999999999999999999999998 99999999999997 7889999999999765432
Q ss_pred ---CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc-CC--------------
Q 006779 185 ---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GI-------------- 245 (631)
Q Consensus 185 ---~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~-~~-------------- 245 (631)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||............... +.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 2234578999999997754 5899999999999999999999999864433332221110 00
Q ss_pred -----CCC---------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 246 -----KPA---------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 246 -----~p~---------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
.+. ......++.+++||.+||. +|.+|||+.++|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000 0112356789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=366.50 Aligned_cols=256 Identities=23% Similarity=0.429 Sum_probs=213.8
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC----------HHHHHHHHHHHHHHHhCCCCCceeeeeeEEc
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS----------PDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~----------~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d 97 (631)
.+.+.||+|.||.|-+|.+..+|..||||++........ -..+++..+||.+|++|+|||||+++++.-|
T Consensus 100 ~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDD 179 (576)
T KOG0585|consen 100 ELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDD 179 (576)
T ss_pred ehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecC
Confidence 556779999999999999999999999999976553321 1124789999999999999999999999888
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
.....+|||+|||..|.+...-.....+++.+++.+++.++.||+|||.+| ||||||||.|+|++ .+|++||+|||.
T Consensus 180 P~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~-~~g~VKIsDFGV 256 (576)
T KOG0585|consen 180 PESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLS-SDGTVKISDFGV 256 (576)
T ss_pred cccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEc-CCCcEEeeccce
Confidence 888899999999999988654333334999999999999999999999999 99999999999997 789999999999
Q ss_pred cchhcCC-------CCccccCCCCCCCccccccc-----cCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006779 178 AIVMQQP-------TARSVIGTPEFMAPELYEEE-----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 245 (631)
Q Consensus 178 a~~~~~~-------~~~~~~GTp~Y~APEvl~~~-----ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~ 245 (631)
+...... .....+|||.|||||++.++ -+.+.||||+|++||.|+.|++||.+ .....++.+|....
T Consensus 257 s~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-~~~~~l~~KIvn~p 335 (576)
T KOG0585|consen 257 SNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-DFELELFDKIVNDP 335 (576)
T ss_pred eeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-chHHHHHHHHhcCc
Confidence 9755221 12346899999999987652 35789999999999999999999987 56667778877653
Q ss_pred CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 246 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 246 ~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
............++++|.++|. ||.+|.+..++-.|||....
T Consensus 336 L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 336 LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 3222222346889999999998 89999999999999999764
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=358.36 Aligned_cols=249 Identities=29% Similarity=0.433 Sum_probs=211.2
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC---eEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR---TIN 104 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~---~l~ 104 (631)
+-.+++|+|+||+||+|...++++.||||++-...... .+|+++|+.++|||||++..+|...... ++.
T Consensus 27 ~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k--------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 27 EAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK--------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC--------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 55689999999999999999999999999997655433 2699999999999999998888654443 778
Q ss_pred EEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 105 MITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~----~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
+||||++ .+|.++++. +..++.-.++-+..||++||.|||+.+ |+||||||+|+|+|.+.|.+||||||.|+.
T Consensus 99 lVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 99 LVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 8999996 589888874 577999999999999999999999998 999999999999998889999999999987
Q ss_pred hcC-CCCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC-------------
Q 006779 181 MQQ-PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG------------- 244 (631)
Q Consensus 181 ~~~-~~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~------------- 244 (631)
+.. ....+++.|..|+|||++.+ +|+.+.||||.||++.||+-|+.-|.+.....|+...+.--
T Consensus 176 L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 176 LVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred eccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence 654 44567888999999997754 69999999999999999999999999866666665544320
Q ss_pred ---------CCCCC----CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 245 ---------IKPAS----LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 245 ---------~~p~~----l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.++.. +.+..++++.+|+.++|+ +|.+|.++.|+|.||||...
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 11111 334568999999999999 99999999999999999763
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=358.59 Aligned_cols=254 Identities=25% Similarity=0.388 Sum_probs=214.3
Q ss_pred eEecccCceEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 31 EILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~---~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
+.||+|+||.||+|.+. .+|..||+|.+..............+..|+.+|+.++||||++++++|... ..+|+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG--GKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC--CeEEEEE
Confidence 57999999999999874 578999999997654333334456678999999999999999999988654 4789999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc--CCC
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPT 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~~~ 185 (631)
||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... ...
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLD-AQGHVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEeeCcCCeecccCCCc
Confidence 99999999999999888999999999999999999999999 99999999999997 78999999999986432 223
Q ss_pred CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 006779 186 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264 (631)
Q Consensus 186 ~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~ 264 (631)
.....||+.|+|||++.+ .++.++|||||||++|||++|+.||.. .+.......+..+.. .++...++.+++||.+
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~ 233 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILKGKL--NLPPYLTPEARDLLKK 233 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHH
Confidence 345679999999998764 488999999999999999999999987 445555566655432 3455668899999999
Q ss_pred hcC-CCCCCC-----CHHHHhcCCCCCCCCCccc
Q 006779 265 CIV-PASLRL-----PALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 265 cL~-~p~~Rp-----sa~elL~hpff~~~~~~~~ 292 (631)
||. +|.+|| ++.+++.||||....+..+
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~ 267 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDL 267 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 998 899999 8999999999988666554
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=354.66 Aligned_cols=257 Identities=27% Similarity=0.426 Sum_probs=205.2
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
..+| ++.+.||+|+||+||+|.++.+|..||+|.+..... ......+.+|+.+++.++||||+++++++.+. ..
T Consensus 4 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 77 (303)
T cd07869 4 ADSY-EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE---EGTPFTAIREASLLKGLKHANIVLLHDIIHTK--ET 77 (303)
T ss_pred cccc-eEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc---cccchhHHHHHHHHhhCCCCCcCeEEEEEecC--Ce
Confidence 3566 667999999999999999999999999999875432 12234577899999999999999999988654 47
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 103 INMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
+++||||+. ++|.+++.++ +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~ 153 (303)
T cd07869 78 LTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLIS-DTGELKLADFGLARAK 153 (303)
T ss_pred EEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECCCCcceec
Confidence 899999995 6777777654 56899999999999999999999999 99999999999997 7899999999998644
Q ss_pred cCC--CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCC-C----------
Q 006779 182 QQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI-K---------- 246 (631)
Q Consensus 182 ~~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~-~---------- 246 (631)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..+.......+.... .
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence 322 2334578999999998753 478899999999999999999999987555444333322100 0
Q ss_pred ------CCCCC-------------CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 247 ------PASLS-------------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 247 ------p~~l~-------------~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
+..+. ...++.+++||.+||+ +|.+|||+.++|.||||+...+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence 00000 0124678999999998 8999999999999999986543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=363.95 Aligned_cols=258 Identities=21% Similarity=0.375 Sum_probs=214.7
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.+| ++.+.||+|+||.||+|.++.+|..||+|.+...... .......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 43 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~--~~~ 118 (370)
T cd05596 43 EDF-DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-KRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD--KYL 118 (370)
T ss_pred HHc-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC--CEE
Confidence 455 6779999999999999999999999999999754321 223445678899999999999999999988654 479
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
++||||+.+|+|.+++.+. .+++..+..++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEc-CCCCEEEEeccceeeccC
Confidence 9999999999999998764 5899999999999999999999998 99999999999997 789999999999976543
Q ss_pred C---CCccccCCCCCCCcccccc-----ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC--C
Q 006779 184 P---TARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK--V 253 (631)
Q Consensus 184 ~---~~~~~~GTp~Y~APEvl~~-----~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~--~ 253 (631)
. .....+||+.|+|||++.. .++.++|||||||++|||++|..||.. .+....+..+........++. .
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~ 273 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMDHKNSLTFPDDIE 273 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCCcCCCCCcCC
Confidence 2 2235679999999998753 378899999999999999999999987 455666677765433333333 4
Q ss_pred CcHHHHHHHHHhcC-CCCC--CCCHHHHhcCCCCCCCCCc
Q 006779 254 TDPQVKQFIEKCIV-PASL--RLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 254 ~~~~l~~lI~~cL~-~p~~--Rpsa~elL~hpff~~~~~~ 290 (631)
.+.++++||.+||. +|.+ |+++.+++.||||+...+.
T Consensus 274 ~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 274 ISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred CCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 67899999999998 5665 9999999999999876543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=357.34 Aligned_cols=258 Identities=19% Similarity=0.332 Sum_probs=216.9
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
.+.+.||+|+||+||+|.++.+|..||+|.++.... ........+.+|+.+++.++||||+++++++.+. ..+++||
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~--~~~~lv~ 80 (330)
T cd05601 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-LAQETVSFFEEERDILSISNSPWIPQLQYAFQDK--DNLYLVM 80 (330)
T ss_pred eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CeEEEEE
Confidence 678999999999999999999999999999975432 2234556788999999999999999999988654 4799999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC-
Q 006779 108 ELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~- 185 (631)
||+.+|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLID-RTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEEC-CCCCEEeccCCCCeECCCCCc
Confidence 999999999999886 67999999999999999999999998 99999999999997 78999999999997654322
Q ss_pred --CccccCCCCCCCccccc-------cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCC
Q 006779 186 --ARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVT 254 (631)
Q Consensus 186 --~~~~~GTp~Y~APEvl~-------~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~--~~~ 254 (631)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||... +....+..+........++ ...
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~ 236 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG-TSAKTYNNIMNFQRFLKFPEDPKV 236 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC-CHHHHHHHHHcCCCccCCCCCCCC
Confidence 23347899999999874 34788999999999999999999999874 4455555555443322222 235
Q ss_pred cHHHHHHHHHhcCCCCCCCCHHHHhcCCCCCCCCCccc
Q 006779 255 DPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 255 ~~~l~~lI~~cL~~p~~Rpsa~elL~hpff~~~~~~~~ 292 (631)
++.+++||.+||.+|.+||++.+++.||||...++..+
T Consensus 237 ~~~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~~~~~~ 274 (330)
T cd05601 237 SSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNNI 274 (330)
T ss_pred CHHHHHHHHHHccChhhCCCHHHHhCCCCcCCCCHHHH
Confidence 78999999999999999999999999999988665543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=363.66 Aligned_cols=258 Identities=21% Similarity=0.385 Sum_probs=213.2
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
.++| ++.+.||+|+||.||+|.++.++..||+|.+...... .......+.+|+.+++.++||||++++++|.+. ..
T Consensus 42 ~~~y-~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~--~~ 117 (370)
T cd05621 42 AEDY-DVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD--KY 117 (370)
T ss_pred HHHC-eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CE
Confidence 4566 7789999999999999999999999999998753321 233445688999999999999999999988654 57
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
+++||||+.+|+|.+++... .+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~-~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEEecccceecc
Confidence 99999999999999999765 5899999999999999999999999 99999999999997 78999999999997654
Q ss_pred CCC---CccccCCCCCCCcccccc-----ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC--
Q 006779 183 QPT---ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK-- 252 (631)
Q Consensus 183 ~~~---~~~~~GTp~Y~APEvl~~-----~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~-- 252 (631)
... ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+....+..+........++.
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~ 272 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSKIMDHKNSLNFPEDV 272 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCcccCCCCcc
Confidence 322 245679999999998753 278899999999999999999999986 455555666654332222222
Q ss_pred CCcHHHHHHHHHhcCCC---CCCCCHHHHhcCCCCCCCCC
Q 006779 253 VTDPQVKQFIEKCIVPA---SLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 253 ~~~~~l~~lI~~cL~~p---~~Rpsa~elL~hpff~~~~~ 289 (631)
..+..++++|.+||.++ ..|+++.++++||||+...+
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred cCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 35788999999999843 34889999999999987654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=357.41 Aligned_cols=257 Identities=21% Similarity=0.364 Sum_probs=213.5
Q ss_pred eeeeEecccCceEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCeE
Q 006779 28 RYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~---~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~l 103 (631)
++.+.||+|+||+||+|.+. .+|..||+|.+............+.+..|+.+|+.+ +||||+++++++... ..+
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~~~ 80 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE--AKL 80 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC--CEE
Confidence 67899999999999998864 578999999987544333344556788999999999 599999999987544 478
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
++||||+.+|+|.+++.+...+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLD-SEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEEC-CCCCEEEeeCcCCccccc
Confidence 999999999999999998888999999999999999999999999 99999999999997 788999999999875432
Q ss_pred C---CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCC---CCHHHHHHHHHcCCCCCCCCCCCc
Q 006779 184 P---TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNEC---KNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 184 ~---~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~---~~~~~i~~~i~~~~~p~~l~~~~~ 255 (631)
. ......||+.|+|||++.+ .++.++|||||||++|+|+||..||... .....+...+.... ..++...+
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 235 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD--PPFPSFIG 235 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC--CCCCCCCC
Confidence 2 2234679999999998764 3788999999999999999999999642 23344444444332 23455678
Q ss_pred HHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCcc
Q 006779 256 PQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKD 291 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rp-----sa~elL~hpff~~~~~~~ 291 (631)
+.+++||.+||. +|.+|| ++.++++||||....+..
T Consensus 236 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~ 277 (332)
T cd05614 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEA 277 (332)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 999999999998 899999 888999999998765544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=358.37 Aligned_cols=253 Identities=18% Similarity=0.360 Sum_probs=211.3
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCeEEEEEec
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~l~lV~Ey 109 (631)
++||+|+||.||+|.+..+|..||+|.++.... ........+.+|..+++.+ +||||+++++++.+. ..+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~--~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV-NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE--SRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC--CEEEEEEeC
Confidence 469999999999999999999999999975432 2344556788999999998 799999999988654 479999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc--CCCCc
Q 006779 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~~~~~ 187 (631)
+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEECcCccccccccCCCccc
Confidence 999999999988889999999999999999999999999 99999999999997 78999999999986422 22334
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCC--------CCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006779 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--------KNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 188 ~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~--------~~~~~i~~~i~~~~~p~~l~~~~~~~l 258 (631)
..+||+.|+|||++.+ .++.++|||||||++|+|+||+.||... .....+.+.+.... ..++...++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~ 232 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--CCCCCCCCHHH
Confidence 5689999999998765 5899999999999999999999999631 12233444454432 23455678899
Q ss_pred HHHHHHhcC-CCCCCCC------HHHHhcCCCCCCCCCcc
Q 006779 259 KQFIEKCIV-PASLRLP------ALELLKDPFLVTDNPKD 291 (631)
Q Consensus 259 ~~lI~~cL~-~p~~Rps------a~elL~hpff~~~~~~~ 291 (631)
+++|.+||+ +|.+|++ +.++++||||....+..
T Consensus 233 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~ 272 (329)
T cd05588 233 SSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDL 272 (329)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHH
Confidence 999999998 8999987 78999999998765543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=357.11 Aligned_cols=253 Identities=22% Similarity=0.358 Sum_probs=215.0
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCeEEEEEec
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~l~lV~Ey 109 (631)
++||+|+||.||+|.+..+|+.||+|.+..... ......+.+..|..+++.+ +||||++++++|.+. ..+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~--~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI-LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK--DRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CeEEEEEeC
Confidence 469999999999999999999999999875432 2234556778899999866 899999999998654 469999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc--CCCCc
Q 006779 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~~~~~ 187 (631)
+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 78 VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLD-AEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeecccceecccCCcccc
Confidence 999999999998889999999999999999999999999 99999999999997 78999999999986432 22334
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 006779 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 188 ~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL 266 (631)
...||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...++..+..+.. .++...++++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~ll~~~L 231 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA-DNEDDLFESILHDDV--LYPVWLSKEAVSILKAFM 231 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHh
Confidence 5679999999998764 589999999999999999999999986 456667776665432 234456789999999999
Q ss_pred C-CCCCCC-------CHHHHhcCCCCCCCCCccc
Q 006779 267 V-PASLRL-------PALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 267 ~-~p~~Rp-------sa~elL~hpff~~~~~~~~ 292 (631)
. +|.+|+ ++.+++.||||....+..+
T Consensus 232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~ 265 (321)
T cd05591 232 TKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLL 265 (321)
T ss_pred ccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHH
Confidence 8 899999 8999999999988766554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=374.16 Aligned_cols=256 Identities=27% Similarity=0.407 Sum_probs=206.1
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC-
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD- 98 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~- 98 (631)
..+.++| ++.++||+|+||+||+|.+..+|+.||+|++.... ....+|+.+|+.++||||++++++|...
T Consensus 62 ~~~~~~y-~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~~~ 132 (440)
T PTZ00036 62 RSPNKSY-KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYTEC 132 (440)
T ss_pred cCcCCeE-EEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEeecc
Confidence 4566777 78899999999999999999999999999885321 1234799999999999999999877542
Q ss_pred -----CCCeEEEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCc
Q 006779 99 -----TNRTINMITELFTSGSLRQYRK----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169 (631)
Q Consensus 99 -----~~~~l~lV~Ey~~gGsL~~~l~----~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~ 169 (631)
...++++||||+.+ +|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++..++.
T Consensus 133 ~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~ 209 (440)
T PTZ00036 133 FKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHT 209 (440)
T ss_pred cccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCc
Confidence 22367899999974 7766654 3467999999999999999999999999 9999999999999855568
Q ss_pred EEEccccccchhcC-CCCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC
Q 006779 170 VKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246 (631)
Q Consensus 170 vKL~DFGla~~~~~-~~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~ 246 (631)
+||+|||++..+.. ......+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+.....++...+.....
T Consensus 210 vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 289 (440)
T PTZ00036 210 LKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT 289 (440)
T ss_pred eeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999999976543 23345678999999997654 5899999999999999999999999876555555444321100
Q ss_pred C----------------------C----CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 247 P----------------------A----SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 247 p----------------------~----~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
| . .++...++++++||.+||. +|.+|||+.|+|.||||...
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 0 0 1122356789999999998 89999999999999999764
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=350.50 Aligned_cols=251 Identities=27% Similarity=0.415 Sum_probs=202.0
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.+| ++.+.||.|+||+||+|.++.+|..||+|.+..... ......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 5 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 78 (288)
T cd07871 5 ETY-VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKNLKHANIVTLHDIIHTE--RCL 78 (288)
T ss_pred ccc-eEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc---CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC--CeE
Confidence 345 667899999999999999999999999999875432 22234577899999999999999999988654 478
Q ss_pred EEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 104 NMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~-~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
++||||+.+ +|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 79 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 79 TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLIN-EKGELKLADFGLARAKS 154 (288)
T ss_pred EEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEECcCcceeecc
Confidence 999999974 8999887654 5799999999999999999999998 99999999999997 78999999999986543
Q ss_pred CC--CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC------------
Q 006779 183 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------------ 246 (631)
Q Consensus 183 ~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~------------ 246 (631)
.. ......+++.|+|||++.+ .++.++|||||||++|+|+||+.||......+.+...+.....
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred CCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 22 2334578999999998753 4899999999999999999999999774433332222111000
Q ss_pred --------CC-------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 247 --------PA-------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 247 --------p~-------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
|. ......++++++||.+||. +|.+|||+.|+|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00 0012346789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=355.57 Aligned_cols=256 Identities=22% Similarity=0.354 Sum_probs=216.7
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC-CceeeeeeEEcCCCCeEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~Hp-nIVkl~~~~~d~~~~~l~lV 106 (631)
++.+.||+|+||.||+|.++.++..||+|++..... ......+.+..|+.++..+.|+ +|+++++++.+. ..+|+|
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv 79 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI-IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRLYFV 79 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CEEEEE
Confidence 678999999999999999999999999999875432 2234567788999999999765 578888887654 479999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh--cCC
Q 006779 107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQP 184 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~--~~~ 184 (631)
|||+.+|+|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++... ...
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEc-CCCCEEEeecCcceecCCCCC
Confidence 999999999999998888999999999999999999999998 99999999999997 7889999999998643 222
Q ss_pred CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006779 185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263 (631)
Q Consensus 185 ~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~ 263 (631)
.....+||+.|+|||++.+ .++.++|||||||++|+|+||+.||.. .+...++..+.... ..++...++.++++|.
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~ 233 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQSIMEHN--VSYPKSLSKEAVSICK 233 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHH
Confidence 3345679999999998765 489999999999999999999999976 45666666666543 2345567889999999
Q ss_pred HhcC-CCCCCCCH-----HHHhcCCCCCCCCCccc
Q 006779 264 KCIV-PASLRLPA-----LELLKDPFLVTDNPKDL 292 (631)
Q Consensus 264 ~cL~-~p~~Rpsa-----~elL~hpff~~~~~~~~ 292 (631)
+||. +|.+|+++ .+++.||||...++..+
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~ 268 (324)
T cd05587 234 GLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKL 268 (324)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 9998 89999976 89999999998776554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=355.66 Aligned_cols=255 Identities=25% Similarity=0.435 Sum_probs=212.0
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHH---HhCCCCCceeeeeeEEcCCCCeEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL---KSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL---k~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
++.+.||+|+||.||+|.+..+|..||+|.+...... .....+.+.+|++++ +.++||||+++++++.+. ..+|
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~--~~~~ 78 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII-ARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE--DHVC 78 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC--CEEE
Confidence 6789999999999999999999999999999754322 233456677776665 567899999999988654 4799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC-
Q 006779 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ- 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~- 183 (631)
+||||+.+|+|..++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 79 lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~-~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC-CCCcEEeCcccCCccCCCC
Confidence 99999999999988865 56999999999999999999999998 99999999999998 789999999999864322
Q ss_pred -CCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006779 184 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 184 -~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~l 261 (631)
......+|++.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+..++...+..+.. .++...++.+.+|
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~l 231 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG-DDEEEVFDSIVNDEV--RYPRFLSREAISI 231 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHH
Confidence 22345679999999998764 588999999999999999999999986 455666666655432 2445568899999
Q ss_pred HHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCccc
Q 006779 262 IEKCIV-PASLRL-----PALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 262 I~~cL~-~p~~Rp-----sa~elL~hpff~~~~~~~~ 292 (631)
|.+||. +|.+|| ++.++++||||....+...
T Consensus 232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~ 268 (324)
T cd05589 232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDL 268 (324)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHH
Confidence 999998 899999 6999999999988765544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=363.64 Aligned_cols=255 Identities=27% Similarity=0.456 Sum_probs=221.7
Q ss_pred eeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCceeeeeeEEcCCCCeEE
Q 006779 26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 26 y~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~l~ 104 (631)
+|.+++.||+|.||.||++.++.||..+|+|.+....... ....+.+.+|+.+|+++. |||||.++++|.+.. .++
T Consensus 36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~-~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~--~~~ 112 (382)
T KOG0032|consen 36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG-KEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD--SVY 112 (382)
T ss_pred cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc-cccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC--eEE
Confidence 3488899999999999999999999999999998765433 335678999999999998 999999999997654 799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC---CCcEEEccccccchh
Q 006779 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN---NGEVKIGDLGLAIVM 181 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~---~g~vKL~DFGla~~~ 181 (631)
+|||+|.||.|.+.+.+. .+++..+..+++||+.|+.|||+.| |+||||||+|+|+... ++.+|++|||++...
T Consensus 113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 999999999999998877 4999999999999999999999999 9999999999999743 358999999999877
Q ss_pred cCC-CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHH
Q 006779 182 QQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQ 257 (631)
Q Consensus 182 ~~~-~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p~~l~~~~~~~ 257 (631)
... .....+|||.|+|||++. ..|+..+||||+|+++|.|++|..||.+ .+.......|..+.. +.......+..
T Consensus 190 ~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~-~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 190 KPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWG-ETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred cCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcC-CChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 653 456789999999999988 6799999999999999999999999987 445555556666643 33344456889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 258 VKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 258 l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
+++||.++|. +|.+|+||.++|+|||+...
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 9999999998 89999999999999999875
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=360.32 Aligned_cols=263 Identities=28% Similarity=0.521 Sum_probs=223.9
Q ss_pred ccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEE
Q 006779 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (631)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 96 (631)
-+..-|..-| .+.+.||+|+||.||+|+++++|..||||++... .+++.+..|+.+|++++.|++|++|++|+
T Consensus 26 sL~K~PEEVF-Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------sDLQEIIKEISIMQQC~S~yVVKYYGSYF 98 (502)
T KOG0574|consen 26 ALNKPPEEVF-DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------TDLQEIIKEISIMQQCKSKYVVKYYGSYF 98 (502)
T ss_pred hhcCChHHHH-HHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc------chHHHHHHHHHHHHHcCCchhhhhhhhhc
Confidence 3445555555 4567899999999999999999999999999754 35678999999999999999999999887
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccc
Q 006779 97 DDTNRTINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~l~-~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 175 (631)
... -+|+|||||..|++.+.++ +++.++++.+..+++..+.||+|||... -||||||..|||++ ..|..||+||
T Consensus 99 K~s--DLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLN-T~G~AKLADF 173 (502)
T KOG0574|consen 99 KHS--DLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLN-TDGIAKLADF 173 (502)
T ss_pred cCC--ceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEc-ccchhhhhhc
Confidence 554 5899999999999999876 5678999999999999999999999987 79999999999998 7899999999
Q ss_pred cccchhcCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC--
Q 006779 176 GLAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL-- 250 (631)
Q Consensus 176 Gla~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l-- 250 (631)
|.|..+... ...+++|||.|||||++.. +|+.++||||||++..||+.|+.||.+-.....++..-+. +|+.+
T Consensus 174 GVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~--PPPTF~K 251 (502)
T KOG0574|consen 174 GVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTK--PPPTFKK 251 (502)
T ss_pred cccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCC--CCCCCCC
Confidence 999877654 3567899999999999875 6999999999999999999999999885444444333332 23333
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCcccc
Q 006779 251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 251 ~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~~~~~ 293 (631)
+..++.++.+||++||. .|.+|-||.+|++|||++.+....++
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~ 295 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCDIM 295 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHH
Confidence 34478899999999998 79999999999999999987766543
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=354.22 Aligned_cols=252 Identities=25% Similarity=0.427 Sum_probs=211.8
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCeEEEEEec
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~l~lV~Ey 109 (631)
++||+|+||.||+|.++.+|..||+|.+...... .......+..|..++..+ +||||+++++++.+. ..+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK--EHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC--CEEEEEECC
Confidence 4699999999999999999999999999754321 123445677788888754 899999999988654 479999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh--cCCCCc
Q 006779 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~--~~~~~~ 187 (631)
+.+|+|..++...+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++... ......
T Consensus 78 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 78 LNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLD-RDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEeCccCCCeecccCCCcee
Confidence 999999999998888999999999999999999999998 99999999999998 7889999999998642 222344
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 006779 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 188 ~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL 266 (631)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..++...+.... ..++...+..+++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l 231 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG-DDEDELFESIRVDT--PHYPRWITKESKDILEKLF 231 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHHc
Confidence 5679999999998764 589999999999999999999999976 45666666665442 2344567889999999999
Q ss_pred C-CCCCCCCH-HHHhcCCCCCCCCCcc
Q 006779 267 V-PASLRLPA-LELLKDPFLVTDNPKD 291 (631)
Q Consensus 267 ~-~p~~Rpsa-~elL~hpff~~~~~~~ 291 (631)
. +|.+|+++ .+++.||||...++..
T Consensus 232 ~~dP~~R~~~~~~~~~h~~f~~~~~~~ 258 (316)
T cd05620 232 ERDPTRRLGVVGNIRGHPFFKTINWTA 258 (316)
T ss_pred cCCHHHcCCChHHHHcCCCcCCCCHHH
Confidence 8 89999997 5899999998876544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=356.51 Aligned_cols=254 Identities=25% Similarity=0.417 Sum_probs=210.8
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHH-HHHHHhCCCCCceeeeeeEEcCCCCeEEEEEec
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE-VHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~E-i~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey 109 (631)
+.||+|+||+||+|.+..++..||+|++......... ....+..| ..+++.++||||+++++++... ..+++||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~--~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKK-EEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--DKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhh-HHHHHHHHHHHHHHhCCCCCCCceeEEEEcC--CeEEEEEeC
Confidence 4699999999999999999999999999754332222 22334444 4467889999999999988654 478999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc--CCCCc
Q 006779 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~~~~~ 187 (631)
+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~-~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEEccCCCCcccccCCCCcc
Confidence 999999999998888999999999999999999999999 99999999999997 78899999999986432 22344
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 006779 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 188 ~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL 266 (631)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+....+..+... +..+....++.++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l 231 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNK--PLQLKPNITNSARHLLEGLL 231 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC-CCHHHHHHHHHhC--CcCCCCCCCHHHHHHHHHHc
Confidence 5679999999998765 588999999999999999999999986 4566666666553 22344456789999999999
Q ss_pred C-CCCCCCCHH----HHhcCCCCCCCCCcccc
Q 006779 267 V-PASLRLPAL----ELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 267 ~-~p~~Rpsa~----elL~hpff~~~~~~~~~ 293 (631)
+ +|.+|+++. ++++|+||...++..+.
T Consensus 232 ~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~ 263 (325)
T cd05602 232 QKDRTKRLGAKDDFMEIKNHIFFSPINWDDLI 263 (325)
T ss_pred ccCHHHCCCCCCCHHHHhcCcccCCCCHHHHH
Confidence 8 899999876 89999999987776654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=354.06 Aligned_cols=253 Identities=24% Similarity=0.432 Sum_probs=211.3
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh-CCCCCceeeeeeEEcCCCCeEEEEEec
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS-LKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~-L~HpnIVkl~~~~~d~~~~~l~lV~Ey 109 (631)
++||+|+||.||+|.+..+++.||+|.++..... .....+.+..|..++.. ++||||+++++++... ..+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK--EHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcC
Confidence 4699999999999999999999999999754322 23344556667777765 4899999999988654 479999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc--CCCCc
Q 006779 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~~~~~ 187 (631)
+.+|+|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.... .....
T Consensus 78 ~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 78 LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEEC-CCCCEEEccCcCCeECCCCCCccc
Confidence 999999999998889999999999999999999999998 99999999999997 78999999999986432 22334
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 006779 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 188 ~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL 266 (631)
..+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+ .+..+++..+.... ..++...+..+++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~ll~~~l 231 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILNDR--PHFPRWISKEAKDCLSKLF 231 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHc
Confidence 5679999999998764 589999999999999999999999986 45666666665532 2345567889999999999
Q ss_pred C-CCCCCCCH-HHHhcCCCCCCCCCccc
Q 006779 267 V-PASLRLPA-LELLKDPFLVTDNPKDL 292 (631)
Q Consensus 267 ~-~p~~Rpsa-~elL~hpff~~~~~~~~ 292 (631)
. +|.+||++ .+++.||||....+..+
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~~~~~ 259 (316)
T cd05592 232 ERDPTKRLGVDGDIRQHPFFRGIDWERL 259 (316)
T ss_pred cCCHHHcCCChHHHHcCcccCCCCHHHH
Confidence 8 89999986 58999999988765443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=376.24 Aligned_cols=263 Identities=28% Similarity=0.474 Sum_probs=221.6
Q ss_pred ccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC
Q 006779 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 98 (631)
..+|..-|..+++ ||.|+||.||+|..+.++...|-|.|.. ++.+.++.+.-||.+|..|+||+||++++.|+.+
T Consensus 27 dlnP~d~WeIiGE-LGDGAFGKVyKA~nket~~lAAaKvIet----kseEELEDylVEIeILa~CdHP~ivkLl~ayy~e 101 (1187)
T KOG0579|consen 27 DLNPRDHWEIIGE-LGDGAFGKVYKAVNKETKLLAAAKVIET----KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE 101 (1187)
T ss_pred cCCHHHHHHHHhh-hcCccchhhhhhhcccchhhhhhhhhcc----cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc
Confidence 4567777755544 8999999999999999999999998864 3578889999999999999999999999987665
Q ss_pred CCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 99 TNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
+ .+||+.|||.||-++..+-. ..+|++.+|..+++|++.||.|||+++ |||||||..|||++ .+|.|+|+|||.
T Consensus 102 n--kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~T-ldGdirLADFGV 176 (1187)
T KOG0579|consen 102 N--KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLT-LDGDIRLADFGV 176 (1187)
T ss_pred C--ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEE-ecCcEeeecccc
Confidence 4 48888999999999987654 567999999999999999999999999 99999999999998 899999999999
Q ss_pred cchhcC--CCCccccCCCCCCCccccc------cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC
Q 006779 178 AIVMQQ--PTARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 249 (631)
Q Consensus 178 a~~~~~--~~~~~~~GTp~Y~APEvl~------~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~ 249 (631)
+..... ....+++|||+|||||+.. ..|+.++|||||||+|.||+.+++|..+......+.+.-.+.++...
T Consensus 177 SAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLl 256 (1187)
T KOG0579|consen 177 SAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLL 256 (1187)
T ss_pred cccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCccc
Confidence 854332 2456899999999999753 35999999999999999999999999885444444444444433333
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCcc
Q 006779 250 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 291 (631)
Q Consensus 250 l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~~~ 291 (631)
-+..++..+++|+.+||+ +|..||++.+||+||||+....+.
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK 299 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNK 299 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcch
Confidence 456788999999999998 899999999999999999665543
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=354.81 Aligned_cols=254 Identities=26% Similarity=0.409 Sum_probs=211.4
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHH-HHHHhCCCCCceeeeeeEEcCCCCeEEEEEec
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV-HLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei-~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey 109 (631)
++||+|+||.||+|.+..+|..||+|.+....... ......+..|. .+++.++||||+++++++.+. ..+++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~--~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK-KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA--EKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CEEEEEEcC
Confidence 46999999999999999999999999987543322 22334455555 468899999999999988654 478999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC--CCCc
Q 006779 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~--~~~~ 187 (631)
+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEccCCCCccCCCCCCccc
Confidence 999999999988888999999999999999999999998 99999999999998 789999999999865322 2234
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 006779 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 188 ~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL 266 (631)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+... +..++...+..+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l 231 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILHK--PLQLPGGKTVAACDLLVGLL 231 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC-CCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHc
Confidence 5679999999998764 589999999999999999999999976 4566677776654 33445566789999999999
Q ss_pred C-CCCCCCCH----HHHhcCCCCCCCCCcccc
Q 006779 267 V-PASLRLPA----LELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 267 ~-~p~~Rpsa----~elL~hpff~~~~~~~~~ 293 (631)
+ +|.+|+++ .++++||||...++..+.
T Consensus 232 ~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T cd05603 232 HKDQRRRLGAKADFLEIKNHVFFSPINWDDLY 263 (321)
T ss_pred cCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHh
Confidence 8 89999875 599999999887765543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=372.71 Aligned_cols=250 Identities=32% Similarity=0.555 Sum_probs=223.3
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEecc
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~ 110 (631)
-+||+|+||+||.|+|..|....|||.|..++ ....+-+.+||.+.++|+|.|||++.+++ ..++++-|.||-+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd----sr~~QPLhEEIaLH~~LrHkNIVrYLGs~--senGf~kIFMEqV 654 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD----SREVQPLHEEIALHSTLRHKNIVRYLGSV--SENGFFKIFMEQV 654 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc----chhhccHHHHHHHHHHHhhHhHHHHhhcc--CCCCeEEEEeecC
Confidence 37999999999999999999999999997543 45667899999999999999999999986 4456888899999
Q ss_pred CCCCHHHHHH-hCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc--CCC
Q 006779 111 TSGSLRQYRK-KHKNV--DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPT 185 (631)
Q Consensus 111 ~gGsL~~~l~-~~~~l--~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~~~ 185 (631)
+||+|..++. +.+++ ++.++..+.+||++||.|||.+. |||||||-+||||+.-.|.+||+|||.++.+. ++.
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 9999999876 56888 89999999999999999999998 99999999999999889999999999997764 345
Q ss_pred CccccCCCCCCCcccccc---ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006779 186 ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262 (631)
Q Consensus 186 ~~~~~GTp~Y~APEvl~~---~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI 262 (631)
..++.||..|||||++.. +|+.++|||||||++.||+||++||.+..++...+.++---...+.++.-.+.+++.||
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fi 812 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFI 812 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHH
Confidence 677899999999999864 59999999999999999999999999988888777777655556667777889999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 263 EKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 263 ~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
.+|+. +|..||+|.+||.+||++..+
T Consensus 813 lrcFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 813 LRCFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred HHHcCCCcccCccHHHhccCcccccCC
Confidence 99998 899999999999999998764
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=347.19 Aligned_cols=252 Identities=26% Similarity=0.427 Sum_probs=207.2
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEeccCC
Q 006779 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112 (631)
Q Consensus 33 LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~~g 112 (631)
||+|+||+||++.++.+|+.||+|.+..... ......+.+..|+.+|+.++||||+++++++... ..+++||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL-KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK--TDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHH-hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC--CeEEEEEeCCCC
Confidence 7999999999999999999999999875432 2233446778899999999999999999987554 468999999999
Q ss_pred CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC--CC
Q 006779 113 GSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TA 186 (631)
Q Consensus 113 GsL~~~l~~----~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--~~ 186 (631)
|+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++...... ..
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~ 154 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKT 154 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCccceecCCCCccc
Confidence 999988743 356899999999999999999999998 99999999999997 7889999999998655432 23
Q ss_pred ccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCH---HHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006779 187 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP---AQIYKKVTSGIKPASLSKVTDPQVKQFI 262 (631)
Q Consensus 187 ~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~---~~i~~~i~~~~~p~~l~~~~~~~l~~lI 262 (631)
....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... ..+...+... +..++...++.+++++
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li 232 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKSFC 232 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHHHH
Confidence 34578999999998764 5889999999999999999999999753322 2223333222 2334455788999999
Q ss_pred HHhcC-CCCCCC-----CHHHHhcCCCCCCCCCccc
Q 006779 263 EKCIV-PASLRL-----PALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 263 ~~cL~-~p~~Rp-----sa~elL~hpff~~~~~~~~ 292 (631)
.+||+ +|.+|| ++.++++||||+...+..+
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~ 268 (280)
T cd05608 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQL 268 (280)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHH
Confidence 99998 899999 8899999999988666554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=354.60 Aligned_cols=255 Identities=26% Similarity=0.453 Sum_probs=212.3
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
..+| ++.+.||+|+||.||+|.+..+|..+|+|.+.... .......+.+|+++|+.++||||++++++|.+. ..
T Consensus 4 ~~~y-~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 77 (333)
T cd06650 4 DDDF-EKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GE 77 (333)
T ss_pred hhhh-heeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC--CE
Confidence 4567 67789999999999999999999999999887542 244567789999999999999999999998764 47
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
+++||||+.+|+|.+++.+.+.+++..+..++.|++.||.|||+. + |+||||||+|||++ .+|.+||+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQL 154 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEc-CCCCEEEeeCCcchhh
Confidence 999999999999999999888899999999999999999999975 5 99999999999997 7889999999999766
Q ss_pred cCCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHH----------------------
Q 006779 182 QQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY---------------------- 238 (631)
Q Consensus 182 ~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~---------------------- 238 (631)
.........||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ..++.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 155 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD-AKELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred hhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc-hhHHHHHhcCcccCCccccccCcccCC
Confidence 5544455679999999998765 48899999999999999999999996522 22221
Q ss_pred ----------------------HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 239 ----------------------KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 239 ----------------------~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
..+.....+.......+.++++||.+||+ +|.+|||+.|+|.||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 11111111211122356889999999998 89999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=353.62 Aligned_cols=252 Identities=22% Similarity=0.385 Sum_probs=214.3
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCeEEEEEec
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~l~lV~Ey 109 (631)
++||+|+||+||+|.+..++..||+|.+..... ........+..|..+++.+ +||||+++++++.+. ..+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~--~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI-LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK--DRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcC
Confidence 469999999999999999999999999975432 2234556778899999888 799999999988654 479999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc--CCCCc
Q 006779 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~~~~~ 187 (631)
+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 78 VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLD-SEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEEC-CCCcEEecccCCCeecCcCCCccc
Confidence 999999999998888999999999999999999999998 99999999999997 78999999999986432 22334
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 006779 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 188 ~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL 266 (631)
..+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...++..+..... .++...+..+++||.+||
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l 231 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG-DDEDELFQSILEDEV--RYPRWLSKEAKSILKSFL 231 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHHHc
Confidence 4579999999998764 589999999999999999999999976 456666666655432 344567889999999999
Q ss_pred C-CCCCCCCH-----HHHhcCCCCCCCCCcc
Q 006779 267 V-PASLRLPA-----LELLKDPFLVTDNPKD 291 (631)
Q Consensus 267 ~-~p~~Rpsa-----~elL~hpff~~~~~~~ 291 (631)
. +|.+||++ .+++.||||....+..
T Consensus 232 ~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~ 262 (318)
T cd05570 232 TKNPEKRLGCLPTGEQDIKGHPFFREIDWDK 262 (318)
T ss_pred cCCHHHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 8 89999999 9999999998876544
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=358.08 Aligned_cols=258 Identities=20% Similarity=0.374 Sum_probs=214.7
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
..+| ++.+.||+|+||.||+|.++.+++.||+|.+...... .......+.+|+.+++.++||||+++++.|.+. ..
T Consensus 42 ~~~y-~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~--~~ 117 (371)
T cd05622 42 AEDY-EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD--RY 117 (371)
T ss_pred hhhc-EEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--CE
Confidence 3566 7789999999999999999999999999998754322 223445678999999999999999999988654 57
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
+++||||+.+|+|.+++... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~-~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEEC-CCCCEEEEeCCceeEcC
Confidence 99999999999999998765 5899999999999999999999999 99999999999998 78999999999997654
Q ss_pred CC---CCccccCCCCCCCcccccc-----ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--C
Q 006779 183 QP---TARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--K 252 (631)
Q Consensus 183 ~~---~~~~~~GTp~Y~APEvl~~-----~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~--~ 252 (631)
.. .....+||+.|+|||++.. .++.++|||||||++|+|++|..||.. .+....+..+........++ .
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~ 272 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDN 272 (371)
T ss_pred cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCcccCCCcC
Confidence 32 2235679999999998753 278899999999999999999999976 56666777776543322222 3
Q ss_pred CCcHHHHHHHHHhcCCCC---CCCCHHHHhcCCCCCCCCC
Q 006779 253 VTDPQVKQFIEKCIVPAS---LRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 253 ~~~~~l~~lI~~cL~~p~---~Rpsa~elL~hpff~~~~~ 289 (631)
..+..+++||.+||.+|. .|+++.++++||||....+
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 273 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 467899999999998544 3789999999999987544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=354.57 Aligned_cols=253 Identities=19% Similarity=0.367 Sum_probs=210.7
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCeEEEEEec
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~l~lV~Ey 109 (631)
++||+|+||.||+|.+..++..||+|.+..... ........+.+|+.++.++ +||||+++++++.+. ..+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHh-cchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC--CEEEEEEeC
Confidence 469999999999999999999999999975432 2344566788899988877 899999999988664 478999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC--CCCc
Q 006779 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~--~~~~ 187 (631)
+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~-~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCCEEEeeCCccccccCCCCccc
Confidence 999999999988889999999999999999999999999 99999999999997 789999999999864322 2234
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCC--------CCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006779 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--------KNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 188 ~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~--------~~~~~i~~~i~~~~~p~~l~~~~~~~l 258 (631)
...||+.|+|||++.+ .++.++|||||||++|+|++|+.||... .....+...+.... ..++...+..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~~~~~ 232 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--CCCCCCCCHHH
Confidence 5679999999998764 5889999999999999999999999521 12233444444432 23455678899
Q ss_pred HHHHHHhcC-CCCCCCC------HHHHhcCCCCCCCCCcc
Q 006779 259 KQFIEKCIV-PASLRLP------ALELLKDPFLVTDNPKD 291 (631)
Q Consensus 259 ~~lI~~cL~-~p~~Rps------a~elL~hpff~~~~~~~ 291 (631)
++||.+||+ +|.+|++ ..+++.||||...++..
T Consensus 233 ~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~ 272 (329)
T cd05618 233 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDL 272 (329)
T ss_pred HHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHH
Confidence 999999998 8999998 47999999998876543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=352.68 Aligned_cols=253 Identities=25% Similarity=0.438 Sum_probs=212.0
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh-CCCCCceeeeeeEEcCCCCeEEEEEec
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS-LKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~-L~HpnIVkl~~~~~d~~~~~l~lV~Ey 109 (631)
+.||+|+||.||+|.+..++..||+|.+...... ..........|..+++. ++||||+++++++.+. ..+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK--ENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC--CEEEEEEeC
Confidence 4699999999999999999999999999754321 12334556778888876 5999999999988654 479999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh--cCCCCc
Q 006779 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~--~~~~~~ 187 (631)
+.+|+|..++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++... ......
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 78 LNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEccCCcceECCCCCCcee
Confidence 999999999998888999999999999999999999998 99999999999998 7889999999998643 222334
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 006779 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 188 ~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL 266 (631)
...||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+.... ..++...+..+++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l 231 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSIRMDN--PCYPRWLTREAKDILVKLF 231 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCccCCHHHHHHHHHHh
Confidence 5679999999998764 589999999999999999999999976 45666666665442 2244557789999999999
Q ss_pred C-CCCCCCCHH-HHhcCCCCCCCCCccc
Q 006779 267 V-PASLRLPAL-ELLKDPFLVTDNPKDL 292 (631)
Q Consensus 267 ~-~p~~Rpsa~-elL~hpff~~~~~~~~ 292 (631)
. +|.+|+++. +++.||||....+..+
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~~~~~ 259 (316)
T cd05619 232 VREPERRLGVKGDIRQHPFFREIDWSAL 259 (316)
T ss_pred ccCHhhcCCChHHHHcCcccCCCCHHHH
Confidence 8 899999996 8999999998766543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=355.04 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=209.5
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHH-HHHhCCCCCceeeeeeEEcCCCCeEEEEEec
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~-iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey 109 (631)
++||+|+||+||+|.++.+|..||+|++...... .......+..|.. +++.++||||+++++++... ..+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~--~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT--EKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC--CEEEEEEcC
Confidence 4699999999999999999999999998754322 2233344555554 57889999999999988654 478999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc--CCCCc
Q 006779 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~~~~~ 187 (631)
+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEeecCCcccCCCCCCCcc
Confidence 999999999998889999999999999999999999999 99999999999997 78999999999986432 22334
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 006779 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 188 ~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL 266 (631)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+.... ..+....+..+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~ll~~ll 231 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC-RDVAEMYDNILHKP--LVLRPGASLTAWSILEELL 231 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC-CCHHHHHHHHHcCC--ccCCCCCCHHHHHHHHHHh
Confidence 5679999999998765 589999999999999999999999986 45566666665542 2233346788999999999
Q ss_pred C-CCCCCCCH----HHHhcCCCCCCCCCccc
Q 006779 267 V-PASLRLPA----LELLKDPFLVTDNPKDL 292 (631)
Q Consensus 267 ~-~p~~Rpsa----~elL~hpff~~~~~~~~ 292 (631)
. +|.+||++ .+++.||||....+..+
T Consensus 232 ~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~ 262 (325)
T cd05604 232 EKDRQRRLGAKEDFLEIQEHPFFESLSWTDL 262 (325)
T ss_pred ccCHHhcCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 8 89999876 58999999988766554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=372.21 Aligned_cols=269 Identities=29% Similarity=0.511 Sum_probs=230.8
Q ss_pred CCcccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeee
Q 006779 14 EGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYN 93 (631)
Q Consensus 14 ~~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~ 93 (631)
...|.-.||..+|.-+ +-||.|+||.||.|.|..+.+.||||++.... .++.+..+.+..|+..|++|+|||+|.|.+
T Consensus 16 A~LF~k~DPEklf~dL-rEIGHGSFGAVYfArd~~n~evVAIKKMsySG-KQs~EKWqDIlKEVrFL~~l~HPntieYkg 93 (948)
T KOG0577|consen 16 ADLFFKDDPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDILKEVRFLRQLRHPNTIEYKG 93 (948)
T ss_pred HHHHccCCHHHHHHHH-HHhcCCccceeEEeeccCccceeeeeeccccc-cccHHHHHHHHHHHHHHHhccCCCcccccc
Confidence 4457788999999775 45999999999999999999999999998765 356677889999999999999999999999
Q ss_pred eEEcCCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEE
Q 006779 94 SWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 94 ~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL 172 (631)
+|..+. +.|+|||||- |+-.+++.-+ +++.+..|..++.+.+.||.|||+++ .||||||..|||++ +.|.|||
T Consensus 94 CyLre~--TaWLVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLs-e~g~VKL 167 (948)
T KOG0577|consen 94 CYLREH--TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLS-EPGLVKL 167 (948)
T ss_pred eeeccc--hHHHHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEec-CCCeeee
Confidence 987654 6889999995 6888888765 57999999999999999999999999 99999999999997 8999999
Q ss_pred ccccccchhcCCCCccccCCCCCCCcccc----ccccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC
Q 006779 173 GDLGLAIVMQQPTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 248 (631)
Q Consensus 173 ~DFGla~~~~~~~~~~~~GTp~Y~APEvl----~~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~ 248 (631)
+|||.|.... ...+++|||.|||||++ .+.|+-++|||||||+..||+-.++|+........+|. |...-.|.
T Consensus 168 aDFGSAsi~~--PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH-IAQNesPt 244 (948)
T KOG0577|consen 168 ADFGSASIMA--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-IAQNESPT 244 (948)
T ss_pred ccccchhhcC--chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH-HHhcCCCC
Confidence 9999997644 35789999999999975 36799999999999999999999999987555555554 44444444
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCcccc
Q 006779 249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 249 ~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~~~~~ 293 (631)
--...++..++.||..||+ .|..|||+.++|+|+|.....+..++
T Consensus 245 Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tvi 290 (948)
T KOG0577|consen 245 LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTVI 290 (948)
T ss_pred CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCchHH
Confidence 4455678999999999998 68999999999999999887665543
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=351.28 Aligned_cols=260 Identities=22% Similarity=0.337 Sum_probs=218.1
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCeEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~l~lV 106 (631)
++.+.||+|+||.||+|.++.++..||+|.+..... ......+.+..|..++..+ +||+|+++++++.+. ..+++|
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv 79 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM--DRLYFV 79 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC--CEEEEE
Confidence 678899999999999999999999999999875432 2233455677788888877 588999999987654 479999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc--CC
Q 006779 107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QP 184 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~~ 184 (631)
|||+.+|+|..++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.... ..
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEEC-CCCcEEEccCCCceecCCCCC
Confidence 999999999999998888999999999999999999999998 99999999999998 78999999999986432 22
Q ss_pred CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006779 185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263 (631)
Q Consensus 185 ~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~ 263 (631)
.....+||+.|+|||++.+ .++.++|||||||++|+|+||+.||.. .+...++..+..... .++...+.+++++|.
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~ 233 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVAICK 233 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCcCCHHHHHHHH
Confidence 3445679999999998764 589999999999999999999999986 456666666665432 345567889999999
Q ss_pred HhcC-CCCCCCC-----HHHHhcCCCCCCCCCcccccCC
Q 006779 264 KCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDP 296 (631)
Q Consensus 264 ~cL~-~p~~Rps-----a~elL~hpff~~~~~~~~~~~~ 296 (631)
+||. +|.+|++ ..+++.||||...++..+....
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~ 272 (323)
T cd05616 234 GLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKE 272 (323)
T ss_pred HHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCC
Confidence 9998 8999998 4899999999987776654333
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=349.99 Aligned_cols=257 Identities=28% Similarity=0.403 Sum_probs=222.2
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||+|..|+||++....++..+|+|++..... .......++..|.++|+.++||.++.+|..|.. ..+.+++|
T Consensus 80 ~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l-~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet--~~~~cl~m 156 (459)
T KOG0610|consen 80 RLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESL-ASRKKLKRAQTEREILSLLDHPFLPTLYASFET--DKYSCLVM 156 (459)
T ss_pred HHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHH-hhhhHHHHHHHHHHHHHhcCCCccchhhheeec--cceeEEEE
Confidence 445789999999999999999999999999986654 346677889999999999999999999999854 46899999
Q ss_pred eccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh----
Q 006779 108 ELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM---- 181 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~---- 181 (631)
|||.||+|..+++++ +.+++..++.++.+++.||+|||..| ||+|||||+||||. ++|+|.|.||.++...
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvr-edGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVR-EDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEe-cCCcEEeeeccccccCCCCC
Confidence 999999999998875 56999999999999999999999999 99999999999997 8999999999886311
Q ss_pred ---c---------------------------C-C-----------------------CCccccCCCCCCCcccccc-ccC
Q 006779 182 ---Q---------------------------Q-P-----------------------TARSVIGTPEFMAPELYEE-EYN 206 (631)
Q Consensus 182 ---~---------------------------~-~-----------------------~~~~~~GTp~Y~APEvl~~-~ys 206 (631)
. . . ...+++||-+|.|||++.+ +.+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0 0 0124679999999999976 489
Q ss_pred ccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC----HHHHhcC
Q 006779 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP----ALELLKD 281 (631)
Q Consensus 207 ~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rps----a~elL~h 281 (631)
.++|+|+|||.+|||+.|..||.+..+.+.+...+.+...-+..+ ..+..+++||+++|+ ||.+|.. |.||-+|
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 999999999999999999999999888888888777654433222 456789999999998 8999998 9999999
Q ss_pred CCCCCCCCcc
Q 006779 282 PFLVTDNPKD 291 (631)
Q Consensus 282 pff~~~~~~~ 291 (631)
|||+..+|.-
T Consensus 393 pFF~gVnWaL 402 (459)
T KOG0610|consen 393 PFFEGVNWAL 402 (459)
T ss_pred ccccCCChhh
Confidence 9999999974
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=353.14 Aligned_cols=252 Identities=24% Similarity=0.377 Sum_probs=212.3
Q ss_pred eEecccCceEEEEEEE---ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 31 EILGKGAFKTVYKGFD---EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d---~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
+.||+|+||.||++.+ ..+|..||+|++..... ......++.+|+.+|++++||||+++++++.+. ..+|+||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE--GKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CEEEEEE
Confidence 5799999999999986 46789999999975432 123345678899999999999999999988654 4789999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC--C
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--T 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--~ 185 (631)
||+.+|+|.+++.+...+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...... .
T Consensus 78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 78 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEEC-CCCcEEEeeccCCcccCCCCCc
Confidence 99999999999988888999999999999999999999999 99999999999997 7889999999998654333 2
Q ss_pred CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 006779 186 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264 (631)
Q Consensus 186 ~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~ 264 (631)
.....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+..+....+..... .++...++.+++||.+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~ 231 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG-KDRKETMTMILKAKL--GMPQFLSPEAQSLLRA 231 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHH
Confidence 345679999999998764 588999999999999999999999976 455555555554322 3445568899999999
Q ss_pred hcC-CCCCCCC-----HHHHhcCCCCCCCCCccc
Q 006779 265 CIV-PASLRLP-----ALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 265 cL~-~p~~Rps-----a~elL~hpff~~~~~~~~ 292 (631)
||+ +|.+||+ ..+++.||||....+..+
T Consensus 232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T cd05582 232 LFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKL 265 (318)
T ss_pred HhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHH
Confidence 998 8999999 677999999998765544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=341.83 Aligned_cols=253 Identities=28% Similarity=0.435 Sum_probs=199.3
Q ss_pred ceeeeeeEecccCceEEEEEEEcc-CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC---CCCCceeeeeeEEc---
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEV-DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVD--- 97 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~-tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L---~HpnIVkl~~~~~d--- 97 (631)
|| ++.+.||+|+||+||+|.+.. +|..||+|.+...... ......+.+|+.+++.+ +||||+++++++..
T Consensus 2 ~Y-~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 2 QY-ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred Cc-ceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC--CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence 56 678899999999999999865 5789999998754321 12223455677776665 69999999998753
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccc
Q 006779 98 DTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 175 (631)
.....+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 79 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~-~~~~~kl~Df 154 (290)
T cd07862 79 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADF 154 (290)
T ss_pred CCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEc-CCCCEEEccc
Confidence 23346899999996 6899998764 45899999999999999999999999 99999999999997 7889999999
Q ss_pred cccchhcCC-CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CC---
Q 006779 176 GLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PA--- 248 (631)
Q Consensus 176 Gla~~~~~~-~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p~--- 248 (631)
|++...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+......+...+..... +.
T Consensus 155 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 155 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred cceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 999765433 234567899999999775 45899999999999999999999999875444433333221100 00
Q ss_pred -------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 249 -------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 249 -------------------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
.+....++.+++||.+||+ +|.+|||+.++|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0112356788999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=350.64 Aligned_cols=254 Identities=19% Similarity=0.367 Sum_probs=212.9
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCeEEEEEec
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~l~lV~Ey 109 (631)
++||+|+||.||+|.+..++..||+|++..... ........+.+|+.++.++ +||||+++++++.+. ..+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV-HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT--SRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC--CEEEEEEeC
Confidence 469999999999999999999999999975432 2334567788999999888 699999999988654 469999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc--CCCCc
Q 006779 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~~~~~ 187 (631)
+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 78 VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLD-ADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEe-CCCCEEEeccccceeccCCCCcee
Confidence 999999999988888999999999999999999999998 99999999999997 78899999999986432 22334
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCC------CCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006779 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC------KNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 188 ~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~------~~~~~i~~~i~~~~~p~~l~~~~~~~l~~ 260 (631)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||... .....+...+... +..++...+..+++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~ 232 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKASH 232 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCCHHHHH
Confidence 5679999999998754 5899999999999999999999999532 2233445555443 33456667889999
Q ss_pred HHHHhcC-CCCCCCC------HHHHhcCCCCCCCCCccc
Q 006779 261 FIEKCIV-PASLRLP------ALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 261 lI~~cL~-~p~~Rps------a~elL~hpff~~~~~~~~ 292 (631)
+|.+||. +|.+|++ ..+++.||||...++..+
T Consensus 233 li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~ 271 (327)
T cd05617 233 VLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLL 271 (327)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHH
Confidence 9999998 8999998 569999999998776543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=341.69 Aligned_cols=258 Identities=24% Similarity=0.388 Sum_probs=212.0
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.++||+|+||.||+|.+..+|..||+|++...... .......+.+|+.+++.++||||+++++.+... ..+++||
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 79 (285)
T cd05605 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETK--DALCLVL 79 (285)
T ss_pred eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC--CeEEEEE
Confidence 5678999999999999999999999999998754321 222345577899999999999999999988654 4799999
Q ss_pred eccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC-
Q 006779 108 ELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 184 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~- 184 (631)
||+.+|+|..++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++ .++.++|+|||++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEEC-CCCCEEEeeCCCceecCCCC
Confidence 999999999887653 46999999999999999999999998 99999999999997 7889999999998765332
Q ss_pred CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHH---HHHHHHHcCCCCCCCCCCCcHHHHH
Q 006779 185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPA---QIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 185 ~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~---~i~~~i~~~~~p~~l~~~~~~~l~~ 260 (631)
.....+|++.|+|||++.+ .++.++|||||||++|+|++|+.||.+..... .+...+... +..++...++.+++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 234 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED--QEEYSEKFSEAARS 234 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc--ccccCcccCHHHHH
Confidence 2234578999999998754 58899999999999999999999998643221 222222221 23344557889999
Q ss_pred HHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCcccc
Q 006779 261 FIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 261 lI~~cL~-~p~~Rp-----sa~elL~hpff~~~~~~~~~ 293 (631)
||.+||. +|.+|| ++.+++.||||...+++.+.
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~ 273 (285)
T cd05605 235 ICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLE 273 (285)
T ss_pred HHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHh
Confidence 9999998 899999 89999999999987776654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=352.49 Aligned_cols=251 Identities=24% Similarity=0.390 Sum_probs=208.9
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC---CCCCceeeeeeEEcCCCCeEEEEEec
Q 006779 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 33 LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L---~HpnIVkl~~~~~d~~~~~l~lV~Ey 109 (631)
||+|+||+||+|.++.+|..||+|++...... ..........|..++..+ +||||++++++|.+. ..+|+||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~--~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV-AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD--SDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh-hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC--CeEEEEEcC
Confidence 79999999999999999999999998754322 223344566677777665 799999999988654 468999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc--CCCCc
Q 006779 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~~~~~ 187 (631)
+.+|+|..++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 78 MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLD-ATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred CCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEecCCcCcCCCCCCCCcc
Confidence 999999999998889999999999999999999999999 99999999999997 78999999999986432 22344
Q ss_pred cccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHh
Q 006779 188 SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265 (631)
Q Consensus 188 ~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~c 265 (631)
..+||+.|+|||++.+ .++.++|||||||++|+|+||..||.. .+..++++.+..+.... .....++.+++||.+|
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~~ 232 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA-EDTQQMYRNIAFGKVRF-PKNVLSDEGRQFVKGL 232 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHH
Confidence 5679999999998754 478999999999999999999999976 56667777776553321 1234678999999999
Q ss_pred cC-CCCCCC----CHHHHhcCCCCCCCCCcc
Q 006779 266 IV-PASLRL----PALELLKDPFLVTDNPKD 291 (631)
Q Consensus 266 L~-~p~~Rp----sa~elL~hpff~~~~~~~ 291 (631)
|. +|.+|| ++.+++.||||....+..
T Consensus 233 L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~ 263 (330)
T cd05586 233 LNRNPQHRLGAHRDAVELKEHPFFADIDWDL 263 (330)
T ss_pred cCCCHHHCCCCCCCHHHHhcCccccCCCHHH
Confidence 98 899998 699999999998765544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=332.37 Aligned_cols=251 Identities=34% Similarity=0.586 Sum_probs=212.4
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccC-CHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~-~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV 106 (631)
.+++.||+|++|.||+|.+..+|..||+|.+....... .......+.+|+.++++++||||+++++++.+. ..+++|
T Consensus 5 ~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v 82 (263)
T cd06625 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD--ETLSIF 82 (263)
T ss_pred cccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC--CeEEEE
Confidence 66899999999999999999999999999987543211 123456788999999999999999999998655 479999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC-
Q 006779 107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 185 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~- 185 (631)
+||+.+++|.+++.+.+.+++..++.++.|++.||.|||+++ ++||||+|+||+++ .++.++|+|||++.......
T Consensus 83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~-~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccceecccccc
Confidence 999999999999998888999999999999999999999999 99999999999997 78999999999986543221
Q ss_pred --C--ccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006779 186 --A--RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 186 --~--~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~ 260 (631)
. ....|++.|+|||++.+ .++.++||||||+++|+|++|+.||.......... .+........++...+..+.+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH-HHhccCCCCCCCccCCHHHHH
Confidence 1 34567889999998765 48899999999999999999999998754444443 333333344566677889999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 261 FIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 261 lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
+|.+||. +|.+||++.++|.||||
T Consensus 239 li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 239 FLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999998 89999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=347.96 Aligned_cols=258 Identities=22% Similarity=0.350 Sum_probs=216.1
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCceeeeeeEEcCCCCeEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~l~lV 106 (631)
++.+.||+|+||+||+|.++.+|..||+|++...... .....+.+..|..+++.+. |++|+++++++.+. ..+|+|
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv 79 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV--DRLYFV 79 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCchhheeeEEecC--CEEEEE
Confidence 5678999999999999999999999999998754322 2344566788999998886 56788888887654 479999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC--
Q 006779 107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 184 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-- 184 (631)
|||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~-~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeccccccccCCCCc
Confidence 999999999999999889999999999999999999999998 99999999999998 7899999999998653322
Q ss_pred CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006779 185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263 (631)
Q Consensus 185 ~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~ 263 (631)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...++..+.... ..++...+..+++++.
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~ 233 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHN--VSYPKSLSKEAVSICK 233 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCccCCHHHHHHHH
Confidence 2345679999999998764 589999999999999999999999986 45666666666543 2345567789999999
Q ss_pred HhcC-CCCCCCC-----HHHHhcCCCCCCCCCccccc
Q 006779 264 KCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVC 294 (631)
Q Consensus 264 ~cL~-~p~~Rps-----a~elL~hpff~~~~~~~~~~ 294 (631)
+||. +|.+|++ ..++++||||...++..+..
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~ 270 (323)
T cd05615 234 GLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLEN 270 (323)
T ss_pred HHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhc
Confidence 9998 8999997 57999999999877665443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=353.11 Aligned_cols=256 Identities=30% Similarity=0.420 Sum_probs=204.0
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC-
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN- 100 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~- 100 (631)
...|| ++.+.||+|+||.||+|.+..+|..||+|.+.... .......++.+|+.+++.++||||+++++++.....
T Consensus 19 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 19 VLKRY-QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF--QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhce-EEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc--cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence 35677 67799999999999999999999999999986442 233455678899999999999999999998865432
Q ss_pred ---CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 101 ---RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 101 ---~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
..+++||||+.+ +|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~-~~~~~kl~Dfg~ 169 (359)
T cd07876 96 EEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGL 169 (359)
T ss_pred cccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEecCCC
Confidence 357899999975 5666653 35889999999999999999999999 99999999999997 789999999999
Q ss_pred cchhcCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc------------
Q 006779 178 AIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS------------ 243 (631)
Q Consensus 178 a~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~------------ 243 (631)
+...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+..
T Consensus 170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 9654332 2345678999999998764 5899999999999999999999999865432222111110
Q ss_pred ----------CCC-C----------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 244 ----------GIK-P----------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 244 ----------~~~-p----------------~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
... + .......++.+++||.+||. +|.+|||+.|+|.||||..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 000 0 00112345789999999998 9999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=347.97 Aligned_cols=259 Identities=19% Similarity=0.364 Sum_probs=211.5
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
+| ++.+.||+|+||+||+|.++.+|..||+|.+...... .......+.+|+.+++.++||||+++++++.+. ..++
T Consensus 2 ~y-~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~ 77 (331)
T cd05597 2 DF-EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML-KRAETACFREERDVLVNGDRRWITNLHYAFQDE--NNLY 77 (331)
T ss_pred Cc-eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC--CeEE
Confidence 35 6789999999999999999999999999999753321 233456688999999999999999999988654 5799
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 105 MITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
+||||+.+|+|.+++.+ ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLA 154 (331)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEEC-CCCCEEEEECCceeecCC
Confidence 99999999999999986 457999999999999999999999999 99999999999997 789999999999865433
Q ss_pred CC---CccccCCCCCCCccccc------cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC---C
Q 006779 184 PT---ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL---S 251 (631)
Q Consensus 184 ~~---~~~~~GTp~Y~APEvl~------~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l---~ 251 (631)
.. ....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.. .+..+.+..+........+ .
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~ 233 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKEHFQFPPDV 233 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCcccCCCcc
Confidence 22 12346999999999875 2478899999999999999999999976 4455555555543221111 2
Q ss_pred CCCcHHHHHHHHHhcCC---CCCCCCHHHHhcCCCCCCCCCcc
Q 006779 252 KVTDPQVKQFIEKCIVP---ASLRLPALELLKDPFLVTDNPKD 291 (631)
Q Consensus 252 ~~~~~~l~~lI~~cL~~---p~~Rpsa~elL~hpff~~~~~~~ 291 (631)
...+..+++||.+||.. +..|+++.++|.||||....+..
T Consensus 234 ~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~ 276 (331)
T cd05597 234 TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDN 276 (331)
T ss_pred CCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHH
Confidence 23578999999999863 33478999999999998765544
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=367.96 Aligned_cols=262 Identities=26% Similarity=0.428 Sum_probs=221.4
Q ss_pred ccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEE
Q 006779 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (631)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 96 (631)
.....+.+|| ++.++||+|+||+||+|.+..+|+.||+|.+..... .......+.+|+.+|..++|+||++++..+.
T Consensus 25 ~~~~~~~~rY-~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~ 101 (496)
T PTZ00283 25 ATAKEQAKKY-WISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFA 101 (496)
T ss_pred ccccccCCCE-EEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHhcCCCCcEEEeeccee
Confidence 3445566788 788999999999999999999999999999976543 3556677899999999999999999998775
Q ss_pred cCCC------CeEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC
Q 006779 97 DDTN------RTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 166 (631)
Q Consensus 97 d~~~------~~l~lV~Ey~~gGsL~~~l~~~----~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~ 166 (631)
.... ..+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .
T Consensus 102 ~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~-~ 178 (496)
T PTZ00283 102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLC-S 178 (496)
T ss_pred cccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEe-C
Confidence 4322 2478999999999999998653 46899999999999999999999998 99999999999998 7
Q ss_pred CCcEEEccccccchhcCC----CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006779 167 NGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241 (631)
Q Consensus 167 ~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i 241 (631)
++.+||+|||++..+... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.. .+...++..+
T Consensus 179 ~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~-~~~~~~~~~~ 257 (496)
T PTZ00283 179 NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKT 257 (496)
T ss_pred CCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHH
Confidence 889999999998755432 2345679999999998765 589999999999999999999999976 5666666666
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 242 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 242 ~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
..+..+ .++...+++++++|.+||. +|.+||++.++|.|||++.
T Consensus 258 ~~~~~~-~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 258 LAGRYD-PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred hcCCCC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 655433 3455678999999999998 8999999999999999864
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=348.54 Aligned_cols=251 Identities=24% Similarity=0.490 Sum_probs=221.0
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
-|| .+.+.||+|+||.|-+|.+...|+.||||.|+.... .+..++-++.+||++|..|+||||+.+|++|... ..+
T Consensus 53 HRy-E~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkI-kdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk--dKI 128 (668)
T KOG0611|consen 53 HRY-EITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKI-KDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK--DKI 128 (668)
T ss_pred hHH-HHHHHhcCCcccceeehhhccCCcEeehhhhhhhhc-ccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC--ceE
Confidence 356 667899999999999999999999999999986654 5677788899999999999999999999998544 569
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
++||||..+|.|.+|+...+.+++...+.+++||++|+.|||.++ ++|||||.+|||++ .|+++||+|||++..+..
T Consensus 129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD-~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLD-QNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeec-CCCCeeeeccchhhhhcc
Confidence 999999999999999999999999999999999999999999999 99999999999998 899999999999988765
Q ss_pred C-CCccccCCCCCCCccccccc-c-CccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006779 184 P-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 184 ~-~~~~~~GTp~Y~APEvl~~~-y-s~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~ 260 (631)
. ...++||+|-|.+||+.++. | ++.+|-||||++||-|+.|..||++ .+-..++..|..|.... ...+..+.-
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-~Dhk~lvrQIs~GaYrE---P~~PSdA~g 281 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-RDHKRLVRQISRGAYRE---PETPSDASG 281 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-chHHHHHHHhhcccccC---CCCCchHHH
Confidence 4 57889999999999998764 5 5889999999999999999999988 45556667777764322 122356888
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCCC
Q 006779 261 FIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 261 lI~~cL~-~p~~Rpsa~elL~hpff~ 285 (631)
||+.||. +|.+|.|..++-.|=|+.
T Consensus 282 LIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 282 LIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHHHHHhcCcccchhHHHHhhhheee
Confidence 9999995 999999999999998874
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=341.48 Aligned_cols=256 Identities=29% Similarity=0.444 Sum_probs=211.2
Q ss_pred eeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC-ceeeeeeEEcCC----C
Q 006779 26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN-IIKFYNSWVDDT----N 100 (631)
Q Consensus 26 y~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~Hpn-IVkl~~~~~d~~----~ 100 (631)
|.++ ++||+|+||+||+|+++.+|..||+|++....-. +..-....+|+.+|+.|+|+| |+.+++++...+ .
T Consensus 13 ~~~~-eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 13 YEKV-EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHH-HHhCCCCceEEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 4443 5699999999999999999999999999876421 112244789999999999999 999999887654 2
Q ss_pred CeEEEEEeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccc
Q 006779 101 RTINMITELFTSGSLRQYRKKHK----NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~----~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 176 (631)
..+++|+||+. -+|.+|+.... .++...++.+++||+.||+|||+++ |+||||||+||||+ ..|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~-~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLIS-SSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEEC-CCCcEeeeccc
Confidence 37899999995 59999998765 5888999999999999999999999 99999999999998 79999999999
Q ss_pred ccchhcCC--CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-----
Q 006779 177 LAIVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP----- 247 (631)
Q Consensus 177 la~~~~~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p----- 247 (631)
+|+...-+ .....++|.+|+|||++-+ .|+..+||||+|||++||++++..|.+....+++......--.|
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 99866533 3456688999999997755 49999999999999999999999999877777766554421011
Q ss_pred -------------------CCCC---CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 248 -------------------ASLS---KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 248 -------------------~~l~---~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
..+. +..++...+++.+||. +|.+|.||..+|.||||....
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 0000 1123588999999999 999999999999999998753
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=331.91 Aligned_cols=250 Identities=24% Similarity=0.453 Sum_probs=222.8
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
.+++.||+|-||.||+|+.+.++-.||+|++......+ ......+.+|+++-..|+||||+++|++|.|.. .+|+++
T Consensus 25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~-~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~--riyLil 101 (281)
T KOG0580|consen 25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILK-TQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK--RIYLIL 101 (281)
T ss_pred cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHH-hcchhhhhheeEeecccCCccHHhhhhheeccc--eeEEEE
Confidence 45788999999999999999999999999987666433 233466889999999999999999999998764 699999
Q ss_pred eccCCCCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC
Q 006779 108 ELFTSGSLRQYRK--KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~--~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~ 185 (631)
||...|+|...+. +.+++++.....+++|++.||.|||.++ ||||||||+|+|+. ..|.+||+|||-+.......
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg-~~~~lkiAdfGwsV~~p~~k 178 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSNK 178 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccC-CCCCeeccCCCceeecCCCC
Confidence 9999999999998 6778999999999999999999999998 99999999999996 89999999999998777777
Q ss_pred CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 006779 186 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264 (631)
Q Consensus 186 ~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~ 264 (631)
..+.|||..|.+||+.++ .++..+|+|++|++.||++.|..||.. .+..+.|++|.+-. ..++...+..++++|.+
T Consensus 179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes-~~~~etYkrI~k~~--~~~p~~is~~a~dlI~~ 255 (281)
T KOG0580|consen 179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFES-QSHSETYKRIRKVD--LKFPSTISGGAADLISR 255 (281)
T ss_pred ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhh-hhhHHHHHHHHHcc--ccCCcccChhHHHHHHH
Confidence 788999999999998875 599999999999999999999999977 44788888887642 23446778899999999
Q ss_pred hcC-CCCCCCCHHHHhcCCCCCC
Q 006779 265 CIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 265 cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
||. +|.+|++..|++.|||+..
T Consensus 256 ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 256 LLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HhccCccccccHHHHhhhHHHHh
Confidence 998 8999999999999999865
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=331.49 Aligned_cols=254 Identities=34% Similarity=0.578 Sum_probs=213.4
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeeccccc-CCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~-~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV 106 (631)
+++++||+|+||.||+|.+..+|..||+|.+...... ......+.+.+|+.+++.++||||++++++|.+.....++++
T Consensus 5 ~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (265)
T cd06652 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIF 84 (265)
T ss_pred eEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEE
Confidence 7789999999999999999999999999998654322 223456788999999999999999999998877656688999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC--
Q 006779 107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 184 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-- 184 (631)
|||+.+++|.+++.+.+.+++..+..++.|++.||.|||+++ ++|+||||+||+++ .++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 85 MEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRD-SVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEec-CCCCEEECcCccccccccccc
Confidence 999999999999998888999999999999999999999998 99999999999997 7889999999998654321
Q ss_pred ---CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006779 185 ---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 185 ---~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~ 260 (631)
......|+..|+|||++.+ .++.++|||||||++|+|++|+.||........+.. +.........+...+..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK-IATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH-HhcCCCCCCCchhhCHHHHH
Confidence 2234568999999997754 588999999999999999999999987544444433 33332233344456778999
Q ss_pred HHHHhcCCCCCCCCHHHHhcCCCCC
Q 006779 261 FIEKCIVPASLRLPALELLKDPFLV 285 (631)
Q Consensus 261 lI~~cL~~p~~Rpsa~elL~hpff~ 285 (631)
+|.+|+.+|.+||++.++++|||+.
T Consensus 241 ~i~~~l~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFVEAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhcChhhCCCHHHHhcCcccC
Confidence 9999999999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=335.54 Aligned_cols=255 Identities=30% Similarity=0.550 Sum_probs=211.1
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcC
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 98 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~ 98 (631)
.+|.|+| ++.+.||+|+||.||+|.+..+++.||+|.+.... .....+..|+.+++.+ +||||+++++++...
T Consensus 2 ~~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (272)
T cd06637 2 RDPAGIF-ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 75 (272)
T ss_pred CChhhhh-hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence 4789999 66788999999999999999999999999986432 2235678899999998 799999999998754
Q ss_pred C----CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEE
Q 006779 99 T----NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 99 ~----~~~l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL 172 (631)
. ...+++||||+.+++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++ .++.+||
T Consensus 76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~-~~~~~~l 152 (272)
T cd06637 76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKL 152 (272)
T ss_pred CCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEEC-CCCCEEE
Confidence 3 24689999999999999998864 46899999999999999999999998 99999999999998 7889999
Q ss_pred ccccccchhcCC--CCccccCCCCCCCccccc------cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006779 173 GDLGLAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244 (631)
Q Consensus 173 ~DFGla~~~~~~--~~~~~~GTp~Y~APEvl~------~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~ 244 (631)
+|||++...... ......|++.|+|||++. ..|+.++|||||||++|+|++|..||.... +......+...
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~-~~~~~~~~~~~ 231 (272)
T cd06637 153 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRN 231 (272)
T ss_pred ccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC-HHHHHHHHhcC
Confidence 999998755332 234467899999999874 247889999999999999999999997643 33333333333
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 245 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 245 ~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
..+.......+..+++||.+||. +|.+|||+.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 232 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 22333334567899999999998 89999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=335.50 Aligned_cols=251 Identities=33% Similarity=0.590 Sum_probs=207.2
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEE
Q 006779 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV 106 (631)
|++.+.||+|+||+||+|.+..++..||+|.+..... .........+|+.++++++||||+++++++.+. ..+++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~v 76 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI--EEEEREENIREIKILRRLRHPNIVQILDVFQDD--NYLYIV 76 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH--HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES--SEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc--cccccchhhhhhhcccccccccccccccccccc--cccccc
Confidence 4889999999999999999999999999999986542 122233456699999999999999999998763 578899
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh--cCC
Q 006779 107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQP 184 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~--~~~ 184 (631)
|||+.+++|.+++.+.+.+++..+..++.||+.||.+||+++ ++||||||+||+++ .++.++|+|||.+... ...
T Consensus 77 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~-~~~~~~l~Dfg~~~~~~~~~~ 153 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLD-ENGEVKLIDFGSSVKLSENNE 153 (260)
T ss_dssp EEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEES-TTSEEEESSGTTTEESTSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc-ccccccccccccccccccccc
Confidence 999999999999998888999999999999999999999998 99999999999998 8899999999999753 223
Q ss_pred CCccccCCCCCCCccccc--cccCccccchhhhHHHHHHhhcCCCCCCCC--CHHHHHHHHHcCCCCCCCC--CCCcHHH
Q 006779 185 TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGIKPASLS--KVTDPQV 258 (631)
Q Consensus 185 ~~~~~~GTp~Y~APEvl~--~~ys~~sDIwSLGiilyELltG~~Pf~~~~--~~~~i~~~i~~~~~p~~l~--~~~~~~l 258 (631)
......+++.|+|||++. ..++.++||||||+++|+|++|..||.... +.............+.... ......+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEEL 233 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHH
Confidence 345567899999999876 458999999999999999999999998752 2222222222211111111 1123799
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 259 KQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 259 ~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
+++|.+||. +|.+||++.++++||||
T Consensus 234 ~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 234 RDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 999999998 89999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=336.46 Aligned_cols=262 Identities=26% Similarity=0.462 Sum_probs=221.9
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
+| ++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+.+|+++|+.++||||+++++++.+. ..++
T Consensus 2 ~y-~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 77 (290)
T cd05580 2 DF-EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI-VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD--SNLY 77 (290)
T ss_pred ce-EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CeEE
Confidence 35 678999999999999999999999999999875432 2234567789999999999999999999988654 4789
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
+||||+.+++|.+++.+.+.+++..+..++.||+.||.|||+++ ++||||+|.|||++ .+|.+||+|||++......
T Consensus 78 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLD-SDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEC-CCCCEEEeeCCCccccCCC
Confidence 99999999999999998889999999999999999999999998 99999999999997 7889999999998765444
Q ss_pred CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006779 185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263 (631)
Q Consensus 185 ~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~ 263 (631)
.....|++.|+|||.+.. .++.++||||||+++|+|++|..||... ......+.+..+.. .++...++.++++|.
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~--~~~~~~~~~l~~li~ 230 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD-NPIQIYEKILEGKV--RFPSFFSPDAKDLIR 230 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCc--cCCccCCHHHHHHHH
Confidence 344578999999997654 5788999999999999999999999764 45556666654432 344556899999999
Q ss_pred HhcC-CCCCCC-----CHHHHhcCCCCCCCCCcccccCCC
Q 006779 264 KCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPL 297 (631)
Q Consensus 264 ~cL~-~p~~Rp-----sa~elL~hpff~~~~~~~~~~~~~ 297 (631)
+||. +|.+|+ ++.+++.||||....+..+....+
T Consensus 231 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 270 (290)
T cd05580 231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKI 270 (290)
T ss_pred HHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhccC
Confidence 9998 899999 899999999998877666544333
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=347.43 Aligned_cols=250 Identities=24% Similarity=0.410 Sum_probs=203.9
Q ss_pred CCCceeeeeeEecccCceEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeE
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSW 95 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d-----~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~ 95 (631)
|..|| ++.++||+|+||.||+|.+ ..++..||+|.+.... .......+.+|+.+|+.+ +||||+++++++
T Consensus 5 ~~~~~-~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 5 PRDRL-RLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA---TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred chhHc-eeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc---chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 55678 7889999999999999975 3456789999986332 234556789999999999 899999999988
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhC-----------------------------------------------------
Q 006779 96 VDDTNRTINMITELFTSGSLRQYRKKH----------------------------------------------------- 122 (631)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~~~l~~~----------------------------------------------------- 122 (631)
... ...+++||||+.+|+|.+++...
T Consensus 81 ~~~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 81 TKP-NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred cCC-CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 654 34688999999999999998753
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC----Cccc
Q 006779 123 ---------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSV 189 (631)
Q Consensus 123 ---------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~ 189 (631)
..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....... ....
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 236 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSA 236 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEc-CCCcEEEeecccccccccCcchhcccCC
Confidence 23778899999999999999999998 99999999999997 78899999999997543221 2233
Q ss_pred cCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC
Q 006779 190 IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 267 (631)
Q Consensus 190 ~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~ 267 (631)
.+++.|+|||++. ..|+.++|||||||++|||++ |..||........+...+..+..+ ..+...++.++++|.+||.
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~ 315 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM-RAPENATPEIYRIMLACWQ 315 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcc
Confidence 4578899999775 458999999999999999997 999998755555555555555433 3345677899999999998
Q ss_pred -CCCCCCCHHHHhc
Q 006779 268 -PASLRLPALELLK 280 (631)
Q Consensus 268 -~p~~Rpsa~elL~ 280 (631)
+|.+|||+.++++
T Consensus 316 ~dp~~RPs~~el~~ 329 (338)
T cd05102 316 GDPKERPTFSALVE 329 (338)
T ss_pred CChhhCcCHHHHHH
Confidence 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=336.55 Aligned_cols=253 Identities=30% Similarity=0.424 Sum_probs=198.8
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC---CCCCceeeeeeEEcC---
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVDD--- 98 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L---~HpnIVkl~~~~~d~--- 98 (631)
|| ++.+.||+|+||+||+|.++.+|..||+|.+....... .....+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y-~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QY-EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED--GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred Cc-eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC--CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence 45 67789999999999999999999999999987543211 1122345667666655 799999999987643
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 176 (631)
....+++|+||+. ++|..++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 78 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~kl~dfg 153 (288)
T cd07863 78 RETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGQVKLADFG 153 (288)
T ss_pred CCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccC
Confidence 2346899999997 5898888764 35899999999999999999999999 99999999999997 78999999999
Q ss_pred ccchhcCCC-CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC------C-
Q 006779 177 LAIVMQQPT-ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------P- 247 (631)
Q Consensus 177 la~~~~~~~-~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~------p- 247 (631)
++....... .....||+.|+|||++. ..++.++|||||||++|+|++|..||........+.+.+..... +
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 154 LARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred ccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 997654332 33457899999999775 45899999999999999999999999765443333222211000 0
Q ss_pred -----------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 248 -----------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 248 -----------------~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
..+....+..+++||.+||+ +|.+|||+.++|.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00112346778999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=345.37 Aligned_cols=260 Identities=19% Similarity=0.367 Sum_probs=212.8
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
+| ++.+.||+|+||.||++.++.++..||+|.+...... .......+.+|+.++..++|+||+++++++.+. ..+|
T Consensus 2 ~y-~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~--~~~~ 77 (331)
T cd05624 2 DF-EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML-KRAETACFREERNVLVNGDCQWITTLHYAFQDE--NYLY 77 (331)
T ss_pred Cc-eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEE
Confidence 35 7789999999999999999999999999998753321 233456688899999999999999999988654 5799
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 105 MITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
+||||+.+|+|.+++.+ ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLD-MNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEc-CCCCEEEEeccceeeccC
Confidence 99999999999999987 467999999999999999999999998 99999999999997 788999999999976543
Q ss_pred CC---CccccCCCCCCCcccccc------ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC---
Q 006779 184 PT---ARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--- 251 (631)
Q Consensus 184 ~~---~~~~~GTp~Y~APEvl~~------~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~--- 251 (631)
.. .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+..+.+..+........++
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~ 233 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHEERFQFPSHI 233 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC-CCHHHHHHHHHcCCCcccCCCcc
Confidence 32 123579999999998753 478899999999999999999999976 44555565555432211222
Q ss_pred CCCcHHHHHHHHHhcCCCCC---CCCHHHHhcCCCCCCCCCccc
Q 006779 252 KVTDPQVKQFIEKCIVPASL---RLPALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 252 ~~~~~~l~~lI~~cL~~p~~---Rpsa~elL~hpff~~~~~~~~ 292 (631)
...+..+++||.+||..+.+ |+++.++++||||...++..+
T Consensus 234 ~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~ 277 (331)
T cd05624 234 TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENI 277 (331)
T ss_pred ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHH
Confidence 23478999999999974333 568999999999998766553
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=345.41 Aligned_cols=258 Identities=18% Similarity=0.357 Sum_probs=211.7
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.++||+|+||.||++.++.++..||+|.+...... .......+.+|+.++..++|+||+++++.+.+. ..+++||
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ 80 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGDNQWITTLHYAFQDE--NNLYLVM 80 (332)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CEEEEEE
Confidence 6789999999999999999999999999998643321 223445688899999999999999999988654 4789999
Q ss_pred eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC--
Q 006779 108 ELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 184 (631)
Q Consensus 108 Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-- 184 (631)
||+.+|+|.+++.+ ...+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~-~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEeecchheecccCCc
Confidence 99999999999987 467999999999999999999999999 99999999999997 7889999999998654322
Q ss_pred -CCccccCCCCCCCccccc------cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC---CCCC
Q 006779 185 -TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL---SKVT 254 (631)
Q Consensus 185 -~~~~~~GTp~Y~APEvl~------~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l---~~~~ 254 (631)
.....+||+.|+|||++. ..++.++|||||||++|||++|+.||.. .+..+.+..+........+ ....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPAQVTDV 236 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCccccCCCccccC
Confidence 122357999999999874 3488999999999999999999999986 4555666666554322222 2345
Q ss_pred cHHHHHHHHHhcCC---CCCCCCHHHHhcCCCCCCCCCccc
Q 006779 255 DPQVKQFIEKCIVP---ASLRLPALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 255 ~~~l~~lI~~cL~~---p~~Rpsa~elL~hpff~~~~~~~~ 292 (631)
++.+++||.+||.. +..|+++.++++||||...++..+
T Consensus 237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~~ 277 (332)
T cd05623 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNI 277 (332)
T ss_pred CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHHH
Confidence 78999999999963 334789999999999998766543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=352.24 Aligned_cols=262 Identities=24% Similarity=0.414 Sum_probs=221.3
Q ss_pred cccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEc
Q 006779 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d 97 (631)
...-..|-| -+.+.||+|-|++|-+|++..||+.||+|+|...+. ..-....+++|++.|+.++|||||++|++.
T Consensus 12 ~DgkIAGLY-DLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl--D~~st~hlfqEVRCMKLVQHpNiVRLYEVi-- 86 (864)
T KOG4717|consen 12 YDGKIAGLY-DLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL--DTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-- 86 (864)
T ss_pred cccceeeee-hhhhhhcCCceehhhhhhhhcccceeEEEEeccccc--chhhhhHHHHHHHHHHHhcCcCeeeeeehh--
Confidence 334445555 677899999999999999999999999999987664 233446799999999999999999999975
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccc
Q 006779 98 DTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 176 (631)
+....+|+|+|+-.+|+|.+||-++ ..+.+...+++++||+.|+.|||+.. +|||||||+||.+...-|.|||.|||
T Consensus 87 DTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFG 164 (864)
T KOG4717|consen 87 DTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFG 164 (864)
T ss_pred cccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeecc
Confidence 3345799999999999999999887 56999999999999999999999998 99999999999776688999999999
Q ss_pred ccchhcC-CCCccccCCCCCCCcccccc-ccC-ccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006779 177 LAIVMQQ-PTARSVIGTPEFMAPELYEE-EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 177 la~~~~~-~~~~~~~GTp~Y~APEvl~~-~ys-~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~ 253 (631)
++..+.. ....+.||+..|.|||++.+ .|+ +++||||||+|||.|++|+.||.+..+.+.+- +|..- --..+..
T Consensus 165 FSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT-mImDC--KYtvPsh 241 (864)
T KOG4717|consen 165 FSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT-MIMDC--KYTVPSH 241 (864)
T ss_pred ccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh-hhhcc--cccCchh
Confidence 9966544 45678899999999997755 575 78999999999999999999998855444443 33322 1234567
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 254 ~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
.+.++++||..||+ +|.+|.+.+++..|+|++..+.
T Consensus 242 vS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 242 VSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred hhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 78999999999998 9999999999999999997654
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=355.48 Aligned_cols=246 Identities=27% Similarity=0.382 Sum_probs=198.6
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
++| ++.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+|+.|+||||++++++|... ...
T Consensus 92 ~~y-~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~----------~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~ 158 (391)
T PHA03212 92 AGF-SILETFTPGAEGFAFACIDNKTCEHVVIKAGQR----------GGTATEAHILRAINHPSIIQLKGTFTYN--KFT 158 (391)
T ss_pred CCc-EEEEEEcCCCCeEEEEEEECCCCCEEEEechhh----------hhhHHHHHHHHhCCCCCCCCEeEEEEEC--Cee
Confidence 456 778999999999999999999999999996431 2367899999999999999999988654 468
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
++|+|++. ++|..++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 159 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~-~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 159 CLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLGDFGAACFPVD 234 (391)
T ss_pred EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEc-CCCCEEEEeCCccccccc
Confidence 89999995 789999988888999999999999999999999998 99999999999997 789999999999864322
Q ss_pred ---CCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCC-------CHHHHHHHHHc-CCC-----
Q 006779 184 ---PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK-------NPAQIYKKVTS-GIK----- 246 (631)
Q Consensus 184 ---~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~-------~~~~i~~~i~~-~~~----- 246 (631)
.......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.. ...++...+.. +..
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 22334679999999998754 58999999999999999999998875321 11111111110 000
Q ss_pred ---------------------CCCCC-----CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 247 ---------------------PASLS-----KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 247 ---------------------p~~l~-----~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
+...+ ...+.++++||.+||. +|.+||||.|+|.||||+.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 10000 0134578999999998 9999999999999999976
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=348.96 Aligned_cols=256 Identities=29% Similarity=0.392 Sum_probs=204.4
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC--
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT-- 99 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~-- 99 (631)
..+|| ++.+.||+|+||.||+|.+..++..||+|.+.... .......++.+|+.+++.++||||++++++|....
T Consensus 15 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 15 VLKRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhce-eEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc--cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 34688 66789999999999999999999999999986432 23445677889999999999999999999886433
Q ss_pred --CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 100 --NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 100 --~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
...+++||||+.+ +|.+++.. .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~-~~~~~kl~Dfg~ 165 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGL 165 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEC-CCCCEEEeeCcc
Confidence 2357999999965 67776653 4889999999999999999999998 99999999999997 789999999999
Q ss_pred cchhcCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC-----------
Q 006779 178 AIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG----------- 244 (631)
Q Consensus 178 a~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~----------- 244 (631)
+...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..........+..-
T Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 9765443 2345678999999998764 58999999999999999999999997643322222111100
Q ss_pred -----------CC------C-----------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 245 -----------IK------P-----------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 245 -----------~~------p-----------~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
.. + .......+..+++||.+||. +|.+|||+.|+|+||||..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 00 0 00112234678999999998 8999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=329.63 Aligned_cols=254 Identities=34% Similarity=0.571 Sum_probs=212.0
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeeccccc-CCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~-~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV 106 (631)
++.+.||+|+||.||+|.+..+|..||+|.+...... ........+.+|+.+++.++||||+++++++.+.....++++
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence 5679999999999999999999999999998754321 123455678999999999999999999998876656789999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC--
Q 006779 107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 184 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-- 184 (631)
+||+.+++|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||+|+||+++ .++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~-~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 85 MEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCCCccccccccc
Confidence 999999999999988888999999999999999999999998 99999999999997 7889999999998654321
Q ss_pred ---CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006779 185 ---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 185 ---~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~ 260 (631)
......++..|+|||.+.+ .++.++|||||||++|+|++|+.||........+.+..... ....++...++.+++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 240 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP-TNPQLPSHISEHARD 240 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC-CCCCCchhcCHHHHH
Confidence 1223468889999998764 47899999999999999999999998765555554443332 334455567889999
Q ss_pred HHHHhcCCCCCCCCHHHHhcCCCCC
Q 006779 261 FIEKCIVPASLRLPALELLKDPFLV 285 (631)
Q Consensus 261 lI~~cL~~p~~Rpsa~elL~hpff~ 285 (631)
||..|+.+|.+||++.|+++||||+
T Consensus 241 li~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 241 FLGCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHhcCChhhCcCHHHHhcCcccc
Confidence 9954445999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.42 Aligned_cols=248 Identities=27% Similarity=0.474 Sum_probs=202.5
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
.+.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+|+.++|+||++++++|.+. ..+++||
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 151 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDTVRRQICREIEILRDVNHPNVVKCHDMFDHN--GEIQVLL 151 (353)
T ss_pred hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC--CeEEEEE
Confidence 44578999999999999999999999999986432 344557789999999999999999999988554 4789999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC--C
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--T 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--~ 185 (631)
||+.+|+|... ...++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...... .
T Consensus 152 e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 152 EFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLIN-SAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred ecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCCEEEcccccceeccccccc
Confidence 99999998643 34678889999999999999999999 99999999999998 7899999999999765433 2
Q ss_pred CccccCCCCCCCcccccc-----c-cCccccchhhhHHHHHHhhcCCCCCCCC--CHHHHHHHHHcCCCCCCCCCCCcHH
Q 006779 186 ARSVIGTPEFMAPELYEE-----E-YNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 186 ~~~~~GTp~Y~APEvl~~-----~-ys~~sDIwSLGiilyELltG~~Pf~~~~--~~~~i~~~i~~~~~p~~l~~~~~~~ 257 (631)
.....||+.|+|||++.. . ++.++|||||||++|||++|+.||.... ....+...+.... +.......+.+
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 303 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ-PPEAPATASRE 303 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-CCCCCCccCHH
Confidence 345679999999998742 2 3468999999999999999999997422 2222333333222 23344566789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 258 VKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 258 l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
+++||.+||. +|.+||++.|+|+||||....
T Consensus 304 l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 304 FRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 9999999998 899999999999999998753
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=336.24 Aligned_cols=242 Identities=22% Similarity=0.318 Sum_probs=205.8
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEc--CCCCeEEEEEe
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD--DTNRTINMITE 108 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d--~~~~~l~lV~E 108 (631)
..||+|+++.||+|.. +|..||+|.+..... ......+.+.+|+.+|++++||||+++++++.+ .....+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHK-GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEecccccc-ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 4699999999999976 799999999875432 233445778899999999999999999999877 44557899999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCCc
Q 006779 109 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187 (631)
Q Consensus 109 y~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~ 187 (631)
|+.+|+|.+++.+.+.+++.....++.|++.||.|||+. + ++||||||+|||++ .++.+||+|||++....... .
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~-~~~~~kl~dfg~~~~~~~~~-~ 178 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVT-ENYKLKIICHGLEKILSSPP-F 178 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEEC-CCCcEEEcccchHhhhcccc-c
Confidence 999999999999888899999999999999999999984 6 88999999999998 78999999999997654332 3
Q ss_pred cccCCCCCCCcccccc---ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 006779 188 SVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264 (631)
Q Consensus 188 ~~~GTp~Y~APEvl~~---~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~ 264 (631)
...|++.|+|||++.+ .|+.++|||||||++|||++|+.||.. .+..+++..+..+.....++...++.+++||.+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN-LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 4568999999998854 689999999999999999999999986 456666666654433444555678899999999
Q ss_pred hcC-CCCCCCCHHHHhc
Q 006779 265 CIV-PASLRLPALELLK 280 (631)
Q Consensus 265 cL~-~p~~Rpsa~elL~ 280 (631)
||+ +|.+|||+.+++.
T Consensus 258 cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 258 CTSHDSIKRPNIKEILY 274 (283)
T ss_pred HhcCCcccCcCHHHHHH
Confidence 998 8999999999985
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=331.78 Aligned_cols=254 Identities=27% Similarity=0.492 Sum_probs=210.5
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
..+.++| ++.+.||+|+||.||+|.+..++..||+|.++... ......+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~~-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~- 78 (267)
T cd06645 5 RNPQEDF-ELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR- 78 (267)
T ss_pred cCcHHHH-HHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-
Confidence 4455677 66789999999999999999999999999987542 23445678899999999999999999988764
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
..+++||||+.+++|.+++...+.+++..++.++.|++.||.|||+++ ++|+||||+||+++ .++.+||+|||++.
T Consensus 79 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~~ 154 (267)
T cd06645 79 -DKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLT-DNGHVKLADFGVSA 154 (267)
T ss_pred -CEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECcceeee
Confidence 478999999999999999998889999999999999999999999998 99999999999997 78899999999986
Q ss_pred hhcCC--CCccccCCCCCCCccccc----cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--
Q 006779 180 VMQQP--TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS-- 251 (631)
Q Consensus 180 ~~~~~--~~~~~~GTp~Y~APEvl~----~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~-- 251 (631)
..... ......|++.|+|||++. ..++.++|||||||++|+|++|..||........+.........+....
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06645 155 QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDK 234 (267)
T ss_pred EccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCccccc
Confidence 54332 223457899999999763 3488999999999999999999999976443333333333332232222
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 006779 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPF 283 (631)
Q Consensus 252 ~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpf 283 (631)
...+..+++||.+||. +|.+||++.+++.|||
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 235 MKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 1356789999999998 8999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=361.05 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=213.5
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccC-CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVD-GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~t-g~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~ 100 (631)
|..+-|++.+.||+|+||.||+|.+..+ +..||+|.+... .......+.+|+.+|+.++||||++++++|...
T Consensus 64 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-- 137 (478)
T PTZ00267 64 PREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAYARSELHCLAACDHFGIVKHFDDFKSD-- 137 (478)
T ss_pred CcceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC--
Confidence 3333358889999999999999999888 789999977533 344556788899999999999999999998765
Q ss_pred CeEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccc
Q 006779 101 RTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~----~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 176 (631)
..+++||||+.+|+|.+++.+ ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 138 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~~kL~DFg 214 (478)
T PTZ00267 138 DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLM-PTGIIKLGDFG 214 (478)
T ss_pred CEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEEC-CCCcEEEEeCc
Confidence 479999999999999987754 456899999999999999999999998 99999999999998 78899999999
Q ss_pred ccchhcCC----CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006779 177 LAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 251 (631)
Q Consensus 177 la~~~~~~----~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~ 251 (631)
++...... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...++..+..+..+ .++
T Consensus 215 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~-~~~~~~~~~~~~~~~~-~~~ 292 (478)
T PTZ00267 215 FSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG-PSQREIMQQVLYGKYD-PFP 292 (478)
T ss_pred CceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC-CCC
Confidence 99765432 2345679999999998764 589999999999999999999999976 4555666666554332 234
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 252 ~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
...++.+++||.+||. +|.+||++.++|.|||++.
T Consensus 293 ~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 293 CPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 4567899999999998 8999999999999999864
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=348.24 Aligned_cols=254 Identities=29% Similarity=0.413 Sum_probs=204.1
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC---
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--- 99 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~--- 99 (631)
.+|| ++.+.||+|+||.||+|.+..++..||+|++.... ........+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 23 LKRY-QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hcce-eEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc--cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 4677 67799999999999999999999999999986432 23345567889999999999999999999875432
Q ss_pred -CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 100 -NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 -~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
...+|+||||+.+ +|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a 173 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA 173 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEEC-CCCcEEEEeCCCc
Confidence 2368999999964 77777753 4889999999999999999999998 99999999999997 7899999999999
Q ss_pred chhcCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC----------
Q 006779 179 IVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---------- 246 (631)
Q Consensus 179 ~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~---------- 246 (631)
...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..... .+..+.....
T Consensus 174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 174 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred cccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHhh
Confidence 765443 2345678999999998754 58999999999999999999999997644333 2222221100
Q ss_pred -----------C-------------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 247 -----------P-------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 247 -----------p-------------------~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
| .......+..+++||.+||. +|.+|||+.++|.||||..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0 00111234678999999998 9999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=334.45 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=203.7
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEeccCC
Q 006779 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112 (631)
Q Consensus 33 LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~~g 112 (631)
||+|+||.||++.++.+|..||+|.+...... .......+..|+++++.++||||+++++++.+. ..+++||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLK-KKSGEKMALLEKEILEKVNSPFIVNLAYAFESK--THLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhh-cchhhHHHHHHHHHHHhcCCCcEEEEEEEEecC--CeEEEEEecCCC
Confidence 79999999999999999999999998754321 122234466799999999999999999988654 478999999999
Q ss_pred CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC-CCccc
Q 006779 113 GSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSV 189 (631)
Q Consensus 113 GsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-~~~~~ 189 (631)
++|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.++|+|||++...... .....
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~ 154 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQR 154 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEc-CCCCEEEeeceeeeecCCCceeecc
Confidence 99998886543 5889999999999999999999998 99999999999997 7889999999998765433 22345
Q ss_pred cCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHh
Q 006779 190 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265 (631)
Q Consensus 190 ~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~---~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~c 265 (631)
.|++.|+|||++.+ .++.++|||||||++|+|++|..||..... ..++.........+. .....++++++||.+|
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~ 233 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLF 233 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHHHHHHHHH
Confidence 68999999998754 589999999999999999999999975332 233333333322221 2234678999999999
Q ss_pred cC-CCCCCCCH----HHHhcCCCCCCCCCcc
Q 006779 266 IV-PASLRLPA----LELLKDPFLVTDNPKD 291 (631)
Q Consensus 266 L~-~p~~Rpsa----~elL~hpff~~~~~~~ 291 (631)
|+ +|.+||++ .++++||||+..++..
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~ 264 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKTINFPR 264 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcCCCHHH
Confidence 98 89999999 6788999998765544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=359.73 Aligned_cols=253 Identities=19% Similarity=0.321 Sum_probs=198.2
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC------CCceeeeeeEE
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH------ENIIKFYNSWV 96 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~H------pnIVkl~~~~~ 96 (631)
.+|| ++.++||+|+||+||+|.+..++..||+|+++.. ......+..|+.+++.++| ++|++++++|.
T Consensus 128 ~~~y-~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 128 TQRF-KILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred CCcE-EEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 4677 7789999999999999999999999999998632 1223345567777777654 45888988876
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccCCCCCeeecCCCC-------
Q 006779 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNG------- 168 (631)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs-~~~~IiHrDLKp~NILl~~~~g------- 168 (631)
.. ...+++||+++ +++|.+++.+++.+++..++.++.||+.||.|||+ .+ ||||||||+|||++ .++
T Consensus 202 ~~-~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~-~~~~~~~~~~ 276 (467)
T PTZ00284 202 NE-TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILME-TSDTVVDPVT 276 (467)
T ss_pred cC-CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEe-cCCccccccc
Confidence 54 34788999988 78999999888899999999999999999999998 47 99999999999997 333
Q ss_pred ---------cEEEccccccchhcCCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHH
Q 006779 169 ---------EVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238 (631)
Q Consensus 169 ---------~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~ 238 (631)
.+||+|||.+.... ......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||....+...+.
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDER-HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred ccccCCCCceEEECCCCccccCc-cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 59999999875432 22345689999999998754 59999999999999999999999997744433222
Q ss_pred HHHHc--CCCCCC--------------------------------------CCCCCcHHHHHHHHHhcC-CCCCCCCHHH
Q 006779 239 KKVTS--GIKPAS--------------------------------------LSKVTDPQVKQFIEKCIV-PASLRLPALE 277 (631)
Q Consensus 239 ~~i~~--~~~p~~--------------------------------------l~~~~~~~l~~lI~~cL~-~p~~Rpsa~e 277 (631)
.+.. +..|.. .....++.+.+||.+||+ ||.+|||+.|
T Consensus 356 -~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e 434 (467)
T PTZ00284 356 -LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ 434 (467)
T ss_pred -HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence 1111 000000 001134678899999998 9999999999
Q ss_pred HhcCCCCCCCC
Q 006779 278 LLKDPFLVTDN 288 (631)
Q Consensus 278 lL~hpff~~~~ 288 (631)
+|+||||....
T Consensus 435 ~L~Hp~~~~~~ 445 (467)
T PTZ00284 435 MTTHPYVLKYY 445 (467)
T ss_pred HhcCccccccC
Confidence 99999998643
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=377.82 Aligned_cols=261 Identities=25% Similarity=0.448 Sum_probs=219.7
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
.++| ++.+.||+|+||+||+|.+..++..||+|.+..... .......+..|+.+|+.|+|||||+++++|.+.....
T Consensus 12 l~~Y-eIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l--~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 12 LNEY-EVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL--KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred cCCE-EEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3566 778999999999999999999999999999876543 3455677899999999999999999999998877778
Q ss_pred EEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCEEeccCCCCCeeecC--------
Q 006779 103 INMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHN-----PPIIHRDLKCDNIFVNG-------- 165 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~----~~~l~~~~i~~i~~QIl~aL~yLHs~~-----~~IiHrDLKp~NILl~~-------- 165 (631)
+||||||+.+|+|.+++.. .+.+++..++.|+.||+.||.|||+.+ .+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 9999999999999999875 357999999999999999999999854 34999999999999952
Q ss_pred --------CCCcEEEccccccchhcCC-CCccccCCCCCCCcccccc---ccCccccchhhhHHHHHHhhcCCCCCCCCC
Q 006779 166 --------NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKN 233 (631)
Q Consensus 166 --------~~g~vKL~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~---~ys~~sDIwSLGiilyELltG~~Pf~~~~~ 233 (631)
..+.+||+|||++..+... .....+||+.|+|||++.+ .++.++|||||||++|+|+||..||.....
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 1235899999999765433 2345679999999998743 488999999999999999999999987777
Q ss_pred HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 234 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 234 ~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
..++...+..+... .....++.+.+||..||. +|.+||++.++|.||||....
T Consensus 249 ~~qli~~lk~~p~l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 249 FSQLISELKRGPDL--PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred HHHHHHHHhcCCCC--CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 77777776654322 123457899999999998 899999999999999997543
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=340.39 Aligned_cols=246 Identities=26% Similarity=0.425 Sum_probs=193.1
Q ss_pred eeEecccCceEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 30 DEILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 30 ~e~LG~G~fg~Vy~a~d~--~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
+.+||+|+||+||+|.++ .++..||+|.+..... ...+.+|+.+|+.++||||++++++|.......+++|+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence 467999999999999975 4779999999864321 23467899999999999999999999877777899999
Q ss_pred eccCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeec---CCCCcEEEccc
Q 006779 108 ELFTSGSLRQYRKKH---------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN---GNNGEVKIGDL 175 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~---------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~---~~~g~vKL~DF 175 (631)
||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+. ..++.+||+||
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 9985 5888887532 25899999999999999999999999 99999999999994 24578999999
Q ss_pred cccchhcCC-----CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCH---------HHHHH
Q 006779 176 GLAIVMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNP---------AQIYK 239 (631)
Q Consensus 176 Gla~~~~~~-----~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~---------~~i~~ 239 (631)
|++...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||...... .++..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence 999765432 2234678999999998754 4889999999999999999999999643211 11111
Q ss_pred HHHcCCCC------------C-----------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 006779 240 KVTSGIKP------------A-----------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF 283 (631)
Q Consensus 240 ~i~~~~~p------------~-----------------------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpf 283 (631)
.+.....| . ......+..+.+||.+||. ||.+|||+.|+|+|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07868 237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 316 (317)
T ss_pred HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 11100000 0 0001235678999999998 9999999999999999
Q ss_pred C
Q 006779 284 L 284 (631)
Q Consensus 284 f 284 (631)
|
T Consensus 317 f 317 (317)
T cd07868 317 F 317 (317)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=333.54 Aligned_cols=251 Identities=25% Similarity=0.459 Sum_probs=213.5
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEeecccccCC----HHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCeEE
Q 006779 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS----PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 30 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~----~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~l~ 104 (631)
+++||+|..++|.++.++.+|.+.|+|++.......+ ....+.-.+|+.+|+++ .||+|+++.++|. ....++
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye--s~sF~F 99 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE--SDAFVF 99 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc--Ccchhh
Confidence 4789999999999999999999999999876543222 23446677899999999 6999999999884 445889
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
+|+|+|..|.|.+|+...-.++++..+++++|++.|++|||.++ |+||||||+|||++ ++.++||.|||+++.+...
T Consensus 100 lVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILld-dn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 100 LVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLD-DNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeec-cccceEEeccceeeccCCc
Confidence 99999999999999999999999999999999999999999999 99999999999998 7889999999999887654
Q ss_pred -CCccccCCCCCCCccccc-------cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCC
Q 006779 185 -TARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVT 254 (631)
Q Consensus 185 -~~~~~~GTp~Y~APEvl~-------~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--~~l~~~~ 254 (631)
.....||||.|+|||.+. .+|+..+|+|++|+|||-|+.|..||... ..-.+...|.+|... ..-....
T Consensus 177 ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-kQmlMLR~ImeGkyqF~speWadi 255 (411)
T KOG0599|consen 177 EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-KQMLMLRMIMEGKYQFRSPEWADI 255 (411)
T ss_pred hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-HHHHHHHHHHhcccccCCcchhhc
Confidence 466789999999999774 25899999999999999999999999752 222334455555432 2223445
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
+..+++||.+||+ ||.+|.|++|+|.||||..
T Consensus 256 s~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 256 SATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred cccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 6789999999998 9999999999999999965
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=336.42 Aligned_cols=251 Identities=28% Similarity=0.457 Sum_probs=209.4
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||+|+||.||+|.+..+|..+|+|.+.... ......++.+|++++++++||||+++++.+.+. ..+++||
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 78 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI---KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD--GEISICM 78 (308)
T ss_pred eEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--CEEEEEe
Confidence 77899999999999999999999999999987432 344566788999999999999999999988764 4799999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCC
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 186 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~ 186 (631)
||+.+++|.+++.+.+.+++..+..++.||+.||.|||+ ++ ++||||||+|||++ .++.+||+|||++........
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~ 155 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA 155 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEe-cCCcEEEccCCCccccccccc
Confidence 999999999999988889999999999999999999997 46 99999999999998 788999999999876655445
Q ss_pred ccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc----------------------
Q 006779 187 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---------------------- 243 (631)
Q Consensus 187 ~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~---------------------- 243 (631)
....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||.... .......+..
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-AKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc-hhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 56788999999998754 48889999999999999999999996432 2222222211
Q ss_pred --------------CCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 244 --------------GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 244 --------------~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
...|.......++++++||.+||. +|.+||++.++++||||...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 111111112356789999999998 89999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=322.96 Aligned_cols=249 Identities=28% Similarity=0.556 Sum_probs=210.2
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||.|++|.||+|.++.+++.||+|.+..... .....+.+.+|+.+++.++||||+++++.+... ...+++|+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~ 79 (257)
T cd08223 3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA--SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIVM 79 (257)
T ss_pred eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEEe
Confidence 788999999999999999999999999999875432 234556788999999999999999999977533 34689999
Q ss_pred eccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC-
Q 006779 108 ELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 184 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~- 184 (631)
||+.+++|.+++... ..+++.+++.++.|++.||.|||+.+ ++||||||+||+++ .++.++|+|||++......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~-~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEe-cCCcEEEecccceEEecccC
Confidence 999999999998763 45899999999999999999999999 99999999999997 7889999999998755432
Q ss_pred -CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006779 185 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262 (631)
Q Consensus 185 -~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI 262 (631)
......+++.|+|||++.+ .++.++||||||+++|+|++|+.||... +.......+..+..+ ..+...++.+.+||
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li 234 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-DMNSLVYRIIEGKLP-PMPKDYSPELGELI 234 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhcCCC-CCccccCHHHHHHH
Confidence 2334568999999998754 4888999999999999999999999763 444444455454433 24456788999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCCCC
Q 006779 263 EKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 263 ~~cL~-~p~~Rpsa~elL~hpff 284 (631)
.+||+ +|.+||++.+++.||||
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 235 ATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHhccCcccCCCHHHHhcCCCC
Confidence 99998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=327.45 Aligned_cols=251 Identities=32% Similarity=0.525 Sum_probs=208.8
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeeccccc--CCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~--~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~l 105 (631)
++++.||+|+||.||+|.+ .+|..+|+|.+...... ........+.+|+.+|+.++|+||+++++++.+. ..+++
T Consensus 3 ~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 79 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NTISI 79 (265)
T ss_pred cccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--CeEEE
Confidence 6788999999999999986 47899999998754321 1234456789999999999999999999988654 57999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC--
Q 006779 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-- 183 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~-- 183 (631)
|+||+.+++|.+++.+...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++ .++.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLM-PNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEEC-CCCeEEeccchhhHhhhhcc
Confidence 9999999999999998888999999999999999999999998 99999999999997 789999999999865421
Q ss_pred ------CCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006779 184 ------PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 184 ------~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~ 256 (631)
.......|++.|+|||.+.+ .++.++||||||+++|+|++|..||...................+.++...+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCH
Confidence 11234568999999998764 48899999999999999999999997654444443333221222334556788
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 257 QVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
.+++||.+||. +|.+||++.++|.||||
T Consensus 237 ~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 237 AAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 99999999998 89999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=328.10 Aligned_cols=255 Identities=29% Similarity=0.534 Sum_probs=210.1
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcC
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 98 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~ 98 (631)
.+|.+|| ++.+.||+|++|.||+|.++.++..+++|.+.... ...+.+.+|+.+++.+ +||||++++++|...
T Consensus 2 ~~~~~~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (275)
T cd06608 2 PDPTGIF-ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKK 75 (275)
T ss_pred CCchhhe-eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhcCCCChheEEEEEEec
Confidence 4688999 77899999999999999999999999999987542 2346688999999999 799999999998764
Q ss_pred C----CCeEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcE
Q 006779 99 T----NRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 170 (631)
Q Consensus 99 ~----~~~l~lV~Ey~~gGsL~~~l~~----~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~v 170 (631)
. ...+++||||+.+++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||+|+||+++ .++.+
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~-~~~~~ 152 (275)
T cd06608 76 NPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLT-KNAEV 152 (275)
T ss_pred CCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEc-cCCeE
Confidence 4 3568999999999999998865 357999999999999999999999998 99999999999998 68899
Q ss_pred EEccccccchhcCC--CCccccCCCCCCCcccccc------ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006779 171 KIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 242 (631)
Q Consensus 171 KL~DFGla~~~~~~--~~~~~~GTp~Y~APEvl~~------~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~ 242 (631)
||+|||++...... ......|++.|+|||++.. .++.++|||||||++|+|++|..||........+. .+.
T Consensus 153 ~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~ 231 (275)
T cd06608 153 KLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF-KIP 231 (275)
T ss_pred EECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH-Hhh
Confidence 99999998654332 2234568999999997642 36789999999999999999999997643333333 333
Q ss_pred cCCCCCC-CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 243 SGIKPAS-LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 243 ~~~~p~~-l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
.+..+.. .....+..+++||.+||. +|.+|||+.+++.|||+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 232 RNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 3322221 122256789999999998 99999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=348.39 Aligned_cols=254 Identities=29% Similarity=0.430 Sum_probs=206.6
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC---CeEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---RTIN 104 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~---~~l~ 104 (631)
.+.+.||+|+||.||+|.+..+|..||+|.+... ........++.+|+.+|+.++||||+++++++..... ..+|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV--FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEecccc--ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4568899999999999999999999999988533 1233455678999999999999999999998865431 2689
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
+||||+. ++|..++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVN-SNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEEC-CCCCEEeccccceeecccC
Confidence 9999996 689888888888999999999999999999999999 99999999999998 7899999999999754322
Q ss_pred ---CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc----------------
Q 006779 185 ---TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---------------- 243 (631)
Q Consensus 185 ---~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~---------------- 243 (631)
......+|+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.. +.+....+..
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS-PIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC-HHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 2234568999999998764 37899999999999999999999997643 3332222211
Q ss_pred --------CCCCC------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 244 --------GIKPA------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 244 --------~~~p~------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
...+. .+....++++++||.+||. +|.+|||+.++|.||||....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 11111 1223347889999999998 899999999999999998743
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=334.21 Aligned_cols=257 Identities=22% Similarity=0.362 Sum_probs=209.3
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
+..++||+|+||.||+|.+..+|+.||+|.+...... .......+.+|+.+++.++|+||+++++.+.+. ..+++||
T Consensus 3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~ 79 (285)
T cd05630 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGESMALNEKQILEKVNSRFVVSLAYAYETK--DALCLVL 79 (285)
T ss_pred eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc-chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC--CEEEEEE
Confidence 5568899999999999999999999999998754322 233345677899999999999999999988654 4799999
Q ss_pred eccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC-
Q 006779 108 ELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 184 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~- 184 (631)
||+.+++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++ .++.++|+|||++......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeccceeecCCCc
Confidence 999999999988654 35899999999999999999999998 99999999999997 7889999999998654322
Q ss_pred CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006779 185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPA--QIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 185 ~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~--~i~~~i~~~~~p~~l~~~~~~~l~~l 261 (631)
......|++.|+|||++.+ .++.++||||||+++|+|++|+.||....... .....+... .+..+....++.+++|
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l 235 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEEYSEKFSPDARSL 235 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-hhhhcCccCCHHHHHH
Confidence 2234578999999998754 58999999999999999999999997643221 111222111 1223445678899999
Q ss_pred HHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCcc
Q 006779 262 IEKCIV-PASLRLP-----ALELLKDPFLVTDNPKD 291 (631)
Q Consensus 262 I~~cL~-~p~~Rps-----a~elL~hpff~~~~~~~ 291 (631)
|.+||+ +|.+||| +.|+++||||.......
T Consensus 236 i~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~ 271 (285)
T cd05630 236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKR 271 (285)
T ss_pred HHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHH
Confidence 999998 8999999 99999999998765553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=334.39 Aligned_cols=262 Identities=30% Similarity=0.508 Sum_probs=218.0
Q ss_pred cccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeE
Q 006779 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 95 (631)
Q Consensus 16 ~~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~ 95 (631)
.+.-.+|..|| ++.+.||+|+||.||+|.+..+|..||+|.+..... ...+.+.+|+.+++.++||||+++++.|
T Consensus 12 ~~~~~~~~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~v~~~~~~~ 86 (296)
T cd06654 12 IVSVGDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSY 86 (296)
T ss_pred ccccCCcccce-eeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc----chHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 35567888999 567889999999999999999999999999875432 2346688999999999999999999988
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccc
Q 006779 96 VDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 175 (631)
.+. ..+++||||+.+++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++ .++.+||+||
T Consensus 87 ~~~--~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~-~~~~~kl~df 160 (296)
T cd06654 87 LVG--DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDF 160 (296)
T ss_pred EeC--CEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCEEECcc
Confidence 764 478999999999999999865 45899999999999999999999998 99999999999997 7889999999
Q ss_pred cccchhcCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006779 176 GLAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 176 Gla~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~ 252 (631)
|++...... ......|++.|+|||.+.+ .++.++|||||||++|+|++|+.||........++.....+..+...+.
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T cd06654 161 GFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240 (296)
T ss_pred ccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCcc
Confidence 998654332 2234578999999997765 4789999999999999999999999764433444443333333333344
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 253 ~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
..++.+.+||.+||. +|.+||++.+++.||||....
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 567889999999998 899999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=338.35 Aligned_cols=254 Identities=27% Similarity=0.412 Sum_probs=203.5
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.+| ++.+.||+|+||.||+|.++.++..||+|.+..... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 79 (309)
T cd07872 6 ETY-IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIVHTD--KSL 79 (309)
T ss_pred Cce-EEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc---CCcchhHHHHHHHHHhCCCCCcceEEEEEeeC--CeE
Confidence 456 677899999999999999999999999999875432 12234577899999999999999999988654 468
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 80 TLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKS 155 (309)
T ss_pred EEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECccccceecC
Confidence 999999975 888887654 45899999999999999999999998 99999999999998 78899999999986543
Q ss_pred CC--CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC---C----------
Q 006779 183 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---I---------- 245 (631)
Q Consensus 183 ~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~---~---------- 245 (631)
.. ......+|+.|+|||++.+ .++.++|||||||++|+|+||+.||......+ ....+... .
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred CCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhhcc
Confidence 32 2234568999999997753 47899999999999999999999997643322 22222110 0
Q ss_pred --------CCC-------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 246 --------KPA-------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 246 --------~p~-------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
.+. ......++++++||.+||. +|.+|||+.|+|.||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 000 0112356789999999998 899999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=345.13 Aligned_cols=254 Identities=29% Similarity=0.443 Sum_probs=203.7
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC---
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--- 100 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~--- 100 (631)
.|| ++.+.||+|+||+||+|.+..++..||+|.+.... ........+.+|+.+|+.++||||++++++|.....
T Consensus 15 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 15 ERY-QNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF--QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhh-hhheecccCCCeEEEEEEECCCCCEEEEEEeCchh--hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 577 56789999999999999999999999999986432 122344668899999999999999999998754321
Q ss_pred -CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 101 -RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 -~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
..++++++++ +++|.++++. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~~ 166 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVN-EDCELRILDFGLAR 166 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEEC-CCCCEEEcCCccce
Confidence 3578999988 7899888754 56999999999999999999999999 99999999999997 78999999999997
Q ss_pred hhcCCCCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC--CC---------
Q 006779 180 VMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IK--------- 246 (631)
Q Consensus 180 ~~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~--~~--------- 246 (631)
..... ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||....... ....+... ..
T Consensus 167 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 167 QADDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred ecCCC-cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHhcc
Confidence 65433 345678999999998754 48899999999999999999999997643222 22222110 00
Q ss_pred --------------C-C---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 247 --------------P-A---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 247 --------------p-~---~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
+ . ......++.+.+||.+||. +|.+|||+.|+|.||||...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 0 0 0011245678999999998 89999999999999999763
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=332.57 Aligned_cols=258 Identities=31% Similarity=0.551 Sum_probs=216.3
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
.+|..+| .+.+.||.|+||.||+|.+..++..||+|.+... .....+.+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~~-~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 74 (280)
T cd06611 1 VNPNDIW-EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYE- 74 (280)
T ss_pred CCchhHH-HHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC-
Confidence 3688888 6678899999999999999999999999998744 345667788999999999999999999988654
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
..+++||||+.+++|..++.+. ..+++..++.++.|++.||.|||+++ |+||||+|+||+++ .++.++|+|||++
T Consensus 75 -~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~-~~~~~~l~d~g~~ 150 (280)
T cd06611 75 -NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLT-LDGDVKLADFGVS 150 (280)
T ss_pred -CeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEC-CCCCEEEccCccc
Confidence 4789999999999999998764 56999999999999999999999999 99999999999997 7899999999998
Q ss_pred chhcCC--CCccccCCCCCCCccccc------cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-CC
Q 006779 179 IVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-AS 249 (631)
Q Consensus 179 ~~~~~~--~~~~~~GTp~Y~APEvl~------~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p-~~ 249 (631)
...... ......+++.|+|||++. ..++.++||||||+++|+|++|+.||... +.......+..+..+ ..
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~ 229 (280)
T cd06611 151 AKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLD 229 (280)
T ss_pred hhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC-CHHHHHHHHhcCCCCCcC
Confidence 654332 223456899999999864 23677999999999999999999999764 444444455544332 22
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 250 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 250 l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
.+...+..+.+||.+||. +|.+||++.++|+||||....
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred CcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence 334567899999999998 899999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=331.64 Aligned_cols=260 Identities=29% Similarity=0.487 Sum_probs=215.5
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
.+|.++| ++.+.||+|+||.||+|.+..+|..|++|.+... .....+.+.+|+.+++.++||||+++++.+...
T Consensus 8 ~~~~~~y-~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 81 (292)
T cd06644 8 LDPNEVW-EIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD- 81 (292)
T ss_pred cCcchhh-hhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-
Confidence 3567777 7888999999999999999999999999998643 355677889999999999999999999988654
Q ss_pred CCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
..+++||||+.+++|..++.+ ...+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++
T Consensus 82 -~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~ 157 (292)
T cd06644 82 -GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLT-LDGDIKLADFGVS 157 (292)
T ss_pred -CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEc-CCCCEEEccCccc
Confidence 478999999999999987754 457899999999999999999999998 99999999999997 7889999999998
Q ss_pred chhcCC--CCccccCCCCCCCccccc------cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-CC
Q 006779 179 IVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-AS 249 (631)
Q Consensus 179 ~~~~~~--~~~~~~GTp~Y~APEvl~------~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p-~~ 249 (631)
...... ......+++.|+|||++. ..++.++|||||||++|+|++|..||... ++...+..+.....+ ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~ 236 (292)
T cd06644 158 AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPTLS 236 (292)
T ss_pred eeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc-cHHHHHHHHhcCCCccCC
Confidence 643322 223456889999999873 23678999999999999999999999764 444444444443332 22
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCc
Q 006779 250 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 250 l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~~ 290 (631)
.+...+..+.+||.+||. +|.+||++.++|.||||....+.
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 278 (292)
T cd06644 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN 278 (292)
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 334567889999999998 89999999999999999875543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=322.94 Aligned_cols=250 Identities=31% Similarity=0.543 Sum_probs=216.2
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
.+.+.||.|+||.||+|.+..+|..||+|.+..... .....+++..|+.+++.++||||+++++.+.......++++|
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM--TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 567889999999999999999999999999875543 355667889999999999999999999988877677899999
Q ss_pred eccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 108 ELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLH-----SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 108 Ey~~gGsL~~~l~~----~~~l~~~~i~~i~~QIl~aL~yLH-----s~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
||+.+++|..++.. ...+++..++.++.||+.||.||| +.+ ++||||+|+||+++ .++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~-~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLD-ANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEe-cCCCEEEeccccc
Confidence 99999999999876 357899999999999999999999 777 99999999999998 7899999999999
Q ss_pred chhcCCC--CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006779 179 IVMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 179 ~~~~~~~--~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~ 255 (631)
....... .....+++.|+|||.+.. .++.++|+||||+++|+|++|..||... +...+...+..+..+ .++...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~ 235 (265)
T cd08217 158 KILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR-NQLQLASKIKEGKFR-RIPYRYS 235 (265)
T ss_pred ccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc-CHHHHHHHHhcCCCC-CCccccC
Confidence 7665433 344578999999998754 4788999999999999999999999874 466666666665433 4555677
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 256 PQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
..+.+++.+||. +|.+||++.++|+|||+
T Consensus 236 ~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 236 SELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 899999999998 89999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=327.08 Aligned_cols=254 Identities=30% Similarity=0.508 Sum_probs=209.7
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccC--CHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~--~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~l 105 (631)
+..++||+|++|.||+|.+..+|..||+|.+....... .......+.+|+.+++.++||||+++++++.+. ..+++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~~ 80 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED--SHFNL 80 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC--CeEEE
Confidence 56789999999999999999999999999987543211 123457899999999999999999999988654 46889
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC
Q 006779 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~ 185 (631)
|+||+.+++|.+++.+.+.+++..++.|+.||+.||.|||+++ ++||||+|+||+++..+..+||+|||.+.......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 9999999999999998888999999999999999999999998 99999999999997444479999999986554321
Q ss_pred ------CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCcH
Q 006779 186 ------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 186 ------~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~--~~~i~~~i~~~~~p~~l~~~~~~ 256 (631)
.....|+..|+|||++.+ .++.++||||||+++|+|++|+.||..... .......+.....+...+...++
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence 223468889999998754 588999999999999999999999964332 22233233333334445556788
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 006779 257 QVKQFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~elL~hpff~ 285 (631)
.++++|.+||. +|.+||++.++|+||||+
T Consensus 239 ~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999997 899999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=331.06 Aligned_cols=255 Identities=30% Similarity=0.536 Sum_probs=210.9
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcC
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 98 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~ 98 (631)
..|.|+| ++.+.||+|+||.||+|.+..+++.||+|.+... ......+..|+.+++.+ +||||++++++|...
T Consensus 12 ~~~~~~~-~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 12 RDPAGIF-ELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred cChhhhh-hhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4578888 6678999999999999999999999999998643 23445688899999998 799999999988643
Q ss_pred ----CCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEE
Q 006779 99 ----TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 99 ----~~~~l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL 172 (631)
....++++|||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||+|+||+++ .++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~-~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLT-ENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEE
Confidence 245789999999999999998764 45889999999999999999999999 99999999999997 7889999
Q ss_pred ccccccchhcCC--CCccccCCCCCCCccccc------cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006779 173 GDLGLAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244 (631)
Q Consensus 173 ~DFGla~~~~~~--~~~~~~GTp~Y~APEvl~------~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~ 244 (631)
+|||++...... ......|++.|+|||++. ..++.++|||||||++|+|++|..||........+. .+...
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-~~~~~ 241 (282)
T cd06636 163 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRN 241 (282)
T ss_pred eeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-hHhhC
Confidence 999998654322 234457899999999764 247889999999999999999999997654333333 33333
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 245 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 245 ~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
..+.......+..+.+||.+||. +|.+||++.|||+||||
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 242 PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 33333344577899999999998 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=325.04 Aligned_cols=253 Identities=31% Similarity=0.557 Sum_probs=215.0
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeeccccc-CCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~-~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV 106 (631)
++.+.||+|+||.||+|.+..+|..||+|.+...... ........+.+|+.+++.++||||+++++.+.+.....++++
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (264)
T cd06653 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF 84 (264)
T ss_pred eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence 7889999999999999999999999999998654221 234456788999999999999999999999877666688999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC--
Q 006779 107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 184 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-- 184 (631)
+||+.+++|.+++...+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 85 VEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEECccccccccccccc
Confidence 999999999999988888999999999999999999999998 99999999999997 7889999999999754321
Q ss_pred ---CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006779 185 ---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 185 ---~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~ 260 (631)
......+++.|+|||.+.+ .++.++|+|||||++|+|++|+.||........+.+. .....+..++...+..+++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI-ATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH-HcCCCCCCCCcccCHHHHH
Confidence 1234568999999998764 4788999999999999999999999875444544433 3333344566677889999
Q ss_pred HHHHhcCCCCCCCCHHHHhcCCCC
Q 006779 261 FIEKCIVPASLRLPALELLKDPFL 284 (631)
Q Consensus 261 lI~~cL~~p~~Rpsa~elL~hpff 284 (631)
||.+||++|..||++.++|.|||.
T Consensus 241 ~i~~~l~~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFVEEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhcCcccCccHHHHhcCCCC
Confidence 999999988999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=332.30 Aligned_cols=253 Identities=23% Similarity=0.378 Sum_probs=203.2
Q ss_pred EecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHH---HHHhCCCCCceeeeeeEEcCCCCeEEEEEe
Q 006779 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH---LLKSLKHENIIKFYNSWVDDTNRTINMITE 108 (631)
Q Consensus 32 ~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~---iLk~L~HpnIVkl~~~~~d~~~~~l~lV~E 108 (631)
+||+|+||.||+|.+..+|..||+|.+........ .......+|.. ++...+||||+.+++++... ..+++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP--DKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc-hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC--CeEEEEEe
Confidence 48999999999999999999999999875433221 22222334443 34445899999999988654 46889999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCCcc
Q 006779 109 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188 (631)
Q Consensus 109 y~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~ 188 (631)
|+.+|+|..++..++.+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.++|+|||++..........
T Consensus 78 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~ 154 (279)
T cd05633 78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHA 154 (279)
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEEC-CCCCEEEccCCcceeccccCccC
Confidence 9999999999998888999999999999999999999999 99999999999997 78899999999986554444445
Q ss_pred ccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 006779 189 VIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264 (631)
Q Consensus 189 ~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~--~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~ 264 (631)
..|++.|+|||.+.. .++.++|||||||++|+|++|..||..... ...+..... ..+..++...++.+++||.+
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~ 232 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TVNVELPDSFSPELKSLLEG 232 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh--cCCcCCccccCHHHHHHHHH
Confidence 578999999998753 478999999999999999999999975322 222222211 12334455678899999999
Q ss_pred hcC-CCCCCC-----CHHHHhcCCCCCCCCCccc
Q 006779 265 CIV-PASLRL-----PALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 265 cL~-~p~~Rp-----sa~elL~hpff~~~~~~~~ 292 (631)
||. +|.+|+ ++.++++||||+..+....
T Consensus 233 ~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~ 266 (279)
T cd05633 233 LLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQV 266 (279)
T ss_pred HhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHH
Confidence 998 899999 6999999999998776554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=326.18 Aligned_cols=252 Identities=33% Similarity=0.585 Sum_probs=210.4
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC-----HHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-----PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~-----~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
|| .++..||+|++|.||+|.+..++..||+|.+........ ....+.+.+|+.+++.++||||+++++++...
T Consensus 1 ~~-~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 78 (267)
T cd06628 1 KW-IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA- 78 (267)
T ss_pred Cc-cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-
Confidence 45 667899999999999999999999999998875433221 12346788999999999999999999988664
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
...++||||+.+++|..++...+.+++..+..++.|++.||.|||+++ ++||||+|+||+++ .++.++|+|||.+.
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~-~~~~~~l~dfg~~~ 154 (267)
T cd06628 79 -DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVD-NKGGIKISDFGISK 154 (267)
T ss_pred -CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEc-CCCCEEecccCCCc
Confidence 468899999999999999999888999999999999999999999998 99999999999997 78899999999986
Q ss_pred hhcCC--------CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 006779 180 VMQQP--------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250 (631)
Q Consensus 180 ~~~~~--------~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l 250 (631)
..... ......|++.|+|||.+.+ .++.++|||||||++|+|++|+.||........+ ..+..... +.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~-~~~ 232 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI-FKIGENAS-PEI 232 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH-HHHhccCC-CcC
Confidence 55421 1123458899999998754 5888999999999999999999999875444433 33333322 234
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 251 ~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
+...+..++++|.+||. +|.+||++.+++.||||
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 233 PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred CcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 45577899999999998 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=328.62 Aligned_cols=257 Identities=27% Similarity=0.474 Sum_probs=210.3
Q ss_pred ccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEE
Q 006779 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (631)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 96 (631)
+.+..|.+.| ++.+.||+|+||.||+|.+..+|..||+|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~ 76 (267)
T cd06646 2 ILRRNPQHDY-ELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP----GDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76 (267)
T ss_pred ccccCchhhc-chhheeecCCCeEEEEEEECCCCeEEEEEEEecCc----cchHHHHHHHHHHHHhcCCCCeeeeeEEEE
Confidence 4556677777 77899999999999999999999999999986442 233456788999999999999999999987
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccc
Q 006779 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 176 (631)
.. ..+++||||+.+++|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||+|+||+++ .++.+||+|||
T Consensus 77 ~~--~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg 151 (267)
T cd06646 77 SR--EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLT-DNGDVKLADFG 151 (267)
T ss_pred eC--CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEECcCc
Confidence 55 478999999999999999988888999999999999999999999998 99999999999997 78899999999
Q ss_pred ccchhcCCC--CccccCCCCCCCccccc----cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 006779 177 LAIVMQQPT--ARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250 (631)
Q Consensus 177 la~~~~~~~--~~~~~GTp~Y~APEvl~----~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l 250 (631)
++....... .....|++.|+|||.+. ..++.++|||||||++|+|++|+.||..................+..+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd06646 152 VAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKL 231 (267)
T ss_pred cceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCC
Confidence 997554322 23456889999999763 337789999999999999999999996543222222221222222222
Q ss_pred --CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 006779 251 --SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF 283 (631)
Q Consensus 251 --~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpf 283 (631)
....+..+++||.+||. +|.+||++.++|.|+|
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 12356899999999998 8999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=321.47 Aligned_cols=248 Identities=31% Similarity=0.573 Sum_probs=212.2
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
.+.+.||+|++|.||+|.+..+|..|++|.+..... .......+.+|+.+++.++||||+++++++.+. ..+++||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYIIRYYESFLDK--GKLNIVM 78 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC--CHHHHHHHHHHHHHHHhcCCCCeehheeeeccC--CEEEEEE
Confidence 567899999999999999999999999999876543 245567799999999999999999999988654 4789999
Q ss_pred eccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC
Q 006779 108 ELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~ 185 (631)
||+.+++|.+++... ..++...+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~-~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEe-CCCCEEEcccccceeccCcc
Confidence 999999999998774 56899999999999999999999998 99999999999998 78899999999987554332
Q ss_pred --CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006779 186 --ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262 (631)
Q Consensus 186 --~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI 262 (631)
.....|++.|+|||++.+ .++.++|||||||++|+|++|+.||... +.......+..+..+. +....+..++++|
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i 233 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN-NQGALILKIIRGVFPP-VSQMYSQQLAQLI 233 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCCC-CccccCHHHHHHH
Confidence 234568999999998754 4789999999999999999999999764 4556666666554333 3446778999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCCCC
Q 006779 263 EKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 263 ~~cL~-~p~~Rpsa~elL~hpff 284 (631)
.+||+ +|.+||++.+++.|||+
T Consensus 234 ~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 234 DQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHccCCcccCcCHHHHhhCCCC
Confidence 99998 89999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=329.23 Aligned_cols=249 Identities=28% Similarity=0.522 Sum_probs=207.5
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.++||+|+||.||+|.+..++..||+|.+.... .......+.+|+.++++++||||+++++++... ...++||
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 78 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE--NRISICT 78 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC--CEEEEEE
Confidence 66789999999999999999999999999986542 344556788999999999999999999988765 4688999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCCc
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~ 187 (631)
||+.+++|..+ ..+++..+..++.|++.||.|||+++ |+|+||||+|||++ .++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~-~~~~~~l~dfg~~~~~~~~~~~ 151 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSIAK 151 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEEC-CCCCEEEeeCCcceeccccccc
Confidence 99999999765 35789999999999999999999998 99999999999997 7899999999999766555555
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCC------HHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006779 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN------PAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 188 ~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~------~~~i~~~i~~~~~p~~l~~~~~~~l~~ 260 (631)
...||+.|+|||++.+ .++.++||||||+++|+|++|..||..... +......+.....+.......++++++
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH 231 (279)
T ss_pred CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHH
Confidence 6789999999998754 588999999999999999999999964221 223333333332232223346789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 261 FIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 261 lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
||.+||. +|.+||++.+++.||||+..+
T Consensus 232 li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 232 FITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 9999998 899999999999999997654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=333.57 Aligned_cols=251 Identities=27% Similarity=0.481 Sum_probs=202.0
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
|| .+.+.||+|+||.||+|.+..+|..||+|.+..... .......+.+|+.+++.++||||+++++++.+. ..++
T Consensus 1 ~y-~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~~~ 75 (284)
T cd07839 1 KY-EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLYDVLHSD--KKLT 75 (284)
T ss_pred Cc-eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc--cccCccchhHHHHHHHhcCCCCeeeHHHHhccC--CceE
Confidence 55 567889999999999999999999999999875432 222335577899999999999999999988654 4689
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 105 MITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
+|+||+. ++|..++.. .+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++.....
T Consensus 76 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLIN-KNGELKLADFGLARAFGI 151 (284)
T ss_pred EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEc-CCCcEEECccchhhccCC
Confidence 9999996 578877765 567999999999999999999999998 99999999999998 788999999999875543
Q ss_pred C--CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-------------
Q 006779 184 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------------- 246 (631)
Q Consensus 184 ~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~------------- 246 (631)
. ......+++.|+|||++.+ .++.++|||||||++|+|+||..||....+....+..+.....
T Consensus 152 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 152 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 2 2234567899999998754 3789999999999999999999997554444443333321100
Q ss_pred ------C--------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 247 ------P--------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 247 ------p--------~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
+ .......++.+++||.+||. +|.+|||+.++|.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 00112356789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=340.06 Aligned_cols=251 Identities=22% Similarity=0.438 Sum_probs=201.8
Q ss_pred eeeEeccc--CceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEE
Q 006779 29 YDEILGKG--AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 29 ~~e~LG~G--~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV 106 (631)
+.++||+| +|++||++.++.+|+.||+|++..... .....+.+.+|+.+++.++||||++++++|..+ ...++|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv 77 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD--NELWVV 77 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc--cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CEEEEE
Confidence 45789999 688999999999999999999875532 234556788899999999999999999998765 468999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 107 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
|||+.+|+|.+++..+ ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.++++||+........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~-~~~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRSNLSMINH 154 (327)
T ss_pred EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEe-cCCcEEEcccchhhccccc
Confidence 9999999999999764 45899999999999999999999999 99999999999997 7889999999865332111
Q ss_pred ---------CCccccCCCCCCCcccccc---ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC----
Q 006779 185 ---------TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---- 248 (631)
Q Consensus 185 ---------~~~~~~GTp~Y~APEvl~~---~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~---- 248 (631)
......++..|+|||++.+ .|+.++|||||||++|+|++|+.||............+. +..+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~ 233 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN-GTVPCLLDT 233 (327)
T ss_pred cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc-CCccccccc
Confidence 1122356778999998754 488999999999999999999999976443333322221 11110
Q ss_pred ----------------------------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 249 ----------------------------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 249 ----------------------------------------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
......++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 0112246789999999998 99999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=321.63 Aligned_cols=253 Identities=35% Similarity=0.596 Sum_probs=213.1
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeeccccc-CCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~-~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
|| +.++.||+|++|.||+|.+..+|..|++|.+...... ...+....+.+|+.+++.++||||+++++++.+. ..+
T Consensus 1 ~~-~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~ 77 (258)
T cd06632 1 RW-RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE--DNL 77 (258)
T ss_pred Cc-cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC--CeE
Confidence 56 5679999999999999999999999999998754321 2345567899999999999999999999987654 468
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
++++||+.+++|.+++.+.+.+++..+..++.||+.||.|||+++ ++|+||+|+||+++ .++.+||+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~-~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 78 YIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVD-TNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCccceeccc
Confidence 999999999999999998888999999999999999999999998 99999999999998 788999999999876543
Q ss_pred CC-CccccCCCCCCCcccccc-c-cCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006779 184 PT-ARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 184 ~~-~~~~~GTp~Y~APEvl~~-~-ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~ 260 (631)
.. .....|++.|+|||.+.. . ++.++|+||||+++|+|++|+.||........... +........++...++.+++
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 233 (258)
T cd06632 155 FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK-IGRSKELPPIPDHLSDEAKD 233 (258)
T ss_pred cccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH-HHhcccCCCcCCCcCHHHHH
Confidence 32 345678999999997643 3 78999999999999999999999987553333333 33322333455567889999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 261 FIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 261 lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
||.+||. +|.+||++.++|.|||+
T Consensus 234 li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 234 FILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHhhcCcccCcCHHHHhcCCCC
Confidence 9999998 89999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=327.63 Aligned_cols=251 Identities=27% Similarity=0.496 Sum_probs=212.9
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
.+.+.||+|++|.||+|.++.++..||+|.+.... .......+.+|+.+++.++||||+++++.+... ..+++++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ 78 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDISICM 78 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEEEEE
Confidence 55688999999999999999999999999987543 235567789999999999999999999988765 5799999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC
Q 006779 108 ELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~ 185 (631)
||+.+++|.+++... ..+++..+..++.|++.||.|||+ .+ ++||||||+||+++ .++.++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~-~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEEC-CCCCEEEeecccchhhHHHH
Confidence 999999999999876 789999999999999999999999 88 99999999999998 68899999999987654443
Q ss_pred CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCC----CCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006779 186 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC----KNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 186 ~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~----~~~~~i~~~i~~~~~p~~l~~~~~~~l~~ 260 (631)
.....+++.|+|||.+.+ .++.++||||||+++|+|++|..||... .......+.+..+..+.......++++++
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06605 156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD 235 (265)
T ss_pred hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 334778999999997754 5889999999999999999999999764 23344445555544333333337889999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 261 FIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 261 lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
||.+||. +|.+||++.+++.||||+.
T Consensus 236 li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 236 FVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 9999998 8999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=328.85 Aligned_cols=253 Identities=23% Similarity=0.397 Sum_probs=205.2
Q ss_pred EecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHH---HHHHHhCCCCCceeeeeeEEcCCCCeEEEEEe
Q 006779 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE---VHLLKSLKHENIIKFYNSWVDDTNRTINMITE 108 (631)
Q Consensus 32 ~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~E---i~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~E 108 (631)
+||+|+||.||+|.+..+|+.||+|.+......... .......| +.+++...||||+++++++... ..+++|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ-GETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccch-hHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CEEEEEEe
Confidence 489999999999999999999999998755432211 11222333 3455566899999999988654 47899999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCCcc
Q 006779 109 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188 (631)
Q Consensus 109 y~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~ 188 (631)
|+.||+|.+++.+.+.+++..++.|+.|++.||.|||+++ |+||||||+||+++ .++.+||+|||++..........
T Consensus 78 ~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~-~~~~~kl~dfg~~~~~~~~~~~~ 154 (278)
T cd05606 78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHA 154 (278)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEEC-CCCCEEEccCcCccccCccCCcC
Confidence 9999999999988888999999999999999999999998 99999999999997 78899999999987655444455
Q ss_pred ccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCC--CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 006779 189 VIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264 (631)
Q Consensus 189 ~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~--~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~ 264 (631)
..|++.|+|||++.+ .++.++||||||+++|+|++|+.||.... ....+...+.. .+..++...++.++++|.+
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~ 232 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPELRSLLEG 232 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc--cCCCCCCcCCHHHHHHHHH
Confidence 679999999998753 48899999999999999999999997642 22233222222 2333455568999999999
Q ss_pred hcC-CCCCCC-----CHHHHhcCCCCCCCCCccc
Q 006779 265 CIV-PASLRL-----PALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 265 cL~-~p~~Rp-----sa~elL~hpff~~~~~~~~ 292 (631)
||. +|.+|| ++.++++||||....+..+
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~ 266 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMV 266 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHhCccccCCCchHh
Confidence 998 899999 9999999999998776554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=334.29 Aligned_cols=263 Identities=31% Similarity=0.527 Sum_probs=217.5
Q ss_pred cccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeE
Q 006779 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 95 (631)
Q Consensus 16 ~~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~ 95 (631)
-+...++..|| ++.+.||+|+||.||+|.+..+|..||+|.+.... ....+.+.+|+.+++.++||||++++++|
T Consensus 11 ~~~~~~~~~~y-~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 85 (297)
T cd06656 11 IVSVGDPKKKY-TRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSY 85 (297)
T ss_pred hcccCChhhhc-eeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc----cchHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 35567888999 66788999999999999999999999999987543 23346688999999999999999999988
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccc
Q 006779 96 VDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 175 (631)
... ..+++||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++||||||+|||++ .++.++|+||
T Consensus 86 ~~~--~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~-~~~~~~l~Df 159 (297)
T cd06656 86 LVG--DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDF 159 (297)
T ss_pred ecC--CEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEECcC
Confidence 654 478999999999999999865 45899999999999999999999998 99999999999997 7899999999
Q ss_pred cccchhcCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006779 176 GLAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 176 Gla~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~ 252 (631)
|++...... ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||........+......+..+...+.
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (297)
T cd06656 160 GFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE 239 (297)
T ss_pred ccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCcc
Confidence 998654332 2234578999999997754 4889999999999999999999999764333333322222322333445
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 253 ~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
..++.+++||.+||. +|.+||++.++|.||||....+
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 567889999999998 8999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=331.38 Aligned_cols=259 Identities=32% Similarity=0.558 Sum_probs=214.7
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
.+|..|| ++.+.||.|+||.||+|.+..+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 15 ~~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 88 (296)
T cd06655 15 GDPKKKY-TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK----QPKKELIINEILVMKELKNPNIVNFLDSFLVG- 88 (296)
T ss_pred CCCcceE-EEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc----CchHHHHHHHHHHHHhcCCCceeeeeeeEecC-
Confidence 4567788 56788999999999999999999999999987542 23346788999999999999999999988654
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
..+++|+||+.+++|..++... .+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++.
T Consensus 89 -~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~-~~~~~kl~dfg~~~ 163 (296)
T cd06655 89 -DELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLG-MDGSVKLTDFGFCA 163 (296)
T ss_pred -ceEEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCccch
Confidence 4789999999999999998764 5899999999999999999999998 99999999999997 78899999999986
Q ss_pred hhcCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006779 180 VMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 180 ~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~ 256 (631)
..... ......+++.|+|||.+.. .++.++|||||||++|+|++|..||........+.........+...+...++
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T cd06655 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSP 243 (296)
T ss_pred hcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCH
Confidence 54332 2234568899999997764 48899999999999999999999997744333333333333223334455678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 257 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
.+++||.+||. +|.+||++.+++.||||....+
T Consensus 244 ~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 244 IFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred HHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 99999999998 8999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=323.69 Aligned_cols=251 Identities=26% Similarity=0.423 Sum_probs=213.5
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEeccCC
Q 006779 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112 (631)
Q Consensus 33 LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~~g 112 (631)
||.|++|.||+|.+..++..||+|.+..... ........+.+|+.+++.++||||+++++.+.+. ..+++|+||+.+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHI-VETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK--KYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcc-hhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC--CccEEEEecCCC
Confidence 6999999999999999999999999875442 2234557799999999999999999999988654 468899999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC-CCccccC
Q 006779 113 GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIG 191 (631)
Q Consensus 113 GsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-~~~~~~G 191 (631)
++|.+++.+...+++..+..++.||+.||.|||+++ ++|+||+|+||+++ .++.++|+|||++...... ......+
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~-~~~~~~l~df~~~~~~~~~~~~~~~~~ 154 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCG 154 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEc-CCCCEEEeeCCcccccCcccccccccC
Confidence 999999998888999999999999999999999998 99999999999997 6889999999999766543 2234578
Q ss_pred CCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-C
Q 006779 192 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-P 268 (631)
Q Consensus 192 Tp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~-~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~ 268 (631)
++.|+|||.+. ..++.++|+||||+++|+|++|..||.... ++..++..+..+......+...++.+++||.+||. +
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCC
Confidence 99999999765 458899999999999999999999997644 25566666664444444555558899999999998 8
Q ss_pred CCCCCC-----HHHHhcCCCCCCCCC
Q 006779 269 ASLRLP-----ALELLKDPFLVTDNP 289 (631)
Q Consensus 269 p~~Rps-----a~elL~hpff~~~~~ 289 (631)
|.+||+ +.|+++||||...++
T Consensus 235 p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred hhhCcCCcccCHHHHhcChhhhCCCC
Confidence 999999 999999999987554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=321.59 Aligned_cols=252 Identities=29% Similarity=0.533 Sum_probs=210.8
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
|..+| .+.+.||.|+||.||+|.+..++..+++|.+.... ......+.+|+.+++.++||||+++++++.+. .
T Consensus 1 ~~~~~-~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~ 73 (262)
T cd06613 1 PQEDY-ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRR--D 73 (262)
T ss_pred Cccce-EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc----hhhHHHHHHHHHHHHhCCCCChhceEEEEEeC--C
Confidence 56778 67799999999999999999999999999987543 23567789999999999999999999988664 4
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 102 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
.++++|||+.+++|..++... ..+++..+..++.|++.||.|||+++ ++||||+|+||+++ .++.+||+|||++..
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~ 150 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLT-EDGDVKLADFGVSAQ 150 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEEC-CCCCEEECccccchh
Confidence 789999999999999998876 78999999999999999999999998 99999999999998 788999999999876
Q ss_pred hcCC--CCccccCCCCCCCcccccc----ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CC
Q 006779 181 MQQP--TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SK 252 (631)
Q Consensus 181 ~~~~--~~~~~~GTp~Y~APEvl~~----~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l--~~ 252 (631)
.... ......+++.|+|||++.. .++.++|||||||++|+|+||..||..................+..+ ..
T Consensus 151 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (262)
T cd06613 151 LTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKE 230 (262)
T ss_pred hhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchh
Confidence 5432 2334578899999997753 57889999999999999999999998755444443333332222221 22
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 006779 253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPF 283 (631)
Q Consensus 253 ~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpf 283 (631)
..+..+++||.+||. +|..||++.+++.|||
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 231 KWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 346789999999998 8999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=326.99 Aligned_cols=251 Identities=29% Similarity=0.522 Sum_probs=208.8
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||+|+||.||+|.+..++..+++|.+... .....+.+.+|+.+++.++||||+++++++... ...++|+
T Consensus 8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~~v~ 81 (282)
T cd06643 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWILI 81 (282)
T ss_pred HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC--CEEEEEE
Confidence 6678899999999999999999999999998643 345567788999999999999999999988764 4788999
Q ss_pred eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC--
Q 006779 108 ELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 184 (631)
Q Consensus 108 Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-- 184 (631)
||+.+++|..++.+ ...+++..+..++.||+.||.|||+.+ ++||||||+||+++ .++.+||+|||++......
T Consensus 82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEc-cCCCEEEcccccccccccccc
Confidence 99999999988765 467999999999999999999999998 99999999999997 7889999999998654322
Q ss_pred CCccccCCCCCCCccccc------cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCcHH
Q 006779 185 TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQ 257 (631)
Q Consensus 185 ~~~~~~GTp~Y~APEvl~------~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~-p~~l~~~~~~~ 257 (631)
......+++.|+|||++. ..++.++|||||||++|+|++|+.||... ++......+..... ....+...+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPTLAQPSRWSSE 237 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc-CHHHHHHHHhhcCCCCCCCccccCHH
Confidence 223456899999999863 23778999999999999999999999764 34444434433322 22334456789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 258 VKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 258 l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
+++||.+||. +|.+||++.++++||||....
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 238 FKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 9999999998 899999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=326.99 Aligned_cols=255 Identities=28% Similarity=0.470 Sum_probs=207.6
Q ss_pred CCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCC
Q 006779 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDT 99 (631)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~ 99 (631)
++.++| .+.+.||+|+||.||+|.+..+|..+|+|.+.... .....+.+|+.+++.+ +||||++++++|...+
T Consensus 19 ~~~~~y-~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 19 DPTDTW-EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCCCe-EEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 478888 67789999999999999999999999999886331 2235577899999999 8999999999887543
Q ss_pred ---CCeEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEE
Q 006779 100 ---NRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 100 ---~~~l~lV~Ey~~gGsL~~~l~~----~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL 172 (631)
...+++||||+.+++|.++++. ...+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~-~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLT-TEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEEE
Confidence 2468999999999999998763 457899999999999999999999998 99999999999997 7889999
Q ss_pred ccccccchhcCCC--CccccCCCCCCCcccccc------ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006779 173 GDLGLAIVMQQPT--ARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244 (631)
Q Consensus 173 ~DFGla~~~~~~~--~~~~~GTp~Y~APEvl~~------~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~ 244 (631)
+|||++....... .....|++.|+|||.+.. .++.++|||||||++|+|++|+.||........+ ..+..+
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~-~~~~~~ 248 (291)
T cd06639 170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL-FKIPRN 248 (291)
T ss_pred eecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH-HHHhcC
Confidence 9999987544322 234568899999998743 2678999999999999999999999874333333 334333
Q ss_pred CCCC-CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 006779 245 IKPA-SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 245 ~~p~-~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~ 285 (631)
..+. ..+......+++||.+||. +|.+||++.++|.||||+
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 249 PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 2221 1222355789999999998 899999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=316.83 Aligned_cols=252 Identities=38% Similarity=0.624 Sum_probs=218.6
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||+|++|.||+|.+..+|..|++|.+..... .....+.+.+|+.++++++||||+++++.+.+.....+++|+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD--SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 667899999999999999999999999999875542 245678899999999999999999999988765446799999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC--
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-- 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~-- 185 (631)
||+.+++|.+++.+...+++..+..++.|++.||.|||+++ ++|+||+|+||+++ .++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVD-SDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEc-CCCCEEEcccccEEeccccccc
Confidence 99999999999998889999999999999999999999998 99999999999998 68899999999997665443
Q ss_pred --CccccCCCCCCCccccccc-cCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006779 186 --ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262 (631)
Q Consensus 186 --~~~~~GTp~Y~APEvl~~~-ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI 262 (631)
.....++..|+|||.+... ++.++||||||+++|+|++|..||....+.......+........++...+..+++||
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 237 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence 3445789999999987654 8899999999999999999999998766555555555543444455666789999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCCCC
Q 006779 263 EKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 263 ~~cL~-~p~~Rpsa~elL~hpff 284 (631)
.+||. +|.+||++.+++.||||
T Consensus 238 ~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 238 RKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHhCcCChhhCCCHHHHhhCCCC
Confidence 99998 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=328.56 Aligned_cols=257 Identities=24% Similarity=0.381 Sum_probs=209.8
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
+..+.||+|+||+||+|.+..+|+.||+|.+...... .......+.+|+.+|+.++|+||+++++.+... ..+++||
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~ 79 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-KRKGESMALNEKQILEKVNSQFVVNLAYAYETK--DALCLVL 79 (285)
T ss_pred eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh-hhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC--CEEEEEE
Confidence 4568899999999999999999999999998754321 223345578899999999999999999988654 4789999
Q ss_pred eccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC-
Q 006779 108 ELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 184 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~- 184 (631)
||+.+++|..++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++ .++.+||+|||++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEC-CCCCEEEecCCcceecCCCC
Confidence 999999999887653 46999999999999999999999998 99999999999997 6789999999998654322
Q ss_pred CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCHH---HHHHHHHcCCCCCCCCCCCcHHHHH
Q 006779 185 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA---QIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 185 ~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~---~i~~~i~~~~~p~~l~~~~~~~l~~ 260 (631)
......|++.|+|||++. ..++.++|||||||++|+|++|..||....... .+...+... ...+....++.+.+
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 234 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET--EEVYSAKFSEEAKS 234 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc--ccccCccCCHHHHH
Confidence 234457899999999775 458999999999999999999999998643322 222222222 22334456788999
Q ss_pred HHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCccc
Q 006779 261 FIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 261 lI~~cL~-~p~~Rps-----a~elL~hpff~~~~~~~~ 292 (631)
|+.+||+ +|.+||+ +.+++.||||.....+.+
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 272 (285)
T cd05632 235 ICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRL 272 (285)
T ss_pred HHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHH
Confidence 9999998 8999999 889999999998766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=325.97 Aligned_cols=255 Identities=29% Similarity=0.515 Sum_probs=215.2
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
|| ++.+.||.|++|.||+|.+..+|..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ..++
T Consensus 2 ~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 75 (274)
T cd06609 2 LF-TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLW 75 (274)
T ss_pred hh-hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEE
Confidence 56 56688999999999999999999999999987543 234456788999999999999999999988765 5799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
+|+||+.+++|.+++... .+++..++.++.|++.||.|||+++ ++||||+|+||+++ .++.++|+|||++......
T Consensus 76 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLS-EEGDVKLADFGVSGQLTST 151 (274)
T ss_pred EEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEcccccceeeccc
Confidence 999999999999999876 7899999999999999999999998 99999999999998 7899999999999766543
Q ss_pred --CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006779 185 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 185 --~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~l 261 (631)
......+++.|+|||.+.+ .++.++||||||+++|+|+||..||... ++......+..+..+.......++.+.++
T Consensus 152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (274)
T cd06609 152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL-HPMRVLFLIPKNNPPSLEGNKFSKPFKDF 230 (274)
T ss_pred ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC-chHHHHHHhhhcCCCCCcccccCHHHHHH
Confidence 2334578899999997754 5899999999999999999999999763 45555555555443332222267899999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCCCCCCCc
Q 006779 262 IEKCIV-PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 262 I~~cL~-~p~~Rpsa~elL~hpff~~~~~~ 290 (631)
|.+||. +|.+||++.++++||||......
T Consensus 231 l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 231 VSLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred HHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 999997 89999999999999999875544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=326.23 Aligned_cols=255 Identities=26% Similarity=0.478 Sum_probs=207.6
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcC
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 98 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~ 98 (631)
.++..+| .+.+.||+|+||.||+|.++.+|..+|+|.+.... .....+..|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~-~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 14 PDPSDTW-EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred CCcccce-eeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 4677888 67789999999999999999999999999875321 2235577899999999 699999999987532
Q ss_pred ---CCCeEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEE
Q 006779 99 ---TNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 171 (631)
Q Consensus 99 ---~~~~l~lV~Ey~~gGsL~~~l~~----~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 171 (631)
....+++||||+.+++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLT-TEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEEC-CCCCEE
Confidence 33578999999999999998753 356899999999999999999999998 99999999999997 788999
Q ss_pred EccccccchhcCC--CCccccCCCCCCCccccc------cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006779 172 IGDLGLAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 243 (631)
Q Consensus 172 L~DFGla~~~~~~--~~~~~~GTp~Y~APEvl~------~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~ 243 (631)
|+|||++...... ......|++.|+|||++. ..++.++|||||||++|+|++|+.||........+.. +..
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~-~~~ 243 (286)
T cd06638 165 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK-IPR 243 (286)
T ss_pred EccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh-ccc
Confidence 9999998655432 233456899999999874 2378899999999999999999999987544343332 222
Q ss_pred CCC-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 244 GIK-PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 244 ~~~-p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
... ....+...+..+++||.+||. +|.+||++.|+|.|+||
T Consensus 244 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 244 NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 222 222344567789999999998 89999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=332.65 Aligned_cols=246 Identities=27% Similarity=0.422 Sum_probs=191.8
Q ss_pred eeEecccCceEEEEEEEcc--CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 30 DEILGKGAFKTVYKGFDEV--DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 30 ~e~LG~G~fg~Vy~a~d~~--tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
+.+||+|+||.||+|.++. ++..||+|.+.... ....+.+|+.+|+.++||||+++++++.......+++|+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence 4689999999999998654 67899999886432 123477899999999999999999999877777899999
Q ss_pred eccCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeec---CCCCcEEEccc
Q 006779 108 ELFTSGSLRQYRKKH---------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN---GNNGEVKIGDL 175 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~---------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~---~~~g~vKL~DF 175 (631)
||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+. ..++.+||+||
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 80 DYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 9986 5787776532 24889999999999999999999998 99999999999994 24678999999
Q ss_pred cccchhcCCC-----CccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCH---------HHHHH
Q 006779 176 GLAIVMQQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNP---------AQIYK 239 (631)
Q Consensus 176 Gla~~~~~~~-----~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~---------~~i~~ 239 (631)
|++....... .....||+.|+|||++.+ .++.++|||||||++|||+||+.||...... .++..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence 9997654321 234578999999998754 4789999999999999999999999642211 11111
Q ss_pred HHHc--------------CC--------------CCC-------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 006779 240 KVTS--------------GI--------------KPA-------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF 283 (631)
Q Consensus 240 ~i~~--------------~~--------------~p~-------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpf 283 (631)
.+.. .. ... ......+..+++||.+||+ +|.+|||+.|+|+|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07867 237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY 316 (317)
T ss_pred HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCC
Confidence 1100 00 000 0011235678899999998 9999999999999999
Q ss_pred C
Q 006779 284 L 284 (631)
Q Consensus 284 f 284 (631)
|
T Consensus 317 f 317 (317)
T cd07867 317 F 317 (317)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=351.55 Aligned_cols=252 Identities=27% Similarity=0.467 Sum_probs=208.3
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-C-----CCceeeeeeEE
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-H-----ENIIKFYNSWV 96 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-H-----pnIVkl~~~~~ 96 (631)
+.|| .+.++||+|+||.|.+|.|..||+.||||+++.. +....+...|+.+|..|+ | -|||+++++|.
T Consensus 185 ~~rY-~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~ 258 (586)
T KOG0667|consen 185 AYRY-EVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY 258 (586)
T ss_pred EEEE-EEEEEecccccceeEEEEecCCCcEEEEEeeccC-----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence 3466 5689999999999999999999999999999743 566777889999999997 4 38999999997
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC-CCCcEEEc
Q 006779 97 DDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIG 173 (631)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~-~~g~vKL~ 173 (631)
..+ +++||+|++ +.+|.++++.+ .+|+...++.+++||+.||.+||+.+ |||+||||+|||+.. ....|||+
T Consensus 259 fr~--HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVI 333 (586)
T KOG0667|consen 259 FRN--HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVI 333 (586)
T ss_pred ccc--ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEE
Confidence 664 688999999 57999999976 46999999999999999999999999 999999999999962 22379999
Q ss_pred cccccchhcCCCCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc-CC------
Q 006779 174 DLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GI------ 245 (631)
Q Consensus 174 DFGla~~~~~~~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~-~~------ 245 (631)
|||.++...+... +++-+..|+|||++- ..|+.+.||||||||++||++|.+.|.+....+|+..++.- |.
T Consensus 334 DFGSSc~~~q~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL 412 (586)
T KOG0667|consen 334 DFGSSCFESQRVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML 412 (586)
T ss_pred ecccccccCCcce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9999987666554 788899999999765 57999999999999999999998888875555555433221 00
Q ss_pred ----------------------------------------------CCCC-------CCCCCcHHHHHHHHHhcC-CCCC
Q 006779 246 ----------------------------------------------KPAS-------LSKVTDPQVKQFIEKCIV-PASL 271 (631)
Q Consensus 246 ----------------------------------------------~p~~-------l~~~~~~~l~~lI~~cL~-~p~~ 271 (631)
.|.. +....+..+.+||.+||. +|.+
T Consensus 413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~ 492 (586)
T KOG0667|consen 413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE 492 (586)
T ss_pred HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence 0100 011234568999999998 9999
Q ss_pred CCCHHHHhcCCCCCC
Q 006779 272 RLPALELLKDPFLVT 286 (631)
Q Consensus 272 Rpsa~elL~hpff~~ 286 (631)
|+|+.++|+||||..
T Consensus 493 R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 493 RITPAQALNHPFLTG 507 (586)
T ss_pred cCCHHHHhcCccccc
Confidence 999999999999985
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=326.05 Aligned_cols=249 Identities=28% Similarity=0.452 Sum_probs=201.5
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||+|++|.||+|.+..+|..||+|.+..... .......+.+|+.+++.++||||+++++++.++ ..+++||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 78 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQHPNIVCLQDVLMQE--SRLYLIF 78 (285)
T ss_pred eEeeEecccCceEEEEEEECCCCcEEEEEEeccccc--cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC--CeEEEEE
Confidence 677899999999999999999999999999875432 222345678899999999999999999998764 4789999
Q ss_pred eccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 108 ELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~---~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
||+. ++|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++......
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGIP 154 (285)
T ss_pred ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEc-CCCcEEECcccceeecCCC
Confidence 9997 6898887653 46899999999999999999999998 99999999999997 7899999999998654332
Q ss_pred C--CccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-------------
Q 006779 185 T--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP------------- 247 (631)
Q Consensus 185 ~--~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p------------- 247 (631)
. .....+++.|+|||++.+ .++.++|||||||++|+|+||+.||.+................+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 1 233467899999997754 47889999999999999999999998654433333222110000
Q ss_pred -------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 248 -------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 248 -------------~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
.......++++++||.+||. +|.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 01122357889999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=324.93 Aligned_cols=257 Identities=27% Similarity=0.476 Sum_probs=212.0
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
+| ...+.||.|++|.||+|.+..++..||+|.+.... ......++.+|+++++.++||||++++++|.+.....++
T Consensus 2 ~~-~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 2 KI-VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred ce-EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence 45 55688999999999999999999999999987542 234557789999999999999999999998877667899
Q ss_pred EEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 105 MITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~----~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
+||||+.+++|.+++.. ...+++..+..++.||+.||.|||+++ ++|+||+|+||+++ .++.++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~ 154 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLT-RKGQVKLCDFGVSGE 154 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEe-cCCeEEEeecccccc
Confidence 99999999999988653 355899999999999999999999998 99999999999997 788999999999866
Q ss_pred hcCCCCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCC----CCHHHHHHHHHcCCCCC---CCC-
Q 006779 181 MQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNEC----KNPAQIYKKVTSGIKPA---SLS- 251 (631)
Q Consensus 181 ~~~~~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~----~~~~~i~~~i~~~~~p~---~l~- 251 (631)
..........++..|+|||.+. ..++.++|||||||++|+|++|..||... ..+.+....+.....+. ...
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd06621 155 LVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234 (287)
T ss_pred ccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence 5544444556788999999765 45889999999999999999999999764 23344444444322211 111
Q ss_pred -CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 252 -KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 252 -~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
...++.+++||.+||. +|.+|||+.|++.||||+...
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 2246789999999998 899999999999999996644
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=321.02 Aligned_cols=250 Identities=32% Similarity=0.565 Sum_probs=207.9
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
|..+| .+.+.||+|+||.||+|.+..++..|++|.+.... ..+.+.+|+++++.++||||+++++.+.+. .
T Consensus 1 ~~~~y-~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~ 71 (256)
T cd06612 1 PEEVF-DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQCDSPYIVKYYGSYFKN--T 71 (256)
T ss_pred Ccccc-hhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHHHHHHHHHHHHhCCCCcEeeeeeeeecC--C
Confidence 45677 67789999999999999999999999999986432 257789999999999999999999988765 5
Q ss_pred eEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 102 TINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
.+++++||+.+++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||+|+||+++ .++.++|+|||++..
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~-~~~~~~l~dfg~~~~ 148 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLN-EEGQAKLADFGVSGQ 148 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEC-CCCcEEEcccccchh
Confidence 78999999999999999875 457899999999999999999999998 99999999999998 788999999999976
Q ss_pred hcCCC--CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCcH
Q 006779 181 MQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDP 256 (631)
Q Consensus 181 ~~~~~--~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~-p~~l~~~~~~ 256 (631)
..... .....+++.|+|||++.+ .++.++||||||+++|+|++|+.||...... .....+..... ....+...+.
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd06612 149 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM-RAIFMIPNKPPPTLSDPEKWSP 227 (256)
T ss_pred cccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh-hhhhhhccCCCCCCCchhhcCH
Confidence 54432 234568899999998754 4889999999999999999999999764332 22222222111 1122334567
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 257 QVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
.+.+||.+||. +|.+||++.++|.||||
T Consensus 228 ~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 228 EFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 89999999998 89999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=317.42 Aligned_cols=250 Identities=29% Similarity=0.506 Sum_probs=213.1
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
|| ++.++||.|+||.||.+.+..+|..|++|.+..... .......+.+|+.+|++++|+||+++++++.+. ..++
T Consensus 1 ~y-~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~ 75 (256)
T cd08221 1 HY-IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYNHFMDD--NTLL 75 (256)
T ss_pred Cc-eEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc--chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC--CeEE
Confidence 56 677999999999999999999999999999876543 345566788999999999999999999998764 4789
Q ss_pred EEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 105 MITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
++|||+.+|+|.+++.+. ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++ .++.+||+|||++....
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~-~~~~~kl~d~~~~~~~~ 152 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILG 152 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEe-CCCCEEECcCcceEEcc
Confidence 999999999999999875 46899999999999999999999998 99999999999998 78899999999987554
Q ss_pred CCC--CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006779 183 QPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 183 ~~~--~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~ 259 (631)
... .....|++.|+|||++.+ .++.++||||||+++|+|++|..||.. .+..+....+..+..+. .....+..++
T Consensus 153 ~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (256)
T cd08221 153 SEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQGNYTP-VVSVYSSELI 230 (256)
T ss_pred cccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCC-CccccCHHHH
Confidence 332 344578999999997754 478899999999999999999999976 45555555555543332 3355678999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 260 QFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 260 ~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
++|.+||. +|.+||++.++|+|||+
T Consensus 231 ~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 231 SLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHcccCcccCCCHHHHhhCcCC
Confidence 99999997 89999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=329.85 Aligned_cols=259 Identities=22% Similarity=0.371 Sum_probs=211.9
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
+| ++.+.||+|++|+||+|.+..+|..||+|.+..... ........+..|+++++.++||||+++++.+.+. ..++
T Consensus 2 ~y-~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 77 (316)
T cd05574 2 HF-KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM-IKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE--TYLC 77 (316)
T ss_pred ce-EEeeeecCCccEEEEEEEEcCCCcEEEEEEEecccc-chHHHHHHHHHHHHHHHhCCCCCchhheeeeecC--CEEE
Confidence 45 667899999999999999999999999999976543 2234567789999999999999999999988554 5789
Q ss_pred EEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 105 MITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
+||||+.+++|.+++.+. ..+++..++.++.||+.||.|||+.+ ++||||||+|||++ .++.++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLH-ESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEc-CCCCEEEeecchhhccc
Confidence 999999999999998764 56899999999999999999999998 99999999999997 78999999999975432
Q ss_pred CC-------------------------------CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCC
Q 006779 183 QP-------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNE 230 (631)
Q Consensus 183 ~~-------------------------------~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~ 230 (631)
.. .....+||..|+|||++.+ .++.++||||||+++|+|++|..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 11 1123468899999997754 488899999999999999999999987
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC----HHHHhcCCCCCCCCCcc
Q 006779 231 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP----ALELLKDPFLVTDNPKD 291 (631)
Q Consensus 231 ~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rps----a~elL~hpff~~~~~~~ 291 (631)
......... +.............+..+++||.+||. +|.+||+ +.++|.||||+...+..
T Consensus 235 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~ 299 (316)
T cd05574 235 SNRDETFSN-ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWAL 299 (316)
T ss_pred CchHHHHHH-HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhh
Confidence 544444433 333222211122257899999999998 8999999 99999999998765544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=322.55 Aligned_cols=249 Identities=26% Similarity=0.426 Sum_probs=212.3
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||.|+||.||+|.+..+|..||+|.+..... ........+.+|++++++++||||+++++.+.+. ..+++|+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 79 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE--ENMYLVV 79 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh-cchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC--CeEEEEE
Confidence 678999999999999999999999999999975443 2234567899999999999999999999987543 5799999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC-CC
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TA 186 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-~~ 186 (631)
||+.+++|..++.+...+++..+..|+.||+.||.|||+++ ++|+||+|+||+++ .++.++|+|||++...... ..
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLT 156 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEc-CCCCEEEeecccccccCCCccc
Confidence 99999999999988888999999999999999999999998 99999999999998 7899999999998765443 23
Q ss_pred ccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006779 187 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263 (631)
Q Consensus 187 ~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~--~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~ 263 (631)
....|+..|+|||.+.. .++.++|+||||+++|+|++|..||..... ...+...... .....+...+..+.++|.
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~ 234 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAIN 234 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHHH
Confidence 44568889999997754 478999999999999999999999987543 4444444432 223344556789999999
Q ss_pred HhcC-CCCCCCCH--HHHhcCCCC
Q 006779 264 KCIV-PASLRLPA--LELLKDPFL 284 (631)
Q Consensus 264 ~cL~-~p~~Rpsa--~elL~hpff 284 (631)
+||. +|.+||++ .|++.||||
T Consensus 235 ~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 235 KLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHccCChhHcCCccHHHHhcCCCC
Confidence 9998 89999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=329.79 Aligned_cols=254 Identities=27% Similarity=0.430 Sum_probs=203.7
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.+| ++.+.||.|+||.||+|.++.++..||+|.+..... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~y-~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~ 79 (301)
T cd07873 6 ETY-IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSL 79 (301)
T ss_pred cce-EEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc---cCchhHHHHHHHHHHhcCCCCcceEEEEEecC--CeE
Confidence 345 667889999999999999999999999999875432 12234577899999999999999999998654 478
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
++||||+. ++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKS 155 (301)
T ss_pred EEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEEC-CCCcEEECcCcchhccC
Confidence 99999997 5898888764 56899999999999999999999998 99999999999998 78899999999986543
Q ss_pred CC--CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC---C----------
Q 006779 183 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---I---------- 245 (631)
Q Consensus 183 ~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~---~---------- 245 (631)
.. ......+++.|+|||++.+ .++.++|||||||++|+|+||+.||.......+ ...+... .
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 156 IPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-LHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred CCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCChhhchhhhc
Confidence 22 2233467899999998754 478899999999999999999999986443322 2221110 0
Q ss_pred --------CCC-------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 246 --------KPA-------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 246 --------~p~-------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
.+. ......++.+++||.+||. +|.+|||+.|+|.||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 000 0112357789999999998 899999999999999997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=316.47 Aligned_cols=251 Identities=29% Similarity=0.513 Sum_probs=210.6
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
|| ++.+.||+|+||.||+|.+..++..+|+|.+..... .......+.+|+.+|+.++||||+++++.+... ..++
T Consensus 1 ~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~ 75 (256)
T cd08220 1 KY-EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM--TKDERLAAQNECQVLKLLSHPNIIEYYENFLED--KALM 75 (256)
T ss_pred Cc-eEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHhhCCCCchhheeeeEecC--CEEE
Confidence 45 677999999999999999999999999999976543 344567899999999999999999999988644 4789
Q ss_pred EEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 105 MITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
+||||+.+++|.+++.+. ..+++..+..++.|++.||.|||+++ ++||||+|+||+++..++.+||+|||++....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILS 153 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence 999999999999999764 35899999999999999999999998 99999999999998556678999999997654
Q ss_pred CCC-CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006779 183 QPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 183 ~~~-~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~ 260 (631)
... .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.... .......+..+..+ .++...++.+++
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~l~~ 231 (256)
T cd08220 154 SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN-LPALVLKIMSGTFA-PISDRYSPDLRQ 231 (256)
T ss_pred CCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc-hHHHHHHHHhcCCC-CCCCCcCHHHHH
Confidence 332 234568999999998764 47889999999999999999999997744 44444444443322 344456789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 261 FIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 261 lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
+|.+||. +|.+|||+.++|.||||
T Consensus 232 li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 232 LILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHccCChhhCCCHHHHhhCCCC
Confidence 9999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=323.85 Aligned_cols=252 Identities=25% Similarity=0.437 Sum_probs=205.6
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
|| ++.+.||+|++|.||+|.++.+|..||+|++..... .....+.+.+|+.+++.++||||+++++++... ..++
T Consensus 2 ~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~ 76 (286)
T cd07847 2 KY-EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK--RKLH 76 (286)
T ss_pred ce-eeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc--CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC--CEEE
Confidence 56 667889999999999999999999999998864421 122334578999999999999999999988654 4688
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
+||||+.+++|..++.....+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++......
T Consensus 77 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 77 LVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGP 153 (286)
T ss_pred EEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEc-CCCcEEECccccceecCCC
Confidence 99999999999988887778999999999999999999999998 99999999999997 7889999999999765433
Q ss_pred C--CccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC--C-------------
Q 006779 185 T--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--I------------- 245 (631)
Q Consensus 185 ~--~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~--~------------- 245 (631)
. .....++..|+|||.+.+ .++.++||||||+++|+|++|+.||.+..+.+.+....... .
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 2 233467889999998754 47889999999999999999999998755544443322110 0
Q ss_pred -----CCC--C------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 246 -----KPA--S------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 246 -----~p~--~------l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
.|. . .....+..+.+||.+||. +|.+||++.++|.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 0 011346789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=318.26 Aligned_cols=247 Identities=31% Similarity=0.536 Sum_probs=206.6
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||.|+||+||+|.+..+|..+|+|.+..... ......+.+|+.+|+.++|+||+++++.+.+. ..+++|+
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~iv~ 78 (267)
T cd06610 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG--DELWLVM 78 (267)
T ss_pred eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc---chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC--CEEEEEE
Confidence 778999999999999999999999999999865432 23567799999999999999999999988664 4789999
Q ss_pred eccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 108 ELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~---~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
|++.+++|.+++.+. ..+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++..+...
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~-~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLG-EDGSVKIADFGVSASLADG 155 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEc-CCCCEEEcccchHHHhccC
Confidence 999999999999764 45899999999999999999999998 99999999999998 6889999999998655432
Q ss_pred C------CccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC-----
Q 006779 185 T------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS----- 251 (631)
Q Consensus 185 ~------~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~----- 251 (631)
. .....|++.|+|||.+.. .++.++|+||||+++|+|++|+.||...... ..+..+.....+ .+.
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~~~-~~~~~~~~ 233 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQNDPP-SLETGADY 233 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcCCCC-CcCCcccc
Confidence 2 233568999999997754 4889999999999999999999999875443 333333333221 121
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 252 ~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
...++.+++||.+||. +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 234 KKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 2456889999999998 89999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=320.50 Aligned_cols=246 Identities=31% Similarity=0.513 Sum_probs=204.0
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEecc
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~ 110 (631)
..||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.+++.++|+||+++++++... ..+++|+||+
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~ 87 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPER----DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN--GFFKIFMEQV 87 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCC----CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC--CEEEEEEecC
Confidence 5799999999999999999999999988643 234556789999999999999999999987654 5789999999
Q ss_pred CCCCHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC--C
Q 006779 111 TSGSLRQYRKKH-KNV--DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--T 185 (631)
Q Consensus 111 ~gGsL~~~l~~~-~~l--~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--~ 185 (631)
.+++|.+++... ..+ ++..+..++.||+.||.|||+++ |+||||||+||+++..++.++|+|||++...... .
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 165 (268)
T cd06624 88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165 (268)
T ss_pred CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence 999999998764 455 88999999999999999999998 9999999999999755789999999998654322 2
Q ss_pred CccccCCCCCCCcccccc---ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006779 186 ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262 (631)
Q Consensus 186 ~~~~~GTp~Y~APEvl~~---~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI 262 (631)
.....|++.|+|||.+.. .++.++||||||+++|+|++|+.||............+........++...++++++||
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFI 245 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHH
Confidence 233468999999998753 37889999999999999999999997654433332222221223345566788999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCCCC
Q 006779 263 EKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 263 ~~cL~-~p~~Rpsa~elL~hpff 284 (631)
.+||. +|.+||++.+++.||||
T Consensus 246 ~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 246 LRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHcCCCchhCCCHHHHHhCCCC
Confidence 99998 89999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=317.36 Aligned_cols=251 Identities=33% Similarity=0.621 Sum_probs=211.9
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
|| ++.+.||+|+||.||+|.+..++..|++|.+..... .......+.+|+.+++.++|+||+++++.+... ..++
T Consensus 1 ~y-~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~ 75 (264)
T cd06626 1 RW-QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN--DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR--EKVY 75 (264)
T ss_pred Cc-eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc--chHHHHHHHHHHHHHHhCCCCChhheeeeEecC--CEEE
Confidence 56 677999999999999999999999999999876543 245678899999999999999999999976543 5789
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
+|+||+.+++|.+++.+...+++..+..++.|++.||.|||+++ ++|+||+|+||+++ .++.+||+|||++......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~-~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEcccccccccCCC
Confidence 99999999999999998888999999999999999999999999 99999999999998 6889999999998765432
Q ss_pred CC------ccccCCCCCCCcccccc-c---cCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC-
Q 006779 185 TA------RSVIGTPEFMAPELYEE-E---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV- 253 (631)
Q Consensus 185 ~~------~~~~GTp~Y~APEvl~~-~---ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~- 253 (631)
.. ....+++.|+|||++.. . ++.++||||||+++|+|++|+.||....+.......+..+. +..++..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH-KPPIPDSL 231 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCC-CCCCCccc
Confidence 11 13467889999998754 2 78899999999999999999999977555554444444432 2223333
Q ss_pred -CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 254 -TDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 254 -~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
.++.+.+||.+||+ +|.+||++.+++.|||+
T Consensus 232 ~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 232 QLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 37899999999998 89999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=383.37 Aligned_cols=258 Identities=30% Similarity=0.528 Sum_probs=227.5
Q ss_pred CCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC
Q 006779 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~ 100 (631)
.-+-||+| +..||.|.||.||.|.+..||+..|+|.+++.+.. ......+.+|..+|..|+|||+|++|++=++.+
T Consensus 1232 nV~~rWqr-g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe- 1307 (1509)
T KOG4645|consen 1232 NVTFRWQR-GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE- 1307 (1509)
T ss_pred cceeeecc-ccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeecHH-
Confidence 44567854 78899999999999999999999999999876543 344566889999999999999999999766554
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
.++|.||||++|+|.+.+...+-.++...+.+..|++.|+.|||++| ||||||||.|||++ .+|.+|++|||.|..
T Consensus 1308 -kv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld-~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1308 -KVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLD-FNGLIKYGDFGSAVK 1383 (1509)
T ss_pred -HHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeee-cCCcEEeecccceeE
Confidence 57788999999999999998888899999999999999999999999 99999999999998 899999999999976
Q ss_pred hcCCC------CccccCCCCCCCcccccc----ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 006779 181 MQQPT------ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250 (631)
Q Consensus 181 ~~~~~------~~~~~GTp~Y~APEvl~~----~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l 250 (631)
+.... .....|||-|||||++.+ +...++|||||||+..||+||+.||....+.-+|+-+|..|.+|+..
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P 1463 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP 1463 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc
Confidence 65432 346789999999998864 36689999999999999999999999999999999999999888644
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 251 ~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
...+++-++||++||. ||.+|.++.|||.|.|-+..
T Consensus 1464 -~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1464 -ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred -hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 4488999999999997 99999999999999987653
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=322.16 Aligned_cols=252 Identities=28% Similarity=0.462 Sum_probs=202.3
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHH-HHHhCCCCCceeeeeeEEcCCCCeEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~-iLk~L~HpnIVkl~~~~~d~~~~~l~lV 106 (631)
++.+.||+|+||.||+|.+..+|..||+|++..... .. ...++..|+. .++.++||||+++++++... ..+++|
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~--~~~~lv 78 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFRE--GDVWIC 78 (283)
T ss_pred eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecC--CcEEEE
Confidence 667889999999999999999999999999875421 22 2334555655 47778999999999988654 468999
Q ss_pred EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 107 TELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~----~~~l~~~~i~~i~~QIl~aL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
|||+. |+|.+++.. ...+++..++.++.||+.||.|||++ + ++||||||+|||++ .++.+||+|||++...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~-~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLIN-RNGQVKLCDFGISGYL 154 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEEC-CCCCEEEeeccccccc
Confidence 99996 688877654 34689999999999999999999997 7 99999999999998 7889999999998765
Q ss_pred cCCCC-ccccCCCCCCCcccccc-----ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006779 182 QQPTA-RSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 182 ~~~~~-~~~~GTp~Y~APEvl~~-----~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~ 255 (631)
..... ....|+..|+|||++.+ .++.++|+|||||++|+|++|+.||.......+....+..+..+.......+
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS 234 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccC
Confidence 43322 23568899999998743 3688999999999999999999999764444333334444333332233467
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
.++++||.+||. +|.+||++.+++.||||....
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 899999999998 899999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=322.14 Aligned_cols=252 Identities=23% Similarity=0.423 Sum_probs=205.3
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
|| ++.+.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++.+. ..++
T Consensus 1 ~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~ 75 (286)
T cd07832 1 RY-KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL--EGGIPNQALREIKALQACQHPYVVKLLDVFPHG--SGFV 75 (286)
T ss_pred Cc-eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc--cchhhHHHHHHHHHHHhCCCCCCcceeeEEecC--CeeE
Confidence 35 778999999999999999999999999999876542 233456788999999999999999999988664 5789
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 105 MITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
+|+||+ +++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||||+||+++ .++.++|+|||++.....
T Consensus 76 ~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~-~~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLIS-ADGVLKIADFGLARLFSE 151 (286)
T ss_pred EEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEc-CCCcEEEeeeeecccccC
Confidence 999999 9999999865 456999999999999999999999998 99999999999998 688999999999876544
Q ss_pred CC---CccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-----------
Q 006779 184 PT---ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP----------- 247 (631)
Q Consensus 184 ~~---~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p----------- 247 (631)
.. .....|++.|+|||.+.+ .++.++||||||+++|+|+||..||....+...+...+..-..+
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 152 EEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCc
Confidence 32 334568999999998753 36899999999999999999988886644333332222210000
Q ss_pred ---------C-------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 006779 248 ---------A-------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 248 ---------~-------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~ 285 (631)
. ......+..+++||.+||. +|.+||++.++|.||||.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 0112345789999999998 899999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=325.11 Aligned_cols=250 Identities=29% Similarity=0.542 Sum_probs=209.7
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
.+.+.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.++++++||||+++++.+... ..+++||
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ 78 (286)
T cd06622 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQIIMELDILHKAVSPYIVDFYGAFFIE--GAVYMCM 78 (286)
T ss_pred hhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC--CeEEEEE
Confidence 66788999999999999999999999999886431 344557789999999999999999999988654 5799999
Q ss_pred eccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 108 ELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~---~~l~~~~i~~i~~QIl~aL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
||+.+++|..++... ..+++..+..++.||+.||.|||+ ++ |+||||||+||+++ .++.+||+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVN-GNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEEC-CCCCEEEeecCCcccccC
Confidence 999999999998764 479999999999999999999996 46 99999999999998 688999999999976655
Q ss_pred CCCccccCCCCCCCcccccc-------ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHH---HHHcCCCCCCCCCC
Q 006779 184 PTARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK---KVTSGIKPASLSKV 253 (631)
Q Consensus 184 ~~~~~~~GTp~Y~APEvl~~-------~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~---~i~~~~~p~~l~~~ 253 (631)
.......+++.|+|||.+.+ .++.++|||||||++|+|++|..||.... ...... .+..+ .+..++..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~-~~~~~~~~ 233 (286)
T cd06622 156 SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-YANIFAQLSAIVDG-DPPTLPSG 233 (286)
T ss_pred CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-hhhHHHHHHHHhhc-CCCCCCcc
Confidence 55555678999999998743 25789999999999999999999997532 233322 23333 23344555
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 254 ~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.++.+++||.+||. +|.+||++.+++.||||...
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 78999999999998 89999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=328.50 Aligned_cols=263 Identities=23% Similarity=0.422 Sum_probs=228.7
Q ss_pred eeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEe
Q 006779 29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE 108 (631)
Q Consensus 29 ~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~E 108 (631)
+.++||+|.||.|-+++.+.+|+.+|+|+++.+-. -..+.+..-..|-+.|+.++||.+..+..+|.. +.++++|||
T Consensus 172 fLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevi-iakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt--~drlCFVMe 248 (516)
T KOG0690|consen 172 FLKVLGKGTFGKVILCREKATGKLYAIKILKKEVI-IAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT--QDRLCFVME 248 (516)
T ss_pred HHHHhcCCccceEEEEeecccCceeehhhhhhhhe-eehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc--CceEEEEEE
Confidence 34789999999999999999999999999976544 346777888899999999999999999888854 457999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh--cCCCC
Q 006779 109 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTA 186 (631)
Q Consensus 109 y~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~--~~~~~ 186 (631)
|..||.|.-.+.+.+.+++...+.+...|+.||.|||+++ ||+||||.+|+|++ .+|++||.|||+++.- .....
T Consensus 249 yanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLD-kDGHIKitDFGLCKE~I~~g~t~ 325 (516)
T KOG0690|consen 249 YANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLD-KDGHIKITDFGLCKEEIKYGDTT 325 (516)
T ss_pred EccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheec-cCCceEeeecccchhccccccee
Confidence 9999999999999999999999999999999999999999 99999999999998 8999999999999643 33456
Q ss_pred ccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHh
Q 006779 187 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265 (631)
Q Consensus 187 ~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~c 265 (631)
.++||||.|+|||++.. .|+.++|+|-+|+++|||++|+.||... +-..++..|.-. ...++...+++++.|+..+
T Consensus 326 kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~-dh~kLFeLIl~e--d~kFPr~ls~eAktLLsGL 402 (516)
T KOG0690|consen 326 KTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK-DHEKLFELILME--DLKFPRTLSPEAKTLLSGL 402 (516)
T ss_pred ccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc-chhHHHHHHHhh--hccCCccCCHHHHHHHHHH
Confidence 78999999999999976 4999999999999999999999999874 444555555432 2345667789999999999
Q ss_pred cC-CCCCCCC-----HHHHhcCCCCCCCCCcccccCCCCCC
Q 006779 266 IV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLP 300 (631)
Q Consensus 266 L~-~p~~Rps-----a~elL~hpff~~~~~~~~~~~~~~~p 300 (631)
|. +|.+|.. |.|+..|+||...+|...+.+.+..|
T Consensus 403 L~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PP 443 (516)
T KOG0690|consen 403 LKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPP 443 (516)
T ss_pred hhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCC
Confidence 98 8999985 89999999999999988776666544
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.77 Aligned_cols=258 Identities=22% Similarity=0.397 Sum_probs=213.8
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
.+.+.||+|+||.||+|.+..++..||+|.+..... ........+.+|+.+++.++||||+++++.+... ..+++||
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ 80 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-ILRNQIQQVFVERDILTFAENPFVVSMFCSFETK--RHLCMVM 80 (305)
T ss_pred eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC--CEEEEEE
Confidence 667899999999999999999999999999875432 2234556788999999999999999999988644 4789999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC---
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--- 184 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--- 184 (631)
||+.|++|.+++...+.+++..+..++.|++.||.|||+++ ++||||||+||+++ .+|.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~-~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEEC-CCCCEEEeeCCCccccCcCccc
Confidence 99999999999998888999999999999999999999998 99999999999997 7899999999987531100
Q ss_pred --------------CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-C
Q 006779 185 --------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-A 248 (631)
Q Consensus 185 --------------~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p-~ 248 (631)
......+++.|+|||.+. ..++.++|||||||++|+|++|..||.+ ....++...+..+..+ +
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~ 236 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEWP 236 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCCC
Confidence 011235788999999764 4589999999999999999999999986 4556666666554322 2
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCC---HHHHhcCCCCCCCCCccc
Q 006779 249 SLSKVTDPQVKQFIEKCIV-PASLRLP---ALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 249 ~l~~~~~~~l~~lI~~cL~-~p~~Rps---a~elL~hpff~~~~~~~~ 292 (631)
......++.+++||.+||+ +|.+||+ +.++|.||||....+...
T Consensus 237 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~ 284 (305)
T cd05609 237 EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGL 284 (305)
T ss_pred CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHH
Confidence 2223567889999999998 8999998 799999999987665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=337.45 Aligned_cols=245 Identities=27% Similarity=0.395 Sum_probs=193.3
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
+| ++.+.||+|+||.||+|.+..++..||+|..... ....|+.+|+.++||||+++++++... ...+
T Consensus 67 ~y-~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 133 (357)
T PHA03209 67 GY-TVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVSG--AITC 133 (357)
T ss_pred Cc-EEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEeC--CeeE
Confidence 45 7789999999999999999999999999975322 134699999999999999999998765 4688
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 105 MITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
+|+||+. ++|.+++.+ ...+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEecCcccccccc
Confidence 9999995 578877764 567999999999999999999999998 99999999999997 788999999999864332
Q ss_pred -CCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCC----------HHHHHHHHHc-CCCCCCC
Q 006779 184 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN----------PAQIYKKVTS-GIKPASL 250 (631)
Q Consensus 184 -~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~----------~~~i~~~i~~-~~~p~~l 250 (631)
.......||+.|+|||++.+ .|+.++|||||||++|||+++..|+..... ...+...+.. +..|..+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 289 (357)
T PHA03209 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289 (357)
T ss_pred CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence 23345679999999998754 589999999999999999986655432211 1122222211 1111111
Q ss_pred C------------------------------CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 251 S------------------------------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 251 ~------------------------------~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
+ ...+..+.+||.+||+ +|.+|||+.|+|+||||+.
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 1 1234567789999998 8999999999999999974
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=324.37 Aligned_cols=252 Identities=24% Similarity=0.434 Sum_probs=209.5
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||+|+||+||+|.+..+|..||+|.+.... .......+.+|+++++.++||||+++++++.+. ..+++||
T Consensus 8 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 82 (284)
T cd06620 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NNICMCM 82 (284)
T ss_pred HHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC--CEEEEEE
Confidence 66788999999999999999999999999886542 234557789999999999999999999998765 4789999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCC
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 186 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~ 186 (631)
||+.+++|..++.+.+.+++..+..++.|++.||.|||+ ++ ++||||+|+||+++ .++.++|+|||++........
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~-~~~~~~l~d~gl~~~~~~~~~ 159 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVN-SRGQIKLCDFGVSGELINSIA 159 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEEC-CCCcEEEccCCcccchhhhcc
Confidence 999999999999888889999999999999999999997 56 99999999999997 788999999999865544444
Q ss_pred ccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCH-------H---HHHHHHHcCCCCCCCCCCCc
Q 006779 187 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP-------A---QIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 187 ~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~-------~---~i~~~i~~~~~p~~l~~~~~ 255 (631)
....|+..|+|||++. ..++.++|||||||++|+|+||..||...... . .....+.....+.......+
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP 239 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcC
Confidence 4567899999999764 46889999999999999999999999753321 1 22233332222221122256
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
..+.+||.+||. +|.+||++.|+++||||...
T Consensus 240 ~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 789999999998 89999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=316.74 Aligned_cols=251 Identities=29% Similarity=0.541 Sum_probs=215.9
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
.+.+.||+|++|.||+|.+..+|..|++|++..... ......+.+|+..+..++||||+++++++... ..+++|+
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 78 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---EEFRKQLLRELKTLRSCESPYVVKCYGAFYKE--GEISIVL 78 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--CeEEEEE
Confidence 567999999999999999999999999999875532 24567799999999999999999999988655 5789999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCC
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 186 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~ 186 (631)
||+.+++|.+++.....+++..++.++.|++.||.|||+ .+ ++||||+|+||+++ .++.++|+|||++........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~-~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEEC-CCCCEEEccCccceecccCCC
Confidence 999999999999988889999999999999999999999 88 99999999999998 789999999999876544332
Q ss_pred c--cccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCC--CHHHHHHHHHcCCCCCCCCCC-CcHHHHH
Q 006779 187 R--SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGIKPASLSKV-TDPQVKQ 260 (631)
Q Consensus 187 ~--~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~--~~~~i~~~i~~~~~p~~l~~~-~~~~l~~ 260 (631)
. ...++..|+|||.+.. .++.++|+||||+++|+|+||..||.... ...+....+.....+. +... .+..+++
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 234 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS-LPAEEFSPEFRD 234 (264)
T ss_pred cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC-CCcccCCHHHHH
Confidence 2 4568899999997754 47889999999999999999999997764 5556666666544433 3333 7789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 261 FIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 261 lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
+|.+||. +|.+||++.++|.||||+..
T Consensus 235 li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 235 FISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 9999998 89999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=327.78 Aligned_cols=257 Identities=23% Similarity=0.339 Sum_probs=206.6
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
+..+| ++.+.||+|+||.||+|.+..+|..||+|.+...... ......+.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~y-~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (309)
T cd07845 5 SVTEF-EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER--DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLD 81 (309)
T ss_pred cccce-eEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC--CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence 45566 6778999999999999999999999999998755321 12223456799999999999999999998876656
Q ss_pred eEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 102 TINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
.+++||||+. ++|..++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++..
T Consensus 82 ~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~kL~dfg~~~~ 157 (309)
T cd07845 82 SIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLT-DKGCLKIADFGLART 157 (309)
T ss_pred eEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccceeee
Confidence 7899999996 588888776 367899999999999999999999999 99999999999997 788999999999976
Q ss_pred hcCC--CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-C--------
Q 006779 181 MQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-P-------- 247 (631)
Q Consensus 181 ~~~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~-p-------- 247 (631)
.... ......+++.|+|||++.+ .++.++|||||||++|+|++|+.||.... ..+.+..+..... +
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS-EIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCChhhchhh
Confidence 5433 2223356888999998753 47899999999999999999999998744 4433333322100 0
Q ss_pred -------------CCC------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 248 -------------ASL------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 248 -------------~~l------~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
..+ ....++.+++||.+||. +|.+|||+.++|.||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 000 01246888999999998 8999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.99 Aligned_cols=262 Identities=29% Similarity=0.465 Sum_probs=214.8
Q ss_pred cccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeE
Q 006779 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 95 (631)
Q Consensus 16 ~~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~ 95 (631)
.+...+|..|| +..+.||+|+||.||+|.+..+|..||+|.+..... ........+.+|+.+++.++||||+++++++
T Consensus 7 ~~~~~~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~ 84 (307)
T cd06607 7 LFSKDDPEKLF-TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCY 84 (307)
T ss_pred hhcCCCcchhh-hhheeecCCCCeEEEEEEEcCCCcEEEEEEEecccc-CcHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 35567888898 567899999999999999999999999999865432 2345556789999999999999999999998
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcc
Q 006779 96 VDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~D 174 (631)
.+. ...++|+||+. |+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||+|+||+++ .++.++|+|
T Consensus 85 ~~~--~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~-~~~~~kL~d 158 (307)
T cd06607 85 LRE--HTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLT-EPGTVKLAD 158 (307)
T ss_pred EeC--CeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEC-CCCCEEEee
Confidence 765 36889999996 577776654 456999999999999999999999998 99999999999997 789999999
Q ss_pred ccccchhcCCCCccccCCCCCCCccccc----cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 006779 175 LGLAIVMQQPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250 (631)
Q Consensus 175 FGla~~~~~~~~~~~~GTp~Y~APEvl~----~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l 250 (631)
||++..... .....+++.|+|||++. +.++.++||||||+++|+|+||..||... +.......+.....+...
T Consensus 159 fg~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~ 235 (307)
T cd06607 159 FGSASLVSP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNDSPTLS 235 (307)
T ss_pred cCcceecCC--CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc-cHHHHHHHHhcCCCCCCC
Confidence 999865432 23456889999999763 34888999999999999999999999764 333333334433333333
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 251 ~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
....+..++++|.+||. +|.+||++.+++.||||....
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 236 SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred chhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 34467889999999998 899999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=314.88 Aligned_cols=250 Identities=27% Similarity=0.497 Sum_probs=210.4
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
|| ++.+.||+|+||.||++.+..+|..||+|.+..... .......+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ~y-~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 75 (256)
T cd08218 1 KY-VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQESFEEN--GNLY 75 (256)
T ss_pred Cc-eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC--CeEE
Confidence 45 678999999999999999999999999999876533 234456789999999999999999999988544 4789
Q ss_pred EEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 105 MITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
+|+||+.+++|.+++... ..+++..+..|+.|++.||.|||+++ ++|+||+|+|||++ .++.++|+|||++....
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~-~~~~~~l~d~~~~~~~~ 152 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTIKLGDFGIARVLN 152 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEEeeccceeecC
Confidence 999999999999998764 35899999999999999999999998 99999999999997 68899999999986554
Q ss_pred CCC--CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006779 183 QPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 183 ~~~--~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~ 259 (631)
... .....|++.|+|||++.+ .++.++|+|||||++|+|++|..||... +...+...+..+..+. .+...+..++
T Consensus 153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (256)
T cd08218 153 STVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-NMKNLVLKIIRGSYPP-VSSHYSYDLR 230 (256)
T ss_pred cchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-CHHHHHHHHhcCCCCC-CcccCCHHHH
Confidence 322 234568899999998754 4788999999999999999999999764 4555555555544332 3445678999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 260 QFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 260 ~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
++|.+||. +|.+||++.++|.||||
T Consensus 231 ~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 231 NLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 99999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=341.47 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=200.8
Q ss_pred CceeeeeeEecccCceEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~--~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
.+| ++.+.||+|+||.||+|... .++..||+|.+.... ...+|+.+|+.++||||++++++|... .
T Consensus 92 ~~y-~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~---------~~~~E~~il~~l~h~~iv~~~~~~~~~--~ 159 (392)
T PHA03207 92 MQY-NILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK---------TPGREIDILKTISHRAIINLIHAYRWK--S 159 (392)
T ss_pred Cce-EEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc---------cHHHHHHHHHhcCCCCccceeeeEeeC--C
Confidence 356 77899999999999999754 467889999875321 245799999999999999999988654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
.+++|||++. ++|.+++.....+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.++|+|||++...
T Consensus 160 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~-~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 160 TVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKL 235 (392)
T ss_pred EEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEc-CCCCEEEccCcccccc
Confidence 7899999995 689999988888999999999999999999999998 99999999999998 7889999999998655
Q ss_pred cCC----CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCC---HHHHHHHHHc----------
Q 006779 182 QQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTS---------- 243 (631)
Q Consensus 182 ~~~----~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~---~~~i~~~i~~---------- 243 (631)
... ......||+.|+|||++.. .|+.++|||||||++|||++|+.||.+... ..++...+..
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 432 1234579999999998764 589999999999999999999999976432 1122111110
Q ss_pred ---------------CCCC-CCCC-----CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCcc
Q 006779 244 ---------------GIKP-ASLS-----KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 291 (631)
Q Consensus 244 ---------------~~~p-~~l~-----~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~~~ 291 (631)
...+ ..++ ...+..+++||.+||. +|.+||++.|+|.||||....+..
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~ 385 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINL 385 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhh
Confidence 0000 0011 1245678999999998 899999999999999998755443
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=325.70 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=197.0
Q ss_pred CCCceeeeeeEecccCceEEEEEEEcc----------------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEV----------------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~----------------tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~H 85 (631)
|.+|| ++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+|+.++|
T Consensus 3 ~~~~~-~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h 78 (304)
T cd05096 3 PRGHL-LFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARNDFLKEVKILSRLKD 78 (304)
T ss_pred chhhC-eeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHHHHHHHHHHHhhcCC
Confidence 56778 788999999999999997532 45689999886432 34456678999999999999
Q ss_pred CCceeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHh
Q 006779 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-------------------NVDMKAIKNWARQILRGLHYLHS 146 (631)
Q Consensus 86 pnIVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~-------------------~l~~~~i~~i~~QIl~aL~yLHs 146 (631)
|||+++++++.+.. .+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+
T Consensus 79 ~niv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 156 (304)
T cd05096 79 PNIIRLLGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156 (304)
T ss_pred CCeeEEEEEEecCC--ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 99999999987653 5899999999999999986532 36778899999999999999999
Q ss_pred CCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHH
Q 006779 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 221 (631)
Q Consensus 147 ~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyEL 221 (631)
++ |+||||||+|||++ .++.+||+|||++....... .....+++.|+|||++. +.++.++|||||||++|+|
T Consensus 157 ~~--ivH~dlkp~Nill~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 233 (304)
T cd05096 157 LN--FVHRDLATRNCLVG-ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233 (304)
T ss_pred CC--ccccCcchhheEEc-CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHH
Confidence 98 99999999999998 78899999999997553322 12334578899999764 5689999999999999999
Q ss_pred hh--cCCCCCCCCCHHHHHHHHHc----CC--CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 222 VT--CEYPYNECKNPAQIYKKVTS----GI--KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 222 lt--G~~Pf~~~~~~~~i~~~i~~----~~--~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
++ +..||.... ..++...+.. .. .....+...+..+++||.+||. +|.+|||+.++..
T Consensus 234 ~~~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 234 LMLCKEQPYGELT-DEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred HHccCCCCCCcCC-HHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 86 667887643 3333333221 10 1111233456889999999998 8999999999843
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=318.26 Aligned_cols=250 Identities=23% Similarity=0.421 Sum_probs=204.0
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHH-HHhCCCCCceeeeeeEEcCCCCeEEEEEec
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL-LKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~i-Lk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey 109 (631)
+.||+|+||.||+|.+..+|..||+|.+...... .......+..|..+ ...++||||+++++++... ..+++|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI-AKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK--DYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh-HHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC--CeEEEEEec
Confidence 4689999999999999999999999998644321 12223344555544 4556999999999988654 479999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCCccc
Q 006779 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 189 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~~ 189 (631)
+.+++|.+++...+.+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.+||+|||++..... ....
T Consensus 79 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~--~~~~ 153 (260)
T cd05611 79 LNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLE--NKKF 153 (260)
T ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEeecccceeccc--cccC
Confidence 999999999998888999999999999999999999998 99999999999997 788999999999865433 2345
Q ss_pred cCCCCCCCccccccc-cCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHHHHHHHHHhc
Q 006779 190 IGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 190 ~GTp~Y~APEvl~~~-ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p~~l~~~~~~~l~~lI~~cL 266 (631)
.+++.|+|||.+.+. ++.++||||||+++|+|++|..||.. .+...++..+..+.. +.......++.++++|.+||
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 232 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA-ETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHc
Confidence 688999999987654 78999999999999999999999976 445555555544322 33334456889999999999
Q ss_pred C-CCCCCCCH---HHHhcCCCCCCCCC
Q 006779 267 V-PASLRLPA---LELLKDPFLVTDNP 289 (631)
Q Consensus 267 ~-~p~~Rpsa---~elL~hpff~~~~~ 289 (631)
+ +|.+||++ .|+|.||||...+|
T Consensus 233 ~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 233 CMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred cCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 8 89999955 79999999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=321.85 Aligned_cols=252 Identities=24% Similarity=0.397 Sum_probs=207.8
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEeccCC
Q 006779 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112 (631)
Q Consensus 33 LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~~g 112 (631)
||+|+||+||+|.+..+|+.||+|.+..... ........+..|+.+|+.++||||+++++++... ..+++||||+.+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL-KKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK--DDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhh-hhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC--CeEEEEEecCCC
Confidence 6999999999999999999999999875432 1223445677899999999999999999988654 478999999999
Q ss_pred CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC-CCccc
Q 006779 113 GSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSV 189 (631)
Q Consensus 113 GsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-~~~~~ 189 (631)
++|.+++.+.+ .+++..++.++.|++.||.|||+++ ++||||+|+||+++ .++.++|+|||++...... .....
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGR 154 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEccCcchhhhccCCccccc
Confidence 99999987765 7999999999999999999999998 99999999999997 7889999999998765432 23345
Q ss_pred cCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHh
Q 006779 190 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265 (631)
Q Consensus 190 ~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~---~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~c 265 (631)
.++..|+|||.+.+ .++.++||||||+++|+|++|+.||..... ...+...+.. .+...+...++.++++|.+|
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~ 232 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLCEAL 232 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCCHHHHHHHHHH
Confidence 67889999997654 488899999999999999999999976432 2233222222 23345556789999999999
Q ss_pred cC-CCCCCC-----CHHHHhcCCCCCCCCCccc
Q 006779 266 IV-PASLRL-----PALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 266 L~-~p~~Rp-----sa~elL~hpff~~~~~~~~ 292 (631)
|+ +|.+|| ++.+++.||||...++...
T Consensus 233 l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~ 265 (277)
T cd05577 233 LQKDPEKRLGCRGGSADEVREHPLFKDLNWRRL 265 (277)
T ss_pred ccCChhHccCCCcccHHHHHhChhhhcCChhhh
Confidence 98 899999 8999999999988776554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=316.65 Aligned_cols=250 Identities=26% Similarity=0.456 Sum_probs=209.2
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEeccCC
Q 006779 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112 (631)
Q Consensus 33 LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~~g 112 (631)
||.|+||.||+|.+..+|+.|++|.+..... ......+.+.+|+.+++.++||||+++++.+.. ...+++|+||+.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh-hhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCC
Confidence 6899999999999999999999999865432 224566789999999999999999999998754 3578999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC--------
Q 006779 113 GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-------- 184 (631)
Q Consensus 113 GsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-------- 184 (631)
++|..++.+.+.+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++......
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILID-SNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEc-CCCCEEEEecccchhcccCcccccccc
Confidence 999999998888999999999999999999999998 99999999999998 7889999999998644322
Q ss_pred --CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006779 185 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 185 --~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~l 261 (631)
......+++.|+|||.+.. .++.++||||||+++|+|++|..||.. .........+..+..+.......++.+++|
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSDEAIDL 233 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCcCCCccccCCHHHHHH
Confidence 2234567889999997654 478899999999999999999999976 455666666655433222122247899999
Q ss_pred HHHhcC-CCCCCCCH---HHHhcCCCCCCCCC
Q 006779 262 IEKCIV-PASLRLPA---LELLKDPFLVTDNP 289 (631)
Q Consensus 262 I~~cL~-~p~~Rpsa---~elL~hpff~~~~~ 289 (631)
|.+||. +|.+||++ .++|+||||...+|
T Consensus 234 i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 234 ISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred HHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 999998 89999999 99999999986543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=366.50 Aligned_cols=258 Identities=21% Similarity=0.385 Sum_probs=225.1
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
.+.++||+|+||.|.+++++.|+..+|.|+++.-...+ ......|..|-.+|..-+.+-|+.++..|.|+ .++|+||
T Consensus 78 eilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK-r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~--~~LYlVM 154 (1317)
T KOG0612|consen 78 EILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK-RAETACFREERDIMVFGNSEWIVQLHYAFQDE--RYLYLVM 154 (1317)
T ss_pred HHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh-chhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc--cceEEEE
Confidence 45688999999999999999999999999998654433 23446688999999999999999999999765 5799999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC--
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-- 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~-- 185 (631)
||+.||+|..++.++.+++++-++.|+..|+.||.-||+.| +|||||||+|||++ ..|+|||+|||.+..+....
T Consensus 155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld-~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLD-KSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEec-ccCcEeeccchhHHhcCCCCcE
Confidence 99999999999999999999999999999999999999999 99999999999998 89999999999997776432
Q ss_pred -CccccCCCCCCCccccc------cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCcH
Q 006779 186 -ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDP 256 (631)
Q Consensus 186 -~~~~~GTp~Y~APEvl~------~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~--~~~~~ 256 (631)
....+|||.|++||++. +.|+.-+|+||+||++|||+.|..||.. .+....|.+|..-.....+| ...+.
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~l~FP~~~~VSe 310 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKESLSFPDETDVSE 310 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhhcCCCcccccCH
Confidence 34568999999999884 3499999999999999999999999986 56667777777653333333 33789
Q ss_pred HHHHHHHHhcCCCCCCCC---HHHHhcCCCCCCCCCccc
Q 006779 257 QVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 257 ~l~~lI~~cL~~p~~Rps---a~elL~hpff~~~~~~~~ 292 (631)
++++||.+.|.+|..|.. +.++-.||||....|..+
T Consensus 311 eakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~~i 349 (1317)
T KOG0612|consen 311 EAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWDNI 349 (1317)
T ss_pred HHHHHHHHHhcChhhhcccccHHHHHhCccccCCChhhh
Confidence 999999999999999888 999999999999999664
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=323.50 Aligned_cols=255 Identities=27% Similarity=0.423 Sum_probs=205.7
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccC-CHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~-~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
|| .+.+.||+|+||.||+|.+..+|..||+|.+....... .......+..|+.+++.++|+||+++++++.+ ...+
T Consensus 1 ~y-~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~ 77 (298)
T cd07841 1 RY-EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNI 77 (298)
T ss_pred Cc-eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEE
Confidence 45 56688999999999999999999999999997654321 12234557789999999999999999999876 3579
Q ss_pred EEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 104 NMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~-~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
++||||+ +|+|..++.... .+++..++.++.||+.||.|||+++ ++||||+|+|||++ .+|.++|+|||++....
T Consensus 78 ~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 78 NLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIA-SDGVLKLADFGLARSFG 153 (298)
T ss_pred EEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEc-CCCCEEEccceeeeecc
Confidence 9999999 899999998776 7999999999999999999999999 99999999999998 78999999999997654
Q ss_pred CC--CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-C----------
Q 006779 183 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-P---------- 247 (631)
Q Consensus 183 ~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~-p---------- 247 (631)
.. ......+++.|+|||.+.+ .++.++|||||||++|+|++|..||....... ....+..... +
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 154 SPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred CCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCchhhhhhccc
Confidence 43 2233456889999997743 47889999999999999999977776544333 2333221100 0
Q ss_pred ---------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 248 ---------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 248 ---------------~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.......+..+++||.+||. +|.+|||+.++|.||||...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 00112346789999999998 89999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=317.39 Aligned_cols=254 Identities=30% Similarity=0.520 Sum_probs=207.7
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccC------CHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ------SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~------~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 98 (631)
|| .+.+.||+|+||.||+|.+..+|..||+|.+....... .....+.+.+|+.+++.++||||+++++++...
T Consensus 2 ~~-~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KW-VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE 80 (272)
T ss_pred ce-eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC
Confidence 45 66889999999999999999999999999986532111 112345688999999999999999999987654
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
..+++||||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++
T Consensus 81 --~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~d~~~~ 155 (272)
T cd06629 81 --EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVD-ADGICKISDFGIS 155 (272)
T ss_pred --CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEc-CCCeEEEeecccc
Confidence 478999999999999999998888999999999999999999999998 99999999999997 7899999999998
Q ss_pred chhcCC----CCccccCCCCCCCcccccc---ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC---CC
Q 006779 179 IVMQQP----TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---PA 248 (631)
Q Consensus 179 ~~~~~~----~~~~~~GTp~Y~APEvl~~---~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~---p~ 248 (631)
...... ......|+..|+|||.+.. .++.++|+||||+++|+|++|..||........+......... +.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP 235 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCc
Confidence 654322 1223467889999998753 3788999999999999999999999764444333332222211 22
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 249 ~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
......+..+++||.+||. +|.+||++.++|.||||
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 2333457899999999998 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.38 Aligned_cols=262 Identities=26% Similarity=0.368 Sum_probs=209.4
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHH----------HHHHHHHHHHHHHhCCCCCce
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD----------QLERLYSEVHLLKSLKHENII 89 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~----------~~~~l~~Ei~iLk~L~HpnIV 89 (631)
-+..+||..+.+.||+|+||+||+|.+..+|+.||+|.+.......... ....+.+|+.+++.++||||+
T Consensus 4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 83 (335)
T PTZ00024 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM 83 (335)
T ss_pred cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence 3567899888899999999999999999999999999987543221110 012477899999999999999
Q ss_pred eeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCc
Q 006779 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169 (631)
Q Consensus 90 kl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~ 169 (631)
++++++... ..+++||||+. |+|.+++.....+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.
T Consensus 84 ~~~~~~~~~--~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~-~~~~ 157 (335)
T PTZ00024 84 GLVDVYVEG--DFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFIN-SKGI 157 (335)
T ss_pred eeeEEEecC--CcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEEC-CCCC
Confidence 999988654 47899999996 699999988888999999999999999999999998 99999999999997 7889
Q ss_pred EEEccccccchhcC----------------CCCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCC
Q 006779 170 VKIGDLGLAIVMQQ----------------PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNEC 231 (631)
Q Consensus 170 vKL~DFGla~~~~~----------------~~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~ 231 (631)
++|+|||++..... .......+++.|+|||.+.+ .++.++|||||||++|+|++|..||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999865441 11123356889999997754 3788999999999999999999999864
Q ss_pred CCHHHHHHHHHcCCCC--C-----------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 006779 232 KNPAQIYKKVTSGIKP--A-----------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 232 ~~~~~i~~~i~~~~~p--~-----------------------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~ 285 (631)
.....+.........| . ......+..+++||.+||. +|.+||++.++|.||||+
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~ 317 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK 317 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence 4333322221110000 0 0012346789999999998 899999999999999998
Q ss_pred CC
Q 006779 286 TD 287 (631)
Q Consensus 286 ~~ 287 (631)
..
T Consensus 318 ~~ 319 (335)
T PTZ00024 318 SD 319 (335)
T ss_pred CC
Confidence 64
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=316.77 Aligned_cols=244 Identities=20% Similarity=0.332 Sum_probs=201.5
Q ss_pred eeeeeEecccCceEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 27 GRYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~---~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
+++.++||+|+||.||+|.++ ..+..||+|.++... +......+.+|+..|+.++||||+++++++... ..+
T Consensus 7 ~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 81 (266)
T cd05064 7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC---SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG--NTM 81 (266)
T ss_pred eEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC--CCc
Confidence 388899999999999999875 456899999987542 344556789999999999999999999988654 468
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
++||||+.+|+|.+++.+. ..+++..++.++.||+.||+|||+++ ++||||||+|||++ .++.+|++|||.+....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~-~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVN-SDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEc-CCCcEEECCCccccccc
Confidence 9999999999999999874 57899999999999999999999998 99999999999997 78899999999875432
Q ss_pred CCC---CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006779 183 QPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 183 ~~~---~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~ 257 (631)
... .....+++.|+|||.+. ..++.++|||||||++|||++ |+.||.. .+...+.+.+..+..++ .+...+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~ 236 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD-MSGQDVIKAVEDGFRLP-APRNCPNL 236 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc-CCHHHHHHHHHCCCCCC-CCCCCCHH
Confidence 221 11233567899999775 458999999999999999775 9999976 45556666666654432 45567789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 258 VKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 258 l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+.+++.+||+ +|.+||++.++++
T Consensus 237 ~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 237 LHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHH
Confidence 9999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=325.18 Aligned_cols=261 Identities=31% Similarity=0.532 Sum_probs=214.0
Q ss_pred ccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEE
Q 006779 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (631)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 96 (631)
....++.+|| .+.+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~ 86 (293)
T cd06647 12 VSVGDPKKKY-TRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKHPNIVNYLDSYL 86 (293)
T ss_pred eeccCchhhc-eeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHHHHHHHHHHHhhcCCCCeeehhheee
Confidence 4457778899 66789999999999999999999999999986432 233467889999999999999999999887
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccc
Q 006779 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 176 (631)
+. ...++|+||+.+++|.+++.+. .+++..+..++.|++.||.|||+++ ++||||+|+||+++ .++.++|+|||
T Consensus 87 ~~--~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~-~~~~~kL~dfg 160 (293)
T cd06647 87 VG--DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFG 160 (293)
T ss_pred eC--CcEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEc-CCCCEEEccCc
Confidence 65 3688999999999999998764 4889999999999999999999998 99999999999997 78899999999
Q ss_pred ccchhcCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006779 177 LAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 177 la~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~ 253 (631)
++...... ......|++.|+|||.+.. .++.++|+||||+++|+|++|+.||.......++......+.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd06647 161 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK 240 (293)
T ss_pred ceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccc
Confidence 88654332 2234568899999997654 58899999999999999999999997644333332222222222222334
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 254 ~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
.+..+++||.+||. +|.+||++.+++.||||+..+
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 56789999999998 899999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=309.48 Aligned_cols=250 Identities=31% Similarity=0.566 Sum_probs=214.2
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
|| ++.+.||+|+||.||+|.+..++..|++|.+..... .......+.+|+++++.++|||++++++.+.+. ..++
T Consensus 1 ~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~ 75 (258)
T cd08215 1 KY-EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM--SEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLC 75 (258)
T ss_pred Cc-eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC--ChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEE
Confidence 35 677999999999999999999999999999876542 345667789999999999999999999988765 5789
Q ss_pred EEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 105 MITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~----~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
+|+||+.+++|.+++.+. ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++ .++.++|+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~-~~~~~~l~d~~~~~~ 152 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLT-SNGLVKLGDFGISKV 152 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEc-CCCcEEECCccceee
Confidence 999999999999998764 67999999999999999999999998 99999999999998 788999999999976
Q ss_pred hcCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006779 181 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 181 ~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~ 257 (631)
.... ......|++.|+|||.+.. .++.++|+||||+++++|++|..||... +...+...+.... ...++...+..
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~ 230 (258)
T cd08215 153 LSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE-NLLELALKILKGQ-YPPIPSQYSSE 230 (258)
T ss_pred cccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC-cHHHHHHHHhcCC-CCCCCCCCCHH
Confidence 5443 2344578999999997654 4889999999999999999999999764 4556666555543 33455567889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 258 VKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 258 l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
++++|.+||. +|.+||++.++|.||||
T Consensus 231 ~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 231 LRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 9999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=337.72 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=203.9
Q ss_pred CCCceeeeeeEecccCceEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeE
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSW 95 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d-----~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~ 95 (631)
|..+| ++.+.||+|+||.||+|.+ ..++..||+|.++... .....+.+.+|+.+|+.+ +||||++++++|
T Consensus 33 ~~~~~-~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 33 PRNRL-SFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred chHHe-ehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 34456 7789999999999999974 4567899999986432 234456788999999999 899999999988
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhCC----------------------------------------------------
Q 006779 96 VDDTNRTINMITELFTSGSLRQYRKKHK---------------------------------------------------- 123 (631)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~~~l~~~~---------------------------------------------------- 123 (631)
.+. ...++||||+.+|+|.+++....
T Consensus 109 ~~~--~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 109 TVG--GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred ccC--CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 655 46889999999999999986421
Q ss_pred -----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 124 -----------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 124 -----------------------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~-~~~~~kl~DfG~a~~ 263 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLT-HGRITKICDFGLARD 263 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEE-CCCcEEEecCcccee
Confidence 4778899999999999999999998 99999999999998 788999999999975
Q ss_pred hcCCCC----ccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006779 181 MQQPTA----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 181 ~~~~~~----~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 254 (631)
...... ....+++.|+|||++.+ .++.++|||||||++|+|++ |..||........+.+.+..+..+. .+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 342 (375)
T cd05104 264 IRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML-SPECA 342 (375)
T ss_pred ccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC-CCCCC
Confidence 543221 12234567999997754 58999999999999999998 8999987666666777776664432 33456
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 255 DPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
+.++++||.+||. +|.+||++.+++..
T Consensus 343 ~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 343 PSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 7899999999998 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.64 Aligned_cols=249 Identities=27% Similarity=0.456 Sum_probs=201.9
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||.|++|.||+|.++.+|..||+|.+..... .......+.+|++++++++||||+++++++.+. ..+++||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 78 (284)
T cd07860 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLYLVF 78 (284)
T ss_pred eeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc--ccccchHHHHHHHHHHhcCCCCCcchhhhcccC--CcEEEEe
Confidence 667889999999999999999999999998875432 223345688999999999999999999988654 4689999
Q ss_pred eccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC-
Q 006779 108 ELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 184 (631)
Q Consensus 108 Ey~~gGsL~~~l~~--~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~- 184 (631)
||+. ++|..++.. ...+++..++.++.||+.||+|||+++ ++||||+|+||+++ .++.+||+|||++......
T Consensus 79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~-~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEeeccchhhcccCc
Confidence 9995 689988865 356899999999999999999999998 99999999999998 7889999999998655432
Q ss_pred -CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-------------
Q 006779 185 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA------------- 248 (631)
Q Consensus 185 -~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~------------- 248 (631)
......+++.|+|||++.+ .++.++||||||+++|+|+||+.||........+.+.+.....+.
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 2233457889999997754 268899999999999999999999977554444433332111110
Q ss_pred -------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 249 -------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 249 -------------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
......++.++++|.+||. +|.+||++.++|.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0112356889999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=345.46 Aligned_cols=246 Identities=22% Similarity=0.332 Sum_probs=198.0
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.+| ++.+.||+|+||.||+|.+..++..||+|.... ..+.+|+++|++|+|||||++++++... ...
T Consensus 169 ~gy-~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~--~~~ 235 (461)
T PHA03211 169 LGF-AIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVVG--GLT 235 (461)
T ss_pred CCe-EEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEEC--CEE
Confidence 356 778999999999999999999999999996432 2256899999999999999999988654 468
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
++|||++. ++|..++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++...
T Consensus 236 ~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~-~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 236 CLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVN-GPEDICLGDFGAACFAR 311 (461)
T ss_pred EEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEEC-CCCCEEEcccCCceecc
Confidence 89999995 6888887654 56999999999999999999999999 99999999999997 78899999999997653
Q ss_pred CCC----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCC-------CCHHHHHHHHHcCCCC-CC
Q 006779 183 QPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC-------KNPAQIYKKVTSGIKP-AS 249 (631)
Q Consensus 183 ~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~-------~~~~~i~~~i~~~~~p-~~ 249 (631)
... .....||+.|+|||++.+ .++.++|||||||++|||++|..|+... ....++...+...... ..
T Consensus 312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 321 224579999999998764 5899999999999999999987664321 1234455444432110 00
Q ss_pred -----------------------------CC--CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 250 -----------------------------LS--KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 250 -----------------------------l~--~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
+. ...+..+++||.+||. ||.+|||+.|+|+||||+.
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00 0234678999999998 9999999999999999974
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=345.11 Aligned_cols=232 Identities=31% Similarity=0.480 Sum_probs=198.0
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEecc
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~ 110 (631)
+-||.|+.|.||+|+ -.++.||||+|+.- -..+|+-|++|+|||||.|.++|.. ..+++||||||
T Consensus 130 eWlGSGaQGAVF~Gr--l~netVAVKKV~el-----------kETdIKHLRkLkH~NII~FkGVCtq--sPcyCIiMEfC 194 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGR--LHNETVAVKKVREL-----------KETDIKHLRKLKHPNIITFKGVCTQ--SPCYCIIMEFC 194 (904)
T ss_pred hhhccCcccceeeee--ccCceehhHHHhhh-----------hhhhHHHHHhccCcceeeEeeeecC--CceeEEeeecc
Confidence 669999999999995 56899999988622 1247899999999999999998854 45899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC-CCCccc
Q 006779 111 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSV 189 (631)
Q Consensus 111 ~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~-~~~~~~ 189 (631)
..|-|...++....++...+..|.++|+.|++|||.+. |||||||.-||||. .+..|||+|||.++.... .+..++
T Consensus 195 a~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs-~~d~VKIsDFGTS~e~~~~STkMSF 271 (904)
T KOG4721|consen 195 AQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILIS-YDDVVKISDFGTSKELSDKSTKMSF 271 (904)
T ss_pred ccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEee-ccceEEeccccchHhhhhhhhhhhh
Confidence 99999999999999999999999999999999999999 99999999999997 788999999999987654 355678
Q ss_pred cCCCCCCCccccccc-cCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-
Q 006779 190 IGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV- 267 (631)
Q Consensus 190 ~GTp~Y~APEvl~~~-ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~- 267 (631)
+||..|||||+++.+ .++++||||||++|||||||+.||.+-.. ..|+--|-........+..++..++-||+.||.
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds-sAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~s 350 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS-SAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNS 350 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch-heeEEeccCCcccccCcccCchHHHHHHHHHHhc
Confidence 999999999998765 78999999999999999999999976322 222222222223334556678899999999998
Q ss_pred CCCCCCCHHHHhcC
Q 006779 268 PASLRLPALELLKD 281 (631)
Q Consensus 268 ~p~~Rpsa~elL~h 281 (631)
+|.+||+..++|.|
T Consensus 351 KpRNRPSFrqil~H 364 (904)
T KOG4721|consen 351 KPRNRPSFRQILLH 364 (904)
T ss_pred CCCCCccHHHHHHH
Confidence 89999999999988
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=319.99 Aligned_cols=253 Identities=25% Similarity=0.427 Sum_probs=207.6
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
+|| ++.+.||+|+||.||+|.+..+|+.||+|.++.... .......+.+|+++++.++|+||+++++++.+. ..+
T Consensus 1 ~~y-~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 75 (288)
T cd07833 1 NKY-EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLRHENIVNLKEAFRRK--GRL 75 (288)
T ss_pred Cce-eEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--cccchhHHHHHHHHHHhcCCCCeeehhheEEEC--CEE
Confidence 356 778999999999999999999999999998865432 234457789999999999999999999998764 478
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
++|+||+.++.+..+..+...+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.+||+|||++.....
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~-~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 76 YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVS-ESGVLKLCDFGFARALRA 152 (288)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEEeeecccccCC
Confidence 999999998888777777677999999999999999999999998 99999999999998 789999999999876543
Q ss_pred C---CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC--------------
Q 006779 184 P---TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-------------- 244 (631)
Q Consensus 184 ~---~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~-------------- 244 (631)
. ......+++.|+|||++.+ .++.++||||||+++|+|++|+.||........+.......
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 3 2334578899999997653 47899999999999999999999998754444333221100
Q ss_pred -----CC--C--------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 245 -----IK--P--------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 245 -----~~--p--------~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
.. + ..++...++++++||.+||. +|.+||++.++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00 0 01122347889999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=346.29 Aligned_cols=257 Identities=33% Similarity=0.493 Sum_probs=214.9
Q ss_pred cCCcCCcccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCce
Q 006779 10 SETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89 (631)
Q Consensus 10 ~~~~~~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIV 89 (631)
..-+..++++.-+.. ..+++.||+|.||+||+|++-. .||||.++.... +++..+.|..|+..+++-+|.||+
T Consensus 379 ~~s~s~~~WeIp~~e--v~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p--t~~qlqaFKnEVa~lkkTRH~NIl 451 (678)
T KOG0193|consen 379 QASDSLEEWEIPPEE--VLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP--TPEQLQAFKNEVAVLKKTRHENIL 451 (678)
T ss_pred cCCccccccccCHHH--hhccceeccccccceeeccccc---ceEEEEEecCCC--CHHHHHHHHHHHHHHhhcchhhhe
Confidence 333444455444432 2567899999999999998764 599999987764 567899999999999999999999
Q ss_pred eeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCC
Q 006779 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 168 (631)
Q Consensus 90 kl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g 168 (631)
-|.+++..+. +.||+-+|+|.+|..++.-. .+|++.+++.|++||+.|+.|||.++ |||||||..|||+. +++
T Consensus 452 LFMG~~~~p~---~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~-~~~ 525 (678)
T KOG0193|consen 452 LFMGACMNPP---LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLH-EDL 525 (678)
T ss_pred eeehhhcCCc---eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEc-cCC
Confidence 9999986543 48999999999999988643 46999999999999999999999999 99999999999997 679
Q ss_pred cEEEccccccchhc----CCCCccccCCCCCCCcccccc----ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHH
Q 006779 169 EVKIGDLGLAIVMQ----QPTARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240 (631)
Q Consensus 169 ~vKL~DFGla~~~~----~~~~~~~~GTp~Y~APEvl~~----~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~ 240 (631)
+|||+|||++..-. ......-.|...|||||+++. .|++.+|||||||++|||+||..||. ..+.++|.-.
T Consensus 526 kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifm 604 (678)
T KOG0193|consen 526 KVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFM 604 (678)
T ss_pred cEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEE
Confidence 99999999995432 223344467889999998753 49999999999999999999999999 6899999999
Q ss_pred HHcCCCCC---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 241 VTSGIKPA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 241 i~~~~~p~---~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+.+|...+ ......+.++++|+..||. ++.+||...+||.
T Consensus 605 VGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 605 VGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 99984433 3444566799999999998 8999999999886
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=339.38 Aligned_cols=241 Identities=26% Similarity=0.410 Sum_probs=201.5
Q ss_pred eeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEE
Q 006779 26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 y~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~l 105 (631)
..++.+.||+|-||.||.|.... ...||+|.++.... ..+.+.+|+++|++|+|+|||++|+++..+. .++|
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m-----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~--piyI 278 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM-----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQE--PIYI 278 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc-----ChhHHHHHHHHHHhCcccCeEEEEEEEecCC--ceEE
Confidence 34566789999999999997652 34899999875432 1245779999999999999999999886543 6999
Q ss_pred EEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 106 ITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~--~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
|||||..|+|.+|++. ++.+...+.+.++.||++|++||++++ +|||||...||||+ +++.+||+|||+|+....
T Consensus 279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~-~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVD-EDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeec-cCceEEEcccccccccCC
Confidence 9999999999999997 567999999999999999999999999 99999999999997 888999999999985443
Q ss_pred CCCcccc---CCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006779 184 PTARSVI---GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 184 ~~~~~~~---GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l 258 (631)
..-.... -...|.|||.+. +.++.++|||||||+||||+| |+.||.+ .+..++...+.+|...+. +..+++++
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~-msn~ev~~~le~GyRlp~-P~~CP~~v 433 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG-MSNEEVLELLERGYRLPR-PEGCPDEV 433 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC-CCHHHHHHHHhccCcCCC-CCCCCHHH
Confidence 3211111 234699999775 569999999999999999999 8999987 566778888998876543 44578999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHh
Q 006779 259 KQFIEKCIV-PASLRLPALELL 279 (631)
Q Consensus 259 ~~lI~~cL~-~p~~Rpsa~elL 279 (631)
.+++..||. +|.+|||...|.
T Consensus 434 Y~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 434 YELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHHHHhhCCcccCCCHHHHH
Confidence 999999998 899999998654
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=314.87 Aligned_cols=251 Identities=28% Similarity=0.486 Sum_probs=208.4
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
++| .+.+.||+|+||.||+|.++.+|..||+|.+..... ........+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~-~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 77 (267)
T cd08228 2 ANF-QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED--NEL 77 (267)
T ss_pred cce-eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC--CeE
Confidence 355 778999999999999999999999999998875432 2345567788999999999999999999988765 468
Q ss_pred EEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 104 NMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~----~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
++|+||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~d~g~~~ 154 (267)
T cd08228 78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEc-CCCCEEECccccce
Confidence 899999999999988753 345899999999999999999999998 99999999999997 78899999999987
Q ss_pred hhcCCC--CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCc
Q 006779 180 VMQQPT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 180 ~~~~~~--~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~-~~~~i~~~i~~~~~p~~l~~~~~ 255 (631)
...... .....|++.|+|||.+. ..++.++|+||||+++|+|++|+.||.... +...+...+.....+.......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08228 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYS 234 (267)
T ss_pred eccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcC
Confidence 654322 23456889999999775 458889999999999999999999986533 34555566655444444444567
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 256 PQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
..++++|.+||. +|.+||++.++|+.
T Consensus 235 ~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 235 EKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 889999999998 89999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=321.60 Aligned_cols=250 Identities=25% Similarity=0.358 Sum_probs=203.7
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||+|+||.||+|.+..+|..||+|.++..... ......+.+|+.+++.++||||+++++++.+.....+++||
T Consensus 8 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 8 EKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 5678899999999999999999999999999755422 22334577899999999999999999998877557899999
Q ss_pred eccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC--
Q 006779 108 ELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 184 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~-~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-- 184 (631)
||+. ++|.+++.... .+++..++.++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++......
T Consensus 86 e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 86 EYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred hhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEEC-CCCcEEEeecCceeeccCCcc
Confidence 9997 59999887654 5899999999999999999999998 99999999999998 7899999999998765443
Q ss_pred CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC----------------
Q 006779 185 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---------------- 246 (631)
Q Consensus 185 ~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~---------------- 246 (631)
......+++.|+|||.+.+ .++.++||||||+++|+|++|..||........+ .++.....
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL-NKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCchHHHHHhhccchh
Confidence 2234567899999998754 3688999999999999999999999865433322 22211000
Q ss_pred -------------CCCCCCC-CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 247 -------------PASLSKV-TDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 247 -------------p~~l~~~-~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
...++.. .++.+++||.+||+ +|.+|||+.|+|.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0112222 47789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=320.23 Aligned_cols=252 Identities=27% Similarity=0.459 Sum_probs=199.8
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
.++| ++.+.||+|+||.||+|.++.+|..||+|.+..... ......+.+|+.+|+.++|+||+++++++.+. ..
T Consensus 4 ~~~y-~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~ 77 (291)
T cd07870 4 ATSY-LNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE---EGVPFTAIREASLLKGLKHANIVLLHDIIHTK--ET 77 (291)
T ss_pred ccee-EEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc---CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC--Ce
Confidence 4566 778999999999999999999999999999865432 12223467899999999999999999988654 47
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 103 INMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
.++|+||+. ++|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLIS-YLGELKLADFGLARAK 153 (291)
T ss_pred EEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEc-CCCcEEEecccccccc
Confidence 889999996 677766654 456889999999999999999999998 99999999999997 7889999999998654
Q ss_pred cCC--CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc--CC----------
Q 006779 182 QQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GI---------- 245 (631)
Q Consensus 182 ~~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~--~~---------- 245 (631)
... ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||.......+....+.. +.
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 322 2234467899999998754 4788999999999999999999999765444333322211 00
Q ss_pred -------------CCCCC----C-CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 246 -------------KPASL----S-KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 246 -------------~p~~l----~-~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
.+..+ . ...++.+.+|+.+||+ +|.+|||+.++|.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000 0 0125689999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=318.70 Aligned_cols=257 Identities=30% Similarity=0.559 Sum_probs=213.7
Q ss_pred CCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC
Q 006779 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~ 100 (631)
+|.+.|. ..+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.+.||||+++++.+.+.
T Consensus 1 ~~~~~y~-~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 74 (277)
T cd06640 1 DPEELFT-KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG-- 74 (277)
T ss_pred ChHHhhh-hhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--
Confidence 3556674 4577999999999999999999999999987543 245567899999999999999999999988764
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
..+++||||+.+|+|.+++.. +++++..+..++.|++.||.|||+++ ++|+||+|+||+++ .++.++|+|||++..
T Consensus 75 ~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~-~~~~~~l~dfg~~~~ 150 (277)
T cd06640 75 TKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLS-EQGDVKLADFGVAGQ 150 (277)
T ss_pred CEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEc-CCCCEEEccccccee
Confidence 479999999999999999875 46899999999999999999999998 99999999999997 788999999999865
Q ss_pred hcCCC--CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006779 181 MQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 181 ~~~~~--~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~ 257 (631)
..... .....++..|+|||++.+ .++.++|+|||||++|+|+||..||... ++......+..+. ++.+....+..
T Consensus 151 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~ 228 (277)
T cd06640 151 LTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM-HPMRVLFLIPKNN-PPTLTGEFSKP 228 (277)
T ss_pred ccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCc-ChHhHhhhhhcCC-CCCCchhhhHH
Confidence 43322 233467889999998754 4789999999999999999999999864 3444444443332 33444556788
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 258 VKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 258 l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
+.+||.+||. +|.+||++.+++.||||.....
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 229 FKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred HHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 9999999998 8999999999999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=335.81 Aligned_cols=249 Identities=25% Similarity=0.413 Sum_probs=201.7
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCC-----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeE
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDG-----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSW 95 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg-----~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~ 95 (631)
|..+| ++.+.||+|+||.||+|.+..+| ..||+|.+.... .....+.+.+|+.+|+.+ +||||++++++|
T Consensus 36 ~~~~~-~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 36 PRDNL-QFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cHHHc-eehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 44456 77899999999999999875544 579999986442 234567789999999999 899999999988
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhC-----------------------------------------------------
Q 006779 96 VDDTNRTINMITELFTSGSLRQYRKKH----------------------------------------------------- 122 (631)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~~~l~~~----------------------------------------------------- 122 (631)
... ..+++||||+.+|+|.+++.+.
T Consensus 112 ~~~--~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 112 THG--GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred cCC--CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 654 4689999999999999998642
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC
Q 006779 123 -----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185 (631)
Q Consensus 123 -----------------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~ 185 (631)
..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~-~~~~~kL~DfGla~~~~~~~ 266 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDS 266 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEe-CCCeEEEeeceeeeeccCCc
Confidence 24788899999999999999999998 99999999999998 78899999999997554322
Q ss_pred Cc----cccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006779 186 AR----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 186 ~~----~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~ 259 (631)
.. ...+++.|||||++. ..++.++|||||||++|+|++ |..||........+...+..+..+ ..+...+++++
T Consensus 267 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 345 (374)
T cd05106 267 NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM-SRPDFAPPEIY 345 (374)
T ss_pred ceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc-cCCCCCCHHHH
Confidence 11 223456799999765 468999999999999999997 999998755444555555544332 23445678999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhc
Q 006779 260 QFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 260 ~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
++|.+||+ +|.+||++.++++
T Consensus 346 ~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 346 SIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 99999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=318.64 Aligned_cols=255 Identities=25% Similarity=0.370 Sum_probs=201.5
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCceeeeeeEEcCCC---
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTN--- 100 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~--- 100 (631)
+| ++.+.||+|+||.||+|.+..+|..||+|.+..... .......+.+|+.+++.+. ||||+++++++.....
T Consensus 2 ~y-~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 78 (295)
T cd07837 2 AY-EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD--EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK 78 (295)
T ss_pred Cc-eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc--ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence 55 667899999999999999999999999998865432 2223356788999999995 6999999998765432
Q ss_pred CeEEEEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccc
Q 006779 101 RTINMITELFTSGSLRQYRKKH-----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~-----~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 175 (631)
..+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||+|+|||++..++.+||+||
T Consensus 79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeec
Confidence 247899999985 888887642 35899999999999999999999998 9999999999999843889999999
Q ss_pred cccchhcCCC--CccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC---
Q 006779 176 GLAIVMQQPT--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--- 248 (631)
Q Consensus 176 Gla~~~~~~~--~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~--- 248 (631)
|++....... .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||.......+..+....-..|.
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 9986543321 223357889999997743 478999999999999999999999987555444433222100000
Q ss_pred ----------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 006779 249 ----------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 249 ----------------------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~ 285 (631)
......+..+++||.+||. +|.+||++.++|.||||+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0112356889999999998 899999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=316.57 Aligned_cols=257 Identities=28% Similarity=0.560 Sum_probs=212.8
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
.++-.+|.. -+.||+|++|.||+|.+..++..|++|.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~~~~~~-~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~- 88 (285)
T cd06648 15 GDPRSYLDN-FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG- 88 (285)
T ss_pred CcchHhhhc-ceEeccCCCeEEEEEEECCCCCEEEEEEEeccc----hhHHHHHHHHHHHHHHcCCCChheEEEEEEcC-
Confidence 344445544 378999999999999999999999999886432 33456688999999999999999999988754
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
...++|+||+.+++|.+++.. .++++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||.+.
T Consensus 89 -~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~d~g~~~ 163 (285)
T cd06648 89 -DELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLT-SDGRVKLSDFGFCA 163 (285)
T ss_pred -CeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEc-CCCcEEEcccccch
Confidence 468899999999999999887 67999999999999999999999999 99999999999997 78999999999886
Q ss_pred hhcCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCCc
Q 006779 180 VMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-LSKVTD 255 (631)
Q Consensus 180 ~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~-l~~~~~ 255 (631)
..... ......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||.. .++......+.....+.. .....+
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (285)
T cd06648 164 QVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKNLHKVS 242 (285)
T ss_pred hhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHhcCCCCCcccccCC
Confidence 54332 2234568999999998754 488999999999999999999999976 455555666665532221 122367
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
..+.+||.+||. +|.+||++.++|.||||....
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 899999999998 899999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=330.29 Aligned_cols=254 Identities=29% Similarity=0.430 Sum_probs=203.2
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC--
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-- 100 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~-- 100 (631)
..|| ++.+.||+|+||.||+|.+..+|..||+|.+.... ........+.+|+.+++.++||||++++++|.....
T Consensus 15 ~~~y-~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 15 LKRY-QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF--QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hcce-EEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc--cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 4677 66789999999999999999999999999886432 233455678899999999999999999998864322
Q ss_pred --CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 101 --RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 101 --~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
..+|+||||+. ++|.+++... +++..+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~ 165 (353)
T cd07850 92 EFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA 165 (353)
T ss_pred ccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCccc
Confidence 35789999995 5888887654 899999999999999999999998 99999999999998 7889999999999
Q ss_pred chhcCCC-CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCC-CC--------
Q 006779 179 IVMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI-KP-------- 247 (631)
Q Consensus 179 ~~~~~~~-~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~-~p-------- 247 (631)
....... .....+++.|+|||.+.+ .++.++|||||||++|+|++|+.||........ +..+.... .|
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 166 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ-WNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred eeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHh
Confidence 7654432 234568999999997754 589999999999999999999999976433222 22221100 00
Q ss_pred ----------------CCC----------------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 248 ----------------ASL----------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 248 ----------------~~l----------------~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
..+ ....++.+++||.+||. +|.+|||+.|+|.||||..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 000 11345678999999998 9999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=316.72 Aligned_cols=244 Identities=25% Similarity=0.380 Sum_probs=204.7
Q ss_pred eeeeEecccCceEEEEEEEccCC-----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDG-----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg-----~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ..
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~ 82 (283)
T cd05048 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA---EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE--QP 82 (283)
T ss_pred chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC---CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC--Cc
Confidence 67789999999999999886655 789999886432 345567789999999999999999999988654 46
Q ss_pred EEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC
Q 006779 103 INMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 166 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~----------------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~ 166 (631)
.+++|||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~-~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG-E 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEc-C
Confidence 88999999999999999764 45788999999999999999999998 99999999999997 7
Q ss_pred CCcEEEccccccchhcCC----CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHH
Q 006779 167 NGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKK 240 (631)
Q Consensus 167 ~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~ 240 (631)
++.+||+|||++...... ......+++.|+|||.+. ..++.++|||||||++|||++ |..||.+ .+..++...
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~-~~~~~~~~~ 238 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG-FSNQEVIEM 238 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHH
Confidence 889999999998654322 122345688999999764 568999999999999999998 9999976 456677777
Q ss_pred HHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 241 VTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 241 i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
+..+..+. .+...++++.+|+.+||+ +|.+||++.+++++
T Consensus 239 i~~~~~~~-~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 239 IRSRQLLP-CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHcCCcCC-CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 77665443 445677999999999998 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=319.68 Aligned_cols=260 Identities=24% Similarity=0.381 Sum_probs=202.7
Q ss_pred ccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEE
Q 006779 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (631)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 96 (631)
+.-.+.-++| ++.+.||+|+||.||+|.+..+|..||+|.+..... .......+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 81 (310)
T cd07865 5 FPFCDEVSKY-EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICR 81 (310)
T ss_pred Ccccchhhhe-EEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC--cCCchhHHHHHHHHHHhCCCCCccceEEEEe
Confidence 3345566778 667889999999999999999999999999865432 1222344678999999999999999999876
Q ss_pred cCC------CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCc
Q 006779 97 DDT------NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169 (631)
Q Consensus 97 d~~------~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~ 169 (631)
... ....++||||+. ++|.+++.+. ..+++..++.++.||+.||+|||+++ ++|+||||+||+++ .++.
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~ 157 (310)
T cd07865 82 TKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILIT-KDGI 157 (310)
T ss_pred cccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEC-CCCc
Confidence 543 236799999996 5788777654 46899999999999999999999998 99999999999997 7889
Q ss_pred EEEccccccchhcCCC------CccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006779 170 VKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241 (631)
Q Consensus 170 vKL~DFGla~~~~~~~------~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i 241 (631)
+||+|||++....... .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||.... .......+
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~-~~~~~~~~ 236 (310)
T cd07865 158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT-EQHQLTLI 236 (310)
T ss_pred EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHH
Confidence 9999999996553321 123457889999997754 36889999999999999999999997643 22222111
Q ss_pred Hc---CCCCC------------------C---------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 242 TS---GIKPA------------------S---------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 242 ~~---~~~p~------------------~---------l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
.. ...+. . .....++.+++||.+||. +|.+||++.++|.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 237 SQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred HHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 11 10000 0 011235678899999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=310.85 Aligned_cols=251 Identities=27% Similarity=0.502 Sum_probs=207.5
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
|| .+.+.||+|+||.||+|.++.+|..||+|.+..... .....+.+.+|+.+++.++||||+++++.+... ..++
T Consensus 1 ~~-~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~--~~~~ 75 (257)
T cd08225 1 RY-EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKEASKKEVILLAKMKHPNIVTFFASFQEN--GRLF 75 (257)
T ss_pred Cc-eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc--cchhhHHHHHHHHHHHhCCCCChhhhhheeccC--CeEE
Confidence 45 678999999999999999999999999999876532 223456788999999999999999999987554 5789
Q ss_pred EEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 105 MITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
+|+||+.+++|.+++.+.. .+++..++.|+.|++.||.|||+++ ++|+||+|+||+++..+..+||+|||.+....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence 9999999999999987643 4799999999999999999999998 99999999999998443467999999987654
Q ss_pred CCC--CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006779 183 QPT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 183 ~~~--~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~ 259 (631)
... .....|++.|+|||.+. ..++.++|+||||+++|+|++|..||... +.......+..+..+ ......+..++
T Consensus 154 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (257)
T cd08225 154 DSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQGYFA-PISPNFSRDLR 231 (257)
T ss_pred CCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHhcccCC-CCCCCCCHHHH
Confidence 432 23346899999999775 45889999999999999999999999764 444444444443332 22334567899
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 260 QFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 260 ~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
++|.+||. +|.+|||+.++++||||
T Consensus 232 ~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 232 SLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHhccChhhCcCHHHHhhCCCC
Confidence 99999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=352.70 Aligned_cols=246 Identities=21% Similarity=0.396 Sum_probs=200.7
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCceeeeee-EEcC---C-CC
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNS-WVDD---T-NR 101 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~-~~d~---~-~~ 101 (631)
++.++|.+|||+.||+|.+...|.+||+|++-.. ++...+.+.+||.+|+.|+ |+|||.|++. .... . ..
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 6778999999999999999999999999998643 4678889999999999997 9999999993 3222 1 23
Q ss_pred eEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 102 TINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~--~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
.+.+.||||.||.|-+++.+ ..+|++..|++|++|++.|+.+||.+.|||||||||-+||||+ .+|.+||||||.++
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls-~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS-ADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc-CCCCEEeCcccccc
Confidence 57788999999999999984 3469999999999999999999999999999999999999997 78999999999985
Q ss_pred hhcCCC-Cc----------cccCCCCCCCccccc---c-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006779 180 VMQQPT-AR----------SVIGTPEFMAPELYE---E-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244 (631)
Q Consensus 180 ~~~~~~-~~----------~~~GTp~Y~APEvl~---~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~ 244 (631)
..-... .. ...-||.|+|||++. + ..++|+|||+|||+||-|+....||.+.... .|..+
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-----aIlng 269 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-----AILNG 269 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----eEEec
Confidence 332211 11 124699999999763 3 4899999999999999999999999874221 13333
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 006779 245 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF 283 (631)
Q Consensus 245 ~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpf 283 (631)
.........++..+++||..||+ +|.+||++.+++.+-+
T Consensus 270 ~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 270 NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 22222224567899999999998 8999999999886543
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=316.50 Aligned_cols=259 Identities=36% Similarity=0.609 Sum_probs=215.2
Q ss_pred ccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC
Q 006779 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 98 (631)
..++...| .+.+.||+|++|.||+|.+..++..|++|.+..... ..+.+.+|+.+++.++|+||+++++.+...
T Consensus 14 ~~~~~~~~-~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 87 (286)
T cd06614 14 EGDPRELY-KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVG 87 (286)
T ss_pred CCCccccc-hHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC
Confidence 34566666 667899999999999999999999999999875431 456788999999999999999999998765
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~-~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
..+++|+||+.+++|.+++..+. .++...+..++.|++.||.|||+.+ ++|+||+|+||+++ .++.++|+|||+
T Consensus 88 --~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~-~~~~~~l~d~~~ 162 (286)
T cd06614 88 --DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLS-KDGSVKLADFGF 162 (286)
T ss_pred --CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEc-CCCCEEECccch
Confidence 47899999999999999999876 8999999999999999999999998 99999999999998 788999999999
Q ss_pred cchhcCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCC
Q 006779 178 AIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IKPASLSKV 253 (631)
Q Consensus 178 a~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~-~~p~~l~~~ 253 (631)
+...... ......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||... ++......+... ..+......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~ 241 (286)
T cd06614 163 AAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE-PPLRALFLITTKGIPPLKNPEK 241 (286)
T ss_pred hhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCcchhh
Confidence 8654332 2234467889999997754 4889999999999999999999999764 443333333332 222222233
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 254 ~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
.+..+++||.+||. +|.+||++.++|.||||....+
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 278 (286)
T cd06614 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP 278 (286)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence 67899999999998 8999999999999999988543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=309.41 Aligned_cols=245 Identities=27% Similarity=0.454 Sum_probs=207.5
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||+|+||.||++.+..++..+|+|.++... .....+.+.+|+.+++.++||||+++++.+.+. ..+++|+
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 77 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD--GHLYIVM 77 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEEEE
Confidence 67899999999999999999999999999987543 234567788999999999999999999988654 4799999
Q ss_pred eccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC-
Q 006779 108 ELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 184 (631)
Q Consensus 108 Ey~~gGsL~~~l~~--~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~- 184 (631)
||+.+|+|.+++.. ...+++..++.|+.||+.||.|||+++ |+|+||||+||+++ .++.++|+|||.+......
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEC-CCCcEEEcccCcceeecccc
Confidence 99999999998865 345899999999999999999999998 99999999999997 7889999999998755432
Q ss_pred -CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006779 185 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262 (631)
Q Consensus 185 -~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI 262 (631)
......|++.|+|||++.+ .++.++|+||||+++|+|++|..||.. .+.......+..+..+ .++...+..+++||
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li 232 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA-NSWKNLILKVCQGSYK-PLPSHYSYELRSLI 232 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC-CCHHHHHHHHhcCCCC-CCCcccCHHHHHHH
Confidence 2334578999999998764 488999999999999999999999976 4555555555554332 24455678899999
Q ss_pred HHhcC-CCCCCCCHHHHhcCC
Q 006779 263 EKCIV-PASLRLPALELLKDP 282 (631)
Q Consensus 263 ~~cL~-~p~~Rpsa~elL~hp 282 (631)
.+||. +|.+||++.+++.--
T Consensus 233 ~~~l~~~P~~Rp~~~~il~~~ 253 (255)
T cd08219 233 KQMFKRNPRSRPSATTILSRG 253 (255)
T ss_pred HHHHhCCcccCCCHHHHhhcc
Confidence 99998 899999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=329.26 Aligned_cols=257 Identities=25% Similarity=0.402 Sum_probs=204.8
Q ss_pred CCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC
Q 006779 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~ 100 (631)
++.+|| ++.+.||.|+||.||+|.++.+|..||+|++..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 2 ~~~~~y-~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 2 DLGSRY-MDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred CcCcce-EEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence 456888 678999999999999999999999999999875542 345668899999999999999999987654332
Q ss_pred ------------CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCC
Q 006779 101 ------------RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 168 (631)
Q Consensus 101 ------------~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g 168 (631)
..+++|+||+. ++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+||+++..++
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~ 152 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDL 152 (342)
T ss_pred ccccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCc
Confidence 35789999996 589888864 46899999999999999999999998 999999999999975667
Q ss_pred cEEEccccccchhcCCC-----CccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006779 169 EVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241 (631)
Q Consensus 169 ~vKL~DFGla~~~~~~~-----~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i 241 (631)
.+||+|||++....... .....+++.|+|||.+.. .++.++|||||||++|+|++|+.||............+
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 89999999987553221 122357889999997643 47889999999999999999999997644333322222
Q ss_pred HcCC----------------------CCC-----CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 242 TSGI----------------------KPA-----SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 242 ~~~~----------------------~p~-----~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
.... .+. .+....+.++++||.+||+ +|.+||++.++|.||||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 1100 000 0112356789999999998 8999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=315.63 Aligned_cols=248 Identities=21% Similarity=0.323 Sum_probs=197.8
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCceeeeeeEEcCCCCeEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~l~lV 106 (631)
++.+.||+|+||.||+|.+..++..||+|.+..... .... ....+|+..++++. ||||+++++++.+.....+++|
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 677899999999999999999999999998864321 2222 23457899999885 9999999999987755689999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC
Q 006779 107 TELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~ 185 (631)
|||+. |+|.+++.. ...+++..++.++.||+.||.|||+++ ++||||+|+||+++ . +.+||+|||++.......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~-~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIK-D-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEc-C-CCeEEEecccccccccCC
Confidence 99997 577777765 457899999999999999999999998 99999999999998 4 999999999997654332
Q ss_pred -CccccCCCCCCCccccc--cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCC----------------C
Q 006779 186 -ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI----------------K 246 (631)
Q Consensus 186 -~~~~~GTp~Y~APEvl~--~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~----------------~ 246 (631)
.....+++.|+|||.+. +.++.++|||||||++|+|++|..||.... ....+..+.... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN-ELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC-HHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 23456899999999653 346889999999999999999999997643 332222221100 0
Q ss_pred CCCC-----------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 247 PASL-----------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 247 p~~l-----------~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
...+ ....+..+++||.+||. +|.+||++.++|.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0001 12346899999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=321.00 Aligned_cols=254 Identities=30% Similarity=0.482 Sum_probs=199.9
Q ss_pred ceeeeeeEecccCceEEEEEEEcc--CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEV--DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~--tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
|| ++.+.||+|+||.||+|.+.. +|..||+|.+..... ......+.+.+|+.+++.++||||+++++++.+.....
T Consensus 1 ~y-~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 1 KY-EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS 78 (316)
T ss_pred Cc-eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence 45 677889999999999999988 899999999876431 12233456788999999999999999999998776678
Q ss_pred EEEEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC----CCcEEEc
Q 006779 103 INMITELFTSGSLRQYRKKH-----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN----NGEVKIG 173 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~-----~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~----~g~vKL~ 173 (631)
+++||||+.+ +|.+++..+ ..+++..++.++.||+.||.|||+++ |+||||||+||+++ . ++.+||+
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~-~~~~~~~~~kl~ 154 (316)
T cd07842 79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVM-GEGPERGVVKIG 154 (316)
T ss_pred EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEc-CCCCccceEEEC
Confidence 9999999964 677766532 36899999999999999999999998 99999999999997 6 7899999
Q ss_pred cccccchhcCCC-----CccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHH--------HHH
Q 006779 174 DLGLAIVMQQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPA--------QIY 238 (631)
Q Consensus 174 DFGla~~~~~~~-----~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~--------~i~ 238 (631)
|||++....... .....+++.|+|||++.+ .++.++||||||+++|+|++|+.||....... ...
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (316)
T cd07842 155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL 234 (316)
T ss_pred CCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence 999987553321 234567899999997654 47899999999999999999999997532211 000
Q ss_pred HHHHc------------------------CCCCCCCC-----------CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 006779 239 KKVTS------------------------GIKPASLS-----------KVTDPQVKQFIEKCIV-PASLRLPALELLKDP 282 (631)
Q Consensus 239 ~~i~~------------------------~~~p~~l~-----------~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hp 282 (631)
..+.. .......+ ...+..+.++|.+||. +|.+|||+.|++.||
T Consensus 235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~ 314 (316)
T cd07842 235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHP 314 (316)
T ss_pred HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCC
Confidence 00000 00000011 1456789999999998 899999999999999
Q ss_pred CC
Q 006779 283 FL 284 (631)
Q Consensus 283 ff 284 (631)
||
T Consensus 315 ~f 316 (316)
T cd07842 315 YF 316 (316)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=315.97 Aligned_cols=249 Identities=33% Similarity=0.570 Sum_probs=206.6
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC---CCCceeeeeeEEcCCCCeEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~---HpnIVkl~~~~~d~~~~~l~ 104 (631)
++.+.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.+++.++ ||||+++++++.+. ..++
T Consensus 4 ~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~--~~~~ 78 (277)
T cd06917 4 QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG--PRLW 78 (277)
T ss_pred hhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC--CEEE
Confidence 56688999999999999999999999999986542 2345567889999999997 99999999988654 4789
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
+||||+.+++|.+++... .+++..++.++.|++.||.|||+.+ ++||||+|+||+++ .++.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 79 IIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVT-NTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EEEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEc-CCCCEEEccCCceeecCCC
Confidence 999999999999998764 7999999999999999999999998 99999999999998 6889999999998765433
Q ss_pred C--CccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC-CCcHHHH
Q 006779 185 T--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK-VTDPQVK 259 (631)
Q Consensus 185 ~--~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~-~~~~~l~ 259 (631)
. .....|++.|+|||.+.. .++.++|+||||+++|+|++|..||.... .......+... .++.+.. ..+.++.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (277)
T cd06917 155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD-AFRAMMLIPKS-KPPRLEDNGYSKLLR 232 (277)
T ss_pred ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC-hhhhhhccccC-CCCCCCcccCCHHHH
Confidence 2 234568999999997754 36889999999999999999999997643 33332223222 2333333 3678999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 260 QFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 260 ~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
+||.+||. +|.+||++.+++.||||+..
T Consensus 233 ~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 233 EFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred HHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 99999998 89999999999999999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=316.29 Aligned_cols=251 Identities=28% Similarity=0.469 Sum_probs=198.8
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.+| ++.+.||+|++|.||+|.++.+|..||+|.+...... .....+.+|+.+++.++||||+++++++.+. ..+
T Consensus 5 ~~y-~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 78 (291)
T cd07844 5 ETY-KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE---GAPFTAIREASLLKDLKHANIVTLHDIIHTK--KTL 78 (291)
T ss_pred cce-eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc---CCchhHHHHHHHHhhCCCcceeeEEEEEecC--CeE
Confidence 355 6779999999999999999999999999998754321 1223466899999999999999999988654 578
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
++||||+. ++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 79 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 79 TLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLIS-ERGELKLADFGLARAKS 154 (291)
T ss_pred EEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEc-CCCCEEECccccccccC
Confidence 99999997 5999988764 46899999999999999999999998 99999999999997 78899999999986433
Q ss_pred CC--CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC------------
Q 006779 183 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------------ 246 (631)
Q Consensus 183 ~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~------------ 246 (631)
.. ......+++.|+|||++.+ .++.++||||||+++|+|++|+.||............+.....
T Consensus 155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 22 1223356889999998753 4789999999999999999999999765433332222211000
Q ss_pred -------------CCCC---CCCCc--HHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 247 -------------PASL---SKVTD--PQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 247 -------------p~~l---~~~~~--~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
+..+ ....+ ..+.++|.+||. +|.+|||+.++|.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 01122 678899999998 89999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=321.86 Aligned_cols=255 Identities=28% Similarity=0.539 Sum_probs=208.9
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
|...|.. ...||+|+||.||++.+..+|..||+|.+... .....+.+.+|+.+++.++||||+++++.+... .
T Consensus 20 ~~~~~~~-~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~ 92 (292)
T cd06658 20 PREYLDS-FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG--D 92 (292)
T ss_pred hHHHHhh-hhcccCCCCeEEEEEEECCCCCEEEEEEEecc----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC--C
Confidence 3334433 46799999999999999999999999998643 234556788999999999999999999988654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
..++||||+.+++|..++.. +.+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.++|+|||++...
T Consensus 93 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kL~dfg~~~~~ 168 (292)
T cd06658 93 ELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLT-SDGRIKLSDFGFCAQV 168 (292)
T ss_pred eEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCCEEEccCcchhhc
Confidence 68999999999999998865 46899999999999999999999998 99999999999997 7889999999998654
Q ss_pred cCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCcHH
Q 006779 182 QQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQ 257 (631)
Q Consensus 182 ~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~-~l~~~~~~~ 257 (631)
... ......|++.|+|||.+.+ .++.++||||||+++|||++|..||... ........+.....+. ......+..
T Consensus 169 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (292)
T cd06658 169 SKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE-PPLQAMRRIRDNLPPRVKDSHKVSSV 247 (292)
T ss_pred ccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCccccccccCHH
Confidence 322 2234578999999998754 5889999999999999999999999763 4444444444432221 122345788
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 258 VKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 258 l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
+++||.+||. +|.+|||+.++|.||||....
T Consensus 248 ~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 248 LRGFLDLMLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred HHHHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence 9999999998 899999999999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=303.28 Aligned_cols=247 Identities=33% Similarity=0.591 Sum_probs=206.8
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEE
Q 006779 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV 106 (631)
+.+.+.||+|++|.||+|.+..+|..+++|++..... .....+.+|+.+++.++||||+++++.+... ...+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l~ 75 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELWIV 75 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEE
Confidence 3667899999999999999999999999999875432 4567789999999999999999999988665 468899
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC
Q 006779 107 TELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~ 185 (631)
+||+.+++|.+++... ..+++..+..++.|++.||.|||.++ ++||||+|+||+++ .++.++|+|||.+.......
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEc-cCCeEEEeeccccccccccc
Confidence 9999999999999876 67999999999999999999999988 99999999999998 78899999999987655433
Q ss_pred -CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCcHHHHHHH
Q 006779 186 -ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL-SKVTDPQVKQFI 262 (631)
Q Consensus 186 -~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l-~~~~~~~l~~lI 262 (631)
.....++..|+|||.+.. .++.++|+||||+++|+|++|+.||........+..... ...+... ....+..+++||
T Consensus 153 ~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i 231 (253)
T cd05122 153 ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFL 231 (253)
T ss_pred cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHH
Confidence 345678999999997754 478899999999999999999999987533333333222 2222211 222378899999
Q ss_pred HHhcC-CCCCCCCHHHHhcCCC
Q 006779 263 EKCIV-PASLRLPALELLKDPF 283 (631)
Q Consensus 263 ~~cL~-~p~~Rpsa~elL~hpf 283 (631)
.+||. +|.+|||+.++|.|||
T Consensus 232 ~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 232 KKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHccCChhhCCCHHHHhcCCC
Confidence 99998 8999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=308.43 Aligned_cols=250 Identities=30% Similarity=0.517 Sum_probs=208.1
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
++| ++.+.||+|+||.||+|.+..+|..||+|.++.... .......++.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~--~~~ 77 (267)
T cd08224 2 GNF-KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM-MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN--NEL 77 (267)
T ss_pred Cce-eeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc-cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeE
Confidence 466 778999999999999999999999999999875443 2334567799999999999999999999998765 468
Q ss_pred EEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 104 NMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~----~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
++||||+.+|+|..++.. ...+++..++.|+.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++.
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~-~~~~~~l~d~~~~~ 154 (267)
T cd08224 78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFIT-ATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEEC-CCCcEEEeccceee
Confidence 999999999999999864 245899999999999999999999998 99999999999998 78899999999986
Q ss_pred hhcCCC--CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCC-CCHHHHHHHHHcCCCCCCCCCCCc
Q 006779 180 VMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC-KNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 180 ~~~~~~--~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~-~~~~~i~~~i~~~~~p~~l~~~~~ 255 (631)
...... .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||... .+...+...+..+..++......+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08224 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS 234 (267)
T ss_pred eccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcC
Confidence 554322 234568999999997654 5889999999999999999999999643 234455555555544433333567
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 256 PQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
..++++|.+||. +|.+||++.+++.
T Consensus 235 ~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 235 EELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 899999999998 8999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=316.95 Aligned_cols=252 Identities=27% Similarity=0.452 Sum_probs=204.0
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
+| ++.+.||+|+||.||+|.++.+|..||+|.+..... .....+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus 2 ~y-~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 76 (286)
T cd07846 2 KY-ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRK--KRLY 76 (286)
T ss_pred ce-eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC--cchhhHHHHHHHHHHHhcCCcchhhHHHhcccC--CeEE
Confidence 45 667999999999999999999999999998764332 223445688999999999999999999988543 5789
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
+|+||+.+++|..+......+++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++......
T Consensus 77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~-~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 77 LVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCcEEEEeeeeeeeccCC
Confidence 99999999999988877777999999999999999999999998 99999999999997 7889999999998755332
Q ss_pred --CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc-----------------
Q 006779 185 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS----------------- 243 (631)
Q Consensus 185 --~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~----------------- 243 (631)
......+++.|+|||++.+ .++.++||||||+++|+|++|+.||...............
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 2234568899999997754 3778999999999999999999999764433322222210
Q ss_pred --CCC-CC--------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 244 --GIK-PA--------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 244 --~~~-p~--------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
+.. +. ......+..+++||.+||. +|.+||++.++|.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000 00 0012346789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=319.26 Aligned_cols=253 Identities=30% Similarity=0.552 Sum_probs=209.2
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
+...| +..+.||+|+||.||+|.+..+|..||+|.+.... .....+.+.+|+.+++.++||||+++++++.+. .
T Consensus 2 ~~~~y-~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 75 (277)
T cd06642 2 PEELF-TKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG--T 75 (277)
T ss_pred hHHHH-HHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCCCCccHhhhcccccC--C
Confidence 33455 44577999999999999999999999999886443 234557789999999999999999999988654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
.+++||||+.+++|.+++.. ..+++..++.++.||+.||.|||+++ ++|+||+|+||+++ .++.++|+|||++...
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~-~~~~~~l~dfg~~~~~ 151 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLS-EQGDVKLADFGVAGQL 151 (277)
T ss_pred ceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEe-CCCCEEEccccccccc
Confidence 68999999999999998865 46899999999999999999999998 99999999999997 7899999999998655
Q ss_pred cCCC--CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006779 182 QQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 182 ~~~~--~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l 258 (631)
.... .....|+..|+|||.+.+ .++.++|||||||++|+|++|..||... .+......+..+. +..+....+..+
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~ 229 (277)
T cd06642 152 TDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNS-PPTLEGQYSKPF 229 (277)
T ss_pred cCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc-chhhHHhhhhcCC-CCCCCcccCHHH
Confidence 4322 223467889999998765 4788999999999999999999999763 3333333333332 333444567889
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 259 KQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 259 ~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
.++|.+||. +|.+||++.++|.||||..
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 230 KEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred HHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 999999998 8999999999999999975
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=306.96 Aligned_cols=250 Identities=31% Similarity=0.511 Sum_probs=213.0
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
|| ++.+.||+|+||.||++.+..+|..+|+|.+..... .......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y-~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 75 (256)
T cd08530 1 DF-KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM--SQKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLC 75 (256)
T ss_pred Cc-eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc--cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEE
Confidence 35 677899999999999999999999999999875442 244567788999999999999999999988765 5789
Q ss_pred EEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 105 MITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~----~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
+|+||+.+++|..++.+ ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++ .++.+||+|||++..
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~-~~~~~kl~d~g~~~~ 152 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLV-ANDLVKIGDLGISKV 152 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEe-cCCcEEEeeccchhh
Confidence 99999999999999876 356899999999999999999999999 99999999999998 688999999999977
Q ss_pred hcCCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006779 181 MQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 181 ~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~ 259 (631)
..........+++.|+|||.+.+ .++.++|+||||+++|+|++|+.||... +...+...+..+..+. ++...+.+++
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (256)
T cd08530 153 LKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR-SMQDLRYKVQRGKYPP-IPPIYSQDLQ 230 (256)
T ss_pred hccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCCCC-CchhhCHHHH
Confidence 66554445678999999997754 4788999999999999999999999764 4555555555544332 3346778999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 260 QFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 260 ~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
++|.+||. +|.+||++.++|+||++
T Consensus 231 ~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 231 NFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 99999998 89999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=321.42 Aligned_cols=251 Identities=28% Similarity=0.536 Sum_probs=207.9
Q ss_pred eeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEE
Q 006779 26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 y~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~l 105 (631)
++.....||+|+||.||+|.+..+|..||+|.+..... ...+.+.+|+.+++.++||||+++++.+... ..+++
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~i 95 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVG--EELWV 95 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc----chHHHHHHHHHHHHhCCCCchhhhhhheeeC--CeEEE
Confidence 33445679999999999999999999999999865432 2345688999999999999999999988654 46899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC-
Q 006779 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 184 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~- 184 (631)
|+||+.+++|..++.. ..+++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.+||+|||++......
T Consensus 96 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~-~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 96 LMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred EEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEc-cCCcEEEeechhHhhccccc
Confidence 9999999999998765 56899999999999999999999998 99999999999997 7899999999998654332
Q ss_pred -CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCcHHHHHH
Q 006779 185 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQF 261 (631)
Q Consensus 185 -~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p-~~l~~~~~~~l~~l 261 (631)
......|++.|+|||++.+ .++.++|||||||++|+|++|+.||... .+......+.....+ .......+..+++|
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 250 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD-SPVQAMKRLRDSPPPKLKNAHKISPVLRDF 250 (297)
T ss_pred ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhccCCCCccccCCCCHHHHHH
Confidence 2334678999999998754 5889999999999999999999999763 444444455443222 12223457889999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 262 IEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 262 I~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
|.+||. +|.+||++.+++.||||...
T Consensus 251 i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 251 LERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred HHHHhcCCcccCcCHHHHhhChhhccC
Confidence 999998 89999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=338.30 Aligned_cols=262 Identities=28% Similarity=0.478 Sum_probs=225.4
Q ss_pred cccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEc
Q 006779 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d 97 (631)
.+..-.|-| .+...||+|.|+.|.+|.+..||..||||.+..... +....+.+.+|+++|+.|+|||||++|.+...
T Consensus 50 ~~~~~vg~y-~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l--n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t 126 (596)
T KOG0586|consen 50 DDSNSVGLY-VIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL--NPSKRQKLGREVDIMKSLNHPNIVKLFSVIET 126 (596)
T ss_pred cccccccce-eeeeeeccceeEEEEeeEecCCCceEEEEEehhccc--ChHHHHHHHHHHHHHHhcCCcceeeeeeeeee
Confidence 444445555 778999999999999999999999999999886653 45566779999999999999999999998754
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
. ..+|+||||+.+|.+.+|+.+++++.+..++.++.|+++|++|||+++ |+|||||.+|||++ .+..+||+|||+
T Consensus 127 ~--~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~-~~mnikIaDfgf 201 (596)
T KOG0586|consen 127 E--ATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLD-ENMNIKIADFGF 201 (596)
T ss_pred c--ceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccc-cccceeeecccc
Confidence 4 579999999999999999999999999999999999999999999999 99999999999998 677899999999
Q ss_pred cchhcC-CCCccccCCCCCCCccccccc-c-CccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006779 178 AIVMQQ-PTARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 178 a~~~~~-~~~~~~~GTp~Y~APEvl~~~-y-s~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 254 (631)
+..+.. ....+.+|+|.|.|||++.+. | .+.+|+||+|+++|-|+.|.+||.+ .+...+...+..+... ++...
T Consensus 202 S~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG-~~lk~Lr~rvl~gk~r--Ip~~m 278 (596)
T KOG0586|consen 202 STFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG-QNLKELRPRVLRGKYR--IPFYM 278 (596)
T ss_pred ceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC-cccccccchheeeeec--cccee
Confidence 987764 457789999999999998764 4 5899999999999999999999987 4555555555555433 23345
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCc
Q 006779 255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~~ 290 (631)
+-+++++|.++|+ +|.+|++..++..|+|.......
T Consensus 279 s~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 279 SCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred echhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 6789999999998 89999999999999999765444
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=316.10 Aligned_cols=258 Identities=24% Similarity=0.385 Sum_probs=211.7
Q ss_pred eeeeEecccCceEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCeE
Q 006779 28 RYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~---~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~l 103 (631)
++.+.||.|+||.||+|.+. .+|..||+|.+............+.+.+|+.+|+.+ +|+||+++++.+... ..+
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~~~ 80 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--TKL 80 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC--CeE
Confidence 67899999999999999875 489999999987543323334456788999999999 599999999987543 478
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
++||||+.+++|.+++.....+++..+..++.||+.||.|||+++ ++||||+|+|||++ .++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEC-CCCCEEEeeCccceeccc
Confidence 899999999999999998888999999999999999999999998 99999999999997 788999999999865533
Q ss_pred C---CCccccCCCCCCCcccccc---ccCccccchhhhHHHHHHhhcCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCC
Q 006779 184 P---TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 184 ~---~~~~~~GTp~Y~APEvl~~---~ys~~sDIwSLGiilyELltG~~Pf~~~~---~~~~i~~~i~~~~~p~~l~~~~ 254 (631)
. ......|++.|+|||.+.. .++.++||||||+++|+|++|..||.... ....+...+..... .++...
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 235 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQEM 235 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC--CCCccC
Confidence 2 2234568999999998753 46789999999999999999999996422 22333333333322 234557
Q ss_pred cHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCccc
Q 006779 255 DPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rp-----sa~elL~hpff~~~~~~~~ 292 (631)
++.+.+|+.+||. +|.+|| ++.+++.||||...++..+
T Consensus 236 ~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 279 (290)
T cd05613 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDL 279 (290)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHH
Confidence 8899999999998 899997 8999999999998876543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=327.68 Aligned_cols=251 Identities=23% Similarity=0.392 Sum_probs=202.9
Q ss_pred CCCceeeeeeEecccCceEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeE
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSW 95 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~-----~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~ 95 (631)
|..|| ++.+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++++ +||||+++++++
T Consensus 5 ~~~~~-~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 5 PRDRL-KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred CHHHh-hhhcccccCcCceEEeccccccccccccceeeeeeccCCC---CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 45577 78899999999999999753 356899999886432 234556788999999999 899999999987
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhC-----------------------------------------------------
Q 006779 96 VDDTNRTINMITELFTSGSLRQYRKKH----------------------------------------------------- 122 (631)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~~~l~~~----------------------------------------------------- 122 (631)
.... ..+++++||+.+|+|.+++...
T Consensus 81 ~~~~-~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 81 TKPG-GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred ecCC-CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 6543 4788999999999999998642
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC----Ccccc
Q 006779 123 --------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVI 190 (631)
Q Consensus 123 --------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~ 190 (631)
..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..+.... .....
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~-~~~~vkL~DfG~a~~~~~~~~~~~~~~~~ 236 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDAR 236 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEe-CCCcEEEeccccchhcccCcchhhccCCC
Confidence 25789999999999999999999998 99999999999998 68899999999997653221 22334
Q ss_pred CCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-
Q 006779 191 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV- 267 (631)
Q Consensus 191 GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~- 267 (631)
+++.|+|||++. ..++.++|||||||++|+|++ |..||.+....+.+...+..+..+ ..+...++.+.+++.+||+
T Consensus 237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~ 315 (337)
T cd05054 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-RAPEYATPEIYSIMLDCWHN 315 (337)
T ss_pred CCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-CCCccCCHHHHHHHHHHccC
Confidence 567899999765 569999999999999999998 999997644334444555544333 2344567899999999998
Q ss_pred CCCCCCCHHHHhcC
Q 006779 268 PASLRLPALELLKD 281 (631)
Q Consensus 268 ~p~~Rpsa~elL~h 281 (631)
+|.+||++.++++|
T Consensus 316 ~p~~RPs~~ell~~ 329 (337)
T cd05054 316 NPEDRPTFSELVEI 329 (337)
T ss_pred ChhhCcCHHHHHHH
Confidence 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=313.72 Aligned_cols=248 Identities=28% Similarity=0.498 Sum_probs=200.8
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||.|++|.||+|.+..+|..||+|.+..... ......+.+|+.+++.++||||+++++++.+. ..+++||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 77 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHENIVRLHDVIHTE--NKLMLVF 77 (284)
T ss_pred eEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc---ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC--CcEEEEE
Confidence 667899999999999999999999999999876532 22345577899999999999999999998765 3688999
Q ss_pred eccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 108 ELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~---~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
||+.+ +|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+||+++ .++.++|+|||++......
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~-~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLIN-KRGELKLADFGLARAFGIP 153 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCcEEEeecchhhhhcCC
Confidence 99974 888887654 35899999999999999999999998 99999999999997 7889999999999654332
Q ss_pred --CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC------------
Q 006779 185 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA------------ 248 (631)
Q Consensus 185 --~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~------------ 248 (631)
......+++.|+|||.+.+ .++.++||||||+++|+|++|..||.+..........+.....|.
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 2233467899999997754 378899999999999999999999987554433332221110000
Q ss_pred --------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 249 --------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 249 --------------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
.+....++.++++|.+||+ +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0111346788999999998 99999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=304.45 Aligned_cols=248 Identities=34% Similarity=0.612 Sum_probs=211.5
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
.+.+.||+|++|.||+|.+..+|..|++|.+..... .....+.+.+|++++++++||||+++++++.+. ..++++|
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS--DSLYIIL 78 (254)
T ss_pred eeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc--CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEEEEE
Confidence 678999999999999999999999999999876542 235667899999999999999999999988654 5789999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCC-
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA- 186 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~- 186 (631)
||+.+++|.+++.+...+++..+..++.|++.||.|||+++ |+||||+|+||+++ .++.++|+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTT-KDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEC-CCCCEEEeccccceecCCCccc
Confidence 99999999999998888999999999999999999999998 99999999999998 688999999999976544332
Q ss_pred -ccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 006779 187 -RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264 (631)
Q Consensus 187 -~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~ 264 (631)
....+++.|+|||.+.+ .++.++||||||+++|+|++|..||........... +.... ...++...+..++++|.+
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~i~~ 233 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR-IVQDD-HPPLPEGISPELKDFLMQ 233 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH-HhccC-CCCCCCCCCHHHHHHHHH
Confidence 34568999999997654 478899999999999999999999976443333333 33222 233555678899999999
Q ss_pred hcC-CCCCCCCHHHHhcCCCC
Q 006779 265 CIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 265 cL~-~p~~Rpsa~elL~hpff 284 (631)
||. +|.+||++.+++.||||
T Consensus 234 ~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 234 CFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHhCChhhCcCHHHHhcCCCC
Confidence 998 89999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.81 Aligned_cols=250 Identities=27% Similarity=0.414 Sum_probs=200.3
Q ss_pred CCceeeeeeEecccCceEEEEEE----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~----d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 98 (631)
.+||+++.++||+|+||+||++. ...++..||+|.+.... .......+.+|+++|+.++||||+++++++...
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 47998999999999999998764 34578899999986432 233456788999999999999999999988766
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
....+++||||+.+++|.+++... .+++..++.++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~ 154 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLA 154 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEc-CCCcEEEeecccc
Confidence 666799999999999999999765 4999999999999999999999998 99999999999997 7889999999998
Q ss_pred chhcCCC-----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCHH--------------HHH
Q 006779 179 IVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA--------------QIY 238 (631)
Q Consensus 179 ~~~~~~~-----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~--------------~i~ 238 (631)
....... .....++..|+|||.+. ..++.++||||||+++|+|+||..||....... .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence 7654321 11234566799999775 458899999999999999999999986432110 111
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 239 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 239 ~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
..+..+..+ ..+...+..+++++.+||. +|++||++.+++.
T Consensus 235 ~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 235 ELLERGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 111111111 2234567899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.80 Aligned_cols=256 Identities=25% Similarity=0.408 Sum_probs=203.6
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
++| .+.+.||+|++|+||+|.++.+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 76 (294)
T PLN00009 2 DQY-EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KRL 76 (294)
T ss_pred Cce-EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchHHHHHHHHHHHhccCCCEeeEEEEEecC--CeE
Confidence 356 667899999999999999999999999999865432 223345678899999999999999999998654 478
Q ss_pred EEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 104 NMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~--l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
++||||+. ++|.+++..... +++..++.++.||+.||+|||+++ ++||||+|+||+++..++.+||+|||++...
T Consensus 77 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred EEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 99999995 588888765443 588899999999999999999998 9999999999999855668999999999654
Q ss_pred cCC--CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC----------
Q 006779 182 QQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP---------- 247 (631)
Q Consensus 182 ~~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p---------- 247 (631)
... ......+++.|+|||.+.+ .++.++|||||||++|+|+||..||........+.+.+.....|
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 332 2234467899999997754 47889999999999999999999997654444444332210000
Q ss_pred -------------C---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 248 -------------A---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 248 -------------~---~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
. ......++.+++||.+||. +|.+||++.++|.||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0 0112346789999999998 89999999999999999764
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=324.23 Aligned_cols=256 Identities=27% Similarity=0.431 Sum_probs=201.8
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC---
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--- 99 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~--- 99 (631)
.++| ++.+.||+|+||.||+|.+..+|..||+|.+.... ......++.+|+.+++.++||||+++++++....
T Consensus 4 ~~~y-~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 4 GPRY-QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE---HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79 (336)
T ss_pred ccce-EEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence 4567 67899999999999999999999999999986422 2334566889999999999999999999775443
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
...+++|+||+. ++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 80 ~~~~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~ 154 (336)
T cd07849 80 FNDVYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TNCDLKICDFGLAR 154 (336)
T ss_pred cceEEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEECccccee
Confidence 235899999996 588887754 56999999999999999999999999 99999999999997 78999999999986
Q ss_pred hhcCCC-----CccccCCCCCCCccccc--cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHH------------
Q 006779 180 VMQQPT-----ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK------------ 240 (631)
Q Consensus 180 ~~~~~~-----~~~~~GTp~Y~APEvl~--~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~------------ 240 (631)
...... .....||+.|+|||.+. ..++.++|||||||++|+|++|+.||.+......+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 543221 22357899999999764 35889999999999999999999999764322111110
Q ss_pred --HHcCC-------CC--C-----CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 241 --VTSGI-------KP--A-----SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 241 --i~~~~-------~p--~-----~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
+.... .+ . ......++.+++||.+||. +|.+||++.+++.||||...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 00000 00 0 0112246789999999998 89999999999999999853
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=306.43 Aligned_cols=241 Identities=24% Similarity=0.421 Sum_probs=205.8
Q ss_pred eEecccCceEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 31 EILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~t---g~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
+.||+|+||.||+|.+... +..|++|.+..... ....+.+.+|+.+++.++|+||+++++++.+ ...+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS---EEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc---hhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEE
Confidence 4699999999999999876 99999999875432 2256789999999999999999999998876 45789999
Q ss_pred eccCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 108 ELFTSGSLRQYRKKH---------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~---------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
||+.+++|.+++... ..+++..+..++.||+.||+|||+++ ++||||+|+||+++ .++.+||+|||.+
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~-~~~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVG-EDLVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEEC-CCCcEEEcccccc
Confidence 999999999999875 77999999999999999999999998 99999999999998 7799999999999
Q ss_pred chhcCC----CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006779 179 IVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 179 ~~~~~~----~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~ 252 (631)
...... ......+++.|+|||.+.. .++.++||||||+++|+|++ |..||... ...++...+..+... ..+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~ 230 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRKGYRL-PKPE 230 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCc
Confidence 765542 2334567889999997764 58899999999999999999 69999874 666777777765433 3344
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 253 VTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 253 ~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
..++++.++|.+||. +|.+||++.+++.+
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 231 YCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred cCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 568899999999998 89999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=315.30 Aligned_cols=251 Identities=25% Similarity=0.420 Sum_probs=200.7
Q ss_pred eeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCceeeeeeEEcCCCCeEEEEE
Q 006779 29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 29 ~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
..+.||+|+||.||++.+..+|..||+|.+..... ......+.+|+.++.++. ||||+++++++..+ ...+++|
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~--~~~~~~~ 82 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD---EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE--GDCWICM 82 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC---hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC--CcEEEEE
Confidence 34679999999999999999999999999875432 245567889999999996 99999999988764 3577899
Q ss_pred eccCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 108 ELFTSGSLRQYRK-----KHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 108 Ey~~gGsL~~~l~-----~~~~l~~~~i~~i~~QIl~aL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
||+. ++|.++.. ....+++..+..++.|++.||+|||+. + ++||||||+||+++ .++.+||+|||++...
T Consensus 83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLD-RNGNIKLCDFGISGQL 158 (288)
T ss_pred eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEc-cCCcEEEeecchhHHh
Confidence 9986 46555332 346799999999999999999999974 7 99999999999997 7889999999999755
Q ss_pred cCCC-CccccCCCCCCCcccccc----ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC---CCCC
Q 006779 182 QQPT-ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS---LSKV 253 (631)
Q Consensus 182 ~~~~-~~~~~GTp~Y~APEvl~~----~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~---l~~~ 253 (631)
.... .....|++.|+|||++.. .++.++|||||||++|+|++|+.||.......+....+..+..+.. ....
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238 (288)
T ss_pred ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence 4332 234468999999998754 4889999999999999999999999775433333333333322221 1223
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 254 ~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
.+..+.+||.+||. +|.+||++.+++.||||....
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 67899999999998 899999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=318.03 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=199.0
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC--
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-- 100 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~-- 100 (631)
.++| ++.+.||+|+||.||+|.+..+|..||+|++...... ......+.+|+++++.++||||+++++.+.+...
T Consensus 7 ~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 7 LRDY-EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccE-EEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC--CCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 4677 7789999999999999999999999999998754321 1122356789999999999999999998765432
Q ss_pred ----CeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccc
Q 006779 101 ----RTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 101 ----~~l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 175 (631)
..+++|+||+.+ +|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.++|+||
T Consensus 84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~df 159 (311)
T cd07866 84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADF 159 (311)
T ss_pred cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECcC
Confidence 368999999965 66666554 457999999999999999999999999 99999999999997 7899999999
Q ss_pred cccchhcCCC-------------CccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHH
Q 006779 176 GLAIVMQQPT-------------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240 (631)
Q Consensus 176 Gla~~~~~~~-------------~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~ 240 (631)
|++....... .....+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+....... ..
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~-~~ 238 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL-HL 238 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH-HH
Confidence 9986543221 123457889999997653 4789999999999999999999999764433322 22
Q ss_pred HHcC---CCCCC------------------C-------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 241 VTSG---IKPAS------------------L-------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 241 i~~~---~~p~~------------------l-------~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
+... ..+.. . .....+.+++||.+||. +|.+|||+.++|.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 2110 00000 0 01233678899999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=325.41 Aligned_cols=257 Identities=26% Similarity=0.394 Sum_probs=205.9
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC--
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-- 100 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~-- 100 (631)
..|| ++.+.||+|+||+||+|.+..+|..||+|.+.... ........+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~y-~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 4 DTKY-VPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF--DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA 80 (337)
T ss_pred ccce-eEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc--cccchhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence 3466 66789999999999999999999999999986432 122334567789999999999999999998765432
Q ss_pred -CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 101 -RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 -~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
..+++|+||+. ++|.+++.+.+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++.
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~ 156 (337)
T cd07858 81 FNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLN-ANCDLKICDFGLAR 156 (337)
T ss_pred cCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEECcCcccc
Confidence 35899999995 789999988888999999999999999999999998 99999999999997 78899999999997
Q ss_pred hhcCC--CCccccCCCCCCCccccc--cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc---C--------
Q 006779 180 VMQQP--TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---G-------- 244 (631)
Q Consensus 180 ~~~~~--~~~~~~GTp~Y~APEvl~--~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~---~-------- 244 (631)
..... ......++..|+|||.+. ..++.++|||||||++|+|++|+.||.+.. .......+.. .
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD-YVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHHHhCCCChHHhhh
Confidence 65433 223456889999999765 348899999999999999999999997532 2111111110 0
Q ss_pred ----------------CCC--CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 245 ----------------IKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 245 ----------------~~p--~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
..+ .......++.+++||.+||+ +|.+|||+.++|+||||...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000 01123457889999999998 89999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.63 Aligned_cols=264 Identities=28% Similarity=0.480 Sum_probs=215.1
Q ss_pred CcccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeee
Q 006779 15 GEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 94 (631)
Q Consensus 15 ~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~ 94 (631)
+-+...++..+|.. .+.||+|+||+||+|.+..+|..|++|.+..... ........+.+|+.+++.++||||++++++
T Consensus 12 ~~~~~~~~~~~~~~-~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 89 (313)
T cd06633 12 DLFYKDDPEEIFVG-LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQDIIKEVKFLQQLKHPNTIEYKGC 89 (313)
T ss_pred HHhccCCHHHHhhc-ceeeccCCCeEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHHhCCCCCCccEEEE
Confidence 34566788888744 4679999999999999999999999999875432 234555678899999999999999999999
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEc
Q 006779 95 WVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173 (631)
Q Consensus 95 ~~d~~~~~l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~ 173 (631)
+.+. ...|+||||+. |+|.+++.. ...+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.+||+
T Consensus 90 ~~~~--~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~-~~~~~kL~ 163 (313)
T cd06633 90 YLKE--HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLA 163 (313)
T ss_pred EEeC--CEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEEC-CCCCEEEe
Confidence 8765 46889999996 577777654 456899999999999999999999998 99999999999997 78899999
Q ss_pred cccccchhcCCCCccccCCCCCCCccccc----cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC
Q 006779 174 DLGLAIVMQQPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 249 (631)
Q Consensus 174 DFGla~~~~~~~~~~~~GTp~Y~APEvl~----~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~ 249 (631)
|||++.... ......|++.|+|||++. +.++.++||||||+++|+|++|..||........+.. +.....+..
T Consensus 164 dfg~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~ 240 (313)
T cd06633 164 DFGSASKSS--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-IAQNDSPTL 240 (313)
T ss_pred ecCCCcccC--CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHhcCCCCC
Confidence 999985432 223457899999999863 3478899999999999999999999987544444443 333333433
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 250 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 250 l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
.....+..+++||.+||+ +|.+||++.++|.||||....+
T Consensus 241 ~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~ 281 (313)
T cd06633 241 QSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRP 281 (313)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCch
Confidence 344566789999999998 8999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=306.80 Aligned_cols=240 Identities=23% Similarity=0.405 Sum_probs=197.3
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEecc
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~ 110 (631)
+.||+|+||.||+|.++.+|..||+|.+... ...+....+.+|+.+++.++||||+++++++... ..+++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET---LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CCeEEEEeec
Confidence 4699999999999999999999999987532 2345567799999999999999999999988654 4688999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCCcc-
Q 006779 111 TSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS- 188 (631)
Q Consensus 111 ~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~- 188 (631)
.+++|.+++.+. ..+++..++.++.|++.||.|||+++ ++||||||+|||++ .++.+||+|||++..........
T Consensus 76 ~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 76 QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred cCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEc-CCCcEEECccccCccccccccccc
Confidence 999999998764 46899999999999999999999998 99999999999997 78899999999986543321111
Q ss_pred ---ccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006779 189 ---VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263 (631)
Q Consensus 189 ---~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~ 263 (631)
..++..|+|||.+.+ .++.++||||||+++|+|++ |..||.. .........+.....+ ..+...+..+.+||.
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 230 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN-LSNQQTREAIEQGVRL-PCPELCPDAVYRLME 230 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc-cCHHHHHHHHHcCCCC-CCcccCCHHHHHHHH
Confidence 122456999997754 58899999999999999998 8888875 3445555555544332 345566789999999
Q ss_pred HhcC-CCCCCCCHHHHhc
Q 006779 264 KCIV-PASLRLPALELLK 280 (631)
Q Consensus 264 ~cL~-~p~~Rpsa~elL~ 280 (631)
+||+ +|.+||++.++++
T Consensus 231 ~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 231 RCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 9998 8999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=308.63 Aligned_cols=247 Identities=21% Similarity=0.366 Sum_probs=202.3
Q ss_pred eeeeEecccCceEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC----
Q 006779 28 RYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---- 100 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~t---g~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~---- 100 (631)
++.+.||+|+||.||+|.+..+ +..||+|.+..... .......+.+|+.+++.++||||+++++++.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH--TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 5778999999999999987654 48899999875432 34556789999999999999999999998765432
Q ss_pred CeEEEEEeccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcc
Q 006779 101 RTINMITELFTSGSLRQYRKKH------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~D 174 (631)
...++|+||+.+|+|..++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++ +++.+||+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLR-EDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEEC-CCCeEEECC
Confidence 3478999999999999988542 35899999999999999999999998 99999999999997 788999999
Q ss_pred ccccchhcCCC----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCC
Q 006779 175 LGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPA 248 (631)
Q Consensus 175 FGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~ 248 (631)
||++....... .....++..|+|||.+.. .++.++|||||||++|||++ |..||.+ ....++++.+..+..+
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~- 234 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG-VENHEIYDYLRHGNRL- 234 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-
Confidence 99987554321 112234678999997754 58899999999999999999 8899976 4455666666655433
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 249 ~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
..+...+..+.++|.+||+ +|.+||++.+++.+
T Consensus 235 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3455678899999999998 89999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=313.73 Aligned_cols=243 Identities=28% Similarity=0.514 Sum_probs=198.6
Q ss_pred eeeeEecccCceEEEEEEEc----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 28 RYDEILGKGAFKTVYKGFDE----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~----~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.+.+.||.|+||.||+|... ..+..|++|.++.. ......+.+.+|++.|++++||||+++++++.... .+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~--~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS---SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE--PL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT---SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS--SE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc---cccccceeeeecccccccccccccccccccccccc--cc
Confidence 45689999999999999988 45788999998542 24556788999999999999999999999998443 48
Q ss_pred EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 104 NMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
++|+||+.+|+|.+++... ..+++..+..|+.||+.||.|||+++ ++||+|+|+|||++ .++.+||+|||++...
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~-~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLD-SNGQVKLSDFGLSRPI 153 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEE-TTTEEEEESTTTGEET
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc-cccccccccccccccc
Confidence 8999999999999999987 67999999999999999999999998 99999999999998 7889999999999765
Q ss_pred cCCC----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006779 182 QQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 182 ~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~ 255 (631)
.... .....+...|+|||.+.. .++.++||||||+++|||++ |+.||.+. +..++...+..+..+. .+...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~ 231 (259)
T PF07714_consen 154 SEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKLKQGQRLP-IPDNCP 231 (259)
T ss_dssp TTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHHHTTEETT-SBTTSB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccce-eccchh
Confidence 2211 223346778999998764 48999999999999999999 78999875 6777777776664433 455678
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 256 PQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
..+.++|.+||. +|.+||++.++++
T Consensus 232 ~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 232 KDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 899999999997 8999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=314.06 Aligned_cols=249 Identities=27% Similarity=0.448 Sum_probs=201.6
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||.|++|.||+|.++.+|..||+|++..... .......+.+|+.+++.++||||+++++++.+. ...++|+
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--~~~~iv~ 77 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELNHPNIVRLLDVVHSE--NKLYLVF 77 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc--cccchhHHHHHHHHHHhcCCCCccCHhheeccC--CeEEEEE
Confidence 567889999999999999999999999999875532 122335678899999999999999999988654 5789999
Q ss_pred eccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC-
Q 006779 108 ELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 184 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~- 184 (631)
||+. ++|.+++.... .+++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++......
T Consensus 78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLID-REGALKLADFGLARAFGVPV 153 (283)
T ss_pred eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEc-CCCcEEEeecccccccCCCc
Confidence 9995 69999998766 7999999999999999999999998 99999999999998 6899999999998654322
Q ss_pred -CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC---------------
Q 006779 185 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--------------- 246 (631)
Q Consensus 185 -~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--------------- 246 (631)
......+++.|+|||++.+ .++.++||||||+++|+|++|..||.......++.+.+.....
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 1223456889999997754 3788999999999999999999999765443333332221000
Q ss_pred -----------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 247 -----------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 247 -----------p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
........+..+.++|.+||+ +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 001123355789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=305.37 Aligned_cols=253 Identities=24% Similarity=0.317 Sum_probs=202.8
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC---
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--- 99 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~--- 99 (631)
..|| |+.+.||+|||+-||++....++..+|+|+|... +.+..+...+|++..++++||||++++++.+.+.
T Consensus 20 ~~Ry-ri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~----~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 20 NKRY-RIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH----SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred CceE-EEeeeecCCCceeeeeecccCcccchhhheeecc----chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 4688 9999999999999999999999999999999765 3577888999999999999999999998765432
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~----~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 175 (631)
....|++++|+..|||.+.+.+. ..+++.+++.|+.+|++||++||+..||++||||||.|||+. ..+.++|.||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls-~~~~~vl~D~ 173 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS-DSGLPVLMDL 173 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec-CCCceEEEec
Confidence 34799999999999999988753 369999999999999999999999999999999999999997 6899999999
Q ss_pred cccchhcCCC-----C------ccccCCCCCCCccccccc----cCccccchhhhHHHHHHhhcCCCCCCCCC-HHHHHH
Q 006779 176 GLAIVMQQPT-----A------RSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKN-PAQIYK 239 (631)
Q Consensus 176 Gla~~~~~~~-----~------~~~~GTp~Y~APEvl~~~----ys~~sDIwSLGiilyELltG~~Pf~~~~~-~~~i~~ 239 (631)
|.++...-.. . .....|..|+|||++.-+ .++++|||||||++|.|+.|..||..-.. -..+.-
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL 253 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL 253 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence 9986442110 0 012358899999998643 67899999999999999999999963100 000000
Q ss_pred HHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 240 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 240 ~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.+..+.....-...++..+.+||+.||+ ||.+||++.+||.+
T Consensus 254 Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 254 AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 0111111111122377899999999998 99999999999864
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.97 Aligned_cols=247 Identities=22% Similarity=0.351 Sum_probs=201.7
Q ss_pred eeeeEecccCceEEEEEEEccCCe--EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC----CC
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGI--EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----NR 101 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~--~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~----~~ 101 (631)
.++++||+|+||.||+|.+..++. .||+|.++... ......+.+.+|+.+++.++||||+++++++.... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI--CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 457889999999999999887775 69999886542 24556778999999999999999999999775432 23
Q ss_pred eEEEEEeccCCCCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccc
Q 006779 102 TINMITELFTSGSLRQYRKK------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~------~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 175 (631)
..++|+||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLN-ENMNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEc-CCCCEEECCC
Confidence 57889999999999998742 234889999999999999999999998 99999999999997 7889999999
Q ss_pred cccchhcCCC----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCC
Q 006779 176 GLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPAS 249 (631)
Q Consensus 176 Gla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~ 249 (631)
|++....... .....+++.|+|||.+.. .++.++|||||||++|+|++ |+.||.. ....+++..+..+..+.
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~- 234 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG-VENSEIYDYLRQGNRLK- 234 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCCC-
Confidence 9997654321 122345778999997754 58999999999999999999 8899976 45667777777664432
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 250 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 250 l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.....+..++++|.+||+ +|.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 235 QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 233466789999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=325.55 Aligned_cols=258 Identities=26% Similarity=0.434 Sum_probs=206.5
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC--CC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD--TN 100 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~--~~ 100 (631)
..+| .+.+.||+|+||.||+|.++.+|..||+|.+..... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 4 ~~~y-~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (334)
T cd07855 4 GSRY-KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD--VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADF 80 (334)
T ss_pred hhce-eeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc--cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCC
Confidence 3455 677899999999999999999999999999875321 223456678899999999999999999977543 23
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
..+++|+||+. |+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~~~~ 156 (334)
T cd07855 81 KDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVN-EDCELRIGDFGMARG 156 (334)
T ss_pred ceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEeccccccee
Confidence 47899999995 689999988888999999999999999999999998 99999999999998 789999999999865
Q ss_pred hcCCC------CccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc-C-------
Q 006779 181 MQQPT------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-G------- 244 (631)
Q Consensus 181 ~~~~~------~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~-~------- 244 (631)
..... .....|+..|+|||.+.. .++.++||||||+++|+|++|+.||.......++...+.. +
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 43221 124478999999998743 4889999999999999999999999764332222111110 0
Q ss_pred ---------------CCCCC-----CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 245 ---------------IKPAS-----LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 245 ---------------~~p~~-----l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
..... +....++.+++||.+||+ +|.+||++.++|.||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 00000 112357889999999998 89999999999999999753
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=318.81 Aligned_cols=246 Identities=27% Similarity=0.465 Sum_probs=201.6
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeE----EEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIE----VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~----VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
.+| ++.+.||+|+||.||+|.+..+|.. ||+|.+... ......+.+.+|+.+++.++||||+++++++...
T Consensus 7 ~~f-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 7 TEF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred hhc-eeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 345 7778999999999999998766654 899988632 2345567788999999999999999999988653
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
..++|+||+.+|+|.+++..+ ..++...+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 82 --~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~-~~~~~kl~DfG~a 156 (316)
T cd05108 82 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVK-TPQHVKITDFGLA 156 (316)
T ss_pred --CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEec-CCCcEEEcccccc
Confidence 367899999999999999875 46899999999999999999999998 99999999999997 7889999999999
Q ss_pred chhcCCCC----ccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006779 179 IVMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 179 ~~~~~~~~----~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~ 252 (631)
........ ....+++.|+|||.+. ..++.++|||||||++|||++ |..||.+ ....++...+..+..+. .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~ 234 (316)
T cd05108 157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP-QPP 234 (316)
T ss_pred ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhCCCCCC-CCC
Confidence 76543221 1223466899999775 458999999999999999998 9999976 45556665555544332 234
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 253 VTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 253 ~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
..+..+.++|.+||. +|.+||++.+++.+
T Consensus 235 ~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 235 ICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 567889999999998 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=311.25 Aligned_cols=243 Identities=25% Similarity=0.390 Sum_probs=201.7
Q ss_pred eeeeEecccCceEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 28 RYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~-----~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
.+.+.||+|+||.||+|.+. .++..||+|.+.... ..+....+.+|+++|+.++||||+++++++... ..
T Consensus 8 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 82 (280)
T cd05049 8 VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA---SNDARKDFEREAELLTNFQHENIVKFYGVCTEG--DP 82 (280)
T ss_pred hHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC---CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC--CC
Confidence 66789999999999999874 346889999886432 233557899999999999999999999988765 46
Q ss_pred EEEEEeccCCCCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCC
Q 006779 103 INMITELFTSGSLRQYRKKHK--------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 168 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~--------------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g 168 (631)
+++||||+.+++|.+++...+ .+++..+..++.||+.||.|||+++ ++||||||+||+++ .++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~-~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVG-YDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEc-CCC
Confidence 899999999999999997642 4788999999999999999999998 99999999999997 789
Q ss_pred cEEEccccccchhcCC----CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006779 169 EVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT 242 (631)
Q Consensus 169 ~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~ 242 (631)
.+||+|||++...... ......+++.|+|||++.+ .++.++|||||||++|+|++ |..||... +.......+.
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~-~~~~~~~~~~ 238 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL-SNEEVIECIT 238 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHH
Confidence 9999999998654322 1223346788999997754 58899999999999999998 99999764 4556666666
Q ss_pred cCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 243 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 243 ~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.+..+. .+...+..++++|.+||. +|.+||++.|++.
T Consensus 239 ~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 239 QGRLLQ-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred cCCcCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 654433 334577899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.98 Aligned_cols=250 Identities=30% Similarity=0.504 Sum_probs=209.3
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCceeeeeeEEcCCCCeE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~l 103 (631)
+| .+.+.||+|+||.||+|.+..+|..||+|.+..... ........+.+|+.+++.++ ||||+++++++.+. ..+
T Consensus 2 ~y-~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~ 77 (280)
T cd05581 2 DF-KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL-IKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE--ENL 77 (280)
T ss_pred Cc-eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhc-cchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC--ceE
Confidence 45 678899999999999999999999999999875432 22344567889999999998 99999999987544 478
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
++||||+.+++|.+++.+.+.+++..++.++.|++.||.|||+++ ++|+||+|+||+++ .+|.++|+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~-~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 78 YFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLD-KDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEecCCccccccCC
Confidence 999999999999999999888999999999999999999999998 99999999999997 788999999999865433
Q ss_pred CC----------------------CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHH
Q 006779 184 PT----------------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240 (631)
Q Consensus 184 ~~----------------------~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~ 240 (631)
.. .....+++.|+|||.+.. .++.++||||||+++++|++|+.||.... ..+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~ 233 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-EYLTFQK 233 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHH
Confidence 21 123467889999997654 47889999999999999999999998643 3444444
Q ss_pred HHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH----HHHhcCCCC
Q 006779 241 VTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA----LELLKDPFL 284 (631)
Q Consensus 241 i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa----~elL~hpff 284 (631)
+... ...++...++.+.+||.+||. +|.+||++ .++|+||||
T Consensus 234 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILKL--EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHhc--CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 4332 122334557899999999998 89999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=311.68 Aligned_cols=249 Identities=32% Similarity=0.566 Sum_probs=209.5
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ..+++||
T Consensus 7 ~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 81 (277)
T cd06641 7 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWIIM 81 (277)
T ss_pred hhheeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC--CeEEEEE
Confidence 55678999999999999999999999999876443 234556788999999999999999999998654 4688999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC--C
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--T 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--~ 185 (631)
||+.+++|..++.+ ..++...+..++.|++.||.|||+++ ++|+||+|+||+++ .++.++|+|||++...... .
T Consensus 82 e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~-~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 82 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEEC-CCCCEEEeecccceecccchhh
Confidence 99999999999875 45899999999999999999999998 99999999999997 7889999999998654332 2
Q ss_pred CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 006779 186 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264 (631)
Q Consensus 186 ~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~ 264 (631)
.....++..|+|||.+.. .++.++|+|||||++|+|++|..||.. .+.......+..+. ++.+....+..+.++|.+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~ 235 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE-LHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEA 235 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc-cchHHHHHHHhcCC-CCCCCcccCHHHHHHHHH
Confidence 233568889999997754 478899999999999999999999976 34455555554432 334555678899999999
Q ss_pred hcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 265 CIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 265 cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
||. +|.+||++.+++.||||...
T Consensus 236 ~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 236 CLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HccCChhhCcCHHHHHhCHHHhhh
Confidence 997 89999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=311.23 Aligned_cols=255 Identities=23% Similarity=0.378 Sum_probs=204.4
Q ss_pred CCceeeeeeEecccCceEEEEEEEcc-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEc
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~-----tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d 97 (631)
..|| ++.+.||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~~-~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 5 REKI-TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA---SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred HHHc-eeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 3567 677999999999999997652 35689999876432 23344568899999999999999999998765
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCC
Q 006779 98 DTNRTINMITELFTSGSLRQYRKKH----------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 167 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~----------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~ 167 (631)
. ...++||||+.+|+|.+++.+. ..++...+..++.||+.||.|||+++ |+||||||+||+++ .+
T Consensus 81 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~-~~ 155 (288)
T cd05061 81 G--QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVA-HD 155 (288)
T ss_pred C--CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEc-CC
Confidence 4 4689999999999999999753 23467788999999999999999998 99999999999998 78
Q ss_pred CcEEEccccccchhcCCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006779 168 GEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKV 241 (631)
Q Consensus 168 g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i 241 (631)
+.++|+|||++....... .....++..|+|||.+. +.++.++|||||||++|||++ |..||.. ....++.+.+
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~-~~~~~~~~~~ 234 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-LSNEQVLKFV 234 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHH
Confidence 899999999986543221 12234567899999775 458999999999999999998 7889976 4556666666
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc------CCCCCCCC
Q 006779 242 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK------DPFLVTDN 288 (631)
Q Consensus 242 ~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~------hpff~~~~ 288 (631)
..+..+. .+...++.++++|.+||+ +|.+||++.++++ ||||....
T Consensus 235 ~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 235 MDGGYLD-QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred HcCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 5543322 234456899999999998 8999999999986 89987654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=309.57 Aligned_cols=250 Identities=26% Similarity=0.415 Sum_probs=203.5
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
.+.+.||+|+||.||+|.+..+|..+|+|.+.... ........+.+|+.+++.++||||+++++++.+.....+++|+
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 56788999999999999999999999999998653 1233445688999999999999999999998765346799999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC-
Q 006779 108 ELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~- 185 (631)
||+. ++|..++.+. ..+++..++.++.||+.||+|||+++ ++|+||+|+||+++ .++.+||+|||++.......
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~-~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 80 EYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEc-CCCCEEEccccceeeccCCCc
Confidence 9997 5898888765 57999999999999999999999998 99999999999998 78999999999997654432
Q ss_pred --CccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-C--C----------
Q 006779 186 --ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-P--A---------- 248 (631)
Q Consensus 186 --~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~-p--~---------- 248 (631)
.....+++.|+|||.+.+ .++.++||||||+++|+|+||+.||.....+.. ...+..... + .
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ-LEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchhhccccccchh
Confidence 233456889999997653 478999999999999999999999987443333 222221100 0 0
Q ss_pred ----------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 249 ----------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 249 ----------------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
.+....++.+.++|.+||. +|.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0111236789999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=305.99 Aligned_cols=239 Identities=23% Similarity=0.372 Sum_probs=199.9
Q ss_pred EecccCceEEEEEEE--ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEec
Q 006779 32 ILGKGAFKTVYKGFD--EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 32 ~LG~G~fg~Vy~a~d--~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey 109 (631)
.||+|+||.||+|.+ +.++..||+|++.... ......+.+.+|+.+++.++||||+++++++.+ ...++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC--CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEec
Confidence 589999999999964 5678999999886442 234556778999999999999999999997643 356889999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCC---
Q 006779 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--- 186 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~--- 186 (631)
+.+|+|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||.||+++ .++.+||+|||++........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~-~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 77 AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEc-CCCeEEECCCccccccCCCCCeee
Confidence 999999999988888999999999999999999999998 99999999999998 788999999999976543321
Q ss_pred --ccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006779 187 --RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262 (631)
Q Consensus 187 --~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI 262 (631)
....+++.|+|||.+.. .++.++|||||||++|||++ |..||.. .+...+...+..+..+ ..+...+++++++|
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li 231 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG-MKGNEVTQMIESGERM-ECPQRCPPEMYDLM 231 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHHHHH
Confidence 12234578999997754 57889999999999999998 9999976 4566777777766543 34556789999999
Q ss_pred HHhcC-CCCCCCCHHHHhc
Q 006779 263 EKCIV-PASLRLPALELLK 280 (631)
Q Consensus 263 ~~cL~-~p~~Rpsa~elL~ 280 (631)
.+||+ +|.+||++.++..
T Consensus 232 ~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 232 KLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHhccCchhCcCHHHHHH
Confidence 99998 8999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=309.84 Aligned_cols=235 Identities=23% Similarity=0.369 Sum_probs=191.3
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCeEEEEEeccC
Q 006779 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFT 111 (631)
Q Consensus 33 LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~l~lV~Ey~~ 111 (631)
||+|+||.||++.++.+|..+|+|.+....... .|+.....+ +||||+++++.|.... .+++||||+.
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---------~e~~~~~~~~~h~~iv~~~~~~~~~~--~~~iv~e~~~ 92 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---------IEPMVHQLMKDNPNFIKLYYSVTTLK--GHVLIMDYIK 92 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---------hhHHHHHHhhcCCCEEEEEEEEecCC--eeEEEEEcCC
Confidence 699999999999999999999999987543211 122222222 7999999999887653 7999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCC-cEEEccccccchhcCCCCcccc
Q 006779 112 SGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIVMQQPTARSVI 190 (631)
Q Consensus 112 gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g-~vKL~DFGla~~~~~~~~~~~~ 190 (631)
+++|.+++.....+++..++.++.||+.||.|||+.+ ++||||||+||+++ .++ .++|+|||++...... ....
T Consensus 93 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~~l~dfg~~~~~~~~--~~~~ 167 (267)
T PHA03390 93 DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYD-RAKDRIYLCDYGLCKIIGTP--SCYD 167 (267)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEe-CCCCeEEEecCccceecCCC--ccCC
Confidence 9999999998888999999999999999999999999 99999999999998 555 9999999998655432 2346
Q ss_pred CCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCH----HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHh
Q 006779 191 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP----AQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265 (631)
Q Consensus 191 GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~----~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~c 265 (631)
+++.|+|||++.+ .++.++||||||+++|+|++|..||...... ..+.... ..+.......++.+++||.+|
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~ 244 (267)
T PHA03390 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---QKKLPFIKNVSKNANDFVQSM 244 (267)
T ss_pred CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---cccCCcccccCHHHHHHHHHH
Confidence 8999999998764 5889999999999999999999999753322 1222222 223344456789999999999
Q ss_pred cC-CCCCCCC-HHHHhcCCCCCC
Q 006779 266 IV-PASLRLP-ALELLKDPFLVT 286 (631)
Q Consensus 266 L~-~p~~Rps-a~elL~hpff~~ 286 (631)
|+ +|.+|++ ..++|+||||..
T Consensus 245 l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 245 LKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred hccChhhCCchHHHHhcCCcccC
Confidence 98 8999997 599999999963
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=308.57 Aligned_cols=249 Identities=31% Similarity=0.532 Sum_probs=205.8
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
+| ++.+.||+|+||.||+|.+..+|..||+|.+..... ........+.+|+.+++.++||||+++++++.+. ..++
T Consensus 3 ~y-~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~ 78 (267)
T cd08229 3 NF-RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NELN 78 (267)
T ss_pred hh-hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC--CeEE
Confidence 34 667899999999999999999999999998875432 2344557788999999999999999999988764 4688
Q ss_pred EEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 105 MITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~----~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
++|||+.+++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||||+||+++ .++.++|+|||++..
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~ 155 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRF 155 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEECcchhhhc
Confidence 99999999999998864 356899999999999999999999999 99999999999998 788999999999876
Q ss_pred hcCCC--CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCcH
Q 006779 181 MQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN-PAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 181 ~~~~~--~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~-~~~i~~~i~~~~~p~~l~~~~~~ 256 (631)
..... .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||..... ...+.+.+.....+.......++
T Consensus 156 ~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08229 156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 235 (267)
T ss_pred cccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccH
Confidence 54322 234578999999997754 588899999999999999999999965332 23444555544444334445778
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 257 QVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.++++|.+||. +|.+|||+.+++.
T Consensus 236 ~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 236 ELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHHH
Confidence 99999999998 8999999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=322.06 Aligned_cols=255 Identities=31% Similarity=0.444 Sum_probs=209.3
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC---CC
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---NR 101 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~---~~ 101 (631)
|| ++.+.||+|++|.||+|.+..+|..||+|.+.... ........+.+|+.+++.++||||+++++++.+.. ..
T Consensus 1 ~y-~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (330)
T cd07834 1 RY-ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN 77 (330)
T ss_pred Cc-eeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc--ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence 55 77899999999999999999999999999986432 22345567899999999999999999999886653 23
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
.+|+||||+. ++|.+++.+...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.++|+|||++...
T Consensus 78 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~-~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 78 DVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVN-SNCDLKICDFGLARGV 153 (330)
T ss_pred ceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEcccCceEee
Confidence 6899999997 589999988888999999999999999999999999 99999999999998 6799999999999765
Q ss_pred cCCC-----CccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-CC-----
Q 006779 182 QQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PA----- 248 (631)
Q Consensus 182 ~~~~-----~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~-p~----- 248 (631)
.... .....+++.|+|||++.+ .++.++||||||+++|+|++|..||.... ..+.+..+..... +.
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD-YIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC-HHHHHHHHHHhcCCCChhHhh
Confidence 4432 334568999999998754 47899999999999999999999997743 3333333332110 00
Q ss_pred -----------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 249 -----------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 249 -----------------------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
......++.+.+||.+||. +|.+||++.++|.||||...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 0112246789999999998 89999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=307.50 Aligned_cols=265 Identities=22% Similarity=0.415 Sum_probs=217.8
Q ss_pred CcccccCCCCcee------eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCC
Q 006779 15 GEFSEKDPSCRYG------RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN 87 (631)
Q Consensus 15 ~~~~e~dp~gRy~------r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~Hpn 87 (631)
+.+++.+...||. .+...||.|+-|+|++++.+.+|...|+|.+.... +.++..++...+.++... +.|+
T Consensus 76 tg~lti~~g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~---Nkee~kRILmDldvv~~s~dcpy 152 (391)
T KOG0983|consen 76 TGYLTIGGGQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPY 152 (391)
T ss_pred ceeEEecCCcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC---CHHHHHHHHHhhhHHhhccCCCe
Confidence 4455555555552 11245999999999999999999999999997553 567788899999877665 4899
Q ss_pred ceeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC
Q 006779 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 166 (631)
Q Consensus 88 IVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~ 166 (631)
||+.|++|+.... +++.||.|. .-+..++++ .+++++..+-.+...++.||.||..+. +|||||+||+|||++ .
T Consensus 153 IV~c~GyFi~n~d--V~IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlD-e 227 (391)
T KOG0983|consen 153 IVQCFGYFITNTD--VFICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLD-E 227 (391)
T ss_pred eeeeeeEEeeCch--HHHHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEc-c
Confidence 9999999987654 666789984 345555554 467999999999999999999998764 499999999999998 8
Q ss_pred CCcEEEccccccchhcCCCCc-cccCCCCCCCcccccc----ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006779 167 NGEVKIGDLGLAIVMQQPTAR-SVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241 (631)
Q Consensus 167 ~g~vKL~DFGla~~~~~~~~~-~~~GTp~Y~APEvl~~----~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i 241 (631)
.|.+||||||++..+-...++ ...|-+.|||||.+.. .|+..+||||||++++||+||.+||.+|....+...+|
T Consensus 228 ~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv 307 (391)
T KOG0983|consen 228 RGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV 307 (391)
T ss_pred CCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH
Confidence 999999999999766554443 3478999999998753 49999999999999999999999999999988888888
Q ss_pred HcCCCCCCCCC--CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 242 TSGIKPASLSK--VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 242 ~~~~~p~~l~~--~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
....+ +.++. ..++.+++|+..||. |+.+||...+||+|||+....
T Consensus 308 ln~eP-P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 308 LNEEP-PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred HhcCC-CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 87544 33432 378999999999998 899999999999999997643
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=316.39 Aligned_cols=253 Identities=26% Similarity=0.451 Sum_probs=214.1
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCeEEEEEe
Q 006779 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITE 108 (631)
Q Consensus 30 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~l~lV~E 108 (631)
.++||+|+|+.|-.+....+|.++|+|+|... ......++++|++++.++ .|+||++++++|.++. .+|+|||
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq----~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~--~FYLVfE 156 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ----PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT--RFYLVFE 156 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC----CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc--eEEEEEe
Confidence 37899999999999999999999999998743 345668899999999999 5999999999997664 6999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCC--CcEEEccccccchhc----
Q 006779 109 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN--GEVKIGDLGLAIVMQ---- 182 (631)
Q Consensus 109 y~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~--g~vKL~DFGla~~~~---- 182 (631)
-|.||+|...|.+++.|++..+.++.+.|+.||.|||.+| |.||||||+|||....+ .-||||||.++.-..
T Consensus 157 Km~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 157 KMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred cccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 9999999999999999999999999999999999999999 99999999999997333 248999998874332
Q ss_pred -----CCCCccccCCCCCCCccccc---c---ccCccccchhhhHHHHHHhhcCCCCCCCC--------------CHHHH
Q 006779 183 -----QPTARSVIGTPEFMAPELYE---E---EYNELVDIYSFGMCILEMVTCEYPYNECK--------------NPAQI 237 (631)
Q Consensus 183 -----~~~~~~~~GTp~Y~APEvl~---~---~ys~~sDIwSLGiilyELltG~~Pf~~~~--------------~~~~i 237 (631)
.+...+.+|+..|||||+.. + .|+.++|.||||||+|-|+.|..||.+.= -...+
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 12234568899999999653 2 48999999999999999999999996421 13567
Q ss_pred HHHHHcCCC--CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCc
Q 006779 238 YKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 238 ~~~i~~~~~--p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~~ 290 (631)
+..|..|.. |..-....+.+++++|..+|. ++..|.+|.++|+|||++...+.
T Consensus 315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 788888754 443344567899999999998 89999999999999999876554
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=323.40 Aligned_cols=251 Identities=25% Similarity=0.396 Sum_probs=203.8
Q ss_pred CCCceeeeeeEecccCceEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeE
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSW 95 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d-----~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~ 95 (631)
|.+|| ++.+.||+|+||.||+|.+ ..+++.||+|.++... .......+.+|+.+|..+ +||||+++++++
T Consensus 5 ~~~~~-~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 5 PRDRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred chhHh-cccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 56788 8899999999999999984 4568899999986432 234556788999999999 689999999988
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhC-----------------------------------------------------
Q 006779 96 VDDTNRTINMITELFTSGSLRQYRKKH----------------------------------------------------- 122 (631)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~~~l~~~----------------------------------------------------- 122 (631)
.... ..+++||||+.+|+|.+++...
T Consensus 81 ~~~~-~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 81 TKPG-GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred ecCC-CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 6543 4688999999999999998642
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC---
Q 006779 123 --------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--- 185 (631)
Q Consensus 123 --------------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~--- 185 (631)
..+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~ 236 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYV 236 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEc-CCCcEEEEecccccccccCcchh
Confidence 23678888999999999999999998 99999999999997 78899999999986543221
Q ss_pred -CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006779 186 -ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262 (631)
Q Consensus 186 -~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI 262 (631)
.....+++.|+|||.+. ..++.++||||||+++|+|++ |..||........+...+..+..+ ..+...++.+.+++
T Consensus 237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 315 (343)
T cd05103 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTM 315 (343)
T ss_pred hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC-CCCCCCCHHHHHHH
Confidence 11234567899999764 458999999999999999997 999998755555565556555433 23345678999999
Q ss_pred HHhcC-CCCCCCCHHHHhcC
Q 006779 263 EKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 263 ~~cL~-~p~~Rpsa~elL~h 281 (631)
.+||. +|.+||++.++++|
T Consensus 316 ~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 316 LDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHccCChhhCcCHHHHHHH
Confidence 99998 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=305.53 Aligned_cols=242 Identities=26% Similarity=0.418 Sum_probs=203.2
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEE
Q 006779 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV 106 (631)
+.+.+.||+|+||.||+|.+..++..||+|.+... ......+.+|+.+++.++||||+++++++... ..+++|
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 80 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYII 80 (263)
T ss_pred eEEeeecCCcccceEEEEEEecCCceEEEEEecCC-----chHHHHHHHHHHHHHhCCCCChhheEEEEcCC--CCcEEE
Confidence 36788999999999999999999999999987632 23356688999999999999999999987654 468899
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 107 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
|||+.+++|.+++... ..+++..++.++.|++.||+|||+++ ++||||||+||+++ .++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCcEEeCCCccccccccc
Confidence 9999999999998764 35899999999999999999999998 99999999999997 7889999999999765443
Q ss_pred CCc---cccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006779 185 TAR---SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 185 ~~~---~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~ 259 (631)
... ...+++.|+|||.+. ..++.++|||||||++|+|++ |..||.. .+.......+..+..+ ..+...++++.
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 235 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKGYRM-ERPEGCPPKVY 235 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHH
Confidence 221 123456799999775 458899999999999999998 9999976 4666777777665443 34455678999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhc
Q 006779 260 QFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 260 ~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
++|.+||. +|.+||++.++++
T Consensus 236 ~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 236 ELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHccCCcccCCCHHHHHH
Confidence 99999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=309.36 Aligned_cols=248 Identities=23% Similarity=0.410 Sum_probs=199.5
Q ss_pred CCceeeeeeEecccCceEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEc
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~-----~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d 97 (631)
..|| ++.+.||+|+||.||+|.++ .++..||+|.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~~-~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 5 REKI-TMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred HHHc-eeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 3456 77899999999999999865 346789999875332 23445668899999999999999999998754
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCC
Q 006779 98 DTNRTINMITELFTSGSLRQYRKKHK----------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 167 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~----------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~ 167 (631)
. ..+++||||+.+|+|.+++.+.. .++...+..++.|++.||.|||+++ ++||||||+||+++ .+
T Consensus 81 ~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~-~~ 155 (277)
T cd05062 81 G--QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-ED 155 (277)
T ss_pred C--CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEc-CC
Confidence 3 46889999999999999987532 3577889999999999999999998 99999999999998 78
Q ss_pred CcEEEccccccchhcCCC----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006779 168 GEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKV 241 (631)
Q Consensus 168 g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i 241 (631)
+.++|+|||++....... .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+ .+.......+
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~-~~~~~~~~~~ 234 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-MSNEQVLRFV 234 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHH
Confidence 899999999986543221 112345778999998764 58999999999999999999 7889876 4555555555
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 242 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 242 ~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
..+..+ ..+...+..++++|.+||. +|.+||++.|++.+
T Consensus 235 ~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 235 MEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HcCCcC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 544322 3345567889999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.33 Aligned_cols=257 Identities=26% Similarity=0.375 Sum_probs=207.3
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~ 101 (631)
.+|| .+.+.||+|+||.||+|.+..+|..||+|.+.... ........+.+|+.+++++ +||||+++++++......
T Consensus 6 ~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 6 LRKY-EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF--RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhHH-HHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc--CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 3456 66789999999999999999999999999885321 2234456678899999999 999999999988766666
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
.+++||||+. ++|..++.+. .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~-~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLN-SDCRVKLADFGLARSL 157 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccchhcc
Confidence 7899999997 5999998776 7899999999999999999999998 99999999999997 7899999999998654
Q ss_pred cCC-------CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC------
Q 006779 182 QQP-------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------ 246 (631)
Q Consensus 182 ~~~-------~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~------ 246 (631)
... ......|++.|+|||++.+ .++.++||||||+++|+|+||+.||............+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 322 2234568999999997643 4788999999999999999999999765444332222111100
Q ss_pred ----------------------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 247 ----------------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 247 ----------------------p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
+.......+.++++||.+||+ +|.+|||+.++|.||||+.-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 011122357889999999998 89999999999999999763
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=329.28 Aligned_cols=248 Identities=27% Similarity=0.403 Sum_probs=201.6
Q ss_pred CCceeeeeeEecccCceEEEEEEEcc-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCceeeeeeEE
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWV 96 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~-----tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~ 96 (631)
.++| +++++||+|+||.||+|.+.. ++..||+|.+.... .....+.+.+|+++|+.+. ||||++++++|.
T Consensus 36 ~~~~-~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 36 RDGL-VLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA---RSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred ccce-ehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 4455 677999999999999998743 34579999986432 2345577999999999996 999999999986
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhC------------------------------------------------------
Q 006779 97 DDTNRTINMITELFTSGSLRQYRKKH------------------------------------------------------ 122 (631)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~l~~~------------------------------------------------------ 122 (631)
+. ..+++|||||.+|+|.+++.+.
T Consensus 112 ~~--~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 112 KS--GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred cC--CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 54 4689999999999999987642
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCC
Q 006779 123 ------------------------------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160 (631)
Q Consensus 123 ------------------------------------------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~N 160 (631)
..+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~N 267 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHh
Confidence 24778889999999999999999998 9999999999
Q ss_pred eeecCCCCcEEEccccccchhcCCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCH
Q 006779 161 IFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNP 234 (631)
Q Consensus 161 ILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~ 234 (631)
||++ .++.+||+|||++....... .....+++.|+|||++. ..++.++|||||||++|+|++ |..||......
T Consensus 268 ill~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 268 VLLA-QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred EEEe-CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 9998 78899999999987543321 22345678899999775 458999999999999999997 99999875555
Q ss_pred HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 235 AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 235 ~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
..++..+..+..+. .+...+..++++|.+||. +|.+||++.++.+
T Consensus 347 ~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 347 STFYNKIKSGYRMA-KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHHhcCCCCC-CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 56666666654432 344567899999999998 8999999988765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=315.68 Aligned_cols=260 Identities=29% Similarity=0.490 Sum_probs=212.5
Q ss_pred ccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEE
Q 006779 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (631)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 96 (631)
+-..+|..+|. ..+.||+|+||.||+|.++.+|..||+|.+..... .......++.+|+.+++.++|+|++++++++.
T Consensus 8 ~~~~~~~~~~~-~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 85 (308)
T cd06634 8 FFKDDPEKLFS-DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (308)
T ss_pred hhcCCcHHHHH-HHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc-cChHHHHHHHHHHHHHHhCCCCCcccEEEEEE
Confidence 44567788874 45779999999999999999999999999864322 23445567889999999999999999999887
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccc
Q 006779 97 DDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 175 (631)
.. ...++|+||+. |+|.+++.. ...+++..+..++.|++.||.|||+++ ++||||+|+||+++ .++.++|+||
T Consensus 86 ~~--~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~kl~df 159 (308)
T cd06634 86 RE--HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDF 159 (308)
T ss_pred cC--CeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEEC-CCCcEEECCc
Confidence 65 46889999996 578776654 456899999999999999999999998 99999999999997 6889999999
Q ss_pred cccchhcCCCCccccCCCCCCCccccc----cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006779 176 GLAIVMQQPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 251 (631)
Q Consensus 176 Gla~~~~~~~~~~~~GTp~Y~APEvl~----~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~ 251 (631)
|++...... ....+++.|+|||.+. +.++.++|||||||++|+|++|..||........+. .+..+..+....
T Consensus 160 g~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~ 236 (308)
T cd06634 160 GSASIMAPA--NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQS 236 (308)
T ss_pred ccceeecCc--ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH-HHhhcCCCCcCc
Confidence 998654332 3456889999999763 347889999999999999999999997643333333 344444444444
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 252 ~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
...+..+++||.+||. +|.+||++.+++.|||+...
T Consensus 237 ~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 5677899999999998 89999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=320.95 Aligned_cols=250 Identities=24% Similarity=0.405 Sum_probs=199.6
Q ss_pred eEeccc--CceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEe
Q 006779 31 EILGKG--AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE 108 (631)
Q Consensus 31 e~LG~G--~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~E 108 (631)
+.||+| +|++||+|.+..+|..||+|.+..... .....+.+.+|+.+++.++||||++++++|... ..+++|+|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~~~v~e 79 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG--SWLWVISP 79 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC--CceEEEEe
Confidence 456776 999999999999999999999875532 345567899999999999999999999998765 46899999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC-
Q 006779 109 LFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 185 (631)
Q Consensus 109 y~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~- 185 (631)
|+.+++|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.++++||+.+.......
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~-~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILIS-GDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEe-CCCcEEEechHHHhhhhccCc
Confidence 99999999998875 35899999999999999999999998 99999999999997 78899999998653321110
Q ss_pred --------CccccCCCCCCCcccccc---ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-C------
Q 006779 186 --------ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-P------ 247 (631)
Q Consensus 186 --------~~~~~GTp~Y~APEvl~~---~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~-p------ 247 (631)
.....++..|+|||++.+ .++.++|||||||++|+|++|..||............+..... |
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccccc
Confidence 011234567999998754 3789999999999999999999999876554444433322110 0
Q ss_pred -------------------------------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 248 -------------------------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 248 -------------------------------------~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.......++.+++||.+||. +|.+|||+.++|+||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 00112245678999999998 99999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=308.73 Aligned_cols=245 Identities=25% Similarity=0.373 Sum_probs=201.7
Q ss_pred eeeeeEecccCceEEEEEEE----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 27 GRYDEILGKGAFKTVYKGFD----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d----~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
+++.+.||+|+||+||+|.. ..++..||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 81 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN---NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE--QP 81 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--Cc
Confidence 37789999999999999985 3456889999986432 344557788999999999999999999987654 46
Q ss_pred EEEEEeccCCCCHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC
Q 006779 103 INMITELFTSGSLRQYRKKH-----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 165 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~-----------------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~ 165 (631)
.++||||+.+++|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~- 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIG- 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEc-
Confidence 88999999999999998532 24788999999999999999999998 99999999999998
Q ss_pred CCCcEEEccccccchhcCC----CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHH
Q 006779 166 NNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYK 239 (631)
Q Consensus 166 ~~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~ 239 (631)
.++.+||+|||++...... ......++..|+|||.+. ..++.++|||||||++|||++ |..||.+ .++..+..
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~-~~~~~~~~ 237 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG-FSNQEVIE 237 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHH
Confidence 7889999999999755322 123344567899999775 458999999999999999998 9999976 45566666
Q ss_pred HHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 240 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 240 ~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.+.....+ ..+...++.++++|.+||+ +|.+||++.+++++
T Consensus 238 ~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 238 MVRKRQLL-PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHcCCcC-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 66655433 3455678899999999998 89999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=302.57 Aligned_cols=243 Identities=27% Similarity=0.462 Sum_probs=208.0
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEeccCC
Q 006779 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112 (631)
Q Consensus 33 LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~~g 112 (631)
||+|+||.||++.+..+|..||+|.+..... ........+..|+.+++.++||||+++++.+.. ...+++||||+.+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-IKRKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh-cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEecCCC
Confidence 6999999999999999999999999876543 233456789999999999999999999998754 3579999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC--CCcccc
Q 006779 113 GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVI 190 (631)
Q Consensus 113 GsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--~~~~~~ 190 (631)
++|.+++.+...+++..+..++.|++.||.|||+++ ++|+||+|+||+++ .++.++|+|||++...... ......
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEc-CCCcEEEeecCcceecccCCCcccCCc
Confidence 999999998888999999999999999999999998 99999999999997 7889999999998765443 334556
Q ss_pred CCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-C
Q 006779 191 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-P 268 (631)
Q Consensus 191 GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~ 268 (631)
++..|+|||...+ .++.++|+||||+++|+|++|..||.. .....+...+.... ..++...+..+++||.+||. +
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~--~~~~~~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKILKDP--LRFPEFLSPEARDLISGLLQKD 231 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHhcCC
Confidence 8889999997754 478899999999999999999999976 34455566665532 23455567899999999998 8
Q ss_pred CCCCCCH---HHHhcCCCC
Q 006779 269 ASLRLPA---LELLKDPFL 284 (631)
Q Consensus 269 p~~Rpsa---~elL~hpff 284 (631)
|.+||++ .+++.||||
T Consensus 232 p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 232 PTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HhhCCCcccHHHHHhCCCC
Confidence 9999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=308.07 Aligned_cols=246 Identities=22% Similarity=0.371 Sum_probs=199.9
Q ss_pred eeeeeEecccCceEEEEEEEcc-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 27 GRYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~-----tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
+++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++.+..
T Consensus 8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 82 (277)
T cd05036 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC---SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL-- 82 (277)
T ss_pred cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--
Confidence 3777999999999999999987 78999999876432 2344466889999999999999999999886543
Q ss_pred eEEEEEeccCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC--CCcEEE
Q 006779 102 TINMITELFTSGSLRQYRKKHK-------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKI 172 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~-------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~--~g~vKL 172 (631)
..++||||+.+++|.+++.+.+ .+++..+..++.||+.||.|||+++ ++||||||+||+++.. ...+||
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEe
Confidence 5789999999999999997653 4899999999999999999999998 9999999999999732 236999
Q ss_pred ccccccchhcCCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCC
Q 006779 173 GDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 246 (631)
Q Consensus 173 ~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~ 246 (631)
+|||++....... ......++.|+|||++. ..++.++|||||||++|+|++ |..||... +...+...+.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~-~~~~~~~~~~~~~~ 239 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR-TNQEVMEFVTGGGR 239 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCCc
Confidence 9999997653221 11223356799999875 458999999999999999997 99999864 44555566655433
Q ss_pred CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 247 PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 247 p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
+ ..+...+..+.+|+.+||+ +|.+||++.++|+|
T Consensus 240 ~-~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 L-DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 2 3344567899999999998 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=309.25 Aligned_cols=243 Identities=26% Similarity=0.409 Sum_probs=201.2
Q ss_pred eeeeeEecccCceEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 27 GRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d-----~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
+++.+.||+|+||.||++.+ ..++..+|+|.+... .......+.+|+.+|+.++||||+++++++... .
T Consensus 7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 80 (288)
T cd05093 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG--D 80 (288)
T ss_pred eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--C
Confidence 47789999999999999986 345677999987632 344567799999999999999999999988654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCC
Q 006779 102 TINMITELFTSGSLRQYRKKHK-------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 168 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~-------------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g 168 (631)
.+++|+||+.+++|.+++..++ .+++..++.++.||+.||+|||+++ ++||||||+|||++ .++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~-~~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVG-ENL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc-cCC
Confidence 6889999999999999997543 4899999999999999999999998 99999999999997 789
Q ss_pred cEEEccccccchhcCCC----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006779 169 EVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT 242 (631)
Q Consensus 169 ~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~ 242 (631)
.+||+|||++....... .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.. .+...+...+.
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~-~~~~~~~~~i~ 236 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ-LSNNEVIECIT 236 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHH
Confidence 99999999986543221 123345778999998764 58899999999999999998 8999876 35556666676
Q ss_pred cCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 243 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 243 ~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.+..+ ..+...++.+++|+.+||+ +|.+|||+.+++.
T Consensus 237 ~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 237 QGRVL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 65433 2344567899999999998 8999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=303.59 Aligned_cols=239 Identities=23% Similarity=0.405 Sum_probs=198.3
Q ss_pred eEecccCceEEEEEEEccCC---eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 31 EILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg---~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++||+|+||.||+|.+..++ ..||+|.+..... ......+.+|+.+++.++||||+++++++.. ..+++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI---AAGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEE
Confidence 46999999999999876655 8999999875432 2455678999999999999999999997643 3578999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCC-
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA- 186 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~- 186 (631)
||+.+|+|.+++.+.+.+++..+..|+.|++.||.|||.++ ++||||||+|||++ .++.+||+|||++........
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~-~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 75 ELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred EeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEc-CCCcEEeccccccceeecCCcc
Confidence 99999999999998888999999999999999999999998 99999999999997 788999999999875533221
Q ss_pred ----ccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006779 187 ----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 187 ----~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~ 260 (631)
....++..|+|||.+. ..++.++|||||||++|+|++ |..||... +..++...+..+.. ...+...++.+++
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 229 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-KGAEVIAMLESGER-LPRPEECPQEIYS 229 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHHcCCc-CCCCCCCCHHHHH
Confidence 1112345799999765 458899999999999999998 99999774 45666666666543 2344556789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhc
Q 006779 261 FIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 261 lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+|.+||. +|.+||++.+++.
T Consensus 230 li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 230 IMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 9999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=313.75 Aligned_cols=263 Identities=28% Similarity=0.473 Sum_probs=213.9
Q ss_pred ccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEE
Q 006779 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (631)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 96 (631)
+-..+|...| ...+.||+|+||.||+|.+..+|..||+|.+..... ...+....+.+|+.+++.++|||++++++++.
T Consensus 18 ~~~~~~~~~f-~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 95 (317)
T cd06635 18 FFKEDPEKLF-TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL 95 (317)
T ss_pred hcCCCchhhh-hhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 3556676666 556889999999999999999999999999875432 23455677899999999999999999999887
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccc
Q 006779 97 DDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 175 (631)
+. ...++||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+++ |+||||+|+||+++ .++.+||+||
T Consensus 96 ~~--~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~-~~~~~kl~df 169 (317)
T cd06635 96 RE--HTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADF 169 (317)
T ss_pred eC--CeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEEC-CCCCEEEecC
Confidence 65 368899999974 77777654 456899999999999999999999998 99999999999997 7889999999
Q ss_pred cccchhcCCCCccccCCCCCCCccccc----cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006779 176 GLAIVMQQPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 251 (631)
Q Consensus 176 Gla~~~~~~~~~~~~GTp~Y~APEvl~----~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~ 251 (631)
|++..... .....|++.|+|||.+. +.++.++|||||||++|+|++|..||........+ ..+..+..+....
T Consensus 170 g~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~ 246 (317)
T cd06635 170 GSASIASP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQNESPTLQS 246 (317)
T ss_pred CCccccCC--cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH-HHHHhccCCCCCC
Confidence 98864432 23456899999999763 35888999999999999999999999774433333 3444333333334
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCc
Q 006779 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 252 ~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~~ 290 (631)
...++.+++||.+||+ +|.+||++.+++.|+|+....++
T Consensus 247 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 247 NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred ccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 4567889999999998 89999999999999999765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=305.66 Aligned_cols=246 Identities=24% Similarity=0.403 Sum_probs=202.3
Q ss_pred CceeeeeeEecccCceEEEEEEEccC-----CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVD-----GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~t-----g~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 98 (631)
.+| ++.+.||+|+||.||+|.++.. +..||+|.+.... .......+.+|+.+|+.++||||+++++++...
T Consensus 6 ~~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 6 EKI-TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred HHe-eEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 456 6789999999999999988654 4899999975432 234456788999999999999999999988654
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCC
Q 006779 99 TNRTINMITELFTSGSLRQYRKKH----------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 168 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~----------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g 168 (631)
..+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+|||++ .++
T Consensus 82 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~-~~~ 156 (277)
T cd05032 82 --QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVA-EDL 156 (277)
T ss_pred --CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEc-CCC
Confidence 4688999999999999998653 23678899999999999999999998 99999999999998 789
Q ss_pred cEEEccccccchhcCCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006779 169 EVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT 242 (631)
Q Consensus 169 ~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~ 242 (631)
.+||+|||++....... .....++..|+|||.+. +.++.++|||||||++|+|+| |..||.+ .+..++.+.+.
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~~~ 235 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG-LSNEEVLKFVI 235 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc-CCHHHHHHHHh
Confidence 99999999987554321 22335678899999765 458899999999999999998 9999976 45666666666
Q ss_pred cCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 243 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 243 ~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.+..+ ..+...+..+.++|.+||. +|.+|||+.+++.
T Consensus 236 ~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 236 DGGHL-DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred cCCCC-CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 54332 3344568899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=309.53 Aligned_cols=249 Identities=24% Similarity=0.321 Sum_probs=201.1
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCC----------------eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDG----------------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg----------------~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~H 85 (631)
+.++| ++.+.||+|+||.||+|.+..++ ..||+|.+.... .....+.+.+|+++|+.++|
T Consensus 3 ~~~~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~~ 78 (296)
T cd05051 3 PRQPL-NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNAREDFLKEVKILSRLSD 78 (296)
T ss_pred chhhC-cccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhcCC
Confidence 34567 78899999999999999876644 568999886442 24556778999999999999
Q ss_pred CCceeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEec
Q 006779 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-----------NVDMKAIKNWARQILRGLHYLHSHNPPIIHR 154 (631)
Q Consensus 86 pnIVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~-----------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHr 154 (631)
|||++++++|... ..++++|||+.+++|.+++.+.. .+++..++.++.|++.||.|||+++ ++||
T Consensus 79 ~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~ 154 (296)
T cd05051 79 PNIARLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHR 154 (296)
T ss_pred CCEeEEEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccc
Confidence 9999999988665 46889999999999999998766 6899999999999999999999998 9999
Q ss_pred cCCCCCeeecCCCCcEEEccccccchhcCCC----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh--cCCC
Q 006779 155 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT--CEYP 227 (631)
Q Consensus 155 DLKp~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt--G~~P 227 (631)
||||+||+++ .++.++|+|||++....... .....+++.|+|||.+.. .++.++|||||||++|+|++ +..|
T Consensus 155 dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 233 (296)
T cd05051 155 DLATRNCLVG-KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP 233 (296)
T ss_pred ccchhceeec-CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCC
Confidence 9999999997 67899999999986543321 223456778999997654 68999999999999999998 7788
Q ss_pred CCCCCCHHHHHHHHHcC------CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 228 YNECKNPAQIYKKVTSG------IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 228 f~~~~~~~~i~~~i~~~------~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
|.... ..++...+... ......+...+.++.++|.+||+ +|.+||++.+++.
T Consensus 234 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 234 YEHLT-DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CCCcC-hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 87643 44444444322 11111233456899999999998 8999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=318.11 Aligned_cols=258 Identities=30% Similarity=0.426 Sum_probs=207.7
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC-
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN- 100 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~- 100 (631)
..+|| ++.+.||+|+||.||+|.+..+|..||+|++.... ........+.+|+.+|+.++||||+++++++.....
T Consensus 13 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 13 VPDRY-RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred cccce-EEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 46778 56788999999999999999999999999986432 233445678899999999999999999998865432
Q ss_pred ---CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 101 ---RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 101 ---~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
..+++||||+ +++|..++.. ..+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.++|+|||+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~-~~~~~kl~dfg~ 164 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGL 164 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeeccc
Confidence 2568999999 7899988864 56999999999999999999999998 99999999999997 788999999999
Q ss_pred cchhcCCCCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC---------
Q 006779 178 AIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--------- 246 (631)
Q Consensus 178 a~~~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--------- 246 (631)
+...... .....+++.|+|||.+.+ .++.++|+||||+++|+|++|+.||..........+.......
T Consensus 165 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 165 ARQTDSE-MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred ccccccC-ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 8755432 234567899999998754 4788999999999999999999999865433333222211100
Q ss_pred ----------------C---CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 247 ----------------P---ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 247 ----------------p---~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
+ ..+....++.+.++|.+||. +|.+|||+.+++.||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 0 01123456789999999998 899999999999999998643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=306.53 Aligned_cols=243 Identities=25% Similarity=0.427 Sum_probs=200.2
Q ss_pred eeeeeEecccCceEEEEEEEccCCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 27 GRYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~tg~----~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
+++.++||+|+||+||+|.+..+|. .||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~ 82 (279)
T cd05109 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS---T 82 (279)
T ss_pred eeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC---CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC---C
Confidence 4677999999999999999877776 48999886432 345567788999999999999999999988643 4
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 103 INMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
.++++||+.+|+|.+++..+ +.+++..+..++.||+.||.|||+++ |+||||||+|||++ +++.+||+|||++...
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~-~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVK-SPNHVKITDFGLARLL 159 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEc-CCCcEEECCCCceeec
Confidence 67899999999999998764 56999999999999999999999998 99999999999997 7889999999999765
Q ss_pred cCCCC----ccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006779 182 QQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 182 ~~~~~----~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~ 255 (631)
..... ....+++.|+|||.+. ..++.++|||||||++|||++ |..||.. .....+...+..+..+. .+...+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~ 237 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG-IPAREIPDLLEKGERLP-QPPICT 237 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcCC-CCccCC
Confidence 43221 1223467899999765 458999999999999999998 8999875 34555666666554332 344567
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 256 PQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
..+.++|.+||. +|.+||++.+++.
T Consensus 238 ~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 238 IDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 899999999998 8999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=310.13 Aligned_cols=259 Identities=23% Similarity=0.374 Sum_probs=209.5
Q ss_pred eeeeEecccCceEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCeE
Q 006779 28 RYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~---~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~l 103 (631)
++.+.||+|++|.||+|.+. .++..||+|.+..............+.+|+.++.++ +||||+++++.+... ..+
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~--~~~ 80 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD--TKL 80 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC--CEE
Confidence 67799999999999999864 467899999987543322334456788999999999 599999999987543 478
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
++||||+.+|+|.+++.+...+++..++.++.|++.||.|||+.+ ++||||+|+||+++ .++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLD-SEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEEECcccccccc
Confidence 899999999999999988888999999999999999999999988 99999999999997 688999999999865433
Q ss_pred CC---CccccCCCCCCCccccccc---cCccccchhhhHHHHHHhhcCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCC
Q 006779 184 PT---ARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 184 ~~---~~~~~GTp~Y~APEvl~~~---ys~~sDIwSLGiilyELltG~~Pf~~~~---~~~~i~~~i~~~~~p~~l~~~~ 254 (631)
.. .....|++.|+|||.+.+. ++.++||||||+++|+|++|..||.... ....+.+.+..... ..+...
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 235 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--PFPKTM 235 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--CCCccc
Confidence 21 2234689999999987543 6789999999999999999999996322 22333344433322 234456
Q ss_pred cHHHHHHHHHhcC-CCCCCCC---HHHHhcCCCCCCCCCcccc
Q 006779 255 DPQVKQFIEKCIV-PASLRLP---ALELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rps---a~elL~hpff~~~~~~~~~ 293 (631)
++.++++|.+||+ +|++||| +.++|+||||+...+..+.
T Consensus 236 ~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~ 278 (288)
T cd05583 236 SAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLA 278 (288)
T ss_pred CHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHh
Confidence 7899999999998 8999998 5788999999987775543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=326.24 Aligned_cols=269 Identities=25% Similarity=0.396 Sum_probs=223.8
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEE
Q 006779 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV 106 (631)
.+.-++||+|+||.||-+..+.||..+|.|.+..+.... .........|-.+|..++.+.||.+-..|... ..+++|
T Consensus 187 F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk-r~ge~maLnEk~iL~kV~s~FiVslaYAfeTk--d~LClV 263 (591)
T KOG0986|consen 187 FRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK-RKGETMALNEKQILEKVSSPFIVSLAYAFETK--DALCLV 263 (591)
T ss_pred eeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH-hhhhHHhhHHHHHHHHhccCcEEEEeeeecCC--CceEEE
Confidence 345588999999999999999999999999887655432 23335577899999999999999998888554 469999
Q ss_pred EeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 107 TELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
+..|.||+|+-.|.+.+ .++++.++.++.+|+.||++||..+ ||+|||||+|||+| +.|+++|+|+|+|..+...
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLD-d~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLD-DHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeec-cCCCeEeeccceEEecCCC
Confidence 99999999999888876 8999999999999999999999998 99999999999998 8999999999999877554
Q ss_pred -CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006779 185 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 185 -~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~---~~~i~~~i~~~~~p~~l~~~~~~~l~ 259 (631)
.....+||..|||||++.+ .|+..+|+|||||++|||+.|+.||..... .+++-.++.. .+..++...+++++
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~~kFS~eak 418 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYSDKFSEEAK 418 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhcccccCHHHH
Confidence 3445599999999998865 499999999999999999999999975332 1233333333 34556777899999
Q ss_pred HHHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCcccccCCCCCCCCc
Q 006779 260 QFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLPNLV 303 (631)
Q Consensus 260 ~lI~~cL~-~p~~Rps-----a~elL~hpff~~~~~~~~~~~~~~~p~~~ 303 (631)
+|.+..|. +|++|+. +.++-.||||+..+++.+....+..|..+
T Consensus 419 slc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiP 468 (591)
T KOG0986|consen 419 SLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIP 468 (591)
T ss_pred HHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCC
Confidence 99999998 8998874 77999999999999998765555444443
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=308.30 Aligned_cols=251 Identities=26% Similarity=0.424 Sum_probs=201.7
Q ss_pred CceeeeeeEecccCceEEEEEEE----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFD----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d----~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
+|++++.+.||+|+||.||+|.. +.++..||+|.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 79 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 57778889999999999999974 4678999999986432 2445577999999999999999999999987765
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
...+++||||+.+++|.+++.+. ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~-~~~~~~l~dfg~~ 156 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLT 156 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEc-CCCCEEECCCccc
Confidence 56789999999999999999765 45899999999999999999999998 99999999999997 7889999999999
Q ss_pred chhcCCC-----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCC--------------CHHHHH
Q 006779 179 IVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK--------------NPAQIY 238 (631)
Q Consensus 179 ~~~~~~~-----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~--------------~~~~i~ 238 (631)
....... .....++..|+|||.+. ..++.++|||||||++|+|+|+..|+.... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 7654321 12345677899999765 458899999999999999999876653211 112222
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 239 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 239 ~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
..+..+... ..+...+..+.+||.+||. +|.+||++.++++.
T Consensus 237 ~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 237 RVLEEGKRL-PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHcCccC-CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 223333222 2334567899999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=320.46 Aligned_cols=256 Identities=31% Similarity=0.475 Sum_probs=206.5
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC--
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-- 100 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~-- 100 (631)
.++| .+.+.||+|++|.||+|.+..++..||+|.+.... ........+.+|+.+++.++||||+++++++.....
T Consensus 14 ~~~y-~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 14 PDRY-QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF--QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cCce-EEEEEeccCCceEEEEEEECCCCcEEEEEeccccc--chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 4567 67799999999999999999999999999886432 223445668899999999999999999987754332
Q ss_pred --CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 101 --RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 101 --~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
..+++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++ .++.++|+|||++
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~-~~~~~kL~dfg~~ 165 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVN-EDCELKILDFGLA 165 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEcccccc
Confidence 3588999999 6799999876 46999999999999999999999998 99999999999997 7899999999999
Q ss_pred chhcCCCCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-CC-------
Q 006779 179 IVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PA------- 248 (631)
Q Consensus 179 ~~~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~-p~------- 248 (631)
...... .....+++.|+|||++.+ .++.++|||||||++|+|++|+.||....... .+..+..... +.
T Consensus 166 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 166 RHTDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cccccc-ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHHHHhhc
Confidence 765433 344568899999997754 47889999999999999999999997644333 2332222110 00
Q ss_pred ---------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 249 ---------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 249 ---------------------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
......++.+.+||.+||. +|.+|||+.++|.||||....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 0112247889999999998 899999999999999998643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=348.93 Aligned_cols=250 Identities=27% Similarity=0.415 Sum_probs=198.7
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
+|| ++.++||+|+||.||+|.+..+|+.||+|++.... .......+++.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 grY-eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l-~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~--~~l 77 (932)
T PRK13184 2 QRY-DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL-SENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG--DPV 77 (932)
T ss_pred CCe-EEEEEEecCCCEEEEEEEECCCCcEEEEEEECccc-ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC--CEE
Confidence 678 77899999999999999999999999999987432 23345567899999999999999999999988654 478
Q ss_pred EEEEeccCCCCHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEE
Q 006779 104 NMITELFTSGSLRQYRKKH-----------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~-----------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL 172 (631)
++||||+.||+|.+++.+. ..++...+..++.||+.||.|||+++ |+||||||+||+++ .+|.+||
T Consensus 78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd-~dg~vKL 154 (932)
T PRK13184 78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLG-LFGEVVI 154 (932)
T ss_pred EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEc-CCCCEEE
Confidence 9999999999999988642 23566788999999999999999998 99999999999997 7889999
Q ss_pred ccccccchhcCC--------------------CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCC
Q 006779 173 GDLGLAIVMQQP--------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC 231 (631)
Q Consensus 173 ~DFGla~~~~~~--------------------~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~ 231 (631)
+|||++...... .....+||+.|+|||++.+ .++.++|||||||++|||+||..||...
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 999999654110 1123579999999997754 5899999999999999999999999763
Q ss_pred CCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 232 KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 232 ~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.......................++.+.+++.+||. +|.+|+++.+.|.
T Consensus 235 ~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 235 KGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred chhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 322222221111111111123457889999999998 8999988766554
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=314.64 Aligned_cols=244 Identities=24% Similarity=0.428 Sum_probs=196.2
Q ss_pred CceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEeccCCCCHH
Q 006779 37 AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR 116 (631)
Q Consensus 37 ~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~~gGsL~ 116 (631)
+++.||++.++.+|..||+|++.... ........+.+|+.+++.++||||++++++|.+. ..++++|||+.+|+|.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~--~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDS--CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD--SELYVVSPLMAYGSCE 87 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccc--cchhHHHHHHHHHHHHHhcCCcchhhhhheeecC--CeEEEEEeccCCCCHH
Confidence 45667777778899999999997653 2345677899999999999999999999998765 4689999999999999
Q ss_pred HHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC---------C
Q 006779 117 QYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---------T 185 (631)
Q Consensus 117 ~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~---------~ 185 (631)
+++.+. ..+++..++.+++||+.||+|||+++ |+||||||+||+++ .+|.+||+|||.+...... .
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLS-GDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEe-cCCceEEecCccceeeccccccccccccc
Confidence 999864 45899999999999999999999998 99999999999998 7899999999988543211 1
Q ss_pred CccccCCCCCCCcccccc---ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC---------------
Q 006779 186 ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--------------- 247 (631)
Q Consensus 186 ~~~~~GTp~Y~APEvl~~---~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--------------- 247 (631)
.....++..|+|||++.. .|+.++|||||||++|+|++|..||............+......
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcC
Confidence 223457788999998754 48899999999999999999999998755544444443321100
Q ss_pred ----------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 248 ----------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 248 ----------------~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.......+..+++||.+||. +|.+|||+.++|.||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 00111224678999999998 89999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=332.69 Aligned_cols=263 Identities=23% Similarity=0.404 Sum_probs=235.5
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEecc
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~ 110 (631)
..||-||||.|-++........+|+|+++...... ..+.+.++.|-++|..++.|.||++|..|-+ .+++||.||-|
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd-tkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd--~kyvYmLmEaC 502 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD-TKQQEHVFSERNIMMECRSDFIVRLYRTFRD--SKYVYMLMEAC 502 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccc-hhHHHHHHhHHHHHHhcCchHHHHHHHHhcc--chhhhhhHHhh
Confidence 46999999999999877666678999988776544 4667889999999999999999999998854 46899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC-CCCccc
Q 006779 111 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSV 189 (631)
Q Consensus 111 ~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~-~~~~~~ 189 (631)
-||.|...+...+.|+..+.+.++.-+++|++|||++| ||+|||||+|++++ .+|-+||.|||+|+.+.. ..+.++
T Consensus 503 lGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd-~~Gy~KLVDFGFAKki~~g~KTwTF 579 (732)
T KOG0614|consen 503 LGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLD-NRGYLKLVDFGFAKKIGSGRKTWTF 579 (732)
T ss_pred cCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeec-cCCceEEeehhhHHHhccCCceeee
Confidence 99999999999999999999999999999999999999 99999999999998 899999999999987765 457889
Q ss_pred cCCCCCCCccc-cccccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-
Q 006779 190 IGTPEFMAPEL-YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV- 267 (631)
Q Consensus 190 ~GTp~Y~APEv-l~~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~- 267 (631)
+|||.|.|||+ +..+++.++|+|||||++|||+||.+||++ .++...|..|.+|+....+++.....+.+||+++-.
T Consensus 580 cGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~-~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~ 658 (732)
T KOG0614|consen 580 CGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG-VDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRD 658 (732)
T ss_pred cCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC-CchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhc
Confidence 99999999995 567799999999999999999999999987 789999999999999888898899999999998665
Q ss_pred CCCCCCC-----HHHHhcCCCCCCCCCcccccCCCCCC
Q 006779 268 PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLP 300 (631)
Q Consensus 268 ~p~~Rps-----a~elL~hpff~~~~~~~~~~~~~~~p 300 (631)
.|.+|.. ..++-+|.||..-+|..+....++.|
T Consensus 659 ~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pP 696 (732)
T KOG0614|consen 659 NPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPP 696 (732)
T ss_pred CcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCC
Confidence 7999886 78999999999999988765544444
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=351.78 Aligned_cols=247 Identities=33% Similarity=0.575 Sum_probs=208.3
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEc-------------
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD------------- 97 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d------------- 97 (631)
++||+||||.||+++++-+|+.+|||+|.+.. +.....++.+|+.+|.+|+|||||+||..|+.
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~ 561 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVAS 561 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccccc
Confidence 57999999999999999999999999998764 45667889999999999999999999988863
Q ss_pred ------------------------------------------C-------------------------------------
Q 006779 98 ------------------------------------------D------------------------------------- 98 (631)
Q Consensus 98 ------------------------------------------~------------------------------------- 98 (631)
.
T Consensus 562 ~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~ 641 (1351)
T KOG1035|consen 562 DSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVI 641 (1351)
T ss_pred chhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccc
Confidence 0
Q ss_pred -------------------------CCCeEEEEEeccCCCCHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhCCCCEE
Q 006779 99 -------------------------TNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNPPII 152 (631)
Q Consensus 99 -------------------------~~~~l~lV~Ey~~gGsL~~~l~~~~~l-~~~~i~~i~~QIl~aL~yLHs~~~~Ii 152 (631)
....+||=||||+..+|++++.++... .....+++++||+.||.|+|++| ||
T Consensus 642 ~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g--iI 719 (1351)
T KOG1035|consen 642 LDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG--II 719 (1351)
T ss_pred cCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc--ee
Confidence 003577889999998999998887655 57889999999999999999999 99
Q ss_pred eccCCCCCeeecCCCCcEEEccccccchhc----------C----------CCCccccCCCCCCCcccccc----ccCcc
Q 006779 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----------Q----------PTARSVIGTPEFMAPELYEE----EYNEL 208 (631)
Q Consensus 153 HrDLKp~NILl~~~~g~vKL~DFGla~~~~----------~----------~~~~~~~GTp~Y~APEvl~~----~ys~~ 208 (631)
||||||.|||++ .++.|||+|||+|+... . ...++.+||.-|+|||++.+ .|+.|
T Consensus 720 HRDLKP~NIFLd-~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K 798 (1351)
T KOG1035|consen 720 HRDLKPRNIFLD-SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK 798 (1351)
T ss_pred eccCCcceeEEc-CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence 999999999998 78899999999997511 0 02345689999999998853 49999
Q ss_pred ccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 006779 209 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 209 sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~--l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~ 285 (631)
+|+|||||+++||+ +||........+...+..+..|.. +....-+.-+.+|..+|+ +|++||||.|||++.||.
T Consensus 799 iDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 799 IDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred hhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 99999999999999 578776677778888887776655 222223567889999998 999999999999999998
Q ss_pred C
Q 006779 286 T 286 (631)
Q Consensus 286 ~ 286 (631)
+
T Consensus 876 p 876 (1351)
T KOG1035|consen 876 P 876 (1351)
T ss_pred c
Confidence 5
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=300.31 Aligned_cols=240 Identities=23% Similarity=0.432 Sum_probs=197.5
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||+|+||.||+|..+ .+..+|+|.+..... ....+.+|+.+|+.++||||+++++++... ..+++||
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~iv~ 78 (256)
T cd05114 7 TFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM-----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ--KPLYIVT 78 (256)
T ss_pred EEeeEecCCcCceEEEEEec-cCceEEEEecccCCc-----cHHHHHHHHHHHHHCCCCCceeEEEEEccC--CCEEEEE
Confidence 66788999999999999775 456799998763321 235688899999999999999999987554 4689999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCC
Q 006779 108 ELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 186 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~ 186 (631)
||+.+|+|.+++... +.+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEc-CCCeEEECCCCCccccCCCce
Confidence 999999999998753 46899999999999999999999998 99999999999998 788999999999875433221
Q ss_pred ---ccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006779 187 ---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 187 ---~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~l 261 (631)
....++..|+|||.+. ..++.++||||||+++|+|++ |+.||.. .+..++...+..+..+. .+...+..+.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~l 233 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK-KSNYEVVEMISRGFRLY-RPKLASMTVYEV 233 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCCC-CCCCCCHHHHHH
Confidence 1223456899999875 458899999999999999999 8999976 45566666776654432 344567889999
Q ss_pred HHHhcC-CCCCCCCHHHHhc
Q 006779 262 IEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 262 I~~cL~-~p~~Rpsa~elL~ 280 (631)
+.+||. +|.+||++.+++.
T Consensus 234 i~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 234 MYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 999998 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=301.39 Aligned_cols=241 Identities=24% Similarity=0.427 Sum_probs=198.5
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEE
Q 006779 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV 106 (631)
+++.+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++.+.+. ..++++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 79 (261)
T cd05072 8 IKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKE--EPIYII 79 (261)
T ss_pred eEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--CCcEEE
Confidence 478899999999999999865 56779999876432 2356789999999999999999999987554 468899
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 107 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
+||+.+|+|.+++.+. ..+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVS-ESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEec-CCCcEEECCCccceecCCC
Confidence 9999999999998753 56889999999999999999999998 99999999999998 7889999999999765432
Q ss_pred C---CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006779 185 T---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 185 ~---~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~ 259 (631)
. .....++..|+|||.+. +.++.++|||||||++|+|+| |..||.. .....+...+..+...+ .....+..+.
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 234 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG-MSNSDVMSALQRGYRMP-RMENCPDELY 234 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCCHHHH
Confidence 2 12234567899999775 458889999999999999998 9999976 44555666666554333 2334678899
Q ss_pred HHHHHhcC-CCCCCCCHHHHhc
Q 006779 260 QFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 260 ~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
++|.+||. +|.+||++.++++
T Consensus 235 ~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 235 DIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 99999998 8999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=301.51 Aligned_cols=240 Identities=28% Similarity=0.447 Sum_probs=198.1
Q ss_pred eEecccCceEEEEEEEcc-CC--eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 31 EILGKGAFKTVYKGFDEV-DG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~-tg--~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
+.||+|++|.||+|.+.. .+ ..||+|.+..... ....+.+.+|+.++++++||||+++++.+.+ ..+++|+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL---SDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCccc---HHHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEE
Confidence 468999999999999865 33 4699999875542 1566789999999999999999999998876 5789999
Q ss_pred eccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC
Q 006779 108 ELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~ 185 (631)
||+.+|+|.+++.+.. .+++..+..++.|++.||.|||+++ ++||||+|+||+++ .++.+||+|||++.......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~-~~~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLA-SDDKVKIGDFGLMRALPQNE 151 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEe-cCCEEEeccccccccccccc
Confidence 9999999999998754 6899999999999999999999998 99999999999998 67999999999987654321
Q ss_pred -----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006779 186 -----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 186 -----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l 258 (631)
.....++..|+|||.+.. .++.++|||||||++|+|++ |+.||... +..++.+.+.........+...+..+
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
T cd05040 152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKIDKEGERLERPEACPQDI 230 (257)
T ss_pred cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcCCcCCCCccCCHHH
Confidence 112346778999997754 58899999999999999998 99999764 45555555553222222334567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhc
Q 006779 259 KQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 259 ~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.+++.+||. +|.+||++.+++.
T Consensus 231 ~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 231 YNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHHCCCCcccCCCHHHHHH
Confidence 999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.25 Aligned_cols=244 Identities=23% Similarity=0.409 Sum_probs=198.4
Q ss_pred eeeeEecccCceEEEEEEEccCCe--EEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCeEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGI--EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~--~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~l~ 104 (631)
++.++||+|+||.||+|.++.+|. .+++|.++.. ......+.+.+|+.++.++ +||||+++++++... ..++
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~ 79 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF---ASENDHRDFAGELEVLCKLGHHPNIINLLGACENR--GYLY 79 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc---CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC--Ccce
Confidence 778999999999999999988775 4688876532 2334556789999999999 799999999987554 4688
Q ss_pred EEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCC
Q 006779 105 MITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 168 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~----------------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g 168 (631)
+|+||+.+|+|.+++.+.. .+++..++.++.||+.||+|||+++ |+||||||+|||++ .++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVG-ENL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEEC-CCC
Confidence 9999999999999997542 4888999999999999999999998 99999999999997 788
Q ss_pred cEEEccccccchhcCCCCcc-ccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCC
Q 006779 169 EVKIGDLGLAIVMQQPTARS-VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI 245 (631)
Q Consensus 169 ~vKL~DFGla~~~~~~~~~~-~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~ 245 (631)
.+||+|||++.......... ...+..|+|||.+.. .++.++|||||||++|+|++ |..||.. .....+...+..+.
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~-~~~~~~~~~~~~~~ 235 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGY 235 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCC
Confidence 99999999986432221111 123457999997754 58899999999999999997 9999976 45566666666554
Q ss_pred CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 246 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 246 ~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.+ ..+...+..+++||.+||. +|.+||++.++++.
T Consensus 236 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RM-EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 32 2345577899999999998 89999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=301.00 Aligned_cols=239 Identities=23% Similarity=0.410 Sum_probs=198.9
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEE
Q 006779 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV 106 (631)
+++.++||+|+||.||+|.. .|..||+|.+... ...+.+.+|+.+++.++|+||+++++++.... ..+++|
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~lv 78 (256)
T cd05082 8 LKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIV 78 (256)
T ss_pred CeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC-CceEEE
Confidence 37789999999999999965 4888999987532 23456889999999999999999999765433 468899
Q ss_pred EeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 107 TELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
+||+.+++|.+++.+.. .+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEc-CCCcEEecCCccceecccc
Confidence 99999999999997654 4889999999999999999999998 99999999999997 7899999999998654332
Q ss_pred CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006779 185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262 (631)
Q Consensus 185 ~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI 262 (631)
. ....++..|+|||++.. .++.++|||||||++|+|++ |+.||.. .+..++...+..+..+ ......++.++++|
T Consensus 156 ~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li 232 (256)
T cd05082 156 Q-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKM-DAPDGCPPVVYDVM 232 (256)
T ss_pred C-CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCCHHHHHHH
Confidence 2 23345668999997754 48899999999999999998 9999975 4666777777665443 34456788999999
Q ss_pred HHhcC-CCCCCCCHHHHhc
Q 006779 263 EKCIV-PASLRLPALELLK 280 (631)
Q Consensus 263 ~~cL~-~p~~Rpsa~elL~ 280 (631)
.+||. +|.+|||+.+++.
T Consensus 233 ~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 233 KQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHhcCChhhCcCHHHHHH
Confidence 99998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.84 Aligned_cols=242 Identities=25% Similarity=0.421 Sum_probs=197.4
Q ss_pred eeeeEecccCceEEEEEEEccCCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~----~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
++.+.||+|+||+||+|.+..+|. .|++|.+... ........+..|+..++.++||||+++++++.. ..+
T Consensus 10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~~~ 83 (279)
T cd05111 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR---SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---ASL 83 (279)
T ss_pred eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc---cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---Ccc
Confidence 667899999999999999988876 4666766422 123445678889999999999999999998743 347
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
++|+||+.+|+|.+++... +.+++..++.|+.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++....
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~-~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLK-SDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEc-CCCcEEEcCCccceecc
Confidence 7899999999999999764 56899999999999999999999998 99999999999997 78899999999997543
Q ss_pred CC----CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006779 183 QP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 183 ~~----~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~ 256 (631)
.. ......++..|+|||.+. +.++.++|||||||++|||++ |..||.+ ..+..+.+.+..+..+. .+...+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 238 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG-MRPHEVPDLLEKGERLA-QPQICTI 238 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcCC-CCCCCCH
Confidence 22 122345677899999775 468999999999999999998 9999976 35555555566554432 3445677
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 257 QVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.+.+++.+||. +|.+||++.|+++
T Consensus 239 ~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 239 DVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHH
Confidence 89999999998 8999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=309.50 Aligned_cols=247 Identities=23% Similarity=0.385 Sum_probs=202.3
Q ss_pred CceeeeeeEecccCceEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEc
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD 97 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d-----~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d 97 (631)
.+| .+.+.||+|+||.||+|.+ ..++..||+|.+.... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 35 ~~~-~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 35 NNL-SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred HHe-EEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC---ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 345 6789999999999999975 3456789999876432 234557789999999999 79999999998865
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccc
Q 006779 98 DTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 175 (631)
. ..+++||||+.+|+|..++.... .+++.++..++.||+.||.|||+++ |+|+||||+|||++ .++.++|+||
T Consensus 111 ~--~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~l~df 185 (302)
T cd05055 111 G--GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLT-HGKIVKICDF 185 (302)
T ss_pred C--CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEc-CCCeEEECCC
Confidence 4 46899999999999999987643 3899999999999999999999998 99999999999997 7889999999
Q ss_pred cccchhcCCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCC
Q 006779 176 GLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPAS 249 (631)
Q Consensus 176 Gla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~ 249 (631)
|++....... .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||........+...+..+..+ .
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~ 264 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM-A 264 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC-C
Confidence 9987543322 11234577899999765 458899999999999999998 999998755555555666555433 2
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 250 LSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 250 l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.+...++.+++||.+||. +|.+||++.+++.
T Consensus 265 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 265 QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 344567899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.34 Aligned_cols=248 Identities=27% Similarity=0.421 Sum_probs=202.4
Q ss_pred CCceeeeeeEecccCceEEEEEEEcc-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeee
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNS 94 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~-------tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~ 94 (631)
.++| .+.+.||+|+||.||+|.+.. ++..+|+|.+.... .......+.+|+.+++.+ +||||++++++
T Consensus 17 ~~~~-~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 17 RDRL-VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred hHHe-EEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC---ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 4677 788999999999999998643 33579999886432 234556788999999999 79999999998
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCC
Q 006779 95 WVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158 (631)
Q Consensus 95 ~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~----------------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp 158 (631)
+... ..+++||||+.+|+|.+++...+ .++...++.++.||+.||+|||+++ ++||||||
T Consensus 93 ~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp 168 (307)
T cd05098 93 CTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAA 168 (307)
T ss_pred EecC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccH
Confidence 8654 46889999999999999997642 4788999999999999999999998 99999999
Q ss_pred CCeeecCCCCcEEEccccccchhcCCC----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCC
Q 006779 159 DNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECK 232 (631)
Q Consensus 159 ~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~ 232 (631)
+|||++ .++.+||+|||++....... .....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||.. .
T Consensus 169 ~Nill~-~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~-~ 246 (307)
T cd05098 169 RNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-V 246 (307)
T ss_pred HheEEc-CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc-C
Confidence 999998 78899999999986543211 111234568999997754 58899999999999999998 8888865 5
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 233 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 233 ~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
+..++...+..+..+ ..+...+.++++||.+||. +|.+||++.+++.+
T Consensus 247 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 247 PVEELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred CHHHHHHHHHcCCCC-CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 667777777665433 3445567899999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=301.68 Aligned_cols=244 Identities=24% Similarity=0.413 Sum_probs=201.1
Q ss_pred eeeeEecccCceEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~t---g~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
++.+.||+|+||+||+|.++.+ ...||+|.+.... .......+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 81 (266)
T cd05033 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS--RPVM 81 (266)
T ss_pred eeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC--CceE
Confidence 7789999999999999998654 4689999876432 344556788999999999999999999987654 4688
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 105 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
+||||+.+++|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.++|+|||++.....
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~-~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCCEEECccchhhcccc
Confidence 999999999999998764 46899999999999999999999998 99999999999998 788999999999976642
Q ss_pred CC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006779 184 PT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 184 ~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~ 257 (631)
.. .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||... ....+...+..+..++ .+...+..
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 236 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM-SNQDVIKAVEDGYRLP-PPMDCPSA 236 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHcCCCCC-CCCCCCHH
Confidence 11 11223467899999776 458899999999999999998 99999764 4455666666553322 23456789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 258 VKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 258 l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
+.+++.+||. +|.+||++.+++++
T Consensus 237 l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 237 LYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=303.36 Aligned_cols=241 Identities=22% Similarity=0.329 Sum_probs=190.3
Q ss_pred EecccCceEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEec
Q 006779 32 ILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 32 ~LG~G~fg~Vy~a~d~--~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey 109 (631)
.||+|+||.||+|.+. .++..+|+|.+.... .......+.+|+.+++.++||||+++++++.+. ..+++||||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 76 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV--TPYLLVMEF 76 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--CCcEEEEEC
Confidence 5899999999999764 456789999886443 233445688899999999999999999988654 458899999
Q ss_pred cCCCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 110 FTSGSLRQYRKKHK-----NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 110 ~~gGsL~~~l~~~~-----~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
+.+|+|.+++.... ..+...++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~-~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLT-ADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEc-CCCcEEECCccccccccCc
Confidence 99999999987532 4567788899999999999999998 99999999999997 6889999999998644322
Q ss_pred C----CccccCCCCCCCcccccc--------ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCC---CC
Q 006779 185 T----ARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK---PA 248 (631)
Q Consensus 185 ~----~~~~~GTp~Y~APEvl~~--------~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~---p~ 248 (631)
. .....+++.|+|||++.. .++.++||||||+++|||++ |+.||............+..... .+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC
Confidence 1 223457888999998753 25789999999999999996 99999875444433333332211 12
Q ss_pred CCCCCCcHHHHHHHHHhcCCCCCCCCHHHHhc
Q 006779 249 SLSKVTDPQVKQFIEKCIVPASLRLPALELLK 280 (631)
Q Consensus 249 ~l~~~~~~~l~~lI~~cL~~p~~Rpsa~elL~ 280 (631)
.+....+..+++++++|+.+|.+|||+.+|+.
T Consensus 234 ~~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~ 265 (269)
T cd05087 234 RLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHL 265 (269)
T ss_pred ccCCCCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence 23334567899999999989999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=309.55 Aligned_cols=252 Identities=25% Similarity=0.421 Sum_probs=200.2
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC-----
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----- 99 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~----- 99 (631)
+| .+.+.||+|+||.||+|.++.+|..||+|.++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 8 ~~-~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 8 KF-DIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE--KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hh-heeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc--ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 44 667899999999999999999999999999876532 1223345778999999999999999999886543
Q ss_pred ---CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccc
Q 006779 100 ---NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 100 ---~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 175 (631)
...+++|+||+.+ +|..++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~kl~df 160 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIKLADF 160 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCcEEeCcc
Confidence 2378999999976 677776654 46999999999999999999999998 99999999999997 7889999999
Q ss_pred cccchhcCCC---CccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc---CCCC
Q 006779 176 GLAIVMQQPT---ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---GIKP 247 (631)
Q Consensus 176 Gla~~~~~~~---~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~---~~~p 247 (631)
|++....... .....+++.|+|||.+.+ .++.++|||||||++|+|++|+.||........ ...+.. +..+
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~ 239 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ-LELISRLCGSPCP 239 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCh
Confidence 9997654322 122346788999997753 378899999999999999999999976433322 222221 1111
Q ss_pred CC-------------------------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 248 AS-------------------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 248 ~~-------------------------l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
.. .....++.++++|.+||. +|.+||++.++|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 10 011347889999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=326.88 Aligned_cols=254 Identities=26% Similarity=0.406 Sum_probs=205.5
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~ 101 (631)
.||-|.+.++||+||.+.||++... +...+|+|++..... +...+.-+..|+.+|.+| .|.+||++|+|-+. ..
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~--D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~ 433 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEA--DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DG 433 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhc--CHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--Cc
Confidence 4555666789999999999999754 345677777655432 566778899999999999 49999999998665 45
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCC-HHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 102 TINMITELFTSGSLRQYRKKHKNVD-MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~-~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
++||||||- ..+|.+++++..... .-.++.+.+|+|.|+.++|.+| |||.||||.|+|+- .|.+||+|||+|..
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV--kG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV--KGRLKLIDFGIANA 508 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE--eeeEEeeeechhcc
Confidence 899999986 469999998876543 3588899999999999999999 99999999999995 78999999999987
Q ss_pred hcCCC----CccccCCCCCCCcccccc------------ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006779 181 MQQPT----ARSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244 (631)
Q Consensus 181 ~~~~~----~~~~~GTp~Y~APEvl~~------------~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~ 244 (631)
+...+ ..+.+||+.||+||.+.. +.++++||||||||||+|+.|+.||....+.-.-+..|+..
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P 588 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDP 588 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCC
Confidence 76654 346799999999996631 14678999999999999999999998755544444455443
Q ss_pred CCCCCCCCCCcHH-HHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 245 IKPASLSKVTDPQ-VKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 245 ~~p~~l~~~~~~~-l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
.....++...++. +.++++.||+ ||.+||+..+||+|||++.
T Consensus 589 ~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 589 NHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 2223444444443 9999999998 9999999999999999986
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=310.44 Aligned_cols=263 Identities=21% Similarity=0.316 Sum_probs=215.8
Q ss_pred CCcccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeee
Q 006779 14 EGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFY 92 (631)
Q Consensus 14 ~~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~ 92 (631)
.-++.+..-+.-|..-.++||-|-.|.|..+.++.||+.+|+|.+.- ..+..+|+++.-.. .|||||.++
T Consensus 51 ~m~~k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D---------s~KARrEVeLHw~~s~h~~iV~Ii 121 (400)
T KOG0604|consen 51 DMDFKEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD---------SPKARREVELHWMASGHPHIVSII 121 (400)
T ss_pred hcchhcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc---------CHHHHhHhhhhhhhcCCCceEEee
Confidence 34456666677775445899999999999999999999999998752 23467888875444 799999999
Q ss_pred eeEEc--CCCCeEEEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeec--CC
Q 006779 93 NSWVD--DTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GN 166 (631)
Q Consensus 93 ~~~~d--~~~~~l~lV~Ey~~gGsL~~~l~~~~~--l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~--~~ 166 (631)
++|.. ....++.+|||.|+||.|...++.++. ++++.+..+++||..|+.|||+.+ |.||||||+|+|+. +.
T Consensus 122 dVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~ 199 (400)
T KOG0604|consen 122 DVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSP 199 (400)
T ss_pred hhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCC
Confidence 98853 234689999999999999999987654 999999999999999999999999 99999999999996 34
Q ss_pred CCcEEEccccccchhcC-CCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCC---HHHHHHHH
Q 006779 167 NGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKV 241 (631)
Q Consensus 167 ~g~vKL~DFGla~~~~~-~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~---~~~i~~~i 241 (631)
|..+||+|||+|+.... ....+.+.||.|.|||++.. +|+..+|+||+|+++|-|++|..||..... ...+..+|
T Consensus 200 na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI 279 (400)
T KOG0604|consen 200 NAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRI 279 (400)
T ss_pred CcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHh
Confidence 56799999999987653 34567788999999999875 599999999999999999999999964322 22344556
Q ss_pred HcCCC--CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 242 TSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 242 ~~~~~--p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
..|.. |..-....+..++++|+++|. +|++|.|..+++.|||+...
T Consensus 280 ~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 280 RTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred hccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 55533 444445567889999999997 99999999999999999764
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=317.93 Aligned_cols=254 Identities=31% Similarity=0.449 Sum_probs=202.3
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC----
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---- 99 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~---- 99 (631)
.|| .+.+.||+|+||.||+|.+..+|..||+|++.... ......+.+.+|+.++++++||||+++++++....
T Consensus 17 ~~y-~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 17 ERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred Cce-EEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 667 56789999999999999999999999999886432 22334567889999999999999999999875432
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
...++++++++ +++|.+++... .+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++.
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~dfg~~~ 168 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLAR 168 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEc-CCCCEEEecccccc
Confidence 23477888887 78998887654 5999999999999999999999998 99999999999997 78899999999987
Q ss_pred hhcCCCCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC-C-----------
Q 006779 180 VMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-I----------- 245 (631)
Q Consensus 180 ~~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~-~----------- 245 (631)
.... ......+++.|+|||++.+ .++.++|||||||++|+|++|+.||........+ ..+... .
T Consensus 169 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 169 HTDD-EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL-KLILRLVGTPGAELLKKIS 246 (345)
T ss_pred cccc-cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHHhhcc
Confidence 5433 2334578999999997754 4788999999999999999999999764332222 211110 0
Q ss_pred -------------CC----CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 246 -------------KP----ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 246 -------------~p----~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.+ .......++.+++||.+||. +|.+||++.++|.||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 00 00111347789999999998 89999999999999999863
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.02 Aligned_cols=248 Identities=26% Similarity=0.410 Sum_probs=203.2
Q ss_pred CCceeeeeeEecccCceEEEEEEEccC-----CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEE
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVD-----GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWV 96 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~t-----g~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~ 96 (631)
.++| ++.+.||+|+||.||+|.+... ...||+|.+.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 11 ~~~~-~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 11 RDRL-TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred HhHe-EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3456 6779999999999999988644 3789999886432 344556789999999999 8999999999885
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCC
Q 006779 97 DDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160 (631)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~l~~~----------------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~N 160 (631)
.. ..+++||||+.+|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 87 ~~--~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~N 162 (293)
T cd05053 87 QE--GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARN 162 (293)
T ss_pred CC--CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceee
Confidence 54 4689999999999999998642 45889999999999999999999998 9999999999
Q ss_pred eeecCCCCcEEEccccccchhcCCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCH
Q 006779 161 IFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNP 234 (631)
Q Consensus 161 ILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~ 234 (631)
||++ .++.+||+|||++..+.... .....++..|+|||++. ..++.++|||||||++|+|++ |..||.. .+.
T Consensus 163 il~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~ 240 (293)
T cd05053 163 VLVT-EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPV 240 (293)
T ss_pred EEEc-CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC-CCH
Confidence 9997 78999999999997654322 11223456799999765 458899999999999999997 9999976 455
Q ss_pred HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 235 AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 235 ~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.+++..+..+..+. .+...+..+.+|+.+||. +|.+|||+.+++.+
T Consensus 241 ~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 241 EELFKLLKEGYRME-KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 66677666654433 334567899999999998 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.38 Aligned_cols=245 Identities=24% Similarity=0.392 Sum_probs=199.4
Q ss_pred CCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC
Q 006779 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~ 100 (631)
-|.+|| ++.+.||+|+||.||+|.+..++ .||+|.+..... ..+.+.+|+.+++.++||||+++++.+..
T Consensus 3 ~~~~~~-~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--- 72 (262)
T cd05071 3 IPRESL-RLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--- 72 (262)
T ss_pred CChHHe-eEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCcceEEEEECC---
Confidence 356777 88999999999999999887664 599999874322 22468899999999999999999997632
Q ss_pred CeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 101 RTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
...++||||+.+|+|.+++.+. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++ .++.+||+|||.+
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~-~~~~~~L~dfg~~ 149 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLA 149 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEc-CCCcEEeccCCce
Confidence 3478999999999999999764 45899999999999999999999998 99999999999997 7889999999999
Q ss_pred chhcCCCC---ccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006779 179 IVMQQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 179 ~~~~~~~~---~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~ 253 (631)
........ ....++..|+|||... ..++.++|||||||++|+|+| |..||... ....+...+..+..+ .....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~ 227 (262)
T cd05071 150 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRM-PCPPE 227 (262)
T ss_pred eeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-ChHHHHHHHhcCCCC-CCccc
Confidence 75543321 2234567899999765 458999999999999999999 88888764 455555665554332 23345
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 254 TDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 254 ~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.+..+.++|.+||+ +|.+||++.+++.
T Consensus 228 ~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 228 CPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 67889999999998 8999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.81 Aligned_cols=245 Identities=24% Similarity=0.389 Sum_probs=197.4
Q ss_pred eeeeeEecccCceEEEEEEEccCCeE--EEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCeE
Q 006779 27 GRYDEILGKGAFKTVYKGFDEVDGIE--VAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~tg~~--VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~l 103 (631)
+.+.+.||+|+||.||+|.++.+|.. +|+|.+... ........+.+|+.++.++ +||||+++++++... ..+
T Consensus 9 ~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~--~~~ 83 (303)
T cd05088 9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYL 83 (303)
T ss_pred ceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc---CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC--CCc
Confidence 37789999999999999999888854 566665421 2345567788999999999 899999999988554 468
Q ss_pred EEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCC
Q 006779 104 NMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 167 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~----------------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~ 167 (631)
++||||+.+|+|.+++.+.+ .+++..++.++.||+.||+|||+++ ++||||||+|||++ .+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~-~~ 160 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-EN 160 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEec-CC
Confidence 99999999999999997542 5789999999999999999999998 99999999999997 78
Q ss_pred CcEEEccccccchhcCCC-CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcC
Q 006779 168 GEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244 (631)
Q Consensus 168 g~vKL~DFGla~~~~~~~-~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~ 244 (631)
+.+||+|||++....... .....+++.|+|||.+.. .++.++|||||||++|+|+| |..||.. .+..+....+..+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~ 239 (303)
T cd05088 161 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQG 239 (303)
T ss_pred CcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc-CChHHHHHHHhcC
Confidence 899999999985332111 111234567999997754 47899999999999999998 9999975 4455666666554
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 245 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 245 ~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
..+ ..+...++.+.+||.+||+ +|.+||++.++|.+
T Consensus 240 ~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 240 YRL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CcC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 322 2233457889999999998 89999999999886
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=299.71 Aligned_cols=243 Identities=25% Similarity=0.413 Sum_probs=199.3
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.+| ++.+.||+|++|.||+|.+. .+..||+|.+..... ..+.+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~-~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 76 (261)
T cd05068 6 TSI-QLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM-----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE--EPI 76 (261)
T ss_pred hhe-eeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc-----cHHHHHHHHHHHHHCCCCCccceeEEEecC--CCe
Confidence 344 78899999999999999875 457899999864432 234578899999999999999999987654 468
Q ss_pred EEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 104 NMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
++||||+.+++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVG-ENNICKVADFGLARVI 153 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEc-CCCCEEECCcceEEEc
Confidence 89999999999999997654 6899999999999999999999998 99999999999998 7889999999999766
Q ss_pred cCCCCccccC---CCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006779 182 QQPTARSVIG---TPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 182 ~~~~~~~~~G---Tp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~ 256 (631)
.........| +..|+|||.+.. .++.++||||||+++|+|+| |+.||.+ .+...+...+...... ..+...+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (261)
T cd05068 154 KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG-MTNAEVLQQVDQGYRM-PCPPGCPK 231 (261)
T ss_pred cCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCcCCH
Confidence 5332222222 357999997754 58899999999999999999 9999976 4555566666554332 23445678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 257 QVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.+++++.+||. +|.+||++.+++.
T Consensus 232 ~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 232 ELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHHhhcCcccCCCHHHHHH
Confidence 99999999998 8999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=306.53 Aligned_cols=249 Identities=28% Similarity=0.446 Sum_probs=203.1
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||+|++|.||+|.+..+|+.+++|.+..... .......+.+|+.+|+.++||||+++++++.+. ..+++|+
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 77 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE--SEGIPKTALREIKLLKELNHPNIIKLLDVFRHK--GDLYLVF 77 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCcchHHHhhccC--CCEEEEE
Confidence 456789999999999999999999999999875432 223456788999999999999999999988655 5688999
Q ss_pred eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC-
Q 006779 108 ELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~- 185 (631)
||+.+ +|.+++.. ...+++..+..++.||+.||.|||+++ |+|+||+|+||+++ .++.++|+|||.+.......
T Consensus 78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLIN-TEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEEC-CCCcEEEeeeeeeEecCCCcc
Confidence 99975 88887766 467999999999999999999999999 99999999999998 78899999999987654432
Q ss_pred -CccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--C------------
Q 006779 186 -ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--A------------ 248 (631)
Q Consensus 186 -~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--~------------ 248 (631)
.....++..|+|||.+.+ .++.++||||||+++|+|+||+.||.......++.........+ .
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 223467889999997653 47899999999999999999999997755544443333221110 0
Q ss_pred -------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 249 -------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 249 -------------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
......+..+++||.+||. +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0112346789999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=299.90 Aligned_cols=241 Identities=22% Similarity=0.397 Sum_probs=202.5
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
+.+++.+.||+|+||.||+|... |..||+|.+.... ....++.+|+.+++.++|+||+++++++.+ ...++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 76 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS-----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLY 76 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccch-----hHHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeE
Confidence 34477899999999999999764 8999999986442 245778999999999999999999998865 34688
Q ss_pred EEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 105 MITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
+||||+.+++|.+++.... .+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||.+....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~-~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVS-EDLVAKVSDFGLAKEAS 153 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEe-CCCCEEEcccccccccc
Confidence 9999999999999998765 6999999999999999999999999 99999999999997 78899999999997653
Q ss_pred CCCCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006779 183 QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 183 ~~~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~ 260 (631)
.... ...++..|+|||.+. +.++.++||||||+++|+|++ |..||.. .+...+...+..+..+ ..+...++.+.+
T Consensus 154 ~~~~-~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 230 (256)
T cd05039 154 QGQD-SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPHVEKGYRM-EAPEGCPPEVYK 230 (256)
T ss_pred cccc-cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCC-CCccCCCHHHHH
Confidence 3222 233466799999765 458889999999999999997 9999976 4566666666655433 334556789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhc
Q 006779 261 FIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 261 lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+|.+||. +|.+||++.+++.
T Consensus 231 li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 231 VMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHhccChhhCcCHHHHHH
Confidence 9999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.03 Aligned_cols=248 Identities=28% Similarity=0.399 Sum_probs=200.9
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCceeeeeeEEcCCCCeEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~l~lV 106 (631)
++.+.||+|++|+||+|.+..+++.|++|++..... . .......+|+..++.++ ||||+++++++.+ ....++|
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv 76 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--S-WEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFV 76 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEE
Confidence 677899999999999999999999999998864321 1 22234567999999999 9999999998866 3578999
Q ss_pred EeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 107 TELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
|||+ +|+|.+++.... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++ .++.++|+|||++......
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~-~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVS-GPEVVKIADFGLAREIRSR 152 (283)
T ss_pred EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEc-CCCCEEEeecccceeccCC
Confidence 9999 789999887764 7899999999999999999999998 99999999999998 7899999999999765443
Q ss_pred -CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--------------
Q 006779 185 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-------------- 247 (631)
Q Consensus 185 -~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p-------------- 247 (631)
......++..|+|||++.. .++.++|+||||+++++|++|+.||..........+.......+
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 153 PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 2234568899999997743 47899999999999999999999997755444443322210000
Q ss_pred ----------C---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 248 ----------A---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 248 ----------~---~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
. .+....+..+++||.+||. +|.+||++.|++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0 0011225789999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=306.37 Aligned_cols=243 Identities=26% Similarity=0.401 Sum_probs=199.6
Q ss_pred eeeeeEecccCceEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 27 GRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~-----~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
+.+.+.||+|+||.||+|.+. .++..|++|.+... .......+.+|+.+++.++||||+++++++... .
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 80 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG--D 80 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc----cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC--C
Confidence 377899999999999999854 35677999887533 234456788999999999999999999988654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC
Q 006779 102 TINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 165 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~----------------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~ 165 (631)
.+++||||+.+++|.+++..++ .+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~- 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVG- 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc-
Confidence 6899999999999999997643 3789999999999999999999998 99999999999998
Q ss_pred CCCcEEEccccccchhcCCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHH
Q 006779 166 NNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYK 239 (631)
Q Consensus 166 ~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~ 239 (631)
.++.++|+|||++....... .....+++.|+|||.+. ..++.++|||||||++|+|+| |..||... +......
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-~~~~~~~ 236 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL-SNTEVIE 236 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHH
Confidence 78899999999986543321 22345678899999765 458899999999999999999 99998763 4555556
Q ss_pred HHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 240 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 240 ~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.+..+..+ ......+..++++|.+||. +|.+||++.++++
T Consensus 237 ~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 237 CITQGRVL-ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHhCCCCC-CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 66555433 2345567899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.95 Aligned_cols=242 Identities=23% Similarity=0.404 Sum_probs=198.9
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEE
Q 006779 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV 106 (631)
+++.+.||+|+||.||+|.++ ++..+|+|.+..... ....+.+|+.+++.++||||+++++++... ..+++|
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 77 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ--RPIFIV 77 (256)
T ss_pred cchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCC--CceEEE
Confidence 367889999999999999876 567899998753321 124577899999999999999999987544 468999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC
Q 006779 107 TELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~ 185 (631)
|||+.+++|.+++..+ ..+++..+..++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEEC-CCCcEEECCcccceeccccc
Confidence 9999999999998764 46899999999999999999999999 99999999999997 78999999999986554332
Q ss_pred Cccc---cCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006779 186 ARSV---IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 186 ~~~~---~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~ 260 (631)
.... .++..|+|||.+. ..++.++||||||+++|+|++ |..||.. ....++...+..+..+ ..+...+..+.+
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER-FSNSEVVESVSAGYRL-YRPKLAPTEVYT 232 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHHHcCCcC-CCCCCCCHHHHH
Confidence 2222 2345799999775 458899999999999999999 8999976 4456666666665433 334567899999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcC
Q 006779 261 FIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 261 lI~~cL~-~p~~Rpsa~elL~h 281 (631)
++.+||. +|.+||++.+++..
T Consensus 233 li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 233 IMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHHH
Confidence 9999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=303.09 Aligned_cols=241 Identities=22% Similarity=0.355 Sum_probs=190.0
Q ss_pred EecccCceEEEEEEEcc--CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEec
Q 006779 32 ILGKGAFKTVYKGFDEV--DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 32 ~LG~G~fg~Vy~a~d~~--tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey 109 (631)
.||+|+||.||+|.... ....+|+|.+.... .......+.+|+..++.++||||+++++.+... ..+++||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~--~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA---TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES--IPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC---ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC--CceEEEEEe
Confidence 58999999999996432 45678888765332 344456688999999999999999999988654 468999999
Q ss_pred cCCCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 110 FTSGSLRQYRKKHK-----NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 110 ~~gGsL~~~l~~~~-----~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
+.+|+|.+++.... ..++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLT-ADLSVKIGDYGLALEQYPE 153 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEec-CCCcEEEeccccccccccc
Confidence 99999999997643 2467888999999999999999998 99999999999998 7889999999998643221
Q ss_pred ----CCccccCCCCCCCcccccc--------ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCC---CC
Q 006779 185 ----TARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK---PA 248 (631)
Q Consensus 185 ----~~~~~~GTp~Y~APEvl~~--------~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~---p~ 248 (631)
......+++.|+|||++.. .++.++|||||||++|+|++ |..||....+...+...+..+.. .+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence 1123345778999997632 36789999999999999999 78899775444444444443322 22
Q ss_pred CCCCCCcHHHHHHHHHhcCCCCCCCCHHHHhc
Q 006779 249 SLSKVTDPQVKQFIEKCIVPASLRLPALELLK 280 (631)
Q Consensus 249 ~l~~~~~~~l~~lI~~cL~~p~~Rpsa~elL~ 280 (631)
.+....+..+++++..|+.+|.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~ 265 (269)
T cd05042 234 QLDLKYSDRWYEVMQFCWLDPETRPTAEEVHE 265 (269)
T ss_pred cccccCCHHHHHHHHHHhcCcccccCHHHHHH
Confidence 34445778899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=303.23 Aligned_cols=246 Identities=25% Similarity=0.436 Sum_probs=203.6
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
|...| ++.++||.|+||.||+|.+.. +..||+|.+.... ......+.+|+.+++.++||||+++++++.+. .
T Consensus 4 ~~~~y-~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 75 (261)
T cd05148 4 PREEF-TLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD----LLKQQDFQKEVQALKRLRHKHLISLFAVCSVG--E 75 (261)
T ss_pred cHHHH-HHhhhhccCCCccEEEeEecC-CCcEEEEeccccc----hhhHHHHHHHHHHHhcCCCcchhheeeeEecC--C
Confidence 44445 678999999999999999987 8999999986442 33456688999999999999999999987654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 102 TINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
.+++||||+.+++|.+++... ..+++..+..|+.||+.||.|||+++ ++||||+|+|||++ .++.+||+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~-~~~~~kl~d~g~~~ 152 (261)
T cd05148 76 PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVG-EDLVCKVADFGLAR 152 (261)
T ss_pred CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEc-CCceEEEccccchh
Confidence 688999999999999999753 46899999999999999999999998 99999999999997 78899999999997
Q ss_pred hhcCCC--CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006779 180 VMQQPT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 180 ~~~~~~--~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~ 255 (631)
...... .....+++.|+|||.+. ..++.++||||||+++|+|++ |+.||.. .+..+++..+..+..+ ..+...+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 230 (261)
T cd05148 153 LIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG-MNNHEVYDQITAGYRM-PCPAKCP 230 (261)
T ss_pred hcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHHhCCcC-CCCCCCC
Confidence 654332 12334567899999775 458899999999999999998 8999976 4455566666654333 2345667
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 256 PQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+.+.++|.+||. +|.+|||+.+++.
T Consensus 231 ~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 231 QEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=303.24 Aligned_cols=246 Identities=23% Similarity=0.349 Sum_probs=203.8
Q ss_pred ceeeeeeEecccCceEEEEEEEcc----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEV----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~----tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~ 100 (631)
|| ++.++||+|+||.||+|.+.. ++..|++|.+... ........+.+|+.+|+.++||||+++++++... .
T Consensus 7 ~~-~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~ 81 (280)
T cd05043 7 RV-TLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH---ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-G 81 (280)
T ss_pred he-EEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-C
Confidence 45 788999999999999999876 3688999987532 2455677889999999999999999999987654 3
Q ss_pred CeEEEEEeccCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEE
Q 006779 101 RTINMITELFTSGSLRQYRKKH--------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~--------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL 172 (631)
...+++++|+.+|+|..++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~-~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID-EELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEc-CCCcEEE
Confidence 4678899999999999998764 45889999999999999999999998 99999999999997 7889999
Q ss_pred ccccccchhcCCC----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCC
Q 006779 173 GDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 246 (631)
Q Consensus 173 ~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~ 246 (631)
+|||+++.+.... .....++..|+|||.+.. .++.++|||||||++|+|++ |+.||.. .++..+...+..+..
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~ 237 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE-IDPFEMAAYLKDGYR 237 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc-CCHHHHHHHHHcCCC
Confidence 9999997553321 122345667999997754 48899999999999999999 9999976 466777777766544
Q ss_pred CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 247 PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 247 p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+. .....++.+++++.+||. +|++||++.+++.
T Consensus 238 ~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 238 LA-QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 33 234467899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=309.10 Aligned_cols=247 Identities=30% Similarity=0.556 Sum_probs=205.2
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEecc
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~ 110 (631)
..||+|+||.||+|.+..+|..||+|++... .......+.+|+.+++.++||||+++++.+... ...++||||+
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~ 99 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVVMEFL 99 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc----chhHHHHHHHHHHHHHhcCCcchhheeeEEEeC--CEEEEEEecC
Confidence 5799999999999999999999999987543 234456789999999999999999999988764 4789999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC--CCcc
Q 006779 111 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARS 188 (631)
Q Consensus 111 ~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--~~~~ 188 (631)
.+++|.+++.. ..+++..++.++.|++.||+|||+++ ++||||+|+||+++ .++.++|+|||++...... ....
T Consensus 100 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~-~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 100 EGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEcccccceecccccccccc
Confidence 99999998754 46899999999999999999999998 99999999999998 7889999999988654332 2234
Q ss_pred ccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCcHHHHHHHHHhc
Q 006779 189 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 189 ~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~-~l~~~~~~~l~~lI~~cL 266 (631)
..|++.|+|||.+.. .++.++|+||||+++|+|++|..||.. .........+.....+. ......++.+.++|.+||
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 254 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLL 254 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHH
Confidence 568999999997754 578899999999999999999999976 34444444444433221 122345788999999999
Q ss_pred C-CCCCCCCHHHHhcCCCCCCCC
Q 006779 267 V-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 267 ~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
. +|.+||++.++|.||||....
T Consensus 255 ~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 255 VRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred hCCcccCcCHHHHhcChHHhccC
Confidence 8 899999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.24 Aligned_cols=249 Identities=25% Similarity=0.360 Sum_probs=197.2
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCC--------------eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDG--------------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg--------------~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~Hpn 87 (631)
|..|| ++.+.||+|+||.||+|.+..++ ..||+|.+.... .....+.+.+|+++|+.++|||
T Consensus 3 ~~~~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~ 78 (295)
T cd05097 3 PRQQL-RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV---TKTARNDFLKEIKIMSRLKNPN 78 (295)
T ss_pred chHhC-eehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCC
Confidence 55677 78899999999999999876432 458999886431 3455677999999999999999
Q ss_pred ceeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecc
Q 006779 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRD 155 (631)
Q Consensus 88 IVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~------------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrD 155 (631)
|+++++++... ..+++||||+.+++|.+++.... .+++..+..++.|++.||.|||+++ ++|||
T Consensus 79 i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~d 154 (295)
T cd05097 79 IIRLLGVCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRD 154 (295)
T ss_pred cCeEEEEEcCC--CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccc
Confidence 99999988654 46889999999999999986532 3688899999999999999999998 99999
Q ss_pred CCCCCeeecCCCCcEEEccccccchhcCCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh--cCCCC
Q 006779 156 LKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT--CEYPY 228 (631)
Q Consensus 156 LKp~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt--G~~Pf 228 (631)
|||+||+++ .++.+||+|||++....... .....+++.|+|||.+. +.++.++|||||||++|+|++ +..||
T Consensus 155 lkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~ 233 (295)
T cd05097 155 LATRNCLVG-NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233 (295)
T ss_pred cChhhEEEc-CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 999999997 78899999999986543221 12234567899999764 558999999999999999988 67788
Q ss_pred CCCCCHHHHHHHHHc------CCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 229 NECKNPAQIYKKVTS------GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 229 ~~~~~~~~i~~~i~~------~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
... +..++...+.. .......+...++.+++||.+||. +|.+||++.++++
T Consensus 234 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 234 SLL-SDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ccc-ChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 763 33444333321 111122344567899999999998 8999999999865
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=299.99 Aligned_cols=241 Identities=24% Similarity=0.428 Sum_probs=197.9
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||+|+||+||+|.+.. +..||+|.+..... ..+.+.+|+.+++.++||||+++++++... ..+++||
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd05113 7 TFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ--RPIYIVT 78 (256)
T ss_pred EEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc-----cHHHHHHHHHHHhcCCCCCeeeEEEEEccC--CCcEEEE
Confidence 777899999999999997654 45699998864321 235688999999999999999999988544 4688999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCC
Q 006779 108 ELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 186 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~ 186 (631)
||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ ++|+||||+|||++ .++.+||+|||.+........
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCCEEECCCccceecCCCce
Confidence 999999999999764 46899999999999999999999998 99999999999997 788999999999865433321
Q ss_pred c---cccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006779 187 R---SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 187 ~---~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~l 261 (631)
. ...++..|+|||.+. ..++.++|||||||++|+|++ |..||... +...+...+..+..+ ..+...+..++++
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 233 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF-NNSETVEKVSQGLRL-YRPHLASEKVYAI 233 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHhcCCCC-CCCCCCCHHHHHH
Confidence 1 123456799999875 458899999999999999998 99999764 455566666655433 2344567899999
Q ss_pred HHHhcC-CCCCCCCHHHHhcC
Q 006779 262 IEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 262 I~~cL~-~p~~Rpsa~elL~h 281 (631)
+.+||. +|.+||++.+++.+
T Consensus 234 i~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 234 MYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHcCCCcccCCCHHHHHHh
Confidence 999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=309.07 Aligned_cols=249 Identities=26% Similarity=0.413 Sum_probs=202.3
Q ss_pred CCCCceeeeeeEecccCceEEEEEEEc-------cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeee
Q 006779 21 DPSCRYGRYDEILGKGAFKTVYKGFDE-------VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFY 92 (631)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~a~d~-------~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~ 92 (631)
.|.+|| .+.+.||+|+||.||+|.+. ..+..||+|.+.... .......+.+|+.+++.+ +||||++++
T Consensus 9 ~~~~~~-~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 9 FPRDRL-VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA---TDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred ccHHHe-eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC---ChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 455777 67899999999999999763 235679999876432 345567788999999999 699999999
Q ss_pred eeEEcCCCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccC
Q 006779 93 NSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156 (631)
Q Consensus 93 ~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~----------------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDL 156 (631)
+++.+. ..+++||||+.+|+|.+++... ..++...+..++.||+.||.|||+++ ++||||
T Consensus 85 ~~~~~~--~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dl 160 (314)
T cd05099 85 GVCTQE--GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDL 160 (314)
T ss_pred EEEccC--CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccc
Confidence 988654 4689999999999999999753 34888999999999999999999998 999999
Q ss_pred CCCCeeecCCCCcEEEccccccchhcCCC----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCC
Q 006779 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNE 230 (631)
Q Consensus 157 Kp~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~ 230 (631)
||+|||++ .++.+||+|||++....... .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||..
T Consensus 161 kp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 161 AARNVLVT-EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred cceeEEEc-CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence 99999997 78899999999997554321 112234567999997654 58899999999999999999 8899976
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 231 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 231 ~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.+...++..+..+..+ ..+...+..++++|.+||. +|.+||++.+++.
T Consensus 240 -~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 240 -IPVEELFKLLREGHRM-DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred -CCHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 5566677776665433 2344567789999999998 8999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=300.03 Aligned_cols=242 Identities=22% Similarity=0.377 Sum_probs=194.3
Q ss_pred eEecccCceEEEEEEEcc---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 31 EILGKGAFKTVYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~---tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
+.||+|+||.||+|.+.. .+..||+|.+... ......+.+.+|+.+++.++||||+++++++...+ ...++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI---TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE-GSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc---CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC-CCcEEEE
Confidence 468999999999998754 3468999987532 23455678889999999999999999999776433 3577999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC-
Q 006779 108 ELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~- 185 (631)
||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++.......
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~-~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCccccccccCCcc
Confidence 999999999999764 45678888999999999999999998 99999999999997 78899999999986543221
Q ss_pred -----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006779 186 -----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 186 -----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG-~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l 258 (631)
.....+++.|+|||.+. ..++.++|||||||++|||++| ..||.. .+...+...+..+..+. .+...+..+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VDSFDITVYLLQGRRLL-QPEYCPDPL 231 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCHHH
Confidence 12334577899999765 4588999999999999999995 455554 56666666666654332 334557889
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 259 KQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 259 ~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.+++.+||. +|.+||++.+++..
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999998 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=299.52 Aligned_cols=244 Identities=25% Similarity=0.409 Sum_probs=197.9
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
|.+|| ++.+.||+|++|.||+|.+..++ .||+|.+..... ..+.+.+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~~~-~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~ 73 (260)
T cd05069 4 PRESL-RLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM-----MPEAFLQEAQIMKKLRHDKLVPLYAVVSE---E 73 (260)
T ss_pred ChHHe-eeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc-----cHHHHHHHHHHHHhCCCCCeeeEEEEEcC---C
Confidence 44666 78899999999999999876554 699998764321 23567889999999999999999987632 3
Q ss_pred eEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 102 TINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
..++||||+.+|+|.+++.+.. .+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~-~~~~~~l~dfg~~~ 150 (260)
T cd05069 74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVG-DNLVCKIADFGLAR 150 (260)
T ss_pred CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCeEEECCCccce
Confidence 5789999999999999997643 4789999999999999999999998 99999999999997 78899999999997
Q ss_pred hhcCCCC---ccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006779 180 VMQQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 180 ~~~~~~~---~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 254 (631)
....... ....++..|+|||... ..++.++||||||+++|+|+| |+.||.+. ........+..+..+ ..+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~ 228 (260)
T cd05069 151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-VNREVLEQVERGYRM-PCPQGC 228 (260)
T ss_pred EccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCccc
Confidence 5543221 2234567899999765 458899999999999999999 99999874 444555556554333 234456
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 255 DPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+..++++|.+||. +|.+||++.++++
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 229 PESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 7899999999998 8999999998865
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=300.73 Aligned_cols=246 Identities=24% Similarity=0.412 Sum_probs=201.0
Q ss_pred CceeeeeeEecccCceEEEEEEEccCC---eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg---~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~ 100 (631)
++| ++.+.||+|+||.||+|.+..++ ..+|+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 77 (267)
T cd05066 4 SCI-KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-- 77 (267)
T ss_pred HHe-EeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--
Confidence 356 78899999999999999986554 479999876432 234567789999999999999999999988644
Q ss_pred CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 101 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
..+++||||+.+++|.+++.+. +.+++..+..++.|++.||.|||+++ ++||||||+|||++ .++.++|+|||++.
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~-~~~~~~l~dfg~~~ 154 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVN-SNLVCKVSDFGLSR 154 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEEC-CCCeEEeCCCCccc
Confidence 4689999999999999999765 46899999999999999999999998 99999999999997 78899999999987
Q ss_pred hhcCCCC-----ccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006779 180 VMQQPTA-----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 180 ~~~~~~~-----~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~ 252 (631)
....... ....+++.|+|||.+.+ .++.++|+||||+++|+|++ |..||.+. ...+....+..+..++ .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~ 232 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM-SNQDVIKAIEEGYRLP-APM 232 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC-CHHHHHHHHhCCCcCC-CCC
Confidence 5543211 11223568999998764 68999999999999999886 99999764 4555666666654332 233
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 253 VTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 253 ~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
..++.+++++.+||. +|.+||++.+++.
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 233 DCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 467889999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=325.72 Aligned_cols=257 Identities=28% Similarity=0.458 Sum_probs=214.8
Q ss_pred CCCceeee-eeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC
Q 006779 22 PSCRYGRY-DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 22 p~gRy~r~-~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~ 100 (631)
-..-|+.+ .|+||.|.||+||-|+++.+|+.||+|.|...... ......+..|+.+|+.++||.||.+-..|...
T Consensus 560 ~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp--~kqesqlR~EVaILq~l~HPGiV~le~M~ET~-- 635 (888)
T KOG4236|consen 560 ISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFP--TKQESQLRNEVAILQNLHHPGIVNLECMFETP-- 635 (888)
T ss_pred HHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCC--CchHHHHHHHHHHHHhcCCCCeeEEEEeecCC--
Confidence 34456554 38899999999999999999999999999876543 33447799999999999999999999877544
Q ss_pred CeEEEEEeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCC--CcEEEccccc
Q 006779 101 RTINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN--GEVKIGDLGL 177 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~-~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~--g~vKL~DFGl 177 (631)
..++.|||-+.|.=|.-++. ..+++++...+.++.||+.||.|||-++ |+|+||||+|||+.... -++||||||+
T Consensus 636 ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGf 713 (888)
T KOG4236|consen 636 ERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGF 713 (888)
T ss_pred ceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccc
Confidence 57999999997654544444 3478999999999999999999999999 99999999999997432 2799999999
Q ss_pred cchhcCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCC
Q 006779 178 AIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSKV 253 (631)
Q Consensus 178 a~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~--~~p~~l~~~ 253 (631)
|+.+... ..++++|||.|+|||++.. +|+..-|+||.|+|+|.-+.|..||++..+ |-..|... ..|+...+-
T Consensus 714 ARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd---IndQIQNAaFMyPp~PW~e 790 (888)
T KOG4236|consen 714 ARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED---INDQIQNAAFMYPPNPWSE 790 (888)
T ss_pred eeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc---hhHHhhccccccCCCchhh
Confidence 9987654 5778999999999998864 699999999999999999999999987543 33444332 345555666
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 254 ~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.++++.+||..+|+ +-.+|.|.+..|.|||++..
T Consensus 791 is~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 791 ISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred cCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 78999999999997 89999999999999999874
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.12 Aligned_cols=251 Identities=31% Similarity=0.512 Sum_probs=203.3
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccC-CHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~-~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
|| .+.+.||+|+||.||+|.+..++..+++|.++...... .......+..|+.+++.++||||+++++++.+.. ..
T Consensus 1 ~y-~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 77 (260)
T cd08222 1 RY-ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD--AF 77 (260)
T ss_pred Cc-eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC--ce
Confidence 56 67899999999999999998887777666654322211 2233455778999999999999999999886553 58
Q ss_pred EEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 104 NMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~----~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
++|+||+.+++|..++.. ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++ ++.++|+|||++.
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~--~~~~~l~d~g~~~ 153 (260)
T cd08222 78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLK--NNLLKIGDFGVSR 153 (260)
T ss_pred EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEee--cCCEeecccCcee
Confidence 899999999999988753 356899999999999999999999998 99999999999996 4679999999986
Q ss_pred hhcCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006779 180 VMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 180 ~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~ 256 (631)
..... ......|++.|+|||.+.+ .++.++|+||||+++|+|++|..||... ........+..+.. +.++...+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~ 231 (260)
T cd08222 154 LLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ-NFLSVVLRIVEGPT-PSLPETYSR 231 (260)
T ss_pred ecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHcCCC-CCCcchhcH
Confidence 55332 2234568899999997654 5788999999999999999999999753 44444445544433 334556778
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 257 QVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
.+.++|.+||. +|.+||++.+++.||||
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 232 QLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 99999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.77 Aligned_cols=257 Identities=28% Similarity=0.402 Sum_probs=202.2
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC--
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-- 100 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~-- 100 (631)
..|| .+.+.||+|+||.||+|.+..+|..||+|.+..... .......+.+|+.+++.++||||+++++++.....
T Consensus 14 ~~~y-~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 14 PERY-TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ--SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred ccce-EEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc--cccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 3577 567899999999999999999999999999864321 22334568899999999999999999998864422
Q ss_pred --CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 101 --RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 101 --~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
..+++|+||+. .+|..++ ...+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~-~~~~~kL~dfg~~ 164 (342)
T cd07879 91 EFQDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVN-EDCELKILDFGLA 164 (342)
T ss_pred CCceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCCCC
Confidence 35789999996 4777765 346899999999999999999999998 99999999999998 7899999999998
Q ss_pred chhcCCCCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCC-----------
Q 006779 179 IVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI----------- 245 (631)
Q Consensus 179 ~~~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~----------- 245 (631)
..... ......+++.|+|||.+.+ .++.++|||||||++|+|++|+.||.+......+...+....
T Consensus 165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 165 RHADA-EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred cCCCC-CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 65432 2234567899999998754 478899999999999999999999986432322222111000
Q ss_pred ----------CC----CC---CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 246 ----------KP----AS---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 246 ----------~p----~~---l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
.+ .. .....++.+++||.+||+ +|.+||++.++|.||||.....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00 00 012346789999999998 8999999999999999987543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=304.64 Aligned_cols=243 Identities=26% Similarity=0.419 Sum_probs=199.0
Q ss_pred eeeeEecccCceEEEEEEEcc-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 28 RYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~-----tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
++.++||+|+||.||+|.+.. ....|++|.+.... .......+.+|+.+++.++||||+++++.+... ..
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 77 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD--GP 77 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CC
Confidence 677899999999999998753 23678888876432 234567799999999999999999999987654 45
Q ss_pred EEEEEeccCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCC
Q 006779 103 INMITELFTSGSLRQYRKKH------------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~------------------------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp 158 (631)
.++++||+.+|+|.+++... ..+++..+..++.|++.||.|||+++ ++||||||
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp 155 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAA 155 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhh
Confidence 78899999999999998642 24788999999999999999999998 99999999
Q ss_pred CCeeecCCCCcEEEccccccchhcCCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCC
Q 006779 159 DNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECK 232 (631)
Q Consensus 159 ~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~ 232 (631)
+|||++ +++.+||+|||++....... .....++..|+|||.+. ..++.++||||||+++|+|+| |..||.+ .
T Consensus 156 ~nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~ 233 (290)
T cd05045 156 RNVLVA-EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG-I 233 (290)
T ss_pred heEEEc-CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC-C
Confidence 999997 78899999999986543221 12234567899999764 458899999999999999999 9999976 5
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 233 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 233 ~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.+..+...+..+..+. .+...+..+++||.+||+ +|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 234 APERLFNLLKTGYRME-RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CHHHHHHHHhCCCCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 6777777777654433 345567899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=303.32 Aligned_cols=243 Identities=25% Similarity=0.407 Sum_probs=198.7
Q ss_pred eeeeeEecccCceEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 27 GRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d-----~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
+++.+.||+|+||.||+|.. ..++..+|+|.+... .......+.+|+++++.++||||+++++++.+. .
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 80 (280)
T cd05092 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTVLQHQHIVRFYGVCTEG--R 80 (280)
T ss_pred ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC--C
Confidence 36789999999999999974 345778999987532 345567899999999999999999999988664 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC
Q 006779 102 TINMITELFTSGSLRQYRKKHK---------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 166 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~---------------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~ 166 (631)
.++++|||+.+|+|.+++..++ .+++..++.++.||+.||.|||+++ ++||||||+|||++ .
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~-~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVG-Q 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEc-C
Confidence 5889999999999999997653 4789999999999999999999998 99999999999997 7
Q ss_pred CCcEEEccccccchhcCCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHH
Q 006779 167 NGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKK 240 (631)
Q Consensus 167 ~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~ 240 (631)
++.+||+|||++....... .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||... ........
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~~ 236 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL-SNTEAIEC 236 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC-CHHHHHHH
Confidence 8899999999986543221 12234578899999765 458999999999999999998 89999764 34445555
Q ss_pred HHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 241 VTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 241 i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+..+..+ ..+...++.+.+||.+||. +|.+||++.+++.
T Consensus 237 ~~~~~~~-~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 237 ITQGREL-ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHcCccC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 5554433 2344567899999999998 8999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=311.83 Aligned_cols=255 Identities=31% Similarity=0.474 Sum_probs=203.3
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
-.+|| .+.+.||.|+||.||+|.++.+|..||+|++..... .......+.+|+.+++.++||||++++++|.... .
T Consensus 8 ~~~~y-~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~ 83 (328)
T cd07856 8 ITNRY-VDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS--TPVLAKRTYRELKLLKHLRHENIISLSDIFISPL-E 83 (328)
T ss_pred cccce-EEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC-C
Confidence 35666 677999999999999999999999999998864321 2334566889999999999999999999886543 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
.+++|+||+ +++|..+++. ..+++..+..++.||+.||.|||+++ |+||||+|+||+++ .++.++|+|||++...
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~-~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILIN-ENCDLKICDFGLARIQ 158 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeEC-CCCCEEeCcccccccc
Confidence 688999998 5689888865 45889999999999999999999999 99999999999997 7889999999998754
Q ss_pred cCCCCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc----------------
Q 006779 182 QQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---------------- 243 (631)
Q Consensus 182 ~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~---------------- 243 (631)
... .....+++.|+|||.+.+ .++.++||||||+++|+|+||+.||.... .......+..
T Consensus 159 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd07856 159 DPQ-MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD-HVNQFSIITDLLGTPPDDVINTICSE 236 (328)
T ss_pred CCC-cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHhccch
Confidence 332 234567889999997754 58899999999999999999999997633 2111111100
Q ss_pred --------CC--CCC---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 244 --------GI--KPA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 244 --------~~--~p~---~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.. .+. ......++.++++|.+||+ +|.+||++.++|.||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 00 000 1112356889999999998 89999999999999999753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=298.87 Aligned_cols=237 Identities=19% Similarity=0.387 Sum_probs=195.3
Q ss_pred ecccCceEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEecc
Q 006779 33 LGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 33 LG~G~fg~Vy~a~d~--~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~ 110 (631)
||+|+||.||+|.+. .++..||+|.+.... .....+.+.+|+.++++++||||+++++++.. ..+++||||+
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~~ 76 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEMA 76 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEccccc---ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEeC
Confidence 899999999999775 456789999886432 34455779999999999999999999997742 3688999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCC---
Q 006779 111 TSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--- 186 (631)
Q Consensus 111 ~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~--- 186 (631)
.+++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++........
T Consensus 77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLV-NQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEc-CCCcEEeccCCccccccCCcccee
Confidence 99999999875 457899999999999999999999998 99999999999997 788999999999865433211
Q ss_pred --ccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006779 187 --RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262 (631)
Q Consensus 187 --~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI 262 (631)
....+++.|+|||.+. ..++.++|||||||++|+|++ |..||... ....+...+..+..+ ..+...+++++++|
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li 231 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM-KGPEVMSFIEQGKRL-DCPAECPPEMYALM 231 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCC-CCCCCCCHHHHHHH
Confidence 1112357899999775 458899999999999999996 99999874 455666667666543 34556788999999
Q ss_pred HHhcC-CCCCCCCHHHHhc
Q 006779 263 EKCIV-PASLRLPALELLK 280 (631)
Q Consensus 263 ~~cL~-~p~~Rpsa~elL~ 280 (631)
.+||. +|.+||++.++++
T Consensus 232 ~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 232 KDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 99998 8999999998765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=302.23 Aligned_cols=245 Identities=27% Similarity=0.433 Sum_probs=195.0
Q ss_pred eeeeEecccCceEEEEEE----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 28 RYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~----d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
++.+.||+|+||.||+|. +..+|..||+|.+... .......+.+|+++|+.++||||+++++++.......+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 677999999999999997 4568899999998643 34556778999999999999999999998766655678
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
++||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVE-SENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEEC-CCCeEEECCCccccccc
Confidence 9999999999999999764 46899999999999999999999998 99999999999997 78899999999997654
Q ss_pred CCCC-----ccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCH---------------HHHHHHH
Q 006779 183 QPTA-----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP---------------AQIYKKV 241 (631)
Q Consensus 183 ~~~~-----~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~---------------~~i~~~i 241 (631)
.... ....++..|+|||.+.+ .++.++||||||+++|||++|..|+...... ..+...+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 3221 11223456999997754 5889999999999999999987775432110 0111222
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 242 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 242 ~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
..+..+ ......+..+.+||.+||. +|.+|||+.+++.
T Consensus 240 ~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 240 KNNGRL-PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 222221 2234456899999999998 8999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=301.19 Aligned_cols=250 Identities=30% Similarity=0.436 Sum_probs=197.6
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC---CCCCceeeeeeEEcCCC---C
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVDDTN---R 101 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L---~HpnIVkl~~~~~d~~~---~ 101 (631)
++.+.||+|+||.||+|.++.+|..||+|.+..... .......+.+|+.+++.+ +||||+++++++.+... .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccc--cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 677899999999999999999999999999975432 122234566788777666 69999999999876542 2
Q ss_pred eEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 102 TINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
.++++|||+. ++|.+++.+.. .+++..++.++.||+.||.|||+++ ++|+||+|+||+++ .++.+||+|||++.
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~-~~~~~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVT-SDGQVKIADFGLAR 155 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEc-cCCCEEEeccCcce
Confidence 4889999997 58998887643 5899999999999999999999998 99999999999998 67999999999987
Q ss_pred hhcCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCC-CC---------
Q 006779 180 VMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI-KP--------- 247 (631)
Q Consensus 180 ~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~-~p--------- 247 (631)
.+... ......+++.|+|||++.+ .++.++|||||||++|+|++|..||..... .+...++.... .+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcCCCc
Confidence 65433 2234457889999997754 588999999999999999999999976443 33333332210 00
Q ss_pred ------------C---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 248 ------------A---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 248 ------------~---~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
. ......++.+.+||.+||. +|.+||++.++|.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 0001234678999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=305.54 Aligned_cols=253 Identities=24% Similarity=0.455 Sum_probs=202.9
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCeEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~l~lV 106 (631)
.+.+.||+|+||.||+|.+..+|..||+|.++... .......+.+|+.++..+ .||||+++++++.+. ..+++|
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v 92 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD--SDVFIC 92 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC---ChHHHHHHHHHHHHHHhccCCCchHhhheeeecC--CeEEEE
Confidence 67899999999999999999999999999987543 223445566777766666 599999999998764 468999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 107 TELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
|||+. ++|..++.. ...+++..+..++.||+.||.|||+ ++ |+||||+|+||+++ .++.+||+|||++..+...
T Consensus 93 ~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~-~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 93 MELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEc-CCCCEEECccccchhccCC
Confidence 99985 578777765 4578999999999999999999997 46 99999999999997 7899999999998655432
Q ss_pred C-CccccCCCCCCCcccccc-----ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCcHH
Q 006779 185 T-ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQ 257 (631)
Q Consensus 185 ~-~~~~~GTp~Y~APEvl~~-----~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~-~l~~~~~~~ 257 (631)
. .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.......+....+.....+. ......+.+
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (296)
T cd06618 169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD 248 (296)
T ss_pred CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHH
Confidence 2 223357889999998753 378899999999999999999999976544445555554443222 122236788
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 258 VKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 258 l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
+++||.+||. +|.+||++.+++.||||.....
T Consensus 249 l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 249 FCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred HHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence 9999999998 8999999999999999986443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=326.51 Aligned_cols=245 Identities=26% Similarity=0.404 Sum_probs=204.9
Q ss_pred eeeEecccCceEEEEEEEccCCe---E-EEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 29 YDEILGKGAFKTVYKGFDEVDGI---E-VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 29 ~~e~LG~G~fg~Vy~a~d~~tg~---~-VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
+.++||+|+||.||+|..+..+. . ||+|..+... ......+..+.+|+++|++++|||||++|++.++.. -++
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~--Pl~ 237 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE--PLM 237 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC--ccE
Confidence 34889999999999998876532 3 8999887532 235778889999999999999999999999887765 589
Q ss_pred EEEeccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 105 MITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~-l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
+|||+|.||+|.+|+++.+. ++..+...++.+.+.||+|||+++ +|||||-.+|+|++ .++.+||+|||+++.-..
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~-~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYS-KKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheec-CCCeEEeCccccccCCcc
Confidence 99999999999999999874 999999999999999999999999 99999999999997 677889999999865432
Q ss_pred CC-Cc-cccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006779 184 PT-AR-SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 184 ~~-~~-~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~ 259 (631)
-. .. ..--...|+|||.+.. -|+.++|||||||++||+.+ |..||.+ ....++...|.....+...+...+..+.
T Consensus 315 ~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g-~~~~~v~~kI~~~~~r~~~~~~~p~~~~ 393 (474)
T KOG0194|consen 315 YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG-MKNYEVKAKIVKNGYRMPIPSKTPKELA 393 (474)
T ss_pred eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC-CCHHHHHHHHHhcCccCCCCCCCHHHHH
Confidence 11 11 1123568999998865 59999999999999999998 8889988 5667777777544444455667788999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhc
Q 006779 260 QFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 260 ~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.++.+|+. +|..||++.++.+
T Consensus 394 ~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 394 KVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHhccCChhhccCHHHHHH
Confidence 99999998 8999999988765
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=311.79 Aligned_cols=252 Identities=25% Similarity=0.364 Sum_probs=200.3
Q ss_pred eeeeEecccCceEEEEEEEccC--CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcC--CCCe
Q 006779 28 RYDEILGKGAFKTVYKGFDEVD--GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD--TNRT 102 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~t--g~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~--~~~~ 102 (631)
++.+.||+|+||.||+|.+..+ +..||+|.+.... ........+.+|+.+++.+ +||||+++++.+... ....
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF--SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc--ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 7789999999999999999988 9999999986432 1223456678899999999 599999999865432 2346
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
++++++|+. ++|..++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~-~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVN-ADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEc-CCCCEEeCcCCCceecc
Confidence 788899985 699999988888999999999999999999999998 99999999999997 78899999999996543
Q ss_pred CC------CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc-----------
Q 006779 183 QP------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS----------- 243 (631)
Q Consensus 183 ~~------~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~----------- 243 (631)
.. ......||+.|+|||++.+ .++.++||||||+++|+|++|..||....... ....+..
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPDEETLS 235 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCCHHHHH
Confidence 21 1233578999999997643 48899999999999999999999997633221 1111110
Q ss_pred ---------------CCCCC---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 244 ---------------GIKPA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 244 ---------------~~~p~---~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
..... ......+..+++||.+||. +|.+||++.+++.||||..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~ 297 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhh
Confidence 00001 1112346789999999998 8999999999999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=304.61 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=196.0
Q ss_pred CCCceeeeeeEecccCceEEEEEEEcc----------------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEV----------------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~----------------tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~H 85 (631)
|.+|| ++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+|+.++|
T Consensus 3 ~~~~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~E~~~l~~l~~ 78 (296)
T cd05095 3 PRKRL-TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNARNDFLKEIKIMSRLKD 78 (296)
T ss_pred Chhhc-eeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCC
Confidence 66787 888999999999999986432 35579999886432 34455778999999999999
Q ss_pred CCceeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEec
Q 006779 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-----------NVDMKAIKNWARQILRGLHYLHSHNPPIIHR 154 (631)
Q Consensus 86 pnIVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~-----------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHr 154 (631)
|||+++++++.+.. .+++||||+.+|+|.+++.+.. .+++..+..++.||+.||+|||+++ ++||
T Consensus 79 ~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~ 154 (296)
T cd05095 79 PNIIRLLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHR 154 (296)
T ss_pred CCcceEEEEEecCC--ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecc
Confidence 99999999886653 5889999999999999987643 3677899999999999999999998 9999
Q ss_pred cCCCCCeeecCCCCcEEEccccccchhcCCC----CccccCCCCCCCcccc-ccccCccccchhhhHHHHHHhh--cCCC
Q 006779 155 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT--CEYP 227 (631)
Q Consensus 155 DLKp~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl-~~~ys~~sDIwSLGiilyELlt--G~~P 227 (631)
||||+|||++ .++.++|+|||++..+.... .....+++.|+|||.. .+.++.++|||||||++|||++ |..|
T Consensus 155 dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p 233 (296)
T cd05095 155 DLATRNCLVG-KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233 (296)
T ss_pred cCChheEEEc-CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCC
Confidence 9999999997 78899999999987553322 1223346789999964 4568999999999999999998 7789
Q ss_pred CCCCCCHHHHHHHHHc----C--CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 228 YNECKNPAQIYKKVTS----G--IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 228 f~~~~~~~~i~~~i~~----~--~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
|... +..++...+.. . ......+...++.+++||.+||. +|.+||++.+++.
T Consensus 234 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 234 YSQL-SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred cccc-ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8763 33333332211 0 01111223456899999999998 8999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=297.71 Aligned_cols=243 Identities=24% Similarity=0.403 Sum_probs=198.9
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
...| ++.++||+|+||.||+|.+. ++..||+|.+..... ....+.+|+.+++.++||||+++++++.. ..
T Consensus 5 ~~~~-~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 74 (260)
T cd05067 5 RETL-KLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-----SPEAFLAEANLMKQLQHPRLVRLYAVVTQ---EP 74 (260)
T ss_pred hHHc-eeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-----cHHHHHHHHHHHHhcCCcCeeeEEEEEcc---CC
Confidence 3445 77899999999999999864 578899998864332 23568899999999999999999997632 35
Q ss_pred EEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 103 INMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
++++|||+.+++|.+++... ..++...+..++.|++.||+|||+++ ++||||||+||+++ .++.++|+|||++..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~ 151 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVS-ETLCCKIADFGLARL 151 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEc-CCCCEEEccCcceee
Confidence 88999999999999998753 46899999999999999999999998 99999999999997 788999999999966
Q ss_pred hcCCC---CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006779 181 MQQPT---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 181 ~~~~~---~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~ 255 (631)
..... .....++..|+|||.+.. .++.++||||||+++|+|++ |+.||.+. +...+...+..+..+ ..+...+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~ 229 (260)
T cd05067 152 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM-TNPEVIQNLERGYRM-PRPDNCP 229 (260)
T ss_pred cCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHcCCCC-CCCCCCC
Confidence 54222 122345678999997754 57889999999999999999 99999874 455555666555433 2344567
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 256 PQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.+++++|.+||. +|.+||++.+++.
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 230 EELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHH
Confidence 899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=302.96 Aligned_cols=247 Identities=21% Similarity=0.316 Sum_probs=200.3
Q ss_pred CCceeeeeeEecccCceEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEc
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~-----~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d 97 (631)
..+| ++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 4 RNNI-EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred hHhc-eecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc---CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 4455 77789999999999999875 367899999886432 34455678899999999999999999998765
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecc
Q 006779 98 DTNRTINMITELFTSGSLRQYRKKHK----------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRD 155 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~----------------------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrD 155 (631)
. ..+++|+||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ ++|||
T Consensus 80 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~d 155 (288)
T cd05050 80 G--KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRD 155 (288)
T ss_pred C--CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eeccc
Confidence 4 35889999999999999987432 3678889999999999999999998 99999
Q ss_pred CCCCCeeecCCCCcEEEccccccchhcCCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCC
Q 006779 156 LKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYN 229 (631)
Q Consensus 156 LKp~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~ 229 (631)
|||+|||++ .++.++|+|||++....... .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.
T Consensus 156 l~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 156 LATRNCLVG-ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred ccHhheEec-CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999997 78899999999986543221 12233467799999765 458999999999999999998 888987
Q ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 230 ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 230 ~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+ .+..++...+..+..+. .+...+..+.+||.+||+ +|.+||++.|+++
T Consensus 235 ~-~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 235 G-MAHEEVIYYVRDGNVLS-CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred C-CCHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 5 45566666666554332 234567899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=298.59 Aligned_cols=243 Identities=24% Similarity=0.404 Sum_probs=197.7
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
..+| ++.+.||+|+||.||+|.+. ++..||+|.+..... . .+.+.+|+.+++.++||||+++++++.. ..
T Consensus 5 ~~~~-~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~ 74 (260)
T cd05070 5 RESL-QLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM--S---PESFLEEAQIMKKLRHDKLVQLYAVVSE---EP 74 (260)
T ss_pred hHHh-hhhheeccccCceEEEEEec-CCceeEEEEecCCCC--C---HHHHHHHHHHHHhcCCCceEEEEeEECC---CC
Confidence 3466 77889999999999999765 567799999875432 1 2458899999999999999999997632 34
Q ss_pred EEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 103 INMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
++++|||+.+++|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.++|+|||++..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~-~~~~~~l~dfg~~~~ 151 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVG-DGLVCKIADFGLARL 151 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEe-CCceEEeCCceeeee
Confidence 78999999999999998763 45899999999999999999999998 99999999999997 788999999999976
Q ss_pred hcCCCC---ccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006779 181 MQQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 181 ~~~~~~---~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~ 255 (631)
...... ....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+. +...+...+..+..+ ..+...+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~ 229 (260)
T cd05070 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-NNREVLEQVERGYRM-PCPQDCP 229 (260)
T ss_pred ccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCC
Confidence 543221 1223456799999765 458899999999999999999 89999763 455555666554333 3345567
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 256 PQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
..+++||.+||. +|.+|||+.+++.
T Consensus 230 ~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 230 ISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHH
Confidence 899999999998 8999999998763
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=294.52 Aligned_cols=243 Identities=28% Similarity=0.468 Sum_probs=203.5
Q ss_pred eeeeEecccCceEEEEEEEccCC----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg----~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.+.+.||+|+||.||+|.+..++ ..||+|.+.... .......+..|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA---DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE--EPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC---ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--Cee
Confidence 35688999999999999998876 999999986442 223567899999999999999999999988665 478
Q ss_pred EEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 104 NMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~--l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
++||||+.+++|.+++..... +++..+..++.||+.||+|||+++ ++||||+|+||+++ .++.++|+|||++...
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~-~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVG-ENLVVKISDFGLSRDL 153 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEc-cCCeEEEcccCCceec
Confidence 999999999999999986554 999999999999999999999998 99999999999997 7889999999999655
Q ss_pred cCCCCc---cccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006779 182 QQPTAR---SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 182 ~~~~~~---~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~ 256 (631)
...... ...+++.|+|||.+. ..++.++||||||+++|+|++ |..||.. .+...+...+..+..+. .+...+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYLKKGYRLP-KPENCPP 231 (258)
T ss_pred ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCH
Confidence 433111 123678999999774 458899999999999999998 7888866 56666777776665443 3444778
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 257 QVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.+.+++.+||. +|.+|||+.+++.
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHh
Confidence 99999999998 8999999999885
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=304.41 Aligned_cols=248 Identities=26% Similarity=0.425 Sum_probs=202.3
Q ss_pred CCceeeeeeEecccCceEEEEEEEc-------cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeee
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDE-------VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNS 94 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~-------~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~ 94 (631)
..+| .+.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.+ +||||++++++
T Consensus 14 ~~~~-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 14 RDKL-TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred HHHe-eecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc---chHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 3445 67899999999999999752 245689999876331 244567799999999999 89999999998
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCC
Q 006779 95 WVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158 (631)
Q Consensus 95 ~~d~~~~~l~lV~Ey~~gGsL~~~l~~~----------------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp 158 (631)
+... ..+++||||+.+|+|.+++.+. ..++...+..++.||+.||.|||+++ ++||||||
T Consensus 90 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp 165 (304)
T cd05101 90 CTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAA 165 (304)
T ss_pred EecC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence 8654 4688999999999999998764 24778889999999999999999998 99999999
Q ss_pred CCeeecCCCCcEEEccccccchhcCCC----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCC
Q 006779 159 DNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECK 232 (631)
Q Consensus 159 ~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~ 232 (631)
+||+++ .++.+||+|||++....... .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.. .
T Consensus 166 ~Nili~-~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~ 243 (304)
T cd05101 166 RNVLVT-ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-I 243 (304)
T ss_pred ceEEEc-CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc-C
Confidence 999997 78899999999997554321 122345678999997754 58999999999999999998 7888876 4
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 233 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 233 ~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
...++...+..+..+ ..+...+..+++||.+||. +|.+||++.++++.
T Consensus 244 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 244 PVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 667777777665433 2344567899999999998 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=299.50 Aligned_cols=245 Identities=27% Similarity=0.455 Sum_probs=202.8
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~----~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
++| ++.+.||+|+||.||+|.++.+|. .||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~-~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 80 (279)
T cd05057 7 TEL-EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASVDHPHVVRLLGICLS-- 80 (279)
T ss_pred HHc-EEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--
Confidence 455 778999999999999999877765 58888775442 24556778999999999999999999998875
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
...++|+||+.+|+|.+++... ..+++..+..|+.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~-~~~~~kL~dfg~~ 156 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVK-TPQHVKITDFGLA 156 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEc-CCCeEEECCCccc
Confidence 4688999999999999998874 46899999999999999999999998 99999999999997 7889999999999
Q ss_pred chhcCCCC----ccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006779 179 IVMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 179 ~~~~~~~~----~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~ 252 (631)
........ ....++..|+|||.+. ..++.++||||||+++|||++ |+.||.. ....++...+..+... ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~ 234 (279)
T cd05057 157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG-IPAVEIPDLLEKGERL-PQPP 234 (279)
T ss_pred ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhCCCCC-CCCC
Confidence 76543211 1122356799999775 468899999999999999998 9999977 4566777777665432 3344
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 253 VTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 253 ~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
..+..+.+++.+||. +|..||++.+++.
T Consensus 235 ~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 235 ICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 567899999999997 8999999998765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=338.89 Aligned_cols=149 Identities=26% Similarity=0.415 Sum_probs=133.8
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.+| ++.+.||+|+||.||+|.+..+|+.||+|++..... ........+..|+.+++.++||||++++.++... ..+
T Consensus 4 ~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~ 79 (669)
T cd05610 4 EEF-VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM-INKNMVHQVQAERDALALSKSPFIVHLYYSLQSA--NNV 79 (669)
T ss_pred CCE-EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc-cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC--CEE
Confidence 355 778999999999999999999999999999976543 2345567789999999999999999999887654 479
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
|+||||+.+++|.+++...+.+++..++.++.||+.||.|||.++ |+||||||+|||++ .++.+||+|||++.
T Consensus 80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~-~~g~vkL~DFGls~ 152 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEc-CCCCEEEEeCCCCc
Confidence 999999999999999998888999999999999999999999998 99999999999997 78999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=303.10 Aligned_cols=244 Identities=21% Similarity=0.300 Sum_probs=200.3
Q ss_pred eeeeEecccCceEEEEEEEcc-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 28 RYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~-----tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
++.+.||+|+||.||+|.+.. .+..||+|.+.... .....+.+.+|+.++..++||||+++++++.... .
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--~ 82 (283)
T cd05091 8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ--P 82 (283)
T ss_pred HHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC--c
Confidence 667889999999999998754 36889999987432 2344577889999999999999999999886553 5
Q ss_pred EEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC
Q 006779 103 INMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 166 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~----------------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~ 166 (631)
+++++||+.+++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++ .
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~-~ 159 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF-D 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEec-C
Confidence 88999999999999998532 34788899999999999999999998 99999999999997 7
Q ss_pred CCcEEEccccccchhcCCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHH
Q 006779 167 NGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKK 240 (631)
Q Consensus 167 ~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~ 240 (631)
++.+||+|||++....... .....+++.|+|||.+. +.++.++|||||||++|||++ |..||.+ ....++...
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~ 238 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDVIEM 238 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHH
Confidence 8899999999986543221 12334578999999764 568999999999999999998 8888876 455667777
Q ss_pred HHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 241 VTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 241 i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
+..+..+ ..+...+..+.+|+.+||+ +|.+||++.+++..
T Consensus 239 i~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 239 IRNRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHcCCcC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 7665432 2345577889999999998 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=296.63 Aligned_cols=243 Identities=25% Similarity=0.434 Sum_probs=198.9
Q ss_pred eeeeEecccCceEEEEEEEccCCe---EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGI---EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~---~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
...+.||+|+||.||+|.++.++. .+|+|.+.... .....+.+..|+.+++.++||||+++++++.+. ..++
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 82 (268)
T cd05063 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF--KPAM 82 (268)
T ss_pred eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC--CCcE
Confidence 567899999999999999876664 78999876432 244567789999999999999999999988654 4688
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 105 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
+||||+.+++|.+++... +.+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVN-SNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEc-CCCcEEECCCccceeccc
Confidence 999999999999999764 57899999999999999999999998 99999999999997 788999999999865533
Q ss_pred CCCc-----cccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006779 184 PTAR-----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 184 ~~~~-----~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~ 256 (631)
.... ....++.|+|||++. ..++.++|||||||++|+|++ |..||... +...+...+..+...+ .....+.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~-~~~~~~~~i~~~~~~~-~~~~~~~ 237 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM-SNHEVMKAINDGFRLP-APMDCPS 237 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC-CHHHHHHHHhcCCCCC-CCCCCCH
Confidence 2111 112345799999775 458899999999999999997 99999763 4556666666543322 2334578
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 257 QVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.+++++.+||. +|.+||++.++++
T Consensus 238 ~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 238 AVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHH
Confidence 89999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=297.59 Aligned_cols=233 Identities=23% Similarity=0.411 Sum_probs=187.8
Q ss_pred eEecccCceEEEEEEEccCC----------eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC
Q 006779 31 EILGKGAFKTVYKGFDEVDG----------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg----------~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~ 100 (631)
+.||+|+||.||+|.+..++ ..|++|.+.... .....+.+|+.+|+.++||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDSLAFFETASLMSQLSHKHLVKLYGVCVR--- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hhHHHHHHHHHHHHcCCCcchhheeeEEec---
Confidence 46999999999999998877 457777765332 115678899999999999999999998876
Q ss_pred CeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCC-------cEEE
Q 006779 101 RTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-------EVKI 172 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~-~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g-------~vKL 172 (631)
...++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ ..+ .+||
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~-~~~~~~~~~~~~kl 149 (259)
T cd05037 73 DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVA-RYGLNEGYVPFIKL 149 (259)
T ss_pred CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEe-cCccccCCceeEEe
Confidence 34689999999999999998766 7999999999999999999999998 99999999999997 555 7999
Q ss_pred ccccccchhcCCCCccccCCCCCCCcccccc---ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCC
Q 006779 173 GDLGLAIVMQQPTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPA 248 (631)
Q Consensus 173 ~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~---~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~ 248 (631)
+|||++..... .....++..|+|||++.. .++.++||||||+++|+|++ |..||.... ........... .
T Consensus 150 ~Dfg~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~~~~---~ 223 (259)
T cd05037 150 SDPGIPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQDQ---H 223 (259)
T ss_pred CCCCccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHHhcC---C
Confidence 99999875443 223456788999998764 48899999999999999999 588887643 33222222211 1
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 249 ~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
..+......+.++|.+||. +|.+||++.++++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 224 RLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1122223789999999998 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=283.16 Aligned_cols=249 Identities=26% Similarity=0.447 Sum_probs=200.9
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEecc
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~ 110 (631)
|+||+|+||+||+|++..+++.||+|.++..+- ....-....+|+-+|+.|+|.|||+++++...+ +.+-+|+|||
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddd--degvpssalreicllkelkhknivrl~dvlhsd--kkltlvfe~c 83 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLTLVFEFC 83 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCC--CCCCcHHHHHHHHHHHHhhhcceeehhhhhccC--ceeEEeHHHh
Confidence 779999999999999999999999999998753 223335688999999999999999999976543 4678899999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC--Cc
Q 006779 111 TSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--AR 187 (631)
Q Consensus 111 ~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~--~~ 187 (631)
. .+|+.|... ++.++.+.++.++.|++.||.|+|+++ +.||||||+|+||+ .+|.+|++|||+++.+.-+. -.
T Consensus 84 d-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin-~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 84 D-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLIN-RNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred h-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEec-cCCcEEecccchhhhcCCceEeee
Confidence 5 588888775 578999999999999999999999999 99999999999998 89999999999998777654 22
Q ss_pred cccCCCCCCCcccccc--ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHc-CCC-----C-----------
Q 006779 188 SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTS-GIK-----P----------- 247 (631)
Q Consensus 188 ~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~-~~~-----p----------- 247 (631)
..+.|.+|.+|.++-+ -|++..|+||.|||+.|+.. |+..|.+..-.+|+...... |.. |
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 3467999999998755 39999999999999999987 55557664444454433321 100 0
Q ss_pred CCCCC---------CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 248 ASLSK---------VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 248 ~~l~~---------~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
+.++. ..+..-++++++.|. +|..|.+|++.|+||||...
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 00010 112356899999997 99999999999999999753
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=296.96 Aligned_cols=244 Identities=23% Similarity=0.398 Sum_probs=199.1
Q ss_pred eeeeeEecccCceEEEEEEEccCCe---EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 27 GRYDEILGKGAFKTVYKGFDEVDGI---EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~tg~---~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
+++.+.||+|+||.||+|.++.+|. .||+|.+... ........+..|+.+++.++||||+++++++.+. ..+
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~ 80 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--RPV 80 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC--Cce
Confidence 4889999999999999999987764 6999988643 2355567899999999999999999999987544 468
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
++||||+.+|+|.+++... +.+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~-~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEc-CCCcEEECCCccccccc
Confidence 8999999999999998764 56899999999999999999999998 99999999999997 68899999999986543
Q ss_pred CCCC----c-ccc--CCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006779 183 QPTA----R-SVI--GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 183 ~~~~----~-~~~--GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~ 253 (631)
.... . ... .+..|+|||.+. ..++.++|||||||++|||++ |..||.. .+...+...+...... ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~ 235 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MSNQDVINAIEQDYRL-PPPMD 235 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCC-CCHHHHHHHHHcCCcC-CCccc
Confidence 3211 1 111 245799999875 458899999999999999886 9999976 3455566666544322 22334
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 254 TDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 254 ~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.+..+.+++.+||. +|.+||++.+++.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 236 CPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 57889999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=294.32 Aligned_cols=239 Identities=26% Similarity=0.429 Sum_probs=196.9
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEecc
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~ 110 (631)
++||+|+||.||+|.+.. |..||+|.+..... ......+.+|+.++++++||||+++++++.+. ...++|+||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK--QPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CCeEEEEEcC
Confidence 469999999999999987 99999998875432 24567789999999999999999999988655 4688999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCC---
Q 006779 111 TSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--- 186 (631)
Q Consensus 111 ~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~--- 186 (631)
.+++|.+++.+ ...+++..+..++.|++.||.|||+++ ++||||+|+|||++ .++.+||+|||++........
T Consensus 75 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~ 151 (251)
T cd05041 75 PGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSREEEGGIYTVS 151 (251)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEc-CCCcEEEeeccccccccCCcceec
Confidence 99999999865 456899999999999999999999998 99999999999997 788999999999865432111
Q ss_pred -ccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006779 187 -RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263 (631)
Q Consensus 187 -~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~ 263 (631)
....++..|+|||.+. +.++.++||||||+++|+|+| |..||... ........+..+.. ...+...+..+.++|.
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~ 229 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM-SNQQTRERIESGYR-MPAPQLCPEEIYRLML 229 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC-CHHHHHHHHhcCCC-CCCCccCCHHHHHHHH
Confidence 1123356799999765 458899999999999999999 88888763 44555555555432 2234556789999999
Q ss_pred HhcC-CCCCCCCHHHHhc
Q 006779 264 KCIV-PASLRLPALELLK 280 (631)
Q Consensus 264 ~cL~-~p~~Rpsa~elL~ 280 (631)
+||. +|.+||++.|+|.
T Consensus 230 ~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 230 QCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHhccChhhCcCHHHHHH
Confidence 9998 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=292.45 Aligned_cols=240 Identities=27% Similarity=0.409 Sum_probs=196.3
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEecc
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~ 110 (631)
++||+|+||.||+|... ++..||+|.+.... .......+.+|+.+++.++||||+++++++... ..+++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL---PQELKIKFLSEARILKQYDHPNIVKLIGVCTQR--QPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC--CccEEEEECC
Confidence 47999999999999864 68899999876432 234456788999999999999999999988654 4688999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCC---
Q 006779 111 TSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--- 186 (631)
Q Consensus 111 ~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~--- 186 (631)
.+++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++........
T Consensus 75 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~ 151 (250)
T cd05085 75 PGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSRQEDDGIYSSS 151 (250)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEc-CCCeEEECCCccceeccccccccC
Confidence 999999998754 46899999999999999999999998 99999999999997 788999999999865432211
Q ss_pred ccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 006779 187 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264 (631)
Q Consensus 187 ~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~ 264 (631)
....+++.|+|||++.. .++.++||||||+++|+|++ |..||... +.......+..+... ..+...+..+.+|+.+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ 229 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQAREQVEKGYRM-SCPQKCPDDVYKVMQR 229 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHH
Confidence 12234567999998754 58889999999999999998 99999764 555555666655433 2344567899999999
Q ss_pred hcC-CCCCCCCHHHHhcC
Q 006779 265 CIV-PASLRLPALELLKD 281 (631)
Q Consensus 265 cL~-~p~~Rpsa~elL~h 281 (631)
||. +|.+||++.++++.
T Consensus 230 ~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 230 CWDYKPENRPKFSELQKE 247 (250)
T ss_pred HcccCcccCCCHHHHHHH
Confidence 998 89999999998763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=299.24 Aligned_cols=240 Identities=25% Similarity=0.394 Sum_probs=193.7
Q ss_pred eEecccCceEEEEEEEccCCe--EEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCeEEEEE
Q 006779 31 EILGKGAFKTVYKGFDEVDGI--EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~--~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++||+|+||.||+|.++.+|. .+++|.+... ......+.+.+|++++..+ +||||+++++++... ..+++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc---CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCceEEE
Confidence 469999999999999988875 4678877522 2345556788999999999 899999999988654 4688999
Q ss_pred eccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEE
Q 006779 108 ELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 171 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~----------------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 171 (631)
||+.+|+|.+++.... .+++..++.++.|++.||+|||+++ ++||||||+|||++ .++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~-~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEc-CCCeEE
Confidence 9999999999987543 4789999999999999999999998 99999999999997 788999
Q ss_pred EccccccchhcCCCC-ccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCC
Q 006779 172 IGDLGLAIVMQQPTA-RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPA 248 (631)
Q Consensus 172 L~DFGla~~~~~~~~-~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~ 248 (631)
|+|||++........ .....++.|+|||++.. .++.++||||||+++|+|++ |..||.. .+....+..+..+..+
T Consensus 153 l~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~-~~~~~~~~~~~~~~~~- 230 (270)
T cd05047 153 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRL- 230 (270)
T ss_pred ECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc-cCHHHHHHHHhCCCCC-
Confidence 999999853221111 11223567999997754 58899999999999999997 9999976 4455566666554332
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 249 ~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
..+...+..+.+++.+||. +|.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 231 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 2334567889999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=296.54 Aligned_cols=243 Identities=25% Similarity=0.465 Sum_probs=198.0
Q ss_pred eeeeEecccCceEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~t---g~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
.+.+.||+|+||.||+|.+... ...||+|.+.... .....+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~---~~~ 82 (270)
T cd05056 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN---PVW 82 (270)
T ss_pred eeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC---CcE
Confidence 6789999999999999987654 4578999876432 245567899999999999999999999987643 467
Q ss_pred EEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 105 MITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~-~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
+||||+.+|+|.+++.+.. .+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVS-SPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEe-cCCCeEEccCceeeeccc
Confidence 9999999999999998754 5899999999999999999999998 99999999999997 788999999999865543
Q ss_pred CC---CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006779 184 PT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 184 ~~---~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l 258 (631)
.. .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||..... ......+..+..+ ..+...+..+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~ 237 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-NDVIGRIENGERL-PMPPNCPPTL 237 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCcC-CCCCCCCHHH
Confidence 21 11223456899999765 458899999999999999986 9999987544 3444555554333 3345567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 259 KQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 259 ~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
+++|.+|+. +|.+|||+.+++..
T Consensus 238 ~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 238 YSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999998 89999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=320.05 Aligned_cols=248 Identities=26% Similarity=0.407 Sum_probs=202.1
Q ss_pred CceeeeeeEecccCceEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCceeeeeeEEc
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVD 97 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~-----~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d 97 (631)
.+| .+.+.||+|+||.||+|.+. .++..||+|+++... .....+.+.+|+.+|..+. ||||++++++|..
T Consensus 37 ~~~-~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 37 DNL-VLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred HHe-ehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 344 55789999999999999853 456789999997532 2334567889999999997 9999999999865
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCC------------------------------------------------------
Q 006779 98 DTNRTINMITELFTSGSLRQYRKKHK------------------------------------------------------ 123 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~------------------------------------------------------ 123 (631)
. ..+++||||+.+|+|.+++.+.+
T Consensus 113 ~--~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 113 G--GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred C--CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 4 46899999999999999986532
Q ss_pred --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCC
Q 006779 124 --------------------------------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159 (631)
Q Consensus 124 --------------------------------------------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~ 159 (631)
.+++..+..++.||+.||.|||+.+ ++||||||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~ 268 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAAR 268 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcc
Confidence 3567788899999999999999988 999999999
Q ss_pred CeeecCCCCcEEEccccccchhcCC----CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCC
Q 006779 160 NIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKN 233 (631)
Q Consensus 160 NILl~~~~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~ 233 (631)
|||++ .++.+||+|||++...... ......+++.|+|||.+.. .++.++|||||||++|||++ |..||.....
T Consensus 269 NiLl~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 269 NVLIC-EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred eEEEe-CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 99998 6889999999999754321 1223457889999997754 58899999999999999998 8999987666
Q ss_pred HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 234 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 234 ~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.+.....+..+..+. .+...+..+.+||.+||. +|.+||++.+|+..
T Consensus 348 ~~~~~~~~~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 348 NEQFYNAIKRGYRMA-KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred hHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 666666666654432 344567899999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=333.46 Aligned_cols=260 Identities=26% Similarity=0.385 Sum_probs=190.1
Q ss_pred CceeeeeeEecccCceEEEEEEEccCC-eEEEEEEee-------------cccccCCHHHHHHHHHHHHHHHhCCCCCce
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDG-IEVAWNQVN-------------IEDVMQSPDQLERLYSEVHLLKSLKHENII 89 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg-~~VAiK~i~-------------~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIV 89 (631)
++| ++.+.||+|+||+||++..+... +.++.|.+. .............+.+|+.+|+.++||||+
T Consensus 148 ~~Y-~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 148 AHF-RVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hcc-EEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 456 77899999999999998765432 223222111 011112233456688999999999999999
Q ss_pred eeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeec
Q 006779 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 164 (631)
Q Consensus 90 kl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~-----~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~ 164 (631)
++++++.+. ...|+|++++. ++|..++... .......++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 227 ~l~~~~~~~--~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~ 301 (501)
T PHA03210 227 KIEEILRSE--ANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLN 301 (501)
T ss_pred cEeEEEEEC--CeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC
Confidence 999998665 46888999985 5777766432 23456778899999999999999999 99999999999997
Q ss_pred CCCCcEEEccccccchhcCC---CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCC-CCCCC-CH-HHH
Q 006779 165 GNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYP-YNECK-NP-AQI 237 (631)
Q Consensus 165 ~~~g~vKL~DFGla~~~~~~---~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~P-f~~~~-~~-~~i 237 (631)
.+|.+||+|||++..+... .....+||+.|+|||++.+ .|+.++|||||||++|||++|..+ |.... ++ .++
T Consensus 302 -~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 -CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred -CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 7899999999999765432 2234679999999998764 589999999999999999998865 43221 22 233
Q ss_pred HHHHHcCC-----CC-------------------CCC-----CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 238 YKKVTSGI-----KP-------------------ASL-----SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 238 ~~~i~~~~-----~p-------------------~~l-----~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.+.+.... .| ..+ ....+..+.++|.+||. ||.+|||+.|+|.||||...
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 33222110 00 000 01234567888999998 99999999999999999875
Q ss_pred CCc
Q 006779 288 NPK 290 (631)
Q Consensus 288 ~~~ 290 (631)
..+
T Consensus 461 ~~~ 463 (501)
T PHA03210 461 EEE 463 (501)
T ss_pred Cch
Confidence 443
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=331.49 Aligned_cols=258 Identities=29% Similarity=0.500 Sum_probs=217.9
Q ss_pred ccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEc
Q 006779 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD 97 (631)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d 97 (631)
.-||+.-| .+.++||.|.+|.||+++++.+|..+|+|+..... +.-+.+..|.++|+.+ .|||++.+|++|.-
T Consensus 14 lpdp~d~~-ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-----d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 14 LPDPADIF-EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-----DEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred CCCCCCcc-EEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-----cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 45788888 66799999999999999999999999999887543 2335577899999888 69999999998864
Q ss_pred C---CCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEE
Q 006779 98 D---TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 98 ~---~~~~l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL 172 (631)
. ..+.+|||||||.|||..+++++. .++.+..+..+++.++.||.+||.+. +||||||-.|||++ .+|.|||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT-~e~~VKL 164 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLT-ENAEVKL 164 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEe-ccCcEEE
Confidence 3 235899999999999999999864 57899999999999999999999998 99999999999998 8999999
Q ss_pred ccccccchhcCC--CCccccCCCCCCCcccccc------ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006779 173 GDLGLAIVMQQP--TARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244 (631)
Q Consensus 173 ~DFGla~~~~~~--~~~~~~GTp~Y~APEvl~~------~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~ 244 (631)
+|||++..+... ...+.+|||.|||||++.. .|+..+|+|||||+..||.-|.+|+.+. .|...+-.|-..
T Consensus 165 vDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm-HPmraLF~IpRN 243 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRN 243 (953)
T ss_pred eeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc-chhhhhccCCCC
Confidence 999999776554 3567899999999998753 3788999999999999999999999874 444444444444
Q ss_pred CCCCCC-CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 245 IKPASL-SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 245 ~~p~~l-~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
++|... ++.++.++-+||..||. +-.+||+..++|+|||+..
T Consensus 244 PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 244 PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 333332 45678899999999998 8999999999999999984
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=294.96 Aligned_cols=245 Identities=26% Similarity=0.423 Sum_probs=199.4
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
+..+| ++.++||+|+||.||+|.+. .+..||+|.+..... ....+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~-~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 74 (261)
T cd05034 4 PRESL-KLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE--E 74 (261)
T ss_pred chhhe-eeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-----CHHHHHHHHHHHhhCCCCCEeeeeeeeecC--C
Confidence 34456 78899999999999999875 557899998874332 235688999999999999999999987543 4
Q ss_pred eEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 102 TINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
.+++||||+.+++|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++.
T Consensus 75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~-~~~~~~l~d~g~~~ 151 (261)
T cd05034 75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVG-ENLVCKIADFGLAR 151 (261)
T ss_pred ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEc-CCCCEEECccccce
Confidence 689999999999999999765 36899999999999999999999998 99999999999997 78999999999986
Q ss_pred hhcCCC---CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006779 180 VMQQPT---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 180 ~~~~~~---~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 254 (631)
...... .....++..|+|||.+.+ .++.++||||||+++|+|++ |+.||.+. +.......+..+.... .+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~ 229 (261)
T cd05034 152 LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM-TNREVLEQVERGYRMP-RPPNC 229 (261)
T ss_pred eccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CCCCC
Confidence 554321 112234568999997764 58899999999999999998 99999764 4555556665543322 23334
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 255 DPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+..+++++.+||. +|.+||++.+++.
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 230 PEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7889999999998 8999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=300.61 Aligned_cols=236 Identities=20% Similarity=0.364 Sum_probs=187.8
Q ss_pred eEecccCceEEEEEEEccCCeE-------EEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 31 EILGKGAFKTVYKGFDEVDGIE-------VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~-------VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
+.||+|+||.||+|.+..++.. ||+|.+... .....+.+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~--~~ 74 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD--ES 74 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch----hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC--Cc
Confidence 4699999999999998765544 888776532 2344567889999999999999999999987654 57
Q ss_pred EEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCC--------cEEEcc
Q 006779 104 NMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG--------EVKIGD 174 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~-~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g--------~vKL~D 174 (631)
++||||+.+|+|..++...+ .+++..++.++.||+.||+|||+++ |+||||||+||+++ .++ .++++|
T Consensus 75 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~-~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLI-REEDRKTGNPPFIKLSD 151 (258)
T ss_pred EEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEe-cccccccCCCceEEecc
Confidence 89999999999999997654 5899999999999999999999998 99999999999997 333 379999
Q ss_pred ccccchhcCCCCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcC-CCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006779 175 LGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCE-YPYNECKNPAQIYKKVTSGIKPASLS 251 (631)
Q Consensus 175 FGla~~~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~-~Pf~~~~~~~~i~~~i~~~~~p~~l~ 251 (631)
||++..... .....+++.|+|||++.+ .++.++||||||+++|+|++|. .||.. ..+......... ...++
T Consensus 152 ~g~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~-~~~~~~~~~~~~---~~~~~ 225 (258)
T cd05078 152 PGISITVLP--KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA-LDSQKKLQFYED---RHQLP 225 (258)
T ss_pred cccccccCC--chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh-ccHHHHHHHHHc---cccCC
Confidence 999865433 223567889999998864 4789999999999999999985 56654 333332222222 12233
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 252 ~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
......+.++|.+||+ +|.+|||+.++++.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 226 APKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 3455789999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=297.92 Aligned_cols=241 Identities=20% Similarity=0.327 Sum_probs=187.6
Q ss_pred EecccCceEEEEEEEccC--CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEec
Q 006779 32 ILGKGAFKTVYKGFDEVD--GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 32 ~LG~G~fg~Vy~a~d~~t--g~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey 109 (631)
.||+|+||+||+|..... ...+++|.+.... .....+.+.+|+.+++.++||||+++++.+.+. ..+++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA---SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA--IPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC---ChHHHHHHHHHHHHHhccCCcchhheEEEecCC--CccEEEEec
Confidence 599999999999975433 3456666665432 234567899999999999999999999988654 468999999
Q ss_pred cCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC-
Q 006779 110 FTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 184 (631)
Q Consensus 110 ~~gGsL~~~l~~~----~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~- 184 (631)
+.+|+|.+++.+. ..+++..++.++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~-~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLT-SDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEc-CCccEEecccccccccCcch
Confidence 9999999998764 34677888999999999999999998 99999999999997 7889999999998532211
Q ss_pred ---CCccccCCCCCCCcccccc--------ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCC---CCCC
Q 006779 185 ---TARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI---KPAS 249 (631)
Q Consensus 185 ---~~~~~~GTp~Y~APEvl~~--------~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~---~p~~ 249 (631)
......+++.|+|||++.. .++.++||||||+++|||++ |..||........+...+..+. ..+.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQ 233 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCc
Confidence 1234567889999998642 35678999999999999997 5678876443333333333321 1223
Q ss_pred CCCCCcHHHHHHHHHhcCCCCCCCCHHHHhc
Q 006779 250 LSKVTDPQVKQFIEKCIVPASLRLPALELLK 280 (631)
Q Consensus 250 l~~~~~~~l~~lI~~cL~~p~~Rpsa~elL~ 280 (631)
+....++.+++++..||.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~ 264 (268)
T cd05086 234 LELPYSERWYEVLQFCWLSPEKRATAEEVHR 264 (268)
T ss_pred cCCCCcHHHHHHHHHHhhCcccCCCHHHHHH
Confidence 3445678899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=301.02 Aligned_cols=249 Identities=31% Similarity=0.470 Sum_probs=201.1
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||+|++|.||+|.+..+|+.||+|.+.... ......+.+..|+.+++.++||||+++++++.+. ..+++|+
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v~ 77 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPSTALREISLLKELKHPNIVKLLDVIHTE--RKLYLVF 77 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEecccc--ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--CceEEEe
Confidence 55688999999999999999999999999987653 1223345678899999999999999999988654 5789999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC-
Q 006779 108 ELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~- 185 (631)
||+. ++|.+++.+. ..+++..++.++.|++.||.|||+++ |+||||+|+||+++ .++.++|+|||++.......
T Consensus 78 e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~-~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 78 EYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILIN-RDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred cCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEc-CCCCEEEecCCcccccCCCcc
Confidence 9997 5999999886 57999999999999999999999998 99999999999997 78999999999987554332
Q ss_pred -CccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC------------------
Q 006779 186 -ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG------------------ 244 (631)
Q Consensus 186 -~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~------------------ 244 (631)
.....+++.|+|||.+.. .++.++|||||||++|+|++|..||........+.+.....
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 223456788999997643 57889999999999999999999997644333322221100
Q ss_pred -CCCC-------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 245 -IKPA-------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 245 -~~p~-------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
..+. ......+..+++||.+||. +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0000 0011236789999999998 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=304.41 Aligned_cols=254 Identities=31% Similarity=0.473 Sum_probs=199.8
Q ss_pred eeeeEecccCceEEEEEEEccCCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~----~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.....||+|+||.||+|..+.++. .+|||+++-..-. ...-....+|+.+++.|+||||+.+..+|... ...+
T Consensus 27 e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~--tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~v 103 (438)
T KOG0666|consen 27 EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG--TGISMSACREIALLRELKHPNVISLVKVFLSH-DKKV 103 (438)
T ss_pred hccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC--CCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-CceE
Confidence 445679999999999998777654 7899988755321 12235577999999999999999999998764 5689
Q ss_pred EEEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC---CCcEEEccc
Q 006779 104 NMITELFTSGSLRQYRKKH-----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN---NGEVKIGDL 175 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~-----~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~---~g~vKL~DF 175 (631)
++++||.+. +|.+.++-+ +.++...++.++.||+.|+.|||++. |+||||||.|||+.++ .|.|||+||
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeecc
Confidence 999999975 888888743 45899999999999999999999998 9999999999999742 389999999
Q ss_pred cccchhcCCC-----CccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCC------CH---HHHHH
Q 006779 176 GLAIVMQQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECK------NP---AQIYK 239 (631)
Q Consensus 176 Gla~~~~~~~-----~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~------~~---~~i~~ 239 (631)
|+++.+.++. ...++.|.+|+|||++.+ .|+.++|||++|||+.||+|.++.|.+.. +| .++-.
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 9999887763 345677999999997755 49999999999999999999988875321 11 11111
Q ss_pred H--HHcCCC----------CC----------------CC------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 240 K--VTSGIK----------PA----------------SL------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 240 ~--i~~~~~----------p~----------------~l------~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
. +...+. |. .+ .++.++...+|+.++|. ||-+|.|++++|+|+||
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 1 110000 00 00 12346678999999998 99999999999999999
Q ss_pred CCC
Q 006779 285 VTD 287 (631)
Q Consensus 285 ~~~ 287 (631)
..+
T Consensus 341 ~~d 343 (438)
T KOG0666|consen 341 TED 343 (438)
T ss_pred ccC
Confidence 875
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=299.11 Aligned_cols=248 Identities=20% Similarity=0.341 Sum_probs=201.4
Q ss_pred CceeeeeeEecccCceEEEEEEEccC-----CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVD-----GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~t-----g~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 98 (631)
.+| ++.+.||+|+||.||+|+.+.+ ...|++|.+.... .......+.+|+++++.++||||+++++++.+.
T Consensus 5 ~~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 5 SNL-QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK---DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred Hhc-eeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc---chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 455 5678899999999999997643 4678888775332 233567799999999999999999999987543
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKHK---------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~---------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~ 169 (631)
...++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.
T Consensus 81 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~-~~~~ 155 (275)
T cd05046 81 --EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVS-SQRE 155 (275)
T ss_pred --CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEe-CCCc
Confidence 46889999999999999998765 6899999999999999999999999 99999999999997 7889
Q ss_pred EEEccccccchhcCC---CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcC
Q 006779 170 VKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244 (631)
Q Consensus 170 vKL~DFGla~~~~~~---~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~ 244 (631)
++|+|||++...... ......+++.|+|||.+. ..++.++||||||+++|+|++ |..||... ....++..+..+
T Consensus 156 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~-~~~~~~~~~~~~ 234 (275)
T cd05046 156 VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL-SDEEVLNRLQAG 234 (275)
T ss_pred EEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc-chHHHHHHHHcC
Confidence 999999998543222 122345677899999764 457889999999999999998 88899763 445555666554
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 245 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 245 ~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
..+.......+..+.++|.+||. +|.+||++.+++..
T Consensus 235 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 235 KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 44333445567899999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=293.75 Aligned_cols=244 Identities=23% Similarity=0.402 Sum_probs=198.5
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
+.++| ++.+.||+|+||.||+|.+. .+..+|+|.+... ....+.+.+|+.+++.++|+||+++++.+.. .
T Consensus 4 ~~~~~-~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~ 73 (260)
T cd05073 4 PRESL-KLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---E 73 (260)
T ss_pred cccce-eEEeEecCccceEEEEEEec-CCccEEEEecCCC-----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---C
Confidence 44566 88999999999999999755 4567999987632 2345678899999999999999999998765 4
Q ss_pred eEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 102 TINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
..+++|||+.+++|.+++.+. ..+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.+||+|||.+.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~ 150 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVS-ASLVCKIADFGLAR 150 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCCccee
Confidence 578999999999999999763 45788999999999999999999998 99999999999997 78899999999986
Q ss_pred hhcCCC---CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006779 180 VMQQPT---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 180 ~~~~~~---~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 254 (631)
...... .....++..|+|||++.. .++.++||||||+++|+|+| |..||... +...+...+..+.... .....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~ 228 (260)
T cd05073 151 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRMP-RPENC 228 (260)
T ss_pred eccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhCCCCCC-CcccC
Confidence 554322 112235667999998764 47889999999999999999 99999764 4455555665554332 33456
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 255 DPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+.++.+++.+||. +|.+||++.+++.
T Consensus 229 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 229 PEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 7899999999998 8999999998764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.05 Aligned_cols=246 Identities=26% Similarity=0.430 Sum_probs=200.2
Q ss_pred ceeeeeeEecccCceEEEEEEEcc-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWV 96 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~-------tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~ 96 (631)
|| ++++.||+|+||.||+|.+.. ++..||+|.+... ........+.+|+.+++++ +||||+++++++.
T Consensus 13 ~~-~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 13 RL-TLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD---ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred He-eecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc---cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 45 888999999999999998643 2347899987633 2344567889999999999 8999999999886
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCC
Q 006779 97 DDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160 (631)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~l~~~~----------------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~N 160 (631)
.. ..+++|+||+.+|+|.+++.+.. .++...+..++.||+.||.|||+++ ++||||||+|
T Consensus 89 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~N 164 (334)
T cd05100 89 QD--GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARN 164 (334)
T ss_pred cC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccce
Confidence 54 46889999999999999987532 3778899999999999999999998 9999999999
Q ss_pred eeecCCCCcEEEccccccchhcCCC----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCH
Q 006779 161 IFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNP 234 (631)
Q Consensus 161 ILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~ 234 (631)
||++ .++.+||+|||+++...... .....++..|+|||++.+ .++.++||||||+++|+|++ |..||.. .+.
T Consensus 165 ill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~ 242 (334)
T cd05100 165 VLVT-EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPV 242 (334)
T ss_pred EEEc-CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC-CCH
Confidence 9997 78899999999987553321 112234567999997754 58899999999999999998 8889976 456
Q ss_pred HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 235 AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 235 ~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
..+...+..+..+. .+...+.++.+||.+||. +|.+||++.+++.+
T Consensus 243 ~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 243 EELFKLLKEGHRMD-KPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 66777776654332 334557789999999998 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=296.08 Aligned_cols=227 Identities=17% Similarity=0.258 Sum_probs=187.1
Q ss_pred cCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEeccCCCCH
Q 006779 36 GAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL 115 (631)
Q Consensus 36 G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~~gGsL 115 (631)
|.||.||+|.++.+|+.||+|.+.... ...+|...+....||||+++++++.+. ..+++||||+.+|+|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EYSRERLTIIPHCVPNMVCLHKYIVSE--DSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---------hhhhHHHHHHhcCCCceeehhhheecC--CeEEEEEecCCCCCH
Confidence 899999999999999999999986432 123455566667899999999988654 478999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCCccccCCCCC
Q 006779 116 RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195 (631)
Q Consensus 116 ~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y 195 (631)
.+++.+...+++..+..++.|++.||.|||+++ |+||||||+||+++ .++.++++|||.+....... ....+++.|
T Consensus 73 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~df~~~~~~~~~~-~~~~~~~~y 148 (237)
T cd05576 73 WSHISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLD-DRGHIQLTYFSRWSEVEDSC-DGEAVENMY 148 (237)
T ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEEEecccchhcccccc-ccCCcCccc
Confidence 999988888999999999999999999999998 99999999999998 78899999999876554332 234567789
Q ss_pred CCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC
Q 006779 196 MAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL 273 (631)
Q Consensus 196 ~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rp 273 (631)
+|||.+.. .++.++||||+|+++|+|++|+.|+..... .+ .......++...++.+++||.+||. +|.+|+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~--~~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~ 221 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPS--GI-----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERL 221 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCch--hc-----ccccccCCcccCCHHHHHHHHHHccCCHHHhc
Confidence 99998754 588999999999999999999988754221 11 0111122344567899999999998 899999
Q ss_pred CH-----HHHhcCCCC
Q 006779 274 PA-----LELLKDPFL 284 (631)
Q Consensus 274 sa-----~elL~hpff 284 (631)
++ .++++||||
T Consensus 222 ~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 222 GAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCCccchHHHHcCCCC
Confidence 86 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=297.53 Aligned_cols=250 Identities=26% Similarity=0.424 Sum_probs=200.4
Q ss_pred CceeeeeeEecccCceEEEEEEEc----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDE----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~----~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
.|++++.+.||+|+||.||+|... .++..||+|.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~ 79 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE---EQHRSDFEREIEILRTLDHENIVKYKGVCEKPG 79 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc---hHHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence 356677899999999999999864 3589999999875432 135677999999999999999999999887766
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~-~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
....++||||+.+++|.+++.+.. .+++..+..++.||+.||+|||+++ ++||||||+||+++ .++.++|+|||++
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~ 156 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVE-SEDLVKISDFGLA 156 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEc-CCCCEEEcccccc
Confidence 667999999999999999998755 6899999999999999999999998 99999999999998 7899999999999
Q ss_pred chhcCCCC-----ccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCH--------------HHHH
Q 006779 179 IVMQQPTA-----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP--------------AQIY 238 (631)
Q Consensus 179 ~~~~~~~~-----~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~--------------~~i~ 238 (631)
........ ....++..|+|||.+. ..++.++||||||+++|+|+||..|+...... ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 76542211 1223456799999765 45888999999999999999999998653221 1122
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 239 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 239 ~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
..+..+... ..+...+.++.+++.+||. +|.+||++.+++.
T Consensus 237 ~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 237 ELLKEGERL-PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHcCCcC-CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 223322221 2233456889999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=291.10 Aligned_cols=241 Identities=21% Similarity=0.424 Sum_probs=198.3
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|++++++++||||+++++++... ..+++|+
T Consensus 7 ~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (256)
T cd05112 7 TLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-----SEEDFIEEAQVMMKLSHPKLVQLYGVCTER--SPICLVF 78 (256)
T ss_pred EEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-----CHHHHHHHHHHHHhCCCCCeeeEEEEEccC--CceEEEE
Confidence 67799999999999999875 477899998864322 124578899999999999999999987654 4688999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCC
Q 006779 108 ELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 186 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~ 186 (631)
||+.+++|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVG-ENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEc-CCCeEEECCCcceeecccCcc
Confidence 999999999998764 46899999999999999999999998 99999999999997 788999999999865433221
Q ss_pred ---ccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006779 187 ---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 187 ---~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~l 261 (631)
....++..|+|||.+. +.++.++||||||+++|+|++ |..||.. .....+...+..+..+. .+...+..+.+|
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 233 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN-RSNSEVVETINAGFRLY-KPRLASQSVYEL 233 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHhCCCCCC-CCCCCCHHHHHH
Confidence 1223456899999776 458899999999999999998 9999976 45566666666554332 234567899999
Q ss_pred HHHhcC-CCCCCCCHHHHhcC
Q 006779 262 IEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 262 I~~cL~-~p~~Rpsa~elL~h 281 (631)
+.+||+ +|.+||++.+++++
T Consensus 234 ~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 234 MQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHcccChhhCCCHHHHHHh
Confidence 999998 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=291.88 Aligned_cols=238 Identities=22% Similarity=0.424 Sum_probs=196.9
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
.| ++.+.||+|+||.||++. .++..||+|.+.... ..+.+.+|+.+++.++||||+++++++... .++
T Consensus 7 ~~-~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~~~ 74 (254)
T cd05083 7 KL-TLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV------TAQAFLEETAVMTKLHHKNLVRLLGVILHN---GLY 74 (254)
T ss_pred Hc-eeeeeeccCCCCceEecc--cCCCceEEEeecCcc------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC---CcE
Confidence 45 778999999999999985 578899999886431 235688999999999999999999987543 368
Q ss_pred EEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 105 MITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
+||||+.+++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++....
T Consensus 75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~-~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVS-EDGVAKVSDFGLARVGS 151 (254)
T ss_pred EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCcEEECCCccceecc
Confidence 9999999999999997653 5899999999999999999999998 99999999999997 78899999999986543
Q ss_pred CCCCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006779 183 QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 183 ~~~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~ 260 (631)
.. ......+..|+|||.+. +.++.++|+|||||++|+|++ |..||.. .+.......+..+..+. .....++.+++
T Consensus 152 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 228 (254)
T cd05083 152 MG-VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPK-MSLKEVKECVEKGYRME-PPEGCPADVYV 228 (254)
T ss_pred cc-CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHhCCCCCC-CCCcCCHHHHH
Confidence 22 22233467899999765 458899999999999999997 9999976 44556666666654433 34456789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhc
Q 006779 261 FIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 261 lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+|.+||. +|.+||++.+++.
T Consensus 229 li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 229 LMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 9999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.53 Aligned_cols=243 Identities=28% Similarity=0.464 Sum_probs=188.3
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEecc
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~ 110 (631)
.+||+|+||.||+|.-. +|..||||++...... . ...|..|+.+|.+++|||+|+++++|.+... ..++|+|||
T Consensus 81 ~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~---~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~~LVYEym 154 (361)
T KOG1187|consen 81 NLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQ---G-EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HRLLVYEYM 154 (361)
T ss_pred cceecCCCeEEEEEEEC-CCCEEEEEEecCCCCc---c-hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eEEEEEEcc
Confidence 58999999999999765 4489999977644321 1 3349999999999999999999999987653 588999999
Q ss_pred CCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeccCCCCCeeecCCCCcEEEccccccchhcC-CCC
Q 006779 111 TSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTA 186 (631)
Q Consensus 111 ~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~-~~~ 186 (631)
..|+|.+++.... .+++....+|+.+++.||+|||.. .|||||||||+.|||+| .+...||+|||+|..... ...
T Consensus 155 ~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD-~~~~aKlsDFGLa~~~~~~~~~ 233 (361)
T KOG1187|consen 155 PNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD-EDFNAKLSDFGLAKLGPEGDTS 233 (361)
T ss_pred CCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC-CCCCEEccCccCcccCCccccc
Confidence 9999999987654 899999999999999999999995 45899999999999998 899999999999965543 222
Q ss_pred -ccc-cCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCC-----CHHHH-HHHHHcCCC----CCCCC-C
Q 006779 187 -RSV-IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK-----NPAQI-YKKVTSGIK----PASLS-K 252 (631)
Q Consensus 187 -~~~-~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~-----~~~~i-~~~i~~~~~----p~~l~-~ 252 (631)
.+. .||..|+|||.+. +..+.++||||||++++||+||+.|..... +.... ...+..+.. .+.+. .
T Consensus 234 ~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~ 313 (361)
T KOG1187|consen 234 VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEG 313 (361)
T ss_pred eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCC
Confidence 222 7999999999775 568999999999999999999998876432 11111 122322211 11222 2
Q ss_pred CCc--HHH---HHHHHHhcC-CCCCCCCHHHHhc
Q 006779 253 VTD--PQV---KQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 253 ~~~--~~l---~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
..+ ..+ ..+-.+|+. +|..||+..+++.
T Consensus 314 ~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 314 EYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 222 234 445568998 7899999998644
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=310.75 Aligned_cols=263 Identities=22% Similarity=0.390 Sum_probs=225.9
Q ss_pred eeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCeEEEEE
Q 006779 29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 29 ~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
+..+||+|+||.|.+|..+.+.+.+|||+++..-..+. +.++--..|-++|... +-|.+++++..|... .++|+||
T Consensus 353 Fl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd-DDvectm~EKrvLAL~~kppFL~qlHScFQTm--DRLyFVM 429 (683)
T KOG0696|consen 353 FLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD-DDVECTMVEKRVLALPGKPPFLVQLHSCFQTM--DRLYFVM 429 (683)
T ss_pred eEEEeccCccceeeeecccCcchhhhhhhhccceeeec-CcccceehhhhheecCCCCchHHHHHHHhhhh--hheeeEE
Confidence 45789999999999999999999999999987665553 4556667788888777 567888999888554 4699999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch--hcCCC
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV--MQQPT 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~--~~~~~ 185 (631)
||+.||+|.-.+++.+++.+..+..++..|+-||-|||++| ||+||||.+|||++ ..|++||+|||+++. ....+
T Consensus 430 EyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd-~eGHiKi~DFGmcKEni~~~~T 506 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIFDGVT 506 (683)
T ss_pred EEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEec-cCCceEeeecccccccccCCcc
Confidence 99999999999999999999999999999999999999999 99999999999998 789999999999963 45567
Q ss_pred CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 006779 186 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264 (631)
Q Consensus 186 ~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~ 264 (631)
.++++|||.|+|||++. ..|+.++|+||+|++||||+.|+.||.+ .+.++++..|... ...+++..+.++..+.+.
T Consensus 507 TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG-eDE~elF~aI~eh--nvsyPKslSkEAv~ickg 583 (683)
T KOG0696|consen 507 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQAIMEH--NVSYPKSLSKEAVAICKG 583 (683)
T ss_pred eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHc--cCcCcccccHHHHHHHHH
Confidence 78899999999999776 5699999999999999999999999987 6778888887764 345677788999999999
Q ss_pred hcC-CCCCCCCH-----HHHhcCCCCCCCCCcccccCCCCCC
Q 006779 265 CIV-PASLRLPA-----LELLKDPFLVTDNPKDLVCDPLRLP 300 (631)
Q Consensus 265 cL~-~p~~Rpsa-----~elL~hpff~~~~~~~~~~~~~~~p 300 (631)
.|. .|.+|+.+ .++-.||||+..+|..+....+..|
T Consensus 584 ~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPP 625 (683)
T KOG0696|consen 584 LLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPP 625 (683)
T ss_pred HhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCC
Confidence 997 79999863 5789999999999987655444444
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=300.23 Aligned_cols=253 Identities=21% Similarity=0.251 Sum_probs=188.9
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccC---CeEEEEEEeecccccCCHHH-------HHHHHHHHHHHHhCCCCCce
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQ-------LERLYSEVHLLKSLKHENII 89 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~t---g~~VAiK~i~~~~~~~~~~~-------~~~l~~Ei~iLk~L~HpnIV 89 (631)
....+|| ++.++||+|+||+||+|.+..+ +..+|+|...........+. ......+...+..++|+||+
T Consensus 8 ~i~~~~y-~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 8 DITGKEW-KIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred ccCCCce-EEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 3444566 8899999999999999999887 67777776543321100000 01123344556778999999
Q ss_pred eeeeeEEcCCCC--eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCC
Q 006779 90 KFYNSWVDDTNR--TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 167 (631)
Q Consensus 90 kl~~~~~d~~~~--~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~ 167 (631)
++++.+...... ..+++++++. .++.+++......++..++.++.||+.||.|||+++ |+||||||+|||++ .+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~-~~ 162 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVD-GN 162 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CC
Confidence 999876544322 4567788874 478788777666789999999999999999999998 99999999999997 68
Q ss_pred CcEEEccccccchhcCC---------CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHH
Q 006779 168 GEVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 237 (631)
Q Consensus 168 g~vKL~DFGla~~~~~~---------~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i 237 (631)
+.++|+|||+++..... ......||+.|+|||++.+ .++.++|||||||++|||++|..||........+
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 89999999998654211 1223469999999998764 5899999999999999999999999875333222
Q ss_pred --------HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 238 --------YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 238 --------~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.+.+..+.. .....++.+.+++..|+. +|.+||++.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 243 IHAAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 222332211 123346889999999998 9999999999875
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=294.67 Aligned_cols=236 Identities=20% Similarity=0.367 Sum_probs=185.3
Q ss_pred eEecccCceEEEEEEEcc------------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC
Q 006779 31 EILGKGAFKTVYKGFDEV------------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~------------tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 98 (631)
+.||+|+||.||+|.... ....|++|.+... .......+.+|+.+++.++||||+++++++.+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS----HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 468999999999997532 2346888876533 234456788999999999999999999988755
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCc-------E
Q 006779 99 TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE-------V 170 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~-------v 170 (631)
. ..++||||+.+|+|..++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++. +
T Consensus 77 ~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~~~~~~~~ 151 (262)
T cd05077 77 V--ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLA-REGIDGECGPFI 151 (262)
T ss_pred C--CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEe-cCCccCCCCcee
Confidence 3 578999999999999998764 56999999999999999999999998 99999999999996 4443 8
Q ss_pred EEccccccchhcCCCCccccCCCCCCCccccc--cccCccccchhhhHHHHHHh-hcCCCCCCCCCHHHHHHHHHcCCCC
Q 006779 171 KIGDLGLAIVMQQPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMV-TCEYPYNECKNPAQIYKKVTSGIKP 247 (631)
Q Consensus 171 KL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~--~~ys~~sDIwSLGiilyELl-tG~~Pf~~~~~~~~i~~~i~~~~~p 247 (631)
+++|||++..... .....+++.|+|||.+. ..++.++|||||||++|+|+ +|..||... ...+... ...+..+
T Consensus 152 ~l~d~g~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-~~~~~~~-~~~~~~~ 227 (262)
T cd05077 152 KLSDPGIPITVLS--RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK-TLAEKER-FYEGQCM 227 (262)
T ss_pred EeCCCCCCccccC--cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc-chhHHHH-HHhcCcc
Confidence 9999999864432 23346788999999775 35889999999999999998 588888653 3222222 2222111
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 248 ~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.....+..+++||.+||. +|.+||++.+||.+
T Consensus 228 --~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 228 --LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred --CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 222335789999999998 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=331.80 Aligned_cols=242 Identities=24% Similarity=0.384 Sum_probs=202.9
Q ss_pred eeeeeEecccCceEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 27 GRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~-----~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
.++.+.||+|+||.||+|... .+...||||.++-.. +....+.|.+|+++|..|+|||||++++++..+ +
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a---~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~--~ 562 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA---ENQARQDFRREAELLAELQHPNIVRLLGVCREG--D 562 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc---cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC--C
Confidence 355688999999999999763 234789999987442 345678899999999999999999999988654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCC----------C----CCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCC
Q 006779 102 TINMITELFTSGSLRQYRKKHK----------N----VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 167 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~----------~----l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~ 167 (631)
-++||+|||..|+|.+|+..+. . ++..+.+.++.||+.|+.||-++. +|||||-.+|+||. .+
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVg-e~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVG-EN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceec-cc
Confidence 6999999999999999997531 2 788999999999999999999998 99999999999996 88
Q ss_pred CcEEEccccccchhcCCC----CccccCCCCCCCcc-ccccccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006779 168 GEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKV 241 (631)
Q Consensus 168 g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APE-vl~~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i 241 (631)
..|||+|||+++..-... .....-..+||||| ++.++|++++|||||||+|||+++ |..||.+. ..+++++.|
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl-Sn~EVIe~i 718 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL-SNQEVIECI 718 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc-chHHHHHHH
Confidence 899999999996443221 11122366899999 667889999999999999999998 89999885 456667788
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHH
Q 006779 242 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALEL 278 (631)
Q Consensus 242 ~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~el 278 (631)
+.|.. -.-+..++.++..|+..||+ .|.+||+.+||
T Consensus 719 ~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 719 RAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred HcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 88766 45567889999999999998 89999999986
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=297.40 Aligned_cols=236 Identities=20% Similarity=0.327 Sum_probs=184.7
Q ss_pred EecccCceEEEEEEEccC------------------------CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC
Q 006779 32 ILGKGAFKTVYKGFDEVD------------------------GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87 (631)
Q Consensus 32 ~LG~G~fg~Vy~a~d~~t------------------------g~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~Hpn 87 (631)
.||+|+||.||+|....+ ...|++|.+.... ......+.+|+.+++.++|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH----RDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH----HHHHHHHHHHHHHHhcCCCCC
Confidence 589999999999975322 2458888875332 334467889999999999999
Q ss_pred ceeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC
Q 006779 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 166 (631)
Q Consensus 88 IVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~ 166 (631)
|+++++++.... ..++||||+.+|+|..++.+ .+.+++..+..++.||+.||+|||+++ |+||||||+|||++..
T Consensus 78 iv~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~ 153 (274)
T cd05076 78 LAFVHGVCVRGS--ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARL 153 (274)
T ss_pred eeeEEEEEEeCC--ceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEecc
Confidence 999999987653 67899999999999999875 467899999999999999999999998 9999999999999621
Q ss_pred ------CCcEEEccccccchhcCCCCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHh-hcCCCCCCCCCHHHH
Q 006779 167 ------NGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMV-TCEYPYNECKNPAQI 237 (631)
Q Consensus 167 ------~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELl-tG~~Pf~~~~~~~~i 237 (631)
.+.+|++|||++...... ....+++.|+|||.+.+ .++.++|||||||++|||+ +|..||.... +.+.
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~ 230 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT-PSEK 230 (274)
T ss_pred CcccCccceeeecCCccccccccc--cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC-hHHH
Confidence 224899999987543221 23457888999997754 4889999999999999995 6999997643 3333
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 238 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 238 ~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
........ .++....+.+.++|.+||+ +|.+||++.++|++
T Consensus 231 ~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 231 ERFYEKKH---RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHhcc---CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22222211 1222345789999999998 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=311.00 Aligned_cols=263 Identities=28% Similarity=0.449 Sum_probs=214.2
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC---HHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS---PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~---~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
..|| -+..+||+|||+.||+|+|....+.||+|+-.+.+.-.. ........+|.++.+.|+||-||++|++|.-+.
T Consensus 462 n~RY-LlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 462 NDRY-LLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred HHHH-HHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 4577 556899999999999999999999999998765432111 122456789999999999999999999986543
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC--CCCcEEEccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGL 177 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKL~DFGl 177 (631)
..++-|+|||+|.+|+-|+++++.++++.++.|+.||+.||.||....|||||-||||.|||+-. ..|.+||.|||+
T Consensus 541 -dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 541 -DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred -ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 46888999999999999999999999999999999999999999999999999999999999841 246899999999
Q ss_pred cchhcCCC---------CccccCCCCCCCccccc-c----ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006779 178 AIVMQQPT---------ARSVIGTPEFMAPELYE-E----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 243 (631)
Q Consensus 178 a~~~~~~~---------~~~~~GTp~Y~APEvl~-~----~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~ 243 (631)
++++.... .....||-+|++||.+- + +.+.++||||+|+|+|..+.|+.||........|...-+-
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 98876542 22357899999999552 2 3688999999999999999999999876555555543221
Q ss_pred CCC---CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 244 GIK---PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 244 ~~~---p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
-.. .-+...+.++++++||++||+ .-..|....+|-.||+|.+.
T Consensus 700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 110 111223567899999999999 67889999999999999763
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=292.96 Aligned_cols=247 Identities=22% Similarity=0.337 Sum_probs=197.8
Q ss_pred eeeeEecccCceEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC---
Q 006779 28 RYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR--- 101 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~---~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~--- 101 (631)
++.++||+|+||.||+|.++ .+|..||+|.+.... ......+.+.+|+.+++.++||||+++++++......
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI--FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc--CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 56789999999999999865 367999999986442 2345567789999999999999999999988654321
Q ss_pred -eEEEEEeccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcc
Q 006779 102 -TINMITELFTSGSLRQYRKKH------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 102 -~l~lV~Ey~~gGsL~~~l~~~------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~D 174 (631)
..+++++|+.+|+|..++... ..++...++.++.||+.||+|||+++ |+||||||+||+++ .++.+||+|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~-~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLN-ENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEc-CCCCEEECc
Confidence 346789999999999887532 24789999999999999999999998 99999999999997 788999999
Q ss_pred ccccchhcCCC----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCC
Q 006779 175 LGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPA 248 (631)
Q Consensus 175 FGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~ 248 (631)
||++....... .....+++.|++||.+.. .++.++|||||||++|+|++ |..||.. .+...++..+..+...
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~- 234 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG-VENSEIYNYLIKGNRL- 234 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC-CCHHHHHHHHHcCCcC-
Confidence 99987553221 122345678999997754 47889999999999999999 8888876 4555666656554332
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 249 ~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
..+...+..+.+++.+||. +|.+||++.+++..
T Consensus 235 ~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 235 KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2233456899999999998 89999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=299.57 Aligned_cols=243 Identities=28% Similarity=0.478 Sum_probs=197.1
Q ss_pred eeeeEecccCceEEEEEEEccCCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~----~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
+..+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---~~ 83 (303)
T cd05110 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT---GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---TI 83 (303)
T ss_pred eeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---Cc
Confidence 556889999999999999988876 46888775332 234445688999999999999999999988643 35
Q ss_pred EEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 104 NMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~-~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
++++||+.+|+|.+++..+. .+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++....
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~-~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVK-SPNHVKITDFGLARLLE 160 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeec-CCCceEEcccccccccc
Confidence 68999999999999987754 6899999999999999999999998 99999999999997 78899999999997654
Q ss_pred CCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006779 183 QPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 183 ~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~ 256 (631)
... .....++..|+|||.+. ..++.++|||||||++|||++ |..||.+ .....+...+..+..+. .+...+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 238 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG-IPTREIPDLLEKGERLP-QPPICTI 238 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHCCCCCC-CCCCCCH
Confidence 321 12234567899999775 458899999999999999997 8999976 34455555555443332 3345678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 257 QVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.+++++.+||. +|.+||++.+++..
T Consensus 239 ~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 239 DVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 89999999997 89999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=292.11 Aligned_cols=248 Identities=26% Similarity=0.449 Sum_probs=201.4
Q ss_pred eeeeEecccCceEEEEEEEcc-CCeEEEEEEeeccccc------CCHHHHHHHHHHHHHHHh-CCCCCceeeeeeEEcCC
Q 006779 28 RYDEILGKGAFKTVYKGFDEV-DGIEVAWNQVNIEDVM------QSPDQLERLYSEVHLLKS-LKHENIIKFYNSWVDDT 99 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~-tg~~VAiK~i~~~~~~------~~~~~~~~l~~Ei~iLk~-L~HpnIVkl~~~~~d~~ 99 (631)
.+.+.||+|+||.||+|.+.. ++..+|+|.+...... .......++.+|+.++.. ++||||+++++++.+.
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~- 81 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN- 81 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC-
Confidence 567889999999999999988 7899999988654321 223455678889998865 7999999999988654
Q ss_pred CCeEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccCCCCCeeecCCCCcEEEcc
Q 006779 100 NRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~----~~~l~~~~i~~i~~QIl~aL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKL~D 174 (631)
..+++||||+.+++|.+++.. ...+++..++.++.|++.||.|||+ .+ ++||||+|+|||++ .++.+||+|
T Consensus 82 -~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~-~~~~~~l~d 157 (269)
T cd08528 82 -DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLG-EDDKVTITD 157 (269)
T ss_pred -CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEEC-CCCcEEEec
Confidence 478999999999999988743 3568999999999999999999996 56 99999999999997 788999999
Q ss_pred ccccchhcCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006779 175 LGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 175 FGla~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~ 252 (631)
||++...... ......|+..|+|||.+.+ .++.++||||||+++|+|++|+.||.. .+.......+..+..++....
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc-cCHHHHHHHHhhccCCcCCcc
Confidence 9999765443 3344568999999997754 488999999999999999999999976 344445555554443333334
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 253 VTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 253 ~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
..++.+++||.+||. +|.+||++.|+..+
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 567899999999998 89999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=293.49 Aligned_cols=239 Identities=27% Similarity=0.432 Sum_probs=193.2
Q ss_pred EecccCceEEEEEEEccCC------eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEE
Q 006779 32 ILGKGAFKTVYKGFDEVDG------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 32 ~LG~G~fg~Vy~a~d~~tg------~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~l 105 (631)
.||+|+||.||+|.++..+ ..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ...++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 76 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA---TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN--EPQYI 76 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc---chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC--CCeEE
Confidence 6899999999999886544 789999875332 234456788999999999999999999988654 46889
Q ss_pred EEeccCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCC-----cEEEc
Q 006779 106 ITELFTSGSLRQYRKKH-------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-----EVKIG 173 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~-------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g-----~vKL~ 173 (631)
||||+.+++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++ .++ .++|+
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~~~~~~l~ 153 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVS-EKGYDADRVVKIG 153 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEe-cCCCCCCcceEEC
Confidence 99999999999998642 34788999999999999999999998 99999999999997 555 79999
Q ss_pred cccccchhcCCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCC
Q 006779 174 DLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKP 247 (631)
Q Consensus 174 DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p 247 (631)
|||++....... .....++..|+|||.+. +.++.++|||||||++|+|+| |+.||... +..+....+..+..+
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~-~~~~~~~~~~~~~~~ 232 (269)
T cd05044 154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL-NNQEVLQHVTAGGRL 232 (269)
T ss_pred CcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc-CHHHHHHHHhcCCcc
Confidence 999986543221 12234577899999775 458899999999999999998 99999763 445555555544332
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 248 ~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
..+...+..+.+||.+||. +|.+||++.+++.
T Consensus 233 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 233 -QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred -CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2334567889999999998 8999999999865
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=326.41 Aligned_cols=214 Identities=33% Similarity=0.531 Sum_probs=180.4
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC----
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---- 99 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~---- 99 (631)
+-| -..+.||+||||.||+|+++.+|+.||+|.++... .....++..+|+++|++|+|||||+++++=.+..
T Consensus 13 y~W-~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 13 YLW-EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred cce-eehhhhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence 444 34689999999999999999999999999987654 3456788999999999999999999999644433
Q ss_pred CCeEEEEEeccCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeec-CCCC--cEEEc
Q 006779 100 NRTINMITELFTSGSLRQYRKK---HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNG--EVKIG 173 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~---~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~-~~~g--~vKL~ 173 (631)
.....+|||||.||+|+.++.+ ..+|++.+++.++..+..||.|||+++ |+||||||.||++. |.+| ..||+
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeee
Confidence 3456789999999999999975 457999999999999999999999999 99999999999885 3334 46999
Q ss_pred cccccchhcCC-CCccccCCCCCCCccccc--cccCccccchhhhHHHHHHhhcCCCCCCCCCHH----HHHHHHHc
Q 006779 174 DLGLAIVMQQP-TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA----QIYKKVTS 243 (631)
Q Consensus 174 DFGla~~~~~~-~~~~~~GTp~Y~APEvl~--~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~----~i~~~i~~ 243 (631)
|||.|+.+... ...+.+||+.|.+||+++ +.|+..+|.|||||++|+++||..||.....+. ..+..+++
T Consensus 167 DfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tk 243 (732)
T KOG4250|consen 167 DFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITK 243 (732)
T ss_pred cccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhcc
Confidence 99999877654 577899999999999998 458999999999999999999999996544442 44444444
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=319.18 Aligned_cols=239 Identities=23% Similarity=0.406 Sum_probs=203.7
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCeEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~l~lV 106 (631)
.+...+|.|+|+.|..+.+..++...++|++..... ...+|+.++... +||||+++++++.+. ..+|+|
T Consensus 325 ~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~--------~~~~e~~~~~~~~~h~niv~~~~v~~~~--~~~~~v 394 (612)
T KOG0603|consen 325 EFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD--------DNQDEIPISLLVRDHPNIVKSHDVYEDG--KEIYLV 394 (612)
T ss_pred ccccccCCCCccceeeeeccccccchhheecccccc--------ccccccchhhhhcCCCcceeecceecCC--ceeeee
Confidence 556779999999999999999999999999975521 133567555444 899999999988554 579999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCC
Q 006779 107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 186 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~ 186 (631)
||++.|+-|.+-+...+.+. ..+..|++||+.|+.|||++| ||||||||+|||+++..|+++|+|||.+...+.. .
T Consensus 395 ~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-~ 470 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-C 470 (612)
T ss_pred ehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh-h
Confidence 99999998888777666555 788889999999999999998 9999999999999547899999999999877665 3
Q ss_pred ccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHh
Q 006779 187 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265 (631)
Q Consensus 187 ~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~c 265 (631)
.+.+-|..|.|||++.. +|++++||||||++||+|++|..||....+..+++..+..+. +....+..+++||..|
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~----~s~~vS~~AKdLl~~L 546 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK----FSECVSDEAKDLLQQL 546 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc----cccccCHHHHHHHHHh
Confidence 34456889999998864 599999999999999999999999988777777777776543 3367789999999999
Q ss_pred cC-CCCCCCCHHHHhcCCCC
Q 006779 266 IV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 266 L~-~p~~Rpsa~elL~hpff 284 (631)
|+ +|.+|+++.+++.||||
T Consensus 547 L~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 547 LQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ccCChhhCcChhhhccCcch
Confidence 98 99999999999999999
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=296.65 Aligned_cols=248 Identities=27% Similarity=0.419 Sum_probs=205.9
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHH-HHhCCCCCceeeeeeEEcCCCCeEEEEEec
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL-LKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~i-Lk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey 109 (631)
..||.|+||+|++..++.+|+..|+|+|+.... .....++..|.+. ++.-+.||||+||+..+.+. -.||.||+
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~---~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG--dcWiCMEL 144 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI---EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG--DCWICMEL 144 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccc---hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC--ceeeeHHH
Confidence 469999999999999999999999999986542 4566778888875 45558999999999887654 47788999
Q ss_pred cCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 110 FTSGSLRQYRK-----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 110 ~~gGsL~~~l~-----~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
|. .||..+.+ +...+++..+-.+.--.+.||.||...- .|||||+||+|||++ ..|.+||||||++..+..+
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILld-r~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLD-RHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEe-cCCCEeeecccchHhHHHH
Confidence 95 68877654 3567999999999999999999997652 499999999999998 7899999999999877666
Q ss_pred CCcc-ccCCCCCCCcccccc---ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC----CCcH
Q 006779 185 TARS-VIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK----VTDP 256 (631)
Q Consensus 185 ~~~~-~~GTp~Y~APEvl~~---~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~----~~~~ 256 (631)
.+.+ -.|-..|||||.+.. +|+.++|+||||++|||++||.+||.+..+..+....+..|-.|.-... ..+.
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~ 301 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSF 301 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCH
Confidence 5444 368889999998753 5999999999999999999999999987666555556666655543322 2578
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 257 QVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
.++.||.-||. +.+.||...+|+++||++.
T Consensus 302 ~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 302 SMVRFINTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred HHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence 89999999997 8999999999999999975
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=311.53 Aligned_cols=255 Identities=23% Similarity=0.373 Sum_probs=212.3
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEecc
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~ 110 (631)
+.||-|+||.|.++....|...+|.|.+...+++. ..++.....|-.||..-+.+-||++|.+|.|.+ ++||||+|+
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~-rnQvaHVKAERDILAEADn~WVVrLyySFQDkd--nLYFVMdYI 711 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLM-RNQVAHVKAERDILAEADNEWVVRLYYSFQDKD--NLYFVMDYI 711 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHh-hhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC--ceEEEEecc
Confidence 56999999999999999999999999998777654 456677889999999999999999999998765 699999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC------
Q 006779 111 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP------ 184 (631)
Q Consensus 111 ~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~------ 184 (631)
.||++..++-+-+-|.+..++.++..+..|+++.|..| +|||||||+||||| .+|+|||.|||+++-++-.
T Consensus 712 PGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILID-rdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 712 PGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred CCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEc-cCCceeeeeccccccceeccccccc
Confidence 99999999999999999999999999999999999999 99999999999998 8999999999998522100
Q ss_pred --------------------------------------CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcC
Q 006779 185 --------------------------------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCE 225 (631)
Q Consensus 185 --------------------------------------~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~ 225 (631)
..++.+||+.|+|||++. .+|+..+|+||.|+|||||+.|+
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence 012457999999999875 57999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHHHHHHHHHhcCCCCCCCC---HHHHhcCCCCCCCCCccc
Q 006779 226 YPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 226 ~Pf~~~~~~~~i~~~i~~~~~--p~~l~~~~~~~l~~lI~~cL~~p~~Rps---a~elL~hpff~~~~~~~~ 292 (631)
.||......+..++ |..... ....-...++++.++|.++...++.|+. ++++-.||||+..++..+
T Consensus 869 ~pf~~~tp~~tq~k-v~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfssl 939 (1034)
T KOG0608|consen 869 PPFLADTPGETQYK-VINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSSL 939 (1034)
T ss_pred CCccCCCCCcceee-eeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHhh
Confidence 99987443332222 222111 1122234678999999998888777774 778999999999887664
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=330.12 Aligned_cols=243 Identities=23% Similarity=0.404 Sum_probs=199.7
Q ss_pred eeeeEecccCceEEEEEEEccC-C----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 28 RYDEILGKGAFKTVYKGFDEVD-G----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~t-g----~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
.+.+.||+|+||.||.|....- | ..||+|.+... .+......|.+|..+|+.++|||||++.+++.+. ..
T Consensus 695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~---~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~--~~ 769 (1025)
T KOG1095|consen 695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL---SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS--GP 769 (1025)
T ss_pred EeeeeeccccccceEEEEEecCCCCccceEEEEEecccc---CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC--CC
Confidence 4568999999999999987543 2 34888877643 3567788899999999999999999999999884 45
Q ss_pred EEEEEeccCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccc
Q 006779 103 INMITELFTSGSLRQYRKKH-------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~-------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 175 (631)
.++++|||+||+|+.|+++. ..++...++.++.||+.|++||++++ +|||||.++|+|++ ....+||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~-~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLD-ERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeec-ccCcEEEccc
Confidence 77899999999999999875 35899999999999999999999998 99999999999998 6689999999
Q ss_pred cccchhcCCCCc----cccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCC
Q 006779 176 GLAIVMQQPTAR----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPAS 249 (631)
Q Consensus 176 Gla~~~~~~~~~----~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~ 249 (631)
|+|+.+....-. ...-...|||||.+. +.++.++|||||||++||++| |..||.+..+.+.+......| .-.
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg--RL~ 924 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG--RLD 924 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC--ccC
Confidence 999843322111 112245799999776 669999999999999999999 889998855544444455555 233
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 250 LSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 250 l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.+..++..+.+++..||. +|..||+...|++
T Consensus 925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 455677788899999998 8999999999988
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=275.16 Aligned_cols=240 Identities=34% Similarity=0.591 Sum_probs=204.8
Q ss_pred CceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEeccCCCCHH
Q 006779 37 AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR 116 (631)
Q Consensus 37 ~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~~gGsL~ 116 (631)
+||.||+|.+..+|..||+|.+...... .....+.+|++.++.++|+||+++++.+... ...++++||+.+++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK---KKRERILREISILKKLKHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc---cHHHHHHHHHHHHHhCCCCcHHHHHhheeeC--CEEEEEEeCCCCCCHH
Confidence 5899999999999999999998754321 1157789999999999999999999988654 4688999999999999
Q ss_pred HHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC-CCccccCCCCC
Q 006779 117 QYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEF 195 (631)
Q Consensus 117 ~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-~~~~~~GTp~Y 195 (631)
.++.....++...+..++.+++.+|.|||+.+ ++|+||+|+||+++ .++.++|+|||.+...... ......+++.|
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 152 (244)
T smart00220 76 DLLKKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLD-EDGHVKLADFGLARQLDPGGLLTTFVGTPEY 152 (244)
T ss_pred HHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEEC-CCCcEEEccccceeeeccccccccccCCcCC
Confidence 99988777999999999999999999999998 99999999999998 6789999999999766543 34456788999
Q ss_pred CCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC-CcHHHHHHHHHhcC-CCCCC
Q 006779 196 MAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV-TDPQVKQFIEKCIV-PASLR 272 (631)
Q Consensus 196 ~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~-~~~~l~~lI~~cL~-~p~~R 272 (631)
+|||.+. ..++.++||||||+++++|++|..||....+...+...+..+..+...... .+..+.+++.+||. +|.+|
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 232 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR 232 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence 9999775 458889999999999999999999998756677777766665443322222 66889999999998 89999
Q ss_pred CCHHHHhcCCCC
Q 006779 273 LPALELLKDPFL 284 (631)
Q Consensus 273 psa~elL~hpff 284 (631)
|++.++++||||
T Consensus 233 p~~~~~~~~~~~ 244 (244)
T smart00220 233 LTAEEALQHPFF 244 (244)
T ss_pred cCHHHHhhCCCC
Confidence 999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=318.94 Aligned_cols=255 Identities=21% Similarity=0.279 Sum_probs=178.0
Q ss_pred CCceeeeeeEecccCceEEEEEEEccC----CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEE--
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVD----GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV-- 96 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~t----g~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~-- 96 (631)
..+| .+.+.||+|+||.||+|.+..+ +..||+|++.... . .+....+ .++...+.++..+...|.
T Consensus 131 ~~~y-~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~----~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 131 KDDF-VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG----A--VEIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred cCCe-EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc----h--hHHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 3455 7789999999999999999999 9999999875321 1 1111111 122223333333332221
Q ss_pred --cCCCCeEEEEEeccCCCCHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCCEEec
Q 006779 97 --DDTNRTINMITELFTSGSLRQYRKKHKN--------------------VDMKAIKNWARQILRGLHYLHSHNPPIIHR 154 (631)
Q Consensus 97 --d~~~~~l~lV~Ey~~gGsL~~~l~~~~~--------------------l~~~~i~~i~~QIl~aL~yLHs~~~~IiHr 154 (631)
......+++|+||+.+++|.+++..... .....+..++.||+.||.|||+++ |+||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHR 279 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHR 279 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeC
Confidence 1334578999999999999998875321 123457789999999999999998 9999
Q ss_pred cCCCCCeeecCCCCcEEEccccccchhcCC---CCccccCCCCCCCcccccc-----------------------ccCcc
Q 006779 155 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEE-----------------------EYNEL 208 (631)
Q Consensus 155 DLKp~NILl~~~~g~vKL~DFGla~~~~~~---~~~~~~GTp~Y~APEvl~~-----------------------~ys~~ 208 (631)
||||+|||++..++.+||+|||++..+... .....++|+.|+|||.+.. .++.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 999999999855689999999999755332 2345689999999996521 23456
Q ss_pred ccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCC-------------CCCC------CCCCCcHHHHHHHHHhcC-C
Q 006779 209 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI-------------KPAS------LSKVTDPQVKQFIEKCIV-P 268 (631)
Q Consensus 209 sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~-------------~p~~------l~~~~~~~l~~lI~~cL~-~ 268 (631)
+|||||||++|||+++..|+.. +..++...+.... .... .....+...++||.+||+ +
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 7999999999999998776542 2222222222110 0000 011123345689999998 9
Q ss_pred CCCCCCHHHHhcCCCCCCCCCc
Q 006779 269 ASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 269 p~~Rpsa~elL~hpff~~~~~~ 290 (631)
|.+|||+.++|+||||....+.
T Consensus 438 P~kR~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 438 GRQRISAKAALAHPYFDREGLL 459 (566)
T ss_pred cccCCCHHHHhCCcCcCCCCcc
Confidence 9999999999999999876543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=291.03 Aligned_cols=262 Identities=24% Similarity=0.384 Sum_probs=204.9
Q ss_pred ccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEc-
Q 006779 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD- 97 (631)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d- 97 (631)
..+-.+.|.++ .+||+|.||.||+|+.+.+|+.||+|++-.+.-. ...-....+|+++|..|+|+|++.+++.|-.
T Consensus 12 ~~~~~~~yek~-~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK--eGfpitalreikiL~~lkHenv~nliEic~tk 88 (376)
T KOG0669|consen 12 FCDEVSKYEKL-AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTK 88 (376)
T ss_pred ceecchHHHHH-HhcCCchHHHHHHHhhcCccchhHHHHHHHhccc--cCCcHHHHHHHHHHHHhcchhHHHHHHHHhhc
Confidence 34455667664 6799999999999999999999999987653211 1223457899999999999999998876532
Q ss_pred -----CCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEE
Q 006779 98 -----DTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 171 (631)
Q Consensus 98 -----~~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 171 (631)
..+..+|+|+.+|+. +|.-++... .+++...|++++++++.||.|+|... |+|||+|+.|+||+ .+|.+|
T Consensus 89 ~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt-~dgilk 164 (376)
T KOG0669|consen 89 ATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLIT-KDGILK 164 (376)
T ss_pred cCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEc-CCceEE
Confidence 233469999999975 888888765 67999999999999999999999999 99999999999998 789999
Q ss_pred EccccccchhcCCCC------ccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHH--HH
Q 006779 172 IGDLGLAIVMQQPTA------RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK--KV 241 (631)
Q Consensus 172 L~DFGla~~~~~~~~------~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~--~i 241 (631)
|+|||+++.+..+.. ...+.|.+|++||++.+ +|+++.|||..||++.||.|+.+-+.+..+..++.. .+
T Consensus 165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L 244 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL 244 (376)
T ss_pred eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence 999999976543321 12345999999997654 599999999999999999999988887554443321 11
Q ss_pred HcCCCCCC-----------------C-------------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 242 TSGIKPAS-----------------L-------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 242 ~~~~~p~~-----------------l-------------~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.....+.. + +-+.++++.+|++++|. ||.+|+.+.++|+|.||..+
T Consensus 245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 11111100 1 12236788999999998 99999999999999999764
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=295.43 Aligned_cols=258 Identities=20% Similarity=0.355 Sum_probs=202.6
Q ss_pred ccccCC-CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC--C----Cce
Q 006779 17 FSEKDP-SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--E----NII 89 (631)
Q Consensus 17 ~~e~dp-~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~H--p----nIV 89 (631)
|...|- .+|| .+...+|+|+||.|-.+.|..++..||+|+++.- ....+...-|++.|.++.+ | -+|
T Consensus 81 ~~~gD~l~~Ry-~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-----~kYreAa~iEi~vLqki~~~DP~g~~rcv 154 (415)
T KOG0671|consen 81 YQVGDILTNRY-EIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-----DKYREAALIEIEVLQKINESDPNGKFRCV 154 (415)
T ss_pred EEeccccccce-ehhhhhcCCcccceEEEeecCCCceehHHHHHHH-----HHHhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence 444455 7888 5668899999999999999999999999998632 3445667789999999943 2 256
Q ss_pred eeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC--
Q 006779 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-- 165 (631)
Q Consensus 90 kl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~-- 165 (631)
.+.++|. -++.+++|+|.+ |-|+.++++.+. +++...++.+++|++.+++|||+.+ ++|.||||+|||+..
T Consensus 155 ~m~~wFd--yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 155 QMRDWFD--YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSE 229 (415)
T ss_pred eeehhhh--ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccc
Confidence 6666552 345789999999 669999999864 6899999999999999999999999 999999999999831
Q ss_pred -----------------CCCcEEEccccccchhcCCCCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCC
Q 006779 166 -----------------NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYP 227 (631)
Q Consensus 166 -----------------~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~P 227 (631)
.+..|+|+|||.|+...... .+.+.|..|+|||++. -+++..+||||+||||+|+.||...
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccCc-ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 13368999999997655443 5667899999999765 5799999999999999999999999
Q ss_pred CCCCCCHHH--HHHHHHcCCCCCCC---------------------------------------C---CCCcHHHHHHHH
Q 006779 228 YNECKNPAQ--IYKKVTSGIKPASL---------------------------------------S---KVTDPQVKQFIE 263 (631)
Q Consensus 228 f~~~~~~~~--i~~~i~~~~~p~~l---------------------------------------~---~~~~~~l~~lI~ 263 (631)
|....+.+. +++.|... .|..+ . .....++.+||+
T Consensus 309 FqtHen~EHLaMMerIlGp-~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGP-IPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred cccCCcHHHHHHHHHhhCC-CcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 987665553 33333321 11100 0 001246889999
Q ss_pred HhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 264 KCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 264 ~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
+||. ||.+|+|+.|+|.||||...
T Consensus 388 ~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred HHHccCccccccHHHHhcCHHhhcC
Confidence 9998 99999999999999999753
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=300.93 Aligned_cols=249 Identities=27% Similarity=0.489 Sum_probs=205.9
Q ss_pred cCCCCceeeee-------eEecccCceEEEEEEEcc----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc
Q 006779 20 KDPSCRYGRYD-------EILGKGAFKTVYKGFDEV----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88 (631)
Q Consensus 20 ~dp~gRy~r~~-------e~LG~G~fg~Vy~a~d~~----tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnI 88 (631)
.-|++|-|++. ++||.|-||.||+|.... ....||||..+... .++..+.|..|.-+|+.++||||
T Consensus 377 ~~P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~---t~d~tekflqEa~iMrnfdHphI 453 (974)
T KOG4257|consen 377 STPTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC---TPDDTEKFLQEASIMRNFDHPHI 453 (974)
T ss_pred cCCCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC---ChhhHHHHHHHHHHHHhCCCcch
Confidence 45788877764 579999999999998643 24568889886543 46678999999999999999999
Q ss_pred eeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCC
Q 006779 89 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 167 (631)
Q Consensus 89 Vkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~-~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~ 167 (631)
|++++++.+. ..|+|||++.-|.|+.|++.++ .++...+..++.||..||.|||+.. +|||||..+|||+. ..
T Consensus 454 ikLIGv~~e~---P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVs-Sp 527 (974)
T KOG4257|consen 454 IKLIGVCVEQ---PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVS-SP 527 (974)
T ss_pred hheeeeeecc---ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeec-Cc
Confidence 9999998764 4899999999999999999875 5999999999999999999999999 99999999999997 66
Q ss_pred CcEEEccccccchhcCCC---CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006779 168 GEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT 242 (631)
Q Consensus 168 g~vKL~DFGla~~~~~~~---~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~ 242 (631)
.-|||+|||+++.+.... .....-..-|||||-++ ..++.++|||-||+|+||++. |..||.+-.|.+.| -.+.
T Consensus 528 ~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-~~iE 606 (974)
T KOG4257|consen 528 QCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-GHIE 606 (974)
T ss_pred ceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-EEec
Confidence 789999999998776543 11222245699999665 679999999999999999876 89999886554443 4455
Q ss_pred cCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHh
Q 006779 243 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL 279 (631)
Q Consensus 243 ~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL 279 (631)
.|..+ ..+..++|.+..++.+||+ +|++||...++.
T Consensus 607 nGeRl-P~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 607 NGERL-PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred CCCCC-CCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 55443 3566788999999999999 999999987754
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=284.93 Aligned_cols=263 Identities=17% Similarity=0.328 Sum_probs=217.1
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCeEEE
Q 006779 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~l~l 105 (631)
.++.++||+|+|+.|.++..+.|.+.+|+|+++.+- .+..+.++-...|-....+- +||.+|.++..|..+. .+++
T Consensus 252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel-~nddedidwvqtek~vfe~asn~pflvglhscfqtes--rlff 328 (593)
T KOG0695|consen 252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKEL-VNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES--RLFF 328 (593)
T ss_pred ceeeeeecCcchhhhhheehcccceeeehhhHHHHh-cCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc--eEEE
Confidence 467799999999999999999999999999997553 45556677777888887666 7999999999886554 6889
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc--C
Q 006779 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--Q 183 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~--~ 183 (631)
|.||+.||+|.-.+++.++++++.++.+...|..||.|||++| ||+||||.+|+|++ ..|++||.|+|.++.-- .
T Consensus 329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlld-aeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEc-cCCceeecccchhhcCCCCC
Confidence 9999999999999999999999999999999999999999999 99999999999998 78999999999996432 3
Q ss_pred CCCccccCCCCCCCccccccc-cCccccchhhhHHHHHHhhcCCCCC-------CCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006779 184 PTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYN-------ECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 184 ~~~~~~~GTp~Y~APEvl~~~-ys~~sDIwSLGiilyELltG~~Pf~-------~~~~~~~i~~~i~~~~~p~~l~~~~~ 255 (631)
....+++|||.|+|||++++. |+..+|+|+||++++||+.|+.||. +......+++.|..... .++...+
T Consensus 406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--riprsls 483 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--RIPRSLS 483 (593)
T ss_pred cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--cccceee
Confidence 356788999999999999864 9999999999999999999999995 22233456666655322 2333344
Q ss_pred HHHHHHHHHhcC-CCCCCCC------HHHHhcCCCCCCCCCcccccCCC
Q 006779 256 PQVKQFIEKCIV-PASLRLP------ALELLKDPFLVTDNPKDLVCDPL 297 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rps------a~elL~hpff~~~~~~~~~~~~~ 297 (631)
-.+..+++.-|. ||.+|.. ..++-.|+||+..+|..+..+..
T Consensus 484 vkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v 532 (593)
T KOG0695|consen 484 VKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQV 532 (593)
T ss_pred hhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhccc
Confidence 556667777776 7888764 67899999999988876554443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=312.50 Aligned_cols=267 Identities=27% Similarity=0.498 Sum_probs=231.9
Q ss_pred CCcccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeee
Q 006779 14 EGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYN 93 (631)
Q Consensus 14 ~~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~ 93 (631)
.+++.-.+|...|+- ..+||.|+||.||+|+|+.+|+..|+|.|++.. .+...-+.+|+-+++.++|||||.||+
T Consensus 5 ~~disrrnP~ddyel-lqrvgsgTygdvyKaRd~~s~elaavkvVkLep----~dd~~~iqqei~~~~dc~h~nivay~g 79 (829)
T KOG0576|consen 5 KSDISRRNPQDDYEL-LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP----GDDFSGIQQEIGMLRDCRHPNIVAYFG 79 (829)
T ss_pred cchhhhcCCccchhh-eeeecCCcccchhhhcccccCchhhheeeeccC----CccccccccceeeeecCCCcChHHHHh
Confidence 345667799999954 577999999999999999999999999999765 344566788999999999999999999
Q ss_pred eEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEc
Q 006779 94 SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173 (631)
Q Consensus 94 ~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~ 173 (631)
.+.... .+|+.||||.||+|.+...-.+.+++.++..+++..+.||+|||+.+ =+|||||-.||+++ +.|.+|++
T Consensus 80 sylr~d--klwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanillt-d~gDvkla 154 (829)
T KOG0576|consen 80 SYLRRD--KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLT-DEGDVKLA 154 (829)
T ss_pred hhhhhc--CcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeec-ccCceeec
Confidence 987654 47889999999999998888899999999999999999999999998 89999999999998 89999999
Q ss_pred cccccchhcCC--CCccccCCCCCCCcccc----ccccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006779 174 DLGLAIVMQQP--TARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 247 (631)
Q Consensus 174 DFGla~~~~~~--~~~~~~GTp~Y~APEvl----~~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p 247 (631)
|||.+..+... ..++++|||.|||||+- .++|+.++|||++|+...|+.-.+.|-.+-.....++-..+++..|
T Consensus 155 Dfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qp 234 (829)
T KOG0576|consen 155 DFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQP 234 (829)
T ss_pred ccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCC
Confidence 99999776554 45678999999999974 3579999999999999999999999977755555666667778777
Q ss_pred CCCCC--CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCc
Q 006779 248 ASLSK--VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 248 ~~l~~--~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~~ 290 (631)
+.+.. .+.+.+.+|++.||. .|.+||+++.+|.|||.......
T Consensus 235 p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~ 280 (829)
T KOG0576|consen 235 PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSR 280 (829)
T ss_pred CcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccchhh
Confidence 76643 367899999999997 79999999999999999765433
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=271.68 Aligned_cols=256 Identities=21% Similarity=0.395 Sum_probs=209.6
Q ss_pred ccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCceeeeeeEEc
Q 006779 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVD 97 (631)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d 97 (631)
...-...| .+.+.+|+|-|+.||.|++..++++++||.++ +-...++.+|+.+|+.|. ||||++++++..|
T Consensus 33 ~wg~~ddY-eivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-------PVkkkKIkREikIL~nL~gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 33 DWGNQDDY-EIVRKVGRGKYSEVFEGINITNNEKCVIKILK-------PVKKKKIKREIKILQNLRGGPNIIKLLDIVKD 104 (338)
T ss_pred eccccchH-HHHHHHcCccHhhHhcccccCCCceEEEeeec-------hHHHHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence 33344445 45578999999999999999999999999986 334567999999999997 9999999999999
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
+......+|+||+...+.+++. ..++.-.++.++.|++.||.|||+.| |+|||+||.|++|+.....++|+|+|+
T Consensus 105 p~SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGL 179 (338)
T KOG0668|consen 105 PESKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
T ss_pred ccccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecch
Confidence 9888999999999988777665 45888899999999999999999999 999999999999997778999999999
Q ss_pred cchhcCCCC-ccccCCCCCCCccccc--cccCccccchhhhHHHHHHhhcCCCCC-CCCCHHHHHHHHHc----------
Q 006779 178 AIVMQQPTA-RSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYN-ECKNPAQIYKKVTS---------- 243 (631)
Q Consensus 178 a~~~~~~~~-~~~~GTp~Y~APEvl~--~~ys~~sDIwSLGiilyELltG~~Pf~-~~~~~~~i~~~i~~---------- 243 (631)
|..+..... .-.+.+..|--||++- ..|+..-|+|||||++..|+..+-||. +..|.+|+++..+-
T Consensus 180 AEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 180 AEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred HhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence 987765532 2335677888999774 358999999999999999999998875 44667776654321
Q ss_pred -----CCCC-------------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 244 -----GIKP-------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 244 -----~~~p-------------------~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
...| ..-....++++.+|+.++|. |-.+|+||.|++.||||.+.
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 0000 00112246899999999998 99999999999999999763
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=296.65 Aligned_cols=266 Identities=24% Similarity=0.383 Sum_probs=212.7
Q ss_pred cCCcCCccc----ccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-
Q 006779 10 SETEEGEFS----EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK- 84 (631)
Q Consensus 10 ~~~~~~~~~----e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~- 84 (631)
-|++..+|. .+-..+|| .+....|+|-|++|..|.|...|..||||+|.....+ ...=+.|+++|+.|.
T Consensus 414 NWdDaEGYYrv~igE~LD~RY-~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-----~KtGl~EleiLkKL~~ 487 (752)
T KOG0670|consen 414 NWDDAEGYYRVRIGELLDSRY-EVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-----HKTGLKELEILKKLND 487 (752)
T ss_pred CcccccceEEEehhhhhccee-EEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-----hhhhhHHHHHHHHhhc
Confidence 344544443 34456777 5567789999999999999999999999999865443 344568999999995
Q ss_pred -----CCCceeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccC
Q 006779 85 -----HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156 (631)
Q Consensus 85 -----HpnIVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~---~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDL 156 (631)
.-++++++..|... ++++||+|.+ ..+|+..+++.+ .|...+++.+++|++.||..|..+| |+|.||
T Consensus 488 AD~Edk~Hclrl~r~F~hk--nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDI 562 (752)
T KOG0670|consen 488 ADPEDKFHCLRLFRHFKHK--NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADI 562 (752)
T ss_pred cCchhhhHHHHHHHHhhhc--ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeeccc
Confidence 34789999888544 5799999998 579999999865 5889999999999999999999999 999999
Q ss_pred CCCCeeecCCCCcEEEccccccchhcCCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHH
Q 006779 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPA 235 (631)
Q Consensus 157 Kp~NILl~~~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~ 235 (631)
||+||||+.....+||||||.|..........+..+..|.|||++.+ .|+...|+||.||+||||.||+..|.+..|..
T Consensus 563 KPDNiLVNE~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ 642 (752)
T KOG0670|consen 563 KPDNILVNESKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ 642 (752)
T ss_pred CccceEeccCcceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH
Confidence 99999999767789999999998777776677777889999997655 69999999999999999999999999977765
Q ss_pred HHHHHH-HcCCCCCC-------------------------------------------C----CC---CC------cHHH
Q 006779 236 QIYKKV-TSGIKPAS-------------------------------------------L----SK---VT------DPQV 258 (631)
Q Consensus 236 ~i~~~i-~~~~~p~~-------------------------------------------l----~~---~~------~~~l 258 (631)
++.-.. ..|..|.. + .. .. -.++
T Consensus 643 MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~ 722 (752)
T KOG0670|consen 643 MLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQL 722 (752)
T ss_pred HHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHH
Confidence 543111 11111100 0 00 00 1368
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 259 KQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 259 ~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
++|+.+||. +|.+|.|..++|.||||+.
T Consensus 723 rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 723 RDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 999999998 9999999999999999974
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=294.17 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=201.3
Q ss_pred ccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC
Q 006779 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 98 (631)
++=|-.+- ++++.||+|-||.|.++.-. .+..||+|.++... .......|.+|+++|.+|+|||||+++++|+.+
T Consensus 533 ~EfPRs~L-~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a---~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D 607 (807)
T KOG1094|consen 533 VEFPRSRL-RFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDA---TKNARNDFLKEIKILSRLKHPNIVELLGVCVQD 607 (807)
T ss_pred hhcchhhe-ehhhhhcCcccceeEEEEec-CceEEEEeecCccc---chhHHHHHHHHHHHHhccCCCCeeEEEeeeecC
Confidence 33444444 67899999999999999643 36999999987554 244567899999999999999999999999865
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 176 (631)
+ .+++||||++.|+|.+|+.++. .+......+++.||+.|++||.+.+ +|||||.+.|+|++ .++++||+|||
T Consensus 608 e--PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~-~e~~iKiadfg 682 (807)
T KOG1094|consen 608 D--PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVD-GEFTIKIADFG 682 (807)
T ss_pred C--chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeec-CcccEEecCcc
Confidence 4 5889999999999999999984 3455667789999999999999999 99999999999998 78999999999
Q ss_pred ccchhcCCC----CccccCCCCCCCcc-ccccccCccccchhhhHHHHHHhh--cCCCCCCCCCHHHHHHHHHc---CCC
Q 006779 177 LAIVMQQPT----ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT--CEYPYNECKNPAQIYKKVTS---GIK 246 (631)
Q Consensus 177 la~~~~~~~----~~~~~GTp~Y~APE-vl~~~ys~~sDIwSLGiilyELlt--G~~Pf~~~~~~~~i~~~i~~---~~~ 246 (631)
.++.+-... ....+-..+||||| ++.++++.++|+|+||+++||+++ .+.||... ..+++....-. ...
T Consensus 683 msR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l-t~e~vven~~~~~~~~~ 761 (807)
T KOG1094|consen 683 MSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL-TDEQVVENAGEFFRDQG 761 (807)
T ss_pred cccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh-hHHHHHHhhhhhcCCCC
Confidence 997543322 12234567999999 677899999999999999999865 78999874 44455443322 111
Q ss_pred C---CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 247 P---ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 247 p---~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+ ...+..++..+.+++.+||. +..+|||.++|-.
T Consensus 762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 1 23455678889999999998 8899999998743
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-31 Score=295.06 Aligned_cols=259 Identities=23% Similarity=0.329 Sum_probs=183.1
Q ss_pred CceeeeeeEecccCceEEEEEEEc----------------cCCeEEEEEEeecccccCCHH----------HHHHHHHHH
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDE----------------VDGIEVAWNQVNIEDVMQSPD----------QLERLYSEV 77 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~----------------~tg~~VAiK~i~~~~~~~~~~----------~~~~l~~Ei 77 (631)
..| ++.++||+|+||+||+|.+. ..+..||+|++.........+ ..+....|+
T Consensus 145 d~F-~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 145 DDF-QLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred cCc-eEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 345 77899999999999999752 345689999986542110000 112234577
Q ss_pred HHHHhCCCCCc-----eeeeeeEEcC------CCCeEEEEEeccCCCCHHHHHHhC------------------------
Q 006779 78 HLLKSLKHENI-----IKFYNSWVDD------TNRTINMITELFTSGSLRQYRKKH------------------------ 122 (631)
Q Consensus 78 ~iLk~L~HpnI-----Vkl~~~~~d~------~~~~l~lV~Ey~~gGsL~~~l~~~------------------------ 122 (631)
.++..++|.++ ++++++|... .....++|+||+.+++|.+++...
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77788877654 5666666432 123588999999999999988632
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC---CccccCCCCCCCcc
Q 006779 123 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPE 199 (631)
Q Consensus 123 ~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~---~~~~~GTp~Y~APE 199 (631)
..+++..++.++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++....... .....+||.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVT-VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEEC-CCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 12456788999999999999999998 99999999999998 67899999999996543321 11234589999999
Q ss_pred ccccc---------------------cC--ccccchhhhHHHHHHhhcCC-CCCCCC----------CHHHHHHHHHcCC
Q 006779 200 LYEEE---------------------YN--ELVDIYSFGMCILEMVTCEY-PYNECK----------NPAQIYKKVTSGI 245 (631)
Q Consensus 200 vl~~~---------------------ys--~~sDIwSLGiilyELltG~~-Pf~~~~----------~~~~i~~~i~~~~ 245 (631)
++... |+ .+.||||+||++|+|+++.. ||.... +....+..+....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 76421 22 34799999999999999986 664321 1111122222222
Q ss_pred CCCCCCCCCcHHHHHHHHHhcC-CC---CCCCCHHHHhcCCCCCC
Q 006779 246 KPASLSKVTDPQVKQFIEKCIV-PA---SLRLPALELLKDPFLVT 286 (631)
Q Consensus 246 ~p~~l~~~~~~~l~~lI~~cL~-~p---~~Rpsa~elL~hpff~~ 286 (631)
.........++..++|+.++|. +| .+|+|+.|+|.||||.+
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 2222234457889999999997 44 68999999999999965
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=307.38 Aligned_cols=241 Identities=28% Similarity=0.428 Sum_probs=189.0
Q ss_pred eeEecccCceE-EEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCeEEEEE
Q 006779 30 DEILGKGAFKT-VYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 30 ~e~LG~G~fg~-Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
.+++|.|+-|+ ||+|. ..|++||+|++- .+....+.+|+.+|+.. +|||||++|+ .+.+..++||..
T Consensus 514 ~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll-------~e~~~~A~rEi~lL~eSD~H~NviRyyc--~E~d~qF~YIal 582 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGV--YEGREVAVKRLL-------EEFFDFAQREIQLLQESDEHPNVIRYYC--SEQDRQFLYIAL 582 (903)
T ss_pred HHHcccCCCCcEEEEEe--eCCceehHHHHh-------hHhHHHHHHHHHHHHhccCCCceEEEEe--eccCCceEEEEe
Confidence 47899999985 79995 568999999875 23445688999999999 6999999998 556667999999
Q ss_pred eccCCCCHHHHHHhCC-CCCH---HHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC--C--CcEEEccccccc
Q 006779 108 ELFTSGSLRQYRKKHK-NVDM---KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--N--GEVKIGDLGLAI 179 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~-~l~~---~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~--~--g~vKL~DFGla~ 179 (631)
|+|. .+|.+++.... .+.. -..+.++.|+++||++||+.+ ||||||||+||||... + ..++|+|||+++
T Consensus 583 ELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 583 ELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred hHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 9996 59999998851 1111 345788999999999999999 9999999999999742 2 468999999998
Q ss_pred hhcCC-----CCccccCCCCCCCccccccc-cCccccchhhhHHHHHHhhc-CCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006779 180 VMQQP-----TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 180 ~~~~~-----~~~~~~GTp~Y~APEvl~~~-ys~~sDIwSLGiilyELltG-~~Pf~~~~~~~~i~~~i~~~~~p~~l~~ 252 (631)
.+... ......||-.|+|||++... -..++|||||||++|+.++| ..||.+. .+.-...++.......+..
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~--~~R~~NIl~~~~~L~~L~~ 737 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS--LERQANILTGNYTLVHLEP 737 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch--HHhhhhhhcCccceeeecc
Confidence 76433 13356799999999988754 56799999999999999986 8999752 2322333333322333333
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 253 ~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
..+.++++||.+||. +|..||+|.++|.||||=.
T Consensus 738 ~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 738 LPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred CchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 333489999999998 8999999999999999943
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=262.07 Aligned_cols=210 Identities=27% Similarity=0.465 Sum_probs=179.5
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCeEEEEEec
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~l~lV~Ey 109 (631)
+.||+|+||.|-+.++..+|...|+|.+...- +.....++.+|+.+.... ..|.+|.||+.+.+.. -+|+.||.
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tv---n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg--dvwIcME~ 126 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATV---NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG--DVWICMEL 126 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhc---ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc--cEEEeHHH
Confidence 56999999999999999999999999997553 244556788888876554 7999999999887654 48889999
Q ss_pred cCCCCHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC
Q 006779 110 FTSGSLRQYR----KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185 (631)
Q Consensus 110 ~~gGsL~~~l----~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~ 185 (631)
|. .||..+. ++++.+++..+-+++..++.||.|||++= .+||||+||+|||+| ..|++||||||++..+.++.
T Consensus 127 M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn-~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 127 MD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILIN-YDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred hh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEc-cCCcEEEcccccceeehhhh
Confidence 95 5887664 46788999999999999999999999973 599999999999998 89999999999998877776
Q ss_pred Ccc-ccCCCCCCCcccccc-----ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC
Q 006779 186 ARS-VIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 248 (631)
Q Consensus 186 ~~~-~~GTp~Y~APEvl~~-----~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~ 248 (631)
+.+ -.|-..|||||.+.. +|+.++||||||++++||+++++||.....+.+..+.+.....|.
T Consensus 204 Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~ 272 (282)
T KOG0984|consen 204 AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQ 272 (282)
T ss_pred HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCC
Confidence 665 568889999997753 589999999999999999999999999999988888887765543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=289.34 Aligned_cols=240 Identities=26% Similarity=0.426 Sum_probs=207.9
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
.+..+||.|.||.||.|.++.....||+|.++-. .-.++.|+.|+.+|+.++|||+|+++++|..+ .-+|||+
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E--pPFYIiT 342 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE--PPFYIIT 342 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhc-----chhHHHHHHHHHHHHhhcCccHHHHhhhhccC--CCeEEEE
Confidence 4568899999999999999999999999988632 33568899999999999999999999988654 4599999
Q ss_pred eccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC
Q 006779 108 ELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~ 185 (631)
|||..|+|.+|+.... .++.-.++.++.||.+|++||..++ +|||||...|+|+. .+..||++|||+++.+...+
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVg-EnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhcccc-ccceEEeeccchhhhhcCCc
Confidence 9999999999998753 4777788899999999999999999 99999999999995 88899999999999988765
Q ss_pred CccccC---CCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006779 186 ARSVIG---TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 186 ~~~~~G---Tp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~ 260 (631)
-....| ..-|.|||-+. ..++.++|||+||++|||++| |-.||.+ .+..++|..+..+.... -+.-+++.+.+
T Consensus 420 YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-idlSqVY~LLEkgyRM~-~PeGCPpkVYe 497 (1157)
T KOG4278|consen 420 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYGLLEKGYRMD-GPEGCPPKVYE 497 (1157)
T ss_pred eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHHhcccccc-CCCCCCHHHHH
Confidence 444444 34699999765 458999999999999999998 7788987 78899999999887653 34567889999
Q ss_pred HHHHhcC-CCCCCCCHHHHh
Q 006779 261 FIEKCIV-PASLRLPALELL 279 (631)
Q Consensus 261 lI~~cL~-~p~~Rpsa~elL 279 (631)
|+..||+ .|+.||+..|+-
T Consensus 498 LMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 498 LMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHHHHhcCCcccCccHHHHH
Confidence 9999999 899999988753
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=277.98 Aligned_cols=252 Identities=30% Similarity=0.418 Sum_probs=205.2
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC---
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--- 100 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~--- 100 (631)
.||..+ ..+|.|+- .|--|.|..+++.||+|++.... .......+..+|..++..+.|+||++++.+|.-...
T Consensus 17 ~Ry~nL-~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf--~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 17 KRYVNL-KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF--QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeee-cccCCCCc-eEEecchhhccCceehhhhcCcc--ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 577553 66888988 88999999999999999987652 234455778999999999999999999998854322
Q ss_pred -CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 101 -RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 -~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
..+|+|||||. .+|.+.+. -.++-..+..++.|++.|+.|||+.+ |+||||||+||+++ ..+.+||.|||+|.
T Consensus 93 ~~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~-~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 93 FQEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVN-SDCTLKILDFGLAR 166 (369)
T ss_pred HHhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceec-chhheeeccchhhc
Confidence 35889999995 68988876 45788899999999999999999999 99999999999997 78999999999997
Q ss_pred hhcCC-CCccccCCCCCCCcccc-ccccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC-------------
Q 006779 180 VMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG------------- 244 (631)
Q Consensus 180 ~~~~~-~~~~~~GTp~Y~APEvl-~~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~------------- 244 (631)
..... ....++.|..|.|||++ ..+|.+.+||||+||++.||++|+..|.+....++..+.+..-
T Consensus 167 ~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 167 TEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred ccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 65554 45567889999999965 4569999999999999999999999998765555554443321
Q ss_pred -------------------CCCCC-C------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 006779 245 -------------------IKPAS-L------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 245 -------------------~~p~~-l------~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~ 285 (631)
..|.. + ++.....+++++.+||+ +|.+|.++.++|+|||++
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 00100 0 12234578999999998 999999999999999997
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=299.85 Aligned_cols=251 Identities=25% Similarity=0.451 Sum_probs=210.8
Q ss_pred ccCCCCceeeeeeEecccCceEEEEEEEccCC---eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeE
Q 006779 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 95 (631)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg---~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~ 95 (631)
|.||+ |.++.++||.|.||.|++|..+..| ..||||.++.. ....+...|+.|+.+|-+++||||+++-++.
T Consensus 625 EId~s--~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G---ytekqrrdFL~EAsIMGQFdHPNIIrLEGVV 699 (996)
T KOG0196|consen 625 EIDPS--CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG---YTEKQRRDFLSEASIMGQFDHPNIIRLEGVV 699 (996)
T ss_pred hcChh--heEEEEEEecccccceecccccCCCCcceeEEEeeeccC---ccHHHHhhhhhhhhhcccCCCCcEEEEEEEE
Confidence 44444 5678999999999999999988777 67999998754 3567778899999999999999999999976
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcc
Q 006779 96 VDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~D 174 (631)
. ..+-+.||+|||+.|+|+.|++++ +.|+.-++..+++.|+.|++||-..+ +|||||...|||+| .+-..|++|
T Consensus 700 T--ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVN-snLvCKVsD 774 (996)
T KOG0196|consen 700 T--KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVN-SNLVCKVSD 774 (996)
T ss_pred e--cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeec-cceEEEecc
Confidence 3 445788999999999999999876 66999999999999999999999999 99999999999998 788899999
Q ss_pred ccccchhcCCC--CccccC---CCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCC
Q 006779 175 LGLAIVMQQPT--ARSVIG---TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKP 247 (631)
Q Consensus 175 FGla~~~~~~~--~~~~~G---Tp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p 247 (631)
||+++.+.... ..+..| ..+|.|||.+. ++++.++||||+||+|||.+. |+.||.+.. ..++++.|..+...
T Consensus 775 FGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS-NQdVIkaIe~gyRL 853 (996)
T KOG0196|consen 775 FGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-NQDVIKAIEQGYRL 853 (996)
T ss_pred ccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc-hHHHHHHHHhccCC
Confidence 99999876543 112222 45899999764 679999999999999999765 999999855 45666778887653
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 248 ~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
+. +-.++..+.+|+..||+ +-..||...+|+.+
T Consensus 854 Pp-PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 854 PP-PMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred CC-CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 32 33567889999999998 78999999998764
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=291.48 Aligned_cols=248 Identities=25% Similarity=0.411 Sum_probs=206.9
Q ss_pred eeeeEecccCceEEEEEEEccCC---eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg---~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
++.|.||+|.||+|++|.++.-+ ..||+|.+...... .....|.+|+.+|.+|+|||+|++|++..+. -+.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~---~~mddflrEas~M~~L~H~hliRLyGvVl~q---p~m 186 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN---AIMDDFLREASHMLKLQHPHLIRLYGVVLDQ---PAM 186 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc---hhHHHHHHHHHHHHhccCcceeEEeeeeccc---hhh
Confidence 44588999999999999887643 67999998765432 2567899999999999999999999988763 478
Q ss_pred EEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 105 MITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~--~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
||||++.+|+|.+.+.+ ...|....+..++.||+.|+.||.+++ +|||||...|+|+- ....|||+|||+.+.+.
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNllla-sprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLA-SPRTVKICDFGLMRALG 263 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheec-ccceeeeecccceeccC
Confidence 89999999999998876 345889999999999999999999998 99999999999997 57799999999998776
Q ss_pred CCCCcccc-----CCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006779 183 QPTARSVI-----GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 183 ~~~~~~~~-----GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~ 255 (631)
........ -...|.|||.++ ..++.++|+|+||+++|||+| |+.||.++ +..+|.+.|..+.. ..-++.++
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~-~g~qIL~~iD~~er-LpRPk~cs 341 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC-RGIQILKNIDAGER-LPRPKYCS 341 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC-CHHHHHHhcccccc-CCCCCCCh
Confidence 54332222 234699999765 679999999999999999998 89999884 78888888885533 23456778
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
..+.+++..||. .|..|||...|...-++..
T Consensus 342 edIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 342 EDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred HHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 899999999999 8999999999876555544
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-33 Score=274.39 Aligned_cols=252 Identities=27% Similarity=0.453 Sum_probs=201.4
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC---CeEEEEE
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---RTINMIT 107 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~---~~l~lV~ 107 (631)
+-||.|+||+||.+.|..+|+.||+|++. ...++-....++++|+.+|..++|.|++...+...-..- ..+|.|+
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~p--nvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMP--NVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcc--hHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 56999999999999999999999999874 233444556789999999999999999998876533222 2477899
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC--
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-- 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~-- 185 (631)
|+|. .+|..++-.-..++.+.++-+++||+.||+|||+.+ |.||||||.|+|++ .|..+||||||+++.-....
T Consensus 137 ELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVN-SNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 137 ELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVN-SNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEec-cCceEEecccccccccchhhhh
Confidence 9995 488888888888999999999999999999999999 99999999999998 78999999999998655432
Q ss_pred -CccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc-------------------
Q 006779 186 -ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS------------------- 243 (631)
Q Consensus 186 -~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~------------------- 243 (631)
....+.|..|+|||++.+ .|+.++||||.|||+.||+..+..|... ++.+..+.|+.
T Consensus 213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq-~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA-GPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc-ChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 233456899999998865 4999999999999999999999999763 44433333331
Q ss_pred -----CCCCCCCCC--------CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 244 -----GIKPASLSK--------VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 244 -----~~~p~~l~~--------~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
+.+++.++. ....+...++.++|. +|.+|.+..+.+.|+++.....
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL 351 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence 233333322 123466777778887 8999999999999999876543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=275.51 Aligned_cols=256 Identities=27% Similarity=0.413 Sum_probs=196.3
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-----C---CCceeeeee
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-----H---ENIIKFYNS 94 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-----H---pnIVkl~~~ 94 (631)
.||| -+.++||.|-|++||+|.|+...+.||+|+++-. ....+....||++|++++ | ..||++++.
T Consensus 77 ~gRY-~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 77 GGRY-HVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred CceE-EEEEeccccccceeEEEeeccCCeEEEEEEEehh-----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 4788 6678999999999999999999999999999743 334577889999999983 3 369999998
Q ss_pred EEc--CCCCeEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC----
Q 006779 95 WVD--DTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN---- 166 (631)
Q Consensus 95 ~~d--~~~~~l~lV~Ey~~gGsL~~~l~~--~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~---- 166 (631)
|.. .++.+++||+|++ |.+|..+|++ ++.++...++.|++|||.||.|||..- +|||.||||+|||+...
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl~~~e~~~ 228 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLLCSTEIDP 228 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeeeeccccch
Confidence 864 3456899999999 6788888876 467999999999999999999999863 59999999999999200
Q ss_pred --------------------------------------------------------------------------------
Q 006779 167 -------------------------------------------------------------------------------- 166 (631)
Q Consensus 167 -------------------------------------------------------------------------------- 166 (631)
T Consensus 229 ~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~ 308 (590)
T KOG1290|consen 229 AKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPR 308 (590)
T ss_pred hhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccC
Confidence
Q ss_pred -----------------------------C--------------------------------------------------
Q 006779 167 -----------------------------N-------------------------------------------------- 167 (631)
Q Consensus 167 -----------------------------~-------------------------------------------------- 167 (631)
+
T Consensus 309 ~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~ 388 (590)
T KOG1290|consen 309 INGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPE 388 (590)
T ss_pred CCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCc
Confidence 0
Q ss_pred --CcEEEccccccchhcCCCCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCC------CH---H
Q 006779 168 --GEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK------NP---A 235 (631)
Q Consensus 168 --g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~------~~---~ 235 (631)
-++||+|||-|+......+ .-+-|..|+|||++- .+|++.+||||++|+++||+||.+.|.... +. +
T Consensus 389 ~di~vKIaDlGNACW~~khFT-~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA 467 (590)
T KOG1290|consen 389 CDIRVKIADLGNACWVHKHFT-EDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA 467 (590)
T ss_pred cceeEEEeeccchhhhhhhhc-hhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence 0257777777776554432 234588999999765 579999999999999999999999985321 11 2
Q ss_pred HHHHHH--------HcCCC------------------CCCC----------CCCCcHHHHHHHHHhcC-CCCCCCCHHHH
Q 006779 236 QIYKKV--------TSGIK------------------PASL----------SKVTDPQVKQFIEKCIV-PASLRLPALEL 278 (631)
Q Consensus 236 ~i~~~i--------~~~~~------------------p~~l----------~~~~~~~l~~lI~~cL~-~p~~Rpsa~el 278 (631)
.+++.+ ..|.. +-.+ +.....++.+|+.-||. +|.+||||.+.
T Consensus 468 ~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c 547 (590)
T KOG1290|consen 468 LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC 547 (590)
T ss_pred HHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence 222211 11111 1000 11112568899999998 99999999999
Q ss_pred hcCCCCCCC
Q 006779 279 LKDPFLVTD 287 (631)
Q Consensus 279 L~hpff~~~ 287 (631)
|+||||.+.
T Consensus 548 l~hPwLn~~ 556 (590)
T KOG1290|consen 548 LKHPWLNPV 556 (590)
T ss_pred hcCccccCC
Confidence 999999763
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=312.97 Aligned_cols=236 Identities=20% Similarity=0.320 Sum_probs=178.3
Q ss_pred eeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEe
Q 006779 29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE 108 (631)
Q Consensus 29 ~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~E 108 (631)
..++||+|+||.||+|.+..+|..||+|++..... ....|++.+++++|||||++++++.+.. ..++|||
T Consensus 694 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~l~~l~HpnIv~~~~~~~~~~--~~~lv~E 763 (968)
T PLN00113 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--------IPSSEIADMGKLQHPNIVKLIGLCRSEK--GAYLIHE 763 (968)
T ss_pred cccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--------ccHHHHHHHhhCCCCCcceEEEEEEcCC--CCEEEEe
Confidence 34689999999999999999999999998863321 1124688999999999999999987653 5789999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCCc
Q 006779 109 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187 (631)
Q Consensus 109 y~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~ 187 (631)
|+++|+|.+++.. +++..+..++.||+.||+|||.+ .++|+||||||+||+++ .++..++. ||.+..... ..
T Consensus 764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~-~~~~~~~~-~~~~~~~~~--~~ 836 (968)
T PLN00113 764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID-GKDEPHLR-LSLPGLLCT--DT 836 (968)
T ss_pred CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC-CCCceEEE-ecccccccc--CC
Confidence 9999999999963 88999999999999999999954 34599999999999998 56666664 555433222 12
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCC----CHHHHHHHHHcCC-----CCCCCCC-----
Q 006779 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK----NPAQIYKKVTSGI-----KPASLSK----- 252 (631)
Q Consensus 188 ~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~----~~~~i~~~i~~~~-----~p~~l~~----- 252 (631)
...||+.|+|||++.+ .|+.++|||||||++|||+||+.||.... ............. ..+.+..
T Consensus 837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (968)
T PLN00113 837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916 (968)
T ss_pred CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence 3468999999998764 59999999999999999999999985321 1111111111100 0011100
Q ss_pred -CCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 253 -VTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 253 -~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
....++.+++.+||. +|.+||++.|+++.
T Consensus 917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 917 QNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred HHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 112356788999998 89999999999874
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=289.03 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=207.8
Q ss_pred ccccCCCCceeeeeeEecccCceEEEEEEEc----c---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCc
Q 006779 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDE----V---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENI 88 (631)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~----~---tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnI 88 (631)
.+|.+..++ .+.+.||.|+||.|++|.-. . ....||+|..+... ...+.+.+..|+.+|+.+ +||||
T Consensus 290 ~~e~~~~~l--~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~---~~~~~~~~~~El~~m~~~g~H~ni 364 (609)
T KOG0200|consen 290 KWEIPRENL--KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA---SSSEKKDLMSELNVLKELGKHPNI 364 (609)
T ss_pred ceeechhhc--cccceeecccccceEeEEEeecccccccceEEEEEEeccccc---CcHHHHHHHHHHHHHHHhcCCcch
Confidence 556666655 45569999999999999642 1 25679999876443 236778899999999999 69999
Q ss_pred eeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEE
Q 006779 89 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPII 152 (631)
Q Consensus 89 Vkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~----------------~l~~~~i~~i~~QIl~aL~yLHs~~~~Ii 152 (631)
+.+.+.+.. ...+++|+||+..|+|..|++..+ .++...+..++.||+.|++||++.. +|
T Consensus 365 v~llG~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~v 440 (609)
T KOG0200|consen 365 VNLLGACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CV 440 (609)
T ss_pred hhheeeecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--cc
Confidence 999998866 457889999999999999998766 3889999999999999999999998 99
Q ss_pred eccCCCCCeeecCCCCcEEEccccccchhcCCCCc---cccC--CCCCCCcccccc-ccCccccchhhhHHHHHHhh-cC
Q 006779 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIG--TPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CE 225 (631)
Q Consensus 153 HrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~---~~~G--Tp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~ 225 (631)
||||-.+|||+. .+..+||+|||+++........ ...| ...|||||.+.. .|+.++|||||||+||||+| |.
T Consensus 441 HRDLAaRNVLi~-~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~ 519 (609)
T KOG0200|consen 441 HRDLAARNVLIT-KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGG 519 (609)
T ss_pred chhhhhhhEEec-CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCC
Confidence 999999999997 7779999999999754433222 1122 335999997764 69999999999999999998 88
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 226 YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 226 ~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.||.+......+++.+..|.+.. .+..+++++.++++.||. +|..||+..++..
T Consensus 520 ~PYp~~~~~~~l~~~l~~G~r~~-~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 520 TPYPGIPPTEELLEFLKEGNRME-QPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CCCCCCCcHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 99988655777788888887754 345568999999999998 8999999988764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=268.33 Aligned_cols=247 Identities=30% Similarity=0.500 Sum_probs=190.2
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC--CCCCceeeeeeEEcC--
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL--KHENIIKFYNSWVDD-- 98 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L--~HpnIVkl~~~~~d~-- 98 (631)
-.|-.++.+.||+|.||.||+|.+ .|+.||+|++.-. +....++|.++.+.. +|+||+.|+..=...
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~sr-------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSR-------DERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred hhheeEEEEEecCccccceeeccc--cCCceEEEEeccc-------chhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 356678889999999999999965 5899999998633 335588888888765 999999999742211
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh------CCCCEEeccCCCCCeeecCCCCcEEE
Q 006779 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS------HNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs------~~~~IiHrDLKp~NILl~~~~g~vKL 172 (631)
.-..+|+|++|.+.|||.+|+.+ ..++.....+++..++.||++||. ..|.|.|||||..||||. .+|..-|
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK-kn~~C~I 357 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCI 357 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc-cCCcEEE
Confidence 12369999999999999999998 569999999999999999999995 236799999999999996 8999999
Q ss_pred ccccccchhcCC------CCccccCCCCCCCccccccccC-------ccccchhhhHHHHHHhh----------cCCCCC
Q 006779 173 GDLGLAIVMQQP------TARSVIGTPEFMAPELYEEEYN-------ELVDIYSFGMCILEMVT----------CEYPYN 229 (631)
Q Consensus 173 ~DFGla~~~~~~------~~~~~~GTp~Y~APEvl~~~ys-------~~sDIwSLGiilyELlt----------G~~Pf~ 229 (631)
+|+|+|...... .....+||.+|||||++....+ ..+||||||.++||++. -..||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 999999654433 2456789999999999976432 36899999999999985 257775
Q ss_pred CC----CCHHHHHHHHHcCCCCCCCCCCC--cH---HHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 230 EC----KNPAQIYKKVTSGIKPASLSKVT--DP---QVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 230 ~~----~~~~~i~~~i~~~~~p~~l~~~~--~~---~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+. .+.+++.+.+--....+.++..+ ++ .+.++++.||. +|.-|.||-.+-+
T Consensus 438 d~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 438 DVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred cCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 42 33455555544333322333222 23 45677899997 8999999876543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=268.96 Aligned_cols=238 Identities=28% Similarity=0.456 Sum_probs=184.6
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh--CCCCCceeeeeeEEcCC--CCeE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS--LKHENIIKFYNSWVDDT--NRTI 103 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~--L~HpnIVkl~~~~~d~~--~~~l 103 (631)
.+.++||+|.||.||+|. -+++.||||++.. ...+.+..|-.+.+. ++|+||++|+++=...+ ...+
T Consensus 213 ~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~-------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPE-------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred hhHHHhhcCccceeehhh--ccCceeEEEecCH-------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 567899999999999995 5579999999863 345667777777665 48999999998532222 3378
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCEEeccCCCCCeeecCCCCcEEEcccc
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH-------NPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~-------~~~IiHrDLKp~NILl~~~~g~vKL~DFG 176 (631)
++|++|.+.|+|-+|++.+- +++....+++.-++.||+|||+- .|+|+|||||..||||. ++++.-|+|||
T Consensus 284 wLVt~fh~kGsL~dyL~~nt-isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK-~DlTccIaDFG 361 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKANT-ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK-NDLTCCIADFG 361 (534)
T ss_pred eEEeeeccCCcHHHHHHhcc-ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc-cCCcEEeeccc
Confidence 99999999999999998865 89999999999999999999973 36799999999999996 89999999999
Q ss_pred ccchhcCC----CCccccCCCCCCCccccccccC-------ccccchhhhHHHHHHhhcC------------CCCC----
Q 006779 177 LAIVMQQP----TARSVIGTPEFMAPELYEEEYN-------ELVDIYSFGMCILEMVTCE------------YPYN---- 229 (631)
Q Consensus 177 la~~~~~~----~~~~~~GTp~Y~APEvl~~~ys-------~~sDIwSLGiilyELltG~------------~Pf~---- 229 (631)
+|..+... .....+||.+|||||++++..+ ...||||+|.++|||++.- .||.
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 99766432 2344789999999999987432 3589999999999998743 2232
Q ss_pred CCCCHHHHHHHHHcCCCCCCCCC----C-CcHHHHHHHHHhcC-CCCCCCCHH
Q 006779 230 ECKNPAQIYKKVTSGIKPASLSK----V-TDPQVKQFIEKCIV-PASLRLPAL 276 (631)
Q Consensus 230 ~~~~~~~i~~~i~~~~~p~~l~~----~-~~~~l~~lI~~cL~-~p~~Rpsa~ 276 (631)
.....+++...+.+....+.++. . .-..+++.|+.||. |+..|+||.
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 11223445555554443333332 2 23568999999998 999999974
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=234.42 Aligned_cols=208 Identities=38% Similarity=0.652 Sum_probs=183.1
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEeccCC
Q 006779 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112 (631)
Q Consensus 33 LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~~g 112 (631)
||+|++|.||++.+..+|..+++|.+..... ......+.+|++.++.++|++|+++++++... ...++++||+.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS---SSLLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccc---hhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCCC
Confidence 6899999999999988899999999875432 11456799999999999999999999988654 578899999999
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC-CCcEEEccccccchhcCCC--Ccc
Q 006779 113 GSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQPT--ARS 188 (631)
Q Consensus 113 GsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~-~g~vKL~DFGla~~~~~~~--~~~ 188 (631)
++|..++... ..++...+..++.+++.+|.+||+++ ++|+||+|.||+++ . ++.++|+|||.+....... ...
T Consensus 76 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~-~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (215)
T cd00180 76 GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLD-SDNGKVKLADFGLSKLLTSDKSLLKT 152 (215)
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEe-CCCCcEEEecCCceEEccCCcchhhc
Confidence 9999999876 57899999999999999999999998 99999999999998 5 7899999999997665543 444
Q ss_pred ccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 006779 189 VIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 189 ~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL 266 (631)
..+...|++||.+.. .++.+.|+|+||+++++| ..+.+++.+|+
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~~~l 198 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------PELKDLIRKML 198 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------HHHHHHHHHHh
Confidence 567889999998765 678899999999999999 57899999999
Q ss_pred C-CCCCCCCHHHHhcCC
Q 006779 267 V-PASLRLPALELLKDP 282 (631)
Q Consensus 267 ~-~p~~Rpsa~elL~hp 282 (631)
. +|.+||++.++++|+
T Consensus 199 ~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 199 QKDPEKRPSAKEILEHL 215 (215)
T ss_pred hCCcccCcCHHHHhhCC
Confidence 7 899999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=279.40 Aligned_cols=240 Identities=31% Similarity=0.494 Sum_probs=199.8
Q ss_pred eeEecccCceEEEEEEEccCC----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEE
Q 006779 30 DEILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 30 ~e~LG~G~fg~Vy~a~d~~tg----~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~l 105 (631)
.++||+|+||+||+|.+...| .+||||++... ..++....+..|+-.|.+|+|||++++++++... .+-|
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~---t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s---~~ql 774 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF---TSPKASIELLDEALRMASLDHPNLLRLLGVCMLS---TLQL 774 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeecc---CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc---hHHH
Confidence 478999999999999987766 46777776533 3445567799999999999999999999988654 3778
Q ss_pred EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 106 ITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
|++|++.|+|.+|++.+ .++-.+..+.|+.||++|+.|||.+. ++||||-.+||||. .-..+||.|||+++.+...
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVk-sP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVK-SPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeec-CCCeEEEEecchhhccCcc
Confidence 99999999999999876 46899999999999999999999998 99999999999997 6679999999999877654
Q ss_pred CCc----cccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006779 185 TAR----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 185 ~~~----~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l 258 (631)
... .....+-|||-|.+. ..|+.++||||||+++||++| |..||.+ ...++|-+.+..|.+ ..-+.+.+..+
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g-i~~~eI~dlle~geR-LsqPpiCtiDV 929 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG-IPAEEIPDLLEKGER-LSQPPICTIDV 929 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC-CCHHHhhHHHhcccc-CCCCCCccHHH
Confidence 322 112245688888554 569999999999999999998 8899987 667788888877766 34456778889
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhc
Q 006779 259 KQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 259 ~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
..++.+||. |+..||+++++..
T Consensus 930 y~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 930 YMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHhccCcccCccHHHHHH
Confidence 999999997 8999999888653
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=269.78 Aligned_cols=208 Identities=29% Similarity=0.441 Sum_probs=179.5
Q ss_pred ccccCCCCc--eeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCH----HHHHHHHHHHHHHHhCC---CCC
Q 006779 17 FSEKDPSCR--YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP----DQLERLYSEVHLLKSLK---HEN 87 (631)
Q Consensus 17 ~~e~dp~gR--y~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~----~~~~~l~~Ei~iLk~L~---Hpn 87 (631)
-+|.-+... |.. -+.+|.|+||.|++|.++...-+|+||.|..++...+. ..+-.+-.||++|..|+ |+|
T Consensus 552 ~~e~~~~k~s~ytt-lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~N 630 (772)
T KOG1152|consen 552 GCEKEYKKFSDYTT-LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHEN 630 (772)
T ss_pred cceeeeccccccee-eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccc
Confidence 444445444 533 46799999999999999999999999998776544321 12234678999999997 999
Q ss_pred ceeeeeeEEcCCCCeEEEEEeccC-CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC
Q 006779 88 IIKFYNSWVDDTNRTINMITELFT-SGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 166 (631)
Q Consensus 88 IVkl~~~~~d~~~~~l~lV~Ey~~-gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~ 166 (631)
|++++++|.+. .++|++||-.. |-+|.+|+..+..+++...+.+++|++.|+++||++| |||||||-+|+.++ .
T Consensus 631 IlKlLdfFEdd--d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd-~ 705 (772)
T KOG1152|consen 631 ILKLLDFFEDD--DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVD-S 705 (772)
T ss_pred hhhhhheeecC--CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEe-c
Confidence 99999999654 57999999874 5699999999999999999999999999999999999 99999999999998 7
Q ss_pred CCcEEEccccccchhcCCCCccccCCCCCCCccccccc-c-CccccchhhhHHHHHHhhcCCCCCC
Q 006779 167 NGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNE 230 (631)
Q Consensus 167 ~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~~-y-s~~sDIwSLGiilyELltG~~Pf~~ 230 (631)
+|-+||+|||.+....+.....++||..|.|||++.++ | +..-|||+||+++|-++..+.||..
T Consensus 706 ~g~~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 706 NGFVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred CCeEEEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 89999999999988888888899999999999999875 4 6789999999999999999999853
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-27 Score=236.06 Aligned_cols=211 Identities=34% Similarity=0.553 Sum_probs=181.0
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||.|++|.||+|.+..++..+|+|.+...... .....+.+|+..++.++|+|++++++.+... ...++++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~ 76 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDP--EPLYLVM 76 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecC--CceEEEE
Confidence 5678999999999999999999999999998754321 2567889999999999999999999987654 4688999
Q ss_pred eccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC--
Q 006779 108 ELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 184 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~-l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-- 184 (631)
||+.+++|.+++..... +++..+..++.|++.+|.|||+++ ++|+||+|.||+++ .++.++|+|||.+......
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~-~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLG-MDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeeCceeeEecCccc
Confidence 99999999999988777 899999999999999999999998 99999999999998 6789999999999766543
Q ss_pred -CCccccCCCCCCCcccc-c-cccCccccchhhhHHHHHHhhcCCCCCC-CCCHHHHHHHHHcCCC
Q 006779 185 -TARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILEMVTCEYPYNE-CKNPAQIYKKVTSGIK 246 (631)
Q Consensus 185 -~~~~~~GTp~Y~APEvl-~-~~ys~~sDIwSLGiilyELltG~~Pf~~-~~~~~~i~~~i~~~~~ 246 (631)
......++..|++||.+ . ..++.++|+|+||+++++|++|+.||.. ..+..++.+.+..+..
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence 23445678899999987 3 3477799999999999999999999976 4555677777777653
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=261.19 Aligned_cols=250 Identities=26% Similarity=0.436 Sum_probs=198.0
Q ss_pred ceeeeeeEecccCceEEEEEEEcc---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCC
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN 100 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~---tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~ 100 (631)
.+++..++||.|.|++||+|.+.. .++.||+|.+.... ...++..|+++|..+ -+.||+++.+.+- .+
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts------~p~ri~~El~~L~~~gG~~ni~~~~~~~r--nn 107 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS------SPSRILNELEMLYRLGGSDNIIKLNGCFR--NN 107 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc------CchHHHHHHHHHHHhccchhhhcchhhhc--cC
Confidence 356778999999999999999988 78999999987553 235588999999999 5899999999774 45
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
..+.+|+||++.....++... ++...++.+++.++.||.++|.+| ||||||||.|+|.+...+.-.|+|||+|..
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred CeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHHH
Confidence 578899999999999888765 679999999999999999999999 999999999999998888999999999851
Q ss_pred hc---------C------CC-------------------------------CccccCCCCCCCcccccc--ccCccccch
Q 006779 181 MQ---------Q------PT-------------------------------ARSVIGTPEFMAPELYEE--EYNELVDIY 212 (631)
Q Consensus 181 ~~---------~------~~-------------------------------~~~~~GTp~Y~APEvl~~--~ys~~sDIw 212 (631)
.. . .. .-...|||+|.|||++.. .-++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 10 0 00 001358999999998754 367899999
Q ss_pred hhhHHHHHHhhcCCCCCCCCCHHHHHHHHH--------------cCC---------------------------------
Q 006779 213 SFGMCILEMVTCEYPYNECKNPAQIYKKVT--------------SGI--------------------------------- 245 (631)
Q Consensus 213 SLGiilyELltG~~Pf~~~~~~~~i~~~i~--------------~~~--------------------------------- 245 (631)
|.|+|++-++++.+||....+.......+. .|.
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 999999999999999965443211111100 000
Q ss_pred --CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 246 --KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 246 --~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.+.......+..+.+|+.+||. +|.+|.||+++|+||||...
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 0011122345689999999998 99999999999999999843
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-28 Score=247.99 Aligned_cols=273 Identities=33% Similarity=0.552 Sum_probs=213.2
Q ss_pred cCCcCCcccccCCCCceeeeeeEecccC---ceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC
Q 006779 10 SETEEGEFSEKDPSCRYGRYDEILGKGA---FKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86 (631)
Q Consensus 10 ~~~~~~~~~e~dp~gRy~r~~e~LG~G~---fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~Hp 86 (631)
...++.+|++.+|++||++.++.+|+.. .-.||++.+..+|.+|+|..|..........+.++...-++.|-++.|.
T Consensus 48 ~s~~~~eIleesp~~rw~krreqv~qrdvPgid~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHs 127 (458)
T KOG1266|consen 48 DSEDESEILEESPCGRWGKRREQVGQRDVPGIDDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHS 127 (458)
T ss_pred cccchhhhhccCchhhhhhhhhhccCCCCCchHHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHH
Confidence 4466899999999999999999999854 3578999999999999999998776666555666677778889999999
Q ss_pred CceeeeeeEEcCCC---CeEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCC
Q 006779 87 NIIKFYNSWVDDTN---RTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159 (631)
Q Consensus 87 nIVkl~~~~~d~~~---~~l~lV~Ey~~gGsL~~~l~~~----~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~ 159 (631)
|||+++.+|.+... ..+.|++|||..|+|.+++++. ..+....+++|+.||+.||.|||++.|||+|+++.|+
T Consensus 128 nlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~ 207 (458)
T KOG1266|consen 128 NLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCD 207 (458)
T ss_pred HHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchh
Confidence 99999999977543 4688999999999999999863 4688999999999999999999999999999999999
Q ss_pred CeeecCCCCcEEEccccccchhc------CCCCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCC
Q 006779 160 NIFVNGNNGEVKIGDLGLAIVMQ------QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK 232 (631)
Q Consensus 160 NILl~~~~g~vKL~DFGla~~~~------~~~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~ 232 (631)
.||+. ++|.+||+--.....-. ........+-++|.|||.-. .+.+.++|||+||+|+++|..++..-....
T Consensus 208 tifiq-~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnse 286 (458)
T KOG1266|consen 208 TIFIQ-HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSE 286 (458)
T ss_pred heeec-CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCc
Confidence 99998 99999987543321110 00111234678899999643 346678999999999999999987754433
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 233 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 233 ~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
.....-..+.. .+....++.-+.+|.+||. .|..||++.++|.||.+....
T Consensus 287 S~~~~ee~ia~-----~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh 338 (458)
T KOG1266|consen 287 SKVEVEENIAN-----VIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH 338 (458)
T ss_pred ceeehhhhhhh-----heeeccCccccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence 22111111111 1122334567889999999 799999999999999887643
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=277.55 Aligned_cols=199 Identities=19% Similarity=0.239 Sum_probs=146.9
Q ss_pred HhCCC-CCceeeeeeEEc----C-CCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEe
Q 006779 81 KSLKH-ENIIKFYNSWVD----D-TNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIH 153 (631)
Q Consensus 81 k~L~H-pnIVkl~~~~~d----~-~~~~l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiH 153 (631)
+.++| +||++++++|.. . ....+++++||+ +++|.+++.. ...+++..++.+++||+.||.|||+++ |+|
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvH 103 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVV 103 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence 34455 577778877621 1 123577788987 6799999975 456999999999999999999999999 999
Q ss_pred ccCCCCCeeecC------------------CCCcEEEccccccchhcCC------------------CCccccCCCCCCC
Q 006779 154 RDLKCDNIFVNG------------------NNGEVKIGDLGLAIVMQQP------------------TARSVIGTPEFMA 197 (631)
Q Consensus 154 rDLKp~NILl~~------------------~~g~vKL~DFGla~~~~~~------------------~~~~~~GTp~Y~A 197 (631)
|||||+||||+. .++.+||+|||+++..... .....+||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999951 3456777788877532110 0012468999999
Q ss_pred ccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH
Q 006779 198 PELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA 275 (631)
Q Consensus 198 PEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa 275 (631)
||++. ..|+.++|||||||++|||++|..|+.. .......+.....|.... ...+...+++.+||. +|.+||++
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~---~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~L~~~P~~Rps~ 259 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE---KSRTMSSLRHRVLPPQIL-LNWPKEASFCLWLLHPEPSCRPSM 259 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh---HHHHHHHHHHhhcChhhh-hcCHHHHHHHHHhCCCChhhCcCh
Confidence 99765 4699999999999999999999888753 222222333222232221 124567889999998 89999999
Q ss_pred HHHhcCCCCCC
Q 006779 276 LELLKDPFLVT 286 (631)
Q Consensus 276 ~elL~hpff~~ 286 (631)
.|+|+||||..
T Consensus 260 ~eil~h~~~~~ 270 (793)
T PLN00181 260 SELLQSEFINE 270 (793)
T ss_pred HHHhhchhhhh
Confidence 99999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-26 Score=220.19 Aligned_cols=160 Identities=26% Similarity=0.352 Sum_probs=128.1
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCCccccC
Q 006779 113 GSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 191 (631)
Q Consensus 113 GsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~~~G 191 (631)
|+|.+++..+ ..+++..++.|+.||+.||.|||+++ ||+|||++ .++.+|+ ||++....... ..|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~-~~~~~~~--fG~~~~~~~~~---~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLT-WDGLLKL--DGSVAFKTPEQ---SRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEc-Cccceee--ccceEeecccc---CCC
Confidence 7899999874 56999999999999999999999986 99999997 7889999 99987654322 268
Q ss_pred CCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC-----CCCCcH--HHHHHHH
Q 006779 192 TPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL-----SKVTDP--QVKQFIE 263 (631)
Q Consensus 192 Tp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l-----~~~~~~--~l~~lI~ 263 (631)
|+.|||||++.+ .|+.++|||||||++|||+||+.||............+.....+... ....+. .+++||.
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 146 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR 146 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence 999999998754 58999999999999999999999997654444444444443322211 111222 6999999
Q ss_pred HhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 264 KCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 264 ~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
+||. +|.+||++.+++.|+|+..
T Consensus 147 ~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 147 VCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhcccccccCHHHHHHHHHHHH
Confidence 9998 8999999999999999853
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=227.67 Aligned_cols=254 Identities=21% Similarity=0.314 Sum_probs=189.5
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcC
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 98 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~ 98 (631)
.+-...| .+.++||+|.||.+-++.|+.++..+++|.+.... .....|.+|.+.--.| .|.||+.-|++-+..
T Consensus 20 v~l~d~y-~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt 93 (378)
T KOG1345|consen 20 VDLEDVY-TINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT 93 (378)
T ss_pred cchhhhh-hHHHHhcccceeeEEeeeccCCceEEEeeccCcch-----hhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence 3344445 56788999999999999999999999999997543 3456789999887777 589999999865543
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC-CCCcEEEccccc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGL 177 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~-~~g~vKL~DFGl 177 (631)
.+.+++++||++-|+|..-+...+ +-+...+.++.|+++||.|+|+.+ +||||||.+||||-. +.-.|||||||+
T Consensus 94 -~d~YvF~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 94 -SDAYVFVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred -CceEEEeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeeccc
Confidence 347889999999999998776644 789999999999999999999999 999999999999953 334899999999
Q ss_pred cchhcCCCCccccCCCCCCCcccccc----c--cCccccchhhhHHHHHHhhcCCCCCCCCCHHHHH---HHHHcCCCC-
Q 006779 178 AIVMQQPTARSVIGTPEFMAPELYEE----E--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY---KKVTSGIKP- 247 (631)
Q Consensus 178 a~~~~~~~~~~~~GTp~Y~APEvl~~----~--ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~---~~i~~~~~p- 247 (631)
.+..... ....-.+..|.+||++.. . .++.+|||.|||++|.++||..||.......+-| ....++..+
T Consensus 170 t~k~g~t-V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~ 248 (378)
T KOG1345|consen 170 TRKVGTT-VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPA 248 (378)
T ss_pred ccccCce-ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCcc
Confidence 8643332 222334667899997642 2 4688999999999999999999997532222222 222222222
Q ss_pred -CCCCCCCcHHHHHHHHHhcC-CCCCC---CCHHHHhcCCCC
Q 006779 248 -ASLSKVTDPQVKQFIEKCIV-PASLR---LPALELLKDPFL 284 (631)
Q Consensus 248 -~~l~~~~~~~l~~lI~~cL~-~p~~R---psa~elL~hpff 284 (631)
+..-+..++.+..+.++-|. ++..| .++....+..|.
T Consensus 249 ~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 249 LPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred CchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 22223456778888888888 56556 466666666655
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.9e-25 Score=227.10 Aligned_cols=244 Identities=22% Similarity=0.321 Sum_probs=198.9
Q ss_pred eeeeEecccCceEEEEEEEccCC-----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDG-----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg-----~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
|+.-++-+|+||.||.|+..++. +.|-+|.++.. .++-+...+..|--++..+.|||+..+.++.+... ..
T Consensus 287 ~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~---AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~-~~ 362 (563)
T KOG1024|consen 287 RLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH---ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY-AT 362 (563)
T ss_pred echhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc---ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc-Cc
Confidence 55567889999999999776543 33445555422 24566788999999999999999999999887644 46
Q ss_pred EEEEEeccCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcc
Q 006779 103 INMITELFTSGSLRQYRKKH--------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~--------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~D 174 (631)
.+.++.++.-|+|+.|+... ..++..++..++.|+..|++|||.++ |||.||..+|.+|+ +.-++||+|
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvId-d~LqVkltD 439 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVID-DQLQVKLTD 439 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceeh-hheeEEecc
Confidence 67788999999999999832 24677888999999999999999999 99999999999998 778999999
Q ss_pred ccccchhcCCCC----ccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCC
Q 006779 175 LGLAIVMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPA 248 (631)
Q Consensus 175 FGla~~~~~~~~----~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~ 248 (631)
=.+++.+-...- ........||+||.+. ..|+.++|+||||+++|||+| |+.||.+ .+|.++...++.|.+-.
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae-IDPfEm~~ylkdGyRla 518 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE-IDPFEMEHYLKDGYRLA 518 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc-cCHHHHHHHHhccceec
Confidence 988865433211 1122355799999775 469999999999999999998 8999987 78999999999987643
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 249 ~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
-+.+++.++..++..||+ .|.+||+..++..
T Consensus 519 -QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 519 -QPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred -CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 345678899999999998 8999999998764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-23 Score=209.16 Aligned_cols=251 Identities=30% Similarity=0.456 Sum_probs=203.8
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC-CceeeeeeEEcCCCCeEEE
Q 006779 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~Hp-nIVkl~~~~~d~~~~~l~l 105 (631)
+++.+.||.|+|+.||++.+. ..+++|.+....... ......+.+|+.+++.+.|+ +|+++++.+... ...++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESK-SKEVERFLREIQILASLNHPPNIVKLYDFFQDE--GSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccc-hhHHHHHHHHHHHHHHccCCcceeeEEEEEecC--CEEEE
Confidence 367789999999999999888 788999887654322 23567799999999999988 799999988443 34789
Q ss_pred EEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCC-cEEEccccccchh
Q 006779 106 ITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIVM 181 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~---~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g-~vKL~DFGla~~~ 181 (631)
+++++.+++|.+++.... .++......++.|++.++.|+|+.+ ++|||+||+||+++ ..+ .++++|||.+...
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~-~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLD-RDGRVVKLIDFGLAKLL 152 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeec-CCCCeEEEeccCcceec
Confidence 999999999998887765 7999999999999999999999999 99999999999998 555 7999999998754
Q ss_pred cCC--------CCccccCCCCCCCcccccc----ccCccccchhhhHHHHHHhhcCCCCCCCCC---HHHHHHHHHcCCC
Q 006779 182 QQP--------TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIK 246 (631)
Q Consensus 182 ~~~--------~~~~~~GTp~Y~APEvl~~----~ys~~sDIwSLGiilyELltG~~Pf~~~~~---~~~i~~~i~~~~~ 246 (631)
... ......||+.|+|||.+.. .+....|+||+|++++++++|..||..... ..+....+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (384)
T COG0515 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232 (384)
T ss_pred CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence 432 2356789999999998764 578899999999999999999999876553 4566666655443
Q ss_pred C-CCCCCCC------cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 247 P-ASLSKVT------DPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 247 p-~~l~~~~------~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
+ ....... ...+.+++.+++. +|..|.+..+...++|...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 3 1111111 1578999999998 7999999999888866654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-25 Score=249.74 Aligned_cols=261 Identities=25% Similarity=0.380 Sum_probs=202.2
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecc--cccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIE--DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~--~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
..|++..+++|.|++|.|+.+.........++|.+... ...........+..|+-+-..|+|||++.....+.+...
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~- 395 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG- 395 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-
Confidence 45778889999999999999988888777777765422 111122222337788888899999999887765544332
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
..-+||||++ +|..++...+.+....+..+++|++.||.|+|++| |.||||||+|++++ .+|.+||+|||.+...
T Consensus 396 -~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~-~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 396 -ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVT-ENGILKIIDFGAASVF 470 (601)
T ss_pred -chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEe-cCCceEEeecCcceee
Confidence 3334999998 99999998888999999999999999999999999 99999999999998 8899999999999765
Q ss_pred cCC------CCccccCCCCCCCcccccc-ccC-ccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHH-HcC-----CCC
Q 006779 182 QQP------TARSVIGTPEFMAPELYEE-EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV-TSG-----IKP 247 (631)
Q Consensus 182 ~~~------~~~~~~GTp~Y~APEvl~~-~ys-~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i-~~~-----~~p 247 (631)
..+ .....+|+..|+|||++.+ +|+ ..+||||.|++++.|++|+.||.......+.+... -.. ..+
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~ 550 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGP 550 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccCh
Confidence 443 2345689999999998865 475 57999999999999999999996533332221111 110 112
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCc
Q 006779 248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 248 ~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~~ 290 (631)
..+....+.+.+.+|.++|+ +|.+|.|+.++++++||+.....
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c 594 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC 594 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence 23344456788999999998 99999999999999999876543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-23 Score=220.49 Aligned_cols=173 Identities=21% Similarity=0.262 Sum_probs=132.7
Q ss_pred CCceeeeeeEecccCceEEEEEEEcc-CCeEEEEEEeecccc-cCCHHHHHHHHHHHHHHHhCCCCCcee-eeeeEEcCC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEV-DGIEVAWNQVNIEDV-MQSPDQLERLYSEVHLLKSLKHENIIK-FYNSWVDDT 99 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~-tg~~VAiK~i~~~~~-~~~~~~~~~l~~Ei~iLk~L~HpnIVk-l~~~~~d~~ 99 (631)
.++| ++.+.||+|+||+||+|.++. +|..||+|++..... .........+.+|+++|++|+|+||+. +++ +
T Consensus 17 ~~~Y-~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-~---- 90 (365)
T PRK09188 17 SARF-VETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-T---- 90 (365)
T ss_pred cCCc-eEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-c----
Confidence 3456 888999999999999999876 788889998652211 012334567999999999999999985 543 1
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccC-CCCCeeecCCCCcEEEcccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL-KCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDL-Kp~NILl~~~~g~vKL~DFGla 178 (631)
...|+||||+.|++|... .. .. ...++.|++.||.|||+++ |+|||| ||+|||++ .++.+||+|||++
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~-~~~~ikLiDFGlA 159 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMG-PDGEAAVIDFQLA 159 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEc-CCCCEEEEECccc
Confidence 247899999999999732 11 11 2578999999999999998 999999 99999997 6789999999999
Q ss_pred chhcCCC----------CccccCCCCCCCccccccc-------cCccccch
Q 006779 179 IVMQQPT----------ARSVIGTPEFMAPELYEEE-------YNELVDIY 212 (631)
Q Consensus 179 ~~~~~~~----------~~~~~GTp~Y~APEvl~~~-------ys~~sDIw 212 (631)
..+.... .....+++.|+|||.+... .+...|-|
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 7554332 1345688899999988532 33456777
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.5e-21 Score=202.29 Aligned_cols=247 Identities=21% Similarity=0.243 Sum_probs=181.3
Q ss_pred ceeeeeeEecccCceEEEEEEEccCC-eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC----CCceeeeeeEEcCC
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDG-IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH----ENIIKFYNSWVDDT 99 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg-~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~H----pnIVkl~~~~~d~~ 99 (631)
+| ++.+.||+|+||.||++.+..++ ..+|+|.......... ..+..|+.+|..+.. +++..+++... ..
T Consensus 19 ~~-~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~ 92 (322)
T KOG1164|consen 19 RY-KLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-ST 92 (322)
T ss_pred ce-EEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC----ccchhHHHHHHHHhhhcCCCCCCEEEEecc-CC
Confidence 67 88899999999999999998885 7889988765432111 147789999988873 58888888653 34
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCC----CcEEEc
Q 006779 100 NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN----GEVKIG 173 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~----g~vKL~ 173 (631)
..+-++||+++ |.+|.++++.. +.++..++.+++.|++.+|++||+.| ++||||||+|+++.... ..+.|.
T Consensus 93 ~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 93 EDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred CceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEE
Confidence 45788999998 78999998765 57999999999999999999999999 99999999999996322 469999
Q ss_pred cccccc--hhcCC---------C-CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHH--H
Q 006779 174 DLGLAI--VMQQP---------T-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI--Y 238 (631)
Q Consensus 174 DFGla~--~~~~~---------~-~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i--~ 238 (631)
|||+++ .+... . .....||..|.++....+ +.+.+.|+||++.++.+|+.|..||......... +
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~ 249 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF 249 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence 999998 32111 1 123459999999997654 5889999999999999999999999765433222 1
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 239 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 239 ~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
................+.++..+...+-. +...+|....+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 250 EKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred HHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 22221111111223334556666555544 5667777665544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.3e-23 Score=224.16 Aligned_cols=245 Identities=19% Similarity=0.290 Sum_probs=199.5
Q ss_pred EecccCceEEEEEE---EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCceeeeeeEEcCCCCeEEEEE
Q 006779 32 ILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 32 ~LG~G~fg~Vy~a~---d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++|+|+||.|+++. -...|..+|.|..+.......... +-..|..++..++ ||.+|+++..|..+. .+++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyafqt~~--kl~l~l 76 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAFQTDG--KLYLIL 76 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeeecccc--chhHhh
Confidence 47999999998753 244567788887765443332222 5567888898887 999999999886554 577889
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCCc
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~ 187 (631)
++..||.|...+.+...+++...+.+...++.+++++|+.+ |+|||+|++||+++ .+|++++.|||+++..-.....
T Consensus 77 d~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld-~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLL-LEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred hhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeec-ccCccccCCchhhhHhHhhhhc
Confidence 99999999999999899999999999999999999999999 99999999999998 7999999999999765443333
Q ss_pred cccCCCCCCCccccccccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC
Q 006779 188 SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 267 (631)
Q Consensus 188 ~~~GTp~Y~APEvl~~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~ 267 (631)
+||..|||||+.. ++..++|.||||+++++|+||..||.. ++...|.... ...+...++.+++++..++.
T Consensus 154 --cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~--~~~p~~l~~~a~~~~~~l~~ 223 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAE--LEMPRELSAEARSLFRQLFK 223 (612)
T ss_pred --ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhc--cCCchhhhHHHHHHHHHHHh
Confidence 8999999999988 778899999999999999999999976 4445554422 12345567889999999886
Q ss_pred -CCCCCCC-----HHHHhcCCCCCCCCCcccc
Q 006779 268 -PASLRLP-----ALELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 268 -~p~~Rps-----a~elL~hpff~~~~~~~~~ 293 (631)
.|.+|.- +.|+++|+||+..++..+.
T Consensus 224 r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~ 255 (612)
T KOG0603|consen 224 RNPENRLGAGPDGVDEIKQHEFFQSIDWNELE 255 (612)
T ss_pred hCHHHHhccCcchhHHHhccchheeeeHhhHh
Confidence 7888775 4799999999998887654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7e-21 Score=194.80 Aligned_cols=209 Identities=21% Similarity=0.348 Sum_probs=171.4
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCceeeeeeEEcCCCCeE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~l 103 (631)
--+|++++||+|+||..+.|.+..+++.||||.-..+ .....+..|.+..+.|. .++|..+|.+ .....+-
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk------S~APQLrdEYr~YKlL~g~~GIP~vYYF--GqeG~~N 99 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK------SEAPQLRDEYRTYKLLGGTEGIPQVYYF--GQEGKYN 99 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc------CCcchHHHHHHHHHHHcCCCCCCceeee--ccccchh
Confidence 3359999999999999999999999999999976533 23345778999999885 5888888763 4555667
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC----CCCcEEEcccccc
Q 006779 104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG----NNGEVKIGDLGLA 178 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~----~~g~vKL~DFGla 178 (631)
.||+|++ |-||.++..-. ++|+.+++..++.|++.-++|+|+++ +|.|||||+|+||.. ....|.|+|||+|
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccch
Confidence 7899998 78999988754 57999999999999999999999999 999999999999941 2236899999999
Q ss_pred chhcCCCC---------ccccCCCCCCCccc-cccccCccccchhhhHHHHHHhhcCCCCCCCC--CHHHHHHHHHcC
Q 006779 179 IVMQQPTA---------RSVIGTPEFMAPEL-YEEEYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSG 244 (631)
Q Consensus 179 ~~~~~~~~---------~~~~GTp~Y~APEv-l~~~ys~~sDIwSLGiilyELltG~~Pf~~~~--~~~~i~~~i~~~ 244 (631)
+.+..+.+ ++..||.+||+--. +..+-+..-|+-|||-++++.|.|.+||.+.. +..+-|++|-..
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 88766532 35679999999873 45567889999999999999999999998754 445667777554
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.6e-21 Score=191.47 Aligned_cols=182 Identities=16% Similarity=0.133 Sum_probs=138.7
Q ss_pred cccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHH------HHHHHHHHHhCCCCCce
Q 006779 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER------LYSEVHLLKSLKHENII 89 (631)
Q Consensus 16 ~~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~------l~~Ei~iLk~L~HpnIV 89 (631)
++.+.--.+|| |..++||.|+||.||++.+ ++..+|+|.+.... ...+...++ +.+|++.+.+|.||+|.
T Consensus 23 ~~~~~~l~~~y-~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~-~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~ 98 (232)
T PRK10359 23 EIFDDFLSYNI-KTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKV-KRTERFLKSFVKGDYYENLIVQTDRVRSEGLA 98 (232)
T ss_pred HHHHHHhhCce-EEEEEecCCCceEEEEEec--CCCcEEEEEechhc-CchHHHHHhhhhhHHHHHHHHHHHHHHHCCCC
Confidence 34444557899 8899999999999999654 47789999986443 233444444 57999999999999999
Q ss_pred eeeeeEEcCCC------CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeee
Q 006779 90 KFYNSWVDDTN------RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV 163 (631)
Q Consensus 90 kl~~~~~d~~~------~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl 163 (631)
.+.+++.+... ...++||||++|.+|.++.. +++ ....+++.+|..||..| ++|||+||+||++
T Consensus 99 ~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili 168 (232)
T PRK10359 99 SLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIV 168 (232)
T ss_pred cceEeeeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEE
Confidence 99998775432 34789999999999988732 333 34669999999999999 9999999999999
Q ss_pred cCCCCcEEEccccccchhcCCCCccccCCCCCCCccccccccCccccchhhhHHHHHHh
Q 006779 164 NGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMV 222 (631)
Q Consensus 164 ~~~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~~ys~~sDIwSLGiilyELl 222 (631)
+ .+| ++|+|||............. | ++...|+.++|||+||+++..+.
T Consensus 169 ~-~~g-i~liDfg~~~~~~e~~a~d~-----~----vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 169 S-KNG-LRIIDLSGKRCTAQRKAKDR-----I----DLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred e-CCC-EEEEECCCcccccchhhHHH-----H----HHHhHhcccccccceeEeehHHH
Confidence 7 677 99999998754432211110 0 23455788999999999887654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=186.27 Aligned_cols=234 Identities=22% Similarity=0.315 Sum_probs=180.7
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC-CCceeeeeeEEcCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIKFYNSWVDDTN 100 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~H-pnIVkl~~~~~d~~~ 100 (631)
-.|.| ++.+.||.|+||.+|+|.....|++||||.-.... ....+..|..+.+.|++ ..|..+..+. .+.
T Consensus 13 v~gky-~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a------~hpqL~yEskvY~iL~~g~GiP~i~~y~--~e~ 83 (341)
T KOG1163|consen 13 VGGKY-KLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA------KHPQLLYESKVYRILQGGVGIPHIRHYG--TEK 83 (341)
T ss_pred eccce-EEEEeecCCchhheeeeeeccCCceEEEEeecccC------CCcchhHHHHHHHHhccCCCCchhhhhc--ccc
Confidence 34566 88899999999999999999999999999865332 22447789999999976 5666666544 334
Q ss_pred CeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeec--CCCCcEEEccccc
Q 006779 101 RTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGL 177 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~--~~~g~vKL~DFGl 177 (631)
.+-.+||+++ |-||.++..- .+.++.++++-++-|++.-++|+|.++ +|||||||+|+|+. .+..++.++|||+
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred ccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccc
Confidence 5677899998 7899998774 467999999999999999999999999 99999999999983 2344799999999
Q ss_pred cchhcCCC---------CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCC--CHHHHHHHHHcCC
Q 006779 178 AIVMQQPT---------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGI 245 (631)
Q Consensus 178 a~~~~~~~---------~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~--~~~~i~~~i~~~~ 245 (631)
|+.+.... .+...||.+|.+--... -+-+...|+-|+|.++..+..|..||.+.. +..|.+++|....
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 97664322 23457899998766433 345778899999999999999999998754 3456677776543
Q ss_pred CC---CCCCCCCcHHHHHHHHHhcC
Q 006779 246 KP---ASLSKVTDPQVKQFIEKCIV 267 (631)
Q Consensus 246 ~p---~~l~~~~~~~l~~lI~~cL~ 267 (631)
.. ..+-+-.+.++.-.+.-|-.
T Consensus 241 ~s~~ie~LC~G~P~EF~myl~Y~R~ 265 (341)
T KOG1163|consen 241 MSTPIEVLCKGFPAEFAMYLNYCRG 265 (341)
T ss_pred cCCCHHHHhCCCcHHHHHHHHHHhh
Confidence 32 23334567788888887754
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=184.51 Aligned_cols=146 Identities=16% Similarity=0.184 Sum_probs=113.0
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHH----------------------HHHHHHHHHHHHHhCCCCC
Q 006779 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD----------------------QLERLYSEVHLLKSLKHEN 87 (631)
Q Consensus 30 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~----------------------~~~~l~~Ei~iLk~L~Hpn 87 (631)
.+.||+|+||.||+|.+. +|+.||+|+++......... .......|+.+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 367999999999999987 89999999997542110000 0123345999999998887
Q ss_pred ceeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCEEeccCCCCCeeecCC
Q 006779 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL-HSHNPPIIHRDLKCDNIFVNGN 166 (631)
Q Consensus 88 IVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yL-Hs~~~~IiHrDLKp~NILl~~~ 166 (631)
+...+.... .. .+|||||+.|+++...+.+.+.+++..++.++.|++.+|.|+ |++| |+||||||+|||++
T Consensus 81 v~~p~~~~~--~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-- 152 (190)
T cd05147 81 IPCPEPILL--KS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-- 152 (190)
T ss_pred CCCCcEEEe--cC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE--
Confidence 644333221 11 279999999988876655567899999999999999999999 7888 99999999999997
Q ss_pred CCcEEEccccccchhcCC
Q 006779 167 NGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 167 ~g~vKL~DFGla~~~~~~ 184 (631)
++.++|+|||++.....+
T Consensus 153 ~~~v~LiDFG~a~~~~~~ 170 (190)
T cd05147 153 DGKLYIIDVSQSVEHDHP 170 (190)
T ss_pred CCcEEEEEccccccCCCc
Confidence 478999999999654443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.1e-20 Score=179.03 Aligned_cols=145 Identities=18% Similarity=0.215 Sum_probs=113.8
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEeeccccc--------------------CCHH--HHHHHHHHHHHHHhCCCCC
Q 006779 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--------------------QSPD--QLERLYSEVHLLKSLKHEN 87 (631)
Q Consensus 30 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~--------------------~~~~--~~~~l~~Ei~iLk~L~Hpn 87 (631)
.+.||+|+||.||+|.+. +|+.||+|+++..... .... ....+.+|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 467999999999999987 9999999998764210 0000 1233568999999999998
Q ss_pred ceeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccCCCCCeeecCC
Q 006779 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGN 166 (631)
Q Consensus 88 IVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs-~~~~IiHrDLKp~NILl~~~ 166 (631)
|.....++... .++||||+.|+++.........++...+..++.|++.+|.++|+ +| |+||||||+|||++
T Consensus 81 i~~p~~~~~~~----~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-- 152 (190)
T cd05145 81 VPVPEPILLKK----NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-- 152 (190)
T ss_pred CCCceEEEecC----CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE--
Confidence 85544433322 37899999988665443344568899999999999999999999 88 99999999999996
Q ss_pred CCcEEEccccccchhcC
Q 006779 167 NGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 167 ~g~vKL~DFGla~~~~~ 183 (631)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 68999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.5e-20 Score=209.99 Aligned_cols=227 Identities=25% Similarity=0.427 Sum_probs=168.4
Q ss_pred ccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC
Q 006779 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 98 (631)
...|+.--....+.|..|+||.||+++|+.+.+.+|+ +++.... +.+- +|.....|.+
T Consensus 77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l---------ilRn--ilt~a~npfv---------- 134 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL---------ILRN--ILTFAGNPFV---------- 134 (1205)
T ss_pred ccCCCccccceeEeeccCCCCceeeeeccccccchhh-cccccch---------hhhc--cccccCCcce----------
Confidence 3344443334457899999999999999999999998 4443221 1111 2222222222
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
| |+-...++.-+.++... +.+++|||+.+ |+|||+||+|.+|+ .-|++|+.|||++
T Consensus 135 -------v------gDc~tllk~~g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT-~mGhiKlTDfgLs 190 (1205)
T KOG0606|consen 135 -------V------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLS 190 (1205)
T ss_pred -------e------chhhhhcccCCCCcchh--------hHHhHhhccCC--eecCCCCCCcceee-ecccccccchhhh
Confidence 2 56666677766666555 78999999998 99999999999998 8999999999998
Q ss_pred chhc--CC---------------CCccccCCCCCCCcccc-ccccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHH
Q 006779 179 IVMQ--QP---------------TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240 (631)
Q Consensus 179 ~~~~--~~---------------~~~~~~GTp~Y~APEvl-~~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~ 240 (631)
...- .. ..+.++|||.|+|||++ ..+|+..+|+|++|+|+||.+.|..||.+ ..+++++..
T Consensus 191 k~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG-dtpeelfg~ 269 (1205)
T KOG0606|consen 191 KKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQ 269 (1205)
T ss_pred hhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC-CCHHHHHhh
Confidence 5321 00 12356899999999965 56799999999999999999999999987 677887777
Q ss_pred HHcCCC--CCCCCCCCcHHHHHHHHHhcC-CCCCCC---CHHHHhcCCCCCCCCCcccc
Q 006779 241 VTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRL---PALELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 241 i~~~~~--p~~l~~~~~~~l~~lI~~cL~-~p~~Rp---sa~elL~hpff~~~~~~~~~ 293 (631)
+..... |.. ..-..++++++|.++|+ .|..|. .+.++-+|+||+.-+++.++
T Consensus 270 visd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~ll 327 (1205)
T KOG0606|consen 270 VISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLL 327 (1205)
T ss_pred hhhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhh
Confidence 665422 332 34457899999999997 777775 47789999999998887443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=187.43 Aligned_cols=233 Identities=18% Similarity=0.214 Sum_probs=149.9
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC----------CCceeeeeeEE
Q 006779 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH----------ENIIKFYNSWV 96 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~H----------pnIVkl~~~~~ 96 (631)
.+.++.||.|+++.||.+.|..||+++|+|++.... .......+.+.+|......+.+ -.++.-++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 455689999999999999999999999999987766 3445567788888776666433 11111111111
Q ss_pred ---------cCCCC------eEEEEEeccCCCCHHHHHHh---CCC----CCHHHHHHHHHHHHHHHHHHHhCCCCEEec
Q 006779 97 ---------DDTNR------TINMITELFTSGSLRQYRKK---HKN----VDMKAIKNWARQILRGLHYLHSHNPPIIHR 154 (631)
Q Consensus 97 ---------d~~~~------~l~lV~Ey~~gGsL~~~l~~---~~~----l~~~~i~~i~~QIl~aL~yLHs~~~~IiHr 154 (631)
...+. ..+++|+-+ .++|.+++.- ... +.......+..|++..+++||+.| ++|+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHg 169 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVHG 169 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEES
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEec
Confidence 11101 235677777 5688887542 221 223344556699999999999999 9999
Q ss_pred cCCCCCeeecCCCCcEEEccccccchhcCCCCccccCCCCCCCcccccc---------ccCccccchhhhHHHHHHhhcC
Q 006779 155 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE---------EYNELVDIYSFGMCILEMVTCE 225 (631)
Q Consensus 155 DLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~---------~ys~~sDIwSLGiilyELltG~ 225 (631)
||+|+|+|++ .+|.++|+||+.....+..... ...+..|.+||+... .++.+.|.|+||+++|.|++++
T Consensus 170 di~~~nfll~-~~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 170 DIKPENFLLD-QDGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp T-SGGGEEE--TTS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ccceeeEEEc-CCCCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 9999999998 7999999999877554443222 344678999996532 3788999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCC
Q 006779 226 YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLR 272 (631)
Q Consensus 226 ~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~R 272 (631)
.||.... +...... .-.... ..+..++.||..+|+ +|.+|
T Consensus 248 lPf~~~~-~~~~~~~-----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSS-PEADPEW-----DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCG-GGSTSGG-----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCC-ccccccc-----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9997531 1110000 001112 456789999999998 77766
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.5e-19 Score=175.07 Aligned_cols=184 Identities=15% Similarity=0.100 Sum_probs=137.5
Q ss_pred eeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCceeeeeeEEcCCCCeEEEEE
Q 006779 29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 29 ~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
....|++|+||+||++.. .+.+++.+.+.....-...-....+.+|+++|++|. |++|++++++ ...+++|
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvm 77 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLDR 77 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEE
Confidence 357899999999998754 678888776654432111112235789999999995 5889999884 1368899
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccC-CCCCeeecCCCCcEEEccccccchhcCCCC
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL-KCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 186 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDL-Kp~NILl~~~~g~vKL~DFGla~~~~~~~~ 186 (631)
||+.|.+|.+.+.. ....++.|++.+|.++|++| |+|||| ||+|||++ .+|.++|+|||++........
T Consensus 78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~-~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQ-EDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEc-CCCCEEEEECCCceecCCcch
Confidence 99999999754322 12457899999999999999 999999 79999997 788999999999974433221
Q ss_pred ---------------ccccCCCCCCCccccc--cccC-ccccchhhhHHHHHHhhcCCCCCC
Q 006779 187 ---------------RSVIGTPEFMAPELYE--EEYN-ELVDIYSFGMCILEMVTCEYPYNE 230 (631)
Q Consensus 187 ---------------~~~~GTp~Y~APEvl~--~~ys-~~sDIwSLGiilyELltG~~Pf~~ 230 (631)
.-..+++.|++|+... ...+ ...+.++.|+-+|.++|+..|+..
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0113688889888322 2233 567888999999999999998754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=174.37 Aligned_cols=136 Identities=19% Similarity=0.246 Sum_probs=108.4
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-----CCCCceeeeeeEEcCCC-CeEE
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-----KHENIIKFYNSWVDDTN-RTIN 104 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-----~HpnIVkl~~~~~d~~~-~~l~ 104 (631)
+.||+|+|+.||. +..++.. +||++..... ...+.+.+|+.+++.| +||||+++|+++.+..+ ..++
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred ceecCCCceEEEE--CCCCcCe-EEEEEecccc----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 6899999999995 7778777 5998875432 2346689999999999 67999999999876542 3434
Q ss_pred -EEEec--cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCEEeccCCCCCeeecC---CCCcEEEccccc
Q 006779 105 -MITEL--FTSGSLRQYRKKHKNVDMKAIKNWARQILRGL-HYLHSHNPPIIHRDLKCDNIFVNG---NNGEVKIGDLGL 177 (631)
Q Consensus 105 -lV~Ey--~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL-~yLHs~~~~IiHrDLKp~NILl~~---~~g~vKL~DFGl 177 (631)
+|+|| +.+|+|.+++++. .+++. ..+++|++.++ +|||+++ |+||||||+|||++. .++.++|+||+.
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 78999 5589999999774 46666 46788888888 9999999 999999999999962 234799999543
Q ss_pred c
Q 006779 178 A 178 (631)
Q Consensus 178 a 178 (631)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-19 Score=207.77 Aligned_cols=241 Identities=22% Similarity=0.300 Sum_probs=175.2
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
-+.+.||.+.|=+|.+|++. .|. |++|++-..+-.-+-+...+..+|++ .+.++|||.++|..+-+ ..+..|||=
T Consensus 26 ~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~--t~kAAylvR 100 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV--TDKAAYLVR 100 (1431)
T ss_pred eeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH--hhHHHHHHH
Confidence 56799999999999999875 455 88888754442223334444555666 77779999999987533 334677788
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch--h--cC
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV--M--QQ 183 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~--~--~~ 183 (631)
+|+.. +|.+.+....-+..-+.+.++.||+.||.-+|..| |+|||||++||||+ .-.-+.|.||..-+- + .+
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiT-SWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILIT-SWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEe-eechhhhhcccccCCccCCCCC
Confidence 88864 88888887777888889999999999999999999 99999999999998 566789999976421 1 11
Q ss_pred CCC-cccc----CCCCCCCcccccc-----------c-cCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCC
Q 006779 184 PTA-RSVI----GTPEFMAPELYEE-----------E-YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI 245 (631)
Q Consensus 184 ~~~-~~~~----GTp~Y~APEvl~~-----------~-ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~ 245 (631)
+.. .-+. .-.+|+|||.+-. . .+++-||||+||+++||++ |++||. ..|+...-..+.
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~~~ 252 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSGNA 252 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhccCc
Confidence 111 1111 2237999996521 1 4578899999999999988 677773 334433332211
Q ss_pred C-C-CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 246 K-P-ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 246 ~-p-~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
. + .-+.++.+..+|++|..|++ +|++|.+|++.|+.
T Consensus 253 ~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 253 DDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1 1 11334556789999999998 99999999999976
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.2e-18 Score=176.55 Aligned_cols=188 Identities=21% Similarity=0.358 Sum_probs=141.3
Q ss_pred CCCCceeeeeeEEc-------------------------CCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHH
Q 006779 84 KHENIIKFYNSWVD-------------------------DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 138 (631)
Q Consensus 84 ~HpnIVkl~~~~~d-------------------------~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl 138 (631)
+|||||+++..|.+ .....+|+||.-+. .+|++|+-.+. .+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-CchHHHHHHHHHHH
Confidence 59999999988875 23357999999885 59999987644 57778888999999
Q ss_pred HHHHHHHhCCCCEEeccCCCCCeeecC-CCC--cEEEccccccchhcCC-----CC---ccccCCCCCCCccccccc---
Q 006779 139 RGLHYLHSHNPPIIHRDLKCDNIFVNG-NNG--EVKIGDLGLAIVMQQP-----TA---RSVIGTPEFMAPELYEEE--- 204 (631)
Q Consensus 139 ~aL~yLHs~~~~IiHrDLKp~NILl~~-~~g--~vKL~DFGla~~~~~~-----~~---~~~~GTp~Y~APEvl~~~--- 204 (631)
+|+.|||.+| |.|||||.+|||+.- +++ .+.|+|||.+..-... .. -..-|...-||||+...-
T Consensus 352 Eav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 352 EAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 9999999999 999999999999952 222 5789999987432221 11 123478889999987532
Q ss_pred ----cCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHH
Q 006779 205 ----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPAL 276 (631)
Q Consensus 205 ----ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~ 276 (631)
.-.++|.|+.|.+.||+++...||..... ..+-...-+.-..+.++...++.+++++...|+ +|++|+++.
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccch-heechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 12589999999999999999999976211 111111112223445777788999999999998 899999953
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.9e-18 Score=172.30 Aligned_cols=152 Identities=18% Similarity=0.166 Sum_probs=118.2
Q ss_pred CCceeeeeeEecccCceEEEEEE-EccCCeEEEEEEeecccccC------------------CHH--HHHHHHHHHHHHH
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGF-DEVDGIEVAWNQVNIEDVMQ------------------SPD--QLERLYSEVHLLK 81 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~-d~~tg~~VAiK~i~~~~~~~------------------~~~--~~~~l~~Ei~iLk 81 (631)
.||-+++.+.||+|+||.||+|. +..+|..||+|++....... ... ....+.+|+.+++
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 56667889999999999999999 77899999999987543100 000 1234678999999
Q ss_pred hCCCC--CceeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCC
Q 006779 82 SLKHE--NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159 (631)
Q Consensus 82 ~L~Hp--nIVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~ 159 (631)
.+.+. .+.+++.. . ..++||||+.|++|..+......+....+..++.||+.+|.+||+++ +|+||||||+
T Consensus 106 ~L~~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~ 178 (237)
T smart00090 106 RLYEAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEY 178 (237)
T ss_pred HHHhcCCCCCeeeEe---c---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChh
Confidence 99763 23444431 1 24799999999898776545556777788899999999999999986 4999999999
Q ss_pred CeeecCCCCcEEEccccccchhcC
Q 006779 160 NIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 160 NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
||+++ ++.++|+|||.+.....
T Consensus 179 NIli~--~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 179 NILVH--DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hEEEE--CCCEEEEEChhhhccCC
Confidence 99997 67899999999865443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-18 Score=187.36 Aligned_cols=243 Identities=20% Similarity=0.347 Sum_probs=166.2
Q ss_pred eeeeEecccCceEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeee-------eEEc
Q 006779 28 RYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYN-------SWVD 97 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~t---g~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~-------~~~d 97 (631)
++.+..++.+++.++...-... .+.++-+..... .........+++-.+....|-+..-+.+ .+..
T Consensus 247 ~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d----~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~ 322 (516)
T KOG1033|consen 247 SISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVD----SLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKR 322 (516)
T ss_pred cccccccccccCCchhhhhcccchhhhhccchhhhcc----chhhhhhhhhhhhheeccccCCcccccCCCCchhhhccc
Confidence 3345566666666665543332 223333322222 1123344555666665554443333222 1211
Q ss_pred ---CCCCeEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEE
Q 006779 98 ---DTNRTINMITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 171 (631)
Q Consensus 98 ---~~~~~l~lV~Ey~~gGsL~~~l~~~~---~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 171 (631)
....++||.|++|...+|.+|+.+.. ..+....+.|+.|+..|++| ++ .+|||+||.||++. .+..+|
T Consensus 323 ~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~-~d~q~k 396 (516)
T KOG1033|consen 323 NKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFS-DDDQLK 396 (516)
T ss_pred cccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccc-cchhhh
Confidence 11236899999999999999997543 46778899999999999999 66 99999999999996 788999
Q ss_pred EccccccchhcCCC--------CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006779 172 IGDLGLAIVMQQPT--------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKV 241 (631)
Q Consensus 172 L~DFGla~~~~~~~--------~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i 241 (631)
|+|||+.+...... ....+||+.||+||.+.+ .|+.++||||||++|+||+. -..+|.. ......+
T Consensus 397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t~~d~ 472 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----IATLTDI 472 (516)
T ss_pred hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----HHhhhhh
Confidence 99999986554322 234579999999998764 69999999999999999998 4444432 2234455
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 006779 242 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 242 ~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~ 285 (631)
..+..|+.+.. ..|.-..|+..+|. .|.+||++.+.-.|+|++
T Consensus 473 r~g~ip~~~~~-d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 473 RDGIIPPEFLQ-DYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred hcCCCChHHhh-cCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 66666643332 23567789999997 799999888877777753
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.7e-18 Score=170.63 Aligned_cols=235 Identities=18% Similarity=0.302 Sum_probs=180.4
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEecc
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~ 110 (631)
.+|...-.|..|+|+.. |..++.|+++..+. +......|..|.-.|+-+.||||+.+++.+..+ ..+.+|..||
T Consensus 196 tkl~e~hsgelwrgrwq--gndivakil~vr~~--t~risrdfneefp~lrifshpnilpvlgacnsp--pnlv~isq~m 269 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQ--GNDIVAKILNVREV--TARISRDFNEEFPALRIFSHPNILPVLGACNSP--PNLVIISQYM 269 (448)
T ss_pred hhhccCCCccccccccc--Ccchhhhhhhhhhc--chhhcchhhhhCcceeeecCCchhhhhhhccCC--CCceEeeeec
Confidence 35667778899999765 45566677766554 334446688999999999999999999988655 4588899999
Q ss_pred CCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEE--ccccccchhcCCCC
Q 006779 111 TSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI--GDLGLAIVMQQPTA 186 (631)
Q Consensus 111 ~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL--~DFGla~~~~~~~~ 186 (631)
+-|+|...+.... .++..++.+++..|+.|++|||+..|-|.---|....++++ ++-+.+| +|--++.. .
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmid-edltarismad~kfsfq-----e 343 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMID-EDLTARISMADTKFSFQ-----E 343 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEec-chhhhheecccceeeee-----c
Confidence 9999999987643 46788999999999999999999986455557889999997 5555444 44333321 1
Q ss_pred ccccCCCCCCCccccccc----cCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006779 187 RSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262 (631)
Q Consensus 187 ~~~~GTp~Y~APEvl~~~----ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI 262 (631)
......|.||+||.+... .-.++|+|||++++|||.|.+.||.+..+.+--++.-..|..+ .++...++.+..|+
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv-~ippgis~hm~klm 422 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRV-HIPPGISRHMNKLM 422 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccc-cCCCCccHHHHHHH
Confidence 123458999999988653 3368999999999999999999999876666556666666544 35556678999999
Q ss_pred HHhcC-CCCCCCCHHHH
Q 006779 263 EKCIV-PASLRLPALEL 278 (631)
Q Consensus 263 ~~cL~-~p~~Rpsa~el 278 (631)
.-|+. ||.+||....+
T Consensus 423 ~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 423 NICMNEDPGKRPKFDMI 439 (448)
T ss_pred HHHhcCCCCcCCCccee
Confidence 99998 89999987653
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=7.7e-17 Score=177.03 Aligned_cols=196 Identities=27% Similarity=0.424 Sum_probs=153.2
Q ss_pred HHhCCCCCceeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCC
Q 006779 80 LKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158 (631)
Q Consensus 80 Lk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp 158 (631)
|+.+.|.|+.+|++.+++. ...+.|.+||..|+|.+.+.. ...++.-....+++.|+.||.|||.-- -..|+.|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP-IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeeecc
Confidence 4678999999999999887 468889999999999999987 456888889999999999999999864 229999999
Q ss_pred CCeeecCCCCcEEEccccccchhcC----CCCccccCCCCCCCccccccc--------cCccccchhhhHHHHHHhhcCC
Q 006779 159 DNIFVNGNNGEVKIGDLGLAIVMQQ----PTARSVIGTPEFMAPELYEEE--------YNELVDIYSFGMCILEMVTCEY 226 (631)
Q Consensus 159 ~NILl~~~~g~vKL~DFGla~~~~~----~~~~~~~GTp~Y~APEvl~~~--------ys~~sDIwSLGiilyELltG~~ 226 (631)
.|.+++ ....+||.|||+...... .......-...|.|||++... .+.+.|||||||+++|+++...
T Consensus 78 ~nClvd-~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 78 SNCLVD-SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred ccceee-eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999998 788999999999866532 111111234469999988653 4667999999999999999999
Q ss_pred CCCCC---CCHHHHHHHHHc-CCCC--CCCC-C-CCcHHHHHHHHHhcC-CCCCCCCHHHHh
Q 006779 227 PYNEC---KNPAQIYKKVTS-GIKP--ASLS-K-VTDPQVKQFIEKCIV-PASLRLPALELL 279 (631)
Q Consensus 227 Pf~~~---~~~~~i~~~i~~-~~~p--~~l~-~-~~~~~l~~lI~~cL~-~p~~Rpsa~elL 279 (631)
||... ..+.++...+.. +..+ +.+. . ...+++..++..||. +|..||+...+-
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred ccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 99753 233567666766 3221 1111 1 234578999999998 899999988754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.2e-16 Score=155.19 Aligned_cols=138 Identities=22% Similarity=0.264 Sum_probs=111.6
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCC----HHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEE
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS----PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~----~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV 106 (631)
+.||+|++|.||+|.+ .|..|++|.......... .....++.+|+.++..+.|++|+....++.+.. ..++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE--NFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC--CCEEE
Confidence 5799999999999976 788899997653321111 112356889999999999999877666555543 46789
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
|||+.|++|.+++..... ....++.+++.+|.++|+.+ ++|||++|.|||++ ++.++|+|||.+..
T Consensus 78 ~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~--~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS--GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE--CCCEEEEECCcccC
Confidence 999999999999876442 78899999999999999998 99999999999997 67899999998854
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.1e-16 Score=186.91 Aligned_cols=188 Identities=22% Similarity=0.302 Sum_probs=147.8
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC---CCCceeeeeeEEcCCCCeE
Q 006779 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~---HpnIVkl~~~~~d~~~~~l 103 (631)
+.+.+.||+|+||+||+|.+.. |+.||+|+-+.... . .++=-.+++.+|+ -+-|+.++..++-.+ .-
T Consensus 700 ~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~--W-----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~--~S 769 (974)
T KOG1166|consen 700 FCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP--W-----EFYICLQVMERLKPQMLPSIMHISSAHVFQN--AS 769 (974)
T ss_pred EEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc--e-----eeeehHHHHHhhchhhhcchHHHHHHHccCC--cc
Confidence 4667889999999999999877 99999998654321 0 0222233444444 244555555544433 35
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeec------CCCCcEEEccccc
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN------GNNGEVKIGDLGL 177 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~------~~~g~vKL~DFGl 177 (631)
++|+||...|||.+++...+.+++..+..+..|++..++.||.++ |||+||||+|.||. ..+--++|+|||.
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 679999999999999998899999999999999999999999999 99999999999994 1233589999999
Q ss_pred cchhc----CCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCC
Q 006779 178 AIVMQ----QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEY 226 (631)
Q Consensus 178 a~~~~----~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~ 226 (631)
+.-+. .......++|-.|-.+|+..+ .++..+|.|.|+.+++.||.|++
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 96443 223456678999999998876 48999999999999999999975
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=7.5e-18 Score=191.99 Aligned_cols=257 Identities=24% Similarity=0.363 Sum_probs=202.3
Q ss_pred CCCceeeeeeEecccCceEEEEEEEcc-CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCceeeeeeEEcCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEV-DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDT 99 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~-tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~ 99 (631)
|..-| ++.+.||+|+|+.|-.+.... ....+|.|.+.... .......++..|..+-+.+. |+|++.+++.+...
T Consensus 18 ~~~~~-~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~- 93 (601)
T KOG0590|consen 18 PNSQY-KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP- 93 (601)
T ss_pred ccccc-cccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCCC-
Confidence 44455 666789999999999887643 44667777776553 34556677778999988887 99999999977544
Q ss_pred CCeEEEEEeccCCCCHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCCCEEeccCCCCCeeecCCCC-cEEEccc
Q 006779 100 NRTINMITELFTSGSLRQYR-KKHK-NVDMKAIKNWARQILRGLHYLH-SHNPPIIHRDLKCDNIFVNGNNG-EVKIGDL 175 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l-~~~~-~l~~~~i~~i~~QIl~aL~yLH-s~~~~IiHrDLKp~NILl~~~~g-~vKL~DF 175 (631)
...+++++|..|+++...+ .... ..+......++.|+..++.|+| ..+ +.|||+||+|.+++ .++ .++++||
T Consensus 94 -~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~-~s~~~l~~~df 169 (601)
T KOG0590|consen 94 -RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLD-ESGSALKIADF 169 (601)
T ss_pred -cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhc-cCCCcccCCCc
Confidence 4678899999999999988 5554 6788889999999999999999 888 99999999999998 677 9999999
Q ss_pred cccchhcC-CC----CccccC-CCCCCCcccccc-c-cCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-
Q 006779 176 GLAIVMQQ-PT----ARSVIG-TPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK- 246 (631)
Q Consensus 176 Gla~~~~~-~~----~~~~~G-Tp~Y~APEvl~~-~-ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~- 246 (631)
|+|..+.. .. ....+| ++.|+|||.+.+ . .....|+||.|+++.-|++|..|+.........+........
T Consensus 170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~ 249 (601)
T KOG0590|consen 170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR 249 (601)
T ss_pred hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccc
Confidence 99987655 22 234578 999999998866 3 568899999999999999999999754333322222222211
Q ss_pred -CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 247 -PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 247 -p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
........+....+++.++|. +|+.|.+.+++-.+||+..
T Consensus 250 ~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 250 FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 123344556788999999996 8999999999999999987
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=4e-16 Score=153.84 Aligned_cols=144 Identities=22% Similarity=0.180 Sum_probs=110.0
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccC-----C-------------HHHHHHHHHHHHHHHhCCC
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-----S-------------PDQLERLYSEVHLLKSLKH 85 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~-----~-------------~~~~~~l~~Ei~iLk~L~H 85 (631)
++.+.+.+.||+|+||.||+|.+. +|+.||+|.+....... . .........|+.++..+.|
T Consensus 14 ~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 14 GVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred CchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 444577899999999999999875 89999999876532100 0 0111236789999999988
Q ss_pred CC--ceeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeee
Q 006779 86 EN--IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV 163 (631)
Q Consensus 86 pn--IVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl 163 (631)
++ ++..++ . ...++||||+.|++|..+... .....++.+|+.++.++|+.+ |+||||||+||++
T Consensus 93 ~~i~v~~~~~----~--~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill 158 (198)
T cd05144 93 EGFPVPKPID----W--NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILV 158 (198)
T ss_pred cCCCCCceee----c--CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEE
Confidence 74 444443 1 235789999999999765431 346788999999999999998 9999999999999
Q ss_pred cCCCCcEEEccccccchhcC
Q 006779 164 NGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 164 ~~~~g~vKL~DFGla~~~~~ 183 (631)
+ .++.++|+|||.+.....
T Consensus 159 ~-~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 159 D-DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred c-CCCcEEEEECCccccCCC
Confidence 8 688999999999864443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.4e-16 Score=150.90 Aligned_cols=134 Identities=22% Similarity=0.284 Sum_probs=104.9
Q ss_pred EecccCceEEEEEEEccCCeEEEEEEeecccccCC----HHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS----PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 32 ~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~----~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
.||+|+||.||+|. .+|..|++|.......... .....++.+|+++++.+.|+++....-++.+.. ..++||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD--NKTIVM 76 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC--CCEEEE
Confidence 48999999999997 4678899998653321111 122467889999999999887554443334333 357899
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
||+.|++|.+++..... .++.|++.+|.+||+.+ ++|||++|.||+++ ++.++++|||++..
T Consensus 77 e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~--~~~~~liDfg~a~~ 138 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR--DDKLYLIDFGLGKY 138 (199)
T ss_pred EEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE--CCcEEEEECCCCcC
Confidence 99999999998765432 88999999999999998 99999999999997 68999999998854
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.6e-15 Score=171.91 Aligned_cols=137 Identities=20% Similarity=0.211 Sum_probs=107.8
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeeccccc----CCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM----QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~----~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
...+.||+|+||+||+|.+.. ..+++|+....... ......+++.+|+++++.++|++|+..+.++.+.. ..
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~ 411 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE--EK 411 (535)
T ss_pred CccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC--CC
Confidence 557899999999999997643 34444443222111 11123467889999999999999988776665543 46
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
++||||+.|++|.+++. ....++.|++.+|.|||+++ ++||||||+|||++ ++.++|+|||++..
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl~--~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIVR--DDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEEE--CCcEEEEeCccccc
Confidence 78999999999999885 35678999999999999999 99999999999994 67899999999864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=8e-15 Score=142.38 Aligned_cols=140 Identities=22% Similarity=0.230 Sum_probs=99.1
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHH---------------------HHHHHHHHHHhCCCCC-
Q 006779 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE---------------------RLYSEVHLLKSLKHEN- 87 (631)
Q Consensus 30 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~---------------------~l~~Ei~iLk~L~Hpn- 87 (631)
.+.||+|+||+||+|.+. +|+.||+|.+....... ..... ....|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSF-KKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccch-hhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 467999999999999887 89999999987542211 11111 1135666777665443
Q ss_pred -ceeeeeeEEcCCCCeEEEEEeccCCCCHHHH-HHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccCCCCCeeec
Q 006779 88 -IIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVN 164 (631)
Q Consensus 88 -IVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~-l~~~~~l~~~~i~~i~~QIl~aL~yLHs-~~~~IiHrDLKp~NILl~ 164 (631)
+.+.+.. ...++||||+.++++... +.... .. ..+..++.+++.++.++|. ++ |+||||||+||+++
T Consensus 80 ~~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~ 149 (187)
T cd05119 80 PVPKPIDL------NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD 149 (187)
T ss_pred CCCceEec------CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE
Confidence 4444432 125789999998543211 11111 11 6678999999999999999 88 99999999999997
Q ss_pred CCCCcEEEccccccchhcC
Q 006779 165 GNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 165 ~~~g~vKL~DFGla~~~~~ 183 (631)
++.++|+|||.+.....
T Consensus 150 --~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 --DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred --CCcEEEEECcccccccC
Confidence 78999999999965544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.5e-14 Score=144.83 Aligned_cols=143 Identities=14% Similarity=0.175 Sum_probs=107.9
Q ss_pred eeeeEec-ccCceEEEEEEEccCCeEEEEEEeecccc----c-----CCHHHHHHHHHHHHHHHhCCCCCc--eeeeeeE
Q 006779 28 RYDEILG-KGAFKTVYKGFDEVDGIEVAWNQVNIEDV----M-----QSPDQLERLYSEVHLLKSLKHENI--IKFYNSW 95 (631)
Q Consensus 28 r~~e~LG-~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~----~-----~~~~~~~~l~~Ei~iLk~L~HpnI--Vkl~~~~ 95 (631)
.-+.+|| .||.|+||++... |..+++|.+..... . .......++.+|+.++..|.|++| ++.+.+.
T Consensus 34 ~~~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~ 111 (239)
T PRK01723 34 QQARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAAR 111 (239)
T ss_pred hcCceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeee
Confidence 3346788 8999999998654 78899998864321 0 012334678899999999998875 5666654
Q ss_pred EcCCCC--eEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEE
Q 006779 96 VDDTNR--TINMITELFTS-GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 96 ~d~~~~--~l~lV~Ey~~g-GsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL 172 (631)
...... ..++|||+++| .+|.+++... .+++.. +.||+.+|.+||.+| |+||||||.|||++ .++.++|
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~-~~~~v~L 183 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQEA-PLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLD-PDGKFWL 183 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHhcC-CCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEc-CCCCEEE
Confidence 333221 23589999997 6999988653 466543 578999999999999 99999999999997 5779999
Q ss_pred ccccccch
Q 006779 173 GDLGLAIV 180 (631)
Q Consensus 173 ~DFGla~~ 180 (631)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998854
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.3e-13 Score=124.89 Aligned_cols=132 Identities=20% Similarity=0.121 Sum_probs=107.4
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC--CCceeeeeeEEcCCCCeEEEEE
Q 006779 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 30 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~H--pnIVkl~~~~~d~~~~~l~lV~ 107 (631)
.+.||+|.++.||++.+.. ..+++|.+..... ...+.+|+.+++.++| .++++++.+.... ...++++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v~ 72 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESD--GWSYLLM 72 (155)
T ss_pred ceecccccccceEEEEecC--CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEEE
Confidence 4679999999999998754 6889998754321 4568899999999976 5888888865433 4688999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN-PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~-~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
||+.++.+..+ +......++.+++.+|.++|... .+++|+|++|+||+++ ..+.+++.|||.+.
T Consensus 73 e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~-~~~~~~l~Df~~~~ 137 (155)
T cd05120 73 EWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD-DGKILGIIDWEYAG 137 (155)
T ss_pred EecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE-CCcEEEEEeccccc
Confidence 99998888654 56677888999999999999852 2499999999999998 57899999999885
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.6e-13 Score=148.50 Aligned_cols=246 Identities=24% Similarity=0.282 Sum_probs=189.0
Q ss_pred eEecc--cCceEEEEEEE--ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCeEEE
Q 006779 31 EILGK--GAFKTVYKGFD--EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 31 e~LG~--G~fg~Vy~a~d--~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~l~l 105 (631)
..+|. |.+|.||.+.. ..++..+|+|.=++.. ..+....+=.+|+...+.+ .|+|.++.+..|... ...++
T Consensus 120 ~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~--s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~--~~lfi 195 (524)
T KOG0601|consen 120 SRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF--SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS--GILFI 195 (524)
T ss_pred cccccCCCCCceeecccCCcccCCcccccccccCCC--CCccccccccchhhcccccCccccccccCcccccC--Cccee
Confidence 56899 99999999999 8999999998743321 1122223344677777777 599999999988655 45778
Q ss_pred EEeccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHhCCCCEEeccCCCCCeeecCCC-CcEEEccccccc
Q 006779 106 ITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILR----GLHYLHSHNPPIIHRDLKCDNIFVNGNN-GEVKIGDLGLAI 179 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~~-l~~~~i~~i~~QIl~----aL~yLHs~~~~IiHrDLKp~NILl~~~~-g~vKL~DFGla~ 179 (631)
=+|+|. .+|..+...... ++...++..+.+... ||.++|+.+ ++|-|+||.||++. .+ ...+++|||+..
T Consensus 196 qtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~-~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 196 QTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTT-SDWTSCKLTDFGLVS 271 (524)
T ss_pred eecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecc-cccceeecCCcceeE
Confidence 889995 788888776554 889999999999999 999999998 99999999999997 45 788999999987
Q ss_pred hhcCCCCc-------cccCCCCCCCccccccccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006779 180 VMQQPTAR-------SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 180 ~~~~~~~~-------~~~GTp~Y~APEvl~~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~ 252 (631)
.+...... ...|...|++||+.++-++.+.|||++|.++.+-.++-.++..+.+.. +..+..+..|..+-.
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS--WSQLRQGYIPLEFCE 349 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC--ccccccccCchhhhc
Confidence 66544311 124677899999999999999999999999999999887765542211 122333334444444
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 253 ~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
..+..++..+..++. ++..|+++..++.|+++..
T Consensus 350 ~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 350 GGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred CcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 445666778888887 7899999999999999873
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.2e-13 Score=155.72 Aligned_cols=255 Identities=19% Similarity=0.332 Sum_probs=198.1
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEecc
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~ 110 (631)
+-+-+|+++.++.+.-..+|...+++......... ....+.+..+-.++-..++|.++..+-.+.. ....+++++|.
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~-~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~--rsP~~L~~~~~ 886 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIR-TNDYESIRSKSNILITPRSPAVVRSFPSFPC--RSPLPLVGHYL 886 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhc-cccccccCCccCccccCCCCceecccCCCCC--CCCcchhhHHh
Confidence 35678999999999877778666666554433222 1223445556666666677888887766433 34588999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh-------cC
Q 006779 111 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-------QQ 183 (631)
Q Consensus 111 ~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~-------~~ 183 (631)
.+++|...+.+.+..+....+.....+..+++|||+.. +.|||++|.|++.. .+|..++.+||..... ..
T Consensus 887 ~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~-~~gh~~l~~~~t~~~vg~~~p~~~~ 963 (1205)
T KOG0606|consen 887 NGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIA-YDGHRPLTDFGTLSKVGLIPPTTDL 963 (1205)
T ss_pred ccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhhc-ccCCcccCccccccccccccCcCCc
Confidence 99999999988888888999999999999999999987 89999999999996 8999999999842100 00
Q ss_pred --------------------------CCCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCHHH
Q 006779 184 --------------------------PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ 236 (631)
Q Consensus 184 --------------------------~~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~ 236 (631)
.......||+.|.+||.+. .....++|+|++|++++|.++|..||.. ..+++
T Consensus 964 sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na-~tpq~ 1042 (1205)
T KOG0606|consen 964 SGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA-ETPQQ 1042 (1205)
T ss_pred ccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC-cchhh
Confidence 0012356899999999665 4578899999999999999999999987 67788
Q ss_pred HHHHHHcCCCC-CCCCCCCcHHHHHHHHHhcC-CCCCCCCHH---HHhcCCCCCCCCCccc
Q 006779 237 IYKKVTSGIKP-ASLSKVTDPQVKQFIEKCIV-PASLRLPAL---ELLKDPFLVTDNPKDL 292 (631)
Q Consensus 237 i~~~i~~~~~p-~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~---elL~hpff~~~~~~~~ 292 (631)
++..+..+..| +.-+...++++++++.+.|. .|.+|..+. ++-.||||+..+|..+
T Consensus 1043 ~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l 1103 (1205)
T KOG0606|consen 1043 IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENL 1103 (1205)
T ss_pred hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccc
Confidence 87777666544 33344568899999999998 899999987 8999999999888764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.20 E-value=3.8e-11 Score=135.14 Aligned_cols=141 Identities=14% Similarity=0.171 Sum_probs=94.1
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccc--------------------------cCCH----HHHHH------HH
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV--------------------------MQSP----DQLER------LY 74 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~--------------------------~~~~----~~~~~------l~ 74 (631)
+-||.|++|.||+|..+.+|+.||+|+.+..-. .+.. +.... +.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 469999999999999998899999999864310 0000 11222 33
Q ss_pred HHHHHHHhCC----CCCceeeeeeEEcCCCCeEEEEEeccCCCCHHHH--HHhCC----CCCHHHHHHHHHHHHHHHHHH
Q 006779 75 SEVHLLKSLK----HENIIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHK----NVDMKAIKNWARQILRGLHYL 144 (631)
Q Consensus 75 ~Ei~iLk~L~----HpnIVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~--l~~~~----~l~~~~i~~i~~QIl~aL~yL 144 (631)
+|+..+.++. +.+.+.+-.++.+-. ...++||||+.|+.+.++ +.+.+ .+.+..+..++.|++
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s-t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------ 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYC-SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------ 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccC-CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH------
Confidence 4444444442 344444444333322 245689999999999875 33333 245555666667765
Q ss_pred HhCCCCEEeccCCCCCeeecCCCC----cEEEccccccchhc
Q 006779 145 HSHNPPIIHRDLKCDNIFVNGNNG----EVKIGDLGLAIVMQ 182 (631)
Q Consensus 145 Hs~~~~IiHrDLKp~NILl~~~~g----~vKL~DFGla~~~~ 182 (631)
..| ++|+|+||.||+++ .+| .++++|||+...+.
T Consensus 278 -~~G--ffHaDpHPGNIlv~-~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 -RDG--FFHADMHPGNIFVS-YDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -hCC--eeeCCCChHHeEEe-cCCCCCCeEEEEecceEEECC
Confidence 367 99999999999997 566 99999999986543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.2e-10 Score=129.96 Aligned_cols=167 Identities=26% Similarity=0.335 Sum_probs=127.9
Q ss_pred EEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhC
Q 006779 43 KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH 122 (631)
Q Consensus 43 ~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~ 122 (631)
.|..+.+|.+|.+...+... ....+.+.+-++.|+.|+||||++|++.+... .++|+|||.+. .|..++++-
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~----~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~--~~~ylvTErV~--Pl~~~lk~l 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSN----GEVTELAKRAVKRLKTLRHPNILSYLDTTEEE--GTLYLVTERVR--PLETVLKEL 101 (690)
T ss_pred ccceeccCCceEEEEEeCCC----chhhHHHHHHHHHhhhccCchhhhhhhhhccc--CceEEEeeccc--cHHHHHHHh
Confidence 56778899999998887543 24556688899999999999999999988654 47999999985 688888774
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC--CccccCCCCCCCcc
Q 006779 123 KNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE 199 (631)
Q Consensus 123 ~~l~~~~i~~i~~QIl~aL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~--~~~~~GTp~Y~APE 199 (631)
+ ...+..-+.||+.||.|||. ++ ++|++|.-+.|||+ ..|..||++|-++....... .+...---.|..|+
T Consensus 102 ~---~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn-~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 102 G---KEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVN-ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPE 175 (690)
T ss_pred H---HHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEc-CCCcEEEeeeEEEeccccCCcccccchhhhcccChh
Confidence 4 66677778999999999984 55 99999999999998 89999999998875433322 12112122345555
Q ss_pred ccccccCccccchhhhHHHHHHhhc
Q 006779 200 LYEEEYNELVDIYSFGMCILEMVTC 224 (631)
Q Consensus 200 vl~~~ys~~sDIwSLGiilyELltG 224 (631)
.+... .-..|.|-|||++++++.|
T Consensus 176 ~~~~s-~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 176 EIDPS-EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcCcc-ccchhhhhHHHHHHHHhCc
Confidence 33211 1356999999999999998
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.19 E-value=8.5e-11 Score=130.10 Aligned_cols=143 Identities=21% Similarity=0.174 Sum_probs=95.6
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCH--------------------------H----HH------HHHH
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--------------------------D----QL------ERLY 74 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~--------------------------~----~~------~~l~ 74 (631)
+.||.|++|.||+|..+ +|+.||||+.+......-. . .. -.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 46999999999999864 7999999987543100000 0 00 0244
Q ss_pred HHHHHHHhC----CCCCceeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 006779 75 SEVHLLKSL----KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILR-GLHYLHSHN 148 (631)
Q Consensus 75 ~Ei~iLk~L----~HpnIVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~-aL~yLHs~~ 148 (631)
+|+..+..+ +|.+-+.+-.++.+-. ..-++||||+.|++|.++.... ..++ ...++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~-~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRT-SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhc-CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 566666555 2333344333332222 2357899999999998876532 1222 2345555555 467889988
Q ss_pred CCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 149 ~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
++|+|++|.||+++ .+|.++++|||++..+
T Consensus 278 --~~H~D~hPgNilv~-~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 278 --FFHADLHPGNIFVL-KDGKIIALDFGIVGRL 307 (437)
T ss_pred --ceeCCCCcccEEEC-CCCcEEEEeCCCeeEC
Confidence 99999999999997 7889999999998644
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.1e-10 Score=113.37 Aligned_cols=144 Identities=15% Similarity=0.146 Sum_probs=102.3
Q ss_pred eeEecccCceEEEEEEEcc------CCeEEEEEEeecccc--c-------CC---------HHHHHHH----HHHHHHHH
Q 006779 30 DEILGKGAFKTVYKGFDEV------DGIEVAWNQVNIEDV--M-------QS---------PDQLERL----YSEVHLLK 81 (631)
Q Consensus 30 ~e~LG~G~fg~Vy~a~d~~------tg~~VAiK~i~~~~~--~-------~~---------~~~~~~l----~~Ei~iLk 81 (631)
...||.|-=+.||.|.... .+..+|+|+.+.... . .. ......+ .+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999998654 358999998764210 0 00 0112223 38999999
Q ss_pred hCCC--CCceeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCEEeccCCC
Q 006779 82 SLKH--ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL-HSHNPPIIHRDLKC 158 (631)
Q Consensus 82 ~L~H--pnIVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yL-Hs~~~~IiHrDLKp 158 (631)
+|.. -++.+.+.+ . .-++||||+.++.+....-+...++...+..+..|++.+|..| |..+ ||||||++
T Consensus 82 rl~~~Gv~vP~pi~~--~----~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~ 153 (197)
T cd05146 82 RMQKAGIPCPEVVVL--K----KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSE 153 (197)
T ss_pred HHHHcCCCCCeEEEe--c----CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence 9953 466666653 1 2457999997654432222233466677788899999999998 8888 99999999
Q ss_pred CCeeecCCCCcEEEccccccchhcC
Q 006779 159 DNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 159 ~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
.||++. ++.+.|+|||.+.....
T Consensus 154 ~NIL~~--~~~v~iIDF~qav~~~h 176 (197)
T cd05146 154 YNMLWH--DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred HHEEEE--CCcEEEEECCCceeCCC
Confidence 999996 57899999998865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.1e-10 Score=111.22 Aligned_cols=128 Identities=20% Similarity=0.080 Sum_probs=93.7
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCce-eeeeeEEcCCCCeEEEEEec
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII-KFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIV-kl~~~~~d~~~~~l~lV~Ey 109 (631)
+.|+.|.++.||++... |..|++|....... ....+..|+.+++.+.+.+++ +++.. +... -++||||
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~--~~lv~e~ 72 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYF--DPET--GVLITEF 72 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEE--eCCC--CeEEEEe
Confidence 56889999999999754 78899998753321 112356899999998665544 45443 2222 3689999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC---CEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP---PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~---~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
++|.++... ......++.+++.+|..||..+. .++|+|++|.||+++ ++.++++|||.+.
T Consensus 73 i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf~~a~ 135 (170)
T cd05151 73 IEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD--DGRLWLIDWEYAG 135 (170)
T ss_pred cCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE--CCeEEEEeccccc
Confidence 999888643 01123467899999999999862 259999999999997 5689999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=9.9e-11 Score=129.40 Aligned_cols=250 Identities=20% Similarity=0.170 Sum_probs=173.9
Q ss_pred CCCceeeeeeEecccCceEEEEEEEc-cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDE-VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDT 99 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~-~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~ 99 (631)
+.+++.. ...||.|.|+.|+...-. .++..+++|.+...- .. ......-..|+-+...+ .|.+++.++..|..-.
T Consensus 263 ~~~df~~-v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~-~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 263 KLTDFGL-VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-AT-FASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ecCCcce-eEEccCCccccceeeeecCCCCceEeChhhhccc-cc-hHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3444433 467999999999887644 677888888875432 22 22333445677777776 6999999999996544
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
+ .|+=.|||.++++...+.-...+++...++...|++.++.++|+.. ++|+|++|+||++...++.-+++|||.++
T Consensus 340 ~--~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 340 Q--GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred c--ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhcccccccc
Confidence 3 4567899999999887765567889999999999999999999988 99999999999997223778999999986
Q ss_pred hhcCCCCccccCCCCCC-Ccccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006779 180 VMQQPTARSVIGTPEFM-APELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 180 ~~~~~~~~~~~GTp~Y~-APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~ 256 (631)
.+.-... ...+.-+++ .+|++.. .+..++|++|||..+.+.+++..--.... ....+.++..|. .+... .
T Consensus 416 ~~~~~~~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~p~-~~~~~-~ 488 (524)
T KOG0601|consen 416 RLAFSSG-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGDTPN-LPGLK-L 488 (524)
T ss_pred ccceecc-cccccccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeecccccC-CCchH-H
Confidence 4222111 122333444 3555543 36789999999999999999874332211 122333343332 12222 5
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 006779 257 QVKQFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~elL~hpff~ 285 (631)
++..+.+.++. ++..|+.+.++..|.-|.
T Consensus 489 ~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 489 QLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 66677777776 778888898888876553
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=8.1e-09 Score=99.70 Aligned_cols=145 Identities=21% Similarity=0.265 Sum_probs=105.9
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEeeccccc----CCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEE
Q 006779 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM----QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 30 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~----~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~l 105 (631)
.++|-||+-+.|+++. ..|+.+.||.=..+... +..-...+..+|+++|.++.--.|.----+|+|...+.+
T Consensus 12 l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i-- 87 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQI-- 87 (229)
T ss_pred ceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeE--
Confidence 4789999999999995 56888888753222211 112234678899999999875554443334566666665
Q ss_pred EEeccCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcE--EEccccccch
Q 006779 106 ITELFTS-GSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV--KIGDLGLAIV 180 (631)
Q Consensus 106 V~Ey~~g-GsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~v--KL~DFGla~~ 180 (631)
+|||++| -++++++.... .........++++|-..+.-||..+ |||+||..+||++..+++.+ .++|||++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhc
Confidence 5699976 48888887643 2233344789999999999999999 99999999999998655554 8999999854
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.9e-08 Score=109.60 Aligned_cols=213 Identities=19% Similarity=0.261 Sum_probs=152.9
Q ss_pred ceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC--CCeEEEEEeccCC-CC
Q 006779 38 FKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--NRTINMITELFTS-GS 114 (631)
Q Consensus 38 fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~--~~~l~lV~Ey~~g-Gs 114 (631)
-.+.|+++...+|..|++|+++..+. ++. .+...-+++++++.|+|||+|.++|.... ...+++|++|.++ ++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~-~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRD-QST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccc-cCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 35789999999999999999954432 221 22345688999999999999999887322 2478999999875 67
Q ss_pred HHHHHH---------------hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 115 LRQYRK---------------KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 115 L~~~l~---------------~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
|.++.- .+.+.++..++.++.|+..||.++|+.| +..+-|.|.+|+++| +.+++|...|+..
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G-~~RIriS~C~i~D 441 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTG-KMRIRISGCGIMD 441 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeC-cceEEEeccccee
Confidence 776542 1235788999999999999999999999 888999999999984 4489998888876
Q ss_pred hhcCCCCccccCCCCCCCccccccccCccccchhhhHHHHHHhhcCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCCcHHH
Q 006779 180 VMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI-YKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 180 ~~~~~~~~~~~GTp~Y~APEvl~~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i-~~~i~~~~~p~~l~~~~~~~l 258 (631)
++..... +.++ -..+-|.-.||.+++.|.||..--.......+. ...|+ ..++.++
T Consensus 442 vl~~d~~------------~~le--~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~---------~~yS~D~ 498 (655)
T KOG3741|consen 442 VLQEDPT------------EPLE--SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT---------TTYSTDL 498 (655)
T ss_pred eecCCCC------------cchh--HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh---------hhhhHHH
Confidence 5544321 1111 123568889999999999996443222222222 23333 2456788
Q ss_pred HHHHHHhcCC-CCCCCCHHHHhcC
Q 006779 259 KQFIEKCIVP-ASLRLPALELLKD 281 (631)
Q Consensus 259 ~~lI~~cL~~-p~~Rpsa~elL~h 281 (631)
+++|.-...+ +.. .+..+++.+
T Consensus 499 rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 499 RNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHhcCccc-ccHHHHHHH
Confidence 8898887763 433 677887765
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.93 E-value=4.7e-09 Score=103.85 Aligned_cols=144 Identities=19% Similarity=0.197 Sum_probs=104.2
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC--CceeeeeeEEcCC-CCeEEEEE
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE--NIIKFYNSWVDDT-NRTINMIT 107 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~Hp--nIVkl~~~~~d~~-~~~l~lV~ 107 (631)
+.||.|.++.||++.... |..+++|........ .....+..|+.+++.+.+. ++.+++.+..... ....++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 568999999999997643 688999987543321 1234578899999999763 4566666543221 12567999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN--------------------------------------- 148 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~--------------------------------------- 148 (631)
||+.|.++...+.. ..+++.....++.+++.+|.+||+..
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99999888765432 35677777788888888888887521
Q ss_pred ---------------CCEEeccCCCCCeeecCC-CCcEEEccccccc
Q 006779 149 ---------------PPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAI 179 (631)
Q Consensus 149 ---------------~~IiHrDLKp~NILl~~~-~g~vKL~DFGla~ 179 (631)
..++|+|++|.||+++.+ ++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 237999999999999832 5678999998774
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.9e-08 Score=97.49 Aligned_cols=132 Identities=23% Similarity=0.342 Sum_probs=96.1
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHH-----HHHHHHHHHHHHHhCCCCCc--eeeeeeEEcCCCCeE
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD-----QLERLYSEVHLLKSLKHENI--IKFYNSWVDDTNRTI 103 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~-----~~~~l~~Ei~iLk~L~HpnI--Vkl~~~~~d~~~~~l 103 (631)
..+++|+-+.+|.+.. -|..+++|. .+.+....++ ..++-.+|+.+|..++--.| ..+|+ +++.+ -
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~-Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~d--vD~~~--~ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKE-RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYD--VDPDN--G 74 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEe-ecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEE--EcCCC--C
Confidence 3578999999999844 455565654 3333333332 23567789999998865443 33444 55654 3
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
.|+|||.+|-.|++++... ...+++.+-.-+.-||..| |+|+||+++||++. ++.+.++|||++..
T Consensus 75 ~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~--~~~i~~IDfGLg~~ 140 (204)
T COG3642 75 LIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILS--GGRIYFIDFGLGEF 140 (204)
T ss_pred EEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEe--CCcEEEEECCcccc
Confidence 4688999999999998776 1456777777788899999 99999999999996 45599999999963
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.4e-07 Score=92.87 Aligned_cols=131 Identities=27% Similarity=0.288 Sum_probs=83.7
Q ss_pred EEEEEEEccCCeEEEEEEeeccccc----------------------CCHHHHHHHHHHHHHHHhCCCC--CceeeeeeE
Q 006779 40 TVYKGFDEVDGIEVAWNQVNIEDVM----------------------QSPDQLERLYSEVHLLKSLKHE--NIIKFYNSW 95 (631)
Q Consensus 40 ~Vy~a~d~~tg~~VAiK~i~~~~~~----------------------~~~~~~~~l~~Ei~iLk~L~Hp--nIVkl~~~~ 95 (631)
.||.|.. .+|..||+|+.+..... ..........+|++.|..+..- ++.+.+.+
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 4888876 46889999987653110 0011235577999999999765 56667653
Q ss_pred EcCCCCeEEEEEeccC--CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCEEeccCCCCCeeecCCCCcEEE
Q 006779 96 VDDTNRTINMITELFT--SGSLRQYRKKHKNVDMKAIKNWARQILRGLHY-LHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 96 ~d~~~~~l~lV~Ey~~--gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~y-LHs~~~~IiHrDLKp~NILl~~~~g~vKL 172 (631)
.. -++||||+. |..+..+.... ++......++.+++..+.. +|..| |+|+||++.||+++ .+.+.|
T Consensus 79 -~~----~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~--~~~~~i 147 (188)
T PF01163_consen 79 -NR----NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVD--DGKVYI 147 (188)
T ss_dssp -ET----TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEE--TTCEEE
T ss_pred -eC----CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEee--cceEEE
Confidence 22 247999998 65665543322 1244567788888886555 57888 99999999999997 348999
Q ss_pred ccccccchhcC
Q 006779 173 GDLGLAIVMQQ 183 (631)
Q Consensus 173 ~DFGla~~~~~ 183 (631)
+|||.+.....
T Consensus 148 IDf~qav~~~~ 158 (188)
T PF01163_consen 148 IDFGQAVDSSH 158 (188)
T ss_dssp --GTTEEETTS
T ss_pred EecCcceecCC
Confidence 99998865443
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.65 E-value=5.8e-07 Score=93.35 Aligned_cols=106 Identities=18% Similarity=0.127 Sum_probs=78.7
Q ss_pred HHHHHHHHHHhCCCCCce--eeeeeEEc---CCCCeEEEEEeccCCC-CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHH
Q 006779 72 RLYSEVHLLKSLKHENII--KFYNSWVD---DTNRTINMITELFTSG-SLRQYRKK--HKNVDMKAIKNWARQILRGLHY 143 (631)
Q Consensus 72 ~l~~Ei~iLk~L~HpnIV--kl~~~~~d---~~~~~l~lV~Ey~~gG-sL~~~l~~--~~~l~~~~i~~i~~QIl~aL~y 143 (631)
.+.+|...+..|..-+|. +...+... .....-++|||++++. +|.+++.. ....+......++.++...+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 367888888887433222 22222222 1123467899999875 89999864 2445677788999999999999
Q ss_pred HHhCCCCEEeccCCCCCeeecC------CCCcEEEccccccc
Q 006779 144 LHSHNPPIIHRDLKCDNIFVNG------NNGEVKIGDLGLAI 179 (631)
Q Consensus 144 LHs~~~~IiHrDLKp~NILl~~------~~g~vKL~DFGla~ 179 (631)
||..| |+|+||++.|||++. .++.+.|+||+.+.
T Consensus 154 LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 154 MHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99999 999999999999973 24689999999774
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.3e-06 Score=93.54 Aligned_cols=236 Identities=17% Similarity=0.250 Sum_probs=148.4
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEE------cCCC
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWV------DDTN 100 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~------d~~~ 100 (631)
-.++-||+|+-+.+|.. .+-+..| -|++.... +.... +-+..|... .||-+-. --.|- ....
T Consensus 14 ~~gr~LgqGgea~ly~l--~e~~d~V-AKIYh~Pp----pa~~a---qk~a~la~~p~~p~~~~-rvaWPqa~L~G~~~~ 82 (637)
T COG4248 14 PPGRPLGQGGEADLYTL--GEVRDQV-AKIYHAPP----PAAQA---QKVAELAATPDAPLLNY-RVAWPQATLHGGRRG 82 (637)
T ss_pred CCCccccCCccceeeec--chhhchh-heeecCCC----chHHH---HHHHHhccCCCCcchhh-hhcccHHHhhCCCcc
Confidence 34566999999999975 2223334 35555332 11111 122333333 5664332 11121 1222
Q ss_pred CeEEEEEeccCCC-CHHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEc
Q 006779 101 RTINMITELFTSG-SLRQYRK------KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173 (631)
Q Consensus 101 ~~l~lV~Ey~~gG-sL~~~l~------~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~ 173 (631)
..+.+.|..+.|. -...+.. ......+..+.+.++.|+.+...||.+| .+-+|+.++|+|+. +.+.|.|+
T Consensus 83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVs-d~~~V~LV 159 (637)
T COG4248 83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVS-DDSKVVLV 159 (637)
T ss_pred ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeee-cCceEEEE
Confidence 3478889988764 2222221 2345788999999999999999999999 99999999999996 88999998
Q ss_pred cccccch-hcCCCCccccCCCCCCCccccc-c-----ccCccccchhhhHHHHHHhhc-CCCCCCCCC----HHHHHHHH
Q 006779 174 DLGLAIV-MQQPTARSVIGTPEFMAPELYE-E-----EYNELVDIYSFGMCILEMVTC-EYPYNECKN----PAQIYKKV 241 (631)
Q Consensus 174 DFGla~~-~~~~~~~~~~GTp~Y~APEvl~-~-----~ys~~sDIwSLGiilyELltG-~~Pf~~~~~----~~~i~~~i 241 (631)
|=..-.+ .+.......+|.++|.+||+-. + +-+...|.|-||+++++++.| +.||++-.- +.-.-..|
T Consensus 160 dsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I 239 (637)
T COG4248 160 DSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI 239 (637)
T ss_pred cccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence 8543322 2222233457899999999644 1 246789999999999999986 999976311 10111122
Q ss_pred Hc-----------CCCCC--CCC-CCCcHHHHHHHHHhcCC---CCCCCCHHH
Q 006779 242 TS-----------GIKPA--SLS-KVTDPQVKQFIEKCIVP---ASLRLPALE 277 (631)
Q Consensus 242 ~~-----------~~~p~--~l~-~~~~~~l~~lI~~cL~~---p~~Rpsa~e 277 (631)
.. +.+|. .++ ...++.+..+..+|+.+ +.-|||++.
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 22 22222 221 23578899999999974 558999653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=5.2e-08 Score=109.66 Aligned_cols=148 Identities=20% Similarity=0.299 Sum_probs=105.9
Q ss_pred HHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCC-----------ccccCCCCCCCccccccc-c
Q 006779 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-----------RSVIGTPEFMAPELYEEE-Y 205 (631)
Q Consensus 138 l~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~-----------~~~~GTp~Y~APEvl~~~-y 205 (631)
..|+.|+|.+ +.+||++|.|++|.++ .+|.+||+.|+++.....+.. ........|.|||++... .
T Consensus 109 ~dgl~flh~s-Ak~VH~ni~p~~i~~n-a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~ 186 (700)
T KOG2137|consen 109 ADGLAFLHRS-AKVVHGNIQPEAIVVN-ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN 186 (700)
T ss_pred cchhhhhccC-cceeecccchhheeec-cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence 3899999987 4799999999999998 799999999999854433211 111235679999977654 6
Q ss_pred CccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHH-HHc-CCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 206 NELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKK-VTS-GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 206 s~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~-i~~-~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
+.++|+||||+.+|.+.. |..-+...... ..+.. ... +..........+.++++-+.++|. ++..||++.+++..
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAANGGL-LSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhccCCc-chhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence 789999999999999984 44444332211 11111 111 111222345667899999999997 89999999999999
Q ss_pred CCCCCCC
Q 006779 282 PFLVTDN 288 (631)
Q Consensus 282 pff~~~~ 288 (631)
|||....
T Consensus 266 ~ff~D~~ 272 (700)
T KOG2137|consen 266 PFFSDPG 272 (700)
T ss_pred cccCCch
Confidence 9997543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.7e-06 Score=84.78 Aligned_cols=108 Identities=21% Similarity=0.210 Sum_probs=82.5
Q ss_pred HHHHHHHHHHHHhCCCCC--ceeeeeeEEcCC--CCeEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 006779 70 LERLYSEVHLLKSLKHEN--IIKFYNSWVDDT--NRTINMITELFTS-GSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144 (631)
Q Consensus 70 ~~~l~~Ei~iLk~L~Hpn--IVkl~~~~~d~~--~~~l~lV~Ey~~g-GsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yL 144 (631)
..+..+|...+..|..-. +++.+.+..... ...-++|||++++ .+|.+++......+......++.++...+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 356788888888774332 223333332221 1345789999987 48999998866678888899999999999999
Q ss_pred HhCCCCEEeccCCCCCeeecCCCC---cEEEccccccch
Q 006779 145 HSHNPPIIHRDLKCDNIFVNGNNG---EVKIGDLGLAIV 180 (631)
Q Consensus 145 Hs~~~~IiHrDLKp~NILl~~~~g---~vKL~DFGla~~ 180 (631)
|.+| |+|+|+++.|||++ .++ .+.++||+-+..
T Consensus 135 H~~g--i~H~Dl~~~NILv~-~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAG--IYHGDLNPSNILVD-PDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCc--CCCCCCCcccEEEe-CCCCceeEEEEcchhcee
Confidence 9999 99999999999998 444 789999997753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=8.6e-07 Score=90.76 Aligned_cols=140 Identities=21% Similarity=0.214 Sum_probs=100.1
Q ss_pred eeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccc-----cCC-------------HHHHHHHHHHHHHHHhCCCC-
Q 006779 26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV-----MQS-------------PDQLERLYSEVHLLKSLKHE- 86 (631)
Q Consensus 26 y~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~-----~~~-------------~~~~~~l~~Ei~iLk~L~Hp- 86 (631)
...++..||-|-=+.||.|.+. .|.++|+|.-+.... ... .-......+|.++|..|.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 4567889999999999999876 789999997554210 000 01234577999999999755
Q ss_pred -CceeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC
Q 006779 87 -NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 165 (631)
Q Consensus 87 -nIVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~ 165 (631)
.|.+-+++ +.-.+||||++|-.|.... ++......++..|+.-+.-+-..| |||+|+++-||+++
T Consensus 171 ~~VP~P~~~------nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~- 236 (304)
T COG0478 171 VKVPKPIAW------NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVT- 236 (304)
T ss_pred CCCCCcccc------ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEe-
Confidence 67776652 2355799999997775433 234444555555655555555667 99999999999998
Q ss_pred CCCcEEEccccccch
Q 006779 166 NNGEVKIGDLGLAIV 180 (631)
Q Consensus 166 ~~g~vKL~DFGla~~ 180 (631)
.+|.+.++||-.+..
T Consensus 237 ~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 237 EDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCCEEEEeCccccc
Confidence 789999999976643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.8e-08 Score=110.71 Aligned_cols=242 Identities=20% Similarity=0.273 Sum_probs=165.0
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC-ceeeeeeEEcC
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN-IIKFYNSWVDD 98 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~Hpn-IVkl~~~~~d~ 98 (631)
.|++ ||+.+-.-+++|+++.+++++...+...+ .+.+... ....-++++|.+++||| .+.+++.+ +
T Consensus 238 kDk~-kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---------l~~rl~~eLLdK~n~P~~~v~~~~d~--~ 304 (829)
T KOG0576|consen 238 KDKT-KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---------LSRRLAIELLDKVNNPNPVVRYLEDY--D 304 (829)
T ss_pred cCCc-cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---------hhhHHHHHHHHHccCCCCcccccccC--C
Confidence 3444 44455566899999999999888777666 6666532 33567899999999999 55555543 3
Q ss_pred CCCeEEEEEeccCCC-CHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccc
Q 006779 99 TNRTINMITELFTSG-SLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gG-sL~~~l~-~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 176 (631)
.+.+.+++++++.++ +....+. ....+..-+....++.-..+|+|+|+.. =+||| ||+.. ++..+.++|+
T Consensus 305 ~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s--~~~~~~~~~~ 376 (829)
T KOG0576|consen 305 GEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGS--EEEVKLLDFA 376 (829)
T ss_pred cccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----ccccc--cccccccccc
Confidence 445788999999887 2222111 1112344456667777788999999874 48888 77774 5789999999
Q ss_pred ccchhcCC-CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC--C-C
Q 006779 177 LAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--L-S 251 (631)
Q Consensus 177 la~~~~~~-~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~--l-~ 251 (631)
....+... ..++..+|+.++|||+.. +.+....|.|++|.-..+|.-|-.|-.. |......+ +..|.. + .
T Consensus 377 v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~---P~~~~~~~--g~~p~s~~L~~ 451 (829)
T KOG0576|consen 377 VPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS---PPAVLPMI--GNGPNSPMLTD 451 (829)
T ss_pred CCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC---CccccCCC--CCCCCccccch
Confidence 98766544 456778999999999654 5589999999999988888888777543 11110111 111110 0 0
Q ss_pred -CCCcHHH-HHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 252 -KVTDPQV-KQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 252 -~~~~~~l-~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
....+.. +++...|+. .|..|+..-.+++|.+|..-
T Consensus 452 ~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 452 KSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred hhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 0111122 347788888 68899999999999998653
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.30 E-value=2.6e-06 Score=100.78 Aligned_cols=206 Identities=22% Similarity=0.346 Sum_probs=146.6
Q ss_pred HHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC--eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 006779 68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR--TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145 (631)
Q Consensus 68 ~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~--~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLH 145 (631)
..+....-|+..+..+.|+|++.++.+-...... .+.+..++|...++...+..-+.++..+++.|..++++||.|+|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 4455566777888899999999999876644322 23345689999999999998899999999999999999999999
Q ss_pred hCCCCEEeccCCCC---CeeecCCCCcEEEc--cccccchhcCCC-CccccCCCCCCCccccccc-c--CccccchhhhH
Q 006779 146 SHNPPIIHRDLKCD---NIFVNGNNGEVKIG--DLGLAIVMQQPT-ARSVIGTPEFMAPELYEEE-Y--NELVDIYSFGM 216 (631)
Q Consensus 146 s~~~~IiHrDLKp~---NILl~~~~g~vKL~--DFGla~~~~~~~-~~~~~GTp~Y~APEvl~~~-y--s~~sDIwSLGi 216 (631)
+.. ..|.-|... +--.+ ..+.+.++ ||+....+.... .....-+..+.+||.+... + ....|+|++|.
T Consensus 304 ~~~--l~~v~L~~s~~~~~~~~-~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 304 SLS--LEHVVLSASSSKESTVD-GEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred Hhc--cceeEEecccccccccC-ccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 986 666666555 33333 34456666 888776554332 2233445667888876544 3 34579999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 217 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 217 ilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
.+..+..|..+-.....+.. .+.........++..+|+. ++.+|+++.++|.|||.....
T Consensus 381 l~~~~~~~~~i~~~~~~~~~------------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSAVPVS------------LLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred HHhhhhhcCcccccccchhh------------hhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence 99999988765432111111 1111122267889999997 899999999999999997643
|
|
| >PF12202 OSR1_C: Oxidative-stress-responsive kinase 1 C terminal; InterPro: IPR024678 Oxidative-stress-responsive kinase 1 (OSR1) is involved in the signalling cascade which activates Na/K/2Cl co-transporter during osmotic stress | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.3e-06 Score=61.97 Aligned_cols=32 Identities=38% Similarity=0.523 Sum_probs=27.3
Q ss_pred eEEEEEecCCCC------CceeeeeecccCCCCHHHHH
Q 006779 366 VSLTLRIGDKSG------HVSNIHFVFYLNADTAISIA 397 (631)
Q Consensus 366 i~l~Lri~d~~~------~~~~i~f~f~~~~Dta~~va 397 (631)
|.|+||++|+.+ +.++|+|+|++++|+|++||
T Consensus 1 i~l~Lrv~d~kK~~~k~ken~aI~F~F~~~~D~~e~VA 38 (38)
T PF12202_consen 1 INLRLRVRDPKKRKGKHKENEAIEFEFDLGKDTAEEVA 38 (38)
T ss_dssp EEEEEEEC-TTSSSSS--TCEEEEEEEETTT--HHHHH
T ss_pred CcEEEEEeccccccCccccCccEEEEEecCCCcccccC
Confidence 679999999998 78999999999999999998
|
This entry represents the CCT domain found in OSR1, STE20/SPS1-related kinase and in WNK activators []. This domain is found in eukaryotes, and is approximately 40 amino acids in length. There is a single completely conserved residue F that may be functionally important. ; PDB: 2V3S_A 2LRU_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.9e-05 Score=77.64 Aligned_cols=141 Identities=15% Similarity=0.159 Sum_probs=96.4
Q ss_pred cccCceEEEEEEEccCCeEEEEEEee--cccccCCHHHHHHHHHHHHHHHhCCCCC--ceeee--eeEEcCCCCeEEEEE
Q 006779 34 GKGAFKTVYKGFDEVDGIEVAWNQVN--IEDVMQSPDQLERLYSEVHLLKSLKHEN--IIKFY--NSWVDDTNRTINMIT 107 (631)
Q Consensus 34 G~G~fg~Vy~a~d~~tg~~VAiK~i~--~~~~~~~~~~~~~l~~Ei~iLk~L~Hpn--IVkl~--~~~~d~~~~~l~lV~ 107 (631)
|+||-+.|+.... .|..+-+|+-. ......-+--...+.+|+..|..|..-+ +.+.. +.-.......-+|||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 3467777777532 34467777643 1111111334567999999999985322 33322 222122233567899
Q ss_pred eccCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCc--EEEccccccc
Q 006779 108 ELFTS-GSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAI 179 (631)
Q Consensus 108 Ey~~g-GsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~--vKL~DFGla~ 179 (631)
|-+.+ -+|.+++... .+.+......++.++...+.-||..| +.|+|+-+.|||++ .+|. ++++||--++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~-~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVK-TEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeec-CCCCeeEEEEEhhccc
Confidence 97754 6899888664 34577888899999999999999999 99999999999997 3456 9999997653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.07 E-value=9.3e-05 Score=73.25 Aligned_cols=141 Identities=21% Similarity=0.251 Sum_probs=81.2
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC--CceeeeeeEEc-CCCCeEEEEE
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE--NIIKFYNSWVD-DTNRTINMIT 107 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~Hp--nIVkl~~~~~d-~~~~~l~lV~ 107 (631)
+.|+.|..+.||+..... ..+++|.... ......+.+|+.+++.|... .+.+++..... ......+++|
T Consensus 3 ~~l~~G~~n~~~~v~~~~--~~~vlK~~~~------~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD--GRYVLKFYRP------PDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEESSSSEEEEEEETT--SEEEEEEESS------HHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC--cEEEEEEeCC------CCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 568999999999997655 4888888642 23456678899988888533 34566653322 2233578999
Q ss_pred eccCCCCHHH----------------HHH---hC----CCCCH------H---HHHHH------------HHHHHH-HHH
Q 006779 108 ELFTSGSLRQ----------------YRK---KH----KNVDM------K---AIKNW------------ARQILR-GLH 142 (631)
Q Consensus 108 Ey~~gGsL~~----------------~l~---~~----~~l~~------~---~i~~i------------~~QIl~-aL~ 142 (631)
+++.|..+.. .+. +. ..+.. . ....+ ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999988877 111 11 00110 0 00000 011222 233
Q ss_pred HHHh-----CCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 143 YLHS-----HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 143 yLHs-----~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
.++. ....++|+|+.|.|||++..++.+-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3332 223499999999999998456777899998763
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.01 E-value=4.6e-05 Score=77.24 Aligned_cols=135 Identities=13% Similarity=0.133 Sum_probs=79.1
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC--ceeeeeeEEcCCCCeEEEEEe
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN--IIKFYNSWVDDTNRTINMITE 108 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~Hpn--IVkl~~~~~d~~~~~l~lV~E 108 (631)
+.||+|..+.||+. .|..+++|...... ....+.+|.++++.+..-. +.+.+.+..+ .....+|||
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv~e 74 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF------DKETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLIYE 74 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC------CHHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeeeee
Confidence 56899999999984 25567788765321 1234688999999886433 3556664433 345678999
Q ss_pred ccCCCC-HHHH--------------HHh-----CC----CCCHHH-HHHHHHH----------HHHH-HHHHH--hCCCC
Q 006779 109 LFTSGS-LRQY--------------RKK-----HK----NVDMKA-IKNWARQ----------ILRG-LHYLH--SHNPP 150 (631)
Q Consensus 109 y~~gGs-L~~~--------------l~~-----~~----~l~~~~-i~~i~~Q----------Il~a-L~yLH--s~~~~ 150 (631)
+++|.+ +... +.+ |. ..+... ...+..+ +... ..+|. ...+.
T Consensus 75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 999863 2111 110 10 111111 1111111 1111 12222 22334
Q ss_pred EEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 151 IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
++|+|+.|.||+++ .++ +.|+||+.+.
T Consensus 155 ~~HgD~~~~Nii~~-~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITS-GKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEc-CCC-cEEEechhcC
Confidence 79999999999997 566 9999999774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.94 E-value=4.7e-05 Score=85.83 Aligned_cols=151 Identities=14% Similarity=0.149 Sum_probs=92.1
Q ss_pred Cceeeee-eEecccCceEEEEEEEccCCeEEEEEEeeccccc--------------------------CCHH----HHHH
Q 006779 24 CRYGRYD-EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--------------------------QSPD----QLER 72 (631)
Q Consensus 24 gRy~r~~-e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~--------------------------~~~~----~~~~ 72 (631)
..|..+. +-|+.++-|.||+|..+. |+.||||+.+..-.. .... ..++
T Consensus 123 e~F~eF~~~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~ 201 (517)
T COG0661 123 ELFSEFEPEPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKR 201 (517)
T ss_pred HHHHHcCCCchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHH
Confidence 3444454 569999999999998764 999999976542100 0000 0111
Q ss_pred ------HHHHHHHHHhCC----CCCceeeeeeEEcCCCCeEEEEEeccCCCCHHHH--HHhCCCCCHHHHHHHHHHHHHH
Q 006779 73 ------LYSEVHLLKSLK----HENIIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRG 140 (631)
Q Consensus 73 ------l~~Ei~iLk~L~----HpnIVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~--l~~~~~l~~~~i~~i~~QIl~a 140 (631)
+.+|...+.+++ ...=+.+=.+|.+-+. .-+++|||+.|-.+.++ ++. ..++.+.+...+.++..-
T Consensus 202 l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~-~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~ 279 (517)
T COG0661 202 LREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTT-RRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLR 279 (517)
T ss_pred HHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccC-CcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 334555555442 2222223333322222 34589999999999887 444 446654444433333221
Q ss_pred HHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 141 L~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
--+ ..| ++|.|.+|.||+++ .+|++-+.|||+...+.
T Consensus 280 q~~--~dg--ffHaDpHpGNi~v~-~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 280 QLL--RDG--FFHADPHPGNILVR-SDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHH--hcC--ccccCCCccceEEe-cCCcEEEEcCcceecCC
Confidence 111 246 99999999999998 78999999999885443
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.84 E-value=9.7e-05 Score=75.19 Aligned_cols=143 Identities=19% Similarity=0.195 Sum_probs=92.4
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccC------------------CHHH--HHHHHHHHHHHHhCC--CCCc
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ------------------SPDQ--LERLYSEVHLLKSLK--HENI 88 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~------------------~~~~--~~~l~~Ei~iLk~L~--HpnI 88 (631)
-.|+.|--+.||+|.. .++..||+|++......- +... ..-..+|+..|+++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3566777789999964 568999999886432100 0111 112447888888873 3333
Q ss_pred eeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccCCCCCeeecCCC
Q 006779 89 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNN 167 (631)
Q Consensus 89 Vkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs-~~~~IiHrDLKp~NILl~~~~ 167 (631)
.+-+.+. .-.+||||+....+.--.-+.-.+.......+..+++..+.-|-. .+ +||+||+.=|||+. .
T Consensus 133 P~Pi~~~------~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~--~ 202 (268)
T COG1718 133 PEPIAFR------NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH--D 202 (268)
T ss_pred CCceeec------CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE--C
Confidence 3444422 134799999653111000011223344678888899999988766 66 99999999999995 7
Q ss_pred CcEEEccccccchhcCC
Q 006779 168 GEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 168 g~vKL~DFGla~~~~~~ 184 (631)
|.+.|+|||.|.....+
T Consensus 203 ~~p~iID~~QaV~~~hp 219 (268)
T COG1718 203 GEPYIIDVSQAVTIDHP 219 (268)
T ss_pred CeEEEEECccccccCCC
Confidence 89999999998765544
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00022 Score=72.38 Aligned_cols=77 Identities=16% Similarity=0.055 Sum_probs=50.1
Q ss_pred eEecccCc-eEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCceeeeeeEEcCCCCeEEEEEe
Q 006779 31 EILGKGAF-KTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITE 108 (631)
Q Consensus 31 e~LG~G~f-g~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~l~lV~E 108 (631)
+.|..|.. ..||+.... +..+.+|+..... ...+.+|+++++.+. +-.+.+++.+.... ..-++|||
T Consensus 4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e 72 (244)
T cd05150 4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTS 72 (244)
T ss_pred eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEE
Confidence 34555665 789998543 4677777764321 234667999888884 34455677655433 35678999
Q ss_pred ccCCCCHHHH
Q 006779 109 LFTSGSLRQY 118 (631)
Q Consensus 109 y~~gGsL~~~ 118 (631)
+++|.+|...
T Consensus 73 ~i~G~~l~~~ 82 (244)
T cd05150 73 AVPGVPAAAL 82 (244)
T ss_pred eeCCccHhHh
Confidence 9999877643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00026 Score=71.26 Aligned_cols=141 Identities=16% Similarity=0.223 Sum_probs=82.7
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHH------HHHHHHHHHhCC---CCCceeeee
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER------LYSEVHLLKSLK---HENIIKFYN 93 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~------l~~Ei~iLk~L~---HpnIVkl~~ 93 (631)
.+.| +..+++-......| +.-.-+|..+++|..+.... ........ ..+++..+..+. --.+..+|-
T Consensus 30 ~~~~-~~~kv~k~~~r~~V--alIei~~~kyIlK~pr~~~~-r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 30 DNNY-KIIKVFKNTKRNYV--ALIEIDGKKYILKEPREENR-RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred hCCc-eEEEeecCCCccEE--EEEEECCcEEEEeccchhhh-hHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 3444 44455554444434 43356778888887654321 11111111 223344343332 223333332
Q ss_pred eEEcCC---CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcE
Q 006779 94 SWVDDT---NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 170 (631)
Q Consensus 94 ~~~d~~---~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~v 170 (631)
+..-.. ....+++|||++|..|.++.. +++ .+...|..++.-||..| +.|+|..|.|++++ ++.+
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~--~~~i 173 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVS--NNGI 173 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEE--CCcE
Confidence 221111 124568999999988876532 232 24466778899999999 99999999999996 4569
Q ss_pred EEccccccc
Q 006779 171 KIGDLGLAI 179 (631)
Q Consensus 171 KL~DFGla~ 179 (631)
+++||+...
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.54 E-value=9.5e-06 Score=97.82 Aligned_cols=215 Identities=13% Similarity=0.026 Sum_probs=148.3
Q ss_pred HHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHH
Q 006779 68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHY 143 (631)
Q Consensus 68 ~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~----~~l~~~~i~~i~~QIl~aL~y 143 (631)
...+....|...++...|+++...+.-.........|..++|+.+|.+...+-++ ..++..-+....++.+.+..-
T Consensus 1271 Plkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~ 1350 (2724)
T KOG1826|consen 1271 PLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNV 1350 (2724)
T ss_pred HHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccch
Confidence 3445566777778888999999988876666666788899999999999988654 345555566666666777777
Q ss_pred HHhCC---CCEEeccCCCCCeeecCCCCcEEEccccccchhcCC--CCccccCCCCCCCcccccc-ccCccccchhhhHH
Q 006779 144 LHSHN---PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMC 217 (631)
Q Consensus 144 LHs~~---~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGii 217 (631)
+|+.. .-.+|++||+-|.+|. .+-.+|++++|+.+..... ......++|.|++|++... .++.++|||..|+-
T Consensus 1351 ~ls~tnlg~T~v~~~Lkf~lpmIV-tny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ 1429 (2724)
T KOG1826|consen 1351 ILSLTNLGNTNVSKSLKFTLPMIV-TNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLS 1429 (2724)
T ss_pred hhhcccCCccchhhhhhhhcccee-cCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHH
Confidence 77643 2369999999999998 5668999999999843332 3456678899999998765 57778999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc-CCCCCCCCHHHHhcCCCCC
Q 006779 218 ILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLV 285 (631)
Q Consensus 218 lyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL-~~p~~Rpsa~elL~hpff~ 285 (631)
+|++..|..+|-.. ..-+.+.+........++...+.+.-......| -+-..||+-...+.-+.|.
T Consensus 1430 ly~rs~~n~~fi~f--lq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1430 LYLRSDGNAYFIFF--LQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHHHhcccHHHHHH--HHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 99999988777431 111112222222222334443333333333333 3566788888888777664
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0014 Score=78.67 Aligned_cols=147 Identities=20% Similarity=0.297 Sum_probs=90.8
Q ss_pred eEecccCceEEEEEEEccCC--eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCc--eeeeeeEEcCC-CCeEE
Q 006779 31 EILGKGAFKTVYKGFDEVDG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENI--IKFYNSWVDDT-NRTIN 104 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg--~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnI--Vkl~~~~~d~~-~~~l~ 104 (631)
+.|+.|.+..+|+......+ ..+++|+........ ....+.+|+++|+.|. |++| .+++.++.+.. ....|
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~---~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ---SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc---cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 66899999999997654432 467777754332211 2245779999999995 6664 67777654432 13578
Q ss_pred EEEeccCCCCHHH--------------------HHHh-CC------C---------CCHHHHHHHHHHH-----------
Q 006779 105 MITELFTSGSLRQ--------------------YRKK-HK------N---------VDMKAIKNWARQI----------- 137 (631)
Q Consensus 105 lV~Ey~~gGsL~~--------------------~l~~-~~------~---------l~~~~i~~i~~QI----------- 137 (631)
+||||+.|..+.+ .+.+ |. . ....++..|..|.
T Consensus 121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 9999998864321 1110 10 0 1123454444432
Q ss_pred ----HHHHHHHHhCCC---------CEEeccCCCCCeeecCCCCc-EEEccccccch
Q 006779 138 ----LRGLHYLHSHNP---------PIIHRDLKCDNIFVNGNNGE-VKIGDLGLAIV 180 (631)
Q Consensus 138 ----l~aL~yLHs~~~---------~IiHrDLKp~NILl~~~~g~-vKL~DFGla~~ 180 (631)
...+.+|..+-| .+||+|++++||+++..++. +-|.||.++..
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 233566754333 29999999999999743444 57899988753
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00048 Score=69.79 Aligned_cols=75 Identities=8% Similarity=0.016 Sum_probs=44.1
Q ss_pred eEecccCce-EEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC---CceeeeeeEEcCCC-CeEEE
Q 006779 31 EILGKGAFK-TVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE---NIIKFYNSWVDDTN-RTINM 105 (631)
Q Consensus 31 e~LG~G~fg-~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~Hp---nIVkl~~~~~d~~~-~~l~l 105 (631)
+.|+.|+.. .||+. +..+++|..... .....+.+|.++|+.|... .+.+++........ ...++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~------~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA------GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCcc------chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 457777766 48876 234666754321 1234688899999888532 34444443222111 24578
Q ss_pred EEeccCCCCHH
Q 006779 106 ITELFTSGSLR 116 (631)
Q Consensus 106 V~Ey~~gGsL~ 116 (631)
+|++++|.++.
T Consensus 72 l~~~i~G~~l~ 82 (235)
T cd05155 72 VYRWLEGETAT 82 (235)
T ss_pred EEEeecCCCCC
Confidence 99999987763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00044 Score=78.01 Aligned_cols=154 Identities=16% Similarity=0.125 Sum_probs=95.6
Q ss_pred CCCCceeeee-eEecccCceEEEEEEEccCCeEEEEEEeecccccCC---------------------------HHHHHH
Q 006779 21 DPSCRYGRYD-EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS---------------------------PDQLER 72 (631)
Q Consensus 21 dp~gRy~r~~-e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~---------------------------~~~~~~ 72 (631)
.+..-|..+. +-||.-+.|.||+|.-+. |+.||+|+-+..-.... .+..+.
T Consensus 156 ~ie~if~~f~~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~ 234 (538)
T KOG1235|consen 156 PIEDIFSEFDEEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKS 234 (538)
T ss_pred CHHHHHHhcCcchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhh
Confidence 3444455555 569999999999998776 99999996442110000 011122
Q ss_pred ------HHHHHHHHHh----CCCCC------ceeeeeeEEcCCCCeEEEEEeccCCCCHHH--HHHhCCCCCHHHHHHHH
Q 006779 73 ------LYSEVHLLKS----LKHEN------IIKFYNSWVDDTNRTINMITELFTSGSLRQ--YRKKHKNVDMKAIKNWA 134 (631)
Q Consensus 73 ------l~~Ei~iLk~----L~Hpn------IVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~--~l~~~~~l~~~~i~~i~ 134 (631)
+.+|.+...+ +.|-+ |.++|-.+ . ..-+++||||.|..+.+ ++++++ ++...+..-+
T Consensus 235 L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~---s-t~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l 309 (538)
T KOG1235|consen 235 LPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL---S-TKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKL 309 (538)
T ss_pred hHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhc---C-cceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHH
Confidence 3344443333 24555 55555433 1 23568999999977654 455544 6666555555
Q ss_pred HHHHHHHHHHHhCCCCEEeccCCCCCeeecC---CCCcEEEccccccchhcCC
Q 006779 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNG---NNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 135 ~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~---~~g~vKL~DFGla~~~~~~ 184 (631)
.+...-.-+. .| ++|.|=+|.||++.. .++.+.+.|||+...+...
T Consensus 310 ~~~~~~qIf~--~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 310 VEAYLEQIFK--TG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHHHHHHHh--cC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 4444333333 35 899999999999973 3678999999998655443
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0014 Score=63.69 Aligned_cols=129 Identities=26% Similarity=0.252 Sum_probs=87.4
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcee-eeeeEEcCCCCeEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK-FYNSWVDDTNRTINMI 106 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVk-l~~~~~d~~~~~l~lV 106 (631)
+..+.||+|+++.||++. ..|.++|+|.=.. ++....+..|+++|..+.-.++.+ +|.+ +. .++.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~------ds~r~~l~kEakiLeil~g~~~~p~vy~y--g~----~~i~ 90 (201)
T COG2112 25 RVEKELAKGTTSVVYLGE--WRGGEVALKVRRR------DSPRRNLEKEAKILEILAGEGVTPEVYFY--GE----DFIR 90 (201)
T ss_pred hhhhhhhcccccEEEEee--ccCceEEEEEecC------CcchhhHHHHHHHHHHhhhcCCCceEEEe--ch----hhhh
Confidence 445779999999999995 4577999987542 234466889999999998777655 4442 22 3456
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCC--CeeecCCCCcEEEccccccchh
Q 006779 107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD--NIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~--NILl~~~~g~vKL~DFGla~~~ 181 (631)
|||..|-.|...-... +-+. ...+++.---|-..| |-|+.|.-- ||+++ ++.+.|+||..|+.-
T Consensus 91 me~i~G~~L~~~~~~~---~rk~----l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~--~~~~~iIDFd~At~k 156 (201)
T COG2112 91 MEYIDGRPLGKLEIGG---DRKH----LLRVLEKAYKLDRLG--IEHGELSRPWKNVLVN--DRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhcCcchhhhhhcc---cHHH----HHHHHHHHHHHHHhc--cchhhhcCCceeEEec--CCcEEEEEccchhhc
Confidence 9999998887664421 2222 233444433355556 888888743 67774 558999999988743
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0038 Score=65.91 Aligned_cols=77 Identities=12% Similarity=0.101 Sum_probs=51.8
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC---CCceeeeeeEEcCC-CCeEEEE
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH---ENIIKFYNSWVDDT-NRTINMI 106 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~H---pnIVkl~~~~~d~~-~~~l~lV 106 (631)
+-||.|..+.||..... +| .+.+|..+.. . ....+..|...|+.|.- -.+.++++++.+.. ...-++|
T Consensus 20 ~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~---~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 20 ECISEQPYAALWALYDS-QG-NPMPLMARSF---S---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred eecCCccceeEEEEEcC-CC-CEEEEEeccc---c---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 56999999999998432 23 4566664310 0 11357889999998853 36777887654432 2457899
Q ss_pred EeccCCCCH
Q 006779 107 TELFTSGSL 115 (631)
Q Consensus 107 ~Ey~~gGsL 115 (631)
||++.|+++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998765
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.00098 Score=65.71 Aligned_cols=99 Identities=26% Similarity=0.201 Sum_probs=77.9
Q ss_pred HHHHHHHhCCC-CCceeeeeeEEcCCCCeEEEEEeccCCCCHHH---HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC-
Q 006779 75 SEVHLLKSLKH-ENIIKFYNSWVDDTNRTINMITELFTSGSLRQ---YRKKHKNVDMKAIKNWARQILRGLHYLHSHNP- 149 (631)
Q Consensus 75 ~Ei~iLk~L~H-pnIVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~---~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~- 149 (631)
.|.-+|+.+.+ +++++++++| + -++|+||...+++.. .+.+.-.-++....+++.+++..+.+|+....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C--G----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC--G----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC--C----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 58889999976 6999999987 2 235789998776542 12222346899999999999999999987321
Q ss_pred CEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 150 ~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
++.-.|++++|+-++ ++|.+|++|......
T Consensus 82 ~~~lcDv~~~nfgv~-~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVN-DDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEe-CCCcEEEEechhcch
Confidence 388899999999998 789999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0064 Score=60.54 Aligned_cols=132 Identities=21% Similarity=0.337 Sum_probs=86.1
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeeccccc------------CCHHHHHHHHHHHHHHHhCC------CCCceeee
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM------------QSPDQLERLYSEVHLLKSLK------HENIIKFY 92 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~------------~~~~~~~~l~~Ei~iLk~L~------HpnIVkl~ 92 (631)
..||+|+.-.||.- .......||+....... ..........+|+.....+. +.+|.++|
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 57999999999874 34445567877654300 00112344666777666665 78999999
Q ss_pred eeEEcCCCCeEEEEEeccC------CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC
Q 006779 93 NSWVDDTNRTINMITELFT------SGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 166 (631)
Q Consensus 93 ~~~~d~~~~~l~lV~Ey~~------gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~ 166 (631)
++... +..+.+|+|.+. +-||.++++... ++. .+...+. .-..||-.++ |+.+||+|.||++...
T Consensus 84 G~veT--~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-~~~-~~~~~L~---~f~~~l~~~~--Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 84 GFVET--NLGLGLVVELIRDADGNISPTLEDYLKEGG-LTE-ELRQALD---EFKRYLLDHH--IVIRDLNPHNIVVQRR 154 (199)
T ss_pred EEEec--CCceEEEEEEEECCCCCcCccHHHHHHcCC-ccH-HHHHHHH---HHHHHHHHcC--CeecCCCcccEEEEec
Confidence 97644 345778888764 247888885544 665 4444443 4445666777 9999999999999622
Q ss_pred C-C--cEEEcc
Q 006779 167 N-G--EVKIGD 174 (631)
Q Consensus 167 ~-g--~vKL~D 174 (631)
. | .+.|+|
T Consensus 155 ~~~~~~lvlID 165 (199)
T PF10707_consen 155 DSGEFRLVLID 165 (199)
T ss_pred CCCceEEEEEe
Confidence 1 2 467777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0072 Score=66.40 Aligned_cols=80 Identities=21% Similarity=0.217 Sum_probs=54.5
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeeccccc--C-CHHHHHHHHHHHHHHHhCC---CCCceeeeeeEEcCCCCeEE
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--Q-SPDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~--~-~~~~~~~l~~Ei~iLk~L~---HpnIVkl~~~~~d~~~~~l~ 104 (631)
+.||.|.+..||++.+...++.|++|+-...... . .+-..++...|.+.|+.+. ..+++++|.+ +.. .-+
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~--~~~ 107 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEE--LAV 107 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCC--CCE
Confidence 5699999999999988654468999985421110 1 1234567788888888863 3467778774 343 356
Q ss_pred EEEeccCCCC
Q 006779 105 MITELFTSGS 114 (631)
Q Consensus 105 lV~Ey~~gGs 114 (631)
+||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 8999998744
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0049 Score=62.00 Aligned_cols=74 Identities=15% Similarity=0.137 Sum_probs=45.7
Q ss_pred eEecccCceEEEEEEEcc-CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC-CceeeeeeEEcCCCCeEEEEEe
Q 006779 31 EILGKGAFKTVYKGFDEV-DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NIIKFYNSWVDDTNRTINMITE 108 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~-tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~Hp-nIVkl~~~~~d~~~~~l~lV~E 108 (631)
+.|..|-...+|+..... .+..|++|....... ......+|+.+++.+... -.++++..+ .. .+|||
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-----~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~~----~~l~e 72 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-----LIIDRERELRIHKLLSKHGLAPKLYATF--QN----GLIYE 72 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-----ceecHHHHHHHHHHHHhCCCCCeEEEEe--CC----cEEEE
Confidence 457778888999985443 356888887643211 111234688888888533 344455432 21 26999
Q ss_pred ccCCCCH
Q 006779 109 LFTSGSL 115 (631)
Q Consensus 109 y~~gGsL 115 (631)
|++|.++
T Consensus 73 ~i~G~~l 79 (235)
T cd05157 73 FIPGRTL 79 (235)
T ss_pred eeCCCcC
Confidence 9998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0073 Score=64.82 Aligned_cols=148 Identities=18% Similarity=0.238 Sum_probs=97.2
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeeccc--------------------ccCCHHHHH--HHHHHHHHHHhCCC
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIED--------------------VMQSPDQLE--RLYSEVHLLKSLKH 85 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~--------------------~~~~~~~~~--~l~~Ei~iLk~L~H 85 (631)
.+...|..|--+.||.|. ..+|..+|||+++-.- +..++...- -...|++.|++|+.
T Consensus 147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 344567788889999986 4578889999875321 011122221 24578888888875
Q ss_pred CCceeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCEEeccCCCCCeeec
Q 006779 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL-HSHNPPIIHRDLKCDNIFVN 164 (631)
Q Consensus 86 pnIVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yL-Hs~~~~IiHrDLKp~NILl~ 164 (631)
-.|.----..+ . .-++||+|+.......-.-+...++...+..+-.|++.-+.-| |.++ +||.||+--|+|+
T Consensus 226 aGIP~PePIlL-k---~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Ly- 298 (520)
T KOG2270|consen 226 AGIPCPEPILL-K---NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLY- 298 (520)
T ss_pred cCCCCCCceee-e---cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheE-
Confidence 55332111111 1 2357999996433222222334577778888888888887776 4556 9999999999999
Q ss_pred CCCCcEEEccccccchhcCC
Q 006779 165 GNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 165 ~~~g~vKL~DFGla~~~~~~ 184 (631)
+.|.+.|+|.+.+.....+
T Consensus 299 -hdG~lyiIDVSQSVE~DHP 317 (520)
T KOG2270|consen 299 -HDGKLYIIDVSQSVEHDHP 317 (520)
T ss_pred -ECCEEEEEEccccccCCCh
Confidence 5899999999988654443
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.03 Score=55.81 Aligned_cols=131 Identities=21% Similarity=0.252 Sum_probs=87.6
Q ss_pred ceeeeeeEecccCc-eEEEEEEEccCCeEEEEEEeecccccC----------CH-------HHHHHHHHHHHHHHhC---
Q 006779 25 RYGRYDEILGKGAF-KTVYKGFDEVDGIEVAWNQVNIEDVMQ----------SP-------DQLERLYSEVHLLKSL--- 83 (631)
Q Consensus 25 Ry~r~~e~LG~G~f-g~Vy~a~d~~tg~~VAiK~i~~~~~~~----------~~-------~~~~~l~~Ei~iLk~L--- 83 (631)
.-.++.+.||.|+- |.||++. -.|..+|+|.+..-.... .. .....|..|.+...+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 34467799999999 9999994 568899999933211000 00 1234577777766555
Q ss_pred CCCCc--eeeeeeEEcCC----------------CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 006779 84 KHENI--IKFYNSWVDDT----------------NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145 (631)
Q Consensus 84 ~HpnI--Vkl~~~~~d~~----------------~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLH 145 (631)
.+.++ |+.|++..-.. .....||.||..... .+. ..-+.+|++-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHHH
Confidence 56667 88998764221 112356777776543 222 234567888888999
Q ss_pred hCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 146 s~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
..| |+-+|+++.|.. + | ||+|||.+
T Consensus 182 k~g--I~~~Dv~~~ny~-~---G--~lvDfs~~ 206 (207)
T PF13095_consen 182 KLG--IVPRDVKPRNYR-G---G--KLVDFSSS 206 (207)
T ss_pred HCC--eeeccCcccccc-C---C--EEEecccC
Confidence 999 999999999965 2 2 78999854
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0048 Score=63.23 Aligned_cols=133 Identities=19% Similarity=0.195 Sum_probs=74.3
Q ss_pred ecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc-eeeeeeEEcCCCCeEEEEEeccC
Q 006779 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNRTINMITELFT 111 (631)
Q Consensus 33 LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnI-Vkl~~~~~d~~~~~l~lV~Ey~~ 111 (631)
+..|-...+|+.. .+|..+++|....... ...-...+|..+++.+....+ .+++.. +. -++|+||++
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~----~~~~~r~~E~~~l~~l~~~g~~P~~i~~--~~----~~~v~e~i~ 71 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCK----ALGVDRQREYQILQALSALGLAPKPILV--NE----HWLLVEWLE 71 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccc----cccCcHHHHHHHHHHHHhcCCCCceEEE--eC----CEEEEEecc
Confidence 4567778899885 4567888886432211 100124678889988864433 334432 22 247899999
Q ss_pred CCCHHH-----------H---HHh-C------CCCCH-HHHHHHHHHH---------HHHHHHHHhC------CCCEEec
Q 006779 112 SGSLRQ-----------Y---RKK-H------KNVDM-KAIKNWARQI---------LRGLHYLHSH------NPPIIHR 154 (631)
Q Consensus 112 gGsL~~-----------~---l~~-~------~~l~~-~~i~~i~~QI---------l~aL~yLHs~------~~~IiHr 154 (631)
|..+.. . +.+ | .+++. ..+..+..++ ...+..+-.. .+-++|+
T Consensus 72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~ 151 (256)
T TIGR02721 72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM 151 (256)
T ss_pred CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence 866532 1 111 1 11221 1222332222 1112222221 1238999
Q ss_pred cCCCCCeeecCCCCcEEEccccccc
Q 006779 155 DLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 155 DLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
|+.|.||+++ .++ +.|+||..+.
T Consensus 152 Dl~~~Nil~~-~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 152 DVHAYNLVVT-PQG-LKLIDWEYAS 174 (256)
T ss_pred CCCcCcEEEe-CCC-CEEEeccccC
Confidence 9999999997 455 7899998774
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.0077 Score=66.98 Aligned_cols=162 Identities=20% Similarity=0.285 Sum_probs=102.0
Q ss_pred HHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCE
Q 006779 72 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151 (631)
Q Consensus 72 ~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~I 151 (631)
.+..-.++++.+.|+|...+.++- .+...+..+|+|++ +.||.+++..+. +-..... .++ +
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~-r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~--~ 88 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFS-RGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHG--V 88 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeee-cCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------ccc--c
Confidence 466778999999999999998854 34445688999999 579999887655 2111111 112 2
Q ss_pred EeccCCCCCeeecCCCCcEEEccccccchhcCCCCccccCCCCCCCccccccccCccccchhhhHHHHHHhhcCCCCCCC
Q 006779 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNEC 231 (631)
Q Consensus 152 iHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~~ys~~sDIwSLGiilyELltG~~Pf~~~ 231 (631)
.|- | .++++| .++. .. .+.+| +++||||+|.++.++..|...+..-
T Consensus 89 ~~~-----~--------~~~~td-~~~t---~~--~~~~~---------------pKsdVwsl~~i~~el~L~~~l~~~~ 134 (725)
T KOG1093|consen 89 LHL-----N--------IIYITD-HFLT---KY--PSPIG---------------PKSDVWSLGFIILELYLGISLEAEL 134 (725)
T ss_pred cee-----h--------hhhccc-cccc---cC--CCCCC---------------cchhhhhHHHHHHHHHHhhHHHHHH
Confidence 221 2 223333 1110 00 11111 3899999999999999998877654
Q ss_pred CCHHHHHHHHHcCCCCCCCC---------CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 232 KNPAQIYKKVTSGIKPASLS---------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 232 ~~~~~i~~~i~~~~~p~~l~---------~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
.+.++.....+-...+.... ...+..+.++..+|+- .|..||...++++++-|..
T Consensus 135 ~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~e 199 (725)
T KOG1093|consen 135 TESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTE 199 (725)
T ss_pred HHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHH
Confidence 44444333332222222211 1245667888899996 8999999999999998864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.018 Score=60.12 Aligned_cols=139 Identities=17% Similarity=0.164 Sum_probs=77.1
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC--ceeeeee----EEcCCCCeEE
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN--IIKFYNS----WVDDTNRTIN 104 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~Hpn--IVkl~~~----~~d~~~~~l~ 104 (631)
+.|..|....+|+... .+..+++|.... .+ ...+..|+.++..|.+.+ +.+++.. +.....+..+
T Consensus 20 ~~i~~G~~n~~y~v~~--~~~~~vLr~~~~----~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 20 EGISAGIENTNYFVTT--DSGRYVLTLFEK----VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred ecccCccccceEEEEe--CCCcEEEEEcCC----CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 4577787788998743 344688887652 11 234667888887774332 4444331 1111123567
Q ss_pred EEEeccCCCCHHH-----H------HHh-C---CCCC--------HHHHH------------HHHHHHHHHHHHHHhC--
Q 006779 105 MITELFTSGSLRQ-----Y------RKK-H---KNVD--------MKAIK------------NWARQILRGLHYLHSH-- 147 (631)
Q Consensus 105 lV~Ey~~gGsL~~-----~------l~~-~---~~l~--------~~~i~------------~i~~QIl~aL~yLHs~-- 147 (631)
+|++|++|..+.. + +.+ | ..+. ..-.. .....+..++.++...
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 8999999866421 1 110 0 0000 00000 0111123344444431
Q ss_pred ---CCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 148 ---NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 148 ---~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
...++|+|+.|.||+++ .++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~-~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFD-GDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEe-CCceEEEeehhhhc
Confidence 12389999999999997 55566899998773
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.0049 Score=65.18 Aligned_cols=136 Identities=19% Similarity=0.222 Sum_probs=93.1
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccc-----cCCH---------H----HHHHHHHHHHHHHhCC-C-CC
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV-----MQSP---------D----QLERLYSEVHLLKSLK-H-EN 87 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~-----~~~~---------~----~~~~l~~Ei~iLk~L~-H-pn 87 (631)
-++..||-|--+.||.+-+. .|.+.++|.-++... .... . ..-...+|+..|+.|. | -.
T Consensus 95 svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 95 SVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 56788999999999999764 678888886543221 1100 0 1123568999999984 3 23
Q ss_pred ceeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCC
Q 006779 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 167 (631)
Q Consensus 88 IVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~ 167 (631)
+.+.+++ ..-++|||++.|..|.+...- .+ ...+...++.-+.-|-.+| +||+|..-=||++. .+
T Consensus 174 VPkpiD~------~RH~Vvmelv~g~Pl~~v~~v---~d---~~~ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~-dd 238 (465)
T KOG2268|consen 174 VPKPIDH------NRHCVVMELVDGYPLRQVRHV---ED---PPTLYDDLMGLIVRLANHG--LIHGDFNEFNIMVK-DD 238 (465)
T ss_pred CCCcccc------cceeeHHHhhcccceeeeeec---CC---hHHHHHHHHHHHHHHHHcC--ceecccchheeEEe-cC
Confidence 4444442 235578999999888765321 22 3344555666666777888 99999999999997 78
Q ss_pred CcEEEccccccc
Q 006779 168 GEVKIGDLGLAI 179 (631)
Q Consensus 168 g~vKL~DFGla~ 179 (631)
+.++++||-...
T Consensus 239 ~~i~vIDFPQmv 250 (465)
T KOG2268|consen 239 DKIVVIDFPQMV 250 (465)
T ss_pred CCEEEeechHhh
Confidence 899999997654
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.072 Score=57.71 Aligned_cols=84 Identities=15% Similarity=0.121 Sum_probs=53.8
Q ss_pred EecccCceEEEEEEEccCCeEEEEEEeeccccc---CCHHHHHHHHHHHHHHHhCC--CC-CceeeeeeEEcCCCCeEEE
Q 006779 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM---QSPDQLERLYSEVHLLKSLK--HE-NIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 32 ~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~---~~~~~~~~l~~Ei~iLk~L~--Hp-nIVkl~~~~~d~~~~~l~l 105 (631)
.||.|....||++.+...+..|+||+-...-.. ..+-..++..-|...|+... -| .++++|. .++. ...+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e--~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTE--MAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccc--ccee
Confidence 479999999999998644478999974321111 12444567778888887763 24 4666665 3443 3457
Q ss_pred EEeccCC-CCHHHHH
Q 006779 106 ITELFTS-GSLRQYR 119 (631)
Q Consensus 106 V~Ey~~g-GsL~~~l 119 (631)
|||+++. ..|++.+
T Consensus 78 vMEdL~~~~ilR~~L 92 (370)
T TIGR01767 78 VMEDLSHHKIARKGL 92 (370)
T ss_pred hHhhCccchHHHHHH
Confidence 8999954 3344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.0049 Score=69.41 Aligned_cols=71 Identities=30% Similarity=0.439 Sum_probs=59.2
Q ss_pred CCCceEEEEEecCCCC----CceeeeeecccCCCCHHHHHHHHHHccCCCCcCHHHHHHHHHHHHHHhCCCCCCC
Q 006779 362 DDDTVSLTLRIGDKSG----HVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPS 432 (631)
Q Consensus 362 ~~~~i~l~Lri~d~~~----~~~~i~f~f~~~~Dta~~va~EmV~~~~i~~~d~~~ia~~i~~~i~~~~~~~~~~ 432 (631)
.+..++|.+|..|.++ ..|.|+|.|+++.|+++.||+|||++++++++|...+|..+...+.++--....-
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~n~i~~~~~~~~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~~~ 389 (632)
T KOG0584|consen 315 SDPALSLSLRDEDGKKNKRPKANAIQFDYNLNTDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRNDR 389 (632)
T ss_pred ccccccccccccchhhcCCcccccccceeecCCCchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhhcc
Confidence 3455667788887763 3568999999999999999999999999999999999999999988877655443
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.073 Score=55.80 Aligned_cols=75 Identities=20% Similarity=0.197 Sum_probs=45.7
Q ss_pred eEecccCceEEEEEEEcc------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc-eeeeeeEEcCCCCeE
Q 006779 31 EILGKGAFKTVYKGFDEV------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNRTI 103 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~------tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnI-Vkl~~~~~d~~~~~l 103 (631)
+.|..|-...+|+..... ++..+++|+..... .......+|+.+++.+....+ .+++.++ ..
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~--~~---- 72 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-----ELLIDRERELVVFARLSERNLGPKLYGIF--PN---- 72 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-----cceechHHHHHHHHHHHhCCCCCceEEEe--CC----
Confidence 446667777899886533 26788888864321 122335678888888853333 3455543 22
Q ss_pred EEEEeccCCCCHH
Q 006779 104 NMITELFTSGSLR 116 (631)
Q Consensus 104 ~lV~Ey~~gGsL~ 116 (631)
.+|++|++|.++.
T Consensus 73 ~~v~e~i~G~~l~ 85 (302)
T cd05156 73 GRIEEFIPSRTLT 85 (302)
T ss_pred CchhheeCCCcCC
Confidence 2478998887663
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.074 Score=57.38 Aligned_cols=138 Identities=14% Similarity=0.193 Sum_probs=78.5
Q ss_pred eEecccCceEEEEEEEcc----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCce-eeeeeEEcCCCCeEEE
Q 006779 31 EILGKGAFKTVYKGFDEV----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII-KFYNSWVDDTNRTINM 105 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~----tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIV-kl~~~~~d~~~~~l~l 105 (631)
+.|..|-.-.+|++.... .+..|++|+..... ...+++ .+|+.+++.+..-++. ++++.+ ... .
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t----~~~idR-~~E~~~~~~l~~~gl~P~~~~~~--~~g----~ 110 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV----ELFFDR-DDEIRTFECMSRHGQGPRLLGRF--PNG----R 110 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC----Ceeech-HHHHHHHHHHHHcCCCCceEEEE--CCc----e
Confidence 345557788899986432 34688888764321 122232 5788888888544433 455544 221 3
Q ss_pred EEeccCCCCHHHH--------------HHh-CC--------CCCHHHHHHHHHHHHH-----------------HHHH--
Q 006779 106 ITELFTSGSLRQY--------------RKK-HK--------NVDMKAIKNWARQILR-----------------GLHY-- 143 (631)
Q Consensus 106 V~Ey~~gGsL~~~--------------l~~-~~--------~l~~~~i~~i~~QIl~-----------------aL~y-- 143 (631)
|++|+.+.+|..- +.+ |. ......+..|..++.. .+..
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~ 190 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE 190 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence 7888887665321 111 10 1113344455433321 1111
Q ss_pred --HHh--CCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 144 --LHS--HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 144 --LHs--~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
+.. ...-++|+|+++.||+++..++.+.|+||..+.
T Consensus 191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 221 112389999999999997445789999998773
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.24 Score=52.27 Aligned_cols=29 Identities=28% Similarity=0.322 Sum_probs=23.8
Q ss_pred CEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 150 ~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
++||+|+.|.||+++ .+...-|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~-~~~~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFE-GDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEE-CCceEEEEeccccc
Confidence 499999999999997 44445799999773
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.4 Score=51.34 Aligned_cols=137 Identities=16% Similarity=0.194 Sum_probs=75.2
Q ss_pred eEecccCceEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCce-eeeeeEEcCCCCeEEEE
Q 006779 31 EILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII-KFYNSWVDDTNRTINMI 106 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~t---g~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIV-kl~~~~~d~~~~~l~lV 106 (631)
+.|..|=.-.+|+...... +..|++|+..... . ..-.-.+|..+++.+..-++- +++.++ ... +|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t----~-~~IdR~~E~~il~~l~~~gl~P~~l~~~--~~G----~i 88 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT----D-YVIDRERELQAIKYLSAAGFGAKLLGVF--GNG----MI 88 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc----C-eEechHHHHHHHHHHHhcCCCCceeEEe--CCc----Ee
Confidence 4454466777888764332 3478888764321 1 111134688888888654443 455443 221 47
Q ss_pred EeccCCCCHHH-------H-------HHh-CC-C------C-CHHHHHHHHHHHH-------------------------
Q 006779 107 TELFTSGSLRQ-------Y-------RKK-HK-N------V-DMKAIKNWARQIL------------------------- 138 (631)
Q Consensus 107 ~Ey~~gGsL~~-------~-------l~~-~~-~------l-~~~~i~~i~~QIl------------------------- 138 (631)
.+|+.|-+|.. . +++ |. . . ....+..|..++-
T Consensus 89 ~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 168 (330)
T PLN02421 89 QSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEI 168 (330)
T ss_pred ehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHH
Confidence 88987765521 1 111 10 1 1 1233333433321
Q ss_pred HHHH-HHHhCCC--CEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 139 RGLH-YLHSHNP--PIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 139 ~aL~-yLHs~~~--~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
..+. ++...+. -++|.|+.+.||+++..++.++++||..|
T Consensus 169 ~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYa 211 (330)
T PLN02421 169 VELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYG 211 (330)
T ss_pred HHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEccccc
Confidence 1111 1212121 27999999999999745678999999877
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.085 Score=55.14 Aligned_cols=29 Identities=21% Similarity=0.340 Sum_probs=23.8
Q ss_pred CEEeccCCCCCeeecCCCCc-EEEccccccc
Q 006779 150 PIIHRDLKCDNIFVNGNNGE-VKIGDLGLAI 179 (631)
Q Consensus 150 ~IiHrDLKp~NILl~~~~g~-vKL~DFGla~ 179 (631)
-++|+|++|.|||++ .++. .-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~-~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILID-EDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEe-CCCCEEEEECcHhcc
Confidence 389999999999997 4354 5699999874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.07 Score=58.51 Aligned_cols=85 Identities=20% Similarity=0.214 Sum_probs=55.5
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeeccc-c-cCCHHHHHHHHHHHHHHHhCC--CC-CceeeeeeEEcCCCCeEEE
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIED-V-MQSPDQLERLYSEVHLLKSLK--HE-NIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~-~-~~~~~~~~~l~~Ei~iLk~L~--Hp-nIVkl~~~~~d~~~~~l~l 105 (631)
+.||-|.-.-||++.+...+..|+||+-...- . ...+-..+|..-|.+.|+.+. -| .++++|. .|+. ...+
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e--~~~~ 110 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSV--MNCC 110 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcH--HhhH
Confidence 56899999999999885445679999743211 1 122445677888889888773 24 4666776 3443 3557
Q ss_pred EEeccCCC-CHHHHH
Q 006779 106 ITELFTSG-SLRQYR 119 (631)
Q Consensus 106 V~Ey~~gG-sL~~~l 119 (631)
|||+++.. .|++.+
T Consensus 111 vMEdL~~~~ilR~~L 125 (409)
T PRK12396 111 VMEDLSDHTILRTAL 125 (409)
T ss_pred HHHhCcccHHHHHHH
Confidence 89999643 355544
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.95 E-value=0.27 Score=54.30 Aligned_cols=82 Identities=18% Similarity=0.110 Sum_probs=52.9
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCC---HHHHHHHHHHHHHHHhCC---CCCceeeeeeEEcCCCCeEE
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS---PDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~---~~~~~~l~~Ei~iLk~L~---HpnIVkl~~~~~d~~~~~l~ 104 (631)
+.||.|....||+..+. +..++||+-........ +-...+...|...|+.+. ..++.++|.+. +. .-+
T Consensus 38 ~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d--ed--~~v 111 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD--RT--MAL 111 (418)
T ss_pred EEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC--CC--CCE
Confidence 66899999999998763 45688887542221111 124566667788887764 24778888854 32 245
Q ss_pred EEEeccCC--CCHHHH
Q 006779 105 MITELFTS--GSLRQY 118 (631)
Q Consensus 105 lV~Ey~~g--GsL~~~ 118 (631)
++||++++ ..+++.
T Consensus 112 lvME~L~~~~~ilr~~ 127 (418)
T PLN02756 112 IGMRYLEPPHIILRKG 127 (418)
T ss_pred EEEeecCCcceehhhh
Confidence 78999977 345544
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.95 E-value=0.29 Score=51.55 Aligned_cols=139 Identities=18% Similarity=0.157 Sum_probs=75.1
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC--ceeeeee----EEcCCCCeEE
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN--IIKFYNS----WVDDTNRTIN 104 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~Hpn--IVkl~~~----~~d~~~~~l~ 104 (631)
+.++.|....+|+... .+| .+++|+.... ... +.+..|+.++..|.... +.+++.. +.....+..+
T Consensus 28 ~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~---~~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 28 KGIAEGVENSNYLLTT-DVG-RYILTLYEKR---VKA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred cccCCccccceEEEEe-CCC-cEEEEEecCC---CCH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 4567777788998753 344 5778876432 112 23455677777764222 3343331 1111124578
Q ss_pred EEEeccCCCCH-----HHHH------Hh-C---CCC--------CHHHHHH---------------HHHHHHHHHHHHHh
Q 006779 105 MITELFTSGSL-----RQYR------KK-H---KNV--------DMKAIKN---------------WARQILRGLHYLHS 146 (631)
Q Consensus 105 lV~Ey~~gGsL-----~~~l------~~-~---~~l--------~~~~i~~---------------i~~QIl~aL~yLHs 146 (631)
++++|++|..+ .++. .+ | ..+ ....... ....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 89999988543 1111 10 0 111 0111000 01122334555532
Q ss_pred -----CCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 147 -----HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 147 -----~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
....++|+|+.+.||+++ .++.+.|+||+.+
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~-~~~~~~vIDfd~~ 215 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFD-GDSVKGVIDFYFA 215 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEE-CCceEEEeecccc
Confidence 123499999999999997 5666689999977
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.45 E-value=0.49 Score=50.58 Aligned_cols=135 Identities=13% Similarity=0.194 Sum_probs=78.4
Q ss_pred EEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC--CCceeeeeeEEcCCCCeEEEEEeccCCCCH--
Q 006779 40 TVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDTNRTINMITELFTSGSL-- 115 (631)
Q Consensus 40 ~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~H--pnIVkl~~~~~d~~~~~l~lV~Ey~~gGsL-- 115 (631)
.+|...+. +++++++ ... .........+..+|+.+|+.+.- --+...++.+.++.....|+||+|++|..+
T Consensus 40 ~t~~~~~~--~~~~vlR-~P~--~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~ 114 (321)
T COG3173 40 DTFRLGDT--GQKYVLR-KPP--RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWS 114 (321)
T ss_pred ceEEEecC--CceEEEe-cCC--ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccC
Confidence 34554333 7778877 221 11223445667788888888743 233445555544443467899999988322
Q ss_pred -------H-HHHH--------h-C-------------CCCCHHHHHHHHHHH--------------HHHHHHHHhCCC--
Q 006779 116 -------R-QYRK--------K-H-------------KNVDMKAIKNWARQI--------------LRGLHYLHSHNP-- 149 (631)
Q Consensus 116 -------~-~~l~--------~-~-------------~~l~~~~i~~i~~QI--------------l~aL~yLHs~~~-- 149 (631)
. ++.. . | ......++..|..+. ..-..+|+.+.|
T Consensus 115 ~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~ 194 (321)
T COG3173 115 ALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPW 194 (321)
T ss_pred cCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCc
Confidence 2 2221 0 0 011233344444443 223456665543
Q ss_pred ----CEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 150 ----PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 150 ----~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
.++|+|+.+.||+++ ..+.+=+.||+.+..
T Consensus 195 ~~~~~lvHGD~~~gNlii~-~~~~~gVlDwe~~~l 228 (321)
T COG3173 195 AGPPVLVHGDYRPGNLIID-PGRPTGVLDWELATL 228 (321)
T ss_pred CCCceeeeCCcccCCEEEe-CCCeeEEEecccccc
Confidence 399999999999998 555688999998854
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.83 E-value=0.23 Score=53.70 Aligned_cols=103 Identities=18% Similarity=0.249 Sum_probs=68.0
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
..+.|++|++- |++|.- + +.-..+++..++.+.+..+.-+... .+.-|||+..+||||+ +|.|.|+||-+++
T Consensus 298 ~~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId--~GnvtLIDfklsR 369 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID--EGNVTLIDFKLSR 369 (488)
T ss_pred ceEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee--cCceEEEEeeeee
Confidence 35777888876 455532 1 2235677888888888877777665 4799999999999996 8999999999997
Q ss_pred hhcCCCCccccCCCCCCCccccccccCccccchh
Q 006779 180 VMQQPTARSVIGTPEFMAPELYEEEYNELVDIYS 213 (631)
Q Consensus 180 ~~~~~~~~~~~GTp~Y~APEvl~~~ys~~sDIwS 213 (631)
.-.... .+--..+--|-++.+.-+..-+||-
T Consensus 370 l~~~q~---~isy~rldhp~lF~G~dd~QFeIYr 400 (488)
T COG5072 370 LSYSQG---IISYNRLDHPDLFNGVDDYQFEIYR 400 (488)
T ss_pred cccCCc---eeeccccCchhhhcCccceeeeHHH
Confidence 322211 1111123344455554455566665
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.58 E-value=0.27 Score=49.80 Aligned_cols=84 Identities=23% Similarity=0.306 Sum_probs=58.0
Q ss_pred HHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEE
Q 006779 73 LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152 (631)
Q Consensus 73 l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~Ii 152 (631)
++.+.+++.+++ .|+++.. ++...+.+|.|+|..-.. ... .++.-=+.+|.-.|+.++..+
T Consensus 105 y~nky~v~Armh--GilrL~N----Dn~~~yGvIlE~Cy~~~i---------~~~----N~i~agi~~L~~fH~~~~~~l 165 (308)
T PF07387_consen 105 YFNKYRVFARMH--GILRLKN----DNNYKYGVILERCYKIKI---------NFS----NFITAGIKDLMDFHSENQHCL 165 (308)
T ss_pred hhhhhhHHHHhh--heeEeec----CCCceeEEEEeeccCccc---------chh----HHHHHhHHHHHHhhccCCCee
Confidence 567788888765 5677764 244457788999953111 111 111111456777897777899
Q ss_pred eccCCCCCeeecCCCCcEEEcccc
Q 006779 153 HRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 153 HrDLKp~NILl~~~~g~vKL~DFG 176 (631)
|+|-.|+||+-+ ..|.+||.|=+
T Consensus 166 HGD~np~NiM~D-~~G~lKlVDP~ 188 (308)
T PF07387_consen 166 HGDCNPDNIMCD-KFGYLKLVDPV 188 (308)
T ss_pred cCCCChhheeec-CCCCEEecChh
Confidence 999999999998 79999999955
|
The function of this family is unknown. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.38 E-value=0.75 Score=48.59 Aligned_cols=29 Identities=10% Similarity=0.124 Sum_probs=25.2
Q ss_pred CEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 150 ~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
.++|+|+.++|++++ .++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~-~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYD-ETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEc-CCCCEEEEEhhhcc
Confidence 499999999999997 56789999998774
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=92.67 E-value=0.61 Score=49.16 Aligned_cols=73 Identities=18% Similarity=0.088 Sum_probs=42.2
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC---CCCceeeeeeEEcCCCCeEEEE
Q 006779 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 30 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~---HpnIVkl~~~~~d~~~~~l~lV 106 (631)
.+.|+.|....+|+.. .++..+.+|.-... ....+..|..-|+.|. --.+++.+.+....+ .-++|
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~-------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~--~~fLl 90 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSES-------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD--DAFLL 90 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEEGG-------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS--CCEEE
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecChh-------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC--CceEE
Confidence 3668889999999985 67788888876521 1234677888888883 334666777554433 24789
Q ss_pred EeccCCC
Q 006779 107 TELFTSG 113 (631)
Q Consensus 107 ~Ey~~gG 113 (631)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.56 E-value=0.81 Score=50.28 Aligned_cols=60 Identities=17% Similarity=0.180 Sum_probs=42.9
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCEEeccCCCCCeeecC
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL-HSHNPPIIHRDLKCDNIFVNG 165 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yL-Hs~~~~IiHrDLKp~NILl~~ 165 (631)
..++-+|..|-++..+++..+ .+++..+.++.-...||--+ --.+ ++|.|+.|.||++-.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEEe
Confidence 457778899999998886543 55666666666555555443 2335 999999999999953
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=90.50 E-value=0.061 Score=59.87 Aligned_cols=67 Identities=21% Similarity=0.524 Sum_probs=57.7
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 30 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
+..+|.|+||+|+.+..+.++-.+|||+|..... .....+..+|+.-+..+.|++|++++..|....
T Consensus 54 ~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~---e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~~ 120 (516)
T KOG1033|consen 54 GQCLGRGGFGVVFSAQNKADENKYAVKRITLKNR---EESRSRVLREVSSLAEFEHPGIKRYFHAWYERP 120 (516)
T ss_pred cccccccCccccCCccccccchhhHHHHhcccch---hhhhhhhhccccchhhhcccchhhheeceecCC
Confidence 4689999999999999998898999999987653 455677889999999999999999999886543
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.78 E-value=1.8 Score=47.60 Aligned_cols=26 Identities=31% Similarity=0.326 Sum_probs=22.5
Q ss_pred EEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 151 IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
.+|.|+-+.||+.+ ++.+.++||-.|
T Consensus 229 fCHNDL~~gNIL~~--~~~l~lID~EYA 254 (383)
T PTZ00384 229 FCHNDLFFTNILDF--NQGIYFIDFDFA 254 (383)
T ss_pred eeeccCCcccEEec--CCCEEEEEeccc
Confidence 79999999999985 456999999766
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=89.23 E-value=1.8 Score=44.20 Aligned_cols=74 Identities=20% Similarity=0.249 Sum_probs=45.9
Q ss_pred eEecccCceEEEEEEEccCC-eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC---ceeeeeeEEcCCCCeEEEE
Q 006779 31 EILGKGAFKTVYKGFDEVDG-IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN---IIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg-~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~Hpn---IVkl~~~~~d~~~~~l~lV 106 (631)
+.|..|..-..|.. .+| .++.+|.= .......+..|+.-|..|.--| +.+++. .+..+.+.|+|
T Consensus 22 ~~v~gG~inea~~v---~dg~~~~FvK~n-------~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~--~G~~~~~sylV 89 (286)
T COG3001 22 EEVSGGDINEAWRL---RDGTDPFFVKCN-------QREQLSMFTAEADGLELLARSNTITVPKVIA--VGASRDHSYLV 89 (286)
T ss_pred cccCCccccceeEe---ecCCcceEEEec-------chhhHHHHHHHHHHHHHHHhcCCccccceEE--ecCCCCeeEEE
Confidence 33444544444444 444 45655542 2345566888888888775444 555555 44566789999
Q ss_pred EeccCCCCHH
Q 006779 107 TELFTSGSLR 116 (631)
Q Consensus 107 ~Ey~~gGsL~ 116 (631)
+||++-|.+.
T Consensus 90 le~L~~~~~d 99 (286)
T COG3001 90 LEYLPTGPLD 99 (286)
T ss_pred EeeccCCCCC
Confidence 9999876664
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=87.20 E-value=12 Score=46.40 Aligned_cols=30 Identities=30% Similarity=0.531 Sum_probs=23.8
Q ss_pred CEEeccCCCCCeeecCCC-CcEE-Eccccccc
Q 006779 150 PIIHRDLKCDNIFVNGNN-GEVK-IGDLGLAI 179 (631)
Q Consensus 150 ~IiHrDLKp~NILl~~~~-g~vK-L~DFGla~ 179 (631)
.+||+|+.+.|||+++.. +.+. |+|||-+.
T Consensus 204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 204 QVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred ceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 499999999999998432 1555 99999874
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=85.39 E-value=1.5 Score=45.77 Aligned_cols=28 Identities=25% Similarity=0.417 Sum_probs=23.8
Q ss_pred CCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 149 ~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
..++|+|+.+.||+++ . +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~-~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK-D-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEe-C-CcEEEEECccc
Confidence 3499999999999997 3 57899999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 631 | ||||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-76 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-30 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-30 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-29 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-26 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-26 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-26 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-26 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-26 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-26 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-25 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-25 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-24 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-24 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-24 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-24 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-23 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-23 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-23 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-23 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-23 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-23 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-23 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-23 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-23 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-23 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-23 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-23 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-23 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-22 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-22 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-22 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-22 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-22 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-22 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-22 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-22 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-22 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-22 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-22 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-22 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-22 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-22 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-22 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-22 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-22 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-22 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-22 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-22 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-21 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-21 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-21 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-21 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-21 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-21 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-21 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-21 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-21 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-21 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-21 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-21 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-20 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-20 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-20 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-20 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-20 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-20 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-20 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-19 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-19 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-19 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-19 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-19 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-19 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-18 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-18 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-18 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-18 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-18 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-18 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-17 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-17 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-17 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-17 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-17 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-17 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-17 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-17 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-17 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-17 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-17 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-17 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-17 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-17 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-17 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-17 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-17 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-17 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-17 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-17 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-17 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-16 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-16 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-16 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-16 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-16 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-16 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-16 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-16 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-16 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-16 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-16 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-16 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-16 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-16 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-16 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-16 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-16 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-16 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-16 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-16 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-16 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-16 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-16 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-16 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-16 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-16 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-16 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-16 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-16 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-16 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-16 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-16 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-16 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-16 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-16 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-16 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-16 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-16 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-16 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-16 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-16 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-16 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-16 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-16 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-16 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-16 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-16 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-16 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-16 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-16 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-16 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-16 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-16 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-16 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-16 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-16 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-16 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-16 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-16 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-16 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-16 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-16 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-16 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-16 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-16 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-16 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-16 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-16 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-16 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-16 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-16 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-16 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-16 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-16 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-16 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-15 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-15 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-15 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-15 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-15 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-15 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-15 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-15 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-15 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-15 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-15 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-15 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-15 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-15 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-15 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-15 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-15 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-15 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-15 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-15 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-15 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-15 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-15 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-15 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-15 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-15 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-15 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-15 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-15 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-14 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-14 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-14 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-14 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-14 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-14 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-14 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-14 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-14 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-14 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-14 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-14 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-14 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-14 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-14 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-14 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-14 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-14 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-14 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-14 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-14 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-14 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-14 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-14 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-14 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-13 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-13 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-13 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-13 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-12 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-12 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-12 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-12 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-12 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-12 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-11 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-10 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-10 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-10 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-10 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-10 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-10 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-10 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-09 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 6e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-08 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-07 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-06 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-06 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-05 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-05 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-05 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-05 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-05 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-05 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-05 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-05 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-05 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-05 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-05 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-05 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 8e-05 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-04 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 1e-04 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 1e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-04 | ||
| 2kty_A | 368 | Solution Structure Of Human Vaccinia Related Kinase | 4e-04 | ||
| 2lav_A | 361 | Nmr Solution Structure Of Human Vaccinia-Related Ki | 4e-04 | ||
| 3op5_A | 364 | Human Vaccinia-Related Kinase 1 Length = 364 | 6e-04 |
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368 | Back alignment and structure |
|
| >pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361 | Back alignment and structure |
|
| >pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 449 bits (1156), Expect = e-156
Identities = 136/281 (48%), Positives = 188/281 (66%), Gaps = 5/281 (1%)
Query: 10 SETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ 69
E E + R+ ++D +G+G+FKTVYKG D +EVAW ++ + +
Sbjct: 11 IEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSE 68
Query: 70 LERLYSEVHLLKSLKHENIIKFYNSWVD--DTNRTINMITELFTSGSLRQYRKKHKNVDM 127
+R E +LK L+H NI++FY+SW + I ++TEL TSG+L+ Y K+ K + +
Sbjct: 69 RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKI 128
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187
K +++W RQIL+GL +LH+ PPIIHRDLKCDNIF+ G G VKIGDLGLA + + A+
Sbjct: 129 KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK 188
Query: 188 SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 247
+VIGTPEFMAPE+YEE+Y+E VD+Y+FGMC+LEM T EYPY+EC+N AQIY++VTSG+KP
Sbjct: 189 AVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP 248
Query: 248 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTD 287
AS KV P+VK+ IE CI R +LL F +
Sbjct: 249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 2e-67
Identities = 70/293 (23%), Positives = 133/293 (45%), Gaps = 16/293 (5%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ +G+G+F DG + ++NI S + E EV +L ++KH NI++
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISR--MSSKEREESRREVAVLANMKHPNIVQ 87
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM--KAIKNWARQILRGLHYLHSHN 148
+ S+ ++ + + ++ + G L + K V I +W QI L ++H
Sbjct: 88 YRESFEENGS--LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK 145
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEEE-Y 205
I+HRD+K NIF+ +G V++GD G+A V+ AR+ IGTP +++PE+ E + Y
Sbjct: 146 --ILHRDIKSQNIFLT-KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPY 202
Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
N DI++ G + E+ T ++ + E + + K+ SG +S ++ + +
Sbjct: 203 NNKSDIWALGCVLYELCTLKHAF-EAGSMKNLVLKIISG-SFPPVSLHYSYDLRSLVSQL 260
Query: 266 IVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPM 317
R +L+ F + + + L + + S+P P
Sbjct: 261 FKRNPRDRPSVNSILEKGF-IAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPA 312
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 2e-67
Identities = 72/267 (26%), Positives = 133/267 (49%), Gaps = 18/267 (6%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+G G++ K + DG + W +++ + + + L SEV+LL+ LKH NI++
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLLRELKHPNIVR 69
Query: 91 FYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
+Y+ +D TN T+ ++ E G L + K+ + +D + + Q+ L H
Sbjct: 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 147 HNPP---IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY 201
+ ++HRDLK N+F++G VK+GD GLA ++ T A++ +GTP +M+PE
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 202 EEE-YNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259
YNE DI+S G C+L E+ P+ + ++ K+ G K + ++
Sbjct: 189 NRMSYNEKSDIWSLG-CLLYELCALMPPFTA-FSQKELAGKIREG-KFRRIPYRYSDELN 245
Query: 260 QFIEKCIVP-ASLRLPALELLKDPFLV 285
+ I + + R E+L++P ++
Sbjct: 246 EIITRMLNLKDYHRPSVEEILENPLIL 272
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 8e-66
Identities = 78/289 (26%), Positives = 133/289 (46%), Gaps = 17/289 (5%)
Query: 8 TKSETEEGEFSEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ 65
+ + + +G+G F VY+ +DG+ VA +V I D+M
Sbjct: 13 VPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM- 71
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL----RQYRKK 121
E+ LLK L H N+IK+Y S+++D +N++ EL +G L + ++K+
Sbjct: 72 DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQ 129
Query: 122 HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181
+ + + + + Q+ L ++HS ++HRD+K N+F+ G VK+GDLGL
Sbjct: 130 KRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRFF 186
Query: 182 QQPT--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYN-ECKNPAQI 237
T A S++GTP +M+PE E YN DI+S G + EM + P+ + N +
Sbjct: 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 246
Query: 238 YKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLV 285
KK+ P S +++Q + CI P R + +
Sbjct: 247 CKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 1e-65
Identities = 65/284 (22%), Positives = 116/284 (40%), Gaps = 19/284 (6%)
Query: 8 TKSETEEGEFSEKDPSCRYG-RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM 64
+ + P + + + LG G++ V+K + DG A +
Sbjct: 37 ASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF-- 94
Query: 65 QSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH- 122
+ P R +EV + + +H ++ +W + + + TE SL+Q+ +
Sbjct: 95 RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI--LYLQTE-LCGPSLQQHCEAWG 151
Query: 123 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182
++ + + R L L +LHS ++H D+K NIF+ G G K+GD GL + +
Sbjct: 152 ASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFL-GPRGRCKLGDFGLLVELG 208
Query: 183 QPT-ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
G P +MAPEL + Y D++S G+ ILE+ + + Q+ +
Sbjct: 209 TAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY 268
Query: 242 TSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
A LS +++ + + P LR A LL P L
Sbjct: 269 LPPEFTAGLS----SELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 5e-65
Identities = 92/299 (30%), Positives = 136/299 (45%), Gaps = 29/299 (9%)
Query: 10 SETEEGEFSEKDPSCRYGRYD----EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ 65
TEEG+ Y + +LGKG + VY G D + + +A ++ D
Sbjct: 3 RSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--- 59
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ-YRKKHKN 124
+ L+ E+ L K LKH+NI+++ S+ ++ I + E GSL R K
Sbjct: 60 -SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG--FIKIFMEQVPGGSLSALLRSKWGP 116
Query: 125 VDMK--AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IV 180
+ I + +QIL GL YLH + I+HRD+K DN+ +N +G +KI D G + +
Sbjct: 117 LKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174
Query: 181 MQQPTARSVIGTPEFMAPE---LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 237
P + GT ++MAPE Y + DI+S G I+EM T + P+ E P
Sbjct: 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA 234
Query: 238 YKKVTSGIK----PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 291
KV P S+S + K FI KC P R A +LL D FL + K
Sbjct: 235 MFKVGMFKVHPEIPESMS----AEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 1e-63
Identities = 73/275 (26%), Positives = 118/275 (42%), Gaps = 26/275 (9%)
Query: 4 GSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVA---WNQVNI 60
GS F KS +E + Y++ +GKG F V+KG D VA +
Sbjct: 5 GSEFPKSRLPTLADNEIE-------YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDS 57
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-R 119
E + ++ + EV ++ +L H NI+K Y + M+ E G L
Sbjct: 58 EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL----MHNPPRMVMEFVPCGDLYHRLL 113
Query: 120 KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE----VKIGDL 175
K + I G+ Y+ + NPPI+HRDL+ NIF+ + K+ D
Sbjct: 114 DKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 176 GLAIVMQQPTARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECK 232
GL+ + ++G ++MAPE E Y E D YSF M + ++T E P++E
Sbjct: 174 GLSQQSVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232
Query: 233 NP--AQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
I G++P ++ + P+++ IE C
Sbjct: 233 YGKIKFINMIREEGLRP-TIPEDCPPRLRNVIELC 266
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 5e-63
Identities = 66/284 (23%), Positives = 114/284 (40%), Gaps = 39/284 (13%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
+ EI +G G F V+K +DG +V + E+ EV L L H
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDH 63
Query: 86 ENIIKFYNSWVDD--------------TNRTINMITELFTSGSLRQYRKKHKNVDM--KA 129
NI+ + W + + + E G+L Q+ +K + +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-S 188
QI +G+ Y+HS +I+RDLK NIF+ + +VKIGD GL ++ R
Sbjct: 124 ALELFEQITKGVDYIHSKK--LINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTR 180
Query: 189 VIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 247
GT +M+PE + Y + VD+Y+ G+ + E++ E + + GI
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK---FFTDLRDGIIS 237
Query: 248 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
+ K ++K + R E+L+ + +P+
Sbjct: 238 DIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 1e-62
Identities = 73/243 (30%), Positives = 124/243 (51%), Gaps = 14/243 (5%)
Query: 29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
E +G G+F TV++ E G +VA + +D +++ EV ++K L+H NI
Sbjct: 41 IKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDF--HAERVNEFLREVAIMKRLRHPNI 96
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNVDMKAIKNWARQILRGLHYLH 145
+ F + N +I +TE + GSL + + +D + + A + +G++YLH
Sbjct: 97 VLFMGAVTQPPNLSI--VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELYE- 202
+ NPPI+HR+LK N+ V+ VK+ D GL+ + +++S GTPE+MAPE+
Sbjct: 155 NRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
E NE D+YSFG+ + E+ T + P+ + + + + +PQV I
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL-EIPRNLNPQVAAII 272
Query: 263 EKC 265
E C
Sbjct: 273 EGC 275
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-61
Identities = 65/292 (22%), Positives = 122/292 (41%), Gaps = 42/292 (14%)
Query: 25 RY-GRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK 81
RY ++ I LG+G F V++ ++VD A ++ + + E++ EV L
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALA 58
Query: 82 SLKHENIIKFYNSWVDDTN----------RTINMITELFTSGSLRQY---RKKHKNVDMK 128
L+H I++++N+W++ + + +L +L+ + R + +
Sbjct: 59 KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR- 187
+ QI + +LHS ++HRDLK NIF + VK+GD GL M Q
Sbjct: 119 VCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 188 -------------SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKN 233
+GT +M+PE Y+ VDI+S G+ + E++ YP++
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQME 232
Query: 234 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
+ V + K L P ++ + P R A+ ++++
Sbjct: 233 RVRTLTDVRNL-KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 1e-60
Identities = 67/243 (27%), Positives = 115/243 (47%), Gaps = 20/243 (8%)
Query: 29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
+E++G+GAF V K + +VA I+ ++S + + E+ L + H NI
Sbjct: 12 VEEVVGRGAFGVVCKA--KWRAKDVA-----IK-QIESESERKAFIVELRQLSRVNHPNI 63
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNVDMKAIKNWARQILRGLHYLH 145
+K Y + + ++ E GSL + +W Q +G+ YLH
Sbjct: 64 VKLYGA----CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 146 SHNP-PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-E 203
S P +IHRDLK N+ + +KI D G A +Q + G+ +MAPE++E
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-HMTNNKGSAAWMAPEVFEGS 178
Query: 204 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGIKPASLSKVTDPQVKQFI 262
Y+E D++S+G+ + E++T P++E PA I V +G +P L K ++ +
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-PLIKNLPKPIESLM 237
Query: 263 EKC 265
+C
Sbjct: 238 TRC 240
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 4e-60
Identities = 87/298 (29%), Positives = 132/298 (44%), Gaps = 47/298 (15%)
Query: 23 SCRYG-RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL 79
S RY ++EI LG+GAF V K + +D A ++ + ++L + SEV L
Sbjct: 1 SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-----HTEEKLSTILSEVML 55
Query: 80 LKSLKHENIIKFYNSWVDDTNR-----------TINMITELFTSGSLRQY-RKKHKNVDM 127
L SL H+ ++++Y +W++ N T+ + E +G+L ++ N
Sbjct: 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR 115
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187
RQIL L Y+HS IIHRDLK NIF++ + VKIGD GLA + +
Sbjct: 116 DEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDI 172
Query: 188 ----------------SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYN 229
S IGT ++A E+ + YNE +D+YS G+ EM+ YP++
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFS 229
Query: 230 ECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
I KK+ S P K+ I I + R A LL +L
Sbjct: 230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 1e-59
Identities = 66/305 (21%), Positives = 116/305 (38%), Gaps = 30/305 (9%)
Query: 1 MDCGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI 60
+ G +E + E + + +G+G+F V++ D+ G + A +V +
Sbjct: 34 TEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL 93
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK 120
E E+ L I+ Y + + +N+ EL GSL Q K
Sbjct: 94 EVFRVE---------ELVACAGLSSPRIVPLYGAVREGP--WVNIFMELLEGGSLGQLIK 142
Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
+ + + Q L GL YLH+ I+H D+K DN+ ++ + + D G A+
Sbjct: 143 QMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALC 200
Query: 181 MQQ-------PTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECK 232
+Q T + GT MAPE+ + + VDI+S +L M+ +P+ +
Sbjct: 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260
Query: 233 NPAQIYKKVTSGI----KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTD 287
K + P S + P Q I++ + R A+EL +
Sbjct: 261 RGPLCLKIASEPPPIREIPPSCA----PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316
Query: 288 NPKDL 292
L
Sbjct: 317 EVGGL 321
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 3e-59
Identities = 69/244 (28%), Positives = 106/244 (43%), Gaps = 15/244 (6%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
EI+G G F VY+ G EVA + +E + E L LKH NII
Sbjct: 13 EIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP- 149
+ + N + + E G L + + + + NWA QI RG++YLH
Sbjct: 71 LRGVCLKEPNLCL--VMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 150 PIIHRDLKCDNIFVN-------GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE 202
PIIHRDLK NI + +N +KI D GLA + T S G +MAPE+
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIR 187
Query: 203 -EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261
+++ D++S+G+ + E++T E P+ A Y + + + +
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL-PIPSTCPEPFAKL 246
Query: 262 IEKC 265
+E C
Sbjct: 247 MEDC 250
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 1e-58
Identities = 47/243 (19%), Positives = 94/243 (38%), Gaps = 15/243 (6%)
Query: 29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
+ L + ++KG G ++ + + D S + E L+ H N+
Sbjct: 14 FLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDW--STRKSRDFNEECPRLRIFSHPNV 69
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLHS 146
+ + +IT GSL + VD +A + RG+ +LH+
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-- 204
P I L ++ ++ + +I + Q P + P ++APE +++
Sbjct: 130 LEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQSPG---RMYAPAWVAPEALQKKPE 185
Query: 205 --YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
D++SF + + E+VT E P+ + N K G++P ++ P V + +
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP-TIPPGISPHVSKLM 244
Query: 263 EKC 265
+ C
Sbjct: 245 KIC 247
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 6e-58
Identities = 58/281 (20%), Positives = 115/281 (40%), Gaps = 39/281 (13%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENII 89
E +G G F +V+K +DG A + + EV+ L +H +++
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPL--AGSVDEQNALREVYAHAVLGQHSHVV 74
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM----KAIKNWARQILRGLHYLH 145
+++++W +D + + + E GSL ++ + +K+ Q+ RGL Y+H
Sbjct: 75 RYFSAWAEDDH--MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 146 SHNPPIIHRDLKCDNIFVNGNN------------------GEVKIGDLGLAIVMQQPTAR 187
S + ++H D+K NIF++ + KIGDLG + P +
Sbjct: 133 SMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP--Q 188
Query: 188 SVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 245
G F+A E+ +E + DI++ + ++ E + ++ G
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN----GDQWHEIRQGR 244
Query: 246 KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLV 285
P + +V + + ++ I P R A+ L+K L+
Sbjct: 245 LP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-57
Identities = 65/253 (25%), Positives = 116/253 (45%), Gaps = 30/253 (11%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E++GKG F VY G G EVA ++IE + DQL+ EV + +HEN++
Sbjct: 39 ELIGKGRFGQVYHGR--WHG-EVAIRLIDIERD--NEDQLKAFKREVMAYRQTRHENVVL 93
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
F + + + I IT L +L R +D+ + A++I++G+ YLH+
Sbjct: 94 FMGACMSPPHLAI--ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG- 150
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-------QQPTARSVIGTPEFMAPEL-- 200
I+H+DLK N+F + NG+V I D GL + ++ R G +APE+
Sbjct: 151 -ILHKDLKSKNVFYD--NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 201 --------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
+ +++ D+++ G E+ E+P+ + I ++ +G+KP
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGTGMKPNLSQI 266
Query: 253 VTDPQVKQFIEKC 265
++ + C
Sbjct: 267 GMGKEISDILLFC 279
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-56
Identities = 79/248 (31%), Positives = 128/248 (51%), Gaps = 23/248 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ +G G+F TVYKG + G +VA +N+ +P QL+ +EV +L+ +H NI+
Sbjct: 30 QRIGSGSFGTVYKG--KWHG-DVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILL 84
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
F + I +T+ SL + +MK + + ARQ RG+ YLH+ +
Sbjct: 85 FM-GYSTAPQLAI--VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS- 140
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----PTARSVIGTPEFMAPELYEEE- 204
IIHRDLK +NIF+ + VKIGD GLA + + G+ +MAPE+ +
Sbjct: 141 -IIHRDLKSNNIFL-HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 205 ---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV---TDPQV 258
Y+ D+Y+FG+ + E++T + PY+ N QI + V G LSKV ++
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258
Query: 259 KQFIEKCI 266
K+ + +C+
Sbjct: 259 KRLMAECL 266
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 5e-56
Identities = 61/279 (21%), Positives = 115/279 (41%), Gaps = 29/279 (10%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENI 88
+ +G G V++ +E A VN+E+ L+ +E+ L L+ + I
Sbjct: 15 KQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKI 71
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
I+ Y+ + D I M+ E + L + KK K++D K++ + +L +H +H H
Sbjct: 72 IRLYDYEITDQY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 128
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPEL---- 200
I+H DLK N + +G +K+ D G+A MQ T S +GT +M PE
Sbjct: 129 --IVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 201 --------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
+ + + D++S G + M + P+ + N +
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244
Query: 253 VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
+ + ++ ++ C+ R+ ELL P++
Sbjct: 245 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-55
Identities = 64/274 (23%), Positives = 117/274 (42%), Gaps = 31/274 (11%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENI 88
+ +G G V++ +E A VN+E+ L+ +E+ L L+ + I
Sbjct: 34 KQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKI 90
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
I+ Y+ + D I M+ E + L + KK K++D K++ + +L +H +H H
Sbjct: 91 IRLYDYEITDQY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 147
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEEE 204
I+H DLK N + +G +K+ D G+A MQ T S +GT +M PE ++
Sbjct: 148 --IVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 205 ------------YNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 251
+ D++S G CIL M + P+ + N +
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLG-CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 262
Query: 252 KVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
+ + ++ ++ C+ R+ ELL P++
Sbjct: 263 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 190 bits (483), Expect = 2e-54
Identities = 63/280 (22%), Positives = 116/280 (41%), Gaps = 31/280 (11%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENI 88
+ +G G V++ +E A VN+E+ L+ +E+ L L+ + I
Sbjct: 62 KQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKI 118
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
I+ Y+ + D I M+ E + L + KK K++D K++ + +L +H +H H
Sbjct: 119 IRLYDYEITDQY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEEE 204
I+H DLK N + +G +K+ D G+A MQ T S +G +M PE ++
Sbjct: 176 --IVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 205 ------------YNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 251
+ D++S G CIL M + P+ + N +
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLG-CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 290
Query: 252 KVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
+ + ++ ++ C+ R+ ELL P++
Sbjct: 291 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-49
Identities = 72/293 (24%), Positives = 118/293 (40%), Gaps = 50/293 (17%)
Query: 29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
+ +GKG + V+ G + G +VA + E E++ ++HENI
Sbjct: 41 MVKQIGKGRYGEVWMG--KWRGEKVAVKVFFTTEEAS--WFRET---EIYQTVLMRHENI 93
Query: 89 IKFYNSWVDDTNRTINM--ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
+ F + + T + IT+ +GSL Y K +D K++ A + GL +LH+
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHLHT 152
Query: 147 ------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR------SVIGTPE 194
P I HRDLK NI V NG I DLGLA+ T + +GT
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 195 FMAPELYEE-------EYNELVDIYSFGMCILEMVTC----------EYPYNECKNPAQI 237
+M PE+ +E + + D+YSFG+ + E+ + PY++
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271
Query: 238 YKKVTSG---------IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
Y+ + S Q+ + + +C + RL AL + K
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-49
Identities = 88/298 (29%), Positives = 145/298 (48%), Gaps = 24/298 (8%)
Query: 8 TKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP 67
+S + + DP + + ++I GKG+F V+KG D VA +++E ++
Sbjct: 6 VQSGLPGMQNLKADPEELFTKLEKI-GKGSFGEVFKGIDNRTQKVVAIKIIDLE---EAE 61
Query: 68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 127
D++E + E+ +L + K+Y S++ DT I M E GS + +D
Sbjct: 62 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM--EYLGGGSALDLL-EPGPLDE 118
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187
I R+IL+GL YLHS IHRD+K N+ ++ +GEVK+ D G+A + +
Sbjct: 119 TQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIK 175
Query: 188 --SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPA----QIYKK 240
+ +GTP +MAPE+ ++ Y+ DI+S G+ +E+ E P++E +P I K
Sbjct: 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE-LHPMKVLFLIPKN 234
Query: 241 VTSGIKPASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVCDPL 297
P +L +K+F+E C S R A ELLK F++ + K L
Sbjct: 235 -----NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTEL 287
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 7e-49
Identities = 86/312 (27%), Positives = 144/312 (46%), Gaps = 26/312 (8%)
Query: 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
F + DP + EI G G+F VY D + VA +++ QS ++ + + E
Sbjct: 47 FFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKE 104
Query: 77 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ-YRKKHKNVDMKAIKNWAR 135
V L+ L+H N I++ ++ + + M E + GS K + I
Sbjct: 105 VRFLQKLRHPNTIQYRGCYLREHTAWLVM--E-YCLGSASDLLEVHKKPLQEVEIAAVTH 161
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
L+GL YLHSHN +IHRD+K NI ++ G VK+GD G A +M A S +GTP +
Sbjct: 162 GALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP--ANSFVGTPYW 216
Query: 196 MAPE----LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ----IYKKVTSGIKP 247
MAPE + E +Y+ VD++S G+ +E+ + P N I + + ++
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQS 275
Query: 248 ASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVCDPL-RLPNLVPE 305
S + F++ C R + LLK F++ + P ++ D + R + V E
Sbjct: 276 GHWS----EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRE 331
Query: 306 VMNLAHSEPHPM 317
+ NL + + +
Sbjct: 332 LDNLQYRKMKKI 343
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 3e-48
Identities = 88/276 (31%), Positives = 140/276 (50%), Gaps = 25/276 (9%)
Query: 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
S DP +Y R+++I G+GA TVY D G EVA Q+N++ + E + +E+
Sbjct: 14 SVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKELIINEI 68
Query: 78 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQI 137
+++ K+ NI+ + +S++ + M E GSL +D I R+
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVM--EYLAGGSLTDVV-TETCMDEGQIAAVCREC 125
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEF 195
L+ L +LHS+ +IHRD+K DNI + +G VK+ D G I +Q +++GTP +
Sbjct: 126 LQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 196 MAPEL-YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGI----KPAS 249
MAPE+ + Y VDI+S G+ +EM+ E PY +NP + +Y T+G P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPEK 241
Query: 250 LSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFL 284
LS + F+ +C + R A ELL+ FL
Sbjct: 242 LS----AIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 4e-48
Identities = 73/293 (24%), Positives = 114/293 (38%), Gaps = 50/293 (17%)
Query: 29 YDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
E +GKG F V++G + G EVA + + E E++ L+HENI
Sbjct: 46 LQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERS--WFREA---EIYQTVMLRHENI 98
Query: 89 IKFYNSWVDDTNRTINM--ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
+ F + D + +++ GSL Y ++ V ++ + A GL +LH
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHM 157
Query: 147 ------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPE 194
P I HRDLK NI V NG I DLGLA+ T +GT
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 195 FMAPELYEE-------EYNELVDIYSFGMCILEMVTC----------EYPYNECKNP--- 234
+MAPE+ ++ E + DIY+ G+ E+ + PY +
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276
Query: 235 -AQIYKKVTSG-----IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
++ K V I S + + + +C + RL AL + K
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 8e-48
Identities = 75/291 (25%), Positives = 116/291 (39%), Gaps = 50/291 (17%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E +GKG + V++G G VA + D E E++ L+HENI+
Sbjct: 14 ECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKS--WFRET---ELYNTVMLRHENILG 66
Query: 91 FYNSWVDDTNRTINM--ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-- 146
F S + + + + IT GSL Y + +D + I GL +LH
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGLAHLHIEI 125
Query: 147 ----HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR------SVIGTPEFM 196
P I HRDLK NI V NG+ I DLGLA++ Q T + +GT +M
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVK-KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 197 APELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG----- 244
APE+ +E + + VDI++FG+ + E+ ++ + V
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 245 --------------IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
I S T + + +++C S RL AL + K
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 8e-48
Identities = 78/301 (25%), Positives = 137/301 (45%), Gaps = 26/301 (8%)
Query: 8 TKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP 67
KS E + DP+ + E+ G GAF VYK ++ G A + + S
Sbjct: 3 RKSREYEHVRRDLDPNEVWEIVGEL-GDGAFGKVYKAKNKETGALAAAKVIETK----SE 57
Query: 68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ-YRKKHKNVD 126
++LE E+ +L + H I+K ++ D I + E G++ + + +
Sbjct: 58 EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI--EFCPGGAVDAIMLELDRGLT 115
Query: 127 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQP 184
I+ RQ+L L++LHS IIHRDLK N+ + G++++ D G++ +
Sbjct: 116 EPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQ 172
Query: 185 TARSVIGTPEFMAPE------LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-I 237
S IGTP +MAPE + + Y+ DI+S G+ ++EM E P++E NP + +
Sbjct: 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVL 231
Query: 238 YKKVTSGIKPASLSKVTD--PQVKQFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVC 294
K S P +L + + + F++ R A +LL+ PF+ + +
Sbjct: 232 LKIAKSD--PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALR 289
Query: 295 D 295
+
Sbjct: 290 E 290
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 8e-48
Identities = 83/289 (28%), Positives = 136/289 (47%), Gaps = 26/289 (8%)
Query: 20 KDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
DP RY LGKG F ++ D A V + ++ P Q E++ E+
Sbjct: 9 VDPR-SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQREKMSMEI 66
Query: 78 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQI 137
+ +SL H++++ F+ + D+ + ++ EL SL + K+ K + + + RQI
Sbjct: 67 SIHRSLAHQHVVGFHGFFEDNDF--VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 124
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEF 195
+ G YLH + +IHRDLK N+F+N + EVKIGD GLA ++ R + GTP +
Sbjct: 125 VLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 181
Query: 196 MAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSK 252
+APE L ++ ++ VD++S G CI+ + P E + Y ++ P ++
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHIN- 239
Query: 253 VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 300
P I+K + + R ELL D F + P RLP
Sbjct: 240 ---PVAASLIQKMLQTDPTARPTINELLNDEFFTSG------YIPARLP 279
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 8e-48
Identities = 77/276 (27%), Positives = 131/276 (47%), Gaps = 25/276 (9%)
Query: 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
+ DP Y +I G+G+ V ++ G +VA +++ + E L++EV
Sbjct: 39 DQGDPRLLLDSYVKI-GEGSTGIVCLAREKHSGRQVAVKMMDLR----KQQRRELLFNEV 93
Query: 78 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQI 137
+++ +H N+++ Y S++ + M E G+L ++ + I +
Sbjct: 94 VIMRDYQHFNVVEMYKSYLVGEELWVLM--EFLQGGALTDIV-SQVRLNEEQIATVCEAV 150
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEF 195
L+ L YLH+ +IHRD+K D+I + +G VK+ D G I P +S++GTP +
Sbjct: 151 LQALAYLHAQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYW 207
Query: 196 MAPEL-YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGI----KPAS 249
MAPE+ Y VDI+S G+ ++EMV E PY +P Q + + S
Sbjct: 208 MAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNSHK 266
Query: 250 LSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFL 284
+S P ++ F+E+ + R A ELL PFL
Sbjct: 267 VS----PVLRDFLERMLVRDPQERATAQELLDHPFL 298
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-47
Identities = 61/274 (22%), Positives = 111/274 (40%), Gaps = 28/274 (10%)
Query: 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
+ILG+GA V++G + G A + + + + ++ E +LK L H+NI+
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM---KAIKNWARQILRGLHYLHS 146
K + + T R +I E GSL ++ N R ++ G+++L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 147 HNPPIIHRDLKCDNIFVNGN---NGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE 202
+ I+HR++K NI K+ D G A ++ S+ GT E++ P++YE
Sbjct: 131 NG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 203 ---------EEYNELVDIYSFGMCIL-EMVTCE---YPYNECKNPAQIYKKVTSGIKPAS 249
++Y VD++S G T P+ + ++ K+ +G +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 250 LSKVTDPQ--VKQFIEKCIVPASLRLPALELLKD 281
+S V + + V SL LL
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTP 281
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-47
Identities = 79/288 (27%), Positives = 136/288 (47%), Gaps = 27/288 (9%)
Query: 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
K P + +++ G+G++ +VYK + G VA QV +E L+ + E+
Sbjct: 23 LTKQPEEVFDVLEKL-GEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQEIIKEI 75
Query: 78 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ-YRKKHKNVDMKAIKNWARQ 136
+++ +++K+Y S+ +T+ I M E +GS+ R ++K + I +
Sbjct: 76 SIMQQCDSPHVVKYYGSYFKNTDLWIVM--EYCGAGSVSDIIRLRNKTLTEDEIATILQS 133
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPE 194
L+GL YLH IHRD+K NI +N G K+ D G+A + +VIGTP
Sbjct: 134 TLKGLEYLHFMR--KIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPF 190
Query: 195 FMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ----IYKKVTSGIK-PA 248
+MAPE + E YN + DI+S G+ +EM + PY + +P + I + P
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD-IHPMRAIFMIPTNPPPTFRKPE 249
Query: 249 SLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVCD 295
S F+++C + R A +LL+ PF+ + ++ D
Sbjct: 250 LWS----DNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRD 293
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-47
Identities = 73/303 (24%), Positives = 123/303 (40%), Gaps = 42/303 (13%)
Query: 11 ETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL 70
+ Y + I G GA V + +VA ++N+E + +
Sbjct: 2 SEDSSALPWSINRDDYELQEVI-GSGATAVVQAAYCAPKKEKVAIKRINLE---KCQTSM 57
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR--------QYRKKH 122
+ L E+ + H NI+ +Y S+V + M +L + GS+ + K
Sbjct: 58 DELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM--KLLSGGSVLDIIKHIVAKGEHKS 115
Query: 123 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---- 178
+D I R++L GL YLH + IHRD+K NI + +G V+I D G++
Sbjct: 116 GVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLG-EDGSVQIADFGVSAFLA 172
Query: 179 ---IVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNEC-- 231
+ + ++ +GTP +MAPE+ E+ Y+ DI+SFG+ +E+ T PY++
Sbjct: 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP 232
Query: 232 ---------KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKD 281
+P + V K ++ I C R A ELL+
Sbjct: 233 MKVLMLTLQNDPPSLETGVQDKEMLKKYGKS----FRKMISLCLQKDPEKRPTAAELLRH 288
Query: 282 PFL 284
F
Sbjct: 289 KFF 291
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-46
Identities = 81/282 (28%), Positives = 134/282 (47%), Gaps = 25/282 (8%)
Query: 27 GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY LGKG F ++ D A V + ++ P Q E++ E+ + +SL
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQREKMSMEISIHRSLA 99
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
H++++ F+ + D+ + ++ EL SL + K+ K + + + RQI+ G YL
Sbjct: 100 HQHVVGFHGFFEDNDF--VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 157
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE-LY 201
H + +IHRDLK N+F+N + EVKIGD GLA ++ R + GTP ++APE L
Sbjct: 158 HRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 214
Query: 202 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVK 259
++ ++ VD++S G CI+ + P E + Y ++ P ++ P
Sbjct: 215 KKGHSFEVDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHIN----PVAA 269
Query: 260 QFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 300
I+K + + R ELL D F + P RLP
Sbjct: 270 SLIQKMLQTDPTARPTINELLNDEFFTSG------YIPARLP 305
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-46
Identities = 82/310 (26%), Positives = 140/310 (45%), Gaps = 34/310 (10%)
Query: 9 KSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPD 68
+S E + +DP+ + + + G G + VYKG G A +++ D
Sbjct: 9 RSLDEIDLSALRDPAGIFELVELV-GNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----D 62
Query: 69 QLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTIN----MITELFTSGSLRQYRKKHK 123
+ E + E+++LK H NI +Y +++ ++ ++ E +GS+ K K
Sbjct: 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122
Query: 124 NVDMK--AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181
+K I R+ILRGL +LH H +IHRD+K N+ + N EVK+ D G++ +
Sbjct: 123 GNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQL 179
Query: 182 QQPTAR--SVIGTPEFMAPE------LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKN 233
+ R + IGTP +MAPE + Y+ D++S G+ +EM P + +
Sbjct: 180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-MH 238
Query: 234 PA----QIYKKVTSGIKPASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFLVTDN 288
P I + +K SK + + FIE C + S R +L+K PF+
Sbjct: 239 PMRALFLIPRNPAPRLKSKKWSK----KFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294
Query: 289 PKDLVCDPLR 298
+ V L+
Sbjct: 295 NERQVRIQLK 304
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-46
Identities = 55/276 (19%), Positives = 92/276 (33%), Gaps = 33/276 (11%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ LG+G F V DG A ++ E E + + H NI++
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILC----HEQQDREEAQREADMHRLFNHPNILR 90
Query: 91 FYNSWVDDTNRT--INMITELFTSGSLRQY----RKKHKNVDMKAIKNWARQILRGLHYL 144
+ + ++ F G+L + K + I I RGL +
Sbjct: 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----------VIGTP 193
H+ HRDLK NI + + G+ + DLG S T
Sbjct: 151 HA--KGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 194 EFMAPELYEEE----YNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYK-KVTSGIKP 247
+ APEL+ + +E D++S G C+L M+ E PY+ V + +
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLG-CVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 248 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDP 282
+ + + Q + + R LL
Sbjct: 267 PQSPRHS-SALWQLLNSMMTVDPHQRPHIPLLLSQL 301
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-46
Identities = 65/253 (25%), Positives = 98/253 (38%), Gaps = 27/253 (10%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E+LGKG F K G + E + + EV +++ L+H N++K
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMV----MKELIRFDEETQRTFLKEVKVMRCLEHPNVLK 71
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
F D +N ITE G+LR + ++A+ I G+ YLHS N
Sbjct: 72 FIGVLYKDKR--LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN- 128
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----------------PTARSVIGTP 193
IIHRDL N V N V + D GLA +M +V+G P
Sbjct: 129 -IIHRDLNSHNCLVRENK-NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 194 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
+MAPE + Y+E VD++SFG+ + E++ + + G
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPP 246
Query: 253 VTDPQVKQFIEKC 265
P +C
Sbjct: 247 NCPPSFFPITVRC 259
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-46
Identities = 65/290 (22%), Positives = 118/290 (40%), Gaps = 31/290 (10%)
Query: 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
+ILG+GA V++G + G A + + + + ++ E +LK L H+NI+
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM---KAIKNWARQILRGLHYLHS 146
K + + T R +I E GSL ++ N R ++ G+++L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 147 HNPPIIHRDLKCDNIFVNGN---NGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE 202
+ I+HR++K NI K+ D G A ++ S+ GT E++ P++YE
Sbjct: 131 NG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 203 ---------EEYNELVDIYSFGMCIL-EMVTCE---YPYNECKNPAQIYKKVTSGIKPAS 249
++Y VD++S G T P+ + ++ K+ +G +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 250 LSKVTDPQVKQFIEKCIVPASLRLPA-LELLKDPFLVTDNPKDLVCDPLR 298
+S V + +P S L L++L P L L D +
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA----NILEADQEK 293
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-44
Identities = 71/395 (17%), Positives = 128/395 (32%), Gaps = 73/395 (18%)
Query: 5 SGFTKSETEEGEFSEKDPSCRYGRYDEILGKGA--FKTVYKGFDEVDGIEVAWNQVNIED 62
++ +G S Y I GKG TV + G V ++N+E
Sbjct: 6 HHHMENLYFQGMSSFLPEGGCYELLTVI-GKGFEDLMTVNLARYKPTGEYVTVRRINLEA 64
Query: 63 VMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH 122
S + + L E+H+ K H NI+ + +++ D + ++T GS + H
Sbjct: 65 --CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE--LWVVTSFMAYGSAKDLICTH 120
Query: 123 KNVDMK--AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
M AI + +L+ L Y+H +HR +K +I ++ +G+V + L +
Sbjct: 121 FMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRSNLS 177
Query: 181 MQQPTAR---------SVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPY 228
M R + +++PE+ ++ Y+ DIYS G+ E+ P+
Sbjct: 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237
Query: 229 ---------------------------NECKNPAQIYKKVTSGIKPASLSKVTDPQV--- 258
E + SG+ + + P
Sbjct: 238 KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDS 297
Query: 259 -------------KQFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVP 304
F+E+C R A LL F + LP L+
Sbjct: 298 PSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEA----LPELLR 353
Query: 305 EVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTW 339
V + + E D + + + W
Sbjct: 354 PVTPITNFEGSQSQ-DHSGIFGLVTNLEELEVDDW 387
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-44
Identities = 56/272 (20%), Positives = 124/272 (45%), Gaps = 19/272 (6%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENII 89
+G G V+K G +A Q+ + ++ +R+ ++ +LKS I+
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS---GNKEENKRILMDLDVVLKSHDCPYIV 87
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
+ + +++ +T+ + + EL + + + ++ + + + I++ L+YL +
Sbjct: 88 QCFGTFITNTD--VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH- 144
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTPEFMAPE------LYE 202
+IHRD+K NI ++ G++K+ D G++ + A+ G +MAPE +
Sbjct: 145 GVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD--PQVKQ 260
+Y+ D++S G+ ++E+ T ++PY CK ++ KV +P L +
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE-EPPLLPGHMGFSGDFQS 262
Query: 261 FIEKCIV-PASLRLPALELLKDPFLVTDNPKD 291
F++ C+ R +LL+ F+ +
Sbjct: 263 FVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-44
Identities = 64/281 (22%), Positives = 125/281 (44%), Gaps = 17/281 (6%)
Query: 27 GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
++ LGKG F VY ++ +A + + ++ +L EV + L+
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA-GVEHQLRREVEIQSHLR 67
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
H NI++ Y + D T + +I E G++ + +K D + + ++ L Y
Sbjct: 68 HPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 125
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE- 203
HS +IHRD+K +N+ + G+ GE+KI D G ++ + GT +++ PE+ E
Sbjct: 126 HSKR--VIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGR 182
Query: 204 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASLSKVTDPQVKQF 261
++E VD++S G+ E + P E + YK+++ P ++ +
Sbjct: 183 MHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEFTFPDFVT----EGARDL 237
Query: 262 IEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 301
I + + S R E+L+ P++ ++ K C +
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 278
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 4e-44
Identities = 93/400 (23%), Positives = 143/400 (35%), Gaps = 40/400 (10%)
Query: 22 PSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL 79
P+ G ++ E LG G F V + + G +VA + SP ER E+ +
Sbjct: 9 PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVA---IKQCRQELSPKNRERWCLEIQI 65
Query: 80 LKSLKHENIIKFYNSWVDDTNRTIN------MITELFTSGSLRQYRKKHKNVDM---KAI 130
+K L H N++ V D + + + E G LR+Y + +N I
Sbjct: 66 MKKLNHPNVVSARE--VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 123
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNI--FVNGNNGEVKIGDLGLAIVMQQPT-AR 187
+ I L YLH + IIHRDLK +NI KI DLG A + Q
Sbjct: 124 RTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 181
Query: 188 SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246
+GT +++APEL E ++Y VD +SFG E +T P+ P Q + KV
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241
Query: 247 PASLSKVTDPQVKQFIEKCIVPASL---------RLPALELLKDP-----FLVTDNPKDL 292
+ +F P L R L+ N
Sbjct: 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCF 301
Query: 293 VCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENN 352
L + VMN+ H + N + S + +TG + E Q L + +
Sbjct: 302 QALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTG---IPEEEQELLQAS 358
Query: 353 EFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADT 392
L + V + + D ++ F+F
Sbjct: 359 GLALNSAQPLTQYV-IDCTVIDGRQGEGDLIFLFDNRKTV 397
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-43
Identities = 52/272 (19%), Positives = 105/272 (38%), Gaps = 28/272 (10%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
+ A+ + + E+ + + + SP ++ ++ + +N +
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 92 YNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
I M +L +L+ + R ++ + + QI + +LHS
Sbjct: 127 LQPSSPKVYLYIQM--QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--------------SVIGTPE 194
++HRDLK NIF + VK+GD GL M Q +GT
Sbjct: 185 --LMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 195 FMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 253
+M+PE Y+ VDI+S G+ + E++ Y ++ +I V + P ++
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELL---YSFSTQMERVRIITDVRNLKFPLLFTQ- 297
Query: 254 TDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
PQ ++ + P + R A +++++
Sbjct: 298 KYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 7e-43
Identities = 66/311 (21%), Positives = 138/311 (44%), Gaps = 32/311 (10%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENII 89
+G+GA+ +V K + G +A ++ + ++L ++ +++S I+
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIV 84
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM----KAIKNWARQILRGLHYLH 145
+FY + + + + EL ++ + Y+ + +D + + ++ L++L
Sbjct: 85 QFYGALFREGD--CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142
Query: 146 S-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPE---- 199
IIHRD+K NI ++ +G +K+ D G++ + A++ G +MAPE
Sbjct: 143 ENLK--IIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP 199
Query: 200 -LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD--- 255
+ Y+ D++S G+ + E+ T +PY + + +V G P LS +
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG-DPPQLSNSEEREF 258
Query: 256 -PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSE 313
P F+ C+ S R ELLK PF++ + + + V ++++ +
Sbjct: 259 SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA-----VEVACYVCKILDQMPAT 313
Query: 314 P-HPMDIDLNH 323
P PM +D +H
Sbjct: 314 PSSPMYVDHHH 324
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-42
Identities = 70/276 (25%), Positives = 131/276 (47%), Gaps = 22/276 (7%)
Query: 25 RYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
+ + +LGKG+F VY+ G+EVA ++ + M ++R+ +EV +
Sbjct: 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA-MYKAGMVQRVQNEVKIHCQ 67
Query: 83 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGL 141
LKH +I++ YN + D + ++ E+ +G + +Y + + K +++ QI+ G+
Sbjct: 68 LKHPSILELYNYFEDSNY--VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE 199
YLHSH I+HRDL N+ + N +KI D GLA ++ P + ++ GTP +++PE
Sbjct: 126 LYLHSHG--ILHRDLTLSNLLL-TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE 182
Query: 200 -LYEEEYNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTD 255
+ D++S G C+ ++ P+ + KV P+ LS
Sbjct: 183 IATRSAHGLESDVWSLG-CMFYTLLIGRPPF-DTDTVKNTLNKVVLADYEMPSFLS---- 236
Query: 256 PQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
+ K I + + + RL +L PF+ ++
Sbjct: 237 IEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSST 272
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-42
Identities = 63/274 (22%), Positives = 120/274 (43%), Gaps = 22/274 (8%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENII 89
LG+GA+ V K G +A ++ + + +RL ++ ++++ +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATV---NSQEQKRLLMDLDISMRTVDCPFTV 69
Query: 90 KFYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
FY + + + + + E SL +Q K + + + A I++ L +LH
Sbjct: 70 TFYGALFREGD--VWICME-LMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 146 S-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTPEFMAPE---- 199
S + +IHRD+K N+ +N G+VK+ D G++ + A+ G +MAPE
Sbjct: 127 SKLS--VIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINP 183
Query: 200 -LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258
L ++ Y+ DI+S G+ ++E+ +PY+ P Q K+V P + +
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEF 243
Query: 259 KQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 291
F +C+ + R EL++ PF K
Sbjct: 244 VDFTSQCLKKNSKERPTYPELMQHPFFTLHESKG 277
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-42
Identities = 71/333 (21%), Positives = 130/333 (39%), Gaps = 61/333 (18%)
Query: 5 SGFTKSETEEGEFSEKDPSCRYGRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIED 62
F + + GE + D +++I LG G V+K + G+ +A +++E
Sbjct: 18 EAFLTQKQKVGELKDDD-------FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI 70
Query: 63 VMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH 122
P ++ E+ +L I+ FY ++ D I++ E GSL Q KK
Sbjct: 71 ---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EISICMEHMDGGSLDQVLKKA 125
Query: 123 KNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181
+ + + + +++GL YL H I+HRD+K NI VN + GE+K+ D G++ +
Sbjct: 126 GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQL 182
Query: 182 QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240
A S +GT +M+PE L Y+ DI+S G+ ++EM YP
Sbjct: 183 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242
Query: 241 VTSGIKPASLSKVTD-----------------------------------------PQVK 259
A+ + + +
Sbjct: 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 302
Query: 260 QFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 291
F+ KC++ + R +L+ F+ + ++
Sbjct: 303 DFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 335
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 4e-42
Identities = 68/294 (23%), Positives = 118/294 (40%), Gaps = 50/294 (17%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
+ E+ +G F V+K ++ VA V I +Q + EV+ L +KHEN
Sbjct: 27 QLLEVKARGRFGCVWKA--QLLNEYVA---VKIFP-IQDKQSWQNE-YEVYSLPGMKHEN 79
Query: 88 IIKFYNSWVDDTNRTINM--ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
I++F + T+ +++ IT GSL + K + V + + A + RGL YLH
Sbjct: 80 ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGLAYLH 138
Query: 146 S--------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTP 193
H P I HRD+K N+ + NN I D GLA+ +GT
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLK-NNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197
Query: 194 EFMAPEL------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI---------- 237
+MAPE+ ++ + +D+Y+ G+ + E+ + + + +
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257
Query: 238 ----------YKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
+KK ++ + + IE+C A RL A + +
Sbjct: 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 9e-42
Identities = 65/279 (23%), Positives = 128/279 (45%), Gaps = 17/279 (6%)
Query: 18 SEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
+D LGKG F VY ++ + +A + + + +L
Sbjct: 5 EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKE-GVEHQLRR 63
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
E+ + L+H NI++ YN + D I ++ E G L + +KH D + +
Sbjct: 64 EIEIQSHLRHPNILRMYNYFHDRKR--IYLMLEFAPRGELYKELQKHGRFDEQRSATFME 121
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
++ LHY H +IHRD+K +N+ + G GE+KI D G ++ R++ GT ++
Sbjct: 122 ELADALHYCHERK--VIHRDIKPENLLM-GYKGELKIADFGWSVHAPSLRRRTMCGTLDY 178
Query: 196 MAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASLSK 252
+ PE+ E + ++E VD++ G+ E + P+ + + + ++++ + +K P LS
Sbjct: 179 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF-DSPSHTETHRRIVNVDLKFPPFLS- 236
Query: 253 VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
K I K + RLP +++ P++ ++ +
Sbjct: 237 ---DGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-41
Identities = 69/300 (23%), Positives = 115/300 (38%), Gaps = 31/300 (10%)
Query: 8 TKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP 67
+ + +E + ++LG GA T+ D +VA ++ E
Sbjct: 8 EQDDGDEETSVVIVGKISFCP-KDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF---- 61
Query: 68 DQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNV 125
+R EV LL+ +H N+I+++ + D + EL + +L++Y +K
Sbjct: 62 SFADR---EVQLLRESDEHPNVIRYFCTEKDRQF--QYIAIEL-CAATLQEYVEQKDFAH 115
Query: 126 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE----VKIGDLGLAIVM 181
+Q GL +LHS N I+HRDLK NI ++ N I D GL +
Sbjct: 116 LGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173
Query: 182 QQP-----TARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEY-PYNEC 231
V GT ++APE+ E+ VDI+S G +++ P+ +
Sbjct: 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233
Query: 232 KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
+ K D ++ IEK I R A +LK PF + +
Sbjct: 234 LQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQ 293
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 63/315 (20%), Positives = 113/315 (35%), Gaps = 42/315 (13%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENII 89
+L +G F VY+ D G E A ++ ++ + EV +K L H NI+
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLS----NEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 90 KFYNSWVD-----DTNRTINMITELFTSGSLRQYRKKHKNVDM---KAIKNWARQILRGL 141
+F ++ DT + ++ G L ++ KK ++ + Q R +
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV------------ 189
++H PPIIHRDLK +N+ + N G +K+ D G A + S
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLL-SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 190 --IGTPEFMAPELYE----EEYNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVT 242
TP + PE+ + E DI++ G CIL + ++P+ + +I
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG-CILYLLCFRQHPFED-GAKLRIVNGKY 266
Query: 243 SGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 301
S + I + RL E++ + P +
Sbjct: 267 SIPPHDTQY----TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSP--ITE 320
Query: 302 LVPEVMNLAHSEPHP 316
L+ + +
Sbjct: 321 LLEQNGGYGSATLSR 335
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 76/301 (25%), Positives = 131/301 (43%), Gaps = 24/301 (7%)
Query: 7 FTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVN----IED 62
F ++ K Y + LG GA V F+ +VA ++
Sbjct: 118 FFDLTVDDQSVYPKALRDEY-IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIG 176
Query: 63 VMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH 122
+ D + +E+ +LK L H IIK N D + ++ EL G L +
Sbjct: 177 SAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAED--YYIVLELMEGGELFDKVVGN 233
Query: 123 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIV 180
K + K + Q+L + YLH + IIHRDLK +N+ + + +KI D G + +
Sbjct: 234 KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291
Query: 181 MQQPTA-RSVIGTPEFMAPE----LYEEEYNELVDIYSFGMCILEMVTCEY-PYNECKNP 234
+ + + R++ GTP ++APE + YN VD +S G IL + Y P++E +
Sbjct: 292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG-VILFICLSGYPPFSEHRTQ 350
Query: 235 AQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
+ ++TSG P ++V++ ++K +V R E L+ P+L ++ K
Sbjct: 351 VSLKDQITSGKYNFIPEVWAEVSEK-ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 409
Query: 291 D 291
Sbjct: 410 R 410
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-41
Identities = 79/280 (28%), Positives = 127/280 (45%), Gaps = 14/280 (5%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+LGKG+F V D++ G E A ++ ++ E L EV LLK L H NI+K
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQ-VKQKTDKESLLREVQLLKQLDHPNIMK 90
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
Y + D ++ E++T G L K RQ+L G+ Y+H +
Sbjct: 91 LYEFFEDKGY--FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK-- 146
Query: 151 IIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEEYNE 207
I+HRDLK +N+ + + ++I D GL+ + + IGT ++APE+ Y+E
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDE 206
Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEK 264
D++S G IL ++ P N I KKV G + KV++ K I K
Sbjct: 207 KCDVWSTG-VILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE-SAKDLIRK 264
Query: 265 CIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 303
+ S+R+ A + L ++ T + + D L N +
Sbjct: 265 MLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAI 304
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-40
Identities = 83/283 (29%), Positives = 131/283 (46%), Gaps = 20/283 (7%)
Query: 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
+ + RY +LGKG+F V K D + E A +N + EV
Sbjct: 16 FQGTFAERY-NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREV 72
Query: 78 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQI 137
LLK L H NI+K + D ++ ++ EL+T G L K K +Q+
Sbjct: 73 ELLKKLDHPNIMKLFEILEDSSS--FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV 130
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTA-RSVIGTPE 194
G+ Y+H HN I+HRDLK +NI + + ++KI D GL+ QQ T + IGT
Sbjct: 131 FSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY 188
Query: 195 FMAPELYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPAS 249
++APE+ Y+E D++S G IL ++ P Y + N I K+V +G
Sbjct: 189 YIAPEVLRGTYDEKCDVWSAG-VILYILLSGTPPFYGK--NEYDILKRVETGKYAFDLPQ 245
Query: 250 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 291
++D K I K + SLR+ A + L+ P++ + ++
Sbjct: 246 WRTISD-DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-40
Identities = 63/277 (22%), Positives = 119/277 (42%), Gaps = 29/277 (10%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVN---IEDVMQSPDQLERLYSEVHLLKS 82
Y +G+G++ V + I A ++ +EDV +R E+ ++KS
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV-------DRFKQEIEIMKS 62
Query: 83 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
L H NII+ Y ++ D+T+ I ++ EL T G L + + + +L +
Sbjct: 63 LDHPNIIRLYETFEDNTD--IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVA 120
Query: 143 YLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE 199
Y H N + HRDLK +N + + +K+ D GLA + R+ +GTP +++P+
Sbjct: 121 YCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ 178
Query: 200 LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVT 254
+ E Y D +S G ++ ++ C YP +++ K+ G V+
Sbjct: 179 VLEGLYGPECDEWSAG-VMMYVLLCGYPPFSAP--TDSEVMLKIREGTFTFPEKDWLNVS 235
Query: 255 DPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
Q + I + + R+ +L+ L+ +
Sbjct: 236 P-QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-40
Identities = 75/298 (25%), Positives = 129/298 (43%), Gaps = 25/298 (8%)
Query: 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVN----IEDVMQSPDQLERLYSEVHLLKSLKH 85
+ LG GA V F+ +VA ++ + D + +E+ +LK L H
Sbjct: 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
IIK N + D + ++ EL G L +K + K + Q+L + YLH
Sbjct: 75 PCIIKIKN-FFDAED--YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH 131
Query: 146 SHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE--- 199
+ IIHRDLK +N+ + + +KI D G + ++ + + R++ GTP ++APE
Sbjct: 132 ENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 200 -LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKV 253
+ YN VD +S G IL + YP + + ++TSG P ++V
Sbjct: 190 SVGTAGYNRAVDCWSLG-VILFICLSGYPPFSEH-RTQVSLKDQITSGKYNFIPEVWAEV 247
Query: 254 TDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLA 310
++ ++K +V R E L+ P+L ++ K D L N + +
Sbjct: 248 SEK-ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVL 304
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-40
Identities = 81/280 (28%), Positives = 125/280 (44%), Gaps = 15/280 (5%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+LGKG+F V K D + E A +N + EV LLK L H NI+K
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREVELLKKLDHPNIMK 85
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
+ D ++ ++ EL+T G L K K +Q+ G+ Y+H HN
Sbjct: 86 LFEILEDSSS--FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN-- 141
Query: 151 IIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEEYNE 207
I+HRDLK +NI + + ++KI D GL+ QQ + IGT ++APE+ Y+E
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201
Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEK 264
D++S G IL ++ P KN I K+V +G ++D K I K
Sbjct: 202 KCDVWSAG-VILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD-DAKDLIRK 259
Query: 265 CIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 303
+ SLR+ A + L+ P++ + + L
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESA 299
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 62/281 (22%), Positives = 123/281 (43%), Gaps = 26/281 (9%)
Query: 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
+ + + + LG GAF V+ + G+E + + +S +E++ +E
Sbjct: 15 YFQGTIDDLF-IFKRKLGSGAFGDVHLVEERSSGLERV---IKTINKDRSQVPMEQIEAE 70
Query: 77 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKN 132
+ +LKSL H NIIK + + D N + ++ E G L + + K + +
Sbjct: 71 IEVLKSLDHPNIIKIFEVFEDYHN--MYIVMETCEGGELLERIVSAQARGKALSEGYVAE 128
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTA-RSV 189
+Q++ L Y HS + ++H+DLK +NI F + + +KI D GLA + + +
Sbjct: 129 LMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA 186
Query: 190 IGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---- 245
GT +MAPE+++ + DI+S G ++ + + ++ +K T
Sbjct: 187 AGTALYMAPEVFKRDVTFKCDIWSAG-VVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA 245
Query: 246 -KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
+ L+ PQ +++ + R A ++L +
Sbjct: 246 VECRPLT----PQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-39
Identities = 75/281 (26%), Positives = 126/281 (44%), Gaps = 15/281 (5%)
Query: 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
+ LG GA+ V D+V +E A + V S +L EV +LK L H NI+
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV--STSSNSKLLEEVAVLKLLDHPNIM 99
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
K Y+ + D N ++ E + G L + +Q+L G+ YLH HN
Sbjct: 100 KLYDFFEDKRN--YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN- 156
Query: 150 PIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEEYN 206
I+HRDLK +N+ + + +KI D GL+ V + + +GT ++APE+ ++Y+
Sbjct: 157 -IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYD 215
Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIE 263
E D++S G IL ++ YP + +I +KV G V++ K I+
Sbjct: 216 EKCDVWSIG-VILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE-GAKDLIK 273
Query: 264 KCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 303
+ + + R+ A + L+ P++ K L
Sbjct: 274 QMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANA 314
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-39
Identities = 80/294 (27%), Positives = 127/294 (43%), Gaps = 22/294 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVA---------WNQVNIEDVMQSPDQLERLYSEVHLLK 81
LG GA+ V ++ E A +D E +Y+E+ LLK
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 82 SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
SL H NIIK ++ + D ++TE + G L + D N +QIL G+
Sbjct: 102 SLDHPNIIKLFDVFEDKKY--FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGI 159
Query: 142 HYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAP 198
YLH HN I+HRD+K +NI N + +KI D GL+ + R +GT ++AP
Sbjct: 160 CYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217
Query: 199 ELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASLSKVTD 255
E+ +++YNE D++S G I+ ++ C YP +N I KKV G ++
Sbjct: 218 EVLKKKYNEKCDVWSCG-VIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNIS- 275
Query: 256 PQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 308
+ K+ I+ + + R A E L ++ D L + +
Sbjct: 276 DEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRK 329
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 7e-39
Identities = 72/276 (26%), Positives = 132/276 (47%), Gaps = 22/276 (7%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
YD E LGKGAF V + + G+E A +N + + S ++L E + + L+H
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQH 64
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
NI++ ++S +++ ++ +L T G L + + + +QIL + Y H
Sbjct: 65 PNIVRLHDSIQEESF--HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 122
Query: 146 SHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEFMAPE-LY 201
S+ I+HR+LK +N+ + VK+ D GLAI + GTP +++PE L
Sbjct: 123 SNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK 180
Query: 202 EEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDP 256
++ Y++ VDI++ G IL ++ YP ++E + ++Y ++ +G VT
Sbjct: 181 KDPYSKPVDIWACG-VILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTP- 236
Query: 257 QVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 291
+ K I+ + R+ A + LK P++
Sbjct: 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA 272
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 72/294 (24%), Positives = 126/294 (42%), Gaps = 28/294 (9%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ-LERLYSEVHLLKSLK 84
Y+ E++GKG F V + + G + A V++ SP E L E + LK
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSL--RQYRKKHKNVDM--KAIKNWARQILRG 140
H +I++ ++ D + M+ E L ++ ++ RQIL
Sbjct: 85 HPHIVELLETYSSDGM--LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 141 LHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFM 196
L Y H +N IIHRD+K + + N+ VK+G G+AI + + A +GTP FM
Sbjct: 143 LRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASL 250
APE + E Y + VD++ G IL ++ Y ++++ + G P
Sbjct: 201 APEVVKREPYGKPVDVWGCG-VILFILLSGCLPFYGT---KERLFEGIIKGKYKMNPRQW 256
Query: 251 SKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK-DLVCDPLRLPNL 302
S +++ K + + ++ + R+ E L P+L + + P + L
Sbjct: 257 SHISE-SAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQL 309
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-38
Identities = 58/317 (18%), Positives = 117/317 (36%), Gaps = 46/317 (14%)
Query: 18 SEKDPSCRYGRYD--EILGKGAFKTVY-----------KGFDEVDGIEVAWNQVNIEDVM 64
K+ Y L +G F + K +++ + + D +
Sbjct: 22 YVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKI 81
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 124
+ + +E+ ++ +K+E + + + +I E + S+ ++ +
Sbjct: 82 SIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDE--VYIIYEYMENDSILKFDEYFFV 139
Query: 125 VDMKA--------IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176
+D IK + +L Y+H+ I HRD+K NI + NG VK+ D G
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDVKPSNILM-DKNGRVKLSDFG 197
Query: 177 LAIVMQQPTARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECKN 233
+ M + GT EFM PE + E VDI+S G+C+ M P++ +
Sbjct: 198 ESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257
Query: 234 PAQIYKKVTSG-----------------IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPA 275
+++ + + K + + F++ + + R+ +
Sbjct: 258 LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS 317
Query: 276 LELLKDPFLVTDNPKDL 292
+ LK +L N +DL
Sbjct: 318 EDALKHEWLADTNIEDL 334
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 39/297 (13%), Positives = 81/297 (27%), Gaps = 55/297 (18%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVA------------------------WNQVNIEDVMQS 66
+LG+ + D+ G + +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 67 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS------GSLRQYRK 120
R L+K + + +I+ D + + S L +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
HK++ A Q++R L LH + ++H L+ +I ++ G V + +
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQ-RGGVFLTGFEHLVR 255
Query: 181 MQQPTARSVIGTPEFMAPELYEEE------------YNELVDIYSFGMCILEMVTCEYPY 228
+ F PEL D ++ G+ I + + P
Sbjct: 256 DGARV--VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313
Query: 229 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
+ + + K V+ +E + RL L+ ++ P
Sbjct: 314 TK-DAALGGSEWIFRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQAMETPEY 363
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 67/295 (22%), Positives = 120/295 (40%), Gaps = 25/295 (8%)
Query: 7 FTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS 66
+ K + E + Y E LG GAF V++ ++ G +N
Sbjct: 34 WKKYVPQPVEVKQGSVYDYY-DILEELGSGAFGVVHRCVEKATGRVFVAKFINT----PY 88
Query: 67 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL--RQYRKKHKN 124
P + +E+ ++ L H +I ++++ D + +I E + G L R + +K
Sbjct: 89 PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKM 146
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQ 183
+ + I N+ RQ GL ++H H+ I+H D+K +NI VKI D GLA +
Sbjct: 147 SEAEVI-NYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203
Query: 184 PTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYK 239
+ T EF APE + E D+++ G + ++ E + + +
Sbjct: 204 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIG-VLGYVLLSGLSPFAGE--DDLETLQ 260
Query: 240 KVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
V + S V+ + K FI+ + RL + L+ P+L D+
Sbjct: 261 NVKRCDWEFDEDAFSSVSP-EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 73/274 (26%), Positives = 133/274 (48%), Gaps = 22/274 (8%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
YD E LGKGAF V + + G+E A +N + + S ++L E + + L+H
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQH 87
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
NI++ ++S +++ ++ +L T G L + + + +QIL + Y H
Sbjct: 88 PNIVRLHDSIQEESF--HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 145
Query: 146 SHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE-LY 201
S+ I+HR+LK +N+ + VK+ D GLAI + A GTP +++PE L
Sbjct: 146 SNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK 203
Query: 202 EEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDP 256
++ Y++ VDI++ G IL ++ YP ++E + ++Y ++ +G VT
Sbjct: 204 KDPYSKPVDIWACG-VILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTP- 259
Query: 257 QVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNP 289
+ K I+ + R+ A + LK P++
Sbjct: 260 EAKSLIDSMLTVNPKKRITADQALKVPWICNRER 293
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-37
Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 43/225 (19%)
Query: 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLY---SEVHLLKSLKHE 86
E++G+G + VYKG +D VA V + + ++ + ++H+
Sbjct: 18 LELIGRGRYGAVYKG--SLDERPVA--------VKVFSFANRQNFINEKNIYRVPLMEHD 67
Query: 87 NIIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 143
NI +F T ++ E + +GSL +Y H D + A + RGL Y
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAY 126
Query: 144 LHS-------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----------QQPTA 186
LH+ + P I HRDL N+ V N+G I D GL++ + + A
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVK-NDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 187 RSVIGTPEFMAPELYE--------EEYNELVDIYSFGMCILEMVT 223
S +GT +MAPE+ E E + VD+Y+ G+ E+
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 7e-37
Identities = 69/288 (23%), Positives = 126/288 (43%), Gaps = 27/288 (9%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
+ E+LG GAF V+ + G A + + L +E+ +LK +KH
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD----SSLENEIAVLKKIKH 65
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSL--RQYRKKHKNVDMKAIKNWARQILRGLHY 143
ENI+ + + T+ ++ +L + G L R + K +Q+L + Y
Sbjct: 66 ENIVTLEDIYESTTH--YYLVMQLVSGGELFDRILERGVYT--EKDASLVIQQVLSAVKY 121
Query: 144 LHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-L 200
LH + I+HRDLK +N+ N ++ I D GL+ + Q + GTP ++APE L
Sbjct: 122 LHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVL 179
Query: 201 YEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTD 255
++ Y++ VD +S G I ++ C YP Y E +++++K+ G + +++
Sbjct: 180 AQKPYSKAVDCWSIG-VITYILLCGYPPFYEE--TESKLFEKIKEGYYEFESPFWDDISE 236
Query: 256 PQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 302
K FI + + R + L P++ + P +
Sbjct: 237 -SAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSVSLQI 283
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 8e-37
Identities = 74/290 (25%), Positives = 132/290 (45%), Gaps = 23/290 (7%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSL 83
YD E LG G F V K ++ G+E A + S + R + EV +L+ +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 143
H N+I ++ + + T+ + +I EL + G L + + +++ + ++ +QIL G++Y
Sbjct: 73 LHHNVITLHDVYENRTD--VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 144 LHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE 199
LH+ I H DLK +NI + N +K+ D GLA ++ +++ GTPEF+APE
Sbjct: 131 LHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 200 -LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKV 253
+ E D++S G I ++ + + +TS S
Sbjct: 189 IVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANITSVSYDFDEEFFSHT 245
Query: 254 TDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 302
++ K FI K +V RL E L+ P++ + + + + NL
Sbjct: 246 SE-LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNL 294
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 42/337 (12%), Positives = 91/337 (27%), Gaps = 57/337 (16%)
Query: 27 GRY-----DEILGKGAFKTVYKGFDEVDGIEVA------WNQVNIEDV------------ 63
R +LG+ + D+ G + +
Sbjct: 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 134
Query: 64 ---MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS-------- 112
+++ Q + + +K K +D+ + + L+
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194
Query: 113 -GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 171
L + HK++ A Q++R L LH + ++H L+ +I + G V
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVL-DQRGGVF 251
Query: 172 IGDLGLAIVMQQPT---ARSVIGTPEFMAPELY------EEEYNELVDIYSFGMCILEMV 222
+ + PE A + D ++ G+ I +
Sbjct: 252 LTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311
Query: 223 TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKD 281
+ P + + + K V+ +E + RL L+ ++
Sbjct: 312 CADLPNTD-DAALGGSEWIFRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQAMET 364
Query: 282 PFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMD 318
P + + + L L E + P
Sbjct: 365 PEY--EQLRTELSAALPLYQTDGEPTREGGAPPSGTS 399
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 66/320 (20%), Positives = 115/320 (35%), Gaps = 63/320 (19%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLK 84
+Y +G+G++ V + A +N + Q +P +ER+ +EV L+K L
Sbjct: 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWA---------- 134
H NI + Y + D+ I ++ EL G L +
Sbjct: 87 HPNIARLYEVYEDEQY--ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 135 ------------------------------RQILRGLHYLHSHNPPIIHRDLKCDNI-FV 163
RQI LHYLH+ I HRD+K +N F
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFS 202
Query: 164 NGNNGEVKIGDLGLAIVMQQPTA------RSVIGTPEFMAPEL---YEEEYNELVDIYSF 214
+ E+K+ D GL+ + + GTP F+APE+ E Y D +S
Sbjct: 203 TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262
Query: 215 GMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSKVTDPQVKQFIEKCIVP-AS 270
G +L ++ N A +V + + + + ++ + + +
Sbjct: 263 G-VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSP-LARDLLSNLLNRNVD 320
Query: 271 LRLPALELLKDPFLVTDNPK 290
R A+ L+ P++ + K
Sbjct: 321 ERFDAMRALQHPWISQFSDK 340
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 69/279 (24%), Positives = 129/279 (46%), Gaps = 24/279 (8%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
EILG G F V+K + G+++A + + E + +E+ ++ L H N+I+
Sbjct: 95 EILGGGRFGQVHKCEETATGLKLAAKIIKT----RGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 91 FYNSWVDDTNRTINMITELFTSGSL--RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
Y+++ + I ++ E G L R + + ++ I + +QI G+ ++H
Sbjct: 151 LYDAFESKND--IVLVMEYVDGGELFDRIIDESYNLTELDTI-LFMKQICEGIRHMHQMY 207
Query: 149 PPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE-LYEEEY 205
I+H DLK +NI VN + ++KI D GLA + + GTPEF+APE + +
Sbjct: 208 --ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFV 265
Query: 206 NELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQ 260
+ D++S G+ I M+ + N A+ + + + +++ + K+
Sbjct: 266 SFPTDMWSVGV-IAYMLLSGLSPFLGD--NDAETLNNILACRWDLEDEEFQDISE-EAKE 321
Query: 261 FIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLR 298
FI K ++ S R+ A E LK P+L + +
Sbjct: 322 FISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKK 360
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-36
Identities = 74/290 (25%), Positives = 133/290 (45%), Gaps = 23/290 (7%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL--ERLYSEVHLLKSL 83
YD E LG G F V K ++ G+E A + S + E + EV +L+ +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 143
H NII ++ + + T+ + +I EL + G L + + +++ + ++ +QIL G++Y
Sbjct: 73 LHPNIITLHDVYENRTD--VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 144 LHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE 199
LH+ I H DLK +NI + N +K+ D GLA ++ +++ GTPEF+APE
Sbjct: 131 LHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 200 -LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKV 253
+ E D++S G I ++ + + +T+ S+
Sbjct: 189 IVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANITAVSYDFDEEFFSQT 245
Query: 254 TDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 302
++ K FI K +V RL E L+ P++ + + + + NL
Sbjct: 246 SE-LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNL 294
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 78/296 (26%), Positives = 142/296 (47%), Gaps = 23/296 (7%)
Query: 18 SEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLY 74
S D G Y + +GKG F V + G EVA + I D Q +P L++L+
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVA---IKIIDKTQLNPTSLQKLF 62
Query: 75 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWA 134
EV ++K L H NI+K + V +T +T+ +I E + G + Y H + K ++
Sbjct: 63 REVRIMKILNHPNIVKLFE--VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF 120
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTP 193
RQI+ + Y H I+HRDLK +N+ + + +KI D G + + G P
Sbjct: 121 RQIVSAVQYCHQKR--IVHRDLKAENLLL-DADMNIKIADFGFSNEFTVGGKLDAFCGAP 177
Query: 194 EFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPAS 249
+ APEL++ ++Y+ VD++S G+ + +V+ P++ +N ++ ++V G P
Sbjct: 178 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYRIPFY 236
Query: 250 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVP 304
+S + +++ +V R +++KD ++ + +D + P P L
Sbjct: 237 MS----TDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDEL-KPFVEPELDI 287
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 9e-36
Identities = 50/276 (18%), Positives = 101/276 (36%), Gaps = 33/276 (11%)
Query: 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENI 88
+LG+GAF VY+ + ++ + P + + LK
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMF 129
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKN-----WARQILRGLHY 143
+KFY++ + ++ EL++ G+L +KN K + +A ++L +
Sbjct: 130 MKFYSAHLFQNG--SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187
Query: 144 LHSHNPPIIHRDLKCDNIFVNG----------NNGEVKIGDLGLAIVMQQP----TARSV 189
+H IIH D+K DN + + + + DLG +I M+ +
Sbjct: 188 VHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 190 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 248
T F E L + +N +D + + M+ Y + + + + +
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHL 305
Query: 249 SLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPF 283
+ +F + +P LP+L+LL+
Sbjct: 306 DMW-------NEFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 134 bits (341), Expect = 9e-36
Identities = 69/280 (24%), Positives = 128/280 (45%), Gaps = 23/280 (8%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER--LYSEVHLLKSL 83
Y+ E LG G F V K + G E A + + S + R + EV++L+ +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 143
+H NII ++ + + T+ + +I EL + G L + + +++ + +QIL G+HY
Sbjct: 66 RHPNIITLHDIFENKTD--VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 123
Query: 144 LHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE 199
LHS I H DLK +NI + N N +K+ D G+A ++ +++ GTPEF+APE
Sbjct: 124 LHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 200 -LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKV 253
+ E D++S G I ++ E + +++ S
Sbjct: 182 IVNYEPLGLEADMWSIG-VITYILLSGASPFLGE--TKQETLTNISAVNYDFDEEYFSNT 238
Query: 254 TDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 292
++ K FI + +V R+ + L+ ++ +++
Sbjct: 239 SE-LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 55/276 (19%), Positives = 114/276 (41%), Gaps = 27/276 (9%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
+Y E LG+G F V++ + + V + E+ +L +H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYM-----AKFVKVKGTDQVLVKKEISILNIARH 60
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM--KAIKNWARQILRGLHY 143
NI+ + S+ + MI E + + + R ++ + I ++ Q+ L +
Sbjct: 61 RNILHLHESFESMEE--LVMIFEFISGLDIFE-RINTSAFELNEREIVSYVHQVCEALQF 117
Query: 144 LHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE-L 200
LHSHN I H D++ +NI + + +KI + G A ++ R + PE+ APE
Sbjct: 118 LHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175
Query: 201 YEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTD 255
+ + D++S G ++ ++ E QI + + + + +++
Sbjct: 176 QHDVVSTATDMWSLG-TLVYVLLSGINPFLAE--TNQQIIENIMNAEYTFDEEAFKEISI 232
Query: 256 PQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
+ F+++ +V R+ A E L+ P+L +
Sbjct: 233 -EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 46/308 (14%), Positives = 88/308 (28%), Gaps = 47/308 (15%)
Query: 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
S R + E L G V+ D + A +V S +LERL+
Sbjct: 55 SLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFAL-KVFTMGAENSRSELERLHEAT 113
Query: 78 HLLKSLKHEN------------------------IIKFYNSWVDDTNRTINMITELFTS- 112
L E+ + D ++ +
Sbjct: 114 FAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVD 173
Query: 113 -----GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 167
+L + + A+ Q++R L S ++H DN+F+ +
Sbjct: 174 LELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFI-MPD 230
Query: 168 GEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVT 223
G + +GD+ + T P AP + + ++ + G+ I +
Sbjct: 231 GRLMLGDVSAL--WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288
Query: 224 CEYPYNEC-KNPAQIYKKVTSGIK-----PASLSKVTDPQVKQFIEKCIVP-ASLRLPAL 276
P+ +K+ + + VK I + + RL L
Sbjct: 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPL 348
Query: 277 ELLKDPFL 284
E ++ P
Sbjct: 349 EAMETPEF 356
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-35
Identities = 73/289 (25%), Positives = 134/289 (46%), Gaps = 24/289 (8%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
Y E LGKGAF V + + G E A +N + + S ++L E + + LKH
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKH 69
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
NI++ ++S ++ + +I +L T G L + + + +QIL + + H
Sbjct: 70 PNIVRLHDSISEEGH--HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127
Query: 146 SHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE-L 200
++HR+LK +N+ + VK+ D GLAI ++ GTP +++PE L
Sbjct: 128 QMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185
Query: 201 YEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTD 255
++ Y + VD+++ G IL ++ YP ++E + ++Y+++ +G VT
Sbjct: 186 RKDPYGKPVDLWACG-VILYILLVGYPPFWDE--DQHRLYQQIKAGAYDFPSPEWDTVTP 242
Query: 256 PQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNP-KDLVCDPLRLPNL 302
+ K I K + S R+ A E LK P++ + + + L
Sbjct: 243 -EAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCL 290
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 69/298 (23%), Positives = 123/298 (41%), Gaps = 29/298 (9%)
Query: 8 TKSETEEGEFSEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ 65
T S + + ++ LG+GA VY+ + A +
Sbjct: 34 TASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK- 92
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 125
+ + +E+ +L L H NIIK + T I+++ EL T G L +
Sbjct: 93 -----KIVRTEIGVLLRLSHPNIIKLKEIFETPTE--ISLVLELVTGGELFDRIVEKGYY 145
Query: 126 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ 183
+ + +QIL + YLH + I+HRDLK +N+ + + +KI D GL+ +++
Sbjct: 146 SERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203
Query: 184 PTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFG--MCILEMVTCEYP--YNECKNPAQI 237
++V GTP + APE L Y VD++S G IL C + Y+E + +
Sbjct: 204 QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYIL---LCGFEPFYDE-RGDQFM 259
Query: 238 YKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 291
++++ + +V+ K + K IV RL + L+ P++
Sbjct: 260 FRRILNCEYYFISPWWDEVSL-NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANF 316
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 70/308 (22%), Positives = 124/308 (40%), Gaps = 36/308 (11%)
Query: 8 TKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVA--------WNQVN 59
T+ G S Y EILG+G V + + E A +
Sbjct: 1 TRDAALPGSHSTHGFYENY-EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFS 59
Query: 60 IEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQY 118
E+V + + + EV +L+ + H NII+ +++ +T ++ +L G L Y
Sbjct: 60 AEEVQELREATLK---EVDILRKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDY 114
Query: 119 RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178
+ + K + R +L + LH N I+HRDLK +NI ++ ++ +K+ D G +
Sbjct: 115 LTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFS 171
Query: 179 IVMQQPTA-RSVIGTPEFMAPE-------LYEEEYNELVDIYSFGMCILEMVTCEYP--Y 228
+ R V GTP ++APE Y + VD++S G I+ + P +
Sbjct: 172 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG-VIMYTLLAGSPPFW 230
Query: 229 NECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
+ + + + SG +D VK + + +V R A E L PF
Sbjct: 231 HR--KQMLMLRMIMSGNYQFGSPEWDDYSDT-VKDLVSRFLVVQPQKRYTAEEALAHPFF 287
Query: 285 VTDNPKDL 292
+++
Sbjct: 288 QQYVVEEV 295
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 70/279 (25%), Positives = 125/279 (44%), Gaps = 23/279 (8%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL--ERLYSEVHLLKSL 83
YD E LG G F V K ++ G++ A + S + E + EV +LK +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 143
+H N+I + + + T+ + +I EL G L + + +++ + + +QIL G++Y
Sbjct: 72 QHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 144 LHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE 199
LHS I H DLK +NI + N +KI D GLA + +++ GTPEF+APE
Sbjct: 130 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 200 -LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKV 253
+ E D++S G I ++ + + V++ + S
Sbjct: 188 IVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANVSAVNYEFEDEYFSNT 244
Query: 254 TDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 291
+ K FI + +V R+ + L+ P++ + +
Sbjct: 245 SA-LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 61/310 (19%), Positives = 130/310 (41%), Gaps = 23/310 (7%)
Query: 25 RYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
G+Y ++LG+G++ V + D A + + + + P+ + E+ LL+
Sbjct: 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 83 LKHENIIKFYNSWVDDTNRTINMITELFTSGS--LRQYRKKHKNVDMKAIKNWARQILRG 140
L+H+N+I+ + ++ + + M+ E G + + + +A + Q++ G
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHG-YFCQLIDG 121
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFM 196
L YLHS I+H+D+K N+ + G +KI LG+A + A G+P F
Sbjct: 122 LEYLHSQG--IVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178
Query: 197 APELY--EEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLS 251
PE+ + ++ VDI+S G+ + + T YP+ N ++++ + G P
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSYAIPGDCG 237
Query: 252 KVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLA 310
P + ++ + + R ++ + + +P P+ +
Sbjct: 238 ----PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSM 293
Query: 311 HSEPHPMDID 320
P+ D+
Sbjct: 294 TVVPYLEDLH 303
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 65/306 (21%), Positives = 115/306 (37%), Gaps = 31/306 (10%)
Query: 10 SETEEGEFSEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP 67
T KD Y +LGKG F TV+ G D ++VA + V+
Sbjct: 14 PGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWS 73
Query: 68 --DQLERLYSEVHLLKSL----KHENIIKFYNSWVDDTNRTINMITELFTSGS-LRQYRK 120
EV LL + H +I+ + +T ++ E L Y
Sbjct: 74 PLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD--WFETQEGFMLVLERPLPAQDLFDYIT 131
Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
+ + + + Q++ + + HS ++HRD+K +NI ++ G K+ D G +
Sbjct: 132 EKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGAL 189
Query: 181 MQQPTARSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCIL-EMVTCEYPYNECKNPAQI 237
+ GT + PE +Y+ ++S G+ +L +MV + P+
Sbjct: 190 LHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGI-LLYDMVCGDIPFER------- 241
Query: 238 YKKVTSGI--KPASLSKVTDPQVKQFIEKCIVPA-SLRLPALELLKDPFLVTDNPKDLVC 294
+++ PA +S P I +C+ P S R E+L DP++ T +
Sbjct: 242 DQEILEAELHFPAHVS----PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLN 297
Query: 295 DPLRLP 300
P
Sbjct: 298 PSKGGP 303
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 8e-35
Identities = 66/327 (20%), Positives = 126/327 (38%), Gaps = 39/327 (11%)
Query: 7 FTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS 66
F E ++ ++ Y ++LG G V + F G + A ++
Sbjct: 16 FQGPEPKKYAVTDD-----YQLSKQVLGLGVNGKVLECFHRRTGQKCA---------LKL 61
Query: 67 PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN--RTINMITELFTSGSL--RQYRKK 121
+ EV +I+ + + + + R + +I E G L R +
Sbjct: 62 LYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERG 121
Query: 122 HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAI 179
+ + R I + +LHSHN I HRD+K +N+ + + + +K+ D G A
Sbjct: 122 DQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
Query: 180 VMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKN--P 234
Q ++ TP ++APE L E+Y++ D++S G I+ ++ C +P Y+
Sbjct: 180 ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLG-VIMYILLCGFPPFYSNTGQAIS 238
Query: 235 AQIYKKVTSG---IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL-----V 285
+ +++ G S+V++ KQ I + + RL + + P++ V
Sbjct: 239 PGMKRRIRLGQYGFPNPEWSEVSE-DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV 297
Query: 286 TDNPKDLVCDPLRLPNLVPEVMNLAHS 312
P + EV S
Sbjct: 298 PQTPLHTARVLQEDKDHWDEVKEEMTS 324
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 58/260 (22%), Positives = 113/260 (43%), Gaps = 35/260 (13%)
Query: 15 GEFSEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVA------------------ 54
G + +Y + +GKG++ V ++E D A
Sbjct: 1 GSSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRR 60
Query: 55 ----WNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110
+ +Q +E++Y E+ +LK L H N++K D + M+ EL
Sbjct: 61 PPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELV 120
Query: 111 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 170
G + + + +A + + +++G+ YLH IIHRD+K N+ V G +G +
Sbjct: 121 NQGPVMEVPTLKPLSEDQARF-YFQDLIKGIEYLHYQK--IIHRDIKPSNLLV-GEDGHI 176
Query: 171 KIGDLGLAIVMQQPTA--RSVIGTPEFMAPEL---YEEEYN-ELVDIYSFGMCILEMVTC 224
KI D G++ + A + +GTP FMAPE + ++ + +D+++ G+ + V
Sbjct: 177 KIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236
Query: 225 EYPYNECKNPAQIYKKVTSG 244
+ P+ + + ++ K+ S
Sbjct: 237 QCPFMD-ERIMCLHSKIKSQ 255
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 88/369 (23%), Positives = 148/369 (40%), Gaps = 71/369 (19%)
Query: 1 MDCGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI 60
+D + K +G+ E+ Y +++G G+F V++ EVA I
Sbjct: 18 LDDPNKVIKVLASDGKTGEQREI-AYTNC-KVIGNGSFGVVFQAKLVESD-EVA-----I 69
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIK----FYNSWVDDTNRTINMITELFTS---G 113
+ V+Q E+ +++ +KH N++ FY++ +N++ E
Sbjct: 70 KKVLQDK---RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYR 126
Query: 114 SLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173
+ R Y K + + M IK + Q+LR L Y+HS I HRD+K N+ ++ +G +K+
Sbjct: 127 ASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLI 184
Query: 174 DLGLA-IVMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTCE---- 225
D G A I++ S I + + APEL Y +DI+S G C++ E++ +
Sbjct: 185 DFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTG-CVMAELMQGQPLFP 243
Query: 226 ----------------YPYNE---CKNPAQIYKKVTSGIKPASLSKV----TDPQVKQFI 262
P E NP + K I+P SKV T P I
Sbjct: 244 GESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQ-IRPHPFSKVFRPRTPPDAIDLI 302
Query: 263 EKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDID 320
+ + P S RL A+E L PF D LR + + P +
Sbjct: 303 SRLLEYTP-SARLTAIEALCHPFF----------DELRTGE-----ARMPNGRELPPLFN 346
Query: 321 LNHKKVSAD 329
+++S
Sbjct: 347 WTKEELSVR 355
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 62/253 (24%), Positives = 108/253 (42%), Gaps = 35/253 (13%)
Query: 28 RYDEILGKGAFKTVYKG----FDEVDGIEVAWNQVNIEDV----MQSPDQLERLYSEVHL 79
+Y LGKG F +V + G VA V PDQ E+ +
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVA--------VKQLQHSGPDQQRDFQREIQI 77
Query: 80 LKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQIL 138
LK+L + I+K+ +++ ++ E SG LR + ++H+ +D + ++ QI
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPE 194
+G+ YL S +HRDL NI V + VKI D GLA ++ R +P
Sbjct: 138 KGMEYLGSRR--CVHRDLAARNILV-ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 194
Query: 195 F-MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 251
F APE L + ++ D++SFG+ + E+ T C+ + ++
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP------ 248
Query: 252 KVTDPQVKQFIEK 264
++ + +E+
Sbjct: 249 --ALSRLLELLEE 259
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 64/282 (22%), Positives = 116/282 (41%), Gaps = 23/282 (8%)
Query: 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
Y + LG+G F V + + G E A + D + E+ +L+ K
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRAEILHEIAVLELAK 86
Query: 85 H-ENIIKFYNSWVDDTNRTINMITELFTSGSL--RQYRKKHKNVDMKAIKNWARQILRGL 141
+I + + + + I +I E G + + + V + +QIL G+
Sbjct: 87 SCPRVINLHEVYENTSE--IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGV 144
Query: 142 HYLHSHNPPIIHRDLKCDNI-FVNGN-NGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAP 198
+YLH +N I+H DLK NI + G++KI D G++ + R ++GTPE++AP
Sbjct: 145 YYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAP 202
Query: 199 E-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSK 252
E L + D+++ G+ I M+ E + + Y ++ + S
Sbjct: 203 EILNYDPITTATDMWNIGI-IAYMLLTHTSPFVGE--DNQETYLNISQVNVDYSEETFSS 259
Query: 253 VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLV 293
V+ FI+ +V R A L +L + ++L
Sbjct: 260 VSQ-LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF 300
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-34
Identities = 68/289 (23%), Positives = 122/289 (42%), Gaps = 26/289 (8%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
YD E LG GAF V++ + G A V E + E+ + L+H
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT----PHESDKETVRKEIQTMSVLRH 213
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSL-RQYRKKHKNVDMKAIKNWARQILRGLHYL 144
++ ++++ DD + MI E + G L + +H + + RQ+ +GL ++
Sbjct: 214 PTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 145 HSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE-LY 201
H +N +H DLK +NI F + E+K+ D GL + + + GT EF APE
Sbjct: 272 HENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 329
Query: 202 EEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDP 256
+ D++S G + ++ E N + + V S ++ S +++
Sbjct: 330 GKPVGYYTDMWSVG-VLSYILLSGLSPFGGE--NDDETLRNVKSCDWNMDDSAFSGISE- 385
Query: 257 QVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN--PKDLVCDPLRLPNL 302
K FI K ++ + R+ + L+ P+L N +D R +
Sbjct: 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKI 434
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 58/300 (19%), Positives = 116/300 (38%), Gaps = 28/300 (9%)
Query: 18 SEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS--PDQLERL 73
K+ +Y +LG G F +VY G D + VA V + + R+
Sbjct: 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 93
Query: 74 YSEVHLLKSLKHE--NIIKFYNSWVDDTNRTINMITELFT-SGSLRQYRKKHKNVDMKAI 130
EV LLK + +I+ + + + +I E L + + + +
Sbjct: 94 PMEVVLLKKVSSGFSGVIRLLD--WFERPDSFVLILERPEPVQDLFDFITERGALQEELA 151
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
+++ Q+L + + H+ ++HRD+K +NI ++ N GE+K+ D G +++
Sbjct: 152 RSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 209
Query: 191 GTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--K 246
GT + PE Y+ ++S G+ + +MV + P+ +++ G
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------DEEIIRGQVFF 262
Query: 247 PASLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLVTDNPKDLVCDPLRLPNLVPE 305
+S + + I C+ P E+ P++ + L +L P
Sbjct: 263 RQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETA-EIHLHSLSPG 317
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 68/319 (21%), Positives = 114/319 (35%), Gaps = 52/319 (16%)
Query: 10 SETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ 69
S E+ ++ILG G+ TV G VA ++ D
Sbjct: 1 SRIANIPNFEQSLKNLV-VSEKILGYGSSGTVVFQ-GSFQGRPVAVKRML-------IDF 51
Query: 70 LERLYSEVHLL-KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-------RQYRKK 121
+ E+ LL +S H N+I++Y S D + + EL + +L +
Sbjct: 52 CDIALMEIKLLTESDDHPNVIRYYCSETTDRF--LYIALEL-CNLNLQDLVESKNVSDEN 108
Query: 122 HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN------------GNNGE 169
K + RQI G+ +LHS IIHRDLK NI V+ N
Sbjct: 109 LKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166
Query: 170 VKIGDLGLAIVMQ------QPTARSVIGTPEFMAPEL--------YEEEYNELVDIYSFG 215
+ I D GL + + + GT + APEL + +DI+S G
Sbjct: 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG 226
Query: 216 MCILEMVTCEYP--YNECKNPAQIYKKVTSGIKPASLSKVT-DPQVKQFIEKCIVP-ASL 271
+++ ++ + I + + S + L + + I + I
Sbjct: 227 CVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLK 286
Query: 272 RLPALELLKDPFLVTDNPK 290
R A+++L+ P + K
Sbjct: 287 RPTAMKVLRHPLFWPKSKK 305
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-34
Identities = 68/248 (27%), Positives = 109/248 (43%), Gaps = 24/248 (9%)
Query: 28 RYDEILGKGAFKTVYKG----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
++ + LGKG F +V + G VA ++ + + L E+ +LKSL
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSL 68
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLH 142
+H+NI+K+ R + +I E GSLR Y +KHK +D + + QI +G+
Sbjct: 69 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT--PEF-MA 197
YL + IHRDL NI V N VKIGD GL + + + P F A
Sbjct: 129 YLGTKR--YIHRDLATRNILV-ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 198 PE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256
PE L E +++ D++SFG+ + E+ T Y E G ++
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGNDK--QGQMIVF 239
Query: 257 QVKQFIEK 264
+ + ++
Sbjct: 240 HLIELLKN 247
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-34
Identities = 66/304 (21%), Positives = 122/304 (40%), Gaps = 32/304 (10%)
Query: 26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK- 84
D+ LG+G+F K + A ++ E+ LK +
Sbjct: 12 LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS-------KRMEANTQKEITALKLCEG 64
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
H NI+K + + D + ++ EL G L + KK K+ R+++ + ++
Sbjct: 65 HPNIVKLHEVFHDQLH--TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 145 HSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPE- 199
H ++HRDLK +N+ F + +N E+KI D G A + ++ T + APE
Sbjct: 123 HDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL 180
Query: 200 LYEEEYNELVDIYSFGMCILEMVTCEYP-------YNECKNPAQIYKKVTSG---IKPAS 249
L + Y+E D++S G IL + C + +I KK+ G + +
Sbjct: 181 LNQNGYDESCDLWSLG-VILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239
Query: 250 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 308
V+ + K I+ + + RL L + +L + +PL P+++
Sbjct: 240 WKNVSQ-EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSS--NPLMTPDILGSSGA 296
Query: 309 LAHS 312
H+
Sbjct: 297 AVHT 300
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 67/275 (24%), Positives = 122/275 (44%), Gaps = 17/275 (6%)
Query: 27 GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
+D + LG+GA+ V + V VA V+++ + P+ +++ E+ + K L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLN 63
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
HEN++KFY + E + G L + + + + Q++ G+ YL
Sbjct: 64 HENVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPE- 199
H I HRD+K +N+ ++ +KI D GLA V + ++ GT ++APE
Sbjct: 122 HGIG--ITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 200 LYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258
L E++ E VD++S G+ + M+ E P+++ + Q Y + K D
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 259 KQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 292
+ K +V S R+ ++ KD + K
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 273
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 79/339 (23%), Positives = 134/339 (39%), Gaps = 66/339 (19%)
Query: 4 GSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV 63
GS T G+ ++ Y +++G G+F VY+ G VA I+ V
Sbjct: 34 GSKVTTVVATPGQGPDRPQEVSY-TDTKVIGNGSFGVVYQAKLCDSGELVA-----IKKV 87
Query: 64 MQSPDQLERLYSEVHLLKSLKHENIIK----FYNSWVDDTNRTINMITELFTS---GSLR 116
+Q E+ +++ L H NI++ FY+S +N++ + R
Sbjct: 88 LQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 144
Query: 117 QYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176
Y + + + + +K + Q+ R L Y+HS I HRD+K N+ ++ + +K+ D G
Sbjct: 145 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFG 202
Query: 177 LA-IVMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTCE------- 225
A +++ S I + + APEL +Y +D++S G C+L E++ +
Sbjct: 203 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG-CVLAELLLGQPIFPGDS 261
Query: 226 -------------YPYNE---CKNPAQIYKKVT-SGIKPASLSKV----TDPQVKQFIEK 264
P E NP Y + IK +KV T P+ +
Sbjct: 262 GVDQLVEIIKVLGTPTREQIREMNPN--YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 319
Query: 265 CIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 301
+ P + RL LE F D LR PN
Sbjct: 320 LLEYTP-TARLTPLEACAHSFF----------DELRDPN 347
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 68/248 (27%), Positives = 109/248 (43%), Gaps = 24/248 (9%)
Query: 28 RYDEILGKGAFKTVYKG----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
++ + LGKG F +V + G VA ++ + + L E+ +LKSL
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSL 99
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLH 142
+H+NI+K+ R + +I E GSLR Y +KHK +D + + QI +G+
Sbjct: 100 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT--PEF-MA 197
YL + IHRDL NI V N VKIGD GL + + + P F A
Sbjct: 160 YLGTKR--YIHRDLATRNILV-ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 216
Query: 198 PE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256
PE L E +++ D++SFG+ + E+ T Y E G ++
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGNDK--QGQMIVF 270
Query: 257 QVKQFIEK 264
+ + ++
Sbjct: 271 HLIELLKN 278
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 25 RYGRYDEILGKGAFKTVYKG--FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
+ +G+G + VYK D D + A Q+ + S E+ LL+
Sbjct: 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA------CREIALLRE 74
Query: 83 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA---------IKNW 133
LKH N+I ++ +R + ++ + + L K H+ +K+
Sbjct: 75 LKHPNVISLQKVFLSHADRKVWLLFD-YAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG---NNGEVKIGDLGLAIVMQQPTARSVI 190
QIL G+HYLH++ ++HRDLK NI V G G VKI D+G A + P
Sbjct: 134 LYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191
Query: 191 GTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 223
P + APEL Y + +DI++ G CI E++T
Sbjct: 192 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIG-CIFAELLT 231
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 65/278 (23%), Positives = 124/278 (44%), Gaps = 30/278 (10%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL----ERLYSEVHLLK 81
+YD +++G+G V + G E A + + SP+QL E E H+L+
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 82 SLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
+ H +II +S+ + + ++ +L G L Y + + K ++ R +L
Sbjct: 155 QVAGHPHIITLIDSYESSSF--MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA 212
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE 199
+ +LH++N I+HRDLK +NI ++ +N ++++ D G + ++ R + GTP ++APE
Sbjct: 213 VSFLHANN--IVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPE 269
Query: 200 -------LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KP 247
Y + VD+++ G IL + P ++ + + + G
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACG-VILFTLLAGSPPFWHR--RQILMLRMIMEGQYQFSS 326
Query: 248 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
+ VK I + + RL A + L+ PF
Sbjct: 327 PEWDDRSST-VKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 68/304 (22%), Positives = 128/304 (42%), Gaps = 19/304 (6%)
Query: 27 GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
+D + LG+GA+ V + V VA V+++ + P+ +++ E+ + K L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLN 63
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
HEN++KFY + E + G L + + + + Q++ G+ YL
Sbjct: 64 HENVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPEL 200
H I HRD+K +N+ ++ +KI D GLA V + ++ GT ++APEL
Sbjct: 122 HGIG--ITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 201 YE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIY-KKVTSGIKPASLSKVTDPQ 257
+ E++ E VD++S G+ + M+ E P+++ + Q Y K+ D
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI-DSA 237
Query: 258 VKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHP 316
+ K +V S R+ ++ KD + K + + +
Sbjct: 238 PLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSN 297
Query: 317 MDID 320
+D
Sbjct: 298 LDFS 301
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 67/312 (21%), Positives = 123/312 (39%), Gaps = 30/312 (9%)
Query: 8 TKSETEEGEFSEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVN----IE 61
+ E E +Y LG GAF V+ D+ EV + +E
Sbjct: 5 EPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLE 64
Query: 62 DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGS-LRQYRK 120
D +L ++ E+ +L ++H NIIK + + + ++ E SG L +
Sbjct: 65 DCWIEDPKLGKVTLEIAILSRVEHANIIKVLD--IFENQGFFQLVMEKHGSGLDLFAFID 122
Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
+H +D RQ++ + YL + IIHRD+K +NI + + +K+ D G A
Sbjct: 123 RHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAE-DFTIKLIDFGSAAY 179
Query: 181 MQQ-PTARSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQI 237
+++ + GT E+ APE+ Y ++++S G+ L + E NP
Sbjct: 180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGV-TLYTLVFEE------NPFCE 232
Query: 238 YKKVTSGI--KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTD-NPKDLV 293
++ P +S ++ + + P R +L+ DP++ N D
Sbjct: 233 LEETVEAAIHPPYLVS----KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYT 288
Query: 294 CDPLRLPNLVPE 305
+ + N
Sbjct: 289 WEEVFRVNKPES 300
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-33
Identities = 72/270 (26%), Positives = 121/270 (44%), Gaps = 26/270 (9%)
Query: 27 GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNI--EDVMQSPDQLERLYSEVHLLKS 82
RY + LG G TVY D + I+VA + + + L+R EVH
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVA---IKAIFIPPREKEETLKRFEREVHNSSQ 67
Query: 83 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
L H+NI+ + +D + M E +L +Y + H + + N+ QIL G+
Sbjct: 68 LSHQNIVSMIDVDEEDDCYYLVM--EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPE 199
+ H I+HRD+K NI + +N +KI D G+A + + + V+GT ++ +PE
Sbjct: 126 HAHDMR--IVHRDIKPQNILI-DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
Query: 200 LYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI-YKKVTSGIKPASLSKVTDPQ 257
+ E +E DIYS G+ + EM+ E P+N + I K + + P + V
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEPPFNG-ETAVSIAIKHIQDSV-PNVTTDV-RKD 239
Query: 258 VKQFIEKCIVPASLRLP------ALELLKD 281
+ Q + I+ A+ + E+ D
Sbjct: 240 IPQSLSNVILRATEKDKANRYKTIQEMKDD 269
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 78/284 (27%), Positives = 131/284 (46%), Gaps = 21/284 (7%)
Query: 18 SEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
S+ D + G Y + LG G F V G ++ G +VA +N ++S D + ++
Sbjct: 2 SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKR 60
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
E+ LK +H +IIK Y V T M+ E + G L Y KH V+ + +
Sbjct: 61 EIQNLKLFRHPHIIKLYQ--VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ 118
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPE 194
QIL + Y H H ++HRDLK +N+ ++ + KI D GL+ +M R+ G+P
Sbjct: 119 QILSAVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPN 175
Query: 195 FMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEY-PYNECKNPAQIYKKVTSGI--KPAS 249
+ APE+ Y VDI+S G+ IL + C P+++ ++ ++KK+ G+ P
Sbjct: 176 YAAPEVISGRLYAGPEVDIWSCGV-ILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEY 233
Query: 250 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 292
L+ V + + R ++ + + D P L
Sbjct: 234 LN----RSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYL 273
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 63/226 (27%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 30 DEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
++LG GAF TVYKG E I VA + SP + + E +++ S+ +
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVA---IKELREATSPKANKEILDEAYVMASVDN 76
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYL 144
++ + + T+ +IT+L G L Y ++HK N+ + + NW QI +G++YL
Sbjct: 77 PHVCRLLG--IC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGT--P-EFMAPE- 199
++HRDL N+ V VKI D GLA ++ + G P ++MA E
Sbjct: 134 EDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 200 LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+ Y D++S+G+ + E++T PY+ ++I + G
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKG 235
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 28 RYDEILGKGAFKTVYKG----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
+ LG+G F V + G +VA V + + L E+ +L++L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVA---VKSLKPESGGNHIADLKKEIEILRNL 80
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLH 142
HENI+K+ +D I +I E SGSL++Y K+K +++K +A QI +G+
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 140
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEF-MA 197
YL S +HRDL N+ V + +VKIGD GL ++ T + +P F A
Sbjct: 141 YLGSRQ--YVHRDLAARNVLV-ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA 197
Query: 198 PE-LYEEEYNELVDIYSFGMCILEMVT 223
PE L + ++ D++SFG+ + E++T
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 17/206 (8%)
Query: 28 RYDEILGKGAFKTVYKG----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
+ LG+G F V ++ G VA V P E+ +L++L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVA---VKALKADAGPQHRSGWKQEIDILRTL 90
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 143
HE+IIK+ D ++ ++ E GSLR Y +H + + + +A+QI G+ Y
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAY 149
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEF-MAP 198
LH+ + IHRDL N+ + N+ VKIGD GLA + + R +P F AP
Sbjct: 150 LHAQH--YIHRDLAARNVLL-DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 206
Query: 199 E-LYEEEYNELVDIYSFGMCILEMVT 223
E L E ++ D++SFG+ + E++T
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-32
Identities = 58/281 (20%), Positives = 117/281 (41%), Gaps = 30/281 (10%)
Query: 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL- 83
Y ++LG G V + F++ + A ++D + EV L
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM--LQDC-------PKARREVELHWRAS 112
Query: 84 KHENIIKFYNSWVD--DTNRTINMITELFTSGSL--RQYRKKHKNVDMKAIKNWARQILR 139
+ +I++ + + + + + ++ E G L R + + + + I
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 140 GLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEFM 196
+ YLHS N I HRD+K +N+ + + N +K+ D G A + + TP ++
Sbjct: 173 AIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYV 230
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQ--IYKKVTSGI---KPA 248
APE L E+Y++ D++S G I+ ++ C YP Y+ + ++ G
Sbjct: 231 APEVLGPEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289
Query: 249 SLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 288
S+V++ +VK I + + R+ E + P+++
Sbjct: 290 EWSEVSE-EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 62/216 (28%), Positives = 111/216 (51%), Gaps = 31/216 (14%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS----EVHLLK 81
+Y+ E +G+G + TV+K + VA +V ++ D E + S E+ LLK
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD------DDDEGVPSSALREICLLK 56
Query: 82 SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRG 140
LKH+NI++ ++ V +++ + ++ E F L++Y D + +K++ Q+L+G
Sbjct: 57 ELKHKNIVRLHD--VLHSDKKLTLVFE-FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM---- 196
L + HS N ++HRDLK N+ +N NGE+K+ + GLA P R + E +
Sbjct: 114 LGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPV-RCY--SAEVVTLWY 167
Query: 197 -APELY--EEEYNELVDIYSFGMCIL-EMVTCEYPY 228
P++ + Y+ +D++S G CI E+ P
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAG-CIFAELANAGRPL 202
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 58/221 (26%), Positives = 87/221 (39%), Gaps = 16/221 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E +G+G F V+ G D VA E + PD + E +LK H NI++
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLP--PDLKAKFLQEARILKQYSHPNIVR 176
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
V + I ++ EL G + R + + +K + G+ YL S
Sbjct: 177 LIG--VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC- 233
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF----MAPE-LYEEE 204
IHRDL N V N +KI D G++ + G + APE L
Sbjct: 234 -CIHRDLAARNCLVTEKN-VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 205 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
Y+ D++SFG+ + E + PY N Q + V G
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSN-QQTREFVEKG 331
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 34/221 (15%)
Query: 22 PSCRY-GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS--- 75
PS RY LG+G + VYK D V VA ++ +E + E +
Sbjct: 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLE------HEEEGVPGTAI 81
Query: 76 -EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWA 134
EV LLK L+H NII+ + V N +++I E + L++Y K+ +V M+ IK++
Sbjct: 82 REVSLLKELQHRNIIELKS--VIHHNHRLHLIFE-YAENDLKKYMDKNPDVSMRVIKSFL 138
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVN----GNNGEVKIGDLGLAIVMQQPTARSVI 190
Q++ G+++ HS +HRDLK N+ ++ +KIGD GLA P +
Sbjct: 139 YQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-- 194
Query: 191 GTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 223
T E + PE+ Y+ VDI+S CI EM+
Sbjct: 195 -THEIITLWYRPPEILLGSRHYSTSVDIWSIA-CIWAEMLM 233
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 69/277 (24%), Positives = 118/277 (42%), Gaps = 30/277 (10%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLK 84
Y+ E +G G++ + + +E A V I + +S E+ LL+ +
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFA---VKI--IDKSKRDPTE---EIEILLRYGQ 74
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
H NII + V D + + ++TEL G L + K + I + + YL
Sbjct: 75 HPNIITLKD--VYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYL 132
Query: 145 HSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPE 199
H+ ++HRDLK NI +GN ++I D G A ++ + T F+APE
Sbjct: 133 HAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE 190
Query: 200 -LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECK-NPAQIYKKVTSG---IKPASLSK 252
L + Y+ DI+S G +L + Y N P +I ++ SG + +
Sbjct: 191 VLERQGYDAACDIWSLG-VLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS 249
Query: 253 VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 288
V+D K + K + RL A +L+ P++V +
Sbjct: 250 VSD-TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 71/323 (21%), Positives = 131/323 (40%), Gaps = 38/323 (11%)
Query: 18 SEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
+ RYD + +G G F D++ VA + + E +
Sbjct: 11 LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-----ENVQR 65
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
E+ +SL+H NI++F V T + +I E + G L + + + +
Sbjct: 66 EIINHRSLRHPNIVRFKE--VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ 123
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQPTA-RSVIGTP 193
Q+L G+ Y HS I HRDLK +N ++G+ +KI D G + + +S +GTP
Sbjct: 124 QLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 181
Query: 194 EFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-- 249
++APE+ +EY+ ++ D++S G+ + M+ YP+ E + Y+K I
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKTIQRILSVKYS 240
Query: 250 ------LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 302
+S P+ I + V + R+ E+ + + + P DL+ +
Sbjct: 241 IPDDIRIS----PECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQF 296
Query: 303 ---------VPEVMNLAHSEPHP 316
+ +M + P
Sbjct: 297 QEPEQPMQSLDTIMQIISEATIP 319
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 9e-31
Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
Y + LG+G + TVYKG ++ VA ++ +E +P R EV LLK LKH
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKH 59
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYL 144
NI+ ++ + T +++ ++ E + L+QY N+ +M +K + Q+LRGL Y
Sbjct: 60 ANIVTLHD--IIHTEKSLTLVFE-YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----APE 199
H ++HRDLK N+ +N GE+K+ D GLA PT E + P+
Sbjct: 117 HRQK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTY---DNEVVTLWYRPPD 170
Query: 200 LY--EEEYNELVDIYSFGMCIL-EMVT 223
+ +Y+ +D++ G CI EM T
Sbjct: 171 ILLGSTDYSTQIDMWGVG-CIFYEMAT 196
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 65/225 (28%), Positives = 100/225 (44%), Gaps = 23/225 (10%)
Query: 30 DEILGKGAFKTVYKGF---DEVDGIEVAWNQVNI--EDVMQSPDQLERLYSEVHLLKSLK 84
E LG G+F V +G + VA V DV+ P+ ++ EV+ + SL
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVA---VKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHY 143
H N+I+ Y V + M+TEL GSL +KH+ + + + +A Q+ G+ Y
Sbjct: 80 HRNLIRLYG--V-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 136
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT--P-EFMAP 198
L S IHRDL N+ + + VKIGD GL + P + AP
Sbjct: 137 LESKR--FIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
Query: 199 E-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKV 241
E L ++ D + FG+ + EM T + P+ +QI K+
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-SQILHKI 237
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 67/211 (31%), Positives = 105/211 (49%), Gaps = 28/211 (13%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE----RLYSEVHLLK 81
RY+ + LG+G F TVYK D+ VA ++ + ++ D + R E+ LL+
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR---EIKLLQ 67
Query: 82 SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRG 140
L H NII +++ +N I+++ + F L K + V IK + L+G
Sbjct: 68 ELSHPNIIGLLDAFGHKSN--ISLVFD-FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQG 124
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM---- 196
L YLH H I+HRDLK +N+ ++ NG +K+ D GLA P R+ T + +
Sbjct: 125 LEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPN-RAY--THQVVTRWY 178
Query: 197 -APELY--EEEYNELVDIYSFGMCIL-EMVT 223
APEL Y VD+++ G CIL E++
Sbjct: 179 RAPELLFGARMYGVGVDMWAVG-CILAELLL 208
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 68/327 (20%), Positives = 131/327 (40%), Gaps = 52/327 (15%)
Query: 10 SETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ 69
+++ G F + Y +++LG+GA V + + E A V I + +
Sbjct: 3 TDSFSGRFEDV-----YQLQEDVLGEGAHARVQTCINLITSQEYA---VKIIEKQPGHIR 54
Query: 70 LERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
R++ EV +L + H N+++ + ++ ++ E GS+ + K ++ +
Sbjct: 55 -SRVFREVEMLYQCQGHRNVLELIEFFEEEDR--FYLVFEKMRGGSILSHIHKRRHFNEL 111
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ---- 182
+ + L +LH+ I HRDLK +NI + VKI D L ++
Sbjct: 112 EASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169
Query: 183 -----QPTARSVIGTPEFMAPE------LYEEEYNELVDIYSFGMCILEMVTCEYP--YN 229
P + G+ E+MAPE Y++ D++S G IL ++ YP
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG-VILYILLSGYPPFVG 228
Query: 230 ECK-------------NPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLR 272
C +++ + G + ++ K I K +V A R
Sbjct: 229 RCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISC-AAKDLISKLLVRDAKQR 287
Query: 273 LPALELLKDPFLVTDNPKDLVCDPLRL 299
L A ++L+ P++ P++ + P+ L
Sbjct: 288 LSAAQVLQHPWVQGCAPENTLPTPMVL 314
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 88/341 (25%), Positives = 151/341 (44%), Gaps = 29/341 (8%)
Query: 25 RYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIED--VMQSPDQLERLYSEVHLL 80
G Y E LG+G+F V +VA + +++ D R+ E+ L
Sbjct: 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVA---LKFISRQLLKKSDMHMRVEREISYL 63
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
K L+H +IIK Y+ V T I M+ E + G L Y + K + + + +QI+
Sbjct: 64 KLLRHPHIIKLYD--VITTPTDIVMVIE-YAGGELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPE 199
+ Y H H I+HRDLK +N+ ++ +N VKI D GL+ +M ++ G+P + APE
Sbjct: 121 IEYCHRHK--IVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPE 177
Query: 200 LYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTD 255
+ + Y VD++S G+ + M+ P+++ + ++KKV S + P LS
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSCVYVMPDFLS---- 232
Query: 256 PQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEP 314
P + I + IV R+ E+ +DP+ + P L + + E
Sbjct: 233 PGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEA 292
Query: 315 HPMDIDLNHKKVSADSCAKSN--TGTWFLTLELQRLTENNE 353
D + + +D ++N + L E Q + E E
Sbjct: 293 MGFSEDYIVEALRSD---ENNEVKEAYNLLHENQVIQEKLE 330
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 67/207 (32%), Positives = 106/207 (51%), Gaps = 27/207 (13%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E LG G + TVYKG ++ G+ VA +V ++ +P R E+ L+K LKHENI++
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR---EISLMKELKHENIVR 67
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA------IKNWARQILRGLHYL 144
Y+ V T + ++ E F L++Y + +K + Q+L+GL +
Sbjct: 68 LYD--VIHTENKLTLVFE-FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----APE 199
H + I+HRDLK N+ +N G++K+GD GLA P + E + AP+
Sbjct: 125 HENK--ILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPVNTF---SSEVVTLWYRAPD 178
Query: 200 LY--EEEYNELVDIYSFGMCIL-EMVT 223
+ Y+ +DI+S G CIL EM+T
Sbjct: 179 VLMGSRTYSTSIDIWSCG-CILAEMIT 204
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 30/206 (14%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS----EVHLLKSLKHE 86
E +G+G + VYK D I VA ++ ++ + E + S E+ LLK L H
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRI-VALKRIRLD------AEDEGIPSTAIREISLLKELHHP 79
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLH 145
NI+ + V + R + ++ E F L++ ++K IK + Q+LRG+ + H
Sbjct: 80 NIVSLID--VIHSERCLTLVFE-FMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----APEL 200
H I+HRDLK N+ +N ++G +K+ D GLA P T E + AP++
Sbjct: 137 QHR--ILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSY---THEVVTLWYRAPDV 190
Query: 201 Y--EEEYNELVDIYSFGMCIL-EMVT 223
++Y+ VDI+S G CI EM+T
Sbjct: 191 LMGSKKYSTSVDIWSIG-CIFAEMIT 215
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 30/206 (14%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS----EVHLLKSLKHE 86
E +G+G + VYK + A ++ +E + E + S E+ +LK LKH
Sbjct: 8 EKIGEGTYGVVYKAQNNYGET-FALKKIRLE------KEDEGIPSTTIREISILKELKHS 60
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLH 145
NI+K Y+ V T + + ++ E L++ + + K++ Q+L G+ Y H
Sbjct: 61 NIVKLYD--VIHTKKRLVLVFE-HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----APEL 200
++HRDLK N+ +N GE+KI D GLA P R T E + AP++
Sbjct: 118 DRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPV-RKY--THEIVTLWYRAPDV 171
Query: 201 Y--EEEYNELVDIYSFGMCIL-EMVT 223
++Y+ +DI+S G CI EMV
Sbjct: 172 LMGSKKYSTTIDIWSVG-CIFAEMVN 196
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-30
Identities = 80/287 (27%), Positives = 135/287 (47%), Gaps = 19/287 (6%)
Query: 18 SEKDPSCRYGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
+ D + G Y + LG G F V G E+ G +VA +N ++S D + ++
Sbjct: 7 QKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRR 65
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
E+ LK +H +IIK Y V T I M+ E + G L Y K+ +D K + +
Sbjct: 66 EIQNLKLFRHPHIIKLYQ--VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ 123
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPE 194
QIL G+ Y H H ++HRDLK +N+ ++ + KI D GL+ +M R+ G+P
Sbjct: 124 QILSGVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPN 180
Query: 195 FMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASL 250
+ APE+ Y VDI+S G+ + ++ P+++ + ++KK+ GI P L
Sbjct: 181 YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFYTPQYL 239
Query: 251 SKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDP 296
+ P V ++ + R ++ + + D PK L +
Sbjct: 240 N----PSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPED 282
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 49/208 (23%), Positives = 97/208 (46%), Gaps = 25/208 (12%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLK 84
+Y+ +G+G++ V+K + G VA + D R E+ +LK LK
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR---EIRMLKQLK 60
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHY 143
H N++ V R ++++ E + ++ +++ V +K+ Q L+ +++
Sbjct: 61 HPNLVNLLE--VFRRKRRLHLVFE-YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----AP 198
H HN IHRD+K +NI + + +K+ D G A ++ P+ E +P
Sbjct: 118 CHKHN--CIHRDVKPENILIT-KHSVIKLCDFGFARLLTGPSDYY---DDEVATRWYRSP 171
Query: 199 ELY--EEEYNELVDIYSFGMCIL-EMVT 223
EL + +Y VD+++ G C+ E+++
Sbjct: 172 ELLVGDTQYGPPVDVWAIG-CVFAELLS 198
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 63/226 (27%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 30 DEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
++LG GAF TVYKG E I VA + SP + + E +++ S+ +
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVA---IKELREATSPKANKEILDEAYVMASVDN 76
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYL 144
++ + T+ +IT+L G L Y ++HK N+ + + NW QI +G++YL
Sbjct: 77 PHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG-TP-EFMAPE- 199
++HRDL N+ V VKI D GLA + ++ + G P ++MA E
Sbjct: 134 EDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 200 LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+ Y D++S+G+ + E++T PY+ ++I + G
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKG 235
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 8e-30
Identities = 51/211 (24%), Positives = 88/211 (41%), Gaps = 21/211 (9%)
Query: 27 GRY--DEILGKGAFKTVYKGFDE-VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
G+Y + G +Y D V+G V + + +E L +
Sbjct: 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVV---LKGLVHSGDAEAQAMAMAERQFLAEV 136
Query: 84 KHENIIKFYNSWVDDTNRTINMIT----ELFTSGSLRQYRKKHKNVDMKAIKNWARQILR 139
H +I++ +N +V+ T+R + + E SL++ + + V +AI + +IL
Sbjct: 137 VHPSIVQIFN-FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVA-EAI-AYLLEILP 193
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE 199
L YLHS +++ DLK +NI + ++K+ DLG + + GTP F APE
Sbjct: 194 ALSYLHSIG--LVYNDLKPENIMLTE--EQLKLIDLGAVSRINSFGY--LYGTPGFQAPE 247
Query: 200 LYEEEYNELVDIYSFGMCIL-EMVTCEYPYN 229
+ DIY+ G L + N
Sbjct: 248 IVRTGPTVATDIYTVG-RTLAALTLDLPTRN 277
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 75/350 (21%), Positives = 125/350 (35%), Gaps = 79/350 (22%)
Query: 4 GSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV 63
GS + + + + R+ + + + G+G F TV G ++ G+ VA I+ V
Sbjct: 3 GSMMSLNAAAAADERSRKEMDRF-QVERMAGQGTFGTVQLGKEKSTGMSVA-----IKKV 56
Query: 64 MQSPDQLERLYSEVHLLKSLKHENIIK----FYNSWVDDTNRT-INMITELFTS---GSL 115
+Q P R + L L H NI++ FY D +N++ E
Sbjct: 57 IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCC 116
Query: 116 RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175
R Y ++ IK + Q++R + LH + + HRD+K N+ VN +G +K+ D
Sbjct: 117 RNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176
Query: 176 GLAIVMQQPTARSVIGTPEFM----------APELY--EEEYNELVDIYSFGMCIL-EMV 222
G A+ + + E APEL + Y VDI+S G CI EM+
Sbjct: 177 GS--------AKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVG-CIFAEMM 226
Query: 223 TCE--YPYNECKN------------PAQIYKKVTSG--------IKPASLSKV------- 253
E + + ++ +K+ K S V
Sbjct: 227 LGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLK 286
Query: 254 TDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 301
+ + + P R+ E L P+ D L P
Sbjct: 287 DAKEAYDLLSALLQYLP-EERMKPYEALCHPYF----------DELHDPA 325
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 49/209 (23%), Positives = 101/209 (48%), Gaps = 24/209 (11%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK- 84
Y + LG+G + V++ + + +V + P + +++ E+ +L++L+
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRG 89
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
NII + D +RT ++ E + +Q + + D I+ + +IL+ L Y
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYC 146
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGTPEFMAPE-- 199
HS I+HRD+K N+ ++ + ++++ D GLA Q+ R + + F PE
Sbjct: 147 HSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR--VASRYFKGPELL 202
Query: 200 LYEEEYNELVDIYSFGMCIL-EMVTCEYP 227
+ + Y+ +D++S G C+L M+ + P
Sbjct: 203 VDYQMYDYSLDMWSLG-CMLASMIFRKEP 230
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 76/328 (23%), Positives = 130/328 (39%), Gaps = 59/328 (17%)
Query: 18 SEKDPSCRY-GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERL 73
++ + +Y+ ++G+G++ V K ++ G VA + D + R
Sbjct: 15 GTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR- 73
Query: 74 YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKN 132
E+ LLK L+HEN++ V + ++ E F ++ + N +D + ++
Sbjct: 74 --EIKLLKQLRHENLVNLLE--VCKKKKRWYLVFE-FVDHTILDDLELFPNGLDYQVVQK 128
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 192
+ QI+ G+ + HSHN IIHRD+K +NI V+ +G VK+ D G A + P
Sbjct: 129 YLFQIINGIGFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVY---D 182
Query: 193 PEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVTCEYPY---------------- 228
E APEL + +Y + VD+++ G C++ EM E P
Sbjct: 183 DEVATRWYRAPELLVGDVKYGKAVDVWAIG-CLVTEMFMGE-PLFPGDSDIDQLYHIMMC 240
Query: 229 ----NE------CKNPAQIYKKVTSGIKPASLSKV---TDPQVKQFIEKCIV--PASLRL 273
KNP ++ + L + V +KC+ P R
Sbjct: 241 LGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDK-RP 299
Query: 274 PALELLKDPFLVTDNPKDLVCDPLRLPN 301
ELL F D + L+L
Sbjct: 300 FCAELLHHDFFQMDGFAERFSQELQLKV 327
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 46/241 (19%), Positives = 96/241 (39%), Gaps = 41/241 (17%)
Query: 28 RYDEILGKGAFKTVYKG-------FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
++E LG+G F ++KG + ++ EV ++ + E + ++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA----HRNYSESFFEAASMM 66
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILR 139
L H++++ Y V ++ E GSL Y KK+KN +++ A+Q+
Sbjct: 67 SKLSHKHLVLNYG--VCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAA 124
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVN-------GNNGEVKIGDLGLAIVMQQPTARSVIGT 192
+H+L + +IH ++ NI + GN +K+ D G+ + +V+
Sbjct: 125 AMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI--------SITVLPK 174
Query: 193 PEF------MAPE--LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTS 243
+ PE + N D +SFG + E+ + + P + + + +
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRKLQFYED 233
Query: 244 G 244
Sbjct: 234 R 234
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 52/226 (23%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 30 DEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
++LG G F TV+KG E I V + + + + + + + SL H
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVC---IKVIEDKSGRQSFQAVTDHMLAIGSLDH 74
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYL 144
+I++ ++ ++T+ GSL + ++H+ + + + NW QI +G++YL
Sbjct: 75 AHIVRLLGLC---PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTP-EFMAPE- 199
H ++HR+L N+ + + +V++ D G+A ++ S TP ++MA E
Sbjct: 132 EEHG--MVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 200 LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
++ +Y D++S+G+ + E++T PY + A++ + G
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-AEVPDLLEKG 233
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 51/228 (22%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 30 DEILGKGAFKTVYKGF--DEVDGIEVAWNQVNI----EDVMQSPDQLERLYSEVHLLKSL 83
D+ LG G F TV KG+ + VA + + P + L +E ++++ L
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVA-----VKILKNEAN-DPALKDELLAEANVMQQL 75
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 143
+ I++ + + ++ E+ G L +Y +++++V K I Q+ G+ Y
Sbjct: 76 DNPYIVRMIG--IC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 132
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT--P-EFMAP 198
L N +HRDL N+ + KI D GL+ + + ++ P ++ AP
Sbjct: 133 LEESN--FVHRDLAARNVLL-VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 189
Query: 199 E-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
E + +++ D++SFG+ + E + + PY K ++ + G
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAMLEKG 236
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 67/276 (24%), Positives = 110/276 (39%), Gaps = 33/276 (11%)
Query: 27 GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNI--EDVMQSPDQLERLYSEVHLLKS 82
RY EILG G V+ D D +VA V + D+ + P R E +
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDHRDVA---VKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 83 LKHENIIKFYNSWVDDTNRT----INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 138
L H I+ Y++ +T I M E +LR + K
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLPYIVM--EYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-----SVIGTP 193
+ L++ H + IIHRD+K NI + VK+ D G+A + +VIGT
Sbjct: 127 QALNFSHQNG--IIHRDVKPANIMI-SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 194 EFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI-YKKVTSGIKPASLS 251
++++PE + + D+YS G + E++T E P+ +P + Y+ V P S
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF-TGDSPVSVAYQHVREDPIPPS-- 240
Query: 252 KVTDPQVKQFIEKCIVPASLRLP------ALELLKD 281
+ ++ ++ A + P A E+ D
Sbjct: 241 -ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 68/316 (21%), Positives = 120/316 (37%), Gaps = 77/316 (24%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY + LG G V+ D VA ++ + D + E+ +++ L H
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSV----KHALREIKIIRRLDH 67
Query: 86 ENIIKFYN------------SWVDDTNRTINMITEL--------FTSGSLRQYRKKHKNV 125
+NI+K + ++ ++ E G L ++H
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLL---EEH--- 121
Query: 126 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185
+ + Q+LRGL Y+HS N ++HRDLK N+F+N + +KIGD GLA +M
Sbjct: 122 ----ARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175
Query: 186 ARSVIGTPE-----FMAPE--LYEEEYNELVDIYSFGMCIL-EMVT-------------- 223
+ + + +P L Y + +D+++ G CI EM+T
Sbjct: 176 SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG-CIFAEMLTGKTLFAGAHELEQM 234
Query: 224 ----------CEYPYNECKNPAQIYKKVTSGIKPASLSKV---TDPQVKQFIEKCIV--P 268
E E + +Y + L+++ + F+E+ + P
Sbjct: 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP 294
Query: 269 ASLRLPALELLKDPFL 284
RL A E L P++
Sbjct: 295 MD-RLTAEEALSHPYM 309
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 73/380 (19%), Positives = 137/380 (36%), Gaps = 107/380 (28%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ LG G+F V + FD G A ++ V+Q P E+ ++K L H NIIK
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFA-----LKKVLQDP---RYKNRELDIMKVLDHVNIIK 64
Query: 91 ----FYNSWVDDTNRT--------------------------------INMITELFTS-- 112
FY + ++ +N+I E
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124
Query: 113 -GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 171
L+ + + +++ M I + Q+ R + ++HS I HRD+K N+ VN + +K
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLK 182
Query: 172 IGDLGLAIVMQQPTARSVIGTPEFM----------APELY--EEEYNELVDIYSFGMCIL 219
+ D G A+ +I + E APEL EY +D++S G C+
Sbjct: 183 LCDFGS--------AKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG-CVF 232
Query: 220 -EMVTCE--YPYNECKN------------PAQIYKKVTSG--------IKPASLSKV--- 253
E++ + + + + ++ +K K+
Sbjct: 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPE 292
Query: 254 -TDPQVKQFIEKCIV--PASLRLPALELLKDPFLVT-DNPKDL-VCDPLRLPNL----VP 304
T +E+ + P LR+ E + PF N + V + P+ +P
Sbjct: 293 GTPSLAIDLLEQILRYEP-DLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIP 351
Query: 305 EVMNLAHSEPHPMDIDLNHK 324
++ N + E + ++ ++
Sbjct: 352 QLFNFSPYELSIIPGNVLNR 371
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 69/212 (32%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS----EVHLLKSLK-- 84
+G GA+ TVYK D G VA V + L EV LL+ L+
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVP---NGGGGGGGLPISTVREVALLRRLEAF 71
Query: 85 -HENIIKFYN---SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA--IKNWARQIL 138
H N+++ + + D + ++ E LR Y K + A IK+ RQ L
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 130
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-- 196
RGL +LH++ I+HRDLK +NI V + G VK+ D GLA + A TP +
Sbjct: 131 RGLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMAL----TPVVVTL 183
Query: 197 ---APE-LYEEEYNELVDIYSFGMCIL-EMVT 223
APE L + Y VD++S G CI EM
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVG-CIFAEMFR 214
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 57/224 (25%), Positives = 105/224 (46%), Gaps = 19/224 (8%)
Query: 30 DEILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
+ ILG+G F VY+G + + I VA +D D E+ SE ++K+L H
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCT--LDNKEKFMSEAVIMKNLDHP 73
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLH 145
+I+K + +I EL+ G L Y + ++ + + ++ QI + + YL
Sbjct: 74 HIVKLIG--II-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT--P-EFMAPE-LY 201
S N +HRD+ NI V + VK+GD GL+ ++ T P ++M+PE +
Sbjct: 131 SIN--CVHRDIAVRNILV-ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN 187
Query: 202 EEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+ D++ F +C+ E+++ + P+ +N + + G
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKG 230
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 63/216 (29%), Positives = 92/216 (42%), Gaps = 29/216 (13%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
+ +LG+GA+ V + G VA ++ P R E+ +LK KH
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKILKHFKH 68
Query: 86 ENIIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
ENII +N D+ N +I EL + L + D I+ + Q LR +
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDH-IQYFIYQTLRAVK 126
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFM---- 196
LH N +IHRDLK N+ +N N ++K+ D GLA I G M
Sbjct: 127 VLHGSN--VIHRDLKPSNLLINS-NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 197 ------APE--LYEEEYNELVDIYSFGMCIL-EMVT 223
APE L +Y+ +D++S G CIL E+
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCG-CILAELFL 218
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 19/223 (8%)
Query: 31 EILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
+G+G F V++G + VA E+ E ++ H +
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTS--DSVREKFLQEALTMRQFDHPH 77
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHS 146
I+K V T + +I EL T G LR + + K ++D+ ++ +A Q+ L YL S
Sbjct: 78 IVKLIG--V-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 134
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT--P-EFMAPE-LYE 202
+HRD+ N+ V+ N+ VK+GD GL+ M+ T P ++MAPE +
Sbjct: 135 KR--FVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 191
Query: 203 EEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+ D++ FG+C+ E++ P+ KN + ++ +G
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENG 233
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ LG G F V G + +VA + E M + + E + L H ++K
Sbjct: 14 KELGSGQFGVVKLGKWK-GQYDVAVKMIK-EGSMSEDEFFQ----EAQTMMKLSHPKLVK 67
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
FY V I ++TE ++G L Y R K ++ + + G+ +L SH
Sbjct: 68 FYG--VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ- 124
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF----MAPE-LYEEE 204
IHRDL N V+ + VK+ D G+ + S +GT +F APE + +
Sbjct: 125 -FIHRDLAARNCLVDRDL-CVKVSDFGMTRYVLDDQYVSSVGT-KFPVKWSAPEVFHYFK 181
Query: 205 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
Y+ D+++FG+ + E+ + + PY+ N +++ KV+ G
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMPYDLYTN-SEVVLKVSQG 221
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-28
Identities = 55/237 (23%), Positives = 98/237 (41%), Gaps = 44/237 (18%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY+ ++G G++ V + +D+++ VA + I V + +R+ E+ +L L H
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKK--ILRVFEDLIDCKRILREIAILNRLNH 111
Query: 86 ENIIKFYN---SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
++++K + + + ++ E+ S ++ + + IK +L G+
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVK 170
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-------------------IVMQQ 183
Y+HS I+HRDLK N VN + VK+ D GLA M
Sbjct: 171 YVHSAG--ILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 184 PTARSVIGTPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVTCEYP 227
T + APE L +E Y E +D++S G CI E++
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG-CIFAELLNMIKE 283
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-28
Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 18/221 (8%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
LG G + VY+G + + VA + ED M+ +E E ++K +KH N+++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAV-KTLKEDTME----VEEFLKEAAVMKEIKHPNLVQ 280
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHN 148
V +ITE T G+L Y ++ + V + A QI + YL N
Sbjct: 281 LLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPE-LYEEE 204
IHR+L N V G N VK+ D GL+ +M TA + P ++ APE L +
Sbjct: 339 --FIHRNLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 205 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
++ D+++FG+ + E+ T PY +Q+Y+ +
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKD 435
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 20/222 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
LG G + VY+G + + VA + ED M+ E E ++K +KH N+++
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEV----EEFLKEAAVMKEIKHPNLVQ 73
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHN 148
V +ITE T G+L Y ++ + V + A QI + YL N
Sbjct: 74 LLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF----MAPE-LYEE 203
IHRDL N V N+ VK+ D GL+ +M T + G +F APE L
Sbjct: 132 --FIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGA-KFPIKWTAPESLAYN 187
Query: 204 EYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+++ D+++FG+ + E+ T PY +Q+Y+ +
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKD 228
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 68/228 (29%), Positives = 105/228 (46%), Gaps = 38/228 (16%)
Query: 19 EKDPSCRY-GRYD--EILGKGAFKTVYKGFDE-VDGIEVAWNQVNIEDVMQSPDQLERLY 74
EKD CR +Y+ +G+GA+ V+K D G VA +V ++ E +
Sbjct: 2 EKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT------GEEGMP 55
Query: 75 S----EVHLLKSLK---HENIIKFYN---SWVDDTNRTINMITELFTSGSLRQYRKKHKN 124
EV +L+ L+ H N+++ ++ D + ++ E L Y K
Sbjct: 56 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPE 114
Query: 125 V--DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182
+ IK+ Q+LRGL +LHSH ++HRDLK NI V ++G++K+ D GLA +
Sbjct: 115 PGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYS 171
Query: 183 QPTARSVIGTPEFM-----APE-LYEEEYNELVDIYSFGMCIL-EMVT 223
A T + APE L + Y VD++S G CI EM
Sbjct: 172 FQMAL----TSVVVTLWYRAPEVLLQSSYATPVDLWSVG-CIFAEMFR 214
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 63/319 (19%), Positives = 119/319 (37%), Gaps = 61/319 (19%)
Query: 1 MDCGSGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVA------ 54
M + + + Y + G++ V G D +GI VA
Sbjct: 2 MQAKGEAAMRDLIAELHAMQS---PY-TVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFN 56
Query: 55 -WNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYN---SWVDDTNRTINMITELF 110
+ +++ +R+ E+ LL H NI+ + + + + ++TEL
Sbjct: 57 TVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM 116
Query: 111 TSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169
+ L Q + + + I+ + IL GLH LH ++HRDL NI + NN +
Sbjct: 117 RT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNN-D 172
Query: 170 VKIGDLGLAIVMQQPTARSVIGTPEFM----------APE--LYEEEYNELVDIYSFGMC 217
+ I D L AR APE + + + +LVD++S G C
Sbjct: 173 ITICDFNL--------ARE-DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAG-C 222
Query: 218 IL-EMVTCE--YPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCI----- 266
++ EM + + + N Q+ K+ + K + + P + ++ +
Sbjct: 223 VMAEMFNRKALFRGSTFYN--QL-NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPA 279
Query: 267 VPASLRLP-----ALELLK 280
+ +P AL+L+
Sbjct: 280 RAWTAVVPTADPVALDLIA 298
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 8e-28
Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 20/221 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ +G G F V+ G+ + +VA + E M D +E E ++ L H +++
Sbjct: 14 QEIGSGQFGLVHLGYWL-NKDKVAIKTIR-EGAMSEEDFIE----EAEVMMKLSHPKLVQ 67
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNP 149
Y V I ++TE G L Y + + + + + G+ YL
Sbjct: 68 LYG--VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 124
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF----MAPE-LYEEE 204
+IHRDL N V G N +K+ D G+ + S GT +F +PE
Sbjct: 125 -VIHRDLAARNCLV-GENQVIKVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEVFSFSR 181
Query: 205 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
Y+ D++SFG+ + E+ + + PY N +++ + +++G
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTG 221
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
Y +G GA+ +V D+ G +VA + + QS +R Y E+ LLK ++H
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKK--LSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 86 ENIIKFYN----SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
EN+I + + ++ + L++ + I+ Q+L+GL
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG--LKFSEEKIQYLVYQMLKGL 139
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-- 199
Y+HS ++HRDLK N+ VN + E+KI D GLA V+ T + APE
Sbjct: 140 KYIHSAG--VVHRDLKPGNLAVNE-DCELKILDFGLARHADAEMTGYVV-TRWYRAPEVI 195
Query: 200 LYEEEYNELVDIYSFGMCIL-EMVT 223
L YN+ VDI+S G CI+ EM+T
Sbjct: 196 LSWMHYNQTVDIWSVG-CIMAEMLT 219
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 28/222 (12%)
Query: 22 PSCRY-GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEV 77
P C +Y+ +G+G F V+K G +VA +V +E+ + P R E+
Sbjct: 11 PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EI 67
Query: 78 HLLKSLKHENIIKFY------NSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAI 130
+L+ LKHEN++ S + +I ++ + F L + I
Sbjct: 68 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFD-FCEHDLAGLLSNVLVKFTLSEI 126
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
K + +L GL+Y+H + I+HRD+K N+ + +G +K+ D GLA
Sbjct: 127 KRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPN 183
Query: 191 G-TPE-----FMAPELY--EEEYNELVDIYSFGMCIL-EMVT 223
T + PEL E +Y +D++ G CI+ EM T
Sbjct: 184 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG-CIMAEMWT 224
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 69/284 (24%), Positives = 128/284 (45%), Gaps = 20/284 (7%)
Query: 1 MDCGSGFTKSETEEGEFSEKDPSCR-YGRYD----EILGKGAFKTVYKGFDEVDGIEVAW 55
MD + + + ++ P R D +ILG+G+F TV + E A
Sbjct: 1 MDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAI 60
Query: 56 NQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL 115
+ +++ +++ + E ++ L H +K Y ++ DD + +G L
Sbjct: 61 KILEKRHIIKE-NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK--LYFGLSYAKNGEL 117
Query: 116 RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175
+Y +K + D + + +I+ L YLH IIHRDLK +NI +N + ++I D
Sbjct: 118 LKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDF 174
Query: 176 GLA----IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNE 230
G A +Q A S +GT ++++PE L E+ + D+++ G I ++V P+
Sbjct: 175 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-R 233
Query: 231 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRL 273
N I++K+ + P+ + +EK +V A+ RL
Sbjct: 234 AGNEYLIFQKIIKL--EYDFPEKFFPKARDLVEKLLVLDATKRL 275
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 20/221 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ LG G F V G +VA + E M + +E E ++ +L HE +++
Sbjct: 30 KELGTGQFGVVKYGKWR-GQYDVAIKMIK-EGSMSEDEFIE----EAKVMMNLSHEKLVQ 83
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
Y V R I +ITE +G L Y R+ + + + + + YL S
Sbjct: 84 LYG--VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ- 140
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF----MAPE-LYEEE 204
+HRDL N VN VK+ D GL+ + S +G+ +F PE L +
Sbjct: 141 -FLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSSVGS-KFPVRWSPPEVLMYSK 197
Query: 205 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
++ DI++FG+ + E+ + + PY N ++ + + G
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEHIAQG 237
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 54/228 (23%), Positives = 98/228 (42%), Gaps = 39/228 (17%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
Y ++G+G++ VY +D+ VA + + + + +R+ E+ +L LK
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKK--VNRMFEDLIDCKRILREITILNRLKS 84
Query: 86 ENIIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
+ II+ Y+ + D + ++ E+ S L++ K + + IK +L G +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--------------IVMQQPTARS 188
++H IIHRDLK N +N + VK+ D GLA + +
Sbjct: 144 FIHESG--IIHRDLKPANCLLN-QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 189 VIGTPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVT 223
+ + APE L +E Y + +DI+S G CI E++
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG-CIFAELLN 247
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY + +G+GA+ V +D ++ + VA +++ + +R E+ +L +H
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRH 84
Query: 86 ENIIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
ENII + T + ++ +L + L + K + I + QILRGL
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDH-ICYFLYQILRGLK 142
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-----FMA 197
Y+HS N ++HRDLK N+ +N ++KI D GLA V + T + A
Sbjct: 143 YIHSAN--VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 198 PE--LYEEEYNELVDIYSFGMCIL-EMVT 223
PE L + Y + +DI+S G CIL EM++
Sbjct: 200 PEIMLNSKGYTKSIDIWSVG-CILAEMLS 227
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-27
Identities = 57/224 (25%), Positives = 100/224 (44%), Gaps = 19/224 (8%)
Query: 30 DEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
+G+G F V++G + VA S E+ E ++ H
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHP 451
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLH 145
+I+K T + +I EL T G LR + + K +D+ ++ +A Q+ L YL
Sbjct: 452 HIVKLIGVI---TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT--P-EFMAPE-LY 201
S +HRD+ N+ V+ N+ VK+GD GL+ M+ T P ++MAPE +
Sbjct: 509 SKR--FVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 565
Query: 202 EEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+ D++ FG+C+ E++ P+ KN + ++ +G
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENG 608
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 55/238 (23%), Positives = 99/238 (41%), Gaps = 20/238 (8%)
Query: 19 EKDPSCRYGRYDEILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
PS ++E++G+G F VY G ++ I A V + + ++ + +
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA---VKSLNRITDIGEVSQFLT 75
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWA 134
E ++K H N++ + + ++ G LR + R + N +K + +
Sbjct: 76 EGIIMKDFSHPNVLSLLGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 134
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 194
Q+ +G+ YL S +HRDL N ++ VK+ D GLA M SV
Sbjct: 135 LQVAKGMKYLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTG 191
Query: 195 F------MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244
MA E L +++ D++SFG+ + E++T PY + I + G
Sbjct: 192 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQG 248
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 55/267 (20%), Positives = 97/267 (36%), Gaps = 30/267 (11%)
Query: 25 RYGRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNI--EDVMQSPDQLERLYSEVHLL 80
++G Y ++G+G VY+ D V VA + + E + P R+ E
Sbjct: 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVA---LKLMSETLSSDPVFRTRMQREARTA 88
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
L+ +++ ++ D ++M L L ++ + RQI
Sbjct: 89 GRLQEPHVVPIHDFGEIDGQLYVDM--RLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSA 146
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMA 197
L H+ HRD+K +NI V + + D G+A + +GT +MA
Sbjct: 147 LDAAHAAG--ATHRDVKPENILV-SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMA 203
Query: 198 PELYE-EEYNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255
PE + DIY+ C+L E +T PY + + + + I S
Sbjct: 204 PERFSESHATYRADIYALT-CVLYECLTGSPPY-QGDQLSVMGAHINQAIPRPS---TVR 258
Query: 256 PQVKQFIEKCIVPASLRLPALELLKDP 282
P + + I + K+P
Sbjct: 259 PGIPVAFDAVIARG--------MAKNP 277
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-27
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 20/221 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
LG+G F V+ G VA M E E ++K L+HE +++
Sbjct: 190 VKLGQGCFGEVWMGTWN-GTTRVAIK-TLKPGTMSP----EAFLQEAQVMKKLRHEKLVQ 243
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHN 148
Y + I ++TE + GSL + K K + + + + A QI G+ Y+ N
Sbjct: 244 LYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPE-LYEEE 204
+HRDL+ NI V N K+ D GLA +++ TAR P ++ APE
Sbjct: 301 --YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 205 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+ D++SFG+ + E+ T PY N ++ +V G
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERG 397
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 52/229 (22%), Positives = 93/229 (40%), Gaps = 20/229 (8%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
D ++GKG F VY G I+ A ++ + Q+E E L++ L
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS---RITEMQQVEAFLREGLLMRGLN 80
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHY 143
H N++ + +++ G L Q+ R +N +K + ++ Q+ RG+ Y
Sbjct: 81 HPNVLALIGI-MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY 139
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEF----MA 197
L +HRDL N ++ + VK+ D GLA I+ ++ + A
Sbjct: 140 LAEQK--FVHRDLAARNCMLDESF-TVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196
Query: 198 PE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
E L + D++SFG+ + E++T PY + + G
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFLAQG 244
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 1e-26
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 20/221 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
LG+G F V+ G VA M E E ++K L+HE +++
Sbjct: 273 VKLGQGCFGEVWMGTWN-GTTRVAIK-TLKPGTMSP----EAFLQEAQVMKKLRHEKLVQ 326
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHN 148
Y + I ++TE + GSL + K K + + + + A QI G+ Y+ N
Sbjct: 327 LYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 383
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPE-LYEEE 204
+HRDL+ NI V N K+ D GLA +++ TAR P ++ APE
Sbjct: 384 --YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440
Query: 205 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+ D++SFG+ + E+ T PY N ++ +V G
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERG 480
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 20/226 (8%)
Query: 30 DEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
++I+G G V G V G + VA + + + L SE ++ H
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK-AGYT-ERQRRDFL-SEASIMGQFDHP 110
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLH 145
NII+ V R ++TE +GSL + + H + + R + G+ YL
Sbjct: 111 NIIRLEG--VVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT--P-EFMAPE- 199
+HRDL N+ V+ N K+ D GL+ + A + G P + APE
Sbjct: 169 DLG--YVHRDLAARNVLVDSNL-VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 200 LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+ ++ D++SFG+ + E++ E PY N + V G
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-RDVISSVEEG 270
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 46/225 (20%), Positives = 94/225 (41%), Gaps = 20/225 (8%)
Query: 30 DEILGKGAFKTVYKGF--DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
D LG G F +V +G I+VA + + E + E ++ L +
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPY 71
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHS 146
I++ V + ++ E+ G L ++ K + + + + Q+ G+ YL
Sbjct: 72 IVRLIG--VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 128
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT--P-EFMAPE-L 200
N +HRDL N+ + + KI D GL+ + + P ++ APE +
Sbjct: 129 KN--FVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185
Query: 201 YEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+++ D++S+G+ + E ++ + PY + K ++ + G
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQG 229
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 51/245 (20%), Positives = 96/245 (39%), Gaps = 43/245 (17%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI----EDVMQSPDQLERLYSEVHLLKSL 83
+LGKG F +V + ++ + ++ +V + D++ + +E E +K
Sbjct: 26 TLGRMLGKGEFGSVREA--QLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEF 82
Query: 84 KHENIIKFY----NSWVDDTNRTINMITELFTSGSLRQYRKKHK------NVDMKAIKNW 133
H ++ K S +I G L + + N+ ++ + +
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
I G+ YL S N IHRDL N + + V + D GL+ R +
Sbjct: 143 MVDIACGMEYLSSRN--FIHRDLAARNCMLAEDM-TVCVADFGLS--------RKIYSGD 191
Query: 194 EF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYK 239
+ +A E L + Y D+++FG+ + E++T + PY +N A+IY
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-AEIYN 250
Query: 240 KVTSG 244
+ G
Sbjct: 251 YLIGG 255
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 72/215 (33%), Positives = 104/215 (48%), Gaps = 38/215 (17%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY + +G GA+ +V FD G+ VA + QS +R Y E+ LLK +KH
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 86 ENIIKFYN----SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
EN+I + + + + ++T L + L K + + ++ QILRGL
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNI-VKCQKLTDDHVQFLIYQILRGL 145
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM----- 196
Y+HS + IIHRDLK N+ VN + E+KI D GL AR T + M
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGL--------ARH---TADEMTGYVA 191
Query: 197 -----APE--LYEEEYNELVDIYSFGMCIL-EMVT 223
APE L YN+ VDI+S G CI+ E++T
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVG-CIMAELLT 225
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 21/227 (9%)
Query: 30 DEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
+++G G F VYKG + VA + +++ L E ++ H
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYT-EKQRVDFL-GEAGIMGQFSH 105
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYL 144
NII+ V + + +ITE +G+L ++ ++ + + R I G+ YL
Sbjct: 106 HNIIRLEG--VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGT--P-EFMAPE 199
+ N +HRDL NI VN N K+ D GL+ V++ + G P + APE
Sbjct: 164 ANMN--YVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220
Query: 200 -LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+ ++ D++SFG+ + E++T E PY E N ++ K + G
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDG 266
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 57/233 (24%), Positives = 96/233 (41%), Gaps = 53/233 (22%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK- 84
+Y+ + LGKGA+ V+K D G VA + I D Q+ +R + E+ +L L
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKK--IFDAFQNSTDAQRTFREIMILTELSG 67
Query: 85 HENIIKFYNSWVDDTNRTINMITEL--------FTSGSLRQYRKKHKNVDMKAIKNWARQ 136
HENI+ N D +R + ++ + + L H + Q
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANIL---EPVH-------KQYVVYQ 117
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-------------IVMQQ 183
+++ + YLHS ++HRD+K NI +N VK+ D GL+ +
Sbjct: 118 LIKVIKYLHSGG--LLHRDMKPSNILLNA-ECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 184 PTARSVIGTPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVT 223
+ + APE L +Y + +D++S G CIL E++
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG-CILGEILC 226
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY + +G GA V +D + VA + + Q+ +R Y E+ L+K + H
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKK--LSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 86 ENIIKFYNSWVDDTNRT----INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
+NII N + + + ++ EL + +L Q + +D + + Q+L G+
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGI 140
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-----FM 196
+LHS IIHRDLK NI V ++ +KI D GLA + S + TP +
Sbjct: 141 KHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 193
Query: 197 APE-LYEEEYNELVDIYSFGMCIL-EMVT 223
APE + Y E VDI+S G CI+ EM+
Sbjct: 194 APEVILGMGYKENVDIWSVG-CIMGEMIK 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 18/205 (8%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
Y ++ +G GA+ V D G +VA + + QS +R Y E+ LLK ++H
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKK--LYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 86 ENIIKFYNSWVDDTNRT----INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
EN+I + + D ++ + L + KH+ + I+ Q+L+GL
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKL-MKHEKLGEDRIQFLVYQMLKGL 141
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-- 199
Y+H+ IIHRDLK N+ VN + E+KI D GLA V+ T + APE
Sbjct: 142 RYIHAAG--IIHRDLKPGNLAVNE-DCELKILDFGLARQADSEMTGYVV-TRWYRAPEVI 197
Query: 200 LYEEEYNELVDIYSFGMCIL-EMVT 223
L Y + VDI+S G CI+ EM+T
Sbjct: 198 LNWMRYTQTVDIWSVG-CIMAEMIT 221
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 49/219 (22%), Positives = 95/219 (43%), Gaps = 20/219 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ +GKG F V G + G +VA + D + +E ++ L+H N+++
Sbjct: 27 QTIGKGEFGDVMLG--DYRGNKVAVKCIK-NDATA-----QAFLAEASVMTQLRHSNLVQ 78
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHN 148
+ + + ++TE GSL Y + + + ++ + + YL +N
Sbjct: 79 LLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 137
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-EFMAPE-LYEEEYN 206
+HRDL N+ V+ +N K+ D GL + P ++ APE L E++++
Sbjct: 138 --FVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALREKKFS 192
Query: 207 ELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
D++SFG+ + E+ + PY + +V G
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKG 230
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 54/238 (22%), Positives = 100/238 (42%), Gaps = 20/238 (8%)
Query: 19 EKDPSCRYGRYDEILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYS 75
PS ++E++G+G F VY G ++ I A V + + ++ + +
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA---VKSLNRITDIGEVSQFLT 139
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWA 134
E ++K H N++ + + ++ G LR + R + N +K + +
Sbjct: 140 EGIIMKDFSHPNVLSLLGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 198
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 194
Q+ +G+ +L S +HRDL N ++ VK+ D GLA M SV
Sbjct: 199 LQVAKGMKFLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTG 255
Query: 195 ------FMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244
+MA E L +++ D++SFG+ + E++T PY + I + G
Sbjct: 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQG 312
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 63/239 (26%), Positives = 120/239 (50%), Gaps = 15/239 (6%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
LG G+F V + G A ++ + V++ Q+E +E +L+++ ++K
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
S+ D++N + M+ E G + + ++ + +A QI+ YLHS + +I
Sbjct: 108 FSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LI 163
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
+RDLK +N+ ++ G +++ D G A ++ T ++ GTPE +APE + + YN+ VD
Sbjct: 164 YRDLKPENLLID-QQGYIQVTDFGFAKRVKGRT-WTLCGTPEALAPEIILSKGYNKAVDW 221
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASLSKVTDPQVKQFIEKCIVP 268
++ G+ I EM P+ P QIY+K+ SG ++ P+ S +K + +
Sbjct: 222 WALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKVRFPSHFS----SDLKDLLRNLLQV 275
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 52/279 (18%), Positives = 107/279 (38%), Gaps = 47/279 (16%)
Query: 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL- 83
Y ++LG G V + F++ + A ++D + EV L
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM--LQDC-------PKARREVELHWRAS 68
Query: 84 KHENIIKFYNSWVD--DTNRTINMITELFTSGSL--RQYRKKHKNVDMKAIKNWARQILR 139
+ +I++ + + + + + ++ E G L R + + + + I
Sbjct: 69 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 140 GLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMA 197
+ YLHS N I HRD+K +N+ + + N +K+ D G A
Sbjct: 129 AIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF-------------------A 167
Query: 198 PELYEEEYNELVDIYSFGMCILEMVTCEYP----YNECKNPAQIYKKVTSGI---KPASL 250
E E+Y++ D++S G I+ ++ C YP + + ++ G
Sbjct: 168 KETTGEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226
Query: 251 SKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 288
S+V++ +VK I + + R+ E + P+++
Sbjct: 227 SEVSE-EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 50/243 (20%), Positives = 102/243 (41%), Gaps = 40/243 (16%)
Query: 28 RYDEILGKGAFKTVYKGF---DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
+ILG+G F +V +G ++ ++VA + +++ S ++E SE +K
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS--SQREIEEFLSEAACMKDFS 94
Query: 85 HENIIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHK------NVDMKAIKNWAR 135
H N+I+ ++ +++ I +I G L Y + ++ ++ + +
Sbjct: 95 HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
I G+ YL + N +HRDL N + + V + D GL ++ + +
Sbjct: 155 DIALGMEYLSNRN--FLHRDLAARNCMLRDDM-TVCVADFGL--------SKKIYSGDYY 203
Query: 196 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKV 241
+A E L + Y D+++FG+ + E+ T PY +N ++Y +
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-HEMYDYL 262
Query: 242 TSG 244
G
Sbjct: 263 LHG 265
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 20/226 (8%)
Query: 30 DEILGKGAFKTVYKG---FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE 86
D+++G G F V G I VA + + + L E ++ H
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYT-EKQRRDFL-GEASIMGQFDHP 106
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLH 145
NII+ V ++ + ++TE +GSL + +KH + + R I G+ YL
Sbjct: 107 NIIRLEG--VVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGT--P-EFMAPE- 199
+HRDL NI +N N K+ D GL V++ A + G P + +PE
Sbjct: 165 DMG--YVHRDLAARNILINSNL-VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 200 LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+ ++ D++S+G+ + E+++ E PY E N + K V G
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEG 266
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 20/221 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ LG G F V+ +VA M L E +++K+L+H+ ++K
Sbjct: 194 KKLGAGQFGEVWMATYN-KHTKVAVK-TMKPGSMSVEAFLA----EANVMKTLQHDKLVK 247
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHN 148
+ T I +ITE GSL + K + + + +++ QI G+ ++ N
Sbjct: 248 LHAVV---TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPE-LYEEE 204
IHRDL+ NI V+ + KI D GLA V++ TAR P ++ APE +
Sbjct: 305 --YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 361
Query: 205 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244
+ D++SFG+ ++E+VT PY NP ++ + + G
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRALERG 401
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 2e-25
Identities = 45/225 (20%), Positives = 94/225 (41%), Gaps = 20/225 (8%)
Query: 30 DEILGKGAFKTVYKGFDEVDG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
D LG G F +V +G + I+VA + + E + E ++ L +
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPY 397
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHS 146
I++ + ++ E+ G L ++ + + + + Q+ G+ YL
Sbjct: 398 IVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 454
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT--P-EFMAPE-L 200
N +HR+L N+ + N KI D GL+ + + P ++ APE +
Sbjct: 455 KN--FVHRNLAARNVLL-VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 511
Query: 201 YEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+++ D++S+G+ + E ++ + PY + K P ++ + G
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIEQG 555
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 51/228 (22%), Positives = 116/228 (50%), Gaps = 20/228 (8%)
Query: 68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 127
+++ ++ E+ +++ L+H ++ + S+ D+ + + M+ +L G LR + +++ +
Sbjct: 57 NEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED--MFMVVDLLLGGDLRYHLQQNVHFKE 114
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-A 186
+ +K + +++ L YL + IIHRD+K DNI ++ +G V I D +A ++ + T
Sbjct: 115 ETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQI 171
Query: 187 RSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPY--NECKNPAQIYKK 240
++ GT +MAPE++ Y+ VD +S G+ E++ PY + +I
Sbjct: 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT 231
Query: 241 VTSGIK--PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKD-PFL 284
+ + P++ S ++ ++K + P R L +++ P++
Sbjct: 232 FETTVVTYPSAWS----QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E LG G F V+ G+ +VA + + M L E +L+K L+H+ +++
Sbjct: 19 ERLGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLA----EANLMKQLQHQRLVR 72
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHN 148
Y T I +ITE +GSL + K + + + + A QI G+ ++ N
Sbjct: 73 LYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPE-LYEEE 204
IHRDL+ NI V+ KI D GLA +++ TAR P ++ APE +
Sbjct: 130 --YIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 205 YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+ D++SFG+ + E+VT PY NP ++ + + G
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERG 226
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 4e-25
Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 36/214 (16%)
Query: 28 RYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
RY + +G GA V +D V VA + + Q+ +R Y E+ L+K + H
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKK--LSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 86 ENIIKFYN----SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
+NII N + + + ++ EL + +L Q + +D + + Q+L G+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGI 177
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM----- 196
+LHS IIHRDLK NI V + +KI D GL AR+ GT M
Sbjct: 178 KHLHSAG--IIHRDLKPSNIVVKSDC-TLKILDFGL--------ART-AGTSFMMTPYVV 225
Query: 197 -----APE-LYEEEYNELVDIYSFGMCIL-EMVT 223
APE + Y E VDI+S G CI+ EMV
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVG-CIMGEMVR 258
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 57/243 (23%), Positives = 94/243 (38%), Gaps = 40/243 (16%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----------SPDQLERLYSEV 77
LG+G+F VY+G VA V E + S + +E
Sbjct: 28 TMSRELGQGSFGMVYEG--------VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 79
Query: 78 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY----------RKKHKNVDM 127
++K ++++ V + +I EL T G L+ Y +
Sbjct: 80 SVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187
+ A +I G+ YL+++ +HRDL N V + VKIGD G+ + +
Sbjct: 138 SKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYY 194
Query: 188 SVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKV 241
G M+PE L + + D++SFG+ + E+ T E PY N Q+ + V
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-EQVLRFV 253
Query: 242 TSG 244
G
Sbjct: 254 MEG 256
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 61/256 (23%), Positives = 101/256 (39%), Gaps = 61/256 (23%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ---------SPDQLERLYSEVH 78
LG+GAF V+ +N +D M + + E
Sbjct: 18 VLKRELGEGAFGKVFLA--------ECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAE 69
Query: 79 LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---------------- 122
LL +L+HE+I+KFY V + M+ E G L ++ + H
Sbjct: 70 LLTNLQHEHIVKFYG--VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127
Query: 123 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182
+ + + + A QI G+ YL S + +HRDL N V N VKIGD G+
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANL-LVKIGDFGM----- 179
Query: 183 QPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPY 228
+R V T + M PE + ++ D++SFG+ + E+ T + P+
Sbjct: 180 ---SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 236
Query: 229 NECKNPAQIYKKVTSG 244
+ N ++ + +T G
Sbjct: 237 FQLSN-TEVIECITQG 251
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 56/237 (23%), Positives = 96/237 (40%), Gaps = 28/237 (11%)
Query: 28 RYDEILGKGAFKTVYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
LG GAF VY+G ++ ++VA + + S E ++
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISK 89
Query: 83 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-------KNVDMKAIKNWAR 135
H+NI++ V + ++ EL G L+ + ++ ++ M + + AR
Sbjct: 90 FNHQNIVRCIG--VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
I G YL ++ IHRD+ N + G KIGD G+A + + + G
Sbjct: 148 DIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 205
Query: 194 EF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244
M PE E + D +SFG+ + E+ + PY N ++ + VTSG
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSG 261
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 56/254 (22%), Positives = 102/254 (40%), Gaps = 53/254 (20%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI------EDVMQSPDQLERLYSEVHLLK 81
+ + LG+GAF V + + GI+ + E S + L SE+ +L
Sbjct: 30 KLGKPLGRGAFGQVIEA--DAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILI 85
Query: 82 SL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KN 124
+ H N++ + + +I E G+L Y +
Sbjct: 86 HIGHHLNVVNLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184
+ ++ + ++ Q+ +G+ +L S IHRDL NI ++ N VKI D GL
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKN-VVKICDFGL------- 194
Query: 185 TARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNE 230
AR + P++ MAPE +++ Y D++SFG+ + E+ + PY
Sbjct: 195 -ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253
Query: 231 CKNPAQIYKKVTSG 244
K + +++ G
Sbjct: 254 VKIDEEFCRRLKEG 267
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 49/225 (21%), Positives = 95/225 (42%), Gaps = 32/225 (14%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ +GKG F V G + G +VA + D + +E ++ L+H N+++
Sbjct: 199 QTIGKGEFGDVMLG--DYRGNKVAVKCIK-NDATA-----QAFLAEASVMTQLRHSNLVQ 250
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHN 148
+ + + ++TE GSL Y + + + ++ + + YL +N
Sbjct: 251 LLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 309
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-------FMAPE-L 200
+HRDL N+ V+ +N K+ D GL + T + + APE L
Sbjct: 310 --FVHRDLAARNVLVSEDN-VAKVSDFGL--------TKEASSTQDTGKLPVKWTAPEAL 358
Query: 201 YEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
E++++ D++SFG+ + E+ + PY + +V G
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKG 402
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 56/247 (22%), Positives = 95/247 (38%), Gaps = 44/247 (17%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ---------SPDQLERLYSEVH 78
LG+GAF V+ N + +D M S + E
Sbjct: 44 VLKWELGEGAFGKVFLA--------ECHNLLPEQDKMLVAVKALKEASESARQDFQREAE 95
Query: 79 LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---------------K 123
LL L+H++I++F+ V R + M+ E G L ++ + H
Sbjct: 96 LLTMLQHQHIVRFFG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
+ + + A Q+ G+ YL + +HRDL N V VKIGD G++ +
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYS 210
Query: 184 PTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 237
V G M PE + ++ D++SFG+ + E+ T + P+ + N +
Sbjct: 211 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-TEA 269
Query: 238 YKKVTSG 244
+T G
Sbjct: 270 IDCITQG 276
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 54/244 (22%), Positives = 94/244 (38%), Gaps = 36/244 (14%)
Query: 28 RYDEILGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
R+ E LG+ F VYKG VA + + E E L
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAE--GPLREEFRHEAMLRAR 68
Query: 83 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVD 126
L+H N++ V ++ ++MI + G L ++ ++
Sbjct: 69 LQHPNVVCLLG--VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 127 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 186
+ QI G+ YL SH+ ++H+DL N+ V VKI DLGL +
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKL-NVKISDLGLFREVYAADY 183
Query: 187 RSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKK 240
++G MAPE + +++ DI+S+G+ + E+ + PY N + +
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVVEM 242
Query: 241 VTSG 244
+ +
Sbjct: 243 IRNR 246
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 56/237 (23%), Positives = 96/237 (40%), Gaps = 28/237 (11%)
Query: 28 RYDEILGKGAFKTVYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
LG GAF VY+G ++ ++VA + + S E ++
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISK 130
Query: 83 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-------NVDMKAIKNWAR 135
H+NI++ V + ++ EL G L+ + ++ + ++ M + + AR
Sbjct: 131 FNHQNIVRCIG--VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
I G YL ++ IHRD+ N + G KIGD G+A + + G
Sbjct: 189 DIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCA 246
Query: 194 EF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244
M PE E + D +SFG+ + E+ + PY N ++ + VTSG
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSG 302
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 56/260 (21%), Positives = 97/260 (37%), Gaps = 64/260 (24%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----------SPDQLERLYSEV 77
+ + LG GAF V + A+ + + M + E L SE+
Sbjct: 26 SFGKTLGAGAFGKVVEA--------TAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 77
Query: 78 HLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-------------- 122
+L L H NI+ +ITE G L + ++
Sbjct: 78 KVLSYLGNHMNIVNLLG--ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 123 ----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178
+D++ + +++ Q+ +G+ +L S N IHRDL NI + + KI D GL
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILL-THGRITKICDFGL- 191
Query: 179 IVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC- 224
AR + + MAPE ++ Y D++S+G+ + E+ +
Sbjct: 192 -------ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244
Query: 225 EYPYNECKNPAQIYKKVTSG 244
PY ++ YK + G
Sbjct: 245 SSPYPGMPVDSKFYKMIKEG 264
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 59/256 (23%), Positives = 104/256 (40%), Gaps = 60/256 (23%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----------SPDQLERLYSEV 77
++ + LG GAF V + A+ + V++ D+ E L SE+
Sbjct: 49 QFGKTLGAGAFGKVVEA--------TAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSEL 100
Query: 78 HLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKN--- 132
++ L +HENI+ + +ITE G L + R+K + ++
Sbjct: 101 KIMSHLGQHENIVNLLG--ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 133 ----------WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182
++ Q+ +G+ +L S N IHRD+ N+ + N KIGD GL
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLL-TNGHVAKIGDFGL----- 210
Query: 183 QPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPY 228
AR ++ + MAPE +++ Y D++S+G+ + E+ + PY
Sbjct: 211 ---ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267
Query: 229 NECKNPAQIYKKVTSG 244
++ YK V G
Sbjct: 268 PGILVNSKFYKLVKDG 283
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 54/277 (19%), Positives = 117/277 (42%), Gaps = 32/277 (11%)
Query: 16 EFSEKDPSCRYGRYD----EILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSP 67
+ K R D +++G+GAF V K +V +++ ++ ++++
Sbjct: 56 DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL----LSKFEMIKR- 110
Query: 68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 127
+ E ++ +++ + ++ DD + M+ E G L + V
Sbjct: 111 SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY--LYMVMEYMPGGDLVNLMSNYD-VPE 167
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--- 184
K + + +++ L +HS IHRD+K DN+ ++ +G +K+ D G + M +
Sbjct: 168 KWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMV 224
Query: 185 TARSVIGTPEFMAPEL-----YEEEYNELVDIYSFGMCILEMVTCEYP-YNECKNPAQIY 238
+ +GTP++++PE+ + Y D +S G+ + EM+ + P Y + + Y
Sbjct: 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--SLVGTY 282
Query: 239 KKVTSGIKPASLSKVTD--PQVKQFIEKCIVPASLRL 273
K+ + + D + K I + +RL
Sbjct: 283 SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRL 319
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 99.1 bits (248), Expect = 5e-23
Identities = 67/241 (27%), Positives = 115/241 (47%), Gaps = 19/241 (7%)
Query: 33 LGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
LG G+F V+ + ++V + E V++ Q+E E +L + H I
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKV----LKKEIVVRL-KQVEHTNDERLMLSIVTHPFI 68
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
I+ + ++ D I MI + G L +K + K +A ++ L YLHS +
Sbjct: 69 IRMWGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 126
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNE 207
II+RDLK +NI ++ NG +KI D G A + T ++ GTP+++APE + + YN+
Sbjct: 127 --IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDVT-YTLCGTPDYIAPEVVSTKPYNK 182
Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 267
+D +SFG+ I EM+ P+ N + Y+K+ + + VK + + I
Sbjct: 183 SIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLIT 239
Query: 268 P 268
Sbjct: 240 R 240
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 49/265 (18%), Positives = 85/265 (32%), Gaps = 70/265 (26%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----------SPDQLERLYSEV 77
Y +G+GAF V++ A + E S D E
Sbjct: 50 EYVRDIGEGAFGRVFQA--------RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREA 101
Query: 78 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--------------- 122
L+ + NI+K + + ++ E G L ++ +
Sbjct: 102 ALMAEFDNPNIVKLLGVCAVG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 159
Query: 123 ---------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173
+ ARQ+ G+ YL +HRDL N V N VKI
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENM-VVKIA 216
Query: 174 DLGLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILE 220
D GL+ R++ + M PE ++ Y D++++G+ + E
Sbjct: 217 DFGLS--------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 268
Query: 221 MVT-CEYPYNECKNPAQIYKKVTSG 244
+ + PY + ++ V G
Sbjct: 269 IFSYGLQPYYGMAH-EEVIYYVRDG 292
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 60/261 (22%), Positives = 103/261 (39%), Gaps = 62/261 (23%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI------EDVMQSPDQLERLYSEVHLLK 81
+ LG+G F V K ++ + E+ S +L L SE ++LK
Sbjct: 26 VLGKTLGEGEFGKVVKA--TAFHLKGRAGYTTVAVKMLKENASPS--ELRDLLSEFNVLK 81
Query: 82 SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH------------------- 122
+ H ++IK Y + + +I E GSLR + ++
Sbjct: 82 QVNHPHVIKLYG--ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 123 -----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177
+ + M + ++A QI +G+ YL ++HRDL NI V ++KI D GL
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGR-KMKISDFGL 196
Query: 178 AIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC 224
+R V + MA E L++ Y D++SFG+ + E+VT
Sbjct: 197 --------SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248
Query: 225 -EYPYNECKNPAQIYKKVTSG 244
PY +++ + +G
Sbjct: 249 GGNPYPGIPP-ERLFNLLKTG 268
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 58/247 (23%), Positives = 105/247 (42%), Gaps = 26/247 (10%)
Query: 32 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
+LG+G F V+ K ++ + + + + E +L +
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKR-----KGYQGAMVEKKILAKVHSRF 246
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHY 143
I+ ++ +T + ++ + G + + + + QI+ GL +
Sbjct: 247 IVSLAYAF--ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-L 200
LH N II+RDLK +N+ ++ ++G V+I DLGLA + Q + GTP FMAPE L
Sbjct: 305 LHQRN--IIYRDLKPENVLLD-DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 201 YEEEYNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
EEY+ VD ++ G+ + EM+ P+ E ++ ++V + P
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ--AVTYPDKFSPA 419
Query: 258 VKQFIEK 264
K F E
Sbjct: 420 SKDFCEA 426
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 60/261 (22%), Positives = 96/261 (36%), Gaps = 61/261 (23%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI------EDVMQSPDQLERLYSEVHLLK 81
+ ++LG GAF V GI + + E S + E L SE+ ++
Sbjct: 48 EFGKVLGSGAFGKVMNA--TAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMMT 103
Query: 82 SL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKN-------- 132
L HENI+ + I +I E G L Y + + +
Sbjct: 104 QLGSHENIVNLLGACTLS--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 133 ---------------WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177
+A Q+ +G+ +L + +HRDL N+ V VKI D GL
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGK-VVKICDFGL 218
Query: 178 AIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC 224
AR ++ + MAPE L+E Y D++S+G+ + E+ +
Sbjct: 219 --------ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270
Query: 225 -EYPYNECKNPAQIYKKVTSG 244
PY A YK + +G
Sbjct: 271 GVNPYPGIPVDANFYKLIQNG 291
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 65/256 (25%), Positives = 105/256 (41%), Gaps = 57/256 (22%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI--------EDVMQSPDQLERLYSEVHL 79
+ LG+GAF V E GI+ + + +D + L L SE+ +
Sbjct: 38 TLGKPLGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEM 93
Query: 80 LKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---------------- 122
+K + KH+NII + + +I E + G+LR+Y +
Sbjct: 94 MKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 123 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182
+ + K + + Q+ RG+ YL S IHRDL N+ V NN +KI D GL
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGL----- 203
Query: 183 QPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPY 228
AR + + MAPE L++ Y D++SFG+ + E+ T PY
Sbjct: 204 ---ARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 229 NECKNPAQIYKKVTSG 244
+++K + G
Sbjct: 261 PGIPV-EELFKLLKEG 275
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 6e-22
Identities = 64/311 (20%), Positives = 125/311 (40%), Gaps = 61/311 (19%)
Query: 2 DCGSGFTKSETEEGEFSEKD-------PSCRYGRYD----EILGKGAFKTVY----KGFD 46
+C + + E E+ E R R D +++G+GAF V K D
Sbjct: 40 ECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNAD 99
Query: 47 EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106
+V +++ + M + E +L + + I + ++ DD N + ++
Sbjct: 100 KVFAMKIL-----NKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN--LYLV 152
Query: 107 T------ELFTSGSLRQYRKKHKNVDMKAIKNWAR----QILRGLHYLHSHNPPIIHRDL 156
+L T L ++ + AR +++ + +H + +HRD+
Sbjct: 153 MDYYVGGDLLTL--LSKFEDRLPE-------EMARFYLAEMVIAIDSVHQLH--YVHRDI 201
Query: 157 KCDNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGTPEFMAPELYEEE------YNE 207
K DNI ++ NG +++ D G + + +GTP++++PE+ + Y
Sbjct: 202 KPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGP 260
Query: 208 LVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIK----PASLSKVTDPQVKQFI 262
D +S G+C+ EM+ E P Y E + + Y K+ + + P ++ V K I
Sbjct: 261 ECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKERFQFPTQVTDV-SENAKDLI 317
Query: 263 EKCIVPASLRL 273
+ I RL
Sbjct: 318 RRLICSREHRL 328
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-22
Identities = 64/256 (25%), Positives = 104/256 (40%), Gaps = 57/256 (22%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNI--------EDVMQSPDQLERLYSEVHL 79
+ LG+G F V E GI+ + + +D + L L SE+ +
Sbjct: 84 TLGKPLGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEM 139
Query: 80 LKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---------------- 122
+K + KH+NII + + +I E + G+LR+Y +
Sbjct: 140 MKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 123 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182
+ + K + + Q+ RG+ YL S IHRDL N+ V NN +KI D GLA
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLA---- 250
Query: 183 QPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPY 228
R + + MAPE L++ Y D++SFG+ + E+ T PY
Sbjct: 251 ----RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306
Query: 229 NECKNPAQIYKKVTSG 244
+++K + G
Sbjct: 307 PGIPV-EELFKLLKEG 321
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 8e-22
Identities = 41/170 (24%), Positives = 82/170 (48%), Gaps = 9/170 (5%)
Query: 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158
T ++ I +L G L + +H ++ +A +I+ GL ++H+ +++RDLK
Sbjct: 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKP 320
Query: 159 DNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGM 216
NI ++ +G V+I DLGLA + + +GT +MAPE Y+ D +S G
Sbjct: 321 ANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGC 379
Query: 217 CILEMVTCEYPY--NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
+ +++ P+ ++ K+ +I + + L P+++ +E
Sbjct: 380 MLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AVELPDSFSPELRSLLEG 427
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 34/227 (14%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
ILG+G F VYKG DG VA ++ E Q + +EV ++ H N
Sbjct: 33 SNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQ---TEVEMISMAVHRN 88
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW-ARQ-----ILRGL 141
+++ + T R + + +GS+ + + + +W RQ RGL
Sbjct: 89 LLRLRGFCMTPTERLL--VYPYMANGSVASCL--RERPESQPPLDWPKRQRIALGSARGL 144
Query: 142 HYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEF 195
YLH H +P IIHRD+K NI ++ E +GD GLA +M + V GT
Sbjct: 145 AYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLM--DYKDTHVTTAVRGTIGH 201
Query: 196 MAPELYEEEY------NELVDIYSFGMCILEMVTCEYPYNECKNPAQ 236
+AP EY +E D++ +G+ +LE++T + ++ +
Sbjct: 202 IAP-----EYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 63/254 (24%), Positives = 102/254 (40%), Gaps = 53/254 (20%)
Query: 28 RYDEILGKGAFKTVYKG--FDEVDGIEVAWNQVNI----EDVMQSPDQLERLYSEVHLLK 81
+ LG+GAF V +V + D + L L SE+ ++K
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMK 129
Query: 82 SL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KN 124
+ KH+NII + + +I E + G+LR+Y + +
Sbjct: 130 MIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184
+ K + + A Q+ RG+ YL S IHRDL N+ V +N +KI D GLA
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLA------ 238
Query: 185 TARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNE 230
R + + MAPE L++ Y D++SFG+ + E+ T PY
Sbjct: 239 --RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296
Query: 231 CKNPAQIYKKVTSG 244
+++K + G
Sbjct: 297 VPV-EELFKLLKEG 309
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 28/219 (12%)
Query: 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER-LYS 75
F E+ S +G+G F VYKG+ V+ VA ++ + + +L++
Sbjct: 27 FDERPIS----VGGNKMGEGGFGVVYKGY--VNNTTVAVKKLAAMVDITTE-ELKQQFDQ 79
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNVD----MK 128
E+ ++ +HEN+++ D + ++ +GSL + K
Sbjct: 80 EIKVMAKCQHENLVELLGFSSDGDDLC--LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTA 186
+ A G+++LH IHRD+K NI ++ KI D GLA T
Sbjct: 138 IAQGAAN----GINFLH--ENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTV 190
Query: 187 RS--VIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVT 223
+ ++GT +MAPE E DIYSFG+ +LE++T
Sbjct: 191 MTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIIT 229
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 52/302 (17%), Positives = 118/302 (39%), Gaps = 41/302 (13%)
Query: 2 DCGSGFTKSETEEGEFSEK-------DPSCRYGRYD----EILGKGAFKTVY----KGFD 46
+ G+ + +F + R R D +++G+GAF V K
Sbjct: 27 ELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTG 86
Query: 47 EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106
+V +++ + M ++ E +L + I + + ++ D+ + ++
Sbjct: 87 QVYAMKIM-----NKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY--LYLV 139
Query: 107 TELFTSGSL-RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 165
E + G L K + + + + + +I+ + +H +HRD+K DNI ++
Sbjct: 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLD- 196
Query: 166 NNGEVKIGDLGLA---IVMQQPTARSVIGTPEFMAPEL--------YEEEYNELVDIYSF 214
G +++ D G + +GTP++++PE+ Y D ++
Sbjct: 197 RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWAL 256
Query: 215 GMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSKVTDPQVKQFIEKCIVPASL 271
G+ EM + P+ + A+ Y K+ + + + + + FI++ + P
Sbjct: 257 GVFAYEMFYGQTPF-YADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPET 315
Query: 272 RL 273
RL
Sbjct: 316 RL 317
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 38/124 (30%), Positives = 69/124 (55%), Gaps = 9/124 (7%)
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 191
A +I L YLHS N I++RDLK +NI ++ + G + + D GL + T + G
Sbjct: 145 AAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNSTTSTFCG 201
Query: 192 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PA 248
TPE++APE L+++ Y+ VD + G + EM+ P+ +N A++Y + + ++
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILNKPLQLKP 260
Query: 249 SLSK 252
+++
Sbjct: 261 NITN 264
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 2e-20
Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 14/228 (6%)
Query: 33 LGKGAFKTVY---KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
LGKG + V+ K G A + ++++ +E ++L+ +KH I+
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
++ T + +I E + G L ++ + +I L +LH
Sbjct: 85 DLIYAF--QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG- 141
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEYN 206
II+RDLK +NI +N + G VK+ D GL + + GT E+MAPE L +N
Sbjct: 142 -IIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHN 199
Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASLSK 252
VD +S G + +M+T P+ +N + K+ + P L++
Sbjct: 200 RAVDWWSLGALMYDMLTGAPPF-TGENRKKTIDKILKCKLNLPPYLTQ 246
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 2e-20
Identities = 52/244 (21%), Positives = 103/244 (42%), Gaps = 23/244 (9%)
Query: 32 ILGKGAFKTVY----KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
+LGKG F V + ++ + + + +E +L+ +
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR-----KGEAMALNEKQILEKVNSRF 245
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQ--YRKKHKNVDMKAIKNWARQILRGLHYLH 145
++ ++ +T + ++ L G L+ Y +A +I GL LH
Sbjct: 246 VVSLAYAY--ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPE-LYEE 203
I++RDLK +NI ++ ++G ++I DLGLA+ + + T + +GT +MAPE + E
Sbjct: 304 RER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE 360
Query: 204 EYNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
Y D ++ G + EM+ + P+ + ++ + V P S+ PQ +
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--VPEEYSERFSPQARS 418
Query: 261 FIEK 264
+
Sbjct: 419 LCSQ 422
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 56/239 (23%), Positives = 98/239 (41%), Gaps = 31/239 (12%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-K 84
++ +++G+G F V K + DG ++ A ++ E + E+ +L L
Sbjct: 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKD--DHRDFAGELEVLCKLGH 84
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW----------- 133
H NII + + + E G+L + +K + ++
Sbjct: 85 HPNIINLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 134 -----ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
A + RG+ YL IHRDL NI V N KI D GL+ + ++
Sbjct: 143 QLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKT 199
Query: 189 VIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+ P +MA E L Y D++S+G+ + E+V+ PY A++Y+K+ G
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKLPQG 257
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 56/223 (25%), Positives = 95/223 (42%), Gaps = 31/223 (13%)
Query: 27 GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY LG G F TV+ D V+ VA ++ V E E+ LL+ +
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVA-----MKIVRGDKVYTEAAEDEIKLLQRVN 73
Query: 85 -----------HENIIKFYNS--WVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKA 129
+I+K + + M+ E+ +L KK+++ +
Sbjct: 74 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEV-LGENLLALIKKYEHRGIPLIY 132
Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV-----NGNNGEVKIGDLGLAIVMQQP 184
+K ++Q+L GL Y+H IIH D+K +N+ + N ++KI DLG A +
Sbjct: 133 VKQISKQLLLGLDYMHRRC-GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE- 190
Query: 185 TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEY 226
+ I T E+ +PE L + DI+S I E++T ++
Sbjct: 191 HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 33/208 (15%)
Query: 32 ILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER-LYSEVHLLKSLKHENIIK 90
++G G F VYKG DG +VA + E Q +E+ L +H +++
Sbjct: 46 LIGHGVFGKVYKGVLR-DGAKVALKRRTPESS-----QGIEEFETEIETLSFCRHPHLVS 99
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQ--YRKKHKNVDMKAIKNWAR--QIL----RGLH 142
+ + I + +G+L++ Y + M +W + +I RGLH
Sbjct: 100 LIGFCDERNEMIL--IYKYMENGNLKRHLYGSDLPTMSM----SWEQRLEICIGAARGLH 153
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP------TARSVIGTPEFM 196
YLH IIHRD+K NI ++ N KI D G++ + T V GT ++
Sbjct: 154 YLH--TRAIIHRDVKSINILLDENF-VPKITDFGISKKGTELDQTHLSTV--VKGTLGYI 208
Query: 197 APELYEEEY-NELVDIYSFGMCILEMVT 223
PE + + E D+YSFG+ + E++
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLC 236
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 6e-20
Identities = 64/276 (23%), Positives = 123/276 (44%), Gaps = 27/276 (9%)
Query: 2 DCGSGFTKSETEEGEFSEKDPSCRYGRYD----EILGKGAFKTVY----KGFDEVDGIEV 53
GS S EE E S P R + ++LGKG F V K +++
Sbjct: 121 RSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI 180
Query: 54 AWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSG 113
+V + D++ +E +L++ +H + S+ T+ + + E G
Sbjct: 181 LKKEVIVAK-----DEVAHTLTENRVLQNSRHPFLTALKYSF--QTHDRLCFVMEYANGG 233
Query: 114 SLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173
L + + + + + +I+ L YLHS +++RDLK +N+ ++ + G +KI
Sbjct: 234 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLDKD-GHIKIT 291
Query: 174 DLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNE 230
D GL + T ++ GTPE++APE L + +Y VD + G+ + EM+ P+
Sbjct: 292 DFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-Y 350
Query: 231 CKNPAQIYKKVTSG-IK-PASLSKVTDPQVKQFIEK 264
++ ++++ + I+ P +L P+ K +
Sbjct: 351 NQDHEKLFELILMEEIRFPRTLG----PEAKSLLSG 382
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-20
Identities = 53/229 (23%), Positives = 110/229 (48%), Gaps = 20/229 (8%)
Query: 33 LGKGAFKTV----YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88
LGKG F V K +++ +V I D++ +E +L++ +H +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-----DEVAHTVTESRVLQNTRHPFL 67
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
++ T+ + + E G L + + + + + + +I+ L YLHS +
Sbjct: 68 TALKYAF--QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEY 205
+++RD+K +N+ ++ +G +KI D GL + T ++ GTPE++APE L + +Y
Sbjct: 126 --VVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASLSK 252
VD + G+ + EM+ P+ ++ ++++ + I+ P +LS
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIRFPRTLSP 230
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 7e-20
Identities = 38/122 (31%), Positives = 63/122 (51%), Gaps = 9/122 (7%)
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 193
++ L +LHS II+RDLK +NI ++ G +K+ D GL+ + + A S GT
Sbjct: 134 ELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 194 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 250
E+MAPE + + + D +SFG+ + EM+T P+ + K+ + + P L
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKETMTMILKAKLGMPQFL 249
Query: 251 SK 252
S
Sbjct: 250 SP 251
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 9e-20
Identities = 36/128 (28%), Positives = 67/128 (52%), Gaps = 14/128 (10%)
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGT 192
+I+ L +LH II+RD+K +NI ++ +NG V + D GL+ + + A GT
Sbjct: 167 EIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGT 223
Query: 193 PEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSG-I 245
E+MAP++ +++ VD +S G+ + E++T P+ E + A+I +++
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 283
Query: 246 K-PASLSK 252
P +S
Sbjct: 284 PYPQEMSA 291
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 30/262 (11%), Positives = 63/262 (24%), Gaps = 50/262 (19%)
Query: 27 GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
GRY G ++ D +VA V+ + D L+ S L +
Sbjct: 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVD-PQGVLPDDVLQETLSRTLRLSRID 89
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
+ + + + E GSL++ + + +
Sbjct: 90 KPGVARVLDVVHTRAGGLVVA--EWIRGGSLQEVADTSPSPVGAI--RAMQSLAAAADAA 145
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE 204
H + + V +G+V + M +
Sbjct: 146 HRAG--VALSIDHPSRVRV-SIDGDVVLAYPA---TMPDANPQD---------------- 183
Query: 205 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQI---YKKVTSGIKPASLSKVTDPQVKQF 261
DI G + ++ +P E + + + + D
Sbjct: 184 -----DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA---DIDRD---- 231
Query: 262 IEKCIVPASLRLPALELL-KDP 282
+P + A + D
Sbjct: 232 -----IPFQISAVAARSVQGDG 248
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 33/110 (30%), Positives = 57/110 (51%), Gaps = 6/110 (5%)
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 191
+ +I L+YLH II+RDLK DN+ ++ G +K+ D G+ + T + G
Sbjct: 116 SAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCG 172
Query: 192 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240
TP ++APE L E+Y VD ++ G+ + EM+ P++ + +
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 13/154 (8%)
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 193
+I+ GL +LHS I++RDLK DNI ++ +G +KI D G+ ++ + GTP
Sbjct: 126 EIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTP 182
Query: 194 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 250
+++APE L ++YN VD +SFG+ + EM+ + P+ ++ +++ + P L
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWL 241
Query: 251 SKVTDPQVKQFIEKCIVPASLRLPALELLKD-PF 283
K + + + RL ++ P
Sbjct: 242 EKEAKDLLVKLFVRE---PEKRLGVRGDIRQHPL 272
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 27 GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY +++GKG+F V K +D VA ++ V + E+ +L+ L+
Sbjct: 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVA-----LKMVRNEKRFHRQAAEEIRILEHLR 151
Query: 85 HE------NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKAIKNWARQ 136
+ N+I N M EL S +L + KK+K + ++ +A
Sbjct: 152 KQDKDNTMNVIHMLE-NFTFRNHIC-MTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
IL+ L LH + IIH DLK +NI +K+ D G + Q + I + +
Sbjct: 209 ILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY-TYIQSRFY 265
Query: 196 MAPE-LYEEEYNELVDIYSFGMCIL-EMVT 223
APE + Y +D++S G CIL E++T
Sbjct: 266 RAPEVILGARYGMPIDMWSLG-CILAELLT 294
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 36/122 (29%), Positives = 64/122 (52%), Gaps = 9/122 (7%)
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 193
+I+ L +LH II+RDLK DN+ ++ G K+ D G+ + T + GTP
Sbjct: 132 EIISALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICNGVTTATFCGTP 188
Query: 194 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 250
+++APE L E Y VD ++ G+ + EM+ P+ E +N +++ + + + P L
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWL 247
Query: 251 SK 252
+
Sbjct: 248 HE 249
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 9e-19
Identities = 38/122 (31%), Positives = 71/122 (58%), Gaps = 9/122 (7%)
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 193
+I GL +L S II+RDLK DN+ ++ + G +KI D G+ + T ++ GTP
Sbjct: 129 EIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKTFCGTP 185
Query: 194 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 250
+++APE + + Y + VD ++FG+ + EM+ + P+ E ++ ++++ + P S+
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSM 244
Query: 251 SK 252
SK
Sbjct: 245 SK 246
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 33/110 (30%), Positives = 57/110 (51%), Gaps = 6/110 (5%)
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 191
+ +I L+YLH II+RDLK DN+ ++ G +K+ D G+ + T + G
Sbjct: 159 SAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCG 215
Query: 192 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240
TP ++APE L E+Y VD ++ G+ + EM+ P++ + +
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 88.2 bits (218), Expect = 3e-18
Identities = 39/124 (31%), Positives = 71/124 (57%), Gaps = 9/124 (7%)
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 191
A +I GL +L S II+RDLK DN+ ++ G +KI D G+ + T ++ G
Sbjct: 448 AAEIAIGLFFLQSKG--IIYRDLKLDNVMLDS-EGHIKIADFGMCKENIWDGVTTKTFCG 504
Query: 192 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPA 248
TP+++APE + + Y + VD ++FG+ + EM+ + P+ E ++ ++++ + P
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPK 563
Query: 249 SLSK 252
S+SK
Sbjct: 564 SMSK 567
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 7e-18
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 27 GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY+ ++GKG+F V K +D V+ VA I+ + L + EV LL+ +
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVA-----IKIIKNKKAFLNQAQIEVRLLELMN 108
Query: 85 HE------NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQ 136
I+ N ++ E+ S +L + V + + +A+Q
Sbjct: 109 KHDTEMKYYIVHLKR-HFMFRNHLC-LVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
+ L +L + IIH DLK +NI N +KI D G + + Q I + +
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY-QYIQSRFY 224
Query: 196 MAPE-LYEEEYNELVDIYSFGMCIL-EMVT 223
+PE L Y+ +D++S G CIL EM T
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLG-CILVEMHT 253
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 34/158 (21%), Positives = 67/158 (42%), Gaps = 9/158 (5%)
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
+S ++ + + + ++ + ++ Q+ +G+ +L S I
Sbjct: 158 SSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CI 215
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTP---EFMAPE-LYEEEYNE 207
HRDL NI + VKI D GLA + + P ++MAPE +++ Y
Sbjct: 216 HRDLAARNILL-SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 274
Query: 208 LVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
D++SFG+ + E+ + PY K + +++ G
Sbjct: 275 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 312
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 40/206 (19%), Positives = 72/206 (34%), Gaps = 29/206 (14%)
Query: 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--QSPDQLER--LYSEVHLLKSL-K 84
+ LG+GAF V + + GI+ + M + E L SE+ +L +
Sbjct: 27 GKPLGRGAFGQVIEA--DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
H N++ + +I E G+L Y + +N + K + +G Y+
Sbjct: 85 HLNVVNLL-GACTKPGGPLMVIVEFCKFGNLSTYLRSKRN-EFVPYKTKGARFRQGKDYV 142
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE 204
+ I DLK + + G + +S+ E APE ++
Sbjct: 143 GA-----IPVDLKRRLDSITSSQSSASSGFVE---------EKSLSDVEEEEAPEDLYKD 188
Query: 205 YNELVDIYSF------GMCILEMVTC 224
+ L + + GM L C
Sbjct: 189 FLTLEHLICYSFQVAKGMEFLASRKC 214
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 47/232 (20%), Positives = 90/232 (38%), Gaps = 47/232 (20%)
Query: 27 GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
+ +G G F V + A ++ V E +LK ++
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYA-----VKVVRNIKKYTRSAKIEADILKKIQ 89
Query: 85 HE-----NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKAIKNWARQI 137
++ NI+K++ + + +I E SL + ++ ++ IK + +I
Sbjct: 90 NDDINNNNIVKYHG-KFMYYDH-MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEI 146
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVN------------------------GNNGEVKIG 173
L+ L+YL + + H DLK +NI ++ + +K+
Sbjct: 147 LKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 174 DLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVT 223
D G A S+I T ++ APE + ++ D++SFG C+L E+ T
Sbjct: 205 DFGCATFKSD-YHGSIINTRQYRAPEVILNLGWDVSSDMWSFG-CVLAELYT 254
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 46/185 (24%), Positives = 70/185 (37%), Gaps = 26/185 (14%)
Query: 27 GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY +G G+F +Y G D G EVA + +E V QL E + K ++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVA---IKLECVKTKHPQLHI---ESKIYKMMQ 62
Query: 85 H-ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLH 142
I + M+ EL SL + +K + A Q++ +
Sbjct: 63 GGVGIPTIRWCGAEGDYNV--MVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIE 119
Query: 143 YLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQP---------TARSVIG 191
Y+HS N IHRD+K DN + V I D GLA + +++ G
Sbjct: 120 YIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 177
Query: 192 TPEFM 196
T +
Sbjct: 178 TARYA 182
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 35/193 (18%), Positives = 68/193 (35%), Gaps = 39/193 (20%)
Query: 33 LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
+G G F +Y F + A + V +E + L+SE+ + + ++ I
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVE-----YQENGPLFSELKFYQRVAKKDCI--- 96
Query: 93 NSWVDDTNRTINMITELFTSG-------------------SLRQYRKKHKNVDMKAIKNW 133
W++ I + SG L++ ++ +
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQL 156
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLA---------IVMQQ 183
++L L Y+H + +H D+K N+ + N +V + D GL+ Q+
Sbjct: 157 GIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214
Query: 184 PTARSVIGTPEFM 196
+ GT EF
Sbjct: 215 NPRKGHNGTIEFT 227
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 46/227 (20%), Positives = 89/227 (39%), Gaps = 41/227 (18%)
Query: 27 GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY LG+G F V + D G QV ++ + E E+++LK +K
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKS----QVALKIIRNVGKYREAARLEINVLKKIK 74
Query: 85 HE------NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKAIKNWARQ 136
+ + + W + + + EL + ++ K++ + +++ A Q
Sbjct: 75 EKDKENKFLCVLMSD-WFNFHGH-MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQ 131
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGN------------------NGEVKIGDLGLA 178
+ L +LH + + H DLK +NI + N +++ D G A
Sbjct: 132 LCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
Query: 179 IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVT 223
+ +++ T + PE + E + + D++S G CIL E
Sbjct: 190 TFDHE-HHTTIVATRHYRPPEVILELGWAQPCDVWSIG-CILFEYYR 234
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 66/331 (19%), Positives = 123/331 (37%), Gaps = 85/331 (25%)
Query: 27 GRYD--EILGKGAFKTVYKGFD-EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
RY+ + LG+GAF V + D + G VA ++ V E SE+ +L+ L
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVA-----VKIVKNVDRYCEAARSEIQVLEHL 68
Query: 84 KHE------NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKAIKNWAR 135
++ W + I ++ EL S + K++ + + I+ A
Sbjct: 69 NTTDPNSTFRCVQMLE-WFEHHGH-ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAY 125
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGN------------------NGEVKIGDLGL 177
QI + +++LHS+ + H DLK +NI + N ++K+ D G
Sbjct: 126 QICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 178 AIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL----------------E 220
A + +++ T + APE + +++ D++S G CIL E
Sbjct: 184 ATYDDE-HHSTLVSTRHYRAPEVILALGWSQPCDVWSIG-CILIEYYLGFTVFPTHDSKE 241
Query: 221 MVTC-------------------------EYPYNECKNPAQIYKKVTSGIKPASLSK-VT 254
+ ++E + + + +K LS+ V
Sbjct: 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVE 301
Query: 255 DPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
++ I+K + + R+ E LK PF
Sbjct: 302 HERLFDLIQKMLEYDPAKRITLREALKHPFF 332
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 71.4 bits (174), Expect = 6e-13
Identities = 107/701 (15%), Positives = 204/701 (29%), Gaps = 220/701 (31%)
Query: 16 EFSEKDPSCRYGRYDEILG--KGAFKTVYKGFD--EV-DGIEVAWNQVNIEDVMQSPDQL 70
E E + +IL + AF FD +V D + ++ I+ ++ S D +
Sbjct: 10 ETGEHQYQYK-----DILSVFEDAFV---DNFDCKDVQDMPKSILSKEEIDHIIMSKDAV 61
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTN------------RTINMITELFTSGSLRQY 118
L S K E +++ + V N R +M+T ++ R Y
Sbjct: 62 SGTLRLFWTLLS-KQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLY 120
Query: 119 R-----KKHKNV----DMKAIKNWARQILRGLHYLHSHNPPIIH---------------R 154
K+ NV ++ + LR + +I
Sbjct: 121 NDNQVFAKY-NVSRLQPYLKLRQALLE-LRPAKNV------LIDGVLGSGKTWVALDVCL 172
Query: 155 DLKCDNIFVNG----NNGEVKIGDLGLAI-------VMQQPTARSVIGTPEFMAPELYEE 203
K N + L + + T+RS + + +
Sbjct: 173 SYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQA 232
Query: 204 EYNELVDIYSFGMC--ILEMV----TCEYPYNECKNPAQI-----YKKVTSGIKPASLSK 252
E L+ + C +L V CK I +K+VT + A+ +
Sbjct: 233 ELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCK----ILLTTRFKQVTDFLSAATTTH 288
Query: 253 VT-DPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAH 311
++ D LL K L C P LP EV+
Sbjct: 289 ISLDHHSMTLTPD---------EVKSLLL---------KYLDCRPQDLP---REVLTT-- 325
Query: 312 SEPHPMDIDLNHKKVSADSCAKSNTGTW--FLTLELQRLTENNEFTLRGEKNDDDT---V 366
+P + + A+S + TW + + +LT E +L + +
Sbjct: 326 ---NPRRLSI-----IAESI-RDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFD 376
Query: 367 SLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQL--DLSHEDVVSIAELIDNLIMK 424
L VF +A I ++ + D+ DV ++ N + K
Sbjct: 377 RL---------------SVFPPSAH----IPTILLSLIWFDVIKSDV----MVVVNKLHK 413
Query: 425 --LVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSEL 482
LV ST S + L+ + +K E + + +
Sbjct: 414 YSLVEKQPKE--STISIPSIYLE---------LKVKLENEYALHRSIVD----------- 451
Query: 483 ASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSL 542
Y + D+ + D Y + + H + + ++L
Sbjct: 452 ---HYNIPKTFDSDDLIPPYL---------------DQYFYSHIGH-HLKNIEHPERMTL 492
Query: 543 GESILFNESTQNSETSFIDS---CSGMSKNLSFSSISSLS--------LADKE-HSDGL- 589
+ + F++ + N S S +++L + D + + L
Sbjct: 493 FRMVFLD-------FRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLV 545
Query: 590 --------KLELDAINSKYQQCFQELLRQREDEM--ENARK 620
K+E + I SKY + L ++ + E ++
Sbjct: 546 NAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQ 586
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 4e-05
Identities = 40/296 (13%), Positives = 84/296 (28%), Gaps = 98/296 (33%)
Query: 6 GFTKSETEE----------------------------GEFSEKDPSCRYGRYD------- 30
T E + E S +D + +
Sbjct: 297 TLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAE-SIRDGLATWDNWKHVNCDKL 355
Query: 31 --------EILGKGAFKTVYKGF----DEVDGI-----EVAWNQVNIEDVMQSPDQL--- 70
+L ++ ++ I + W V DVM ++L
Sbjct: 356 TTIIESSLNVLEPAEYRKMFDRLSVFPPSAH-IPTILLSLIWFDVIKSDVMVVVNKLHKY 414
Query: 71 --------ERLYS--EVHLLKSLK-------HENIIKFYNSW--VDDTNRTINMITELFT 111
E S ++L +K H +I+ YN D + + + F
Sbjct: 415 SLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFY 474
Query: 112 S--GS-LRQYRKKHKNVDMKAIK---NWARQILRGLHYLHSHNPPIIH--RDLKC--DNI 161
S G L+ + + + + Q +R + + I++ + LK I
Sbjct: 475 SHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYI 534
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-------FMAPE--LYEEEYNEL 208
N E + + L + + ++I + MA + ++EE + ++
Sbjct: 535 CDNDPKYERLVNAI-LDFLPK--IEENLICSKYTDLLRIALMAEDEAIFEEAHKQV 587
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 36/160 (22%), Positives = 60/160 (37%), Gaps = 19/160 (11%)
Query: 27 GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
+ + +G G F + G + VA + +E + QL E K L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVA---IKLEPMKSRAPQLHL---EYRFYKQLG 62
Query: 85 H-ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLH 142
+ I + Y M+ EL SL + +K + A Q++ +
Sbjct: 63 SGDGIPQVYYFGPCGKYNA--MVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRME 119
Query: 143 YLHSHNPPIIHRDLKCDNIFV----NGNNGEVKIGDLGLA 178
Y+HS N +I+RD+K +N + N + I D LA
Sbjct: 120 YVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 36/158 (22%), Positives = 66/158 (41%), Gaps = 17/158 (10%)
Query: 27 GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
++ +G G+F +Y G + EVA + +E+V QL E + + L+
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLLY---ESKIYRILQ 60
Query: 85 -HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLH 142
I V+ ++ +L SL + + +K + A Q++ +
Sbjct: 61 GGTGIPNVRWFGVEGDYNV--LVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
Query: 143 YLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLA 178
++HS + +HRD+K DN + +V I D GLA
Sbjct: 118 FVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 31/160 (19%), Positives = 64/160 (40%), Gaps = 19/160 (11%)
Query: 27 GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
Y +G+G+F +++G + ++ +VA + E QL E K L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVA---IKFEPRRSDAPQLRD---EYRTYKLLA 63
Query: 85 H-ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLH 142
I Y + + ++ +L SL + +K + A+Q+L +
Sbjct: 64 GCTGIPNVYYFGQEGLHNV--LVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 120
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGE----VKIGDLGLA 178
+H + +++RD+K DN + N + + + D G+
Sbjct: 121 SIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 27/194 (13%), Positives = 59/194 (30%), Gaps = 38/194 (19%)
Query: 33 LGKGAFKTVYKGFDEVDGI--------EVA----------WNQVNIEDVMQSPDQLERLY 74
+ +Y+ + + +N+ N P Q+ +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 75 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKN 132
L S I V ++ SL+ + +++
Sbjct: 110 K----LYSTPLLAIPTCMGFGVHQDKYRF-LVLPSLGR-SLQSALDVSPKHVLSERSVLQ 163
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLA---------IVMQ 182
A ++L L +LH + +H ++ +NIFV+ + +V + G A +
Sbjct: 164 VACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV 221
Query: 183 QPTARSVIGTPEFM 196
+ + G EF+
Sbjct: 222 EGSRSPHEGDLEFI 235
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 63/264 (23%), Positives = 99/264 (37%), Gaps = 71/264 (26%)
Query: 27 GRYDEI--LGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
GRY I LG G F TV+ +D VA + + V + E E+ LLKS++
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVA---MKV--VKSAEHYTETALDEIRLLKSVR 91
Query: 85 --------HENIIKFYNS-WVDDTNRT-INMITELFTSGSLRQYRKKHKN--VDMKAIKN 132
E +++ + + N T I M+ E+ L ++ K + + +K
Sbjct: 92 NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEV-LGHHLLKWIIKSNYQGLPLPCVKK 150
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFV----------------------------- 163
+Q+L+GL YLH+ IIH D+K +NI +
Sbjct: 151 IIQQVLQGLDYLHTKC-RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209
Query: 164 -------------------NGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEE 203
N +VKI DLG A + + I T ++ + E L
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-TEDIQTRQYRSLEVLIGS 268
Query: 204 EYNELVDIYSFGMCILEMVTCEYP 227
YN DI+S E+ T +Y
Sbjct: 269 GYNTPADIWSTACMAFELATGDYL 292
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.8 bits (149), Expect = 2e-10
Identities = 57/333 (17%), Positives = 96/333 (28%), Gaps = 74/333 (22%)
Query: 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIED----VMQSPDQLE 71
FS P+ + R ++I G+G F V++ D VA + IE E
Sbjct: 12 PFSHCLPTEKLQRCEKI-GEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFE 68
Query: 72 RLYSEVHLLKSL---------KHENIIKFYNSWV----------------DDTNRTINMI 106
+ E+ + K L + E I + + T + N
Sbjct: 69 EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128
Query: 107 TELFTSG-------------SLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIH 153
+ F L Q R K ++ K+ Q+ L + H
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLAT--AKSILHQLTASLAVAE-ASLRFEH 185
Query: 154 RDLKCDNIFVN----------GNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFM----A 197
RDL N+ + N I GL + + T G F
Sbjct: 186 RDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMD 245
Query: 198 PELYEEEYNELVDIYSFGMCILEMVTCEY-PYNECK-----NPAQIYKKVTSGIKPASLS 251
+L+ + + DIY EY PY+ + +
Sbjct: 246 EDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAM 305
Query: 252 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 284
K ++++F + +S A +LL L
Sbjct: 306 KQIKRKIQEFHRTMLNFSS----ATDLLCQHSL 334
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 39/200 (19%), Positives = 67/200 (33%), Gaps = 36/200 (18%)
Query: 27 GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
+ +G+G F +Y D V + + V P L++E+ +
Sbjct: 35 AAWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVE--PSDNGPLFTELKFYQRAA 91
Query: 85 HENIIKFYNSWVDDTNRTI----------------N-MITELFTSGSLRQYRKKHKNV-D 126
I+ + + MI + F S L++ + +
Sbjct: 92 KPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFS 150
Query: 127 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLA------- 178
K + + +IL L Y+H H +H D+K N+ +N N +V + D GLA
Sbjct: 151 RKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 179 --IVMQQPTARSVIGTPEFM 196
R GT EF
Sbjct: 209 VHKAYAADPKRCHDGTIEFT 228
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} Length = 98 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 7e-06
Identities = 20/73 (27%), Positives = 33/73 (45%), Gaps = 6/73 (8%)
Query: 359 EKNDDDTVSLTLRIGD----KSGHVSN--IHFVFYLNADTAISIAEEMVEQLDLSHEDVV 412
+ + + L LRI D K + N I F F L D +A+EMVE + D
Sbjct: 19 DDGEKIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESGYVCEGDHK 78
Query: 413 SIAELIDNLIMKL 425
++A+ I + + +
Sbjct: 79 TMAKAIKDRVSLI 91
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 631 | |||
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.6 | |
| 2v3s_A | 96 | Serine/threonine-protein kinase OSR1; ATP-binding, | 99.53 | |
| 2lru_A | 98 | Serine/threonine-protein kinase WNK1; autoinhibito | 99.02 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.06 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.89 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.83 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.71 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.46 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.25 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.24 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.03 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.82 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.72 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.56 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.54 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.1 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.92 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.46 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.35 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.24 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.23 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.76 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.73 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.58 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 95.55 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.45 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 94.82 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 93.92 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.72 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 87.61 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.0 |
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-62 Score=509.77 Aligned_cols=272 Identities=50% Similarity=0.929 Sum_probs=246.7
Q ss_pred CCcccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeee
Q 006779 14 EGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYN 93 (631)
Q Consensus 14 ~~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~ 93 (631)
+...+...+.|||+++.+.||+|+||+||+|.++.+|..||+|.+..... .....+++.+|+.+|++|+|||||++|+
T Consensus 15 ~~~~~~~~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~ 92 (290)
T 3fpq_A 15 ETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYD 92 (290)
T ss_dssp --CEEEECTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hhhhcCcCCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 44556678899999999999999999999999999999999999976543 4566788999999999999999999999
Q ss_pred eEEcC--CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEE
Q 006779 94 SWVDD--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 171 (631)
Q Consensus 94 ~~~d~--~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 171 (631)
+|.+. ....+|||||||.||+|.+++.+.+.+++..++.|++||+.||+|||+++++||||||||+|||+++.+|.+|
T Consensus 93 ~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vK 172 (290)
T 3fpq_A 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVK 172 (290)
T ss_dssp EEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEE
T ss_pred EEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEE
Confidence 98653 3457999999999999999999999999999999999999999999999888999999999999985689999
Q ss_pred EccccccchhcCCCCccccCCCCCCCccccccccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006779 172 IGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 251 (631)
Q Consensus 172 L~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~ 251 (631)
|+|||+|+........+.+|||.|||||++.+.|+.++|||||||++|||+||+.||.+..+..+++..+..+..|..++
T Consensus 173 l~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 252 (290)
T 3fpq_A 173 IGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 252 (290)
T ss_dssp ECCTTGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred EEeCcCCEeCCCCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCC
Confidence 99999998766666778899999999999998999999999999999999999999998888899999999988887777
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 252 ~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
...++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 253 ~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 8888999999999998 89999999999999999853
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-56 Score=471.80 Aligned_cols=258 Identities=27% Similarity=0.446 Sum_probs=228.4
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEE
Q 006779 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV 106 (631)
|++.++||+|+||+||+|+++.+|+.||+|++....... ....+.+.+|+++|+.|+|||||++|++|.+. ..+|||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~yiv 110 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLYFG 110 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEE
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEEE
Confidence 488899999999999999999999999999997654321 23457799999999999999999999999765 479999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC--
Q 006779 107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 184 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-- 184 (631)
||||.||+|.+++.+.+.+++..++.|++||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+|+.+...
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~-~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEc-CCCCEEEEEcCCceecCCCCC
Confidence 999999999999999999999999999999999999999999 99999999999998 7899999999999866422
Q ss_pred --CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006779 185 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 185 --~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~l 261 (631)
...+.+|||.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+.. .++...++++++|
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~dl 264 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEGLIFAKIIKLEY--DFPEKFFPKARDL 264 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC--CCCTTCCHHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCcccCHHHHHH
Confidence 3456799999999998865 599999999999999999999999976 577788888877643 3556678999999
Q ss_pred HHHhcC-CCCCCCCHHH------HhcCCCCCCCCCcccc
Q 006779 262 IEKCIV-PASLRLPALE------LLKDPFLVTDNPKDLV 293 (631)
Q Consensus 262 I~~cL~-~p~~Rpsa~e------lL~hpff~~~~~~~~~ 293 (631)
|.+||+ ||.+|||+.| +++||||+..+|..+.
T Consensus 265 i~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~ 303 (311)
T 4aw0_A 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 303 (311)
T ss_dssp HHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred HHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhc
Confidence 999998 9999999987 5899999999888764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-56 Score=475.87 Aligned_cols=258 Identities=29% Similarity=0.529 Sum_probs=224.8
Q ss_pred ccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC
Q 006779 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 98 (631)
..||..+| ++.+.||+|+||+||+|.++.+|+.||||++...... ..+.+.+|+.+|+.|+|||||++|++|.+.
T Consensus 69 ~~dp~~~y-~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~----~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~ 143 (346)
T 4fih_A 69 PGDPRSYL-DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ----RRELLFNEVVIMRDYQHENVVEMYNSYLVG 143 (346)
T ss_dssp SSCGGGTE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS----SGGGGHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred CCChhHhc-EEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh----HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 45677777 6668899999999999999999999999999865432 235588999999999999999999999875
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
..+|||||||.||+|.+++.+ +.+++..++.|++||+.||+|||+++ ||||||||+|||++ .+|.+||+|||+|
T Consensus 144 --~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla 217 (346)
T 4fih_A 144 --DELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFC 217 (346)
T ss_dssp --TEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTC
T ss_pred --CEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEC-CCCCEEEecCcCc
Confidence 479999999999999999976 46999999999999999999999999 99999999999998 7899999999999
Q ss_pred chhcCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCC
Q 006779 179 IVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVT 254 (631)
Q Consensus 179 ~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~-~l~~~~ 254 (631)
+.+... ...+.+|||.|||||++.+ .|+.++|||||||++|||++|+.||.+ .+..+++..+..+..+. ......
T Consensus 218 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~ 296 (346)
T 4fih_A 218 AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKV 296 (346)
T ss_dssp EECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCSCGGGS
T ss_pred eecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCCccccC
Confidence 876543 3567899999999998865 599999999999999999999999987 56777777777654432 233456
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
++++++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 297 s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 297 SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 8999999999998 999999999999999998654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-56 Score=460.67 Aligned_cols=258 Identities=26% Similarity=0.509 Sum_probs=210.8
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
.-||| ++.+.||+|+||+||+|.++.+|+.||+|+++..... ......++.+|+.+|+.|+|||||+++++|.+. .
T Consensus 11 ~ig~Y-~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~ 86 (275)
T 3hyh_A 11 HIGNY-QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA-KSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK--D 86 (275)
T ss_dssp ---CC-EEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred EeeCe-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcC-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--C
Confidence 34788 7889999999999999999999999999999765432 234456799999999999999999999998764 5
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
.+|+||||| +|+|.+++.+.+.+++..++.+++||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+|+..
T Consensus 87 ~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~~ 162 (275)
T 3hyh_A 87 EIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLD-EHLNVKIADFGLSNIM 162 (275)
T ss_dssp EEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEEC-TTCCEEECCSSCC---
T ss_pred EEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEEC-CCCCEEEeecCCCeec
Confidence 799999999 7899999999999999999999999999999999999 99999999999998 7899999999999766
Q ss_pred cCC-CCccccCCCCCCCccccccc-c-CccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006779 182 QQP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 182 ~~~-~~~~~~GTp~Y~APEvl~~~-y-s~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l 258 (631)
... ...+.+|||.|||||++.+. | +.++|||||||++|+|+||+.||.+ .+..++++.+..+.. .++...++++
T Consensus 163 ~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~ 239 (275)
T 3hyh_A 163 TDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVY--TLPKFLSPGA 239 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC--CCCTTSCHHH
T ss_pred CCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHH
Confidence 543 34567899999999988754 4 6899999999999999999999986 677788888877643 3556778999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCc
Q 006779 259 KQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 259 ~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~~ 290 (631)
++||.+||+ +|.+|||+.|+|+||||+...++
T Consensus 240 ~~li~~~L~~dP~~R~s~~eil~hpw~k~~~p~ 272 (275)
T 3hyh_A 240 AGLIKRMLIVNPLNRISIHEIMQDDWFKVDLPE 272 (275)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHCHHHHTTCCG
T ss_pred HHHHHHHccCChhHCcCHHHHHcCcccccCCCh
Confidence 999999998 89999999999999999875443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-56 Score=473.38 Aligned_cols=255 Identities=25% Similarity=0.458 Sum_probs=218.6
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
-.|| ++.+.||+|+||+||+|+++.+|+.||+|++..... .....+++.+|+.+|++|+|||||++|++|.+. ..
T Consensus 23 me~Y-~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~--~~ 97 (350)
T 4b9d_A 23 MEKY-VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM--SSKEREESRREVAVLANMKHPNIVQYRESFEEN--GS 97 (350)
T ss_dssp CCCE-EEEEEC------CEEEEEETTTCCEEEEEEEECTTS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TE
T ss_pred ccce-EEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC--CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC--CE
Confidence 3578 777999999999999999999999999999986543 456678899999999999999999999999765 47
Q ss_pred EEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 103 INMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
+|||||||.||+|.+++... ..+++..++.|++||+.||+|||+++ ||||||||+|||++ .+|.+||+|||+|+.
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~ 174 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTVQLGDFGIARV 174 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEEC-TTCCEEECSTTEESC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEEC-CCCCEEEccccccee
Confidence 99999999999999999754 45799999999999999999999999 99999999999998 789999999999986
Q ss_pred hcCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006779 181 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 181 ~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~ 257 (631)
.... ...+.+|||.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..+++..+..+..| .++...+++
T Consensus 175 ~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~-~~~~~~s~~ 252 (350)
T 4b9d_A 175 LNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-GSMKNLVLKIISGSFP-PVSLHYSYD 252 (350)
T ss_dssp CCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCC-CCCTTSCHH
T ss_pred ecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCC-CCCccCCHH
Confidence 6543 2345789999999998875 599999999999999999999999987 5677777777776544 345567899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 258 VKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 258 l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
+++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 253 ~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 253 LRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 9999999998 89999999999999999764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=479.22 Aligned_cols=258 Identities=29% Similarity=0.531 Sum_probs=225.3
Q ss_pred ccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC
Q 006779 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 98 (631)
..||..+| ++.+.||+|+||+||+|.++.+|+.||||++..... ...+.+.+|+.+|+.|+|||||++|++|.+.
T Consensus 146 ~~dp~~~y-~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~ 220 (423)
T 4fie_A 146 PGDPRSYL-DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLVG 220 (423)
T ss_dssp SSCGGGTE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC----SSGGGHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred CCChhHhc-EeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch----hHHHHHHHHHHHHHhCCCCCCCceEEEEEEC
Confidence 45777777 667889999999999999999999999999986542 2335688999999999999999999999875
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
..+|||||||.||+|.++++. +.+++..++.|++||+.||+|||+++ ||||||||+||||+ .+|.+||+|||+|
T Consensus 221 --~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~-~~g~vKl~DFGla 294 (423)
T 4fie_A 221 --DELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFC 294 (423)
T ss_dssp --TEEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEEC-TTCCEEECCCTTC
T ss_pred --CEEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEc-CCCCEEEecCccc
Confidence 479999999999999999976 45999999999999999999999999 99999999999998 7899999999999
Q ss_pred chhcCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCC
Q 006779 179 IVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVT 254 (631)
Q Consensus 179 ~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~-~l~~~~ 254 (631)
+.+... ...+.+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+ .+..+++..+..+..+. ......
T Consensus 295 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~ 373 (423)
T 4fie_A 295 AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKV 373 (423)
T ss_dssp EECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCCCCSCTTSS
T ss_pred eECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCcccccC
Confidence 876443 4567899999999998865 599999999999999999999999987 56777777777664432 233457
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
++++++||.+||+ ||.+|||+.|+|+||||+...
T Consensus 374 s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 374 SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 8999999999998 999999999999999998654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-56 Score=464.60 Aligned_cols=267 Identities=23% Similarity=0.348 Sum_probs=222.6
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEE
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~---~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 96 (631)
.+| .+| ++.+.||+|+||+||+|++. .+|+.||+|.++...... ....++.+|+.+|++|+|||||++|++|.
T Consensus 21 ~~p-~~Y-~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 96 (304)
T 3ubd_A 21 ADP-SQF-ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV--RDRVRTKMERDILVEVNHPFIVKLHYAFQ 96 (304)
T ss_dssp CCG-GGE-EEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE--EECC------CCCCCCCCTTEECEEEEEE
T ss_pred CCc-ccc-EEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh--HHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 455 356 88899999999999999884 578999999997543211 12245788999999999999999999997
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccc
Q 006779 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 176 (631)
+. ..+|+|||||.||+|.+++.+.+.+++..++.+++||+.||+|||+++ |+||||||+|||++ .+|.+||+|||
T Consensus 97 ~~--~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFG 171 (304)
T 3ubd_A 97 TE--GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFG 171 (304)
T ss_dssp ET--TEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-TTSCEEEESSE
T ss_pred EC--CEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEc-CCCCEEecccc
Confidence 65 479999999999999999999999999999999999999999999999 99999999999998 78999999999
Q ss_pred ccchhcC--CCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006779 177 LAIVMQQ--PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 177 la~~~~~--~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~ 253 (631)
+|+.... ....+.+|||.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..+++..+..+.. .++..
T Consensus 172 la~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~--~~p~~ 248 (304)
T 3ubd_A 172 LSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAKL--GMPQF 248 (304)
T ss_dssp EEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTT
T ss_pred cceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC-cCHHHHHHHHHcCCC--CCCCc
Confidence 9976533 34556799999999998864 599999999999999999999999987 577777777776543 34566
Q ss_pred CcHHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCcccccCCCC
Q 006779 254 TDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLR 298 (631)
Q Consensus 254 ~~~~l~~lI~~cL~-~p~~Rps-----a~elL~hpff~~~~~~~~~~~~~~ 298 (631)
.++++++||.+||+ +|.+||| ++|+|+||||+..++..+....+.
T Consensus 249 ~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~ 299 (304)
T 3ubd_A 249 LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIH 299 (304)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCC
Confidence 78999999999998 8999998 479999999999888766544443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-54 Score=457.27 Aligned_cols=247 Identities=27% Similarity=0.400 Sum_probs=211.4
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
.++++.++||+|+||+||+|+++.+|+.||+|+++.... ..+|+.+|+.|+|||||++|++|.+. ..+|
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~E~~il~~l~HpnIV~l~~~~~~~--~~~~ 126 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------RVEELVACAGLSSPRIVPLYGAVREG--PWVN 126 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------CTHHHHTTTTCCCTTBCCEEEEEEET--TEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------HHHHHHHHHhCCCCCCCcEEEEEEEC--CEEE
Confidence 456888999999999999999999999999999986532 23699999999999999999999765 4799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCC-cEEEccccccchhcC
Q 006779 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g-~vKL~DFGla~~~~~ 183 (631)
||||||+||+|.+++++.+.+++..++.|+.||+.||+|||+++ ||||||||+|||++ .+| .+||+|||+|+.+..
T Consensus 127 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLS-SDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEEC-TTSCCEEECCCTTCEEC--
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEe-CCCCEEEEeeCCCCeEccC
Confidence 99999999999999999999999999999999999999999999 99999999999998 565 699999999976543
Q ss_pred C-------CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCC
Q 006779 184 P-------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVT 254 (631)
Q Consensus 184 ~-------~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p-~~l~~~~ 254 (631)
. .....+|||.|||||++.+ .|+.++|||||||++|||+||+.||.+.. ..+++..+..+..+ ..++...
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~ 282 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF-RGPLCLKIASEPPPIREIPPSC 282 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC-CSCCHHHHHHSCCGGGGSCTTS
T ss_pred CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC-HHHHHHHHHcCCCCchhcCccC
Confidence 2 1234689999999998865 59999999999999999999999998743 34444555554332 3456678
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHH-------------hcCCCCCC
Q 006779 255 DPQVKQFIEKCIV-PASLRLPALEL-------------LKDPFLVT 286 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rpsa~el-------------L~hpff~~ 286 (631)
++.+++||.+||+ +|.+|||+.|+ |+|||+..
T Consensus 283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 8999999999998 89999999997 57899865
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-53 Score=444.80 Aligned_cols=255 Identities=24% Similarity=0.433 Sum_probs=203.1
Q ss_pred Cce---eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC
Q 006779 24 CRY---GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 24 gRy---~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~ 100 (631)
||| +++.+.||+|+||+||+|.++.+|+.||+|+++... .....+++.+|+.+|++|+|||||++|++|.+.+.
T Consensus 1 GR~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 77 (299)
T 4g31_A 1 GRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNT 77 (299)
T ss_dssp CHHHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-
T ss_pred CCcchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCc
Confidence 566 578899999999999999999999999999997543 35566789999999999999999999999976543
Q ss_pred ----------CeEEEEEeccCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCC
Q 006779 101 ----------RTINMITELFTSGSLRQYRKKHKN---VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 167 (631)
Q Consensus 101 ----------~~l~lV~Ey~~gGsL~~~l~~~~~---l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~ 167 (631)
.++|+|||||.+|+|.+++.+... .+...++.|+.||+.||+|||+++ ||||||||+|||++ .+
T Consensus 78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~-~~ 154 (299)
T 4g31_A 78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MD 154 (299)
T ss_dssp ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TT
T ss_pred cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEEC-CC
Confidence 258999999999999999987654 455678999999999999999999 99999999999998 78
Q ss_pred CcEEEccccccchhcCCC--------------CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCC
Q 006779 168 GEVKIGDLGLAIVMQQPT--------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK 232 (631)
Q Consensus 168 g~vKL~DFGla~~~~~~~--------------~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~ 232 (631)
|.+||+|||+|+...... ..+.+|||.|||||++.+ .|+.++|||||||++|||++ ||....
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~ 231 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM 231 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence 999999999997654321 234579999999998865 59999999999999999996 886533
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 233 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 233 ~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
........+.....|+.+ ...++.+++||.+||+ +|.+|||+.|+|+||||+..+
T Consensus 232 ~~~~~~~~~~~~~~p~~~-~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 232 ERVRTLTDVRNLKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHHHHHHHTTCCCHHH-HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHHHHHHHhcCCCCCCC-cccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 333444455554433222 2234678899999998 899999999999999998654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=451.47 Aligned_cols=257 Identities=27% Similarity=0.412 Sum_probs=214.7
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC----
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD---- 98 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~---- 98 (631)
..|| ++.+.||+|+||+||+|.++.+|+.||||+++... .......++.+|+++|+.|+|||||++++++...
T Consensus 53 ~~~Y-~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 53 GDEY-EIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF--DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp CSSE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred CCCe-EEEEEEecccCeEEEEEEECCCCCEEEEEEECccc--cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence 3577 77899999999999999999999999999996443 3455667899999999999999999999987643
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
....+|||||||. |+|.+++.+.+.+++..++.+++||+.||.|||++| ||||||||+|||++ .+|.+||+|||+|
T Consensus 130 ~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~-~~~~~Ki~DFGla 205 (398)
T 4b99_A 130 EFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVN-ENCELKIGDFGMA 205 (398)
T ss_dssp TCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTCCEEECCCTTC
T ss_pred cCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccC-CCCCEEEeeccee
Confidence 2357999999995 689999999999999999999999999999999999 99999999999998 7899999999999
Q ss_pred chhcC------CCCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC-CCCC-
Q 006779 179 IVMQQ------PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IKPA- 248 (631)
Q Consensus 179 ~~~~~------~~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~-~~p~- 248 (631)
+.+.. ....+.+||+.|||||++.+ .|+.++||||+||++|||++|+.||.+. +....+..|... ..|.
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~-~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK-NYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS-SHHHHHHHHHHHHCCCCG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC-CHHHHHHHHHHhcCCCCh
Confidence 75532 23456799999999998754 4799999999999999999999999874 444444433221 1110
Q ss_pred ------------------------C---CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 249 ------------------------S---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 249 ------------------------~---l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
. +....++++++||.+||+ +|.+||||.|+|+||||+..
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 0 012357899999999998 99999999999999999864
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=465.82 Aligned_cols=268 Identities=22% Similarity=0.353 Sum_probs=229.2
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeeccccc--CCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~--~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
+++.++||+|+||+||+|.++.+|+.||+|++...... ...........++.+++.++|||||+++++|.+. ..+|
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~--~~ly 268 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLS 268 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--SEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC--CEEE
Confidence 48889999999999999999999999999999754322 1222233344557788889999999999999765 4799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
||||||.||+|.+++.+.+.+++..++.|++||+.||+|||++| ||||||||+|||++ .+|.+||+|||+|+.+...
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld-~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSSC
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEe-CCCCEEecccceeeecCCC
Confidence 99999999999999999999999999999999999999999999 99999999999998 7899999999999887777
Q ss_pred CCccccCCCCCCCccccc-c-ccCccccchhhhHHHHHHhhcCCCCCCC--CCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006779 185 TARSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILEMVTCEYPYNEC--KNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 185 ~~~~~~GTp~Y~APEvl~-~-~ys~~sDIwSLGiilyELltG~~Pf~~~--~~~~~i~~~i~~~~~p~~l~~~~~~~l~~ 260 (631)
...+.+|||.|||||++. + .|+.++|||||||++|||++|+.||.+. .+..++...+.... ..++...++++++
T Consensus 346 ~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~--~~~p~~~S~~a~d 423 (689)
T 3v5w_A 346 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--VELPDSFSPELRS 423 (689)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC--CCCCTTSCHHHHH
T ss_pred CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC--CCCCccCCHHHHH
Confidence 778889999999999885 3 5999999999999999999999999653 24455666665543 3455667899999
Q ss_pred HHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCcccccCCCCCCC
Q 006779 261 FIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLPN 301 (631)
Q Consensus 261 lI~~cL~-~p~~Rps-----a~elL~hpff~~~~~~~~~~~~~~~p~ 301 (631)
||.+||+ +|.+|++ +.|+++||||+..+|..+....+..|.
T Consensus 424 LI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~ 470 (689)
T 3v5w_A 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPL 470 (689)
T ss_dssp HHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSC
T ss_pred HHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCc
Confidence 9999998 9999998 799999999999999887655554443
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=425.31 Aligned_cols=251 Identities=31% Similarity=0.490 Sum_probs=209.3
Q ss_pred ccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEE
Q 006779 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (631)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 96 (631)
.+|.++. .+ ++.+.||+|+||+||+|.+.. .||||.++... .+....+.|.+|+.+|++|+|||||++++++.
T Consensus 30 ~Wei~~~-~l-~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~--~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 102 (307)
T 3omv_A 30 YWEIEAS-EV-MLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD--PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102 (307)
T ss_dssp CCBCCTT-SC-CEEEECCCCSSSEEEEEESSS---EEEEEECCCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred CcEEcHH-He-EEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4454443 34 678999999999999997543 59999987543 35667788999999999999999999999774
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccc
Q 006779 97 DDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 175 (631)
+ ..++||||||++|+|.+++... ..+++..+..|+.||+.||+|||+++ ||||||||+|||++ .++.+||+||
T Consensus 103 ~---~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~-~~~~~Ki~DF 176 (307)
T 3omv_A 103 K---DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLH-EGLTVKIGDF 176 (307)
T ss_dssp S---SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEE-TTEEEEECCC
T ss_pred C---CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEEC-CCCcEEEeec
Confidence 3 2478999999999999999764 57999999999999999999999998 99999999999998 7899999999
Q ss_pred cccchhcCC----CCccccCCCCCCCcccccc----ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006779 176 GLAIVMQQP----TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 247 (631)
Q Consensus 176 Gla~~~~~~----~~~~~~GTp~Y~APEvl~~----~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p 247 (631)
|+|+..... .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+..+...+...+..+..+
T Consensus 177 Gla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~ 256 (307)
T 3omv_A 177 GLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYAS 256 (307)
T ss_dssp SSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCC
T ss_pred cCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC
Confidence 999765432 2345689999999998753 48999999999999999999999999877788888888777554
Q ss_pred CC---CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 248 AS---LSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 248 ~~---l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+. ++...++.+++||.+||+ +|.+|||+.|++.
T Consensus 257 p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 257 PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 33 445578899999999998 8999999998654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=433.24 Aligned_cols=251 Identities=19% Similarity=0.358 Sum_probs=204.6
Q ss_pred CCceeeeeeEecccCceEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 98 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~---~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~ 98 (631)
.+|| ++.+.||+|+||+||+|.++ .+++.||+|.+.... ...++.+|+++|+.+ +|||||+++++|.+.
T Consensus 20 ~~~Y-~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~------~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 20 SNVF-KIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS------HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGTC-EEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS------CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred cCcE-EEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc------CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 4677 88999999999999999885 468999999886432 234678999999998 699999999998765
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
..+|+|||||.+|+|.++++ .+++..++.+++||+.||+|||++| |+||||||+|||++.+.+.+||+|||+|
T Consensus 93 --~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 93 --DHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp --TEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred --CEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 47999999999999999984 5999999999999999999999999 9999999999999855589999999999
Q ss_pred chhcCC------------------------------CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCC
Q 006779 179 IVMQQP------------------------------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEY 226 (631)
Q Consensus 179 ~~~~~~------------------------------~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~ 226 (631)
+..... ...+.+|||.|||||++.+ .|+.++||||+||++|||+||+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 643321 1234589999999998754 48999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHc--C--------------------------------------CCC------------CCCCCCC
Q 006779 227 PYNECKNPAQIYKKVTS--G--------------------------------------IKP------------ASLSKVT 254 (631)
Q Consensus 227 Pf~~~~~~~~i~~~i~~--~--------------------------------------~~p------------~~l~~~~ 254 (631)
||....+..+....+.. | ..| .......
T Consensus 246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i 325 (361)
T 4f9c_A 246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV 325 (361)
T ss_dssp SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence 99766655443333211 0 000 0112345
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
++++++||.+||+ ||.+|+||.|+|+||||+..
T Consensus 326 s~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 326 PDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 7899999999998 99999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=424.12 Aligned_cols=250 Identities=25% Similarity=0.391 Sum_probs=211.2
Q ss_pred CCCceeeeeeEecccCceEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEE
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~-----~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 96 (631)
+-..| .+.+.||+|+||+||+|.+. .+|..||||.++.. +....+.|.+|+++|++|+|||||++|+++.
T Consensus 11 ~r~~~-~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 11 KRHNI-VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp CGGGE-EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred CHHHe-EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 33445 77899999999999999874 46899999998633 4566788999999999999999999999987
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeee
Q 006779 97 DDTNRTINMITELFTSGSLRQYRKKH-------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV 163 (631)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~l~~~-------------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl 163 (631)
+. ..+++|||||++|+|.+++.++ ..+++..++.|+.||+.||.|||+++ ||||||||+|||+
T Consensus 86 ~~--~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl 161 (299)
T 4asz_A 86 EG--DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLV 161 (299)
T ss_dssp SS--SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred eC--CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEE
Confidence 64 4689999999999999999764 36999999999999999999999998 9999999999999
Q ss_pred cCCCCcEEEccccccchhcCCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHH
Q 006779 164 NGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 237 (631)
Q Consensus 164 ~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i 237 (631)
+ .++.+||+|||+|+...... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ .+..++
T Consensus 162 ~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~-~~~~~~ 239 (299)
T 4asz_A 162 G-ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ-LSNNEV 239 (299)
T ss_dssp C-GGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHH
T ss_pred C-CCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHH
Confidence 8 78999999999997654321 23456899999999875 569999999999999999999 8999987 567788
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 006779 238 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 238 ~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~ 285 (631)
+..+..+..+. .+...++++++||.+||+ +|.+|||+.+++ +||+
T Consensus 240 ~~~i~~~~~~~-~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~ 285 (299)
T 4asz_A 240 IECITQGRVLQ-RPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ 285 (299)
T ss_dssp HHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred HHHHHcCCCCC-CCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence 88888876543 456678999999999998 899999999984 4554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=423.30 Aligned_cols=244 Identities=23% Similarity=0.375 Sum_probs=204.1
Q ss_pred eeeeeEecccCceEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 27 GRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~-----~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
..+.+.||+|+||+||+|.+. .+|..||||+++.. +....+.|.+|+.+|++|+|||||++|++|.+. .
T Consensus 43 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~--~ 116 (329)
T 4aoj_A 43 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTMLQHQHIVRFFGVCTEG--R 116 (329)
T ss_dssp EEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--S
T ss_pred eEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--C
Confidence 467889999999999999864 47899999998632 456678899999999999999999999998654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC
Q 006779 102 TINMITELFTSGSLRQYRKKH---------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 166 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~---------------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~ 166 (631)
.++||||||.+|+|.+++.++ +++++..++.|+.||+.||.|||+++ ||||||||+|||++ .
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~-~ 193 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVG-Q 193 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-T
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEEC-C
Confidence 689999999999999999764 35899999999999999999999998 99999999999998 7
Q ss_pred CCcEEEccccccchhcCC----CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHH
Q 006779 167 NGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKK 240 (631)
Q Consensus 167 ~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~ 240 (631)
++.+||+|||+++..... .....+||+.|||||++.+ .|+.++|||||||++|||+| |+.||.+ .+..+++..
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~-~~~~~~~~~ 272 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ-LSNTEAIDC 272 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-SCHHHHHHH
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC-CCHHHHHHH
Confidence 899999999999765432 2334679999999998765 59999999999999999999 8999987 466777788
Q ss_pred HHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 241 VTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 241 i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
+..+..+ ..+..+++++++||.+||. +|.+|||+.|++.+
T Consensus 273 i~~g~~~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 273 ITQGREL-ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHTCCC-CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHcCCCC-CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 8877544 3456678999999999998 89999999999764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=419.60 Aligned_cols=248 Identities=23% Similarity=0.313 Sum_probs=209.1
Q ss_pred CCceeeeeeEecccCceEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEc
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d-----~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d 97 (631)
...+ ++.+.||+|+||+||+|.. ..+++.||||.++... .....+.|.+|+.+|++|+|||||++++++.+
T Consensus 25 ~~~~-~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~---~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 25 LSAV-RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA---EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp GGGE-EEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C---CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHC-eEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc---ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 3444 7889999999999999985 3578999999986432 23345679999999999999999999999865
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCe
Q 006779 98 DTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~----------------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NI 161 (631)
. ..+++|||||++|+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+||
T Consensus 101 ~--~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NI 176 (308)
T 4gt4_A 101 D--QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNV 176 (308)
T ss_dssp S--SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred C--CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccce
Confidence 4 4588999999999999999653 35899999999999999999999998 99999999999
Q ss_pred eecCCCCcEEEccccccchhcCC----CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHH
Q 006779 162 FVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPA 235 (631)
Q Consensus 162 Ll~~~~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~ 235 (631)
|++ .++.+||+|||+++..... .....+||+.|||||++. +.|+.++|||||||++|||+| |..||.+ .+..
T Consensus 177 Ll~-~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~-~~~~ 254 (308)
T 4gt4_A 177 LVY-DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQ 254 (308)
T ss_dssp EEC-GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-CCHH
T ss_pred EEC-CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC-CCHH
Confidence 998 7899999999999765332 234568999999999775 569999999999999999998 8999987 5677
Q ss_pred HHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 236 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 236 ~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
++...+..+..++ .+..+++.+.+||.+||. +|.+|||+.||+.+
T Consensus 255 ~~~~~i~~~~~~~-~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 255 DVVEMIRNRQVLP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8888888776543 455678999999999998 89999999999874
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=448.95 Aligned_cols=257 Identities=25% Similarity=0.395 Sum_probs=222.9
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
..+| ++.+.||+|+||+||+|.++.+|+.||+|++... .....+.+.+|+.+|+.|+|||||+++++|.+. ..
T Consensus 156 l~~Y-~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 228 (573)
T 3uto_A 156 LDHY-DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NE 228 (573)
T ss_dssp GGTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS--SE
T ss_pred cccc-EEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc----chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CE
Confidence 3567 7889999999999999999999999999999754 245567789999999999999999999999764 57
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC-CCcEEEccccccch
Q 006779 103 INMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~-~g~vKL~DFGla~~ 180 (631)
+|||||||.||+|.+++.+ .+.+++..++.+++||+.||.|||+++ |+||||||+|||++.. .|.+||+|||+++.
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 9999999999999999864 567999999999999999999999999 9999999999999732 47999999999987
Q ss_pred hcCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcH
Q 006779 181 MQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDP 256 (631)
Q Consensus 181 ~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p~~l~~~~~~ 256 (631)
+... .....+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+ .+..+++..+..+.. +.......++
T Consensus 307 ~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~ 385 (573)
T 3uto_A 307 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISE 385 (573)
T ss_dssp CCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCSGGGTTSCH
T ss_pred ccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 6543 3456789999999998865 599999999999999999999999987 566777777766533 2333455789
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 257 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
++++||.+||+ +|.+|||+.|+|+||||+..++
T Consensus 386 ~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 99999999998 9999999999999999987554
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=423.43 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=214.4
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccC-----CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC-CCceeeeeeE
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVD-----GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIKFYNSW 95 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~t-----g~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~H-pnIVkl~~~~ 95 (631)
|-.+| ++.+.||+|+||+||+|.+..+ ++.||+|.+.... .....+.+.+|+.+|++++| ||||+++++|
T Consensus 62 ~~~~~-~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~---~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~ 137 (353)
T 4ase_A 62 PRDRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGAC 137 (353)
T ss_dssp CGGGE-EEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cHHHe-EEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence 44566 8889999999999999987654 4789999986432 35566789999999999965 8999999988
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCC
Q 006779 96 VDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159 (631)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~~~l~~~----------------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~ 159 (631)
.... ..+++|||||++|+|.+++++. ..+++..+..|+.||+.||+|||+++ ||||||||+
T Consensus 138 ~~~~-~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~~ 214 (353)
T 4ase_A 138 TKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAAR 214 (353)
T ss_dssp CCTT-SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred EecC-CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCcc
Confidence 6543 4688999999999999999753 34899999999999999999999999 999999999
Q ss_pred CeeecCCCCcEEEccccccchhcCCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCC
Q 006779 160 NIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKN 233 (631)
Q Consensus 160 NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~ 233 (631)
|||++ .++.+||+|||+|+...... ....+||+.|||||++. +.|+.++|||||||++|||+| |+.||.+...
T Consensus 215 NILl~-~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 215 NILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GEEEC-GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred ceeeC-CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 99998 78999999999998654332 23467899999999875 469999999999999999998 8999988777
Q ss_pred HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 234 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 234 ~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
...+...+..+..+. .+...++++++||.+||. +|.+|||+.|+++|
T Consensus 294 ~~~~~~~i~~g~~~~-~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 294 DEEFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp SHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 778888888876543 455678999999999998 89999999999987
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=399.92 Aligned_cols=273 Identities=49% Similarity=0.923 Sum_probs=243.8
Q ss_pred cCCcccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeee
Q 006779 13 EEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92 (631)
Q Consensus 13 ~~~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~ 92 (631)
-+......+..++|+++.+.||+|+||+||+|.+..++..||+|.+..... .....+.+.+|+.+|+.++||||++++
T Consensus 14 l~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~ 91 (290)
T 1t4h_A 14 LETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFY 91 (290)
T ss_dssp ----CCEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred HhhhhhhcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh--CHHHHHHHHHHHHHHHhCCCCCeeeee
Confidence 345566778889999999999999999999999999999999999876543 456678899999999999999999999
Q ss_pred eeEEcC--CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcE
Q 006779 93 NSWVDD--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 170 (631)
Q Consensus 93 ~~~~d~--~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~v 170 (631)
++|... ....+++||||+.+|+|.+++.+.+.+++..++.|+.||+.||.|||+++++|+||||||+|||++..++.+
T Consensus 92 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~ 171 (290)
T 1t4h_A 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSV 171 (290)
T ss_dssp EEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCE
T ss_pred eeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCE
Confidence 988653 345789999999999999999998899999999999999999999999987799999999999997678899
Q ss_pred EEccccccchhcCCCCccccCCCCCCCccccccccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 006779 171 KIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250 (631)
Q Consensus 171 KL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l 250 (631)
||+|||++............||+.|+|||++.+.++.++|||||||++|+|++|+.||....+..+++..+..+..+..+
T Consensus 172 kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (290)
T 1t4h_A 172 KIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF 251 (290)
T ss_dssp EECCTTGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGG
T ss_pred EEeeCCCcccccccccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcccc
Confidence 99999999776666666778999999999998889999999999999999999999999988889999999888777777
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 251 ~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
....++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 252 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 252 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 77788999999999998 89999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=396.11 Aligned_cols=255 Identities=25% Similarity=0.496 Sum_probs=224.3
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
.++| ++.+.||+|+||.||+|.+..+|+.||+|++..... .....+++.+|+.+|+.++||||+++++++.+. ..
T Consensus 14 ~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~ 88 (328)
T 3fe3_A 14 IGNY-RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLFREVRIMKILNHPNIVKLFEVIETE--KT 88 (328)
T ss_dssp ETTE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred cCCE-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CE
Confidence 4567 788999999999999999999999999999976542 456678899999999999999999999988654 57
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLD-ADMNIKIADFGFSNEFT 165 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSTTCCGGGS
T ss_pred EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEc-CCCCEEEeeccCceecC
Confidence 9999999999999999998899999999999999999999999999 99999999999998 78999999999997654
Q ss_pred CC-CCccccCCCCCCCccccccc-c-CccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006779 183 QP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 183 ~~-~~~~~~GTp~Y~APEvl~~~-y-s~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~ 259 (631)
.. .....+||+.|+|||++.+. + +.++|||||||++|+|++|+.||.+ .+..++...+..+... ++...++.++
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~ 242 (328)
T 3fe3_A 166 VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYR--IPFYMSTDCE 242 (328)
T ss_dssp SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHH
T ss_pred CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCCCCCHHHH
Confidence 33 34567899999999987654 4 4799999999999999999999987 5677777777776443 3445789999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 260 QFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 260 ~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
+||.+||. +|.+|||+.|+|+||||....
T Consensus 243 ~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 243 NLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999998 999999999999999998644
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=398.99 Aligned_cols=248 Identities=28% Similarity=0.389 Sum_probs=193.8
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC--Ce
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--RT 102 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~--~~ 102 (631)
|.+.+++.||+|+||+||+|.+ +|+.||||+++... ........|+..+..++|||||++++++.+... ..
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 4568899999999999999976 69999999986432 122223456777788999999999999876543 36
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCEEeccCCCCCeeecCCCCcEEEcccc
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH------NPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~------~~~IiHrDLKp~NILl~~~~g~vKL~DFG 176 (631)
+++|||||++|+|.+++.+. .+++..+.+++.|++.||+|||++ .++||||||||+|||++ .++.+||+|||
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~-~~~~~Ki~DFG 153 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLG 153 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC-TTSCEEECCCT
T ss_pred EEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC-CCCCEEEEeCC
Confidence 89999999999999999875 589999999999999999999987 23599999999999998 78999999999
Q ss_pred ccchhcCCC------CccccCCCCCCCcccccc-------ccCccccchhhhHHHHHHhhcCCCCCCC------------
Q 006779 177 LAIVMQQPT------ARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNEC------------ 231 (631)
Q Consensus 177 la~~~~~~~------~~~~~GTp~Y~APEvl~~-------~ys~~sDIwSLGiilyELltG~~Pf~~~------------ 231 (631)
+++...... ....+||+.|||||++.+ .|+.++|||||||++|||+||..||...
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 997654322 234589999999998854 3678999999999999999997665321
Q ss_pred --CCHHHHHHHHHcCCCCCCCCCC-----CcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 232 --KNPAQIYKKVTSGIKPASLSKV-----TDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 232 --~~~~~i~~~i~~~~~p~~l~~~-----~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
....++.+.+......+.++.. ....+.+|+.+||. +|.+|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1234555555544333333322 12468899999998 89999999998863
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=391.27 Aligned_cols=260 Identities=30% Similarity=0.516 Sum_probs=222.4
Q ss_pred cccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEc
Q 006779 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d 97 (631)
...++.+|| ++.+.||+|+||+||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||++++++|.+
T Consensus 14 ~~~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (297)
T 3fxz_A 14 SVGDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLV 88 (297)
T ss_dssp BSSCGGGTB-CCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred CcCChhhce-eeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc----cHHHHHHHHHHHHhcCCCCCCCeEeEEEEE
Confidence 345678888 778999999999999999999999999999976542 224568899999999999999999999876
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
. ..+++||||+.+|+|.+++.+. .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+
T Consensus 89 ~--~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~ 162 (297)
T 3fxz_A 89 G--DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGF 162 (297)
T ss_dssp T--TEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTT
T ss_pred C--CEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEC-CCCCEEEeeCCC
Confidence 5 4689999999999999999875 5999999999999999999999999 99999999999997 789999999999
Q ss_pred cchhcCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006779 178 AIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 178 a~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 254 (631)
+...... ......||+.|+|||++.+ .|+.++|||||||++|+|+||+.||........+......+......+...
T Consensus 163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (297)
T 3fxz_A 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242 (297)
T ss_dssp CEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGS
T ss_pred ceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccc
Confidence 8765433 3345689999999998754 589999999999999999999999987544445554444444444445567
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
++.+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 243 ~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 243 SAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 8899999999998 899999999999999998654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=397.04 Aligned_cols=264 Identities=23% Similarity=0.441 Sum_probs=227.3
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
++| ++.+.||+|+||+||+|.++.+|+.||+|.++..... .......+.+|+.+|+.++||||++++++|.+. ..+
T Consensus 5 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~ 80 (337)
T 1o6l_A 5 NDF-DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRL 80 (337)
T ss_dssp GGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEE
T ss_pred HHe-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC--CEE
Confidence 456 7789999999999999999999999999999754321 123456788999999999999999999998764 479
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc-
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ- 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~- 182 (631)
++||||+.||+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEEC-CCCCEEEeeccchhhccc
Confidence 999999999999999999889999999999999999999999999 99999999999997 78999999999997532
Q ss_pred -CCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006779 183 -QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 183 -~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~ 260 (631)
.......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.. .+...++..+..+. ..++...++++++
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~~ 234 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE--IRFPRTLSPEAKS 234 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHH
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHH
Confidence 234456789999999998765 589999999999999999999999976 56667777766543 2345567899999
Q ss_pred HHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCcccccCCC
Q 006779 261 FIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPL 297 (631)
Q Consensus 261 lI~~cL~-~p~~Rp-----sa~elL~hpff~~~~~~~~~~~~~ 297 (631)
||.+||. +|.+|| ++.++++||||...++..+....+
T Consensus 235 li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~ 277 (337)
T 1o6l_A 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL 277 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred HHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCC
Confidence 9999998 899999 899999999999988877654444
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=400.83 Aligned_cols=266 Identities=21% Similarity=0.395 Sum_probs=224.1
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCe
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~ 102 (631)
++| ++.++||+|+||+||+|.++.+|+.||+|++...... .....+.+.+|..+|+.+ +||||++++++|.+. ..
T Consensus 23 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~ 98 (353)
T 3txo_A 23 DNF-EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP--DR 98 (353)
T ss_dssp CCE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred hhe-EEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc-chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC--CE
Confidence 456 7789999999999999999999999999999754321 133456788999999988 799999999998764 47
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
+|+||||+.||+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~-~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEEC-CCCCEEEccccceeecc
Confidence 9999999999999999999899999999999999999999999999 99999999999998 78999999999997533
Q ss_pred C--CCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006779 183 Q--PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 183 ~--~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~ 259 (631)
. ....+.+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.. .+..+++..+..+.. .++...++.++
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~ 252 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEV--VYPTWLHEDAT 252 (353)
T ss_dssp C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHH
T ss_pred cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHH
Confidence 2 23456789999999998765 599999999999999999999999987 567777777776543 24456789999
Q ss_pred HHHHHhcC-CCCCCCCH------HHHhcCCCCCCCCCcccccCCCCC
Q 006779 260 QFIEKCIV-PASLRLPA------LELLKDPFLVTDNPKDLVCDPLRL 299 (631)
Q Consensus 260 ~lI~~cL~-~p~~Rpsa------~elL~hpff~~~~~~~~~~~~~~~ 299 (631)
+||.+||. +|.+||++ .++++||||+..+|..+....+..
T Consensus 253 ~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~ 299 (353)
T 3txo_A 253 GILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEP 299 (353)
T ss_dssp HHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred HHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCC
Confidence 99999998 89999998 899999999998887664444433
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=389.81 Aligned_cols=266 Identities=27% Similarity=0.442 Sum_probs=227.3
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.+| ++.+.||+|+||.||+|.++.+|+.||+|.+....... ....+.+.+|+.+|+.++||||++++++|.+. ..+
T Consensus 6 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~ 81 (318)
T 1fot_A 6 QDF-QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQI 81 (318)
T ss_dssp GGE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SEE
T ss_pred HHc-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC--CEE
Confidence 456 77899999999999999999999999999997543211 12346688999999999999999999998754 479
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEECSS
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEc-CCCCEEEeecCcceecCC
Confidence 999999999999999999899999999999999999999999999 99999999999997 789999999999976543
Q ss_pred CCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006779 184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262 (631)
Q Consensus 184 ~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI 262 (631)
. ..+.+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.. .+....+..+..+.. .++...++++++||
T Consensus 159 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li 234 (318)
T 1fot_A 159 V-TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL--RFPPFFNEDVKDLL 234 (318)
T ss_dssp C-BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHH
T ss_pred c-cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHH
Confidence 2 345689999999998764 589999999999999999999999987 456666666665432 34556789999999
Q ss_pred HHhcC-CCCCCC-----CHHHHhcCCCCCCCCCcccccCCCCCC
Q 006779 263 EKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLP 300 (631)
Q Consensus 263 ~~cL~-~p~~Rp-----sa~elL~hpff~~~~~~~~~~~~~~~p 300 (631)
.+||. +|.+|| ++.++++||||+..++..+....+..|
T Consensus 235 ~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p 278 (318)
T 1fot_A 235 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP 278 (318)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCS
T ss_pred HHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCC
Confidence 99998 899999 899999999999988877654444433
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=395.55 Aligned_cols=265 Identities=26% Similarity=0.413 Sum_probs=225.0
Q ss_pred cccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC--HHHHHHHHHHHHHHHhCCCCCceeeeeeE
Q 006779 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS--PDQLERLYSEVHLLKSLKHENIIKFYNSW 95 (631)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~--~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~ 95 (631)
...+..++| ++.+.||+|+||+||+|.++.+|..||+|.+........ ....+.+.+|+.+|+.++||||++++++|
T Consensus 6 ~~~~~~~~y-~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 84 (361)
T 2yab_A 6 KQQKVEDFY-DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY 84 (361)
T ss_dssp BCSCGGGTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCCChhhce-EEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE
Confidence 344556667 888999999999999999999999999999986543221 11346788999999999999999999998
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCC----cEE
Q 006779 96 VDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVK 171 (631)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g----~vK 171 (631)
.+. ..+++||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++ .+|
T Consensus 85 ~~~--~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~~~~~~~vk 159 (361)
T 2yab_A 85 ENR--TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLL-DKNIPIPHIK 159 (361)
T ss_dssp ECS--SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEES-CTTSSSCCEE
T ss_pred EeC--CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEe-CCCCCccCEE
Confidence 654 579999999999999999998889999999999999999999999999 99999999999997 444 799
Q ss_pred EccccccchhcCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--
Q 006779 172 IGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-- 247 (631)
Q Consensus 172 L~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p-- 247 (631)
|+|||++...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+..+++..+..+...
T Consensus 160 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~ 238 (361)
T 2yab_A 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITAVSYDFD 238 (361)
T ss_dssp ECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCC
T ss_pred EEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCC
Confidence 9999999766543 3456789999999998865 589999999999999999999999987 5666777777665432
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 248 ~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
.......++.+++||.+||. +|.+|||+.|+|+||||+...+
T Consensus 239 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 281 (361)
T 2yab_A 239 EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT 281 (361)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence 12234567899999999998 8999999999999999987554
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=393.77 Aligned_cols=267 Identities=23% Similarity=0.392 Sum_probs=229.6
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
.++| ++.+.||+|+||.||+|.++.+|+.||+|++....... ....+.+.+|+.+|+.++||||++++++|.+. ..
T Consensus 40 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~ 115 (350)
T 1rdq_E 40 LDQF-DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SN 115 (350)
T ss_dssp GGGE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SE
T ss_pred HHHC-EEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhcc-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--CE
Confidence 3566 77899999999999999999999999999997543211 22356788999999999999999999998754 47
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
+|+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECS
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEEC-CCCCEEEcccccceecc
Confidence 9999999999999999999889999999999999999999999999 99999999999997 78999999999997654
Q ss_pred CCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006779 183 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 183 ~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~l 261 (631)
.. ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+..+++..+..+.. .++...++.+++|
T Consensus 193 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~l 268 (350)
T 1rdq_E 193 GR-TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV--RFPSHFSSDLKDL 268 (350)
T ss_dssp SC-BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTCCHHHHHH
T ss_pred CC-cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHH
Confidence 43 345689999999998754 589999999999999999999999986 567777777777643 3455678999999
Q ss_pred HHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCcccccCCCCCC
Q 006779 262 IEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLP 300 (631)
Q Consensus 262 I~~cL~-~p~~Rps-----a~elL~hpff~~~~~~~~~~~~~~~p 300 (631)
|.+||. +|.+||+ +.++++||||...++..+....+..|
T Consensus 269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p 313 (350)
T 1rdq_E 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP 313 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred HHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCC
Confidence 999998 8999998 99999999999988876554444333
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=400.41 Aligned_cols=266 Identities=18% Similarity=0.347 Sum_probs=223.8
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCe
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~ 102 (631)
.+| ++.++||+|+||+||+|.++.+|+.||+|+++.... ......+.+.+|..+|+++ +||||++++++|.+. ..
T Consensus 52 ~~y-~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~-~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~ 127 (396)
T 4dc2_A 52 QDF-DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SR 127 (396)
T ss_dssp GGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGT-C----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS--SE
T ss_pred hHc-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc-cCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC--CE
Confidence 455 778999999999999999999999999999986543 2344556688999999887 899999999998754 47
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
+++||||+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++...
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~-~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCC
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEC-CCCCEEEeecceeeecc
Confidence 9999999999999999999899999999999999999999999999 99999999999998 78999999999997532
Q ss_pred --CCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCC--------CCHHHHHHHHHcCCCCCCCC
Q 006779 183 --QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--------KNPAQIYKKVTSGIKPASLS 251 (631)
Q Consensus 183 --~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~--------~~~~~i~~~i~~~~~p~~l~ 251 (631)
.....+.+||+.|+|||++.+ .|+.++|||||||++|||++|+.||... .....++..+.... ..++
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p 282 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIP 282 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--CCCC
T ss_pred cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--cCCC
Confidence 234566789999999998765 5999999999999999999999999632 23344566666543 2355
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCH------HHHhcCCCCCCCCCcccccCCCC
Q 006779 252 KVTDPQVKQFIEKCIV-PASLRLPA------LELLKDPFLVTDNPKDLVCDPLR 298 (631)
Q Consensus 252 ~~~~~~l~~lI~~cL~-~p~~Rpsa------~elL~hpff~~~~~~~~~~~~~~ 298 (631)
...++++++||.+||+ +|.+||++ .|+++||||+..+|..+....+.
T Consensus 283 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~ 336 (396)
T 4dc2_A 283 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVV 336 (396)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSC
T ss_pred CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCC
Confidence 5678999999999998 89999995 79999999999888776544343
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=388.75 Aligned_cols=262 Identities=18% Similarity=0.353 Sum_probs=224.5
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCe
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~ 102 (631)
.+| ++.+.||+|+||.||+|.++.+|+.||+|++..... ......+.+.+|+.+|+.+ +||||++++++|.+. ..
T Consensus 9 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~ 84 (345)
T 3a8x_A 9 QDF-DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SR 84 (345)
T ss_dssp GGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS-CSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred hhe-EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh-cchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC--CE
Confidence 456 778999999999999999999999999999986543 3456677899999999988 899999999998664 47
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
+|+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCGGGCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEC-CCCCEEEEecccccccc
Confidence 9999999999999999998889999999999999999999999999 99999999999998 78999999999997532
Q ss_pred --CCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCC--------CCHHHHHHHHHcCCCCCCCC
Q 006779 183 --QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--------KNPAQIYKKVTSGIKPASLS 251 (631)
Q Consensus 183 --~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~--------~~~~~i~~~i~~~~~p~~l~ 251 (631)
.......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||... .....++..+.... ..++
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p 239 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIP 239 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC--CCCC
T ss_pred CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC--CCCC
Confidence 233456789999999998765 5899999999999999999999999642 23445566665543 2345
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCH------HHHhcCCCCCCCCCccccc
Q 006779 252 KVTDPQVKQFIEKCIV-PASLRLPA------LELLKDPFLVTDNPKDLVC 294 (631)
Q Consensus 252 ~~~~~~l~~lI~~cL~-~p~~Rpsa------~elL~hpff~~~~~~~~~~ 294 (631)
...++.+++||.+||. +|.+||++ .+++.||||...+|..+..
T Consensus 240 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~ 289 (345)
T 3a8x_A 240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQ 289 (345)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHT
T ss_pred CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHh
Confidence 5678999999999998 89999995 7999999999888766543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=381.17 Aligned_cols=257 Identities=23% Similarity=0.451 Sum_probs=212.8
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccC----------------------CHHHHHHHHHHHHHH
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----------------------SPDQLERLYSEVHLL 80 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~----------------------~~~~~~~l~~Ei~iL 80 (631)
.++| ++.+.||+|+||.||+|.+..+|..||+|++....... .....+.+.+|+.+|
T Consensus 12 ~~~y-~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 12 LNQY-TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp ETTE-EEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred ecce-EEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 3577 78899999999999999999999999999997654211 112346688999999
Q ss_pred HhCCCCCceeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCC
Q 006779 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160 (631)
Q Consensus 81 k~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~N 160 (631)
+.++||||+++++++.+.....+++||||+.+++|.+++. .+.+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~N 167 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSN 167 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHH
Confidence 9999999999999998766678999999999999988654 457999999999999999999999999 9999999999
Q ss_pred eeecCCCCcEEEccccccchhcCCC--CccccCCCCCCCccccccc----cCccccchhhhHHHHHHhhcCCCCCCCCCH
Q 006779 161 IFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNP 234 (631)
Q Consensus 161 ILl~~~~g~vKL~DFGla~~~~~~~--~~~~~GTp~Y~APEvl~~~----ys~~sDIwSLGiilyELltG~~Pf~~~~~~ 234 (631)
||++ .+|.+||+|||++....... .....||+.|+|||++.+. ++.++|||||||++|+|++|+.||.. .+.
T Consensus 168 il~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~ 245 (298)
T 2zv2_A 168 LLVG-EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERI 245 (298)
T ss_dssp EEEC-TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC-SSH
T ss_pred EEEC-CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC-ccH
Confidence 9997 78899999999997654432 3456799999999988653 47889999999999999999999986 455
Q ss_pred HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 006779 235 AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 235 ~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~ 285 (631)
..+...+.....+.......++.+++||.+||. +|.+|||+.|+|+||||+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 566666665544333334567899999999998 899999999999999985
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=395.18 Aligned_cols=266 Identities=23% Similarity=0.417 Sum_probs=227.3
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~ 101 (631)
.++| ++.++||+|+||.||+|.++.+|+.||+|.++...... ....+.+..|..+|+.+ +||||++++++|.+. .
T Consensus 16 ~~~y-~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~--~ 91 (345)
T 1xjd_A 16 IEDF-ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--E 91 (345)
T ss_dssp CTTE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--S
T ss_pred hHHe-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh-hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC--C
Confidence 3566 77899999999999999999999999999997543211 12345678899999876 999999999998764 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
.+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEEC-CCCCEEEeEChhhhhc
Confidence 79999999999999999998889999999999999999999999999 99999999999998 7899999999999754
Q ss_pred c--CCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006779 182 Q--QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 182 ~--~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l 258 (631)
. .......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.. .+...++..+..+.. .++...++++
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~ 245 (345)
T 1xjd_A 169 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNP--FYPRWLEKEA 245 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHH
T ss_pred ccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhCCC--CCCcccCHHH
Confidence 2 234556789999999998765 589999999999999999999999976 567777777776532 3455678999
Q ss_pred HHHHHHhcC-CCCCCCCHH-HHhcCCCCCCCCCcccccCCCC
Q 006779 259 KQFIEKCIV-PASLRLPAL-ELLKDPFLVTDNPKDLVCDPLR 298 (631)
Q Consensus 259 ~~lI~~cL~-~p~~Rpsa~-elL~hpff~~~~~~~~~~~~~~ 298 (631)
++||.+||. +|.+||++. ++++||||+..++..+....+.
T Consensus 246 ~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~~~~~~ 287 (345)
T 1xjd_A 246 KDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEID 287 (345)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCSC
T ss_pred HHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHHhhCCCC
Confidence 999999998 899999998 9999999999888766444333
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=375.41 Aligned_cols=256 Identities=23% Similarity=0.408 Sum_probs=212.4
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.|| ++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+|++++||||+++++++.+. ..+
T Consensus 2 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 76 (292)
T 3o0g_A 2 QKY-EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKL 76 (292)
T ss_dssp CSE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEE
T ss_pred CCc-eeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC--cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC--CEE
Confidence 466 778999999999999999999999999999986542 344557788999999999999999999998765 478
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
++||||+.++.+..+....+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGI 153 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCS
T ss_pred EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccceecCC
Confidence 999999986544445555678999999999999999999999999 99999999999998 789999999999976543
Q ss_pred C--CCccccCCCCCCCcccccc-c-cCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCC--C-C---------
Q 006779 184 P--TARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--K-P--------- 247 (631)
Q Consensus 184 ~--~~~~~~GTp~Y~APEvl~~-~-ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~--~-p--------- 247 (631)
. ......||+.|+|||++.+ . |+.++|||||||++|+|++|..||....+.......+.... . .
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence 3 2345678999999998754 3 89999999999999999999999766666666555553310 0 0
Q ss_pred ---------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 248 ---------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 248 ---------------~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.......++.+++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 01112357899999999998 89999999999999999863
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=384.60 Aligned_cols=265 Identities=24% Similarity=0.345 Sum_probs=213.8
Q ss_pred CCCceeeeeeEecccCceEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~---~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 98 (631)
..++| ++.+.||+|+||.||+|.+. .+|..||+|++..............+.+|+.+|+.++||||+++++++.+.
T Consensus 15 ~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 15 RPECF-ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CGGGE-EEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CHHHe-EEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 34566 78899999999999999985 689999999997654333344556788999999999999999999998764
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
..+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++
T Consensus 94 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~-~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 94 --GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLN-HQGHVKLTDFGLC 168 (327)
T ss_dssp --SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEEC-TTSCEEECCCSCC
T ss_pred --CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEEC-CCCcEEEEeCCcc
Confidence 468999999999999999998889999999999999999999999999 99999999999997 7899999999998
Q ss_pred chhcC--CCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006779 179 IVMQQ--PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 179 ~~~~~--~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~ 255 (631)
..... ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+.......+..... .++...+
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~ 245 (327)
T 3a62_A 169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCKL--NLPPYLT 245 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCC--CCCTTSC
T ss_pred cccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCC
Confidence 65432 23445689999999998754 589999999999999999999999987 455666666655432 3445678
Q ss_pred HHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCcccccC
Q 006779 256 PQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCD 295 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rp-----sa~elL~hpff~~~~~~~~~~~ 295 (631)
+.+++||.+||. +|.+|| ++.++|.||||+..++..+...
T Consensus 246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~ 291 (327)
T 3a62_A 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLAR 291 (327)
T ss_dssp HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTT
T ss_pred HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhc
Confidence 999999999998 899999 8899999999998877665433
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=391.29 Aligned_cols=268 Identities=21% Similarity=0.341 Sum_probs=228.1
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~ 101 (631)
-++| ++.++||+|+||.||+|.++.+|+.||+|++....... ....+.+..|..+|..+ +||||++++++|.+. .
T Consensus 19 ~~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~ 94 (353)
T 2i0e_A 19 LTDF-NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--D 94 (353)
T ss_dssp CTTE-EEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS--S
T ss_pred hHHc-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc-chHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC--C
Confidence 3556 77899999999999999999999999999997543211 23356788999999988 899999999998654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
.+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEc-CCCcEEEEeCCccccc
Confidence 79999999999999999998888999999999999999999999999 99999999999998 7899999999999753
Q ss_pred c--CCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006779 182 Q--QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 182 ~--~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l 258 (631)
. .......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.. .+..+++..+..+.. .++...++++
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~ 248 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEA 248 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHH
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHH
Confidence 2 234556789999999998764 599999999999999999999999976 567777777776532 3455678999
Q ss_pred HHHHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCcccccCCCCCC
Q 006779 259 KQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLP 300 (631)
Q Consensus 259 ~~lI~~cL~-~p~~Rps-----a~elL~hpff~~~~~~~~~~~~~~~p 300 (631)
++||.+||. +|.+||+ +.+++.||||+..+|..+....+..|
T Consensus 249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p 296 (353)
T 2i0e_A 249 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPP 296 (353)
T ss_dssp HHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCC
Confidence 999999998 8999994 69999999999988876654444333
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=384.91 Aligned_cols=258 Identities=25% Similarity=0.390 Sum_probs=216.2
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
.++| ++.+.||+|+||+||+|.+..+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 6 ~~~y-~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~ 79 (323)
T 3tki_A 6 VEDW-DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG--NI 79 (323)
T ss_dssp TTCE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred hhhc-eeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc---cchHHHHHHHHHHHHhCCCCCCCeEEEEEecC--Ce
Confidence 3567 788999999999999999999999999999975532 23346688999999999999999999988654 57
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
+++||||+.+|+|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..+.
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFR 156 (323)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECE
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEe-CCCCEEEEEeeccceec
Confidence 8999999999999999988888999999999999999999999999 99999999999997 78899999999997553
Q ss_pred CC----CCccccCCCCCCCccccccc--cCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006779 183 QP----TARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 183 ~~----~~~~~~GTp~Y~APEvl~~~--ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~ 256 (631)
.. .....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.........+................++
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (323)
T 3tki_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236 (323)
T ss_dssp ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCH
T ss_pred cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCH
Confidence 22 23456899999999987643 4778999999999999999999998765554555555544333333345678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 257 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
.+++||.+||. +|.+|||+.|+|+||||.....
T Consensus 237 ~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 237 APLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence 99999999998 8999999999999999986543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=396.72 Aligned_cols=267 Identities=21% Similarity=0.403 Sum_probs=227.5
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
-++| ++.+.||+|+||.||+|.+..+|..||+|.+....... ......+.+|+.+|+.++||||++++++|.+. ..
T Consensus 14 ~~~y-~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~ 89 (384)
T 4fr4_A 14 FDHF-EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE-RNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE--ED 89 (384)
T ss_dssp GGGE-EEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SE
T ss_pred hHHe-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhccc-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CE
Confidence 3566 77899999999999999999999999999997543211 23356788999999999999999999998765 47
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
+|+||||+.||+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++....
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLD-EHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEC-CCCCEEEeccceeeecc
Confidence 9999999999999999999989999999999999999999999999 99999999999998 78999999999997664
Q ss_pred C-CCCccccCCCCCCCcccccc----ccCccccchhhhHHHHHHhhcCCCCCCC--CCHHHHHHHHHcCCCCCCCCCCCc
Q 006779 183 Q-PTARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNEC--KNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 183 ~-~~~~~~~GTp~Y~APEvl~~----~ys~~sDIwSLGiilyELltG~~Pf~~~--~~~~~i~~~i~~~~~p~~l~~~~~ 255 (631)
. ......+||+.|+|||++.. .|+.++|||||||++|+|++|+.||... .....++..+.... ..++...+
T Consensus 167 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~p~~~s 244 (384)
T 4fr4_A 167 RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--VTYPSAWS 244 (384)
T ss_dssp TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC--CCCCTTSC
T ss_pred CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc--cCCCCcCC
Confidence 3 34556789999999998752 4899999999999999999999999742 34455555555443 23455678
Q ss_pred HHHHHHHHHhcC-CCCCCCC-HHHHhcCCCCCCCCCcccccCCCC
Q 006779 256 PQVKQFIEKCIV-PASLRLP-ALELLKDPFLVTDNPKDLVCDPLR 298 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rps-a~elL~hpff~~~~~~~~~~~~~~ 298 (631)
+.+++||.+||. +|.+||+ +.+++.||||...++..+....+.
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~~~~~~ 289 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLI 289 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHHhCCCC
Confidence 999999999998 8999998 899999999999988776554443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=382.51 Aligned_cols=261 Identities=25% Similarity=0.398 Sum_probs=219.2
Q ss_pred CCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCH--HHHHHHHHHHHHHHhCCCCCceeeeeeEEcC
Q 006779 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--DQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~--~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 98 (631)
+...+| ++.+.||+|+||.||+|.++.+|..||+|.+......... ...+.+.+|+.+|+.++||||++++++|.+.
T Consensus 8 ~~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 8 NVDDYY-DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp CHHHHE-EEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred Ccccce-EeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 344556 8889999999999999999999999999999765432211 1356788999999999999999999998654
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCC----cEEEcc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVKIGD 174 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g----~vKL~D 174 (631)
..+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++ .+||+|
T Consensus 87 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~-~~~~~~~~~kl~D 161 (326)
T 2y0a_A 87 --TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLL-DRNVPKPRIKIID 161 (326)
T ss_dssp --SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEES-CSSSSSCCEEECC
T ss_pred --CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEe-cCCCCCCCEEEEE
Confidence 479999999999999999998889999999999999999999999999 99999999999997 555 799999
Q ss_pred ccccchhcC-CCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--CCC
Q 006779 175 LGLAIVMQQ-PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASL 250 (631)
Q Consensus 175 FGla~~~~~-~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--~~l 250 (631)
||++..... .......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+. +.......+...... ...
T Consensus 162 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~ 240 (326)
T 2y0a_A 162 FGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-TKQETLANVSAVNYEFEDEY 240 (326)
T ss_dssp CTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHHHHHHHTCCCCCHHH
T ss_pred CCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC-CHHHHHHHHHhcCCCcCccc
Confidence 999976643 23445689999999998764 5899999999999999999999999874 455555555543221 112
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 251 ~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
....++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 241 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 24567899999999998 899999999999999998654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=398.23 Aligned_cols=255 Identities=26% Similarity=0.438 Sum_probs=220.0
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.+| ++.+.||+|+||+||+|.++.+|..||+|.+..... .....+.+.+|+.+|+.++||||++++++|.+. ..+
T Consensus 11 ~~Y-~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~ 85 (444)
T 3soa_A 11 EEY-QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKHPNIVRLHDSISEE--GHH 85 (444)
T ss_dssp HHE-EEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC--HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS--SEE
T ss_pred CCe-EEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC--CEE
Confidence 455 788999999999999999999999999999976542 345567799999999999999999999998654 578
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC--CCCcEEEccccccchh
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKL~DFGla~~~ 181 (631)
++||||+.||+|.+++...+.+++..++.+++||+.||.|||+++ |+||||||+|||++. .++.+||+|||++...
T Consensus 86 ~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 999999999999999999999999999999999999999999999 999999999999973 3578999999999766
Q ss_pred cCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCcH
Q 006779 182 QQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDP 256 (631)
Q Consensus 182 ~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--~~l~~~~~~ 256 (631)
... ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+...++..+..+... .......++
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~ 242 (444)
T 3soa_A 164 EGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTP 242 (444)
T ss_dssp CTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred cCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHhCCCCCCccccccCCH
Confidence 543 2345689999999998865 599999999999999999999999977 5667777777766432 223345689
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 257 QVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
.+++||.+||. +|.+|||+.|+|+||||..
T Consensus 243 ~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 243 EAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred HHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 99999999998 8999999999999999964
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=400.57 Aligned_cols=263 Identities=20% Similarity=0.352 Sum_probs=219.2
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
..+| ++.++||+|+||+||+|.++.+|..||+|++....... ....+.+.+|+.+|+.++||||++++++|.+. ..
T Consensus 68 ~~~y-~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~ 143 (410)
T 3v8s_A 68 AEDY-EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAFQDD--RY 143 (410)
T ss_dssp GGGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred cccc-EEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CE
Confidence 3456 77899999999999999999999999999987532111 11123477899999999999999999998754 57
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
+|+||||+.||+|.+++.+. .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~-~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMN 219 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECC
T ss_pred EEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeEC-CCCCEEEeccceeEeec
Confidence 99999999999999999764 6999999999999999999999999 99999999999998 78999999999997655
Q ss_pred CCC---CccccCCCCCCCccccccc-----cCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCC
Q 006779 183 QPT---ARSVIGTPEFMAPELYEEE-----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSK 252 (631)
Q Consensus 183 ~~~---~~~~~GTp~Y~APEvl~~~-----ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p~~l~~ 252 (631)
... ..+.+||+.|+|||++.+. |+.++|||||||++|||++|+.||.. .+...++..+..+.. ......
T Consensus 220 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~ 298 (410)
T 3v8s_A 220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDN 298 (410)
T ss_dssp TTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCTTC
T ss_pred cCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC-CChhhHHHHHHhccccccCCCcc
Confidence 432 3467899999999987532 78999999999999999999999986 566777777765421 111223
Q ss_pred CCcHHHHHHHHHhcC-CCCC--CCCHHHHhcCCCCCCCCCccccc
Q 006779 253 VTDPQVKQFIEKCIV-PASL--RLPALELLKDPFLVTDNPKDLVC 294 (631)
Q Consensus 253 ~~~~~l~~lI~~cL~-~p~~--Rpsa~elL~hpff~~~~~~~~~~ 294 (631)
..++++++||.+||. +|.+ |+++.|+++||||+..+|..+..
T Consensus 299 ~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~ 343 (410)
T 3v8s_A 299 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETL 343 (410)
T ss_dssp CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTG
T ss_pred cccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhh
Confidence 568999999999998 5666 89999999999999987765433
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=388.33 Aligned_cols=255 Identities=25% Similarity=0.472 Sum_probs=220.4
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
++| ++.+.||+|+||.||+|.++.+|..||+|++..... .....+.+.+|+.+|+.|+||||++++++|.+. ..+
T Consensus 29 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~ 103 (362)
T 2bdw_A 29 DNY-DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEE--SFH 103 (362)
T ss_dssp HHE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEE
T ss_pred cCe-EEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEE
Confidence 456 788999999999999999999999999999976543 456678899999999999999999999998654 478
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC--CCcEEEccccccchh
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~--~g~vKL~DFGla~~~ 181 (631)
++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.. ++.+||+|||++...
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp EEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 999999999999999998888999999999999999999999999 9999999999999732 346999999999766
Q ss_pred cCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCcHH
Q 006779 182 QQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQ 257 (631)
Q Consensus 182 ~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--~~l~~~~~~~ 257 (631)
... ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+...++..+..+... .......+++
T Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 260 (362)
T 2bdw_A 182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPE 260 (362)
T ss_dssp TTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTGGGGSCHH
T ss_pred cCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 543 3345689999999998865 599999999999999999999999987 4566777777665432 2222346789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 258 VKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 258 l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
+++||.+||. +|.+||++.++|+||||..
T Consensus 261 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 261 AKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 9999999998 8999999999999999974
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=400.88 Aligned_cols=264 Identities=23% Similarity=0.420 Sum_probs=216.5
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
++| ++.+.||+|+||.||+|.+..+|..||+|++..... ........+.+|+.+|+.++||||++++++|.+. ..+
T Consensus 148 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~ 223 (446)
T 4ejn_A 148 NEF-EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRL 223 (446)
T ss_dssp GGE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-C-------------CCCCCSCTTSCCEEEEEEET--TEE
T ss_pred HHc-EEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh-hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC--CEE
Confidence 456 778999999999999999999999999999975432 2344556788999999999999999999998765 468
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+ ++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~-~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEEC-SSSCEEECCCCCCCTTC
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEEC-CCCCEEEccCCCceecc
Confidence 9999999999999999998999999999999999999999998 88 99999999999998 78999999999997543
Q ss_pred C--CCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006779 183 Q--PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 183 ~--~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~ 259 (631)
. ......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.. .+...+...+..... .++...++.++
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~ 377 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLGPEAK 377 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHH
T ss_pred CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHH
Confidence 2 23456789999999998754 599999999999999999999999987 456666666665432 34556789999
Q ss_pred HHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCcccccCCC
Q 006779 260 QFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPL 297 (631)
Q Consensus 260 ~lI~~cL~-~p~~Rp-----sa~elL~hpff~~~~~~~~~~~~~ 297 (631)
+||.+||. +|.+|| ++.|+|+||||...++..+....+
T Consensus 378 ~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~ 421 (446)
T 4ejn_A 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKL 421 (446)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred HHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcC
Confidence 99999998 899999 999999999999988776554433
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=381.45 Aligned_cols=255 Identities=22% Similarity=0.348 Sum_probs=218.2
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
-.+|| ++.+.||+|+||+||+|.++.+|..||+|.+... ......+.+|+.+|+.++||||++++++|.+. .
T Consensus 3 ~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~ 74 (321)
T 1tki_A 3 LYEKY-MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFESM--E 74 (321)
T ss_dssp CTTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--T
T ss_pred hhhce-EeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecC--C
Confidence 35677 7889999999999999999999999999998643 23456788999999999999999999998765 4
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC-CCcEEEccccccc
Q 006779 102 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAI 179 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~-~g~vKL~DFGla~ 179 (631)
.+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.. ++.+||+|||++.
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~ 152 (321)
T 1tki_A 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence 799999999999999999765 47999999999999999999999999 9999999999999732 6899999999997
Q ss_pred hhcCC-CCccccCCCCCCCccccccc-cCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCCc
Q 006779 180 VMQQP-TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTD 255 (631)
Q Consensus 180 ~~~~~-~~~~~~GTp~Y~APEvl~~~-ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~--l~~~~~ 255 (631)
..... ......||+.|+|||++.+. ++.++|||||||++|+|++|..||.. .+..++...+..+..... .....+
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s 231 (321)
T 1tki_A 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEIS 231 (321)
T ss_dssp ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred ECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHcCCCCCChhhhccCC
Confidence 66443 23456799999999988655 79999999999999999999999987 456666666665543221 123467
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
+++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 232 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 899999999998 89999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=386.92 Aligned_cols=258 Identities=22% Similarity=0.421 Sum_probs=213.1
Q ss_pred CCceeeeeeEeccc--CceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC
Q 006779 23 SCRYGRYDEILGKG--AFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 23 ~gRy~r~~e~LG~G--~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~ 100 (631)
.+|| ++.+.||+| +||+||+|.++.+|+.||+|++..... .....+.+.+|+.+|+.++||||++++++|.+.
T Consensus 24 ~~~y-~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 98 (389)
T 3gni_B 24 GGCY-ELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC--SNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-- 98 (389)
T ss_dssp GGGE-EEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred CCcE-EEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC--
Confidence 4566 888999999 999999999999999999999986542 456678899999999999999999999999765
Q ss_pred CeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 101 RTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
..+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~dfg~~ 175 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRSN 175 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCGGGC
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEcccccc
Confidence 4799999999999999999876 67999999999999999999999999 99999999999997 7899999999988
Q ss_pred chhcC---------CCCccccCCCCCCCcccccc---ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC
Q 006779 179 IVMQQ---------PTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246 (631)
Q Consensus 179 ~~~~~---------~~~~~~~GTp~Y~APEvl~~---~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~ 246 (631)
..... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+......+...+.....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 54321 12233578999999998765 5899999999999999999999999875544444332221100
Q ss_pred -------------------------------------------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 006779 247 -------------------------------------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 282 (631)
Q Consensus 247 -------------------------------------------p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hp 282 (631)
...+....++.+++||.+||+ +|.+|||+.|+|+||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 011334467889999999998 899999999999999
Q ss_pred CCCCCC
Q 006779 283 FLVTDN 288 (631)
Q Consensus 283 ff~~~~ 288 (631)
||+...
T Consensus 336 ~f~~~~ 341 (389)
T 3gni_B 336 FFKQIK 341 (389)
T ss_dssp GGGGC-
T ss_pred HHHHHh
Confidence 998754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=372.29 Aligned_cols=261 Identities=23% Similarity=0.395 Sum_probs=214.8
Q ss_pred ccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEE
Q 006779 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (631)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 96 (631)
-.+..-.+|| ++.+.||+|+||.||+|.+..+|..||+|.+..... ....+.+.+|+.+|+.++||||+++++++.
T Consensus 15 ~~~g~i~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 90 (285)
T 3is5_A 15 YFQGTIDDLF-IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS---QVPMEQIEAEIEVLKSLDHPNIIKIFEVFE 90 (285)
T ss_dssp EESSCHHHHE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---CSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCCCChhhhe-eecceeccCCCeEEEEEEEccCCceEEEEEeecccc---chhHHHHHHHHHHHHhCCCchHHhHHHhee
Confidence 3444555777 788999999999999999999999999999976542 223567889999999999999999999986
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC--CCCcE
Q 006779 97 DDTNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEV 170 (631)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~l~~----~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~--~~g~v 170 (631)
+. ..+++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++. .++.+
T Consensus 91 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~ 166 (285)
T 3is5_A 91 DY--HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPI 166 (285)
T ss_dssp CS--SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCE
T ss_pred cC--CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCE
Confidence 54 478999999999999998854 367999999999999999999999999 999999999999952 45789
Q ss_pred EEccccccchhcCC-CCccccCCCCCCCccccccccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-
Q 006779 171 KIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA- 248 (631)
Q Consensus 171 KL~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~- 248 (631)
||+|||++...... ......||+.|+|||++.+.++.++|||||||++|+|++|+.||.+ .+...+...+.......
T Consensus 167 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~ 245 (285)
T 3is5_A 167 KIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTG-TSLEEVQQKATYKEPNYA 245 (285)
T ss_dssp EECCCCCCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCC
T ss_pred EEEeeecceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCC-CCHHHHHhhhccCCcccc
Confidence 99999999765443 3445679999999999988899999999999999999999999987 45555555554433222
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 249 ~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
......++.+++||.+||. +|.+|||+.|+|+||||+.
T Consensus 246 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 246 VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 2223367899999999998 8999999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=391.26 Aligned_cols=266 Identities=23% Similarity=0.407 Sum_probs=219.5
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHH-HHhCCCCCceeeeeeEEcCCCCe
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL-LKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~i-Lk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
++| ++.++||+|+||.||+|.++.+|..||+|++....... ......+.+|..+ ++.++||||++++++|.+. ..
T Consensus 38 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~--~~ 113 (373)
T 2r5t_A 38 SDF-HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK-KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--DK 113 (373)
T ss_dssp GGE-EEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECS--SE
T ss_pred hhe-EEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC--CE
Confidence 455 77899999999999999999999999999998665432 3344567777776 5788999999999998764 47
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCBCGGGB
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEC-CCCCEEEeeCccccccc
Confidence 9999999999999999999889999999999999999999999999 99999999999998 78999999999997543
Q ss_pred --CCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006779 183 --QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 183 --~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~ 259 (631)
.......+||+.|+|||++.+ .|+.++|||||||++|||++|..||.. .+..+++..+..+. ..++...++.++
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~ 267 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKP--LQLKPNITNSAR 267 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SBHHHHHHHHHHSC--CCCCSSSCHHHH
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcc--cCCCCCCCHHHH
Confidence 234556789999999998765 589999999999999999999999976 56677777776653 334556789999
Q ss_pred HHHHHhcC-CCCCCCCH----HHHhcCCCCCCCCCcccccCCCCC
Q 006779 260 QFIEKCIV-PASLRLPA----LELLKDPFLVTDNPKDLVCDPLRL 299 (631)
Q Consensus 260 ~lI~~cL~-~p~~Rpsa----~elL~hpff~~~~~~~~~~~~~~~ 299 (631)
+||.+||. +|.+||++ .+++.||||...+|..+....+..
T Consensus 268 ~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~p 312 (373)
T 2r5t_A 268 HLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITP 312 (373)
T ss_dssp HHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred HHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCC
Confidence 99999998 89999996 699999999999888765544433
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=388.28 Aligned_cols=256 Identities=24% Similarity=0.394 Sum_probs=204.1
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCceeeeeeEEcCCCCe
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~ 102 (631)
+|| ++.+.||+|+||.||+|.+..+|+.||+|++... ........++.+|+.+|+.+. ||||++++++|...+...
T Consensus 9 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 9 RKY-ELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA--FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp TTE-EEEEC-------CEEEEEETTTCCEEEEEEECC----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred Cce-EEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc--ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 567 7789999999999999999999999999998643 234567788999999999997 999999999998776678
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
+|+|||||. |+|..++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++...
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLN-AECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEESS
T ss_pred EEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEc-CCCCEEecCCccccccc
Confidence 999999997 689999876 46999999999999999999999999 99999999999998 78999999999997542
Q ss_pred C-----------------------CCCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHH
Q 006779 183 Q-----------------------PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 237 (631)
Q Consensus 183 ~-----------------------~~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i 237 (631)
. ......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.....++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 2 11234689999999998754 5899999999999999999999999875444443
Q ss_pred HHHHHcCCCCC----------------------------C----------------CCCCCcHHHHHHHHHhcC-CCCCC
Q 006779 238 YKKVTSGIKPA----------------------------S----------------LSKVTDPQVKQFIEKCIV-PASLR 272 (631)
Q Consensus 238 ~~~i~~~~~p~----------------------------~----------------l~~~~~~~l~~lI~~cL~-~p~~R 272 (631)
...+.....|. . .....++++++||.+||+ +|.+|
T Consensus 241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 33322111110 0 011457899999999998 99999
Q ss_pred CCHHHHhcCCCCCCC
Q 006779 273 LPALELLKDPFLVTD 287 (631)
Q Consensus 273 psa~elL~hpff~~~ 287 (631)
||+.|+|+||||...
T Consensus 321 ~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 321 ISANDALKHPFVSIF 335 (388)
T ss_dssp CCHHHHTTSTTTTTT
T ss_pred CCHHHHhCCHHHHHh
Confidence 999999999999753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=364.17 Aligned_cols=259 Identities=26% Similarity=0.473 Sum_probs=221.8
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
-.++| ++.+.||+|+||.||+|.++.+|..||+|.+..... .....+.+.+|+.+++.++||||+++++++.+. .
T Consensus 4 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 78 (284)
T 3kk8_A 4 FSDNY-DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEE--S 78 (284)
T ss_dssp TTTTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred hhhhh-hhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC--C
Confidence 35677 788999999999999999999999999999976543 456678899999999999999999999988654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC--CCCcEEEccccccc
Q 006779 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAI 179 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKL~DFGla~ 179 (631)
..++||||+.+++|.+++.....+++..++.++.||+.||.|||+++ |+||||||+||+++. .++.+||+|||++.
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 68999999999999999998889999999999999999999999999 999999999999972 23459999999997
Q ss_pred hhcCCC-CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCc
Q 006779 180 VMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTD 255 (631)
Q Consensus 180 ~~~~~~-~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p~~l~~~~~ 255 (631)
...... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.. .+...+...+..+.. +.......+
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T 3kk8_A 157 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVT 235 (284)
T ss_dssp ECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred EcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC-CchhHHHHHHHhccccCCchhhcccC
Confidence 655433 345679999999998765 489999999999999999999999987 456666666665543 222334568
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
+.+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 236 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 236 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 999999999998 899999999999999998654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=375.50 Aligned_cols=260 Identities=25% Similarity=0.415 Sum_probs=208.3
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
+.-.+|| ++.+.||+|+||+||+|.+. +|+.||+|++..... .......+.+|+.+|+.++||||+++++++.+.
T Consensus 17 q~l~~~y-~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 91 (311)
T 3niz_A 17 QGLMEKY-QKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE--DEGIPSTAIREISLLKELHHPNIVSLIDVIHSE- 91 (311)
T ss_dssp ECSSCEE-EEEEEEEECSSCEEEEEEET-TSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS-
T ss_pred cchHhhh-HhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc--cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC-
Confidence 3455777 77899999999999999985 599999999875432 233456788999999999999999999988644
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
..+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 92 -~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a 166 (311)
T 3niz_A 92 -RCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLIN-SDGALKLADFGLA 166 (311)
T ss_dssp -SCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTC
T ss_pred -CEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEEC-CCCCEEEccCcCc
Confidence 578999999975 787777664 45999999999999999999999999 99999999999997 7889999999999
Q ss_pred chhcCC--CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHH--cCCCCCCC--
Q 006779 179 IVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT--SGIKPASL-- 250 (631)
Q Consensus 179 ~~~~~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~--~~~~p~~l-- 250 (631)
...... ......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||........+..... ....+..+
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 167 RAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp EETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGG
T ss_pred eecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhh
Confidence 766433 2344578999999998754 489999999999999999999999987555444433322 11111111
Q ss_pred -----------------------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 251 -----------------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 251 -----------------------~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
....++++++||.+||. +|.+|||+.|+|+||||+..++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 12246789999999998 9999999999999999987554
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=400.20 Aligned_cols=262 Identities=19% Similarity=0.356 Sum_probs=219.0
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
..+| ++.++||+|+||+||+|.++.+|+.||+|++....... ......+.+|+.+|+.++||||++++++|.+. ..
T Consensus 73 ~~~y-~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~--~~ 148 (437)
T 4aw2_A 73 REDF-EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDSKWITTLHYAFQDD--NN 148 (437)
T ss_dssp GGGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS--SE
T ss_pred hhhe-EEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--CE
Confidence 3456 77899999999999999999999999999997532211 11223478899999999999999999998764 47
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 103 INMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
+|+|||||.+|+|.+++.+ .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~-~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKL 225 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEc-CCCCEEEcchhhhhhc
Confidence 9999999999999999987 578999999999999999999999999 99999999999998 7899999999999755
Q ss_pred cCCC---CccccCCCCCCCccccc------cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCC---CCCC
Q 006779 182 QQPT---ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPAS 249 (631)
Q Consensus 182 ~~~~---~~~~~GTp~Y~APEvl~------~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~---~p~~ 249 (631)
.... ....+||+.|+|||++. +.|+.++|||||||++|||++|+.||.+ .+..+.+..+.... ..+.
T Consensus 226 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~ 304 (437)
T 4aw2_A 226 MEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPT 304 (437)
T ss_dssp CTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCS
T ss_pred ccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC-CChhHHHHhhhhccccccCCc
Confidence 4332 23468999999999875 3589999999999999999999999987 56666666665421 1122
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCC--CCCHHHHhcCCCCCCCCCccc
Q 006779 250 LSKVTDPQVKQFIEKCIV-PASL--RLPALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 250 l~~~~~~~l~~lI~~cL~-~p~~--Rpsa~elL~hpff~~~~~~~~ 292 (631)
.....++++++||.+||. +|.+ |+++.|+++||||+..+|..+
T Consensus 305 ~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence 223468999999999997 5555 899999999999999988876
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=389.65 Aligned_cols=257 Identities=28% Similarity=0.468 Sum_probs=214.8
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
.-|+| ++.+.||+|+||.||+|.+..+|..||+|++...... ......++.+|+.+|+.++||||+++++++.+. .
T Consensus 7 ~i~~Y-~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~ 82 (336)
T 3h4j_B 7 HIGPY-IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK-KSDMHMRVEREISYLKLLRHPHIIKLYDVITTP--T 82 (336)
T ss_dssp EETTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS--S
T ss_pred ccCCE-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc-chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--C
Confidence 34778 8889999999999999999999999999998743211 112235688999999999999999999998764 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
.+++||||+ +|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLD-DNLNVKIADFGLSNIM 158 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEEC-TTCCEEECCSSCTBTT
T ss_pred EEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEc-CCCCEEEEEeccceec
Confidence 789999999 7899999988889999999999999999999999999 99999999999998 7889999999999766
Q ss_pred cCC-CCccccCCCCCCCccccccc-c-CccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006779 182 QQP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 182 ~~~-~~~~~~GTp~Y~APEvl~~~-y-s~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l 258 (631)
... .....+||+.|+|||++.+. + +.++|||||||++|+|++|+.||.+... ..+...+..+ ...++...++.+
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-~~~~~~i~~~--~~~~p~~~s~~~ 235 (336)
T 3h4j_B 159 TDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI-PNLFKKVNSC--VYVMPDFLSPGA 235 (336)
T ss_dssp TTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS-TTCBCCCCSS--CCCCCTTSCHHH
T ss_pred cCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH-HHHHHHHHcC--CCCCcccCCHHH
Confidence 443 34566899999999988654 4 7899999999999999999999976322 2222222221 223455678999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 259 KQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 259 ~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
++||.+||. +|.+|||+.|+++||||+...+
T Consensus 236 ~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 267 (336)
T 3h4j_B 236 QSLIRRMIVADPMQRITIQEIRRDPWFNVNLP 267 (336)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred HHHHHHHcCCChhHCcCHHHHHhChhhccCCc
Confidence 999999998 8999999999999999986543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=396.44 Aligned_cols=262 Identities=19% Similarity=0.364 Sum_probs=219.3
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
..+| ++.++||+|+||.||+|.++.+|+.||+|+++..... .....+.+.+|..+|..++||||++++++|.+. ..
T Consensus 60 ~~~f-~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~-~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~--~~ 135 (412)
T 2vd5_A 60 RDDF-EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML-KRGEVSCFREERDVLVNGDRRWITQLHFAFQDE--NY 135 (412)
T ss_dssp GGGE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS--SE
T ss_pred hhhE-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--CE
Confidence 3456 7789999999999999999999999999999753221 122334578999999999999999999998765 47
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 103 INMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
+|+||||+.||+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld-~~g~vkL~DFGla~~~ 212 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLD-RCGHIRLADFGSCLKL 212 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeec-CCCCEEEeechhheec
Confidence 99999999999999999875 47999999999999999999999999 99999999999998 7899999999999765
Q ss_pred cCCC---CccccCCCCCCCccccc--------cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCC---CC
Q 006779 182 QQPT---ARSVIGTPEFMAPELYE--------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KP 247 (631)
Q Consensus 182 ~~~~---~~~~~GTp~Y~APEvl~--------~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~---~p 247 (631)
.... ....+||+.|+|||++. ..|+.++|||||||++|||++|+.||.. .+..+++..+.... ..
T Consensus 213 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~ 291 (412)
T 2vd5_A 213 RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLSL 291 (412)
T ss_dssp CTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCC
T ss_pred cCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCcCC
Confidence 4432 23468999999999875 3589999999999999999999999987 55666666665421 22
Q ss_pred CCCCCCCcHHHHHHHHHhcCCCCCC---CCHHHHhcCCCCCCCCCccc
Q 006779 248 ASLSKVTDPQVKQFIEKCIVPASLR---LPALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 248 ~~l~~~~~~~l~~lI~~cL~~p~~R---psa~elL~hpff~~~~~~~~ 292 (631)
+.+....++++++||.+||.+|.+| +++.|+++||||+..+|..+
T Consensus 292 p~~~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 292 PLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp C----CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred CccccCCCHHHHHHHHHHcCChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 2233567899999999999988877 59999999999999988776
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=383.75 Aligned_cols=259 Identities=23% Similarity=0.384 Sum_probs=205.4
Q ss_pred CCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC
Q 006779 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~ 100 (631)
...+|| ++.+.||+|+||+||+|.++.+|+.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 17 ~~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-- 88 (361)
T 3uc3_A 17 HDSDRY-DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-----IDENVQREIINHRSLRHPNIVRFKEVILTP-- 88 (361)
T ss_dssp CCTTTE-EEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-----SCHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred CCCCcE-EEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-----ccHHHHHHHHHHHhCCCCCCCcEEEEEeeC--
Confidence 345788 788999999999999999999999999999975432 124578999999999999999999998754
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCC--cEEEcccccc
Q 006779 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG--EVKIGDLGLA 178 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g--~vKL~DFGla 178 (631)
..+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++ .+||+|||++
T Consensus 89 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~-~~~~~~~kl~Dfg~a 165 (361)
T 3uc3_A 89 THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLD-GSPAPRLKICDFGYS 165 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEEC-SSSSCCEEECCCCCC
T ss_pred CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCceEEEeecCcc
Confidence 479999999999999999998889999999999999999999999999 99999999999997 444 4999999999
Q ss_pred chhcC-CCCccccCCCCCCCcccccc-ccCc-cccchhhhHHHHHHhhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCC
Q 006779 179 IVMQQ-PTARSVIGTPEFMAPELYEE-EYNE-LVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 179 ~~~~~-~~~~~~~GTp~Y~APEvl~~-~ys~-~sDIwSLGiilyELltG~~Pf~~~~~---~~~i~~~i~~~~~p~~l~~ 252 (631)
..... ......+||+.|+|||++.+ .++. ++|||||||++|+|++|+.||..... ...+...+...........
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (361)
T 3uc3_A 166 KSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDI 245 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTS
T ss_pred ccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcC
Confidence 64332 23455679999999998754 4554 48999999999999999999976433 2344444544433322333
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCc
Q 006779 253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 253 ~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~~ 290 (631)
..++.+++||.+||+ +|.+|||+.|+|+||||....+.
T Consensus 246 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 284 (361)
T 3uc3_A 246 RISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPA 284 (361)
T ss_dssp CCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCCC
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCch
Confidence 567899999999998 89999999999999999765443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=371.00 Aligned_cols=254 Identities=26% Similarity=0.420 Sum_probs=205.1
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.|| ++.+.||+|+||+||+|.+ .+|+.||+|++..... .......+.+|+.+|+.++||||+++++++.+. ..+
T Consensus 2 ~~y-~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 75 (288)
T 1ob3_A 2 EKY-HGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRL 75 (288)
T ss_dssp CSE-EEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCE
T ss_pred ccc-hhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc--ccccchhHHHHHHHHHhcCCCCEeeeeeEEccC--CeE
Confidence 467 7789999999999999998 6899999999875432 122235678999999999999999999998754 468
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
++||||+.+ +|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~ 151 (288)
T 1ob3_A 76 VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFG 151 (288)
T ss_dssp EEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCTTHHHHHC
T ss_pred EEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEEeECccccccC
Confidence 999999975 999988764 67999999999999999999999999 99999999999997 78999999999997664
Q ss_pred CC--CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCC-CC--------
Q 006779 183 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK-PA-------- 248 (631)
Q Consensus 183 ~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~-~~~-p~-------- 248 (631)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...... +.. ..
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 33 2344578999999998754 4899999999999999999999999875444444333221 000 00
Q ss_pred ----------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 249 ----------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 249 ----------------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.+....++.+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 1123367899999999998 99999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=378.99 Aligned_cols=263 Identities=27% Similarity=0.401 Sum_probs=206.9
Q ss_pred ccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC
Q 006779 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 98 (631)
.....+|| ++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+|+.++||||+++++++.+.
T Consensus 29 ~~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (329)
T 3gbz_A 29 SATSIDRY-RRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQHRNIIELKSVIHHN 105 (329)
T ss_dssp ---CGGGE-EEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred cccchhhE-EEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc--ccccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 44555677 778999999999999999999999999999975532 233456688999999999999999999998765
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeec----CCCCcEEEcc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN----GNNGEVKIGD 174 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~----~~~g~vKL~D 174 (631)
..+++||||+. |+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ...+.+||+|
T Consensus 106 --~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 106 --HRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp --TEEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred --CEEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECc
Confidence 47899999997 599999999999999999999999999999999999 99999999999995 1445699999
Q ss_pred ccccchhcCC--CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC--
Q 006779 175 LGLAIVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-- 248 (631)
Q Consensus 175 FGla~~~~~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~-- 248 (631)
||++...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||........+...+.....|.
T Consensus 181 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 181 FGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260 (329)
T ss_dssp TTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred CCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence 9999766533 2345578999999998754 489999999999999999999999987555444444433211111
Q ss_pred CC-------------------------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 249 SL-------------------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 249 ~l-------------------------~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
.+ ....++++++||.+||. +|.+|||+.|+|+||||+..++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 00 01156889999999998 9999999999999999998664
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=364.19 Aligned_cols=253 Identities=23% Similarity=0.412 Sum_probs=218.3
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
.+|| ++.+.||+|+||.||+|.+..++..||+|.+..... ...+.+.+|+.+|+.++||||+++++++.+. ..
T Consensus 8 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 80 (277)
T 3f3z_A 8 NQYY-TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV----EDVDRFKQEIEIMKSLDHPNIIRLYETFEDN--TD 80 (277)
T ss_dssp HHHE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SE
T ss_pred hhhE-EeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEecC--Ce
Confidence 4556 888999999999999999999999999999875432 2346788999999999999999999998654 57
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeee---cCCCCcEEEccccccc
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAI 179 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl---~~~~g~vKL~DFGla~ 179 (631)
+++||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||+ + .++.+||+|||++.
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~-~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDS-PDSPLKLIDFGLAA 157 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSS-TTCCEEECCCTTCE
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCC-CCCcEEEEecccce
Confidence 8999999999999999998888999999999999999999999999 9999999999999 4 67899999999997
Q ss_pred hhcCC-CCccccCCCCCCCccccccccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCCcH
Q 006779 180 VMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDP 256 (631)
Q Consensus 180 ~~~~~-~~~~~~GTp~Y~APEvl~~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~--l~~~~~~ 256 (631)
..... ......||+.|+|||++.+.++.++||||||+++|+|++|+.||.. .+..++...+..+..+.. .....++
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (277)
T 3f3z_A 158 RFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSA-PTDSEVMLKIREGTFTFPEKDWLNVSP 236 (277)
T ss_dssp ECCTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred eccCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCchhhhcCCH
Confidence 65433 3455679999999999988899999999999999999999999987 455556666665533221 1124678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 257 QVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
.+++||.+||. +|.+|||+.++|+||||+.
T Consensus 237 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 99999999998 8999999999999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=371.74 Aligned_cols=261 Identities=28% Similarity=0.414 Sum_probs=205.3
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC-HHHHHHHHHHHHHHHhC---CCCCceeeeeeEEc
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSL---KHENIIKFYNSWVD 97 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~-~~~~~~l~~Ei~iLk~L---~HpnIVkl~~~~~d 97 (631)
..+|| ++.+.||+|+||+||+|.+..+|+.||+|.+........ ......+.+|+.+++.+ +||||+++++++..
T Consensus 7 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 7 ATSRY-EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ---CC-EEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred cccce-EEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 35688 788999999999999999999999999999975432111 11123455677766666 59999999999876
Q ss_pred CCCC---eEEEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEE
Q 006779 98 DTNR---TINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 98 ~~~~---~l~lV~Ey~~gGsL~~~l~~~~~--l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL 172 (631)
.... .+++||||+. |+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~-~~~~~kl 161 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGTVKL 161 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEEC-TTSCEEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCEEE
Confidence 5432 6889999996 699999987654 999999999999999999999999 99999999999997 7889999
Q ss_pred ccccccchhcCC-CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC--CCC-
Q 006779 173 GDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKP- 247 (631)
Q Consensus 173 ~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~--~~p- 247 (631)
+|||++...... ......||+.|+|||++. ..|+.++|||||||++|+|++|+.||.... .......+... ..+
T Consensus 162 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 162 ADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS-EADQLGKIFDLIGLPPE 240 (308)
T ss_dssp CSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS-HHHHHHHHHHHHCCCCT
T ss_pred eeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCh
Confidence 999999766543 345568999999999875 568999999999999999999999998744 44333333221 111
Q ss_pred CCC----------------------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 248 ASL----------------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 248 ~~l----------------------~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
..+ ....++.+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 111 12356889999999998 899999999999999998753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=381.11 Aligned_cols=262 Identities=29% Similarity=0.491 Sum_probs=221.2
Q ss_pred ccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEE
Q 006779 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (631)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 96 (631)
+...+|..+| ++.+.||+|+||+||+|.+..+|..||+|++..... ......+.+.+|+.+|+.++||||++++++|.
T Consensus 47 ~~~~~~~~~y-~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 124 (348)
T 1u5q_A 47 FFKDDPEKLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124 (348)
T ss_dssp CCCSCHHHHE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hcccchhhhe-eeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4456777787 667889999999999999999999999999975432 23455678999999999999999999999987
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccc
Q 006779 97 DDTNRTINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~l~-~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 175 (631)
+. ..+++||||+. |+|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+||
T Consensus 125 ~~--~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~Df 198 (348)
T 1u5q_A 125 RE--HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDF 198 (348)
T ss_dssp ET--TEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEE-TTTEEEECCC
T ss_pred EC--CeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEeec
Confidence 65 47899999997 67877775 4567999999999999999999999999 99999999999998 7899999999
Q ss_pred cccchhcCCCCccccCCCCCCCccccc----cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006779 176 GLAIVMQQPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 251 (631)
Q Consensus 176 Gla~~~~~~~~~~~~GTp~Y~APEvl~----~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~ 251 (631)
|++..... .....||+.|+|||++. +.|+.++|||||||++|||++|+.||........+ ..+..+..+....
T Consensus 199 G~a~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~~~ 275 (348)
T 1u5q_A 199 GSASIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQNESPALQS 275 (348)
T ss_dssp TTCBSSSS--BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHHHSCCCCCCC
T ss_pred cCceecCC--CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhcCCCCCCC
Confidence 99976543 34567999999999873 45899999999999999999999999875444444 4444444554455
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 252 ~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
...++.+++||.+||. +|.+|||+.++|+||||....+
T Consensus 276 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 276 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314 (348)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred CCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence 6678999999999998 8999999999999999976543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=383.35 Aligned_cols=256 Identities=25% Similarity=0.444 Sum_probs=212.9
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC-HHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~-~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
++| ++.+.||+|+||+||+|.++.+|+.||+|++........ ....+.+.+|+.+|+.++||||++++++|.+. ..
T Consensus 24 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~ 100 (351)
T 3c0i_A 24 DVY-ELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD--GM 100 (351)
T ss_dssp HHE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TE
T ss_pred cce-EEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CE
Confidence 466 788999999999999999999999999999975432111 11346789999999999999999999998764 47
Q ss_pred EEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC--CCcEEEcccc
Q 006779 103 INMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLG 176 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~----~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~--~g~vKL~DFG 176 (631)
+|+|||||.+|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.. .+.+||+|||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCc
Confidence 99999999999998877543 35899999999999999999999999 9999999999999732 2359999999
Q ss_pred ccchhcCCC--CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC--CC
Q 006779 177 LAIVMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LS 251 (631)
Q Consensus 177 la~~~~~~~--~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~--l~ 251 (631)
++....... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ ....++..+..+..... ..
T Consensus 179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~i~~~~~~~~~~~~ 256 (351)
T 3c0i_A 179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG--TKERLFEGIIKGKYKMNPRQW 256 (351)
T ss_dssp TCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS--SHHHHHHHHHHTCCCCCHHHH
T ss_pred ceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC--cHHHHHHHHHcCCCCCCcccc
Confidence 997665432 345689999999998765 589999999999999999999999976 34556666655533221 12
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 252 ~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
...++.+++||.+||. +|.+|||+.++|+||||+.
T Consensus 257 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 3467899999999998 8999999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=379.98 Aligned_cols=255 Identities=24% Similarity=0.391 Sum_probs=204.9
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
.++| ++.+.||+|+||.||+|.+..+++.||+|.+.... ..+.+.+|+.+|+.++||||++++++|.+. ..
T Consensus 52 ~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 122 (349)
T 2w4o_A 52 SDFF-EVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKIVRTEIGVLLRLSHPNIIKLKEIFETP--TE 122 (349)
T ss_dssp GGTE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred cCcE-EEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHHHHHHHHHHHHhCCCCCCcceeeeEecC--Ce
Confidence 3456 78899999999999999999999999999987432 235678899999999999999999998654 47
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC--CCCcEEEccccccch
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKL~DFGla~~ 180 (631)
+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .++.+||+|||++..
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 8999999999999999998888999999999999999999999999 999999999999962 378999999999976
Q ss_pred hcCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCcH
Q 006779 181 MQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDP 256 (631)
Q Consensus 181 ~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--~~l~~~~~~ 256 (631)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||........++..+...... .......+.
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 201 VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred cCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 5443 3345679999999998765 58999999999999999999999998877776677777665332 233345678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 257 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
.+++||.+||. +|.+|||+.++|+||||....
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 99999999998 899999999999999998643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=397.61 Aligned_cols=261 Identities=29% Similarity=0.442 Sum_probs=219.8
Q ss_pred CCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC---------HHHHHHHHHHHHHHHhCCCCCceee
Q 006779 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS---------PDQLERLYSEVHLLKSLKHENIIKF 91 (631)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~---------~~~~~~l~~Ei~iLk~L~HpnIVkl 91 (631)
.-.++| ++.+.||+|+||+||+|.++.+|..||+|.+........ ....+.+.+|+.+|+.++||||+++
T Consensus 33 ~i~~~Y-~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 33 KIGESY-FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp CGGGTE-EEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred Ccccce-EEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 345666 778999999999999999999999999999976532211 1235678999999999999999999
Q ss_pred eeeEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCC--Cc
Q 006779 92 YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN--GE 169 (631)
Q Consensus 92 ~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~--g~ 169 (631)
+++|.+. ..+++|||||.+|+|.+++.+.+.+++..++.+++||+.||.|||+++ |+||||||+|||++..+ ..
T Consensus 112 ~~~~~~~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 112 FDVFEDK--KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEEEECS--SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSS
T ss_pred EEEEEcC--CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCcc
Confidence 9998654 579999999999999999998889999999999999999999999999 99999999999997332 26
Q ss_pred EEEccccccchhcCC-CCccccCCCCCCCccccccccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC
Q 006779 170 VKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 248 (631)
Q Consensus 170 vKL~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~ 248 (631)
+||+|||++...... .....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+ .+..++...+..+....
T Consensus 188 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~ 266 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGG-QNDQDIIKKVEKGKYYF 266 (504)
T ss_dssp EEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCC
T ss_pred EEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCC
Confidence 999999999766543 3456689999999999988899999999999999999999999987 56777777777765432
Q ss_pred CC--CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 249 SL--SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 249 ~l--~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.. ....++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 267 DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 21 24567899999999998 89999999999999999764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=367.69 Aligned_cols=256 Identities=23% Similarity=0.422 Sum_probs=215.8
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
.++| ++.+.||+|+||+||+|.+..++..||+|.+..... ........+.+|+.+++.++||||+++++++.+. ..
T Consensus 8 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 83 (279)
T 3fdn_A 8 LEDF-EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TR 83 (279)
T ss_dssp GGGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SE
T ss_pred cccE-EEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc-chhhHHHHHHHHHHHHHcCCCCCCcchhheEecC--CE
Confidence 3566 788999999999999999999999999999865432 1122245688999999999999999999998654 47
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
+++||||+.+|+|.+++.+...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~-~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAP 160 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEEC-TTSCEEECSCCEESCC-
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEc-CCCCEEEEeccccccCC
Confidence 8999999999999999998889999999999999999999999998 99999999999997 78999999999987665
Q ss_pred CCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006779 183 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 183 ~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~l 261 (631)
........||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+.......+..... .++...++.+++|
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~l 237 (279)
T 3fdn_A 161 SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEF--TFPDFVTEGARDL 237 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHH
T ss_pred cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC-CcHHHHHHHHHhCCC--CCCCcCCHHHHHH
Confidence 555556789999999998765 478899999999999999999999986 556666666665432 3445678899999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 262 IEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 262 I~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
|.+||. +|.+|||+.|+|+||||+...
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred HHHHhccChhhCCCHHHHhhCccccCCc
Confidence 999998 899999999999999997643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=398.38 Aligned_cols=255 Identities=27% Similarity=0.464 Sum_probs=216.2
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
+| ++.+.||+|+||+||+|.++.+|..||+|++...... ......+.+|+.+|+.++||||++++++|.+. ..++
T Consensus 38 ~y-~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~ 112 (494)
T 3lij_A 38 MY-QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS--TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK--RNYY 112 (494)
T ss_dssp HE-EEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEE
T ss_pred Ce-EEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC--chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEE
Confidence 56 7789999999999999999999999999999765432 22346788999999999999999999998654 4789
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC--CCCcEEEccccccchhc
Q 006779 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKL~DFGla~~~~ 182 (631)
+|||||.+|+|.+++.+...+++..++.+++||+.||.|||+++ |+||||||+|||++. .++.+||+|||++....
T Consensus 113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 99999999999999988889999999999999999999999999 999999999999963 24569999999997665
Q ss_pred CC-CCccccCCCCCCCccccccccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCCcHHHH
Q 006779 183 QP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQVK 259 (631)
Q Consensus 183 ~~-~~~~~~GTp~Y~APEvl~~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~--l~~~~~~~l~ 259 (631)
.. .....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+ .+..++...+..+..+.. .....++.++
T Consensus 191 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 269 (494)
T 3lij_A 191 NQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGG-QTDQEILRKVEKGKYTFDSPEWKNVSEGAK 269 (494)
T ss_dssp TTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred CCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCchhcccCCHHHH
Confidence 43 3456689999999999988899999999999999999999999987 566777777776644322 2245678999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 260 QFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 260 ~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
+||.+||. +|.+|||+.++|+||||+..
T Consensus 270 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 270 DLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 99999998 89999999999999999753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=400.15 Aligned_cols=259 Identities=31% Similarity=0.493 Sum_probs=224.6
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
.+|| ++.++||+|+||+||+|.++.+|..||+|++...... .....+.+.+|+.+|++++||||++++++|.+. ..
T Consensus 25 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~ 100 (484)
T 3nyv_A 25 SDRY-KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK-QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK--GY 100 (484)
T ss_dssp HHHE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-BSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SE
T ss_pred cCce-EEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcc-cchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CE
Confidence 4567 7889999999999999999999999999999765432 233457789999999999999999999998654 57
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeec--CCCCcEEEccccccch
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~--~~~g~vKL~DFGla~~ 180 (631)
+++||||+.+|+|.+++...+.+++..++.+++||+.||.|||+++ |+||||||+|||++ ..++.+||+|||++..
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 9999999999999999999899999999999999999999999999 99999999999995 2568999999999976
Q ss_pred hcCC-CCccccCCCCCCCccccccccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCCcHH
Q 006779 181 MQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTDPQ 257 (631)
Q Consensus 181 ~~~~-~~~~~~GTp~Y~APEvl~~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l--~~~~~~~ 257 (631)
.... .....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+ .+..++...+..+..+... ....++.
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 257 (484)
T 3nyv_A 179 FEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEKGKYTFELPQWKKVSES 257 (484)
T ss_dssp BCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGGGSCHH
T ss_pred cccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCCcccccCCHH
Confidence 6543 3345689999999999988999999999999999999999999987 5667777777776543322 2346789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 258 VKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 258 l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
+++||.+||+ +|.+|||+.++|+||||+...
T Consensus 258 ~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 258 AKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred HHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 9999999998 899999999999999998643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=372.09 Aligned_cols=258 Identities=22% Similarity=0.367 Sum_probs=207.6
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~ 101 (631)
..+|....++||+|+||+||+|.+..+|+.||+|++.... ....+++.+|+.+|+++ +||||+++++++.+. .
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~--~ 84 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP----GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE--D 84 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS----SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--T
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc----chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--C
Confidence 4567444588999999999999999999999999987542 23346788999999985 799999999998765 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCc---EEEcccccc
Q 006779 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE---VKIGDLGLA 178 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~---vKL~DFGla 178 (631)
.+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++. +||+|||++
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCE-HPNQVSPVKICDFDLG 161 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEES-CSSSSCSEEECCTTCC
T ss_pred EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEc-cCCCcCceEEEEccCc
Confidence 79999999999999999998888999999999999999999999999 99999999999997 4444 999999998
Q ss_pred chhcCC---------CCccccCCCCCCCccccc------cccCccccchhhhHHHHHHhhcCCCCCCCCC----------
Q 006779 179 IVMQQP---------TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKN---------- 233 (631)
Q Consensus 179 ~~~~~~---------~~~~~~GTp~Y~APEvl~------~~ys~~sDIwSLGiilyELltG~~Pf~~~~~---------- 233 (631)
...... .....+||+.|+|||++. ..|+.++|||||||++|+|++|+.||.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 241 (316)
T 2ac3_A 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241 (316)
T ss_dssp C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence 654321 123456999999999875 3489999999999999999999999976432
Q ss_pred ----HHHHHHHHHcCCCCCC--CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 234 ----PAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 234 ----~~~i~~~i~~~~~p~~--l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
...+...+..+..... .....++.+++||.+||. +|.+|||+.|+|+||||+...+
T Consensus 242 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 242 CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304 (316)
T ss_dssp CHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred chhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence 2445566665533211 113467899999999998 9999999999999999986543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=400.06 Aligned_cols=264 Identities=30% Similarity=0.501 Sum_probs=224.6
Q ss_pred ccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEE
Q 006779 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (631)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 96 (631)
.....-.+|| ++.++||+|+||+||+|.++.+|..||+|++....... .....+.+|+.+|++++||||+++++++.
T Consensus 15 ~~~g~~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 91 (486)
T 3mwu_A 15 YFQGTFAERY-NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDTSTILREVELLKKLDHPNIMKLFEILE 91 (486)
T ss_dssp TTCCHHHHHE-EEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cccCChhcce-EEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc--hHHHHHHHHHHHHHhCCCCCcCeEEEEEE
Confidence 3344455677 77899999999999999999999999999997543221 23467889999999999999999999986
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC--CCCcEEEcc
Q 006779 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGD 174 (631)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKL~D 174 (631)
+. ..+++|||||.+|+|.+++.+.+.+++..++.+++||+.||.|||+++ |+||||||+|||++. .++.+||+|
T Consensus 92 ~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~D 167 (486)
T 3mwu_A 92 DS--SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIID 167 (486)
T ss_dssp CS--SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECS
T ss_pred cC--CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEE
Confidence 54 579999999999999999988889999999999999999999999999 999999999999962 456899999
Q ss_pred ccccchhcCC-CCccccCCCCCCCccccccccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--
Q 006779 175 LGLAIVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS-- 251 (631)
Q Consensus 175 FGla~~~~~~-~~~~~~GTp~Y~APEvl~~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~-- 251 (631)
||++...... .....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+ .+..++...+..+..+...+
T Consensus 168 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~ 246 (486)
T 3mwu_A 168 FGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQW 246 (486)
T ss_dssp CSCTTTBCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCSGGG
T ss_pred CCcCeECCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCCccc
Confidence 9999766443 3455689999999999998999999999999999999999999987 56677777777665433322
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 252 ~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
...++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 247 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 3467899999999998 899999999999999998643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=369.75 Aligned_cols=259 Identities=22% Similarity=0.390 Sum_probs=209.1
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
+|| ++.+.||+|+||+||+|.+..+|..||+|++.... ......+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 3 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 77 (311)
T 4agu_A 3 EKY-EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK--RRL 77 (311)
T ss_dssp CCE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC--C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEE
T ss_pred ccc-eEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc--cchHHHHHHHHHHHHHHhCCCCCccchhheeecC--CeE
Confidence 567 77899999999999999999999999999986543 3445567788999999999999999999998764 468
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
++||||+.+++|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILIT-KHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp EEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECC-
T ss_pred EEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEc-CCCCEEEeeCCCchhccC
Confidence 999999999999999998888999999999999999999999999 99999999999997 789999999999976543
Q ss_pred C--CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc--C-------------
Q 006779 184 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--G------------- 244 (631)
Q Consensus 184 ~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~--~------------- 244 (631)
. ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+......+...... .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 155 PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 2 2345678999999998754 5899999999999999999999999875444433322111 0
Q ss_pred ----CC-C--CCC------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCc
Q 006779 245 ----IK-P--ASL------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 245 ----~~-p--~~l------~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~~ 290 (631)
.. + ... ....++.+.+||.+||. +|.+|||+.|+|+||||+.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 00 0 000 12356789999999998 89999999999999999875443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=375.85 Aligned_cols=255 Identities=24% Similarity=0.421 Sum_probs=215.0
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC--CCceeeeeeEEcCCC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDTN 100 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~H--pnIVkl~~~~~d~~~ 100 (631)
.++.|++.+.||+|+||.||+|.+. +|..||+|++.... ......+.+.+|+.+|+.++| |||+++++++.+.
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-- 81 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-- 81 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccc--cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC--
Confidence 3555588999999999999999884 68999999997654 245666889999999999987 9999999988754
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
..+++||| +.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++..
T Consensus 82 ~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~--~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 82 QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIANQ 156 (343)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE--TTEEEECCCSSSCC
T ss_pred CEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE--CCcEEEeecccccc
Confidence 47999999 558899999999999999999999999999999999999 99999999999996 67899999999976
Q ss_pred hcCCC----CccccCCCCCCCccccc------------cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006779 181 MQQPT----ARSVIGTPEFMAPELYE------------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244 (631)
Q Consensus 181 ~~~~~----~~~~~GTp~Y~APEvl~------------~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~ 244 (631)
..... ....+||+.|+|||++. ..|+.++|||||||++|+|++|+.||....+.......+...
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 236 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 236 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC
Confidence 54332 23567999999999874 358889999999999999999999998766665556666655
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 245 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 245 ~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.....++...++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 55556677778899999999998 89999999999999999753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=382.89 Aligned_cols=259 Identities=23% Similarity=0.369 Sum_probs=218.8
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
.+-.++| ++.+.||+|+||.||+|.++.+|..||+|.+... .......+.+|+.+|+.++||||++++++|.+.
T Consensus 47 ~~~~~~y-~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~- 120 (387)
T 1kob_A 47 GSVYDYY-DILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK- 120 (387)
T ss_dssp SCGGGTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-
T ss_pred Cccccce-EEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc----chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC-
Confidence 3444566 7889999999999999999999999999998743 234556789999999999999999999998654
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC-CCCcEEEccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGL 177 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~-~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~-~~g~vKL~DFGl 177 (631)
..+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++. ..+.+||+|||+
T Consensus 121 -~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~ 197 (387)
T 1kob_A 121 -YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGL 197 (387)
T ss_dssp -SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred -CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEeccc
Confidence 57999999999999999987654 7999999999999999999999999 999999999999973 357899999999
Q ss_pred cchhcCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCC
Q 006779 178 AIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKV 253 (631)
Q Consensus 178 a~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p~~l~~~ 253 (631)
+...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+.......+..... +......
T Consensus 198 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~ 276 (387)
T 1kob_A 198 ATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSS 276 (387)
T ss_dssp CEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTT
T ss_pred ceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccc
Confidence 9766543 2344579999999998765 589999999999999999999999987 455555555555432 2233345
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 254 ~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
.++++++||.+||. +|.+|||+.++|+||||+...
T Consensus 277 ~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 277 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 68999999999998 899999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=373.13 Aligned_cols=257 Identities=29% Similarity=0.538 Sum_probs=217.5
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
.+|...| ...+.||+|+||.||+|.+..+|+.||+|.+.... ....+.+.+|+.+|+.++||||++++++|...
T Consensus 41 ~~~~~~~-~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~- 114 (321)
T 2c30_A 41 GDPRLLL-DSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG- 114 (321)
T ss_dssp SCHHHHE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-
T ss_pred CCchhhh-hccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc----hhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-
Confidence 3444455 55679999999999999999999999999987543 22346688999999999999999999998765
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
..+++||||+.+|+|.+++.+ ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 115 -~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~ 189 (321)
T 2c30_A 115 -EELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCA 189 (321)
T ss_dssp -TEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCE
T ss_pred -CEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCcEEEeeeeeee
Confidence 468999999999999999875 46999999999999999999999998 99999999999997 78899999999987
Q ss_pred hhcCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCc
Q 006779 180 VMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTD 255 (631)
Q Consensus 180 ~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~-~l~~~~~ 255 (631)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+..+....+.....+. ......+
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2c30_A 190 QISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNSHKVS 268 (321)
T ss_dssp ECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCTTGGGSC
T ss_pred ecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCCCcCccccCC
Confidence 65433 3345689999999998764 589999999999999999999999986 45666666666554432 2223467
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
+.+++||.+||. +|.+|||+.++|+||||....
T Consensus 269 ~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 269 PVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 899999999998 899999999999999997643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=370.73 Aligned_cols=260 Identities=26% Similarity=0.421 Sum_probs=219.5
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCH--HHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--DQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~--~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
..++| ++.+.||+|+||.||+|.++.+|..||+|.+......... ...+.+.+|+.+|+.++||||+++++++.+.
T Consensus 10 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 87 (321)
T 2a2a_A 10 VEDFY-DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR- 87 (321)
T ss_dssp HHHHE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-
T ss_pred hhccE-EEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC-
Confidence 34455 8899999999999999999999999999999765432211 1356788999999999999999999998654
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCC----cEEEccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVKIGDL 175 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g----~vKL~DF 175 (631)
..+++||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++ .+||+||
T Consensus 88 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~-~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 88 -TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLL-DKNIPIPHIKLIDF 163 (321)
T ss_dssp -SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEES-CTTSSSCCEEECCC
T ss_pred -CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEe-cCCCCcCCEEEccC
Confidence 579999999999999999998888999999999999999999999999 99999999999997 555 7999999
Q ss_pred cccchhcCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--CCCC
Q 006779 176 GLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLS 251 (631)
Q Consensus 176 Gla~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--~~l~ 251 (631)
|++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+.......+...... ..+.
T Consensus 164 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~ 242 (321)
T 2a2a_A 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITSVSYDFDEEFF 242 (321)
T ss_dssp TTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCHHHH
T ss_pred ccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccccChhhh
Confidence 999765443 3345679999999998764 589999999999999999999999987 4555666666654322 1122
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 252 ~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
...++.+++||.+||. +|.+|||+.++|+||||....
T Consensus 243 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 4567899999999998 899999999999999998654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=361.72 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=217.2
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
++| ++.+.||+|+||.||+|.++.+|+.||+|.+..... ....+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 7 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 80 (276)
T 2yex_A 7 EDW-DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQ 80 (276)
T ss_dssp HHE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC---TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEE
T ss_pred cce-EEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc---hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC--CEE
Confidence 456 778999999999999999999999999999976542 34557789999999999999999999988754 478
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
++||||+.+++|.+++.....+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRY 157 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECEE
T ss_pred EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEc-cCCCEEEeeCCCccccCC
Confidence 999999999999999988888999999999999999999999999 99999999999997 788999999999975532
Q ss_pred C----CCccccCCCCCCCcccccc-c-cCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006779 184 P----TARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 184 ~----~~~~~~GTp~Y~APEvl~~-~-ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~ 257 (631)
. ......||+.|+|||++.+ . ++.++||||||+++|+|++|+.||.........+..+.............++.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 237 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHH
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHH
Confidence 2 2345679999999998865 3 36789999999999999999999987655444555555443322223456789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 258 VKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 258 l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
+++||.+||. +|.+|||+.++++||||+...
T Consensus 238 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 238 PLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 9999999998 899999999999999998643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=378.34 Aligned_cols=251 Identities=24% Similarity=0.406 Sum_probs=214.6
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~ 101 (631)
.++| ++.+.||+|+||.||+|.++.+|+.||+|++..... ...+|+++|.++ +||||++++++|.+. .
T Consensus 21 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~ 89 (342)
T 2qr7_A 21 TDGY-EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DPTEEIEILLRYGQHPNIITLKDVYDDG--K 89 (342)
T ss_dssp HHHE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------CCHHHHHHHHHHTTSTTBCCEEEEEECS--S
T ss_pred cccE-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------ChHHHHHHHHHhcCCCCcCeEEEEEEcC--C
Confidence 4566 778999999999999999999999999999975432 134688888887 799999999998654 5
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCC---CcEEEcccccc
Q 006779 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLA 178 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~---g~vKL~DFGla 178 (631)
.+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||+...+ +.+||+|||++
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 79999999999999999999889999999999999999999999999 99999999999985333 35999999999
Q ss_pred chhcCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCC--CCHHHHHHHHHcCCCCC--CCC
Q 006779 179 IVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--KNPAQIYKKVTSGIKPA--SLS 251 (631)
Q Consensus 179 ~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~--~~~~~i~~~i~~~~~p~--~l~ 251 (631)
...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||... .+..++...+..+..+. ...
T Consensus 168 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 247 (342)
T 2qr7_A 168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247 (342)
T ss_dssp EECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred ccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence 765433 3455689999999998865 4899999999999999999999999753 45677888887765432 233
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 252 ~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
...++.+++||.+||. +|.+||++.++|+||||..
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 5578999999999998 8999999999999999964
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=383.71 Aligned_cols=255 Identities=24% Similarity=0.418 Sum_probs=216.8
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC--CCCceeeeeeEEcCCC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK--HENIIKFYNSWVDDTN 100 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~--HpnIVkl~~~~~d~~~ 100 (631)
.++.|++.+.||+|+||+||+|.+.. |..||+|++..... .....+.+.+|+.+|+.|+ ||||+++++++...
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~-- 128 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-- 128 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc--cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC--
Confidence 34556889999999999999999875 99999999976542 4566788999999999996 59999999988765
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
..+++||| +.+++|.+++.+...+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++..
T Consensus 129 ~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~--~~~~kl~DFG~a~~ 203 (390)
T 2zmd_A 129 QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIANQ 203 (390)
T ss_dssp SEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES--SSCEEECCCSSSCC
T ss_pred CEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE--CCeEEEEecCcccc
Confidence 46999999 568899999999889999999999999999999999999 99999999999995 57999999999976
Q ss_pred hcCCC----CccccCCCCCCCcccccc------------ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006779 181 MQQPT----ARSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244 (631)
Q Consensus 181 ~~~~~----~~~~~GTp~Y~APEvl~~------------~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~ 244 (631)
+.... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||....+.......+...
T Consensus 204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~ 283 (390)
T 2zmd_A 204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283 (390)
T ss_dssp C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT
T ss_pred ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc
Confidence 54322 345679999999998753 58899999999999999999999998766665666666665
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 245 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 245 ~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.....++...+..+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 284 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 284 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 55555666678899999999998 89999999999999999753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=374.10 Aligned_cols=252 Identities=23% Similarity=0.429 Sum_probs=206.5
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC---
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--- 100 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~--- 100 (631)
++| ++.+.||+|+||.||+|.++.+|..||+|++.... .....+.+.+|+.+|+.++||||++++++|.+...
T Consensus 6 ~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 6 TDF-EPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHE-EEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hcC-ceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 355 77899999999999999999999999999997543 33456779999999999999999999999876432
Q ss_pred ----------------------------------------------------CeEEEEEeccCCCCHHHHHHhCCC---C
Q 006779 101 ----------------------------------------------------RTINMITELFTSGSLRQYRKKHKN---V 125 (631)
Q Consensus 101 ----------------------------------------------------~~l~lV~Ey~~gGsL~~~l~~~~~---l 125 (631)
.++++|||||.+|+|.+++.+... .
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 248999999999999999987653 5
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC--------------CCccccC
Q 006779 126 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--------------TARSVIG 191 (631)
Q Consensus 126 ~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--------------~~~~~~G 191 (631)
++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...... ......|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEe-CCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 66679999999999999999999 99999999999997 7889999999999765433 1234579
Q ss_pred CCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CC
Q 006779 192 TPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PA 269 (631)
Q Consensus 192 Tp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p 269 (631)
|+.|+|||++.+ .++.++|||||||++|+|++|..|+. ....+...+.....|.. ....++.+++||.+||. +|
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p 314 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM---ERVRIITDVRNLKFPLL-FTQKYPQEHMMVQDMLSPSP 314 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH---HHHHHHHHHHTTCCCHH-HHHHCHHHHHHHHHHHCSSG
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh---HHHHHHHHhhccCCCcc-cccCChhHHHHHHHHccCCC
Confidence 999999998765 58999999999999999999877653 23344444444433321 12235778999999998 89
Q ss_pred CCCCCHHHHhcCCCCCC
Q 006779 270 SLRLPALELLKDPFLVT 286 (631)
Q Consensus 270 ~~Rpsa~elL~hpff~~ 286 (631)
.+|||+.|+|+||||+.
T Consensus 315 ~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 315 TERPEATDIIENAIFEN 331 (332)
T ss_dssp GGSCCHHHHHHSTTCCC
T ss_pred CcCCCHHHHhhchhhhc
Confidence 99999999999999975
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=383.48 Aligned_cols=267 Identities=24% Similarity=0.339 Sum_probs=211.0
Q ss_pred ccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEE
Q 006779 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (631)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 96 (631)
+....-.+|| ++.+.||+|+||.||+|.++.+|+.||+|++... ........++.+|+.+|+.++||||+++++++.
T Consensus 19 ~~~~~i~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 19 IKNVHVPDNY-IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM--FEDLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp GGGCCCCTTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEECST--TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCcceecCCE-EEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch--hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 3444556778 7889999999999999999999999999999643 234566788999999999999999999999887
Q ss_pred cCCC---CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEc
Q 006779 97 DDTN---RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173 (631)
Q Consensus 97 d~~~---~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~ 173 (631)
.... ..+|+||||+. |+|.+++.....+++..++.+++||+.||.|||+++ |+||||||+|||++ .++.+||+
T Consensus 96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~-~~~~~kL~ 171 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLN-QDCSVKVC 171 (432)
T ss_dssp CSCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEEC
T ss_pred cCCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEEC-CCCCEEEc
Confidence 6532 46899999996 699999999888999999999999999999999999 99999999999998 78999999
Q ss_pred cccccchhcCC------------------------CCccccCCCCCCCcccc-c-cccCccccchhhhHHHHHHhhcCCC
Q 006779 174 DLGLAIVMQQP------------------------TARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILEMVTCEYP 227 (631)
Q Consensus 174 DFGla~~~~~~------------------------~~~~~~GTp~Y~APEvl-~-~~ys~~sDIwSLGiilyELltG~~P 227 (631)
|||++...... .....+||+.|+|||++ . ..|+.++|||||||++|||++|..|
T Consensus 172 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 251 (432)
T 3n9x_A 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251 (432)
T ss_dssp CCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred cCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence 99999765332 12567899999999975 3 4599999999999999999985433
Q ss_pred C-----------CCCCC-----------------HHHH-----------------------HHHHHcCCCCCC-----CC
Q 006779 228 Y-----------NECKN-----------------PAQI-----------------------YKKVTSGIKPAS-----LS 251 (631)
Q Consensus 228 f-----------~~~~~-----------------~~~i-----------------------~~~i~~~~~p~~-----l~ 251 (631)
| .+... ..++ ...+........ ..
T Consensus 252 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (432)
T 3n9x_A 252 HINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY 331 (432)
T ss_dssp TCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHS
T ss_pred cccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHC
Confidence 3 22110 1111 111111111000 01
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCc
Q 006779 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 252 ~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~~ 290 (631)
...++.+++||.+||+ +|.+|||+.|+|+||||+.....
T Consensus 332 ~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 332 PSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred CCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 3467899999999998 99999999999999999876543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=372.83 Aligned_cols=255 Identities=28% Similarity=0.524 Sum_probs=197.5
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
.++| ++.+.||+|+||+||+|.++.+|+.||+|.+..... ....+.+.+|+.+|+.++||||+++++++.+. ..
T Consensus 4 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~ 77 (317)
T 2pmi_A 4 SSQF-KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKELKHENIVRLYDVIHTE--NK 77 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCST---TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT--TE
T ss_pred ccce-eEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc---cccHHHHHHHHHHHHhcCCCCcceEEEEEEEC--Ce
Confidence 4566 778999999999999999999999999999975532 22335678999999999999999999988654 57
Q ss_pred EEEEEeccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccc
Q 006779 103 INMITELFTSGSLRQYRKKH------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 176 (631)
+++||||+. |+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||
T Consensus 78 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg 153 (317)
T 2pmi_A 78 LTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFG 153 (317)
T ss_dssp EEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCS
T ss_pred EEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEc-CCCCEEECcCc
Confidence 999999997 6999998754 35899999999999999999999999 99999999999998 78999999999
Q ss_pred ccchhcCC--CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc--CCCCC--
Q 006779 177 LAIVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPA-- 248 (631)
Q Consensus 177 la~~~~~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~--~~~p~-- 248 (631)
++...... ......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.. .......+.. +..+.
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 154 LARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN-DEEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp SCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCSCCTTT
T ss_pred cceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCChhH
Confidence 99765433 3345678999999998754 48999999999999999999999998744 4333333321 11000
Q ss_pred ----------------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 249 ----------------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 249 ----------------------------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
......++.+++||.+||. +|.+|||+.|+|+||||....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 0112457899999999998 899999999999999998643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=397.03 Aligned_cols=256 Identities=28% Similarity=0.478 Sum_probs=221.3
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
.++| ++.+.||+|+||.||+|.+..+|+.||+|++...... .......+.+|+.+|+.++||||+++++++.+. ..
T Consensus 15 ~~~Y-~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~ 90 (476)
T 2y94_A 15 IGHY-ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP--SD 90 (476)
T ss_dssp ETTE-EEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH-HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SE
T ss_pred ecCE-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CE
Confidence 3567 7889999999999999999999999999999754321 122356789999999999999999999998654 47
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~-~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEC-TTCCEEECCCSSCEECC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEe-cCCCeEEEeccchhhcc
Confidence 9999999999999999998889999999999999999999999999 99999999999998 78899999999997654
Q ss_pred CC-CCccccCCCCCCCccccccc-c-CccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006779 183 QP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 183 ~~-~~~~~~GTp~Y~APEvl~~~-y-s~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~ 259 (631)
.. .....+||+.|+|||++.+. + +.++|||||||++|+|++|+.||.+ .+...++..+..+... .+...++.++
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~ 244 (476)
T 2y94_A 168 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFY--TPQYLNPSVI 244 (476)
T ss_dssp TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC-SSSHHHHHHHHTTCCC--CCTTCCHHHH
T ss_pred ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCcC--CCccCCHHHH
Confidence 43 34567899999999988764 4 6899999999999999999999987 4556666777766432 3445688999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 260 QFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 260 ~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
+||.+||. +|.+|||+.+++.||||+...
T Consensus 245 ~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 274 (476)
T 2y94_A 245 SLLKHMLQVDPMKRATIKDIREHEWFKQDL 274 (476)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred HHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence 99999998 899999999999999998643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=378.32 Aligned_cols=260 Identities=25% Similarity=0.448 Sum_probs=218.3
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
.-..++| ++.+.||+|+||+||+|.+..+|..||+|.+.... .....+.+.+|+.+|+.++||||+++++++.+.
T Consensus 29 ~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 103 (360)
T 3eqc_A 29 ELKDDDF-EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD- 103 (360)
T ss_dssp CCCGGGE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC---CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-
T ss_pred ccccccc-eeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc---CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-
Confidence 3345677 77899999999999999999999999999987542 456678899999999999999999999998765
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
..+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+. + |+||||||+|||++ .++.+||+|||++
T Consensus 104 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 104 -GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVS 179 (360)
T ss_dssp -TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEEC-TTCCEEECCCCCC
T ss_pred -CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEEC-CCCCEEEEECCCC
Confidence 46899999999999999999988999999999999999999999995 7 99999999999998 7889999999999
Q ss_pred chhcCCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHH--------------------
Q 006779 179 IVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI-------------------- 237 (631)
Q Consensus 179 ~~~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i-------------------- 237 (631)
............||+.|+|||++.+ .++.++|||||||++|+|++|+.||... +...+
T Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3eqc_A 180 GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP-DAKELELMFGCQVEGDAAETPPRPR 258 (360)
T ss_dssp HHHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC-CHHHHHHHHC---------------
T ss_pred cccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhcccccccCCCCCCCcc
Confidence 7665555566789999999998765 5899999999999999999999999763 32222
Q ss_pred ----------------------HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 238 ----------------------YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 238 ----------------------~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
...+.....+.......+.++++||.+||. +|.+|||+.++|+||||+...+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 333 (360)
T 3eqc_A 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 333 (360)
T ss_dssp ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence 222333333333344568899999999998 8999999999999999986443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=380.58 Aligned_cols=257 Identities=30% Similarity=0.442 Sum_probs=207.9
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC-
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN- 100 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~- 100 (631)
-.+|| ++.+.||+|+||.||+|.+..+|+.||+|++.... .......++.+|+.+|+.++||||+++++++.....
T Consensus 23 ~~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 99 (367)
T 1cm8_A 23 VRAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 99 (367)
T ss_dssp CBSSE-EEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred ecceE-EEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcc
Confidence 34677 77899999999999999999999999999986432 345567789999999999999999999999865432
Q ss_pred ---CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 101 ---RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 101 ---~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
..+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+
T Consensus 100 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 100 DDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGL 174 (367)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTT
T ss_pred ccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEc-CCCCEEEEeeec
Confidence 3578999999 8899999977 56999999999999999999999999 99999999999998 789999999999
Q ss_pred cchhcCCCCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCCC-------
Q 006779 178 AIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKP------- 247 (631)
Q Consensus 178 a~~~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~-~~~p------- 247 (631)
+...... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.....++...+.. +..+
T Consensus 175 a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 175 ARQADSE-MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp CEECCSS-CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred ccccccc-cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 9765433 345688999999998754 5899999999999999999999999875444443332221 1100
Q ss_pred --------------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 248 --------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 248 --------------------~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
..+....++.+++||.+||. +|.+|||+.++|.||||...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 11223457899999999998 99999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=390.73 Aligned_cols=262 Identities=23% Similarity=0.384 Sum_probs=198.3
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC---
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--- 99 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~--- 99 (631)
.+|| ++.+.||+|+||+||+|.++.+|+.||+|++... ........++.+|+.+|+.++||||++++++|....
T Consensus 52 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 52 PDRY-EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV--FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CTTE-EECCC-------CEEEEEECC--CEEEEEEECST--TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred CCCe-EEeeEeeecCCeEEEEEEECCCCcEEEEEEechh--hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 4677 7889999999999999999999999999998643 234566788999999999999999999999886543
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
...+|+||||+ +|+|.+++.....+++..++.+++||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~-~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 129 FDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVN-QDCSVKVCDFGLAR 204 (458)
T ss_dssp CCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTCCEEECCCTTCB
T ss_pred CceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEEC-CCCCEeecccccch
Confidence 24789999998 5799999998889999999999999999999999999 99999999999998 78999999999997
Q ss_pred hhcCC-----------------------------CCccccCCCCCCCcccc-c-cccCccccchhhhHHHHHHhh-----
Q 006779 180 VMQQP-----------------------------TARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILEMVT----- 223 (631)
Q Consensus 180 ~~~~~-----------------------------~~~~~~GTp~Y~APEvl-~-~~ys~~sDIwSLGiilyELlt----- 223 (631)
..... .....+||+.|+|||++ . ..|+.++|||||||++|||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 65321 12345789999999965 3 459999999999999999999
Q ss_pred ------cCCCCCCCCC--------------------HHHHHHHHHc-CC--------------------CC-------CC
Q 006779 224 ------CEYPYNECKN--------------------PAQIYKKVTS-GI--------------------KP-------AS 249 (631)
Q Consensus 224 ------G~~Pf~~~~~--------------------~~~i~~~i~~-~~--------------------~p-------~~ 249 (631)
|+.+|.+... ..++...+.. +. .+ ..
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 6666654221 1111111000 00 00 01
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCcc
Q 006779 250 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 291 (631)
Q Consensus 250 l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~~~ 291 (631)
.....++.+++||.+||. +|.+|||+.|+|+||||+......
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~ 407 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence 112347899999999998 999999999999999999865543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=369.63 Aligned_cols=250 Identities=24% Similarity=0.390 Sum_probs=206.1
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCe
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~ 102 (631)
++| ++.++||+|+||+||+|.+..+|+.||+|++.... .......+...|+..+..+ +||||++++++|.+. ..
T Consensus 57 ~~y-~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~--~~ 131 (311)
T 3p1a_A 57 QSF-QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF--RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG--GI 131 (311)
T ss_dssp HHE-EEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSC--CSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TE
T ss_pred hhe-eeeheeccCCCeEEEEEEECCCCeEEEEEEecccc--cChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC--CE
Confidence 456 77889999999999999999999999999876432 2334445555666555544 999999999998754 47
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 103 INMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
+++||||+ +++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLG-PRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-GGGCEEECCCTTCEEC
T ss_pred EEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEC-CCCCEEEccceeeeec
Confidence 99999999 67898887764 46999999999999999999999998 99999999999997 7889999999998765
Q ss_pred cCC-CCccccCCCCCCCccccccccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006779 182 QQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 182 ~~~-~~~~~~GTp~Y~APEvl~~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~ 260 (631)
... ......||+.|+|||++.+.++.++|||||||++|||++|..|+.. ...+..+..+..+..+....++.+++
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~ 283 (311)
T 3p1a_A 208 GTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHG----GEGWQQLRQGYLPPEFTAGLSSELRS 283 (311)
T ss_dssp C------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSS----HHHHHHHTTTCCCHHHHTTSCHHHHH
T ss_pred ccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC----ccHHHHHhccCCCcccccCCCHHHHH
Confidence 443 2344579999999999988999999999999999999999777654 23344555555555555667899999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 261 FIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 261 lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
||.+||. +|.+|||+.|+|+||||+.
T Consensus 284 li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 284 VLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHcCCChhhCcCHHHHHhCccccC
Confidence 9999998 8999999999999999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=367.08 Aligned_cols=255 Identities=24% Similarity=0.400 Sum_probs=217.6
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
.++| ++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+.+.+|+.+|+.++||||+++++++.+. ..
T Consensus 8 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 80 (304)
T 2jam_A 8 RKTF-IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP----AFRDSSLENEIAVLKKIKHENIVTLEDIYEST--TH 80 (304)
T ss_dssp HHHE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred hccc-eeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc----ccchHHHHHHHHHHHhCCCCCeeehhhhcccC--CE
Confidence 4566 88899999999999999999999999999997543 22335688999999999999999999988654 47
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeec--CCCCcEEEccccccch
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~--~~~g~vKL~DFGla~~ 180 (631)
+++||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||++. ..++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 8999999999999999988888999999999999999999999999 99999999999992 2678999999999976
Q ss_pred hcCCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHH
Q 006779 181 MQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQ 257 (631)
Q Consensus 181 ~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p~~l~~~~~~~ 257 (631)
..........||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...+...+..+.. +.......++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (304)
T 2jam_A 159 EQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWDDISES 237 (304)
T ss_dssp CCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHCCCCCCTTTTTTSCHH
T ss_pred cCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCccccccCCHH
Confidence 55444455679999999998765 589999999999999999999999987 456666677766543 22334557899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 258 VKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 258 l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
+++||.+||. +|.+|||+.++|+||||...
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 238 AKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 9999999998 89999999999999999764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=393.85 Aligned_cols=255 Identities=28% Similarity=0.389 Sum_probs=202.9
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC--
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-- 100 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~-- 100 (631)
.+|| ++.+.||+|+||+||+|.+..+|+.||+|++.... .......++.+|+.+|+.++||||++++++|.....
T Consensus 61 ~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 61 LKRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 137 (464)
T ss_dssp ETTE-EEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG--GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred cCCe-EEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc--cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence 3567 77899999999999999999999999999997542 345667889999999999999999999999865432
Q ss_pred --CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 101 --RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 101 --~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
..+|+||||+.++ |.+++.. .+++..++.+++||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 138 ~~~~~~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~-~~~~~kl~DFG~a 211 (464)
T 3ttj_A 138 EFQDVYLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA 211 (464)
T ss_dssp TCCEEEEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCCC
T ss_pred cCCeEEEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEe-CCCCEEEEEEEee
Confidence 4789999999764 6666643 4899999999999999999999999 99999999999998 7899999999999
Q ss_pred chhcCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC--------
Q 006779 179 IVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-------- 248 (631)
Q Consensus 179 ~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~-------- 248 (631)
...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.....++...+.....|.
T Consensus 212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 212 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp -----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred eecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 766544 3455789999999997754 699999999999999999999999987544444433332110000
Q ss_pred -----------CCCCC--------------------CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 249 -----------SLSKV--------------------TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 249 -----------~l~~~--------------------~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
..... .++++++||.+||+ +|.+|||+.|+|+||||..
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 00000 14679999999998 9999999999999999974
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=361.83 Aligned_cols=259 Identities=27% Similarity=0.479 Sum_probs=220.3
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
.++| ++.+.||+|+||.||+|.++.+|+.||+|.+..... .....+.+.+|+.+++.++||||+++++++.+.....
T Consensus 5 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 5 AEDY-EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp GGGE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred hhhe-eeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 4577 778999999999999999999999999999976542 4566788999999999999999999999988766678
Q ss_pred EEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC---CCEEeccCCCCCeeecCCCCcEEEccc
Q 006779 103 INMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHN---PPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~----~~l~~~~i~~i~~QIl~aL~yLHs~~---~~IiHrDLKp~NILl~~~~g~vKL~DF 175 (631)
+++||||+.+++|.+++... ..+++..++.++.||+.||.|||+++ .+|+||||||+|||++ .++.+||+||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~-~~~~~kl~df 160 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDF 160 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC-SSSCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc-CCCCEEEecC
Confidence 99999999999999998754 34999999999999999999999986 3499999999999997 7889999999
Q ss_pred cccchhcCCC--CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006779 176 GLAIVMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 176 Gla~~~~~~~--~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~ 252 (631)
|++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+...+...+..+..+ .++.
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~ 238 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFR-RIPY 238 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC-CCCT
T ss_pred chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcc-cCHHHHHHHHhhcccc-cCCc
Confidence 9997654432 234578999999998765 589999999999999999999999987 4566777777766543 3455
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 253 ~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
..++.++++|.+||. +|.+||++.++|+|+|+...
T Consensus 239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 678999999999998 89999999999999999764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=365.32 Aligned_cols=262 Identities=27% Similarity=0.477 Sum_probs=215.1
Q ss_pred cccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEc
Q 006779 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d 97 (631)
...++..+| ++.+.||+|+||.||+|.+..+|..||+|.+.... ....+.+.+|+.+|+.++||||+++++++.+
T Consensus 13 ~~~~~~~~y-~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 87 (302)
T 2j7t_A 13 RDLDPNEVW-EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELEDYIVEIEILATCDHPYIVKLLGAYYH 87 (302)
T ss_dssp SSSCGGGTE-EEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cccCCccce-eecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC----HHHHHHHHHHHHHHhcCCCCCEeeeeeeeee
Confidence 346788888 78899999999999999999999999999986442 2345678899999999999999999999876
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccc
Q 006779 98 DTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 176 (631)
. ..+++||||+.+++|.+++.+ ...+++..++.++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||
T Consensus 88 ~--~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg 162 (302)
T 2j7t_A 88 D--GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMT-LEGDIRLADFG 162 (302)
T ss_dssp C---CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTSCEEECCCH
T ss_pred C--CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEC-CCCCEEEEECC
Confidence 5 468999999999999998876 567999999999999999999999998 99999999999997 78899999999
Q ss_pred ccchhcC--CCCccccCCCCCCCccccc------cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-
Q 006779 177 LAIVMQQ--PTARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP- 247 (631)
Q Consensus 177 la~~~~~--~~~~~~~GTp~Y~APEvl~------~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p- 247 (631)
++..... .......||+.|+|||++. ..++.++||||||+++|+|++|..||... +.......+.....+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~ 241 (302)
T 2j7t_A 163 VSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSDPPT 241 (302)
T ss_dssp HHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCC
T ss_pred CCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC-CHHHHHHHHhccCCcc
Confidence 9754322 1234457899999999873 35889999999999999999999999874 444444444444333
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCc
Q 006779 248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 248 ~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~~ 290 (631)
...+...+..+++||.+||. +|.+|||+.++|+||||......
T Consensus 242 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 242 LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN 285 (302)
T ss_dssp CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence 22344567899999999998 89999999999999999875543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=362.42 Aligned_cols=254 Identities=23% Similarity=0.431 Sum_probs=218.3
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
++| ++.+.||+|+||.||+|.+..++..||+|.+....... ......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 14 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 89 (284)
T 2vgo_A 14 DDF-DIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK-EGVEHQLRREIEIQSHLRHPNILRMYNYFHDR--KRI 89 (284)
T ss_dssp GGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEE
T ss_pred hhc-eeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccch-HHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC--CEE
Confidence 456 78899999999999999999999999999987543211 12245688999999999999999999998654 578
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMG-YKGELKIADFGWSVHAPS 166 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECSS
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEc-CCCCEEEecccccccCcc
Confidence 999999999999999998888999999999999999999999999 99999999999997 788999999999976655
Q ss_pred CCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006779 184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262 (631)
Q Consensus 184 ~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI 262 (631)
.......|++.|+|||++.+ .++.++||||||+++|+|++|..||... +.......+..... .++...+..+++||
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~li 243 (284)
T 2vgo_A 167 LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP-SHTETHRRIVNVDL--KFPPFLSDGSKDLI 243 (284)
T ss_dssp SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHTTCC--CCCTTSCHHHHHHH
T ss_pred cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC-CHhHHHHHHhcccc--CCCCcCCHHHHHHH
Confidence 55566789999999998765 5899999999999999999999999764 45555555554322 34456788999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 263 EKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 263 ~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.+||. +|.+||++.++|+||||+..
T Consensus 244 ~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 244 SKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp HHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 99998 89999999999999999854
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=379.85 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=206.8
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC---
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD--- 98 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~--- 98 (631)
..+|| ++.+.||+|+||+||+|.+..+|+.||+|++...... ..+|+.+|+.++||||++++++|...
T Consensus 5 ~~~~y-~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~--------~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 5 SSKKY-SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY--------KNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp -CTTE-EEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS--------CCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred ccceE-EEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch--------HHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 35677 8889999999999999999999999999998654321 23699999999999999999988653
Q ss_pred ---------------------------------CCCeEEEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHH
Q 006779 99 ---------------------------------TNRTINMITELFTSGSLRQYRK----KHKNVDMKAIKNWARQILRGL 141 (631)
Q Consensus 99 ---------------------------------~~~~l~lV~Ey~~gGsL~~~l~----~~~~l~~~~i~~i~~QIl~aL 141 (631)
...++++||||+. |+|.+++. ....+++..++.++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 2346899999998 47666554 467899999999999999999
Q ss_pred HHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC-CCccccCCCCCCCcccccc--ccCccccchhhhHHH
Q 006779 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCI 218 (631)
Q Consensus 142 ~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiil 218 (631)
.|||+++ |+||||||+|||++..++.+||+|||++...... ......||+.|+|||++.+ .|+.++|||||||++
T Consensus 155 ~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 155 GFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 9999999 9999999999999766889999999999765433 3456688999999997754 489999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCCC------------------C--------CCCCCCcHHHHHHHHHhcC-CCCC
Q 006779 219 LEMVTCEYPYNECKNPAQIYKKVTSGIKP------------------A--------SLSKVTDPQVKQFIEKCIV-PASL 271 (631)
Q Consensus 219 yELltG~~Pf~~~~~~~~i~~~i~~~~~p------------------~--------~l~~~~~~~l~~lI~~cL~-~p~~ 271 (631)
|+|++|+.||.+.....++...+.....| . .++...++.+++||.+||+ +|.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 99999999998865555554444311110 0 0233467889999999998 8999
Q ss_pred CCCHHHHhcCCCCCC
Q 006779 272 RLPALELLKDPFLVT 286 (631)
Q Consensus 272 Rpsa~elL~hpff~~ 286 (631)
|||+.|+|+||||+.
T Consensus 313 R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 313 RINPYEAMAHPFFDH 327 (383)
T ss_dssp SCCHHHHHTSGGGHH
T ss_pred CCCHHHHhcCHHHHH
Confidence 999999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=375.71 Aligned_cols=259 Identities=26% Similarity=0.432 Sum_probs=209.7
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccC-CHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~-~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
.+|| ++.+.||+|+||+||+|.+..++..||+|++....... .....+.+.+|+.+|+.++||||++++++|.+. .
T Consensus 25 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~ 101 (345)
T 3hko_A 25 QKKY-HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE--Q 101 (345)
T ss_dssp HHHE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred hhhe-eecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC--C
Confidence 4566 78899999999999999999999999999997543211 345567899999999999999999999998654 5
Q ss_pred eEEEEEeccCCCCHHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 006779 102 TINMITELFTSGSLRQYRKK----------------------------------------HKNVDMKAIKNWARQILRGL 141 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~----------------------------------------~~~l~~~~i~~i~~QIl~aL 141 (631)
.+++||||+.+|+|.+++.. ...+++..++.++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 79999999999999999852 11246788999999999999
Q ss_pred HHHHhCCCCEEeccCCCCCeeecCCCC--cEEEccccccchhcCC------CCccccCCCCCCCccccc---cccCcccc
Q 006779 142 HYLHSHNPPIIHRDLKCDNIFVNGNNG--EVKIGDLGLAIVMQQP------TARSVIGTPEFMAPELYE---EEYNELVD 210 (631)
Q Consensus 142 ~yLHs~~~~IiHrDLKp~NILl~~~~g--~vKL~DFGla~~~~~~------~~~~~~GTp~Y~APEvl~---~~ys~~sD 210 (631)
.|||+++ |+||||||+|||++ .++ .+||+|||++..+... ......||+.|+|||++. ..++.++|
T Consensus 182 ~~LH~~~--ivH~Dlkp~NIll~-~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHNQG--ICHRDIKPENFLFS-TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHTT--EECCCCCGGGEEES-CSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHCC--ccccCCChhhEEEe-cCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 9999999 99999999999997 455 8999999999755321 134567999999999875 45889999
Q ss_pred chhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 211 IYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 211 IwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~--l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
||||||++|+|++|+.||.+.... +....+........ .....++.+++||.+||. +|.+||++.++|+||||+..
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDA-DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHHHHHCCCCCCCCChH-HHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence 999999999999999999875444 44444444332221 222367899999999998 89999999999999999864
Q ss_pred C
Q 006779 288 N 288 (631)
Q Consensus 288 ~ 288 (631)
.
T Consensus 338 ~ 338 (345)
T 3hko_A 338 S 338 (345)
T ss_dssp S
T ss_pred h
Confidence 3
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=400.83 Aligned_cols=263 Identities=23% Similarity=0.377 Sum_probs=224.1
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
++| ++.++||+|+||.||+|.++.+|..||+|++....... ......+.+|+.+|+.++||||++++++|.+. ..+
T Consensus 184 ~~f-~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~l 259 (576)
T 2acx_A 184 NTF-RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAYETK--DAL 259 (576)
T ss_dssp GGE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEE
T ss_pred cce-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC--CEE
Confidence 345 77899999999999999999999999999997543211 12345688999999999999999999998754 479
Q ss_pred EEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 104 NMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
|+||||+.||+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld-~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLD-DHGHIRISDLGLAVHV 336 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEe-CCCCeEEEecccceec
Confidence 99999999999999998754 4999999999999999999999999 99999999999998 7899999999999766
Q ss_pred cCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCCcH
Q 006779 182 QQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 182 ~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~---~~~~i~~~i~~~~~p~~l~~~~~~ 256 (631)
... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.... ....+...+... +..++...++
T Consensus 337 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~--~~~~p~~~s~ 414 (576)
T 2acx_A 337 PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--PEEYSERFSP 414 (576)
T ss_dssp CTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC--CCCCCTTSCH
T ss_pred ccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc--cccCCccCCH
Confidence 433 3345689999999998765 59999999999999999999999997643 345666666654 3345567789
Q ss_pred HHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCcccccC
Q 006779 257 QVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCD 295 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rp-----sa~elL~hpff~~~~~~~~~~~ 295 (631)
++++||.+||. +|.+|| ++.|+++||||+..++..+...
T Consensus 415 ~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~ 459 (576)
T 2acx_A 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAG 459 (576)
T ss_dssp HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTT
T ss_pred HHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcC
Confidence 99999999998 899999 7999999999999888765443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=374.79 Aligned_cols=261 Identities=24% Similarity=0.388 Sum_probs=210.3
Q ss_pred ccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC
Q 006779 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 98 (631)
..+..+|| ++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+|+.++||||+++++++.+.
T Consensus 12 ~~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 88 (351)
T 3mi9_A 12 FCDEVSKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTK 88 (351)
T ss_dssp TSCBGGGE-EEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC--SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred ccccccce-eEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc--cccchHHHHHHHHHHHhccCCCcccHhheeecc
Confidence 33556788 778999999999999999999999999999865542 222335678999999999999999999998764
Q ss_pred C------CCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEE
Q 006779 99 T------NRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 171 (631)
Q Consensus 99 ~------~~~l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 171 (631)
. ...+++||||+.+ +|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+|
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~-~~~~~k 164 (351)
T 3mi9_A 89 ASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLK 164 (351)
T ss_dssp --------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEE
T ss_pred ccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEc-CCCCEE
Confidence 3 3578999999975 67666654 467999999999999999999999999 99999999999997 788999
Q ss_pred EccccccchhcCC------CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006779 172 IGDLGLAIVMQQP------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 243 (631)
Q Consensus 172 L~DFGla~~~~~~------~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~ 243 (631)
|+|||++...... ......||+.|+|||++.+ .|+.++|||||||++|+|+||..||.+.. .......+..
T Consensus 165 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~ 243 (351)
T 3mi9_A 165 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-EQHQLALISQ 243 (351)
T ss_dssp ECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHH
T ss_pred EccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHH
Confidence 9999999765321 2234578999999998754 48999999999999999999999998744 4333333322
Q ss_pred ---CCCCCCCCCC---------------------------CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 244 ---GIKPASLSKV---------------------------TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 244 ---~~~p~~l~~~---------------------------~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
...+..++.. .++.+++||.+||+ +|.+|||+.|+|+||||...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 2222211111 26789999999998 99999999999999999764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=371.58 Aligned_cols=245 Identities=24% Similarity=0.362 Sum_probs=193.2
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCceeeeeeEEcCCCCeEEEEEec
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~l~lV~Ey 109 (631)
+.||+|+||+||+|.++.+|+.||+|++... ....+.+|+.+|+.+. ||||++++++|.+. ..+++||||
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~--~~~~lv~e~ 87 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------MEANTQKEITALKLCEGHPNIVKLHEVFHDQ--LHTFLVMEL 87 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG-------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEEECC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh-------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC--CEEEEEEEc
Confidence 6799999999999999999999999998633 2355778999999997 99999999998654 578999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCC---cEEEccccccchhcCC--
Q 006779 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG---EVKIGDLGLAIVMQQP-- 184 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g---~vKL~DFGla~~~~~~-- 184 (631)
+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++ .+||+|||++......
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~-~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 88 LNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFT-DENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp CCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEE-C----CEEEECCCTTCEECCC---
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEe-cCCCcccEEEeccccceecCCCCC
Confidence 999999999999999999999999999999999999999 99999999999997 333 8999999999755432
Q ss_pred CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCC------CCHHHHHHHHHcCCCCCCC--CCCCc
Q 006779 185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC------KNPAQIYKKVTSGIKPASL--SKVTD 255 (631)
Q Consensus 185 ~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~------~~~~~i~~~i~~~~~p~~l--~~~~~ 255 (631)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||... ....++...+..+..+... ....+
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSC
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCC
Confidence 3345678999999998764 5899999999999999999999999753 2345667777665433221 12467
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
+++++||.+||. +|.+|||+.++|+||||+..
T Consensus 245 ~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp HHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred HHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 899999999998 89999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=365.08 Aligned_cols=258 Identities=22% Similarity=0.450 Sum_probs=217.3
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
+|| ++.+.||+|+||.||+|.+..+|..||+|.+..............+.+|+.+++.++||||+++++++.+.....+
T Consensus 5 ~~y-~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 5 GKY-LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp CCB-CCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred cce-eEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 677 7889999999999999999999999999999765432223456789999999999999999999999877666789
Q ss_pred EEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 104 NMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~--~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
++||||+.++ |.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~-~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLT-TGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEc-CCCcEEeecccccccc
Confidence 9999999876 7777765 456999999999999999999999999 99999999999997 7899999999999765
Q ss_pred cCC----CCccccCCCCCCCccccccc---cCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006779 182 QQP----TARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 182 ~~~----~~~~~~GTp~Y~APEvl~~~---ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 254 (631)
... ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||.. .+...+...+..+.. .++...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~--~~~~~~ 236 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSY--AIPGDC 236 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHCCC--CCCSSS
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC-chHHHHHHHHhcCCC--CCCCcc
Confidence 322 23355789999999987642 47899999999999999999999986 566667777766533 344567
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
++.+.+||.+||. +|.+|||+.++|+||||+...+
T Consensus 237 ~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 8899999999998 8999999999999999987543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=366.89 Aligned_cols=258 Identities=29% Similarity=0.534 Sum_probs=214.7
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcC
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 98 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~ 98 (631)
.++.++| ++.+.||+|+||.||+|.+..+|+.||+|.+..... ..+.+.+|+.+++.+ +||||+++++++...
T Consensus 20 ~~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 20 RDPAGIF-ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-----EEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCTTTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cCCCCcE-EEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-----cHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 4678888 788999999999999999999999999999875431 235688999999999 899999999999764
Q ss_pred C----CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEE
Q 006779 99 T----NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 99 ~----~~~l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL 172 (631)
. ...+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~-~~~~~kl 170 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKL 170 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTCCEEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEc-CCCCEEE
Confidence 3 45799999999999999999875 56999999999999999999999999 99999999999997 7899999
Q ss_pred ccccccchhcCC--CCccccCCCCCCCccccc------cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006779 173 GDLGLAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244 (631)
Q Consensus 173 ~DFGla~~~~~~--~~~~~~GTp~Y~APEvl~------~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~ 244 (631)
+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||... +.......+...
T Consensus 171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~ 249 (326)
T 2x7f_A 171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRN 249 (326)
T ss_dssp CCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHS
T ss_pred eeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHhhcC
Confidence 999999765432 234567999999999874 34889999999999999999999999774 444444555555
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 245 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 245 ~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
..+.......++.+++||.+||. +|.+||++.++|+||||+..
T Consensus 250 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 250 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred ccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 55554556678999999999998 89999999999999999764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=368.96 Aligned_cols=261 Identities=21% Similarity=0.351 Sum_probs=214.0
Q ss_pred CcccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCceeeee
Q 006779 15 GEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYN 93 (631)
Q Consensus 15 ~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnIVkl~~ 93 (631)
....+....++| ++.+.||+|+||+||+|.+..+|+.||+|++.... ...+.+|+.+|+.++ ||||+++++
T Consensus 27 ~~~~~~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~~~~ 98 (330)
T 3nsz_A 27 SHVVEWGNQDDY-QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLAD 98 (330)
T ss_dssp GCCCCCEEGGGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-------HHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred hhhhcccCCCce-EEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-------hHHHHHHHHHHHHcCCCCCEEEeee
Confidence 344455556777 78899999999999999999999999999986321 356889999999997 999999999
Q ss_pred eEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEc
Q 006779 94 SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173 (631)
Q Consensus 94 ~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~ 173 (631)
++.+.....+++||||+.+++|.+++.. +++..++.++.||+.||.|||+++ |+||||||+|||++..++.+||+
T Consensus 99 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~ 173 (330)
T 3nsz_A 99 IVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLI 173 (330)
T ss_dssp EEECTTTCCEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEEC
T ss_pred eeccCCCCceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEE
Confidence 9987666789999999999999998854 899999999999999999999999 99999999999998444489999
Q ss_pred cccccchhcCC-CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHH--------
Q 006779 174 DLGLAIVMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT-------- 242 (631)
Q Consensus 174 DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~-------- 242 (631)
|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||....+.......+.
T Consensus 174 Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~ 253 (330)
T 3nsz_A 174 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 253 (330)
T ss_dssp CCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred eCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchh
Confidence 99999765433 3445679999999998754 489999999999999999999999966544433222211
Q ss_pred -----cCCC----------------------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 243 -----SGIK----------------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 243 -----~~~~----------------------p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
.... +.......++.+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred hhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 1100 001112257899999999998 899999999999999998754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=407.48 Aligned_cols=267 Identities=21% Similarity=0.351 Sum_probs=229.1
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCe
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~ 102 (631)
++| ++.++||+|+||.||+|.++.+|+.||+|++....... ....+.+..|..+|..+ +||||++++++|.+. ..
T Consensus 341 ~~f-~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~--~~ 416 (674)
T 3pfq_A 341 TDF-NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DR 416 (674)
T ss_dssp TTE-EEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH-TTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS--SE
T ss_pred cce-EEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC--CE
Confidence 345 77899999999999999999999999999997543211 23346688899999988 799999999988544 57
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
+||||||+.+|+|..++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~-~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEEC-SSSCEEECCCTTCEECC
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEc-CCCcEEEeecceeeccc
Confidence 9999999999999999999889999999999999999999999999 99999999999998 78999999999997532
Q ss_pred --CCCCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006779 183 --QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 183 --~~~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~ 259 (631)
.....+.+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+ .+..+++..+..+.. .++...+++++
T Consensus 494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~ 570 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAV 570 (674)
T ss_dssp CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHSSCC--CCCTTSCHHHH
T ss_pred cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHH
Confidence 23455678999999999876 4699999999999999999999999987 577778888877533 35566789999
Q ss_pred HHHHHhcC-CCCCCCCH-----HHHhcCCCCCCCCCcccccCCCCCC
Q 006779 260 QFIEKCIV-PASLRLPA-----LELLKDPFLVTDNPKDLVCDPLRLP 300 (631)
Q Consensus 260 ~lI~~cL~-~p~~Rpsa-----~elL~hpff~~~~~~~~~~~~~~~p 300 (631)
+||.+||. +|.+||++ .|++.||||+..+|..+....+..|
T Consensus 571 ~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp 617 (674)
T 3pfq_A 571 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPP 617 (674)
T ss_dssp HHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCS
T ss_pred HHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCC
Confidence 99999998 89999997 9999999999998877655444433
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=357.32 Aligned_cols=251 Identities=23% Similarity=0.403 Sum_probs=207.8
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCe
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~ 102 (631)
++| ++.+.||+|+||+||+|.+..+|..||+|.+..... .......+.+|+..+..+ +||||+++++++.+. ..
T Consensus 11 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~--~~ 85 (289)
T 1x8b_A 11 TEF-HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA--GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED--DH 85 (289)
T ss_dssp HHE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT--TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET--TE
T ss_pred chh-hhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC--Ce
Confidence 456 778999999999999999999999999999875432 234567788999999999 999999999998765 47
Q ss_pred EEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC-------------
Q 006779 103 INMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG------------- 165 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~----~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~------------- 165 (631)
+++||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC--------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCccccccccc
Confidence 89999999999999999865 67999999999999999999999999 999999999999972
Q ss_pred -----CCCcEEEccccccchhcCCCCccccCCCCCCCccccccc--cCccccchhhhHHHHHHhhcCCCCCCCCCHHHHH
Q 006779 166 -----NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238 (631)
Q Consensus 166 -----~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~~--ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~ 238 (631)
..+.+||+|||++....... ...||+.|+|||++.+. ++.++|||||||++|+|++|..|+... ...
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~ 237 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSPQ--VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQW 237 (289)
T ss_dssp ------CCCEEECCCTTCEETTCSC--CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHH
T ss_pred ccccCCceEEEEcccccccccCCcc--ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHH
Confidence 23479999999997655432 34689999999988654 557999999999999999999877542 223
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 239 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 239 ~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
..+..+..+ .++...++.+++||.+||. +|.+|||+.++|+||||....
T Consensus 238 ~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 238 HEIRQGRLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp HHHHTTCCC-CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred HHHHcCCCC-CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 444444433 3456678999999999998 899999999999999998643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=361.11 Aligned_cols=257 Identities=24% Similarity=0.377 Sum_probs=203.4
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
..++| ++.+.||+|+||+||+|.+..+|+.||+|++.... ......+.+.++...++.++||||+++++++.+. .
T Consensus 5 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~--~ 79 (290)
T 3fme_A 5 KADDL-EPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV--NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE--G 79 (290)
T ss_dssp CGGGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEC-----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--S
T ss_pred cHHhh-hhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc--CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc--C
Confidence 34667 77899999999999999999999999999987542 2233444555666678999999999999998765 4
Q ss_pred eEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeccCCCCCeeecCCCCcEEEcccc
Q 006779 102 TINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~----~~~l~~~~i~~i~~QIl~aL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKL~DFG 176 (631)
.+++||||+. |+|.+++.. ...+++..++.++.||+.||.|||++ + |+||||||+|||++ .++.+||+|||
T Consensus 80 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg 155 (290)
T 3fme_A 80 DVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLIN-ALGQVKMCDFG 155 (290)
T ss_dssp SEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEEC-TTCCEEBCCC-
T ss_pred CEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEEC-CCCCEEEeecC
Confidence 6889999997 588777653 56899999999999999999999998 8 99999999999998 78899999999
Q ss_pred ccchhcCCC-CccccCCCCCCCccccc-----cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 006779 177 LAIVMQQPT-ARSVIGTPEFMAPELYE-----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250 (631)
Q Consensus 177 la~~~~~~~-~~~~~GTp~Y~APEvl~-----~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l 250 (631)
++....... .....||+.|+|||++. ..++.++|||||||++|+|+||+.||..................+...
T Consensus 156 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 235 (290)
T 3fme_A 156 ISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP 235 (290)
T ss_dssp --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCC
T ss_pred CcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcc
Confidence 997655433 33457999999999852 348899999999999999999999998766666655555555555444
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 251 ~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
....++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 236 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 55678999999999998 89999999999999999753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=365.97 Aligned_cols=256 Identities=31% Similarity=0.541 Sum_probs=209.1
Q ss_pred CCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC
Q 006779 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~ 100 (631)
-+.++| ++.+.||+|+||+||+|.+ +|..||+|++.... ......+.+.+|+.+|++++||||+++++++.+.
T Consensus 34 i~~~~y-~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 106 (309)
T 3p86_A 34 IPWCDL-NIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQD--FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP-- 106 (309)
T ss_dssp CCGGGE-EEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCC--CSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--
T ss_pred CChhHc-eeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--
Confidence 345666 7889999999999999976 68999999987543 2456677899999999999999999999988654
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 101 RTINMITELFTSGSLRQYRKKHKN---VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~---l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
..+++||||+.+|+|.+++.+.+. +++..++.++.||+.||.|||+++++|+||||||+|||++ .++.+||+|||+
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~-~~~~~kL~Dfg~ 185 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGL 185 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC-TTCCEEECCCC-
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe-CCCcEEECCCCC
Confidence 358899999999999999987654 9999999999999999999999988899999999999997 788999999999
Q ss_pred cchhcCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006779 178 AIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 178 a~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 254 (631)
+...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+..+....+........++...
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~ 264 (309)
T 3p86_A 186 SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN-LNPAQVVAAVGFKCKRLEIPRNL 264 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT-SCHHHHHHHHHHSCCCCCCCTTS
T ss_pred CccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCccC
Confidence 9755433 2345679999999998765 489999999999999999999999987 45666666665555555667778
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhc--CCCCC
Q 006779 255 DPQVKQFIEKCIV-PASLRLPALELLK--DPFLV 285 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rpsa~elL~--hpff~ 285 (631)
++.+++||.+||. +|.+|||+.++++ .+++.
T Consensus 265 ~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 265 NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 8999999999998 8999999999987 44443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=371.84 Aligned_cols=250 Identities=23% Similarity=0.327 Sum_probs=206.7
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-----CCCceeeeeeEEc
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-----HENIIKFYNSWVD 97 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-----HpnIVkl~~~~~d 97 (631)
.+|| ++.+.||+|+||+||+|.+..+|+.||+|++.. .......+..|+.+++.+. ||||++++++|..
T Consensus 34 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 34 NNAF-LVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp TTTE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred cCEE-EEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-----chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 3566 788999999999999999999999999999863 2445567888999999997 9999999999876
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC----------
Q 006779 98 DTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG---------- 165 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~---------- 165 (631)
. ..+++||||+ +++|.+++.+.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 108 ~--~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 108 Y--DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp T--TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEE
T ss_pred C--CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccch
Confidence 5 4789999999 999999998764 5999999999999999999999999 999999999999962
Q ss_pred --------------CCCcEEEccccccchhcCCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCC
Q 006779 166 --------------NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNE 230 (631)
Q Consensus 166 --------------~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~ 230 (631)
.++.+||+|||++..... ......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTS-CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred hcccccccccccccCCCCEEEEeccCceecCC-CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 278999999999975443 2345679999999998754 599999999999999999999999987
Q ss_pred CCCHHHHHHHHHcCCCCCC------------------------C--------------------CCCCcHHHHHHHHHhc
Q 006779 231 CKNPAQIYKKVTSGIKPAS------------------------L--------------------SKVTDPQVKQFIEKCI 266 (631)
Q Consensus 231 ~~~~~~i~~~i~~~~~p~~------------------------l--------------------~~~~~~~l~~lI~~cL 266 (631)
. +.......+.....+.. + ....++.+.+||.+||
T Consensus 262 ~-~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 340 (360)
T 3llt_A 262 H-EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL 340 (360)
T ss_dssp S-SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred C-cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence 4 33333333332111100 0 0112367889999999
Q ss_pred C-CCCCCCCHHHHhcCCCCC
Q 006779 267 V-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 267 ~-~p~~Rpsa~elL~hpff~ 285 (631)
+ +|.+|||+.|+|+||||+
T Consensus 341 ~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 341 QIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CSSGGGSCCHHHHTTSGGGC
T ss_pred cCChhhCCCHHHHhcCcccC
Confidence 8 999999999999999995
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=370.31 Aligned_cols=253 Identities=23% Similarity=0.378 Sum_probs=209.5
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
.+|| ++.++||+|+||+||+|.+..+|+.||+|++...... ...+.+.+|+.+|+.++||||+++++++.+.....
T Consensus 8 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 8 NHLW-LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp SEEE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCE-EEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc---chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 3555 8899999999999999999999999999999754432 23466789999999999999999999998777678
Q ss_pred EEEEEeccCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeee----cCCCCcEEEccc
Q 006779 103 INMITELFTSGSLRQYRKKHKN---VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV----NGNNGEVKIGDL 175 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~---l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl----~~~~g~vKL~DF 175 (631)
+++||||+.+|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||+ + .++.+||+||
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~-~~~~~kL~Df 160 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGED-GQSVYKLTDF 160 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTT-SCEEEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCC-CCceEEEccC
Confidence 9999999999999999986543 999999999999999999999999 9999999999998 5 5678999999
Q ss_pred cccchhcCC-CCccccCCCCCCCccccc---------cccCccccchhhhHHHHHHhhcCCCCCCCCC---HHHHHHHHH
Q 006779 176 GLAIVMQQP-TARSVIGTPEFMAPELYE---------EEYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVT 242 (631)
Q Consensus 176 Gla~~~~~~-~~~~~~GTp~Y~APEvl~---------~~ys~~sDIwSLGiilyELltG~~Pf~~~~~---~~~i~~~i~ 242 (631)
|++...... ......||+.|+|||++. ..++.++|||||||++|+|+||+.||..... ...+...+.
T Consensus 161 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred CCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 999766443 334567999999999874 4588999999999999999999999964332 233344443
Q ss_pred cCCCCC-----------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 006779 243 SGIKPA-----------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 282 (631)
Q Consensus 243 ~~~~p~-----------------------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hp 282 (631)
.+..+. .+....++.+.+||.+||+ +|.+|||+.|+|+||
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 332211 1122235688999999998 999999999999997
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=357.64 Aligned_cols=257 Identities=28% Similarity=0.463 Sum_probs=221.0
Q ss_pred CCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC
Q 006779 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~ 100 (631)
...+|| ++.+.||+|+||.||+|.+..+|+.||+|.+..... ......+.+.+|+.+++.++||||+++++++.+.
T Consensus 12 ~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 87 (294)
T 2rku_A 12 RSRRRY-VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-- 87 (294)
T ss_dssp TTTEEE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred Ccccce-EEEEEEeecCCEEEEEEEECCCCceEEEEEechhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC--
Confidence 344555 888999999999999999999999999999975543 3456678899999999999999999999988654
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
..+++||||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 88 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 88 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATK 164 (294)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEc-CCCCEEEEeccCcee
Confidence 578999999999999999998889999999999999999999999999 99999999999998 788999999999976
Q ss_pred hcC--CCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006779 181 MQQ--PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 181 ~~~--~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~ 257 (631)
... .......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.. ....+.+..+..... .++...++.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~~~ 241 (294)
T 2rku_A 165 VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKNEY--SIPKHINPV 241 (294)
T ss_dssp CCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCTTSCHH
T ss_pred cccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhhccC--CCccccCHH
Confidence 542 23345679999999998765 488999999999999999999999976 445555555555432 344567889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 258 VKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 258 l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
++++|.+||. +|.+|||+.++|+||||...
T Consensus 242 ~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 242 AASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp HHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 9999999998 89999999999999999753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=356.54 Aligned_cols=261 Identities=25% Similarity=0.401 Sum_probs=218.9
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccC-C----HHHHHHHHHHHHHHHhCC-CCCceeeeeeE
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-S----PDQLERLYSEVHLLKSLK-HENIIKFYNSW 95 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~-~----~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~ 95 (631)
-.++| ++.+.||+|+||.||+|.++.+|+.||+|.+....... . ....+.+.+|+.+|+++. ||||+++++++
T Consensus 15 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 15 FYENY-EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp CTTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhcc-ceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34667 77899999999999999999999999999997653211 1 233567889999999995 99999999988
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccc
Q 006779 96 VDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 175 (631)
.+. ..+++||||+.+++|.+++.....+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+||
T Consensus 94 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~df 168 (298)
T 1phk_A 94 ETN--TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDF 168 (298)
T ss_dssp ECS--SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCC
T ss_pred ccC--CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEc-CCCcEEEecc
Confidence 654 579999999999999999998888999999999999999999999999 99999999999997 7889999999
Q ss_pred cccchhcCC-CCccccCCCCCCCccccc-------cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006779 176 GLAIVMQQP-TARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 247 (631)
Q Consensus 176 Gla~~~~~~-~~~~~~GTp~Y~APEvl~-------~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p 247 (631)
|++...... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||.. .+.......+..+...
T Consensus 169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~ 247 (298)
T 1phk_A 169 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQ 247 (298)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC
T ss_pred cchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC-ccHHHHHHHHhcCCcc
Confidence 999765433 344567999999999874 2478899999999999999999999977 4555555666554332
Q ss_pred CC--CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 248 AS--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 248 ~~--l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
.. .....+..+++||.+||. +|.+|||+.++|+||||+....
T Consensus 248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence 22 223467899999999998 8999999999999999987544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=372.68 Aligned_cols=260 Identities=23% Similarity=0.334 Sum_probs=213.7
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
-.+|| ++.+.||+|+||.||+|.+..+|+.||+|++.... ........++.+|+.+++.++||||+++++++......
T Consensus 10 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 10 LSDRY-ELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL-ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp ETTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTT-TTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ecCcE-EEEEEEccCCCEEEEEEEECCCCceEEEEEeCccc-cCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 35677 78899999999999999999999999999997543 23456677899999999999999999999988765432
Q ss_pred --eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 102 --TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 102 --~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
.+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMIS-ATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTSCEEECCCSCC-
T ss_pred CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEc-CCCCEEEeeccCcc
Confidence 56899999999999999998889999999999999999999999999 99999999999998 78899999999997
Q ss_pred hhcCC-----CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-CCCC
Q 006779 180 VMQQP-----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSK 252 (631)
Q Consensus 180 ~~~~~-----~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~-~l~~ 252 (631)
..... ......||+.|+|||++.+ .++.++|||||||++|+|+||+.||............+.....+. ....
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 244 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHST
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccC
Confidence 65432 2234579999999998765 589999999999999999999999987544444444444443322 2234
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 253 ~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
..++.+++||.+||. +|.+||++.++|.|+|++.
T Consensus 245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 467899999999998 8999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=372.33 Aligned_cols=255 Identities=24% Similarity=0.466 Sum_probs=216.2
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCH----HHHHHHHHHHHHHHhC-CCCCceeeeeeEEcC
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP----DQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 98 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~----~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~ 98 (631)
++| ++.+.||+|+||.||+|.+..+|+.||+|++......... ...+.+.+|+.+++.+ +||||++++++|...
T Consensus 94 ~~y-~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 94 QKY-DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhc-ccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 456 7789999999999999999999999999998765422222 2346688999999999 899999999998654
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
..+++||||+.+++|.+++.....+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++
T Consensus 173 --~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~-~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 173 --SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLD-DNMQIRLSDFGFS 247 (365)
T ss_dssp --SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTC
T ss_pred --CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEEecCcc
Confidence 478999999999999999998888999999999999999999999999 99999999999998 7899999999998
Q ss_pred chhcCC-CCccccCCCCCCCcccccc-------ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 006779 179 IVMQQP-TARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250 (631)
Q Consensus 179 ~~~~~~-~~~~~~GTp~Y~APEvl~~-------~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l 250 (631)
...... ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+.......+..+......
T Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~ 326 (365)
T 2y7j_A 248 CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIMEGQYQFSS 326 (365)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCH
T ss_pred cccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCC
Confidence 765443 3455789999999998753 478899999999999999999999977 4555566666555432211
Q ss_pred --CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 006779 251 --SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 251 --~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~ 285 (631)
....++.+++||.+||. +|.+|||+.++|+||||+
T Consensus 327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 13457889999999998 899999999999999996
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=370.19 Aligned_cols=264 Identities=22% Similarity=0.339 Sum_probs=215.8
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN 100 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~ 100 (631)
-.+||....+.||+|+||+||+|.++.+|..||+|++..... .......+.+|+.+++.+ +||||++++++|.+.
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~-- 101 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRAEILHEIAVLELAKSCPRVINLHEVYENT-- 101 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET--TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC--
Confidence 345675555899999999999999999999999999875432 233456788999999999 569999999998654
Q ss_pred CeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC--CCCcEEEcccc
Q 006779 101 RTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLG 176 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKL~DFG 176 (631)
..+++||||+.+|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++. .++.+||+|||
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 4799999999999999998653 67999999999999999999999999 999999999999973 26899999999
Q ss_pred ccchhcCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCC
Q 006779 177 LAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSK 252 (631)
Q Consensus 177 la~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p~~l~~ 252 (631)
++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||... +....+..+..... +.....
T Consensus 180 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~ 258 (327)
T 3lm5_A 180 MSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE-DNQETYLNISQVNVDYSEETFS 258 (327)
T ss_dssp GCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCCCTTTTT
T ss_pred cccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CchHHHHHHHhcccccCchhhc
Confidence 99766443 3345679999999998764 5899999999999999999999999874 44445444444322 333345
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCccc
Q 006779 253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 253 ~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~~~~ 292 (631)
..++.+++||.+||. +|.+|||+.++|+||||+..++..+
T Consensus 259 ~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 259 SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299 (327)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence 578899999999998 8999999999999999998776654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=387.45 Aligned_cols=260 Identities=26% Similarity=0.419 Sum_probs=210.0
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccC----CHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ----SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~----~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 98 (631)
.++| ++.+.||+|+||+||+|.+..+|+.||+|++....... .......+.+|+.+|++++||||+++++++..
T Consensus 134 ~~~y-~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 134 RDEY-IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HTTE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hccE-EEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 4567 78899999999999999999999999999998654321 12223457899999999999999999998743
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC--CCCcEEEcccc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLG 176 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKL~DFG 176 (631)
..+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .++.+||+|||
T Consensus 212 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 --EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp --SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred --CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecc
Confidence 347899999999999999988889999999999999999999999999 999999999999962 23469999999
Q ss_pred ccchhcCC-CCccccCCCCCCCccccc----cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC--C
Q 006779 177 LAIVMQQP-TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--S 249 (631)
Q Consensus 177 la~~~~~~-~~~~~~GTp~Y~APEvl~----~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~--~ 249 (631)
++...... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||........+...+..+..+. .
T Consensus 288 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~ 367 (419)
T 3i6u_A 288 HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 367 (419)
T ss_dssp TTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHH
T ss_pred cceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCch
Confidence 99766543 345678999999999874 3588899999999999999999999987655555666666654322 1
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 250 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 250 l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
.....++.+++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 368 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 407 (419)
T 3i6u_A 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407 (419)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred hhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence 223467899999999998 999999999999999998644
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=369.27 Aligned_cols=260 Identities=26% Similarity=0.427 Sum_probs=211.3
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeeccccc----CCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM----QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~----~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
++| ++.+.||+|+||.||+|.+..+|..||+|.+...... ........+.+|+.+|+.++||||+++++++...
T Consensus 10 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 10 DEY-IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hce-eEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 466 7889999999999999999999999999998754321 1122335588999999999999999999988543
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC--CCcEEEccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGL 177 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~--~g~vKL~DFGl 177 (631)
.+++||||+.+|+|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++.. ++.+||+|||+
T Consensus 88 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 88 --DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp --SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred --ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 37899999999999999998889999999999999999999999999 9999999999999732 23599999999
Q ss_pred cchhcCCC-CccccCCCCCCCccccc----cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC--CC
Q 006779 178 AIVMQQPT-ARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SL 250 (631)
Q Consensus 178 a~~~~~~~-~~~~~GTp~Y~APEvl~----~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~--~l 250 (631)
+....... .....||+.|+|||++. ..++.++|||||||++|+|++|..||........+...+..+..+. ..
T Consensus 164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T 2ycf_A 164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243 (322)
T ss_dssp CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence 97654432 23457999999999863 4588999999999999999999999987655545555555543321 12
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 251 ~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
....++.+++||.+||. +|.+||++.++|+||||+....
T Consensus 244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~ 283 (322)
T 2ycf_A 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 283 (322)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHH
T ss_pred hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHH
Confidence 23467899999999998 8999999999999999986443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=358.76 Aligned_cols=256 Identities=26% Similarity=0.469 Sum_probs=211.5
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
+|| ++.+.||+|+||.||+|.+..+|+.||+|.+...... .....+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 11 ~~y-~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 86 (276)
T 2h6d_A 11 GHY-VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR-SLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP--TDF 86 (276)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEE
T ss_pred ccE-EEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc-chhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC--CeE
Confidence 567 7889999999999999999999999999998754321 122346788999999999999999999988654 578
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
++||||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEEC-TTSCEEECCCCGGGCCCC
T ss_pred EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEEC-CCCCEEEeecccccccCC
Confidence 999999999999999998888999999999999999999999999 99999999999997 788999999999976544
Q ss_pred C-CCccccCCCCCCCccccccc-c-CccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006779 184 P-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 184 ~-~~~~~~GTp~Y~APEvl~~~-y-s~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~ 260 (631)
. ......||+.|+|||++.+. + +.++||||||+++|+|++|+.||.. .+...+...+..+..+ ++...+..+++
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 240 (276)
T 2h6d_A 164 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFY--IPEYLNRSVAT 240 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHH
T ss_pred CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhcCccc--CchhcCHHHHH
Confidence 3 23455789999999988754 3 6899999999999999999999976 4566677777665432 34556789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 261 FIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 261 lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
+|.+||. +|.+|||+.++|+||||+...+
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h~~~~~~~~ 270 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREHEWFKQDLP 270 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred HHHHHccCChhhCCCHHHHHhChhhccCch
Confidence 9999998 8999999999999999986543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=365.32 Aligned_cols=258 Identities=28% Similarity=0.461 Sum_probs=221.7
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
....+|| ++.+.||+|+||.||+|.+..+|+.||+|.+..... ......+.+.+|+.+++.++||||+++++++.+.
T Consensus 37 ~~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 113 (335)
T 2owb_A 37 PRSRRRY-VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN- 113 (335)
T ss_dssp TTTTEEE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-
T ss_pred cccCCce-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-
Confidence 3344555 788999999999999999999999999999975543 3456678899999999999999999999998654
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
..+++||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 114 -~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~ 189 (335)
T 2owb_A 114 -DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLAT 189 (335)
T ss_dssp -SEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCE
T ss_pred -CeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEc-CCCCEEEeeccCce
Confidence 579999999999999999998889999999999999999999999999 99999999999998 78899999999997
Q ss_pred hhcCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006779 180 VMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 180 ~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~ 256 (631)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+....+..+..+.. .++...++
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~ 266 (335)
T 2owb_A 190 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKNEY--SIPKHINP 266 (335)
T ss_dssp ECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCC--CCCTTSCH
T ss_pred ecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHhcCCC--CCCccCCH
Confidence 65432 3345679999999998765 488999999999999999999999976 445555555555432 24456788
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 257 QVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.+++||.+||. +|.+||++.++|+||||...
T Consensus 267 ~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 267 VAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 99999999998 89999999999999999764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=358.96 Aligned_cols=257 Identities=26% Similarity=0.494 Sum_probs=193.0
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
.-++| ++.+.||+|+||.||+|.+..+|+.||+|.+...... .....+++.+|+.+++.++||||+++++++.+. .
T Consensus 9 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 84 (278)
T 3cok_A 9 KIEDF-KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY-KAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS--N 84 (278)
T ss_dssp SGGGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS--S
T ss_pred ccccc-eeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh-hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC--C
Confidence 34566 7889999999999999999999999999999754321 112346789999999999999999999998654 5
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 102 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
.+++||||+.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~-~~~~~kl~dfg~~~~ 161 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLT-RNMNIKIADFGLATQ 161 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEEC-TTCCEEECCCTTCEE
T ss_pred eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEEEeecceee
Confidence 789999999999999999875 67999999999999999999999999 99999999999997 788999999999976
Q ss_pred hcCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006779 181 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 181 ~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~ 257 (631)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||........ ...+... ...++...+++
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~--~~~~~~~~~~~ 238 (278)
T 3cok_A 162 LKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-LNKVVLA--DYEMPSFLSIE 238 (278)
T ss_dssp CC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCSS--CCCCCTTSCHH
T ss_pred ccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-HHHHhhc--ccCCccccCHH
Confidence 5432 2334678999999998765 488999999999999999999999976433222 2222111 12344557889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 258 VKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 258 l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
+++||.+||. +|.+|||+.++|+||||....
T Consensus 239 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 239 AKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 9999999998 899999999999999997643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=394.52 Aligned_cols=263 Identities=24% Similarity=0.385 Sum_probs=222.8
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.+| ++.++||+|+||.||+|.++.+|+.||+|++....... ....+.+.+|+.+|+.++||||++++++|.+. ..+
T Consensus 185 ~~f-~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~l 260 (543)
T 3c4z_A 185 DWF-LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK-RKGYQGAMVEKKILAKVHSRFIVSLAYAFETK--TDL 260 (543)
T ss_dssp GGE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEE
T ss_pred hhe-EEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh-hHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC--CEE
Confidence 445 77899999999999999999999999999997543211 12346788999999999999999999998654 479
Q ss_pred EEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 104 NMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~----~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
|+||||+.||+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~-~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDLGLAV 337 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCE
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEe-CCCCEEEeecceee
Confidence 9999999999999999764 36999999999999999999999999 99999999999998 78999999999997
Q ss_pred hhcCCC--CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCC---CHHHHHHHHHcCCCCCCCCCC
Q 006779 180 VMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 180 ~~~~~~--~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~---~~~~i~~~i~~~~~p~~l~~~ 253 (631)
...... ....+||+.|+|||++.+ .|+.++|||||||++|||+||+.||.... ....+...+..... .++..
T Consensus 338 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~--~~p~~ 415 (543)
T 3c4z_A 338 ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--TYPDK 415 (543)
T ss_dssp ECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC--CCCTT
T ss_pred eccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc--CCCcc
Confidence 654432 344689999999998765 59999999999999999999999997642 45667776665432 34556
Q ss_pred CcHHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCcccccC
Q 006779 254 TDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCD 295 (631)
Q Consensus 254 ~~~~l~~lI~~cL~-~p~~Rps-----a~elL~hpff~~~~~~~~~~~ 295 (631)
.++.+++||.+||. +|.+||+ +.+++.||||+..++..+...
T Consensus 416 ~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~ 463 (543)
T 3c4z_A 416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAG 463 (543)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTT
T ss_pred cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcC
Confidence 78999999999998 8999996 589999999999888765433
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=371.29 Aligned_cols=255 Identities=26% Similarity=0.425 Sum_probs=201.5
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
+|| ++.+.||+|+||+||+|.+..+|..||+|++..... ......+.+|+.+|+.++||||+++++++.+. ..+
T Consensus 2 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 75 (324)
T 3mtl_A 2 ETY-IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSL 75 (324)
T ss_dssp CSE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECS--SCE
T ss_pred Cce-EEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc---cccchhHHHHHHHHHhcCCCCCCeeeeEEeeC--CEE
Confidence 467 778999999999999999999999999999875431 12222356799999999999999999998754 468
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
++||||+. |+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 76 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 76 TLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKS 151 (324)
T ss_dssp EEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEEC-TTCCEEECSSSEEECC-
T ss_pred EEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEEC-CCCCEEEccCccccccc
Confidence 99999997 5899888765 45999999999999999999999999 99999999999997 78899999999997554
Q ss_pred CC--CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc---CCCCCCCC----
Q 006779 183 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---GIKPASLS---- 251 (631)
Q Consensus 183 ~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~---~~~p~~l~---- 251 (631)
.. ......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.. .......+.. ...+..++
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST-VEEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCChHhchhhhc
Confidence 32 2344578999999998754 48999999999999999999999998744 3333333322 11111111
Q ss_pred ---------------------CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 252 ---------------------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 252 ---------------------~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
...++.+++||.+||+ +|.+|||+.|+|+||||.....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 1356889999999998 9999999999999999987543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=377.65 Aligned_cols=252 Identities=26% Similarity=0.378 Sum_probs=207.0
Q ss_pred eee--eeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 27 GRY--DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 27 ~r~--~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
+++ .++||+|+||.||+|.+..+|..||+|++.... ....+.+.+|+.+|+.++||||++++++|.+. ..++
T Consensus 89 ~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~ 162 (373)
T 2x4f_A 89 YTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG----MKDKEEVKNEISVMNQLDHANLIQLYDAFESK--NDIV 162 (373)
T ss_dssp EEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEE
T ss_pred eeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEE
Confidence 355 468999999999999999999999999997542 34567799999999999999999999998754 4789
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeec-CCCCcEEEccccccchhc
Q 006779 105 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~-~~~g~vKL~DFGla~~~~ 182 (631)
+||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+. ..++.+||+|||++....
T Consensus 163 lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~ 240 (373)
T 2x4f_A 163 LVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240 (373)
T ss_dssp EEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence 999999999999988654 46999999999999999999999999 99999999999984 256799999999997665
Q ss_pred CC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcHHH
Q 006779 183 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQV 258 (631)
Q Consensus 183 ~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p~~l~~~~~~~l 258 (631)
.. .....+||+.|+|||++.. .++.++|||||||++|+|++|..||.+. +.......+..... +.......++++
T Consensus 241 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 241 PREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD-NDAETLNNILACRWDLEDEEFQDISEEA 319 (373)
T ss_dssp TTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred CccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccCCCChhhhccCCHHH
Confidence 43 3345579999999998764 4889999999999999999999999874 44445555544322 122224567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 259 KQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 259 ~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
++||.+||. +|.+|||+.|+|+||||...
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 999999998 89999999999999999753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=376.00 Aligned_cols=264 Identities=22% Similarity=0.356 Sum_probs=217.8
Q ss_pred CceeeeeeEecccCceEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCC
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDT 99 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~---~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~ 99 (631)
++| ++.+.||+|+||.||+|.+. .+|+.||+|+++...........+.+.+|+.+|+.+ +||||+++++++.+.
T Consensus 54 ~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 131 (355)
T 1vzo_A 54 ENF-ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 131 (355)
T ss_dssp GGE-EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred cce-EEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-
Confidence 566 77899999999999999984 589999999986543222222334567899999999 699999999988765
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
..+++||||+.+|+|.+++.+...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 132 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 132 -TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSK 207 (355)
T ss_dssp -TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEESCSSEEE
T ss_pred -ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCcEEEeeCCCCe
Confidence 468999999999999999998889999999999999999999999999 99999999999997 78899999999997
Q ss_pred hhcCC---CCccccCCCCCCCcccccc---ccCccccchhhhHHHHHHhhcCCCCCCC---CCHHHHHHHHHcCCCCCCC
Q 006779 180 VMQQP---TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNEC---KNPAQIYKKVTSGIKPASL 250 (631)
Q Consensus 180 ~~~~~---~~~~~~GTp~Y~APEvl~~---~ys~~sDIwSLGiilyELltG~~Pf~~~---~~~~~i~~~i~~~~~p~~l 250 (631)
..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||... .....+...+.... ..+
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~ 285 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPY 285 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--CCC
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC--CCC
Confidence 54322 2345679999999998864 3789999999999999999999999643 23455555555432 234
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCcccccC
Q 006779 251 SKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCD 295 (631)
Q Consensus 251 ~~~~~~~l~~lI~~cL~-~p~~Rp-----sa~elL~hpff~~~~~~~~~~~ 295 (631)
+...++.+++||.+||. +|.+|| ++.++++||||+..++..+...
T Consensus 286 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~ 336 (355)
T 1vzo_A 286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAK 336 (355)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTT
T ss_pred CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhc
Confidence 45677899999999998 899999 9999999999998877665433
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=357.08 Aligned_cols=250 Identities=32% Similarity=0.518 Sum_probs=207.3
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEecc
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey~ 110 (631)
.+||+|+||.||+|.+..+|..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+. ..+++||||+
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~ 101 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN--GFIKIFMEQV 101 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCC----C---HHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEEECC
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCc----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC--CcEEEEEEeC
Confidence 48999999999999999999999999987542 34456789999999999999999999998764 4789999999
Q ss_pred CCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC--C
Q 006779 111 TSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--T 185 (631)
Q Consensus 111 ~gGsL~~~l~~~~---~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--~ 185 (631)
.+++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++..++.+||+|||++...... .
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 9999999998752 4679999999999999999999998 9999999999999854889999999999765432 2
Q ss_pred CccccCCCCCCCccccccc---cCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006779 186 ARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262 (631)
Q Consensus 186 ~~~~~GTp~Y~APEvl~~~---ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI 262 (631)
.....||+.|+|||++.+. ++.++||||||+++|+|++|+.||.....................++...++.+++||
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 259 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFI 259 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHH
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHH
Confidence 3456789999999987542 7899999999999999999999997655544433333222233345566789999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 263 EKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 263 ~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
.+||. +|.+||++.++|.||||+...
T Consensus 260 ~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 260 LKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHccCChhhCCCHHHHhcChhhhhcc
Confidence 99998 899999999999999998654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=361.83 Aligned_cols=260 Identities=28% Similarity=0.536 Sum_probs=210.0
Q ss_pred cccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEc
Q 006779 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d 97 (631)
....+..+| ++.+.||+|+||.||+|.+..+|..||+|.+.... ..+.+.+|+.+|+.++||||+++++++..
T Consensus 23 ~~~~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 23 LTKQPEEVF-DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQEIIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp -------CE-EEEEECC----CEEEEEEETTTCCEEEEEEEETTS------CCHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred hhhcchhhh-hhheeeccCCCeEEEEEEECCCCCEEEEEecCchH------HHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 345677777 77899999999999999999999999999997542 23568899999999999999999999876
Q ss_pred CCCCeEEEEEeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccc
Q 006779 98 DTNRTINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~-~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 176 (631)
. ..+++||||+.+++|.+++. ....+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||
T Consensus 96 ~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg 170 (314)
T 3com_A 96 N--TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLN-TEGHAKLADFG 170 (314)
T ss_dssp T--TEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCT
T ss_pred C--CEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEEC-CCCCEEEeecc
Confidence 4 46899999999999999987 4567999999999999999999999999 99999999999997 78899999999
Q ss_pred ccchhcCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCC
Q 006779 177 LAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSK 252 (631)
Q Consensus 177 la~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~-p~~l~~ 252 (631)
++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.... .......+..... ....+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~ 249 (314)
T 3com_A 171 VAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH-PMRAIFMIPTNPPPTFRKPE 249 (314)
T ss_dssp TCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHSCCCCCSSGG
T ss_pred cchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHhcCCCcccCCcc
Confidence 99765443 2345678999999998764 58999999999999999999999998744 3333333333322 222334
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCc
Q 006779 253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 253 ~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~~ 290 (631)
..++.+++||.+||. +|.+|||+.++|+||||......
T Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~ 288 (314)
T 3com_A 250 LWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGV 288 (314)
T ss_dssp GSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCG
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcc
Confidence 567899999999998 89999999999999999875543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=378.37 Aligned_cols=256 Identities=20% Similarity=0.326 Sum_probs=203.0
Q ss_pred CCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHH-HhCCCCCceeeeeeEEc--
Q 006779 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHENIIKFYNSWVD-- 97 (631)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL-k~L~HpnIVkl~~~~~d-- 97 (631)
.-.++|+...++||+|+||+||+|.++.+|+.||+|++... ..+.+|+.++ +.++||||++++++|..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 33456755568999999999999999999999999998622 2466788887 55689999999998854
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC--CCcEEEc
Q 006779 98 DTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIG 173 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~--~g~vKL~ 173 (631)
....++|+|||||.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.. ++.+||+
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEEC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEE
Confidence 33457999999999999999998754 5999999999999999999999999 9999999999999732 6899999
Q ss_pred cccccchhcCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHH---HHHHHHHcCCC--
Q 006779 174 DLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPA---QIYKKVTSGIK-- 246 (631)
Q Consensus 174 DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~---~i~~~i~~~~~-- 246 (631)
|||++...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||....... .+...+..+..
T Consensus 207 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~ 286 (400)
T 1nxk_A 207 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 286 (400)
T ss_dssp CCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred ecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence 99999765432 3456689999999998854 59999999999999999999999997643211 13334443322
Q ss_pred CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 247 PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 247 p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
+.......++++++||.+||. +|.+|||+.++|+||||...
T Consensus 287 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 222234568899999999998 89999999999999999753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=363.69 Aligned_cols=265 Identities=30% Similarity=0.493 Sum_probs=224.5
Q ss_pred CcccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeee
Q 006779 15 GEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 94 (631)
Q Consensus 15 ~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~ 94 (631)
.......-.+|| ++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.++++++||||++++++
T Consensus 13 ~~~~~~~~~~~y-~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 89 (287)
T 2wei_A 13 NLYFQGTFAERY-NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPNIMKLFEI 89 (287)
T ss_dssp HHHHTHHHHHHE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS--SSCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred chhHHHHHhhcc-eeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc--hHHHHHHHHHHHHHHhccCCCccEEEEE
Confidence 334444455788 7789999999999999999999999999999755432 2345678999999999999999999998
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC--CCcEEE
Q 006779 95 WVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKI 172 (631)
Q Consensus 95 ~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~--~g~vKL 172 (631)
+.+. ..+++||||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+||+++.. ++.+||
T Consensus 90 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL 165 (287)
T 2wei_A 90 LEDS--SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKI 165 (287)
T ss_dssp EECS--SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred EeCC--CeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEE
Confidence 8654 578999999999999999988888999999999999999999999999 9999999999999732 347999
Q ss_pred ccccccchhcCC-CCccccCCCCCCCccccccccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006779 173 GDLGLAIVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 251 (631)
Q Consensus 173 ~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~ 251 (631)
+|||++...... ......||+.|+|||++.+.++.++||||||+++|+|++|..||.. .+...+...+..+..+...+
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~ 244 (287)
T 2wei_A 166 IDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLP 244 (287)
T ss_dssp CSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSG
T ss_pred eccCcceeecCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCch
Confidence 999999765443 2344568999999999988899999999999999999999999987 45666777776665433322
Q ss_pred --CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 252 --KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 252 --~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
...++.+++||.+||. +|.+|||+.++|.||||+..
T Consensus 245 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 3567899999999998 89999999999999999754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=375.42 Aligned_cols=254 Identities=24% Similarity=0.399 Sum_probs=212.4
Q ss_pred ccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC----HHHHHHHHHHHHHHHhCCCCCceeeeee
Q 006779 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS----PDQLERLYSEVHLLKSLKHENIIKFYNS 94 (631)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~----~~~~~~l~~Ei~iLk~L~HpnIVkl~~~ 94 (631)
+..-.+|| ++.+.||+|+||+||+|.++.+|..||+|.+........ ......+.+|+.+|+.++||||++++++
T Consensus 19 ~~~~~~~y-~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 97 (335)
T 3dls_A 19 EGEYSQKY-STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDI 97 (335)
T ss_dssp TTHHHHHE-EEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEE
T ss_pred Ccccccce-EEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 33445677 778999999999999999999999999999986543221 1123457789999999999999999999
Q ss_pred EEcCCCCeEEEEEeccCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEc
Q 006779 95 WVDDTNRTINMITELFTSG-SLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173 (631)
Q Consensus 95 ~~d~~~~~l~lV~Ey~~gG-sL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~ 173 (631)
|.+. ..+++||||+.+| +|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+
T Consensus 98 ~~~~--~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~ 172 (335)
T 3dls_A 98 FENQ--GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIA-EDFTIKLI 172 (335)
T ss_dssp EECS--SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEEC
T ss_pred EeeC--CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEc-CCCcEEEe
Confidence 8654 5789999999776 99999999989999999999999999999999999 99999999999997 78999999
Q ss_pred cccccchhcCC-CCccccCCCCCCCccccccc-c-CccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 006779 174 DLGLAIVMQQP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250 (631)
Q Consensus 174 DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~~-y-s~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l 250 (631)
|||++...... .....+||+.|+|||++.+. + +.++|||||||++|+|++|..||..... ... .....
T Consensus 173 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~--~~~~~ 243 (335)
T 3dls_A 173 DFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------TVE--AAIHP 243 (335)
T ss_dssp CCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------GTT--TCCCC
T ss_pred ecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------HHh--hccCC
Confidence 99999766543 34456799999999987653 4 7899999999999999999999975211 111 11223
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 251 ~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
+...++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 244 ~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 244 PYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 34568999999999998 89999999999999999763
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=356.75 Aligned_cols=257 Identities=25% Similarity=0.404 Sum_probs=213.7
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC--HHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS--PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~--~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
++| ++.+.||+|+||.||+|.+..+|..||+|.+........ ....+.+.+|+.+|+.++||||+++++++.+. .
T Consensus 5 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~ 81 (283)
T 3bhy_A 5 DHY-EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK--T 81 (283)
T ss_dssp HHE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred hhh-hhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC--C
Confidence 356 788999999999999999999999999999976543221 11356789999999999999999999998654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCC----cEEEccccc
Q 006779 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVKIGDLGL 177 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g----~vKL~DFGl 177 (631)
.+++||||+.+++|.+++.+...+++..++.++.||+.||.|||+++ |+||||||+||+++ .++ .+||+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLL-DKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEES-CSSSSSCCEEECCCTT
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEe-cCCCCCCceEEEeccc
Confidence 78999999999999999998888999999999999999999999999 99999999999997 444 899999999
Q ss_pred cchhcCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC--CCCCC
Q 006779 178 AIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SLSKV 253 (631)
Q Consensus 178 a~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~--~l~~~ 253 (631)
+...... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+.......+....... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T 3bhy_A 159 AHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-ETKQETLTNISAVNYDFDEEYFSN 237 (283)
T ss_dssp CEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred ceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC-cchHHHHHHhHhcccCCcchhccc
Confidence 9765432 3345579999999998764 589999999999999999999999987 45555556555543221 12245
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 254 ~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.++.+++||.+||. +|.+||++.++|+||||+..
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 238 TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp CCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 67889999999998 89999999999999999764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=369.55 Aligned_cols=256 Identities=25% Similarity=0.396 Sum_probs=211.0
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC---
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--- 99 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~--- 99 (631)
.+|| ++.+.||+|+||.||+|.+..+|..||+|++... .......++.+|+.+|+.++||||+++++++....
T Consensus 26 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 26 GPRY-TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF---EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp TTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT---TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred cccE-EEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc---cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 4678 7889999999999999999999999999998643 24556678999999999999999999999886543
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
...+++||||+. |+|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 102 ~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 102 MKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLAR 176 (364)
T ss_dssp CCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCE
T ss_pred cceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEEC-CCCCEEEEeCcceE
Confidence 246899999997 599999876 45999999999999999999999999 99999999999997 78899999999997
Q ss_pred hhcCC-----CCccccCCCCCCCccccc-c-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC--------
Q 006779 180 VMQQP-----TARSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-------- 244 (631)
Q Consensus 180 ~~~~~-----~~~~~~GTp~Y~APEvl~-~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~-------- 244 (631)
..... .....+||+.|+|||++. . .++.++|||||||++|+|++|+.||.+......+...+...
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 55432 134568999999999764 3 48999999999999999999999998754444333322110
Q ss_pred ---------------CCCC-----CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 245 ---------------IKPA-----SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 245 ---------------~~p~-----~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
..+. .+....++.+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 0000 0113457899999999998 89999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=369.35 Aligned_cols=259 Identities=26% Similarity=0.413 Sum_probs=212.0
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
.-+|| ++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++.+. .
T Consensus 23 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 97 (331)
T 4aaa_A 23 SMEKY-ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK--K 97 (331)
T ss_dssp CGGGE-EEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--T
T ss_pred hhhhh-eeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC--CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC--C
Confidence 45677 77899999999999999999999999999986543 3455567788999999999999999999998754 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
.+++||||+.+++|..++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 98 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 98 RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTL 174 (331)
T ss_dssp EEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCTTC---
T ss_pred EEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEc-CCCcEEEEeCCCceee
Confidence 78999999999999999888888999999999999999999999999 99999999999997 7889999999999765
Q ss_pred cCC--CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc--------------
Q 006779 182 QQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-------------- 243 (631)
Q Consensus 182 ~~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~-------------- 243 (631)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||........+...+..
T Consensus 175 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 175 AAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred cCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 432 2345679999999998765 5889999999999999999999999875554444433321
Q ss_pred -----CCCCCCC---------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 244 -----GIKPASL---------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 244 -----~~~p~~l---------~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
+...+.+ ....++.+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence 0000000 12357889999999998 999999999999999998643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=360.95 Aligned_cols=258 Identities=27% Similarity=0.430 Sum_probs=210.6
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
.-..+|| ++.+.||+|+||.||+|.+..+|..||+|.+..... ......+++.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~~~~y-~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~- 83 (294)
T 4eqm_A 7 KIINERY-KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED- 83 (294)
T ss_dssp SCEETTE-EEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS-
T ss_pred hHhhccE-EEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC-
Confidence 3445788 788999999999999999999999999999875443 3456678899999999999999999999988644
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
..+++||||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 84 -~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~ 159 (294)
T 4eqm_A 84 -DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILID-SNKTLKIFDFGIAK 159 (294)
T ss_dssp -SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCSSST
T ss_pred -CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEEeCCCcc
Confidence 579999999999999999999899999999999999999999999999 99999999999997 78899999999997
Q ss_pred hhcCC---CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCC
Q 006779 180 VMQQP---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKV 253 (631)
Q Consensus 180 ~~~~~---~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--~~l~~~ 253 (631)
..... ......||+.|+|||++.+ .++.++||||||+++|+|+||+.||.+..........+.....+ ......
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T 4eqm_A 160 ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKD 239 (294)
T ss_dssp TC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTT
T ss_pred ccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccC
Confidence 65433 2334579999999998765 48899999999999999999999998754444444444333221 123455
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 254 ~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
.++.+.++|.+||. +|.+||+..+.+.+.|.
T Consensus 240 ~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 240 IPQSLSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred CCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 77899999999998 89999966666665554
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=361.64 Aligned_cols=261 Identities=27% Similarity=0.509 Sum_probs=191.2
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
.++| ++.+.||+|+||.||+|.+..+|+.||+|.+..... ....+.+.+|+.+++.++||||+++++++.... .
T Consensus 14 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~ 87 (303)
T 2vwi_A 14 RDDY-ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC---QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD--E 87 (303)
T ss_dssp CCCC-EEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEESSS--C
T ss_pred hhhh-hhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc---chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC--C
Confidence 4455 888999999999999999999999999999865432 334567889999999999999999999987654 5
Q ss_pred EEEEEeccCCCCHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcc
Q 006779 103 INMITELFTSGSLRQYRKK--------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~--------~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~D 174 (631)
+++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~d 164 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLG-EDGSVQIAD 164 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTCCEEECC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEc-CCCCEEEEe
Confidence 8899999999999999874 456999999999999999999999999 99999999999997 788999999
Q ss_pred ccccchhcCC-------CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006779 175 LGLAIVMQQP-------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 245 (631)
Q Consensus 175 FGla~~~~~~-------~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~ 245 (631)
||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||............+....
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 244 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 244 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC
Confidence 9998654322 2234579999999998764 589999999999999999999999987554444443333221
Q ss_pred CC-------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCccc
Q 006779 246 KP-------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 246 ~p-------~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~~~~ 292 (631)
.. .......++.+++||.+||. +|.+||++.++|+||||+....+.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~ 299 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEF 299 (303)
T ss_dssp CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--------
T ss_pred CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCCcc
Confidence 11 12234567899999999998 8999999999999999987655443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=356.33 Aligned_cols=253 Identities=32% Similarity=0.503 Sum_probs=208.5
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC----
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---- 99 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~---- 99 (631)
++| ++.+.||+|+||.||+|.+..+|+.||+|.+... ....+.+.+|+.+++.++||||++++++|.+..
T Consensus 6 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 6 SDF-EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccc-hhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 456 7789999999999999999999999999998642 455678999999999999999999999887632
Q ss_pred -------CCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEE
Q 006779 100 -------NRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 171 (631)
Q Consensus 100 -------~~~l~lV~Ey~~gGsL~~~l~~~~-~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 171 (631)
...+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~-~~~~~k 156 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFID-ESRNVK 156 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEE
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEc-CCCCEE
Confidence 357899999999999999998654 5889999999999999999999999 99999999999997 788999
Q ss_pred EccccccchhcCC----------------CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCC
Q 006779 172 IGDLGLAIVMQQP----------------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKN 233 (631)
Q Consensus 172 L~DFGla~~~~~~----------------~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~ 233 (631)
|+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++ ||....+
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~ 233 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME 233 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence 9999999755321 2234578999999998764 58999999999999999998 6654444
Q ss_pred HHHHHHHHHcCC--CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 234 PAQIYKKVTSGI--KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 234 ~~~i~~~i~~~~--~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
...+...+.... .|..+....++.+++||.+||. +|.+|||+.++|+||||....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (303)
T 1zy4_A 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291 (303)
T ss_dssp HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred HHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence 455556665432 2444556667889999999998 899999999999999997644
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=377.44 Aligned_cols=256 Identities=30% Similarity=0.438 Sum_probs=193.8
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC---
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--- 99 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~--- 99 (631)
.+|| ++.+.||+|+||.||+|.+..+|+.||+|++.... .......++.+|+.+|+.++||||+++++++....
T Consensus 28 ~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 28 PERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp ETTE-EEEEECC----CCEEEEEETTTTEEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CCce-EEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 3677 77899999999999999999999999999986432 34566778999999999999999999999886532
Q ss_pred -CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 100 -NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 -~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
...+++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kL~DFG~a 179 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLA 179 (367)
T ss_dssp GCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECC----
T ss_pred cCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEEC-CCCCEEEeecccc
Confidence 24578999999 7899998876 56999999999999999999999999 99999999999998 7899999999999
Q ss_pred chhcCCCCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCC---------
Q 006779 179 IVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK--------- 246 (631)
Q Consensus 179 ~~~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~-~~~--------- 246 (631)
...... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.....++...+.. +..
T Consensus 180 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 180 RHTADE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred cccccc-CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 765433 345689999999998754 5899999999999999999999999875443333322221 000
Q ss_pred ---------------CCC---CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 247 ---------------PAS---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 247 ---------------p~~---l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
... .....++.+++||.+||+ +|.+|||+.++|.||||...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 000 112346889999999998 99999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=375.97 Aligned_cols=255 Identities=26% Similarity=0.415 Sum_probs=206.0
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC------CCCCceeeeeeE
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL------KHENIIKFYNSW 95 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L------~HpnIVkl~~~~ 95 (631)
...|| ++.++||+|+||+||+|.+..+|+.||+|++... ......+.+|+.+++.+ .|+||++++++|
T Consensus 95 ~~~ry-~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~ 168 (429)
T 3kvw_A 95 VAYRY-EVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF 168 (429)
T ss_dssp ETTTE-EEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred ccCcE-EEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence 34567 7889999999999999999999999999998642 34456678888888887 577999999998
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCc--EE
Q 006779 96 VDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VK 171 (631)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~--vK 171 (631)
... ..+++||||+. ++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++. +|
T Consensus 169 ~~~--~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~-~~~~~~vk 242 (429)
T 3kvw_A 169 TFR--NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLK-QQGRSGIK 242 (429)
T ss_dssp EET--TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEES-STTSCCEE
T ss_pred ccC--CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEc-cCCCcceE
Confidence 765 47899999995 69999988754 4999999999999999999999998 99999999999998 5665 99
Q ss_pred EccccccchhcCCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCCCC-
Q 006779 172 IGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA- 248 (631)
Q Consensus 172 L~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~-~~~p~- 248 (631)
|+|||++...... ....+||+.|+|||++.+ .|+.++|||||||++|||+||..||.+......+...+.. +..+.
T Consensus 243 L~DFG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~ 321 (429)
T 3kvw_A 243 VIDFGSSCYEHQR-VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK 321 (429)
T ss_dssp ECCCTTCEETTCC-CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred EeecccceecCCc-ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 9999999654433 345689999999998754 5999999999999999999999999875444443332221 00000
Q ss_pred ------------------------------------------------------CCCCCCcHHHHHHHHHhcC-CCCCCC
Q 006779 249 ------------------------------------------------------SLSKVTDPQVKQFIEKCIV-PASLRL 273 (631)
Q Consensus 249 ------------------------------------------------------~l~~~~~~~l~~lI~~cL~-~p~~Rp 273 (631)
.+....++.+++||.+||+ +|.+||
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp 401 (429)
T 3kvw_A 322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM 401 (429)
T ss_dssp HHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred HHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence 0112347889999999998 999999
Q ss_pred CHHHHhcCCCCCCCCC
Q 006779 274 PALELLKDPFLVTDNP 289 (631)
Q Consensus 274 sa~elL~hpff~~~~~ 289 (631)
|+.|+|+||||+...+
T Consensus 402 ta~e~L~Hpw~~~~~~ 417 (429)
T 3kvw_A 402 TPGQALRHPWLRRRLP 417 (429)
T ss_dssp CHHHHHTSTTTC----
T ss_pred CHHHHhCChhhccCCC
Confidence 9999999999987543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=377.03 Aligned_cols=250 Identities=20% Similarity=0.313 Sum_probs=203.5
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC----CCCe
Q 006779 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD----TNRT 102 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~----~~~~ 102 (631)
|++.++||+|+||.||+|.+..+|+.||+|++..... ...+|+++|+.|+||||++++++|... ...+
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 4778999999999999999999999999999864432 133699999999999999999988642 2336
Q ss_pred EEEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 103 INMITELFTSGSLRQYRK----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~----~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
+++||||+.+ +|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.+++.+||+|||++
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 7899999975 5655543 3567999999999999999999999999 9999999999999855678999999999
Q ss_pred chhcC-CCCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCC----------
Q 006779 179 IVMQQ-PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---------- 245 (631)
Q Consensus 179 ~~~~~-~~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~---------- 245 (631)
+.... ......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.....++.+.+....
T Consensus 205 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 205 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp EECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred hhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 76543 23455789999999998754 589999999999999999999999988655555544443100
Q ss_pred ----CCCC------------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 246 ----KPAS------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 246 ----~p~~------------l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.... +....++++++||.+||. +|.+||++.|+|.||||...
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 0000 123457899999999998 99999999999999999753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=368.40 Aligned_cols=259 Identities=25% Similarity=0.382 Sum_probs=203.3
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC-HHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~-~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~ 100 (631)
..+|| ++.+.||+|+||.||+|.+..+|+.||+|++........ ......+.+|+.+|+.++||||++++++|.+.
T Consensus 8 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 84 (346)
T 1ua2_A 8 RAKRY-EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-- 84 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred Hhccc-EEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC--
Confidence 45677 778999999999999999999999999999875432111 11234688999999999999999999998654
Q ss_pred CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 101 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
..+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAK 160 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCGGGS
T ss_pred CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEc-CCCCEEEEecccce
Confidence 468899999975 898888765 46899999999999999999999999 99999999999998 78999999999997
Q ss_pred hhcCC--CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCC-CCCC---
Q 006779 180 VMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK-PASL--- 250 (631)
Q Consensus 180 ~~~~~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~-~~~-p~~l--- 250 (631)
..... ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+......+...+.. +.. +..+
T Consensus 161 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 161 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred eccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 66433 2345679999999998754 4889999999999999999999999875444333333221 111 1111
Q ss_pred --------------------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 251 --------------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 251 --------------------~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
....++.+++||.+||. +|.+|||+.|+|+||||...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 13346889999999998 89999999999999999764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=382.97 Aligned_cols=251 Identities=16% Similarity=0.199 Sum_probs=198.9
Q ss_pred CCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHH---HHHHhCCCCCceeee-----
Q 006779 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV---HLLKSLKHENIIKFY----- 92 (631)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei---~iLk~L~HpnIVkl~----- 92 (631)
.+.++| ++.+.||+|+||+||+|.+..+|+.||+|++..... ......+.+.+|+ .+|+.++||||++++
T Consensus 70 ~~~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~ 147 (377)
T 3byv_A 70 ERPRTL-VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 147 (377)
T ss_dssp CCCEEE-EEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC--CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC
T ss_pred CCCceE-EEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccc-cchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhh
Confidence 345555 888999999999999999999999999999975433 2345667899999 556666899999998
Q ss_pred --eeEEcCCC----------C-----eEEEEEeccCCCCHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhCC
Q 006779 93 --NSWVDDTN----------R-----TINMITELFTSGSLRQYRKKHKNVDM-------KAIKNWARQILRGLHYLHSHN 148 (631)
Q Consensus 93 --~~~~d~~~----------~-----~l~lV~Ey~~gGsL~~~l~~~~~l~~-------~~i~~i~~QIl~aL~yLHs~~ 148 (631)
+++.+.+. . ..++||||+ +|+|.+++.+.+.+++ ..++.++.||+.||+|||+++
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 226 (377)
T 3byv_A 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 226 (377)
T ss_dssp CSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 55443321 0 378999999 6899999987665655 888899999999999999999
Q ss_pred CCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCCccccCCCCCCCcccccc------------ccCccccchhhhH
Q 006779 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE------------EYNELVDIYSFGM 216 (631)
Q Consensus 149 ~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~------------~ys~~sDIwSLGi 216 (631)
|+||||||+|||++ .+|.+||+|||++..... .....+| +.|+|||++.+ .|+.++|||||||
T Consensus 227 --ivHrDikp~NIll~-~~~~~kL~DFG~a~~~~~-~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 --LVHTYLRPVDIVLD-QRGGVFLTGFEHLVRDGA-RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp --EECSCCCGGGEEEC-TTCCEEECCGGGCEETTC-EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred --eecCCCCHHHEEEc-CCCCEEEEechhheecCC-cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999998 789999999999975433 3345577 99999998754 4899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 217 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 217 ilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
++|+|++|+.||.... .......+.. .....++.+++||.+||. +|.+|||+.++|+||||+.
T Consensus 302 il~elltg~~Pf~~~~-~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 302 VIYWIWCADLPITKDA-ALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHHHSSCCC-------CCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHHHCCCCCcccc-cccchhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 9999999999997632 2111112211 123557899999999998 8999999999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=356.03 Aligned_cols=260 Identities=31% Similarity=0.549 Sum_probs=222.5
Q ss_pred cccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeE
Q 006779 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 95 (631)
Q Consensus 16 ~~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~ 95 (631)
.....+|..+| ++.+.||+|+||.||+|.+..+|..||+|.+..... ....+.+.+|+.+++.++||||+++++++
T Consensus 14 ~~~~~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 89 (303)
T 3a7i_A 14 QNLKADPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKYYGSY 89 (303)
T ss_dssp TTCEECGGGTE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC---STTHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hcCCCChHHHH-HHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 34456778888 678999999999999999999999999999976543 23457789999999999999999999998
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccc
Q 006779 96 VDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 175 (631)
.+. ..+++||||+.+++|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 90 ~~~--~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~Df 163 (303)
T 3a7i_A 90 LKD--TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADF 163 (303)
T ss_dssp EET--TEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCC
T ss_pred ecC--CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEEC-CCCCEEEeec
Confidence 765 468999999999999999875 56999999999999999999999999 99999999999997 7889999999
Q ss_pred cccchhcCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006779 176 GLAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 176 Gla~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~ 252 (631)
|++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.. .+.......+..+.. ..+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~ 241 (303)
T 3a7i_A 164 GVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE-LHPMKVLFLIPKNNP-PTLEG 241 (303)
T ss_dssp TTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCC-CCCCS
T ss_pred ccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC-cCHHHHHHHhhcCCC-CCCcc
Confidence 999765443 2345679999999998764 588999999999999999999999986 455555555555433 34556
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 253 ~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
..+..+++||.+||. +|.+|||+.++|+||||...
T Consensus 242 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 242 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 678899999999998 89999999999999999753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=373.11 Aligned_cols=254 Identities=25% Similarity=0.366 Sum_probs=204.2
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC----
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---- 99 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~---- 99 (631)
+|| ++.++||+|+||+||+|.+..++. ||+|++...... ..+|+.+|+.++||||++++++|....
T Consensus 40 ~~Y-~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~--------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 40 IAY-TNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF--------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEE-EEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred ceE-EEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch--------HHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 456 778999999999999999987776 888887643321 236999999999999999999886533
Q ss_pred CCeEEEEEeccCCCCHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccc
Q 006779 100 NRTINMITELFTSGSLRQYR---KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l---~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 176 (631)
..++++||||+.++.+.... .....+++..++.++.||+.||.|||+++ |+||||||+|||++..++.+||+|||
T Consensus 110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 23588999999875444332 33567999999999999999999999999 99999999999998568899999999
Q ss_pred ccchhcC-CCCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-------
Q 006779 177 LAIVMQQ-PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------- 246 (631)
Q Consensus 177 la~~~~~-~~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~------- 246 (631)
++..... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.....++...+.....
T Consensus 188 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 188 SAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp TCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred CcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9976543 33456789999999998754 4899999999999999999999999886555554444331000
Q ss_pred -----------CC--------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 247 -----------PA--------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 247 -----------p~--------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
|. .+....++++++||.+||+ +|.+|||+.|+|.||||+....
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 00 1223467899999999998 8999999999999999987544
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=368.28 Aligned_cols=259 Identities=23% Similarity=0.390 Sum_probs=218.7
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCH-------------HHHHHHHHHHHHHHhCCCCCcee
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP-------------DQLERLYSEVHLLKSLKHENIIK 90 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~-------------~~~~~l~~Ei~iLk~L~HpnIVk 90 (631)
++| ++.+.||+|+||.||+|.+ +|..||+|.+......... ...+.+.+|+.+++.++||||++
T Consensus 31 ~~y-~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 31 NDY-RIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp TTE-EEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred Cce-EEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 566 7889999999999999998 9999999999755332111 11267899999999999999999
Q ss_pred eeeeEEcCCCCeEEEEEeccCCCCHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccCCCCCe
Q 006779 91 FYNSWVDDTNRTINMITELFTSGSLRQY------RKK--HKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNI 161 (631)
Q Consensus 91 l~~~~~d~~~~~l~lV~Ey~~gGsL~~~------l~~--~~~l~~~~i~~i~~QIl~aL~yLHs-~~~~IiHrDLKp~NI 161 (631)
+++++.+. ..+++||||+.+|+|.++ +.+ ...+++..++.++.||+.||.|||+ ++ |+||||||+||
T Consensus 108 ~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Ni 183 (348)
T 2pml_X 108 CEGIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNI 183 (348)
T ss_dssp CSEEEESS--SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGE
T ss_pred EEEEEeeC--CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhE
Confidence 99998764 479999999999999998 665 5779999999999999999999999 88 99999999999
Q ss_pred eecCCCCcEEEccccccchhcCCCCccccCCCCCCCccccccc--cCc-cccchhhhHHHHHHhhcCCCCCCCCCHHHHH
Q 006779 162 FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE--YNE-LVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238 (631)
Q Consensus 162 Ll~~~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~~--ys~-~sDIwSLGiilyELltG~~Pf~~~~~~~~i~ 238 (631)
|++ .++.+||+|||++............||+.|+|||++.+. ++. ++|||||||++|+|++|+.||........+.
T Consensus 184 l~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 184 LMD-KNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp EEC-TTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred EEc-CCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 997 788999999999987655555667899999999988654 555 9999999999999999999998866657777
Q ss_pred HHHHcCCCCCCC-----------------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCc
Q 006779 239 KKVTSGIKPASL-----------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 239 ~~i~~~~~p~~l-----------------~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~~ 290 (631)
..+..+..+... ....++.+++||.+||. +|.+|||+.++|+||||+..++.
T Consensus 263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~ 332 (348)
T 2pml_X 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIE 332 (348)
T ss_dssp HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHH
T ss_pred HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHH
Confidence 777665332221 14568899999999998 89999999999999999876543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=360.56 Aligned_cols=259 Identities=26% Similarity=0.398 Sum_probs=209.9
Q ss_pred CCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC-
Q 006779 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT- 99 (631)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~- 99 (631)
.-.++| ++.+.||+|+||.||+|.+..+|+.||+|.+... .......++.+|+.+|+.++||||+++++++....
T Consensus 8 ~i~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 8 NISSDF-QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSF 83 (353)
T ss_dssp CSCTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred ccccce-EEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc---ccchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence 345677 7889999999999999999999999999998643 24556677889999999999999999999775432
Q ss_pred --CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 100 --NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 100 --~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
...+++||||+. |+|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 84 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 84 ENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLIN-SNCDLKVCDFGL 158 (353)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTT
T ss_pred CccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEc-CCCcEEEEeccc
Confidence 257899999997 699999877 56999999999999999999999999 99999999999997 788999999999
Q ss_pred cchhcCC------------CCccccCCCCCCCccccc--cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006779 178 AIVMQQP------------TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 243 (631)
Q Consensus 178 a~~~~~~------------~~~~~~GTp~Y~APEvl~--~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~ 243 (631)
+...... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+......+......
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 238 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence 9754321 122357899999999764 45899999999999999999999999875433333222211
Q ss_pred CCCCC-----------------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 244 GIKPA-----------------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 244 ~~~p~-----------------------------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
...|. ......++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 00000 0112457889999999998 999999999999999998643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=357.56 Aligned_cols=258 Identities=25% Similarity=0.408 Sum_probs=206.5
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC-
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD- 98 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~- 98 (631)
.+..+|| ++.+.||+|+||.||+|.+..+|+.||+|.+... .....+.+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 7 FDLGSRY-MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSG 81 (320)
T ss_dssp EEETTTE-EEEEECC-----CEEEEEETTTTEEEEEEEEECC----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred CccCCce-eEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC----ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence 3456788 7789999999999999999999999999998743 356678899999999999999999999987432
Q ss_pred -----------CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCC
Q 006779 99 -----------TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 167 (631)
Q Consensus 99 -----------~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~ 167 (631)
....+++||||+. |+|.+++.+ +.+++..++.++.||+.||.|||+++ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTED 157 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTT
T ss_pred cccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCC
Confidence 2357899999997 699999865 56999999999999999999999999 99999999999997567
Q ss_pred CcEEEccccccchhcCC-----CCccccCCCCCCCccccc--cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHH
Q 006779 168 GEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240 (631)
Q Consensus 168 g~vKL~DFGla~~~~~~-----~~~~~~GTp~Y~APEvl~--~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~ 240 (631)
+.+||+|||++...... ......+|+.|+|||++. ..++.++|||||||++|+|++|+.||..... ......
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~~~~~ 236 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE-LEQMQL 236 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH-HHHHHH
Confidence 89999999999765322 233456899999999764 4589999999999999999999999987543 333333
Q ss_pred HHcCCC------------------------C----CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 241 VTSGIK------------------------P----ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 241 i~~~~~------------------------p----~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
+..... + ..+....++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 322111 0 01123467899999999998 89999999999999999754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=366.95 Aligned_cols=254 Identities=28% Similarity=0.404 Sum_probs=199.9
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC--
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-- 100 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~-- 100 (631)
.+|| ++.+.||+|+||.||+|.+..+|..||+|++.... ........+.+|+.+|+.++||||+++++++.....
T Consensus 24 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 24 LKRY-QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp ETTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred hhhe-eEeeeeEecCCEEEEEEEECCCCceEEEEEecccc--CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence 3577 77899999999999999999999999999987542 345666789999999999999999999999865432
Q ss_pred --CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 101 --RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 101 --~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
..+++||||+. |+|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++
T Consensus 101 ~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 101 EFQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA 174 (371)
T ss_dssp TCCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCCCC-
T ss_pred cccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEc-CCCCEEEEEeecc
Confidence 37899999997 47888875 45899999999999999999999999 99999999999997 7899999999999
Q ss_pred chhcCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC--------
Q 006779 179 IVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-------- 248 (631)
Q Consensus 179 ~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~-------- 248 (631)
...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.. ....+..+......+
T Consensus 175 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 175 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD-HIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHC-CCCCCHHHHTTS
T ss_pred cccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHHh
Confidence 765443 3345689999999998764 58999999999999999999999998744 434444443321110
Q ss_pred ------------CC--------------CC------CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 249 ------------SL--------------SK------VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 249 ------------~l--------------~~------~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
.+ +. ..++.+++||.+||. +|.+|||+.|+|+||||..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 00 00 014678999999998 9999999999999999974
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=346.78 Aligned_cols=248 Identities=19% Similarity=0.297 Sum_probs=209.5
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
-++| ++.+.||+|+||+||+|.+. |..||+|.+.... ......+.+.+|+.+|+.++||||+++++++.+.....
T Consensus 9 ~~~y-~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 9 FKQL-NFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD--WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp GGGC-EEEEEEEEETTEEEEEEEET--TEEEEEEEECCTT--CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred HHHh-HHHHHhcCCCcceEEEEEEC--CeeEEEEEecccc--cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence 4566 77899999999999999875 8999999987653 24566678999999999999999999999998775567
Q ss_pred EEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 103 INMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
+++||||+.+|+|.+++.+.. .+++..++.++.||+.||.|||+++++|+||||||+|||++ .+|.++|+|||++..
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~-~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFS 162 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC-TTSCEEEEGGGSCCT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc-CCcceeEEeccceee
Confidence 899999999999999998765 48999999999999999999999988899999999999997 788999999988754
Q ss_pred hcCCCCccccCCCCCCCccccccc-c---CccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006779 181 MQQPTARSVIGTPEFMAPELYEEE-Y---NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 181 ~~~~~~~~~~GTp~Y~APEvl~~~-y---s~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~ 256 (631)
... ....||+.|+|||++.+. + +.++|||||||++|+|++|+.||.... .......+........++...++
T Consensus 163 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3kmu_A 163 FQS---PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS-NMEIGMKVALEGLRPTIPPGISP 238 (271)
T ss_dssp TSC---TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC-HHHHHHHHHHSCCCCCCCTTCCH
T ss_pred ecc---cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC-hHHHHHHHHhcCCCCCCCCCCCH
Confidence 322 345789999999987643 3 347999999999999999999998754 44444444444344456667889
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 257 QVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.++++|.+||. +|.+|||+.++++
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 239 HVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999998 8999999999886
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=367.36 Aligned_cols=258 Identities=24% Similarity=0.320 Sum_probs=195.3
Q ss_pred CCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC-
Q 006779 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT- 99 (631)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~- 99 (631)
...+|| ++.+.||+|+||+||+|.+..+|..||+|++..... ...+..++++.++.++||||++++++|....
T Consensus 20 ~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 20 KEMDRF-QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-----FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHTTE-EEC----------CEEEEETTTCCEEEEEEEECCTT-----CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhccce-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-----ccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 344677 788999999999999999999999999999864432 2234667888899999999999999986532
Q ss_pred ----CCeEEEEEeccCCCCHHHH----HHhCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCEEeccCCCCCeeecCCCCc
Q 006779 100 ----NRTINMITELFTSGSLRQY----RKKHKNVDMKAIKNWARQILRGLHYLH--SHNPPIIHRDLKCDNIFVNGNNGE 169 (631)
Q Consensus 100 ----~~~l~lV~Ey~~gGsL~~~----l~~~~~l~~~~i~~i~~QIl~aL~yLH--s~~~~IiHrDLKp~NILl~~~~g~ 169 (631)
..++++||||+.++ |... ......+++..++.++.||+.||.||| +++ |+||||||+|||++..++.
T Consensus 94 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp SCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTE
T ss_pred ccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCc
Confidence 23588999999864 4433 335677999999999999999999999 777 9999999999999844889
Q ss_pred EEEccccccchhcCC-CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC
Q 006779 170 VKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246 (631)
Q Consensus 170 vKL~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~ 246 (631)
+||+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||........+...+.....
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 250 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250 (360)
T ss_dssp EEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence 999999999766543 3345678999999998743 3899999999999999999999999875444333333221000
Q ss_pred C-----------------------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 247 P-----------------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 247 p-----------------------------~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
+ .......++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 0 01112246789999999998 89999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=348.28 Aligned_cols=256 Identities=26% Similarity=0.427 Sum_probs=211.1
Q ss_pred cccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHH---HHHHHHHHHHHhCCCCCceeeeee
Q 006779 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL---ERLYSEVHLLKSLKHENIIKFYNS 94 (631)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~---~~l~~Ei~iLk~L~HpnIVkl~~~ 94 (631)
...-..++| ++.+.||+|+||+||+|.+..+|..||+|.+............ +.+.+|+.+++.++||||++++++
T Consensus 13 ~~~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (287)
T 4f0f_A 13 LPTLADNEI-EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL 91 (287)
T ss_dssp CCBCCSTTE-EEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhhhhhccc-eehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence 344556778 7889999999999999999999999999998765443333222 678999999999999999999998
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCc----
Q 006779 95 WVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE---- 169 (631)
Q Consensus 95 ~~d~~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~---- 169 (631)
+.+.. ++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++++|+||||||+|||++ .++.
T Consensus 92 ~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~-~~~~~~~~ 166 (287)
T 4f0f_A 92 MHNPP----RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQ-SLDENAPV 166 (287)
T ss_dssp ETTTT----EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEES-CCCTTCSC
T ss_pred ecCCC----eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEe-ccCCCCce
Confidence 85432 5899999999998887654 579999999999999999999999987899999999999997 5555
Q ss_pred -EEEccccccchhcCCCCccccCCCCCCCccccc---cccCccccchhhhHHHHHHhhcCCCCCCCCCHH-HHHHHHHcC
Q 006779 170 -VKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA-QIYKKVTSG 244 (631)
Q Consensus 170 -vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~---~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~-~i~~~i~~~ 244 (631)
+||+|||++..... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||....... .....+...
T Consensus 167 ~~kl~Dfg~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 245 (287)
T 4f0f_A 167 CAKVADFGLSQQSVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE 245 (287)
T ss_dssp CEEECCCTTCBCCSS-CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS
T ss_pred eEEeCCCCccccccc-cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc
Confidence 99999999974433 234467999999999873 347899999999999999999999998654333 334444444
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 245 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 245 ~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
..+..++...++.+++||.+||. +|.+|||+.++++
T Consensus 246 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 246 GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 44555667788999999999998 8999999999886
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=365.64 Aligned_cols=252 Identities=25% Similarity=0.391 Sum_probs=213.5
Q ss_pred CCCCceeeeeeEecccCceEEEEEE-----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeee
Q 006779 21 DPSCRYGRYDEILGKGAFKTVYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNS 94 (631)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~a~-----d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~ 94 (631)
-+.+|| ++.+.||+|+||.||+|. +..+|+.||+|.+... ......+.+.+|+.+|+++ +||||++++++
T Consensus 19 ~~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 94 (359)
T 3vhe_A 19 FPRDRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRALMSELKILIHIGHHLNVVNLLGA 94 (359)
T ss_dssp CCGGGE-EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccce-eeceeecCCCCceEEEEEeccccccccceEEEEEEecCc---CCHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence 356777 788999999999999999 5677899999999743 2455667899999999999 89999999998
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHhCCC--------------------------------------------------
Q 006779 95 WVDDTNRTINMITELFTSGSLRQYRKKHKN-------------------------------------------------- 124 (631)
Q Consensus 95 ~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~-------------------------------------------------- 124 (631)
|.+.. ..+++||||+.+|+|.+++.....
T Consensus 95 ~~~~~-~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 95 CTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp ECSTT-SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eecCC-CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 87643 458899999999999999987543
Q ss_pred ----------------CCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC----
Q 006779 125 ----------------VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---- 184 (631)
Q Consensus 125 ----------------l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~---- 184 (631)
+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCGGGSCTTSCTTCE
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEc-CCCcEEEEeccceeeecccccch
Confidence 899999999999999999999999 99999999999997 7889999999999755332
Q ss_pred CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006779 185 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262 (631)
Q Consensus 185 ~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI 262 (631)
......||+.|+|||++. ..|+.++|||||||++|+|+| |..||.+......+...+..+..+ ..+...+++++++|
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li 329 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTM 329 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-CCCTTCCHHHHHHH
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-CCCCCCCHHHHHHH
Confidence 123456889999999775 458999999999999999998 999998876666676666665433 34556789999999
Q ss_pred HHhcC-CCCCCCCHHHHhcC
Q 006779 263 EKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 263 ~~cL~-~p~~Rpsa~elL~h 281 (631)
.+||. +|.+|||+.++++|
T Consensus 330 ~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 330 LDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCChhhCCCHHHHHHH
Confidence 99998 89999999999976
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=360.38 Aligned_cols=243 Identities=27% Similarity=0.437 Sum_probs=202.9
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
.++| ++.+.||+|+||+||+|.+..+|..||+|.+.. ......+.+.+|+.+|+.++||||+++++++.+. ..
T Consensus 9 ~~~~-~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~ 81 (310)
T 3s95_A 9 PSDL-IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR----FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD--KR 81 (310)
T ss_dssp GGGE-EEEEEEECCSSEEEEEEEETTTCCEEEEEEESC----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TE
T ss_pred hhHe-eccceecCCCCEEEEEEEECCCCcEEEEEEecc----CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC--Ce
Confidence 3566 778999999999999999999999999998853 2456778899999999999999999999998765 46
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 103 INMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
+++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 82 LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVR-ENKNVVVADFGLARLM 158 (310)
T ss_dssp EEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEC-TTSCEEECCCTTCEEC
T ss_pred eEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEEC-CCCCEEEeecccceec
Confidence 8999999999999999987 567999999999999999999999999 99999999999997 7899999999999755
Q ss_pred cCCCC----------------ccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHH-----HHHH
Q 006779 182 QQPTA----------------RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPA-----QIYK 239 (631)
Q Consensus 182 ~~~~~----------------~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~-----~i~~ 239 (631)
..... ...+||+.|+|||++.+ .++.++|||||||++|+|++|..||....... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~ 238 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc
Confidence 33211 15679999999998765 58999999999999999999999986532211 0111
Q ss_pred HHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 240 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 240 ~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.... ..+...++.+.++|.+||. +|.+|||+.+++.
T Consensus 239 ~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 239 FLDR-----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHH-----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccc-----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1111 1233456789999999998 8999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=367.35 Aligned_cols=254 Identities=28% Similarity=0.405 Sum_probs=205.1
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC--
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR-- 101 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~-- 101 (631)
+|| ++.+.||+|+||.||+|.++.+|+.||+|++.... .......++.+|+.+++.++||||+++++++......
T Consensus 42 ~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 42 KTY-VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred ccE-EEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc--cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 466 77899999999999999999999999999987542 3455678899999999999999999999998765432
Q ss_pred --eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 102 --TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 102 --~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
.+++||||+. ++|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVN-EDCELKILDFGLAR 192 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECSTTCC-
T ss_pred ceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEEC-CCCCEEEEecCccc
Confidence 3489999997 68888774 45999999999999999999999999 99999999999997 78999999999997
Q ss_pred hhcCCCCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC----------
Q 006779 180 VMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP---------- 247 (631)
Q Consensus 180 ~~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p---------- 247 (631)
..... ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+.....+
T Consensus 193 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 193 HADAE-MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred ccccC-cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 65433 345678999999998764 58999999999999999999999998754333333322211000
Q ss_pred -----------C-------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 248 -----------A-------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 248 -----------~-------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
. .+....++.+++||.+||+ +|.+|||+.|+|+||||...
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 0 0112457899999999998 89999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=356.01 Aligned_cols=260 Identities=28% Similarity=0.426 Sum_probs=206.9
Q ss_pred CCceeeeeeEecccCceEEEEEEEc-cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC---CCCCceeeeeeEEc-
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDE-VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVD- 97 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~-~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L---~HpnIVkl~~~~~d- 97 (631)
.++| ++.+.||+|+||.||+|.+. .+|+.||+|++...... ......+.+|+.+++.+ +||||+++++++..
T Consensus 10 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 10 DQQY-ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp GGTE-EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT--TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred hhce-eeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc--ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 3566 78899999999999999995 78899999998754321 11122355677666665 89999999998862
Q ss_pred --CCCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEc
Q 006779 98 --DTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173 (631)
Q Consensus 98 --~~~~~l~lV~Ey~~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~ 173 (631)
.....+++||||+. |+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~-~~~~~kl~ 162 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLA 162 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEEC
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEc-CCCCEEEe
Confidence 23457899999997 69999998754 4999999999999999999999999 99999999999997 78899999
Q ss_pred cccccchhcCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC----
Q 006779 174 DLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP---- 247 (631)
Q Consensus 174 DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p---- 247 (631)
|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||........+...+.....+
T Consensus 163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 99999765432 2345678999999997754 58999999999999999999999998754443333332210000
Q ss_pred --------------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 248 --------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 248 --------------------~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
..+....++.+++||.+||. +|.+|||+.++|.||||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 11224467899999999998 8999999999999999987543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=368.56 Aligned_cols=252 Identities=27% Similarity=0.394 Sum_probs=201.4
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC--------CCCceeeeee
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK--------HENIIKFYNS 94 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~--------HpnIVkl~~~ 94 (631)
.+|| ++.+.||+|+||+||+|++..+|+.||+|++... ....+.+.+|+.+|+.++ ||||++++++
T Consensus 36 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 36 NGRY-HVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp TTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred CCeE-EEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 3677 7889999999999999999999999999998632 445677899999999996 7889999998
Q ss_pred EEcC--CCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeccCCCCCeeecCCCC-
Q 006779 95 WVDD--TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNG- 168 (631)
Q Consensus 95 ~~d~--~~~~l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~-~~~IiHrDLKp~NILl~~~~g- 168 (631)
|... ....+++||||+ +++|.+++.+. ..+++..++.++.||+.||.|||++ + |+||||||+|||++ .++
T Consensus 110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~-~~~~ 185 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLS-VNEQ 185 (397)
T ss_dssp EEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEEC-CCHH
T ss_pred eeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEe-ccch
Confidence 8632 345799999999 56666666543 5699999999999999999999998 8 99999999999997 443
Q ss_pred ------------------------------------------------cEEEccccccchhcCCCCccccCCCCCCCccc
Q 006779 169 ------------------------------------------------EVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL 200 (631)
Q Consensus 169 ------------------------------------------------~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEv 200 (631)
.+||+|||++...... ....+||+.|+|||+
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-SCSCCSCGGGCCHHH
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-CccCCCCCcccCChh
Confidence 7999999999766543 345679999999998
Q ss_pred ccc-ccCccccchhhhHHHHHHhhcCCCCCCCCC-----HHHHHHHHHc--CCCCC------------------------
Q 006779 201 YEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN-----PAQIYKKVTS--GIKPA------------------------ 248 (631)
Q Consensus 201 l~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~-----~~~i~~~i~~--~~~p~------------------------ 248 (631)
+.+ .|+.++|||||||++|+|+||+.||..... .......+.. +..|.
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 765 589999999999999999999999975432 1111111111 11100
Q ss_pred --------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 006779 249 --------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 249 --------------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~ 285 (631)
.+....++.+++||.+||. +|.+|||+.|+|+||||+
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0111224678999999998 899999999999999996
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=358.78 Aligned_cols=263 Identities=20% Similarity=0.342 Sum_probs=194.9
Q ss_pred CCCCceeeeeeEecccCceEEEEEEEccCCe---EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEc
Q 006779 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGI---EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~---~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d 97 (631)
-+.++| ++.+.||+|+||+||+|.+..++. .||+|.+..... .....+.+.+|+.+++.++||||+++++++..
T Consensus 20 i~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 20 IPEQQF-TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII--ASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp CC---C-EEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred cChhHe-EEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc--CHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 456677 788999999999999999988775 899999875432 33556789999999999999999999999876
Q ss_pred CCCC----eEEEEEeccCCCCHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCC
Q 006779 98 DTNR----TINMITELFTSGSLRQYRKKHK------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 167 (631)
Q Consensus 98 ~~~~----~l~lV~Ey~~gGsL~~~l~~~~------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~ 167 (631)
.... .+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~-~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLA-ED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEc-CC
Confidence 5432 2489999999999999986543 5999999999999999999999999 99999999999997 78
Q ss_pred CcEEEccccccchhcCCC----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006779 168 GEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKV 241 (631)
Q Consensus 168 g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i 241 (631)
+.+||+|||++....... .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||... +...+...+
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~-~~~~~~~~~ 252 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI-ENAEIYNYL 252 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHHHH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc-ChHHHHHHH
Confidence 999999999997654321 223456889999998765 48999999999999999999 99999874 455556666
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-------HHHHhcCCCCCCCCCcc
Q 006779 242 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-------ALELLKDPFLVTDNPKD 291 (631)
Q Consensus 242 ~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rps-------a~elL~hpff~~~~~~~ 291 (631)
..+..+ ..+...++.+++||.+||. +|.+||| ..+++.|||+....+..
T Consensus 253 ~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~p 309 (323)
T 3qup_A 253 IGGNRL-KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP 309 (323)
T ss_dssp HTTCCC-CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----------
T ss_pred hcCCCC-CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCC
Confidence 655433 2344567899999999998 8999999 77888999998765444
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=346.63 Aligned_cols=252 Identities=28% Similarity=0.451 Sum_probs=197.7
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
.++| ++.+.||+|+||.||+|.+. |..||+|.+............+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 6 ~~~~-~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 80 (271)
T 3dtc_A 6 FAEL-TLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE--PN 80 (271)
T ss_dssp TTSE-EEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC----
T ss_pred hhhe-eeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC--Cc
Confidence 4567 78899999999999999874 8999999987654333334457789999999999999999999988654 46
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CEEeccCCCCCeeecC-------CCCcEEEcc
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP-PIIHRDLKCDNIFVNG-------NNGEVKIGD 174 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~-~IiHrDLKp~NILl~~-------~~g~vKL~D 174 (631)
+++||||+.+++|.+++. .+.+++..++.++.||+.||.|||+++. +|+||||||+|||++. .++.+||+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 889999999999999986 4579999999999999999999999873 4899999999999973 267899999
Q ss_pred ccccchhcCCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006779 175 LGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 175 FGla~~~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~ 253 (631)
||++............||+.|+|||++.+ .++.++||||||+++|+|++|+.||... +.......+.........+..
T Consensus 160 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3dtc_A 160 FGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI-DGLAVAYGVAMNKLALPIPST 238 (271)
T ss_dssp CCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS-CHHHHHHHHHTSCCCCCCCTT
T ss_pred CCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHhhhcCCCCCCCCcc
Confidence 99998766655556789999999998765 4899999999999999999999999874 444444555555445556667
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 254 TDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 254 ~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.++.+++||.+||. +|.+|||+.+++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 78999999999998 89999999999874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=375.14 Aligned_cols=256 Identities=26% Similarity=0.424 Sum_probs=192.1
Q ss_pred CceeeeeeEecccCceEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~--~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
.+|...+++||+|+||+||+|.++ .++..||+|++..... ...+.+|+.+|+.|+||||++++++|......
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC------CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC------CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 455434678999999999999966 5789999999864422 13577899999999999999999999877777
Q ss_pred eEEEEEeccCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeec---CCCCc
Q 006779 102 TINMITELFTSGSLRQYRKKH---------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN---GNNGE 169 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~---------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~---~~~g~ 169 (631)
.+++||||+. |+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+. ..++.
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTC
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCc
Confidence 8999999996 5888877532 24999999999999999999999999 99999999999993 25689
Q ss_pred EEEccccccchhcCC-----CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCC---------
Q 006779 170 VKIGDLGLAIVMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKN--------- 233 (631)
Q Consensus 170 vKL~DFGla~~~~~~-----~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~--------- 233 (631)
+||+|||++...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.....
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 999999999766432 2345689999999998764 489999999999999999999999965332
Q ss_pred HHHHHHHHHc-CCCCC-CC---------------------------------CCCCcHHHHHHHHHhcC-CCCCCCCHHH
Q 006779 234 PAQIYKKVTS-GIKPA-SL---------------------------------SKVTDPQVKQFIEKCIV-PASLRLPALE 277 (631)
Q Consensus 234 ~~~i~~~i~~-~~~p~-~l---------------------------------~~~~~~~l~~lI~~cL~-~p~~Rpsa~e 277 (631)
..++...+.. +..+. .+ ....++.+++||.+||. +|.+|||+.|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 1222222211 11110 00 01126788999999998 9999999999
Q ss_pred HhcCCCCCCCC
Q 006779 278 LLKDPFLVTDN 288 (631)
Q Consensus 278 lL~hpff~~~~ 288 (631)
+|+||||....
T Consensus 331 ~L~hp~f~~~~ 341 (405)
T 3rgf_A 331 AMQDPYFLEDP 341 (405)
T ss_dssp HHTSGGGTSSS
T ss_pred HhcChhhccCC
Confidence 99999998643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=353.44 Aligned_cols=258 Identities=24% Similarity=0.415 Sum_probs=214.1
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC--CCCceeeeeeEEc
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK--HENIIKFYNSWVD 97 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~--HpnIVkl~~~~~d 97 (631)
..-.++-|++.+.||+|+||.||+|.+. +|..||+|++..... .....+.+.+|+.+++.++ ||||+++++++.+
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc--cccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 3344554588999999999999999985 589999999976542 4566788999999999997 5999999998865
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
. ..+++||| +.+++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+
T Consensus 100 ~--~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~--~~~~kL~Dfg~ 172 (313)
T 3cek_A 100 D--QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGI 172 (313)
T ss_dssp S--SEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE--TTEEEECCCSS
T ss_pred C--CEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEE--CCeEEEeeccc
Confidence 4 47999999 568899999999889999999999999999999999999 99999999999996 48999999999
Q ss_pred cchhcCCC----CccccCCCCCCCcccccc------------ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006779 178 AIVMQQPT----ARSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241 (631)
Q Consensus 178 a~~~~~~~----~~~~~GTp~Y~APEvl~~------------~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i 241 (631)
+....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||....+.......+
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence 97654322 234578999999998753 58889999999999999999999998766665555555
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 242 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 242 ~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
........++...+..+++||.+||. +|.+||++.++|+||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 253 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 55544445566678899999999998 89999999999999999753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=363.82 Aligned_cols=248 Identities=26% Similarity=0.430 Sum_probs=209.7
Q ss_pred CCceeeeeeEecccCceEEEEEEEc-------cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeee
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDE-------VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNS 94 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~-------~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~ 94 (631)
..+| ++.+.||+|+||.||+|.+. .++..||+|.++... .....+.+.+|+.+|+.+ +||||++++++
T Consensus 80 ~~~~-~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 80 RDKL-TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp GGGE-EEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC---BHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred HHHC-EeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc---CHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 3556 78899999999999999874 456789999986442 356678899999999999 89999999998
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCC
Q 006779 95 WVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158 (631)
Q Consensus 95 ~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~----------------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp 158 (631)
+.+. ..+|+||||+.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||
T Consensus 156 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp 231 (370)
T 2psq_A 156 CTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAA 231 (370)
T ss_dssp ECSS--SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCG
T ss_pred EccC--CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccch
Confidence 8654 46889999999999999998753 4789999999999999999999999 99999999
Q ss_pred CCeeecCCCCcEEEccccccchhcCC----CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCC
Q 006779 159 DNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECK 232 (631)
Q Consensus 159 ~NILl~~~~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~ 232 (631)
+|||++ .+|.+||+|||++...... ......+|+.|+|||++.+ .|+.++|||||||++|||+| |..||.+ .
T Consensus 232 ~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~-~ 309 (370)
T 2psq_A 232 RNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-I 309 (370)
T ss_dssp GGEEEC-TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-C
T ss_pred hhEEEC-CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC-C
Confidence 999997 7899999999999755432 2233467889999997754 58999999999999999999 9999987 4
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 233 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 233 ~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
...++...+..+..+ ..+...++.+++||.+||. +|.+||++.|++++
T Consensus 310 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 310 PVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp CGGGHHHHHHTTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 566677777766543 3455678899999999998 89999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=362.10 Aligned_cols=260 Identities=25% Similarity=0.370 Sum_probs=201.9
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeeccccc-------CCHHHHHHHHHHHHHHHhCCCCCceeeeee
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-------QSPDQLERLYSEVHLLKSLKHENIIKFYNS 94 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~-------~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~ 94 (631)
..++| ++.+.||+|+||.||+|.+.. |..||+|++...... ......+++.+|+.+|+.++||||++++++
T Consensus 20 ~~~~y-~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 20 MQSPY-TVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp TTCSC-EEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred hccce-EEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 45777 788999999999999999865 999999998653221 223445789999999999999999999998
Q ss_pred EEcC---CCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcE
Q 006779 95 WVDD---TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 170 (631)
Q Consensus 95 ~~d~---~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~v 170 (631)
+... ....+++||||+. |+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~-~~~~~ 173 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLA-DNNDI 173 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCE
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEc-CCCCE
Confidence 8653 3347899999997 5788777654 47999999999999999999999999 99999999999997 78899
Q ss_pred EEccccccchhcCC-CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006779 171 KIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 247 (631)
Q Consensus 171 KL~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p 247 (631)
||+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||........+...+.....|
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 174 TICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253 (362)
T ss_dssp EECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 99999999754433 3345678999999998754 58999999999999999999999998754333332222110000
Q ss_pred ---------------------C--------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 248 ---------------------A--------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 248 ---------------------~--------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
. ......++.+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 0 0122346889999999998 89999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=361.48 Aligned_cols=267 Identities=20% Similarity=0.304 Sum_probs=188.4
Q ss_pred cCCcCCcccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCce
Q 006779 10 SETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89 (631)
Q Consensus 10 ~~~~~~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIV 89 (631)
.++..+......-.++|..++++||+|+||+||+|.++.+|+.||+|++... ... ..+....++.+.||||+
T Consensus 14 ~~~~~p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~---~~e~~~~~~~~~h~~i~ 85 (336)
T 3fhr_A 14 VLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKA---RQEVDHHWQASGGPHIV 85 (336)
T ss_dssp ------CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHH---HHHHHHHHHHTTSTTBC
T ss_pred ccccCCCCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHH---HHHHHHHHHhcCCCChH
Confidence 3444555666677889966678899999999999999999999999998632 222 22333456778999999
Q ss_pred eeeeeEEcC--CCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC
Q 006779 90 KFYNSWVDD--TNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 165 (631)
Q Consensus 90 kl~~~~~d~--~~~~l~lV~Ey~~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~ 165 (631)
+++++|... ....+++||||+.+|+|.+++.+.+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 86 ~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~ 163 (336)
T 3fhr_A 86 CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTS 163 (336)
T ss_dssp CEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESC
T ss_pred HHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEe
Confidence 999988652 2346899999999999999998764 6999999999999999999999999 999999999999973
Q ss_pred --CCCcEEEccccccchhcCCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHH---HHH
Q 006779 166 --NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ---IYK 239 (631)
Q Consensus 166 --~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~---i~~ 239 (631)
.++.+||+|||++............||+.|+|||++.. .++.++|||||||++|+|++|..||........ ...
T Consensus 164 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 243 (336)
T 3fhr_A 164 KEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR 243 (336)
T ss_dssp SSTTCCEEECCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred cCCCceEEEeccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH
Confidence 24569999999998766655666789999999998754 588999999999999999999999976332211 111
Q ss_pred HHHcCC--CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 240 KVTSGI--KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 240 ~i~~~~--~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
.+..+. .+.......++.+++||.+||. +|.+|||+.++|+||||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 244 RIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp -------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred hhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 122111 1222334568899999999998 8999999999999999975
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=356.00 Aligned_cols=253 Identities=23% Similarity=0.376 Sum_probs=210.0
Q ss_pred ccccCCCCceeeeeeEecccCceEEEEEEEccCC---eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeee
Q 006779 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYN 93 (631)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg---~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~ 93 (631)
+...-..+|| ++.+.||+|+||.||+|.+..+| ..||+|.+... ......+.+.+|+.+|+.++||||+++++
T Consensus 42 ~~~~~~~~~y-~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 117 (325)
T 3kul_A 42 FTREIEASRI-HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG---YTERQRRDFLSEASIMGQFDHPNIIRLEG 117 (325)
T ss_dssp -CCBCCGGGE-EEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT---CCHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hccccChhHe-EEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC---CCHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 3344456677 88899999999999999998655 45999998743 24556678999999999999999999999
Q ss_pred eEEcCCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEE
Q 006779 94 SWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 94 ~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL 172 (631)
++.+. ..+++||||+.+|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||
T Consensus 118 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl 192 (325)
T 3kul_A 118 VVTRG--RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVD-SNLVCKV 192 (325)
T ss_dssp EECGG--GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEE
T ss_pred EEEeC--CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEC-CCCCEEE
Confidence 88654 4688999999999999999765 57999999999999999999999999 99999999999997 7899999
Q ss_pred ccccccchhcCCC-----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCC
Q 006779 173 GDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI 245 (631)
Q Consensus 173 ~DFGla~~~~~~~-----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~ 245 (631)
+|||++....... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.. .....+...+..+.
T Consensus 193 ~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~ 271 (325)
T 3kul_A 193 SDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN-MTNRDVISSVEEGY 271 (325)
T ss_dssp CCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHHHHTTC
T ss_pred CCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHcCC
Confidence 9999997654331 22234678899999876 458999999999999999999 9999977 45666777777664
Q ss_pred CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 246 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 246 ~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.+. .+...++.+.+||.+||. +|.+|||+.+++.
T Consensus 272 ~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 272 RLP-APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp CCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC-CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 432 445678899999999998 8999999999886
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=360.24 Aligned_cols=255 Identities=28% Similarity=0.412 Sum_probs=205.5
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC--
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-- 100 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~-- 100 (631)
.++| ++.+.||+|+||.||+|.++.+|+.||+|++.... .......++.+|+.+|+.++||||+++++++.....
T Consensus 23 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 23 PKTY-VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp ETTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CceE-EEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 3567 77899999999999999999999999999986542 345566789999999999999999999999876543
Q ss_pred --CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 101 --RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 101 --~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
..+++||||+. ++|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 100 ~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 100 NFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVN-EDCELKILDFGLA 173 (353)
T ss_dssp GCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-TTCCEEECSTTCT
T ss_pred cceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeEC-CCCcEEEeecccc
Confidence 24589999997 68887764 35999999999999999999999999 99999999999998 7889999999999
Q ss_pred chhcCCCCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc-CC----------
Q 006779 179 IVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GI---------- 245 (631)
Q Consensus 179 ~~~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~-~~---------- 245 (631)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+.. +.
T Consensus 174 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 174 RHADAE-MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp TC---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred cCCCCC-ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 765433 344678999999998754 5899999999999999999999999874433332222210 00
Q ss_pred -----------------CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 246 -----------------KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 246 -----------------~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
....+....++.+++||.+||. +|.+|||+.++|.||||...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0011223467899999999998 99999999999999999764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=352.77 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=204.3
Q ss_pred CCceeeeeeEecccCceEEEEEEE-ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC------ceeeeeeE
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFD-EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN------IIKFYNSW 95 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d-~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~Hpn------IVkl~~~~ 95 (631)
.+|| ++.+.||+|+||+||+|.+ ..+|..||+|++... ....+.+.+|+.+++.++|++ |+++++++
T Consensus 13 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 13 SARY-EIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp TTTE-EEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred cCce-EEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 4577 7889999999999999999 668999999998632 345677889999999987654 99999988
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC-------
Q 006779 96 VDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN------- 166 (631)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~------- 166 (631)
.+. ..+++||||+ +++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++..
T Consensus 87 ~~~--~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 87 EHH--GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EET--TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC
T ss_pred ccC--CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccC
Confidence 655 4799999999 899999998765 6899999999999999999999999 9999999999999732
Q ss_pred -----------CCcEEEccccccchhcCCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCH
Q 006779 167 -----------NGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP 234 (631)
Q Consensus 167 -----------~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~ 234 (631)
++.+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.... .
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-~ 239 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEH-HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD-S 239 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSC-CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC-H
T ss_pred CccccccccccCCCceEeeCcccccCccc-cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-h
Confidence 567999999999764432 345679999999998765 58999999999999999999999998743 3
Q ss_pred HHHHHHHHc--CCCCC----------------------------------------CCCCCCcHHHHHHHHHhcC-CCCC
Q 006779 235 AQIYKKVTS--GIKPA----------------------------------------SLSKVTDPQVKQFIEKCIV-PASL 271 (631)
Q Consensus 235 ~~i~~~i~~--~~~p~----------------------------------------~l~~~~~~~l~~lI~~cL~-~p~~ 271 (631)
.+....+.. +..|. ......++.+++||.+||. +|.+
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 332222211 11110 0011224678999999998 8999
Q ss_pred CCCHHHHhcCCCCCC
Q 006779 272 RLPALELLKDPFLVT 286 (631)
Q Consensus 272 Rpsa~elL~hpff~~ 286 (631)
|||+.|+|+||||+.
T Consensus 320 Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 320 RITLREALKHPFFDL 334 (339)
T ss_dssp SCCHHHHTTSGGGGG
T ss_pred ccCHHHHhcCHHHHH
Confidence 999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=349.83 Aligned_cols=248 Identities=26% Similarity=0.425 Sum_probs=209.8
Q ss_pred CCceeeeeeEecccCceEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEc
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d-----~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d 97 (631)
..+| ++.+.||+|+||.||+|.+ ..+|..||+|.+... ......+.+.+|+.+|+.++||||+++++++.+
T Consensus 22 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 22 RKNL-VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN---ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp GGGE-EEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhhe-eeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC---CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 3444 8899999999999999998 356699999998743 245667889999999999999999999998865
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCCCEEe
Q 006779 98 DTNRTINMITELFTSGSLRQYRKKHKN------------------------VDMKAIKNWARQILRGLHYLHSHNPPIIH 153 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~~------------------------l~~~~i~~i~~QIl~aL~yLHs~~~~IiH 153 (631)
. ..+++||||+.+|+|.+++..... +++..++.++.||+.||.|||+++ |+|
T Consensus 98 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH 173 (314)
T 2ivs_A 98 D--GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVH 173 (314)
T ss_dssp S--SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred C--CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Ccc
Confidence 4 458899999999999999987543 899999999999999999999999 999
Q ss_pred ccCCCCCeeecCCCCcEEEccccccchhcCCC----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCC
Q 006779 154 RDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYP 227 (631)
Q Consensus 154 rDLKp~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~P 227 (631)
|||||+|||++ .++.+||+|||++....... .....+|+.|+|||++.+ .++.++|||||||++|+|+| |..|
T Consensus 174 ~dikp~NIli~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 174 RDLAARNILVA-EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCCSGGGEEEE-TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cccchheEEEc-CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999998 78899999999997554321 233457889999997754 58999999999999999999 9999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 228 YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 228 f~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
|.. .+...+...+..+..+ ..+...++.+++||.+||. +|.+||++.+++++
T Consensus 253 ~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 253 YPG-IPPERLFNLLKTGHRM-ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp STT-CCGGGHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC-CCHHHHHHHhhcCCcC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 976 4556666677665433 3445678999999999998 89999999999875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=364.51 Aligned_cols=255 Identities=15% Similarity=0.162 Sum_probs=188.8
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC--CCCCceeee-------eeEEc
Q 006779 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL--KHENIIKFY-------NSWVD 97 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L--~HpnIVkl~-------~~~~d 97 (631)
+++.+.||+|+||+||+|.+..+|+.||+|++..... ......+.+.+|+.+++.| +||||++++ +++..
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE-NSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST-THHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc-ccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 4788999999999999999999999999999986542 2345567788885544444 699988865 34333
Q ss_pred CCC---------------CeEEEEEeccCCCCHHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHHhCCCCEEecc
Q 006779 98 DTN---------------RTINMITELFTSGSLRQYRKKH-KNVDMKAI------KNWARQILRGLHYLHSHNPPIIHRD 155 (631)
Q Consensus 98 ~~~---------------~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i------~~i~~QIl~aL~yLHs~~~~IiHrD 155 (631)
... ..+++||||+. |+|.+++... ..++.... ..++.||+.||+|||+++ |+|||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivHrD 219 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGH 219 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEETT
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--CccCc
Confidence 222 35899999998 8999999864 33455555 677799999999999999 99999
Q ss_pred CCCCCeeecCCCCcEEEccccccchhcCCCCccccCCCCCCCcccccc---ccCccccchhhhHHHHHHhhcCCCCCCCC
Q 006779 156 LKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECK 232 (631)
Q Consensus 156 LKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~---~ys~~sDIwSLGiilyELltG~~Pf~~~~ 232 (631)
|||+|||++ .+|.+||+|||++........ ...+|+.|+|||++.+ .|+.++|||||||++|+|+||+.||....
T Consensus 220 ikp~NIll~-~~~~~kL~DFG~a~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 297 (371)
T 3q60_A 220 FTPDNLFIM-PDGRLMLGDVSALWKVGTRGP-ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297 (371)
T ss_dssp CSGGGEEEC-TTSCEEECCGGGEEETTCEEE-GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred CCHHHEEEC-CCCCEEEEecceeeecCCCcc-CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence 999999998 789999999999976543322 4567799999998764 58999999999999999999999997642
Q ss_pred CHH-HHHHH---HHcCCCCC--CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 233 NPA-QIYKK---VTSGIKPA--SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 233 ~~~-~i~~~---i~~~~~p~--~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
... ..+.. ........ ......++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp TTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred cccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 110 00000 00001111 1123568999999999998 89999999999999999753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=361.49 Aligned_cols=254 Identities=24% Similarity=0.386 Sum_probs=203.3
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CC-----CceeeeeeEE
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HE-----NIIKFYNSWV 96 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-Hp-----nIVkl~~~~~ 96 (631)
.+|| ++.+.||+|+||+||+|.+..+|+.||+|++... ......+..|+.+++.++ |+ +|+++++++.
T Consensus 53 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 53 MDRY-EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp TTTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred eeeE-EEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 4667 7789999999999999999999999999998632 345567888999998885 55 4999999887
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC-CCCcEEEc
Q 006779 97 DDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIG 173 (631)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~-~~g~vKL~ 173 (631)
.. ..+++||||+. |+|.+++... +.+++..++.++.||+.||.|||++..+|+||||||+|||++. .++.+||+
T Consensus 127 ~~--~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 127 FR--NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp ET--TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred cC--CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 65 47999999996 5999998875 4699999999999999999999964334999999999999952 46789999
Q ss_pred cccccchhcCCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC--CCCCC-
Q 006779 174 DLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPAS- 249 (631)
Q Consensus 174 DFGla~~~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~--~~p~~- 249 (631)
|||++...... ....+||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.+... .+....+... ..+..
T Consensus 204 DFG~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~ 281 (382)
T 2vx3_A 204 DFGSSCQLGQR-IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE-VDQMNKIVEVLGIPPAHI 281 (382)
T ss_dssp CCTTCEETTCC-CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSCCHHH
T ss_pred eccCceecccc-cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHH
Confidence 99999766443 345689999999998765 589999999999999999999999987543 3333333221 11000
Q ss_pred -------------CC-------------------C---------------------------CCcHHHHHHHHHhcC-CC
Q 006779 250 -------------LS-------------------K---------------------------VTDPQVKQFIEKCIV-PA 269 (631)
Q Consensus 250 -------------l~-------------------~---------------------------~~~~~l~~lI~~cL~-~p 269 (631)
++ . ...+.+++||.+||+ +|
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 361 (382)
T 2vx3_A 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 361 (382)
T ss_dssp HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence 00 0 001478999999998 99
Q ss_pred CCCCCHHHHhcCCCCCCC
Q 006779 270 SLRLPALELLKDPFLVTD 287 (631)
Q Consensus 270 ~~Rpsa~elL~hpff~~~ 287 (631)
.+|||+.|+|+||||+..
T Consensus 362 ~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 362 KTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TTSCCHHHHTTSGGGCC-
T ss_pred hhCCCHHHHhcCcccccC
Confidence 999999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=345.20 Aligned_cols=257 Identities=26% Similarity=0.410 Sum_probs=207.0
Q ss_pred ccccCCCCceeeeeeEecccCceEEEEEE----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeee
Q 006779 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92 (631)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~----d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~ 92 (631)
+....-..+++++.+.||+|+||.||+|. +..+|+.||+|.+.... .....+.+.+|+.+|+.++||||++++
T Consensus 13 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~ 89 (302)
T 4e5w_A 13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYK 89 (302)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCeeeee
Confidence 33334445666889999999999999998 67899999999987543 233456789999999999999999999
Q ss_pred eeEEcCCCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEE
Q 006779 93 NSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 171 (631)
Q Consensus 93 ~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 171 (631)
+++.+.....+++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+|
T Consensus 90 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~k 166 (302)
T 4e5w_A 90 GICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVK 166 (302)
T ss_dssp EEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEE
T ss_pred eEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEc-CCCCEE
Confidence 99987766779999999999999999954 467999999999999999999999999 99999999999998 788999
Q ss_pred EccccccchhcCCC-----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCC--------------
Q 006779 172 IGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC-------------- 231 (631)
Q Consensus 172 L~DFGla~~~~~~~-----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~-------------- 231 (631)
|+|||++....... .....||+.|+|||++.+ .++.++|||||||++|+|+||..|+...
T Consensus 167 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (302)
T 4e5w_A 167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ 246 (302)
T ss_dssp ECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGG
T ss_pred ECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccc
Confidence 99999997654332 334568888999998754 5889999999999999999999876321
Q ss_pred CCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 232 KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 232 ~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.....+...+..+.. ...+...++.+.+||.+||. +|.+|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 247 MTVTRLVNTLKEGKR-LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp GHHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHhccCC-CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 122333444444433 33455678999999999998 8999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=348.17 Aligned_cols=249 Identities=27% Similarity=0.419 Sum_probs=202.6
Q ss_pred CCceeeeeeEecccCceEEEEEE----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~----d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 98 (631)
..|| ++.+.||+|+||+||+|. +..+|..||+|++... .....+.+.+|+.+|+.++||||+++++++...
T Consensus 9 ~~~~-~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 9 ERHL-KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp GGGE-EEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred HHHh-hhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3455 889999999999999998 6779999999998643 456677899999999999999999999998765
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~-~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
....+++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGL 160 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCCS
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEc-CCCeEEEccCcc
Confidence 5556899999999999999998764 4999999999999999999999998 99999999999998 788999999999
Q ss_pred cchhcCCC-----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCH---------------HH
Q 006779 178 AIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP---------------AQ 236 (631)
Q Consensus 178 a~~~~~~~-----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~---------------~~ 236 (631)
+....... .....+++.|+|||++. ..++.++||||||+++|+|+||..||...... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 97654321 22345677899999875 45899999999999999999999998642100 12
Q ss_pred HHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 237 IYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 237 i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+...+..+.. ...+...++++.+||.+||. +|.+|||+.+++.
T Consensus 241 ~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 241 LIELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhccCc-CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 2233333322 23455678999999999998 8999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=354.20 Aligned_cols=246 Identities=28% Similarity=0.358 Sum_probs=200.2
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC--C
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--N 100 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~--~ 100 (631)
.++| ++.++||+|+||+||+|.+. |+.||+|++.... .......+|+.+|+.++||||+++++++.+.. .
T Consensus 23 ~~~y-~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 23 SMPL-QLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp TEEE-EEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred hhhc-hhhheecccCceEEEEEEEC--CCEEEEEEeecCc-----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 3566 78899999999999999765 8999999986432 33455667999999999999999999987654 3
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCEEeccCCCCCeeecCCCCcE
Q 006779 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH----------NPPIIHRDLKCDNIFVNGNNGEV 170 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~----------~~~IiHrDLKp~NILl~~~~g~v 170 (631)
..+++||||+.+|+|.+++.+. .+++..++.++.||+.||.|||++ + |+||||||+|||++ .++.+
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~-~~~~~ 170 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLK-NNLTA 170 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEEC-TTCCE
T ss_pred ceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEEC-CCCeE
Confidence 4689999999999999999775 499999999999999999999998 7 99999999999997 78899
Q ss_pred EEccccccchhcCC----CCccccCCCCCCCcccccc------ccCccccchhhhHHHHHHhhcCCCCCCCC--------
Q 006779 171 KIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECK-------- 232 (631)
Q Consensus 171 KL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~~------~ys~~sDIwSLGiilyELltG~~Pf~~~~-------- 232 (631)
||+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+..
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 99999999765432 2334679999999998764 46778999999999999999999996532
Q ss_pred -------CHHHHHHHHHcCCCCCCCCCC-----CcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 233 -------NPAQIYKKVTSGIKPASLSKV-----TDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 233 -------~~~~i~~~i~~~~~p~~l~~~-----~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
....+...+......+.+... .++.+++||.+||. +|.+|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 234444444444333333222 23459999999998 8999999999886
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=361.66 Aligned_cols=257 Identities=23% Similarity=0.352 Sum_probs=212.7
Q ss_pred CCCCceeeeeeEecccCceEEEEEE-----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeE
Q 006779 21 DPSCRYGRYDEILGKGAFKTVYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 95 (631)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~a~-----d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~ 95 (631)
-+..+| ++.+.||+|+||+||+|. +..++..||+|.+... ........+.+|+.+|+.++||||+++++++
T Consensus 68 ~~~~~~-~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 68 VPRKNI-TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV---CSEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp CCGGGE-EEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCHhHe-EEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc---cChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 345566 788999999999999999 5568899999998633 2455667789999999999999999999988
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC--C
Q 006779 96 VDDTNRTINMITELFTSGSLRQYRKKHK-------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--N 166 (631)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~~~l~~~~-------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~--~ 166 (631)
.+. ...++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++. .
T Consensus 144 ~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~ 219 (367)
T 3l9p_A 144 LQS--LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGP 219 (367)
T ss_dssp CSS--SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSST
T ss_pred ecC--CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCC
Confidence 654 35789999999999999998643 5899999999999999999999999 999999999999972 2
Q ss_pred CCcEEEccccccchhcC----CCCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHH
Q 006779 167 NGEVKIGDLGLAIVMQQ----PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKK 240 (631)
Q Consensus 167 ~g~vKL~DFGla~~~~~----~~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~ 240 (631)
+..+||+|||++..... .......||+.|+|||++. ..|+.++|||||||++|||++ |..||.. .+...+...
T Consensus 220 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~-~~~~~~~~~ 298 (367)
T 3l9p_A 220 GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEF 298 (367)
T ss_dssp TCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHH
T ss_pred CceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHH
Confidence 33599999999975422 2234457899999999775 569999999999999999998 9999977 566777777
Q ss_pred HHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 241 VTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 241 i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
+..+..+. .+...++.+.+||.+||. +|.+||++.+++++.++...
T Consensus 299 i~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 299 VTSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCCCC-CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 77765433 345667899999999998 89999999999999877543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=354.10 Aligned_cols=252 Identities=23% Similarity=0.400 Sum_probs=204.9
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCH--HHHHHHHHHHHHHHhC----CCCCceeeeeeE
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--DQLERLYSEVHLLKSL----KHENIIKFYNSW 95 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~--~~~~~l~~Ei~iLk~L----~HpnIVkl~~~~ 95 (631)
-.+|| ++.+.||+|+||.||+|.+..+|+.||+|.+......... .....+.+|+.+++.+ +||||+++++++
T Consensus 29 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 29 FEAEY-RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp ----C-EEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhce-EEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 35667 7889999999999999999999999999999755432111 2234466799999999 899999999988
Q ss_pred EcCCCCeEEEEEec-cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcc
Q 006779 96 VDDTNRTINMITEL-FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 96 ~d~~~~~l~lV~Ey-~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~D 174 (631)
.+. ..+++|+|| +.+++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++..++.+||+|
T Consensus 108 ~~~--~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 108 ETQ--EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp -------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEECC
T ss_pred ecC--CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEEE
Confidence 654 457889999 789999999998888999999999999999999999999 999999999999975688999999
Q ss_pred ccccchhcCCCCccccCCCCCCCcccccc-cc-CccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006779 175 LGLAIVMQQPTARSVIGTPEFMAPELYEE-EY-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 175 FGla~~~~~~~~~~~~GTp~Y~APEvl~~-~y-s~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~ 252 (631)
||++............||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||.. ...+ ... ...++.
T Consensus 184 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~---~~~~----~~~--~~~~~~ 254 (312)
T 2iwi_A 184 FGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER---DQEI----LEA--ELHFPA 254 (312)
T ss_dssp CSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS---HHHH----HHT--CCCCCT
T ss_pred cchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC---hHHH----hhh--ccCCcc
Confidence 99998776666666789999999998754 34 4589999999999999999999965 2222 111 122445
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 253 ~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
..++.+++||.+||. +|.+||++.++|+||||+..
T Consensus 255 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 678899999999998 89999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=352.87 Aligned_cols=256 Identities=20% Similarity=0.340 Sum_probs=204.3
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCC-eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC------ceeeeeeE
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDG-IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN------IIKFYNSW 95 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg-~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~Hpn------IVkl~~~~ 95 (631)
.+|| ++.+.||+|+||+||+|.+..++ ..||+|++.. .....+.+.+|+.+++.++|++ ++.+++++
T Consensus 18 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 18 QERY-EIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-----VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp TTTE-EEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred cccE-EEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-----cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 3567 78899999999999999998887 7999999863 2345677889999999998766 88899887
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeec---------
Q 006779 96 VDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--------- 164 (631)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~--------- 164 (631)
... ..+++||||+ +++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 92 ~~~--~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 92 NFH--GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp EET--TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEEC
T ss_pred eeC--CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccc
Confidence 654 4789999999 66777777654 46999999999999999999999998 99999999999993
Q ss_pred ---------CCCCcEEEccccccchhcCCCCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCH
Q 006779 165 ---------GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP 234 (631)
Q Consensus 165 ---------~~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~ 234 (631)
..++.+||+|||++...... .....||+.|+|||++. ..++.++|||||||++|+|++|..||......
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEH-HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSC-CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccccCCCcEEEeecCcccccccc-ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 15689999999999764433 34567999999999875 46899999999999999999999999874433
Q ss_pred HHHHHHHHc--CCCCCC----------------------------------------CCCCCcHHHHHHHHHhcC-CCCC
Q 006779 235 AQIYKKVTS--GIKPAS----------------------------------------LSKVTDPQVKQFIEKCIV-PASL 271 (631)
Q Consensus 235 ~~i~~~i~~--~~~p~~----------------------------------------l~~~~~~~l~~lI~~cL~-~p~~ 271 (631)
..+ ..+.. +..|.. .....++.+++||.+||. +|.+
T Consensus 246 ~~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 246 EHL-VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHH-HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHH-HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 322 22211 111100 001124578999999998 9999
Q ss_pred CCCHHHHhcCCCCCCCCCcc
Q 006779 272 RLPALELLKDPFLVTDNPKD 291 (631)
Q Consensus 272 Rpsa~elL~hpff~~~~~~~ 291 (631)
|||+.|+|+||||....+..
T Consensus 325 Rpt~~e~l~hp~f~~~~~~~ 344 (355)
T 2eu9_A 325 RITLAEALLHPFFAGLTPEE 344 (355)
T ss_dssp SCCHHHHTTSGGGGGCCHHH
T ss_pred CcCHHHHhcChhhcCCChhh
Confidence 99999999999998765543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=356.43 Aligned_cols=253 Identities=21% Similarity=0.376 Sum_probs=212.3
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC--HHHHHHHHHHHHHHHhCC--CCCceeeeeeEEc
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS--PDQLERLYSEVHLLKSLK--HENIIKFYNSWVD 97 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~--~~~~~~l~~Ei~iLk~L~--HpnIVkl~~~~~d 97 (631)
..+|| ++.+.||+|+||.||+|.+..+|..||+|.+........ .....++.+|+.+++.++ ||||+++++++..
T Consensus 41 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 41 LESQY-QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CTTTE-EEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred ccCce-EEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 45666 888999999999999999999999999999976543210 012244678999999996 5999999998865
Q ss_pred CCCCeEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccc
Q 006779 98 DTNRTINMITELFTS-GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~g-GsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 176 (631)
. ..+++|+|++.+ ++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++..++.+||+|||
T Consensus 120 ~--~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 120 P--DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp S--SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCT
T ss_pred C--CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 4 478999999986 899999998889999999999999999999999999 99999999999997567899999999
Q ss_pred ccchhcCCCCccccCCCCCCCcccccc-c-cCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006779 177 LAIVMQQPTARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 177 la~~~~~~~~~~~~GTp~Y~APEvl~~-~-ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 254 (631)
++............||+.|+|||++.+ . ++.++|||||||++|+|++|+.||.. ... +..+. ..+....
T Consensus 196 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~---~~~----~~~~~--~~~~~~~ 266 (320)
T 3a99_A 196 SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DEE----IIRGQ--VFFRQRV 266 (320)
T ss_dssp TCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS---HHH----HHHCC--CCCSSCC
T ss_pred cccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC---hhh----hhccc--ccccccC
Confidence 998776665666789999999998754 3 36889999999999999999999965 222 22221 2234557
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 267 ~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 267 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 8899999999998 899999999999999998643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=352.46 Aligned_cols=251 Identities=21% Similarity=0.301 Sum_probs=211.5
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeee
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 94 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~-----~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~ 94 (631)
.-+.++| ++.+.||+|+||.||+|.+. .++..||+|.+.... .....+.+.+|+.+|+.++||||++++++
T Consensus 43 ~~~~~~~-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 43 EYPRNNI-EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp BCCGGGC-EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred EecHHHC-eeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3455677 77899999999999999997 466999999987432 45567789999999999999999999998
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 006779 95 WVDDTNRTINMITELFTSGSLRQYRKKH------------------------KNVDMKAIKNWARQILRGLHYLHSHNPP 150 (631)
Q Consensus 95 ~~d~~~~~l~lV~Ey~~gGsL~~~l~~~------------------------~~l~~~~i~~i~~QIl~aL~yLHs~~~~ 150 (631)
+.+. ..+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++
T Consensus 119 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-- 194 (343)
T 1luf_A 119 CAVG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-- 194 (343)
T ss_dssp ECSS--SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred EccC--CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 8654 4688999999999999999874 56999999999999999999999999
Q ss_pred EEeccCCCCCeeecCCCCcEEEccccccchhcCC----CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-c
Q 006779 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-C 224 (631)
Q Consensus 151 IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G 224 (631)
|+||||||+|||++ .++.+||+|||++...... ......+|+.|+|||++. ..++.++|||||||++|+|+| |
T Consensus 195 ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 273 (343)
T 1luf_A 195 FVHRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 273 (343)
T ss_dssp CCCSCCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred eecCCCCcceEEEC-CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcC
Confidence 99999999999997 7889999999999765332 223456789999999775 458999999999999999999 9
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 225 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 225 ~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
..||.. .+..++...+..+..+ ..+...++.+++||.+||. +|.+||++.+++++
T Consensus 274 ~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 274 LQPYYG-MAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp CCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcCCC-CChHHHHHHHhCCCcC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 999987 4566677777666443 3455678899999999998 89999999998864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=352.99 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=209.4
Q ss_pred CCCCceeeeeeEecccCceEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeee
Q 006779 21 DPSCRYGRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNS 94 (631)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~a~d-----~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~ 94 (631)
-+..+| ++.+.||+|+||.||+|.+ ..++..||+|.+.... .....+.+.+|+.+|+++ +||||++++++
T Consensus 42 ~~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 42 FPRENL-EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp CCGGGE-EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCHHHc-eeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 355677 7889999999999999997 3467899999997432 234457799999999999 99999999998
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCE
Q 006779 95 WVDDTNRTINMITELFTSGSLRQYRKKHK-----------------------NVDMKAIKNWARQILRGLHYLHSHNPPI 151 (631)
Q Consensus 95 ~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~-----------------------~l~~~~i~~i~~QIl~aL~yLHs~~~~I 151 (631)
+.+. ..+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ |
T Consensus 118 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i 193 (344)
T 1rjb_A 118 CTLS--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--C 193 (344)
T ss_dssp ECSS--SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred EeeC--CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--c
Confidence 8654 46889999999999999998653 3799999999999999999999999 9
Q ss_pred EeccCCCCCeeecCCCCcEEEccccccchhcCCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cC
Q 006779 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CE 225 (631)
Q Consensus 152 iHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~ 225 (631)
+||||||+|||++ .++.+||+|||++....... .....||+.|+|||++. ..++.++|||||||++|+|+| |.
T Consensus 194 vH~Dikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 272 (344)
T 1rjb_A 194 VHRDLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 272 (344)
T ss_dssp EETTCSGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred ccCCCChhhEEEc-CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCC
Confidence 9999999999998 78899999999997654332 22345788999999775 458999999999999999998 99
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 006779 226 YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 282 (631)
Q Consensus 226 ~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hp 282 (631)
.||........+...+..+..+ ..+...++.+.+||.+||. +|.+|||+.+++.+-
T Consensus 273 ~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 273 NPYPGIPVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp CSSTTCCCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCcccCCcHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 9998876666666666665443 3445568999999999998 899999999999863
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=358.64 Aligned_cols=256 Identities=26% Similarity=0.379 Sum_probs=203.7
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-----------CCCceee
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-----------HENIIKF 91 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-----------HpnIVkl 91 (631)
.+|| ++.+.||+|+||+||+|.+..+|+.||+|++... ....+.+.+|+.+++.++ ||||+++
T Consensus 18 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 18 DARY-ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp TTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CCeE-EEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-----ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 4677 7889999999999999999999999999998632 345567889999999886 8999999
Q ss_pred eeeEEcCC--CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeccCCCCCeeecC-
Q 006779 92 YNSWVDDT--NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNG- 165 (631)
Q Consensus 92 ~~~~~d~~--~~~l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~-~~~IiHrDLKp~NILl~~- 165 (631)
++++.... ...+++||||+ +++|.+++.+. ..+++..++.++.||+.||.|||++ + |+||||||+|||++.
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIV 168 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEE
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEecc
Confidence 99887542 33789999999 89999999874 4599999999999999999999998 8 999999999999951
Q ss_pred ----CCCcEEEccccccchhcCCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCC------H
Q 006779 166 ----NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN------P 234 (631)
Q Consensus 166 ----~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~------~ 234 (631)
..+.+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|+||+.||..... .
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CCCcCcceEEEcccccccccCCC-CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 3448999999999766543 334578999999998765 589999999999999999999999975321 1
Q ss_pred HHHHHHHHc-CCCCC--------------------------------------CCCCCCcHHHHHHHHHhcC-CCCCCCC
Q 006779 235 AQIYKKVTS-GIKPA--------------------------------------SLSKVTDPQVKQFIEKCIV-PASLRLP 274 (631)
Q Consensus 235 ~~i~~~i~~-~~~p~--------------------------------------~l~~~~~~~l~~lI~~cL~-~p~~Rps 274 (631)
..+...+.. +..|. .++...++.+++||.+||. +|.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 111111110 10000 1112235688999999998 8999999
Q ss_pred HHHHhcCCCCCCCC
Q 006779 275 ALELLKDPFLVTDN 288 (631)
Q Consensus 275 a~elL~hpff~~~~ 288 (631)
+.|+|+||||+...
T Consensus 328 ~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 328 AGGLVNHPWLKDTL 341 (373)
T ss_dssp HHHHHTCGGGTTCT
T ss_pred HHHHhhChhhhccc
Confidence 99999999998643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=346.96 Aligned_cols=255 Identities=21% Similarity=0.382 Sum_probs=197.1
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
.++| ++.+.||+|+||.||+|.++.+|+.||+|.+..... .....+.+.++..+++.++||||+++++++.+. ..
T Consensus 24 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~ 98 (318)
T 2dyl_A 24 INDL-ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN--KEENKRILMDLDVVLKSHDCPYIVQCFGTFITN--TD 98 (318)
T ss_dssp GGGE-EEEEEC------CEEEEEETTTCCEEEEEEEETTSC--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred hccc-cccceeeecCCeeEEEEEEecCCeEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--Cc
Confidence 3556 667899999999999999999999999999975431 223334455566678999999999999998764 47
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 103 INMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
+++||||+ ++.+..+... ...+++..++.++.||+.||.|||++ + |+||||||+|||++ .++.+||+|||++..
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLD-ERGQIKLCDFGISGR 174 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEEC-TTSCEEECCCTTC--
T ss_pred EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEEC-CCCCEEEEECCCchh
Confidence 89999999 5677666654 56799999999999999999999995 8 99999999999997 788999999999965
Q ss_pred hcCC-CCccccCCCCCCCccccc------cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC-CCC
Q 006779 181 MQQP-TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-LSK 252 (631)
Q Consensus 181 ~~~~-~~~~~~GTp~Y~APEvl~------~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~-l~~ 252 (631)
.... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||............+..+..+.. ...
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (318)
T 2dyl_A 175 LVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHM 254 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSS
T ss_pred ccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccC
Confidence 5433 334457999999999873 34889999999999999999999999887777777666666544322 223
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 253 ~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
..++.+++||.+||. +|.+||++.++|+||||+.
T Consensus 255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 468999999999998 8999999999999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=353.29 Aligned_cols=256 Identities=23% Similarity=0.412 Sum_probs=188.4
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHH-HHHhCCCCCceeeeeeEEcCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~-iLk~L~HpnIVkl~~~~~d~~~ 100 (631)
..++| ++.+.||+|+||.||+|.++.+|+.||+|++.... .......+..|+. +++.++||||+++++++.+.
T Consensus 20 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-- 93 (327)
T 3aln_A 20 TAEDL-KDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-- 93 (327)
T ss_dssp CSCSE-EC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC---CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS--
T ss_pred CHHHh-hehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc---CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC--
Confidence 34566 67789999999999999999999999999997542 2344455666666 78888999999999998765
Q ss_pred CeEEEEEeccCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEeccCCCCCeeecCCCCcEEEcc
Q 006779 101 RTINMITELFTSGSLRQYRKK-----HKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~-----~~~l~~~~i~~i~~QIl~aL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKL~D 174 (631)
..+++||||+.+ +|.+++.. ...+++..+..++.|++.||.|||++ + |+||||||+|||++ .++.+||+|
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~-~~~~~kl~D 169 (327)
T 3aln_A 94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLD-RSGNIKLCD 169 (327)
T ss_dssp SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEE-TTTEEEECC
T ss_pred CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEc-CCCCEEEcc
Confidence 478999999975 88887763 56799999999999999999999998 8 99999999999998 789999999
Q ss_pred ccccchhcCCC-CccccCCCCCCCccccc-----cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC
Q 006779 175 LGLAIVMQQPT-ARSVIGTPEFMAPELYE-----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 248 (631)
Q Consensus 175 FGla~~~~~~~-~~~~~GTp~Y~APEvl~-----~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~ 248 (631)
||++....... .....||+.|+|||++. ..++.++|||||||++|+|++|+.||............+..+..+.
T Consensus 170 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (327)
T 3aln_A 170 FGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQ 249 (327)
T ss_dssp CSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCC
T ss_pred CCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCC
Confidence 99997654432 23347999999999873 3488999999999999999999999986443323322222222221
Q ss_pred ---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 249 ---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 249 ---~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
......++.+++||.+||. +|.+||++.++|+||||...
T Consensus 250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 1223568899999999998 89999999999999999753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=339.36 Aligned_cols=244 Identities=20% Similarity=0.419 Sum_probs=206.8
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.+| ++.+.||+|+||+||+|.+. ++..||+|.+..... ..+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 10 ~~y-~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 80 (269)
T 4hcu_A 10 SEL-TFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--API 80 (269)
T ss_dssp GGE-EEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSE
T ss_pred hhc-eeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-----CHHHHHHHHHHHHhCCCCCEeeEEEEEecC--Cce
Confidence 356 77899999999999999987 578899999875432 225688999999999999999999988654 458
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
++||||+.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-GGGCEEECCTTGGGGBC
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEc-CCCCEEecccccccccc
Confidence 9999999999999999764 56899999999999999999999999 99999999999997 78899999999997554
Q ss_pred CC---CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006779 183 QP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 183 ~~---~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~ 257 (631)
.. ......+|+.|+|||++. ..++.++||||||+++|+|++ |..||.. .....+...+..+..+ ..+...++.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 235 (269)
T 4hcu_A 158 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLASTH 235 (269)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCHH
T ss_pred ccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhcCccC-CCCCcCCHH
Confidence 32 233445688899999876 458999999999999999999 9999976 5667777777766433 344556899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 258 VKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 258 l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
++++|.+||. +|.+||++.++++|
T Consensus 236 ~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 236 VYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999999998 89999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=340.06 Aligned_cols=245 Identities=22% Similarity=0.399 Sum_probs=204.0
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
..+| ++.+.||+|+||+||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 23 ~~~y-~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 93 (283)
T 3gen_A 23 PKDL-TFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RP 93 (283)
T ss_dssp GGGE-EEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SS
T ss_pred HHHH-HhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-----CHHHHHHHHHHHhcCCCCCEeeEEEEEecC--CC
Confidence 3455 88899999999999999876 688899999975432 125588999999999999999999988554 46
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 103 INMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
+++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDFGLSRYV 170 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEEC-TTSCEEECSTTGGGGB
T ss_pred eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEc-CCCCEEEccccccccc
Confidence 8999999999999999987 567999999999999999999999999 99999999999997 7889999999999765
Q ss_pred cCC---CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006779 182 QQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 182 ~~~---~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~ 256 (631)
... ......+|+.|+|||++. ..++.++||||||+++|+|+| |+.||.. .+.......+..+..+ ..+...++
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 248 (283)
T 3gen_A 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNSETAEHIAQGLRL-YRPHLASE 248 (283)
T ss_dssp CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCH
T ss_pred cccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc-cChhHHHHHHhcccCC-CCCCcCCH
Confidence 432 223345688899999876 458999999999999999998 9999987 4566666777665433 23455678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 257 QVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.+++||.+||. +|.+|||+.+++.|
T Consensus 249 ~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 249 KVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHH
Confidence 99999999998 89999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=344.35 Aligned_cols=252 Identities=23% Similarity=0.376 Sum_probs=212.9
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeee
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYN 93 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d-----~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~ 93 (631)
.-+.+|| ++.+.||+|+||.||+|.+ ..++..||+|.+.... .....+.+.+|+.+|+++ +||||+++++
T Consensus 19 ~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 19 EFPRNRL-SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp BCCGGGE-EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccChhhh-hHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch---hHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 3456788 7889999999999999985 5678999999987442 345668899999999999 9999999999
Q ss_pred eEEcCCCCeEEEEEeccCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecc
Q 006779 94 SWVDDTNRTINMITELFTSGSLRQYRKKHK------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRD 155 (631)
Q Consensus 94 ~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~------------------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrD 155 (631)
++.+. ..+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ |+|||
T Consensus 95 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~d 170 (313)
T 1t46_A 95 ACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRD 170 (313)
T ss_dssp EECSS--SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred EEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCC
Confidence 88654 45789999999999999998754 4899999999999999999999998 99999
Q ss_pred CCCCCeeecCCCCcEEEccccccchhcCCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCC
Q 006779 156 LKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYN 229 (631)
Q Consensus 156 LKp~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~ 229 (631)
|||+|||++ .++.+||+|||++....... .....||+.|+|||++. ..++.++|||||||++|+|+| |..||.
T Consensus 171 lkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 249 (313)
T 1t46_A 171 LAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (313)
T ss_dssp CSGGGEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CccceEEEc-CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999998 78999999999997665432 22345788999999765 458999999999999999999 999998
Q ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 230 ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 230 ~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.......+...+..+..+. .+...++.++++|.+||. +|.+|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 250 GMPVDSKFYKMIKEGFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp TCCSSHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccchhHHHHHhccCCCCC-CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 8666666666666654432 344567899999999998 89999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=344.41 Aligned_cols=249 Identities=31% Similarity=0.517 Sum_probs=202.4
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
+-+.+|| ++.+.||+|+||+||+|.+.. .||+|.++... ......+.+.+|+.+|+.++||||++++++.. .
T Consensus 20 ei~~~~y-~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~- 91 (289)
T 3og7_A 20 EIPDGQI-TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTA--PTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-A- 91 (289)
T ss_dssp BCCTTSC-EEEEEEEECSSEEEEEEESSS---EEEEEEESCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S-
T ss_pred ccCccce-eeeeEecCCCCeEEEEEEEcC---ceEEEEEeccC--CCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-C-
Confidence 4456777 888999999999999997643 59999987553 34667788999999999999999999999653 2
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
..+++||||+.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 92 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~ 167 (289)
T 3og7_A 92 -PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLH-EDNTVKIGDFGLA 167 (289)
T ss_dssp -SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTTEEEECCCC--
T ss_pred -CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEEC-CCCCEEEccceec
Confidence 3478999999999999999654 56999999999999999999999999 99999999999998 7889999999999
Q ss_pred chhcC----CCCccccCCCCCCCccccc----cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 006779 179 IVMQQ----PTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250 (631)
Q Consensus 179 ~~~~~----~~~~~~~GTp~Y~APEvl~----~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l 250 (631)
..... .......||+.|+|||++. ..++.++|||||||++|+|++|+.||....+...+...+..+..+..+
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL 247 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCT
T ss_pred cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcch
Confidence 75432 2233457999999999874 347889999999999999999999999888888888888776554433
Q ss_pred ---CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 251 ---SKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 251 ---~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
....++.+++||.+||. +|.+|||+.++++
T Consensus 248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 34567899999999998 8999999999886
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=357.03 Aligned_cols=251 Identities=27% Similarity=0.417 Sum_probs=213.0
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEcc-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceee
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKF 91 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~-------tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl 91 (631)
+-+.+|| ++.+.||+|+||+||+|.+.. .+..||+|++... ........+.+|+.+++.+ +||||+++
T Consensus 65 ~i~~~~y-~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 65 ELPRDRL-VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp BCCGGGE-EEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccchhhe-EeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc---cCHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 3455677 788999999999999999754 3468999998754 2456678899999999999 99999999
Q ss_pred eeeEEcCCCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEecc
Q 006779 92 YNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRD 155 (631)
Q Consensus 92 ~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~----------------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrD 155 (631)
++++.+. ..+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ |+|||
T Consensus 141 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~D 216 (382)
T 3tt0_A 141 LGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRD 216 (382)
T ss_dssp EEEECSS--SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred eeeeccC--CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCC
Confidence 9988654 45889999999999999998754 4999999999999999999999998 99999
Q ss_pred CCCCCeeecCCCCcEEEccccccchhcCC----CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCC
Q 006779 156 LKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYN 229 (631)
Q Consensus 156 LKp~NILl~~~~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~ 229 (631)
|||+|||++ .++.+||+|||++...... ......+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.
T Consensus 217 lkp~NIll~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~ 295 (382)
T 3tt0_A 217 LAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295 (382)
T ss_dssp CCGGGEEEC-TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCcceEEEc-CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999997 7899999999999765432 2233467889999997754 58999999999999999999 999997
Q ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 230 ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 230 ~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
. .+..++...+..+..+. .+...++++++||.+||. +|.+|||+.+++++
T Consensus 296 ~-~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 296 G-VPVEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp T-CCHHHHHHHHHTTCCCC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-CCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6 56777777777765443 345678899999999998 89999999999985
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=348.85 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=213.1
Q ss_pred CCCCceeeeeeEecccCceEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeee
Q 006779 21 DPSCRYGRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNS 94 (631)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~a~d-----~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~ 94 (631)
-+.+|| ++.+.||+|+||+||+|.+ ..+++.||+|.+.... .....+.+.+|+.+|+.+ +||||++++++
T Consensus 24 ~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 24 FPRDRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp CCGGGE-EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cchhhe-eeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC---CcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 355677 8889999999999999985 4678999999987442 355667899999999999 79999999998
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCC
Q 006779 95 WVDDTNRTINMITELFTSGSLRQYRKKHKN----------------VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158 (631)
Q Consensus 95 ~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~----------------l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp 158 (631)
+.... ..+++||||+.+|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||
T Consensus 100 ~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp 176 (316)
T 2xir_A 100 CTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA 176 (316)
T ss_dssp ECCTT-SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EecCC-CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCcc
Confidence 86543 468899999999999999987654 899999999999999999999998 99999999
Q ss_pred CCeeecCCCCcEEEccccccchhcCCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCC
Q 006779 159 DNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECK 232 (631)
Q Consensus 159 ~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~ 232 (631)
+|||++ .++.+||+|||++....... .....||+.|+|||++. ..++.++|||||||++|+|+| |..||....
T Consensus 177 ~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 177 RNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGEEEC-GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceEEEC-CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999997 78899999999997654332 22346788999999775 458999999999999999998 999998876
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 233 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 233 ~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
....+...+..+..+ ..+...++.++++|.+||. +|.+|||+.+++.|
T Consensus 256 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 256 IDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp CSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHHhccCccC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 666676666665433 3445578999999999998 89999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=364.14 Aligned_cols=252 Identities=22% Similarity=0.374 Sum_probs=206.6
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
.+|| ++.++||+|+||+||+|.+..+|+.||+|++...... ...+.+.+|+.+|+.++||||+++++++.+.....
T Consensus 8 ~~~y-~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 8 NHLW-LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp SEEE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCce-EEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc---chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 3455 8899999999999999999999999999999754432 23466789999999999999999999998777668
Q ss_pred EEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeee----cCCCCcEEEccc
Q 006779 103 INMITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV----NGNNGEVKIGDL 175 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~---~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl----~~~~g~vKL~DF 175 (631)
+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||+ + .++.+||+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~-~~~~~kL~DF 160 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGED-GQSVYKLTDF 160 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTT-SCEEEEECCG
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCC-CceeEEEecC
Confidence 899999999999999997643 3999999999999999999999999 9999999999998 5 5678999999
Q ss_pred cccchhcCC-CCccccCCCCCCCccccc---------cccCccccchhhhHHHHHHhhcCCCCCCCC---CHHHHHHHHH
Q 006779 176 GLAIVMQQP-TARSVIGTPEFMAPELYE---------EEYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVT 242 (631)
Q Consensus 176 Gla~~~~~~-~~~~~~GTp~Y~APEvl~---------~~ys~~sDIwSLGiilyELltG~~Pf~~~~---~~~~i~~~i~ 242 (631)
|++...... ......||+.|+|||++. ..|+.++|||||||++|+|++|+.||.... ...+++..+.
T Consensus 161 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp GGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred CCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 999765433 334567999999999875 357889999999999999999999996422 2234444444
Q ss_pred cCCCCCC-----------------------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 243 SGIKPAS-----------------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 243 ~~~~p~~-----------------------l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.+..+.. +....++.+++||.+||. +|.+||++.+++.+
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 4432211 112235678999999998 99999999998653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=335.39 Aligned_cols=246 Identities=22% Similarity=0.387 Sum_probs=206.0
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
..++| ++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+. .
T Consensus 6 ~~~~y-~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~ 76 (268)
T 3sxs_A 6 KREEI-TLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKE--Y 76 (268)
T ss_dssp CGGGE-EEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--S
T ss_pred chhhe-eeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-----cHHHHHHHHHHHHhCCCCCEeeEEEEEccC--C
Confidence 34567 77899999999999999776 678899999875432 225588999999999999999999988544 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 102 TINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~-~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
.+++||||+.+++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 77 PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVD-RDLCVKVSDFGMTRY 153 (268)
T ss_dssp SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEEC-TTCCEEECCTTCEEE
T ss_pred ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEEC-CCCCEEEccCcccee
Confidence 6899999999999999998754 5999999999999999999999999 99999999999997 789999999999976
Q ss_pred hcCCCC---ccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006779 181 MQQPTA---RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 181 ~~~~~~---~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~ 255 (631)
...... ....+|+.|+|||++.+ .++.++||||||+++|+|+| |..||.. .+.......+..+..+ ..+...+
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 231 (268)
T 3sxs_A 154 VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL-YTNSEVVLKVSQGHRL-YRPHLAS 231 (268)
T ss_dssp CCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCCC-CCCTTSC
T ss_pred cchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc-cChHHHHHHHHcCCCC-CCCCcCh
Confidence 544322 23346778999998765 58999999999999999999 9999976 4555555666655432 3345567
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 256 PQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
+.++++|.+||. +|.+|||+.+++++
T Consensus 232 ~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 232 DTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 899999999998 89999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=348.00 Aligned_cols=249 Identities=27% Similarity=0.441 Sum_probs=209.2
Q ss_pred CCCceeeeeeEecccCceEEEEEEEc-------cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeee
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDE-------VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYN 93 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~-------~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~ 93 (631)
+.++| ++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+|+.+ +||||+++++
T Consensus 33 ~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 33 PRDKL-TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp CGGGE-EEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CHhHe-EEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC---cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 44566 78899999999999999986 467899999987432 456678899999999999 9999999999
Q ss_pred eEEcCCCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCC
Q 006779 94 SWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157 (631)
Q Consensus 94 ~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~----------------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLK 157 (631)
++.+. ..+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ |+|||||
T Consensus 109 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlk 184 (334)
T 2pvf_A 109 ACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLA 184 (334)
T ss_dssp EECSS--SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred EEccC--CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCc
Confidence 88654 46889999999999999998754 3899999999999999999999999 9999999
Q ss_pred CCCeeecCCCCcEEEccccccchhcCCC----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCC
Q 006779 158 CDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNEC 231 (631)
Q Consensus 158 p~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~ 231 (631)
|+|||++ .++.+||+|||++....... .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+
T Consensus 185 p~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~- 262 (334)
T 2pvf_A 185 ARNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG- 262 (334)
T ss_dssp GGGEEEC-TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-
T ss_pred cceEEEc-CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc-
Confidence 9999997 78999999999997654321 233457889999997754 58999999999999999999 9999976
Q ss_pred CCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 232 KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 232 ~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.+..++...+..+..+ ..+...++.+++||.+||. +|.+||++.+++++
T Consensus 263 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 263 IPVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CCHHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 4667777777766543 3445678899999999998 89999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=341.04 Aligned_cols=253 Identities=30% Similarity=0.524 Sum_probs=203.1
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
..++| ++.+.||+|+||.||+|.+..+|..||+|++..... ......+.+.+|+.+++.++||||+++++++... .
T Consensus 30 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~ 105 (310)
T 2wqm_A 30 TLANF-RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--N 105 (310)
T ss_dssp SGGGE-EEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--T
T ss_pred cccce-EEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--C
Confidence 34566 888999999999999999999999999999976433 3456678899999999999999999999998765 4
Q ss_pred eEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 102 TINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~----~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
.+++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~-~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGL 182 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCC--
T ss_pred cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEc-CCCCEEEEeccc
Confidence 78999999999999999874 466999999999999999999999999 99999999999997 788999999999
Q ss_pred cchhcCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCC-CHHHHHHHHHcCCCCCCCCCC
Q 006779 178 AIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 178 a~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~-~~~~i~~~i~~~~~p~~l~~~ 253 (631)
+...... ......|++.|+|||++.+ .++.++||||||+++|+|++|..||.+.. +...+...+.....+......
T Consensus 183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (310)
T 2wqm_A 183 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDH 262 (310)
T ss_dssp ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTT
T ss_pred eeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccc
Confidence 8765433 2334578999999997754 58999999999999999999999997543 445666667666555444456
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 254 TDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 254 ~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.++.+++||.+||. +|.+||++.+++.+
T Consensus 263 ~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 263 YSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 78999999999998 89999999999873
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=350.92 Aligned_cols=253 Identities=26% Similarity=0.448 Sum_probs=202.9
Q ss_pred ccccCCCCceeeeeeEecccCceEEEEEEEccCCeEE----EEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeee
Q 006779 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEV----AWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92 (631)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~V----AiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~ 92 (631)
....-..++| ++.++||+|+||+||+|.+..+|..| |+|.+.... .......+.+|+.+|+.++||||++++
T Consensus 8 ~~~~l~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~ 83 (327)
T 3poz_A 8 LLRILKETEF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLL 83 (327)
T ss_dssp SSEECCGGGE-EEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEE
T ss_pred HHhhcCHHHc-ccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc---CHHHHHHHHHHHHHHHhCCCCCEeEEE
Confidence 3444456677 77899999999999999998887655 777664322 234456789999999999999999999
Q ss_pred eeEEcCCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEE
Q 006779 93 NSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 171 (631)
Q Consensus 93 ~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 171 (631)
+++.+. ..++|+||+.+|+|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+|
T Consensus 84 ~~~~~~---~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~-~~~~~k 157 (327)
T 3poz_A 84 GICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVK 157 (327)
T ss_dssp EEEESS---SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEE
T ss_pred EEEecC---CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEEC-CCCCEE
Confidence 998764 377899999999999999874 57999999999999999999999998 99999999999998 788999
Q ss_pred EccccccchhcCCC----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCC
Q 006779 172 IGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI 245 (631)
Q Consensus 172 L~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~ 245 (631)
|+|||++....... .....+|+.|+|||++.+ .|+.++|||||||++|+|+| |+.||.. .+...+...+..+.
T Consensus 158 l~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~ 236 (327)
T 3poz_A 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGE 236 (327)
T ss_dssp ECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTC
T ss_pred EccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccC-CCHHHHHHHHHcCC
Confidence 99999997664432 223456889999997754 58999999999999999999 9999976 45556666666654
Q ss_pred CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 246 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 246 ~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.+. .+...+..+.++|.+||. +|.+||++.+++.+
T Consensus 237 ~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 237 RLP-QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp CCC-CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCC-CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 332 345567899999999998 89999999999876
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=358.82 Aligned_cols=246 Identities=22% Similarity=0.367 Sum_probs=207.7
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.+| ++.+.||+|+||.||+|.++.+|..||+|.++.. ......+.+.+|+.+|+.++||||+++++++.+. ..+
T Consensus 114 ~~~-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 187 (377)
T 3cbl_A 114 EDL-VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET---LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPI 187 (377)
T ss_dssp GGE-EEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT---SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS--SSC
T ss_pred HHe-EEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc---CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC--CCc
Confidence 455 7889999999999999999999999999998643 2345567789999999999999999999988654 458
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
++||||+.+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~-~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVT-EKNVLKISDFGMSREEA 264 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCGGGCEECT
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEc-CCCcEEECcCCCceecC
Confidence 8999999999999999865 46999999999999999999999999 99999999999997 78999999999997543
Q ss_pred CCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006779 183 QPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 183 ~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~ 256 (631)
... .....+++.|+|||++. +.|+.++|||||||++|||+| |..||.. ....++...+..+..+ ..+...++
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 342 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN-LSNQQTREFVEKGGRL-PCPELCPD 342 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT-SCHHHHHHHHHTTCCC-CCCTTCCH
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCH
Confidence 321 11223567899999876 458999999999999999998 9999987 4566666667665443 34556788
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 257 QVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.+.+||.+||. +|.+|||+.+++.
T Consensus 343 ~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 343 AVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999998 8999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=342.86 Aligned_cols=245 Identities=20% Similarity=0.363 Sum_probs=202.7
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCC-------eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeee
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDG-------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 94 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg-------~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~ 94 (631)
...+| ++.+.||+|+||+||+|.+..+| ..||+|.+.... ....+.+.+|+.+|+.++||||++++++
T Consensus 6 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 6 RNEDL-IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH----RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp CGGGE-EEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG----GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred chhHe-eeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc----HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 45567 78899999999999999999887 579999986432 3445779999999999999999999999
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCc----
Q 006779 95 WVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE---- 169 (631)
Q Consensus 95 ~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~-l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~---- 169 (631)
+.+.. ..++||||+.+|+|.+++.+.+. +++..++.++.||+.||.|||+++ |+||||||+|||++ .++.
T Consensus 81 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~~~~ 155 (289)
T 4fvq_A 81 CVCGD--ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLI-REEDRKTG 155 (289)
T ss_dssp ECCTT--CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-ECCBGGGT
T ss_pred EEeCC--CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEe-cCCccccc
Confidence 86543 57889999999999999987654 999999999999999999999999 99999999999997 5555
Q ss_pred ----EEEccccccchhcCCCCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006779 170 ----VKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 243 (631)
Q Consensus 170 ----vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~ 243 (631)
+||+|||++...... ....||+.|+|||++.+ .++.++|||||||++|+|++|..|+...............
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~ 233 (289)
T 4fvq_A 156 NPPFIKLSDPGISITVLPK--DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233 (289)
T ss_dssp BCCEEEECCCCSCTTTSCH--HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred ccceeeeccCcccccccCc--cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc
Confidence 999999998654322 23457999999998764 4899999999999999999966555554555555544443
Q ss_pred CCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 244 GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 244 ~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
. ..++...++.+++||.+||. +|.+|||+.++++|
T Consensus 234 ~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 234 R---HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp T---CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred c---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 2 22333456789999999998 89999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=341.45 Aligned_cols=248 Identities=25% Similarity=0.433 Sum_probs=198.2
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~t---g~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 98 (631)
..+|| ++.+.||+|+||.||+|.+..+ +..||+|.+... ......+.+.+|+.+++.++||||+++++++.+
T Consensus 13 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 87 (281)
T 1mp8_A 13 QRERI-ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE- 87 (281)
T ss_dssp CGGGE-EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred ehHHe-EEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-
Confidence 45677 8889999999999999998654 567999987643 245667889999999999999999999998732
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~-~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
..+++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 88 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 88 --NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGL 162 (281)
T ss_dssp --SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECC---
T ss_pred --CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEEC-CCCCEEECcccc
Confidence 35789999999999999998654 6999999999999999999999999 99999999999998 788999999999
Q ss_pred cchhcCCC---CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006779 178 AIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 178 a~~~~~~~---~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~ 252 (631)
+....... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||... +...+...+..+..+ .++.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~-~~~~~~~~i~~~~~~-~~~~ 240 (281)
T 1mp8_A 163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-KNNDVIGRIENGERL-PMPP 240 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHHHHHTTCCC-CCCT
T ss_pred ccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC-CHHHHHHHHHcCCCC-CCCC
Confidence 97654432 22345688999999876 458999999999999999997 99999874 444555666655433 3455
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 253 VTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 253 ~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
..++.+++||.+||. +|.+|||+.+++.+
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 241 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 678999999999998 89999999998864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=345.58 Aligned_cols=254 Identities=20% Similarity=0.256 Sum_probs=203.0
Q ss_pred ccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC
Q 006779 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 98 (631)
....-++| ++.+.||+|+||.||+|.+..+|..||+|++..... ......+.+.+|+.+++.++||||+++++++.+.
T Consensus 29 ~~~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 2h34_A 29 EGTQFGPY-RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID 106 (309)
T ss_dssp -----CCE-EEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG-GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred CCcEeccE-EEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc-cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC
Confidence 34445677 788999999999999999999999999999875432 3355568899999999999999999999998764
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
..+++||||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 107 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~-~~~~~kl~Dfg~~ 181 (309)
T 2h34_A 107 --GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVS-ADDFAYLVDFGIA 181 (309)
T ss_dssp --TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSCCC-
T ss_pred --CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEc-CCCCEEEecCccC
Confidence 478999999999999999998888999999999999999999999999 99999999999997 7889999999998
Q ss_pred chhcCC---CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCC
Q 006779 179 IVMQQP---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKV 253 (631)
Q Consensus 179 ~~~~~~---~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~-p~~l~~~ 253 (631)
...... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||... +...+...+..... +......
T Consensus 182 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~ 260 (309)
T 2h34_A 182 SATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD-QLSVMGAHINQAIPRPSTVRPG 260 (309)
T ss_dssp ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC-HHHHHHHHHHSCCCCGGGTSTT
T ss_pred ccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc-hHHHHHHHhccCCCCccccCCC
Confidence 765433 2234578999999998754 5889999999999999999999999863 34444455544432 2334556
Q ss_pred CcHHHHHHHHHhcC-CCCCCC-CHHHHhc
Q 006779 254 TDPQVKQFIEKCIV-PASLRL-PALELLK 280 (631)
Q Consensus 254 ~~~~l~~lI~~cL~-~p~~Rp-sa~elL~ 280 (631)
.++.++++|.+||. +|.+|| ++.+++.
T Consensus 261 ~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 261 IPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp CCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 78899999999998 899999 7887765
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=346.42 Aligned_cols=249 Identities=24% Similarity=0.397 Sum_probs=209.3
Q ss_pred CceeeeeeEecccCceEEEEEE----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 24 CRYGRYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~----d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
.+| ++.+.||+|+||.||+|. +..+|..||+|++... .....+.+.+|+.+|+.++||||+++++++....
T Consensus 23 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 23 RHL-KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp GGE-EEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhh-hhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 455 889999999999999998 5788999999998643 3566678999999999999999999999998777
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
...+++||||+.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVE-SEAHVKIADFGLA 174 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCGGGC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEEC-CCCCEEEcccccc
Confidence 77899999999999999999874 56999999999999999999999998 99999999999998 7899999999999
Q ss_pred chhcCCC-----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCC--------------HHHHH
Q 006779 179 IVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN--------------PAQIY 238 (631)
Q Consensus 179 ~~~~~~~-----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~--------------~~~i~ 238 (631)
....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ...+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 7654332 233467888999998765 489999999999999999999999854211 12333
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 239 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 239 ~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
..+..+.. ...+...++.+++||.+||. +|.+|||+.+++++
T Consensus 255 ~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 255 ELLEEGQR-LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhcccC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 44444433 33455678999999999998 89999999999764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=344.71 Aligned_cols=260 Identities=20% Similarity=0.340 Sum_probs=203.9
Q ss_pred CcccccCCCCceeeeeeEecccCceEEEEEEEcc---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceee
Q 006779 15 GEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91 (631)
Q Consensus 15 ~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~---tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl 91 (631)
..+-......+.+++.+.||+|+||.||+|.+.. ++..||+|.+.... ......+.+.+|+.+++.++||||+++
T Consensus 24 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~ 101 (313)
T 3brb_A 24 NKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN--SSQREIEEFLSEAACMKDFSHPNVIRL 101 (313)
T ss_dssp CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C--CCHHHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred hhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc--cchhHHHHHHHHHHHHhcCCCCCeeee
Confidence 3344444455555889999999999999998765 56799999987553 245667889999999999999999999
Q ss_pred eeeEEcCCCC---eEEEEEeccCCCCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCee
Q 006779 92 YNSWVDDTNR---TINMITELFTSGSLRQYRKK------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIF 162 (631)
Q Consensus 92 ~~~~~d~~~~---~l~lV~Ey~~gGsL~~~l~~------~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NIL 162 (631)
++++.+.... ..++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 102 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIl 179 (313)
T 3brb_A 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCM 179 (313)
T ss_dssp CEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEE
T ss_pred eEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEE
Confidence 9998765433 46899999999999999843 356999999999999999999999998 999999999999
Q ss_pred ecCCCCcEEEccccccchhcCC----CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHH
Q 006779 163 VNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQ 236 (631)
Q Consensus 163 l~~~~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~ 236 (631)
++ .++.+||+|||++...... ......+++.|+|||++.+ .++.++|||||||++|+|++ |..||... ....
T Consensus 180 i~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~ 257 (313)
T 3brb_A 180 LR-DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV-QNHE 257 (313)
T ss_dssp EC-TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CGGG
T ss_pred Ec-CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC-CHHH
Confidence 97 7889999999999765432 1233457889999998754 58999999999999999999 88999764 4555
Q ss_pred HHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 237 IYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 237 i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
+...+..+..+ ..+...++.+++||.+||. +|.+||++.+++.+
T Consensus 258 ~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 258 MYDYLLHGHRL-KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHHHTTCCC-CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCC-CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 56666665433 3345567899999999998 89999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.00 Aligned_cols=250 Identities=26% Similarity=0.415 Sum_probs=207.5
Q ss_pred CCceeeeeeEecccCceEEEEEE----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~----d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 98 (631)
.+||+++.+.||+|+||+||++. +..+|+.||+|++... ......+.+.+|+.+|+.++||||+++++++.+.
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD---AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc---cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 57999999999999999997774 4568999999999754 2456678899999999999999999999999887
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
....+++||||+.+|+|.+++.+.. +++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLD-NDRLVKIGDFGLA 181 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCGGGC
T ss_pred CCceEEEEEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEc-CCCCEEECCcccc
Confidence 6678999999999999999997755 999999999999999999999999 99999999999997 7889999999999
Q ss_pred chhcCCC-----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCH--------------HHHH
Q 006779 179 IVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP--------------AQIY 238 (631)
Q Consensus 179 ~~~~~~~-----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~--------------~~i~ 238 (631)
....... .....+|+.|+|||++.+ .++.++|||||||++|+|+||..||...... ..+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence 7654432 234567889999998765 5889999999999999999999999642111 1222
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 239 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 239 ~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
..+..+. ....+...++.+.+||.+||. +|.+|||+.+++.
T Consensus 262 ~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 262 ELLERGE-RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhccc-CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 3333333 333455678999999999998 8999999999985
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=337.98 Aligned_cols=250 Identities=19% Similarity=0.337 Sum_probs=209.9
Q ss_pred CCCceeeeeeEecccCceEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~--~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
+.++|+.+.+.||+|+||.||+|.+. .++..||+|.+... ......+.+.+|+.+|+.++||||+++++++..
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 81 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-- 81 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc---cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC--
Confidence 34677666669999999999999864 57899999998754 245667889999999999999999999998843
Q ss_pred CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
..+++||||+.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 82 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~Dfg~~ 157 (287)
T 1u59_A 82 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLV-NRHYAKISDFGLS 157 (287)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-ETTEEEECCCTTC
T ss_pred -CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEc-CCCCEEECcccce
Confidence 3588999999999999999754 56999999999999999999999999 99999999999998 7889999999999
Q ss_pred chhcCCC-----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006779 179 IVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 251 (631)
Q Consensus 179 ~~~~~~~-----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~ 251 (631)
....... .....+|+.|+|||++. ..++.++|||||||++|+|+| |+.||... +..++...+..+..+ .++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-~~~~~~~~i~~~~~~-~~~ 235 (287)
T 1u59_A 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRM-ECP 235 (287)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CTHHHHHHHHTTCCC-CCC
T ss_pred eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHhcCCcC-CCC
Confidence 7654321 22345688999999876 458999999999999999998 99999874 445566666665433 345
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 006779 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDP 282 (631)
Q Consensus 252 ~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hp 282 (631)
...++.++++|.+||. +|.+||++.+++++.
T Consensus 236 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 236 PECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 5678999999999998 899999999999863
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=348.68 Aligned_cols=244 Identities=20% Similarity=0.259 Sum_probs=200.7
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~ 101 (631)
.++| ++.+.||+|+||.||+|.+..+|+.||+|.+...... +.+.+|+.+++.| +||||+++++++.+. .
T Consensus 8 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~ 78 (330)
T 2izr_A 8 GPNF-RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA------PQLHLEYRFYKQLGSGDGIPQVYYFGPCG--K 78 (330)
T ss_dssp TTTE-EEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS------CCHHHHHHHHHHHCSCTTSCCEEEEEEET--T
T ss_pred cCCe-EEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch------HHHHHHHHHHHHhhCCCCCCEEEEEEecC--C
Confidence 3566 7889999999999999999999999999998754321 3478899999999 999999999988764 4
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCc-----EEEccc
Q 006779 102 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE-----VKIGDL 175 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~-----vKL~DF 175 (631)
.+++||||+ +++|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++. +||+||
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~-~~~~~~~~~~kl~DF 154 (330)
T 2izr_A 79 YNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIG-RPGNKTQQVIHIIDF 154 (330)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-CGGGTCTTSEEECCC
T ss_pred ccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeec-cCCCCCCceEEEEEc
Confidence 789999999 99999999874 67999999999999999999999999 99999999999997 5666 999999
Q ss_pred cccchhcCCC---------CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCC--CHHHHHHHHHc
Q 006779 176 GLAIVMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTS 243 (631)
Q Consensus 176 Gla~~~~~~~---------~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~--~~~~i~~~i~~ 243 (631)
|++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.. ...+.+..+..
T Consensus 155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 234 (330)
T 2izr_A 155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234 (330)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence 9997654322 245689999999998765 58999999999999999999999998642 33444444433
Q ss_pred CCCCC---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 244 GIKPA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 244 ~~~p~---~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
...+. .+....+ ++++||..||. +|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 235 TKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 21111 1122233 99999999998 8999999988776
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=340.25 Aligned_cols=245 Identities=27% Similarity=0.494 Sum_probs=207.3
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEc------
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD------ 97 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d------ 97 (631)
++| ++.+.||+|+||.||+|.+..+|+.||+|.+.... +.+.+|+.+++.++||||++++++|..
T Consensus 11 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 11 MDF-KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHE-EEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred ccc-ceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 345 77899999999999999999999999999987542 246789999999999999999998754
Q ss_pred --------CCCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCC
Q 006779 98 --------DTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 167 (631)
Q Consensus 98 --------~~~~~l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~ 167 (631)
.....+++||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~ 158 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLV-DT 158 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ET
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEc-CC
Confidence 2234689999999999999999754 57999999999999999999999999 99999999999998 78
Q ss_pred CcEEEccccccchhcCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006779 168 GEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 245 (631)
Q Consensus 168 g~vKL~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~ 245 (631)
+.+||+|||++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .......+..+.
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---~~~~~~~~~~~~ 235 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDGI 235 (284)
T ss_dssp TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---HHHHHHHHHTTC
T ss_pred CCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---HHHHHHHhhccc
Confidence 89999999999765543 3345679999999998764 489999999999999999999988853 334445555443
Q ss_pred CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 246 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 246 ~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
++...++.+++||.+||. +|.+||++.++++|.+....
T Consensus 236 ----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 236 ----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred ----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 334567899999999998 89999999999999876543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=338.41 Aligned_cols=247 Identities=21% Similarity=0.336 Sum_probs=206.0
Q ss_pred CCceeeeee-EecccCceEEEEEEE--ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 23 SCRYGRYDE-ILGKGAFKTVYKGFD--EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 23 ~gRy~r~~e-~LG~G~fg~Vy~a~d--~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
..+| ++.+ .||+|+||+||+|.+ ..++..||+|.+.... ......+.+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~y-~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 89 (291)
T 1xbb_A 15 RKLL-TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-- 89 (291)
T ss_dssp GGGE-EEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES--
T ss_pred chhh-hhccCccccccCeeeEeeeecCCCceeeEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC--
Confidence 4577 5555 999999999999954 6678999999987543 234456789999999999999999999998832
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
..+++||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 90 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 90 -ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSK 165 (291)
T ss_dssp -SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCE
T ss_pred -CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEe-CCCcEEEccCCcce
Confidence 358899999999999999999888999999999999999999999999 99999999999998 78899999999997
Q ss_pred hhcCCC-----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006779 180 VMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 180 ~~~~~~-----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~ 252 (631)
...... .....+++.|+|||++.+ .++.++||||||+++|+|++ |+.||.. .+..++...+..+..+ ..+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~ 243 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPA 243 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCT
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCC
Confidence 654332 122346788999998754 58899999999999999999 9999987 5666777777766543 3455
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 253 VTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 253 ~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
..++.++++|.+||. +|.+||++.++++
T Consensus 244 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 244 GCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 678999999999998 8999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=347.41 Aligned_cols=250 Identities=21% Similarity=0.263 Sum_probs=201.8
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC--CC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD--TN 100 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~--~~ 100 (631)
.+|| ++.+.||+|+||.||+|.+..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 28 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 28 NKHY-LFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp TEEE-EEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred CeEE-EEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 4566 7889999999999999999999999999998643 356677899999999999999999999988643 33
Q ss_pred CeEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccc
Q 006779 101 RTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~----~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 176 (631)
..+++||||+.+|+|.+++.+ ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~dfg 179 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLG-DEGQPVLMDLG 179 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCS
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEc-CCCCEEEEecC
Confidence 478999999999999999876 467999999999999999999999998 99999999999997 78899999999
Q ss_pred ccchhcCCC-----------CccccCCCCCCCcccccc----ccCccccchhhhHHHHHHhhcCCCCCCCC-CHHHHHHH
Q 006779 177 LAIVMQQPT-----------ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKK 240 (631)
Q Consensus 177 la~~~~~~~-----------~~~~~GTp~Y~APEvl~~----~ys~~sDIwSLGiilyELltG~~Pf~~~~-~~~~i~~~ 240 (631)
++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ....+...
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 259 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence 886432211 123457999999998753 26899999999999999999999995310 00112222
Q ss_pred HHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 241 VTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 241 i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
+.... ........++.+++||.+||. +|.+||++.+++++
T Consensus 260 ~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 260 VQNQL-SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhccC-CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 33322 222234567899999999998 89999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=338.19 Aligned_cols=246 Identities=17% Similarity=0.242 Sum_probs=202.2
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~ 101 (631)
.++| ++.+.||+|+||.||+|.+..+|..||+|.+..... .+.+.+|+.+++.+ +|+||+++++++.+. .
T Consensus 9 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~ 79 (298)
T 1csn_A 9 GVHY-KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEG--L 79 (298)
T ss_dssp TTTE-EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEET--T
T ss_pred ccce-EEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc------cHHHHHHHHHHHHHhcCCCCCeEEeecCCC--c
Confidence 4566 888999999999999999999999999999864432 23477899999999 899999999987654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCc-----EEEccc
Q 006779 102 TINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE-----VKIGDL 175 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~-~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~-----vKL~DF 175 (631)
..++||||+ +++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++. +||+||
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~-~~~~~~~~~~kl~Df 155 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIG-RPNSKNANMIYVVDF 155 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-CSSSTTTTCEEECCC
T ss_pred eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEec-cCCCCCCCeEEEEEC
Confidence 789999999 999999998754 5999999999999999999999998 99999999999997 4544 999999
Q ss_pred cccchhcCCC---------CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCC--CHHHHHHHHHc
Q 006779 176 GLAIVMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTS 243 (631)
Q Consensus 176 Gla~~~~~~~---------~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~--~~~~i~~~i~~ 243 (631)
|++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ...+.+..+..
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (298)
T 1csn_A 156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235 (298)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence 9997654331 245679999999998765 58999999999999999999999997642 34444444433
Q ss_pred CC---CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 244 GI---KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 244 ~~---~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.. ....+....++.+++||.+||. +|.+||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 236 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred hccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 21 1112233567899999999997 89999999998763
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=342.21 Aligned_cols=254 Identities=23% Similarity=0.377 Sum_probs=204.8
Q ss_pred cccCCCCceeeeeeEecccCceEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeee
Q 006779 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 94 (631)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~t---g~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~ 94 (631)
....|....+++.+.||+|+||+||+|.+..+ +..||+|.+... ......+.+.+|+.++++++||||++++++
T Consensus 18 ~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 94 (298)
T 3f66_A 18 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 94 (298)
T ss_dssp GBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred eecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC---CCHHHHHHHHHHHHHHHhCCCCCEeeeeeE
Confidence 34455555569999999999999999997544 356899988642 345667889999999999999999999998
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEc
Q 006779 95 WVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173 (631)
Q Consensus 95 ~~d~~~~~l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~ 173 (631)
+.... ...++||||+.+|+|.+++.+ ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+
T Consensus 95 ~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~ 170 (298)
T 3f66_A 95 CLRSE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLD-EKFTVKVA 170 (298)
T ss_dssp ECCSS-SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEEC
T ss_pred EEcCC-CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEC-CCCCEEEC
Confidence 76543 467899999999999999976 456899999999999999999999999 99999999999997 78899999
Q ss_pred cccccchhcCC------CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCC
Q 006779 174 DLGLAIVMQQP------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI 245 (631)
Q Consensus 174 DFGla~~~~~~------~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~ 245 (631)
|||++...... ......||+.|+|||++.+ .++.++||||||+++|+|++ |..||.. .+...+...+..+.
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-~~~~~~~~~~~~~~ 249 (298)
T 3f66_A 171 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VNTFDITVYLLQGR 249 (298)
T ss_dssp SCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-SCTTTHHHHHHTTC
T ss_pred cccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHhcCC
Confidence 99999755332 2234467889999998754 58999999999999999999 4555554 45555555555554
Q ss_pred CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 246 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 246 ~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.+ ..+...++.++++|.+||. +|.+|||+.++++
T Consensus 250 ~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 250 RL-LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp CC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC-CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 33 2345567899999999998 8999999999886
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=344.71 Aligned_cols=248 Identities=23% Similarity=0.400 Sum_probs=208.8
Q ss_pred CCceeeeeeEecccCceEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEc
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~-----~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d 97 (631)
.++| ++.+.||+|+||.||+|.+. .++..||+|.+... ........+.+|+.+|+.++||||+++++++.+
T Consensus 24 ~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 24 REKI-TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp GGGE-EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT---SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred hhhe-eeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc---cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 4566 78899999999999999887 46889999998743 234566779999999999999999999998855
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCC
Q 006779 98 DTNRTINMITELFTSGSLRQYRKKH----------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 167 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~----------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~ 167 (631)
. ..+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+
T Consensus 100 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~-~~ 174 (322)
T 1p4o_A 100 G--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-ED 174 (322)
T ss_dssp S--SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEEC-TT
T ss_pred C--CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEc-CC
Confidence 4 4688999999999999998753 45799999999999999999999999 99999999999998 78
Q ss_pred CcEEEccccccchhcCCC----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006779 168 GEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKV 241 (631)
Q Consensus 168 g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i 241 (631)
+.+||+|||++....... .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.. .+..++...+
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~ 253 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLRFV 253 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc-CCHHHHHHHH
Confidence 899999999997554321 223457899999998764 58999999999999999999 8899976 4566666666
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 242 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 242 ~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
..+..+ ..+...++.+++||.+||. +|.+|||+.+++++
T Consensus 254 ~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 254 MEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 665433 2345677899999999998 89999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=344.44 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=206.6
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEE--EEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEV--AWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 98 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~V--AiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~ 98 (631)
.-++| ++.+.||+|+||.||+|.+..+|..+ |+|.+.... .....+.+.+|+.+|+++ +||||+++++++.+.
T Consensus 23 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 98 (327)
T 1fvr_A 23 DWNDI-KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 98 (327)
T ss_dssp CGGGC-EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred cHHHc-cceeeeecCCCceEEEEEEccCCcccceeeeeecccc---chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence 34667 78899999999999999999999865 899886432 334556789999999999 999999999998765
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCee
Q 006779 99 TNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIF 162 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~----------------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NIL 162 (631)
..+++||||+.+|+|.+++.+.+ .+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 99 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl 174 (327)
T 1fvr_A 99 --GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNIL 174 (327)
T ss_dssp --TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred --CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEE
Confidence 47999999999999999998754 6999999999999999999999999 999999999999
Q ss_pred ecCCCCcEEEccccccchhcCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHH
Q 006779 163 VNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYK 239 (631)
Q Consensus 163 l~~~~g~vKL~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~ 239 (631)
++ .++.+||+|||++...... ......+++.|+|||++.+ .++.++|||||||++|+|+| |..||.. .+...+..
T Consensus 175 ~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~~ 252 (327)
T 1fvr_A 175 VG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYE 252 (327)
T ss_dssp EC-GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHH
T ss_pred Ec-CCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC-CcHHHHHH
Confidence 97 7889999999998643322 2233457889999998765 48999999999999999998 9999976 56677777
Q ss_pred HHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 240 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 240 ~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.+..+..+. .+...++.+++||.+||. +|.+|||+.+++.+
T Consensus 253 ~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 253 KLPQGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HGGGTCCCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhhcCCCCC-CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 777664432 344567899999999998 89999999999985
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=339.07 Aligned_cols=245 Identities=30% Similarity=0.456 Sum_probs=194.7
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh--CCCCCceeeeeeEEcC-
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS--LKHENIIKFYNSWVDD- 98 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~--L~HpnIVkl~~~~~d~- 98 (631)
..++| ++.+.||+|+||+||+|.+ +|..||+|++... ....+.+|.+++.. ++||||+++++++.+.
T Consensus 6 ~~~~y-~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 6 VARDI-TLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CGGGC-EEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccCcE-EEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-------cchhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 34566 7889999999999999977 6999999998643 23445667777766 8999999999987653
Q ss_pred -CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCEEeccCCCCCeeecCCCCc
Q 006779 99 -TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH--------SHNPPIIHRDLKCDNIFVNGNNGE 169 (631)
Q Consensus 99 -~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLH--------s~~~~IiHrDLKp~NILl~~~~g~ 169 (631)
....+++||||+.+|+|.++++. ..+++..++.++.||+.||.||| +++ |+||||||+|||++ .++.
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~-~~~~ 151 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVK-KNGQ 151 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEEC-TTSC
T ss_pred CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEc-CCCC
Confidence 23568999999999999999954 56999999999999999999999 777 99999999999997 7889
Q ss_pred EEEccccccchhcCCC------CccccCCCCCCCccccccc-------cCccccchhhhHHHHHHhhc----------CC
Q 006779 170 VKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYEEE-------YNELVDIYSFGMCILEMVTC----------EY 226 (631)
Q Consensus 170 vKL~DFGla~~~~~~~------~~~~~GTp~Y~APEvl~~~-------ys~~sDIwSLGiilyELltG----------~~ 226 (631)
+||+|||++....... .....||+.|+|||++.+. ++.++|||||||++|||+|| ..
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 231 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence 9999999996554332 2345799999999987653 45799999999999999999 88
Q ss_pred CCCCCC----CHHHHHHHHHcCCCCCCCCC-----CCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 227 PYNECK----NPAQIYKKVTSGIKPASLSK-----VTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 227 Pf~~~~----~~~~i~~~i~~~~~p~~l~~-----~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
||.... ....+...+........++. ..++.+.+||.+||. +|.+|||+.++++
T Consensus 232 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 886532 22333333333322222221 234689999999998 8999999999886
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=336.62 Aligned_cols=246 Identities=22% Similarity=0.368 Sum_probs=206.5
Q ss_pred eeeeEecccCceEEEEEEEccCC---eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg---~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
+++++||+|+||+||+|.+..++ ..||+|.+... ......+.+.+|+.+|+.++||||+++++++.+.. ...+
T Consensus 24 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~ 99 (298)
T 3pls_A 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI---TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE-GLPH 99 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-SCCE
T ss_pred ccCceeccCCCceEEEEEEecCCCceeeeeeeecccc---ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC-CCcE
Confidence 56799999999999999976554 48999988642 34566788999999999999999999999987554 3457
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 105 MITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLD-ESFTVKVADFGLARDILD 176 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECCTTSSCTTTT
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCcEEeCcCCCcccccC
Confidence 89999999999999987 456899999999999999999999999 99999999999997 788999999999975432
Q ss_pred ------CCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006779 184 ------PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 184 ------~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~ 256 (631)
.......+|+.|+|||++.+ .++.++|||||||++|+|++|..|+....+...+...+..+..+ ..+...++
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 255 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-PQPEYCPD 255 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC-CCCTTCCH
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC-CCCccchH
Confidence 22334567899999998765 58999999999999999999777766667777777777766543 33455678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 257 QVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.+++||.+||. +|.+|||+.+++..
T Consensus 256 ~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 256 SLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999998 89999999998863
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=342.71 Aligned_cols=250 Identities=24% Similarity=0.399 Sum_probs=209.4
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCe-----EEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeE
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGI-----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSW 95 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~-----~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~ 95 (631)
+.++| ++.+.||+|+||.||+|.+..+|. .||+|.+.... .....+.+.+|+.+|+.+ +||||+++++++
T Consensus 44 ~~~~~-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 44 PRNNL-QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA---HADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp CTTSE-EEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHc-eeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc---ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34566 788999999999999999987764 79999986442 355678899999999999 899999999988
Q ss_pred EcCCCCeEEEEEeccCCCCHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCe
Q 006779 96 VDDTNRTINMITELFTSGSLRQYRKKH--------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161 (631)
Q Consensus 96 ~d~~~~~l~lV~Ey~~gGsL~~~l~~~--------------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NI 161 (631)
.+. ..+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 120 ~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NI 195 (333)
T 2i1m_A 120 THG--GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNV 195 (333)
T ss_dssp CSS--SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGC
T ss_pred ecC--CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceE
Confidence 654 4688999999999999998753 35899999999999999999999998 99999999999
Q ss_pred eecCCCCcEEEccccccchhcCCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHH
Q 006779 162 FVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPA 235 (631)
Q Consensus 162 Ll~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~ 235 (631)
|++ .++.+||+|||++....... .....||+.|+|||++. ..++.++|||||||++|+|+| |..||.+.....
T Consensus 196 l~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 196 LLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp EEE-GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred EEC-CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 998 78899999999997654332 22345688999999775 458999999999999999998 999998866666
Q ss_pred HHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 236 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 236 ~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.+...+..+..+ ..+...++.++++|.+||. +|.+|||+.+++.+
T Consensus 275 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 275 KFYKLVKDGYQM-AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 666666655433 3345568899999999998 89999999999863
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=345.92 Aligned_cols=258 Identities=23% Similarity=0.356 Sum_probs=210.5
Q ss_pred cCCCCceeeeeeEecccCceEEEEEE-----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeee
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 94 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~-----d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~ 94 (631)
.-+.++| ++.+.||+|+||.||+|. +..+|..||+|.+... .......++.+|+.+++.++||||++++++
T Consensus 26 ~~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 101 (327)
T 2yfx_A 26 EVPRKNI-TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV---CSEQDELDFLMEALIISKFNHQNIVRCIGV 101 (327)
T ss_dssp BCCGGGC-EEEEECC--CSSCEEEEEC--------CCEEEEEECCSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCChhhe-EEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc---cchhhHHHHHHHHHHHhhCCCCCCCeEEEE
Confidence 3456777 788999999999999998 5678899999998633 245566789999999999999999999998
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC--
Q 006779 95 WVDDTNRTINMITELFTSGSLRQYRKKHK-------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-- 165 (631)
Q Consensus 95 ~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~-------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~-- 165 (631)
+.+. ..+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 102 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~ 177 (327)
T 2yfx_A 102 SLQS--LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPG 177 (327)
T ss_dssp ECSS--SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSS
T ss_pred EcCC--CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCC
Confidence 8654 35789999999999999998763 4899999999999999999999999 999999999999972
Q ss_pred CCCcEEEccccccchhcCC----CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHH
Q 006779 166 NNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYK 239 (631)
Q Consensus 166 ~~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~ 239 (631)
.++.+||+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|+| |..||.. .+...+..
T Consensus 178 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~ 256 (327)
T 2yfx_A 178 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLE 256 (327)
T ss_dssp TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHH
T ss_pred CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-cCHHHHHH
Confidence 3446999999999755332 223456899999999775 458999999999999999998 9999976 45666777
Q ss_pred HHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 240 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 240 ~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.+..+..+ ..+...++.+++||.+||. +|.+||++.+++++.|+...
T Consensus 257 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 257 FVTSGGRM-DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcCCCC-CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 77766443 3445678899999999998 89999999999999887543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=337.06 Aligned_cols=245 Identities=24% Similarity=0.394 Sum_probs=208.8
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
..+| ++.+.||+|+||+||+|.+..+|..||+|.+... ....+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 12 ~~~~-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 83 (288)
T 3kfa_A 12 RTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PP 83 (288)
T ss_dssp GGGE-EEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SS
T ss_pred ccce-eEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--CC
Confidence 3445 8889999999999999999999999999998643 23567789999999999999999999988654 46
Q ss_pred EEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 103 INMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
+++||||+.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++..
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRL 160 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEEC-GGGCEEECCCCGGGT
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEc-CCCCEEEccCcccee
Confidence 89999999999999999874 45999999999999999999999999 99999999999997 788999999999976
Q ss_pred hcCCCC---ccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006779 181 MQQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 181 ~~~~~~---~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~ 255 (631)
...... ....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.. .+..++...+.....+ ..+...+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 238 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYRM-ERPEGCP 238 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCCC-CCCTTCC
T ss_pred ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhccCCC-CCCCCCC
Confidence 654332 2345688999999876 458999999999999999999 9999976 4556666666665443 3345667
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 256 PQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+.+++||.+||. +|.+|||+.++++
T Consensus 239 ~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 239 EKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 899999999998 8999999999876
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=331.17 Aligned_cols=244 Identities=20% Similarity=0.426 Sum_probs=206.8
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.+| ++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 8 ~~y-~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 78 (267)
T 3t9t_A 8 SEL-TFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--API 78 (267)
T ss_dssp GGE-EEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSC
T ss_pred hhe-eeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEccC--CCe
Confidence 456 78899999999999999986 678999999875432 225688999999999999999999988654 458
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
++||||+.+++|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++....
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-GGGCEEECCTTGGGGBC
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEC-CCCCEEEcccccccccc
Confidence 8999999999999999875 56899999999999999999999999 99999999999997 78899999999997553
Q ss_pred CC---CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006779 183 QP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 183 ~~---~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~ 257 (631)
.. ......+++.|+|||++. ..++.++||||||+++|+|++ |+.||.. .+...+...+..+..+ ..+...++.
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~ 233 (267)
T 3t9t_A 156 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLASTH 233 (267)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCHH
T ss_pred cccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC-CCHHHHHHHHhcCCcC-CCCccCcHH
Confidence 32 223445788999999876 458999999999999999999 8999976 5666677777766433 334566889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 258 VKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 258 l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
++++|.+||. +|.+||++.+++++
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 234 VYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999998 89999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=354.30 Aligned_cols=254 Identities=23% Similarity=0.407 Sum_probs=201.1
Q ss_pred cccccCCCCceeeeeeEecccCceEEEEEEEc---cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeee
Q 006779 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92 (631)
Q Consensus 16 ~~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~---~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~ 92 (631)
++..+-...+| ++.+.||+|+||.||+|.++ .++..||+|.++... .....+.+.+|+.+|++++||||++++
T Consensus 37 ~~~~~~~~~~~-~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~ 112 (373)
T 2qol_A 37 EFAKELDATNI-SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEASIMGQFDHPNIIRLE 112 (373)
T ss_dssp TTSCBCCGGGC-CCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred HHHhhcCHhhc-eeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 44444455667 77899999999999999887 567889999987542 455667899999999999999999999
Q ss_pred eeEEcCCCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEE
Q 006779 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 171 (631)
Q Consensus 93 ~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~-~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 171 (631)
+++.+. ..+++||||+.+|+|.+++.+.+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+|
T Consensus 113 ~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~k 187 (373)
T 2qol_A 113 GVVTKS--KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILIN-SNLVCK 187 (373)
T ss_dssp EEECSS--SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEE
T ss_pred EEEeeC--CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEc-CCCCEE
Confidence 988654 46889999999999999998764 6999999999999999999999999 99999999999997 789999
Q ss_pred EccccccchhcCCC-----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcC
Q 006779 172 IGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244 (631)
Q Consensus 172 L~DFGla~~~~~~~-----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~ 244 (631)
|+|||++....... .....+++.|+|||++. ..++.++|||||||++|||++ |+.||.. .+...+...+..+
T Consensus 188 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~-~~~~~~~~~i~~~ 266 (373)
T 2qol_A 188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-MSNQDVIKAVDEG 266 (373)
T ss_dssp ECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT-CCHHHHHHHHHTT
T ss_pred ECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcC
Confidence 99999997654321 11234577899999876 458999999999999999998 9999987 4566677777665
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 245 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 245 ~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
..+. .+...+..+.++|.+||. +|.+||++.+++.
T Consensus 267 ~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 267 YRLP-PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp EECC-CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCC-CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 4332 234567899999999998 8999999999876
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=342.79 Aligned_cols=247 Identities=24% Similarity=0.394 Sum_probs=187.1
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCceeeeeeEEc-----
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVD----- 97 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d----- 97 (631)
.|| ++.++||+|+||.||+|.+..+|+.||+|.+... .......+.+|+.+++++. ||||+++++++..
T Consensus 28 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 28 LRL-RVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEE-EEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred ceE-EEEEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 466 8889999999999999999999999999998543 3556678899999999996 9999999998853
Q ss_pred -CCCCeEEEEEeccCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEc
Q 006779 98 -DTNRTINMITELFTSGSLRQYRKK---HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173 (631)
Q Consensus 98 -~~~~~l~lV~Ey~~gGsL~~~l~~---~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~ 173 (631)
.....+++||||+. |+|.+++.. .+.+++..++.++.||+.||.|||+++++|+||||||+|||++ .++.+||+
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~-~~~~~kl~ 180 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLC 180 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC-TTSCEEBC
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC-CCCCEEEe
Confidence 33456899999996 799988865 5679999999999999999999999987899999999999998 78899999
Q ss_pred cccccchhcCCCC--------------ccccCCCCCCCccccc----cccCccccchhhhHHHHHHhhcCCCCCCCCCHH
Q 006779 174 DLGLAIVMQQPTA--------------RSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA 235 (631)
Q Consensus 174 DFGla~~~~~~~~--------------~~~~GTp~Y~APEvl~----~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~ 235 (631)
|||++........ ....||+.|+|||++. ..++.++|||||||++|+|++|+.||..... .
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-~ 259 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK-L 259 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH-H
Confidence 9999976543211 1456899999999873 3478999999999999999999999976322 2
Q ss_pred HHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 006779 236 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 282 (631)
Q Consensus 236 ~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hp 282 (631)
.+ ..+..........++.+++||.+||. +|.+||++.|++++-
T Consensus 260 ~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 260 RI----VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp ----------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred Hh----hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 22 11222222334456789999999998 899999999999873
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=346.78 Aligned_cols=252 Identities=27% Similarity=0.450 Sum_probs=202.8
Q ss_pred cccCCCCceeeeeeEecccCceEEEEEEEccCCeEE----EEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeee
Q 006779 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEV----AWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYN 93 (631)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~V----AiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~ 93 (631)
...-..++| ++.+.||+|+||+||+|.+..+|..| |+|.+.... .......+.+|+.+|+.++||||+++++
T Consensus 9 ~~~l~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 84 (327)
T 3lzb_A 9 LRILKETEF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLG 84 (327)
T ss_dssp CEECCTTTE-EEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS---SCCCHHHHHHHHHHHTTCCBTTBCCCCE
T ss_pred hcccCHhHc-eEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc---CHHHHHHHHHHHHHHHhCCCCCeeEEEE
Confidence 334456777 77899999999999999998888755 666654322 2334567889999999999999999999
Q ss_pred eEEcCCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEE
Q 006779 94 SWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 94 ~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL 172 (631)
++.+. ..++|++|+.+|+|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||
T Consensus 85 ~~~~~---~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kL 158 (327)
T 3lzb_A 85 ICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKI 158 (327)
T ss_dssp EEESS---SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEE
T ss_pred EEecC---CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEc-CCCCEEE
Confidence 98764 377899999999999999874 56999999999999999999999999 99999999999997 7889999
Q ss_pred ccccccchhcCCC----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCC
Q 006779 173 GDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 246 (631)
Q Consensus 173 ~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~ 246 (631)
+|||++....... .....+|+.|+|||++.+ .|+.++|||||||++|+|++ |..||.. .....+...+..+..
T Consensus 159 ~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~ 237 (327)
T 3lzb_A 159 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGER 237 (327)
T ss_dssp CCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCC
T ss_pred ccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCC
Confidence 9999997654322 223456889999997754 58999999999999999999 9999976 455566666666543
Q ss_pred CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 247 PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 247 p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
+ ..+...++.+.+||.+||. +|.+||++.+++..
T Consensus 238 ~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 238 L-PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp C-CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3 2345578899999999998 89999999999873
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=336.32 Aligned_cols=248 Identities=24% Similarity=0.417 Sum_probs=203.4
Q ss_pred CCCceeeeeeEecccCceEEEEEEEcc---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~---tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 98 (631)
..++| ++.+.||+|+||+||+|.+.. ++..||+|.+.... .....+++.+|+.+++.++||||+++++++.+.
T Consensus 10 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 10 AREDV-VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC---TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85 (281)
T ss_dssp CGGGE-EEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS---CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred cccce-EEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc---CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 34566 788999999999999998654 45679999987542 355678899999999999999999999987533
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
..++||||+.+++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 86 ---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~ 159 (281)
T 3cc6_A 86 ---PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVA-SPECVKLGDFGL 159 (281)
T ss_dssp ---SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEE-ETTEEEECCCCG
T ss_pred ---CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEC-CCCcEEeCccCC
Confidence 357899999999999999765 45999999999999999999999999 99999999999998 788999999999
Q ss_pred cchhcCCC---CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006779 178 AIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 178 a~~~~~~~---~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~ 252 (631)
+....... .....+|+.|+|||++. ..++.++||||||+++|+|+| |+.||.... ...+...+..+..+ ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~ 237 (281)
T 3cc6_A 160 SRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-NKDVIGVLEKGDRL-PKPD 237 (281)
T ss_dssp GGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-GGGHHHHHHHTCCC-CCCT
T ss_pred CcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC-hHHHHHHHhcCCCC-CCCC
Confidence 97654332 23345788999999876 458999999999999999998 999997643 34445555554332 2345
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 253 VTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 253 ~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
..++.++++|.+||. +|.+||++.+++.+
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 238 LCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 578899999999998 89999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=358.77 Aligned_cols=242 Identities=22% Similarity=0.407 Sum_probs=203.0
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
..+| ++.+.||+|+||.||+|.+. |..||+|.++... ..+.+.+|+.+|++++||||+++++++.... ..
T Consensus 192 ~~~~-~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~ 261 (450)
T 1k9a_A 192 MKEL-KLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GG 261 (450)
T ss_dssp GGGE-EEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT-SC
T ss_pred hHHe-EEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC-Cc
Confidence 3455 77899999999999999765 8899999987432 3456889999999999999999999887643 36
Q ss_pred EEEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 103 INMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~--l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
+++||||+.+|+|.+++.+.+. +++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKE 338 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTSCEEECCCTTCEE
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEC-CCCCEEEeeCCCccc
Confidence 8999999999999999987653 799999999999999999999999 99999999999997 789999999999975
Q ss_pred hcCCCCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006779 181 MQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 181 ~~~~~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l 258 (631)
.... .....+++.|+|||++. ..++.++|||||||++|||+| |+.||... +..++...+..+..+ ..+...++.+
T Consensus 339 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~-~~~~~~~~i~~~~~~-~~p~~~~~~l 415 (450)
T 1k9a_A 339 ASST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKM-DAPDGCPPAV 415 (450)
T ss_dssp CC-------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS-CTTTHHHHHHTTCCC-CCCTTCCHHH
T ss_pred cccc-ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCCHHH
Confidence 4332 22346788999999875 458999999999999999998 99999874 445566677766543 3455678999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhc
Q 006779 259 KQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 259 ~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.+||.+||. +|.+|||+.+++.
T Consensus 416 ~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 416 YDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 999999998 8999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=347.53 Aligned_cols=247 Identities=22% Similarity=0.409 Sum_probs=202.1
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeE----EEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIE----VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~----VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 98 (631)
..+| ++.+.||+|+||+||+|.+..+|.. ||+|.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 12 ~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 86 (325)
T 3kex_A 12 ETEL-RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS---GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG- 86 (325)
T ss_dssp TTTE-EEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT---SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-
T ss_pred HhHc-eeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc---cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-
Confidence 4566 7889999999999999999888865 7777664332 12223457789999999999999999998743
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
..+++||||+.+|+|.+++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 87 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~ 161 (325)
T 3kex_A 87 --SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLK-SPSQVQVADFGV 161 (325)
T ss_dssp --SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEES-SSSCEEECSCSG
T ss_pred --CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEEC-CCCeEEECCCCc
Confidence 3588999999999999999875 57999999999999999999999999 99999999999997 788999999999
Q ss_pred cchhcCCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006779 178 AIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 251 (631)
Q Consensus 178 a~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~ 251 (631)
+....... .....||+.|+|||++. ..++.++|||||||++|+|+| |..||... +...+...+..+..+ ..+
T Consensus 162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~ 239 (325)
T 3kex_A 162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL-RLAEVPDLLEKGERL-AQP 239 (325)
T ss_dssp GGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CTTHHHHHHHTTCBC-CCC
T ss_pred ccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc-CHHHHHHHHHcCCCC-CCC
Confidence 98664332 23456788999999876 468999999999999999999 99999874 445556666655332 334
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 252 ~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
...++.+.++|.+||. +|.+||++.+++++
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 240 QICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4567789999999998 89999999999987
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=341.81 Aligned_cols=257 Identities=23% Similarity=0.391 Sum_probs=205.8
Q ss_pred CCcccccCCCCceeeeeeEecccCceEEEEEEEccCC----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCce
Q 006779 14 EGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89 (631)
Q Consensus 14 ~~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg----~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIV 89 (631)
...+..+-...+| ++.+.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+.+++.++||||+
T Consensus 34 ~~~~~~~i~~~~~-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv 109 (333)
T 1mqb_A 34 VLKFTTEIHPSCV-TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNII 109 (333)
T ss_dssp ----CCBCCTTTE-EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred hhhccccCChHHh-hcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCCC
Confidence 3445555566677 77899999999999999987653 569999986432 355667799999999999999999
Q ss_pred eeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCC
Q 006779 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 168 (631)
Q Consensus 90 kl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g 168 (631)
++++++.+. ..+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++
T Consensus 110 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~ 184 (333)
T 1mqb_A 110 RLEGVISKY--KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNL 184 (333)
T ss_dssp CEEEEECSS--SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTC
T ss_pred cEEEEEecC--CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEEC-CCC
Confidence 999988543 4689999999999999999865 67999999999999999999999999 99999999999997 788
Q ss_pred cEEEccccccchhcCCC-----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006779 169 EVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKV 241 (631)
Q Consensus 169 ~vKL~DFGla~~~~~~~-----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i 241 (631)
.+||+|||++....... .....+|+.|+|||++. ..++.++|||||||++|+|++ |+.||.. .+..++...+
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~~~~ 263 (333)
T 1mqb_A 185 VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-LSNHEVMKAI 263 (333)
T ss_dssp CEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHH
T ss_pred cEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc-CCHHHHHHHH
Confidence 99999999997654321 12234678899999876 458999999999999999999 9999977 4566677777
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 242 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 242 ~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
..+..+. .+...++.++++|.+||. +|.+||++.+++.+
T Consensus 264 ~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 264 NDGFRLP-TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HTTCCCC-CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HCCCcCC-CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7664433 344568899999999998 89999999998874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=334.01 Aligned_cols=248 Identities=23% Similarity=0.293 Sum_probs=200.9
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
..+|| ++.+.||+|+||.||+|.+..+|+.||+|.+..... .+.+.+|+.+++.++|++++..+..+... ..
T Consensus 7 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~ 78 (296)
T 3uzp_A 7 VGNRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAE-GD 78 (296)
T ss_dssp ETTTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS------CCHHHHHHHHHHHHTTSTTCCCEEEEEEE-TT
T ss_pred eccEE-EEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc------hhHHHHHHHHHHHhhcCCCCCccccccCC-CC
Confidence 45677 888999999999999999999999999999875432 13478999999999999988877665443 45
Q ss_pred eEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeec--CCCCcEEEcccccc
Q 006779 102 TINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLA 178 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~--~~~g~vKL~DFGla 178 (631)
.+++||||+ +++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ ..++.+||+|||++
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 79 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred ceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 789999999 9999999984 457999999999999999999999999 99999999999994 26789999999999
Q ss_pred chhcCCC---------CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCC--HHHHHHHHHcC--
Q 006779 179 IVMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSG-- 244 (631)
Q Consensus 179 ~~~~~~~---------~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~--~~~i~~~i~~~-- 244 (631)
....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... ..+.+..+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence 7654432 245679999999998765 589999999999999999999999976322 11222222211
Q ss_pred -CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 245 -IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 245 -~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.....+....++.+.+||.+||. +|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 11111234567899999999998 8999999999876
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=340.32 Aligned_cols=240 Identities=28% Similarity=0.483 Sum_probs=193.3
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
++| ++.+.||+|+||+||+|.+. +..||+|.+.. ....+.+.+|+.+|+.++||||+++++++.+ .+
T Consensus 8 ~~~-~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~ 74 (307)
T 2eva_A 8 KEI-EVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES------ESERKAFIVELRQLSRVNHPNIVKLYGACLN----PV 74 (307)
T ss_dssp GGE-EEEEEEECCSSSEEEEEEET--TEEEEEEECSS------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT----TT
T ss_pred hHe-eeeeEeecCCCceEEEEEEC--CeeEEEEEecC------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----Cc
Confidence 455 78899999999999999764 78999999853 2345678999999999999999999997753 36
Q ss_pred EEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCCCEEeccCCCCCeeecCCCCc-EEEcccc
Q 006779 104 NMITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHS---HNPPIIHRDLKCDNIFVNGNNGE-VKIGDLG 176 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~---~l~~~~i~~i~~QIl~aL~yLHs---~~~~IiHrDLKp~NILl~~~~g~-vKL~DFG 176 (631)
++||||+.+|+|.+++.... .++...++.|+.||+.||.|||+ ++ |+||||||+|||++ .++. +||+|||
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~-~~~~~~kl~Dfg 151 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLV-AGGTVLKICDFG 151 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEE-TTTTEEEECCCC
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEe-CCCCEEEEcccc
Confidence 78999999999999998765 37899999999999999999999 66 99999999999998 5554 8999999
Q ss_pred ccchhcCCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCC
Q 006779 177 LAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN-PAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 177 la~~~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~-~~~i~~~i~~~~~p~~l~~~~ 254 (631)
++...... .....||+.|+|||++.+ .++.++|||||||++|+|+||+.||..... ...+...+..+..+ ......
T Consensus 152 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 229 (307)
T 2eva_A 152 TACDIQTH-MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-PLIKNL 229 (307)
T ss_dssp C-------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC-CCBTTC
T ss_pred cccccccc-cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC-Cccccc
Confidence 99755433 234468999999998765 589999999999999999999999976433 33444445444433 344567
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 255 DPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
++.++++|.+||. +|.+|||+.+++++
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 7899999999998 89999999999873
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=352.83 Aligned_cols=262 Identities=18% Similarity=0.241 Sum_probs=199.2
Q ss_pred CCcccccCCCCceeeeeeEecccCceEEEEEEEcc---CCeEEEEEEeecccccCCH--H-----HHHHHHHHHHHHHhC
Q 006779 14 EGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEV---DGIEVAWNQVNIEDVMQSP--D-----QLERLYSEVHLLKSL 83 (631)
Q Consensus 14 ~~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~---tg~~VAiK~i~~~~~~~~~--~-----~~~~l~~Ei~iLk~L 83 (631)
+...+.....++| ++.+.||+|+||.||+|.+.. ++..||+|.+......... . ....+.+|+..++.+
T Consensus 27 ~g~~~~~~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l 105 (345)
T 2v62_A 27 EGKVLDDMEGNQW-VLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL 105 (345)
T ss_dssp TTCEEECTTSCEE-EEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC
T ss_pred CCCeeccccCceE-EEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc
Confidence 3444444455667 888999999999999999987 8899999998754210000 0 113366889999999
Q ss_pred CCCCceeeeeeEEcC--CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCe
Q 006779 84 KHENIIKFYNSWVDD--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161 (631)
Q Consensus 84 ~HpnIVkl~~~~~d~--~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NI 161 (631)
+||||+++++++.+. ....+++||||+ +++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 106 ~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NI 182 (345)
T 2v62_A 106 DYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANL 182 (345)
T ss_dssp SCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred cccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHE
Confidence 999999999998762 245899999999 9999999988889999999999999999999999998 99999999999
Q ss_pred eecCCCC--cEEEccccccchhcCC---------CCccccCCCCCCCccccccc-cCccccchhhhHHHHHHhhcCCCCC
Q 006779 162 FVNGNNG--EVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYN 229 (631)
Q Consensus 162 Ll~~~~g--~vKL~DFGla~~~~~~---------~~~~~~GTp~Y~APEvl~~~-ys~~sDIwSLGiilyELltG~~Pf~ 229 (631)
|++ .++ .+||+|||++..+... ......||+.|+|||++.+. ++.++|||||||++|+|+||+.||.
T Consensus 183 ll~-~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 261 (345)
T 2v62_A 183 LLG-YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE 261 (345)
T ss_dssp EEE-SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred EEc-cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 997 455 9999999999655321 12445799999999987654 8999999999999999999999995
Q ss_pred CC-CCHHHHHHHHHc--CCCCCC-----CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 230 EC-KNPAQIYKKVTS--GIKPAS-----LSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 230 ~~-~~~~~i~~~i~~--~~~p~~-----l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.. .+...+...... ...+.. .....++.+++||.+||. +|.+||++.++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 262 QNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp GGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 43 233322221111 111110 011567899999999998 8999999999876
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=330.93 Aligned_cols=244 Identities=25% Similarity=0.423 Sum_probs=205.1
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
+..+| ++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+|+.++||||+++++++.+ .
T Consensus 11 ~~~~y-~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~ 80 (279)
T 1qpc_A 11 PRETL-KLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ---E 80 (279)
T ss_dssp CGGGE-EEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS---S
T ss_pred CHHhh-hheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc-----cHHHHHHHHHHHHhCCCcCcceEEEEEcC---C
Confidence 45677 78899999999999999875 678899999865431 23568899999999999999999998753 2
Q ss_pred eEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 102 TINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
.+++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLAR 157 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCE
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEc-CCCCEEECCCcccc
Confidence 4789999999999999987543 6999999999999999999999999 99999999999997 78899999999997
Q ss_pred hhcCCC---CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006779 180 VMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 180 ~~~~~~---~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 254 (631)
...... .....+++.|+|||++. ..++.++||||||+++|+|++ |+.||.+ .+..++...+..+..+ ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~ 235 (279)
T 1qpc_A 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-MTNPEVIQNLERGYRM-VRPDNC 235 (279)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTC
T ss_pred cccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc-cCHHHHHHHHhcccCC-CCcccc
Confidence 654332 23345688999999876 458999999999999999999 9999987 4556666777665433 234566
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 255 DPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
++.++++|.+||. +|.+|||+.+++.
T Consensus 236 ~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 236 PEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 7899999999998 8999999999876
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=332.81 Aligned_cols=249 Identities=22% Similarity=0.289 Sum_probs=196.8
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
....+|| ++.+.||+|+||+||+|.+..+|+.||+|.+..... ...+.+|+.+++.++|++++..+..+...
T Consensus 5 ~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~- 76 (296)
T 4hgt_A 5 LRVGNRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAE- 76 (296)
T ss_dssp ------C-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---------CCCHHHHHHHHHHHTTSTTCCCEEEEEEE-
T ss_pred cccCCce-EEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc------chHHHHHHHHHHHhcCCCCCCeeeeecCC-
Confidence 3455777 788999999999999999999999999998765432 23478899999999999988887766543
Q ss_pred CCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeee---cCCCCcEEEccc
Q 006779 100 NRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDL 175 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl---~~~~g~vKL~DF 175 (631)
....++||||+ +++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||+ + .++.+||+||
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~-~~~~~kL~Df 152 (296)
T 4hgt_A 77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGK-KGNLVYIIDF 152 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGG-GTTCEEECCC
T ss_pred CCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccC-CCCeEEEecC
Confidence 35789999999 9999999985 467999999999999999999999999 9999999999999 5 6789999999
Q ss_pred cccchhcCCC---------CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCH--HHHHHHHHc
Q 006779 176 GLAIVMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP--AQIYKKVTS 243 (631)
Q Consensus 176 Gla~~~~~~~---------~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~--~~i~~~i~~ 243 (631)
|++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... .+.+..+..
T Consensus 153 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 232 (296)
T 4hgt_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred ccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhc
Confidence 9997654321 235679999999998765 5899999999999999999999999764321 122222221
Q ss_pred CC---CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 244 GI---KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 244 ~~---~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.. ....+....++.+++||.+||. +|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 233 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 11 1111223457899999999998 8999999999876
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=350.61 Aligned_cols=262 Identities=18% Similarity=0.239 Sum_probs=201.3
Q ss_pred CCcccccCCCCceeeeeeEecccCceEEEEEEEccC-----CeEEEEEEeecccccCCHHH--------HHHHHHHHHHH
Q 006779 14 EGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVD-----GIEVAWNQVNIEDVMQSPDQ--------LERLYSEVHLL 80 (631)
Q Consensus 14 ~~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~t-----g~~VAiK~i~~~~~~~~~~~--------~~~l~~Ei~iL 80 (631)
.+.++.....++| ++.+.||+|+||+||+|.+..+ +..||+|.+...... .... ...+..|+..+
T Consensus 25 ~g~~i~~~~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~e~~~~~~~~~~~~~~e~~~~ 102 (364)
T 3op5_A 25 VGEIITDMAAAAW-KVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP-LFTELKFYQRAAKPEQIQKWIRT 102 (364)
T ss_dssp TTCEEECTTCCEE-EEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHH-HHHHHHHHHHHCCHHHHHHHHHH
T ss_pred CCcEeeccCCCeE-EEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchh-HHHHHHHHHhhhhhHHHHHHHHH
Confidence 4455555566677 8889999999999999998765 588999998754210 0000 12244566777
Q ss_pred HhCCCCCceeeeeeEEcCCC--CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCC
Q 006779 81 KSLKHENIIKFYNSWVDDTN--RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157 (631)
Q Consensus 81 k~L~HpnIVkl~~~~~d~~~--~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLK 157 (631)
+.++||||+++++++..... ..+++||||+ +++|.+++... +.+++..++.|+.||+.||.|||+++ |+|||||
T Consensus 103 ~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlk 179 (364)
T 3op5_A 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIK 179 (364)
T ss_dssp TTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCC
T ss_pred hhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCC
Confidence 88899999999999876432 5689999999 99999999876 67999999999999999999999998 9999999
Q ss_pred CCCeeecC-CCCcEEEccccccchhcCC---------CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCC
Q 006779 158 CDNIFVNG-NNGEVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEY 226 (631)
Q Consensus 158 p~NILl~~-~~g~vKL~DFGla~~~~~~---------~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~ 226 (631)
|+|||++. .++.+||+|||++..+... ......||+.|+|||++.+ .++.++|||||||++|+|+||+.
T Consensus 180 p~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~ 259 (364)
T 3op5_A 180 ASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHL 259 (364)
T ss_dssp GGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 99999962 4689999999999654322 1234569999999998765 48999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCC--------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 227 PYNECKNPAQIYKKVTSGIKP--------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 227 Pf~~~~~~~~i~~~i~~~~~p--------~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
||.+................+ .......++++.+||..||. +|.+||++.+++.
T Consensus 260 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 260 PWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp TTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 998533332222211111000 00113457899999999998 8999999999876
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=334.61 Aligned_cols=250 Identities=26% Similarity=0.411 Sum_probs=198.5
Q ss_pred CCCceeeeeeEecccCceEEEEEEEcc-CC--eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEV-DG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~-tg--~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 98 (631)
...+| ++.+.||+|+||+||+|.+.. ++ ..||+|.+..... ......+.+.+|+.+++.++||||+++++++.+.
T Consensus 16 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 16 GEKDL-RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp CGGGE-EEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred chhHe-eeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc-CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 34566 888999999999999998643 33 4799998875432 2345668899999999999999999999988654
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
. .++||||+.+++|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 94 ~---~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~ 167 (291)
T 1u46_A 94 P---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLA-TRDLVKIGDFGL 167 (291)
T ss_dssp S---CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCCTT
T ss_pred C---ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEc-CCCCEEEccccc
Confidence 2 78899999999999998764 56999999999999999999999999 99999999999998 788999999999
Q ss_pred cchhcCCC-----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 006779 178 AIVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASL 250 (631)
Q Consensus 178 a~~~~~~~-----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l 250 (631)
+....... .....+|+.|+|||++.+ .++.++||||||+++|+|++ |+.||.. .+..++...+.........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~~~ 246 (291)
T 1u46_A 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPR 246 (291)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCC
T ss_pred cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc-CCHHHHHHHHHccCCCCCC
Confidence 97654332 223457889999998764 48899999999999999999 9999987 4566666666655444445
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 251 SKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 251 ~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+...+..++++|.+||. +|.+||++.++++
T Consensus 247 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 247 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 56678999999999998 8999999999987
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=356.56 Aligned_cols=244 Identities=23% Similarity=0.407 Sum_probs=205.4
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
+..+| ++.+.||+|+||.||+|.+. ++..||+|.++... ...+.+.+|+.+|+.++||||+++++++. ..
T Consensus 186 ~~~~~-~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~---~~ 255 (454)
T 1qcf_A 186 PRESL-KLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVVT---KE 255 (454)
T ss_dssp CGGGE-EEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC---SS
T ss_pred chHHe-EEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe---CC
Confidence 44566 78899999999999999886 57889999987543 23567899999999999999999999874 23
Q ss_pred eEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 102 TINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
.+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVS-ASLVCKIADFGLAR 332 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEEC-TTCCEEECSTTGGG
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEEC-CCCcEEEeeCCCce
Confidence 588999999999999999754 36899999999999999999999999 99999999999997 78999999999997
Q ss_pred hhcCC---CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006779 180 VMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 180 ~~~~~---~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 254 (631)
..... ......+|+.|+|||++. +.|+.++|||||||++|||+| |+.||.+ .+..++...+..+..++ .+...
T Consensus 333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~~~ 410 (454)
T 1qcf_A 333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG-MSNPEVIRALERGYRMP-RPENC 410 (454)
T ss_dssp GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHHTCCCC-CCTTS
T ss_pred EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCC
Confidence 65432 122344678899999876 569999999999999999999 9999987 45666667777665433 34567
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 255 DPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
++.+.+||.+||. +|.+|||+.+++.
T Consensus 411 ~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 411 PEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 7899999999998 8999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.62 Aligned_cols=247 Identities=23% Similarity=0.371 Sum_probs=200.8
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
..++.||+|+||.||+|.+ +|..||+|++............+.+.+|+.+++.++||||+++++++.+. ..+++||
T Consensus 34 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 109 (307)
T 2nru_A 34 VGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG--DDLCLVY 109 (307)
T ss_dssp TTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEEE
T ss_pred ccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC--CceEEEE
Confidence 4468899999999999975 68899999987544334455677899999999999999999999988654 4688999
Q ss_pred eccCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 108 ELFTSGSLRQYRKK---HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 108 Ey~~gGsL~~~l~~---~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLD-EAFTAKISDFGLARASEKF 186 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECCSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEc-CCCcEEEeecccccccccc
Confidence 99999999999874 356999999999999999999999999 99999999999997 7889999999998755432
Q ss_pred C----CccccCCCCCCCccccccccCccccchhhhHHHHHHhhcCCCCCCCCCHH---HHHHHHHcCCC---------CC
Q 006779 185 T----ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPA---QIYKKVTSGIK---------PA 248 (631)
Q Consensus 185 ~----~~~~~GTp~Y~APEvl~~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~---~i~~~i~~~~~---------p~ 248 (631)
. .....||+.|+|||++.+.++.++||||||+++|+|++|..||....... .+...+..... ..
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN 266 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred cccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence 1 23457899999999998889999999999999999999999997643322 22233322111 11
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 249 ~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
......+..+.++|.+||. +|.+|||+.+++++
T Consensus 267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1122234678999999998 89999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=337.44 Aligned_cols=246 Identities=28% Similarity=0.464 Sum_probs=192.7
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC--CCCCceeeeeeEEcCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL--KHENIIKFYNSWVDDT 99 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L--~HpnIVkl~~~~~d~~ 99 (631)
..++| ++.+.||+|+||.||+|.+. |..||+|++.... .....+|.+++..+ +||||+++++++.+..
T Consensus 35 ~~~~y-~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 35 IAKQI-QMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE-------EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHHHC-EEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccce-EEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc-------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 34567 88899999999999999875 9999999986332 23345556665554 9999999999987764
Q ss_pred C--CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCEEeccCCCCCeeecCCCCc
Q 006779 100 N--RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH--------NPPIIHRDLKCDNIFVNGNNGE 169 (631)
Q Consensus 100 ~--~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~--------~~~IiHrDLKp~NILl~~~~g~ 169 (631)
. ..+++||||+.+|+|.++++.. .+++..++.++.||+.||.|||++ + |+||||||+|||++ .++.
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~-~~~~ 180 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVK-KNGT 180 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEEC-TTSC
T ss_pred CCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEEC-CCCC
Confidence 3 5799999999999999999765 599999999999999999999998 6 99999999999997 7889
Q ss_pred EEEccccccchhcCCC------CccccCCCCCCCccccccc-cCc------cccchhhhHHHHHHhhc----------CC
Q 006779 170 VKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYEEE-YNE------LVDIYSFGMCILEMVTC----------EY 226 (631)
Q Consensus 170 vKL~DFGla~~~~~~~------~~~~~GTp~Y~APEvl~~~-ys~------~sDIwSLGiilyELltG----------~~ 226 (631)
+||+|||++....... .....||+.|+|||++.+. +.. ++|||||||++|||+|| ..
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 9999999996553322 2355799999999988654 333 38999999999999999 77
Q ss_pred CCCCCC----CHHHHHHHHHcCCCCCCCCC-----CCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 227 PYNECK----NPAQIYKKVTSGIKPASLSK-----VTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 227 Pf~~~~----~~~~i~~~i~~~~~p~~l~~-----~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
||.... ....+...+........++. ..++.+++||.+||. +|.+|||+.++++|
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 261 PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 775432 22333333333322222322 235679999999998 89999999999875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=333.31 Aligned_cols=242 Identities=19% Similarity=0.320 Sum_probs=193.8
Q ss_pred CcccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHH-HhCCCCCceeeee
Q 006779 15 GEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHENIIKFYN 93 (631)
Q Consensus 15 ~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL-k~L~HpnIVkl~~ 93 (631)
..+....-.++|+.+.++||+|+||.||+|.+..+|+.||+|.+... ..+.+|+.++ +.++||||+++++
T Consensus 8 ~~~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~~i~~~~~ 78 (299)
T 3m2w_A 8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVD 78 (299)
T ss_dssp CCCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred ccCcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HHHHHHHHHHHHhccCCCchhHHh
Confidence 34455666788877778999999999999999999999999998632 2466788887 6679999999999
Q ss_pred eEEc--CCCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC--C
Q 006779 94 SWVD--DTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--N 167 (631)
Q Consensus 94 ~~~d--~~~~~l~lV~Ey~~gGsL~~~l~~~~--~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~--~ 167 (631)
+|.. .....+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.. +
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~ 156 (299)
T 3m2w_A 79 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPN 156 (299)
T ss_dssp EEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTT
T ss_pred hhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCC
Confidence 8865 33457999999999999999998764 6999999999999999999999999 9999999999999732 6
Q ss_pred CcEEEccccccchhcCCCCccccCCCCCCCccccccccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006779 168 GEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 247 (631)
Q Consensus 168 g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p 247 (631)
+.+||+|||++.... ...|+.++|||||||++|+|+||+.||..... ......+......
T Consensus 157 ~~~kl~Dfg~a~~~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~-~~~~~~~~~~~~~ 216 (299)
T 3m2w_A 157 AILKLTDFGFAKETT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAISPGMKTRIRM 216 (299)
T ss_dssp CCEEECCCTTCEECT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSCCSSCT
T ss_pred CcEEEeccccccccc-------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcc-hhhhHHHHHHHhh
Confidence 889999999885322 13478899999999999999999999976322 1111111111111
Q ss_pred C--CCC----CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 248 A--SLS----KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 248 ~--~l~----~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
. .++ ...++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 217 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 1 111 3467899999999998 89999999999999999763
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=333.03 Aligned_cols=242 Identities=22% Similarity=0.416 Sum_probs=197.1
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
.++| ++.+.||+|+||+||+|.+ +|..||+|.+... ...+.+.+|+.+++.++||||+++++++.... ..
T Consensus 20 ~~~y-~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 89 (278)
T 1byg_A 20 MKEL-KLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GG 89 (278)
T ss_dssp GGGE-EEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---C
T ss_pred hhhc-eEEeEEecCCCceEEEEEE--cCCEEEEEEecch------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-Cc
Confidence 4566 8889999999999999976 4899999998643 23467889999999999999999999876543 46
Q ss_pred EEEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 103 INMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~--l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
+++||||+.+|+|.+++.+.+. +++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKE 166 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC---
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEe-CCCcEEEeecccccc
Confidence 8899999999999999987543 899999999999999999999999 99999999999997 788999999999875
Q ss_pred hcCCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006779 181 MQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 181 ~~~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l 258 (631)
.... .....+++.|+|||++.+ .++.++||||||+++|+|+| |+.||.. .+...+...+..+..+ ..+...++.+
T Consensus 167 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l 243 (278)
T 1byg_A 167 ASST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKM-DAPDGCPPAV 243 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCCC-CCCTTCCHHH
T ss_pred cccc-ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCcccCCHHH
Confidence 5433 223467899999998754 58999999999999999998 9999976 3455666666665433 3455678999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhc
Q 006779 259 KQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 259 ~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+++|.+||. +|.+||++.+++.
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHH
Confidence 999999998 8999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=360.46 Aligned_cols=242 Identities=24% Similarity=0.393 Sum_probs=206.6
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEE
Q 006779 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV 106 (631)
+++.+.||+|+||.||+|.++.++..||+|.+.... ...+.+.+|+.+|+.++||||+++++++.+. ..+++|
T Consensus 222 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv 294 (495)
T 1opk_A 222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYII 294 (495)
T ss_dssp EEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEE
T ss_pred ceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-----cchHHHHHHHHHHHhcCCCCEeeEEEEEecC--CcEEEE
Confidence 377899999999999999999999999999987432 1246789999999999999999999988654 458899
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 107 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
|||+.+|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVG-ENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-GGGCEEECCTTCEECCTTC
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEEC-CCCcEEEeecccceeccCC
Confidence 9999999999999864 45899999999999999999999999 99999999999997 7889999999999765433
Q ss_pred C---CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006779 185 T---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 185 ~---~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~ 259 (631)
. .....+++.|+|||++. ..|+.++|||||||++|||+| |..||.+ .+..++...+..+..+ ..+...++.++
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 449 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYRM-ERPEGCPEKVY 449 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCCC-CCCTTCCHHHH
T ss_pred ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHH
Confidence 2 22334677899999876 458999999999999999999 9999987 4556667777766443 34456788999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhc
Q 006779 260 QFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 260 ~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+||.+||. +|.+|||+.++++
T Consensus 450 ~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 450 ELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCcChhHCcCHHHHHH
Confidence 99999998 8999999999876
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=353.43 Aligned_cols=251 Identities=26% Similarity=0.338 Sum_probs=190.8
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcC
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 98 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~ 98 (631)
.+...+ +...++||+|+||+||.+ ...+|+.||+|++... ..+.+.+|+.+|+.+ +||||+++++++.+.
T Consensus 11 ~~l~~~-~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 81 (434)
T 2rio_A 11 QSLKNL-VVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-------FCDIALMEIKLLTESDDHPNVIRYYCSETTD 81 (434)
T ss_dssp CSCSSC-EEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred hhhhhe-eeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-------HHHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 334444 477899999999999875 5668999999998643 234578899999876 899999999988654
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCCCC-------HHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC------
Q 006779 99 TNRTINMITELFTSGSLRQYRKKHKNVD-------MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG------ 165 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~-------~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~------ 165 (631)
..+++|||||. |+|.+++....... +..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 82 --~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~ 156 (434)
T 2rio_A 82 --RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTA 156 (434)
T ss_dssp --SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHS
T ss_pred --CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCccccc
Confidence 57999999995 69999998765432 2345789999999999999999 999999999999963
Q ss_pred ------CCCcEEEccccccchhcCCC------CccccCCCCCCCcccccc--------ccCccccchhhhHHHHHHhh-c
Q 006779 166 ------NNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-C 224 (631)
Q Consensus 166 ------~~g~vKL~DFGla~~~~~~~------~~~~~GTp~Y~APEvl~~--------~ys~~sDIwSLGiilyELlt-G 224 (631)
.++.+||+|||++....... .....||+.|+|||++.+ .++.++|||||||++|||+| |
T Consensus 157 ~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g 236 (434)
T 2rio_A 157 DQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236 (434)
T ss_dssp CCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred ccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCC
Confidence 23589999999997654321 234579999999998753 48899999999999999999 9
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCC----CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 225 EYPYNECKNPAQIYKKVTSGIKPASLSK----VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 225 ~~Pf~~~~~~~~i~~~i~~~~~p~~l~~----~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
..||....... ...+........... ..++++++||.+||. +|.+|||+.++|+||||..
T Consensus 237 ~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 237 KHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp CCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred CCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 99997644332 222222222222211 134789999999998 8999999999999999965
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=338.61 Aligned_cols=250 Identities=27% Similarity=0.411 Sum_probs=203.5
Q ss_pred CCceeeeeeEecccCceEEEEEE----EccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~----d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 98 (631)
..+.+++.+.||+|+||.||+|. +..+|+.||+|++... .....+.+.+|+.+|+.++||||+++++++...
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 34445889999999999999998 5678999999998743 345667899999999999999999999988766
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
....+++||||+.+++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~-~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGL 191 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCCTT
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEc-CCCcEEEecCcc
Confidence 656789999999999999999876 45999999999999999999999998 99999999999998 788999999999
Q ss_pred cchhcCCC-----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCC---------------HHH
Q 006779 178 AIVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN---------------PAQ 236 (631)
Q Consensus 178 a~~~~~~~-----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~---------------~~~ 236 (631)
+....... .....+++.|+|||++.+ .++.++|||||||++|+|+||..||..... ...
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 97654432 223456788999998764 588999999999999999999999853210 011
Q ss_pred HHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 237 IYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 237 i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+...+..+..+ ..+...++.+++||.+||. +|.+|||+.+++.
T Consensus 272 ~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 272 LIELLKNNGRL-PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHTTCCC-CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhcCCCC-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 22333333322 3345678899999999998 8999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=337.99 Aligned_cols=255 Identities=26% Similarity=0.358 Sum_probs=192.1
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEE---cC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV---DD 98 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~---d~ 98 (631)
.-++| ++.+.||+|+||.||+|.+ +|..||+|++.... ........|+..++.++||||+++++.+. ..
T Consensus 11 ~~~~y-~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 11 DLDNL-KLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp CTTSE-EEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred ChHHh-heeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 44667 7889999999999999965 78999999987432 11112234444455689999999997553 23
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCEEeccCCCCCeeecCCCCc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH---------NPPIIHRDLKCDNIFVNGNNGE 169 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~---------~~~IiHrDLKp~NILl~~~~g~ 169 (631)
....+++||||+.+|+|.+++.... +++..++.++.||+.||.|||++ + |+||||||+|||++ .++.
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~-~~~~ 158 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVK-NDGT 158 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEEC-TTSC
T ss_pred CCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEc-CCCc
Confidence 3446889999999999999997765 58999999999999999999999 7 99999999999997 7889
Q ss_pred EEEccccccchhcCC----------CCccccCCCCCCCcccccc--------ccCccccchhhhHHHHHHhhcCCCCCCC
Q 006779 170 VKIGDLGLAIVMQQP----------TARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVTCEYPYNEC 231 (631)
Q Consensus 170 vKL~DFGla~~~~~~----------~~~~~~GTp~Y~APEvl~~--------~ys~~sDIwSLGiilyELltG~~Pf~~~ 231 (631)
+||+|||++..+... ......||+.|+|||++.+ .++.++|||||||++|||++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 999999999755321 1234579999999998764 4678999999999999999998776432
Q ss_pred CC-----------------HHHHHHHHHcCCCCCCCCCC------CcHHHHHHHHHhcC-CCCCCCCHHHH------hcC
Q 006779 232 KN-----------------PAQIYKKVTSGIKPASLSKV------TDPQVKQFIEKCIV-PASLRLPALEL------LKD 281 (631)
Q Consensus 232 ~~-----------------~~~i~~~i~~~~~p~~l~~~------~~~~l~~lI~~cL~-~p~~Rpsa~el------L~h 281 (631)
.. ...+...+........++.. .++.+++||.+||. +|.+|||+.|+ +.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 21 12222223333222233322 33579999999998 89999999999 456
Q ss_pred CCCCCCC
Q 006779 282 PFLVTDN 288 (631)
Q Consensus 282 pff~~~~ 288 (631)
+|-+..+
T Consensus 319 ~~~~~~~ 325 (336)
T 3g2f_A 319 IWERNKS 325 (336)
T ss_dssp CCCC---
T ss_pred HHHhccc
Confidence 7766543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.36 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=200.1
Q ss_pred CCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC
Q 006779 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~ 100 (631)
...++| ++.+.||+|+||+||+|.+. +|..||+|++... .....+.+.+|+.+|+.++||||+++++++.+.
T Consensus 36 ~~~~~y-~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 107 (321)
T 2qkw_B 36 EATNNF-DHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE----SSQGIEEFETEIETLSFCRHPHLVSLIGFCDER-- 107 (321)
T ss_dssp CCCCCC-SCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC----CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT--
T ss_pred HHHhcc-CccceeecCCCeeEEEEEEC-CCCEEEEEEeccc----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--
Confidence 355677 77899999999999999864 7899999987643 234567799999999999999999999987544
Q ss_pred CeEEEEEeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccc
Q 006779 101 RTINMITELFTSGSLRQYRKKHK----NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~----~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 176 (631)
..+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLD-ENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEEC-TTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEEC-CCCCEEEeecc
Confidence 46889999999999999987643 5899999999999999999999998 99999999999997 78999999999
Q ss_pred ccchhcCC----CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCH-----HHH-HHHHHcCC
Q 006779 177 LAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP-----AQI-YKKVTSGI 245 (631)
Q Consensus 177 la~~~~~~----~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~-----~~i-~~~i~~~~ 245 (631)
++...... ......||+.|+|||++. ..++.++|||||||++|+|+||+.||...... ... ......+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 99754322 223456899999999774 56899999999999999999999999753221 111 11111111
Q ss_pred C-----CC---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 006779 246 K-----PA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 282 (631)
Q Consensus 246 ~-----p~---~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hp 282 (631)
. +. .+....+..+.++|.+||. +|.+|||+.+++++-
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1 11 1111234678999999998 899999999999763
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=343.67 Aligned_cols=251 Identities=26% Similarity=0.390 Sum_probs=196.2
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
..++| ++.+.||+|+||.||+|.+ .+|..||+|++..... ......+.+|+.+++.++||||+++++++.+..
T Consensus 28 ~~~~y-~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 100 (326)
T 3uim_A 28 ASDNF-SNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERT---QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-- 100 (326)
T ss_dssp TTTSS-CSTTEEECCSSSEEEEECC-SSSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS--
T ss_pred Hhhcc-ccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccC---chHHHHHHHHHHHHHhccCCCccceEEEEecCC--
Confidence 45666 7789999999999999975 4699999999875432 112235889999999999999999999886543
Q ss_pred eEEEEEeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CCCEEeccCCCCCeeecCCCCcEEEcc
Q 006779 102 TINMITELFTSGSLRQYRKKHK----NVDMKAIKNWARQILRGLHYLHSH---NPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~----~l~~~~i~~i~~QIl~aL~yLHs~---~~~IiHrDLKp~NILl~~~~g~vKL~D 174 (631)
..++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++ + |+||||||+|||++ .++.+||+|
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~-~~~~~kl~D 177 (326)
T 3uim_A 101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLD-EEFEAVVGD 177 (326)
T ss_dssp CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEEC-TTCCEEECC
T ss_pred ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEEC-CCCCEEecc
Confidence 5789999999999999998653 499999999999999999999998 7 99999999999997 788999999
Q ss_pred ccccchhcCCC---CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCC----CCCHHHHHHHHHcCCC
Q 006779 175 LGLAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNE----CKNPAQIYKKVTSGIK 246 (631)
Q Consensus 175 FGla~~~~~~~---~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~----~~~~~~i~~~i~~~~~ 246 (631)
||++....... .....||+.|+|||++. ..++.++|||||||++|+|+||+.||.. ..........+.....
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 99997654322 33456999999999875 4589999999999999999999999952 0111111111211111
Q ss_pred CCC------------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 006779 247 PAS------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 282 (631)
Q Consensus 247 p~~------------l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hp 282 (631)
... ........+.++|.+||. +|.+|||+.++++|-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 111 111123678999999998 899999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=343.27 Aligned_cols=244 Identities=16% Similarity=0.273 Sum_probs=197.4
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccC--------CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcee---
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVD--------GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK--- 90 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~t--------g~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVk--- 90 (631)
..++| ++.+.||+|+||.||+|.+..+ |..||+|.+... +.+.+|+.+++.++||||++
T Consensus 40 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~niv~~~~ 109 (352)
T 2jii_A 40 SGRQW-KLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKPLQVNKWK 109 (352)
T ss_dssp TSCEE-EEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCHHHHHHHH
T ss_pred cCCeE-EEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcccchhhhhh
Confidence 34555 8899999999999999999884 899999998743 24788999999999999998
Q ss_pred ------------eeeeEEcCCCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccC
Q 006779 91 ------------FYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156 (631)
Q Consensus 91 ------------l~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDL 156 (631)
+++++.. ....+++||||+ +++|.+++... ..+++..++.++.||+.||.|||+++ |+||||
T Consensus 110 ~~~~~~~~~i~~~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Di 185 (352)
T 2jii_A 110 KLYSTPLLAIPTCMGFGVH-QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNV 185 (352)
T ss_dssp HHTTCTTCSCCCCCEEEEE-TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCC
T ss_pred hhccCCccCccchhhcccc-CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCC
Confidence 4555544 245899999999 99999999986 78999999999999999999999998 999999
Q ss_pred CCCCeeecCCCC--cEEEccccccchhcCC---------CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhc
Q 006779 157 KCDNIFVNGNNG--EVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTC 224 (631)
Q Consensus 157 Kp~NILl~~~~g--~vKL~DFGla~~~~~~---------~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG 224 (631)
||+|||++ .++ .+||+|||++..+... ......||+.|+|||++.+ .++.++|||||||++|+|++|
T Consensus 186 kp~NIl~~-~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 264 (352)
T 2jii_A 186 TAENIFVD-PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYG 264 (352)
T ss_dssp CGGGEEEE-TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred CHHHEEEc-CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 99999998 666 8999999999654322 1234579999999998765 589999999999999999999
Q ss_pred CCCCCCCC-CHHHHHHHHHcC-CCCCCCC------CCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 225 EYPYNECK-NPAQIYKKVTSG-IKPASLS------KVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 225 ~~Pf~~~~-~~~~i~~~i~~~-~~p~~l~------~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+.||.... +...+....... ..+..+. ...++.+++||.+||. +|.+||++.++++
T Consensus 265 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 265 FLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp CCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 99998754 444444333211 0111111 2357899999999998 8999999999876
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=335.48 Aligned_cols=244 Identities=28% Similarity=0.447 Sum_probs=199.4
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh--CCCCCceeeeeeEEcCCC-
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS--LKHENIIKFYNSWVDDTN- 100 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~--L~HpnIVkl~~~~~d~~~- 100 (631)
++| ++.+.||+|+||.||+|.+ +|+.||+|.+... ....+.+|+++++. ++||||+++++++.....
T Consensus 42 ~~y-~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 42 RTI-VLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHC-EEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ccE-EEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 455 8889999999999999987 5999999998633 23557789999888 799999999999876543
Q ss_pred -CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCEEeccCCCCCeeecCCCCcEE
Q 006779 101 -RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH--------SHNPPIIHRDLKCDNIFVNGNNGEVK 171 (631)
Q Consensus 101 -~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLH--------s~~~~IiHrDLKp~NILl~~~~g~vK 171 (631)
..+++||||+.+|+|.+++.+. .+++..++.++.||+.||.||| +++ |+||||||+|||++ .++.+|
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~-~~~~~k 187 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVK-KNGTCC 187 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEEC-TTSCEE
T ss_pred cceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEEC-CCCCEE
Confidence 2789999999999999999774 5999999999999999999999 777 99999999999997 788999
Q ss_pred EccccccchhcCCC------CccccCCCCCCCccccccc-------cCccccchhhhHHHHHHhhc----------CCCC
Q 006779 172 IGDLGLAIVMQQPT------ARSVIGTPEFMAPELYEEE-------YNELVDIYSFGMCILEMVTC----------EYPY 228 (631)
Q Consensus 172 L~DFGla~~~~~~~------~~~~~GTp~Y~APEvl~~~-------ys~~sDIwSLGiilyELltG----------~~Pf 228 (631)
|+|||++....... .....||+.|+|||++.+. ++.++|||||||++|+|+|| ..||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 99999997654432 2445799999999987653 34689999999999999999 7898
Q ss_pred CCCC----CHHHHHHHHHcCCCCCCCCC-----CCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 229 NECK----NPAQIYKKVTSGIKPASLSK-----VTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 229 ~~~~----~~~~i~~~i~~~~~p~~l~~-----~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.... ....+...+........++. .....+++||.+||. +|.+|||+.++++|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 6532 34555555554433333332 123578999999998 89999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=354.65 Aligned_cols=248 Identities=27% Similarity=0.335 Sum_probs=190.9
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCe
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~ 102 (631)
.+| ++.++||+|+||+||. ....+|+.||+|++..... ..+.+|+.+|+.+ +||||+++++++.+. ..
T Consensus 24 ~~y-~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--~~ 92 (432)
T 3p23_A 24 ISF-CPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-------SFADREVQLLRESDEHPNVIRYFCTEKDR--QF 92 (432)
T ss_dssp EEE-EEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-------EECHHHHHHHHHSCCCTTBCCEEEEEEET--TE
T ss_pred EEE-ecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-------HHHHHHHHHHHhccCCCCcCeEEEEEecC--CE
Confidence 355 7789999999999763 4567899999999864332 2256799999999 899999999988654 47
Q ss_pred EEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC----CCCcEEEccccc
Q 006779 103 INMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG----NNGEVKIGDLGL 177 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~-~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~----~~g~vKL~DFGl 177 (631)
+|+|||||. |+|.+++.... .+.+..++.++.||+.||.|||+++ |+||||||+|||++. ....+||+|||+
T Consensus 93 ~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 93 QYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred EEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 899999996 69999998654 4566677899999999999999999 999999999999952 123588999999
Q ss_pred cchhcCC-----CCccccCCCCCCCccccc----cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCC
Q 006779 178 AIVMQQP-----TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKP 247 (631)
Q Consensus 178 a~~~~~~-----~~~~~~GTp~Y~APEvl~----~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p 247 (631)
+...... .....+||+.|+|||++. ..++.++|||||||++|+|+| |..||.... ..+.. .+......
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~-~~~~~-~~~~~~~~ 247 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL-QRQAN-ILLGACSL 247 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT-THHHH-HHTTCCCC
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh-HHHHH-HHhccCCc
Confidence 9765432 234567999999999885 347789999999999999999 999996533 22222 22222211
Q ss_pred CC--CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 248 AS--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 248 ~~--l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.. .....++.+++||.+||+ +|.+|||+.++|+||||...
T Consensus 248 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 248 DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 11 122345678999999998 89999999999999999764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=351.91 Aligned_cols=249 Identities=24% Similarity=0.404 Sum_probs=203.3
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
+..+| ++.+.||+|+||.||+|.+.. +..||+|.++.... ..+.+.+|+.+|+.++||||+++++++.+ .
T Consensus 182 ~~~~~-~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~ 251 (452)
T 1fmk_A 182 PRESL-RLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---E 251 (452)
T ss_dssp CGGGE-EEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS---S
T ss_pred ChhHc-eeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC---C
Confidence 44566 788999999999999999875 46799999875431 23568999999999999999999998754 3
Q ss_pred eEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 102 TINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
.+++||||+.+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLAR 328 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCTTC
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEC-CCCCEEECCCccce
Confidence 578999999999999999753 56999999999999999999999999 99999999999997 78899999999997
Q ss_pred hhcCCC---CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006779 180 VMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 180 ~~~~~~---~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 254 (631)
...... .....+++.|+|||++. +.++.++|||||||++|||+| |+.||.+ ....++...+..+..+. .+...
T Consensus 329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~~~ 406 (452)
T 1fmk_A 329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRMP-CPPEC 406 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCCC-CCTTS
T ss_pred ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCC
Confidence 654322 22345678899999775 568999999999999999999 9999987 45667777777765433 34567
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhc--CCCCC
Q 006779 255 DPQVKQFIEKCIV-PASLRLPALELLK--DPFLV 285 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rpsa~elL~--hpff~ 285 (631)
++.+.+||.+||. +|.+|||+.+++. ..++.
T Consensus 407 ~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 8899999999998 8999999999886 34443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=363.12 Aligned_cols=241 Identities=22% Similarity=0.355 Sum_probs=203.1
Q ss_pred eeEecccCceEEEEEEE--ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 30 DEILGKGAFKTVYKGFD--EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 30 ~e~LG~G~fg~Vy~a~d--~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
.+.||+|+||.||+|.+ +.++..||+|+++... ......+.+.+|+.+|+.++|||||++++++.+. .+++||
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---~~~lv~ 448 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVM 448 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG--GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEEEEE
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CEEEEE
Confidence 35799999999999955 5677999999987543 2344567799999999999999999999988532 478999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC--
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-- 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~-- 185 (631)
||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..+....
T Consensus 449 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~-~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 449 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCTTHHHHTTC----
T ss_pred EccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEe-CCCCEEEEEcCCccccccCccc
Confidence 99999999999999899999999999999999999999999 99999999999998 78899999999997664322
Q ss_pred ---CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006779 186 ---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 186 ---~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~ 260 (631)
.....+|+.|+|||++.. .|+.++|||||||++|||++ |+.||.+ .+..++...+..+..+ ..+...++++.+
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~~l~~ 603 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGCPREMYD 603 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHH
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHH
Confidence 223356788999998765 69999999999999999998 9999987 5666777777776543 345567899999
Q ss_pred HHHHhcC-CCCCCCCHHHHhc
Q 006779 261 FIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 261 lI~~cL~-~p~~Rpsa~elL~ 280 (631)
||.+||. +|.+||++.+++.
T Consensus 604 li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 604 LMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHH
Confidence 9999998 8999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=343.97 Aligned_cols=253 Identities=23% Similarity=0.384 Sum_probs=197.8
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEE
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~t---g~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 96 (631)
..+....+++.++||+|+||+||+|.+..+ +..||+|.++.. ......+.+.+|+.+|+.++||||+++++++.
T Consensus 84 i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 160 (373)
T 3c1x_A 84 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 160 (373)
T ss_dssp CCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC---SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEEC
T ss_pred cChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 344444457889999999999999987644 356899987642 23456788999999999999999999999875
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccc
Q 006779 97 DDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 175 (631)
... ...++||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 161 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kL~DF 236 (373)
T 3c1x_A 161 RSE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADF 236 (373)
T ss_dssp CCS-SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC
T ss_pred cCC-CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEEC-CCCCEEEeec
Confidence 443 4678999999999999999865 45899999999999999999999999 99999999999997 7889999999
Q ss_pred cccchhcCCC------CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCC
Q 006779 176 GLAIVMQQPT------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKP 247 (631)
Q Consensus 176 Gla~~~~~~~------~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p 247 (631)
|++....... .....+|+.|+|||++. ..++.++|||||||++|||+| |..||... +..++...+..+..+
T Consensus 237 G~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~-~~~~~~~~~~~~~~~ 315 (373)
T 3c1x_A 237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGRRL 315 (373)
T ss_dssp ---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CSSCHHHHHHTTCCC
T ss_pred cccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC-CHHHHHHHHHcCCCC
Confidence 9997553321 22345788999999875 458999999999999999999 67777653 444445555555433
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 248 ~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
..+...++.+.++|.+||. +|.+||++.+++++
T Consensus 316 -~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 316 -LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2345577899999999998 89999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=343.48 Aligned_cols=237 Identities=21% Similarity=0.314 Sum_probs=187.4
Q ss_pred ceeeeeeEecccCceEEEEE-----EEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC---CCCceeeeeeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK---HENIIKFYNSWV 96 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a-----~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~---HpnIVkl~~~~~ 96 (631)
+.+++.+.||+|+||+||+| .+..+|..||+|.+.... ...+.+|+.+++.++ |+||+++++++.
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-------PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-------hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 33488899999999999999 478889999999986431 235677888888887 999999999987
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCC-----
Q 006779 97 DDTNRTINMITELFTSGSLRQYRKK-----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN----- 166 (631)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~l~~-----~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~----- 166 (631)
... ..++||||+.+|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++ .
T Consensus 138 ~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~-~~~~~~ 212 (365)
T 3e7e_A 138 FQN--GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILG-NGFLEQ 212 (365)
T ss_dssp CSS--CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-GGGTCC
T ss_pred cCC--CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEec-ccccCc
Confidence 654 58899999999999999974 457999999999999999999999999 99999999999997 5
Q ss_pred ------CCcEEEccccccchhcC----CCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHH
Q 006779 167 ------NGEVKIGDLGLAIVMQQ----PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPA 235 (631)
Q Consensus 167 ------~g~vKL~DFGla~~~~~----~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~ 235 (631)
++.+||+|||++..+.. ......+||+.|+|||++.+ .|+.++|||||||++|||+||+.||.......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 78999999999965432 22345679999999998765 48999999999999999999999996422110
Q ss_pred HHHHHHHcCCCCCCCC-CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 236 QIYKKVTSGIKPASLS-KVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 236 ~i~~~i~~~~~p~~l~-~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
. .....+. ...+..+.+++.+||. +|.+|++..+.|.+
T Consensus 293 ~--------~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 293 C--------KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp E--------EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred e--------eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 0 0001111 1236788999999998 78888765554443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=337.60 Aligned_cols=246 Identities=27% Similarity=0.459 Sum_probs=202.6
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
+.++| ++.+.||+|+||.||+|.+.. .||+|.+..... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 31 ~~~~~-~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 102 (319)
T 2y4i_B 31 PFEQL-EIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD--NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP-- 102 (319)
T ss_dssp CCSCE-ECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC--CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS--
T ss_pred CHHHe-EEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC--CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC--
Confidence 34566 788999999999999998764 499999875432 2223345778999999999999999999987654
Q ss_pred eEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 102 TINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~-~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
.+++||||+.+++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++..
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~--~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD--NGKVVITDFGLFSI 178 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC----CCEECCCSCCC-
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe--CCCEEEeecCCccc
Confidence 5899999999999999998765 6999999999999999999999999 99999999999996 67999999999865
Q ss_pred hcC-------CCCccccCCCCCCCcccccc----------ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006779 181 MQQ-------PTARSVIGTPEFMAPELYEE----------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 243 (631)
Q Consensus 181 ~~~-------~~~~~~~GTp~Y~APEvl~~----------~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~ 243 (631)
... .......||+.|+|||++.. .++.++|||||||++|+|++|+.||.. .....+...+..
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~~~~~~ 257 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGT 257 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS-CCHHHHHHHHHT
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhcc
Confidence 421 12234468999999998753 378899999999999999999999976 456666777777
Q ss_pred CCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 244 GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 244 ~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+..+.......+..++++|.+||. +|.+|||+.+++.
T Consensus 258 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 258 GMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp TCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 666655555577889999999998 8999999999987
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=360.28 Aligned_cols=245 Identities=19% Similarity=0.353 Sum_probs=200.9
Q ss_pred ceeeeeeEecccCceEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~--~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
++......||+|+||.||+|.++ .++..||+|.++... .....+.+.+|+.+|+.++|||||++++++.+. .
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~ 409 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---A 409 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC---SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS---S
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC---C
Confidence 34333448999999999999876 456789999987542 233457799999999999999999999998652 4
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 103 INMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~-~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLV-NRHYAKISDFGLSKAL 486 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCSTTTTC
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEc-CCCcEEEeeccCcccc
Confidence 89999999999999999754 45999999999999999999999999 99999999999998 7889999999999765
Q ss_pred cCCC-----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006779 182 QQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 182 ~~~~-----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 254 (631)
.... .....+|+.|+|||++. ..|+.++|||||||++|||+| |+.||.+. +..++...+..+..+ ..+...
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~-~~~~~~~~i~~~~~~-~~p~~~ 564 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRM-ECPPEC 564 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CSHHHHHHHHTTCCC-CCCTTC
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcC
Confidence 4321 12234578999999876 569999999999999999998 99999874 455667777776543 345567
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 255 DPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
++.+.+||.+||. +|.+||++.+++.
T Consensus 565 ~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 565 PPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8999999999998 8999999998754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=342.88 Aligned_cols=252 Identities=19% Similarity=0.218 Sum_probs=193.9
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeeccccc----CCHHHHHHHHHHHHHHHhCC---------CC
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM----QSPDQLERLYSEVHLLKSLK---------HE 86 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~----~~~~~~~~l~~Ei~iLk~L~---------Hp 86 (631)
.-+.++| ++.+.||+|+||+||+|.+ +|+.||+|++...... ......+.+.+|+.+|+.++ ||
T Consensus 16 ~~~~~~y-~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ 92 (336)
T 2vuw_A 16 CLPTEKL-QRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTE 92 (336)
T ss_dssp HSCHHHH-HTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCC
T ss_pred hcccccc-hheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCC
Confidence 3455677 7789999999999999987 7899999999865421 12233467889999998886 77
Q ss_pred CceeeeeeEEcC----------------------------CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHH
Q 006779 87 NIIKFYNSWVDD----------------------------TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 138 (631)
Q Consensus 87 nIVkl~~~~~d~----------------------------~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl 138 (631)
||+++++++... ....+++||||+.+|++.+.+.+ +.+++..++.+++||+
T Consensus 93 niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 93 GFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLT 171 (336)
T ss_dssp CBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHH
T ss_pred chhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHH
Confidence 776666654321 14579999999999976666544 5689999999999999
Q ss_pred HHHHHHH-hCCCCEEeccCCCCCeeecCCCC--------------------cEEEccccccchhcCCCCccccCCCCCCC
Q 006779 139 RGLHYLH-SHNPPIIHRDLKCDNIFVNGNNG--------------------EVKIGDLGLAIVMQQPTARSVIGTPEFMA 197 (631)
Q Consensus 139 ~aL~yLH-s~~~~IiHrDLKp~NILl~~~~g--------------------~vKL~DFGla~~~~~~~~~~~~GTp~Y~A 197 (631)
.||.||| +++ |+||||||+|||++ .+| .+||+|||+++..... ..+||+.|+|
T Consensus 172 ~aL~~lH~~~~--ivHrDlKp~NILl~-~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---~~~gt~~y~a 245 (336)
T 2vuw_A 172 ASLAVAEASLR--FEHRDLHWGNVLLK-KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHHHHC--CBCSCCCGGGEEEE-ECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---EEECCCCTTC
T ss_pred HHHHHHHHhCC--EeECCCCHHHEEEe-ccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---cEEEeecccC
Confidence 9999999 898 99999999999998 555 8999999999866543 4589999999
Q ss_pred ccccccccCccccchhhhHH-HHHHhhcCCCCCCCCCHHHHHHHHHcCCC-CCC----CCCCCcHHHHHHHHHhcCCCCC
Q 006779 198 PELYEEEYNELVDIYSFGMC-ILEMVTCEYPYNECKNPAQIYKKVTSGIK-PAS----LSKVTDPQVKQFIEKCIVPASL 271 (631)
Q Consensus 198 PEvl~~~ys~~sDIwSLGii-lyELltG~~Pf~~~~~~~~i~~~i~~~~~-p~~----l~~~~~~~l~~lI~~cL~~p~~ 271 (631)
||++.+..+.++||||||++ .+++++|..||........+...+..... +.. .....++++++||.+||+.+
T Consensus 246 PE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-- 323 (336)
T 2vuw_A 246 EDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-- 323 (336)
T ss_dssp SGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--
T ss_pred hhhhcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--
Confidence 99998877899999998777 77889999998542111223333332211 111 11235688999999999843
Q ss_pred CCCHHHHh-cCCCCC
Q 006779 272 RLPALELL-KDPFLV 285 (631)
Q Consensus 272 Rpsa~elL-~hpff~ 285 (631)
||.|+| +||||+
T Consensus 324 --sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 --SATDLLCQHSLFK 336 (336)
T ss_dssp --SHHHHHHHCGGGC
T ss_pred --CHHHHHhcCCCcC
Confidence 999999 999995
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=374.11 Aligned_cols=260 Identities=28% Similarity=0.392 Sum_probs=205.8
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEc--
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD-- 97 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d-- 97 (631)
....+|| ++.+.||+|+||+||+|.+..+|..||+|++... ......+.+.+|+.+|+.++||||+++++++.+
T Consensus 10 g~~~grY-~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~---~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~ 85 (676)
T 3qa8_A 10 TQTCGPW-EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE---LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ 85 (676)
T ss_dssp --------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC---CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred CCCCCCe-EEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence 4445888 7889999999999999999999999999988643 245667889999999999999999999998644
Q ss_pred --CCCCeEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCC---c
Q 006779 98 --DTNRTINMITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG---E 169 (631)
Q Consensus 98 --~~~~~l~lV~Ey~~gGsL~~~l~~~~---~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g---~ 169 (631)
......++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++ .
T Consensus 86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~-~~g~~~~ 162 (676)
T 3qa8_A 86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQ-PGPQRLI 162 (676)
T ss_dssp CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEE-CCSSSCE
T ss_pred cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEee-cCCCcee
Confidence 12456789999999999999998754 6999999999999999999999999 99999999999998 444 4
Q ss_pred EEEccccccchhcCC-CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc----
Q 006779 170 VKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---- 243 (631)
Q Consensus 170 vKL~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~---- 243 (631)
+||+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.....+.++...+..
T Consensus 163 vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 163 HKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242 (676)
T ss_dssp EEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred EEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence 899999999766543 344568999999999876 45899999999999999999999999764333322111100
Q ss_pred ---------C--------CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 244 ---------G--------IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 244 ---------~--------~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
+ ..|..+....++.+.+||.+||. +|.+|||+.++|.||||..
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0 01112233356889999999998 8999999999999999975
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=354.01 Aligned_cols=244 Identities=25% Similarity=0.401 Sum_probs=205.1
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
+..+| ++.+.||+|+||.||+|.+.. +..||+|.++.... ..+.+.+|+.+|+.|+||||+++++++.+ .
T Consensus 265 ~~~~~-~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~ 334 (535)
T 2h8h_A 265 PRESL-RLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---E 334 (535)
T ss_dssp CGGGE-EEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS---S
T ss_pred chhhh-hhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEee---c
Confidence 44556 788999999999999999875 46799999875431 23568999999999999999999998754 3
Q ss_pred eEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 102 TINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
.+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLAR 411 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCTTSTT
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEc-CCCcEEEcccccce
Confidence 588999999999999999753 56999999999999999999999999 99999999999997 78899999999997
Q ss_pred hhcCC---CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006779 180 VMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 180 ~~~~~---~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 254 (631)
..... ......+++.|+|||++. +.|+.++|||||||++|||+| |+.||.+ ....++...+..+.... .+...
T Consensus 412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~~~ 489 (535)
T 2h8h_A 412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRMP-CPPEC 489 (535)
T ss_dssp TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT-CCHHHHHHHHHTTCCCC-CCTTC
T ss_pred ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCC
Confidence 65432 122345678899999775 468999999999999999999 9999987 45667777777765432 34567
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 255 DPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+..+++||.+||. +|.+|||+.+|+.
T Consensus 490 ~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 490 PESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8899999999998 8999999999886
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=348.54 Aligned_cols=247 Identities=19% Similarity=0.293 Sum_probs=197.4
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
.++| ++.++||+|+||.||+|.+..+|+.||+|++...... ..+.+|+.+++.|+|++++..+..+.. ....
T Consensus 6 ~~~y-~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~il~~L~~~~~i~~i~~~~~-~~~~ 77 (483)
T 3sv0_A 6 GNKF-RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------PQLLYESKIYRILQGGTGIPNVRWFGV-EGDY 77 (483)
T ss_dssp TTTE-ECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS------CCHHHHHHHHHHTTTSTTCCCEEEEEE-ETTE
T ss_pred CCcE-EEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc------HHHHHHHHHHHHhcCCCCCCeEEEEEe-eCCE
Confidence 4667 8889999999999999999999999999988755432 237789999999988655554444433 2357
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeec--CCCCcEEEccccccc
Q 006779 103 INMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAI 179 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~--~~~g~vKL~DFGla~ 179 (631)
.++||||+ +++|.+++.. .+.+++..++.|+.||+.||.|||+++ |+||||||+||||+ ..++.+||+|||++.
T Consensus 78 ~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 89999999 9999999985 567999999999999999999999999 99999999999993 267899999999997
Q ss_pred hhcCCC---------CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCC--HHHHHHHHHcCCC-
Q 006779 180 VMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIK- 246 (631)
Q Consensus 180 ~~~~~~---------~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~--~~~i~~~i~~~~~- 246 (631)
.+.... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+... ..+.+..+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA 234 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence 654432 225679999999998765 589999999999999999999999976433 3333333332211
Q ss_pred --CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 247 --PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 247 --p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
...+....++++.+||.+||. +|.+||++.+|++
T Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111223457899999999998 8999999987664
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=345.78 Aligned_cols=250 Identities=18% Similarity=0.208 Sum_probs=189.5
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC-CCcee-----------
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIK----------- 90 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~H-pnIVk----------- 90 (631)
..|.++++++||+|+||+||+|.+..+|+.||+|++..... ......+.+.+|+.+++.++| +|+..
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC-ccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 34545778999999999999999999999999999874432 222335778999999999987 32211
Q ss_pred ----------eeeeEEcCC---CCeEEEEEeccCCCCHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 006779 91 ----------FYNSWVDDT---NRTINMITELFTSGSLRQYRKK-------HKNVDMKAIKNWARQILRGLHYLHSHNPP 150 (631)
Q Consensus 91 ----------l~~~~~d~~---~~~l~lV~Ey~~gGsL~~~l~~-------~~~l~~~~i~~i~~QIl~aL~yLHs~~~~ 150 (631)
++.++.... ...++++|+++ +++|.+++.. .+.+++..++.++.||+.||.|||+++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 231 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 231 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 111111111 12456777766 6899998852 234778899999999999999999999
Q ss_pred EEeccCCCCCeeecCCCCcEEEccccccchhcCCCCccccCCCCCCCcccc----------cc-ccCccccchhhhHHHH
Q 006779 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY----------EE-EYNELVDIYSFGMCIL 219 (631)
Q Consensus 151 IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl----------~~-~ys~~sDIwSLGiily 219 (631)
|+||||||+|||++ .+|.+||+|||++...... ....+| +.|+|||++ .. .|+.++|||||||++|
T Consensus 232 iiHrDiKp~NILl~-~~~~~kL~DFG~a~~~~~~-~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 232 LVHTYLRPVDIVLD-QRGGVFLTGFEHLVRDGAS-AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp EECSCCCGGGEEEC-TTCCEEECCGGGCEETTEE-ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cccCCcccceEEEe-cCCeEEEEeccceeecCCc-cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 99999999999998 7889999999998765443 345577 999999987 22 3788999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 220 EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 220 ELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
+|+||+.||.... .......+... ....++.+++||.+||. +|.+||++.++|+||||+.
T Consensus 309 elltg~~Pf~~~~-~~~~~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 309 WIWCADLPNTDDA-ALGGSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHHSSCCCCTTG-GGSCSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHCCCCCCCcc-hhhhHHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 9999999997632 22222222211 12356899999999998 8999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=355.35 Aligned_cols=245 Identities=25% Similarity=0.435 Sum_probs=204.0
Q ss_pred CceeeeeeEecccCceEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~t---g~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~ 100 (631)
++| ++.+.||+|+||.||+|.+..+ +..||+|.+... ......+.+.+|+.+|+.++||||+++++++.+
T Consensus 390 ~~y-~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--- 462 (656)
T 2j0j_A 390 ERI-ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--- 462 (656)
T ss_dssp GGE-EEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST---TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred ccE-EEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---
Confidence 455 7789999999999999998653 578999987643 245566889999999999999999999998743
Q ss_pred CeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 101 RTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~-~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
..+++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~-~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLSR 539 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEe-CCCCEEEEecCCCe
Confidence 34789999999999999998654 6999999999999999999999999 99999999999998 78999999999997
Q ss_pred hhcCCC---CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006779 180 VMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 180 ~~~~~~---~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 254 (631)
...... .....+|+.|+|||++. ..|+.++|||||||++|||++ |..||.+ .+..++...+..+..+ .++...
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~-~~~~~~ 617 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERL-PMPPNC 617 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHHTCCC-CCCTTC
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCCCC-CCCccc
Confidence 654332 22345678999999875 458999999999999999997 9999987 4566666666665433 345567
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 255 DPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
++.+.+||.+||. +|.+||++.+++.
T Consensus 618 ~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 618 PPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8999999999998 8999999999875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=361.25 Aligned_cols=241 Identities=20% Similarity=0.279 Sum_probs=198.2
Q ss_pred CceeeeeeEecccCceEEEEEEEcc-CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC--
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEV-DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-- 100 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~-tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~-- 100 (631)
+|| ++.+.||+|+||+||+|.+.. +|+.||+|.+... ........+.+|+.+|+.++||||+++++++.....
T Consensus 80 ~~y-~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 80 GQY-EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS---GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp TTE-EEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS---CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred Cce-EEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc---CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 677 888999999999999999976 7999999988643 245666788999999999999999999999876543
Q ss_pred -CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 101 -RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 -~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
..+|+||||+.|++|.+++.. .+++..++.|+.||+.||.|||+++ |+||||||+|||++ . +.+||+|||++.
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~-~-~~~kl~DFG~a~ 229 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLT-E-EQLKLIDLGAVS 229 (681)
T ss_dssp CEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-S-SCEEECCCTTCE
T ss_pred CceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEe-C-CcEEEEecccch
Confidence 136899999999999988765 7999999999999999999999999 99999999999997 3 489999999997
Q ss_pred hhcCCCCccccCCCCCCCccccccccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006779 180 VMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 180 ~~~~~~~~~~~GTp~Y~APEvl~~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~ 259 (631)
..... ...+||+.|+|||++.+.++.++|||||||++|+|++|..||.+... .+..........++.+.
T Consensus 230 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~---------~~~~~~~~~~~~~~~l~ 298 (681)
T 2pzi_A 230 RINSF--GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYV---------DGLPEDDPVLKTYDSYG 298 (681)
T ss_dssp ETTCC--SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEEC---------SSCCTTCHHHHHCHHHH
T ss_pred hcccC--CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccc---------ccccccccccccCHHHH
Confidence 65543 45679999999999888889999999999999999999988864210 01000000001246799
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 006779 260 QFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 260 ~lI~~cL~-~p~~Rpsa~elL~hpff~ 285 (631)
+||.+||. +|.+||++.+.+.|+|+.
T Consensus 299 ~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 299 RLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 99999998 899999999999998874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=317.75 Aligned_cols=233 Identities=15% Similarity=0.155 Sum_probs=186.6
Q ss_pred CcccccC--CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeee
Q 006779 15 GEFSEKD--PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92 (631)
Q Consensus 15 ~~~~e~d--p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~ 92 (631)
..+...+ -.+|| ++.+.||+|+||.||+|.+..+|+.||+|.+..... ......+.+.+|+.+++.++||||++++
T Consensus 20 ~~~~~g~~~~~~~y-~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~ 97 (286)
T 3uqc_A 20 VQLVPGARIANGRY-RLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGV-LPDDVLQETLSRTLRLSRIDKPGVARVL 97 (286)
T ss_dssp CCCCTTCEETTTTE-EEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCC-SCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcCCCCCEEecCcE-EEEEEEcccCCeEEEEEEecCCCceEEEEEECcccc-cCHHHHHHHHHHHHHHhcCCCCCcceee
Confidence 3344444 34788 778999999999999999999999999999975432 3456678899999999999999999999
Q ss_pred eeEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEE
Q 006779 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 93 ~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL 172 (631)
+++.+. ..+|+||||+.|++|.+++++. .....+..++.||+.||.|||++| |+||||||+|||++ .+|.+||
T Consensus 98 ~~~~~~--~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~-~~g~~kl 170 (286)
T 3uqc_A 98 DVVHTR--AGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVS-IDGDVVL 170 (286)
T ss_dssp EEEEET--TEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEE-TTSCEEE
T ss_pred EEEEEC--CcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEc-CCCCEEE
Confidence 998765 4689999999999999999653 456678899999999999999999 99999999999998 7889999
Q ss_pred ccccccchhcCCCCccccCCCCCCCccccccccCccccchhhhHHHHHHhhcCCCCCCCCCHHHH---HHHHHcCCC-CC
Q 006779 173 GDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI---YKKVTSGIK-PA 248 (631)
Q Consensus 173 ~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i---~~~i~~~~~-p~ 248 (631)
+++| |++| ++.++|||||||++|+|+||+.||.+......+ ...+..... +.
T Consensus 171 ~~~~------------------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T 3uqc_A 171 AYPA------------------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA 226 (286)
T ss_dssp CSCC------------------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHH
T ss_pred Eecc------------------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChh
Confidence 7443 4443 788999999999999999999999864322111 011111111 11
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 249 ~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.+....++.+++||.+||. +|.+| |+.++++.
T Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 227 DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 2234567899999999998 89999 99999874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-31 Score=298.38 Aligned_cols=189 Identities=13% Similarity=0.046 Sum_probs=137.2
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccC------CHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCCCeE
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ------SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~------~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~~~l 103 (631)
...+.|+.|.+..++....|+.+++|.+....... .....+.+.+|+++|+++ .|+||+++++++.++ ..+
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~--~~~ 317 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA--QSG 317 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS--SEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC--CEE
Confidence 44677888888888888999999999987543211 133456799999999999 799999999998654 579
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
||||||++|++|.+++.+.+++++. .+++||+.||+|||++| ||||||||+|||++ .+|.+||+|||+|+....
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~-~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVD-ARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEEC-TTSCEEECCCTTEESCC-
T ss_pred EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEEC-CCCCEEEeecccCeeCCC
Confidence 9999999999999999999999875 47899999999999999 99999999999998 789999999999976644
Q ss_pred C--CCccccCCCCCCCccccccccCccccchhhhHHHHHHhhcCCC
Q 006779 184 P--TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYP 227 (631)
Q Consensus 184 ~--~~~~~~GTp~Y~APEvl~~~ys~~sDIwSLGiilyELltG~~P 227 (631)
. ...+.+||+.|||||++.+.+..++|+||+|+++++|.++..|
T Consensus 392 ~~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHH
T ss_pred CCccccCceechhhccHHHhCCCCCCcccccccccchhhhccccch
Confidence 3 3456789999999999999888999999999998888766444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-26 Score=259.25 Aligned_cols=189 Identities=18% Similarity=0.195 Sum_probs=144.0
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC----HHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS----PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~----~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
.++..-.++||+|+||+||+| ...+..+++|+......... ....+++.+|+++|++++||||+++..++.+..
T Consensus 335 ~~~~~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 412 (540)
T 3en9_A 335 KKRKIPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD 412 (540)
T ss_dssp -------------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT
T ss_pred cccCCCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC
Confidence 333334578999999999999 56688999998754332211 112456899999999999999995444444443
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
..++||||+++++|.+++.. +..++.||+.||.|||+++ |+||||||+|||++ . .+||+|||+++
T Consensus 413 --~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~-~--~~kL~DFGla~ 477 (540)
T 3en9_A 413 --NKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFD-K--DLYIIDFGLGK 477 (540)
T ss_dssp --TTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEES-S--SEEECCCTTCE
T ss_pred --ccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEEC-C--eEEEEECccCE
Confidence 35899999999999999876 5689999999999999999 99999999999997 3 99999999997
Q ss_pred hhcCCC---------CccccCCCCCCCcccccc---ccCccccchhhhHHHHHHhhcCCCCC
Q 006779 180 VMQQPT---------ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYN 229 (631)
Q Consensus 180 ~~~~~~---------~~~~~GTp~Y~APEvl~~---~ys~~sDIwSLGiilyELltG~~Pf~ 229 (631)
...... ..+.+||+.|||||++.. .|+..+|+|+..+-.++.+.++.+|.
T Consensus 478 ~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 478 ISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp ECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 665431 235689999999998864 58889999999999999888887774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.9e-23 Score=212.93 Aligned_cols=151 Identities=15% Similarity=0.167 Sum_probs=118.5
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccC-----CH---------HHHHHHHHHHHHHHhCCCCCce
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ-----SP---------DQLERLYSEVHLLKSLKHENII 89 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~-----~~---------~~~~~l~~Ei~iLk~L~HpnIV 89 (631)
+.++++.+.||+|+||.||+|.+ .+|..||+|.++...... .. .....+.+|+.+|+.++ | +
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~ 164 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L 164 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence 34456679999999999999999 899999999986432110 00 23567899999999999 4 5
Q ss_pred eeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCc
Q 006779 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169 (631)
Q Consensus 90 kl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~ 169 (631)
++++++.. ...++||||+.||+|.+ +. ......++.||+.||.|||+++ |+||||||+|||++ +|.
T Consensus 165 ~v~~~~~~---~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~--~~~ 230 (282)
T 1zar_A 165 AVPKVYAW---EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS--EEG 230 (282)
T ss_dssp SSCCEEEE---ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE--TTE
T ss_pred CcCeEEec---cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE--CCc
Confidence 56554432 24589999999999987 32 1335579999999999999999 99999999999997 889
Q ss_pred EEEccccccchhcCCCCccccCCCCCCCcccccc
Q 006779 170 VKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE 203 (631)
Q Consensus 170 vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~ 203 (631)
+||+|||++. .+..++|||++.+
T Consensus 231 vkl~DFG~a~-----------~~~~~~a~e~l~r 253 (282)
T 1zar_A 231 IWIIDFPQSV-----------EVGEEGWREILER 253 (282)
T ss_dssp EEECCCTTCE-----------ETTSTTHHHHHHH
T ss_pred EEEEECCCCe-----------ECCCCCHHHHHHH
Confidence 9999999985 3556789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=3e-19 Score=181.78 Aligned_cols=144 Identities=16% Similarity=0.186 Sum_probs=110.4
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeE--EEEEEeecccccC--------------------CHHHHHHHHHHHHHHH
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIE--VAWNQVNIEDVMQ--------------------SPDQLERLYSEVHLLK 81 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~--VAiK~i~~~~~~~--------------------~~~~~~~l~~Ei~iLk 81 (631)
+.++.+.+.||+|+||.||+|.+..+|.. ||+|+++...... .......+.+|+.+|+
T Consensus 46 ~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 125 (258)
T 1zth_A 46 GYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE 125 (258)
T ss_dssp TSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred CCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence 44567889999999999999999889999 9999875432100 0012246889999999
Q ss_pred hCCCCCc--eeeeeeEEcCCCCeEEEEEeccCC-C----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCEEe
Q 006779 82 SLKHENI--IKFYNSWVDDTNRTINMITELFTS-G----SLRQYRKKHKNVDMKAIKNWARQILRGLHYLH-SHNPPIIH 153 (631)
Q Consensus 82 ~L~HpnI--Vkl~~~~~d~~~~~l~lV~Ey~~g-G----sL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLH-s~~~~IiH 153 (631)
.|.|++| +.++. .. ..++||||+.+ | +|.++... .++..+..++.||+.||.||| +++ |+|
T Consensus 126 ~l~~~~i~~p~~~~--~~----~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g--ivH 194 (258)
T 1zth_A 126 RAKEAGVSVPQPYT--YM----KNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE--LVH 194 (258)
T ss_dssp HHHHTTCCCCCEEE--EE----TTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC--EEC
T ss_pred HHHhCCCCCCeEEE--cC----CCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC--EEe
Confidence 9988864 33443 21 35789999942 3 78776543 235567899999999999999 988 999
Q ss_pred ccCCCCCeeecCCCCcEEEccccccchh
Q 006779 154 RDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 154 rDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
|||||+|||++ . .++|+|||++...
T Consensus 195 rDlkp~NILl~-~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYI-D--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEES-S--SEEECCCTTCEET
T ss_pred CCCCHHHEEEc-C--cEEEEECcccccC
Confidence 99999999997 3 8999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.3e-15 Score=163.84 Aligned_cols=140 Identities=16% Similarity=0.130 Sum_probs=98.9
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeeccccc-----------C--CH-HH--H--HHHHHHHHHHHhCCCCCc
Q 006779 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-----------Q--SP-DQ--L--ERLYSEVHLLKSLKHENI 88 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~-----------~--~~-~~--~--~~l~~Ei~iLk~L~HpnI 88 (631)
|+++..||+|+||.||+|.+. +|+.||+|+++..... . .. .. . -...+|+..|.+|.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 488899999999999999885 6999999987643210 0 00 00 0 112457777777755443
Q ss_pred eeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCC
Q 006779 89 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 168 (631)
Q Consensus 89 Vkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g 168 (631)
.-..-+.... .++||||+.|++|.++. .......++.||+.+|.|||++| ||||||||.|||++ .+|
T Consensus 176 ~vp~p~~~~~----~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~-~dg 242 (397)
T 4gyi_A 176 PVPEPIAQSR----HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHG--LIHGDFNEFNILIR-EEK 242 (397)
T ss_dssp SCCCEEEEET----TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-EEE
T ss_pred CCCeeeeccC----ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEe-CCC
Confidence 2211111111 25899999999886542 22345678899999999999999 99999999999997 444
Q ss_pred ----------cEEEccccccch
Q 006779 169 ----------EVKIGDLGLAIV 180 (631)
Q Consensus 169 ----------~vKL~DFGla~~ 180 (631)
.+.|+||+.+..
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEE
T ss_pred CcccccccccceEEEEeCCccc
Confidence 389999998754
|
| >2v3s_A Serine/threonine-protein kinase OSR1; ATP-binding, magnesium, metal-binding, nucleotide-binding, phosphorylation, polymorphism, transferase; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.4e-14 Score=121.04 Aligned_cols=60 Identities=23% Similarity=0.409 Sum_probs=58.4
Q ss_pred CceEEEEEecCCCCCceeeeeecccCCCCHHHHHHHHHHccCCCCcCHHHHHHHHHHHHH
Q 006779 364 DTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIM 423 (631)
Q Consensus 364 ~~i~l~Lri~d~~~~~~~i~f~f~~~~Dta~~va~EmV~~~~i~~~d~~~ia~~i~~~i~ 423 (631)
.+|+|+||++|+.+++++|+|+|.+++|||++||+|||.+|+|++.|+.+||++|+++|.
T Consensus 1 ~pv~LvLRlRn~~rELnDIrFeF~~g~DTaegiA~ELv~AgLVDg~D~~vVAanL~klv~ 60 (96)
T 2v3s_A 1 GPISLVLRLRNSKKELNDIRFEFTPGRDTAEGVSQELISAGLVDGRDLVIVAANLQKIVE 60 (96)
T ss_dssp CCEEEEEEEECTTSCEEEEEEEECTTTCCHHHHHHHHHHTTSSCGGGHHHHHHHHHHHHH
T ss_pred CCeeEEEEeccccchhcceEEEeecCCCcHHHHHHHHHHCCCcccccHHHHHHHHHHHHh
Confidence 378999999999999999999999999999999999999999999999999999999997
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.02 E-value=1.1e-13 Score=117.13 Aligned_cols=64 Identities=30% Similarity=0.378 Sum_probs=59.0
Q ss_pred CCceEEEEEecCCC---CCce---eeeeecccCCCCHHHHHHHHHHccCCCCcCHHHHHHHHHHHHHHhC
Q 006779 363 DDTVSLTLRIGDKS---GHVS---NIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLV 426 (631)
Q Consensus 363 ~~~i~l~Lri~d~~---~~~~---~i~f~f~~~~Dta~~va~EmV~~~~i~~~d~~~ia~~i~~~i~~~~ 426 (631)
..+|.|+|||.|+. |+.| +|+|+|++++|||++||+|||++|+++++|...||++|+.-|..+-
T Consensus 23 ~~~i~L~LRi~Dpkk~~gk~KeNeaIeF~Fdle~Dta~eVA~EMVe~~~l~e~D~~~VaklI~~~v~~~~ 92 (98)
T 2lru_A 23 KIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESGYVCEGDHKTMAKAIKDRVSLIK 92 (98)
Confidence 46899999999994 7888 9999999999999999999999999999999999999999876553
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=9e-10 Score=110.78 Aligned_cols=138 Identities=16% Similarity=0.061 Sum_probs=103.7
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCceeeeeeEEcCCCCeEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~l~lV 106 (631)
++...++.|+.+.||++.. .|..+++|....... .. ...+.+|+.+|+.|. +..+.+++++..+. ...|+|
T Consensus 17 ~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~-~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv 88 (263)
T 3tm0_A 17 RCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK-GT---TYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNLL 88 (263)
T ss_dssp EEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT-TS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEE
T ss_pred eeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC-CC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecC--CceEEE
Confidence 6677788888999999964 368899998864211 11 134788999999984 67788888876543 578899
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 006779 107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN-------------------------------------- 148 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~-------------------------------------- 148 (631)
|||++|.+|.+.+. +......++.++..+|..||+..
T Consensus 89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999999987631 22234578899999999999811
Q ss_pred -------------------CCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 149 -------------------PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 149 -------------------~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
+.++|+|++|.||+++ .++.+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~-~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK-DGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE-TTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE-CCcEEEEEEchhcc
Confidence 2389999999999997 44456799998763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.89 E-value=9e-09 Score=102.33 Aligned_cols=133 Identities=13% Similarity=0.013 Sum_probs=92.5
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC--ceeeeeeEEcCCCCeEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN--IIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~Hpn--IVkl~~~~~d~~~~~l~l 105 (631)
.+..+.+.|..+.||++. ..+|..+++|...... ...+.+|+.+|+.+.+.+ +.+++.+..+. ...++
T Consensus 23 ~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~-------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~~~~~ 92 (264)
T 1nd4_A 23 DWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWL 92 (264)
T ss_dssp EEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEE
T ss_pred ceEecccCCCCceEEEEe-cCCCCeEEEEeCCccc-------chhhhHHHHHHHHHHhCCCCCCeEEEeccCC--CCCEE
Confidence 333333456669999985 4567889999865321 134778999999886544 45577765443 45889
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 006779 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN------------------------------------- 148 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~------------------------------------- 148 (631)
||||++|.+|. . ...+ ...++.++...|..||+..
T Consensus 93 v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 93 LLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp EEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99999998884 1 1122 2356677777788888643
Q ss_pred -------------------CCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 149 -------------------PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 149 -------------------~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
+.++|+|++|.||+++ .++.+.|+||+.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~-~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE-NGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE-TTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE-CCcEEEEEcchhcc
Confidence 1299999999999997 45556799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.83 E-value=7.1e-09 Score=109.48 Aligned_cols=142 Identities=15% Similarity=0.185 Sum_probs=101.2
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEee--cccccCCHHHHHHHHHHHHHHHhCC--CCCceeeeeeEEcCCC-CeEEE
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVN--IEDVMQSPDQLERLYSEVHLLKSLK--HENIIKFYNSWVDDTN-RTINM 105 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~--~~~~~~~~~~~~~l~~Ei~iLk~L~--HpnIVkl~~~~~d~~~-~~l~l 105 (631)
+.|+.|.+..||+.... +..+++|+.. ..... .....+.+|+.+|+.|. +..+++++.++.+... ...|+
T Consensus 44 ~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~---~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL---PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EECCC-CCSCEEEEECS--SCEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred EEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC---CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 67899999999998653 4678888764 22211 12345788999999997 4557788886644321 35788
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 006779 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH-------------------------------------- 147 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~-------------------------------------- 147 (631)
||||+.|..+.+. ....++......++.++...|..||+.
T Consensus 119 vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 119 IMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9999999877431 123477888889999999999999983
Q ss_pred ------------------CCCEEeccCCCCCeeecCCCC-cEEEccccccc
Q 006779 148 ------------------NPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAI 179 (631)
Q Consensus 148 ------------------~~~IiHrDLKp~NILl~~~~g-~vKL~DFGla~ 179 (631)
.+.++|||++|.||+++..++ .+.|+||+.+.
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 134999999999999974332 36899999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.71 E-value=1.6e-08 Score=104.34 Aligned_cols=183 Identities=21% Similarity=0.200 Sum_probs=119.0
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCC--ceeeeeeEEcCCC-CeEEEE
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HEN--IIKFYNSWVDDTN-RTINMI 106 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-Hpn--IVkl~~~~~d~~~-~~l~lV 106 (631)
+.++.|....||++. ..+++|... .......+.+|+.+|+.+. +.. +.+++....+... ...|+|
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~------~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPK------HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEES------SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred EecCCCCcceEEEEC-----CEEEEEecC------CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 458999999999872 457788753 2244567899999998883 333 3344432211111 245789
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 006779 107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN-------------------------------------- 148 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~-------------------------------------- 148 (631)
|++++|.+|..... ..++......++.|+...|..||+..
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999988865332 34677777888888888888888621
Q ss_pred ------------------CCEEeccCCCCCeeecCC-CCcEEEccccccchhcCCCCccccCCCCC---CCccccc---c
Q 006779 149 ------------------PPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQPTARSVIGTPEF---MAPELYE---E 203 (631)
Q Consensus 149 ------------------~~IiHrDLKp~NILl~~~-~g~vKL~DFGla~~~~~~~~~~~~GTp~Y---~APEvl~---~ 203 (631)
+.++|+|++|.||+++.. ++.+.|+||+.+...... ........+ ..|+... .
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~--~Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD--NDFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT--HHHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH--HHHHHHHhhccccCHHHHHHHHH
Confidence 238999999999999833 456789999987542111 000001111 2333221 1
Q ss_pred ccC------------ccccchhhhHHHHHHhhcCCCC
Q 006779 204 EYN------------ELVDIYSFGMCILEMVTCEYPY 228 (631)
Q Consensus 204 ~ys------------~~sDIwSLGiilyELltG~~Pf 228 (631)
.|. ...+.|++|.++|.+.+|..+|
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 121 1258999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=7.9e-06 Score=84.55 Aligned_cols=135 Identities=21% Similarity=0.135 Sum_probs=89.7
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC---CceeeeeeEEcCCCCeEEEEE
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE---NIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~Hp---nIVkl~~~~~d~~~~~l~lV~ 107 (631)
+.++.|....||+. |..+++|+-. .......+.+|+.+|+.|.+. .+.+.+.+... .....++||
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~ 92 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPK------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGY 92 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEES------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEE
T ss_pred eecCCCcceeEEEE-----CCEEEEEecC------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEE
Confidence 55788888899998 5667888742 234557789999999999753 34555554432 334577999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN--------------------------------------- 148 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~--------------------------------------- 148 (631)
+|++|.+|....- ..++......++.|+...|..||+..
T Consensus 93 e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 93 RKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp ECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred eccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 9999988865311 12344444444455554444444321
Q ss_pred -------------------CCEEeccCCCCCeeecC--CCCc-EEEccccccc
Q 006779 149 -------------------PPIIHRDLKCDNIFVNG--NNGE-VKIGDLGLAI 179 (631)
Q Consensus 149 -------------------~~IiHrDLKp~NILl~~--~~g~-vKL~DFGla~ 179 (631)
+.++|+|++|.||+++. .++. +.|+||+.+.
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 23799999999999973 1344 5899999774
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=1.1e-05 Score=81.09 Aligned_cols=135 Identities=15% Similarity=0.079 Sum_probs=93.7
Q ss_pred eEecccCce-EEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCceeeeeeEEcCCCCeEEEEEe
Q 006779 31 EILGKGAFK-TVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITE 108 (631)
Q Consensus 31 e~LG~G~fg-~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~l~lV~E 108 (631)
+.+..|..+ .||+......+..+++|.-.. .....+.+|...|+.|. +-.+.+++.++.+. ...++|||
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme 100 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG-------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTT 100 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET-------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC-------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEE
Confidence 334555554 689987777788899987642 23456788999998884 33366777766554 46789999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC---------------------------------------
Q 006779 109 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP--------------------------------------- 149 (631)
Q Consensus 109 y~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~--------------------------------------- 149 (631)
++.|.++.+..... ......++.++...|..||+..+
T Consensus 101 ~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred eeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 99999887765432 12233455666666666664311
Q ss_pred -----------------CEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 150 -----------------PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 150 -----------------~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
-++|+|+.+.||+++ .++.+-|+||+.+.
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~-~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFD-EGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEE-CCeEEEEEECcccc
Confidence 179999999999997 55566799998774
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.82 E-value=6.6e-05 Score=80.07 Aligned_cols=79 Identities=15% Similarity=0.178 Sum_probs=48.4
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccc-cCC--HHHHHHHHHHHHHHHhCCC--CC-ceeeeeeEEcCCCCeEE
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV-MQS--PDQLERLYSEVHLLKSLKH--EN-IIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~-~~~--~~~~~~l~~Ei~iLk~L~H--pn-IVkl~~~~~d~~~~~l~ 104 (631)
+.||.|.++.||++.+..++..+++|....... ... +...+++..|.++|+.+.. |. +.+++.+ +... .+
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~--~~ 111 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM--AV 111 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT--TE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCc--cE
Confidence 679999999999997766778999998653211 000 0123456789999888742 33 4455542 3332 46
Q ss_pred EEEeccCCC
Q 006779 105 MITELFTSG 113 (631)
Q Consensus 105 lV~Ey~~gG 113 (631)
+|||++.+.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 899999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00014 Score=76.17 Aligned_cols=82 Identities=5% Similarity=-0.111 Sum_probs=51.1
Q ss_pred eEe-cccCceEEEEEEEc--c----CCeEEEEEEeecccc--cCCHHHHHHHHHHHHHHHhCCC---CCceeeeeeEEcC
Q 006779 31 EIL-GKGAFKTVYKGFDE--V----DGIEVAWNQVNIEDV--MQSPDQLERLYSEVHLLKSLKH---ENIIKFYNSWVDD 98 (631)
Q Consensus 31 e~L-G~G~fg~Vy~a~d~--~----tg~~VAiK~i~~~~~--~~~~~~~~~l~~Ei~iLk~L~H---pnIVkl~~~~~d~ 98 (631)
+.| +.|....+|+.... . +|..+++|....... ... ...+.+|+.+|+.|.. -.+.+++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 567 88889999987543 1 267788887643220 000 1346678888888742 3566777755333
Q ss_pred C-CCeEEEEEeccCCCCH
Q 006779 99 T-NRTINMITELFTSGSL 115 (631)
Q Consensus 99 ~-~~~l~lV~Ey~~gGsL 115 (631)
. ....++||||++|.++
T Consensus 103 ~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TTTSSCEEEEECCCCBCC
T ss_pred CccCCceEEEEecCCCCh
Confidence 1 1345789999988654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00058 Score=70.27 Aligned_cols=30 Identities=23% Similarity=0.402 Sum_probs=25.5
Q ss_pred CCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 149 ~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
+.++|+|+++.||+++ .++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~-~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLG-ENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEEC-GGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEe-CCCcEEEEehhhcc
Confidence 3599999999999996 46789999999763
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0026 Score=68.39 Aligned_cols=29 Identities=21% Similarity=0.454 Sum_probs=24.5
Q ss_pred CCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 149 ~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
+.++|+|++|.|||++ .++ +.|+||+.+.
T Consensus 232 ~~liHGDl~~~Nil~~-~~~-~~lID~e~a~ 260 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVT-QDS-TQVIDPEFSF 260 (420)
T ss_dssp CEEECSCCSGGGEEEC-SSC-EEECCCTTCE
T ss_pred CeEEecCCCCCcEEEe-CCC-CEEEeCcccc
Confidence 3499999999999997 444 9999998774
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.006 Score=63.33 Aligned_cols=74 Identities=15% Similarity=0.043 Sum_probs=54.6
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC---CCCceeeeeeEEcCCCCeEEEEE
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~---HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
+.|+.|.+..+|+... ++..+++|..... ....+..|+..|+.|. ...+++++.+..+. ...++||
T Consensus 42 ~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~lvm 110 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND--EVQTVFVKINERS-------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSFLLL 110 (312)
T ss_dssp EEECCSSSSEEEEEES--SSCEEEEEEEEGG-------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEEEEE
T ss_pred EEeCCccceeeeEEEE--CCCeEEEEeCCcc-------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceEEEE
Confidence 5689999999999864 4677888876522 2456788999888883 35677777765433 4688999
Q ss_pred eccCCCCH
Q 006779 108 ELFTSGSL 115 (631)
Q Consensus 108 Ey~~gGsL 115 (631)
||++|..+
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.46 E-value=0.016 Score=57.11 Aligned_cols=122 Identities=20% Similarity=0.182 Sum_probs=80.4
Q ss_pred CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHH-HhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCCcccc
Q 006779 113 GSLRQYRKK-HKNVDMKAIKNWARQILRGLHYL-HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190 (631)
Q Consensus 113 GsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yL-Hs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~~~~~ 190 (631)
-||.+.++. ..++++++++.++.|.+.+|.-+ +...+ ..+=+.|..|++. .+|.|-+.+ +.+. .
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~-~dG~V~f~~-~~s~----------~ 98 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVW-RDGAVTLAP-AADD----------A 98 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEE-TTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEe-cCCceeccc-cccc----------c
Confidence 479998875 56899999999999999998876 32221 2344556889997 788887654 1110 1
Q ss_pred CCCCCCCccccccccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcCC
Q 006779 191 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP 268 (631)
Q Consensus 191 GTp~Y~APEvl~~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~~ 268 (631)
....+.|||......+.+.=|||||+++|.-+--..|-. -+...++.+-.||..|..+
T Consensus 99 ~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~e~--------------------eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 99 GEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLKEN--------------------EERELSPPLEQLIDHMANT 156 (229)
T ss_dssp --------CCSSSSSCHHHHHHHHHHHHHHHHTTTCCTT--------------------EEECCCHHHHHHHHHHTTC
T ss_pred cccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCCcc--------------------cchhhCHHHHHHHHHHHhc
Confidence 233466888765555678889999999999986555432 2234567888888888753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.35 E-value=0.026 Score=56.98 Aligned_cols=75 Identities=13% Similarity=0.002 Sum_probs=49.9
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC---CCceeeeeeEEcCCCCeEEEE
Q 006779 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH---ENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 30 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~H---pnIVkl~~~~~d~~~~~l~lV 106 (631)
.+.+|.|..+.||+.. ..+|+.|++|+-..... .....+..|+..|+.|.- -.+++++.+ +. -++|
T Consensus 20 v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~----~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~----~~lv 88 (288)
T 3f7w_A 20 VAERGHSHRWHLYRVE-LADGTPLFVKALPDDAP----ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD----RTLA 88 (288)
T ss_dssp EEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCC----CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET----TEEE
T ss_pred EEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCc----chhhHHHHHHHHHHHHHhhCCCCcceEEec--cC----ceEE
Confidence 4679999999999986 45789999997543221 112346789999988842 234455542 22 2578
Q ss_pred EeccCCCCH
Q 006779 107 TELFTSGSL 115 (631)
Q Consensus 107 ~Ey~~gGsL 115 (631)
|||+.++..
T Consensus 89 ~e~l~~~~~ 97 (288)
T 3f7w_A 89 MEWVDERPP 97 (288)
T ss_dssp EECCCCCCC
T ss_pred EEeecccCC
Confidence 899987653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.24 E-value=0.014 Score=60.25 Aligned_cols=30 Identities=23% Similarity=0.277 Sum_probs=25.0
Q ss_pred CEEeccCCCCCeeecCC---CCcEEEccccccc
Q 006779 150 PIIHRDLKCDNIFVNGN---NGEVKIGDLGLAI 179 (631)
Q Consensus 150 ~IiHrDLKp~NILl~~~---~g~vKL~DFGla~ 179 (631)
.++|||+.+.||+++.. .+.+.|+||+.+.
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 49999999999999732 2678999999874
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.23 E-value=0.013 Score=59.61 Aligned_cols=71 Identities=8% Similarity=0.063 Sum_probs=41.0
Q ss_pred eeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc-eeeeeeEEcCCCCeEEEEEe
Q 006779 30 DEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNRTINMITE 108 (631)
Q Consensus 30 ~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnI-Vkl~~~~~d~~~~~l~lV~E 108 (631)
.+.|+.|....+|+. ..+++|+..... .......+|+.+++.+...++ .+++.. +.... ++|+|
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~-----~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~--~~v~e 87 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT-----EEYINRANEAVAAREAAKAGVSPEVLHV--DPATG--VMVTR 87 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC---------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTC--CEEEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc-----cceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCC--EEEEe
Confidence 366888999999998 457778765321 011112457777777643222 455543 33322 46889
Q ss_pred cc-CCCCH
Q 006779 109 LF-TSGSL 115 (631)
Q Consensus 109 y~-~gGsL 115 (631)
|+ .|.+|
T Consensus 88 ~i~~g~~l 95 (301)
T 3dxq_A 88 YIAGAQTM 95 (301)
T ss_dssp CCTTCEEC
T ss_pred ecCCCccC
Confidence 99 66444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.76 E-value=0.016 Score=61.87 Aligned_cols=138 Identities=15% Similarity=0.203 Sum_probs=79.5
Q ss_pred eEecccCceEEEEEEEcc-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC-CCceeeeeeEEcCCCCe
Q 006779 31 EILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~-------tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~H-pnIVkl~~~~~d~~~~~ 102 (631)
+.|..|-...+|+..... ++..+++|+... ... ....+.+|..+++.|.- .-..+++..+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~--- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--ILQ---GVDSLVLESVMFAILAERSLGPQLYGVF--PE--- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----C---CHHHHHHHHHHHHHHHHTTSSCCEEEEE--TT---
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--ccc---hHHHHHHHHHHHHHHHhcCCCCeEEEEc--CC---
Confidence 557778888899987642 357888887521 111 23445689998888842 2235566544 32
Q ss_pred EEEEEeccCCCCHH-----------HH---HHh-C-------CCCC--HHHHHHHHHHHHH-------------------
Q 006779 103 INMITELFTSGSLR-----------QY---RKK-H-------KNVD--MKAIKNWARQILR------------------- 139 (631)
Q Consensus 103 l~lV~Ey~~gGsL~-----------~~---l~~-~-------~~l~--~~~i~~i~~QIl~------------------- 139 (631)
.+|+||++|.+|. .. +.+ | +... ..++.+|..|+-.
T Consensus 126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 204 (379)
T 3feg_A 126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD 204 (379)
T ss_dssp -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence 2789999985542 11 111 1 1112 4667777766532
Q ss_pred HHHHH----HhCC--CCEEeccCCCCCeeecCC---CCcEEEccccccc
Q 006779 140 GLHYL----HSHN--PPIIHRDLKCDNIFVNGN---NGEVKIGDLGLAI 179 (631)
Q Consensus 140 aL~yL----Hs~~--~~IiHrDLKp~NILl~~~---~g~vKL~DFGla~ 179 (631)
.+..| ...+ ..++|+|+.+.||+++.. .+.+.|+||..+.
T Consensus 205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 12333 2222 238999999999999743 2689999998773
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.73 E-value=0.025 Score=61.11 Aligned_cols=72 Identities=13% Similarity=0.118 Sum_probs=46.7
Q ss_pred eEecccCceEEEEEEEcc-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc-eeeeeeEEcCCCCe
Q 006779 31 EILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNRT 102 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~-------tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnI-Vkl~~~~~d~~~~~ 102 (631)
+.|+.|....||++.... ++..+++|+.... .. .+.+..|+.+++.|...++ .++++.+ .+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~---~~~li~E~~~l~~L~~~g~~P~l~~~~--~~--- 147 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ET---ESHLVAESVIFTLLSERHLGPKLYGIF--SG--- 147 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CC---HHHHHHHHHHHHHHHHTTSSSCEEEEE--TT---
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEe--CC---
Confidence 568888889999997642 3578888877321 11 1335579998888853333 5566644 22
Q ss_pred EEEEEeccCCCC
Q 006779 103 INMITELFTSGS 114 (631)
Q Consensus 103 l~lV~Ey~~gGs 114 (631)
.+|+||++|.+
T Consensus 148 -g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 -GRLEEYIPSRP 158 (429)
T ss_dssp -EEEECCCCEEE
T ss_pred -CEEEEEeCCcc
Confidence 26889998633
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.58 E-value=0.054 Score=55.43 Aligned_cols=75 Identities=11% Similarity=-0.000 Sum_probs=44.9
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC--CceeeeeeEEcC-----CCCeE
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE--NIIKFYNSWVDD-----TNRTI 103 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~Hp--nIVkl~~~~~d~-----~~~~l 103 (631)
+.|+ |....||+... .+|..+++|....... + ...+..|+.+++.|... .+++++.. +. ..+..
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~--~---~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~ 102 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW--T---ADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFY 102 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS--C---HHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC--C---HHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEE
Confidence 3466 88889998743 3566789998763211 2 23456688887777422 23444432 11 12356
Q ss_pred EEEEeccCCCC
Q 006779 104 NMITELFTSGS 114 (631)
Q Consensus 104 ~lV~Ey~~gGs 114 (631)
+++++|+.|.+
T Consensus 103 ~~l~~~i~G~~ 113 (328)
T 1zyl_A 103 FAVFPSVGGRQ 113 (328)
T ss_dssp EEEEECCCCEE
T ss_pred EEEEEecCCCC
Confidence 78999998743
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.55 E-value=0.043 Score=55.97 Aligned_cols=140 Identities=14% Similarity=0.118 Sum_probs=72.5
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC--ceeeeeeE----EcCCCCeEE
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN--IIKFYNSW----VDDTNRTIN 104 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~Hpn--IVkl~~~~----~d~~~~~l~ 104 (631)
+.|+.|....+|+.... .| .+++|...... ..+.+..|+.+++.|...+ +.+++... ........+
T Consensus 28 ~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~------~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTT-KD-PLILTLYEKRV------EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEECC---EEEEEEEES-SC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eccCCCcccceEEEEeC-Cc-cEEEEEeCCCC------CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 45778888999998643 34 67888876321 1123556777777663212 23333210 000113568
Q ss_pred EEEeccCCCCH-----HHH------HH----hCCC--------CCHHHHHHHH---------------HHHHHHHHHHHh
Q 006779 105 MITELFTSGSL-----RQY------RK----KHKN--------VDMKAIKNWA---------------RQILRGLHYLHS 146 (631)
Q Consensus 105 lV~Ey~~gGsL-----~~~------l~----~~~~--------l~~~~i~~i~---------------~QIl~aL~yLHs 146 (631)
++++|++|..+ ..+ +. .... .........+ ..+...+.+++.
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 89999988543 111 11 1011 1111111100 113344555543
Q ss_pred C-----CCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 147 H-----NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 147 ~-----~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
. .+.++|+|+.+.|||++ .++.+.|+||+.+.
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~-~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFL-GDELSGLIDFYFAC 216 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEE-TTEEEEECCCTTCE
T ss_pred hCcccCCcccCCCCCCccCEEEe-CCceEEEecchhcc
Confidence 2 12489999999999997 44445799998763
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.45 E-value=0.12 Score=56.33 Aligned_cols=74 Identities=18% Similarity=0.144 Sum_probs=46.2
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc-eeeeeeEEcCCCCeEEEEEec
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnI-Vkl~~~~~d~~~~~l~lV~Ey 109 (631)
+.|+.|-...+|+......+..+++|+..... ...+. ..+|..+|+.|...++ .++++.+ .+ . +|+||
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~----~~~id-R~~E~~vl~~L~~~gl~P~ll~~~--~~--G--~v~e~ 182 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT----DEIIN-REREKKISCILYNKNIAKKIYVFF--TN--G--RIEEF 182 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C----CSCSC-HHHHHHHHHHHTTSSSBCCEEEEE--TT--E--EEEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh----hhhcC-HHHHHHHHHHHHhcCCCCCEEEEe--CC--e--EEEEe
Confidence 56888888999999765546888888764221 00011 2478999998865555 4566654 22 2 48999
Q ss_pred cCCCCH
Q 006779 110 FTSGSL 115 (631)
Q Consensus 110 ~~gGsL 115 (631)
++|.+|
T Consensus 183 I~G~~l 188 (458)
T 2qg7_A 183 MDGYAL 188 (458)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 987443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=94.82 E-value=0.032 Score=58.45 Aligned_cols=73 Identities=14% Similarity=0.129 Sum_probs=41.4
Q ss_pred eEecccCceEEEEEEEcc--------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC-ceeeeeeEEcCCCC
Q 006779 31 EILGKGAFKTVYKGFDEV--------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN-IIKFYNSWVDDTNR 101 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~--------tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~Hpn-IVkl~~~~~d~~~~ 101 (631)
+.|+.|....+|+..... .+..+++|+..... ........|..+++.|...+ +.+++..+ . .
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~ 109 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-----DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--G 109 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-----GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-----cceecHHHHHHHHHHHHhcCCCCceEEec--C--C
Confidence 567888888999987543 13678888764321 11111356888888774333 34666543 2 1
Q ss_pred eEEEEEeccCCCC
Q 006779 102 TINMITELFTSGS 114 (631)
Q Consensus 102 ~l~lV~Ey~~gGs 114 (631)
++|++|++|.+
T Consensus 110 --~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 --GRIEEWLYGDP 120 (369)
T ss_dssp --EEEEECCCSEE
T ss_pred --cEEEEEecCCc
Confidence 46899998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=93.92 E-value=0.32 Score=50.50 Aligned_cols=29 Identities=24% Similarity=0.413 Sum_probs=25.1
Q ss_pred CEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 150 ~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
.++|+|+.+.||+++ .++.+.|+||+.+.
T Consensus 207 ~~~HgD~~~~N~l~~-~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVG-NEESIYIIDWDEPM 235 (339)
T ss_dssp EEECSCCCGGGEEEC-GGGCEEECCCSSCE
T ss_pred eeEeCCCCcCCEEEe-CCCeEEEEECCCCe
Confidence 499999999999997 56789999998764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=87.61 E-value=2.7 Score=45.18 Aligned_cols=136 Identities=12% Similarity=0.150 Sum_probs=79.4
Q ss_pred eEecccCceEEEEEEEcc-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC-ceeeeeeEEcCCCCe
Q 006779 31 EILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN-IIKFYNSWVDDTNRT 102 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~-------tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~Hpn-IVkl~~~~~d~~~~~ 102 (631)
+.|..|-...+|+..... ++..+++++..... . ..-...+|..+++.|.--+ ..++++.+ ..
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--- 145 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----G-KFYDSKVELDVFRYLSNINIAPNIIADF--PE--- 145 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC------CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT---
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----c-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC---
Confidence 567778888999987652 15788888754221 1 1111346888887774222 34555533 21
Q ss_pred EEEEEeccCCCCHH-----------HH---HH------h-C-------CC--CCHHHHHHHHHHHHH-------------
Q 006779 103 INMITELFTSGSLR-----------QY---RK------K-H-------KN--VDMKAIKNWARQILR------------- 139 (631)
Q Consensus 103 l~lV~Ey~~gGsL~-----------~~---l~------~-~-------~~--l~~~~i~~i~~QIl~------------- 139 (631)
++|++|++|.+|. .. +. . . .+ .-...+..|..++-.
T Consensus 146 -~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~ 224 (424)
T 3mes_A 146 -GRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKEL 224 (424)
T ss_dssp -EEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHH
T ss_pred -CEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhcccc
Confidence 5689999986531 11 11 0 0 11 124556666654322
Q ss_pred ------HHHHHHhC----------------------CCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 140 ------GLHYLHSH----------------------NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 140 ------aL~yLHs~----------------------~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
.+..|... ...++|+|+.+.||+ + .++.+.|+||..+.
T Consensus 225 ~~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~-~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 225 YSKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-Q-TQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-E-CSSCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-c-CCCcEEEEecccCC
Confidence 22333211 123899999999999 5 67889999998774
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.00 E-value=1.6 Score=46.23 Aligned_cols=29 Identities=17% Similarity=0.264 Sum_probs=23.8
Q ss_pred EEeccCCCCCeeec-----CCCCcEEEccccccc
Q 006779 151 IIHRDLKCDNIFVN-----GNNGEVKIGDLGLAI 179 (631)
Q Consensus 151 IiHrDLKp~NILl~-----~~~g~vKL~DFGla~ 179 (631)
++|+|+.+.|||+. ..++.+.++||-.|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 57999999999993 245679999998774
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 631 | ||||
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-84 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-65 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-63 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-59 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-57 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-54 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-53 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-52 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-51 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-50 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-50 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-50 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-49 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-49 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-49 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-48 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-47 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-47 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-45 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-45 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-45 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-45 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-45 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-44 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-44 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-44 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-44 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-43 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-42 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-42 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-41 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-41 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-40 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-38 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-37 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-36 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-19 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 262 bits (670), Expect = 8e-84
Identities = 134/263 (50%), Positives = 185/263 (70%), Gaps = 5/263 (1%)
Query: 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
R+ ++D +G+G+FKTVYKG D +EVAW ++ + + + +R E +LK L+
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQ 66
Query: 85 HENIIKFYNSWVD--DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
H NI++FY+SW + I ++TEL TSG+L+ Y K+ K + +K +++W RQIL+GL
Sbjct: 67 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 126
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE 202
+LH+ PPIIHRDLKCDNIF+ G G VKIGDLGLA + + A++VIGTPEFMAPE+YE
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE 186
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
E+Y+E VD+Y+FGMC+LEM T EYPY+EC+N AQIY++VTSG+KPAS KV P+VK+ I
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246
Query: 263 EKCIVP-ASLRLPALELLKDPFL 284
E CI R +LL F
Sbjct: 247 EGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 213 bits (544), Expect = 9e-65
Identities = 84/303 (27%), Positives = 140/303 (46%), Gaps = 16/303 (5%)
Query: 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE 76
F + DP + EI G G+F VY D + VA +++ QS ++ + + E
Sbjct: 8 FFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKE 65
Query: 77 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ 136
V L+ L+H N I++ ++ + ++ E + K + I
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHG 123
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 196
L+GL YLHSHN +IHRD+K NI ++ G VK+GD G A +M A S +GTP +M
Sbjct: 124 ALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP--ANSFVGTPYWM 178
Query: 197 APELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
APE+ E +Y+ VD++S G+ +E+ + P N + PA S
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSG 237
Query: 253 VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNLA 310
+ F++ C+ R + LLK F++ + P ++ D + R + V E+ NL
Sbjct: 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQ 297
Query: 311 HSE 313
+ +
Sbjct: 298 YRK 300
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 3e-63
Identities = 70/265 (26%), Positives = 130/265 (49%), Gaps = 16/265 (6%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+G G++ K + DG + W +++ + + + + L SEV+LL+ LKH NI++
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVR 67
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQY----RKKHKNVDMKAIKNWARQILRGLHYLHS 146
+Y+ +D TN T+ ++ E G L K+ + +D + + Q+ L H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 147 HN---PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY 201
+ ++HRDLK N+F++G VK+GD GLA ++ T A++ +GTP +M+PE
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 186
Query: 202 E-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
YNE DI+S G + E+ P+ + ++ K+ G K + ++ +
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREG-KFRRIPYRYSDELNE 244
Query: 261 FIEKCIVP-ASLRLPALELLKDPFL 284
I + + R E+L++P +
Sbjct: 245 IITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 4e-61
Identities = 86/294 (29%), Positives = 141/294 (47%), Gaps = 24/294 (8%)
Query: 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV 77
S DP +Y R+++I G+GA TVY D G EVA Q+N++ + E + +E+
Sbjct: 14 SVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQ----QPKKELIINEI 68
Query: 78 HLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQI 137
+++ K+ NI+ + +S++ + ++ E GSL + D I R+
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCREC 125
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEF 195
L+ L +LHS+ +IHRD+K DNI + +G VK+ D G I +Q +++GTP +
Sbjct: 126 LQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 196 MAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254
MAPE + + Y VDI+S G+ +EM+ E PY +Y T+G +
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242
Query: 255 DPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVM 307
+ F+ +C+ R A ELL+ FL P L +L P +
Sbjct: 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP---------LSSLTPLIA 287
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-60
Identities = 59/260 (22%), Positives = 118/260 (45%), Gaps = 11/260 (4%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
LGKG F VY ++ +A + ++ +L EV + L+H NI++
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNILR 70
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
Y + D T + +I E G++ + +K D + + ++ L Y HS
Sbjct: 71 LYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-- 126
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELV 209
+IHRD+K +N+ + + GE+KI D G ++ ++ GT +++ PE + ++E V
Sbjct: 127 VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 185
Query: 210 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP- 268
D++S G+ E + + P+ E + YK+++ + + I + +
Sbjct: 186 DLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRV--EFTFPDFVTEGARDLISRLLKHN 242
Query: 269 ASLRLPALELLKDPFLVTDN 288
S R E+L+ P++ ++
Sbjct: 243 PSQRPMLREVLEHPWITANS 262
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 1e-59
Identities = 75/282 (26%), Positives = 132/282 (46%), Gaps = 20/282 (7%)
Query: 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL 80
+P + LG GAF VYK ++ + A ++ +S ++LE E+ +L
Sbjct: 9 NPEDFW-EIIGELGDGAFGKVYKAQNKETSVLAAAKVID----TKSEEELEDYMVEIDIL 63
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILR 139
S H NI+K +++ + N + ++ E G++ + + + I+ +Q L
Sbjct: 64 ASCDHPNIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLD 121
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMA 197
L+YLH + IIHRDLK NI +G++K+ D G++ + R S IGTP +MA
Sbjct: 122 ALNYLHDNK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 178
Query: 198 PELY------EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 251
PE+ + Y+ D++S G+ ++EM E P++E + K S +
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP 238
Query: 252 KVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 292
K F++KC+ R +LL+ PF+ D+ K +
Sbjct: 239 SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPI 280
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-57
Identities = 65/267 (24%), Positives = 120/267 (44%), Gaps = 15/267 (5%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ LG+GA+ V + V VA V+++ + P+ +++ E+ + K L HEN++K
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVK 67
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
FY + + E + G L + + + + Q++ G+ YLH
Sbjct: 68 FYGHRREGNI--QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG-- 123
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPELYEEE-- 204
I HRD+K +N+ ++ +KI D GLA V ++ + GT ++APEL +
Sbjct: 124 ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 205 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
+ E VD++S G+ + M+ E P+++ + Q Y + K D + K
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242
Query: 265 CIVP-ASLRLPALELLKDPFLVTDNPK 290
+V S R+ ++ KD + K
Sbjct: 243 ILVENPSARITIPDIKKDRWYNKPLKK 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 4e-57
Identities = 67/304 (22%), Positives = 123/304 (40%), Gaps = 50/304 (16%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
LG G V+K + G+ +A +++E P ++ E+ +L I+
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVG 68
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
FY ++ D I++ E GSL Q KK + + + + +++GL YL +
Sbjct: 69 FYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH-K 125
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELV 209
I+HRD+K NI VN + GE+K+ D G++ + A S +GT +M+PE L Y+
Sbjct: 126 IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 210 DIYSFGMCILEMVTCEYPY----------------------------------------- 228
DI+S G+ ++EM YP
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244
Query: 229 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTD 287
++ + + P S V + + F+ KC++ + R +L+ F+
Sbjct: 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304
Query: 288 NPKD 291
+ ++
Sbjct: 305 DAEE 308
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-54
Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 26/270 (9%)
Query: 26 YGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
G+ + +G G+F TVYKG +VA +N+ +P QL+ +EV +L+
Sbjct: 7 DGQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVT--APTPQQLQAFKNEVGVLRKT 61
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLH 142
+H NI+ F + ++T+ SL + +M + + ARQ +G+
Sbjct: 62 RHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAP 198
YLH+ + IIHRDLK +NIF++ + VKIGD GLA V + + + G+ +MAP
Sbjct: 119 YLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 199 ELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254
E+ + Y+ D+Y+FG+ + E++T + PY+ N QI V G LSKV
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235
Query: 255 D---PQVKQFIEKCIVP-ASLRLPALELLK 280
+K+ + +C+ R ++L
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-53
Identities = 67/263 (25%), Positives = 123/263 (46%), Gaps = 15/263 (5%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
++ +ILG+G+F TV + E A + + +++ + E ++ L H
Sbjct: 11 KFGKILGEGSFSTVVLARELATSREYAIKILEKRH-IIKENKVPYVTRERDVMSRLDHPF 69
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
+K Y ++ DD + +G L +Y +K + D + + +I+ L YLH
Sbjct: 70 FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYE 202
IIHRDLK +NI +N + ++I D G A V+ +Q A S +GT ++++PE L E
Sbjct: 128 G--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
+ + D+++ G I ++V P+ N I++K+ + P+ + +
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKL--EYDFPEKFFPKARDLV 241
Query: 263 EKCIVP-ASLRLPALELLKDPFL 284
EK +V A+ RL E+ L
Sbjct: 242 EKLLVLDATKRLGCEEMEGYGPL 264
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 183 bits (466), Expect = 4e-53
Identities = 70/301 (23%), Positives = 127/301 (42%), Gaps = 20/301 (6%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
YD E LG GAF V++ + G A V E + E+ + L+H
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRH 82
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYL 144
++ ++++ DD + MI E + G L + +H + + RQ+ +GL ++
Sbjct: 83 PTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 145 HSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEFMAPELYE 202
H +N +H DLK +NI + E+K+ D GL + + + + GT EF APE+ E
Sbjct: 141 HENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 198
Query: 203 -EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVK 259
+ D++S G+ +++ P+ +N + + V S S K
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257
Query: 260 QFIEKCIVP-ASLRLPALELLKDPFLVTDNP--KDLVCDPLRLPNLVPEVMNLAHSEPHP 316
FI K ++ + R+ + L+ P+L N +D R + + + P P
Sbjct: 258 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEP 317
Query: 317 M 317
+
Sbjct: 318 L 318
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 181 bits (460), Expect = 9e-53
Identities = 60/290 (20%), Positives = 120/290 (41%), Gaps = 16/290 (5%)
Query: 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL 79
+D Y + ++LG GAF V D+ VA + + + +E E+ +
Sbjct: 5 EDIRDIY-DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMEN---EIAV 60
Query: 80 LKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILR 139
L +KH NI+ + + + + +I +L + G L + + Q+L
Sbjct: 61 LHKIKHPNIVALDDIYESGGH--LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 118
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFM 196
+ YLH I+HRDLK +N+ + ++ I D GL+ + + + GTP ++
Sbjct: 119 AVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 176
Query: 197 AP-ELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKV 253
AP L ++ Y++ VD +S G+ ++ P+ + +N A++++++ +
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDD 235
Query: 254 TDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 302
K FI + R + L+ P++ D D +
Sbjct: 236 ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQI 285
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 182 bits (463), Expect = 1e-52
Identities = 62/273 (22%), Positives = 112/273 (41%), Gaps = 16/273 (5%)
Query: 26 YGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
Y YD E LG GAF V++ ++ G +N P + +E+ ++ L
Sbjct: 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQL 83
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLH 142
H +I ++++ D + +I E + G L + + + N+ RQ GL
Sbjct: 84 HHPKLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPEL 200
++H H+ I+H D+K +NI VKI D GLA + + T EF APE+
Sbjct: 142 HMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 199
Query: 201 YE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQV 258
+ E D+++ G+ +++ P+ + + + P+
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259
Query: 259 KQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
K FI+ + RL + L+ P+L D+
Sbjct: 260 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 6e-51
Identities = 71/296 (23%), Positives = 127/296 (42%), Gaps = 16/296 (5%)
Query: 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ--LERLY 74
F +++ Y E LG G F V K ++ G++ A + S E +
Sbjct: 3 FRQENVDDYY-DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 75 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWA 134
EV +LK ++H N+I + + + T+ + +I EL G L + + +++ + +
Sbjct: 62 REVSILKEIQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFL 119
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTARS-VI 190
+QIL G++YLHS I H DLK +NI + N +KI D GLA + +
Sbjct: 120 KQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 177
Query: 191 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--P 247
GTPEF+APE+ E D++S G+ +++ P+ + V++
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANVSAVNYEFE 236
Query: 248 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 302
T K FI + +V R+ + L+ P++ + + + P
Sbjct: 237 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQF 292
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 174 bits (443), Expect = 1e-50
Identities = 67/278 (24%), Positives = 121/278 (43%), Gaps = 25/278 (8%)
Query: 26 YGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM-----QSPDQLERLYSEVH 78
Y Y+ EILG+G V + + E A +++ + + E EV
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 79 LLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQI 137
+L+ + H NII+ +++ +T ++ +L G L Y + + K + R +
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 119
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFM 196
L + LH N I+HRDLK +NI ++ ++ +K+ D G + + R V GTP ++
Sbjct: 120 LEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYL 176
Query: 197 APELYEEE-------YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 249
APE+ E Y + VD++S G+ + ++ P+ + + + + SG
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFG 235
Query: 250 LSKVTD--PQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
+ D VK + + +V R A E L PF
Sbjct: 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 1e-50
Identities = 57/268 (21%), Positives = 116/268 (43%), Gaps = 19/268 (7%)
Query: 26 YGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
Y +Y E LG+G F V++ + V ++ Q + E+ +L
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-----VLVKKEISILNIA 58
Query: 84 KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLH 142
+H NI+ + S+ + MI E + + + ++ + I ++ Q+ L
Sbjct: 59 RHRNILHLHESFESMEE--LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 143 YLHSHNPPIIHRDLKCDNIFV-NGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPEL 200
+LHSHN I H D++ +NI + +KI + G A ++ R + PE+ APE+
Sbjct: 117 FLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 201 YEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSKVTDPQ 257
++ + + D++S G + +++ P+ + QI + + + K +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPF-LAETNQQIIENIMNAEYTFDEEAFKEISIE 233
Query: 258 VKQFIEKCIVP-ASLRLPALELLKDPFL 284
F+++ +V R+ A E L+ P+L
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQHPWL 261
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (442), Expect = 3e-50
Identities = 55/286 (19%), Positives = 108/286 (37%), Gaps = 19/286 (6%)
Query: 7 FTKSETEEG--EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM 64
FT + E EF+++ + ++++G G F V G ++ G + +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCV-KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHK 123
+ Q SE ++ H N+I T + +ITE +GSL + R+
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP--VMIITEFMENGSLDSFLRQNDG 123
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
+ + R I G+ YL N +HRDL NI VN +N K+ D GL+ ++
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLED 180
Query: 184 PTARSV-------IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA 235
T+ + APE + ++ D++S+G+ + E+++
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240
Query: 236 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
+ + + + Q + C + R +++
Sbjct: 241 DVINAIEQDYRLPPPMDC-PSALHQLMLDCWQKDRNHRPKFGQIVN 285
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 173 bits (439), Expect = 1e-49
Identities = 71/285 (24%), Positives = 129/285 (45%), Gaps = 18/285 (6%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
LG G+F V+ +G A + ++++ Q+E E +L + H II+
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLK-KEIVVRLKQVEHTNDERLMLSIVTHPFIIR 68
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
+ ++ D I MI + G L +K + K +A ++ L YLHS +
Sbjct: 69 MWGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD-- 124
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELV 209
II+RDLK +NI ++ NG +KI D G A + T ++ GTP+++APE + + YN+ +
Sbjct: 125 IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDVT-YTLCGTPDYIAPEVVSTKPYNKSI 182
Query: 210 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-- 267
D +SFG+ I EM+ P+ + N + Y+K+ + + VK + + I
Sbjct: 183 DWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITRD 239
Query: 268 ----PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 308
+L+ ++ P+ + L+ + P P +
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP-YEPPIQQ 283
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 171 bits (433), Expect = 2e-49
Identities = 60/270 (22%), Positives = 106/270 (39%), Gaps = 16/270 (5%)
Query: 27 GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY+ EILG G V+ D +VA + D+ + P R E +L
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRA-DLARDPSFYLRFRREAQNAAALN 65
Query: 85 HENIIKFYNSWVDDTNR--TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
H I+ Y++ +T ++ E +LR + K + L+
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMA 197
+ H + IIHRD+K NI ++ N VK+ D G+A + +VIGT ++++
Sbjct: 126 FSHQNG--IIHRDVKPANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 198 PELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-LSKVTD 255
PE + + D+YS G + E++T E P+ + Y+ V P S +
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242
Query: 256 PQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
+ + K + R ++ +
Sbjct: 243 ADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 6e-49
Identities = 60/285 (21%), Positives = 131/285 (45%), Gaps = 19/285 (6%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
++LGKG F V ++ G A + ++V+ + D++ +E +L++ +H +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILR-KEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP 150
++ + + E G L + + + + + + +I+ L YLHS +
Sbjct: 70 LKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD-- 125
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYE-EEYNE 207
+++RD+K +N+ ++ +G +KI D GL + T ++ GTPE++APE+ E +Y
Sbjct: 126 VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 267
VD + G+ + EM+ P+ ++ ++++ + + P+ K + +
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILME--EIRFPRTLSPEAKSLLAGLLK 241
Query: 268 ------PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 306
A E+++ F ++ N +D+V L P P+V
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP-FKPQV 285
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 8e-49
Identities = 50/267 (18%), Positives = 105/267 (39%), Gaps = 21/267 (7%)
Query: 27 GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDV--MQSPDQLERLYSEVHLLKS 82
+Y +LG G F +VY G D + VA V + + R+ EV LLK
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 83 LK--HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
+ +I+ + + + + + L + + + + +++ Q+L
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLIL-ERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL 200
+ + H+ ++HRD+K +NI ++ N GE+K+ D G +++ GT + PE
Sbjct: 123 VRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEW 180
Query: 201 YEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258
+ ++S G+ + +MV + P+ + + + +
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV---------SSEC 231
Query: 259 KQFIEKCIVP-ASLRLPALELLKDPFL 284
+ I C+ S R E+ P++
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWM 258
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-48
Identities = 54/254 (21%), Positives = 110/254 (43%), Gaps = 18/254 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ +GKG F V G + G +VA +++ + +E ++ L+H N+++
Sbjct: 13 QTIGKGEFGDVMLG--DYRGNKVAVK------CIKNDATAQAFLAEASVMTQLRHSNLVQ 64
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
V++ + ++TE GSL Y + + + ++ + + YL +N
Sbjct: 65 LLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 123
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNE 207
+HRDL N+ V+ + K+ D GL T + ++ APE L E++++
Sbjct: 124 --FVHRDLAARNVLVS-EDNVAKVSDFGLTKEAS-STQDTGKLPVKWTAPEALREKKFST 179
Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 267
D++SFG+ + E+ + + +V G K + P V + ++ C
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC-PPAVYEVMKNCWH 238
Query: 268 P-ASLRLPALELLK 280
A++R L+L +
Sbjct: 239 LDAAMRPSFLQLRE 252
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 1e-47
Identities = 60/270 (22%), Positives = 113/270 (41%), Gaps = 23/270 (8%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
+ E LG G F V+ G+ +VA ++ + Q + +E +L+K L+H+
Sbjct: 16 KLVERLGAGQFGEVWMGYYN-GHTKVA-----VKSLKQGSMSPDAFLAEANLMKQLQHQR 69
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKAIKNWARQILRGLHYLH 145
+++ Y + I +ITE +GSL + K + + + + A QI G+ ++
Sbjct: 70 LVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM---QQPTARSVIGTPEFMAP-ELY 201
N IHRDL+ NI V+ + KI D GLA ++ + ++ AP +
Sbjct: 127 ERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 202 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261
+ D++SFG+ + E+VT ++ + + G + ++ Q
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC-PEELYQL 242
Query: 262 IEKCIVP-ASLRLPA---LELLKDPFLVTD 287
+ C R +L+D F T+
Sbjct: 243 MRLCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 3e-47
Identities = 69/301 (22%), Positives = 120/301 (39%), Gaps = 39/301 (12%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQL-ERLYSEVHLLKSLKHENII 89
+ LG+G F TVYK D+ VA ++ + ++ D + E+ LL+ L H NII
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
+++ +N I+++ + + + + IK + L+GL YLH H
Sbjct: 64 GLLDAFGHKSN--ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY--EEEY 205
I+HRDLK +N+ ++ NG +K+ D GLA P + T + APEL Y
Sbjct: 121 -ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 206 NELVDIYSFGMCILEMVTCEYPY-------------------------NECKNPAQIYKK 240
VD+++ G + E++ + C P + K
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 241 VTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRL 299
GI + + I+ + R+ A + LK + ++ P +L
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF-SNRPGP--TPGCQL 295
Query: 300 P 300
P
Sbjct: 296 P 296
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 3e-47
Identities = 69/282 (24%), Positives = 129/282 (45%), Gaps = 16/282 (5%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHENII 89
++LGKG+F V+ + A + +DV+ D +E E +L + +H +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALK-KDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
+ ++ N M E G L + + D+ +A +I+ GL +LHS
Sbjct: 67 HMFCTFQTKENLFFVM--EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG- 123
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE-LYEEEYN 206
I++RDLK DNI ++ +G +KI D G+ A+ + GTP+++APE L ++YN
Sbjct: 124 -IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN 181
Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266
VD +SFG+ + EM+ + P+ ++ +++ + + + + K + K
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVKLF 238
Query: 267 VP-ASLRLPAL-ELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 306
V RL ++ + P N ++L + P P+V
Sbjct: 239 VREPEKRLGVRGDIRQHPLFREINWEELERKEID-PPFRPKV 279
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 4e-47
Identities = 48/256 (18%), Positives = 99/256 (38%), Gaps = 18/256 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ +G G F V+ G+ + +VA + + E E ++ L H +++
Sbjct: 11 QEIGSGQFGLVHLGYWL-NKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
Y ++ I ++ E G L Y R + + + + G+ YL
Sbjct: 65 LYGVCLEQAP--ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 121
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPE-LYEEEY 205
+IHRDL N V N +K+ D G+ + ++ +PE Y
Sbjct: 122 -VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
+ D++SFG+ + E+ + E ++ +++ + +++G + ++ V Q + C
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-YKPRLASTHVYQIMNHC 238
Query: 266 IVP-ASLRLPALELLK 280
R LL+
Sbjct: 239 WKERPEDRPAFSRLLR 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 9e-47
Identities = 51/266 (19%), Positives = 107/266 (40%), Gaps = 21/266 (7%)
Query: 30 DEILGKGAFKTVYKGFDEV--DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
D+ LG G F TV KG+ ++ VA + E P + L +E ++++ L +
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPALKDELLAEANVMQQLDNPY 69
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
I++ ++ ++ E+ G L +Y +++++V K I Q+ G+ YL
Sbjct: 70 IVRMIGICEAES---WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPE-LY 201
N +HRDL N+ + KI D GL+ ++ ++ APE +
Sbjct: 127 N--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 202 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261
+++ D++SFG+ + E + +++ + G + + ++
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC-PREMYDL 242
Query: 262 IEKCIVP-ASLRLPA---LELLKDPF 283
+ C R L++ +
Sbjct: 243 MNLCWTYDVENRPGFAAVELRLRNYY 268
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 4e-46
Identities = 69/281 (24%), Positives = 126/281 (44%), Gaps = 16/281 (5%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQ-VNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89
++LG GAF TVYKG +G +V + SP + + E +++ S+ + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHN 148
+ + T + +IT+L G L Y ++HK N+ + + NW QI +G++YL
Sbjct: 75 RLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 131
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYEE 203
++HRDL N+ V VKI D GLA ++ ++ A ++MA E +
Sbjct: 132 --LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 204 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263
Y D++S+G+ + E++T + ++I + G + + V +
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-PQPPICTIDVYMIMV 247
Query: 264 KCIVP-ASLRLPALELLKDP-FLVTDNPKDLVCDPLRLPNL 302
KC + A R EL+ + + D + LV +L
Sbjct: 248 KCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHL 288
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 163 bits (413), Expect = 2e-45
Identities = 58/284 (20%), Positives = 116/284 (40%), Gaps = 20/284 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--QSPDQLERLYSEVHLLKSLKHENI 88
I+G+G F VY G A ++ + + Q + L+ + I
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 89 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
+ ++ ++ I +L G L + +H ++ +A +I+ GL ++H+
Sbjct: 70 VCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF 127
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE--YN 206
+++RDLK NI ++ +G V+I DLGLA + + +GT +MAPE+ ++ Y+
Sbjct: 128 --VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYD 184
Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266
D +S G + +++ P+ + K + + L P+++ +E +
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 244
Query: 267 V------PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVP 304
L A E+ + PF + L + L P
Sbjct: 245 QRDVNRRLGCLGRGAQEVKESPFF-----RSLDWQMVFLQKYPP 283
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 6e-45
Identities = 57/262 (21%), Positives = 108/262 (41%), Gaps = 15/262 (5%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
R + +G+G F V++G + S E+ E ++ H
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYL 144
+I+K ++ + +I EL T G LR + + + ++D+ ++ +A Q+ L YL
Sbjct: 68 PHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPE-L 200
S +HRD+ N+ V+ N VK+GD GL+ M+ T ++MAPE +
Sbjct: 125 ESKR--FVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 201 YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
+ D++ FG+C+ E++ + + ++ +G + + P +
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-PMPPNCPPTLYS 240
Query: 261 FIEKCIVP-ASLRLPALELLKD 281
+ KC S R EL
Sbjct: 241 LMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 159 bits (403), Expect = 7e-45
Identities = 58/257 (22%), Positives = 103/257 (40%), Gaps = 18/257 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
LG G + VY+G + + VA + + ++E E ++K +KH N+++
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQ 77
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
+ I E T G+L Y + V + A QI + YL N
Sbjct: 78 LLGVCTREPPFYIIT--EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 135
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT---PEFMAP-ELYEEE 204
IHRDL N V N VK+ D GL+ +M T + G ++ AP L +
Sbjct: 136 --FIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 205 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
++ D+++FG+ + E+ T + +Q+Y+ + + +V + +
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP-EKVYELMRA 251
Query: 265 CIVP-ASLRLPALELLK 280
C S R E+ +
Sbjct: 252 CWQWNPSDRPSFAEIHQ 268
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 7e-45
Identities = 67/319 (21%), Positives = 117/319 (36%), Gaps = 53/319 (16%)
Query: 22 PSCR-YGRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH 78
P C +Y+ +G+G F V+K G +VA +V +E+ + E+
Sbjct: 4 PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPITALREIK 61
Query: 79 LLKSLKHENIIKFYNSWVDDT------NRTINMITELFTSGSLRQYRKKHKNVDMKAIKN 132
+L+ LKHEN++ +I ++ + + IK
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 121
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA------ 186
+ +L GL+Y+H + I+HRD+K N+ + +G +K+ D GLA
Sbjct: 122 VMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 187 RSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY------ 238
+ + T + PE L E +Y +D++ G + EM T Q+
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 239 -----------------------KKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLP 274
K +K + V DP I+K +V + R+
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298
Query: 275 ALELLKDPFLVTD-NPKDL 292
+ + L F +D P DL
Sbjct: 299 SDDALNHDFFWSDPMPSDL 317
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 8e-45
Identities = 69/273 (25%), Positives = 110/273 (40%), Gaps = 22/273 (8%)
Query: 23 SCRYGRYD----EILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYS 75
+C G D E LG G+F V +G + + VA + DV+ P+ ++
Sbjct: 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK-PDVLSQPEAMDDFIR 60
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWA 134
EV+ + SL H N+I+ Y + + M+TEL GSL +KH+ + + +A
Sbjct: 61 EVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 117
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSV 189
Q+ G+ YL S IHRDL N+ + VKIGD GL + Q
Sbjct: 118 VQVAEGMGYLESKR--FIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 190 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 248
+ APE L ++ D + FG+ + EM T N +QI K+ +
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 234
Query: 249 SLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
+ + + +C R + L
Sbjct: 235 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 8e-45
Identities = 45/267 (16%), Positives = 101/267 (37%), Gaps = 23/267 (8%)
Query: 30 DEILGKGAFKTVYKGFDEV--DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
D LG G F +V +G + I+VA + + E + E ++ L +
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPY 70
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHS 146
I++ + ++ E+ G L ++ K + + + + Q+ G+ YL
Sbjct: 71 IVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 127
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVIGTPEFMAPE-L 200
N +HRDL N+ + N KI D GL+ + + ++ APE +
Sbjct: 128 KN--FVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184
Query: 201 YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
+++ D++S+G+ + E ++ + ++ + G + P++
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-ECPPECPPELYA 243
Query: 261 FIEKCIVPASLRLP----ALELLKDPF 283
+ C + P + ++ +
Sbjct: 244 LMSDCWIYKWEDRPDFLTVEQRMRACY 270
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 1e-44
Identities = 53/257 (20%), Positives = 99/257 (38%), Gaps = 18/257 (7%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+ LG G F V G +VA + + + + E ++ +L HE +++
Sbjct: 10 KELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE-----DEFIEEAKVMMNLSHEKLVQ 63
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
Y I +ITE +G L Y R+ + + + + + YL S
Sbjct: 64 LYGVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ- 120
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS---VIGTPEFMAPELYE-EEY 205
+HRDL N VN + G VK+ D GL+ + S + PE+ ++
Sbjct: 121 -FLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
+ DI++FG+ + E+ + E ++ + + G++ + +V + C
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-YRPHLASEKVYTIMYSC 237
Query: 266 IVP-ASLRLPALELLKD 281
A R LL +
Sbjct: 238 WHEKADERPTFKILLSN 254
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-44
Identities = 57/272 (20%), Positives = 107/272 (39%), Gaps = 22/272 (8%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87
R + LG+G F V+ G VA + + E E ++K L+HE
Sbjct: 20 RLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-----EAFLQEAQVMKKLRHEK 73
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLH 145
+++ Y + I ++TE + GSL + + K + + + + A QI G+ Y+
Sbjct: 74 LVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPE-LY 201
N +HRDL+ NI V N K+ D GLA +++ + ++ APE
Sbjct: 131 RMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187
Query: 202 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261
+ D++SFG+ + E+ T ++ +V G + + +
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC-PESLHDL 246
Query: 262 IEKCIVP-ASLRLPALELLK--DPFLVTDNPK 290
+ +C R L + + + P+
Sbjct: 247 MCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 160 bits (405), Expect = 2e-44
Identities = 65/290 (22%), Positives = 129/290 (44%), Gaps = 20/290 (6%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
++D + LG G+F V + G A ++ + + Q+E +E +L+++
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK-VVKLKQIEHTLNEKRILQAVNF 100
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
++K S+ D N + M+ E G + + ++ + +A QI+ YLH
Sbjct: 101 PFLVKLEFSFKD--NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEE 204
S + +I+RDLK +N+ ++ G +++ D G A ++ T ++ GTPE +APE + +
Sbjct: 159 SLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRT-WTLCGTPEALAPEIILSKG 214
Query: 205 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
YN+ VD ++ G+ I EM P+ P QIY+K+ SG +K +
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFF-ADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRN 271
Query: 265 CIV------PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 308
+ +L+ ++ + T + + + P +P+
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP-FIPKFKG 320
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 2e-44
Identities = 57/278 (20%), Positives = 112/278 (40%), Gaps = 14/278 (5%)
Query: 12 TEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE 71
+ + PS ++E++G+G F VY G + + V + + ++
Sbjct: 14 VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS 73
Query: 72 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK-KHKNVDMKAI 130
+ +E ++K H N++ + + ++ G LR + + + N +K +
Sbjct: 74 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDL 132
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-- 188
+ Q+ +G+ + +HRDL N ++ VK+ D GLA M S
Sbjct: 133 IGFGLQVAKGMK--FLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVH 189
Query: 189 ----VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 243
++MA E L +++ D++SFG+ + E++T P N I +
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
Query: 244 GIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
G + DP + + + KC P A +R EL+
Sbjct: 250 GRRLLQPEYCPDP-LYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 1e-43
Identities = 62/275 (22%), Positives = 111/275 (40%), Gaps = 23/275 (8%)
Query: 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERL 73
+E PSC +++G G F VYKG + + VA + + Q
Sbjct: 2 TEIHPSCV--TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVDF 56
Query: 74 YSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKN 132
E ++ H NII+ I ITE +G+L ++ R+K + +
Sbjct: 57 LGEAGIMGQFSHHNIIRLEGVISKYKPMMI--ITEYMENGALDKFLREKDGEFSVLQLVG 114
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TAR 187
R I G+ YL + N +HRDL NI VN +N K+ D GL+ V++ T
Sbjct: 115 MLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTS 171
Query: 188 SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246
+ APE + ++ D++SFG+ + E++T + ++ K + G +
Sbjct: 172 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR 231
Query: 247 PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
+ + Q + +C + R +++
Sbjct: 232 LPTPMDC-PSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-43
Identities = 50/281 (17%), Positives = 108/281 (38%), Gaps = 28/281 (9%)
Query: 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSL 83
Y ++LG G V + F++ + A + + EV ++
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARREVELHWRAS 62
Query: 84 KHENIIKFYNSWVD--DTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILR 139
+ +I++ + + + + + ++ E G L + + + + I
Sbjct: 63 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122
Query: 140 GLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFM 196
+ YLHS N I HRD+K +N+ N +K+ D G A + + TP ++
Sbjct: 123 AIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYV 180
Query: 197 APELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------PAS 249
APE+ E+Y++ D++S G+ + ++ P+ + I + + I+ P
Sbjct: 181 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS-NHGLAISPGMKTRIRMGQYEFPNP 239
Query: 250 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNP 289
+VK I + + R+ E + P+++
Sbjct: 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 4e-43
Identities = 71/348 (20%), Positives = 132/348 (37%), Gaps = 55/348 (15%)
Query: 5 SGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM 64
S T G+ ++ Y +++G G+F VY+ G VA +V +
Sbjct: 1 SKVTTVVATPGQGPDRPQEVSY-TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-- 57
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIK----FYNSWVDDTNRTINMITELFTSG---SLRQ 117
E+ +++ L H NI++ FY+S +N++ + R
Sbjct: 58 ------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 111
Query: 118 YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177
Y + + + + +K + Q+ R L Y+HS I HRD+K N+ ++ + +K+ D G
Sbjct: 112 YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGS 169
Query: 178 AIVMQQPTA-RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECKNP 234
A + + S I + + APEL +Y +D++S G + E++ + +
Sbjct: 170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 229
Query: 235 AQIYKKVT----------------------SGIKPASLSKV----TDPQVKQFIEKCIVP 268
Q+ + + IK +KV T P+ + +
Sbjct: 230 DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEY 289
Query: 269 -ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL--VPEVMNLAHSE 313
+ RL LE F +L ++LPN P + N E
Sbjct: 290 TPTARLTPLEACAHSFF-----DELRDPNVKLPNGRDTPALFNFTTQE 332
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-42
Identities = 58/273 (21%), Positives = 106/273 (38%), Gaps = 27/273 (9%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHE 86
++ +++G+G F V K + DG+ + + S D E+ +L L H
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDA-AIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAI 130
NII + + + E G+L + +K + + +
Sbjct: 72 NIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
++A + RG+ YL IHRDL NI V N KI D GL+ + +++
Sbjct: 130 LHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 191 -GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 248
+MA E L Y D++S+G+ + E+V+ A++Y+K+ G +
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246
Query: 249 SLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
D +V + +C R ++L
Sbjct: 247 KPLNC-DDEVYDLMRQCWREKPYERPSFAQILV 278
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-42
Identities = 63/283 (22%), Positives = 108/283 (38%), Gaps = 39/283 (13%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQ--LERLYSEVHLLKSL-KHEN 87
++LG GAF V QV ++ + + D E L SE+ ++ L HEN
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN----------------------- 124
I+ + I +I E G L Y + +
Sbjct: 103 IVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184
+ + + +A Q+ +G+ +L + +HRDL N+ V + VKI D GLA +
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVT-HGKVVKICDFGLARDIMSD 217
Query: 185 ----TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIY 238
+ ++MAPE L+E Y D++S+G+ + E+ + PY A Y
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 277
Query: 239 KKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
K + +G K T ++ ++ C + R L
Sbjct: 278 KLIQNGFKMDQPFYAT-EEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 151 bits (382), Expect = 5e-42
Identities = 64/290 (22%), Positives = 110/290 (37%), Gaps = 41/290 (14%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
+Y E +G+G + VYK + G A ++ +E + E+ +LK LKH
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLE--KEDEGIPSTTIREISILKELKH 59
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
NI+K Y+ + ++ E + ++ K++ Q+L G+ Y H
Sbjct: 60 SNIVKLYDVIHTKKR--LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEE 203
++HRDLK N+ +N GE+KI D GLA P + I T + AP++
Sbjct: 118 DRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 204 E--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK---------------------- 239
Y+ +DI+S G EMV + Q+ +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 240 ----KVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
V + S K D + K + + R+ A + L+ +
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 6e-42
Identities = 64/286 (22%), Positives = 116/286 (40%), Gaps = 39/286 (13%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E +G+G + VYK +++ G VA ++ ++ ++ E+ LLK L H NI+K
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 65
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNP 149
+ + + ++ E + + + IK++ Q+L+GL + HSH
Sbjct: 66 LLDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 122
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY--EEEY 205
++HRDLK N+ +N G +K+ D GLA P + T + APE+ + Y
Sbjct: 123 -VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP------------------ 247
+ VDI+S G EMVT + Q+++ + P
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 248 --------ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
+ + D + + + + + R+ A L PF
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 9e-42
Identities = 64/303 (21%), Positives = 124/303 (40%), Gaps = 47/303 (15%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH 85
+Y+ E +G+G + TV+K + VA +V ++D E+ LLK LKH
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKH 60
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145
+NI++ ++ D T+ E + + + ++D + +K++ Q+L+GL + H
Sbjct: 61 KNIVRLHDVLHSDKKLTLVF--EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--VIGTPEFMAPELY-- 201
S N ++HRDLK N+ +N NGE+K+ + GLA P + T + P++
Sbjct: 119 SRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 202 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---------------- 245
+ Y+ +D++S G E+ P + K++ +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 246 -----------KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLV 293
++ + + ++ + R+ A E L+ P+ D
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF-----SDF- 289
Query: 294 CDP 296
C P
Sbjct: 290 CPP 292
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (381), Expect = 1e-41
Identities = 54/280 (19%), Positives = 99/280 (35%), Gaps = 32/280 (11%)
Query: 27 GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY +G G+F +Y G D G EVA ++ + +L+ E + K ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT------KHPQLHIESKIYKMMQ 60
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
I W M+ EL + + +K + A Q++ + Y+
Sbjct: 61 GGVGIPTIR-WCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 145 HSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQP---------TARSVIGTP 193
HS N IHRD+K DN + V I D GLA + +++ GT
Sbjct: 120 HSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 194 EFMAPELYE-EEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSG---IKP 247
+ + + E + D+ S G ++ + + Q Y++++
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237
Query: 248 ASLSKVTDPQVKQFIEKCIVPASLRLP----ALELLKDPF 283
L K + ++ C P +L ++ F
Sbjct: 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 66/298 (22%), Positives = 112/298 (37%), Gaps = 47/298 (15%)
Query: 27 GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY +G+GA+ V +D V+ + VA +++ + +R E+ +L +
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFR 64
Query: 85 HENIIKFYNSWVDDTNRTIN--MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
HENII + T + + L + K + I + QILRGL
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLK 123
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVIGTPEFMA 197
Y+HS N ++HRDLK N+ +N ++KI D GLA V + T + A
Sbjct: 124 YIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 198 PELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-------- 247
PE+ Y + +DI+S G + EM++ + Q+ + P
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 248 --------------------ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
L D + ++K + R+ + L P+L
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-41
Identities = 59/295 (20%), Positives = 125/295 (42%), Gaps = 27/295 (9%)
Query: 31 EILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE- 86
++LG GA+ V+ G A + ++Q E +E +L+ ++
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
++ + ++ +T + + + G L + + + ++ + +I+ L +LH
Sbjct: 90 FLVTLHYAFQTETKLHLIL--DYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK 147
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV---MQQPTARSVIGTPEFMAPELY-- 201
II+RD+K +NI ++ +NG V + D GL+ + A GT E+MAP++
Sbjct: 148 LG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204
Query: 202 -EEEYNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
+ +++ VD +S G+ + E++T P+ E + A+I +++ P +
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSAL 262
Query: 258 VKQFIEKCIV------PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 306
K I++ ++ A E+ + F N DL + P P +
Sbjct: 263 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAP-FKPVI 316
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 3e-41
Identities = 80/313 (25%), Positives = 126/313 (40%), Gaps = 43/313 (13%)
Query: 5 SGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM 64
SGF + E + + + Y R + +G GA+ V D G +VA ++
Sbjct: 2 SGFYRQEVTKTAWEVRA---VY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP--F 55
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS--GSLRQYRKKH 122
QS +R Y E+ LLK ++HEN+I + + D L G+ KH
Sbjct: 56 QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH 115
Query: 123 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182
+ + I+ Q+L+GL Y+H+ HRDLK N+ VN + E+KI D GLA
Sbjct: 116 EKLGEDRIQFLVYQMLKGLRYIHAAGII--HRDLKPGNLAVN-EDCELKILDFGLARQAD 172
Query: 183 QPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240
+ T + APE+ Y + VDI+S G + EM+T + + + Q+ +
Sbjct: 173 SEM-TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 231
Query: 241 VTSGIKP----------------------------ASLSKVTDPQVKQFIEKCIVP-ASL 271
+ P AS+ P +EK +V A
Sbjct: 232 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQ 291
Query: 272 RLPALELLKDPFL 284
R+ A E L P+
Sbjct: 292 RVTAGEALAHPYF 304
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 9e-41
Identities = 73/298 (24%), Positives = 124/298 (41%), Gaps = 39/298 (13%)
Query: 23 SCRY-GRYD--EILGKGAFKTVYKGFD-EVDGIEVAWNQVNIEDVMQS-PDQLERLYSEV 77
CR +Y+ +G+GA+ V+K D + G VA +V ++ + P R + +
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 78 HLLKSLKHENIIKFYNSWVD---DTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNW 133
L++ +H N+++ ++ D + ++ E + V + IK+
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGT 192
Q+LRGL +LHSH ++HRDLK NI V ++G++K+ D GLA I Q SV+ T
Sbjct: 122 MFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVT 178
Query: 193 PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-- 249
+ APE L + Y VD++S G EM + + + Q+ K + P
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 250 ----------------------LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
D K + KC+ + R+ A L P+
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 148 bits (374), Expect = 1e-40
Identities = 55/306 (17%), Positives = 118/306 (38%), Gaps = 55/306 (17%)
Query: 28 RYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK- 84
Y LG+G + V++ + + +V + P + +++ E+ +L++L+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRG 88
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
NII + D +RT ++ E + +Q ++ + I+ + +IL+ L Y
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYC 145
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEE 203
HS I+HRD+K N+ ++ + ++++ D GLA + + F PEL +
Sbjct: 146 HSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 203
Query: 204 E--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT------------------- 242
Y+ +D++S G + M+ + P+ + ++
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 243 ----------------SGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLV 285
+ + P+ F++K + RL A E ++ P+
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF- 322
Query: 286 TDNPKD 291
KD
Sbjct: 323 YTVVKD 328
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 9e-40
Identities = 69/291 (23%), Positives = 111/291 (38%), Gaps = 50/291 (17%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
E +GKG F V++G G EVA + + ++ +E++ L+HENI+
Sbjct: 9 ESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILG 61
Query: 91 FYNSWVDDTNRTINM--ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-- 146
F + D + +++ GSL Y ++ V ++ + A GL +LH
Sbjct: 62 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEI 120
Query: 147 ----HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFM 196
P I HRDLK NI V NG I DLGLA+ T +GT +M
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 197 APELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG----- 244
APE+ ++ E + DIY+ G+ E+ ++ Y +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 245 --------------IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
I S + + + +C + RL AL + K
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (364), Expect = 2e-39
Identities = 49/288 (17%), Positives = 91/288 (31%), Gaps = 44/288 (15%)
Query: 28 RYDEILGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
Y +G+GAF V++ VA + E S D E L+
Sbjct: 16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAE 72
Query: 83 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN------------------ 124
+ NI+K + ++ E G L ++ +
Sbjct: 73 FDNPNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 125 ------VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178
+ ARQ+ G+ YL +HRDL N V N VKI D GL+
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVG-ENMVVKIADFGLS 187
Query: 179 IVMQQPTAR----SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKN 233
+ + +M PE ++ Y D++++G+ + E+ +
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247
Query: 234 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
++ V G + + ++ + C + R + +
Sbjct: 248 HEEVIYYVRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 143 bits (362), Expect = 3e-39
Identities = 37/260 (14%), Positives = 94/260 (36%), Gaps = 30/260 (11%)
Query: 27 GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
Y +G+G+F +++G + ++ +VA + E QL Y LL
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVA---IKFEPRRSDAPQLRDEYRTYKLLAGCT 61
Query: 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
+ ++ ++ +L + +K + A+Q+L + +
Sbjct: 62 GIPNVYYF----GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 145 HSHNPPIIHRDLKCDNIFVN----GNNGEVKIGDLGLAIVMQQP---------TARSVIG 191
H + +++RD+K DN + N + + D G+ + P +++ G
Sbjct: 118 HEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 192 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT--CEYPYNECKNPAQIYKKVTSGIKPA 248
T +M+ + E + D+ + G + + + + Q Y+++ +
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 249 SLSKVTD---PQVKQFIEKC 265
L ++ + +++
Sbjct: 236 PLRELCAGFPEEFYKYMHYA 255
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-38
Identities = 67/281 (23%), Positives = 116/281 (41%), Gaps = 39/281 (13%)
Query: 31 EILGKGAFKTVYKGFD-------EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL 83
+ LG+GAF V +VA + + + L L SE+ ++K +
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMI 75
Query: 84 -KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVD 126
KH+NII + D + +I E + G+LR+Y + + +
Sbjct: 76 GKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 127 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 184
K + + A Q+ RG+ YL S IHRDL N+ V + +KI D GLA +
Sbjct: 134 SKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDY 190
Query: 185 --TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
+ ++MAPE L++ Y D++SFG+ + E+ T +++K +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 242 TSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKD 281
G + S T ++ + C S R +L++D
Sbjct: 251 KEGHRMDKPSNCT-NELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 1e-38
Identities = 54/283 (19%), Positives = 108/283 (38%), Gaps = 38/283 (13%)
Query: 28 RYDEILGKGAFKTVYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS 82
+ + LG GAF V + + VA + + E L SE+ +L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSY 82
Query: 83 LK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN----------------- 124
L H NI+ + +ITE G L + ++ ++
Sbjct: 83 LGNHMNIVNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 125 -VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
+D++ + +++ Q+ +G+ +L S N IHRDL NI + + KI D GLA ++
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLT-HGRITKICDFGLARDIKN 197
Query: 184 PTARSV----IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
+ V ++MAPE ++ Y D++S+G+ + E+ + +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 239 KKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
K+ + ++ ++ C R ++++
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 7e-38
Identities = 53/271 (19%), Positives = 105/271 (38%), Gaps = 24/271 (8%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIE--DVMQSPDQLERLYSEVHLLKSLKH 85
LG+G+F VY+G + + +V I+ + S + +E ++K
Sbjct: 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV----------DMKAIKNWAR 135
++++ +I EL T G L+ Y + + + + A
Sbjct: 83 HHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIG 191
+I G+ YL+++ +HRDL N V + VKIGD G+ + + +
Sbjct: 141 EIADGMAYLNANK--FVHRDLAARNCMVA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 192 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250
+M+PE L + + D++SFG+ + E+ T + + Q+ + V G
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257
Query: 251 SKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
+ + + C +R LE++
Sbjct: 258 DNC-PDMLFELMRMCWQYNPKMRPSFLEIIS 287
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 3e-37
Identities = 56/278 (20%), Positives = 108/278 (38%), Gaps = 29/278 (10%)
Query: 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIE--DVMQSPDQLERLYSEVHLLKSLKH 85
+ + LG+GAF V + V ++ + + L SE+ +L + H
Sbjct: 16 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 75
Query: 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN----------------VDMKA 129
+ + +I E G+L Y + +N + ++
Sbjct: 76 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135
Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----T 185
+ ++ Q+ +G+ +L S IHRDL NI ++ VKI D GLA + +
Sbjct: 136 LICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVR 192
Query: 186 ARSVIGTPEFMA-PELYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTS 243
++MA +++ Y D++SFG+ + E+ + PY K + +++
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 252
Query: 244 GIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
G + T P++ Q + C S R EL++
Sbjct: 253 GTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-36
Identities = 82/327 (25%), Positives = 135/327 (41%), Gaps = 45/327 (13%)
Query: 6 GFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQ 65
F + E + + + RY + +G GA+ +V FD G+ VA +++ Q
Sbjct: 3 TFYRQELNKTIWEVPE---RY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP--FQ 56
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI--NMITELFTSGSLRQYRKKHK 123
S +R Y E+ LLK +KHEN+I + + + ++ G+ K +
Sbjct: 57 SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 116
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
+ ++ QILRGL Y+HS + IIHRDLK N+ VN + E+KI D GLA
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDD 173
Query: 184 PTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
+ T + APE+ YN+ VDI+S G + E++T + + Q+ +
Sbjct: 174 EM-TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 232
Query: 242 TSGIKP----------------------------ASLSKVTDPQVKQFIEKCIVP-ASLR 272
P A++ +P +EK +V + R
Sbjct: 233 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 292
Query: 273 LPALELLKDPFLVT-DNPKDL-VCDPL 297
+ A + L + +P D V DP
Sbjct: 293 ITAAQALAHAYFAQYHDPDDEPVADPY 319
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-34
Identities = 72/330 (21%), Positives = 128/330 (38%), Gaps = 62/330 (18%)
Query: 27 GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY + +G GA V +D V VA +++ Q+ +R Y E+ L+K +
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP--FQNQTHAKRAYRELVLMKCVN 74
Query: 85 HENIIKFYNSWVDD----TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRG 140
H+NII N + + + ++ EL + + + + D + + Q+L G
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCG 131
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-VIGTPEFMAPE 199
+ +LHS IHRDLK NI V ++ +KI D GLA + + T + APE
Sbjct: 132 IKHLHSAGI--IHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188
Query: 200 -LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP----------- 247
+ Y E VDI+S G + EMV + + Q K + P
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 248 ----------------------------ASLSKVTDPQVKQFIEKCIVP-ASLRLPALEL 278
+ +K+ Q + + K +V + R+ +
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 279 LKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 308
L+ P++ ++ DP + P++ +
Sbjct: 309 LQHPYI------NVWYDPAEVEAPPPQIYD 332
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (279), Expect = 2e-27
Identities = 64/343 (18%), Positives = 119/343 (34%), Gaps = 79/343 (23%)
Query: 27 GRYD--EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84
RY LG G F TV+ D V+ VA V + V E E+ LL+ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-----EAAEDEIKLLQRVN 67
Query: 85 HENIIK--------------FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
+ K +N + + + L + + +H+ + + +
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI----VMQQPTA 186
K ++Q+L GL Y+H IIH D+K +N+ + + + + +A
Sbjct: 128 KQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY------NECKNPAQIYK 239
+ I T E+ +PE L + DI+S I E++T ++ + + K+ I +
Sbjct: 187 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246
Query: 240 KVTSGIKPAS---------------------------------------LSKVTDPQVKQ 260
+ + S SK ++
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306
Query: 261 FIEKCIVP-ASLRLPALELLKDPFLVTDNPKD-LVCDPLRLPN 301
F+ + R A L+ P+L KD L + +R+P+
Sbjct: 307 FLSPMLQLDPRKRADAGGLVNHPWL-----KDTLGMEEIRVPD 344
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.9 bits (204), Expect = 6e-19
Identities = 30/199 (15%), Positives = 61/199 (30%), Gaps = 22/199 (11%)
Query: 31 EILGKGAFKTVYKGFDEVDGIEVA-----WNQVNIEDVMQSPDQLE-RLYSEVHLLKSLK 84
+++G+G V+ + E E + + V + D + +
Sbjct: 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 85 HENIIKFYNSWVD---DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
+ K V ++ EL K+ V ++ IL +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNA-VLMELI-------DAKELYRVRVENPDEVLDMILEEV 116
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201
+ I+H DL N+ V+ + I D ++ + + R ++ +
Sbjct: 117 AKFYHRG--IVHGDLSQYNVLVSEEG--IWIIDFPQSVEVGEEGWREILERDVRNIITYF 172
Query: 202 EEEYNELVDIYSFGMCILE 220
Y DI S IL+
Sbjct: 173 SRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 631 | |||
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.87 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.59 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.29 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.55 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.81 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 91.18 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-60 Score=485.96 Aligned_cols=266 Identities=50% Similarity=0.945 Sum_probs=244.5
Q ss_pred cccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEc
Q 006779 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d 97 (631)
+...+.|||+++.+.||+|+||+||+|.++.+|..||+|.+..... .....+++.+|+++|++++|||||++|++|.+
T Consensus 2 ~g~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 79 (270)
T d1t4ha_ 2 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 79 (270)
T ss_dssp CEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCcCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee
Confidence 3567899999999999999999999999999999999999976543 45667889999999999999999999999875
Q ss_pred C--CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccc
Q 006779 98 D--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 98 ~--~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 175 (631)
. ....+|+|||||.+|+|.+++.+.+.+++..++.|++||+.||+|||+++++|+||||||+|||+++.++.+||+||
T Consensus 80 ~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DF 159 (270)
T d1t4ha_ 80 TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 159 (270)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred ccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeec
Confidence 3 34578999999999999999999999999999999999999999999998889999999999999756889999999
Q ss_pred cccchhcCCCCccccCCCCCCCccccccccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006779 176 GLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 176 Gla~~~~~~~~~~~~GTp~Y~APEvl~~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~ 255 (631)
|+++........+.+|||.|||||++.++|+.++|||||||++|||++|+.||.+..+..++++.+..+..|..++...+
T Consensus 160 Gla~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (270)
T d1t4ha_ 160 GLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239 (270)
T ss_dssp TGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred CcceeccCCccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCC
Confidence 99987766667778999999999999989999999999999999999999999988889999999999888877888889
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 006779 256 PQVKQFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~ 285 (631)
+++++||.+||. +|.+|||+.|+|+||||+
T Consensus 240 ~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 999999999998 899999999999999996
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-55 Score=455.00 Aligned_cols=260 Identities=30% Similarity=0.515 Sum_probs=225.2
Q ss_pred cccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEc
Q 006779 18 SEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 18 ~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d 97 (631)
...||..|| ++.+.||+|+||+||+|.++.+|+.||+|++..... ...+.+.+|+.+|+.++|||||+++++|.+
T Consensus 14 ~~~dp~~~Y-~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 88 (293)
T d1yhwa1 14 SVGDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLV 88 (293)
T ss_dssp BSSCTTTTB-CSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred CCCCccccc-EEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC----hHHHHHHHHHHHHHhCCCCCEeeEeEEEEE
Confidence 356788899 556889999999999999999999999999986542 224668999999999999999999999976
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
. ..+|+|||||.||+|.+++.++ .+++..++.+++||+.||+|||++| |+||||||+|||++ .+|.+||+|||+
T Consensus 89 ~--~~~~ivmEy~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~vkl~DFG~ 162 (293)
T d1yhwa1 89 G--DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGF 162 (293)
T ss_dssp T--TEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTT
T ss_pred C--CEEEEEEEecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEEC-CCCcEeeccchh
Confidence 5 4699999999999999988764 6999999999999999999999999 99999999999997 789999999999
Q ss_pred cchhcCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006779 178 AIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 178 a~~~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 254 (631)
++.+... .....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+......+...+..+..+...+...
T Consensus 163 a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T d1yhwa1 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242 (293)
T ss_dssp CEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGS
T ss_pred heeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccC
Confidence 9866433 3456689999999998865 489999999999999999999999987655555666666555444555667
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
++.+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 243 s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence 8999999999998 899999999999999997543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-55 Score=447.67 Aligned_cols=254 Identities=26% Similarity=0.420 Sum_probs=217.0
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
.| ++.+.||+|+||+||+|.++.+|+.||+|++..... .+..+++.+|+.+|++++|||||+++++|.+. ..+|
T Consensus 6 dy-~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~--~~~~ 79 (271)
T d1nvra_ 6 DW-DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQY 79 (271)
T ss_dssp EE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEET--TEEE
T ss_pred ce-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chHHHHHHHHHHHHHhCCCCCEeeEeeeeccC--ceeE
Confidence 45 778999999999999999999999999999976532 23446689999999999999999999999765 4799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
+|||||.+|+|.+++.+.+.+++..++.+++||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+|+.....
T Consensus 80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~-~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECEET
T ss_pred EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEEC-CCCCEEEccchhheeeccC
Confidence 99999999999999988889999999999999999999999999 99999999999997 7889999999999765432
Q ss_pred ----CCccccCCCCCCCcccccc-cc-CccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006779 185 ----TARSVIGTPEFMAPELYEE-EY-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 185 ----~~~~~~GTp~Y~APEvl~~-~y-s~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l 258 (631)
.....+||+.|||||++.+ .| +.++|||||||++|||+||+.||.........+..+.............++++
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 236 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHH
Confidence 3456789999999998865 34 67899999999999999999999876655566666655544433444568999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 259 KQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 259 ~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 237 ~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 237 LALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 999999998 89999999999999999754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-55 Score=444.93 Aligned_cols=252 Identities=23% Similarity=0.431 Sum_probs=224.0
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
+| ++.+.||+|+||+||+|.++.+|+.||+|++...... .....+.+.+|+.+|+.++|||||++++++.+. ..+|
T Consensus 7 dy-~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~ 82 (263)
T d2j4za1 7 DF-EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRVY 82 (263)
T ss_dssp GE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEE
T ss_pred He-EEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHcc-ChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC--CEEE
Confidence 45 7889999999999999999999999999999754321 122346788999999999999999999998765 4799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC
Q 006779 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~ 184 (631)
+|||||.+|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~-~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCSCSCCCCC
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceec-CCCCEeecccceeeecCCC
Confidence 99999999999999999899999999999999999999999999 99999999999998 7899999999999877666
Q ss_pred CCccccCCCCCCCccccccc-cCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006779 185 TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263 (631)
Q Consensus 185 ~~~~~~GTp~Y~APEvl~~~-ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~ 263 (631)
.....+||+.|||||++.+. |+.++|||||||++|+|+||+.||.+ .+..+++..+..+.. .++...++++++||.
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~ 236 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEF--TFPDFVTEGARDLIS 236 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCTTSCHHHHHHHH
T ss_pred cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCccCCHHHHHHHH
Confidence 66677899999999988764 89999999999999999999999976 677778888776543 355667899999999
Q ss_pred HhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 264 KCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 264 ~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
+||+ +|.+|||+.|+|+||||+.
T Consensus 237 ~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 237 RLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHccCCHhHCcCHHHHHcCcCcCC
Confidence 9998 8999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=443.32 Aligned_cols=252 Identities=27% Similarity=0.478 Sum_probs=209.7
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||+|+||+||+|+++.+|+.||+|.+..... .....+.+.+|+++|++++|||||+++++|.+.....+|+||
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm 84 (269)
T d2java1 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84 (269)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS--CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred EEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC--CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence 778999999999999999999999999999976543 456678899999999999999999999999887777899999
Q ss_pred eccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---CCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 108 ELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHN---PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 108 Ey~~gGsL~~~l~~----~~~l~~~~i~~i~~QIl~aL~yLHs~~---~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
|||.+|+|.+++.+ .+.+++..++.++.||+.||.|||+++ .+|+||||||+|||++ .+|.+||+|||++..
T Consensus 85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~-~~~~vkl~DFG~a~~ 163 (269)
T d2java1 85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARI 163 (269)
T ss_dssp ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC-TTSCEEECCHHHHHH
T ss_pred ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC-CCCcEEEeeccceee
Confidence 99999999999864 467999999999999999999999865 2499999999999998 789999999999987
Q ss_pred hcCC--CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006779 181 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 181 ~~~~--~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~ 257 (631)
.... .....+|||.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..++...+..+..+ .++...+++
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~-~~~~~~~~~i~~~~~~-~~~~~~s~~ 241 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFR-RIPYRYSDE 241 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCC-CCCTTSCHH
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCC-CCCcccCHH
Confidence 6543 3456789999999998865 599999999999999999999999986 5777888888776544 355667899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 258 VKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 258 l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
+++||.+||+ +|.+|||+.|+|+|||+
T Consensus 242 l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 242 LNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 9999999998 89999999999999996
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=449.63 Aligned_cols=260 Identities=28% Similarity=0.503 Sum_probs=221.6
Q ss_pred ccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC
Q 006779 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~ 98 (631)
+.+|...| ++.+.||+|+||+||+|.++.+|+.||+|++.... ....+.+.+|+++|++|+|||||+++++|.+.
T Consensus 7 ~~~p~d~Y-~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 81 (288)
T d2jfla1 7 DLNPEDFW-EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFYYE 81 (288)
T ss_dssp SSCGGGTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS----SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred CCCcccCe-EEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 46788888 77889999999999999999999999999987542 34456788999999999999999999999765
Q ss_pred CCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 99 TNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
..+++|||||.+|+|.+++.+ .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+
T Consensus 82 --~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFG~ 156 (288)
T d2jfla1 82 --NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFT-LDGDIKLADFGV 156 (288)
T ss_dssp --TEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTT
T ss_pred --CeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeEC-CCCCEEEEechh
Confidence 479999999999999999765 567999999999999999999999999 99999999999997 789999999999
Q ss_pred cchhcCC--CCccccCCCCCCCccccc------cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-CC
Q 006779 178 AIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PA 248 (631)
Q Consensus 178 a~~~~~~--~~~~~~GTp~Y~APEvl~------~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~-p~ 248 (631)
|...... ...+.+||+.|||||++. ..|+.++|||||||++|+|+||+.||.+. ++.+++..+..+.. ..
T Consensus 157 a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~-~~~~~~~~i~~~~~~~~ 235 (288)
T d2jfla1 157 SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIAKSEPPTL 235 (288)
T ss_dssp CEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS-CGGGHHHHHHHSCCCCC
T ss_pred hhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC-CHHHHHHHHHcCCCCCC
Confidence 9654332 234578999999999873 34899999999999999999999999874 45555555555433 33
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 249 ~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
..+...++++++||.+||+ +|.+|||+.|+|+||||+....
T Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~~ 277 (288)
T d2jfla1 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 277 (288)
T ss_dssp SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCCC
T ss_pred CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 3445678999999999998 8999999999999999986443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-54 Score=451.99 Aligned_cols=262 Identities=29% Similarity=0.469 Sum_probs=227.3
Q ss_pred ccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEE
Q 006779 17 FSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (631)
Q Consensus 17 ~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 96 (631)
+...||..+| +..+.||+|+||+||+|.++.+|+.||+|++..... ......+.+.+|+.+|++|+|||||+++++|.
T Consensus 8 ~~~~dp~~~y-~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 85 (309)
T d1u5ra_ 8 FFKDDPEKLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (309)
T ss_dssp CCCSCHHHHE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccccCcHHhc-EeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc-cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE
Confidence 4456788888 556789999999999999999999999999976542 33456678999999999999999999999997
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccc
Q 006779 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFG 176 (631)
+. ..+|+|||||.+|+|..++...+.+++..++.+++||+.||.|||++| |+||||||+|||++ .+|.+||+|||
T Consensus 86 ~~--~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~~Kl~DFG 160 (309)
T d1u5ra_ 86 RE--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFG 160 (309)
T ss_dssp ET--TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEE-TTTEEEECCCT
T ss_pred EC--CEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEC-CCCCEEEeecc
Confidence 65 479999999999999988888889999999999999999999999999 99999999999998 78999999999
Q ss_pred ccchhcCCCCccccCCCCCCCccccc----cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006779 177 LAIVMQQPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 177 la~~~~~~~~~~~~GTp~Y~APEvl~----~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~ 252 (631)
++..... ....+||+.|||||++. +.|+.++|||||||++|||++|+.||.+. +..+....+..+..+.....
T Consensus 161 ~a~~~~~--~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~ 237 (309)
T d1u5ra_ 161 SASIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSG 237 (309)
T ss_dssp TCBSSSS--BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSCT
T ss_pred cccccCC--CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhCCCCCCCCC
Confidence 9976543 34568999999999874 34899999999999999999999999874 45555555655555555566
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 253 ~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
..++++++||.+||+ +|.+|||+.|+|+||||....
T Consensus 238 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred CCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence 678999999999998 899999999999999997643
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-54 Score=452.72 Aligned_cols=257 Identities=26% Similarity=0.456 Sum_probs=215.6
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.+| ++.+.||+|+||+||+|.++.+|+.||+|+++... .....+++.+|+.+|++++|||||+++++|.+. ..+
T Consensus 6 d~y-~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 79 (322)
T d1s9ja_ 6 DDF-EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEI 79 (322)
T ss_dssp GGE-EEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS--SEE
T ss_pred cCC-EEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEE
Confidence 467 56789999999999999999999999999997542 344567899999999999999999999999765 469
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
|+|||||.||+|.+++.+.+.+++..++.++.||+.||.|||+ ++ |+||||||+|||++ .+|.+||+|||+|....
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEEC-TTCCEEECCCCCCHHHH
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeEC-CCCCEEEeeCCCccccC
Confidence 9999999999999999998999999999999999999999997 57 99999999999997 78999999999998776
Q ss_pred CCCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHH-------------------------
Q 006779 183 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ------------------------- 236 (631)
Q Consensus 183 ~~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~------------------------- 236 (631)
.....+.+||+.|||||++.+ .|+.++|||||||++|||++|+.||........
T Consensus 157 ~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 157 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred CCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 666677899999999998865 599999999999999999999999976432211
Q ss_pred ----------------HHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 237 ----------------IYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 237 ----------------i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
....+.....|.......++++++||.+||+ +|.+||||.|+|+||||+..++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 1111222222222233467899999999998 8999999999999999986443
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=439.43 Aligned_cols=267 Identities=25% Similarity=0.398 Sum_probs=224.0
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC--HHHHHHHHHHHHHHHhCCCCCceeeeeeEEc
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS--PDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~--~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d 97 (631)
.+-..|| ++.+.||+|+||+||+|.++.+|+.||+|++........ ....+.+.+|+.+|++|+|||||+++++|.+
T Consensus 6 ~~i~d~Y-~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (293)
T d1jksa_ 6 ENVDDYY-DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 84 (293)
T ss_dssp SCGGGTE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCcccCE-EEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 3445677 888999999999999999999999999999976543221 2235778999999999999999999999976
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCC----cEEEc
Q 006779 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVKIG 173 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g----~vKL~ 173 (631)
. ..+|+|||||.+|+|.+++.+.+.+++..++.+++||+.||+|||+++ |+||||||+|||++ .+| .+||+
T Consensus 85 ~--~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~-~~~~~~~~vkl~ 159 (293)
T d1jksa_ 85 K--TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLL-DRNVPKPRIKII 159 (293)
T ss_dssp S--SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEES-CSSSSSCCEEEC
T ss_pred C--CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEe-cCCCcccceEec
Confidence 5 579999999999999999999889999999999999999999999999 99999999999997 444 59999
Q ss_pred cccccchhcCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--CC
Q 006779 174 DLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--AS 249 (631)
Q Consensus 174 DFGla~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--~~ 249 (631)
|||++...... ......||+.|+|||++.+ .|+.++|||||||++|||+||+.||.+ .+..+.+..+..+... ..
T Consensus 160 DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~ 238 (293)
T d1jksa_ 160 DFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDE 238 (293)
T ss_dssp CCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCCCCCHH
T ss_pred chhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCCCch
Confidence 99999766543 4456789999999998875 499999999999999999999999986 5677777777765432 22
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCcccc
Q 006779 250 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 250 l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~~~~~ 293 (631)
.....++.+++||.+||. +|.+|||+.|+|+||||+..++...+
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~l 283 (293)
T d1jksa_ 239 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQAL 283 (293)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-------
T ss_pred hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhHhh
Confidence 334568899999999998 89999999999999999987665543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=441.10 Aligned_cols=258 Identities=27% Similarity=0.456 Sum_probs=223.9
Q ss_pred eeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEE
Q 006779 26 YGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 y~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~l 105 (631)
| ++.+.||+|+||+||+|.++.+|+.||+|++...... .....+.+.+|+++|++++|||||+++++|.+. ..+|+
T Consensus 10 y-~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~i 85 (288)
T d1uu3a_ 10 F-KFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLYF 85 (288)
T ss_dssp E-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS--SEEEE
T ss_pred C-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHcc-CHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC--CEEEE
Confidence 5 8899999999999999999999999999999754321 123456789999999999999999999998764 57999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC-
Q 006779 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 184 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~- 184 (631)
|||||.||+|.+++...+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+|+.+...
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~-~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECC---
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccC-CCceEEecccccceecccCC
Confidence 9999999999999999999999999999999999999999999 99999999999998 7899999999999766432
Q ss_pred ---CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006779 185 ---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 185 ---~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~ 260 (631)
...+.+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+.. .++...++++++
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~ 239 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLEY--DFPEKFFPKARD 239 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCC--CCCTTCCHHHHH
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC-cCHHHHHHHHHcCCC--CCCccCCHHHHH
Confidence 2345689999999998865 599999999999999999999999986 577788888776542 355667899999
Q ss_pred HHHHhcC-CCCCCCCHHH------HhcCCCCCCCCCcccc
Q 006779 261 FIEKCIV-PASLRLPALE------LLKDPFLVTDNPKDLV 293 (631)
Q Consensus 261 lI~~cL~-~p~~Rpsa~e------lL~hpff~~~~~~~~~ 293 (631)
||.+||+ +|.+|||+.| +++||||+..++..+.
T Consensus 240 li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~ 279 (288)
T d1uu3a_ 240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 279 (288)
T ss_dssp HHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred HHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhh
Confidence 9999998 8999999988 5889999998887754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-53 Score=441.40 Aligned_cols=258 Identities=22% Similarity=0.394 Sum_probs=207.2
Q ss_pred CCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC
Q 006779 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~ 100 (631)
+-..+| ++.+.||+|+||+||+|.++.+|+.||+|.+..... ......+.+|+.+|+.|+|||||+++++|.+.
T Consensus 6 di~d~Y-~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-- 79 (307)
T d1a06a_ 6 DIRDIY-DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL---EGKEGSMENEIAVLHKIKHPNIVALDDIYESG-- 79 (307)
T ss_dssp CGGGTE-EEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred CCccce-EEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHh---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--
Confidence 345667 888999999999999999999999999999976543 22345688999999999999999999998654
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC--CCCcEEEcccccc
Q 006779 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLA 178 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKL~DFGla 178 (631)
..+|+|||||.||+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||+.. .+|.+||+|||++
T Consensus 80 ~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 80 GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred CEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEecccee
Confidence 579999999999999999999999999999999999999999999999 999999999999952 4789999999999
Q ss_pred chhcCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCC
Q 006779 179 IVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVT 254 (631)
Q Consensus 179 ~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--~~l~~~~ 254 (631)
...... ...+.+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..++...+..+..+ .......
T Consensus 158 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (307)
T d1a06a_ 158 KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDI 236 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred EEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCCCCCccccCC
Confidence 766543 3456789999999998865 599999999999999999999999987 5566777777765432 2344567
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 237 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 8999999999998 89999999999999999763
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=444.25 Aligned_cols=262 Identities=23% Similarity=0.436 Sum_probs=229.5
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.++||+|+||+||+|+++.+|+.||+|+++...... ....+.+.+|+.+|+.++||||++++++|.+. ..+|+||
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~iv~ 84 (337)
T d1o6la_ 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCFVM 84 (337)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEEEEEE
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc--cccccce
Confidence 77899999999999999999999999999997543211 23457788999999999999999999999765 4799999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC--CC
Q 006779 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PT 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~--~~ 185 (631)
|||.||+|..++.+.+.+++..++.+++||+.||+|||+++ ||||||||+|||++ .+|.+||+|||+|+.... ..
T Consensus 85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~-~~g~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCTTCC
T ss_pred eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEec-CCCCEEEeecccccccccCCcc
Confidence 99999999999999999999999999999999999999999 99999999999998 789999999999976543 34
Q ss_pred CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 006779 186 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264 (631)
Q Consensus 186 ~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~ 264 (631)
....+|||.|||||++.+ .|+.++|||||||++|||++|+.||.+ .+..++++.+..+. ..++...++++++||.+
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE--IRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHH
T ss_pred cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC-cCHHHHHHHHhcCC--CCCCccCCHHHHHHHHh
Confidence 556789999999998865 599999999999999999999999987 67777888877764 34566788999999999
Q ss_pred hcC-CCCCCCC-----HHHHhcCCCCCCCCCcccccCCCC
Q 006779 265 CIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLR 298 (631)
Q Consensus 265 cL~-~p~~Rps-----a~elL~hpff~~~~~~~~~~~~~~ 298 (631)
||+ +|.+|++ +.|+++||||...++..+....+.
T Consensus 239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~ 278 (337)
T d1o6la_ 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLL 278 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred hccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCC
Confidence 998 8999994 899999999999887766544443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-52 Score=438.12 Aligned_cols=264 Identities=28% Similarity=0.433 Sum_probs=229.2
Q ss_pred eeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEE
Q 006779 27 GRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV 106 (631)
|++.+.||+|+||+||+|.++.+|+.||+|+++..... .....+.+.+|+.+|+.++|||||++++++.+. ..+|+|
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~iv 82 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQIFMI 82 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SEEEEE
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHhccCcChhheeeeEeeC--CeeeeE
Confidence 47889999999999999999999999999999754321 123457789999999999999999999998764 579999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCCC
Q 006779 107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 186 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~~ 186 (631)
||||.||+|..++.....+++..++.+++||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|...... .
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~-~~g~vkL~DFG~a~~~~~~-~ 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDV-T 158 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEECSSC-B
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEc-CCCCEEEecCccceEeccc-c
Confidence 999999999999999999999999999999999999999999 99999999999998 7899999999999776543 3
Q ss_pred ccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHh
Q 006779 187 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265 (631)
Q Consensus 187 ~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~c 265 (631)
.+.+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+.. .++...+++++++|.+|
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~ 235 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL--RFPPFFNEDVKDLLSRL 235 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHH
T ss_pred ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC-cCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence 46789999999998876 499999999999999999999999987 577777777776543 34556789999999999
Q ss_pred cC-CCCCCC-----CHHHHhcCCCCCCCCCcccccCCCCCC
Q 006779 266 IV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLP 300 (631)
Q Consensus 266 L~-~p~~Rp-----sa~elL~hpff~~~~~~~~~~~~~~~p 300 (631)
|. +|.+|+ |+.++|+||||+..++..+....+..|
T Consensus 236 L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p 276 (316)
T d1fota_ 236 ITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP 276 (316)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCS
T ss_pred hhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcC
Confidence 98 899986 899999999999988877654444433
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.8e-52 Score=440.73 Aligned_cols=259 Identities=25% Similarity=0.390 Sum_probs=222.4
Q ss_pred CCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC
Q 006779 21 DPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~ 100 (631)
..-.|| ++.+.||+|+||+||+|.++.+|+.||+|++... .....+.+.+|+.+|++|+|||||+++++|.+.
T Consensus 23 ~il~~Y-~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-- 95 (350)
T d1koaa2 23 HVLDHY-DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-- 95 (350)
T ss_dssp CGGGTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET--
T ss_pred CCccCe-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc----chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--
Confidence 344577 7889999999999999999999999999998643 345567899999999999999999999998765
Q ss_pred CeEEEEEeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC-CCCcEEEcccccc
Q 006779 101 RTINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLA 178 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~-~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~-~~g~vKL~DFGla 178 (631)
..+|+|||||.||+|.+++. +.+.+++..++.|++||+.||.|||++| ||||||||+|||++. .+|.+||+|||++
T Consensus 96 ~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a 173 (350)
T d1koaa2 96 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLT 173 (350)
T ss_dssp TEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTC
T ss_pred CEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchh
Confidence 47999999999999999985 4567999999999999999999999999 999999999999963 3679999999999
Q ss_pred chhcCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCC
Q 006779 179 IVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVT 254 (631)
Q Consensus 179 ~~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p~~l~~~~ 254 (631)
..+... ......||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+.. +.......
T Consensus 174 ~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 252 (350)
T d1koaa2 174 AHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGI 252 (350)
T ss_dssp EECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCCGGGGGC
T ss_pred eecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCC
Confidence 876543 3446789999999998865 589999999999999999999999986 566677776665533 22233446
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 006779 255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~~ 289 (631)
++++++||.+||+ +|.+|||+.|+|+||||+..+.
T Consensus 253 s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 7899999999998 8999999999999999987653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.6e-52 Score=443.05 Aligned_cols=265 Identities=22% Similarity=0.367 Sum_probs=222.1
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeeccccc--CCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM--QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~--~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
.| ++.++||+|+||+||+|+++.+|+.||+|++...... .......+...|+.+++.++|||||+++++|.+. ..
T Consensus 5 dy-~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~--~~ 81 (364)
T d1omwa3 5 DF-SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DK 81 (364)
T ss_dssp TE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--SE
T ss_pred hC-eeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC--CE
Confidence 45 7889999999999999999999999999998754321 1122233344567888888999999999998765 47
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
+|+|||||.||+|.+++.++..+++..++.|+.||+.||.|||+++ ||||||||+|||++ .+|.+||+|||+|+...
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~-~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-SSSCEEECCCTTCEECS
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEc-CCCcEEEeeeceeeecC
Confidence 9999999999999999999999999999999999999999999999 99999999999998 78999999999998777
Q ss_pred CCCCccccCCCCCCCccccc-c-ccCccccchhhhHHHHHHhhcCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCcHHH
Q 006779 183 QPTARSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 183 ~~~~~~~~GTp~Y~APEvl~-~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~--~~~i~~~i~~~~~p~~l~~~~~~~l 258 (631)
.......+||+.|||||++. + .|+.++|||||||++|||+||+.||..... ...+...+. ..+..++...++++
T Consensus 159 ~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~ 236 (364)
T d1omwa3 159 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TMAVELPDSFSPEL 236 (364)
T ss_dssp SSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS--SCCCCCCSSSCHHH
T ss_pred CCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cCCCCCCCCCCHHH
Confidence 66667788999999999875 3 489999999999999999999999976432 223333222 23444566788999
Q ss_pred HHHHHHhcC-CCCCCCC-----HHHHhcCCCCCCCCCcccccCCC
Q 006779 259 KQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPL 297 (631)
Q Consensus 259 ~~lI~~cL~-~p~~Rps-----a~elL~hpff~~~~~~~~~~~~~ 297 (631)
++||.+||+ +|.+||| |.|+|+||||+..++..+.....
T Consensus 237 ~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~ 281 (364)
T d1omwa3 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKY 281 (364)
T ss_dssp HHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred HHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCC
Confidence 999999998 8999999 89999999999988776544333
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-52 Score=441.75 Aligned_cols=266 Identities=23% Similarity=0.395 Sum_probs=229.8
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.+| ++.+.||+|+||+||+|.++.+|+.||+|++...... .....+.+.+|+.+|+.++|||||+++++|.+. ..+
T Consensus 41 d~y-~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~ 116 (350)
T d1rdqe_ 41 DQF-DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SNL 116 (350)
T ss_dssp GGE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred cCe-EEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHHcCCCcEeecccccccc--ccc
Confidence 467 6678999999999999999999999999999754321 123456789999999999999999999998765 478
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
++||||+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ ||||||||+|||++ .+|.+||+|||+|+....
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~-~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSS
T ss_pred ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccC-CCCCEEeeeceeeeeccc
Confidence 999999999999999999999999999999999999999999999 99999999999998 789999999999987654
Q ss_pred CCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006779 184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262 (631)
Q Consensus 184 ~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI 262 (631)
. ..+.+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+...++..+..+.. .++...++++++||
T Consensus 194 ~-~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li 269 (350)
T d1rdqe_ 194 R-TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV--RFPSHFSSDLKDLL 269 (350)
T ss_dssp C-BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTCCHHHHHHH
T ss_pred c-cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC-cCHHHHHHHHhcCCC--CCCccCCHHHHHHH
Confidence 3 345789999999998865 599999999999999999999999976 577777777776643 23456789999999
Q ss_pred HHhcC-CCCCCC-----CHHHHhcCCCCCCCCCcccccCCCCCC
Q 006779 263 EKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLP 300 (631)
Q Consensus 263 ~~cL~-~p~~Rp-----sa~elL~hpff~~~~~~~~~~~~~~~p 300 (631)
.+||. +|.+|+ |+.++|+||||+..++..+....+..|
T Consensus 270 ~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p 313 (350)
T d1rdqe_ 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP 313 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred HHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcC
Confidence 99998 898884 899999999999988876655544444
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3e-51 Score=435.50 Aligned_cols=255 Identities=24% Similarity=0.371 Sum_probs=220.1
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
..+| ++.+.||+|+||+||+|.++.+|+.||+|+++... ......+.+|+.+|++|+|||||+++++|.+. ..
T Consensus 28 ~d~Y-~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~ 100 (352)
T d1koba_ 28 YDYY-DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK--YE 100 (352)
T ss_dssp GGTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--SE
T ss_pred ccce-EEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CE
Confidence 3456 88899999999999999999999999999987542 34556788999999999999999999999754 57
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC-CCCcEEEccccccch
Q 006779 103 INMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~-~~g~vKL~DFGla~~ 180 (631)
+|+|||||.||+|.+++.+. .++++..++.|++||+.||+|||++| |+||||||+|||++. .+|.+||+|||+|..
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeeccccee
Confidence 99999999999999887654 46999999999999999999999999 999999999999963 468999999999987
Q ss_pred hcCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcH
Q 006779 181 MQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDP 256 (631)
Q Consensus 181 ~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p~~l~~~~~~ 256 (631)
.... ......||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+.. +.......++
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~ 257 (352)
T d1koba_ 179 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVSP 257 (352)
T ss_dssp CCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred cCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 6554 3455789999999998865 499999999999999999999999987 455666666665433 3344456789
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 257 QVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 258 ~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 99999999998 89999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=430.30 Aligned_cols=257 Identities=24% Similarity=0.431 Sum_probs=221.6
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHH-HhCCCCCceeeeeeEEcCCCCeEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iL-k~L~HpnIVkl~~~~~d~~~~~l~lV 106 (631)
.+.++||+|+||+||+|.++.+|+.||+|+++...... ....+.+..|..++ +.++|||||+++++|.+. ..+|+|
T Consensus 5 ~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~--~~~yiv 81 (320)
T d1xjda_ 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--ENLFFV 81 (320)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEEEE
T ss_pred EEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC-hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC--CceeEE
Confidence 78899999999999999999999999999997543211 22345566777665 578999999999998765 479999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC--C
Q 006779 107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--P 184 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~--~ 184 (631)
||||.+|+|.+++...+.+++..++.+++||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++..... .
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~-~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTTC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeec-CCCceeccccchhhhcccccc
Confidence 999999999999999999999999999999999999999999 99999999999998 789999999999976543 2
Q ss_pred CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006779 185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263 (631)
Q Consensus 185 ~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~ 263 (631)
......||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.+ .++.+++..+..+. ..++...++++++||.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~dli~ 235 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDN--PFYPRWLEKEAKDLLV 235 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCccCCHHHHHHHH
Confidence 3445689999999998765 599999999999999999999999986 57788888887653 3456677899999999
Q ss_pred HhcC-CCCCCCCHH-HHhcCCCCCCCCCcccc
Q 006779 264 KCIV-PASLRLPAL-ELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 264 ~cL~-~p~~Rpsa~-elL~hpff~~~~~~~~~ 293 (631)
+||. +|.+||++. ++++||||+..++..+.
T Consensus 236 ~~L~~dP~~R~s~~~~l~~hpff~~~~~~~l~ 267 (320)
T d1xjda_ 236 KLFVREPEKRLGVRGDIRQHPLFREINWEELE 267 (320)
T ss_dssp HHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHH
T ss_pred HhcccCCCCCcCHHHHHHhCchhccCCHHHHH
Confidence 9998 899999996 89999999987765543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-50 Score=416.76 Aligned_cols=256 Identities=25% Similarity=0.418 Sum_probs=220.7
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCC-----HHHHHHHHHHHHHHHhCC-CCCceeeeeeEEc
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQS-----PDQLERLYSEVHLLKSLK-HENIIKFYNSWVD 97 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~-----~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d 97 (631)
.+| .+.+.||+|+||+||+|+++.+|+.||+|++........ ....+++.+|+.+|++|+ ||||++++++|.+
T Consensus 3 ~~y-~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 3 ENY-EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred ccC-EEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 366 788999999999999999999999999999986543221 223457889999999997 9999999999875
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
. ..+|||||||++|+|.++++..+.+++..++.|+.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 82 ~--~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~~kl~DFG~ 156 (277)
T d1phka_ 82 N--TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGF 156 (277)
T ss_dssp S--SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTT
T ss_pred C--cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEc-CCCCeEEccchh
Confidence 4 579999999999999999999999999999999999999999999999 99999999999997 789999999999
Q ss_pred cchhcCC-CCccccCCCCCCCcccccc-------ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--C
Q 006779 178 AIVMQQP-TARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--P 247 (631)
Q Consensus 178 a~~~~~~-~~~~~~GTp~Y~APEvl~~-------~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~--p 247 (631)
+...... .....+||+.|+|||++.+ .|+.++||||+||++|+|+||+.||.+ .+...+...+..+.. +
T Consensus 157 a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~-~~~~~~~~~i~~~~~~~~ 235 (277)
T d1phka_ 157 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFG 235 (277)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCC
T ss_pred eeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC-CCHHHHHHHHHhCCCCCC
Confidence 9766543 3455789999999998752 378899999999999999999999987 566666666666543 2
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 248 ~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
.......++++++||.+||+ +|.+|||+.|+|+||||+.
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 22334578999999999998 8999999999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-51 Score=423.22 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=204.2
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeecccccCCH-HHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEEec
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP-DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~-~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~Ey 109 (631)
++||+|+||+||+|.++.+|+.||+|+++........ ....++.+|+.+|++++|||||+++++|.+. ..+|+||||
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~--~~~~ivmE~ 81 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK--SNISLVFDF 81 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--TCCEEEEEC
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC--Cceeehhhh
Confidence 7899999999999999999999999999765432221 2235688999999999999999999998665 468999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCC--CCc
Q 006779 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~--~~~ 187 (631)
+.++++..++.....+++..++.|++||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++...... ...
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~-~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEec-CCCccccccCccccccCCCccccc
Confidence 999888888777788999999999999999999999999 99999999999998 7899999999999766543 344
Q ss_pred cccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCC-CC---------------
Q 006779 188 SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK-PA--------------- 248 (631)
Q Consensus 188 ~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~-~~~-p~--------------- 248 (631)
..+||+.|+|||++.. .|+.++|||||||++|||+||..||.+....+++...... +.. ..
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 5689999999997753 4899999999999999999999999875444443333221 000 00
Q ss_pred C--------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 249 S--------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 249 ~--------l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
. .....++++++||.+||+ +|.+||||.|+|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0 012356899999999998 89999999999999999753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=418.70 Aligned_cols=251 Identities=21% Similarity=0.387 Sum_probs=213.0
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCH--HHHHHHHHHHHHHHhCC--CCCceeeeeeEEcC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSP--DQLERLYSEVHLLKSLK--HENIIKFYNSWVDD 98 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~--~~~~~l~~Ei~iLk~L~--HpnIVkl~~~~~d~ 98 (631)
.+|| +++++||+|+||+||+|.++.+|+.||+|++......... ....++.+|+.+|++++ |||||+++++|.+.
T Consensus 3 ~~~Y-~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 3 ESQY-QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp TTTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCeE-EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 4687 8899999999999999999999999999999754322111 11234668999999997 89999999998765
Q ss_pred CCCeEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 99 TNRTINMITELFTS-GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 99 ~~~~l~lV~Ey~~g-GsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
..+++||||+.+ +++.+++.+...+++..++.|+.||+.||.|||+++ |+||||||+|||++.+++.+||+|||+
T Consensus 82 --~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 82 --DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp --SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred --CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECcccc
Confidence 478999999976 689999998889999999999999999999999999 999999999999985668999999999
Q ss_pred cchhcCCCCccccCCCCCCCcccccc-c-cCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006779 178 AIVMQQPTARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 178 a~~~~~~~~~~~~GTp~Y~APEvl~~-~-ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~ 255 (631)
+.........+..||+.|+|||++.+ . ++.++|||||||++|+|+||+.||.. ... +..+. ..++...+
T Consensus 158 a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~---~~~----i~~~~--~~~~~~~s 228 (273)
T d1xwsa_ 158 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DEE----IIRGQ--VFFRQRVS 228 (273)
T ss_dssp CEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS---HHH----HHHCC--CCCSSCCC
T ss_pred ceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC---chH----Hhhcc--cCCCCCCC
Confidence 98776666677889999999998764 3 46789999999999999999999975 222 22322 23455678
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
+++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999998 89999999999999999763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=426.03 Aligned_cols=255 Identities=22% Similarity=0.350 Sum_probs=219.3
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
--+|| ++.+.||+|+||+||+|.++.+|+.||+|.++... .....+.+|+++|+.++|||||+++++|.+. .
T Consensus 3 ~~~rY-~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~ 74 (321)
T d1tkia_ 3 LYEKY-MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESM--E 74 (321)
T ss_dssp CTTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--T
T ss_pred Cccce-EEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--C
Confidence 45788 78899999999999999999999999999997542 3345688999999999999999999999765 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC-CCCcEEEccccccc
Q 006779 102 TINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAI 179 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~-~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~-~~g~vKL~DFGla~ 179 (631)
.+|+|||||.||+|.+++.+.+ .+++..++.|+.||+.||+|||+++ |+||||||+|||++. ..+.+||+|||++.
T Consensus 75 ~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhh
Confidence 7999999999999999998765 7999999999999999999999999 999999999999973 24589999999997
Q ss_pred hhcCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCc
Q 006779 180 VMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTD 255 (631)
Q Consensus 180 ~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p--~~l~~~~~ 255 (631)
..... ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+..+++..+..+... .......+
T Consensus 153 ~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s 231 (321)
T d1tkia_ 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEIS 231 (321)
T ss_dssp ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred ccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCChhhccCCC
Confidence 66443 3455689999999998764 589999999999999999999999987 5677777777665432 22223467
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
+++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 232 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 899999999998 89999999999999999753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-50 Score=421.64 Aligned_cols=255 Identities=20% Similarity=0.320 Sum_probs=207.0
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHH-hCCCCCceeeeeeEEc--C
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKHENIIKFYNSWVD--D 98 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk-~L~HpnIVkl~~~~~d--~ 98 (631)
--++|..++++||+|+||+||+|.++.+|+.||+|+++.. ..+.+|+.++. .++|||||+++++|.+ .
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 3467866677899999999999999999999999998632 34678999865 5589999999999865 3
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC--CCCcEEEcc
Q 006779 99 TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGD 174 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKL~D 174 (631)
....+|+|||||.||+|.+++.+. ..+++..++.|++||+.||+|||+++ |+||||||+|||++. ..+.+||+|
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECC
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccc
Confidence 346799999999999999999874 46999999999999999999999999 999999999999973 356799999
Q ss_pred ccccchhcC-CCCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHH---HHHHHHcCCC--C
Q 006779 175 LGLAIVMQQ-PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ---IYKKVTSGIK--P 247 (631)
Q Consensus 175 FGla~~~~~-~~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~---i~~~i~~~~~--p 247 (631)
||+++.... ......+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+...... +...+..+.. |
T Consensus 158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~ 237 (335)
T d2ozaa1 158 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237 (335)
T ss_dssp CTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred cceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence 999976544 34556789999999998875 599999999999999999999999976432221 1222221111 1
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 248 ~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.......++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 11112357899999999998 89999999999999999753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=408.59 Aligned_cols=248 Identities=30% Similarity=0.483 Sum_probs=209.3
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
|.++| ++.+.||+|+||+||+|... ..||+|+++.... .....+.+.+|+.+|++++|||||++++++.. .
T Consensus 6 ~~~~~-~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~ 76 (276)
T d1uwha_ 6 PDGQI-TVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---P 76 (276)
T ss_dssp CTTCC-CCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC--CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---S
T ss_pred ccccE-EEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---c
Confidence 45677 77899999999999999643 3699999875532 34567889999999999999999999997643 3
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 102 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
.+++|||||++|+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|..
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~-~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATV 153 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTSSEEECCCCCSCC
T ss_pred EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEc-CCCCEEEccccceee
Confidence 478999999999999999765 56999999999999999999999998 99999999999998 789999999999976
Q ss_pred hcCC----CCccccCCCCCCCcccccc----ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC---
Q 006779 181 MQQP----TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--- 249 (631)
Q Consensus 181 ~~~~----~~~~~~GTp~Y~APEvl~~----~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~--- 249 (631)
.... ...+..||+.|||||++.. .|+.++|||||||++|||+||+.||.+..+..++...+..+..++.
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~ 233 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGG
T ss_pred ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchh
Confidence 5432 2345689999999998753 4899999999999999999999999987778888888877765443
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 250 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 250 l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
++...++.+++||.+||. +|.+|||+.+++.+
T Consensus 234 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 445578899999999998 89999999999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.7e-49 Score=405.71 Aligned_cols=257 Identities=23% Similarity=0.332 Sum_probs=209.6
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC--
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-- 100 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~-- 100 (631)
.+|| ++.+.||+|+||+||+|.++.+|+.||+|+++... .......+++.+|+.+|+.++|||||++++++.....
T Consensus 6 ~drY-~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 6 SDRY-ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL-ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp TTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-TTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred ccee-EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhh-ccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 4788 78899999999999999999999999999997543 3346667889999999999999999999999876543
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
..+|+|||||+||+|.+++...+.+++..++.+++||+.||+|||+++ |+||||||+|||++ .++.++|+|||.+..
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~-~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMIS-ATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-TTSCEEECCCTTCEE
T ss_pred ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccC-ccccceeehhhhhhh
Confidence 468999999999999999999999999999999999999999999999 99999999999998 788999999999864
Q ss_pred hcCC-----CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCC
Q 006779 181 MQQP-----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKV 253 (631)
Q Consensus 181 ~~~~-----~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p-~~l~~~ 253 (631)
.... .....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+....+.+...+.....+ ......
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSS
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccC
Confidence 4322 2345689999999998865 48999999999999999999999998754444444555554433 234456
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 006779 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 254 ~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff 284 (631)
.++.+++||.+||+ +|.+||++.+.|.|+|+
T Consensus 241 ~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 241 LSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 78999999999998 89999944444445554
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-49 Score=408.03 Aligned_cols=245 Identities=24% Similarity=0.372 Sum_probs=213.1
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.+| ++.+.||+|+||+||+|.++.+|+.||+|+++... ...+.+.+|+.+|++|+|||||+++++|.+. ..+
T Consensus 17 ~~~-~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~ 88 (287)
T d1opja_ 17 TDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPF 88 (287)
T ss_dssp GGE-EEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSC
T ss_pred HHe-EEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-----chHHHHHHHHHHHHhCCCCCEecCCccEeeC--Cee
Confidence 456 78899999999999999999999999999986432 2345689999999999999999999998654 458
Q ss_pred EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 104 NMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
++|||||.+|+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++..
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCCTTTC
T ss_pred EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEEC-CCCcEEEccccceeec
Confidence 8999999999999998764 56899999999999999999999998 99999999999998 7899999999999876
Q ss_pred cCCCC---ccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006779 182 QQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 182 ~~~~~---~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~ 257 (631)
..... ....||+.|+|||++. +.|+.++|||||||++|||++|..||....+..++++.+..+..+. .+...++.
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~ 244 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME-RPEGCPEK 244 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC-CCTTCCHH
T ss_pred CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCC-CCccchHH
Confidence 54432 2345789999999775 5699999999999999999998888877788888888888776543 45567899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 258 VKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 258 l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+++||.+||. +|.+|||+.++++
T Consensus 245 l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 245 VYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9999999998 8999999999976
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-49 Score=404.93 Aligned_cols=251 Identities=21% Similarity=0.354 Sum_probs=209.1
Q ss_pred ceeeee-eEecccCceEEEEEEEc--cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 25 RYGRYD-EILGKGAFKTVYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 25 Ry~r~~-e~LG~G~fg~Vy~a~d~--~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
++..+. +.||+|+||+||+|.+. .+++.||+|.++... ..+...+.+.+|+.+|++++|||||++++++.++
T Consensus 6 ~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~--- 80 (277)
T d1xbba_ 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE--- 80 (277)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS---
T ss_pred hhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh--CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC---
Confidence 334454 46999999999999864 456899999986443 2345567899999999999999999999988543
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
..++|||||++|+|.+++.+...+++..+..|+.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+++..
T Consensus 81 ~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~-~~~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 81 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKAL 157 (277)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEEC
T ss_pred CEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhccc-ccCcccccchhhhhhc
Confidence 36899999999999999999999999999999999999999999998 99999999999998 7899999999999765
Q ss_pred cCCC-----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006779 182 QQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 182 ~~~~-----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~ 254 (631)
.... .....||+.|||||++. ..|+.++|||||||++|||+| |+.||.+ .+..++...+..+..+ ..+...
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~ 235 (277)
T d1xbba_ 158 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGC 235 (277)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTC
T ss_pred cccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCccc
Confidence 4321 23457899999999875 458999999999999999998 8999987 5677888888877554 345667
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHH---hcCCCCC
Q 006779 255 DPQVKQFIEKCIV-PASLRLPALEL---LKDPFLV 285 (631)
Q Consensus 255 ~~~l~~lI~~cL~-~p~~Rpsa~el---L~hpff~ 285 (631)
++++++||.+||. +|.+|||+.++ |+|+|+.
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 8999999999998 89999999987 5676653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-49 Score=407.56 Aligned_cols=255 Identities=25% Similarity=0.431 Sum_probs=205.8
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
+| ++.+.||+|+||+||+|.++.+|+.||+|+++.... .....+++.+|+++|++++|||||+++++|.+. ..+|
T Consensus 3 ~Y-~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~--~~~~ 77 (298)
T d1gz8a_ 3 NF-QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLY 77 (298)
T ss_dssp TE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEE
T ss_pred CC-EeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEEeccccccc--ccee
Confidence 56 667999999999999999999999999999975432 223356788999999999999999999999765 4699
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 105 MITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
+||||+.++.+...... .+.+++..++.++.||+.||+|||+++ ||||||||+|||++ .++.+||+|||++.....
T Consensus 78 iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~-~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGV 154 (298)
T ss_dssp EEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSTTHHHHHCC
T ss_pred EEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeec-ccCcceeccCCcceeccC
Confidence 99999976544444333 457999999999999999999999999 99999999999998 788999999999977654
Q ss_pred C--CCccccCCCCCCCcccccc-c-cCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC----------
Q 006779 184 P--TARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS---------- 249 (631)
Q Consensus 184 ~--~~~~~~GTp~Y~APEvl~~-~-ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~---------- 249 (631)
. .....+||+.|+|||++.. . ++.++|||||||++|+|++|+.||.+......+...+.....+..
T Consensus 155 ~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence 3 3445689999999997654 3 578999999999999999999999875545555444332111100
Q ss_pred ----------------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 250 ----------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 250 ----------------l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.....++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 011346789999999998 89999999999999999754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8e-49 Score=403.45 Aligned_cols=254 Identities=25% Similarity=0.396 Sum_probs=207.3
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.|| ++.+.||+|+||+||+|.++ +|+.||+|+++.... .....+++.+|+.+|++++|||||+++++|.+.+ .+
T Consensus 2 ~~Y-~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~ 75 (286)
T d1ob3a_ 2 EKY-HGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTKK--RL 75 (286)
T ss_dssp CSE-EEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--CE
T ss_pred CCc-eeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC--ce
Confidence 488 56688999999999999986 889999999976532 2333567899999999999999999999997664 58
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
++++||+.++.+..+....+.+++..++.+++||+.||+|||+++ ||||||||+|||++ .++.+||+|||++.....
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~-~~~~~kl~DfG~a~~~~~ 152 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGI 152 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC
T ss_pred eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEc-CCCCEEecccccceeccc
Confidence 899999998888888888889999999999999999999999998 99999999999998 789999999999977654
Q ss_pred C--CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCC------------
Q 006779 184 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK------------ 246 (631)
Q Consensus 184 ~--~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~-~~~------------ 246 (631)
+ ......|++.|+|||++.+ .++.++|||||||++|||++|+.||.+.....++...... +..
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred CccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence 3 2345579999999998754 4789999999999999999999999875444433332211 000
Q ss_pred -------------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 247 -------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 247 -------------p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
........++.+++||.+||+ +|.+|||+.|+|+||||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 011223457899999999998 8999999999999999973
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=404.88 Aligned_cols=259 Identities=26% Similarity=0.404 Sum_probs=205.7
Q ss_pred CCceeeeeeEecccCceEEEEEEEccC-CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC---CCCCceeeeeeEEcC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVD-GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVDD 98 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~t-g~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L---~HpnIVkl~~~~~d~ 98 (631)
..|| ++.+.||+|+||+||+|.+..+ ++.||+|+++..... ......+.+|+.+|+.| +||||++++++|...
T Consensus 6 ~~~Y-~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 6 DQQY-ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGTE-EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT--TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCCE-EEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc--chHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 3678 7778999999999999999766 678999999764322 11222355677766655 899999999988642
Q ss_pred ---CCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcc
Q 006779 99 ---TNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 99 ---~~~~l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~D 174 (631)
....++++|||+.++++...... ...+++..++.+++||+.||+|||+++ |+||||||+|||++ ..|.+||+|
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~-~~~~~kl~d 159 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLAD 159 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECS
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEc-CCCCeeecc
Confidence 33578999999998877655443 467999999999999999999999999 99999999999997 789999999
Q ss_pred ccccchhcC-CCCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC--C-----
Q 006779 175 LGLAIVMQQ-PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--I----- 245 (631)
Q Consensus 175 FGla~~~~~-~~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~--~----- 245 (631)
||++..... ......+||+.|+|||++. ..|+.++|||||||++|||+||+.||.+. +..+....+... .
T Consensus 160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS-SDVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCGGG
T ss_pred hhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC-CHHHHHHHHHHhhCCCchhc
Confidence 999875543 3345678999999999775 46999999999999999999999999874 444443333210 0
Q ss_pred ------------------CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 246 ------------------KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 246 ------------------~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
....+....++.+++||.+||+ +|.+||||.|+|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 0011233457899999999998 999999999999999998643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-48 Score=404.58 Aligned_cols=255 Identities=22% Similarity=0.378 Sum_probs=204.2
Q ss_pred cccccCCCCceeeeeeEecccCceEEEEEEEccCCe---EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeee
Q 006779 16 EFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGI---EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92 (631)
Q Consensus 16 ~~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~---~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~ 92 (631)
+|..+.+.++| ++.++||+|+||+||+|.++.+|. .||+|.+... ......+.+.+|+.+|++|+|||||+++
T Consensus 18 ~f~~~i~~~~~-~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 93 (299)
T d1jpaa_ 18 EFAKEIDISCV-KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNVIHLE 93 (299)
T ss_dssp HHSCBCCGGGE-EEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hhchhhChhhc-EEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCCccEE
Confidence 34444555666 889999999999999999987764 5888887543 2456677899999999999999999999
Q ss_pred eeEEcCCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEE
Q 006779 93 NSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 171 (631)
Q Consensus 93 ~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 171 (631)
+++.+. ..+++|||||.+|+|.+++... +.+++..++.|+.||+.||+|||+++ |+||||||+|||++ .++.+|
T Consensus 94 g~~~~~--~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~-~~~~~K 168 (299)
T d1jpaa_ 94 GVVTKS--TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVN-SNLVCK 168 (299)
T ss_dssp EEECSS--SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEE
T ss_pred EEEeeC--CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEEC-CCCcEE
Confidence 998654 4588999999999999988874 56999999999999999999999998 99999999999998 789999
Q ss_pred EccccccchhcCCC-------CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006779 172 IGDLGLAIVMQQPT-------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT 242 (631)
Q Consensus 172 L~DFGla~~~~~~~-------~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~ 242 (631)
|+|||+++...... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ .+..++...+.
T Consensus 169 l~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~-~~~~~~~~~i~ 247 (299)
T d1jpaa_ 169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MTNQDVINAIE 247 (299)
T ss_dssp ECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHH
T ss_pred ECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC-CCHHHHHHHHH
Confidence 99999997654321 11245789999999876 459999999999999999998 8999987 56677888887
Q ss_pred cCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 243 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 243 ~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.+..++ .+...++.+++||.+||. +|.+|||+.|++++
T Consensus 248 ~~~~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 248 QDYRLP-PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp TTCCCC-CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cCCCCC-CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 775543 345578899999999998 89999999998864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=401.15 Aligned_cols=250 Identities=24% Similarity=0.397 Sum_probs=212.7
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCC
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~ 101 (631)
|..+| ++.+.||+|+||+||+|.++ ++..||||+++.... ..+.+.+|+.+|++++|||||++++++.+.
T Consensus 11 ~~~~~-~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~--- 80 (272)
T d1qpca_ 11 PRETL-KLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-----SPDAFLAEANLMKQLQHQRLVRLYAVVTQE--- 80 (272)
T ss_dssp CGGGE-EEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred CHHHe-EEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC-----CHHHHHHHHHHHHhCCCCCEeEEEeeeccC---
Confidence 34566 88899999999999999975 678999999864321 235689999999999999999999977432
Q ss_pred eEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 102 TINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
.+++|||||.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFGla~ 157 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLAR 157 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCE
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeee-cccceeeccccceE
Confidence 468999999999999977543 36999999999999999999999998 99999999999998 78999999999998
Q ss_pred hhcCC---CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006779 180 VMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 180 ~~~~~---~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~ 255 (631)
..... ......||+.|||||++. +.|+.++|||||||++|||+||..|+....+..++...+..+..+. .+...+
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~~ 236 (272)
T d1qpca_ 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-RPDNCP 236 (272)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTCC
T ss_pred EccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CcccCh
Confidence 76543 233457899999999876 4599999999999999999997777666678888888888876554 345678
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhc--CCCCC
Q 006779 256 PQVKQFIEKCIV-PASLRLPALELLK--DPFLV 285 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rpsa~elL~--hpff~ 285 (631)
+++++||.+||. +|.+|||+.++++ |+||.
T Consensus 237 ~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 899999999998 8999999999988 78775
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=408.38 Aligned_cols=248 Identities=24% Similarity=0.370 Sum_probs=207.8
Q ss_pred CceeeeeeEecccCceEEEEEEEccCC-----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEc
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDG-----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD 97 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg-----~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d 97 (631)
.+| ++.++||+|+||+||+|.+..++ ..||+|.+.... .......+.+|+.+|+++ +|||||+++++|.+
T Consensus 37 ~~~-~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 37 ENL-EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp GGE-EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHe-EEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc---CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 456 78899999999999999987654 479999886432 234456789999999998 89999999999876
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEec
Q 006779 98 DTNRTINMITELFTSGSLRQYRKKH-----------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHR 154 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~-----------------------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHr 154 (631)
.. .+++|||||++|+|.+++... ..+++..++.++.||+.||+|||+++ ||||
T Consensus 113 ~~--~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHR 188 (325)
T d1rjba_ 113 SG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHR 188 (325)
T ss_dssp SS--SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEET
T ss_pred CC--eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeec
Confidence 54 588999999999999999754 24899999999999999999999998 9999
Q ss_pred cCCCCCeeecCCCCcEEEccccccchhcCCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCC
Q 006779 155 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPY 228 (631)
Q Consensus 155 DLKp~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf 228 (631)
||||+|||++ .++.+||+|||+|+...... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||
T Consensus 189 DlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 189 DLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp TCSGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred cCchhccccc-cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 9999999998 78999999999997654432 23456899999999775 569999999999999999998 89999
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 229 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 229 ~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.+......+.+.+..+..+ ..+...++++++||.+||+ +|.+|||+.||++|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 268 PGIPVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TTCCCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCC-CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8876767777777776544 3456678999999999998 89999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=408.71 Aligned_cols=272 Identities=29% Similarity=0.426 Sum_probs=213.2
Q ss_pred CCCCccCCcCCcccccCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC
Q 006779 5 SGFTKSETEEGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK 84 (631)
Q Consensus 5 ~~~~~~~~~~~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~ 84 (631)
+|+...+..... .+-..|| ++.+.||+|+||+||+|.++.+|+.||||+++... ......+++.+|+++|++++
T Consensus 2 ~~~~~~~~~~~~---~~~~~~Y-~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~ 75 (346)
T d1cm8a_ 2 SGFYRQEVTKTA---WEVRAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMR 75 (346)
T ss_dssp CSBCCEECSSSE---ECCBSSE-EEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCC
T ss_pred CCcEEEeccCce---eecCCcE-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh--cChHHHHHHHHHHHHHHhcC
Confidence 355555544432 1245688 66789999999999999999999999999997542 34566788999999999999
Q ss_pred CCCceeeeeeEEcCCC----CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCC
Q 006779 85 HENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160 (631)
Q Consensus 85 HpnIVkl~~~~~d~~~----~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~N 160 (631)
|||||+++++|..... ..+|+||||+ +++|..+.+. +.+++..++.+++||+.||+|||++| |+||||||+|
T Consensus 76 hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~N 151 (346)
T d1cm8a_ 76 HENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGN 151 (346)
T ss_dssp BTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGG
T ss_pred CCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcch
Confidence 9999999999876532 3579999999 6678877654 56999999999999999999999999 9999999999
Q ss_pred eeecCCCCcEEEccccccchhcCCCCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHH
Q 006779 161 IFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238 (631)
Q Consensus 161 ILl~~~~g~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~ 238 (631)
||++ .++.+||+|||++...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+.
T Consensus 152 IL~~-~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~ 229 (346)
T d1cm8a_ 152 LAVN-EDCELKILDFGLARQADSE-MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 229 (346)
T ss_dssp EEEC-TTCCEEECCCTTCEECCSS-CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred hhcc-cccccccccccceeccCCc-cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHH
Confidence 9998 7899999999999766543 345689999999998754 47899999999999999999999998754333332
Q ss_pred HHHHcC-------------------------CC---CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 239 KKVTSG-------------------------IK---PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 239 ~~i~~~-------------------------~~---p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
...... .. ........++.+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 230 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 222110 00 111233467899999999998 999999999999999998643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=405.00 Aligned_cols=260 Identities=23% Similarity=0.377 Sum_probs=209.1
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
-++-+|| ++.+.||+|+||+||+|.++.+|+.||||++..... ......++.+|+.+|+.++||||+++++++....
T Consensus 6 ~~~~~rY-~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~ 82 (318)
T d3blha1 6 CDEVSKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKA 82 (318)
T ss_dssp SCBGGGE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C--TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CCccCCE-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHHhcCCCccceEeeeeccc
Confidence 4567999 777899999999999999999999999999876543 2334566889999999999999999999886532
Q ss_pred ------CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEc
Q 006779 100 ------NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173 (631)
Q Consensus 100 ------~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~ 173 (631)
...+++||||+.++++..+......+++..++.+++||+.||.|||+++ |+||||||+|||++ .++.+||+
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~-~~~~~kl~ 159 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLA 159 (318)
T ss_dssp --------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEEC
T ss_pred ccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeec-CCCcEEee
Confidence 3468999999988887777667788999999999999999999999999 99999999999998 78999999
Q ss_pred cccccchhcC------CCCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc--
Q 006779 174 DLGLAIVMQQ------PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-- 243 (631)
Q Consensus 174 DFGla~~~~~------~~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~-- 243 (631)
|||++..... ....+.+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+. +.......+..
T Consensus 160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~-~~~~~~~~i~~~~ 238 (318)
T d3blha1 160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-TEQHQLALISQLC 238 (318)
T ss_dssp CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHH
T ss_pred ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC-CHHHHHHHHHHhc
Confidence 9999965432 12344679999999997753 5899999999999999999999999763 44443333322
Q ss_pred -CCCCCCCCC---------------------------CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 244 -GIKPASLSK---------------------------VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 244 -~~~p~~l~~---------------------------~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
...+..... ..++.+++||.+||+ +|.+||||.|+|+||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 111111110 125678999999998 9999999999999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-48 Score=398.93 Aligned_cols=247 Identities=19% Similarity=0.386 Sum_probs=209.3
Q ss_pred eeeeE-ecccCceEEEEEEEcc--CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 28 RYDEI-LGKGAFKTVYKGFDEV--DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 28 r~~e~-LG~G~fg~Vy~a~d~~--tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
.+.++ ||+|+||+||+|.++. ++..||||.++.. ......+++.+|+.+|++++|||||++++++.++ .++
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---~~~ 84 (285)
T d1u59a_ 11 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---ALM 84 (285)
T ss_dssp EEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEE
T ss_pred EECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh---cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC---eEE
Confidence 55664 9999999999998754 4568999998643 2456678899999999999999999999988543 478
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 105 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
+|||||++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++.+..
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLV-NRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-ETTEEEECCCTTCEECTT
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeec-cCCceeeccchhhhcccc
Confidence 999999999999997654 57999999999999999999999998 99999999999998 789999999999976543
Q ss_pred C-----CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006779 184 P-----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 184 ~-----~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~ 256 (631)
. ......||+.|||||++. +.|+.++|||||||++|||+| |+.||.+. +..++...+..+..+. .+...++
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~-~~~~~~~~i~~~~~~~-~p~~~~~ 239 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRME-CPPECPP 239 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CTHHHHHHHHTTCCCC-CCTTCCH
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CCCcCCH
Confidence 2 223456899999999876 469999999999999999998 89999875 4567777888776553 4566789
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHH---hcCCCCC
Q 006779 257 QVKQFIEKCIV-PASLRLPALEL---LKDPFLV 285 (631)
Q Consensus 257 ~l~~lI~~cL~-~p~~Rpsa~el---L~hpff~ 285 (631)
++.+||.+||. +|.+|||+.++ |+|+|+.
T Consensus 240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999998 89999999887 6677763
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1e-47 Score=402.78 Aligned_cols=253 Identities=21% Similarity=0.373 Sum_probs=210.3
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCceeeeeeEEcCCCC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~ 101 (631)
..|| ++.+.||+|+||+||+|.++.+|+.||+|+++... .+++.+|+.+|+.+. ||||++++++|......
T Consensus 34 ~d~y-~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~ 105 (328)
T d3bqca1 34 QDDY-QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVSR 105 (328)
T ss_dssp GGGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred CcCe-EEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence 3577 77899999999999999999999999999986432 356889999999995 99999999999877777
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
.+++|||||.+++|..+. +.+++..++.+++||+.||+|||++| |+||||||+|||++..++.+||+|||+|...
T Consensus 106 ~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 106 TPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp SEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred ceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceec
Confidence 899999999999997653 56999999999999999999999999 9999999999999855667999999999766
Q ss_pred cCC-CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc-------------C-
Q 006779 182 QQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-------------G- 244 (631)
Q Consensus 182 ~~~-~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~-------------~- 244 (631)
... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||....+.......+.. .
T Consensus 181 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 181 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp CTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred cCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 543 4556789999999997654 4899999999999999999999999876554433222211 0
Q ss_pred C---------------------CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 006779 245 I---------------------KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 245 ~---------------------~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~~ 288 (631)
. .+.......++++++||.+||. +|.+|||++|+|+||||+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 0 0001112357899999999998 899999999999999998754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=392.84 Aligned_cols=255 Identities=24% Similarity=0.408 Sum_probs=217.8
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.|| ++.+.||+|+||+||+|.++.+|+.||||+++.... ......++.+|+.+|+.++||||++++++|.+.. .+
T Consensus 2 ~ry-~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~--~~ 76 (292)
T d1unla_ 2 QKY-EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDK--KL 76 (292)
T ss_dssp CSE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EE
T ss_pred CCC-EeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC--ChHHHHHHHHHHHHHHhcCcCCEEeecccccccc--ce
Confidence 477 777999999999999999999999999999976542 3456788999999999999999999999997654 68
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
++|++++.+++|..++..++.+++..++.+++|++.||+|||+++ |+||||||+|||++ .++.+||+|||.+.....
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~-~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGI 153 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCS
T ss_pred eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccc-cCCceeeeecchhhcccC
Confidence 899999999999999999999999999999999999999999999 99999999999998 688999999999977654
Q ss_pred C--CCccccCCCCCCCccccccc--cCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-------------
Q 006779 184 P--TARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------------- 246 (631)
Q Consensus 184 ~--~~~~~~GTp~Y~APEvl~~~--ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~------------- 246 (631)
. ......+++.|+|||++... ++.++|||||||++|||++|+.||....+..+.+..+.....
T Consensus 154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 3 23345678899999987543 689999999999999999999998777777766665542100
Q ss_pred --------------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 247 --------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 247 --------------p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
........++.+++||.+||+ +|.+||||.|+|+||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 111223356899999999998 8999999999999999975
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=394.46 Aligned_cols=244 Identities=19% Similarity=0.377 Sum_probs=199.8
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEE
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~ 104 (631)
+| ++.+.||+|+||+||+|.+. ++..||||+++.... ..+.+.+|+.+|++++|||||++++++.+.. .++
T Consensus 6 ~~-~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~--~~~ 76 (263)
T d1sm2a_ 6 EL-TFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PIC 76 (263)
T ss_dssp CE-EEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCE
T ss_pred Hc-EEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC-----cHHHHHHHHHHHHhcCCCCcccccceeccCC--ceE
Confidence 35 77899999999999999876 678899999874321 2356899999999999999999999987654 588
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcC
Q 006779 105 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~ 183 (631)
+|||||.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++....
T Consensus 77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEEC-GGGCEEECSCC-------
T ss_pred EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeec-CCCCeEecccchheeccC
Confidence 999999999999998755 56899999999999999999999998 99999999999998 788999999999976644
Q ss_pred CC---CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006779 184 PT---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 184 ~~---~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~ 259 (631)
.. .....||+.|+|||++.+ .|+.++|||||||++|||+|+..|+....+..+++..+..+..+. .+...++++.
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~~~~l~ 232 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-KPRLASTHVY 232 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC-CCTTSCHHHH
T ss_pred CCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC-CccccCHHHH
Confidence 32 234578999999998764 599999999999999999996555555577888888888875543 4566789999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcC
Q 006779 260 QFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 260 ~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
+||.+||. +|.+|||+.|+|+|
T Consensus 233 ~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 233 QIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 99999998 89999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=403.93 Aligned_cols=252 Identities=22% Similarity=0.354 Sum_probs=204.2
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC----CC
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD----TN 100 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~----~~ 100 (631)
+| +..++||+|+||+||+|+++.+|+.||+|++...... +.+|+.+|++|+||||++++++|... +.
T Consensus 21 ~Y-~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 21 SY-TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS--------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred Cc-EeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH--------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 45 6678999999999999999999999999999755322 23699999999999999999998643 34
Q ss_pred CeEEEEEeccCCCCHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccc
Q 006779 101 RTINMITELFTSGSLRQY---RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~---l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGl 177 (631)
.++++|||||.++.+..+ ......+++..++.|++||+.||+|||++| |+||||||+|||++.++..+||+|||+
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccc
Confidence 578999999987644333 344567999999999999999999999999 999999999999985455899999999
Q ss_pred cchhcC-CCCccccCCCCCCCccccc--cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc-C---------
Q 006779 178 AIVMQQ-PTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-G--------- 244 (631)
Q Consensus 178 a~~~~~-~~~~~~~GTp~Y~APEvl~--~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~-~--------- 244 (631)
+..... ....+.+||+.|+|||++. ..|+.++|||||||++|||++|+.||.......++...+.. +
T Consensus 170 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred hhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 976543 3455678999999999764 35899999999999999999999999875544444433321 0
Q ss_pred --------CCCC--------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 245 --------IKPA--------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 245 --------~~p~--------~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
..+. ......++++++||.+||. +|.+||||.|+|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0000 1123457899999999998 99999999999999999753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=390.49 Aligned_cols=251 Identities=23% Similarity=0.376 Sum_probs=206.8
Q ss_pred ccCCCCceeeeeeEecccCceEEEEEEEccCC----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeee
Q 006779 19 EKDPSCRYGRYDEILGKGAFKTVYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 94 (631)
Q Consensus 19 e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg----~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~ 94 (631)
|.+|. .| .+.++||+|+||+||+|.++.++ ..||+|+++.. ........+.+|+.+|++++|||||+++++
T Consensus 3 ei~~~-~~-~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~il~~l~H~nIv~~~g~ 77 (283)
T d1mqba_ 3 EIHPS-CV-TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVDFLGEAGIMGQFSHHNIIRLEGV 77 (283)
T ss_dssp BCCTT-TE-EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCCHH-He-EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc---cChHHHHHHHHHHHHHHhcCCCCEeeeeEE
Confidence 34454 45 66899999999999999987665 57999998643 245566779999999999999999999998
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEc
Q 006779 95 WVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173 (631)
Q Consensus 95 ~~d~~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~ 173 (631)
+.+. ..+++|||||.+|+|.+++... +.+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+
T Consensus 78 ~~~~--~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~-~~~~~Kl~ 152 (283)
T d1mqba_ 78 ISKY--KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVS 152 (283)
T ss_dssp ECSS--SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEEC
T ss_pred EecC--CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEEC-CCCeEEEc
Confidence 8654 4588999999999999987654 67999999999999999999999998 99999999999998 78999999
Q ss_pred cccccchhcCCC-----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006779 174 DLGLAIVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 247 (631)
Q Consensus 174 DFGla~~~~~~~-----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p 247 (631)
|||+++...... .....||+.|||||++.+ .|+.++|||||||++|||++|..||....+..+++..+..+..+
T Consensus 153 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~ 232 (283)
T d1mqba_ 153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 232 (283)
T ss_dssp CCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred ccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC
Confidence 999997654321 223468999999998764 59999999999999999999877777767888899998887665
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 248 ~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+ .+...++.+++||.+||. +|.+|||+.|+++
T Consensus 233 ~-~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 233 P-TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp C-CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred C-CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 4 445678899999999998 8999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=406.73 Aligned_cols=268 Identities=21% Similarity=0.354 Sum_probs=220.0
Q ss_pred CceeeeeeEecccCceEEEEEEE---ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC-CCceeeeeeEEcCC
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFD---EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIKFYNSWVDDT 99 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d---~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~H-pnIVkl~~~~~d~~ 99 (631)
.+| ++.+.||+|+||+||+|.+ +.+|+.||+|+++...........+++.+|+.+|++++| |||+++++++.+.
T Consensus 24 ~~y-~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~- 101 (322)
T d1vzoa_ 24 ENF-ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 101 (322)
T ss_dssp GGE-EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred hce-EEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-
Confidence 345 7889999999999999987 457999999998755432223334568899999999976 8999999998765
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
..+++||||+.+|+|.+++...+.+++..++.+++||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.
T Consensus 102 -~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~-~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 102 -TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSK 177 (322)
T ss_dssp -TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEESCSSEEE
T ss_pred -CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeec-CCCCEEEeeccchh
Confidence 479999999999999999999999999999999999999999999999 99999999999998 78999999999997
Q ss_pred hhcCC---CCccccCCCCCCCcccccc---ccCccccchhhhHHHHHHhhcCCCCCCCC---CHHHHHHHHHcCCCCCCC
Q 006779 180 VMQQP---TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPASL 250 (631)
Q Consensus 180 ~~~~~---~~~~~~GTp~Y~APEvl~~---~ys~~sDIwSLGiilyELltG~~Pf~~~~---~~~~i~~~i~~~~~p~~l 250 (631)
.+... ...+..|++.|+|||.+.+ .++.++|||||||++|+|+||+.||.... ....+........ ..+
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~--~~~ 255 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPY 255 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--CCC
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC--CCC
Confidence 55332 2345689999999998753 37889999999999999999999996642 2334444444432 234
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCCCCCCCcccccCCCCC
Q 006779 251 SKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRL 299 (631)
Q Consensus 251 ~~~~~~~l~~lI~~cL~-~p~~Rp-----sa~elL~hpff~~~~~~~~~~~~~~~ 299 (631)
+...++++++||.+||. +|.+|| +++|+|+||||+..++..+....+..
T Consensus 256 ~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~ 310 (322)
T d1vzoa_ 256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPA 310 (322)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCc
Confidence 55678999999999998 899999 58999999999988876665444443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-47 Score=400.61 Aligned_cols=256 Identities=26% Similarity=0.395 Sum_probs=204.8
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC--
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-- 100 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~-- 100 (631)
..|| ++.+.||+|+||+||+|.++.+|+.||+|++.... .....+++.+|+.+|++|+||||+++++++.....
T Consensus 7 ~~rY-~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 7 GPRY-TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp CTTE-EEEEECC---CCCEEEEEETTTCSEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred CCCe-EEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc---ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence 4578 77899999999999999999999999999987432 35667789999999999999999999999865432
Q ss_pred -CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 101 -RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 -~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
..+++ ++|+.+|+|.+++..+ .+++..++.++.||+.||+|||+++ ||||||||+|||++ .+|.+||+|||++.
T Consensus 83 ~~~~~l-~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~-~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 83 MKDVYL-VTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLAR 157 (345)
T ss_dssp CCCEEE-EEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCE
T ss_pred cceEEE-EEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEEC-CCCCEEEcccCcee
Confidence 23444 4566799999999765 6999999999999999999999999 99999999999998 78999999999996
Q ss_pred hhcCC-----CCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-----
Q 006779 180 VMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP----- 247 (631)
Q Consensus 180 ~~~~~-----~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p----- 247 (631)
..... .....+||+.|+|||++.. .|+.++||||+||++|+|++|+.||.......+....+.....+
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 54322 2445679999999998743 47899999999999999999999997754333332222110000
Q ss_pred --------------------C---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 248 --------------------A---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 248 --------------------~---~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
. ......++++++||.+||+ ||.+|||+.|+|+||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 0 0122356789999999998 99999999999999999754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=386.91 Aligned_cols=241 Identities=22% Similarity=0.407 Sum_probs=208.5
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||+|+||+||+|+++ ++..||||.++.... ..+.+.+|+.++++++||||++++++|.+. ..+++||
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~--~~~~iv~ 78 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPIFIIT 78 (258)
T ss_dssp CCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-----CHHHHHHHHHHHHTCCCTTBCCEEEEECCS--SSEEEEE
T ss_pred EEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-----CHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CceEEEE
Confidence 67889999999999999985 789999999975432 234688999999999999999999988654 4699999
Q ss_pred eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC-
Q 006779 108 ELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~- 185 (631)
||+.+|+|.+++.. ...+++..+++++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.......
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~-~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEEC-TTCCEEECCCSSCCBCSSSSC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEc-CCCcEEECcchhheeccCCCc
Confidence 99999999998654 467999999999999999999999998 99999999999998 78999999999997654332
Q ss_pred --CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006779 186 --ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 186 --~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~l 261 (631)
.....||+.|+|||++. ..|+.++|||||||++|||+| |+.||.+ .+..++...+..+..+ ..+...++++++|
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~~l~~l 233 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNSETAEHIAQGLRL-YRPHLASEKVYTI 233 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCC-CCHHHHHHHHHhCCCC-CCcccccHHHHHH
Confidence 23456899999999876 469999999999999999998 8999987 4577788888877554 3556788999999
Q ss_pred HHHhcC-CCCCCCCHHHHhcC
Q 006779 262 IEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 262 I~~cL~-~p~~Rpsa~elL~h 281 (631)
|.+||+ +|.+|||+.++|+|
T Consensus 234 i~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 234 MYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCCHhHCcCHHHHHHH
Confidence 999998 89999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-47 Score=386.54 Aligned_cols=247 Identities=24% Similarity=0.423 Sum_probs=200.7
Q ss_pred CCceeeeeeEecccCceEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~t---g~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~ 99 (631)
-.+| ++.+.||+|+||+||+|.+..+ +..||+|.++.. ......+.+.+|+.+|++++|||||++++++.+
T Consensus 6 ~~~~-~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-- 79 (273)
T d1mp8a_ 6 RERI-ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-- 79 (273)
T ss_dssp GGGE-EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred HHHe-EEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 3467 8889999999999999998654 467888887533 245667889999999999999999999998843
Q ss_pred CCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEcccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla 178 (631)
..+++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++
T Consensus 80 -~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~-~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 80 -NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLS 155 (273)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECC----
T ss_pred -CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeec-CCCcEEEccchhh
Confidence 358899999999999998765 457999999999999999999999999 99999999999998 7889999999999
Q ss_pred chhcCC---CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006779 179 IVMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 179 ~~~~~~---~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~ 253 (631)
+..... ......||+.|+|||++. +.|+.++|||||||++|||+| |..||.. .+..+++..+..+..+ .++..
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~-~~~~~~~~~i~~~~~~-~~~~~ 233 (273)
T d1mp8a_ 156 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERL-PMPPN 233 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-CCCTT
T ss_pred eeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCC
Confidence 765432 233456899999999876 469999999999999999998 8888876 5667777788877654 35566
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 254 TDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 254 ~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.++.+++||.+||. +|.+|||+.|+++|
T Consensus 234 ~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 234 CPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 78999999999998 89999999999876
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=389.28 Aligned_cols=250 Identities=23% Similarity=0.364 Sum_probs=208.5
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
.+| ++.+.||+|+||.||+|.++.+ ..||+|+++.... ..+.+.+|+.+|++++|||||++|+++.+. .+
T Consensus 17 ~~~-~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~-----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~---~~ 86 (285)
T d1fmka3 17 ESL-RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSEE---PI 86 (285)
T ss_dssp GGE-EEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SC
T ss_pred HHE-EEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC-----CHHHHHHHHHHHHhcccCCEeEEEEEEecC---Ce
Confidence 356 8899999999999999998755 6799999874432 235689999999999999999999987432 47
Q ss_pred EEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 104 NMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~--~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
++|||||.+|+|..++.. .+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++..
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~-~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLI 163 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCTTC--
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEEC-CCCcEEEcccchhhhc
Confidence 899999999999988754 457999999999999999999999999 99999999999998 7899999999999765
Q ss_pred cCC---CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006779 182 QQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 182 ~~~---~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~ 257 (631)
... ......||+.|+|||++. +.++.++|||||||++|||+||..||....+..+++..+..+..++ .+...+++
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~ 242 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPES 242 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTSCHH
T ss_pred cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CCcccCHH
Confidence 432 233457899999999775 4699999999999999999998777777788888888888776544 45667899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhc--CCCCCCC
Q 006779 258 VKQFIEKCIV-PASLRLPALELLK--DPFLVTD 287 (631)
Q Consensus 258 l~~lI~~cL~-~p~~Rpsa~elL~--hpff~~~ 287 (631)
+++||.+||. +|.+|||+.+++. ++||...
T Consensus 243 l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 9999999998 8999999999987 8888653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=389.09 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=202.2
Q ss_pred CCceeeeeeEecccCceEEEEEEEcc-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEE
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWV 96 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~-----tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~ 96 (631)
-.+| ++.+.||+|+||.||+|.+.. +++.||+|.++... .....+.+.+|...+.++ +|+||+.+++++.
T Consensus 12 ~~~y-~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 12 RDRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp GGGE-EEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHE-EEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 3567 788999999999999999754 45789999986432 345566788888888776 6899999999876
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCC
Q 006779 97 DDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160 (631)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~l~~~----------------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~N 160 (631)
... ..+++|||||++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|
T Consensus 88 ~~~-~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~N 164 (299)
T d1ywna1 88 KPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARN 164 (299)
T ss_dssp STT-SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGG
T ss_pred cCC-CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCccc
Confidence 543 4688999999999999999753 24889999999999999999999999 9999999999
Q ss_pred eeecCCCCcEEEccccccchhcCC----CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhc-CCCCCCCCCH
Q 006779 161 IFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTC-EYPYNECKNP 234 (631)
Q Consensus 161 ILl~~~~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG-~~Pf~~~~~~ 234 (631)
||++ .++.+||+|||+|+..... ......||+.|||||++.+ .|+.++|||||||++|||+|| ..||.+....
T Consensus 165 ILl~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 165 ILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp EEEC-GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred eeEC-CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 9998 7899999999999765432 2335679999999998764 589999999999999999986 5678776667
Q ss_pred HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 235 AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 235 ~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
..+...+..+..+. .+...++++++||.+||. +|.+|||+.|+++|
T Consensus 244 ~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 244 EEFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 77778888776553 456678999999999998 89999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=391.45 Aligned_cols=244 Identities=27% Similarity=0.457 Sum_probs=201.8
Q ss_pred eeeeeEecccCceEEEEEEEccCCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 27 GRYDEILGKGAFKTVYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~tg~----~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
+++.++||+|+||+||+|.+..+|+ +||+|.++... +....+.+.+|+.+|++++|||||+++++|.+. .
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~---~ 84 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS---T 84 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS---S
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---C
Confidence 3778999999999999999988876 58888775332 233456799999999999999999999998764 3
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchh
Q 006779 103 INMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~ 181 (631)
.++++||+.+|+|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++..
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~-~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCCSHHHHT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeC-CCCCeEeeccccceec
Confidence 67889999999999887664 67999999999999999999999998 99999999999998 7889999999999766
Q ss_pred cCCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006779 182 QQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 182 ~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~ 255 (631)
.... .....||+.|||||++. +.|+.++|||||||++|||+| |..||.+ .+..++...+..+..+. .+...+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~-~~~~~~~~~i~~~~~~~-~p~~~~ 239 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP-QPPICT 239 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCGGGHHHHHHHTCCCC-CCTTBC
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CCcccC
Confidence 4322 23346899999999775 459999999999999999998 7888876 56667788888776543 445678
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 256 PQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
+.+++||.+||. +|.+|||+.|++.|
T Consensus 240 ~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 240 IDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 899999999998 89999999999988
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=397.37 Aligned_cols=255 Identities=29% Similarity=0.414 Sum_probs=204.8
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCC---C
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---N 100 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~---~ 100 (631)
.|| ++.+.||+|+||+||+|.++.+|+.||||++.... .+....+++.+|+++|++|+|||||+++++|.... .
T Consensus 18 ~rY-~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 18 ERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp TTE-EEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCe-EEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh--cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 578 77899999999999999999999999999987543 34566678999999999999999999999886432 2
Q ss_pred CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccch
Q 006779 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~ 180 (631)
...++|++|+.+|+|.+++.. +++++..++.+++||+.||+|||++| |+||||||+|||++ .+|.+|++|||++..
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~-~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARH 170 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCC----C
T ss_pred CceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCcccccc-ccccccccccchhcc
Confidence 234556777889999999865 56999999999999999999999999 99999999999998 789999999999965
Q ss_pred hcCCCCccccCCCCCCCcccccc--ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcC-CCC----------
Q 006779 181 MQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IKP---------- 247 (631)
Q Consensus 181 ~~~~~~~~~~GTp~Y~APEvl~~--~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~-~~p---------- 247 (631)
.... ..+..||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+. +.......+... ..+
T Consensus 171 ~~~~-~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 171 TDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT-DHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp CTGG-GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred cCcc-cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcCCCChHHhhhccc
Confidence 4432 345678999999997654 3689999999999999999999999874 333333333211 000
Q ss_pred ----------CC--------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 006779 248 ----------AS--------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 248 ----------~~--------l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~~ 287 (631)
.. .....++++++||.+||. +|.+||||.|+|+||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 00 012357899999999998 99999999999999999863
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=396.71 Aligned_cols=253 Identities=28% Similarity=0.396 Sum_probs=196.8
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcC----C
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD----T 99 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~----~ 99 (631)
.|| ++.++||+|+||+||+|.++.+|+.||+|++.... .+.....++.+|+.+|++++|||||+++++|... .
T Consensus 17 ~~Y-~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 17 KRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp TTE-EEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred CCe-EEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh--cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 577 77899999999999999999999999999997553 3456677899999999999999999999998654 2
Q ss_pred CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
...+|+|||||.++.+..+ ...+++..++.+++||+.||.|||++| |+||||||+|||++ .++.+|++|||++.
T Consensus 94 ~~~~~iv~Ey~~~~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~-~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 94 FQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLAR 167 (355)
T ss_dssp CCEEEEEEECCSEEHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC--
T ss_pred CceeEEEEeccchHHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccc-cccceeeechhhhh
Confidence 3689999999977655433 356899999999999999999999999 99999999999998 78899999999987
Q ss_pred hhcCC-CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHc--------------
Q 006779 180 VMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-------------- 243 (631)
Q Consensus 180 ~~~~~-~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~-------------- 243 (631)
..... .....+||+.|+|||++.+ .|+.++||||+||++|+|++|+.||.+.. .......+..
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~-~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD-YIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred ccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC-HHHHHHHHHHhccCCCHHHHHHhh
Confidence 65543 3455689999999998764 58999999999999999999999998743 3332222211
Q ss_pred --------CCCCCC-----------C-C------CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 006779 244 --------GIKPAS-----------L-S------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 244 --------~~~p~~-----------l-~------~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~hpff~~ 286 (631)
...+.. . . ...++++++||.+||. +|.+||||+|+|+||||+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 100000 0 0 0124678999999998 9999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-46 Score=386.34 Aligned_cols=248 Identities=23% Similarity=0.355 Sum_probs=205.9
Q ss_pred CceeeeeeEecccCceEEEEEEEccCCeE--EEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeeeEEcCCC
Q 006779 24 CRYGRYDEILGKGAFKTVYKGFDEVDGIE--VAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN 100 (631)
Q Consensus 24 gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~--VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~~~d~~~ 100 (631)
..| ++.++||+|+||+||+|.++.+|.. ||||.++... ..+..+.+.+|+.+|+++ +|||||++|++|.+.
T Consensus 10 ~~~-~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-- 83 (309)
T d1fvra_ 10 NDI-KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-- 83 (309)
T ss_dssp GGC-EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--
T ss_pred HHc-EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc---ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--
Confidence 344 7789999999999999999999875 6677765322 334566799999999999 799999999999765
Q ss_pred CeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeec
Q 006779 101 RTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 164 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~----------------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~ 164 (631)
..+++||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG 161 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEc
Confidence 4799999999999999998754 57999999999999999999999998 99999999999998
Q ss_pred CCCCcEEEccccccchhcCC-CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006779 165 GNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 242 (631)
Q Consensus 165 ~~~g~vKL~DFGla~~~~~~-~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~ 242 (631)
.++.+||+|||++...... ......||+.|+|||.+. +.|+.++|||||||++|||++|..|+....+..+++..+.
T Consensus 162 -~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~ 240 (309)
T d1fvra_ 162 -ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240 (309)
T ss_dssp -GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred -CCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 7889999999999755433 233557899999999775 4599999999999999999997654334578888888888
Q ss_pred cCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 243 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 243 ~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.+..+. .+...++++++||.+||. +|.+|||+.|+|++
T Consensus 241 ~~~~~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 241 QGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GTCCCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 876554 455678999999999998 89999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-45 Score=383.40 Aligned_cols=248 Identities=21% Similarity=0.316 Sum_probs=209.8
Q ss_pred CCCceeeeeeEecccCceEEEEEEEc-----cCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEE
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~-----~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 96 (631)
|..+| .+.+.||+|+||+||+|.++ .++..||||+++.. ......+++.+|+.+|++++||||++++++|.
T Consensus 11 p~~~~-~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 11 PRNNI-EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp CGGGC-EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CHHHc-EEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh---cChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 66777 77899999999999999875 46789999998643 24556678999999999999999999999986
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEE
Q 006779 97 DDTNRTINMITELFTSGSLRQYRKKH------------------------KNVDMKAIKNWARQILRGLHYLHSHNPPII 152 (631)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~l~~~------------------------~~l~~~~i~~i~~QIl~aL~yLHs~~~~Ii 152 (631)
.. ..+++||||+.+|+|.+++... ..+++..++.++.||+.||+|||+++ ||
T Consensus 87 ~~--~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iv 162 (301)
T d1lufa_ 87 VG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FV 162 (301)
T ss_dssp SS--SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred cC--CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eE
Confidence 54 4588899999999999998643 24889999999999999999999999 99
Q ss_pred eccCCCCCeeecCCCCcEEEccccccchhcCC----CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCC-
Q 006779 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEY- 226 (631)
Q Consensus 153 HrDLKp~NILl~~~~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~- 226 (631)
||||||+|||++ .++.+||+|||++...... ...+..||+.|+|||++.+ .|+.++|||||||++|||++|..
T Consensus 163 HrDlKp~NILld-~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 163 HRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CSCCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred eeEEcccceEEC-CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999998 6889999999999765432 2334678999999997765 59999999999999999999965
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 227 PYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 227 Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
||.+ .+..++...+..+..+. .+...++++.+||.+||. +|.+|||+.|+++
T Consensus 242 p~~~-~~~~e~~~~v~~~~~~~-~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 242 PYYG-MAHEEVIYYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTTT-SCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCC-CCHHHHHHHHHcCCCCC-CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 5654 67888888888876543 455678899999999998 8999999999865
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-45 Score=381.28 Aligned_cols=254 Identities=22% Similarity=0.360 Sum_probs=209.5
Q ss_pred cCCCCceeeeeeEecccCceEEEEEEEccCC---eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEE
Q 006779 20 KDPSCRYGRYDEILGKGAFKTVYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (631)
Q Consensus 20 ~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~tg---~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~ 96 (631)
..+......++++||+|+||+||+|.+..++ ..||||+++.. ......+++.+|+++|++|+|||||++++++.
T Consensus 22 ~~~~~~~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~ 98 (311)
T d1r0pa_ 22 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 98 (311)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC---CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred eChHHceeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEE
Confidence 3344444456899999999999999986643 47999998632 35677788999999999999999999999987
Q ss_pred cCCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccc
Q 006779 97 DDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 97 d~~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DF 175 (631)
+.. ..+++|||||.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 99 ~~~-~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~-~~~~~kL~DF 174 (311)
T d1r0pa_ 99 RSE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADF 174 (311)
T ss_dssp ETT-TEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECSS
T ss_pred ecC-CceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeEC-CCCCEEEecc
Confidence 643 4788999999999999988754 46788899999999999999999998 99999999999998 7899999999
Q ss_pred cccchhcCC------CCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC
Q 006779 176 GLAIVMQQP------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 248 (631)
Q Consensus 176 Gla~~~~~~------~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~~~i~~~~~p~ 248 (631)
|+++..... ......||+.|+|||.+. +.++.++|||||||++|||+||..||....+..++...+..+..+.
T Consensus 175 G~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~ 254 (311)
T d1r0pa_ 175 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 254 (311)
T ss_dssp GGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC
T ss_pred cchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999765432 122356899999999765 5699999999999999999998888877777777888888876554
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 249 ~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.+...++.+.+||.+||. +|.+||++.|+++|
T Consensus 255 -~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 255 -QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 455678899999999998 89999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=377.41 Aligned_cols=246 Identities=26% Similarity=0.399 Sum_probs=194.9
Q ss_pred eeeeeEecccCceEEEEEEEccC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeE
Q 006779 27 GRYDEILGKGAFKTVYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 27 ~r~~e~LG~G~fg~Vy~a~d~~t---g~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l 103 (631)
+++.+.||+|+||.||+|.+..+ +..||||+++.... ......+.+.+|+.+|++++|||||++|+++.++ .+
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~-~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---~~ 85 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---PM 85 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SC
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec---ch
Confidence 38889999999999999986433 35799999875443 3345667899999999999999999999988543 46
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhc
Q 006779 104 NMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~-~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~ 182 (631)
++|||||.+|+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~-~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLA-TRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccc-cccceeeccchhhhhcc
Confidence 899999999999987665 457999999999999999999999998 99999999999998 68899999999998654
Q ss_pred CCC-----CccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006779 183 QPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 183 ~~~-----~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~ 255 (631)
... .....|++.|+|||++.+ .|+.++|||||||++|||+| |+.||.+ .+..++...+.........+...+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~ 241 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPRPEDCP 241 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC-cCHHHHHHHHHhCCCCCCCccccc
Confidence 332 233457889999998765 48999999999999999998 8999987 566666666655544334556678
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 256 PQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 256 ~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+.+++||.+||. +|.+|||+.++++
T Consensus 242 ~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 242 QDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999998 8999999999863
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-46 Score=377.76 Aligned_cols=239 Identities=22% Similarity=0.421 Sum_probs=198.2
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCeEEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~l~lV~ 107 (631)
++.+.||+|+||+||+|.+ .|..||+|.++.. ...+.+.+|+.+|++++||||+++++++.+.. ..+++||
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~lv~ 80 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIVT 80 (262)
T ss_dssp EEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEE
T ss_pred EEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC-CcEEEEE
Confidence 7889999999999999987 4889999998633 23466899999999999999999999886543 3579999
Q ss_pred eccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEccccccchhcCCC
Q 006779 108 ELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~--~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~DFGla~~~~~~~ 185 (631)
||+++|+|.+++.+. ..+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC--------
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheec-CCCCEeecccccceecCCC-
Confidence 999999999998654 35899999999999999999999998 99999999999998 7899999999999765443
Q ss_pred CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006779 186 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263 (631)
Q Consensus 186 ~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~ 263 (631)
.....+|+.|+|||++. +.|+.++|||||||++|||+| |+.||.. .+..++...+..+..+. ++...++++++||.
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~ 234 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKMD-APDGCPPAVYEVMK 234 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCCCC-CCTTCCHHHHHHHH
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHHHHH
Confidence 34456899999999775 569999999999999999998 6777765 57778888888876664 45567899999999
Q ss_pred HhcC-CCCCCCCHHHHhcC
Q 006779 264 KCIV-PASLRLPALELLKD 281 (631)
Q Consensus 264 ~cL~-~p~~Rpsa~elL~h 281 (631)
+||. +|.+|||+.+++++
T Consensus 235 ~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 235 NCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcccCHhHCcCHHHHHHH
Confidence 9998 89999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-45 Score=377.31 Aligned_cols=248 Identities=27% Similarity=0.414 Sum_probs=206.2
Q ss_pred CCCceeeeeeEecccCceEEEEEEEccCC-------eEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeee
Q 006779 22 PSCRYGRYDEILGKGAFKTVYKGFDEVDG-------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYN 93 (631)
Q Consensus 22 p~gRy~r~~e~LG~G~fg~Vy~a~d~~tg-------~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~ 93 (631)
|..+| .+++.||+|+||.||+|++..++ ..||+|.++... .......+.+|+..+.++ +|||||++++
T Consensus 11 ~~~~~-~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~e~~~l~~~~~HpnIv~~~~ 86 (299)
T d1fgka_ 11 PRDRL-VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLG 86 (299)
T ss_dssp CGGGE-EEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cHHHe-EEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc---ChHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence 44677 77899999999999999886654 479999986432 355667789999999888 8999999999
Q ss_pred eEEcCCCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCC
Q 006779 94 SWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157 (631)
Q Consensus 94 ~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~----------------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLK 157 (631)
+|.+. ..+++|||||.+|+|.+++... ..+++..++.++.||+.||+|||+++ |||||||
T Consensus 87 ~~~~~--~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiK 162 (299)
T d1fgka_ 87 ACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLA 162 (299)
T ss_dssp EECSS--SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred ccccC--CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeec
Confidence 98754 4689999999999999999754 35899999999999999999999999 9999999
Q ss_pred CCCeeecCCCCcEEEccccccchhcCCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCCC
Q 006779 158 CDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNEC 231 (631)
Q Consensus 158 p~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~~ 231 (631)
|+|||++ .++.+||+|||++....... .....||+.|+|||++. +.|+.++|||||||++|||++ |..||.+
T Consensus 163 p~NiLl~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~- 240 (299)
T d1fgka_ 163 ARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG- 240 (299)
T ss_dssp GGGEEEC-TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-
T ss_pred ccceeec-CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC-
Confidence 9999998 78999999999997664432 33467899999999775 569999999999999999998 6777765
Q ss_pred CCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 232 KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 232 ~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
.+..+++..+..+..+. .+...++.+++||.+||+ +|.+|||+.|+|+
T Consensus 241 ~~~~~~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 241 VPVEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CCHHHHHHHHHTTCCCC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHcCCCCC-CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 67788888888876553 456678999999999998 8999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=376.99 Aligned_cols=255 Identities=22% Similarity=0.367 Sum_probs=213.2
Q ss_pred CCcccccCCCCceeeeeeEecccCceEEEEEEEcc-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc
Q 006779 14 EGEFSEKDPSCRYGRYDEILGKGAFKTVYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI 88 (631)
Q Consensus 14 ~~~~~e~dp~gRy~r~~e~LG~G~fg~Vy~a~d~~-----tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnI 88 (631)
.++-+|.++ .+| .+.+.||+|+||+||+|.+.. ++..||+|+++.. ........+.+|+.+|++++||||
T Consensus 11 ~~~~~ei~~-~~~-~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~---~~~~~~~~~~~E~~il~~l~h~nI 85 (308)
T d1p4oa_ 11 VPDEWEVAR-EKI-TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHV 85 (308)
T ss_dssp CCCTTBCCG-GGE-EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT---SCHHHHHHHHHHHHHGGGCCCTTB
T ss_pred CccceeecH-HHe-EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc---cChHHHHHHHHHHHHHHHcCCCCE
Confidence 344466665 577 678999999999999998853 4689999998643 245566779999999999999999
Q ss_pred eeeeeeEEcCCCCeEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCC
Q 006779 89 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158 (631)
Q Consensus 89 Vkl~~~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~----------~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp 158 (631)
|++++++.... .+++|||||.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||
T Consensus 86 v~~~~~~~~~~--~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~ 161 (308)
T d1p4oa_ 86 VRLLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAA 161 (308)
T ss_dssp CCEEEEECSSS--SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSG
T ss_pred eeeeeEEecCC--ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcC
Confidence 99999886543 588999999999999998643 34789999999999999999999998 99999999
Q ss_pred CCeeecCCCCcEEEccccccchhcCC----CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcC-CCCCCCC
Q 006779 159 DNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCE-YPYNECK 232 (631)
Q Consensus 159 ~NILl~~~~g~vKL~DFGla~~~~~~----~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~-~Pf~~~~ 232 (631)
+|||++ .++.+||+|||+++..... ......||+.|+|||.+.+ .|+.++|||||||++|||+||. .||.+ .
T Consensus 162 ~NiLld-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-~ 239 (308)
T d1p4oa_ 162 RNCMVA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-L 239 (308)
T ss_dssp GGEEEC-TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-S
T ss_pred Cceeec-CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC-C
Confidence 999998 7899999999999765432 2334568999999997764 5889999999999999999985 56654 6
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 233 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 233 ~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
+..+++..+..+..+. .+...++.++++|.+||+ +|.+|||+.++++
T Consensus 240 ~~~~~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 240 SNEQVLRFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHhCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7888888888776543 445677899999999998 8999999999997
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=375.52 Aligned_cols=250 Identities=24% Similarity=0.382 Sum_probs=210.0
Q ss_pred CCCCceeeeeeEecccCceEEEEEEE-----ccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCceeeeee
Q 006779 21 DPSCRYGRYDEILGKGAFKTVYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNS 94 (631)
Q Consensus 21 dp~gRy~r~~e~LG~G~fg~Vy~a~d-----~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpnIVkl~~~ 94 (631)
-|..+| .++++||+|+||.||+|.+ ..++..||+|+++... .......+.+|+.+++.+ +|||||+++++
T Consensus 20 ~~~~~~-~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 20 FPRNRL-SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp CCGGGE-EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCHHHe-EEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc---CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 344677 7789999999999999986 3577899999997543 456667899999999999 69999999999
Q ss_pred EEcCCCCeEEEEEeccCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccC
Q 006779 95 WVDDTNRTINMITELFTSGSLRQYRKKHK------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156 (631)
Q Consensus 95 ~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~------------------~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDL 156 (631)
+.+. ..+++|||||.+|+|.+++.+.. .+++..++.++.||+.||+|||+++ ++||||
T Consensus 96 ~~~~--~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDL 171 (311)
T d1t46a_ 96 CTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDL 171 (311)
T ss_dssp ECSS--SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred EeeC--CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccc
Confidence 8655 35889999999999999987643 5899999999999999999999999 999999
Q ss_pred CCCCeeecCCCCcEEEccccccchhcCCC----CccccCCCCCCCccccc-cccCccccchhhhHHHHHHhh-cCCCCCC
Q 006779 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNE 230 (631)
Q Consensus 157 Kp~NILl~~~~g~vKL~DFGla~~~~~~~----~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELlt-G~~Pf~~ 230 (631)
||+|||++ .++.+||+|||+++...... .....||+.|+|||++. +.++.++|||||||++|||+| |..||..
T Consensus 172 Kp~NIl~~-~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~ 250 (311)
T d1t46a_ 172 AARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (311)
T ss_dssp SGGGEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cccccccc-ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCC
Confidence 99999998 78999999999997654332 23457899999999776 458999999999999999999 5555656
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006779 231 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 231 ~~~~~~i~~~i~~~~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL~ 280 (631)
......+.+.+..+..+. .+...++.+++||.+||. +|.+|||+.++|+
T Consensus 251 ~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 251 MPVDSKFYKMIKEGFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CCSSHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHhcCCCCC-CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 555566666676665543 445678999999999998 8999999999886
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-43 Score=365.24 Aligned_cols=248 Identities=27% Similarity=0.376 Sum_probs=192.2
Q ss_pred ceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCC--Ce
Q 006779 25 RYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--RT 102 (631)
Q Consensus 25 Ry~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~--~~ 102 (631)
|-+.+.+.||+|+||+||+|++ +|..||+|.++... ........|+..++.++|||||++++++.+... ..
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 3457889999999999999975 69999999986432 222223346666678899999999999986543 36
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCEEeccCCCCCeeecCCCCcEEEcccc
Q 006779 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH------NPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~------~~~IiHrDLKp~NILl~~~~g~vKL~DFG 176 (631)
+++|||||.+|+|.+++++. .+++..+..++.|++.||.|||+. .++|+||||||+|||++ .+|.+||+|||
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~-~~~~~Kl~DFG 153 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLG 153 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC-TTSCEEECCCT
T ss_pred EEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc-CCCCeEEEecC
Confidence 89999999999999999875 589999999999999999999974 13499999999999997 78999999999
Q ss_pred ccchhcCC------CCccccCCCCCCCccccccc-------cCccccchhhhHHHHHHhhcCCCCCCC------------
Q 006779 177 LAIVMQQP------TARSVIGTPEFMAPELYEEE-------YNELVDIYSFGMCILEMVTCEYPYNEC------------ 231 (631)
Q Consensus 177 la~~~~~~------~~~~~~GTp~Y~APEvl~~~-------ys~~sDIwSLGiilyELltG~~Pf~~~------------ 231 (631)
++...... .....+||+.|||||++.+. ++.++|||||||++|||+||..||...
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 99765432 23356899999999987642 677899999999999999998876321
Q ss_pred --CCHHHHHHHHHcCCCCCCCCCCC-----cHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006779 232 --KNPAQIYKKVTSGIKPASLSKVT-----DPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 232 --~~~~~i~~~i~~~~~p~~l~~~~-----~~~l~~lI~~cL~-~p~~Rpsa~elL~h 281 (631)
.....+...+..+...+.++... ...+.+|+.+||+ +|.+|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 23344444444433322232221 2358899999998 89999999998763
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-43 Score=362.26 Aligned_cols=252 Identities=22% Similarity=0.287 Sum_probs=195.5
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCceeeeeeEEcCCCCe
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIVkl~~~~~d~~~~~ 102 (631)
.+|| ++.+.||+|+||+||+|.+..+|+.||+|++...... ..+..|+++++.++|+|++..+..+... ...
T Consensus 6 g~rY-~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~ 77 (299)
T d1ckia_ 6 GNRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDY 77 (299)
T ss_dssp TTTE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS------CCHHHHHHHHHHSTTSTTCCCEEEEEEE-TTE
T ss_pred CCEE-EEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC------HHHHHHHHHHHHccCCCcccEEEEEEec-CCE
Confidence 3588 7889999999999999999999999999998754321 2477899999999988877766555443 357
Q ss_pred EEEEEeccCCCCHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC--CCCcEEEccccccc
Q 006779 103 INMITELFTSGSLRQYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAI 179 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l-~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKL~DFGla~ 179 (631)
.++||||+. ++|.+.+ ...+.+++..++.++.||+.||+|||+++ |+||||||+|||++. .+..+||+|||+|+
T Consensus 78 ~~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 78 NVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred EEEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcce
Confidence 889999995 5665554 44668999999999999999999999999 999999999999752 34579999999997
Q ss_pred hhcCC---------CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCCCHHHHH--HHHHc---C
Q 006779 180 VMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY--KKVTS---G 244 (631)
Q Consensus 180 ~~~~~---------~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~~~~~i~--~~i~~---~ 244 (631)
.+... .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.......... ..... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC
Confidence 65432 2345689999999998765 49999999999999999999999997644332211 11111 1
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHH---HHhcCCCCC
Q 006779 245 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPAL---ELLKDPFLV 285 (631)
Q Consensus 245 ~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~---elL~hpff~ 285 (631)
..+..+....++++.+||.+||. +|.+||++. ++|+|+|.+
T Consensus 235 ~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 11222344567899999999997 999999987 456777653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-41 Score=350.77 Aligned_cols=245 Identities=17% Similarity=0.259 Sum_probs=198.5
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC-CCceeeeeeEEcCCCC
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~H-pnIVkl~~~~~d~~~~ 101 (631)
.+|| ++.+.||+|+||+||+|.+..+|+.||+|.+..... ...+.+|++.++.|.| +||+.+++++... .
T Consensus 4 g~~Y-~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~ 74 (293)
T d1csna_ 4 GVHY-KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEG--L 74 (293)
T ss_dssp TTTE-EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEET--T
T ss_pred CCce-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC------cHHHHHHHHHHHHhcCCCCCCEEEEEeecC--C
Confidence 3688 889999999999999999999999999998864421 1236789999999976 8999999987654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecC----CCCcEEEcccc
Q 006779 102 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG----NNGEVKIGDLG 176 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~-~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~----~~g~vKL~DFG 176 (631)
..++||||+ +++|.+++... ..++...+..++.|++.||+|||++| |+||||||+|||++. ..+.+||+|||
T Consensus 75 ~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 75 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred ccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccc
Confidence 788999999 78999998765 46999999999999999999999999 999999999999962 25789999999
Q ss_pred ccchhcCC---------CCccccCCCCCCCcccccc-ccCccccchhhhHHHHHHhhcCCCCCCCC--CHHHHHHHHHcC
Q 006779 177 LAIVMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSG 244 (631)
Q Consensus 177 la~~~~~~---------~~~~~~GTp~Y~APEvl~~-~ys~~sDIwSLGiilyELltG~~Pf~~~~--~~~~i~~~i~~~ 244 (631)
+|+..... .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+.. +..+.+..+...
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~ 231 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc
Confidence 99765432 2335689999999998765 49999999999999999999999997533 333444333321
Q ss_pred ---CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHh
Q 006779 245 ---IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL 279 (631)
Q Consensus 245 ---~~p~~l~~~~~~~l~~lI~~cL~-~p~~Rpsa~elL 279 (631)
..+..+....++++.+++..|+. +|..||++..+.
T Consensus 232 ~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 232 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred cCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 12222334567899999999997 899999977654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.7e-41 Score=354.51 Aligned_cols=255 Identities=24% Similarity=0.367 Sum_probs=194.6
Q ss_pred CCceeeeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-----------CCCceee
Q 006779 23 SCRYGRYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-----------HENIIKF 91 (631)
Q Consensus 23 ~gRy~r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-----------HpnIVkl 91 (631)
.||| ++.+.||+|+||+||+|+++.+|+.||+|+++.. ....+.+.+|+.+|+.++ |+||+++
T Consensus 12 ~~rY-~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 12 DARY-ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp TTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CCcE-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence 4788 8889999999999999999999999999999743 334466788999998875 5789999
Q ss_pred eeeEEcCCCCeEEEEEeccCCCC-HHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccCCCCCeeecCCC
Q 006779 92 YNSWVDDTNRTINMITELFTSGS-LRQYR--KKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNN 167 (631)
Q Consensus 92 ~~~~~d~~~~~l~lV~Ey~~gGs-L~~~l--~~~~~l~~~~i~~i~~QIl~aL~yLHs-~~~~IiHrDLKp~NILl~~~~ 167 (631)
++++........+++++++..+. ...+. .....+++..++.++.||+.||.|||+ ++ |+||||||+|||++ .+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~-~~ 162 (362)
T d1q8ya_ 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLME-IV 162 (362)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEE-EE
T ss_pred EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeee-cc
Confidence 99887655556667777665543 33322 234679999999999999999999998 77 99999999999997 33
Q ss_pred C------cEEEccccccchhcCCCCccccCCCCCCCccccc-cccCccccchhhhHHHHHHhhcCCCCCCCCCH------
Q 006779 168 G------EVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP------ 234 (631)
Q Consensus 168 g------~vKL~DFGla~~~~~~~~~~~~GTp~Y~APEvl~-~~ys~~sDIwSLGiilyELltG~~Pf~~~~~~------ 234 (631)
+ .++++|||.+...... ....+||+.|+|||++. ..|+.++||||+||++++|++|+.||......
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcccccceeeEeecccccccccc-cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 3 4999999999765443 35568999999999765 45999999999999999999999999643211
Q ss_pred HHHHHHHHc-CC--------------------CCC------------------CCCCCCcHHHHHHHHHhcC-CCCCCCC
Q 006779 235 AQIYKKVTS-GI--------------------KPA------------------SLSKVTDPQVKQFIEKCIV-PASLRLP 274 (631)
Q Consensus 235 ~~i~~~i~~-~~--------------------~p~------------------~l~~~~~~~l~~lI~~cL~-~p~~Rps 274 (631)
..+...+.. +. .+. ......++++++||.+||. +|.+|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 111111100 00 000 0111235789999999998 9999999
Q ss_pred HHHHhcCCCCCCC
Q 006779 275 ALELLKDPFLVTD 287 (631)
Q Consensus 275 a~elL~hpff~~~ 287 (631)
|.|+|+||||+..
T Consensus 322 a~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 322 AGGLVNHPWLKDT 334 (362)
T ss_dssp HHHHHTCGGGTTC
T ss_pred HHHHhcCcccCCC
Confidence 9999999999854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=1.2e-23 Score=202.34 Aligned_cols=170 Identities=18% Similarity=0.189 Sum_probs=122.7
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeeccccc----C----------CHHHHHHHHHHHHHHHhCCCCCceeeee
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM----Q----------SPDQLERLYSEVHLLKSLKHENIIKFYN 93 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~----~----------~~~~~~~l~~Ei~iLk~L~HpnIVkl~~ 93 (631)
-++++||+|+||+||+|.+. +|+.||+|+++..... . .........+|+..|.++.|++++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46899999999999999885 7999999987532110 0 0112234567899999999999999887
Q ss_pred eEEcCCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEeccCCCCCeeecCCCCcEEEc
Q 006779 94 SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173 (631)
Q Consensus 94 ~~~d~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKL~ 173 (631)
+. . .+++|||+.++.+. .++...+..++.|++.||.|||+++ |+||||||+|||++ + +.++|+
T Consensus 82 ~~--~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~-~-~~~~li 144 (191)
T d1zara2 82 WE--G----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-E-EGIWII 144 (191)
T ss_dssp EE--T----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-T-TEEEEC
T ss_pred ec--C----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeee-C-CCEEEE
Confidence 42 2 25799999886553 2556667889999999999999999 99999999999997 4 458999
Q ss_pred cccccchhcCCCCccccC-CCCCCCccccccccCccccchhhhH
Q 006779 174 DLGLAIVMQQPTARSVIG-TPEFMAPELYEEEYNELVDIYSFGM 216 (631)
Q Consensus 174 DFGla~~~~~~~~~~~~G-Tp~Y~APEvl~~~ys~~sDIwSLGi 216 (631)
|||+|.....+....... ... .-.+.+.+.|+..+|+||+.-
T Consensus 145 DFG~a~~~~~~~~~~~l~rd~~-~~~~~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 145 DFPQSVEVGEEGWREILERDVR-NIITYFSRTYRTEKDINSAID 187 (191)
T ss_dssp CCTTCEETTSTTHHHHHHHHHH-HHHHHHHHHHCCCCCHHHHHH
T ss_pred ECCCcccCCCCCcHHHHHHHHH-HHHHHHcCCCCCcccHHHHHH
Confidence 999997654433221110 000 001234467899999999643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.87 E-value=5.1e-05 Score=73.23 Aligned_cols=138 Identities=15% Similarity=0.033 Sum_probs=83.7
Q ss_pred eeeeEecccCceEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCceeeeeeEEcCCCCeEEEE
Q 006779 28 RYDEILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 28 r~~e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpnIVkl~~~~~d~~~~~l~lV 106 (631)
++.+..+.++.+.||+.. .++..+++|+....... ....+.+|...+..|. +--+.+++.+..+. ...++|
T Consensus 17 ~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~----~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~~~~lv 88 (263)
T d1j7la_ 17 RCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG----TTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNLL 88 (263)
T ss_dssp EEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT----STTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEE
T ss_pred EEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc----chhhHHHHHHHHHHHhccCCCCcEEEEEecC--CceEEE
Confidence 334433444457899873 45667778877543221 1223667888887774 33355666654433 468899
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 006779 107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN-------------------------------------- 148 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~~l~~~~i~~i~~QIl~aL~yLHs~~-------------------------------------- 148 (631)
|+++.|.++...... ......++.++...+..||+..
T Consensus 89 ~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 89 MSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred EEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 999999888654321 1112223444444444454321
Q ss_pred -------------------CCEEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 149 -------------------PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 149 -------------------~~IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
+.++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~-~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK-DGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeec-CCceEEEeechhcc
Confidence 1179999999999997 45555699998774
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.59 E-value=7.3e-05 Score=77.63 Aligned_cols=80 Identities=15% Similarity=0.163 Sum_probs=48.8
Q ss_pred eEecccCceEEEEEEEccCCeEEEEEEeeccccc---CCHHHHHHHHHHHHHHHhCC-C--CCceeeeeeEEcCCCCeEE
Q 006779 31 EILGKGAFKTVYKGFDEVDGIEVAWNQVNIEDVM---QSPDQLERLYSEVHLLKSLK-H--ENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~tg~~VAiK~i~~~~~~---~~~~~~~~l~~Ei~iLk~L~-H--pnIVkl~~~~~d~~~~~l~ 104 (631)
+.||.|....||++.+..+|+.|++|+-...-.. ..+...++...|+..|+.+. + ..++++|. .++.. -+
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~--~~ 107 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEM--AV 107 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTT--TE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCC--CE
Confidence 4589999999999988888889999975421111 01122345667888887763 2 34556665 34433 35
Q ss_pred EEEeccCCCC
Q 006779 105 MITELFTSGS 114 (631)
Q Consensus 105 lV~Ey~~gGs 114 (631)
+|||++.+..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 7899997654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.29 E-value=0.00046 Score=65.88 Aligned_cols=75 Identities=9% Similarity=-0.058 Sum_probs=47.7
Q ss_pred eEecccCc-eEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC--CCceeeeeeEEcCCCCeEEEEE
Q 006779 31 EILGKGAF-KTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 31 e~LG~G~f-g~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~H--pnIVkl~~~~~d~~~~~l~lV~ 107 (631)
+.+..|.. +.||+... ..|..+++|....... ..+..|...|+.|.. -.+.+++.+..+. ...++||
T Consensus 16 ~~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~-------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~v~ 85 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL-------NELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLL 85 (255)
T ss_dssp EECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT-------SCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEE
T ss_pred EEcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH-------hHHHHHHHHHHHHHhcCCCCCceeeecccc--cceEEEE
Confidence 34555554 67898754 4566788887653321 236678888877743 3355677655443 4678999
Q ss_pred eccCCCCH
Q 006779 108 ELFTSGSL 115 (631)
Q Consensus 108 Ey~~gGsL 115 (631)
++++|.++
T Consensus 86 ~~i~G~~~ 93 (255)
T d1nd4a_ 86 GEVPGQDL 93 (255)
T ss_dssp ECCSSEET
T ss_pred Eeeecccc
Confidence 99988655
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.55 E-value=0.01 Score=58.94 Aligned_cols=68 Identities=12% Similarity=0.099 Sum_probs=40.3
Q ss_pred eEEEEEEEccCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCce-----eeee-eEEcCCCCeEEEEEeccCC
Q 006779 39 KTVYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII-----KFYN-SWVDDTNRTINMITELFTS 112 (631)
Q Consensus 39 g~Vy~a~d~~tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnIV-----kl~~-~~~d~~~~~l~lV~Ey~~g 112 (631)
-.||++.. .+|..|++|+.+.... + .+.+..|+..|..|....|. ..-+ ... ......+.+++++.|
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~--s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~-~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERW--T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLL-NHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTS--C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCE-EETTEEEEEEECCCC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCC--C---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeee-eeeeEEEEEEeecCC
Confidence 47999864 5788899998764321 2 24467788888887432221 1110 011 112467788999876
Q ss_pred C
Q 006779 113 G 113 (631)
Q Consensus 113 G 113 (631)
.
T Consensus 109 ~ 109 (325)
T d1zyla1 109 R 109 (325)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.81 E-value=0.027 Score=57.32 Aligned_cols=73 Identities=14% Similarity=0.128 Sum_probs=46.6
Q ss_pred eEecccCceEEEEEEEcc-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc-eeeeeeEEcCCCCe
Q 006779 31 EILGKGAFKTVYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNRT 102 (631)
Q Consensus 31 e~LG~G~fg~Vy~a~d~~-------tg~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpnI-Vkl~~~~~d~~~~~ 102 (631)
+.|+.|-.-.+|++.... .+..|.+++.... .... ...+|..+++.+.-.++ .+++.++ ++
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-----~~~i-dr~~E~~i~~~ls~~gl~Pkll~~~--~~--- 116 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETES-HLVAESVIFTLLSERHLGPKLYGIF--SG--- 116 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCHH-HHHHHHHHHHHHHHTTSSSCEEEEE--TT---
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-----chhh-HHHHHHHHHHHHHhCCCCCeEEEEc--CC---
Confidence 568888889999987653 3456777665421 1122 34578888888853344 4677755 22
Q ss_pred EEEEEeccCCCCH
Q 006779 103 INMITELFTSGSL 115 (631)
Q Consensus 103 l~lV~Ey~~gGsL 115 (631)
++|+||+.|.+|
T Consensus 117 -g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 -GRLEEYIPSRPL 128 (395)
T ss_dssp -EEEECCCCEEEC
T ss_pred -ceEEEEeccccC
Confidence 468899987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=91.18 E-value=0.12 Score=50.18 Aligned_cols=28 Identities=32% Similarity=0.387 Sum_probs=24.0
Q ss_pred EEeccCCCCCeeecCCCCcEEEccccccc
Q 006779 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 151 IiHrDLKp~NILl~~~~g~vKL~DFGla~ 179 (631)
+||+|+.++||+++ .+...-|.||+.+.
T Consensus 185 iIHgDl~~dNvl~~-~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 185 VIHADLFQDNVFFL-GDELSGLIDFYFAC 212 (316)
T ss_dssp EECSCCCGGGEEEE-TTEEEEECCCTTCE
T ss_pred cccCCcchhhhhcc-cccceeEecccccc
Confidence 99999999999998 45556799999874
|